archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO FOREBRAIN NEURON FATE COMMITMENT,9.0551e-05,0.9173,0.8793,1,1
1,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0021689,0.59425,0.58532,1,1
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,7.547e-05,0.57006,0.603,1,1
1,GO TRIGEMINAL NERVE DEVELOPMENT,0.00018427,0.55755,0.53144,1,1
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,8.1192e-05,0.43517,0.45891,1,1
1,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00092958,0.43458,0.42883,1,1
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,6.0504e-05,0.42322,0.52557,1,1
1,GO GANGLION DEVELOPMENT,0.001228,0.42277,0.42668,1,1
1,GO NEURON FATE COMMITMENT,1.0184e-05,0.40699,0.46364,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0013457,0.37075,0.42319,1,1
1,GO SPINAL CORD PATTERNING,0.00084609,0.34178,0.36551,1,1
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0066042,0.34075,0.29295,1,1
1,GO KINETOCHORE ASSEMBLY,0.00011241,0.33819,0.26031,1,1
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00010462,0.3379,0.38836,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00098941,0.33782,0.33312,1,1
1,GO SEGMENT SPECIFICATION,0.017549,0.33627,0.27073,1,1
1,GO MYOBLAST MIGRATION,0.001662,0.33318,0.36832,1,1
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0085714,0.33144,0.29015,1,1
1,GO SINGLE STRAND BREAK REPAIR,1.4039e-05,0.29223,0.25547,1,1
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,9.389e-05,0.28646,0.24582,1,1
1,GO POSITIVE REGULATION OF BEHAVIOR,0.0054795,0.28199,0.2627,1,1
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.045624,0.28004,0.26665,1,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.015953,0.27695,0.19153,1,1
1,GO KINETOCHORE ORGANIZATION,0.00017796,0.25907,0.25591,1,1
1,GO APICAL PROTEIN LOCALIZATION,0.00020448,0.25853,0.24438,1,1
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0042883,0.25615,0.22571,1,1
1,GO CENTROMERE COMPLEX ASSEMBLY,7.547e-05,0.25208,0.2223,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.0090226,0.24969,0.22809,1,1
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00031859,0.24856,0.23426,1,1
1,GO DENDRITE SELF AVOIDANCE,0.0090226,0.24787,0.20178,1,1
1,GO POST ANAL TAIL MORPHOGENESIS,0.00038934,0.24666,0.21991,1,1
1,GO MITOTIC DNA REPLICATION,0.0031536,0.24315,0.18747,1,1
1,GO CHROMATIN REMODELING AT CENTROMERE,7.547e-05,0.2424,0.23654,1,1
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.044685,0.23337,0.2169,1,1
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00011241,0.22722,0.21336,1,1
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037747,0.22261,0.23515,1,1
1,GO ESCRT COMPLEX DISASSEMBLY,0.021165,0.22183,0.1464,1,1
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0006154,0.22003,0.17786,1,1
1,GO REGULATION OF SISTER CHROMATID COHESION,0.0026572,0.21515,0.168,1,1
1,GO HISTONE H4 K16 ACETYLATION,5.9841e-06,0.21251,0.23946,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.02843,0.21102,0.15913,1,1
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.013139,0.21063,0.18887,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00037661,0.19894,0.15986,1,1
1,GO MRNA SPLICE SITE SELECTION,0.0017641,0.19719,0.22316,1,1
1,GO NEPHRON TUBULE FORMATION,0.045624,0.19595,0.20706,1,1
1,GO VIRAL LATENCY,0.01282,0.19582,0.14455,1,1
1,GO HISTONE H3 K9 TRIMETHYLATION,0.0006154,0.19125,0.18096,1,1
1,GO FOREBRAIN REGIONALIZATION,0.014841,0.19095,0.20213,1,1
1,GO ATP DEPENDENT CHROMATIN REMODELING,5.2837e-06,0.18939,0.19512,1,1
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00026003,0.18578,0.18914,1,1
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.034637,0.18281,0.13615,1,1
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0023671,0.18043,0.16594,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0094949,0.17856,0.20399,1,1
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.016734,0.17698,0.15303,1,1
1,GO HISTONE EXCHANGE,0.00072223,0.17508,0.1491,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.02068,0.17204,0.2265,1,1
1,GO HISTONE H4 K5 ACETYLATION,0.00050664,0.17139,0.20863,1,1
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0051916,0.16869,0.14651,1,1
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00032948,0.16598,0.17824,1,1
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.004408,0.16579,0.18721,1,1
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00012512,0.16518,0.18372,1,1
1,GO POSITIVE REGULATION OF DNA REPAIR,0.00028792,0.16124,0.13878,1,1
1,GO REGULATION OF HELICASE ACTIVITY,0.0071468,0.15891,0.17739,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.016734,0.15615,0.14783,1,1
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00030804,0.15188,0.16784,1,1
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00065623,0.14947,0.13833,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.031748,0.14876,0.13344,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.031059,0.14665,0.10901,1,1
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0056288,0.14497,0.18825,1,1
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0038387,0.14329,0.1321,1,1
1,GO SPINAL CORD DEVELOPMENT,0.022165,0.14033,0.13177,1,1
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.023741,0.13966,0.12442,1,1
1,GO NUCLEOSOME ASSEMBLY,0.00069957,0.13888,0.16382,1,1
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00040247,0.13635,0.13401,1,1
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.024288,0.13607,0.1959,1,1
1,GO CENTROSOME DUPLICATION,0.0060989,0.13425,0.11631,1,1
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.023741,0.13194,0.090214,1,1
1,GO DNA STRAND ELONGATION,0.0049174,0.12926,0.12958,1,1
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0066042,0.12915,0.13425,1,1
1,GO HISTONE H3 K4 METHYLATION,0.00044439,0.12775,0.14725,1,1
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.035393,0.1275,0.11792,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.012203,0.12571,0.12097,1,1
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.001191,0.1257,0.14973,1,1
1,GO NUCLEOSOME ORGANIZATION,0.00032948,0.12553,0.12845,1,1
1,GO MITOTIC CHROMOSOME CONDENSATION,0.0047853,0.1249,0.15248,1,1
1,GO HISTONE MONOUBIQUITINATION,0.0021062,0.12048,0.11959,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.031748,0.11848,0.13282,1,1
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0069616,0.11596,0.12593,1,1
1,GO CELL CYCLE DNA REPLICATION,0.0067808,0.11454,0.10186,1,1
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.02068,0.11414,0.098551,1,1
1,GO HISTONE H3 K4 TRIMETHYLATION,0.010773,0.11386,0.10834,1,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0079323,0.11377,0.085878,1,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0085714,0.11293,0.10833,1,1
1,GO HISTONE H2A ACETYLATION,0.00353,0.11229,0.17447,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.0017123,0.1121,0.10136,1,1
1,GO G0 TO G1 TRANSITION,0.0028957,0.11183,0.11861,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.034637,0.11158,0.078474,1,1
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.047551,0.11087,0.1328,1,1
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0011549,0.11085,0.19248,1,1
1,GO CHROMATIN SILENCING,0.011612,0.10926,0.092347,1,1
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0016129,0.10636,0.098217,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.029719,0.10505,0.12455,1,1
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00013433,0.10503,0.13417,1,1
1,GO DNA REPLICATION INITIATION,0.018398,0.10424,0.099683,1,1
1,GO HISTONE H4 ACETYLATION,0.00045924,0.10078,0.11882,1,1
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.034637,0.099997,0.075342,1,1
1,GO REGULATION OF MRNA PROCESSING,0.009256,0.099215,0.085085,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.025414,0.09432,0.070677,1,1
1,GO MRNA PROCESSING,0.010245,0.09383,0.063472,1,1
1,GO PEPTIDYL LYSINE METHYLATION,0.0014738,0.09231,0.090475,1,1
1,GO PEPTIDYL LYSINE ACETYLATION,0.00022676,0.090549,0.087649,1,1
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02068,0.090432,0.083375,1,1
1,GO RNA SPLICING,0.0087944,0.090344,0.069266,1,1
1,GO REGULATION OF DNA REPAIR,0.0099891,0.089952,0.076285,1,1
1,GO DNA GEOMETRIC CHANGE,0.044685,0.089177,0.05672,1,1
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0097392,0.088497,0.10006,1,1
1,GO REPLICATION FORK PROCESSING,0.023741,0.088346,0.087783,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.018836,0.088293,0.088846,1,1
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0071468,0.086444,0.10266,1,1
1,GO DNA PACKAGING,0.00063551,0.085236,0.10766,1,1
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00030804,0.08435,0.12125,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.010245,0.083709,0.10556,1,1
1,GO DNA DEPENDENT DNA REPLICATION,0.038561,0.083261,0.064311,1,1
1,GO DNA CONFORMATION CHANGE,0.0029794,0.081802,0.077517,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.031059,0.081327,0.11549,1,1
1,GO REGULATION OF PROTEIN ACETYLATION,0.03939,0.080845,0.061325,1,1
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.022165,0.079163,0.067815,1,1
1,GO CHROMATIN REMODELING,0.00081984,0.079061,0.10882,1,1
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.014486,0.078138,0.09727,1,1
1,GO RECOMBINATIONAL REPAIR,0.043763,0.07368,0.048736,1,1
1,GO INTERSTRAND CROSS LINK REPAIR,0.029068,0.071299,0.068966,1,1
1,GO PROTEIN ACETYLATION,0.011047,0.067564,0.05242,1,1
1,GO PEPTIDYL LYSINE MODIFICATION,0.0050528,0.067307,0.05242,1,1
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.044685,0.064995,0.072617,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.044685,0.060533,0.06492,1,1
1,GO CHROMOSOME SEGREGATION,0.038561,0.059468,0.052624,1,1
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.029068,0.059453,0.058666,1,1
1,GO CHROMATIN ORGANIZATION,0.011047,0.052102,0.055499,1,1
1,GO CELL CYCLE CHECKPOINT,0.033166,0.050958,0.047562,1,1
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.0029794,0.3149,0.40925,1,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0054795,0.21792,0.24402,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.029068,0.20734,0.21965,1,0
1,GO V D J RECOMBINATION,0.011904,0.20601,0.19771,1,0
1,GO NATURAL KILLER CELL PROLIFERATION,0.022165,0.18755,0.22331,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0021689,0.13351,0.16385,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0057817,0.10954,0.13331,1,0
1,GO RNA SURVEILLANCE,0.038561,0.10865,0.13267,1,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.036948,0.10355,0.13547,1,0
1,GO MRNA 3 END PROCESSING,0.02166,0.095971,0.069015,1,0
1,GO CHROMOSOME LOCALIZATION,0.020205,0.083249,0.073959,1,0
1,GO HISTONE UBIQUITINATION,0.033894,0.078599,0.069193,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.023741,0.077886,0.081535,1,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0034322,0.074449,0.091515,1,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.041967,0.069407,0.07414,1,0
1,GO REGULATION OF RNA SPLICING,0.031059,0.060419,0.058366,1,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.027803,0.058702,0.1306,1,0
1,GO CHROMOSOME ORGANIZATION,0.031059,0.034206,0.036833,1,0
1,GO SEXUAL REPRODUCTION,0.013465,-0.031673,-0.064401,1,0
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.037747,-0.035431,-0.054456,1,0
1,GO RESPONSE TO LIGHT STIMULUS,0.015953,-0.036729,-0.061316,1,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.022165,-0.040056,-0.061316,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.018836,-0.043269,-0.053079,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.0073363,-0.045031,-0.073105,1,0
1,GO CIRCADIAN RHYTHM,0.029068,-0.05092,-0.07369,1,0
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.029068,-0.051684,-0.052547,1,0
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.02843,-0.052094,-0.063465,1,0
1,GO RESPONSE TO RADIATION,0.0057817,-0.053423,-0.062401,1,0
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.03245,-0.054854,-0.062199,1,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.011904,-0.055222,-0.059589,1,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.030383,-0.056983,-0.064629,1,0
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.015574,-0.057703,-0.078898,1,0
1,GO DNA BIOSYNTHETIC PROCESS,0.036164,-0.057845,-0.061042,1,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0011199,-0.058727,-0.066335,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0053338,-0.05918,-0.078148,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.015203,-0.060183,-0.087371,1,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.033894,-0.060344,-0.071246,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.043763,-0.060405,-0.067295,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.046579,-0.061434,-0.19027,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.027803,-0.063363,-0.082192,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.023205,-0.066735,-0.10109,1,0
1,GO REGULATION OF CELL DIFFERENTIATION,0.0067808,-0.067838,-0.086939,1,0
1,GO RHYTHMIC PROCESS,0.0083534,-0.068071,-0.083213,1,0
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.043763,-0.068376,-0.073165,1,0
1,GO MULTI ORGANISM PROCESS,0.00059588,-0.068754,-0.092233,1,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.0007696,-0.06904,-0.073457,1,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.043763,-0.069284,-0.11704,1,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.017137,-0.069463,-0.086516,1,0
1,GO POSITIVE REGULATION OF VIRAL PROCESS,0.024288,-0.069611,-0.093515,1,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.02166,-0.069624,-0.10426,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0047853,-0.069726,-0.072989,1,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.030383,-0.069769,-0.085459,1,0
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.009256,-0.06979,-0.06383,1,0
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.046579,-0.070071,-0.11048,1,0
1,GO PEPTIDYL THREONINE MODIFICATION,0.021165,-0.0705,-0.073492,1,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.025994,-0.070678,-0.10286,1,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.031059,-0.070765,-0.10146,1,0
1,GO NEURON DEATH,0.023205,-0.07102,-0.067193,1,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.02068,-0.071354,-0.066695,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0062634,-0.071527,-0.11336,1,0
1,GO HOMOLOGOUS RECOMBINATION,0.027803,-0.071646,-0.10101,1,0
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.036948,-0.071673,-0.12744,1,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.014841,-0.073936,-0.096737,1,0
1,GO POSITIVE REGULATION OF NEURON DEATH,0.026586,-0.074261,-0.096476,1,0
1,GO CARDIOLIPIN METABOLIC PROCESS,0.033166,-0.075224,-0.14256,1,0
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.014841,-0.075236,-0.12274,1,0
1,GO RESPONSE TO INTERLEUKIN 6,0.044685,-0.075523,-0.1306,1,0
1,GO PROTEIN CATABOLIC PROCESS,0.0014299,-0.07689,-0.083997,1,0
1,GO RESPONSE TO IONIZING RADIATION,0.026586,-0.077023,-0.082154,1,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.011612,-0.077096,-0.073715,1,0
1,GO DETECTION OF STIMULUS,0.00026003,-0.077512,-0.099776,1,0
1,GO TRICARBOXYLIC ACID CYCLE,0.022165,-0.077752,-0.14084,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.033894,-0.077951,-0.12162,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.043763,-0.078603,-0.081772,1,0
1,GO REGULATION OF PH,0.009256,-0.078727,-0.089199,1,0
1,GO NEUTROPHIL CHEMOTAXIS,0.0099891,-0.078967,-0.13137,1,0
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.029719,-0.079255,-0.10894,1,0
1,GO ORGANELLE DISASSEMBLY,0.035393,-0.08007,-0.085526,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0036303,-0.080136,-0.10083,1,0
1,GO FEMALE GAMETE GENERATION,0.010773,-0.080547,-0.080134,1,0
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.03245,-0.080612,-0.11782,1,0
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.011612,-0.080966,-0.1353,1,0
1,GO EMBRYO DEVELOPMENT,0.013139,-0.081026,-0.081078,1,0
1,GO RESPONSE TO NUTRIENT,0.0097392,-0.081065,-0.14107,1,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.018398,-0.081188,-0.073159,1,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0027346,-0.08126,-0.091998,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.0041716,-0.081491,-0.10559,1,0
1,GO VACUOLAR ACIDIFICATION,0.013465,-0.082906,-0.14418,1,0
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.041967,-0.082996,-0.090505,1,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0059384,-0.083146,-0.10227,1,0
1,GO CELL CYCLE ARREST,0.0056288,-0.083294,-0.085553,1,0
1,GO CRISTAE FORMATION,0.011612,-0.083546,-0.18895,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,0.017549,-0.083746,-0.086813,1,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.017969,-0.083748,-0.091841,1,0
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.00029782,-0.083933,-0.094075,1,0
1,GO CELLULAR PIGMENTATION,0.02843,-0.0845,-0.1031,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.017137,-0.084622,-0.07427,1,0
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0014299,-0.084879,-0.082338,1,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.016734,-0.084957,-0.085552,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.013465,-0.08506,-0.077655,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.023741,-0.085245,-0.069887,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0006154,-0.085369,-0.082493,1,0
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0031536,-0.085536,-0.085854,1,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.023741,-0.08564,-0.068991,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.010506,-0.085939,-0.09313,1,0
1,GO REGULATION OF HORMONE SECRETION,0.029068,-0.086126,-0.093555,1,0
1,GO TRANSLESION SYNTHESIS,0.035393,-0.086218,-0.08707,1,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.02166,-0.086401,-0.10058,1,0
1,GO VIRION ASSEMBLY,0.038561,-0.086747,-0.092639,1,0
1,GO BLASTOCYST DEVELOPMENT,0.00029782,-0.086833,-0.11012,1,0
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0094949,-0.08697,-0.076776,1,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.023741,-0.087224,-0.093366,1,0
1,GO DEVELOPMENTAL CELL GROWTH,0.010245,-0.08746,-0.10583,1,0
1,GO VESICLE LOCALIZATION,0.01282,-0.087659,-0.074862,1,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.012508,-0.087743,-0.071428,1,0
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0014299,-0.087796,-0.083471,1,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.027803,-0.088321,-0.11811,1,0
1,GO MANGANESE ION TRANSPORT,0.017549,-0.088339,-0.14053,1,0
1,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0069616,-0.088521,-0.13037,1,0
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0099891,-0.088701,-0.16555,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0050528,-0.089691,-0.092405,1,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0034322,-0.089725,-0.089981,1,0
1,GO NEPHRON MORPHOGENESIS,0.036164,-0.089927,-0.10048,1,0
1,GO RHYTHMIC BEHAVIOR,0.0017641,-0.09013,-0.14076,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00020448,-0.090245,-0.10154,1,0
1,GO RESPONSE TO INTERLEUKIN 7,0.027803,-0.090438,-0.12383,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0059384,-0.090628,-0.096374,1,0
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,4.6623e-06,-0.090923,-0.099299,1,0
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0018173,-0.091311,-0.077314,1,0
1,GO CYTOSKELETON ORGANIZATION,0.0037331,-0.091489,-0.087355,1,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.011047,-0.09183,-0.1282,1,0
1,GO REPRODUCTION,0.0012662,-0.091943,-0.094531,1,0
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.047551,-0.091953,-0.12152,1,0
1,GO CELL CELL SIGNALING,0.0087944,-0.092121,-0.083704,1,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0066042,-0.092353,-0.08599,1,0
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.041967,-0.092392,-0.10953,1,0
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.017549,-0.092526,-0.1192,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00095906,-0.092541,-0.095134,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.033894,-0.092611,-0.11692,1,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.022165,-0.092645,-0.098551,1,0
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.020205,-0.092678,-0.13475,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.041093,-0.092764,-0.083503,1,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.010773,-0.093208,-0.095733,1,0
1,GO ENDOSOME ORGANIZATION,0.012203,-0.093292,-0.10852,1,0
1,GO RESPONSE TO ESTRADIOL,0.011326,-0.093301,-0.10812,1,0
1,GO NEGATIVE REGULATION OF CELL SIZE,0.035393,-0.093316,-0.13135,1,0
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.00052342,-0.093478,-0.084922,1,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.042857,-0.093666,-0.099261,1,0
1,GO SENSORY PERCEPTION OF PAIN,0.045624,-0.093796,-0.089806,1,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.016734,-0.093856,-0.07126,1,0
1,GO MACROMOLECULE DEACYLATION,0.016734,-0.093966,-0.069083,1,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.041093,-0.094075,-0.12026,1,0
1,GO TOR SIGNALING,0.001662,-0.09412,-0.09005,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.013139,-0.094301,-0.1433,1,0
1,GO SENSORY PERCEPTION,0.001191,-0.094316,-0.097589,1,0
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0022992,-0.094338,-0.08483,1,0
1,GO GLIAL CELL DIFFERENTIATION,0.034637,-0.094445,-0.10421,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.041967,-0.09453,-0.074761,1,0
1,GO MUSCLE FIBER DEVELOPMENT,0.014841,-0.094725,-0.10978,1,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0037331,-0.094873,-0.091975,1,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0027346,-0.09515,-0.095011,1,0
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.018836,-0.095189,-0.10777,1,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0049174,-0.095226,-0.10655,1,0
1,GO MITOPHAGY,0.026586,-0.095302,-0.11554,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.019739,-0.095487,-0.13901,1,0
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0079323,-0.095516,-0.11043,1,0
1,GO RESPONSE TO ALKALOID,0.015574,-0.095694,-0.1031,1,0
1,GO ALCOHOL CATABOLIC PROCESS,0.010506,-0.095829,-0.13345,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.015203,-0.095885,-0.078902,1,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.040234,-0.096192,-0.076869,1,0
1,GO AMINO ACID TRANSPORT,0.02166,-0.096417,-0.089139,1,0
1,GO OVULATION CYCLE,0.047551,-0.096559,-0.10684,1,0
1,GO MULTI ORGANISM LOCALIZATION,0.02843,-0.09656,-0.11383,1,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.041967,-0.096632,-0.11618,1,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.034637,-0.096645,-0.14908,1,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.019283,-0.096664,-0.087694,1,0
1,GO DEVELOPMENTAL GROWTH,0.013798,-0.097143,-0.083971,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0027346,-0.097315,-0.11976,1,0
1,GO ERAD PATHWAY,0.0054795,-0.09744,-0.12664,1,0
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.02068,-0.097658,-0.089829,1,0
1,GO MOLTING CYCLE,0.020205,-0.097872,-0.11701,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.041967,-0.097888,-0.1038,1,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.024846,-0.097986,-0.084405,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0021062,-0.097997,-0.10495,1,0
1,GO NEURON PROJECTION EXTENSION,0.031059,-0.09835,-0.10158,1,0
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0011199,-0.098382,-0.11569,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.03939,-0.098553,-0.095942,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.027803,-0.099086,-0.097024,1,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.02166,-0.09926,-0.096989,1,0
1,GO PROTEIN DEPHOSPHORYLATION,0.00081984,-0.099422,-0.098696,1,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.046579,-0.099583,-0.0961,1,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0062634,-0.099805,-0.11526,1,0
1,GO ENDOSOMAL TRANSPORT,0.0012662,-0.099894,-0.089671,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.017549,-0.1001,-0.13296,1,0
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.010245,-0.10079,-0.10459,1,0
1,GO LIPID DROPLET ORGANIZATION,0.018836,-0.10085,-0.15554,1,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.019739,-0.10097,-0.098533,1,0
1,GO GOLGI VESICLE TRANSPORT,0.0045306,-0.10117,-0.096268,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.014138,-0.10123,-0.079935,1,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.02166,-0.1014,-0.098245,1,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0042883,-0.10142,-0.11615,1,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.014841,-0.10144,-0.12105,1,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0067808,-0.10155,-0.10181,1,0
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.018836,-0.10173,-0.15047,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.027188,-0.10179,-0.086316,1,0
1,GO CELLULAR RESPONSE TO KETONE,0.0045306,-0.1021,-0.15494,1,0
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0028141,-0.10211,-0.1551,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0010206,-0.10215,-0.13826,1,0
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0019282,-0.10219,-0.12577,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.0027346,-0.10232,-0.091741,1,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.00049035,-0.10236,-0.096445,1,0
1,GO AUTOPHAGY OF MITOCHONDRION,0.017549,-0.10281,-0.11002,1,0
1,GO IMMUNOGLOBULIN PRODUCTION,0.00041602,-0.10303,-0.14717,1,0
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.045624,-0.10306,-0.10229,1,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.017137,-0.10314,-0.095405,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0083534,-0.10344,-0.14992,1,0
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0097392,-0.10352,-0.12736,1,0
1,GO REGULATION OF TOR SIGNALING,0.0020453,-0.10355,-0.097656,1,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.010773,-0.10383,-0.11998,1,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.036948,-0.10392,-0.13374,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0030654,-0.10399,-0.12346,1,0
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00016023,-0.10401,-0.094224,1,0
1,GO ARACHIDONIC ACID SECRETION,0.0046564,-0.1042,-0.15248,1,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.047551,-0.10431,-0.092291,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.043763,-0.10446,-0.11479,1,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.033166,-0.10467,-0.18856,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00014418,-0.10467,-0.10587,1,0
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.040234,-0.10468,-0.14115,1,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.02166,-0.10472,-0.1428,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.026586,-0.10474,-0.10727,1,0
1,GO REGULATION OF HEMOPOIESIS,0.004408,-0.1048,-0.12305,1,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.0018173,-0.10487,-0.10533,1,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.027803,-0.1051,-0.11568,1,0
1,GO AGING,0.00081984,-0.10513,-0.13799,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.029068,-0.10523,-0.11235,1,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.00021909,-0.10559,-0.10369,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0064317,-0.106,-0.12643,1,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0010859,-0.10612,-0.19848,1,0
1,GO CELL GROWTH,0.00054072,-0.10619,-0.12367,1,0
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0062634,-0.10637,-0.17752,1,0
1,GO GROWTH,0.0034322,-0.10646,-0.095816,1,0
1,GO PROTEOLYSIS,0.00021167,-0.10652,-0.11751,1,0
1,GO VACUOLAR TRANSPORT,0.0062634,-0.10652,-0.10737,1,0
1,GO CD40 SIGNALING PATHWAY,0.026586,-0.10658,-0.19074,1,0
1,GO MACROMOLECULE CATABOLIC PROCESS,0.00012964,-0.10661,-0.1049,1,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.022165,-0.10663,-0.13513,1,0
1,GO IMMUNE SYSTEM DEVELOPMENT,0.0037331,-0.10668,-0.10526,1,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0090226,-0.10673,-0.095886,1,0
1,GO REGULATION OF FERTILIZATION,0.0041716,-0.10679,-0.20019,1,0
1,GO ESTABLISHMENT OF CELL POLARITY,0.045624,-0.10698,-0.065482,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0060989,-0.1072,-0.16106,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.033894,-0.10736,-0.10565,1,0
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00065623,-0.10779,-0.090719,1,0
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.021165,-0.10793,-0.1249,1,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.030383,-0.10797,-0.12133,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.012203,-0.10806,-0.1001,1,0
1,GO POSITIVE REGULATION OF GROWTH,0.0059384,-0.10828,-0.092059,1,0
1,GO EMBRYONIC MORPHOGENESIS,0.029719,-0.10832,-0.090275,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.036164,-0.10842,-0.14313,1,0
1,GO INTRACELLULAR TRANSPORT,6.2786e-05,-0.10891,-0.094485,1,0
1,GO VIRAL LIFE CYCLE,0.0090226,-0.10901,-0.15597,1,0
1,GO TRNA 5 END PROCESSING,0.03939,-0.10908,-0.13746,1,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0079323,-0.10913,-0.12258,1,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.0007696,-0.10918,-0.10033,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0099891,-0.10918,-0.12257,1,0
1,GO SKELETAL SYSTEM DEVELOPMENT,0.010245,-0.10931,-0.097247,1,0
1,GO REGULATION OF RESPONSE TO FOOD,0.021165,-0.1096,-0.13265,1,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.016734,-0.10961,-0.14802,1,0
1,GO PROTEIN PALMITOYLATION,0.038561,-0.10962,-0.10312,1,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00072223,-0.1097,-0.17097,1,0
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0062634,-0.10971,-0.14116,1,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.0099891,-0.10972,-0.15101,1,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,2.8418e-05,-0.10983,-0.14227,1,0
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0097392,-0.11028,-0.14596,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0029794,-0.1103,-0.081995,1,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.0018173,-0.11048,-0.11058,1,0
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.00054072,-0.11058,-0.1354,1,0
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.041093,-0.1106,-0.21165,1,0
1,GO NEUTROPHIL MIGRATION,0.0026572,-0.11091,-0.15333,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.014138,-0.11118,-0.14332,1,0
1,GO REGULATION OF GROWTH,0.00032948,-0.1113,-0.12202,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.0010528,-0.11131,-0.12816,1,0
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.029719,-0.11131,-0.10089,1,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.018398,-0.11139,-0.069927,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.025994,-0.11139,-0.13225,1,0
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.011047,-0.11166,-0.13269,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00011241,-0.1119,-0.11532,1,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0060989,-0.11192,-0.15595,1,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.012508,-0.11193,-0.09473,1,0
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.014841,-0.11198,-0.10891,1,0
1,GO LYMPHOCYTE COSTIMULATION,0.018836,-0.11201,-0.12502,1,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.0015653,-0.11202,-0.14088,1,0
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.035393,-0.11216,-0.11043,1,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.0069616,-0.11223,-0.09998,1,0
1,GO REGULATION OF PROTEIN FOLDING,0.0041716,-0.11245,-0.14072,1,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.044685,-0.11265,-0.12065,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00047456,-0.11278,-0.1385,1,0
1,GO RESPONSE TO CATECHOLAMINE,0.031748,-0.11299,-0.10865,1,0
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0013872,-0.11326,-0.13767,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.034637,-0.11332,-0.12579,1,0
1,GO ORGANELLE INHERITANCE,0.0028957,-0.11343,-0.12086,1,0
1,GO MUSCLE ORGAN DEVELOPMENT,0.0038387,-0.11347,-0.10411,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,0.024288,-0.11352,-0.12148,1,0
1,GO SIGNAL RELEASE,0.019283,-0.11369,-0.08072,1,0
1,GO MESENCHYME DEVELOPMENT,0.0069616,-0.1138,-0.1078,1,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0011549,-0.11389,-0.16166,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0031536,-0.1139,-0.12691,1,0
1,GO GOLGI ORGANIZATION,0.0011549,-0.11399,-0.12075,1,0
1,GO OSTEOCLAST DIFFERENTIATION,0.010773,-0.11404,-0.1143,1,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.036948,-0.11407,-0.092514,1,0
1,GO REGIONALIZATION,0.041967,-0.1141,-0.085134,1,0
1,GO CELLULAR RESPONSE TO CAMP,0.026586,-0.11412,-0.11687,1,0
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0059384,-0.11418,-0.16495,1,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.010773,-0.11424,-0.13492,1,0
1,GO INOSITOL METABOLIC PROCESS,0.02843,-0.11429,-0.15911,1,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.013465,-0.1144,-0.10823,1,0
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00090094,-0.11442,-0.13102,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0060989,-0.11459,-0.17621,1,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.027803,-0.11465,-0.12726,1,0
1,GO MALE SEX DIFFERENTIATION,0.038561,-0.11506,-0.1021,1,0
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0025083,-0.11541,-0.16198,1,0
1,GO REGULATION OF SECRETION,0.0019282,-0.11545,-0.10925,1,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0057817,-0.11547,-0.10195,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.045624,-0.11556,-0.16405,1,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0071468,-0.11565,-0.16553,1,0
1,GO MUSCLE TISSUE DEVELOPMENT,0.01282,-0.11569,-0.086753,1,0
1,GO RNA CATABOLIC PROCESS,0.0085714,-0.11578,-0.12035,1,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0026572,-0.11578,-0.14043,1,0
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,4.3218e-05,-0.11592,-0.12374,1,0
1,GO PROTEIN KINASE A SIGNALING,0.0025083,-0.1161,-0.13292,1,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.046579,-0.11617,-0.11033,1,0
1,GO CELLULAR RESPONSE TO HEAT,0.001986,-0.1162,-0.12144,1,0
1,GO ORGAN INDUCTION,0.038561,-0.11639,-0.12695,1,0
1,GO HISTONE PHOSPHORYLATION,0.0018173,-0.11669,-0.13712,1,0
1,GO REGULATION OF CELL SIZE,0.0011549,-0.11679,-0.12172,1,0
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0030654,-0.1169,-0.12147,1,0
1,GO VESICLE DOCKING,0.0054795,-0.11698,-0.13425,1,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.0073363,-0.11709,-0.14461,1,0
1,GO ORGANIC ACID TRANSPORT,3.3132e-05,-0.11717,-0.14141,1,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0081404,-0.11719,-0.14879,1,0
1,GO REGULATION OF HORMONE LEVELS,0.0011199,-0.11732,-0.13992,1,0
1,GO OSSIFICATION,0.011612,-0.11757,-0.11435,1,0
1,GO CELLULAR EXTRAVASATION,0.026586,-0.11758,-0.11771,1,0
1,GO DEPHOSPHORYLATION,0.00047456,-0.11802,-0.10444,1,0
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.017549,-0.11815,-0.15454,1,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,-0.11826,-0.13616,1,0
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,-0.11836,-0.1265,1,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.011326,-0.11839,-0.15159,1,0
1,GO PEPTIDYL SERINE MODIFICATION,0.0017123,-0.11845,-0.098889,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.031059,-0.11848,-0.12275,1,0
1,GO RNA 5 END PROCESSING,0.044685,-0.11853,-0.1376,1,0
1,GO INTERLEUKIN 6 PRODUCTION,0.029068,-0.11855,-0.11117,1,0
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0023671,-0.11855,-0.13638,1,0
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.4878e-05,-0.11864,-0.1312,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0057817,-0.11871,-0.1292,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0059384,-0.11876,-0.16481,1,0
1,GO RENAL TUBULE DEVELOPMENT,0.038561,-0.11891,-0.10796,1,0
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.037747,-0.11892,-0.17895,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.029068,-0.11896,-0.1144,1,0
1,GO HORMONE TRANSPORT,0.017969,-0.11898,-0.10385,1,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00013917,-0.119,-0.11122,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.00042998,-0.11918,-0.13136,1,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0011549,-0.11924,-0.12123,1,0
1,GO FC RECEPTOR SIGNALING PATHWAY,0.0038387,-0.11927,-0.1213,1,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.027803,-0.11927,-0.19599,1,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.022165,-0.11948,-0.14532,1,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.027803,-0.11953,-0.10224,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0014299,-0.11961,-0.12214,1,0
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.034637,-0.11991,-0.11782,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0042883,-0.12003,-0.12402,1,0
1,GO PROTEIN POLYMERIZATION,0.00057693,-0.12007,-0.10856,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0025817,-0.12019,-0.1222,1,0
1,GO INTESTINAL ABSORPTION,0.044685,-0.12024,-0.20393,1,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0090226,-0.12029,-0.13474,1,0
1,GO B CELL DIFFERENTIATION,0.0018173,-0.12032,-0.13663,1,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.00024286,-0.12034,-0.13342,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00034072,-0.12036,-0.16215,1,0
1,GO GLIOGENESIS,0.014138,-0.12052,-0.11283,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.035393,-0.12056,-0.15381,1,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.001986,-0.12056,-0.1461,1,0
1,GO T CELL CHEMOTAXIS,0.02068,-0.12065,-0.13494,1,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0051916,-0.12071,-0.14108,1,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.030383,-0.12071,-0.13343,1,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.026586,-0.12079,-0.095463,1,0
1,GO OSTEOBLAST DIFFERENTIATION,0.011612,-0.12086,-0.12728,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.03245,-0.12096,-0.1114,1,0
1,GO NEGATIVE REGULATION OF CELL DEATH,0.0014738,-0.121,-0.11239,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.0045306,-0.12116,-0.15011,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.034637,-0.12127,-0.17304,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0016129,-0.12153,-0.11891,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0031536,-0.12161,-0.084743,1,0
1,GO POSITIVE REGULATION OF TRANSLATION,0.0032441,-0.12183,-0.14931,1,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.00024286,-0.12187,-0.17723,1,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.017549,-0.12227,-0.14014,1,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.001872,-0.12245,-0.11482,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00063551,-0.12254,-0.11827,1,0
1,GO POSITIVE REGULATION OF HEART GROWTH,0.023205,-0.1227,-0.14465,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.0029794,-0.12273,-0.18617,1,0
1,GO GLYCOSYLATION,0.00052342,-0.12283,-0.14641,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0038387,-0.12284,-0.16079,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00034072,-0.12301,-0.12046,1,0
1,GO CELL AGGREGATION,0.029068,-0.12304,-0.16721,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,2.4346e-05,-0.12306,-0.1499,1,0
1,GO EPITHELIUM DEVELOPMENT,0.015574,-0.12307,-0.09201,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0069616,-0.12308,-0.1596,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.040234,-0.12309,-0.084452,1,0
1,GO LYMPH VESSEL MORPHOGENESIS,0.022165,-0.12314,-0.16965,1,0
1,GO NERVOUS SYSTEM PROCESS,0.0023671,-0.12326,-0.099124,1,0
1,GO CHYLOMICRON ASSEMBLY,0.0038387,-0.12327,-0.18682,1,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.013139,-0.1234,-0.1259,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.013e-05,-0.12342,-0.12186,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.00011241,-0.12343,-0.16022,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.033894,-0.12347,-0.15294,1,0
1,GO CALCIUM MEDIATED SIGNALING,0.00016023,-0.12354,-0.13833,1,0
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.02166,-0.12361,-0.11647,1,0
1,GO REGULATION OF MUSCLE ADAPTATION,0.0056288,-0.1238,-0.13945,1,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.0013457,-0.12411,-0.10059,1,0
1,GO TYPE I INTERFERON PRODUCTION,0.026586,-0.12413,-0.14537,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0071468,-0.12426,-0.11398,1,0
1,GO SYMBIOTIC PROCESS,0.0015189,-0.12439,-0.12724,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.011326,-0.12446,-0.10275,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.047551,-0.12461,-0.12534,1,0
1,GO MESONEPHROS DEVELOPMENT,0.024288,-0.12472,-0.14263,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0013457,-0.12484,-0.17325,1,0
1,GO CYTOSOLIC TRANSPORT,0.0013872,-0.12493,-0.10812,1,0
1,GO DICARBOXYLIC ACID TRANSPORT,0.033166,-0.12503,-0.093248,1,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.0029794,-0.12519,-0.11567,1,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00025131,-0.1252,-0.12621,1,0
1,GO DRUG CATABOLIC PROCESS,0.00025131,-0.12521,-0.21608,1,0
1,GO VESICLE BUDDING FROM MEMBRANE,0.00092958,-0.12526,-0.1532,1,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.033166,-0.12533,-0.11256,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.025994,-0.12548,-0.12145,1,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.011612,-0.12552,-0.12465,1,0
1,GO FILOPODIUM ASSEMBLY,0.031059,-0.12553,-0.11979,1,0
1,GO ANDROGEN METABOLIC PROCESS,0.013798,-0.12561,-0.18392,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00069957,-0.12572,-0.12444,1,0
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.03939,-0.12574,-0.1656,1,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.010506,-0.12581,-0.14107,1,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0050528,-0.12587,-0.1726,1,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.010773,-0.12588,-0.14929,1,0
1,GO REGULATION OF VASOCONSTRICTION,0.025994,-0.12592,-0.13525,1,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.016339,-0.12606,-0.11547,1,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.031748,-0.1261,-0.15464,1,0
1,GO LYSOSOMAL TRANSPORT,0.0083534,-0.12615,-0.11773,1,0
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00013917,-0.12615,-0.13603,1,0
1,GO PROTEIN STABILIZATION,0.00027832,-0.12616,-0.12906,1,0
1,GO ASTROCYTE DIFFERENTIATION,0.03939,-0.12643,-0.13625,1,0
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.012203,-0.12666,-0.18776,1,0
1,GO ANIMAL ORGAN FORMATION,0.034637,-0.12684,-0.10822,1,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.02068,-0.12691,-0.17574,1,0
1,GO REGULATION OF RESPONSE TO STRESS,0.00092958,-0.12703,-0.11935,1,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00040247,-0.12704,-0.15555,1,0
1,GO MYELOID CELL DIFFERENTIATION,0.00052342,-0.12738,-0.1478,1,0
1,GO REGULATION OF CATABOLIC PROCESS,6.5149e-05,-0.12738,-0.1175,1,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0053338,-0.12739,-0.14431,1,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0015189,-0.12744,-0.13246,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00016023,-0.12765,-0.14918,1,0
1,GO MACROPHAGE DIFFERENTIATION,0.0064317,-0.1277,-0.18405,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0010528,-0.12772,-0.18534,1,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.016734,-0.12803,-0.17803,1,0
1,GO ERBB SIGNALING PATHWAY,0.0027346,-0.12807,-0.15121,1,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.016734,-0.12816,-0.12244,1,0
1,GO CELLULAR RESPONSE TO ALCOHOL,0.022165,-0.12816,-0.10178,1,0
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0013054,-0.1282,-0.14968,1,0
1,GO TRANSEPITHELIAL TRANSPORT,0.0013054,-0.12826,-0.17143,1,0
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.001986,-0.1284,-0.16023,1,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.010773,-0.12845,-0.14739,1,0
1,GO LIVER REGENERATION,0.00095906,-0.12856,-0.21438,1,0
1,GO NEGATIVE REGULATION OF TRANSPORT,0.00028792,-0.12868,-0.12444,1,0
1,GO ACUTE PHASE RESPONSE,0.0062634,-0.12894,-0.20072,1,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0073363,-0.12899,-0.15155,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0094949,-0.12904,-0.13959,1,0
1,GO NUCLEOTIDE TRANSPORT,0.027803,-0.12914,-0.10976,1,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.027803,-0.12923,-0.14231,1,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.0025083,-0.12926,-0.13379,1,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.00057693,-0.12937,-0.11925,1,0
1,GO TAXIS,0.0017123,-0.12944,-0.11962,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.019283,-0.12947,-0.16893,1,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,7.2754e-05,-0.12948,-0.16202,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.015203,-0.12956,-0.1317,1,0
1,GO SEX DIFFERENTIATION,0.0010859,-0.12963,-0.11575,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.011326,-0.12965,-0.10853,1,0
1,GO NEGATIVE REGULATION OF SECRETION,0.00079435,-0.12968,-0.12949,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.037747,-0.12976,-0.14129,1,0
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.011612,-0.12978,-0.14395,1,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.024846,-0.12988,-0.12033,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.019283,-0.12991,-0.15724,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.041093,-0.13008,-0.096376,1,0
1,GO CHEMOKINE PRODUCTION,0.03245,-0.1301,-0.15463,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.023205,-0.13031,-0.17057,1,0
1,GO BASIC AMINO ACID TRANSPORT,0.037747,-0.13031,-0.19588,1,0
1,GO TISSUE MORPHOGENESIS,0.0056288,-0.1304,-0.10936,1,0
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.010773,-0.13041,-0.11835,1,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0030654,-0.13054,-0.18359,1,0
1,GO PEPTIDYL PROLINE MODIFICATION,0.0031536,-0.13087,-0.18055,1,0
1,GO AMINE METABOLIC PROCESS,0.00022676,-0.13094,-0.16238,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.014138,-0.13097,-0.098975,1,0
1,GO REGULATION OF VIRAL LIFE CYCLE,0.044685,-0.1311,-0.17038,1,0
1,GO CARBOHYDRATE TRANSPORT,0.00044439,-0.13111,-0.14343,1,0
1,GO MEMORY,0.009256,-0.13116,-0.14016,1,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.00013433,-0.13125,-0.14392,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0021062,-0.1313,-0.13129,1,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.019283,-0.13131,-0.085547,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.047551,-0.13133,-0.12491,1,0
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.014841,-0.13155,-0.15453,1,0
1,GO NEGATIVE REGULATION OF SIGNALING,0.00063551,-0.13159,-0.12129,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,4.6597e-05,-0.13163,-0.15011,1,0
1,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0064317,-0.13166,-0.18332,1,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.014841,-0.13171,-0.11647,1,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.014486,-0.13187,-0.16873,1,0
1,GO ANIMAL ORGAN MORPHOGENESIS,0.0021689,-0.13207,-0.11619,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.013465,-0.13209,-0.1227,1,0
1,GO PEPTIDE CATABOLIC PROCESS,0.0081404,-0.13214,-0.17404,1,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.042857,-0.13217,-0.12825,1,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0075304,-0.13233,-0.11912,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0060989,-0.13253,-0.19324,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00049035,-0.13259,-0.12147,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00092958,-0.13266,-0.18368,1,0
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.023205,-0.13276,-0.14646,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,5.0226e-05,-0.13279,-0.14642,1,0
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.043763,-0.13286,-0.14577,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00040247,-0.13289,-0.14153,1,0
1,GO MITOCHONDRIAL TRANSPORT,1.7118e-05,-0.13289,-0.12725,1,0
1,GO LEUKOCYTE DIFFERENTIATION,0.0011199,-0.13309,-0.13599,1,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.0006154,-0.13315,-0.14458,1,0
1,GO CALCIUM ION IMPORT,0.001872,-0.13316,-0.13369,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0015189,-0.13328,-0.12488,1,0
1,GO LOCOMOTORY BEHAVIOR,0.024846,-0.1333,-0.10352,1,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,5.0226e-05,-0.13358,-0.15294,1,0
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0007696,-0.13359,-0.16225,1,0
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.00010845,-0.1338,-0.14246,1,0
1,GO JNK CASCADE,0.0021062,-0.13382,-0.12585,1,0
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0022332,-0.13383,-0.18938,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0028957,-0.13388,-0.13368,1,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.009256,-0.13399,-0.17347,1,0
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,6.2786e-05,-0.13402,-0.19118,1,0
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.047551,-0.13406,-0.14584,1,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0018173,-0.13406,-0.13014,1,0
1,GO RESPONSE TO GROWTH FACTOR,0.0042883,-0.1341,-0.11468,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00353,-0.13427,-0.1463,1,0
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0059384,-0.1343,-0.18808,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00036427,-0.13433,-0.12673,1,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.00020448,-0.13436,-0.12626,1,0
1,GO REGULATION OF CELL DEATH,0.00028792,-0.13439,-0.12326,1,0
1,GO HEART DEVELOPMENT,0.0051916,-0.13445,-0.1026,1,0
1,GO GLUTAMATE METABOLIC PROCESS,0.012508,-0.13452,-0.13002,1,0
1,GO REGULATION OF BONE REMODELING,0.03939,-0.1346,-0.16075,1,0
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.007729,-0.13462,-0.21028,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.004408,-0.13463,-0.15861,1,0
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00030804,-0.13469,-0.10822,1,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.00019079,-0.1347,-0.15135,1,0
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00016595,-0.13474,-0.17951,1,0
1,GO INTERACTION WITH SYMBIONT,0.010773,-0.13475,-0.11746,1,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0046564,-0.13481,-0.11086,1,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0028141,-0.13483,-0.12085,1,0
1,GO BEHAVIOR,0.018398,-0.13491,-0.095145,1,0
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0057817,-0.13493,-0.13484,1,0
1,GO POSITIVE REGULATION OF SECRETION,0.0064317,-0.13496,-0.10787,1,0
1,GO RESPONSE TO MONOSACCHARIDE,5.2837e-06,-0.13504,-0.16785,1,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.013798,-0.13506,-0.14178,1,0
1,GO REGULATION OF PROTEIN MATURATION,0.00079435,-0.1351,-0.20475,1,0
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00013433,-0.13511,-0.13812,1,0
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,8.7323e-05,-0.13515,-0.13729,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.037747,-0.13518,-0.20089,1,0
1,GO APOPTOTIC PROCESS,0.00014935,-0.1352,-0.12844,1,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0054795,-0.13529,-0.15645,1,0
1,GO RESPONSE TO INTERLEUKIN 1,0.00028792,-0.13529,-0.17355,1,0
1,GO REGULATION OF PROTEIN STABILITY,6.7596e-05,-0.13547,-0.128,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.0039469,-0.13572,-0.1486,1,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.047551,-0.13572,-0.091466,1,0
1,GO NCRNA CATABOLIC PROCESS,0.015953,-0.13594,-0.13226,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.01282,-0.13594,-0.23129,1,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00030804,-0.13595,-0.15085,1,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,2.9532e-05,-0.13619,-0.13891,1,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.018836,-0.13628,-0.12238,1,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00010462,-0.13649,-0.12583,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00067758,-0.13664,-0.1063,1,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.018398,-0.13692,-0.16843,1,0
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0069616,-0.13698,-0.19378,1,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,4.6597e-05,-0.13703,-0.19724,1,0
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.015574,-0.13709,-0.16021,1,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.00017796,-0.13723,-0.13838,1,0
1,GO PEPTIDE HORMONE SECRETION,0.0075304,-0.13735,-0.11221,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00016595,-0.13737,-0.15045,1,0
1,GO HOMEOSTATIC PROCESS,1.4674e-06,-0.13741,-0.14293,1,0
1,GO LYMPHOCYTE ACTIVATION,0.0011199,-0.13744,-0.13763,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.001191,-0.13773,-0.15206,1,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00016595,-0.13773,-0.15785,1,0
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0013457,-0.13775,-0.12163,1,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.015203,-0.13779,-0.15845,1,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.004408,-0.1378,-0.15366,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0051916,-0.13787,-0.13506,1,0
1,GO BONE REMODELING,0.0090226,-0.13791,-0.18479,1,0
1,GO GLAND DEVELOPMENT,0.0026572,-0.1384,-0.12231,1,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.017549,-0.13849,-0.15509,1,0
1,GO ENDOTHELIUM DEVELOPMENT,0.025994,-0.13852,-0.12267,1,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.03939,-0.13858,-0.12344,1,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0033369,-0.1388,-0.12287,1,0
1,GO CELLULAR KETONE METABOLIC PROCESS,0.00050664,-0.13887,-0.17045,1,0
1,GO CELL MATURATION,0.00036427,-0.13905,-0.12712,1,0
1,GO RESPONSE TO KETONE,0.00025131,-0.13914,-0.17989,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.0094949,-0.13924,-0.16195,1,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,2.3418e-05,-0.13925,-0.15363,1,0
1,GO GLUTAMINE METABOLIC PROCESS,0.024288,-0.13946,-0.12326,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY,1.0184e-05,-0.13951,-0.13755,1,0
1,GO POSITIVE REGULATION OF SIGNALING,0.00042998,-0.13953,-0.12376,1,0
1,GO REGULATION OF B CELL ACTIVATION,0.00040247,-0.13968,-0.1821,1,0
1,GO INTERMEMBRANE LIPID TRANSFER,0.00032948,-0.13968,-0.17906,1,0
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0023671,-0.13969,-0.15391,1,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.012203,-0.13971,-0.11152,1,0
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.015574,-0.13974,-0.10502,1,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0079323,-0.13976,-0.12088,1,0
1,GO ASTROCYTE DEVELOPMENT,0.026586,-0.1398,-0.19418,1,0
1,GO LIPID EXPORT FROM CELL,0.016734,-0.1399,-0.14671,1,0
1,GO VESICLE ORGANIZATION,6.2786e-05,-0.13996,-0.15287,1,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0014738,-0.14003,-0.10754,1,0
1,GO RESPONSE TO ABIOTIC STIMULUS,4.8612e-06,-0.14011,-0.1427,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0081404,-0.14024,-0.14156,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION,0.02068,-0.14041,-0.1592,1,0
1,GO GENITALIA DEVELOPMENT,0.0033369,-0.14043,-0.14701,1,0
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.0011549,-0.14044,-0.15972,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,3.3132e-05,-0.14061,-0.15658,1,0
1,GO RESPONSE TO OXYGEN RADICAL,0.007729,-0.14069,-0.13693,1,0
1,GO REGULATION OF CELL SHAPE,0.044685,-0.14072,-0.10067,1,0
1,GO FEAR RESPONSE,0.0042883,-0.14102,-0.1487,1,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.044685,-0.14103,-0.11118,1,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.03939,-0.14127,-0.11878,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.012508,-0.14138,-0.17322,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0064317,-0.14142,-0.1258,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00090094,-0.1415,-0.12251,1,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00092958,-0.14151,-0.13119,1,0
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0045306,-0.14151,-0.21752,1,0
1,GO LEUKOCYTE HOMEOSTASIS,0.00021167,-0.14158,-0.17727,1,0
1,GO TRANSITION METAL ION TRANSPORT,1.1964e-05,-0.14167,-0.1532,1,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.00074557,-0.14176,-0.12949,1,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,1.7806e-05,-0.1418,-0.15459,1,0
1,GO PROTEIN TARGETING TO LYSOSOME,0.020205,-0.14183,-0.18905,1,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,1.8521e-05,-0.14188,-0.18923,1,0
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.015953,-0.14189,-0.10996,1,0
1,GO PEPTIDE BIOSYNTHETIC PROCESS,0.001228,-0.14198,-0.15573,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00092958,-0.14202,-0.14545,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.02843,-0.14212,-0.10583,1,0
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.013139,-0.14216,-0.14351,1,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.019283,-0.1423,-0.12043,1,0
1,GO PROTEIN KINASE B SIGNALING,0.0028141,-0.14251,-0.14978,1,0
1,GO REGULATION OF DEFENSE RESPONSE,0.0021689,-0.14256,-0.13453,1,0
1,GO TRANSLATIONAL TERMINATION,0.014138,-0.14266,-0.14897,1,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00026903,-0.14275,-0.13497,1,0
1,GO REGULATION OF MACROAUTOPHAGY,0.00025131,-0.14275,-0.1307,1,0
1,GO FATTY ACID TRANSPORT,0.0013054,-0.14279,-0.14315,1,0
1,GO RESPONSE TO FATTY ACID,0.0014738,-0.14284,-0.17858,1,0
1,GO TRANSFERRIN TRANSPORT,0.0007696,-0.14291,-0.18458,1,0
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0013872,-0.14291,-0.14824,1,0
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0013457,-0.14301,-0.14919,1,0
1,GO STEROID CATABOLIC PROCESS,0.043763,-0.14307,-0.15978,1,0
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.018398,-0.14322,-0.11367,1,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00013433,-0.14332,-0.15043,1,0
1,GO RESPONSE TO INTERLEUKIN 4,0.0090226,-0.14335,-0.12497,1,0
1,GO CELLULAR RESPIRATION,0.0033369,-0.14338,-0.1506,1,0
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.024846,-0.14346,-0.17218,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,9.389e-05,-0.14348,-0.15634,1,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00032948,-0.1435,-0.16994,1,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,7.8282e-05,-0.14359,-0.16303,1,0
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.001191,-0.14361,-0.14915,1,0
1,GO RESPONSE TO FUNGUS,0.011326,-0.14366,-0.11914,1,0
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,9.389e-05,-0.14371,-0.1393,1,0
1,GO AMINO SUGAR METABOLIC PROCESS,0.001191,-0.14371,-0.18042,1,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0081404,-0.14388,-0.14359,1,0
1,GO T CELL ACTIVATION,0.0030654,-0.14392,-0.14007,1,0
1,GO PROTEIN TARGETING TO MEMBRANE,0.0034322,-0.144,-0.19272,1,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.013798,-0.14426,-0.127,1,0
1,GO PEPTIDE SECRETION,0.00026003,-0.14436,-0.13928,1,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0028141,-0.14444,-0.17999,1,0
1,GO MYELOID CELL HOMEOSTASIS,0.00087311,-0.14446,-0.16281,1,0
1,GO FEEDING BEHAVIOR,0.0040578,-0.1446,-0.12436,1,0
1,GO RESPONSE TO CARBOHYDRATE,1.906e-06,-0.14463,-0.17338,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0049174,-0.14464,-0.17909,1,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0019282,-0.14494,-0.15062,1,0
1,GO REGULATION OF JUN KINASE ACTIVITY,0.040234,-0.14497,-0.10411,1,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00012512,-0.14502,-0.12583,1,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,5.4121e-05,-0.14508,-0.19596,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,4.6597e-05,-0.14534,-0.13932,1,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0014299,-0.14538,-0.21665,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.001228,-0.14553,-0.12278,1,0
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0013872,-0.1457,-0.15818,1,0
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,2.2524e-05,-0.14574,-0.13476,1,0
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.6597e-05,-0.14574,-0.1848,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.010773,-0.14576,-0.14792,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.033894,-0.14587,-0.14323,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,6.7596e-05,-0.14597,-0.14484,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.0010528,-0.14602,-0.15713,1,0
1,GO RESPONSE TO ISCHEMIA,0.013139,-0.14604,-0.13763,1,0
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00081984,-0.1462,-0.15241,1,0
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.0071468,-0.14626,-0.16513,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.023741,-0.14635,-0.13031,1,0
1,GO RESPONSE TO AMYLOID BETA,0.0013457,-0.14636,-0.2015,1,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,7.2754e-05,-0.14638,-0.16793,1,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00012512,-0.14639,-0.14429,1,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0038387,-0.14648,-0.15095,1,0
1,GO ORGANIC ANION TRANSPORT,4.6623e-06,-0.1465,-0.16533,1,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.0051916,-0.14651,-0.14461,1,0
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.017137,-0.14663,-0.15974,1,0
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0031536,-0.14666,-0.23309,1,0
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00092958,-0.14673,-0.15232,1,0
1,GO REGULATION OF PEPTIDE SECRETION,0.0014299,-0.1468,-0.121,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00087311,-0.14681,-0.13264,1,0
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.013139,-0.1469,-0.1591,1,0
1,GO ANION TRANSPORT,3.4728e-06,-0.14702,-0.1638,1,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.017969,-0.14719,-0.13558,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.015203,-0.1472,-0.14425,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0015653,-0.14733,-0.19558,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.019739,-0.14749,-0.178,1,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.041967,-0.14751,-0.087374,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00079435,-0.14764,-0.1234,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00041602,-0.14808,-0.13526,1,0
1,GO ORGANELLE FUSION,0.00063551,-0.14811,-0.1429,1,0
1,GO PROSTAGLANDIN TRANSPORT,0.025414,-0.14813,-0.14738,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.017969,-0.14839,-0.12191,1,0
1,GO NEPHRON DEVELOPMENT,0.025414,-0.14842,-0.11149,1,0
1,GO EATING BEHAVIOR,0.0059384,-0.14843,-0.14848,1,0
1,GO TRANSLATIONAL ELONGATION,0.0032441,-0.14843,-0.17099,1,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.015574,-0.14846,-0.12171,1,0
1,GO CELLULAR RESPONSE TO FATTY ACID,0.031059,-0.14848,-0.15523,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,3.4728e-06,-0.14859,-0.17049,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,5.2139e-05,-0.14866,-0.15244,1,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.030383,-0.14868,-0.16714,1,0
1,GO SINGLE FERTILIZATION,4.4712e-06,-0.14869,-0.1716,1,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.03245,-0.14874,-0.11708,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0014299,-0.14878,-0.13361,1,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0022332,-0.14884,-0.13352,1,0
1,GO ACTIN FILAMENT ORGANIZATION,0.00081984,-0.14886,-0.1385,1,0
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00084609,-0.14895,-0.19958,1,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.016339,-0.14913,-0.10911,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.013139,-0.14913,-0.13403,1,0
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.036948,-0.14921,-0.123,1,0
1,GO PROTEIN TARGETING,2.6307e-05,-0.14925,-0.1777,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,1.8521e-05,-0.14926,-0.1468,1,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00016595,-0.14933,-0.13375,1,0
1,GO REGULATION OF LIPASE ACTIVITY,2.8418e-05,-0.14935,-0.19708,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0017641,-0.14942,-0.1917,1,0
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0073363,-0.14944,-0.2014,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.016734,-0.14966,-0.15586,1,0
1,GO RESPONSE TO IRON ION,0.0015189,-0.14974,-0.18774,1,0
1,GO REGULATION OF T CELL CHEMOTAXIS,0.0054795,-0.14975,-0.17959,1,0
1,GO PIGMENTATION,0.00013433,-0.1498,-0.16289,1,0
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.001662,-0.14995,-0.18503,1,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0013872,-0.14995,-0.16633,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,5.0226e-05,-0.15001,-0.12725,1,0
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0033369,-0.15004,-0.18266,1,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.0024367,-0.15013,-0.22371,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.01282,-0.15036,-0.12291,1,0
1,GO ELECTRON TRANSPORT CHAIN,0.00090094,-0.15045,-0.15029,1,0
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,9.0551e-05,-0.15053,-0.16371,1,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,7.2754e-05,-0.15056,-0.17149,1,0
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00042998,-0.15068,-0.16149,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.0001547,-0.15071,-0.17964,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.00069957,-0.15074,-0.19051,1,0
1,GO LIPID HOMEOSTASIS,4.6597e-05,-0.15074,-0.18383,1,0
1,GO PROTEIN TARGETING TO VACUOLE,0.0014738,-0.15079,-0.17631,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,6.5149e-05,-0.15091,-0.16196,1,0
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,9.7346e-05,-0.15091,-0.15611,1,0
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.010773,-0.15109,-0.20111,1,0
1,GO VISUAL BEHAVIOR,0.0085714,-0.15109,-0.12541,1,0
1,GO REGULATION OF TRANSPORT,3.3132e-05,-0.15119,-0.13286,1,0
1,GO RESPONSE TO DSRNA,0.0067808,-0.15124,-0.15877,1,0
1,GO BILE ACID METABOLIC PROCESS,0.0049174,-0.15129,-0.19123,1,0
1,GO RESPONSE TO INTERLEUKIN 15,0.0060989,-0.1513,-0.24606,1,0
1,GO PIGMENT GRANULE MATURATION,0.038561,-0.15133,-0.16285,1,0
1,GO EXCRETION,0.00067758,-0.15136,-0.16125,1,0
1,GO RESPONSE TO PEPTIDE,3.8583e-05,-0.15162,-0.15591,1,0
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00010845,-0.15172,-0.18909,1,0
1,GO INTERACTION WITH HOST,0.0051916,-0.15176,-0.16718,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,0.022165,-0.15177,-0.11538,1,0
1,GO FERTILIZATION,1.906e-06,-0.15178,-0.17354,1,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00084609,-0.15189,-0.13813,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0011199,-0.15191,-0.17558,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0087944,-0.15191,-0.18289,1,0
1,GO PROTEIN HOMOOLIGOMERIZATION,6.7728e-06,-0.15199,-0.15948,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00059588,-0.15212,-0.18145,1,0
1,GO EPITHELIAL CELL PROLIFERATION,0.0022992,-0.15214,-0.15546,1,0
1,GO REGULATION OF GTPASE ACTIVITY,0.00016595,-0.15218,-0.14354,1,0
1,GO MAMMARY GLAND DEVELOPMENT,0.0079323,-0.15221,-0.1375,1,0
1,GO REGULATION OF ORGAN GROWTH,0.031059,-0.15221,-0.11289,1,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.00031859,-0.15226,-0.14166,1,0
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,2.8418e-05,-0.15247,-0.14575,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,1.5201e-05,-0.15248,-0.14351,1,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.007729,-0.15252,-0.12871,1,0
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00012512,-0.15252,-0.19701,1,0
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00063551,-0.15253,-0.17895,1,0
1,GO RESPONSE TO HEAT,8.1192e-05,-0.15256,-0.15522,1,0
1,GO REGULATION OF HYDROLASE ACTIVITY,0.00023468,-0.15262,-0.13926,1,0
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0081404,-0.15264,-0.17054,1,0
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0006154,-0.15264,-0.14941,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0012662,-0.15267,-0.17202,1,0
1,GO REGULATION OF BINDING,0.0018173,-0.15268,-0.10929,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,9.3916e-06,-0.15281,-0.15656,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00012074,-0.15283,-0.13223,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00014418,-0.15291,-0.14368,1,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.020205,-0.15298,-0.10628,1,0
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.011047,-0.15307,-0.18021,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0013872,-0.1531,-0.15185,1,0
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00041602,-0.15316,-0.13527,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,2.0033e-05,-0.15317,-0.15583,1,0
1,GO CELL KILLING,0.01282,-0.15331,-0.13497,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.040234,-0.15332,-0.15874,1,0
1,GO TUBE DEVELOPMENT,0.0010206,-0.15347,-0.14279,1,0
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00055855,-0.15351,-0.15346,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.041967,-0.1536,-0.13109,1,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,5.4121e-05,-0.15361,-0.15991,1,0
1,GO GLIAL CELL PROLIFERATION,0.024288,-0.15368,-0.14021,1,0
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.033894,-0.1537,-0.22357,1,0
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0079323,-0.15378,-0.16194,1,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00084609,-0.15386,-0.16401,1,0
1,GO GLIAL CELL DEVELOPMENT,0.0022992,-0.15392,-0.1768,1,0
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.03245,-0.15399,-0.1319,1,0
1,GO FATTY ACID BETA OXIDATION,0.020205,-0.15402,-0.12324,1,0
1,GO SMOOTH MUSCLE CONTRACTION,7.6603e-06,-0.15411,-0.19742,1,0
1,GO STEROID BIOSYNTHETIC PROCESS,2.9532e-05,-0.15426,-0.19421,1,0
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.011047,-0.15437,-0.16338,1,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.03939,-0.15438,-0.12161,1,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.040234,-0.1544,-0.14235,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0030654,-0.15446,-0.14083,1,0
1,GO BONE RESORPTION,0.0037331,-0.15462,-0.1916,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.0037331,-0.15485,-0.13882,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.017549,-0.15486,-0.15794,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,2.1663e-05,-0.15491,-0.24887,1,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,1.5201e-05,-0.15496,-0.16562,1,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00037661,-0.15498,-0.15468,1,0
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0057817,-0.15498,-0.15032,1,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,9.389e-05,-0.15528,-0.17274,1,0
1,GO ACTIVATION OF IMMUNE RESPONSE,0.00054072,-0.15534,-0.15621,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0062634,-0.1556,-0.15526,1,0
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,2.0833e-05,-0.15571,-0.18473,1,0
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0013872,-0.15584,-0.19667,1,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.025994,-0.15588,-0.14505,1,0
1,GO PLATELET MORPHOGENESIS,0.00069957,-0.15594,-0.18488,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,2.3654e-06,-0.15595,-0.16396,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,1.7118e-05,-0.15609,-0.14935,1,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.00038934,-0.15614,-0.1539,1,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.00040247,-0.15638,-0.16834,1,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.033166,-0.15653,-0.16906,1,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.029068,-0.15655,-0.10607,1,0
1,GO NUCLEOSIDE METABOLIC PROCESS,0.00090094,-0.15661,-0.13421,1,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00090094,-0.15662,-0.20564,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.027188,-0.15672,-0.14891,1,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0079323,-0.15677,-0.19703,1,0
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.041967,-0.15677,-0.14683,1,0
1,GO MOVEMENT IN HOST ENVIRONMENT,0.00353,-0.15683,-0.19923,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00023468,-0.15692,-0.14951,1,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00032948,-0.15697,-0.17775,1,0
1,GO REGULATION OF BONE DEVELOPMENT,0.00020448,-0.15697,-0.21015,1,0
1,GO FEMALE SEX DIFFERENTIATION,0.00029782,-0.15699,-0.16316,1,0
1,GO NEGATIVE REGULATION OF BINDING,0.00050664,-0.15709,-0.13853,1,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00034072,-0.15718,-0.13386,1,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.029719,-0.15722,-0.13723,1,0
1,GO IRON ION TRANSPORT,2.7343e-05,-0.15723,-0.16961,1,0
1,GO L AMINO ACID TRANSPORT,0.00069957,-0.15732,-0.18383,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00013917,-0.15735,-0.17125,1,0
1,GO REGULATION OF STEROL TRANSPORT,0.0046564,-0.15744,-0.17822,1,0
1,GO REGULATION OF CELL ACTIVATION,0.00063551,-0.15747,-0.15611,1,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.041093,-0.15772,-0.13715,1,0
1,GO RIBOSOME ASSEMBLY,0.02268,-0.15782,-0.2073,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0034322,-0.15798,-0.13182,1,0
1,GO HEART MORPHOGENESIS,0.0064317,-0.158,-0.10123,1,0
1,GO METAL ION HOMEOSTASIS,1.5691e-07,-0.15806,-0.19459,1,0
1,GO DIGESTION,0.00050664,-0.15812,-0.1938,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,9.7346e-05,-0.15815,-0.1341,1,0
1,GO LIVER MORPHOGENESIS,0.011326,-0.15815,-0.24411,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.025994,-0.15822,-0.13734,1,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0028141,-0.15827,-0.16467,1,0
1,GO CELL VOLUME HOMEOSTASIS,0.0025817,-0.15831,-0.12956,1,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00012964,-0.15833,-0.15893,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0059384,-0.15848,-0.12745,1,0
1,GO RESPONSE TO ACID CHEMICAL,9.0551e-05,-0.15852,-0.17813,1,0
1,GO CELL MOTILITY,0.00092958,-0.15861,-0.14056,1,0
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0022992,-0.15862,-0.22,1,0
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0033369,-0.15862,-0.15943,1,0
1,GO PROTEIN FOLDING,1.104e-05,-0.1587,-0.17808,1,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.0779e-06,-0.15871,-0.20008,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0011199,-0.15876,-0.19007,1,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.046579,-0.15877,-0.20687,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0064317,-0.15897,-0.26577,1,0
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.038561,-0.15897,-0.10399,1,0
1,GO POSITIVE REGULATION OF CELL DEATH,0.00017796,-0.159,-0.14509,1,0
1,GO RESPONSE TO MECHANICAL STIMULUS,0.0023671,-0.15916,-0.1568,1,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00017796,-0.15917,-0.16163,1,0
1,GO PIGMENT BIOSYNTHETIC PROCESS,0.0050528,-0.15925,-0.16695,1,0
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.00019753,-0.15929,-0.14718,1,0
1,GO CELLULAR RESPONSE TO LIPID,0.00042998,-0.1593,-0.15455,1,0
1,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.029068,-0.1593,-0.214,1,0
1,GO ACTIN FILAMENT BASED PROCESS,0.00049035,-0.1594,-0.13997,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00042998,-0.15953,-0.15153,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0057817,-0.15958,-0.13164,1,0
1,GO MACROAUTOPHAGY,0.0010206,-0.15967,-0.11573,1,0
1,GO REGULATION OF PROTEOLYSIS,0.00021167,-0.1597,-0.15751,1,0
1,GO TUBE MORPHOGENESIS,0.00087311,-0.15972,-0.15579,1,0
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00079435,-0.15977,-0.16797,1,0
1,GO SKELETAL MUSCLE ADAPTATION,0.037747,-0.15984,-0.15454,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.013139,-0.15988,-0.17075,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.041967,-0.15991,-0.095327,1,0
1,GO NEUROTRANSMITTER TRANSPORT,0.013465,-0.15992,-0.11189,1,0
1,GO COPII COATED VESICLE BUDDING,4.1617e-05,-0.15993,-0.17681,1,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.0010859,-0.15994,-0.14091,1,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0054795,-0.15997,-0.13529,1,0
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.03939,-0.15997,-0.19144,1,0
1,GO CHEMICAL HOMEOSTASIS,1.9873e-07,-0.16,-0.1835,1,0
1,GO AMIDE BIOSYNTHETIC PROCESS,0.00013917,-0.16004,-0.16497,1,0
1,GO ASSOCIATIVE LEARNING,0.0062634,-0.16045,-0.15546,1,0
1,GO APOPTOTIC SIGNALING PATHWAY,0.00021909,-0.16048,-0.15108,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00063551,-0.16049,-0.13592,1,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,3.6414e-07,-0.16056,-0.18245,1,0
1,GO DIGESTIVE SYSTEM PROCESS,0.00031859,-0.16064,-0.20126,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.01282,-0.16069,-0.17176,1,0
1,GO CARDIAC SEPTUM DEVELOPMENT,0.02068,-0.16069,-0.12889,1,0
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.00050664,-0.16074,-0.16858,1,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00019079,-0.16104,-0.17576,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0031536,-0.16108,-0.20557,1,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0066042,-0.16117,-0.13403,1,0
1,GO REGULATION OF PHOSPHORYLATION,2.0033e-05,-0.16122,-0.15352,1,0
1,GO ERYTHROCYTE HOMEOSTASIS,0.0007696,-0.1615,-0.16059,1,0
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.027188,-0.16158,-0.19033,1,0
1,GO MITOCHONDRIAL TRANSLATION,0.0059384,-0.16167,-0.16985,1,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0020453,-0.16173,-0.18709,1,0
1,GO HEART GROWTH,0.0097392,-0.16176,-0.12614,1,0
1,GO CELL RECOGNITION,0.00025131,-0.16192,-0.1582,1,0
1,GO NEURAL CREST CELL MIGRATION,0.025994,-0.16198,-0.1622,1,0
1,GO RESPONSE TO INTERLEUKIN 12,0.014841,-0.16199,-0.16892,1,0
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00069957,-0.162,-0.14903,1,0
1,GO ANION TRANSMEMBRANE TRANSPORT,1.8251e-06,-0.16201,-0.18019,1,0
1,GO SYNAPSE ORGANIZATION,0.045624,-0.16223,-0.09967,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0027346,-0.16223,-0.17197,1,0
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0049174,-0.16226,-0.16612,1,0
1,GO BONE MINERALIZATION,0.00057693,-0.16229,-0.19774,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.014138,-0.16231,-0.21243,1,0
1,GO RESPONSE TO PEPTIDE HORMONE,2.0033e-05,-0.16233,-0.15524,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0020453,-0.16235,-0.21651,1,0
1,GO PROTEIN DEMANNOSYLATION,0.0037331,-0.16235,-0.23587,1,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0010859,-0.16242,-0.21288,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0014738,-0.16255,-0.16375,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0033369,-0.16269,-0.14071,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.036948,-0.16284,-0.16382,1,0
1,GO RESPONSE TO ESTROGEN,0.0069616,-0.16294,-0.17036,1,0
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,3.7145e-05,-0.16306,-0.14274,1,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00067758,-0.16307,-0.184,1,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,5.2139e-05,-0.16317,-0.18561,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.015953,-0.16319,-0.11608,1,0
1,GO GRANULOCYTE MIGRATION,0.00063551,-0.16319,-0.1967,1,0
1,GO CERAMIDE METABOLIC PROCESS,9.0179e-06,-0.1632,-0.1869,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0030654,-0.16323,-0.13578,1,0
1,GO INNATE IMMUNE RESPONSE,0.00353,-0.16327,-0.17023,1,0
1,GO TRANSMEMBRANE TRANSPORT,1.2308e-06,-0.16332,-0.16528,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00049035,-0.16334,-0.15748,1,0
1,GO INTRACELLULAR LIPID TRANSPORT,0.014486,-0.16334,-0.14765,1,0
1,GO REGULATION OF RUFFLE ASSEMBLY,0.00353,-0.16345,-0.16733,1,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.0083534,-0.16352,-0.17122,1,0
1,GO MACROPHAGE MIGRATION,0.0019282,-0.16353,-0.19966,1,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.02843,-0.16356,-0.17509,1,0
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0028957,-0.16364,-0.1668,1,0
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00037661,-0.16366,-0.21803,1,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0030654,-0.16368,-0.14357,1,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,8.6584e-06,-0.16381,-0.17447,1,0
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0042883,-0.16392,-0.17361,1,0
1,GO CELLULAR ION HOMEOSTASIS,1.5691e-07,-0.16397,-0.18449,1,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.010506,-0.16403,-0.27951,1,0
1,GO RESPONSE TO INSULIN,2.2658e-06,-0.16417,-0.17854,1,0
1,GO REGULATION OF GLUCONEOGENESIS,0.00025131,-0.16419,-0.15624,1,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0017123,-0.1642,-0.13207,1,0
1,GO REGULATION OF LIPID TRANSPORT,0.00050664,-0.16423,-0.18043,1,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00044439,-0.16436,-0.19526,1,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.0051916,-0.16445,-0.16097,1,0
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.009256,-0.16449,-0.26906,1,0
1,GO GOLGI VESICLE BUDDING,2.3418e-05,-0.16456,-0.18127,1,0
1,GO MYOTUBE DIFFERENTIATION,0.011904,-0.16457,-0.12734,1,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,2.3418e-05,-0.16467,-0.15067,1,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00098941,-0.16478,-0.14898,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.0026572,-0.16481,-0.16314,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0033369,-0.16486,-0.14964,1,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0027346,-0.16491,-0.13222,1,0
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.035393,-0.16496,-0.13144,1,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.0019282,-0.16501,-0.18459,1,0
1,GO CELL JUNCTION ORGANIZATION,0.0022332,-0.16504,-0.13166,1,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.00081984,-0.16516,-0.16288,1,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0013054,-0.1652,-0.13749,1,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00037661,-0.16524,-0.20302,1,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.02268,-0.16527,-0.16284,1,0
1,GO CYTOPLASMIC TRANSLATION,0.024846,-0.16528,-0.201,1,0
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00017186,-0.1653,-0.19957,1,0
1,GO CELL JUNCTION ASSEMBLY,0.009256,-0.16535,-0.11261,1,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0049174,-0.1654,-0.15518,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,9.3916e-06,-0.1654,-0.19297,1,0
1,GO MUSCLE CELL DIFFERENTIATION,0.0021062,-0.16542,-0.1208,1,0
1,GO REGULATION OF IMMUNE RESPONSE,0.0012662,-0.16553,-0.15537,1,0
1,GO REGULATION OF OSSIFICATION,0.0046564,-0.16553,-0.15752,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0041716,-0.1656,-0.2009,1,0
1,GO DENDRITIC CELL MIGRATION,0.0024367,-0.16561,-0.24157,1,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.031059,-0.1657,-0.15434,1,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00069957,-0.1658,-0.15187,1,0
1,GO INTERLEUKIN 4 PRODUCTION,0.0013872,-0.16583,-0.19975,1,0
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.031748,-0.16594,-0.13539,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.011047,-0.16603,-0.10656,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.0032441,-0.16613,-0.1652,1,0
1,GO REGULATION OF ATP METABOLIC PROCESS,1.1964e-05,-0.16616,-0.1687,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.029068,-0.16617,-0.13243,1,0
1,GO METANEPHROS MORPHOGENESIS,0.025994,-0.16621,-0.16372,1,0
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,9.7346e-05,-0.16629,-0.14432,1,0
1,GO REGULATION OF EXOCYTOSIS,0.013798,-0.16651,-0.095547,1,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00057693,-0.16656,-0.15098,1,0
1,GO EXTRACELLULAR TRANSPORT,0.035393,-0.16687,-0.13203,1,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.004408,-0.16694,-0.12625,1,0
1,GO GLYCEROLIPID METABOLIC PROCESS,2.4346e-05,-0.16698,-0.16245,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,7.8282e-05,-0.16699,-0.19587,1,0
1,GO POSITIVE REGULATION OF BINDING,0.0033369,-0.16703,-0.12171,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,5.0683e-06,-0.16713,-0.20173,1,0
1,GO RECEPTOR RECYCLING,0.00092958,-0.16713,-0.16051,1,0
1,GO ENSHEATHMENT OF NEURONS,0.00041602,-0.16718,-0.15642,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.00045924,-0.16723,-0.19881,1,0
1,GO REGULATION OF T CELL MIGRATION,7.8282e-05,-0.16755,-0.20343,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0042883,-0.16758,-0.22846,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.7346e-05,-0.16768,-0.2051,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.017549,-0.16797,-0.17654,1,0
1,GO B CELL PROLIFERATION,6.5149e-05,-0.16806,-0.20983,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.010773,-0.16822,-0.21734,1,0
1,GO REGULATION OF SYSTEM PROCESS,1.4609e-05,-0.16827,-0.17647,1,0
1,GO POSITIVE REGULATION OF TRANSPORT,0.00011241,-0.16834,-0.1341,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0014738,-0.16852,-0.16351,1,0
1,GO INTERLEUKIN 17 PRODUCTION,0.0015189,-0.16853,-0.21569,1,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0021689,-0.16859,-0.15827,1,0
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.046579,-0.16864,-0.20664,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.00021909,-0.16864,-0.17569,1,0
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0013872,-0.16869,-0.18079,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.1964e-05,-0.16869,-0.16845,1,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.0015189,-0.16875,-0.12801,1,0
1,GO REGENERATION,0.00057693,-0.16876,-0.18039,1,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.025994,-0.16878,-0.31942,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.017969,-0.1688,-0.16024,1,0
1,GO MUSCLE CELL PROLIFERATION,0.0051916,-0.16899,-0.15056,1,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00031859,-0.16915,-0.2458,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00055855,-0.16921,-0.16982,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010245,-0.16923,-0.14992,1,0
1,GO REGULATION OF INSULIN SECRETION,0.0010206,-0.16926,-0.13659,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.029719,-0.16928,-0.20463,1,0
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0027346,-0.1693,-0.16389,1,0
1,GO RENAL SYSTEM PROCESS,0.0032441,-0.16934,-0.1737,1,0
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00013917,-0.16971,-0.15402,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0056288,-0.16975,-0.14785,1,0
1,GO RESPONSE TO ALCOHOL,0.00017796,-0.16976,-0.15629,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00011241,-0.16978,-0.14891,1,0
1,GO POSITIVE REGULATION OF OSSIFICATION,0.019283,-0.1698,-0.16358,1,0
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0087944,-0.16983,-0.1697,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.027803,-0.16995,-0.14811,1,0
1,GO B CELL ACTIVATION,1.0604e-05,-0.17004,-0.18087,1,0
1,GO POSITIVE REGULATION OF MITOPHAGY,0.03245,-0.17004,-0.15685,1,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00023468,-0.17015,-0.14948,1,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,2.3654e-06,-0.17018,-0.17189,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.027188,-0.1702,-0.16901,1,0
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.020205,-0.17021,-0.18527,1,0
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.036164,-0.17023,-0.29779,1,0
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,2.5774e-06,-0.17028,-0.16368,1,0
1,GO GASTRULATION,0.0069616,-0.17031,-0.15757,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00021167,-0.17037,-0.14149,1,0
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.00050664,-0.17052,-0.21068,1,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00059588,-0.17053,-0.19111,1,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.0025817,-0.17054,-0.17487,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,1.8521e-05,-0.17058,-0.14836,1,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0012662,-0.1706,-0.22356,1,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00029782,-0.17067,-0.18302,1,0
1,GO REGULATION OF TUBE SIZE,0.00013433,-0.17069,-0.18033,1,0
1,GO CELLULAR DEFENSE RESPONSE,0.0020453,-0.17078,-0.21343,1,0
1,GO LIPID MODIFICATION,9.0551e-05,-0.1708,-0.17423,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,3.3132e-05,-0.17093,-0.15613,1,0
1,GO RESPONSE TO BIOTIC STIMULUS,0.00065623,-0.17104,-0.16515,1,0
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0064317,-0.17107,-0.165,1,0
1,GO TRABECULA MORPHOGENESIS,0.031748,-0.1711,-0.11559,1,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.8418e-05,-0.17112,-0.15299,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,2.4346e-05,-0.17113,-0.16681,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.023741,-0.17118,-0.12011,1,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,7.2754e-05,-0.17119,-0.14541,1,0
1,GO LACTATION,0.0011549,-0.17121,-0.18637,1,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,1.5816e-05,-0.17129,-0.15818,1,0
1,GO PANCREATIC JUICE SECRETION,0.0015653,-0.1713,-0.18742,1,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0001165,-0.17136,-0.16722,1,0
1,GO RECEPTOR METABOLIC PROCESS,0.00037661,-0.17157,-0.15668,1,0
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.041093,-0.17161,-0.14687,1,0
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.029719,-0.17163,-0.19213,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.011047,-0.17169,-0.21088,1,0
1,GO COLLAGEN FIBRIL ORGANIZATION,0.036948,-0.17169,-0.19699,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0013457,-0.17174,-0.17285,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0017641,-0.17176,-0.1648,1,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00030804,-0.17177,-0.21379,1,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00052342,-0.17182,-0.18134,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.033894,-0.1719,-0.19081,1,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00049035,-0.17196,-0.18531,1,0
1,GO MEMBRANE ORGANIZATION,9.7801e-06,-0.17197,-0.15882,1,0
1,GO SECRETION,2.0033e-05,-0.17205,-0.16417,1,0
1,GO LYTIC VACUOLE ORGANIZATION,0.00059588,-0.17206,-0.17332,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,3.6228e-06,-0.17214,-0.17358,1,0
1,GO HORMONE METABOLIC PROCESS,0.00021167,-0.17215,-0.19856,1,0
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.016734,-0.17227,-0.14609,1,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.013798,-0.17227,-0.16686,1,0
1,GO PROTEIN PROCESSING,0.00072223,-0.17231,-0.175,1,0
1,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0069616,-0.17236,-0.16072,1,0
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00042998,-0.17237,-0.1618,1,0
1,GO SODIUM ION TRANSPORT,0.00010092,-0.17244,-0.17271,1,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0013457,-0.17244,-0.2162,1,0
1,GO RESPONSE TO OSMOTIC STRESS,0.00054072,-0.17259,-0.19663,1,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.0071468,-0.17261,-0.23269,1,0
1,GO CATION TRANSPORT,4.8612e-06,-0.17266,-0.17094,1,0
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0011549,-0.17277,-0.18864,1,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.00016023,-0.1728,-0.22211,1,0
1,GO CELLULAR IRON ION HOMEOSTASIS,6.0504e-05,-0.17303,-0.1854,1,0
1,GO INORGANIC ANION TRANSPORT,2.3654e-06,-0.17317,-0.18618,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.00010092,-0.17323,-0.16715,1,0
1,GO MAST CELL ACTIVATION,0.029068,-0.17332,-0.14645,1,0
1,GO CELLULAR HOMEOSTASIS,2.0829e-07,-0.17339,-0.17723,1,0
1,GO THIOESTER METABOLIC PROCESS,0.0001547,-0.17342,-0.18954,1,0
1,GO RESPONSE TO RETINOIC ACID,0.01282,-0.17347,-0.15354,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.036948,-0.17349,-0.20733,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00050664,-0.17372,-0.18799,1,0
1,GO CELLULAR AMIDE METABOLIC PROCESS,3.4728e-06,-0.17379,-0.18132,1,0
1,GO RESPONSE TO HORMONE,1.5201e-05,-0.17385,-0.17033,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0028957,-0.17392,-0.16423,1,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,1.5816e-05,-0.17426,-0.18751,1,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.6597e-05,-0.1743,-0.15484,1,0
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.8379e-05,-0.17439,-0.19008,1,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0023671,-0.17439,-0.2542,1,0
1,GO OXIDATIVE PHOSPHORYLATION,0.00084609,-0.17454,-0.18389,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.041967,-0.17461,-0.23743,1,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,9.0551e-05,-0.1748,-0.19359,1,0
1,GO METAL ION TRANSPORT,2.0784e-06,-0.17485,-0.17273,1,0
1,GO ANOIKIS,0.020205,-0.17503,-0.18164,1,0
1,GO VITAMIN D METABOLIC PROCESS,0.0040578,-0.17512,-0.2381,1,0
1,GO NEUROMUSCULAR PROCESS,0.0038387,-0.17522,-0.14402,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.012508,-0.17526,-0.15435,1,0
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.00047456,-0.17527,-0.20808,1,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,3.7145e-05,-0.17534,-0.19405,1,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.017969,-0.1754,-0.13972,1,0
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0025817,-0.17545,-0.16434,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0013054,-0.17548,-0.18505,1,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,1.1776e-06,-0.17576,-0.17259,1,0
1,GO RESPONSE TO NITROGEN COMPOUND,6.7728e-06,-0.1758,-0.15109,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,2.5308e-05,-0.17581,-0.14935,1,0
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00090094,-0.1759,-0.19513,1,0
1,GO LYMPHOCYTE MIGRATION,0.0001165,-0.17605,-0.19643,1,0
1,GO ISOPRENOID METABOLIC PROCESS,0.00059588,-0.17612,-0.18734,1,0
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0011199,-0.17615,-0.17919,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,0.0085714,-0.17615,-0.13259,1,0
1,GO LIPID BIOSYNTHETIC PROCESS,6.7728e-06,-0.17624,-0.17685,1,0
1,GO BONE MATURATION,0.023205,-0.17628,-0.13979,1,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00010845,-0.1763,-0.22525,1,0
1,GO ION HOMEOSTASIS,1.6452e-07,-0.17644,-0.19342,1,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0062634,-0.1765,-0.16138,1,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.2754e-05,-0.17651,-0.17757,1,0
1,GO ORGANIC ACID CATABOLIC PROCESS,4.3218e-05,-0.17658,-0.19378,1,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0045306,-0.17661,-0.20288,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00084609,-0.17679,-0.21991,1,0
1,GO REGULATION OF TISSUE REMODELING,0.0016129,-0.17682,-0.19612,1,0
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0015653,-0.17684,-0.16993,1,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,3.1904e-06,-0.17693,-0.17584,1,0
1,GO REGULATION OF BLOOD PRESSURE,2.9532e-05,-0.17712,-0.19487,1,0
1,GO INTEGRIN ACTIVATION,0.0054795,-0.17716,-0.19841,1,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0017123,-0.17716,-0.19137,1,0
1,GO TEMPERATURE HOMEOSTASIS,1.1964e-05,-0.17719,-0.18615,1,0
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0023671,-0.17729,-0.17945,1,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00067758,-0.17753,-0.17514,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0014738,-0.17754,-0.18768,1,0
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00022676,-0.17759,-0.20981,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.03939,-0.17772,-0.18706,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0075304,-0.17778,-0.17789,1,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0011199,-0.17781,-0.19822,1,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.00023468,-0.17784,-0.15842,1,0
1,GO RECEPTOR INTERNALIZATION,0.00034072,-0.17787,-0.15869,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,3.0689e-05,-0.17787,-0.16504,1,0
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.031059,-0.17812,-0.16188,1,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0013054,-0.17813,-0.17981,1,0
1,GO REGULATION OF MACROPHAGE MIGRATION,0.001662,-0.17813,-0.18853,1,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0064317,-0.17813,-0.20794,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.00044439,-0.17815,-0.15531,1,0
1,GO PROTEIN AUTOPROCESSING,0.0010206,-0.1782,-0.22419,1,0
1,GO PROTEIN MATURATION,3.4421e-05,-0.1782,-0.16924,1,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,1.725e-07,-0.17822,-0.20429,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00032948,-0.17829,-0.18206,1,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.00018427,-0.17848,-0.14516,1,0
1,GO GLIAL CELL MIGRATION,0.0069616,-0.17852,-0.17529,1,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,8.2505e-07,-0.17856,-0.19426,1,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.0037331,-0.17861,-0.30403,1,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.045624,-0.17863,-0.29439,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0050528,-0.17886,-0.1729,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00028792,-0.17887,-0.16053,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0030654,-0.1789,-0.18185,1,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0010528,-0.17899,-0.19156,1,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00026903,-0.17902,-0.15065,1,0
1,GO ENDOCYTIC RECYCLING,0.00047456,-0.17907,-0.16342,1,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0024367,-0.17915,-0.20237,1,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,6.5896e-07,-0.17925,-0.19203,1,0
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00029782,-0.17928,-0.16855,1,0
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,6.2786e-05,-0.17934,-0.15419,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.00030804,-0.17937,-0.21221,1,0
1,GO REGULATION OF RECEPTOR RECYCLING,0.0081404,-0.17938,-0.14701,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00027832,-0.17943,-0.19791,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0021062,-0.17945,-0.2433,1,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,2.8418e-05,-0.17947,-0.2115,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0006154,-0.17948,-0.16407,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.015953,-0.1795,-0.24008,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00090094,-0.17952,-0.18168,1,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00041602,-0.17956,-0.19704,1,0
1,GO TISSUE REMODELING,0.0031536,-0.17958,-0.19146,1,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.00010092,-0.17961,-0.23373,1,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.020205,-0.17969,-0.18112,1,0
1,GO FATTY ACID CATABOLIC PROCESS,0.00054072,-0.17986,-0.17951,1,0
1,GO REGULATION OF BONE MINERALIZATION,0.00092958,-0.18001,-0.20886,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0083534,-0.18006,-0.23034,1,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,1.2962e-05,-0.18031,-0.19233,1,0
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.011612,-0.18031,-0.21094,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0029794,-0.18053,-0.21743,1,0
1,GO COENZYME A METABOLIC PROCESS,0.0025817,-0.18064,-0.20195,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0087944,-0.18074,-0.19896,1,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0036303,-0.18074,-0.24384,1,0
1,GO ALANINE TRANSPORT,0.0040578,-0.18081,-0.21282,1,0
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0033369,-0.18103,-0.23214,1,0
1,GO ADAPTIVE THERMOGENESIS,7.3528e-06,-0.18103,-0.19741,1,0
1,GO CYTOKINE PRODUCTION,0.00081984,-0.18134,-0.17244,1,0
1,GO HYALURONAN METABOLIC PROCESS,0.00081984,-0.18139,-0.20921,1,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0026572,-0.18139,-0.1886,1,0
1,GO DEVELOPMENTAL MATURATION,0.00017186,-0.1814,-0.15692,1,0
1,GO REGULATION OF ION TRANSPORT,1.1964e-05,-0.18154,-0.18783,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,7.6603e-06,-0.18175,-0.17517,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.02166,-0.18175,-0.18297,1,0
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00030804,-0.18194,-0.16567,1,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0097392,-0.18195,-0.15731,1,0
1,GO RESPONSE TO ETHANOL,0.00010092,-0.18195,-0.16995,1,0
1,GO SELECTIVE AUTOPHAGY,0.0049174,-0.18196,-0.15428,1,0
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.019283,-0.18201,-0.20835,1,0
1,GO INTERLEUKIN 1 BETA PRODUCTION,0.010506,-0.18204,-0.1863,1,0
1,GO MEMBRANE HYPERPOLARIZATION,0.02843,-0.18204,-0.1951,1,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00017186,-0.18208,-0.16309,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.009256,-0.18213,-0.1666,1,0
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0054795,-0.18215,-0.16171,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00050664,-0.18217,-0.15517,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.013139,-0.18229,-0.20523,1,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00353,-0.18232,-0.19811,1,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00055855,-0.18236,-0.18562,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00019079,-0.18236,-0.16064,1,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0081404,-0.18247,-0.17328,1,0
1,GO ATP METABOLIC PROCESS,3.6228e-06,-0.18248,-0.18089,1,0
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,4.6597e-05,-0.18251,-0.19862,1,0
1,GO POSITIVE REGULATION OF ORGAN GROWTH,0.011047,-0.18282,-0.17314,1,0
1,GO RESPONSE TO ANGIOTENSIN,0.0097392,-0.1829,-0.20882,1,0
1,GO COMPLEMENT ACTIVATION,0.00050664,-0.18291,-0.22418,1,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.0053338,-0.183,-0.27366,1,0
1,GO CELL ACTIVATION,0.00019753,-0.18309,-0.17592,1,0
1,GO FLUID TRANSPORT,3.0689e-05,-0.18312,-0.23315,1,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0060989,-0.18312,-0.17058,1,0
1,GO PROTEIN AUTOPHOSPHORYLATION,1.9263e-05,-0.18313,-0.17177,1,0
1,GO NEUROINFLAMMATORY RESPONSE,2.9532e-05,-0.18316,-0.22966,1,0
1,GO AEROBIC RESPIRATION,0.00020448,-0.1832,-0.19987,1,0
1,GO PEPTIDE METABOLIC PROCESS,2.2524e-05,-0.18323,-0.18012,1,0
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0012662,-0.18337,-0.17323,1,0
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00045924,-0.1834,-0.152,1,0
1,GO INTERFERON GAMMA PRODUCTION,0.00074557,-0.18341,-0.19077,1,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,2.1702e-06,-0.18341,-0.20093,1,0
1,GO CELL CELL ADHESION,0.00063551,-0.18346,-0.16103,1,0
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0085714,-0.18349,-0.1947,1,0
1,GO GLIAL CELL ACTIVATION,0.0001547,-0.1835,-0.24158,1,0
1,GO FIBRINOLYSIS,0.0067808,-0.18355,-0.29089,1,0
1,GO O GLYCAN PROCESSING,0.0047853,-0.18357,-0.21114,1,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.041967,-0.18371,-0.14917,1,0
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0097392,-0.18378,-0.12384,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,8.7323e-05,-0.18389,-0.18016,1,0
1,GO PROTEIN ACTIVATION CASCADE,0.00057693,-0.18393,-0.24518,1,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,6.2985e-07,-0.18409,-0.18423,1,0
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.031059,-0.18412,-0.18801,1,0
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0013054,-0.18424,-0.17746,1,0
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,2.5308e-05,-0.18426,-0.16039,1,0
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,1.1493e-05,-0.18429,-0.15787,1,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,1.1267e-06,-0.18433,-0.18697,1,0
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00020448,-0.18434,-0.24521,1,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0018173,-0.1844,-0.16114,1,0
1,GO RESPONSE TO STEROID HORMONE,0.0001547,-0.18442,-0.17596,1,0
1,GO LIPID OXIDATION,0.00049035,-0.1845,-0.18465,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00090094,-0.18464,-0.23835,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,3.6228e-06,-0.18467,-0.17774,1,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00021167,-0.18471,-0.18925,1,0
1,GO SECONDARY METABOLIC PROCESS,0.00069957,-0.1849,-0.23743,1,0
1,GO P38MAPK CASCADE,0.00353,-0.18491,-0.18108,1,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,1.1493e-05,-0.18491,-0.18662,1,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00018427,-0.18494,-0.21857,1,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00034072,-0.1851,-0.16114,1,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0071468,-0.18512,-0.19504,1,0
1,GO CELLULAR RESPONSE TO STARVATION,0.00017186,-0.1852,-0.1643,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.033894,-0.1853,-0.26027,1,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.7343e-05,-0.18533,-0.19759,1,0
1,GO VASCULATURE DEVELOPMENT,0.00040247,-0.18534,-0.18042,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.001662,-0.18539,-0.16989,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00054072,-0.18557,-0.177,1,0
1,GO ENTRY INTO HOST,0.0017123,-0.18563,-0.23969,1,0
1,GO RESPONSE TO CYTOKINE,0.00038934,-0.18563,-0.183,1,0
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00025131,-0.18568,-0.18756,1,0
1,GO RESPONSE TO CADMIUM ION,0.0056288,-0.18581,-0.22558,1,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.001191,-0.18585,-0.21843,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00014935,-0.18591,-0.2032,1,0
1,GO AUTOPHAGOSOME ORGANIZATION,0.00079435,-0.18599,-0.17759,1,0
1,GO REGULATION OF ACROSOME REACTION,0.021165,-0.18606,-0.23236,1,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.03939,-0.18607,-0.11877,1,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0051916,-0.18622,-0.15937,1,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0001547,-0.1863,-0.24686,1,0
1,GO MODULATION BY HOST OF VIRAL PROCESS,0.00090094,-0.18636,-0.2208,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,1.6455e-05,-0.18643,-0.21418,1,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.8612e-06,-0.18648,-0.19423,1,0
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0015189,-0.18649,-0.21894,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0039469,-0.18655,-0.19445,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0001547,-0.18664,-0.16092,1,0
1,GO REGULATION OF PHAGOCYTOSIS,0.00016595,-0.18665,-0.22336,1,0
1,GO PROTEIN TETRAMERIZATION,1.1776e-06,-0.18669,-0.19202,1,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,4.3218e-05,-0.18678,-0.18734,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.4121e-05,-0.1868,-0.19827,1,0
1,GO MUSCLE ADAPTATION,0.00021167,-0.18681,-0.19996,1,0
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.02166,-0.18684,-0.17811,1,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00092958,-0.1869,-0.17579,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0013054,-0.18702,-0.21678,1,0
1,GO SULFUR COMPOUND TRANSPORT,0.00037661,-0.18711,-0.17226,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00059588,-0.18712,-0.16762,1,0
1,GO TERPENOID METABOLIC PROCESS,0.00050664,-0.18722,-0.20664,1,0
1,GO ETHER BIOSYNTHETIC PROCESS,0.009256,-0.18728,-0.28437,1,0
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.0049174,-0.18738,-0.20511,1,0
1,GO INSULIN SECRETION,0.0014299,-0.1874,-0.14311,1,0
1,GO MYOBLAST PROLIFERATION,0.0025817,-0.1874,-0.19742,1,0
1,GO LYMPHOCYTE CHEMOTAXIS,0.00031859,-0.18754,-0.19706,1,0
1,GO REGULATION OF BIOMINERALIZATION,0.0001165,-0.18763,-0.2152,1,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,4.4712e-06,-0.18784,-0.2015,1,0
1,GO LEUKOCYTE CELL CELL ADHESION,0.00049035,-0.18786,-0.18083,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,1.104e-05,-0.18797,-0.18485,1,0
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.044685,-0.18801,-0.19797,1,0
1,GO SEROTONIN TRANSPORT,0.0079323,-0.18803,-0.23915,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.012203,-0.18824,-0.19978,1,0
1,GO SUPEROXIDE METABOLIC PROCESS,0.0023671,-0.18835,-0.1855,1,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.019283,-0.18838,-0.20004,1,0
1,GO T CELL CYTOKINE PRODUCTION,0.0037331,-0.18843,-0.19204,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,6.0504e-05,-0.18863,-0.1757,1,0
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.02843,-0.18868,-0.21255,1,0
1,GO PIGMENT METABOLIC PROCESS,0.00022676,-0.1889,-0.22166,1,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0011199,-0.18894,-0.1857,1,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.00031859,-0.18896,-0.21677,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.001986,-0.18898,-0.17055,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,9.0221e-07,-0.18902,-0.16275,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0051916,-0.18921,-0.19228,1,0
1,GO STEROL TRANSPORT,7.2754e-05,-0.18933,-0.22657,1,0
1,GO SEQUESTERING OF METAL ION,0.0079323,-0.18936,-0.19287,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.00037661,-0.18947,-0.18644,1,0
1,GO PROTEIN HOMOTETRAMERIZATION,3.0689e-05,-0.18947,-0.17347,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,3.7791e-06,-0.18948,-0.205,1,0
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0060989,-0.18952,-0.24002,1,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.6322e-07,-0.18954,-0.19969,1,0
1,GO MEMBRANE FUSION,8.7323e-05,-0.18958,-0.18978,1,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,1.3441e-06,-0.1897,-0.24727,1,0
1,GO RESPONSE TO OXIDATIVE STRESS,1.7806e-05,-0.18978,-0.19328,1,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0046564,-0.18982,-0.17519,1,0
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0006154,-0.1899,-0.14445,1,0
1,GO NERVE DEVELOPMENT,0.0085714,-0.1899,-0.17406,1,0
1,GO ORGANIC ACID METABOLIC PROCESS,7.889e-07,-0.19,-0.19156,1,0
1,GO EXOCYTIC PROCESS,0.016339,-0.19004,-0.11899,1,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0079323,-0.19013,-0.20378,1,0
1,GO REGULATION OF B CELL PROLIFERATION,0.00022676,-0.19018,-0.22932,1,0
1,GO URETER DEVELOPMENT,0.029719,-0.19019,-0.17323,1,0
1,GO MYELIN ASSEMBLY,0.0029794,-0.19022,-0.21114,1,0
1,GO DIET INDUCED THERMOGENESIS,0.0038387,-0.19022,-0.20068,1,0
1,GO TRANSITION METAL ION HOMEOSTASIS,8.6584e-06,-0.19028,-0.22856,1,0
1,GO FEMALE GENITALIA DEVELOPMENT,0.02843,-0.1903,-0.16103,1,0
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0046564,-0.19032,-0.24721,1,0
1,GO PLATELET ACTIVATION,0.00014418,-0.19038,-0.20359,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,2.0033e-05,-0.19038,-0.18738,1,0
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0021689,-0.19062,-0.1613,1,0
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.046579,-0.19072,-0.14823,1,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00079435,-0.19073,-0.18632,1,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0024367,-0.19075,-0.21818,1,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0020453,-0.19076,-0.16727,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0011549,-0.19082,-0.17771,1,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.7806e-05,-0.19083,-0.22298,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,7.889e-07,-0.19099,-0.19024,1,0
1,GO IMMUNE EFFECTOR PROCESS,0.00049035,-0.19107,-0.18374,1,0
1,GO HYALURONAN CATABOLIC PROCESS,0.014138,-0.19109,-0.29408,1,0
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0014738,-0.19113,-0.18702,1,0
1,GO PROSTANOID METABOLIC PROCESS,0.0071468,-0.19114,-0.25184,1,0
1,GO ION TRANSPORT,1.8251e-06,-0.19117,-0.17525,1,0
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,6.0504e-05,-0.1913,-0.18268,1,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.009256,-0.19147,-0.19523,1,0
1,GO LIPOPROTEIN LOCALIZATION,0.00019079,-0.1915,-0.22522,1,0
1,GO NEGATIVE REGULATION OF GROWTH,8.1192e-05,-0.19154,-0.181,1,0
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.041967,-0.19154,-0.20683,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,6.0198e-07,-0.19155,-0.21074,1,0
1,GO PROGESTERONE METABOLIC PROCESS,0.046579,-0.1916,-0.3228,1,0
1,GO INTERLEUKIN 1 PRODUCTION,0.015574,-0.19183,-0.19053,1,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0015189,-0.19188,-0.22697,1,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,2.1702e-06,-0.19192,-0.21955,1,0
1,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00040247,-0.19203,-0.19872,1,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00087311,-0.19206,-0.18465,1,0
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0012662,-0.19206,-0.17498,1,0
1,GO LIPID CATABOLIC PROCESS,2.3418e-05,-0.19212,-0.18903,1,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,5.2837e-06,-0.19216,-0.20448,1,0
1,GO DEFENSE RESPONSE,0.00034072,-0.19248,-0.17723,1,0
1,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0011199,-0.19252,-0.21459,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0071468,-0.19257,-0.19791,1,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,4.4878e-05,-0.19262,-0.20493,1,0
1,GO STEROID METABOLIC PROCESS,6.2367e-06,-0.19278,-0.21613,1,0
1,GO INFLAMMATORY RESPONSE,0.00019753,-0.19285,-0.19733,1,0
1,GO PENTOSE METABOLIC PROCESS,0.00087311,-0.19287,-0.28247,1,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0021062,-0.19288,-0.17314,1,0
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0083534,-0.1929,-0.16396,1,0
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.015574,-0.19299,-0.20827,1,0
1,GO ELASTIC FIBER ASSEMBLY,0.024288,-0.19322,-0.33728,1,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0056288,-0.19322,-0.15127,1,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00014418,-0.19326,-0.20697,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.00067758,-0.19331,-0.25019,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.019739,-0.19342,-0.12699,1,0
1,GO REGULATION OF NEURON MATURATION,0.025414,-0.19344,-0.17527,1,0
1,GO AMINO ACID ACTIVATION,0.011047,-0.19352,-0.17726,1,0
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.007729,-0.19359,-0.20375,1,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,5.7413e-06,-0.19366,-0.1895,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00067758,-0.19368,-0.23104,1,0
1,GO RESPONSE TO STEROL,0.00021909,-0.19371,-0.25073,1,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00054072,-0.19374,-0.21361,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,2.9532e-05,-0.19387,-0.18567,1,0
1,GO VIRAL GENE EXPRESSION,0.025994,-0.19389,-0.17128,1,0
1,GO SENSORY PERCEPTION OF SMELL,1.1267e-06,-0.19393,-0.1992,1,0
1,GO CIRCULATORY SYSTEM PROCESS,4.8612e-06,-0.19397,-0.18801,1,0
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.00038934,-0.19402,-0.20466,1,0
1,GO ORGANELLE MEMBRANE FUSION,0.00049035,-0.19404,-0.17774,1,0
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,3.3132e-05,-0.19411,-0.23804,1,0
1,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0069616,-0.19414,-0.15986,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00092958,-0.1942,-0.23286,1,0
1,GO COAGULATION,0.00016595,-0.19427,-0.20263,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00063551,-0.19429,-0.17897,1,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.009256,-0.19439,-0.16403,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,9.8628e-07,-0.19439,-0.18836,1,0
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0001547,-0.19444,-0.19753,1,0
1,GO T CELL PROLIFERATION,0.00021167,-0.19454,-0.20433,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.017549,-0.19459,-0.19719,1,0
1,GO SPHINGOLIPID METABOLIC PROCESS,2.2524e-05,-0.19464,-0.20176,1,0
1,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0046564,-0.19467,-0.1816,1,0
1,GO FAT CELL DIFFERENTIATION,0.0006154,-0.19487,-0.17334,1,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.021165,-0.19488,-0.19082,1,0
1,GO VACUOLE ORGANIZATION,4.8379e-05,-0.19501,-0.17276,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,0.0017641,-0.19507,-0.14897,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0007696,-0.19526,-0.27811,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0032441,-0.19546,-0.25081,1,0
1,GO TETRAPYRROLE METABOLIC PROCESS,0.00019079,-0.19552,-0.2309,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.00055855,-0.19561,-0.19613,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.00081984,-0.19568,-0.16066,1,0
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.044685,-0.19575,-0.16477,1,0
1,GO AMYLOID BETA CLEARANCE,0.00092958,-0.19577,-0.24168,1,0
1,GO DE NOVO PROTEIN FOLDING,0.00041602,-0.19578,-0.19361,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,4.6597e-05,-0.19579,-0.24924,1,0
1,GO BIOLOGICAL ADHESION,0.00014418,-0.19579,-0.18129,1,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.0015653,-0.19581,-0.1775,1,0
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00036427,-0.19583,-0.19952,1,0
1,GO STEROL HOMEOSTASIS,4.0073e-05,-0.19585,-0.23522,1,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00023468,-0.19594,-0.19954,1,0
1,GO AMYLOID FIBRIL FORMATION,0.0075304,-0.19595,-0.2538,1,0
1,GO REGULATION OF EXOSOMAL SECRETION,0.0046564,-0.19595,-0.20095,1,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00063551,-0.19599,-0.18673,1,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00026903,-0.19605,-0.25817,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00019753,-0.19606,-0.26854,1,0
1,GO MACROPHAGE CHEMOTAXIS,0.00037661,-0.19609,-0.23419,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00045924,-0.19616,-0.1797,1,0
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.389e-05,-0.1962,-0.22797,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00010845,-0.19626,-0.16886,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.8583e-05,-0.19628,-0.20349,1,0
1,GO MUSCLE ORGAN MORPHOGENESIS,0.0030654,-0.1963,-0.14989,1,0
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00036427,-0.19643,-0.28315,1,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,3.1904e-06,-0.19644,-0.17272,1,0
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,5.4121e-05,-0.19657,-0.23534,1,0
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00095906,-0.19662,-0.1818,1,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00010092,-0.19666,-0.2814,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,5.2837e-06,-0.1969,-0.1895,1,0
1,GO ENDOCYTOSIS,0.00016023,-0.19692,-0.15552,1,0
1,GO RESPONSE TO PH,0.0010859,-0.19704,-0.21073,1,0
1,GO NOTCH SIGNALING PATHWAY,0.0022332,-0.19721,-0.159,1,0
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.010245,-0.19733,-0.18897,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00059588,-0.19736,-0.22458,1,0
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,7.0571e-06,-0.19741,-0.20379,1,0
1,GO RESPONSE TO AXON INJURY,0.0083534,-0.19749,-0.13765,1,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,1.7806e-05,-0.19756,-0.2041,1,0
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00016595,-0.19777,-0.22915,1,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0016129,-0.19787,-0.20324,1,0
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00025131,-0.1979,-0.20256,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0066042,-0.19804,-0.157,1,0
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.011612,-0.1981,-0.17522,1,0
1,GO RESPONSE TO OXYGEN LEVELS,6.7728e-06,-0.19813,-0.20722,1,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013872,-0.19818,-0.17185,1,0
1,GO REGULATION OF LIPID LOCALIZATION,8.7323e-05,-0.19846,-0.20407,1,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0069616,-0.19859,-0.15827,1,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.029719,-0.19864,-0.22369,1,0
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,4.1617e-05,-0.19872,-0.16908,1,0
1,GO CELLULAR RESPONSE TO IRON ION,0.036164,-0.1988,-0.16854,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00045924,-0.19882,-0.20381,1,0
1,GO LIPID TRANSLOCATION,0.010245,-0.19891,-0.17211,1,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.014841,-0.19894,-0.17924,1,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00020448,-0.199,-0.26256,1,0
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0083534,-0.199,-0.18042,1,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.2308e-06,-0.19914,-0.19119,1,0
1,GO BLOOD VESSEL REMODELING,0.0006154,-0.19916,-0.25782,1,0
1,GO COPPER ION TRANSPORT,0.0018173,-0.19921,-0.21789,1,0
1,GO CHLORIDE TRANSPORT,1.5816e-05,-0.19921,-0.2005,1,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,4.1617e-05,-0.19926,-0.19687,1,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.001662,-0.19927,-0.22035,1,0
1,GO REGULATION OF BODY FLUID LEVELS,8.7323e-05,-0.19931,-0.19007,1,0
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00090094,-0.19932,-0.19726,1,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,1.6729e-06,-0.19945,-0.17705,1,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.001662,-0.19945,-0.19485,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00025131,-0.19954,-0.24122,1,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.00010462,-0.19964,-0.19019,1,0
1,GO LIPID LOCALIZATION,1.4609e-05,-0.19969,-0.19936,1,0
1,GO RESPONSE TO MINERALOCORTICOID,0.00034072,-0.19985,-0.24295,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.03939,-0.19986,-0.20981,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00017796,-0.19995,-0.18432,1,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,5.0194e-07,-0.19995,-0.20522,1,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.0090226,-0.20008,-0.14218,1,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00036427,-0.20008,-0.16581,1,0
1,GO RESPONSE TO MANGANESE ION,0.011904,-0.20013,-0.18854,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.004408,-0.20015,-0.20671,1,0
1,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0062634,-0.20015,-0.30156,1,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00045924,-0.20018,-0.22667,1,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.0033369,-0.20042,-0.18613,1,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,7.9801e-06,-0.20042,-0.21607,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0032441,-0.2005,-0.15484,1,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0067808,-0.20074,-0.20171,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.9532e-05,-0.20077,-0.18278,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,4.8612e-06,-0.20082,-0.19088,1,0
1,GO ACTIN FILAMENT SEVERING,0.02166,-0.20084,-0.27481,1,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0053338,-0.20092,-0.20735,1,0
1,GO RESPONSE TO HISTAMINE,0.0081404,-0.20098,-0.29345,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0040578,-0.20099,-0.20079,1,0
1,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00084609,-0.20102,-0.20235,1,0
1,GO BLOOD VESSEL MORPHOGENESIS,0.00019079,-0.20125,-0.20422,1,0
1,GO ACTIN CROSSLINK FORMATION,0.021165,-0.20128,-0.15837,1,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.013139,-0.20144,-0.18679,1,0
1,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0033369,-0.2015,-0.20482,1,0
1,GO OOCYTE DIFFERENTIATION,3.7145e-05,-0.20169,-0.18576,1,0
1,GO MEMBRANE REPOLARIZATION,9.7346e-05,-0.2017,-0.22423,1,0
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0026572,-0.20182,-0.18433,1,0
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00034072,-0.20188,-0.18302,1,0
1,GO REGULATION OF MUSCLE CONTRACTION,1.6729e-06,-0.2019,-0.21998,1,0
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.037747,-0.20194,-0.18974,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0014299,-0.20218,-0.329,1,0
1,GO GLUCOSE METABOLIC PROCESS,3.3202e-07,-0.2022,-0.20034,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,3.7791e-06,-0.20223,-0.22001,1,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.0027346,-0.20225,-0.25143,1,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,6.7596e-05,-0.20226,-0.28543,1,0
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0007696,-0.20234,-0.19464,1,0
1,GO CELLULAR RESPONSE TO PH,0.00026003,-0.20237,-0.21954,1,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.033166,-0.20238,-0.15078,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0007696,-0.20253,-0.33405,1,0
1,GO T CELL APOPTOTIC PROCESS,0.010773,-0.2026,-0.15359,1,0
1,GO DENDRITIC CELL DIFFERENTIATION,0.0032441,-0.20272,-0.29182,1,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0013054,-0.20274,-0.16662,1,0
1,GO VESICLE TARGETING,1.7118e-05,-0.2029,-0.21439,1,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,1.9873e-07,-0.20299,-0.21404,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.03939,-0.20318,-0.21073,1,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00090094,-0.20318,-0.17236,1,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0012662,-0.20327,-0.22423,1,0
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0031536,-0.20327,-0.20991,1,0
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0030654,-0.20336,-0.32892,1,0
1,GO REGULATION OF METAL ION TRANSPORT,1.2308e-06,-0.20337,-0.19862,1,0
1,GO RESPONSE TO PROTOZOAN,0.00067758,-0.20341,-0.23174,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00079435,-0.20348,-0.21435,1,0
1,GO GOLGI RIBBON FORMATION,0.0099891,-0.2036,-0.15102,1,0
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00050664,-0.20373,-0.23069,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0011199,-0.20377,-0.21976,1,0
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0054795,-0.20379,-0.32941,1,0
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0053338,-0.2039,-0.24848,1,0
1,GO BIOMINERALIZATION,0.00026003,-0.20391,-0.19502,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.019283,-0.20398,-0.21553,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.013465,-0.20401,-0.21419,1,0
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0016129,-0.20406,-0.23567,1,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0017641,-0.20419,-0.19311,1,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0038387,-0.20422,-0.18811,1,0
1,GO VITAMIN METABOLIC PROCESS,4.8612e-06,-0.20438,-0.21808,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00052342,-0.20439,-0.22783,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0097392,-0.20452,-0.18106,1,0
1,GO MYOFIBRIL ASSEMBLY,0.001228,-0.20455,-0.1698,1,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,2.8077e-06,-0.20466,-0.20526,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.012203,-0.20475,-0.27604,1,0
1,GO POTASSIUM ION TRANSPORT,0.00069957,-0.20484,-0.1693,1,0
1,GO REGULATION OF CELL ADHESION,0.00034072,-0.20487,-0.1889,1,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.001872,-0.20497,-0.23142,1,0
1,GO MUSCLE CELL DEVELOPMENT,0.00011241,-0.205,-0.18194,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00047456,-0.20502,-0.19693,1,0
1,GO HYPOTONIC RESPONSE,0.0028141,-0.20516,-0.26727,1,0
1,GO STEROL METABOLIC PROCESS,6.5149e-05,-0.20524,-0.19586,1,0
1,GO RESPONSE TO INTERLEUKIN 2,0.0062634,-0.20527,-0.17614,1,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.0023671,-0.20532,-0.18354,1,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00036427,-0.20542,-0.19869,1,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,8.4205e-05,-0.2055,-0.1909,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.1888e-05,-0.20557,-0.17477,1,0
1,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0015189,-0.20561,-0.26631,1,0
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,7.0571e-06,-0.20564,-0.20522,1,0
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00065623,-0.20564,-0.20449,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,2.0033e-05,-0.20571,-0.19838,1,0
1,GO RESPONSE TO CHEMOKINE,4.3763e-07,-0.2058,-0.22913,1,0
1,GO PHOSPHOLIPID TRANSPORT,0.00010845,-0.20582,-0.19274,1,0
1,GO FOCAL ADHESION ASSEMBLY,0.0062634,-0.20599,-0.18457,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00054072,-0.20599,-0.20786,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.045624,-0.2061,-0.14253,1,0
1,GO RESPONSE TO LIPID,6.0504e-05,-0.20621,-0.17673,1,0
1,GO ENDODERM DEVELOPMENT,0.0036303,-0.20637,-0.23807,1,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0069616,-0.2065,-0.19061,1,0
1,GO DETECTION OF BIOTIC STIMULUS,0.0060989,-0.2065,-0.25964,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.2962e-05,-0.20652,-0.21599,1,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,9.7346e-05,-0.20653,-0.19326,1,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,8.7323e-05,-0.20654,-0.23697,1,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,9.0179e-06,-0.20659,-0.22705,1,0
1,GO PHAGOCYTOSIS RECOGNITION,0.02166,-0.2068,-0.23759,1,0
1,GO INTERLEUKIN 8 PRODUCTION,0.0087944,-0.20684,-0.18568,1,0
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.02268,-0.20688,-0.25676,1,0
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0087944,-0.20709,-0.21127,1,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00031859,-0.20712,-0.20963,1,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,2.6902e-06,-0.20714,-0.18397,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,4.3763e-07,-0.20716,-0.236,1,0
1,GO REGULATION OF ACTION POTENTIAL,0.00095906,-0.20724,-0.20234,1,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00017186,-0.20728,-0.23367,1,0
1,GO RESPONSE TO STARVATION,3.8583e-05,-0.20732,-0.18692,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,1.5816e-05,-0.20733,-0.18851,1,0
1,GO ADIPOSE TISSUE DEVELOPMENT,8.4205e-05,-0.20736,-0.20311,1,0
1,GO IRON ION HOMEOSTASIS,2.2524e-05,-0.20736,-0.21537,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.031748,-0.20741,-0.22593,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,3.0264e-07,-0.20743,-0.2021,1,0
1,GO BLASTODERM SEGMENTATION,0.0075304,-0.20756,-0.29828,1,0
1,GO BLASTOCYST FORMATION,2.4346e-05,-0.20768,-0.21171,1,0
1,GO RESPONSE TO LEPTIN,0.00017186,-0.20775,-0.23664,1,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0020453,-0.20782,-0.21101,1,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,7.2111e-07,-0.2079,-0.25463,1,0
1,GO ADAPTIVE IMMUNE RESPONSE,0.0010528,-0.20794,-0.20485,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.034637,-0.20796,-0.12455,1,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,1.104e-05,-0.20824,-0.18846,1,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,4.7955e-07,-0.20854,-0.22859,1,0
1,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.02843,-0.20857,-0.22404,1,0
1,GO ALCOHOL METABOLIC PROCESS,2.6902e-06,-0.2086,-0.21081,1,0
1,GO RESPONSE TO BACTERIUM,0.00034072,-0.20867,-0.18389,1,0
1,GO REGULATION OF AUTOPHAGY,1.6015e-06,-0.20875,-0.18468,1,0
1,GO LIPID METABOLIC PROCESS,7.3528e-06,-0.20876,-0.18515,1,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,1.8084e-07,-0.20884,-0.21328,1,0
1,GO SULFUR COMPOUND METABOLIC PROCESS,9.0221e-07,-0.20914,-0.22346,1,0
1,GO CELLULAR ANION HOMEOSTASIS,0.027188,-0.20927,-0.16278,1,0
1,GO SIGNAL PEPTIDE PROCESSING,0.042857,-0.20929,-0.16832,1,0
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0039469,-0.20933,-0.25394,1,0
1,GO ENDOCRINE HORMONE SECRETION,0.014841,-0.20935,-0.15253,1,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0083534,-0.20936,-0.17043,1,0
1,GO RESPONSE TO TESTOSTERONE,0.017549,-0.2094,-0.15864,1,0
1,GO OXIDATION REDUCTION PROCESS,5.753e-07,-0.20948,-0.20892,1,0
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,2.0033e-05,-0.20975,-0.19508,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,3.4772e-07,-0.20984,-0.2047,1,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0067808,-0.20985,-0.16483,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.4609e-05,-0.21008,-0.21025,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.011326,-0.21019,-0.16189,1,0
1,GO B CELL MEDIATED IMMUNITY,0.00012512,-0.21021,-0.23585,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0030654,-0.21024,-0.24569,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0021689,-0.21027,-0.2257,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.019739,-0.21045,-0.24776,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00079435,-0.21051,-0.19445,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0021062,-0.21061,-0.19328,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00010092,-0.21074,-0.18018,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,0.0025817,-0.21092,-0.2796,1,0
1,GO RESPONSE TO TOXIC SUBSTANCE,6.0198e-07,-0.21104,-0.24154,1,0
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.036948,-0.2111,-0.19579,1,0
1,GO EXOCYTOSIS,6.0504e-05,-0.2111,-0.18982,1,0
1,GO ENGULFMENT OF APOPTOTIC CELL,2.3418e-05,-0.21115,-0.27433,1,0
1,GO PYRUVATE METABOLIC PROCESS,6.5896e-07,-0.21145,-0.2228,1,0
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00012512,-0.21151,-0.25649,1,0
1,GO REFLEX,0.045624,-0.21166,-0.21374,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.012508,-0.2117,-0.17693,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00049035,-0.21174,-0.18334,1,0
1,GO POSITIVE REGULATION OF COAGULATION,0.0054795,-0.21175,-0.20065,1,0
1,GO T CELL MIGRATION,0.00019753,-0.21183,-0.23231,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,1.7474e-06,-0.21193,-0.20933,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0001165,-0.21206,-0.20405,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00016595,-0.21212,-0.21841,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00042998,-0.21233,-0.24281,1,0
1,GO SULFATE TRANSPORT,0.00017796,-0.21234,-0.18267,1,0
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.00049035,-0.21236,-0.24646,1,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0010859,-0.21267,-0.29256,1,0
1,GO REGULATION OF BLOOD CIRCULATION,7.6603e-06,-0.21283,-0.21975,1,0
1,GO REGULATION OF ENDOCYTOSIS,7.013e-05,-0.21295,-0.17296,1,0
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,6.0504e-05,-0.21295,-0.21695,1,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0036303,-0.21296,-0.27742,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00032948,-0.21296,-0.25151,1,0
1,GO SPERM EGG RECOGNITION,9.7801e-06,-0.21308,-0.23485,1,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.038561,-0.21325,-0.15955,1,0
1,GO LEUKOCYTE MEDIATED IMMUNITY,0.00026003,-0.21332,-0.2073,1,0
1,GO REGULATION OF LYMPHOCYTE MIGRATION,4.6597e-05,-0.21339,-0.22646,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00010462,-0.21343,-0.28147,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0019282,-0.21351,-0.20954,1,0
1,GO SPROUTING ANGIOGENESIS,0.00037661,-0.21357,-0.2027,1,0
1,GO CELL CELL RECOGNITION,8.6584e-06,-0.21382,-0.25324,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0028141,-0.21382,-0.23358,1,0
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0011549,-0.21389,-0.24194,1,0
1,GO GLAND MORPHOGENESIS,0.011326,-0.21398,-0.19427,1,0
1,GO TROPHOBLAST CELL MIGRATION,0.017137,-0.21403,-0.26581,1,0
1,GO POLYOL BIOSYNTHETIC PROCESS,2.8891e-07,-0.21404,-0.25242,1,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0022332,-0.21408,-0.20416,1,0
1,GO REGULATION OF LYASE ACTIVITY,0.00063551,-0.21414,-0.20942,1,0
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00017796,-0.21438,-0.22335,1,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.00030804,-0.21438,-0.2559,1,0
1,GO STRIATED MUSCLE ADAPTATION,0.00074557,-0.21439,-0.20547,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00023468,-0.21443,-0.18521,1,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.00026903,-0.21467,-0.20207,1,0
1,GO LEUKOCYTE CHEMOTAXIS,8.4205e-05,-0.21477,-0.2114,1,0
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0040578,-0.21478,-0.18408,1,0
1,GO POSITIVE REGULATION OF JNK CASCADE,0.00057693,-0.21501,-0.16438,1,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00095906,-0.21509,-0.27392,1,0
1,GO LAMELLIPODIUM ORGANIZATION,0.00035231,-0.21513,-0.18983,1,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,5.753e-07,-0.21513,-0.23095,1,0
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.021165,-0.21517,-0.19398,1,0
1,GO FOLIC ACID METABOLIC PROCESS,0.00041602,-0.21523,-0.23319,1,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0040578,-0.21542,-0.20885,1,0
1,GO PROTEIN HYDROXYLATION,0.0010206,-0.21548,-0.29704,1,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0039469,-0.21565,-0.22283,1,0
1,GO FIBROBLAST PROLIFERATION,0.00079435,-0.21566,-0.23527,1,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00052342,-0.21583,-0.23654,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.036164,-0.21586,-0.19506,1,0
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.0604e-05,-0.21591,-0.21491,1,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.00026003,-0.216,-0.19596,1,0
1,GO LAMELLIPODIUM ASSEMBLY,3.0689e-05,-0.21616,-0.2034,1,0
1,GO STRESS FIBER ASSEMBLY,0.0050528,-0.21621,-0.18322,1,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00012964,-0.2163,-0.19823,1,0
1,GO MYELOID CELL APOPTOTIC PROCESS,0.0036303,-0.21645,-0.2623,1,0
1,GO RESPONSE TO SALT,0.00035231,-0.21648,-0.17174,1,0
1,GO PEPTIDYL TYROSINE MODIFICATION,0.00054072,-0.21663,-0.17604,1,0
1,GO WHITE FAT CELL DIFFERENTIATION,0.00032948,-0.21675,-0.23219,1,0
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0087944,-0.21679,-0.35507,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00012512,-0.2168,-0.20323,1,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00067758,-0.21702,-0.28224,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,7.6603e-06,-0.21703,-0.20943,1,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0022332,-0.21706,-0.30547,1,0
1,GO ENDODERMAL CELL DIFFERENTIATION,0.0050528,-0.21708,-0.26942,1,0
1,GO REGULATION OF URINE VOLUME,0.0021689,-0.21727,-0.17499,1,0
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0071468,-0.21733,-0.21417,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0007696,-0.21738,-0.21457,1,0
1,GO DOPAMINE METABOLIC PROCESS,0.011047,-0.21739,-0.17042,1,0
1,GO ICOSANOID METABOLIC PROCESS,1.349e-05,-0.21742,-0.2691,1,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.00024286,-0.21744,-0.22708,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.013798,-0.21745,-0.194,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,6.5149e-05,-0.2175,-0.21916,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00030804,-0.21788,-0.18731,1,0
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,5.2139e-05,-0.2179,-0.23897,1,0
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0099891,-0.2179,-0.23234,1,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,1.5691e-07,-0.21812,-0.21075,1,0
1,GO RESPONSE TO METAL ION,5.4977e-07,-0.21822,-0.22748,1,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00095906,-0.21835,-0.35935,1,0
1,GO REGULATION OF CHEMOTAXIS,1.4039e-05,-0.21839,-0.21096,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0067808,-0.21842,-0.2234,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.025994,-0.21855,-0.24856,1,0
1,GO REGULATION OF VASCULAR PERMEABILITY,2.8418e-05,-0.21855,-0.24996,1,0
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.00029782,-0.2186,-0.15849,1,0
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00021167,-0.21872,-0.229,1,0
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00067758,-0.21876,-0.29026,1,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0075304,-0.21881,-0.13659,1,0
1,GO HISTONE SERINE PHOSPHORYLATION,0.00057693,-0.21883,-0.23799,1,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0025817,-0.21908,-0.21576,1,0
1,GO POSITIVE REGULATION OF T CELL MIGRATION,2.1663e-05,-0.2191,-0.24192,1,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0022332,-0.21919,-0.16944,1,0
1,GO REGULATION OF FIBRINOLYSIS,1.6455e-05,-0.21923,-0.37443,1,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.00038934,-0.21931,-0.20769,1,0
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.0039469,-0.21942,-0.22925,1,0
1,GO LIPID DIGESTION,0.0028141,-0.21943,-0.26863,1,0
1,GO REGULATION OF PROTEIN BINDING,1.6455e-05,-0.21946,-0.19048,1,0
1,GO PROSTAGLANDIN SECRETION,0.0042883,-0.21946,-0.19021,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0087944,-0.21949,-0.24871,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0011199,-0.21959,-0.19621,1,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.0014738,-0.21962,-0.25237,1,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.017549,-0.21965,-0.23163,1,0
1,GO AUTOPHAGOSOME MATURATION,0.017969,-0.21967,-0.13524,1,0
1,GO RESPONSE TO COLD,9.7346e-05,-0.21983,-0.30286,1,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.010245,-0.21987,-0.21001,1,0
1,GO RESPONSE TO FLUID SHEAR STRESS,0.010506,-0.21993,-0.18211,1,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.00069957,-0.22001,-0.2195,1,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,9.4334e-07,-0.22005,-0.22928,1,0
1,GO MYOBLAST FUSION,0.001986,-0.22007,-0.23892,1,0
1,GO RECEPTOR CATABOLIC PROCESS,0.0069616,-0.22011,-0.20556,1,0
1,GO MEMBRANE INVAGINATION,0.00038934,-0.22014,-0.22168,1,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.1702e-06,-0.22042,-0.25907,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00059588,-0.22051,-0.23605,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0038387,-0.22059,-0.23463,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,1.1964e-05,-0.22061,-0.2094,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,7.2111e-07,-0.22063,-0.2249,1,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.7791e-06,-0.22074,-0.21424,1,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,1.8958e-07,-0.22078,-0.21491,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0034322,-0.22089,-0.19455,1,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,3.4421e-05,-0.22096,-0.21743,1,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013139,-0.22104,-0.25278,1,0
1,GO T CELL EXTRAVASATION,0.029068,-0.22105,-0.28871,1,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,3.8131e-07,-0.22108,-0.24485,1,0
1,GO CARNITINE SHUTTLE,0.014138,-0.22112,-0.19032,1,0
1,GO NEGATIVE CHEMOTAXIS,0.0012662,-0.22134,-0.2583,1,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.00037661,-0.22148,-0.18418,1,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.001228,-0.22164,-0.17972,1,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.024288,-0.22178,-0.16283,1,0
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.001872,-0.22185,-0.20111,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0049174,-0.22199,-0.20375,1,0
1,GO CELLULAR RESPONSE TO STEROL,0.0014738,-0.222,-0.23883,1,0
1,GO REGULATION OF MAPK CASCADE,3.7145e-05,-0.22209,-0.18619,1,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.00032948,-0.22248,-0.20592,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0010528,-0.22252,-0.25294,1,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0006154,-0.22265,-0.31226,1,0
1,GO POLYOL METABOLIC PROCESS,1.725e-07,-0.22292,-0.23394,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00029782,-0.22314,-0.25577,1,0
1,GO REGULATION OF CELL CELL ADHESION,0.00019753,-0.22364,-0.19684,1,0
1,GO SERTOLI CELL DEVELOPMENT,0.011612,-0.22395,-0.22998,1,0
1,GO SYNCYTIUM FORMATION,0.0022992,-0.22411,-0.20436,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,4.1617e-05,-0.22443,-0.23022,1,0
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00028792,-0.22464,-0.21616,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0051916,-0.22466,-0.325,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00013433,-0.22479,-0.22675,1,0
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,5.4121e-05,-0.22493,-0.2212,1,0
1,GO RESPONSE TO PEPTIDOGLYCAN,3.3132e-05,-0.22511,-0.25594,1,0
1,GO SPHINGOID METABOLIC PROCESS,2.6307e-05,-0.22516,-0.29214,1,0
1,GO LEUKOCYTE PROLIFERATION,0.0001165,-0.22517,-0.21195,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00020448,-0.22528,-0.19732,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0021689,-0.22534,-0.25438,1,0
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00037661,-0.2254,-0.21583,1,0
1,GO FATTY ACID METABOLIC PROCESS,1.1267e-06,-0.22556,-0.23247,1,0
1,GO WOUND HEALING,0.00072223,-0.22565,-0.20832,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.018836,-0.22576,-0.1842,1,0
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00029782,-0.22589,-0.2404,1,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.00028792,-0.22627,-0.24519,1,0
1,GO FOAM CELL DIFFERENTIATION,0.00017796,-0.2264,-0.2696,1,0
1,GO POSITIVE REGULATION OF MAPK CASCADE,3.1888e-05,-0.22662,-0.19278,1,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00090094,-0.22671,-0.23987,1,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.016339,-0.22678,-0.25779,1,0
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00032948,-0.22696,-0.24776,1,0
1,GO LEUKOCYTE MIGRATION,7.8282e-05,-0.227,-0.21633,1,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.8418e-05,-0.22708,-0.2685,1,0
1,GO RESPONSE TO WOUNDING,0.0006154,-0.22718,-0.19446,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.3127e-06,-0.22731,-0.25525,1,0
1,GO TRANSLATIONAL INITIATION,0.0081404,-0.22735,-0.21407,1,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00044439,-0.22743,-0.23749,1,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,4.6597e-05,-0.22746,-0.24967,1,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00069957,-0.22754,-0.22973,1,0
1,GO PROTEIN DEGLYCOSYLATION,0.0014738,-0.22758,-0.2703,1,0
1,GO PROTEIN TRIMERIZATION,0.0013872,-0.2277,-0.25505,1,0
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00095906,-0.22789,-0.22945,1,0
1,GO RESPONSE TO CORTICOSTERONE,0.00084609,-0.22792,-0.29411,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.010773,-0.22801,-0.22699,1,0
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00022676,-0.22808,-0.27847,1,0
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.2454e-05,-0.22809,-0.20878,1,0
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.3218e-05,-0.22818,-0.22244,1,0
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0013457,-0.22818,-0.19171,1,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,9.7801e-06,-0.22835,-0.23873,1,0
1,GO MUSCLE CONTRACTION,4.7955e-07,-0.22851,-0.22062,1,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,4.6623e-06,-0.22883,-0.22307,1,0
1,GO PEROXISOME ORGANIZATION,1.5331e-06,-0.22902,-0.26622,1,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0097392,-0.22903,-0.19455,1,0
1,GO POSITIVE REGULATION OF CELL SIZE,0.015574,-0.22925,-0.1788,1,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.027188,-0.22938,-0.17582,1,0
1,GO TISSUE REGENERATION,0.0021689,-0.22941,-0.22172,1,0
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00054072,-0.22971,-0.24303,1,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.0013054,-0.22976,-0.21426,1,0
1,GO CELL JUNCTION DISASSEMBLY,0.0036303,-0.22978,-0.20379,1,0
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.00025131,-0.22982,-0.18617,1,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00035231,-0.22993,-0.24617,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00012512,-0.23004,-0.19166,1,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0015653,-0.23006,-0.20441,1,0
1,GO REGULATION OF FATTY ACID OXIDATION,0.0059384,-0.2301,-0.18206,1,0
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.001191,-0.23017,-0.22246,1,0
1,GO ENERGY RESERVE METABOLIC PROCESS,1.0184e-05,-0.2302,-0.2304,1,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.00021909,-0.23041,-0.19552,1,0
1,GO CYTOKINE METABOLIC PROCESS,5.7413e-06,-0.23044,-0.26432,1,0
1,GO CELL REDOX HOMEOSTASIS,0.00026903,-0.23045,-0.22967,1,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.011612,-0.23062,-0.29089,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,1.5201e-05,-0.23068,-0.23713,1,0
1,GO CHRONIC INFLAMMATORY RESPONSE,0.017137,-0.23102,-0.22384,1,0
1,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.031059,-0.23108,-0.17137,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.024288,-0.23116,-0.21316,1,0
1,GO AMINOGLYCAN METABOLIC PROCESS,0.00021909,-0.23122,-0.21635,1,0
1,GO ORGANIC CATION TRANSPORT,1.349e-05,-0.23126,-0.25749,1,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00010092,-0.23127,-0.22318,1,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,7.2754e-05,-0.23135,-0.22319,1,0
1,GO CORPUS CALLOSUM DEVELOPMENT,0.0099891,-0.23143,-0.23357,1,0
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00014935,-0.23143,-0.2692,1,0
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00084609,-0.2315,-0.25025,1,0
1,GO HEME METABOLIC PROCESS,0.00090094,-0.23154,-0.31164,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00049035,-0.23167,-0.23342,1,0
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,-0.23169,-0.24114,1,0
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00019753,-0.23175,-0.21624,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,1.9904e-06,-0.23195,-0.24185,1,0
1,GO MUSCLE HYPERTROPHY,2.9532e-05,-0.23201,-0.22411,1,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0015653,-0.23201,-0.25221,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.023205,-0.23205,-0.18307,1,0
1,GO BODY FLUID SECRETION,3.1888e-05,-0.23208,-0.21856,1,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00014935,-0.23211,-0.22606,1,0
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00029782,-0.23223,-0.22109,1,0
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.013465,-0.23233,-0.20837,1,0
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0001547,-0.23238,-0.29166,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,6.0504e-05,-0.23243,-0.26735,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00018427,-0.23249,-0.24909,1,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.00016023,-0.23268,-0.24374,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,2.6307e-05,-0.2327,-0.22681,1,0
1,GO REGULATION OF LIPID STORAGE,9.389e-05,-0.23297,-0.25205,1,0
1,GO SCHWANN CELL DIFFERENTIATION,0.00032948,-0.23298,-0.20763,1,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,7.0571e-06,-0.23298,-0.26624,1,0
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0023671,-0.23327,-0.2367,1,0
1,GO CHOLESTEROL EFFLUX,1.6455e-05,-0.23328,-0.23871,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0022992,-0.23328,-0.21086,1,0
1,GO RESPONSE TO DEXAMETHASONE,9.0551e-05,-0.23331,-0.26783,1,0
1,GO CHEMOSENSORY BEHAVIOR,2.1663e-05,-0.2337,-0.28311,1,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00011241,-0.23371,-0.18295,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0028141,-0.23372,-0.27979,1,0
1,GO NADP METABOLIC PROCESS,0.00052342,-0.2338,-0.2409,1,0
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0029794,-0.23382,-0.23868,1,0
1,GO MAINTENANCE OF LOCATION,4.3763e-07,-0.23399,-0.21397,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,1.6455e-05,-0.23416,-0.26503,1,0
1,GO CELLULAR HORMONE METABOLIC PROCESS,2.0033e-05,-0.23427,-0.2636,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.026586,-0.23434,-0.27732,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,2.5774e-06,-0.23442,-0.23116,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,8.2505e-07,-0.23442,-0.26304,1,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,4.3218e-05,-0.23449,-0.23399,1,0
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.0689e-05,-0.23457,-0.24073,1,0
1,GO LONG TERM MEMORY,0.0012662,-0.23485,-0.24983,1,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.001191,-0.23491,-0.22495,1,0
1,GO PROTEIN OXIDATION,0.0010859,-0.23496,-0.30347,1,0
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0047853,-0.23498,-0.20629,1,0
1,GO OSTEOBLAST PROLIFERATION,0.0033369,-0.23507,-0.2576,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.001662,-0.2351,-0.17755,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0073363,-0.23514,-0.25488,1,0
1,GO ENDOCRINE PROCESS,0.00054072,-0.23536,-0.21068,1,0
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.001662,-0.23538,-0.29499,1,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00017796,-0.23558,-0.33406,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.022165,-0.23558,-0.2178,1,0
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00045924,-0.23573,-0.22769,1,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0046564,-0.23574,-0.22562,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0027346,-0.23595,-0.24932,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION,0.0001547,-0.23605,-0.21543,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00031859,-0.23609,-0.19756,1,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.0001547,-0.2361,-0.28159,1,0
1,GO AMINE TRANSPORT,0.022165,-0.23617,-0.14106,1,0
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.036164,-0.23623,-0.3687,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.0073363,-0.23624,-0.26234,1,0
1,GO MUSCLE SYSTEM PROCESS,9.0221e-07,-0.23643,-0.21176,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00092958,-0.23649,-0.22993,1,0
1,GO RESPONSE TO CORTICOSTEROID,2.0033e-05,-0.2366,-0.24503,1,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,4.7955e-07,-0.2366,-0.25947,1,0
1,GO SUPEROXIDE ANION GENERATION,0.0051916,-0.23682,-0.2876,1,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0025817,-0.23693,-0.22613,1,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0081404,-0.23697,-0.24369,1,0
1,GO POSITIVE REGULATION OF PROTEIN BINDING,7.013e-05,-0.23698,-0.19977,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.001191,-0.23698,-0.26671,1,0
1,GO RESPONSE TO CALCIUM ION,6.2367e-06,-0.23699,-0.24087,1,0
1,GO PROGRAMMED NECROTIC CELL DEATH,0.0015653,-0.2371,-0.25998,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,8.1192e-05,-0.23715,-0.29242,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0042883,-0.23722,-0.23043,1,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0021689,-0.23724,-0.16037,1,0
1,GO ERK1 AND ERK2 CASCADE,4.4878e-05,-0.23736,-0.22687,1,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.02166,-0.23737,-0.17139,1,0
1,GO T CELL MEDIATED IMMUNITY,0.0024367,-0.23739,-0.23576,1,0
1,GO HEART PROCESS,1.0604e-05,-0.2375,-0.22338,1,0
1,GO DETOXIFICATION,5.0226e-05,-0.2377,-0.25751,1,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,3.1904e-06,-0.23771,-0.24064,1,0
1,GO FORMATION OF PRIMARY GERM LAYER,0.0025817,-0.23773,-0.21103,1,0
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.5816e-05,-0.23774,-0.2445,1,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.1702e-06,-0.23774,-0.24894,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00027832,-0.23783,-0.2998,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0054795,-0.23788,-0.18904,1,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.0051916,-0.2383,-0.25833,1,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00049035,-0.23841,-0.17792,1,0
1,GO MAINTENANCE OF LOCATION IN CELL,4.3763e-07,-0.2386,-0.22716,1,0
1,GO B CELL HOMEOSTASIS,6.0504e-05,-0.2387,-0.24399,1,0
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0094949,-0.23885,-0.19161,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.013798,-0.239,-0.15064,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00032948,-0.23902,-0.24344,1,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00010462,-0.23911,-0.22271,1,0
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0022332,-0.23917,-0.2276,1,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,2.7578e-07,-0.23929,-0.28529,1,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,3.17e-07,-0.23957,-0.26067,1,0
1,GO RESPONSE TO DRUG,5.0194e-07,-0.23973,-0.24564,1,0
1,GO AMELOGENESIS,0.037747,-0.23978,-0.21232,1,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00028792,-0.23998,-0.21132,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.01282,-0.23998,-0.23029,1,0
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0010206,-0.24011,-0.20896,1,0
1,GO PEPTIDE CROSS LINKING,0.0041716,-0.24011,-0.24593,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,2.5122e-07,-0.24014,-0.24432,1,0
1,GO REGULATION OF MYOBLAST FUSION,0.0045306,-0.24035,-0.27457,1,0
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00049035,-0.24043,-0.25598,1,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,1.6729e-06,-0.24051,-0.28977,1,0
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00029782,-0.2406,-0.22899,1,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.018836,-0.24071,-0.1693,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0090226,-0.24107,-0.17516,1,0
1,GO COLLAGEN CATABOLIC PROCESS,0.0012662,-0.24111,-0.26585,1,0
1,GO ETHANOL OXIDATION,0.047551,-0.24126,-0.29797,1,0
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0064317,-0.24126,-0.20269,1,0
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,4.6623e-06,-0.2413,-0.28861,1,0
1,GO STEROID HORMONE SECRETION,0.00049035,-0.24143,-0.2674,1,0
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.016734,-0.24168,-0.25942,1,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.025414,-0.2417,-0.24594,1,0
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00084609,-0.24171,-0.28272,1,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.014138,-0.24184,-0.21645,1,0
1,GO DIOL METABOLIC PROCESS,8.7323e-05,-0.24189,-0.27358,1,0
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.00044439,-0.24219,-0.23423,1,0
1,GO GTP METABOLIC PROCESS,0.0018173,-0.24233,-0.26153,1,0
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.00017796,-0.24254,-0.27166,1,0
1,GO MYELOID LEUKOCYTE ACTIVATION,6.2786e-05,-0.2426,-0.22097,1,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00037661,-0.24267,-0.22225,1,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00020448,-0.24268,-0.24584,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.00019753,-0.2427,-0.26832,1,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0006154,-0.2428,-0.19325,1,0
1,GO REGULATION OF LEUKOCYTE MIGRATION,4.8379e-05,-0.24283,-0.21977,1,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0018173,-0.24305,-0.20222,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.00090094,-0.24307,-0.25662,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,7.8282e-05,-0.24329,-0.25776,1,0
1,GO ACTIN FILAMENT BASED MOVEMENT,1.7118e-05,-0.24329,-0.24122,1,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,8.7323e-05,-0.24341,-0.22613,1,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0016129,-0.24341,-0.21994,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.02068,-0.24356,-0.2328,1,0
1,GO CELLULAR RESPONSE TO DRUG,2.9301e-06,-0.24366,-0.23431,1,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.00017186,-0.24373,-0.27186,1,0
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00050664,-0.2438,-0.24412,1,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.017137,-0.24381,-0.21053,1,0
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0090226,-0.24401,-0.19428,1,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0042883,-0.24401,-0.22936,1,0
1,GO MUSCLE FILAMENT SLIDING,3.1888e-05,-0.24411,-0.29563,1,0
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0050528,-0.24425,-0.23289,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,1.4268e-07,-0.2445,-0.23948,1,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.0071468,-0.24455,-0.19494,1,0
1,GO RESPONSE TO INSECTICIDE,0.0087944,-0.24476,-0.21018,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,9.3916e-06,-0.24493,-0.25248,1,0
1,GO HAIR FOLLICLE MATURATION,0.0046564,-0.2451,-0.24963,1,0
1,GO SKELETAL MUSCLE TISSUE REGENERATION,0.0011199,-0.24521,-0.25624,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY,6.2786e-05,-0.2453,-0.21808,1,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,1.4609e-05,-0.24547,-0.24842,1,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.0053338,-0.2455,-0.21598,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00017186,-0.24573,-0.24962,1,0
1,GO ANIMAL ORGAN REGENERATION,4.2876e-06,-0.24585,-0.29349,1,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0069616,-0.2459,-0.25451,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0060989,-0.24624,-0.2964,1,0
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0011199,-0.24633,-0.22677,1,0
1,GO CERAMIDE TRANSPORT,0.00034072,-0.24641,-0.28754,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,1.4268e-07,-0.24691,-0.2364,1,0
1,GO CELL CHEMOTAXIS,3.1888e-05,-0.24721,-0.23786,1,0
1,GO CARDIAC CELL DEVELOPMENT,0.0001165,-0.24779,-0.21174,1,0
1,GO KETONE BIOSYNTHETIC PROCESS,3.7145e-05,-0.24784,-0.28033,1,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,5.2837e-06,-0.24786,-0.26337,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0019282,-0.24817,-0.30052,1,0
1,GO FUCOSE METABOLIC PROCESS,0.0022992,-0.24819,-0.25467,1,0
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00092958,-0.2482,-0.31835,1,0
1,GO ETHER METABOLIC PROCESS,7.547e-05,-0.24832,-0.29799,1,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,0.00095906,-0.24838,-0.21201,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0051916,-0.24855,-0.22033,1,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,5.508e-06,-0.24856,-0.25171,1,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00012964,-0.24863,-0.30297,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.033894,-0.24866,-0.15234,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.6603e-06,-0.24908,-0.26715,1,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00031859,-0.24909,-0.21021,1,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,3.4728e-06,-0.24931,-0.24501,1,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0050528,-0.24934,-0.24635,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0031536,-0.24936,-0.28176,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0073363,-0.24943,-0.15775,1,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.042857,-0.24974,-0.16398,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0011199,-0.24975,-0.27385,1,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,6.0198e-07,-0.24977,-0.24947,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0001165,-0.24979,-0.2896,1,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.00063551,-0.25001,-0.25593,1,0
1,GO ENDOTHELIAL CELL PROLIFERATION,2.0033e-05,-0.25004,-0.24684,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.025994,-0.25015,-0.26311,1,0
1,GO LENS FIBER CELL DIFFERENTIATION,0.0042883,-0.25048,-0.22198,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0056288,-0.25051,-0.23881,1,0
1,GO MICROVILLUS ASSEMBLY,0.0047853,-0.25068,-0.27156,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00079435,-0.25103,-0.26603,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,0.0030654,-0.25133,-0.2046,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0011199,-0.25155,-0.35298,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.1493e-05,-0.25156,-0.26679,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.1617e-05,-0.25164,-0.23036,1,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0013457,-0.2518,-0.21446,1,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0013457,-0.2519,-0.25055,1,0
1,GO EMBRYO IMPLANTATION,0.014841,-0.25216,-0.16635,1,0
1,GO PROTEIN REFOLDING,0.00054072,-0.2522,-0.25946,1,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0038387,-0.25237,-0.25512,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0010859,-0.2525,-0.23346,1,0
1,GO PHAGOCYTOSIS,4.8379e-05,-0.25251,-0.23362,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0059384,-0.2527,-0.20108,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.019739,-0.25281,-0.21843,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.508e-06,-0.25284,-0.28292,1,0
1,GO RESPONSE TO HYDROGEN PEROXIDE,1.0184e-05,-0.2529,-0.26169,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,2.0784e-06,-0.253,-0.23318,1,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.02068,-0.25307,-0.27717,1,0
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,7.6603e-06,-0.25309,-0.2774,1,0
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.015574,-0.25311,-0.33845,1,0
1,GO RESPONSE TO ACIDIC PH,0.00029782,-0.25315,-0.28783,1,0
1,GO RESPIRATORY BURST,0.00012074,-0.25318,-0.28931,1,0
1,GO LEUKOCYTE APOPTOTIC PROCESS,0.00063551,-0.2533,-0.20803,1,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.1493e-05,-0.25337,-0.25968,1,0
1,GO STRIATED MUSCLE CONTRACTION,3.3287e-06,-0.25343,-0.2494,1,0
1,GO MACROPHAGE ACTIVATION,4.2876e-06,-0.25351,-0.24953,1,0
1,GO IMPORT INTO CELL,2.6902e-06,-0.25353,-0.23707,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,6.2367e-06,-0.25367,-0.26522,1,0
1,GO DIVALENT METAL ION EXPORT,0.0037331,-0.25372,-0.2565,1,0
1,GO FUCOSYLATION,4.3218e-05,-0.25374,-0.29249,1,0
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0007696,-0.25379,-0.24808,1,0
1,GO STORE OPERATED CALCIUM ENTRY,0.00023468,-0.25382,-0.27752,1,0
1,GO HEART TRABECULA FORMATION,0.02166,-0.25417,-0.2263,1,0
1,GO INTESTINAL LIPID ABSORPTION,0.0030654,-0.25436,-0.29016,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.2985e-07,-0.25449,-0.29912,1,0
1,GO RESPONSE TO STEROL DEPLETION,0.00022676,-0.25465,-0.28577,1,0
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00028792,-0.25467,-0.24523,1,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0015653,-0.25503,-0.31671,1,0
1,GO NEURONAL ACTION POTENTIAL,0.0046564,-0.25512,-0.22999,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00044439,-0.25517,-0.23606,1,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0022992,-0.25527,-0.24891,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0001165,-0.25533,-0.25389,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.010506,-0.25539,-0.22267,1,0
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.010506,-0.25573,-0.26882,1,0
1,GO AMEBOIDAL TYPE CELL MIGRATION,0.00011241,-0.25575,-0.22162,1,0
1,GO PLATELET DEGRANULATION,0.00014935,-0.25576,-0.28256,1,0
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,1.7806e-05,-0.2559,-0.2902,1,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,1.6455e-05,-0.25611,-0.24625,1,0
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0040578,-0.25639,-0.31075,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.1888e-05,-0.25652,-0.22599,1,0
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0016129,-0.2566,-0.21392,1,0
1,GO REGULATION OF PLATELET ACTIVATION,0.00044439,-0.25685,-0.30959,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0011549,-0.25738,-0.25148,1,0
1,GO RESPONSE TO MISFOLDED PROTEIN,3.5759e-05,-0.2574,-0.25412,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,1.2862e-06,-0.25749,-0.28786,1,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00014935,-0.25763,-0.26019,1,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,3.6228e-06,-0.25765,-0.26294,1,0
1,GO OVULATION,0.00045924,-0.25766,-0.28617,1,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.012203,-0.25785,-0.18439,1,0
1,GO REGULATION OF MEMBRANE INVAGINATION,0.029068,-0.25786,-0.21059,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00022676,-0.25803,-0.30122,1,0
1,GO RESPONSE TO AMPHETAMINE,2.9532e-05,-0.25825,-0.34233,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0021062,-0.2583,-0.21373,1,0
1,GO CELL SUBSTRATE ADHESION,0.00020448,-0.2586,-0.24641,1,0
1,GO POSITIVE REGULATION OF LIPID STORAGE,0.00032948,-0.25864,-0.30572,1,0
1,GO PEROXISOMAL TRANSPORT,1.9904e-06,-0.25867,-0.28549,1,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.00014418,-0.25876,-0.23452,1,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,6.7728e-06,-0.25883,-0.25362,1,0
1,GO T HELPER 2 CELL DIFFERENTIATION,0.026586,-0.25893,-0.30041,1,0
1,GO PLASMA MEMBRANE ORGANIZATION,1.2454e-05,-0.25897,-0.2612,1,0
1,GO IMP METABOLIC PROCESS,0.013465,-0.25903,-0.25614,1,0
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00031859,-0.25906,-0.27049,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.8282e-05,-0.25916,-0.30788,1,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00029782,-0.25918,-0.27538,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00026903,-0.25934,-0.2969,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.027188,-0.25965,-0.27079,1,0
1,GO CARDIAC MUSCLE CONTRACTION,7.0571e-06,-0.25988,-0.25,1,0
1,GO CAMP METABOLIC PROCESS,0.00055855,-0.25993,-0.24138,1,0
1,GO POSITIVE REGULATION OF WOUND HEALING,0.0042883,-0.26009,-0.25481,1,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0026572,-0.26012,-0.22846,1,0
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00067758,-0.26018,-0.26863,1,0
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,4.8612e-06,-0.26033,-0.29628,1,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0094949,-0.26038,-0.17085,1,0
1,GO LIPID STORAGE,1.8521e-05,-0.26049,-0.26592,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00052342,-0.26055,-0.26078,1,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0036303,-0.26058,-0.23931,1,0
1,GO COLLAGEN METABOLIC PROCESS,0.0036303,-0.26067,-0.23165,1,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.014841,-0.26069,-0.24531,1,0
1,GO CHLORIDE ION HOMEOSTASIS,0.0020453,-0.26085,-0.20267,1,0
1,GO ALDITOL METABOLIC PROCESS,0.00012074,-0.26085,-0.27001,1,0
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0056288,-0.26091,-0.27109,1,0
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.019739,-0.26105,-0.22792,1,0
1,GO OXALATE TRANSPORT,7.0571e-06,-0.26106,-0.29883,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0012662,-0.26108,-0.21376,1,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00041602,-0.26135,-0.26186,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0069616,-0.2614,-0.22708,1,0
1,GO CHOLESTEROL STORAGE,0.00045924,-0.26149,-0.27393,1,0
1,GO ESTROGEN METABOLIC PROCESS,0.00010462,-0.26172,-0.25347,1,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.0020453,-0.2618,-0.29072,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,7.889e-07,-0.26192,-0.25618,1,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.00021167,-0.26192,-0.29445,1,0
1,GO HYPEROSMOTIC RESPONSE,0.001872,-0.26243,-0.2444,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,5.508e-06,-0.26268,-0.27182,1,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,3.0689e-05,-0.26277,-0.3223,1,0
1,GO BICARBONATE TRANSPORT,1.6455e-05,-0.26306,-0.25981,1,0
1,GO REGULATION OF DENDRITE EXTENSION,0.010245,-0.26306,-0.16425,1,0
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.033894,-0.26327,-0.20926,1,0
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02843,-0.26334,-0.19047,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,9.389e-05,-0.26384,-0.29616,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0001547,-0.26384,-0.29145,1,0
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,7.5427e-07,-0.26393,-0.26845,1,0
1,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0075304,-0.26407,-0.26887,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00016595,-0.26413,-0.25455,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,1.5816e-05,-0.26416,-0.25645,1,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0059384,-0.26435,-0.25739,1,0
1,GO AMINE CATABOLIC PROCESS,0.0021689,-0.26461,-0.2852,1,0
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00017796,-0.26521,-0.24298,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.016734,-0.26522,-0.20144,1,0
1,GO CARDIAC CONDUCTION,1.8521e-05,-0.26531,-0.25714,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,3.0689e-05,-0.26543,-0.2428,1,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00019753,-0.2655,-0.24337,1,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00012512,-0.26558,-0.22218,1,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,5.0194e-07,-0.26562,-0.27658,1,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,6.2786e-05,-0.26585,-0.26879,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.2754e-05,-0.26589,-0.2548,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,7.2111e-07,-0.26603,-0.25047,1,0
1,GO B CELL APOPTOTIC PROCESS,0.0015189,-0.26604,-0.22881,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0087944,-0.26607,-0.27739,1,0
1,GO RESPONSE TO AMINE,5.7413e-06,-0.26613,-0.30628,1,0
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.025994,-0.26634,-0.19123,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,2.0033e-05,-0.26645,-0.29799,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.001662,-0.26652,-0.26308,1,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0021689,-0.26654,-0.21758,1,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00012964,-0.26689,-0.24482,1,0
1,GO HEART VALVE DEVELOPMENT,0.00054072,-0.26699,-0.23323,1,0
1,GO SNARE COMPLEX ASSEMBLY,0.0010859,-0.26705,-0.26056,1,0
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.027803,-0.26705,-0.28317,1,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.00098941,-0.2678,-0.28311,1,0
1,GO PODOSOME ASSEMBLY,0.011047,-0.26821,-0.21086,1,0
1,GO VAGINA DEVELOPMENT,0.011326,-0.26822,-0.23319,1,0
1,GO ACTION POTENTIAL,4.1617e-05,-0.26839,-0.23784,1,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00017796,-0.26856,-0.24508,1,0
1,GO MULTI ORGANISM CELLULAR PROCESS,0.0015653,-0.26879,-0.35172,1,0
1,GO CELL MATRIX ADHESION,0.00054072,-0.26906,-0.23798,1,0
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00057693,-0.26918,-0.25725,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0022332,-0.26921,-0.21762,1,0
1,GO TRABECULA FORMATION,0.0045306,-0.2696,-0.25259,1,0
1,GO DRUG METABOLIC PROCESS,2.1663e-05,-0.26974,-0.30655,1,0
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,9.389e-05,-0.27002,-0.26387,1,0
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00057693,-0.27013,-0.21639,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.010245,-0.27017,-0.19939,1,0
1,GO COPPER ION HOMEOSTASIS,0.00072223,-0.27026,-0.27092,1,0
1,GO POSITIVE CHEMOTAXIS,3.3287e-06,-0.27027,-0.28036,1,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00065623,-0.27077,-0.30003,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00030804,-0.27092,-0.26125,1,0
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,4.1617e-05,-0.27099,-0.24535,1,0
1,GO AMYLOID BETA FORMATION,0.00030804,-0.27123,-0.26823,1,0
1,GO ACID SECRETION,7.2754e-05,-0.27151,-0.24351,1,0
1,GO ANION HOMEOSTASIS,1.4609e-05,-0.27213,-0.26139,1,0
1,GO XENOBIOTIC TRANSPORT,4.6623e-06,-0.27233,-0.29426,1,0
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,3.6228e-06,-0.27247,-0.28177,1,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.00020448,-0.27256,-0.24673,1,0
1,GO HORMONE BIOSYNTHETIC PROCESS,1.349e-05,-0.2731,-0.2838,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0028141,-0.27351,-0.23196,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00028792,-0.27426,-0.24034,1,0
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00067758,-0.27488,-0.28437,1,0
1,GO REGULATION OF VACUOLE ORGANIZATION,1.6455e-05,-0.27488,-0.25111,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0025817,-0.27494,-0.21139,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0059384,-0.27517,-0.2679,1,0
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.011047,-0.27534,-0.25552,1,0
1,GO MICROVILLUS ORGANIZATION,0.00059588,-0.27551,-0.31039,1,0
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0037331,-0.27654,-0.32073,1,0
1,GO APOPTOTIC CELL CLEARANCE,1.6455e-05,-0.27668,-0.33845,1,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,3.9418e-06,-0.27668,-0.28093,1,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.010245,-0.27671,-0.29149,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00013917,-0.27672,-0.28738,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,1.0311e-06,-0.27698,-0.29808,1,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,5.4121e-05,-0.27726,-0.32283,1,0
1,GO MAMMARY GLAND MORPHOGENESIS,0.031059,-0.27759,-0.18773,1,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.0029794,-0.27805,-0.22571,1,0
1,GO NECROTIC CELL DEATH,0.00042998,-0.27819,-0.27799,1,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0014738,-0.27839,-0.28011,1,0
1,GO MONOAMINE TRANSPORT,0.0053338,-0.27857,-0.16988,1,0
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0013457,-0.27866,-0.30263,1,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0073363,-0.27929,-0.28992,1,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00054072,-0.27936,-0.26691,1,0
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00055855,-0.27966,-0.2761,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0042883,-0.27993,-0.23876,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0015189,-0.28032,-0.2764,1,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,9.0179e-06,-0.28065,-0.29373,1,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0021062,-0.28123,-0.27983,1,0
1,GO NEGATIVE REGULATION OF CELL KILLING,0.036164,-0.28171,-0.25861,1,0
1,GO CELLULAR COPPER ION HOMEOSTASIS,0.0010528,-0.28181,-0.29522,1,0
1,GO SULFUR COMPOUND CATABOLIC PROCESS,2.8891e-07,-0.28196,-0.31632,1,0
1,GO RESPONSE TO REDOX STATE,2.6307e-05,-0.28197,-0.33492,1,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00016023,-0.28209,-0.29126,1,0
1,GO HEXOSE CATABOLIC PROCESS,4.8612e-06,-0.28234,-0.30888,1,0
1,GO PROTEIN KINASE C SIGNALING,0.00019753,-0.28275,-0.27885,1,0
1,GO REGULATION OF WOUND HEALING,0.00054072,-0.28298,-0.26347,1,0
1,GO SCHWANN CELL DEVELOPMENT,7.889e-07,-0.28333,-0.28137,1,0
1,GO MEMBRANE DEPOLARIZATION,0.00029782,-0.28373,-0.24945,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,0.033166,-0.28373,-0.30261,1,0
1,GO RELAXATION OF MUSCLE,0.00023468,-0.28379,-0.26908,1,0
1,GO AMYLOID BETA METABOLIC PROCESS,0.00025131,-0.28385,-0.25333,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00069957,-0.28405,-0.26179,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00025131,-0.2842,-0.29008,1,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.0038387,-0.28449,-0.28098,1,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,3.4421e-05,-0.28475,-0.27051,1,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.349e-05,-0.28487,-0.33539,1,0
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,7.2754e-05,-0.28516,-0.30741,1,0
1,GO ACROSOME REACTION,0.0001547,-0.28521,-0.25826,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,0.00098941,-0.28528,-0.22583,1,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,4.1617e-05,-0.28547,-0.31929,1,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0001165,-0.2855,-0.31348,1,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00074557,-0.28563,-0.26845,1,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00014418,-0.28586,-0.34328,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0028957,-0.28587,-0.30561,1,0
1,GO KERATINOCYTE MIGRATION,1.5201e-05,-0.286,-0.2927,1,0
1,GO ZYMOGEN INHIBITION,0.0066042,-0.28616,-0.29787,1,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.0024367,-0.28627,-0.31944,1,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.019739,-0.28656,-0.24238,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.012508,-0.28656,-0.1746,1,0
1,GO SKELETAL MUSCLE CONTRACTION,3.5759e-05,-0.28685,-0.2695,1,0
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00029782,-0.28698,-0.26228,1,0
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,8.6584e-06,-0.28732,-0.32142,1,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0014299,-0.28746,-0.23063,1,0
1,GO NEURON MATURATION,0.001872,-0.28758,-0.2141,1,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00032948,-0.28765,-0.35543,1,0
1,GO CERAMIDE CATABOLIC PROCESS,0.00029782,-0.28792,-0.36399,1,0
1,GO KERATAN SULFATE METABOLIC PROCESS,7.0571e-06,-0.28793,-0.32908,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00014418,-0.28814,-0.25902,1,0
1,GO ACUTE INFLAMMATORY RESPONSE,0.00012074,-0.28874,-0.29748,1,0
1,GO KERATAN SULFATE CATABOLIC PROCESS,6.5149e-05,-0.28918,-0.33593,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.025414,-0.28939,-0.30605,1,0
1,GO BEHAVIORAL RESPONSE TO PAIN,0.00025131,-0.28967,-0.38411,1,0
1,GO REGULATION OF CELL MATRIX ADHESION,0.00050664,-0.28967,-0.26157,1,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0016129,-0.29014,-0.29813,1,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,2.8418e-05,-0.29031,-0.2907,1,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.001228,-0.29047,-0.2435,1,0
1,GO ANIMAL ORGAN MATURATION,0.00059588,-0.29064,-0.2123,1,0
1,GO GLOMERULUS DEVELOPMENT,0.0038387,-0.29075,-0.22592,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,9.3916e-06,-0.29078,-0.29371,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,2.3418e-05,-0.29103,-0.28111,1,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,7.547e-05,-0.29107,-0.26361,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0090226,-0.29132,-0.22107,1,0
1,GO DETECTION OF OTHER ORGANISM,0.013465,-0.29141,-0.27201,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0041716,-0.29159,-0.24497,1,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0013872,-0.29175,-0.24031,1,0
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.001872,-0.29193,-0.33277,1,0
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.025414,-0.29224,-0.23778,1,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,3.9418e-06,-0.29266,-0.31671,1,0
1,GO PSEUDOPODIUM ORGANIZATION,0.029719,-0.2927,-0.26609,1,0
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00069957,-0.29291,-0.35803,1,0
1,GO T CELL MEDIATED CYTOTOXICITY,0.0073363,-0.29295,-0.31071,1,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00084609,-0.29309,-0.31417,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,2.0033e-05,-0.2932,-0.27688,1,0
1,GO RENAL ABSORPTION,0.030383,-0.29324,-0.29319,1,0
1,GO COLLAGEN BIOSYNTHETIC PROCESS,0.031748,-0.29348,-0.25553,1,0
1,GO SERTOLI CELL DIFFERENTIATION,0.00035231,-0.29378,-0.27692,1,0
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,8.4205e-05,-0.29391,-0.32093,1,0
1,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00092958,-0.29396,-0.32102,1,0
1,GO REGULATION OF ANOIKIS,0.0018173,-0.29414,-0.30809,1,0
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,1.5816e-05,-0.29438,-0.30372,1,0
1,GO TOXIN METABOLIC PROCESS,0.0041716,-0.29465,-0.28869,1,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00012074,-0.29531,-0.28854,1,0
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.7145e-05,-0.29547,-0.30916,1,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0049174,-0.29547,-0.29222,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.023205,-0.29555,-0.22736,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.001872,-0.29578,-0.30844,1,0
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.038561,-0.2958,-0.23506,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,8.3127e-06,-0.29601,-0.30843,1,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0033369,-0.29603,-0.34731,1,0
1,GO NEGATIVE REGULATION OF WOUND HEALING,0.00044439,-0.29619,-0.27437,1,0
1,GO NUCLEOTIDE SALVAGE,0.00052342,-0.29634,-0.34024,1,0
1,GO VASCULOGENESIS,0.00029782,-0.29639,-0.31344,1,0
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0028141,-0.29667,-0.37511,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,4.8612e-06,-0.29673,-0.31394,1,0
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,8.7323e-05,-0.29687,-0.26154,1,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00027832,-0.29729,-0.27163,1,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.041093,-0.29751,-0.22187,1,0
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.015203,-0.2977,-0.28427,1,0
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00069957,-0.298,-0.25211,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0064317,-0.2985,-0.27634,1,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00038934,-0.29858,-0.30352,1,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,1.1964e-05,-0.29873,-0.40728,1,0
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.0024367,-0.29882,-0.2831,1,0
1,GO ENDODERM FORMATION,0.0010528,-0.29888,-0.29404,1,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,6.2367e-06,-0.29892,-0.29586,1,0
1,GO SEQUESTERING OF CALCIUM ION,1.4963e-07,-0.29899,-0.29631,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0011199,-0.29918,-0.29421,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00014418,-0.29927,-0.31773,1,0
1,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00040247,-0.29946,-0.30285,1,0
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,4.1617e-05,-0.29975,-0.30138,1,0
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0023671,-0.29991,-0.31309,1,0
1,GO AMINOGLYCAN CATABOLIC PROCESS,8.7323e-05,-0.3003,-0.3289,1,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.00022676,-0.30057,-0.32138,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00010462,-0.3013,-0.30005,1,0
1,GO TYPE 2 IMMUNE RESPONSE,0.00016595,-0.30139,-0.31409,1,0
1,GO BONE TRABECULA FORMATION,0.023741,-0.30145,-0.33878,1,0
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.012203,-0.30153,-0.30729,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.024288,-0.30156,-0.23882,1,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00087311,-0.30161,-0.27235,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0001547,-0.30175,-0.26387,1,0
1,GO PLATELET AGGREGATION,4.6597e-05,-0.30179,-0.28862,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.01282,-0.30182,-0.26214,1,0
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0020453,-0.30191,-0.34989,1,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,4.8379e-05,-0.30211,-0.29625,1,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010462,-0.30215,-0.32577,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.013465,-0.30243,-0.237,1,0
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0067808,-0.30247,-0.31197,1,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0030654,-0.30263,-0.30067,1,0
1,GO ZINC ION TRANSPORT,2.9532e-05,-0.30306,-0.25129,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0041716,-0.30367,-0.28575,1,0
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.906e-06,-0.30387,-0.29845,1,0
1,GO REGULATION OF AMYLOID BETA FORMATION,8.1192e-05,-0.30408,-0.33022,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0079323,-0.30456,-0.2342,1,0
1,GO REGULATION OF VESICLE FUSION,0.0031536,-0.30469,-0.27175,1,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.0010206,-0.30472,-0.25822,1,0
1,GO RESPONSE TO GROWTH HORMONE,3.3132e-05,-0.30485,-0.32998,1,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.00079435,-0.30555,-0.28304,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00031859,-0.30596,-0.32172,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,-0.30721,-0.27323,1,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.0021689,-0.30758,-0.28567,1,0
1,GO INTERLEUKIN 5 PRODUCTION,0.00028792,-0.30762,-0.33957,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0040578,-0.30767,-0.28917,1,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,4.6623e-06,-0.30863,-0.30946,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,2.3418e-05,-0.30866,-0.35926,1,0
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0050528,-0.30939,-0.25119,1,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00022676,-0.30961,-0.33425,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00069957,-0.30976,-0.30962,1,0
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00010092,-0.30987,-0.35533,1,0
1,GO REGULATION OF COAGULATION,0.00025131,-0.3101,-0.30268,1,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00014418,-0.31021,-0.25286,1,0
1,GO RESPONSE TO MAGNESIUM ION,0.00067758,-0.31048,-0.33112,1,0
1,GO TOLERANCE INDUCTION,0.001228,-0.31052,-0.42571,1,0
1,GO RESPONSE TO TUMOR CELL,0.0021062,-0.31055,-0.28282,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0022332,-0.31071,-0.2467,1,0
1,GO RESPONSE TO INTERFERON BETA,0.02268,-0.31093,-0.34102,1,0
1,GO ZINC ION HOMEOSTASIS,0.0025817,-0.31137,-0.28753,1,0
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0022992,-0.31142,-0.29239,1,0
1,GO REGULATION OF KERATINOCYTE MIGRATION,2.1663e-05,-0.31194,-0.29655,1,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,5.2837e-06,-0.31348,-0.32908,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,8.4205e-05,-0.31392,-0.33842,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,7.013e-05,-0.31469,-0.25679,1,0
1,GO CATECHOLAMINE SECRETION,0.019739,-0.31505,-0.15182,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00081984,-0.31535,-0.27278,1,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.0184e-05,-0.31633,-0.34772,1,0
1,GO AMP METABOLIC PROCESS,2.9532e-05,-0.31668,-0.3549,1,0
1,GO RESPONSE TO ZINC ION,0.00081984,-0.31718,-0.28153,1,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,5.4121e-05,-0.3177,-0.32329,1,0
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,2.7343e-05,-0.31804,-0.37612,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.018836,-0.31809,-0.24917,1,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,2.2524e-05,-0.31845,-0.30508,1,0
1,GO HEPATOCYTE DIFFERENTIATION,0.011326,-0.31845,-0.27163,1,0
1,GO SECRETION BY TISSUE,5.6174e-05,-0.31853,-0.29362,1,0
1,GO NEUROTRANSMITTER UPTAKE,0.00013917,-0.32006,-0.28776,1,0
1,GO RETINAL METABOLIC PROCESS,0.0017641,-0.32008,-0.36988,1,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,2.8496e-08,-0.32057,-0.33848,1,0
1,GO THYMOCYTE APOPTOTIC PROCESS,0.0083534,-0.32059,-0.23091,1,0
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00032948,-0.32077,-0.27082,1,0
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0032441,-0.32109,-0.27912,1,0
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.9263e-05,-0.32109,-0.26524,1,0
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,1.104e-05,-0.32128,-0.36981,1,0
1,GO MONONUCLEAR CELL MIGRATION,9.7801e-06,-0.32189,-0.29534,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00069957,-0.32207,-0.31968,1,0
1,GO NAD METABOLIC PROCESS,3.1888e-05,-0.32219,-0.32356,1,0
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.024288,-0.3223,-0.25317,1,0
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,7.2754e-05,-0.32253,-0.27206,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0013457,-0.32256,-0.28743,1,0
1,GO PLASMA MEMBRANE FUSION,3.8583e-05,-0.32283,-0.37499,1,0
1,GO TISSUE MIGRATION,3.3132e-05,-0.32396,-0.2723,1,0
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.001662,-0.32466,-0.27041,1,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.4728e-06,-0.32503,-0.36218,1,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00067758,-0.32519,-0.29883,1,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.010773,-0.3258,-0.29987,1,0
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00098941,-0.32691,-0.33344,1,0
1,GO RETINOL METABOLIC PROCESS,2.4346e-05,-0.3273,-0.33678,1,0
1,GO RESPONSE TO INTERFERON GAMMA,0.00079435,-0.32783,-0.31905,1,0
1,GO REGULATION OF CELLULAR RESPIRATION,2.3418e-05,-0.32817,-0.30493,1,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.001662,-0.32824,-0.34938,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.043763,-0.32842,-0.13387,1,0
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.036948,-0.32844,-0.24586,1,0
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0017123,-0.32852,-0.35362,1,0
1,GO AORTIC VALVE DEVELOPMENT,0.00012964,-0.3292,-0.35359,1,0
1,GO RESPONSE TO GONADOTROPIN,1.4674e-06,-0.32942,-0.36505,1,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00044439,-0.3298,-0.32088,1,0
1,GO CORTICOSTEROID HORMONE SECRETION,4.8379e-05,-0.3299,-0.35655,1,0
1,GO REGULATION OF NECROTIC CELL DEATH,0.00030804,-0.32995,-0.32045,1,0
1,GO VASCULAR WOUND HEALING,0.0039469,-0.32995,-0.28615,1,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.00019753,-0.33014,-0.394,1,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.00074557,-0.33025,-0.28564,1,0
1,GO MATURE B CELL DIFFERENTIATION,9.0551e-05,-0.33039,-0.34953,1,0
1,GO VITAMIN TRANSPORT,6.8936e-07,-0.33039,-0.31989,1,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0022332,-0.33065,-0.3478,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.8418e-05,-0.33076,-0.35629,1,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.0029794,-0.33115,-0.34135,1,0
1,GO GASTRIC ACID SECRETION,5.4121e-05,-0.33117,-0.30268,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.026586,-0.3315,-0.27177,1,0
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0051916,-0.33152,-0.23957,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0066042,-0.3319,-0.35895,1,0
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0090226,-0.33201,-0.21721,1,0
1,GO RESPONSE TO THYROID HORMONE,0.0017123,-0.33224,-0.29156,1,0
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00027832,-0.33228,-0.34708,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00074557,-0.33238,-0.31378,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00026003,-0.33253,-0.34399,1,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,4.8379e-05,-0.33255,-0.33789,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0015653,-0.3327,-0.38451,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.0018173,-0.33357,-0.29705,1,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,7.8282e-05,-0.33372,-0.31555,1,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0018173,-0.33408,-0.3396,1,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,6.7596e-05,-0.33492,-0.38576,1,0
1,GO ACTIN MEDIATED CELL CONTRACTION,4.1112e-06,-0.33562,-0.30123,1,0
1,GO SALIVARY GLAND DEVELOPMENT,0.0059384,-0.33565,-0.25355,1,0
1,GO MACROPHAGE APOPTOTIC PROCESS,0.011904,-0.33574,-0.24135,1,0
1,GO RESPONSE TO CAFFEINE,4.4878e-05,-0.33604,-0.32305,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.026586,-0.33621,-0.25516,1,0
1,GO SEROTONIN METABOLIC PROCESS,0.016734,-0.33632,-0.26728,1,0
1,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00010092,-0.33752,-0.37127,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0011549,-0.33753,-0.32766,1,0
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.0069616,-0.33756,-0.36682,1,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0062634,-0.33789,-0.22168,1,0
1,GO ENDOTHELIAL CELL MIGRATION,2.0833e-05,-0.33812,-0.2896,1,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0011199,-0.33857,-0.27982,1,0
1,GO REGULATION OF HEART RATE,1.4044e-06,-0.33954,-0.31231,1,0
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,4.4712e-06,-0.34049,-0.33894,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00042998,-0.34052,-0.3276,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,1.349e-05,-0.34097,-0.33784,1,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0010859,-0.34147,-0.34585,1,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.016339,-0.34178,-0.28869,1,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,1.5816e-05,-0.34213,-0.30903,1,0
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.030383,-0.34237,-0.33312,1,0
1,GO MACROPHAGE PROLIFERATION,0.00090094,-0.34268,-0.36915,1,0
1,GO RESPONSE TO HYPEROXIA,0.0083534,-0.34275,-0.25114,1,0
1,GO GLYCOLIPID CATABOLIC PROCESS,0.00010462,-0.34316,-0.41565,1,0
1,GO ACTIN FILAMENT NETWORK FORMATION,0.011612,-0.34338,-0.28523,1,0
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.024846,-0.34364,-0.30804,1,0
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.024288,-0.34393,-0.27508,1,0
1,GO LENS FIBER CELL DEVELOPMENT,0.00022676,-0.34403,-0.37069,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.025414,-0.34425,-0.23193,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,7.2754e-05,-0.34477,-0.34529,1,0
1,GO RESPONSE TO PAIN,1.3441e-06,-0.34487,-0.39583,1,0
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0021689,-0.34593,-0.30281,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.035393,-0.3462,-0.35473,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,5.2837e-06,-0.34637,-0.35339,1,0
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,5.0226e-05,-0.34682,-0.32986,1,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,7.8282e-05,-0.34701,-0.41932,1,0
1,GO GLYCOPROTEIN CATABOLIC PROCESS,0.00016595,-0.3473,-0.4955,1,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0073363,-0.34801,-0.3009,1,0
1,GO LIPID IMPORT INTO CELL,2.7343e-05,-0.34828,-0.31482,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0001165,-0.34848,-0.37784,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.031748,-0.34859,-0.29923,1,0
1,GO EPIBOLY,0.0017641,-0.349,-0.31299,1,0
1,GO RESPONSE TO MUSCLE STRETCH,0.00016023,-0.34924,-0.36669,1,0
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.0039469,-0.34929,-0.25891,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00012964,-0.34953,-0.44313,1,0
1,GO NEGATIVE REGULATION OF COAGULATION,0.00040247,-0.35031,-0.3436,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00042998,-0.35085,-0.29128,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00029782,-0.35114,-0.32874,1,0
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.2754e-05,-0.35211,-0.35949,1,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.001191,-0.35244,-0.37918,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.00041602,-0.35284,-0.26205,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.1112e-06,-0.35341,-0.40071,1,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00019753,-0.35389,-0.48006,1,0
1,GO REGULATION OF RESPIRATORY BURST,0.001872,-0.35399,-0.26945,1,0
1,GO MEMBRANE RAFT ORGANIZATION,0.0037331,-0.35439,-0.37768,1,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.011047,-0.35503,-0.31183,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,3.8583e-05,-0.35507,-0.31749,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0010859,-0.35513,-0.26423,1,0
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.00095906,-0.35617,-0.42725,1,0
1,GO ESTROGEN BIOSYNTHETIC PROCESS,2.8077e-06,-0.35644,-0.38853,1,0
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0038387,-0.3573,-0.36776,1,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,4.3218e-05,-0.35763,-0.34783,1,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00065623,-0.35818,-0.29407,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00045924,-0.35909,-0.35224,1,0
1,GO FATTY ACID HOMEOSTASIS,2.4346e-05,-0.3595,-0.38935,1,0
1,GO RESPONSE TO EPINEPHRINE,0.013798,-0.36068,-0.32774,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00025131,-0.36096,-0.31166,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.4039e-05,-0.361,-0.34597,1,0
1,GO NEUROTRANSMITTER REUPTAKE,2.4346e-05,-0.36123,-0.36999,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0014738,-0.36234,-0.27799,1,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0062634,-0.3625,-0.31462,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028141,-0.36269,-0.27908,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.0029794,-0.36306,-0.33103,1,0
1,GO PLASMINOGEN ACTIVATION,1.1493e-05,-0.36338,-0.43544,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,6.7728e-06,-0.36447,-0.3144,1,0
1,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00081984,-0.36455,-0.29935,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,7.547e-05,-0.36502,-0.37848,1,0
1,GO CATECHOLAMINE UPTAKE,0.001191,-0.36553,-0.32563,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,1.0604e-05,-0.36585,-0.459,1,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,9.2696e-08,-0.36596,-0.37933,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,6.7728e-06,-0.36627,-0.42016,1,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,5.2837e-06,-0.36633,-0.41904,1,0
1,GO MECHANOSENSORY BEHAVIOR,0.023741,-0.3664,-0.27557,1,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.00052342,-0.36648,-0.32189,1,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0050528,-0.3667,-0.35449,1,0
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0071468,-0.36678,-0.30266,1,0
1,GO NEUTROPHIL HOMEOSTASIS,0.001662,-0.36745,-0.3792,1,0
1,GO MONOCYTE CHEMOTAXIS,1.8521e-05,-0.36849,-0.33491,1,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.014486,-0.36892,-0.29432,1,0
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00026003,-0.37002,-0.39181,1,0
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00035231,-0.37014,-0.29829,1,0
1,GO DETECTION OF CALCIUM ION,0.0067808,-0.37024,-0.2769,1,0
1,GO MINERALOCORTICOID METABOLIC PROCESS,0.00035231,-0.37161,-0.38423,1,0
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00067758,-0.37168,-0.35832,1,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.00057693,-0.37186,-0.39057,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,-0.37202,-0.28303,1,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,-0.37365,-0.34554,1,0
1,GO OLIGOPEPTIDE TRANSPORT,0.029068,-0.37408,-0.23068,1,0
1,GO DENDRITIC CELL APOPTOTIC PROCESS,3.1888e-05,-0.37554,-0.42167,1,0
1,GO IMMUNE RESPONSE TO TUMOR CELL,0.00084609,-0.37635,-0.38681,1,0
1,GO MYELIN MAINTENANCE,1.9263e-05,-0.3774,-0.42884,1,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00021909,-0.38058,-0.30189,1,0
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.037747,-0.38076,-0.30871,1,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.027803,-0.38084,-0.24684,1,0
1,GO CHAPERONE MEDIATED AUTOPHAGY,4.8379e-05,-0.38092,-0.4888,1,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.034637,-0.38093,-0.2762,1,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00041602,-0.38177,-0.40682,1,0
1,GO GERMINAL CENTER FORMATION,0.00041602,-0.3822,-0.42487,1,0
1,GO EPOXYGENASE P450 PATHWAY,5.2837e-06,-0.38299,-0.41434,1,0
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.035393,-0.38373,-0.19571,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,3.1888e-05,-0.384,-0.32408,1,0
1,GO VASODILATION,2.9301e-06,-0.38502,-0.4086,1,0
1,GO HOMOTYPIC CELL CELL ADHESION,1.2454e-05,-0.38661,-0.3376,1,0
1,GO PULMONARY VALVE DEVELOPMENT,0.00010845,-0.38695,-0.4541,1,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0032441,-0.38748,-0.32742,1,0
1,GO LIPOXYGENASE PATHWAY,0.00012964,-0.38777,-0.39881,1,0
1,GO REGULATION OF CHOLESTEROL ESTERIFICATION,3.4421e-05,-0.38792,-0.45407,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00059588,-0.39055,-0.36724,1,0
1,GO POLYOL TRANSPORT,5.2139e-05,-0.39079,-0.34148,1,0
1,GO MITOCHONDRIAL TRANSCRIPTION,3.3287e-06,-0.39117,-0.41123,1,0
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.00021167,-0.39129,-0.36348,1,0
1,GO DISACCHARIDE METABOLIC PROCESS,7.3528e-06,-0.39156,-0.3733,1,0
1,GO DOPAMINE TRANSPORT,0.0020453,-0.3918,-0.28204,1,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00011241,-0.39241,-0.36634,1,0
1,GO REGULATION OF DOPAMINE SECRETION,0.0097392,-0.39245,-0.2798,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.6455e-05,-0.39376,-0.3539,1,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,6.7596e-05,-0.39512,-0.38848,1,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,3.5759e-05,-0.39525,-0.39852,1,0
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00034072,-0.39647,-0.34845,1,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.00090094,-0.39655,-0.46406,1,0
1,GO RESPONSE TO COPPER ION,3.7145e-05,-0.39678,-0.45371,1,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.011904,-0.3969,-0.26985,1,0
1,GO NOTOCHORD DEVELOPMENT,0.0060989,-0.39795,-0.25773,1,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,6.0504e-05,-0.40016,-0.39597,1,0
1,GO ARGININE METABOLIC PROCESS,0.00055855,-0.40018,-0.35555,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,9.7801e-06,-0.40035,-0.36105,1,0
1,GO GAS TRANSPORT,0.00027832,-0.4005,-0.40939,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.3418e-05,-0.40184,-0.45829,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00013917,-0.40231,-0.36426,1,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.015574,-0.40337,-0.55185,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0049174,-0.40374,-0.28112,1,0
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0059384,-0.40463,-0.33086,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.00079435,-0.40616,-0.46237,1,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,6.2367e-06,-0.4075,-0.48185,1,0
1,GO STEROL IMPORT,1.6729e-06,-0.40756,-0.41529,1,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,3.9926e-07,-0.40851,-0.41317,1,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,6.5149e-05,-0.40877,-0.4552,1,0
1,GO EOSINOPHIL MIGRATION,0.00010092,-0.40994,-0.42419,1,0
1,GO FRUCTOSE METABOLIC PROCESS,0.00012074,-0.41007,-0.52069,1,0
1,GO REGULATION OF METANEPHROS DEVELOPMENT,0.00027832,-0.41116,-0.45073,1,0
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.02268,-0.4141,-0.34998,1,0
1,GO STEROID ESTERIFICATION,1.4044e-06,-0.4157,-0.47933,1,0
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,1.9263e-05,-0.41653,-0.41574,1,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.0062634,-0.41747,-0.34958,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,2.1663e-05,-0.41757,-0.38296,1,0
1,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,1.9263e-05,-0.41832,-0.43172,1,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0027346,-0.41844,-0.39776,1,0
1,GO ZYMOGEN ACTIVATION,0.00026003,-0.41856,-0.38456,1,0
1,GO HISTAMINE TRANSPORT,0.0011199,-0.41915,-0.40867,1,0
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,4.6623e-06,-0.41975,-0.46123,1,0
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00092958,-0.41977,-0.42936,1,0
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0019282,-0.41988,-0.51897,1,0
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0010528,-0.42015,-0.342,1,0
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.7118e-05,-0.4213,-0.42471,1,0
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00044439,-0.42171,-0.39033,1,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,7.9801e-06,-0.4231,-0.55645,1,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,3.1904e-06,-0.42356,-0.41251,1,0
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00067758,-0.42632,-0.35005,1,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,1.8521e-05,-0.42891,-0.40279,1,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.7474e-06,-0.42978,-0.48717,1,0
1,GO BIOLOGICAL PHASE,0.010506,-0.43406,-0.36665,1,0
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0012662,-0.43702,-0.40274,1,0
1,GO GLYCINE TRANSPORT,0.00020448,-0.43893,-0.43912,1,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.02166,-0.43933,-0.55706,1,0
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00057693,-0.43936,-0.37605,1,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00059588,-0.44006,-0.3875,1,0
1,GO CYSTEINE METABOLIC PROCESS,2.6307e-05,-0.44026,-0.51207,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.7596e-05,-0.44383,-0.46358,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,4.4878e-05,-0.44603,-0.42999,1,0
1,GO HISTAMINE SECRETION,0.0042883,-0.44665,-0.3884,1,0
1,GO GLUTATHIONE METABOLIC PROCESS,2.5122e-07,-0.44811,-0.46604,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0018173,-0.44876,-0.34195,1,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00040247,-0.44913,-0.43171,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,1.8251e-06,-0.44979,-0.55791,1,0
1,GO L PHENYLALANINE METABOLIC PROCESS,1.6455e-05,-0.45017,-0.45133,1,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,3.8583e-05,-0.45033,-0.50114,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.0576e-06,-0.45481,-0.53064,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00095906,-0.45772,-0.38262,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0010528,-0.46413,-0.40053,1,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.0022992,-0.46499,-0.38696,1,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,5.2837e-06,-0.46503,-0.47692,1,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00059588,-0.46883,-0.41198,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,2.8077e-06,-0.47181,-0.44239,1,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0073363,-0.47208,-0.35691,1,0
1,GO HEART INDUCTION,0.0006154,-0.47216,-0.38864,1,0
1,GO POSITIVE REGULATION OF HEART RATE,6.0504e-05,-0.47263,-0.41075,1,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,6.8936e-07,-0.47309,-0.50205,1,0
1,GO NEURON REMODELING,1.1776e-06,-0.47353,-0.55665,1,0
1,GO REGULATION OF PLASMINOGEN ACTIVATION,1.5201e-05,-0.47475,-0.60965,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.104e-05,-0.47834,-0.39629,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0038387,-0.47988,-0.42337,1,0
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0094949,-0.48022,-0.39549,1,0
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,1.2454e-05,-0.48111,-0.50122,1,0
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.349e-05,-0.48298,-0.45621,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00010845,-0.48468,-0.44297,1,0
1,GO EOSINOPHIL CHEMOTAXIS,3.0689e-05,-0.48603,-0.4869,1,0
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,9.0179e-06,-0.48609,-0.56016,1,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,3.1904e-06,-0.48636,-0.47258,1,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.00016595,-0.48803,-0.46728,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,3.9418e-06,-0.49251,-0.50737,1,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,6.7728e-06,-0.4953,-0.4436,1,0
1,GO POSITIVE REGULATION OF VASCULOGENESIS,5.0683e-06,-0.49542,-0.54751,1,0
1,GO PULMONARY VALVE MORPHOGENESIS,6.0504e-05,-0.49589,-0.55509,1,0
1,GO GALACTOSE METABOLIC PROCESS,9.3916e-06,-0.49917,-0.49003,1,0
1,GO MONONUCLEAR CELL DIFFERENTIATION,5.753e-07,-0.50877,-0.4969,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00011241,-0.51087,-0.45373,1,0
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00045924,-0.51361,-0.44406,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,1.9904e-06,-0.52093,-0.52074,1,0
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00021167,-0.52426,-0.50057,1,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,7.9801e-06,-0.54321,-0.5307,1,0
1,GO BLEB ASSEMBLY,0.00052342,-0.55581,-0.60852,1,0
1,GO MUCUS SECRETION,0.001986,-0.56446,-0.47631,1,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,3.9418e-06,-0.56833,-0.47307,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00010462,-0.56942,-0.46529,1,0
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,5.2837e-06,-0.57026,-0.54757,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.0018173,-0.57363,-0.47695,1,0
1,GO ADHESION OF SYMBIONT TO HOST,5.2533e-07,-0.5866,-0.5641,1,0
1,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.8521e-05,-0.59701,-0.63934,1,0
1,GO REGULATION OF VASCULOGENESIS,7.0571e-06,-0.59737,-0.59151,1,0
1,GO CYCLOOXYGENASE PATHWAY,2.2879e-07,-0.60188,-0.69776,1,0
1,GO XENOBIOTIC CATABOLIC PROCESS,7.6603e-06,-0.62903,-0.6636,1,0
1,GO OXYGEN TRANSPORT,0.00019079,-0.64083,-0.55403,1,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,3.0576e-06,-0.64214,-0.63718,1,0
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,5.0226e-05,-0.6731,-0.64398,1,0
1,GO MEMBRANE RAFT ASSEMBLY,0.0047853,-0.67772,-0.57694,1,0
1,GO FOREBRAIN MORPHOGENESIS,0.18508,0.2127,0.11036,0,1
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.35607,0.20189,0.13626,0,1
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.11039,0.17951,0.15972,0,1
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.068167,0.1771,0.14277,0,1
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.12259,0.17708,0.13201,0,1
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.17653,0.17303,0.088439,0,1
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.11235,0.16767,0.1411,0,1
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.088862,0.16523,0.12189,0,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.084046,0.15502,0.16145,0,1
1,GO RETINAL ROD CELL DIFFERENTIATION,0.17374,0.15142,0.13627,0,1
1,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.10096,0.14862,0.13189,0,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.15015,0.14831,0.12493,0,1
1,GO MITOTIC DNA REPLICATION CHECKPOINT,0.065563,0.14602,0.10072,0,1
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.077957,0.14149,0.11822,0,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0695,0.13873,0.17858,0,1
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.057089,0.13816,0.11039,0,1
1,GO NEURAL TUBE PATTERNING,0.11039,0.1352,0.10121,0,1
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.095625,0.13484,0.072512,0,1
1,GO ESTROUS CYCLE,0.33373,0.13023,0.08909,0,1
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.17374,0.12767,0.081997,0,1
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.064293,0.12493,0.12018,0,1
1,GO PROTEIN O LINKED MANNOSYLATION,0.076492,0.1244,0.11321,0,1
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.073629,0.11142,0.075794,0,1
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.061812,0.10583,0.070679,0,1
1,GO SNORNA 3 END PROCESSING,0.060602,0.10246,0.13938,0,1
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.20621,0.10074,0.083684,0,1
1,GO MRNA METHYLATION,0.16032,0.093686,0.071223,0,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.14526,0.093409,0.10583,0,1
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.050569,0.091546,0.073268,0,1
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.05161,0.09152,0.062501,0,1
1,GO ERYTHROCYTE DEVELOPMENT,0.19695,0.086415,0.027598,0,1
1,GO RESPONSE TO ETHER,0.13355,0.081236,0.07376,0,1
1,GO HISTONE H3 K9 ACETYLATION,0.30402,0.076372,0.0379,0,1
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.30815,0.072548,0.072218,0,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.060602,0.067022,0.0931,0,1
1,GO SNORNA METABOLIC PROCESS,0.16294,0.066196,0.082607,0,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.16828,0.065642,0.050729,0,1
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.27999,0.063712,0.04553,0,1
1,GO PROTEIN MONOUBIQUITINATION,0.061812,0.059679,0.04122,0,1
1,GO DNA INTEGRITY CHECKPOINT,0.11434,0.055462,0.035118,0,1
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.054842,0.055375,0.060788,0,1
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.088862,0.054556,0.067756,0,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.11636,0.049684,0.036007,0,1
1,GO DOUBLE STRAND BREAK REPAIR,0.11235,0.042413,0.031009,0,1
1,GO COVALENT CHROMATIN MODIFICATION,0.080955,0.040161,0.035267,0,1
1,GO MRNA TRANSPORT,0.188,0.03925,0.030531,0,1
1,GO STEM CELL PROLIFERATION,0.22235,0.03719,0.055775,0,1
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.052669,0.036662,0.043382,0,1
1,GO DEMETHYLATION,0.38408,0.034566,0.020295,0,1
1,GO CARDIOBLAST PROLIFERATION,0.0013872,0.50011,0.51119,0,0
1,GO NEURON FATE SPECIFICATION,0.00044439,0.46505,0.46941,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0017123,0.39323,0.46016,0,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.073629,0.36788,0.25221,0,0
1,GO THALAMUS DEVELOPMENT,0.0069616,0.32241,0.26504,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.19393,0.31575,0.20622,0,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.025414,0.28974,0.31315,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.084046,0.27638,0.26021,0,0
1,GO FAT CELL PROLIFERATION,0.0036303,0.27282,0.26133,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0069616,0.2722,0.36877,0,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.049546,0.24932,0.21624,0,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.14526,0.24392,0.11651,0,0
1,GO LATERAL MESODERM DEVELOPMENT,0.049546,0.24213,0.18638,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.0064317,0.23489,0.35422,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.0042883,0.23165,0.22822,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.063042,0.22984,0.26304,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.010773,0.22314,0.29335,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.064293,0.21708,0.16282,0,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.05824,0.20886,0.15432,0,0
1,GO CELL MIGRATION IN HINDBRAIN,0.075049,0.20849,0.16021,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.015574,0.20193,0.18179,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.016734,0.20191,0.28834,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0066042,0.19455,0.17201,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.049546,0.19313,0.18111,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.015953,0.18898,0.15675,0,0
1,GO NOSE DEVELOPMENT,0.027803,0.18239,0.3683,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.27999,0.18231,0.16353,0,0
1,GO LACTATE METABOLIC PROCESS,0.16032,0.17957,0.099186,0,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0059384,0.17511,0.33287,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.188,0.17401,0.090385,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.19695,0.1698,0.12551,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,0.090515,0.16973,0.21788,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.14285,0.16857,0.13924,0,0
1,GO TONGUE DEVELOPMENT,0.19095,0.16732,0.091015,0,0
1,GO DECIDUALIZATION,0.15015,0.16236,0.10448,0,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.14769,0.16215,0.14819,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.11841,0.1617,0.12698,0,0
1,GO ADENOHYPOPHYSIS DEVELOPMENT,0.35153,0.16137,0.1444,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.14048,0.15956,0.15,0,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.019283,0.15828,0.18276,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.023741,0.15721,0.11106,0,0
1,GO CELL FATE SPECIFICATION,0.010245,0.15297,0.17439,0,0
1,GO INTRACILIARY TRANSPORT,0.038561,0.15287,0.11932,0,0
1,GO HISTONE H3 K9 METHYLATION,0.0013457,0.15283,0.15195,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.090515,0.1496,0.11077,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.065563,0.14716,0.18465,0,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.12473,0.1435,0.12478,0,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.04854,0.14262,0.11226,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.10654,0.14139,0.13235,0,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.19393,0.13991,0.12855,0,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.28785,0.13881,0.070237,0,0
1,GO DNA LIGATION,0.12689,0.13864,0.10979,0,0
1,GO LIMB BUD FORMATION,0.42855,0.13721,0.060383,0,0
1,GO TONGUE MORPHOGENESIS,0.22235,0.13311,0.17132,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,0.61497,0.1326,0.10202,0,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.14048,0.13179,0.096254,0,0
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.38888,0.13152,0.067924,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.019739,0.13069,0.11721,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.12473,0.12966,0.098855,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.21256,0.12965,0.098475,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.61497,0.12957,0.045018,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.23937,0.12938,0.095963,0,0
1,GO CARDIAC CHAMBER FORMATION,0.30815,0.12767,0.17176,0,0
1,GO TRACHEA MORPHOGENESIS,0.34256,0.12552,0.11651,0,0
1,GO GENETIC IMPRINTING,0.082489,0.12355,0.10588,0,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.070855,0.12354,0.1131,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.28785,0.12296,0.10397,0,0
1,GO HORMONE CATABOLIC PROCESS,0.58456,0.12266,0.066644,0,0
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.54903,0.12217,0.056928,0,0
1,GO CARDIAC VENTRICLE FORMATION,0.42347,0.12114,0.13987,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.18508,0.12114,0.13475,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.52594,0.1203,0.16359,0,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.016734,0.12003,0.24459,0,0
1,GO FORELIMB MORPHOGENESIS,0.04854,0.11912,0.16297,0,0
1,GO CENTRIOLE ASSEMBLY,0.010245,0.11817,0.10446,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.17374,0.11774,0.17017,0,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.0099891,0.11746,0.15115,0,0
1,GO PROTEIN DEMETHYLATION,0.188,0.11736,0.091236,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.22568,0.11706,0.076551,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,0.17653,0.11575,0.15396,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.40349,0.11563,0.045466,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.12259,0.11182,0.12594,0,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.67776,0.11125,0.03392,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.03939,0.11121,0.12871,0,0
1,GO REGULATION OF STEM CELL DIVISION,0.20309,0.11072,0.085671,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.25001,0.10941,0.059193,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.55487,0.1087,0.034859,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.74288,0.1087,0.025738,0,0
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.69707,0.10866,0.011862,0,0
1,GO SUBPALLIUM DEVELOPMENT,0.5726,0.10829,0.035778,0,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.12689,0.10806,0.18124,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.14285,0.10788,0.091975,0,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.055956,0.10665,0.14733,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.13355,0.10604,0.10998,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.16559,0.10568,0.0512,0,0
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.050569,0.10465,0.079829,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.009256,0.10431,0.14982,0,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.29184,0.10427,0.047978,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.32938,0.10395,0.087775,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.30815,0.1034,0.11442,0,0
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.59664,0.10293,0.013413,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.029068,0.10179,0.097399,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.26471,0.10165,0.096541,0,0
1,GO SIALYLATION,0.48678,0.10075,0.059134,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.059411,0.099741,0.098859,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.3746,0.099696,0.059301,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.12908,0.099495,0.083358,0,0
1,GO RESPONSE TO FOOD,0.27611,0.099485,0.050736,0,0
1,GO RETINA LAYER FORMATION,0.24288,0.098668,0.13368,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.63978,0.098159,0.026302,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.23589,0.097847,0.08568,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.50337,0.096623,0.022054,0,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.10465,0.09619,0.097959,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.13814,0.096114,0.081451,0,0
1,GO PROTEIN MANNOSYLATION,0.10654,0.095559,0.083498,0,0
1,GO SYNAPTIC VESICLE CLUSTERING,0.27227,0.094702,0.23875,0,0
1,GO ER OVERLOAD RESPONSE,0.19095,0.094508,0.099256,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18219,0.094446,0.081076,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.29184,0.094366,0.062717,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,0.53167,0.094086,0.11684,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.78962,0.093834,0.023473,0,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.092194,0.093094,0.08061,0,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.41341,0.092464,0.083178,0,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.043763,0.092084,0.079594,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.0051916,0.091877,0.11721,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.59059,0.091804,0.056903,0,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.53742,0.091523,0.0022047,0,0
1,GO HISTONE H2A UBIQUITINATION,0.03939,0.090787,0.099984,0,0
1,GO REGULATION OF CENTROSOME DUPLICATION,0.095625,0.090434,0.077062,0,0
1,GO POSITIVE T CELL SELECTION,0.077957,0.090114,0.080028,0,0
1,GO CELL FATE DETERMINATION,0.32077,0.090021,0.09378,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.17099,0.089761,0.090917,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.80312,0.088747,0.071945,0,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.30402,0.088722,0.059242,0,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4598,0.088352,0.054041,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.53167,0.088302,0.027002,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.34702,0.08827,0.13118,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.11636,0.088222,0.10302,0,0
1,GO INNER CELL MASS CELL PROLIFERATION,0.11039,0.088128,0.070659,0,0
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.48131,0.088066,0.071566,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.87144,0.088047,-0.018516,0,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.46512,0.08769,0.13145,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.33812,0.087659,0.092213,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.097379,0.086918,0.082399,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.42347,0.086063,0.052757,0,0
1,GO RESPONSE TO UV C,0.47588,0.08562,0.035408,0,0
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.12259,0.084809,0.064898,0,0
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.12259,0.084737,0.059799,0,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.10654,0.084428,0.14002,0,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.0031536,0.084373,0.12077,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.12689,0.084216,0.067501,0,0
1,GO SISTER CHROMATID COHESION,0.0050528,0.084101,0.12217,0,0
1,GO SYNAPTIC VESICLE LOCALIZATION,0.14048,0.083971,0.13503,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.67776,0.082839,0.020233,0,0
1,GO CENTROSOME SEPARATION,0.16032,0.082677,0.080896,0,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.24288,0.082555,0.061116,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.35153,0.082512,0.059077,0,0
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.21579,0.08221,0.085304,0,0
1,GO MIDGUT DEVELOPMENT,0.65866,0.082163,-0.093104,0,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.17374,0.082019,0.10401,0,0
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.33812,0.081967,0.072485,0,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.20309,0.08138,0.10072,0,0
1,GO SEROTONIN SECRETION,0.60883,0.080498,0.049005,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.44924,0.079881,0.04932,0,0
1,GO HISTONE H3 K27 METHYLATION,0.38408,0.079185,0.034322,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.50896,0.078161,0.046579,0,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.31653,0.077601,0.16799,0,0
1,GO SOMITE DEVELOPMENT,0.12473,0.077112,0.055094,0,0
1,GO REGULATION OF STEM CELL PROLIFERATION,0.090515,0.076743,0.08824,0,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.65234,0.076515,0.0086991,0,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.40349,0.076434,0.079106,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.14526,0.076325,0.13365,0,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.3746,0.075956,0.13726,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.55487,0.075703,0.025107,0,0
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.1313,0.075493,0.06504,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.28785,0.075051,0.055444,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.53742,0.074688,0.063209,0,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.050569,0.0746,0.12629,0,0
1,GO DOSAGE COMPENSATION,0.10096,0.074423,0.067313,0,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.64605,0.074331,0.055982,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.19695,0.074211,0.17161,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.079444,0.073847,0.077363,0,0
1,GO DNA REPLICATION CHECKPOINT,0.188,0.073677,0.069995,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.43367,0.073615,0.080461,0,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.25729,0.073287,0.050553,0,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.14285,0.073254,0.080465,0,0
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.19095,0.073155,0.08922,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.12689,0.072145,0.073035,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.21579,0.071686,0.070291,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.15773,0.071085,0.087732,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.18219,0.071075,0.040023,0,0
1,GO RNA DESTABILIZATION,0.33373,0.071073,0.029251,0,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.55487,0.070806,0.03344,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.72969,0.070574,-0.010923,0,0
1,GO RNA 3 END PROCESSING,0.17099,0.070276,0.030087,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.16032,0.069419,0.10137,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.35153,0.069157,0.065633,0,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.5726,0.068211,0.14257,0,0
1,GO REGULATION OF ODONTOGENESIS,0.5726,0.067427,0.03235,0,0
1,GO T CELL SELECTION,0.188,0.067414,0.05386,0,0
1,GO CELLULAR RESPONSE TO X RAY,0.22568,0.067354,0.0063819,0,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.063042,0.066903,0.078614,0,0
1,GO METAPHASE PLATE CONGRESSION,0.063042,0.066627,0.06227,0,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.63978,0.066163,0.019208,0,0
1,GO MICROTUBULE NUCLEATION,0.83713,0.066058,0.0044434,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.8303,0.065558,-0.014497,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.29586,0.065368,0.031226,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.064293,0.065087,0.068178,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.27611,0.064786,0.088167,0,0
1,GO SISTER CHROMATID SEGREGATION,0.016339,0.064701,0.077692,0,0
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.20937,0.064501,0.048674,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.19695,0.064258,0.055322,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.87144,0.064216,-0.0027048,0,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.75615,0.064123,0.028942,0,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.30815,0.064032,0.050578,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.020205,0.064002,0.090861,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.24643,0.063396,0.038013,0,0
1,GO ECTODERM DEVELOPMENT,0.44924,0.062383,0.029458,0,0
1,GO PENILE ERECTION,0.13814,0.061633,0.13142,0,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.17934,0.061614,0.075734,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.26098,0.061563,0.07607,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.30402,0.061481,0.035861,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.34256,0.061368,0.037292,0,0
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.44402,0.061104,0.021378,0,0
1,GO CELL CELL JUNCTION MAINTENANCE,0.39371,0.060803,0.071668,0,0
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.51459,0.060645,0.047986,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.068167,0.059681,0.11273,0,0
1,GO RESPONSE TO HYDROXYUREA,0.11235,0.059611,0.11146,0,0
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.10465,0.059606,0.075726,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.2,0.059569,0.042636,0,0
1,GO MITOTIC RECOMBINATION,0.25363,0.059444,0.053998,0,0
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.18219,0.059293,0.099404,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.23245,0.05913,0.094359,0,0
1,GO NOREPINEPHRINE SECRETION,0.188,0.058596,0.09278,0,0
1,GO INTRACELLULAR MRNA LOCALIZATION,0.17099,0.058039,0.084383,0,0
1,GO NEURAL RETINA DEVELOPMENT,0.39858,0.057929,0.055725,0,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.32506,0.057843,0.036173,0,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.52025,0.057751,0.0050593,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.56666,0.057598,0.024232,0,0
1,GO DENDRITIC TRANSPORT,0.30815,0.057492,0.083262,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.86455,0.056727,0.003989,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.80989,0.056466,0.023997,0,0
1,GO HISTONE METHYLATION,0.022165,0.056427,0.060551,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.62732,0.05629,-0.10135,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.63978,0.056135,0.05028,0,0
1,GO REGULATION OF HISTONE METHYLATION,0.046579,0.056069,0.066675,0,0
1,GO SNRNA TRANSCRIPTION,0.35607,0.05538,0.016107,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.97557,0.055309,-0.014608,0,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.52594,0.054933,0.014382,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.5726,0.054838,0.011159,0,0
1,GO GROWTH HORMONE SECRETION,0.48678,0.054683,0.076556,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.72313,0.05456,-0.008056,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.46512,0.054487,0.060916,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.88523,0.054425,-0.010421,0,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.62113,0.054379,0.0088755,0,0
1,GO REGULATION OF PROTEIN SUMOYLATION,0.80989,0.054236,0.0075432,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.4545,0.054205,0.022085,0,0
1,GO HISTONE H3 K36 METHYLATION,0.34702,0.053626,0.035625,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.12259,0.053515,0.052508,0,0
1,GO PROTEIN SUMOYLATION,0.23937,0.053427,0.030312,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.91987,0.053332,0.022997,0,0
1,GO RRNA 3 END PROCESSING,0.48131,0.053274,0.034178,0,0
1,GO HIPPO SIGNALING,0.60883,0.05326,0.010409,0,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.20937,0.053203,0.055181,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.66501,0.05308,0.021408,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.60883,0.052887,0.038986,0,0
1,GO SULFATION,0.17934,0.052843,0.085032,0,0
1,GO ERYTHROCYTE MATURATION,0.74288,0.052801,0.017871,0,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.35153,0.052746,0.035414,0,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.71658,0.05253,0.058037,0,0
1,GO RESPONSE TO L GLUTAMATE,0.72313,0.052475,0.036056,0,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.47049,0.052447,0.03648,0,0
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.83713,0.052376,0.0049424,0,0
1,GO NCRNA EXPORT FROM NUCLEUS,0.83713,0.051993,-0.00043017,0,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.3746,0.051919,0.041723,0,0
1,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.3746,0.051654,0.062532,0,0
1,GO LYMPHANGIOGENESIS,0.82348,0.05136,-0.028663,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.22235,0.051126,0.027044,0,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,0.52025,0.05026,0.032129,0,0
1,GO PROTEIN NEDDYLATION,0.82348,0.049971,-0.0088552,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.5726,0.049292,-0.11286,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.35607,0.048958,0.032883,0,0
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.10845,0.04888,0.038283,0,0
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.99651,0.048848,-0.019875,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.053746,0.048401,0.067522,0,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.75615,0.048293,0.011084,0,0
1,GO NCRNA TRANSCRIPTION,0.32938,0.048213,0.02171,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.13814,0.047702,0.080968,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.24643,0.047678,0.045473,0,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.28785,0.047609,0.16181,0,0
1,GO DISTAL TUBULE DEVELOPMENT,0.26471,0.047551,0.074943,0,0
1,GO PROSTATE GLAND GROWTH,0.78962,0.047382,-0.041428,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.87144,0.047254,0.012898,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.55487,0.04721,0.02031,0,0
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.12689,0.046792,0.070238,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.38888,0.046444,0.035675,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,0.71658,0.04609,-0.0081451,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.25001,0.04562,0.047618,0,0
1,GO SPINDLE LOCALIZATION,0.25001,0.045404,0.054561,0,0
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.24643,0.045264,0.022154,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.36991,0.045158,0.0095701,0,0
1,GO SMOOTHENED SIGNALING PATHWAY,0.23937,0.045121,0.054976,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.50896,0.045002,0.06308,0,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.69061,0.044769,0.01849,0,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.072231,0.044734,0.053775,0,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,0.85082,0.0447,0.027783,0,0
1,GO MALE SEX DETERMINATION,0.48131,0.044559,0.080995,0,0
1,GO UV DAMAGE EXCISION REPAIR,0.79636,0.044542,-0.017863,0,0
1,GO VASCULAR TRANSPORT,0.95466,0.04432,-0.031863,0,0
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.38888,0.044259,0.05791,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.91293,0.044193,-0.038346,0,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.25363,0.044162,0.038312,0,0
1,GO REGULATION OF CIRCADIAN RHYTHM,0.36064,0.043846,0.022906,0,0
1,GO EMBRYONIC HEMOPOIESIS,0.5726,0.043719,0.035491,0,0
1,GO PROTEIN METHYLATION,0.077957,0.043661,0.043546,0,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.35153,0.043419,0.030464,0,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.85768,0.043308,-0.010503,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.14769,0.043226,0.055734,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.40843,0.042655,0.049698,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.65866,0.042603,0.020408,0,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.98953,0.042556,-0.019656,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.94769,0.042121,-0.0083964,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.54903,0.041766,0.031537,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.69707,0.041519,0.018108,0,0
1,GO MITOTIC SPINDLE ORGANIZATION,0.54321,0.041484,0.0067547,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.34702,0.041074,0.058056,0,0
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.92682,0.041041,-0.054922,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.91987,0.040978,-0.019228,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.74288,0.04057,0.0042649,0,0
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.059411,0.040526,0.045284,0,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.54903,0.040489,0.2073,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.22568,0.040181,0.082838,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.21579,0.040131,0.033452,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.26098,0.039932,0.060272,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.59059,0.039553,0.03902,0,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.33812,0.03942,0.093494,0,0
1,GO RNA STABILIZATION,0.65234,0.03852,0.0061449,0,0
1,GO LEUKOCYTE AGGREGATION,0.72313,0.03831,0.044818,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.7495,0.038246,-0.040636,0,0
1,GO HISTONE H3 ACETYLATION,0.38888,0.038166,0.018978,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.23937,0.038155,0.12094,0,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.60883,0.038142,0.058173,0,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.63978,0.038132,0.02886,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.25729,0.03772,0.077763,0,0
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.67776,0.037533,0.012438,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.92682,0.037341,0.0054167,0,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.60272,0.037291,-0.081891,0,0
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.91293,0.036968,-0.029684,0,0
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.42347,0.036854,0.046498,0,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.63978,0.036614,0.016436,0,0
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.4545,0.036352,0.019333,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.49227,0.03555,0.048855,0,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.69061,0.035154,-0.00082548,0,0
1,GO CHROMATIN DISASSEMBLY,0.96163,0.035073,-0.0034524,0,0
1,GO RESPONSE TO VITAMIN D,0.38408,0.034906,0.051625,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.2839,0.034723,0.078526,0,0
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.25001,0.03458,0.061066,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.92682,0.034216,0.0081289,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.85082,0.034056,-0.019921,0,0
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.64605,0.033897,0.038727,0,0
1,GO MANNOSYLATION,0.62732,0.033751,-0.0029118,0,0
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.60883,0.033539,0.013499,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.44924,0.033446,0.027423,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.87833,0.033071,0.0097451,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.51459,0.033062,0.051915,0,0
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.51459,0.032982,0.015782,0,0
1,GO REGULATION OF CHROMOSOME SEPARATION,0.55487,0.032808,0.028526,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.91987,0.032653,-0.011172,0,0
1,GO RNA PROCESSING,0.9686,0.032565,-0.010958,0,0
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.86455,0.032299,-0.0046684,0,0
1,GO DNA METHYLATION,0.57857,0.032109,0.025208,0,0
1,GO SYNAPTIC VESICLE TRANSPORT,0.52025,0.032108,0.064836,0,0
1,GO REGULATION OF DNA METHYLATION,0.95466,0.032029,-0.0072952,0,0
1,GO REGULATION OF PINOCYTOSIS,0.7495,0.031938,-0.089961,0,0
1,GO REGULATION OF SPINDLE ORGANIZATION,0.69707,0.03191,-0.027529,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.70355,0.031746,0.0022951,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.59059,0.031379,0.022754,0,0
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.75615,0.031274,-0.001692,0,0
1,GO MICROTUBULE DEPOLYMERIZATION,0.42855,0.030895,0.060881,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.36526,0.030681,0.010859,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,0.35153,0.030381,0.052683,0,0
1,GO BRAIN MORPHOGENESIS,0.66501,0.030322,0.0079575,0,0
1,GO RNA CAPPING,0.44924,0.029814,0.012158,0,0
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.4598,0.02961,0.034959,0,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.88523,0.029599,-0.051658,0,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.32506,0.02943,0.037589,0,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.4598,0.029396,0.070292,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.63354,0.029359,0.014365,0,0
1,GO GDP METABOLIC PROCESS,0.96163,0.029178,-0.010517,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.26471,0.029166,0.026271,0,0
1,GO MITOCHONDRIAL TRNA PROCESSING,0.60883,0.028981,0.044473,0,0
1,GO PYRAMIDAL NEURON DIFFERENTIATION,0.47049,0.028884,0.075389,0,0
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.85768,0.02884,-0.087424,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.25729,0.028834,0.096909,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.68418,0.028712,0.011986,0,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.60272,0.02864,-0.028534,0,0
1,GO CILIUM ORGANIZATION,0.48678,0.028541,0.022683,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.68418,0.028538,-0.031941,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.39858,0.028469,0.042885,0,0
1,GO BLASTOCYST GROWTH,0.39858,0.028378,0.022312,0,0
1,GO T CELL LINEAGE COMMITMENT,0.29184,0.028162,0.054679,0,0
1,GO THYMIC T CELL SELECTION,0.62732,0.028118,0.016767,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.80312,0.028084,0.0153,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.38888,0.026954,0.052194,0,0
1,GO RRNA TRANSCRIPTION,0.86455,0.02682,-0.0053219,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.67776,0.026814,0.034358,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.44924,0.026737,0.10059,0,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.5726,0.026724,0.012087,0,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.83713,0.026483,0.0067209,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.44402,0.026311,0.080845,0,0
1,GO DNA REPAIR,0.20937,0.026245,0.02147,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.12473,0.026149,0.062612,0,0
1,GO REGULATION OF MICROTUBULE BINDING,0.35607,0.025925,0.064219,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.7495,0.025817,0.00067981,0,0
1,GO MITOCHONDRIAL FUSION,0.62113,0.025773,0.0055619,0,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.72313,0.025745,0.021419,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.67776,0.025656,0.020704,0,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.62732,0.025449,0.023886,0,0
1,GO TRNA TRANSPORT,0.71006,0.025382,0.012252,0,0
1,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.91987,0.025045,-0.047893,0,0
1,GO HISTONE DEUBIQUITINATION,0.71006,0.025017,0.0065041,0,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.99651,0.024951,-0.0088433,0,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.20621,0.024937,0.051832,0,0
1,GO GENE SILENCING,0.48678,0.024934,0.014233,0,0
1,GO DNA REPLICATION,0.36526,0.024827,0.015667,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.87833,0.024309,-0.02283,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.94769,0.024219,-0.0093153,0,0
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.77618,0.023961,-0.058753,0,0
1,GO MICROTUBULE SEVERING,0.78289,0.023904,0.03112,0,0
1,GO HISTONE H4 DEACETYLATION,0.44924,0.023618,0.032505,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.29184,0.023487,0.06895,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.41341,0.023418,0.010987,0,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.57857,0.023372,0.023525,0,0
1,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.65234,0.023082,0.073215,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,0.80312,0.022476,0.016925,0,0
1,GO NUCLEAR EXPORT,0.44402,0.02238,0.010582,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.87144,0.021968,0.0055158,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.43367,0.021884,0.017452,0,0
1,GO NEGATIVE T CELL SELECTION,0.60883,0.021805,-0.00038342,0,0
1,GO CEREBELLAR CORTEX FORMATION,0.56666,0.021578,0.060334,0,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.4978,0.021479,0.015609,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.59059,0.02145,0.027832,0,0
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.78962,0.021257,0.023159,0,0
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.63354,0.021027,0.013959,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.69707,0.020423,0.041569,0,0
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.7495,0.020087,0.013086,0,0
1,GO CHROMOSOME CONDENSATION,0.24288,0.020079,0.051279,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.37932,0.019987,0.019953,0,0
1,GO NEURON PROJECTION REGENERATION,0.49227,0.019567,-0.036591,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.56075,0.019271,0.0067318,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.53742,0.019261,0.043449,0,0
1,GO HISTONE MRNA METABOLIC PROCESS,0.83713,0.019207,0.0033209,0,0
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.67776,0.019042,-0.00042395,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.077957,0.018973,0.059982,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.61497,0.018908,-0.072443,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.50896,0.018795,0.025365,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.63354,0.018492,-0.041224,0,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.84397,0.018489,-0.046326,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.35607,0.018403,0.078171,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.74288,0.018313,0.034436,0,0
1,GO COPULATION,0.38888,0.018176,0.061121,0,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.11636,0.018114,0.1065,0,0
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.94073,0.018108,-0.0082958,0,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.59664,0.018102,0.045366,0,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.94073,0.018051,-0.017453,0,0
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.96163,0.018039,-0.010531,0,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.65866,0.017855,0.017457,0,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.91987,0.017824,-0.0099405,0,0
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.72969,0.017821,-0.039725,0,0
1,GO IMMATURE B CELL DIFFERENTIATION,0.95466,0.017606,0.0080893,0,0
1,GO REGULATION OF DNA REPLICATION,0.80312,0.017449,0.0041609,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.30402,0.017422,0.038659,0,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.99651,0.017352,0.0022556,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE,0.82348,0.017278,-0.0058283,0,0
1,GO REGULATION OF ACTIN NUCLEATION,0.75615,0.017174,-0.039995,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.58456,0.016967,0.016351,0,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.67776,0.016836,-0.070542,0,0
1,GO DNA DEMETHYLATION,0.81668,0.016693,0.0083175,0,0
1,GO NATURAL KILLER CELL ACTIVATION,0.91293,0.016381,-0.0083986,0,0
1,GO MEIOTIC SPINDLE ORGANIZATION,0.40349,0.01619,0.038215,0,0
1,GO NUCLEOTIDE EXCISION REPAIR,0.56666,0.016157,0.013006,0,0
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.50896,0.016121,0.0039339,0,0
1,GO NODAL SIGNALING PATHWAY,0.74288,0.016103,0.027208,0,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.27227,0.016014,0.063865,0,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.70355,0.015877,0.037482,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.87833,0.015843,0.0034957,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.43367,0.015811,0.015148,0,0
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.82348,0.015791,-0.0045268,0,0
1,GO DNA RECOMBINATION,0.36991,0.015737,0.010091,0,0
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.64605,0.01569,-0.10025,0,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.94073,0.015571,-0.015046,0,0
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.89215,0.01533,-0.049016,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.69061,0.015317,0.016084,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.95466,0.015255,0.00097018,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.55487,0.015176,0.073191,0,0
1,GO FIBROBLAST ACTIVATION,0.72313,0.014948,-0.050152,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.93377,0.014738,-0.027766,0,0
1,GO REGULATION OF NEURON MIGRATION,0.68418,0.014699,0.017436,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.91987,0.014655,-0.0050006,0,0
1,GO REGULATION OF CELL CYCLE PROCESS,0.69707,0.014566,0.00089544,0,0
1,GO RNA LOCALIZATION,0.86455,0.014526,-0.012257,0,0
1,GO NEURON MIGRATION,0.37932,0.01448,0.083589,0,0
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.73628,0.014472,0.0088153,0,0
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.62113,0.014464,0.011649,0,0
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.91293,0.014116,-0.038279,0,0
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.85768,0.014075,-0.016163,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.73628,0.013987,0.047153,0,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.62113,0.013956,0.043284,0,0
1,GO TRANSPORT ALONG MICROTUBULE,0.60272,0.013509,0.022304,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.91987,0.013473,0.094526,0,0
1,GO NEURAL CREST FORMATION,0.59059,0.013406,0.05682,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.78962,0.013357,-0.045347,0,0
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.44924,0.012745,0.013442,0,0
1,GO SPINDLE ASSEMBLY,0.4978,0.012664,0.016159,0,0
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.69707,0.01258,0.013567,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.72969,0.012415,0.048505,0,0
1,GO CELL CYCLE PHASE TRANSITION,0.65866,0.012353,-0.0017913,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.79636,0.012238,-0.03329,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.84397,0.012172,0.00083586,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.72969,0.012137,0.017174,0,0
1,GO REGULATION OF DNA METABOLIC PROCESS,0.46512,0.011911,0.014733,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.69707,0.011893,0.02133,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.71006,0.011609,0.011241,0,0
1,GO MITOTIC NUCLEAR DIVISION,0.52594,0.011584,0.020182,0,0
1,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.47049,0.011392,-0.057827,0,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.81668,0.011332,-0.023941,0,0
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.98255,0.011253,-0.021829,0,0
1,GO DNA METABOLIC PROCESS,0.92682,0.011164,-0.0048116,0,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.74288,0.011124,-0.033414,0,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,1,0.011108,0.0018166,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.29586,0.011052,0.025099,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.59664,0.011039,0.0074672,0,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.60883,0.011014,-0.042113,0,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.68418,0.010992,0.033932,0,0
1,GO REGULATION OF DNA RECOMBINATION,0.87833,0.010641,-0.013298,0,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.85082,0.010215,0.060802,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.99651,0.010206,-0.0044465,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.68418,0.010164,0.028074,0,0
1,GO REGULATION OF CELL CYCLE ARREST,0.83713,0.010103,0.0051093,0,0
1,GO RNA DECAPPING,0.70355,0.0098898,-0.0083464,0,0
1,GO HISTONE H2B UBIQUITINATION,0.19393,0.0098679,0.090179,0,0
1,GO REGULATION OF STEM CELL DIFFERENTIATION,0.77618,0.0098116,-0.0039431,0,0
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.73628,0.0095877,-0.0052373,0,0
1,GO SNRNA METABOLIC PROCESS,0.87144,0.0095028,-0.044137,0,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.26098,0.0093402,0.057019,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.71006,0.0092692,-0.026317,0,0
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.98953,0.0092197,0.0022015,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,0.39371,0.0092142,0.15413,0,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.73628,0.0089137,0.0075701,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.54321,0.0088019,0.063764,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.92682,0.0088014,-0.010856,0,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.72313,0.0087747,0.011338,0,0
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.88523,0.0085953,-0.014445,0,0
1,GO REGULATION OF GENE SILENCING,0.91293,0.0085382,-0.018147,0,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.9686,0.0082598,-0.0083708,0,0
1,GO RESPONSE TO NITROSATIVE STRESS,0.59059,0.0081328,-0.12087,0,0
1,GO STRESS GRANULE ASSEMBLY,0.47588,0.0081317,-0.045765,0,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.27227,0.0080185,0.054372,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.85082,0.0079964,0.0085223,0,0
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.84397,0.0079422,-0.011954,0,0
1,GO P BODY ASSEMBLY,0.53742,0.0078088,0.031999,0,0
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.77618,0.0077594,-0.022646,0,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.36064,0.0076916,0.053387,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.59059,0.0076549,0.033046,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.43367,0.0075825,-0.082566,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.48131,0.0075,-0.019295,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.4978,0.0074261,0.057396,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.72313,0.0073634,-0.023989,0,0
1,GO MAINTENANCE OF CELL NUMBER,0.91293,0.007339,0.017664,0,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,0.76948,0.0070377,0.030976,0,0
1,GO RESPONSE TO INACTIVITY,0.52025,0.0068093,-0.093349,0,0
1,GO MRNA MODIFICATION,0.70355,0.0067856,-0.035012,0,0
1,GO PROTEIN ACYLATION,0.50337,0.0066886,0.015614,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.87833,0.0060234,-0.0040379,0,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.70355,0.0059873,0.045045,0,0
1,GO HINDBRAIN MORPHOGENESIS,0.89215,0.0059215,-0.0025102,0,0
1,GO DNA DEALKYLATION,0.85082,0.0058135,-0.0028804,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.72313,0.0056003,-0.037578,0,0
1,GO SPINDLE ORGANIZATION,0.81668,0.0055805,0.0019816,0,0
1,GO MITOTIC CELL CYCLE,0.90599,0.0055144,-0.0090166,0,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.91987,0.0053719,0.010506,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.9686,0.0053123,-0.0017187,0,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.34256,0.0051232,0.066815,0,0
1,GO CELL DIVISION,0.53167,0.0041778,0.012243,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.91293,0.0040281,-0.0099164,0,0
1,GO TELOMERIC LOOP DISASSEMBLY,0.62113,0.0040057,-0.044689,0,0
1,GO OSTEOBLAST DEVELOPMENT,0.52025,0.0036956,0.047502,0,0
1,GO CELL JUNCTION MAINTENANCE,0.56666,0.0036498,-0.045076,0,0
1,GO NUCLEAR TRANSPORT,0.7495,0.003094,-0.015721,0,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.7495,0.0030636,0.07576,0,0
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.91293,0.0030299,-0.0017021,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.99651,0.0030077,0.0007814,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.96163,0.0030072,-0.018395,0,0
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.96163,0.0028908,-0.02679,0,0
1,GO REGULATION OF CYTOKINESIS,0.97557,0.0028397,-0.0066971,0,0
1,GO SNRNA PROCESSING,0.54321,0.0027862,-0.04177,0,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.69061,0.0026055,-0.018621,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.89907,0.0025457,-0.0054684,0,0
1,GO MYELOID CELL DEVELOPMENT,0.80989,0.0025001,-0.022809,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.65866,0.0024167,0.018936,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.47588,0.0023942,-0.062978,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.54321,0.0020164,-0.029686,0,0
1,GO REGULATION OF APPETITE,0.70355,0.0020085,-0.037444,0,0
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.57857,0.0019687,0.054245,0,0
1,GO SPINDLE MIDZONE ASSEMBLY,0.94769,0.0019383,-0.0025918,0,0
1,GO CYTOKINESIS,0.62732,0.0017428,-0.016659,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.72313,0.0017394,0.020183,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.95466,0.0015711,0.033586,0,0
1,GO TRANSCYTOSIS,0.94073,0.0013302,-0.021151,0,0
1,GO PROTEIN POLYUBIQUITINATION,0.48678,0.0010003,-0.027433,0,0
1,GO EMBRYONIC EYE MORPHOGENESIS,0.52594,0.00092535,0.052363,0,0
1,GO RESPONSE TO VITAMIN,0.32506,0.00086689,-0.073588,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.93377,0.00085196,-0.0046252,0,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.60272,0.00078947,-0.020687,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.56666,0.00074862,0.028365,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.67137,0.00068027,0.030899,0,0
1,GO REGULATION OF CELL DIVISION,0.67137,0.00040656,-0.019532,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.83713,0.0003753,0.026996,0,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.48678,0.00037166,0.057454,0,0
1,GO RUFFLE ASSEMBLY,0.29184,0.00036327,-0.055107,0,0
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.78962,0.00014902,-0.035598,0,0
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.91987,0.00014078,-0.008939,0,0
1,GO WALKING BEHAVIOR,0.53167,-5.8091e-05,0.053326,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.94769,-6.3461e-05,0.0044195,0,0
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,1,-7.467e-05,-0.014751,0,0
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.91987,-9.4328e-05,-0.039426,0,0
1,GO NUCLEOSIDE SALVAGE,0.69061,-0.00015546,-0.048809,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.94769,-0.0002359,-0.043111,0,0
1,GO REGULATION OF ATPASE ACTIVITY,0.78289,-0.00039922,-0.021389,0,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.81668,-0.0004597,-0.034249,0,0
1,GO APOPTOTIC DNA FRAGMENTATION,0.80989,-0.00063497,-0.013927,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.91293,-0.00097952,-0.009241,0,0
1,GO FOREBRAIN DEVELOPMENT,0.71006,-0.0012961,0.01835,0,0
1,GO METENCEPHALON DEVELOPMENT,0.86455,-0.0015015,0.0051784,0,0
1,GO MITRAL VALVE DEVELOPMENT,0.65866,-0.001598,0.030144,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.78289,-0.001601,0.0029159,0,0
1,GO MICROTUBULE ANCHORING,0.55487,-0.0017025,-0.032197,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.98255,-0.0017517,-0.021628,0,0
1,GO DIENCEPHALON DEVELOPMENT,0.25729,-0.0018012,0.11046,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.75615,-0.0018174,-0.028267,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.73628,-0.0018203,-0.038511,0,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.15773,-0.001948,-0.10591,0,0
1,GO ENDODERMAL CELL FATE COMMITMENT,0.97557,-0.0019898,0.009364,0,0
1,GO NEUROBLAST PROLIFERATION,0.41341,-0.0019991,0.058113,0,0
1,GO FOREGUT MORPHOGENESIS,0.60272,-0.0022322,-0.069438,0,0
1,GO PRENYLATION,0.62113,-0.0024336,0.024356,0,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.42347,-0.0025005,-0.046841,0,0
1,GO NEURON PROJECTION GUIDANCE,0.91987,-0.0026041,0.0090968,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.86455,-0.0026738,0.011192,0,0
1,GO MRNA METABOLIC PROCESS,0.54321,-0.0027159,-0.023269,0,0
1,GO PITUITARY GLAND DEVELOPMENT,0.33812,-0.0027607,0.1221,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.78289,-0.002828,-0.013499,0,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.38408,-0.0028563,-0.1155,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.88523,-0.0028572,0.02848,0,0
1,GO CELLULAR SENESCENCE,0.64605,-0.002988,-0.016104,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.84397,-0.0030381,-0.022581,0,0
1,GO CELL CYCLE PROCESS,0.76948,-0.0031073,-0.016976,0,0
1,GO CHROMOSOME SEPARATION,0.63354,-0.0031588,0.02431,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.7495,-0.0033075,-0.01907,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.90599,-0.0033467,0.04008,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.42855,-0.0033613,-0.1018,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.86455,-0.0034589,0.010113,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.96163,-0.0034703,-0.0018344,0,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.8303,-0.0037668,-0.065079,0,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.44402,-0.0038186,0.039635,0,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.86455,-0.0038411,0.013226,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.59059,-0.0040041,-0.028559,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.86455,-0.0040941,0.0070658,0,0
1,GO PRIMARY MIRNA PROCESSING,0.51459,-0.0043736,-0.063957,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.87144,-0.0045616,-0.084569,0,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,1,-0.0045766,-0.012278,0,0
1,GO OXIDATIVE DEMETHYLATION,0.80312,-0.0047559,0.022601,0,0
1,GO NCRNA 3 END PROCESSING,0.80989,-0.0050217,-0.037156,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.49227,-0.0051384,-0.023428,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.89907,-0.0052551,0.019266,0,0
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.80989,-0.0053843,-0.026832,0,0
1,GO COLLATERAL SPROUTING,0.91987,-0.0054468,0.011749,0,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.98953,-0.0054926,0.002339,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.83713,-0.0057609,-0.022223,0,0
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.86455,-0.0058643,0.019261,0,0
1,GO THYMUS DEVELOPMENT,0.72969,-0.0060089,0.027276,0,0
1,GO MRNA CLEAVAGE,0.80989,-0.0060962,-0.0020785,0,0
1,GO CELL FATE COMMITMENT,0.57857,-0.0061319,0.040971,0,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.56666,-0.0062477,-0.031134,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.61497,-0.0063871,-0.049057,0,0
1,GO CARTILAGE MORPHOGENESIS,0.19393,-0.0066979,0.22279,0,0
1,GO REGULATION OF MITOTIC CELL CYCLE,0.64605,-0.0067494,-0.018246,0,0
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.54321,-0.0069097,-0.047315,0,0
1,GO NON RECOMBINATIONAL REPAIR,0.89907,-0.0070163,-0.011948,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.85768,-0.0070954,0.10009,0,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.83713,-0.0071926,-0.0442,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.67137,-0.0072904,0.018491,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.48678,-0.0075007,-0.022469,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.32938,-0.0075216,-0.038388,0,0
1,GO LONG TERM SYNAPTIC DEPRESSION,0.82348,-0.0075755,0.029122,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.86455,-0.0076013,-0.010015,0,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.65234,-0.0076409,0.071259,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.42855,-0.0076623,-0.031887,0,0
1,GO CHROMATIN SILENCING AT TELOMERE,0.54321,-0.0076697,-0.019379,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.89215,-0.0077475,0.0050006,0,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.74288,-0.0077635,0.029658,0,0
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.89215,-0.0077739,0.0073701,0,0
1,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.47049,-0.0078198,-0.041014,0,0
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.87144,-0.0078786,-0.0022636,0,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.87833,-0.0080458,0.013864,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.64605,-0.0081322,-0.024044,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.94073,-0.0081481,-0.0049171,0,0
1,GO TELOMERASE RNA LOCALIZATION,0.68418,-0.008149,-0.057738,0,0
1,GO CYTOKINETIC PROCESS,0.63354,-0.0081818,-0.042323,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.94073,-0.0083561,-0.027794,0,0
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.8303,-0.0085649,-0.011498,0,0
1,GO PHOTOTRANSDUCTION,0.44924,-0.0087713,-0.045918,0,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.4598,-0.0088853,-0.069345,0,0
1,GO DENSE CORE GRANULE TRANSPORT,0.98255,-0.0089909,0.059293,0,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.48131,-0.0090308,-0.0368,0,0
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.93377,-0.0091174,-0.019835,0,0
1,GO SPLEEN DEVELOPMENT,0.84397,-0.0091888,-0.0017944,0,0
1,GO DNA MODIFICATION,0.4598,-0.0092481,-0.019828,0,0
1,GO NUCLEAR PORE ORGANIZATION,0.63354,-0.0092589,0.011048,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.41842,-0.0094909,-0.073226,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.65234,-0.0095456,-0.0088196,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.69061,-0.0095888,-0.03648,0,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.96163,-0.0095948,0.014305,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.63978,-0.010108,0.026261,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.32506,-0.010236,-0.040831,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.67137,-0.010326,-0.036934,0,0
1,GO CELLULAR RESPONSE TO VIRUS,0.7495,-0.010332,-0.030895,0,0
1,GO ORGANELLE FISSION,0.69707,-0.010533,-0.011711,0,0
1,GO REGULATION OF HIPPO SIGNALING,0.54321,-0.010606,-0.073938,0,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.72313,-0.010683,0.037043,0,0
1,GO PHAGOSOME ACIDIFICATION,0.96163,-0.011238,-0.028759,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.67776,-0.011307,-0.016316,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.87144,-0.01144,-0.030502,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.31653,-0.011567,-0.075183,0,0
1,GO GAMETE GENERATION,0.11636,-0.011607,-0.043775,0,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.95466,-0.011644,0.010646,0,0
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.36064,-0.011659,-0.038587,0,0
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.85082,-0.011852,-0.03649,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.79636,-0.011914,-0.0048923,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.93377,-0.012151,-0.027343,0,0
1,GO REGULATION OF CELL CYCLE,0.33812,-0.012152,-0.025455,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.92682,-0.012156,0.01027,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.78289,-0.012168,0.02955,0,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.91987,-0.012178,-0.0051511,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.48678,-0.012549,-0.070508,0,0
1,GO INSEMINATION,0.81668,-0.012566,0.028923,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.99651,-0.012599,0.005321,0,0
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.90599,-0.012772,0.0037227,0,0
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.74288,-0.012888,-0.031178,0,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.57857,-0.01333,-0.023002,0,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.83713,-0.013436,-0.031763,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.89215,-0.013456,-0.018447,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.67137,-0.013457,-0.025253,0,0
1,GO BASE EXCISION REPAIR,0.31232,-0.013571,-0.05973,0,0
1,GO TELOMERE CAPPING,0.68418,-0.013654,-0.010143,0,0
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.67776,-0.013704,0.069702,0,0
1,GO PROSTATIC BUD FORMATION,0.68418,-0.013748,-0.099691,0,0
1,GO ACTIVATION OF MAPKK ACTIVITY,0.85082,-0.013836,-0.023365,0,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.60272,-0.013849,-0.026695,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.54321,-0.0139,-0.016695,0,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.58456,-0.013929,-0.075512,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.29586,-0.014006,-0.066349,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.86455,-0.014022,-0.0047816,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,0.69061,-0.014053,-0.0066893,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.91987,-0.014088,0.005813,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.69707,-0.01413,-0.031181,0,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.52025,-0.01417,-0.080407,0,0
1,GO APPENDAGE MORPHOGENESIS,0.53167,-0.014229,0.052796,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.68418,-0.014516,-0.02476,0,0
1,GO MICROTUBULE BASED PROCESS,0.4545,-0.014821,-0.014236,0,0
1,GO SPERM AXONEME ASSEMBLY,0.77618,-0.014907,-0.014118,0,0
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.85768,-0.015302,-0.028242,0,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.78962,-0.015375,-0.038862,0,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.79636,-0.015448,-0.015224,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.78962,-0.015461,-0.005606,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.59059,-0.015532,-0.01852,0,0
1,GO PORE COMPLEX ASSEMBLY,0.77618,-0.015631,-0.029811,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.77618,-0.015953,-0.013591,0,0
1,GO AXIS ELONGATION,0.73628,-0.016086,0.044743,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.21905,-0.016168,-0.034717,0,0
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.70355,-0.016192,-0.023525,0,0
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.36064,-0.016213,-0.069278,0,0
1,GO DETECTION OF VISIBLE LIGHT,0.97557,-0.016357,-0.020227,0,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.70355,-0.016466,-0.053023,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.83713,-0.016495,-0.0074081,0,0
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.66501,-0.016617,-0.019993,0,0
1,GO RESPONSE TO FORSKOLIN,0.88523,-0.016639,-0.0080471,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.91293,-0.016925,-0.019805,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.93377,-0.017028,0.0094597,0,0
1,GO REGULATION OF BEHAVIOR,0.81668,-0.017139,-0.017488,0,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.52025,-0.01735,-0.018628,0,0
1,GO CELLULAR RESPONSE TO RADIATION,0.19393,-0.017378,-0.048697,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.81668,-0.017511,-0.010712,0,0
1,GO RESPONSE TO LITHIUM ION,0.98953,-0.017579,0.067843,0,0
1,GO AXON DEVELOPMENT,0.61497,-0.017746,-0.011078,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.72969,-0.017779,-0.0065469,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.23937,-0.017936,-0.09958,0,0
1,GO RIG I SIGNALING PATHWAY,0.36064,-0.017973,-0.069976,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.69707,-0.017974,-0.010953,0,0
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.44402,-0.018027,-0.017877,0,0
1,GO CELL PART MORPHOGENESIS,0.58456,-0.018045,-0.014478,0,0
1,GO HINDBRAIN DEVELOPMENT,0.42855,-0.018064,-0.028122,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.9686,-0.018182,-0.0020002,0,0
1,GO REGULATION OF SENSORY PERCEPTION,0.39858,-0.018527,-0.056762,0,0
1,GO SODIUM ION HOMEOSTASIS,0.68418,-0.018667,-0.013154,0,0
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.4545,-0.018765,-0.035261,0,0
1,GO REGULATION OF GLIAL CELL MIGRATION,0.47588,-0.018829,-0.046691,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.86455,-0.018842,-0.0041976,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.58456,-0.018843,-0.015889,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.69061,-0.018884,-0.011403,0,0
1,GO EYE MORPHOGENESIS,0.85082,-0.018956,-0.00076494,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.87833,-0.019006,-0.013547,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.7495,-0.01904,-0.04362,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,0.50896,-0.019089,-0.067213,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.94073,-0.019096,0.036371,0,0
1,GO STEM CELL DIFFERENTIATION,0.4978,-0.019204,-0.022111,0,0
1,GO LIMBIC SYSTEM DEVELOPMENT,0.55487,-0.019226,-0.031503,0,0
1,GO REGULATION OF ERAD PATHWAY,0.3746,-0.01929,-0.043796,0,0
1,GO DNA CATABOLIC PROCESS,0.55487,-0.019424,-0.018964,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.62113,-0.019711,-0.030454,0,0
1,GO DENDRITE MORPHOGENESIS,1,-0.019736,0.022622,0,0
1,GO PRE MIRNA PROCESSING,0.72313,-0.019793,-0.037418,0,0
1,GO CHONDROCYTE DEVELOPMENT,0.67776,-0.019868,0.023062,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.23937,-0.019978,-0.041933,0,0
1,GO MALE GAMETE GENERATION,0.049546,-0.020015,-0.056279,0,0
1,GO MIDBODY ABSCISSION,0.66501,-0.020022,0.053426,0,0
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.73628,-0.020063,0.088588,0,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.7495,-0.020196,-0.046605,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.82348,-0.020332,-0.053976,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.23937,-0.020364,-0.051663,0,0
1,GO REGULATION OF TRANSLATIONAL TERMINATION,0.71658,-0.020368,-0.054114,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.89907,-0.020429,0.01164,0,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.36991,-0.020431,-0.11271,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.94073,-0.020473,0.016265,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.72969,-0.020568,-0.017386,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.68418,-0.020586,-0.013221,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.35153,-0.020655,-0.021456,0,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.80312,-0.020723,-0.040577,0,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.77618,-0.020822,0.039517,0,0
1,GO RESPONSE TO MUSCLE INACTIVITY,0.78289,-0.020838,0.044603,0,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.42347,-0.020847,-0.070428,0,0
1,GO RESPONSE TO UV,0.70355,-0.020901,-0.01622,0,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.65866,-0.020925,0.036059,0,0
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.33373,-0.021124,-0.067035,0,0
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.31232,-0.021187,-0.052234,0,0
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.36526,-0.021378,-0.070684,0,0
1,GO REGULATION OF MYELINATION,0.91987,-0.021386,-0.0097164,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.7495,-0.02179,0.0391,0,0
1,GO NUCLEUS ORGANIZATION,0.40349,-0.021867,-0.030225,0,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.77618,-0.021939,0.0033603,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.72313,-0.022027,-0.039482,0,0
1,GO MITOTIC CYTOKINESIS,0.82348,-0.022215,-0.01252,0,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.82348,-0.022364,-0.023518,0,0
1,GO NEURON APOPTOTIC PROCESS,0.42347,-0.022396,-0.019774,0,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.64605,-0.022514,0.029359,0,0
1,GO TUMOR NECROSIS FACTOR SECRETION,0.98953,-0.022535,-0.0053536,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.46512,-0.022883,-0.0626,0,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.89215,-0.022937,0.0086951,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.72969,-0.023018,0.014231,0,0
1,GO POSITIVE REGULATION OF CELL DIVISION,0.48678,-0.023109,-0.039095,0,0
1,GO LIPID PHOSPHORYLATION,0.12689,-0.023546,-0.072384,0,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.23937,-0.023703,-0.062671,0,0
1,GO TELOMERE ORGANIZATION,0.38888,-0.023718,-0.032167,0,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.12908,-0.02372,-0.063988,0,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.85768,-0.023825,-0.017879,0,0
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.33373,-0.023828,-0.077895,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.86455,-0.023939,-0.0075405,0,0
1,GO SPERM MOTILITY,0.32506,-0.024196,-0.035483,0,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.4545,-0.02426,-0.055825,0,0
1,GO CELLULAR RESPONSE TO UV,0.53742,-0.024272,-0.028067,0,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.59059,-0.024331,-0.016989,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.73628,-0.024679,-0.014679,0,0
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.9686,-0.024853,-0.0072526,0,0
1,GO PINOCYTOSIS,0.22568,-0.024862,-0.12853,0,0
1,GO REGULATION OF MRNA 3 END PROCESSING,0.83713,-0.024895,-0.017808,0,0
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.62732,-0.024902,-0.042054,0,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.53167,-0.025045,-0.024053,0,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.52594,-0.025292,-0.02939,0,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.71006,-0.025296,-0.028565,0,0
1,GO GLIAL CELL FATE COMMITMENT,0.32938,-0.025333,0.16299,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.16294,-0.025333,-0.037485,0,0
1,GO REGULATION OF CILIUM BEAT FREQUENCY,0.63978,-0.025361,-0.041435,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.89215,-0.025534,0.025741,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.69707,-0.025559,-0.023189,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.62732,-0.025604,-0.017409,0,0
1,GO GERM CELL DEVELOPMENT,0.16294,-0.025617,-0.042314,0,0
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.50337,-0.025682,-0.037622,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.68418,-0.026137,-0.043081,0,0
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.71658,-0.026141,0.024355,0,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.51459,-0.026187,-0.02465,0,0
1,GO ONE CARBON COMPOUND TRANSPORT,0.23937,-0.026197,-0.11943,0,0
1,GO CELL CYCLE,0.47049,-0.026247,-0.020426,0,0
1,GO REGULATION OF DNA BINDING,0.71658,-0.026275,0.0032183,0,0
1,GO AORTA MORPHOGENESIS,0.99651,-0.026277,0.0094306,0,0
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.14769,-0.026306,-0.089075,0,0
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.47049,-0.026561,-0.084544,0,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.94073,-0.026655,0.0071771,0,0
1,GO METHYLATION,0.26098,-0.026677,-0.02255,0,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.26098,-0.026754,-0.066174,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.50337,-0.026882,-0.056704,0,0
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44924,-0.026968,-0.086936,0,0
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.46512,-0.027012,-0.027497,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.44924,-0.027067,-0.015783,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.97557,-0.027445,-0.0052053,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.76948,-0.027474,-0.023842,0,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.62732,-0.027633,-0.02065,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.16559,-0.027653,-0.091679,0,0
1,GO ATP BIOSYNTHETIC PROCESS,0.7495,-0.02769,-0.035255,0,0
1,GO MEIOTIC CELL CYCLE,0.21256,-0.027795,-0.03402,0,0
1,GO NEURON DIFFERENTIATION,0.42347,-0.027878,-0.019703,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.65866,-0.028032,-0.014634,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.33812,-0.028152,-0.066066,0,0
1,GO POSITIVE REGULATION OF DNA BINDING,0.94073,-0.028299,0.017209,0,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.95466,-0.028494,0.010203,0,0
1,GO MITOCHONDRION LOCALIZATION,0.29992,-0.028497,-0.038283,0,0
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.1313,-0.028618,-0.052637,0,0
1,GO MITOTIC CYTOKINETIC PROCESS,0.90599,-0.028708,0.023249,0,0
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.54903,-0.028709,-0.041915,0,0
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.89215,-0.028872,-0.022053,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.36526,-0.02892,-0.030604,0,0
1,GO PANCREAS DEVELOPMENT,0.4545,-0.029001,-0.052691,0,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.33812,-0.029068,-0.042597,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.46512,-0.029096,-0.049001,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.41842,-0.029323,-0.042952,0,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.55487,-0.029389,-0.025607,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.21579,-0.029547,-0.052518,0,0
1,GO ACROSOME ASSEMBLY,0.50337,-0.02969,-0.05395,0,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.29586,-0.02979,-0.069393,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.25729,-0.029798,-0.059325,0,0
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.14526,-0.029843,-0.059678,0,0
1,GO HINDLIMB MORPHOGENESIS,0.62732,-0.029854,0.068216,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.33812,-0.030064,-0.022806,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.054842,-0.030079,-0.058353,0,0
1,GO DETECTION OF LIGHT STIMULUS,0.37932,-0.030382,-0.047218,0,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.62732,-0.030733,-0.014556,0,0
1,GO SPECIFICATION OF SYMMETRY,0.66501,-0.030801,-0.0084252,0,0
1,GO MUSCLE CELL MIGRATION,0.38888,-0.030839,-0.078051,0,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,0.77618,-0.031087,0.067574,0,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.55487,-0.031148,-0.076372,0,0
1,GO MULTIVESICULAR BODY ORGANIZATION,0.60272,-0.031246,-0.016386,0,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.1028,-0.031324,-0.08533,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.85768,-0.031416,0.0083904,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.76948,-0.031483,-0.040266,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.74288,-0.03165,-0.011496,0,0
1,GO REGULATION OF VIRAL TRANSCRIPTION,0.39371,-0.031814,-0.055385,0,0
1,GO NEURON CELL CELL ADHESION,0.9686,-0.031881,0.062376,0,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.47588,-0.031927,-0.040135,0,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.32506,-0.031991,-0.069703,0,0
1,GO ACTIN NUCLEATION,0.35153,-0.032176,-0.049382,0,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.35607,-0.032244,-0.039561,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.72313,-0.032585,-0.022161,0,0
1,GO HEAD DEVELOPMENT,0.26471,-0.032761,-0.031154,0,0
1,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.39371,-0.032801,-0.087926,0,0
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.44924,-0.032819,-0.065345,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.69061,-0.03286,-0.0089751,0,0
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.36064,-0.032931,-0.04509,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.89907,-0.032977,-0.031575,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.32077,-0.033074,-0.084527,0,0
1,GO NEURAL TUBE DEVELOPMENT,0.49227,-0.033094,-0.023058,0,0
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.85768,-0.033214,-0.053674,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.30402,-0.033376,-0.04948,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.65234,-0.033522,-0.023054,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.74288,-0.033565,-0.049701,0,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.58456,-0.03364,-0.053756,0,0
1,GO SLEEP,0.47588,-0.033736,-0.051995,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.97557,-0.033743,0.0086383,0,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.81668,-0.033906,-0.011779,0,0
1,GO NEUROGENESIS,0.26471,-0.03422,-0.033718,0,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.059411,-0.034241,-0.043892,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.18508,-0.034344,-0.12188,0,0
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.34256,-0.034345,-0.066423,0,0
1,GO TRNA WOBBLE BASE MODIFICATION,0.21905,-0.034345,-0.084737,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.11841,-0.034428,-0.05869,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.97557,-0.034476,-0.010976,0,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.60272,-0.034519,-0.073791,0,0
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.26098,-0.034789,-0.044211,0,0
1,GO PH REDUCTION,0.72969,-0.034831,-0.018939,0,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.70355,-0.034895,-0.022066,0,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.72969,-0.034924,0.037822,0,0
1,GO RECEPTOR CLUSTERING,0.43367,-0.035015,-0.055434,0,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.42855,-0.035587,-0.041959,0,0
1,GO REGULATION OF NUCLEAR DIVISION,0.52594,-0.03561,-0.018798,0,0
1,GO AXONAL FASCICULATION,0.38408,-0.035665,-0.080556,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.89907,-0.035694,-0.002401,0,0
1,GO REGULATION OF HISTONE UBIQUITINATION,0.31653,-0.035964,-0.040478,0,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.71658,-0.035995,-0.048182,0,0
1,GO MRNA TRANSCRIPTION,0.4545,-0.036005,-0.051439,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.072231,-0.036009,-0.14677,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.22568,-0.036094,-0.08929,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.53167,-0.036107,-0.016948,0,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.58456,-0.036447,-0.057168,0,0
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.4545,-0.036583,-0.077988,0,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.26471,-0.036676,-0.088819,0,0
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.98255,-0.036699,-0.024405,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.2839,-0.036712,-0.055046,0,0
1,GO REGULATION OF RIBOSOME BIOGENESIS,0.11039,-0.036804,-0.1651,0,0
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.44402,-0.036915,-0.1035,0,0
1,GO MICROTUBULE POLYMERIZATION,0.15517,-0.037078,-0.074193,0,0
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.73628,-0.037137,-0.025019,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.75615,-0.037206,-0.024143,0,0
1,GO RESPONSE TO LEAD ION,0.55487,-0.037337,-0.037767,0,0
1,GO TISSUE HOMEOSTASIS,0.10654,-0.037402,-0.078022,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.23245,-0.037488,-0.070249,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.93377,-0.037516,0.024665,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.57857,-0.037701,-0.030946,0,0
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.68418,-0.037703,-0.045692,0,0
1,GO SOMITOGENESIS,0.54903,-0.037732,-0.027344,0,0
1,GO REGULATION OF NEURON DIFFERENTIATION,0.29184,-0.03782,-0.038598,0,0
1,GO AXO DENDRITIC TRANSPORT,0.59664,-0.037924,-0.0061866,0,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.53167,-0.038049,-0.036662,0,0
1,GO EXIT FROM MITOSIS,0.41842,-0.038081,-0.035724,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.80312,-0.038167,0.003916,0,0
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.1028,-0.038268,-0.049443,0,0
1,GO MIRNA METABOLIC PROCESS,0.63354,-0.03829,-0.028005,0,0
1,GO MEMBRANE FISSION,0.77618,-0.0384,-0.017365,0,0
1,GO RNA METHYLATION,0.12473,-0.03845,-0.078076,0,0
1,GO LUNG CELL DIFFERENTIATION,0.86455,-0.03868,0.003468,0,0
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.30815,-0.038722,-0.077167,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.85082,-0.039038,0.0055255,0,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.79636,-0.039147,-0.014649,0,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.65234,-0.039216,-0.023777,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.71006,-0.039377,-0.0495,0,0
1,GO SEX DETERMINATION,0.95466,-0.039461,0.02189,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.34702,-0.039724,-0.082574,0,0
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.10465,-0.03982,-0.09555,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.44402,-0.039869,-0.028209,0,0
1,GO PALLIUM DEVELOPMENT,0.33373,-0.039904,-0.02287,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.36526,-0.039941,-0.023361,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.36526,-0.040008,-0.050338,0,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.30402,-0.040621,-0.062315,0,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.93377,-0.040679,-0.0041563,0,0
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.29992,-0.040878,-0.042966,0,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.16828,-0.041168,-0.044863,0,0
1,GO RNA POLYADENYLATION,0.23589,-0.041194,-0.058459,0,0
1,GO HAIR CELL DIFFERENTIATION,0.85082,-0.041231,0.0079585,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.1313,-0.041347,-0.035242,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.053746,-0.041362,-0.13583,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.087232,-0.041374,-0.051098,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.61497,-0.041703,-0.036652,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.12908,-0.041748,-0.067404,0,0
1,GO BONE MORPHOGENESIS,0.67776,-0.041865,-0.024119,0,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.14048,-0.041923,-0.043329,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.26847,-0.042068,-0.03496,0,0
1,GO RESPONSE TO COCAINE,0.48131,-0.042156,-0.019877,0,0
1,GO DENDRITE DEVELOPMENT,0.72313,-0.042343,-0.0017162,0,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.62732,-0.042347,-0.012635,0,0
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.49227,-0.042428,0.080251,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.1028,-0.042439,-0.039479,0,0
1,GO DETECTION OF ABIOTIC STIMULUS,0.25729,-0.042456,-0.038335,0,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,0.97557,-0.042483,0.082972,0,0
1,GO REGULATION OF RNA BINDING,0.83713,-0.042615,-0.019651,0,0
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.061812,-0.042813,-0.10199,0,0
1,GO SECRETORY GRANULE LOCALIZATION,0.95466,-0.04289,-0.00107,0,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,0.34702,-0.042982,-0.03389,0,0
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.82348,-0.043014,-0.061301,0,0
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.42855,-0.043026,-0.030056,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.82348,-0.043141,-0.014065,0,0
1,GO SPERMATID DIFFERENTIATION,0.11434,-0.043177,-0.045944,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.93377,-0.043203,0.03025,0,0
1,GO RESPONSE TO GLUCAGON,0.061812,-0.04323,-0.1159,0,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.32077,-0.043292,-0.072888,0,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.77618,-0.04343,0.028354,0,0
1,GO EAR DEVELOPMENT,0.7495,-0.043617,0.0028466,0,0
1,GO ORGANELLE LOCALIZATION,0.064293,-0.043739,-0.031633,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.75615,-0.043826,0.049553,0,0
1,GO IMPORT INTO NUCLEUS,0.33812,-0.044028,-0.029558,0,0
1,GO CELL AGING,0.15517,-0.04417,-0.05854,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.81668,-0.044204,-0.010238,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.30815,-0.044354,-0.048996,0,0
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.62732,-0.044697,-0.038156,0,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.23937,-0.044787,-0.13199,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.15264,-0.044852,-0.098534,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.27999,-0.04507,-0.091995,0,0
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.30402,-0.045092,-0.039846,0,0
1,GO REGULATION OF MRNA CATABOLIC PROCESS,0.12473,-0.045205,-0.076756,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.44402,-0.045238,-0.050592,0,0
1,GO PROTEIN DEPOLYMERIZATION,0.26098,-0.045241,-0.037844,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.11235,-0.045251,-0.064936,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.64605,-0.04529,-0.022873,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.4978,-0.045355,-0.046247,0,0
1,GO PHOTOPERIODISM,0.17099,-0.045424,-0.061852,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.5726,-0.045558,-0.054156,0,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.72969,-0.04556,-0.0051355,0,0
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.14048,-0.045711,-0.058427,0,0
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.15264,-0.045732,-0.14828,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.188,-0.045765,-0.052875,0,0
1,GO RRNA METHYLATION,0.16559,-0.045989,-0.10383,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.17099,-0.046323,-0.048237,0,0
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.25363,-0.046364,-0.074297,0,0
1,GO MAGNESIUM ION TRANSPORT,0.5726,-0.046378,-0.042283,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.54321,-0.046425,-0.021664,0,0
1,GO REGULATION OF GLUTAMATE SECRETION,0.96163,-0.046493,0.067822,0,0
1,GO ARTERY MORPHOGENESIS,0.36064,-0.04654,-0.042973,0,0
1,GO NUCLEAR BODY ORGANIZATION,0.13355,-0.046608,-0.07308,0,0
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.50337,-0.046866,-0.02698,0,0
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.12049,-0.046958,-0.051581,0,0
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.26098,-0.046984,-0.096936,0,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.22235,-0.047026,-0.056768,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.49227,-0.047041,-0.073533,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,0.49227,-0.047067,-0.066692,0,0
1,GO BONE CELL DEVELOPMENT,0.20309,-0.047072,-0.077282,0,0
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.57857,-0.047078,-0.030088,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.30815,-0.047181,-0.076067,0,0
1,GO POSTREPLICATION REPAIR,0.16032,-0.047244,-0.048613,0,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.55487,-0.047325,0.085125,0,0
1,GO ADRENAL GLAND DEVELOPMENT,0.22235,-0.047362,-0.11127,0,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.71006,-0.047427,-0.041795,0,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.34702,-0.047466,-0.052255,0,0
1,GO CALCINEURIN MEDIATED SIGNALING,0.13583,-0.047886,-0.095256,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.10845,-0.048002,-0.054895,0,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.19695,-0.04805,-0.058886,0,0
1,GO OTIC VESICLE MORPHOGENESIS,0.83713,-0.048245,-0.014984,0,0
1,GO TOXIN TRANSPORT,0.35153,-0.04859,-0.057181,0,0
1,GO NEURON DEVELOPMENT,0.25001,-0.048666,-0.040293,0,0
1,GO N GLYCAN PROCESSING,0.41341,-0.048669,-0.068486,0,0
1,GO MUSCLE ATROPHY,0.38408,-0.048894,-0.090552,0,0
1,GO SEGMENTATION,0.24643,-0.048961,-0.048575,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.90599,-0.049259,0.0033902,0,0
1,GO OOGENESIS,0.090515,-0.049263,-0.056702,0,0
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.13814,-0.049458,-0.060109,0,0
1,GO RENAL WATER HOMEOSTASIS,0.56666,-0.049538,-0.028635,0,0
1,GO DENDRITIC SPINE MAINTENANCE,0.25363,-0.049547,-0.094488,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.31653,-0.049641,-0.05824,0,0
1,GO COPII COATED VESICLE CARGO LOADING,0.35153,-0.049877,-0.053812,0,0
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.2,-0.049994,-0.051099,0,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.37932,-0.050016,-0.033157,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.32077,-0.050032,-0.05198,0,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.24288,-0.050111,-0.08874,0,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.093897,-0.050128,-0.14171,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.64605,-0.050223,-0.04784,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.43883,-0.050347,-0.031191,0,0
1,GO EAR MORPHOGENESIS,0.92682,-0.050352,0.0049918,0,0
1,GO APPENDAGE DEVELOPMENT,0.62113,-0.050466,-0.0082491,0,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.084046,-0.050602,-0.057998,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.22568,-0.050698,-0.056464,0,0
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.71658,-0.050727,-0.032639,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.11434,-0.050987,-0.029933,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.023205,-0.051027,-0.051302,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.072231,-0.051117,-0.0808,0,0
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.2839,-0.051316,-0.060357,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.079444,-0.051553,-0.078362,0,0
1,GO T CELL DIFFERENTIATION IN THYMUS,0.34256,-0.05157,-0.046672,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27611,-0.05162,-0.10884,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.20621,-0.051638,-0.06843,0,0
1,GO REGULATION OF AXONOGENESIS,0.23937,-0.051828,-0.056958,0,0
1,GO HEART FORMATION,0.69061,-0.051956,-0.020304,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.2,-0.052186,-0.042856,0,0
1,GO GOLGI LOCALIZATION,0.28785,-0.0522,-0.067634,0,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.39858,-0.052281,-0.01982,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.35153,-0.052312,-0.08768,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.34702,-0.05234,-0.029365,0,0
1,GO CELL PROJECTION ASSEMBLY,0.092194,-0.052362,-0.0568,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.30815,-0.052505,-0.052599,0,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.16294,-0.052539,-0.13559,0,0
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.15773,-0.052553,-0.13676,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.079444,-0.052592,-0.057263,0,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.084046,-0.052716,-0.10407,0,0
1,GO METHIONINE METABOLIC PROCESS,0.22905,-0.052901,-0.077759,0,0
1,GO ACTIVATION OF JNKK ACTIVITY,0.69061,-0.053077,-0.021533,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.31232,-0.053097,-0.093381,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.55487,-0.053328,-0.10497,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.52594,-0.053561,-0.040844,0,0
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.26098,-0.0536,-0.13254,0,0
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.36064,-0.053614,-0.10479,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.38888,-0.053721,-0.035313,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.89907,-0.053893,-0.021077,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.11039,-0.053947,-0.084327,0,0
1,GO REGULATION OF ANION TRANSPORT,0.072231,-0.054083,-0.10145,0,0
1,GO REGULATION OF GLIOGENESIS,0.54903,-0.054177,-0.029317,0,0
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.12259,-0.054207,-0.0764,0,0
1,GO PROTEIN ADP RIBOSYLATION,0.55487,-0.054584,-0.035789,0,0
1,GO HISTONE ARGININE METHYLATION,0.29184,-0.0546,-0.05513,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10654,-0.054672,-0.067679,0,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.36991,-0.054688,0.0067231,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.050569,-0.054741,-0.16579,0,0
1,GO NCRNA PROCESSING,0.16294,-0.054848,-0.093256,0,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.22568,-0.055021,-0.13923,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.20309,-0.055049,-0.040724,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.15773,-0.055169,-0.07219,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.065563,-0.055253,-0.050352,0,0
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.87833,-0.055291,-0.014955,0,0
1,GO HISTONE DEACETYLATION,0.15773,-0.055382,-0.050317,0,0
1,GO AXONAL TRANSPORT,0.76281,-0.055656,0.000608,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.061812,-0.05568,-0.083039,0,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.46512,-0.055691,-0.046475,0,0
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.53167,-0.05571,-0.048125,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.057089,-0.055889,-0.0926,0,0
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.4978,-0.055964,-0.048489,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.18219,-0.056038,-0.050573,0,0
1,GO ATP TRANSPORT,0.33812,-0.056074,-0.05153,0,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.43367,-0.056121,-0.048844,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.14526,-0.056162,-0.051736,0,0
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.25729,-0.056223,-0.064136,0,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.29586,-0.056302,-0.054841,0,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.4598,-0.056305,-0.031307,0,0
1,GO TRACHEA DEVELOPMENT,0.58456,-0.056336,-0.026233,0,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.54321,-0.056384,-0.053784,0,0
1,GO REGULATION OF CELL AGING,0.38888,-0.056426,-0.040665,0,0
1,GO G2 DNA DAMAGE CHECKPOINT,0.16294,-0.056479,-0.050945,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.13355,-0.056486,-0.051321,0,0
1,GO CHONDROCYTE PROLIFERATION,0.81668,-0.056563,-0.042651,0,0
1,GO PROTEIN DENEDDYLATION,0.94073,-0.056565,9.3322e-05,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.3746,-0.056658,-0.068034,0,0
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.25363,-0.05687,-0.09623,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.27227,-0.056927,-0.062041,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.15015,-0.057076,-0.076552,0,0
1,GO CONVERGENT EXTENSION,0.53742,-0.057086,-0.02701,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.20937,-0.057173,-0.043859,0,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.63978,-0.057182,-0.073251,0,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.90599,-0.057293,0.024419,0,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.33373,-0.05746,-0.017469,0,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.26847,-0.057763,-0.060939,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.30815,-0.057809,-0.043512,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.12908,-0.057911,-0.08183,0,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.30402,-0.05796,-0.13848,0,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.10654,-0.058101,-0.05694,0,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.20621,-0.058237,-0.10894,0,0
1,GO IMMATURE T CELL PROLIFERATION,0.27227,-0.05844,-0.10142,0,0
1,GO RNA MODIFICATION,0.063042,-0.058464,-0.089897,0,0
1,GO EPITHELIAL TUBE FORMATION,0.31232,-0.058828,-0.030022,0,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.19095,-0.058862,-0.08357,0,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.17374,-0.059046,-0.084198,0,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.24288,-0.059048,-0.10592,0,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.11636,-0.05912,-0.056077,0,0
1,GO MISMATCH REPAIR,0.02166,-0.059374,-0.077548,0,0
1,GO HISTONE H3 DEACETYLATION,0.68418,-0.059405,-0.023548,0,0
1,GO ADULT FEEDING BEHAVIOR,0.50337,-0.059437,-0.06249,0,0
1,GO CILIUM MOVEMENT,0.12049,-0.059519,-0.065873,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.36064,-0.059618,-0.070882,0,0
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.33373,-0.059775,-0.052917,0,0
1,GO VIRAL RNA GENOME REPLICATION,0.19095,-0.059977,-0.091279,0,0
1,GO NUCLEOBASE METABOLIC PROCESS,0.27611,-0.060008,-0.067428,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.049546,-0.060125,-0.067377,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.19393,-0.060195,-0.061073,0,0
1,GO REGULATION OF GTP BINDING,0.54321,-0.060247,-0.057305,0,0
1,GO CELL PROJECTION ORGANIZATION,0.085627,-0.060293,-0.054534,0,0
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.12259,-0.060342,-0.13568,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.75615,-0.060361,-0.068957,0,0
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.12689,-0.060733,-0.07737,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.8303,-0.060799,0.043252,0,0
1,GO DENTATE GYRUS DEVELOPMENT,0.76948,-0.060903,-0.039667,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.21256,-0.060978,-0.099118,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.43883,-0.060989,-0.081887,0,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.15015,-0.061039,-0.059007,0,0
1,GO ORGANELLE ASSEMBLY,0.010773,-0.06104,-0.060949,0,0
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.22568,-0.061048,-0.076834,0,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.61497,-0.061101,-0.04381,0,0
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.67137,-0.061127,-0.014329,0,0
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11636,-0.061287,-0.11153,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.86455,-0.06154,-0.0062289,0,0
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.059411,-0.061556,-0.10885,0,0
1,GO ACTIVATED T CELL PROLIFERATION,0.24643,-0.061588,-0.078462,0,0
1,GO ADULT HEART DEVELOPMENT,0.63354,-0.06161,-0.058183,0,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.48678,-0.061819,-0.040468,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.31653,-0.061832,-0.10222,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.19095,-0.061846,-0.046466,0,0
1,GO SYNAPTIC VESICLE DOCKING,0.21256,-0.062055,-0.049006,0,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,0.47588,-0.06212,-0.025545,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.10845,-0.062218,-0.072414,0,0
1,GO REGULATION OF CELLULAR PH,0.049546,-0.062464,-0.075756,0,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11434,-0.062601,-0.069859,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.11636,-0.062653,-0.14901,0,0
1,GO RESPONSE TO GAMMA RADIATION,0.19695,-0.062867,-0.064398,0,0
1,GO HEAD MORPHOGENESIS,0.43367,-0.062884,-0.039879,0,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.88523,-0.062946,0.042898,0,0
1,GO GLUCOSE IMPORT,0.072231,-0.063135,-0.080359,0,0
1,GO PROTEIN POLYGLUTAMYLATION,0.38888,-0.063183,-0.038998,0,0
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.24643,-0.063404,-0.09095,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.25729,-0.063451,-0.081746,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.29586,-0.063627,-0.07099,0,0
1,GO LEFT RIGHT AXIS SPECIFICATION,0.85082,-0.063659,-0.011411,0,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.16294,-0.063681,-0.13441,0,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.54903,-0.063715,-0.039562,0,0
1,GO MEMBRANE DOCKING,0.13355,-0.063776,-0.035539,0,0
1,GO COCHLEA DEVELOPMENT,0.72313,-0.064018,-0.011156,0,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.85768,-0.064139,0.041912,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.068167,-0.064174,-0.077754,0,0
1,GO REGULATION OF EXCRETION,0.50337,-0.064225,-0.036348,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.17653,-0.064341,-0.059045,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.37932,-0.064371,-0.039421,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.12259,-0.064556,-0.11548,0,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.47588,-0.0646,-0.059368,0,0
1,GO RESPONSE TO NICOTINE,0.53167,-0.064675,-0.014111,0,0
1,GO RUFFLE ORGANIZATION,0.10465,-0.064832,-0.079435,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.05161,-0.064834,-0.1075,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.2839,-0.064844,-0.05076,0,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.33373,-0.064916,-0.057304,0,0
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.17653,-0.064928,-0.10975,0,0
1,GO TELENCEPHALON DEVELOPMENT,0.26098,-0.064996,-0.037976,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.43367,-0.065046,-0.041593,0,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.33373,-0.065061,-0.099896,0,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.30402,-0.065231,-0.12662,0,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.23245,-0.065389,-0.12141,0,0
1,GO RETINA HOMEOSTASIS,0.10845,-0.065444,-0.060116,0,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.48131,-0.065492,-0.04335,0,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.87144,-0.065592,0.034727,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.23245,-0.065692,-0.050258,0,0
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.075049,-0.065759,-0.12112,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.60883,-0.06583,0.024806,0,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.41842,-0.066123,-0.086628,0,0
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.39371,-0.066303,-0.041928,0,0
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.15264,-0.0664,-0.076816,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.53167,-0.066599,-0.025525,0,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.24643,-0.066631,-0.063989,0,0
1,GO LYMPH VESSEL DEVELOPMENT,0.11235,-0.066714,-0.13613,0,0
1,GO GOLGI TO VACUOLE TRANSPORT,0.13814,-0.066733,-0.090543,0,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.40843,-0.06696,-0.031819,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.13583,-0.066966,-0.056457,0,0
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.12473,-0.066977,-0.09362,0,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.75615,-0.067072,-0.012102,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.32938,-0.067236,-0.056574,0,0
1,GO QUINONE METABOLIC PROCESS,0.18508,-0.06729,-0.17243,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.15773,-0.067303,-0.10998,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.087232,-0.067411,-0.12283,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.11235,-0.067554,-0.11448,0,0
1,GO POLYOL CATABOLIC PROCESS,0.17374,-0.067847,-0.065453,0,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.10845,-0.067863,-0.10241,0,0
1,GO PHOSPHATE ION TRANSPORT,0.14048,-0.067878,-0.07166,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.42347,-0.067918,-0.055744,0,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.26471,-0.067919,-0.073724,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.49227,-0.068017,-0.022721,0,0
1,GO MESODERMAL CELL DIFFERENTIATION,0.4978,-0.068082,-0.049044,0,0
1,GO NEURON RECOGNITION,0.50896,-0.068093,-0.040145,0,0
1,GO RESPONSE TO BMP,0.16032,-0.068125,-0.051476,0,0
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.26471,-0.06813,-0.15798,0,0
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.027803,-0.068261,-0.17821,0,0
1,GO SOMATIC STEM CELL DIVISION,0.48678,-0.068349,0.1285,0,0
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.36526,-0.068454,-0.040203,0,0
1,GO INNER EAR MORPHOGENESIS,0.90599,-0.068488,-0.0047145,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.070855,-0.068531,-0.11057,0,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.31232,-0.068602,-0.064301,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.092194,-0.068757,-0.091221,0,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.17099,-0.068767,-0.065519,0,0
1,GO NAD BIOSYNTHETIC PROCESS,0.23937,-0.068903,-0.11154,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.27999,-0.068928,-0.03498,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.065563,-0.069123,-0.11061,0,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.23589,-0.069127,-0.10292,0,0
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.35607,-0.069184,-0.080281,0,0
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.21256,-0.069201,-0.10298,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.38888,-0.069318,-0.074399,0,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.32938,-0.06945,-0.067479,0,0
1,GO COCHLEA MORPHOGENESIS,0.30815,-0.069496,-0.092712,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.74288,-0.069497,-0.043923,0,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.42347,-0.069517,-0.051935,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.20937,-0.069571,-0.12307,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.80989,-0.069592,-0.011326,0,0
1,GO STRIATUM DEVELOPMENT,0.084046,-0.0696,-0.14401,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.079444,-0.069675,-0.070736,0,0
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.25001,-0.069832,-0.093188,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.00010092,-0.070055,-0.081809,0,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.50896,-0.070062,-0.066607,0,0
1,GO THYROID HORMONE METABOLIC PROCESS,0.4978,-0.070103,-0.028638,0,0
1,GO NUCLEAR MIGRATION,0.26847,-0.070136,-0.066705,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.072231,-0.070183,-0.12393,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,0.8303,-0.070238,-0.028749,0,0
1,GO ERBB2 SIGNALING PATHWAY,0.42347,-0.070249,-0.063408,0,0
1,GO POSITIVE REGULATION OF ERAD PATHWAY,0.064293,-0.070297,-0.13563,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.40349,-0.070436,-0.062682,0,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.27999,-0.070447,-0.046414,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.4545,-0.070533,-0.032455,0,0
1,GO WATER TRANSPORT,0.10096,-0.070561,-0.090871,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.14526,-0.070585,-0.08229,0,0
1,GO REGULATION OF MRNA BINDING,0.22568,-0.07059,-0.097933,0,0
1,GO FEVER GENERATION,0.21905,-0.0706,-0.097172,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.7495,-0.070639,-0.028144,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.1313,-0.070721,-0.065195,0,0
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.72969,-0.070722,-0.026164,0,0
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.066855,-0.070812,-0.062262,0,0
1,GO PARTURITION,0.54903,-0.071011,-0.074604,0,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.31653,-0.071224,-0.070426,0,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,0.11841,-0.071242,-0.10746,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.092194,-0.07136,-0.094561,0,0
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.085627,-0.071529,-0.053003,0,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.093897,-0.07155,-0.083405,0,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.14769,-0.071835,-0.051489,0,0
1,GO REGULATION OF OOGENESIS,0.39371,-0.071952,-0.035033,0,0
1,GO PARENTAL BEHAVIOR,0.80312,-0.072226,0.010057,0,0
1,GO RESPONSE TO ACETYLCHOLINE,0.53742,-0.072365,-0.038727,0,0
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.17099,-0.07237,-0.11701,0,0
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.049546,-0.072503,-0.090476,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.23937,-0.072547,-0.069281,0,0
1,GO AXON EXTENSION,0.054842,-0.073311,-0.094976,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.18219,-0.073317,-0.17894,0,0
1,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.15773,-0.073392,-0.10216,0,0
1,GO MIDBRAIN DEVELOPMENT,0.20621,-0.073426,-0.035382,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.33373,-0.073448,-0.1262,0,0
1,GO CELL CELL SIGNALING BY WNT,0.060602,-0.073459,-0.065482,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.30815,-0.073502,-0.053363,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.25363,-0.073518,-0.056257,0,0
1,GO RNA INTERFERENCE,0.2,-0.073526,-0.063558,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.061812,-0.073606,-0.086296,0,0
1,GO SUCKLING BEHAVIOR,0.50337,-0.073794,-0.046833,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.18219,-0.073817,-0.052859,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.20937,-0.073859,-0.11134,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.17653,-0.074051,-0.045878,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.21256,-0.074157,-0.11204,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.11235,-0.074249,-0.085301,0,0
1,GO NUCLEUS LOCALIZATION,0.188,-0.074379,-0.067901,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.19095,-0.074511,-0.083403,0,0
1,GO MITOCHONDRIAL DNA REPLICATION,0.20937,-0.07458,-0.065495,0,0
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.070855,-0.074725,-0.10163,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.054842,-0.074743,-0.14919,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.32077,-0.074836,-0.14373,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.079444,-0.074856,-0.090881,0,0
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.28785,-0.074911,-0.10381,0,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.15773,-0.075008,-0.085665,0,0
1,GO UV PROTECTION,0.70355,-0.075134,-0.040261,0,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.22235,-0.075155,-0.063881,0,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.059411,-0.075254,-0.058793,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.30815,-0.075359,-0.044564,0,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.060602,-0.075366,-0.084047,0,0
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.48678,-0.075445,-0.05583,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.26471,-0.075618,-0.039025,0,0
1,GO TRNA METHYLATION,0.075049,-0.075619,-0.10861,0,0
1,GO REGULATION OF AMINO ACID TRANSPORT,0.3746,-0.075622,-0.054245,0,0
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.60272,-0.075707,-0.037521,0,0
1,GO AORTA DEVELOPMENT,0.17653,-0.075929,-0.085102,0,0
1,GO ARTERY DEVELOPMENT,0.085627,-0.075997,-0.087299,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.054842,-0.076044,-0.063966,0,0
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.059411,-0.076126,-0.094902,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.16559,-0.076248,-0.051696,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.21256,-0.076263,-0.15722,0,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.16559,-0.076507,-0.059186,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.075049,-0.0767,-0.10118,0,0
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.52025,-0.076783,-0.12331,0,0
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.054842,-0.076992,-0.20262,0,0
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.34702,-0.077447,-0.1508,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.32938,-0.077484,-0.089593,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.78289,-0.077558,-0.0063895,0,0
1,GO GAMMA DELTA T CELL ACTIVATION,0.93377,-0.077606,0.028458,0,0
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.34256,-0.077641,-0.072798,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.055956,-0.077667,-0.095915,0,0
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.11841,-0.077689,-0.10237,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.12908,-0.077795,-0.10872,0,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,0.20309,-0.077895,-0.047606,0,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.33812,-0.077923,-0.040651,0,0
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.39858,-0.077989,-0.067272,0,0
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.24288,-0.078026,-0.11025,0,0
1,GO REGULATION OF VIRAL GENOME REPLICATION,0.099158,-0.0781,-0.15194,0,0
1,GO PERICARDIUM DEVELOPMENT,0.79636,-0.078178,0.024858,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.30815,-0.078224,-0.059174,0,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.092194,-0.078267,-0.079526,0,0
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.38408,-0.078293,-0.047092,0,0
1,GO RRNA MODIFICATION,0.18508,-0.0783,-0.10306,0,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.35607,-0.078414,-0.095927,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.78289,-0.078435,-0.014695,0,0
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.16294,-0.078564,-0.11779,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.80312,-0.078604,-0.032186,0,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.18219,-0.078645,-0.081199,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.12689,-0.078668,-0.091053,0,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.36064,-0.078707,-0.024983,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.18219,-0.078729,-0.060996,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.088862,-0.078835,-0.061291,0,0
1,GO EPITHELIAL CELL MATURATION,0.30815,-0.078944,-0.057379,0,0
1,GO CELL MORPHOGENESIS,0.12259,-0.078969,-0.055006,0,0
1,GO LEFT RIGHT PATTERN FORMATION,0.50337,-0.078983,-0.04779,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.12908,-0.078984,-0.080146,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.78962,-0.078999,0.0026512,0,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.17934,-0.079012,-0.046163,0,0
1,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.76281,-0.079036,-0.064791,0,0
1,GO I KAPPAB PHOSPHORYLATION,0.05161,-0.079245,-0.14103,0,0
1,GO RESPONSE TO LEUCINE,0.16032,-0.079276,-0.10311,0,0
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.20621,-0.079292,-0.10761,0,0
1,GO VIRAL GENOME REPLICATION,0.050569,-0.07942,-0.16129,0,0
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.38888,-0.079453,-0.12624,0,0
1,GO TUBE FORMATION,0.21905,-0.079519,-0.044099,0,0
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.085627,-0.079598,-0.11235,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.35153,-0.079677,-0.11097,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.28785,-0.079953,-0.086566,0,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.34256,-0.079985,-0.091576,0,0
1,GO PROTEIN IMPORT,0.068167,-0.080086,-0.064444,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.075049,-0.080109,-0.078748,0,0
1,GO MATING,0.076492,-0.08023,-0.068697,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.15517,-0.080231,-0.1128,0,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.15264,-0.080278,-0.14428,0,0
1,GO T CELL HOMEOSTASIS,0.1028,-0.080476,-0.063458,0,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.42347,-0.08057,-0.039409,0,0
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.12259,-0.080643,-0.076658,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.064293,-0.080645,-0.1599,0,0
1,GO RESPONSE TO AUDITORY STIMULUS,0.52025,-0.080884,-0.023029,0,0
1,GO NEURAL TUBE FORMATION,0.25729,-0.081107,-0.03284,0,0
1,GO TRANSPOSITION,0.40349,-0.081171,-0.076829,0,0
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.10465,-0.081226,-0.12544,0,0
1,GO REGULATION OF MITOPHAGY,0.13355,-0.081262,-0.083051,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.22235,-0.081366,-0.11565,0,0
1,GO REGULATION OF FIBROBLAST MIGRATION,0.32077,-0.081534,-0.071305,0,0
1,GO T CELL DIFFERENTIATION,0.090515,-0.081591,-0.070228,0,0
1,GO FIBROBLAST MIGRATION,0.29184,-0.081702,-0.062052,0,0
1,GO REGULATION OF CALCIUM ION IMPORT,0.05161,-0.081769,-0.12132,0,0
1,GO TRNA METABOLIC PROCESS,0.055956,-0.081812,-0.096875,0,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.37932,-0.082051,-0.15314,0,0
1,GO RESPONSE TO X RAY,0.31653,-0.082147,-0.095498,0,0
1,GO EPITHELIAL CELL CELL ADHESION,0.72313,-0.082152,-0.015596,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.2839,-0.082209,-0.098166,0,0
1,GO POSITIVE REGULATION OF CELL AGING,0.24288,-0.082253,-0.05282,0,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.36526,-0.082321,-0.080626,0,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.93377,-0.082359,0.0048941,0,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.12908,-0.082418,-0.046077,0,0
1,GO INTERLEUKIN 2 PRODUCTION,0.26847,-0.082421,-0.078584,0,0
1,GO VESICLE CARGO LOADING,0.15015,-0.08256,-0.097812,0,0
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.27999,-0.082791,-0.075616,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.045624,-0.082807,-0.15958,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.079444,-0.082893,-0.11989,0,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.24288,-0.082895,-0.048337,0,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.62113,-0.082987,-0.090875,0,0
1,GO LYSOSOME LOCALIZATION,0.079444,-0.083107,-0.072029,0,0
1,GO PHAGOSOME MATURATION,0.12689,-0.083214,-0.076686,0,0
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.092194,-0.083214,-0.070046,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.87833,-0.083262,-0.02117,0,0
1,GO GLUTAMATE SECRETION,0.59664,-0.083279,-0.024083,0,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.32506,-0.083312,-0.057654,0,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.12259,-0.083322,-0.081555,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.093897,-0.083439,-0.085891,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,0.38888,-0.083487,-0.10033,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.23937,-0.083551,-0.094576,0,0
1,GO PARAXIAL MESODERM DEVELOPMENT,0.63354,-0.083819,-0.015254,0,0
1,GO NCRNA METABOLIC PROCESS,0.066855,-0.084016,-0.10288,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.016734,-0.084038,-0.098731,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.18219,-0.084241,-0.074591,0,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.54903,-0.084312,-0.0528,0,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.4978,-0.084576,-0.10982,0,0
1,GO ACETYL COA METABOLIC PROCESS,0.16294,-0.08475,-0.086334,0,0
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.32077,-0.084867,-0.082164,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.26847,-0.084953,-0.080321,0,0
1,GO KETONE CATABOLIC PROCESS,0.19393,-0.085063,-0.15283,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.060602,-0.085229,-0.10178,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.14048,-0.085492,-0.10924,0,0
1,GO VOCALIZATION BEHAVIOR,0.79636,-0.085579,0.00023664,0,0
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.16828,-0.085692,-0.10461,0,0
1,GO MESODERM DEVELOPMENT,0.052669,-0.085726,-0.073713,0,0
1,GO ADHERENS JUNCTION ASSEMBLY,0.31232,-0.085794,-0.055316,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.059411,-0.085914,-0.068884,0,0
1,GO REGULATION OF AXON GUIDANCE,0.14048,-0.085966,-0.088102,0,0
1,GO UTERUS DEVELOPMENT,0.72313,-0.086214,-0.021789,0,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.31653,-0.086221,-0.101,0,0
1,GO TORC1 SIGNALING,0.042857,-0.086303,-0.081354,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.31653,-0.086333,-0.052118,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.29992,-0.086364,-0.063923,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.15773,-0.086438,-0.063614,0,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.21256,-0.086533,-0.13096,0,0
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.35607,-0.086549,-0.11689,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.14285,-0.086634,-0.078575,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.050569,-0.086706,-0.14831,0,0
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.42347,-0.086767,-0.028143,0,0
1,GO BONE DEVELOPMENT,0.1313,-0.086945,-0.052168,0,0
1,GO LEARNING,0.090515,-0.087007,-0.10309,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.068167,-0.087057,-0.11948,0,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.049546,-0.087138,-0.087919,0,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.05824,-0.087157,-0.13293,0,0
1,GO PEPTIDYL ARGININE N METHYLATION,0.25001,-0.087264,-0.084128,0,0
1,GO ALPHA BETA T CELL ACTIVATION,0.077957,-0.087338,-0.093971,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.49227,-0.087365,-0.040805,0,0
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.054842,-0.087605,-0.09432,0,0
1,GO VIRAL BUDDING,0.34702,-0.087637,-0.031964,0,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.27227,-0.087782,-0.061806,0,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.20309,-0.087817,-0.04551,0,0
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.31653,-0.087899,-0.11386,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.78289,-0.087974,-0.024151,0,0
1,GO PRESYNAPSE ORGANIZATION,0.29586,-0.088078,-0.056645,0,0
1,GO REPLICATIVE SENESCENCE,0.075049,-0.088089,-0.17472,0,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.3746,-0.08816,-0.059798,0,0
1,GO MYOBLAST DIFFERENTIATION,0.41341,-0.088311,-0.046832,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.013139,-0.088357,-0.12335,0,0
1,GO SPERM CAPACITATION,0.095625,-0.088419,-0.089025,0,0
1,GO GLIAL CELL APOPTOTIC PROCESS,0.32077,-0.08866,-0.098475,0,0
1,GO RIBOSOME BIOGENESIS,0.10465,-0.088779,-0.12276,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0695,-0.088831,-0.082838,0,0
1,GO CANONICAL WNT SIGNALING PATHWAY,0.082489,-0.088908,-0.067946,0,0
1,GO POSTSYNAPSE ORGANIZATION,0.14285,-0.089018,-0.086458,0,0
1,GO NEURON PROJECTION ORGANIZATION,0.05824,-0.089136,-0.12299,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.060602,-0.089142,-0.084802,0,0
1,GO WATER HOMEOSTASIS,0.055956,-0.089143,-0.1072,0,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.14048,-0.089184,-0.10172,0,0
1,GO AXIS SPECIFICATION,0.052669,-0.089245,-0.091474,0,0
1,GO PROTEIN DESTABILIZATION,0.068167,-0.089317,-0.072286,0,0
1,GO SMOOTH MUSCLE CELL MIGRATION,0.05161,-0.089482,-0.16733,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.88523,-0.08962,0.00776,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.099158,-0.08972,-0.10726,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.0053338,-0.089767,-0.072715,0,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.2,-0.089808,-0.090843,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.13355,-0.089947,-0.093836,0,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.22235,-0.090464,-0.078657,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.097379,-0.090471,-0.088933,0,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.21256,-0.090537,-0.11877,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.27227,-0.09055,-0.045006,0,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.4545,-0.090599,-0.064092,0,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.076492,-0.090608,-0.071385,0,0
1,GO HEMOGLOBIN METABOLIC PROCESS,0.17653,-0.09072,-0.08827,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.063042,-0.090864,-0.10767,0,0
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.75615,-0.090945,-0.0085258,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.060602,-0.091009,-0.11154,0,0
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.2,-0.091187,-0.11123,0,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.35607,-0.091356,-0.085429,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.064293,-0.091381,-0.17639,0,0
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.057089,-0.091487,-0.14635,0,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.092194,-0.09152,-0.058118,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.077957,-0.091535,-0.080735,0,0
1,GO INTRACELLULAR STEROL TRANSPORT,0.21579,-0.091628,-0.092199,0,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.10096,-0.091673,-0.089297,0,0
1,GO MULTICELLULAR ORGANISM AGING,0.04854,-0.091859,-0.087639,0,0
1,GO CAMP BIOSYNTHETIC PROCESS,0.36991,-0.092071,-0.078753,0,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.62732,-0.092128,-0.0094345,0,0
1,GO ASTROCYTE ACTIVATION,0.099158,-0.092197,-0.14445,0,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.16559,-0.092227,-0.10706,0,0
1,GO PROTEASOME ASSEMBLY,0.13355,-0.092275,-0.10471,0,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.18219,-0.092314,-0.067944,0,0
1,GO REGULATION OF TRANSPOSITION,0.33373,-0.092526,-0.11906,0,0
1,GO REGULATION OF HEART MORPHOGENESIS,0.72969,-0.092569,-0.012701,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.12259,-0.092714,-0.084682,0,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.22235,-0.092733,-0.12511,0,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.16032,-0.092765,-0.15321,0,0
1,GO REGULATION OF T CELL DIFFERENTIATION,0.065563,-0.092802,-0.081474,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.23589,-0.092804,-0.051775,0,0
1,GO PIGMENT GRANULE ORGANIZATION,0.064293,-0.092814,-0.12189,0,0
1,GO RESPONSE TO INTERFERON ALPHA,0.39371,-0.093137,-0.2272,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.017549,-0.09318,-0.1189,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.29586,-0.093239,-0.065423,0,0
1,GO VIRAL RELEASE FROM HOST CELL,0.12689,-0.093316,-0.087249,0,0
1,GO TRNA PROCESSING,0.14285,-0.093406,-0.077418,0,0
1,GO NEURAL NUCLEUS DEVELOPMENT,0.29184,-0.093611,-0.039499,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.12689,-0.093634,-0.10997,0,0
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.17374,-0.093705,-0.084984,0,0
1,GO COGNITION,0.072231,-0.093871,-0.081615,0,0
1,GO RRNA METABOLIC PROCESS,0.093897,-0.093971,-0.12063,0,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.059411,-0.094073,-0.13498,0,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,0.31653,-0.094141,-0.060323,0,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.24288,-0.094486,-0.12865,0,0
1,GO HEART TRABECULA MORPHOGENESIS,0.072231,-0.094541,-0.10871,0,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.12908,-0.094551,-0.094852,0,0
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.072231,-0.094585,-0.071304,0,0
1,GO REGULATION OF GASTRULATION,0.33373,-0.094629,-0.035982,0,0
1,GO PEPTIDYL ARGININE METHYLATION,0.15015,-0.094817,-0.087973,0,0
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.31653,-0.094843,-0.12679,0,0
1,GO REPRODUCTIVE BEHAVIOR,0.087232,-0.09488,-0.11235,0,0
1,GO PROTEIN NITROSYLATION,0.25729,-0.094894,-0.088612,0,0
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.20309,-0.095021,-0.15394,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.56666,-0.095082,-0.051524,0,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.17099,-0.095145,-0.034947,0,0
1,GO POLYAMINE METABOLIC PROCESS,0.097379,-0.095158,-0.12106,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.30815,-0.095273,-0.077401,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.01282,-0.095278,-0.10013,0,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.085627,-0.095373,-0.10654,0,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,0.077957,-0.095467,-0.10042,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.080955,-0.095489,-0.10587,0,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.29586,-0.095501,-0.072529,0,0
1,GO RESPONSE TO ACTIVITY,0.0027346,-0.095531,-0.13248,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.16294,-0.095923,-0.098168,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.4545,-0.096044,-0.031449,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.57857,-0.096105,-0.050375,0,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.070855,-0.096148,-0.087854,0,0
1,GO LUNG MORPHOGENESIS,0.26471,-0.096167,-0.058447,0,0
1,GO MICROTUBULE BUNDLE FORMATION,0.15517,-0.096381,-0.050574,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.25363,-0.096507,-0.099036,0,0
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.11434,-0.09654,-0.087257,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.16828,-0.096693,-0.10454,0,0
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.17099,-0.096713,-0.061235,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.20309,-0.0968,-0.077787,0,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.12689,-0.096869,-0.11484,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.082489,-0.096876,-0.091353,0,0
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.097379,-0.096942,-0.083174,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.30402,-0.09701,-0.038388,0,0
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.21905,-0.097132,-0.10569,0,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.054842,-0.09733,-0.127,0,0
1,GO BRONCHUS DEVELOPMENT,0.41341,-0.097424,-0.15038,0,0
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.25001,-0.097523,-0.10291,0,0
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.11039,-0.097578,-0.094353,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.05824,-0.097703,-0.1393,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.034637,-0.097735,-0.13084,0,0
1,GO POTASSIUM ION HOMEOSTASIS,0.082489,-0.097806,-0.11029,0,0
1,GO INTERFERON BETA PRODUCTION,0.11841,-0.097808,-0.11613,0,0
1,GO RESPONSE TO PARATHYROID HORMONE,0.29184,-0.098403,-0.0923,0,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.30402,-0.098529,-0.090195,0,0
1,GO INTERFERON ALPHA PRODUCTION,0.10465,-0.098584,-0.11941,0,0
1,GO NIK NF KAPPAB SIGNALING,0.060602,-0.098828,-0.1171,0,0
1,GO MATING BEHAVIOR,0.11841,-0.098832,-0.10549,0,0
1,GO REGULATION OF CELL MATURATION,0.053746,-0.098858,-0.085812,0,0
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.2,-0.098963,-0.1053,0,0
1,GO REGULATION OF ISOTYPE SWITCHING,0.055956,-0.099011,-0.15278,0,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.43883,-0.09926,-0.056958,0,0
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.12049,-0.099496,-0.17456,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.10465,-0.099568,-0.069507,0,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.15773,-0.099836,-0.10329,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0036303,-0.099923,-0.1046,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0029794,-0.09995,-0.10924,0,0
1,GO CRANIAL NERVE DEVELOPMENT,0.066855,-0.099993,-0.13235,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.019739,-0.10001,-0.16948,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.20309,-0.10004,-0.11568,0,0
1,GO GENITALIA MORPHOGENESIS,0.077957,-0.10032,-0.19288,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.066855,-0.10044,-0.13265,0,0
1,GO MEMBRANE DISASSEMBLY,0.11841,-0.10052,-0.10285,0,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.38408,-0.10069,-0.060201,0,0
1,GO BONE GROWTH,0.19095,-0.10074,-0.14017,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.017549,-0.1009,-0.131,0,0
1,GO CYTOKINE SECRETION,0.12259,-0.1009,-0.07989,0,0
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.24643,-0.10104,-0.20801,0,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.63354,-0.10105,-0.017045,0,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.3746,-0.1011,-0.03953,0,0
1,GO RRNA CATABOLIC PROCESS,0.5726,-0.10118,-0.025034,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.30815,-0.10169,-0.088315,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.3746,-0.10172,-0.064041,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.090515,-0.10178,-0.12553,0,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0695,-0.10179,-0.21493,0,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.085627,-0.10191,-0.094501,0,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.04854,-0.10198,-0.09982,0,0
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.20937,-0.10223,-0.11687,0,0
1,GO CELLULAR RESPONSE TO DSRNA,0.188,-0.10248,-0.11738,0,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.67137,-0.1027,-0.044354,0,0
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.30402,-0.10304,-0.090664,0,0
1,GO ACIDIC AMINO ACID TRANSPORT,0.22905,-0.10314,-0.05254,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.084046,-0.10319,-0.05695,0,0
1,GO CARTILAGE DEVELOPMENT,0.082489,-0.10325,-0.089171,0,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.21579,-0.10348,-0.094884,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.33812,-0.10352,-0.15345,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.075049,-0.10372,-0.13791,0,0
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.35607,-0.10376,-0.086021,0,0
1,GO RESPONSE TO DOPAMINE,0.18508,-0.10407,-0.064242,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.67137,-0.10408,-0.037241,0,0
1,GO RESPONSE TO PROGESTERONE,0.14048,-0.10415,-0.12635,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.16559,-0.10428,-0.079673,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,0.23937,-0.10429,-0.10157,0,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.39371,-0.10439,-0.037757,0,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.25001,-0.10447,-0.068997,0,0
1,GO TRNA MODIFICATION,0.065563,-0.10455,-0.10259,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.29586,-0.1046,-0.063706,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.12689,-0.10482,-0.16207,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.12689,-0.10486,-0.098237,0,0
1,GO DNA DEAMINATION,0.80989,-0.10487,-0.068998,0,0
1,GO REGULATION OF NUCLEASE ACTIVITY,0.10654,-0.10492,-0.091983,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.35153,-0.10525,-0.060386,0,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.13814,-0.10535,-0.082651,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.001228,-0.10555,-0.10819,0,0
1,GO FOREBRAIN CELL MIGRATION,0.13355,-0.10557,-0.066637,0,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.33812,-0.10561,-0.030431,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.065563,-0.10565,-0.085995,0,0
1,GO DEFENSE RESPONSE TO VIRUS,0.17934,-0.10569,-0.11603,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.13814,-0.10572,-0.087679,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.050569,-0.10599,-0.084847,0,0
1,GO REGULATION OF HEAT GENERATION,0.44924,-0.10653,-0.031717,0,0
1,GO MATURATION OF 5 8S RRNA,0.16559,-0.10656,-0.11343,0,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.11434,-0.10665,-0.10196,0,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.050569,-0.10668,-0.11959,0,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.12259,-0.107,-0.087333,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0012662,-0.10707,-0.12802,0,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.055956,-0.10727,-0.1218,0,0
1,GO GLYCINE METABOLIC PROCESS,0.16032,-0.10728,-0.16834,0,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.18508,-0.10734,-0.036514,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,0.13355,-0.10738,-0.16317,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.17374,-0.10757,-0.09442,0,0
1,GO CORONARY VASCULATURE DEVELOPMENT,0.12689,-0.1076,-0.089186,0,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.44924,-0.10776,-0.043638,0,0
1,GO PROTEIN LOCALIZATION TO AXON,0.42855,-0.10776,-0.067923,0,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.4545,-0.10783,-0.10845,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.097379,-0.10784,-0.10647,0,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.37932,-0.10788,-0.068075,0,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.13355,-0.10795,-0.086676,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.099158,-0.10819,-0.14125,0,0
1,GO RENAL VESICLE DEVELOPMENT,0.045624,-0.10821,-0.17512,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.033894,-0.10828,-0.10232,0,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.15264,-0.1083,-0.089519,0,0
1,GO RESPONSE TO WATER,0.14769,-0.10851,-0.1325,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.070855,-0.10852,-0.08144,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.075049,-0.10869,-0.084837,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.082489,-0.1088,-0.09842,0,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.049546,-0.10897,-0.088777,0,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.23245,-0.10906,-0.12689,0,0
1,GO MAST CELL MEDIATED IMMUNITY,0.10654,-0.10926,-0.11059,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.58456,-0.10926,-0.062665,0,0
1,GO MAINTENANCE OF PROTEIN LOCATION,0.059411,-0.10932,-0.082854,0,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.46512,-0.10937,-0.10451,0,0
1,GO OOCYTE MATURATION,0.14048,-0.1095,-0.061434,0,0
1,GO TOOTH MINERALIZATION,0.11841,-0.10951,-0.16414,0,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027188,-0.10953,-0.16571,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0062634,-0.10958,-0.10888,0,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.35153,-0.10969,-0.067933,0,0
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.060602,-0.1098,-0.15113,0,0
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.070855,-0.10985,-0.086034,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.35607,-0.11008,-0.057359,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.065563,-0.1105,-0.10341,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.061812,-0.11107,-0.088063,0,0
1,GO SHORT TERM MEMORY,0.72969,-0.11114,-0.040712,0,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.088862,-0.11119,-0.079408,0,0
1,GO CHONDROCYTE DIFFERENTIATION,0.092194,-0.11123,-0.11149,0,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.085627,-0.11134,-0.10957,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.076492,-0.11147,-0.11253,0,0
1,GO CYTOLYSIS,0.11636,-0.1115,-0.13042,0,0
1,GO DRINKING BEHAVIOR,0.10465,-0.1116,-0.17596,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.099158,-0.11181,-0.16894,0,0
1,GO HEAT GENERATION,0.188,-0.11199,-0.068064,0,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.16294,-0.11221,-0.087092,0,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.17374,-0.11257,-0.093214,0,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.049546,-0.11276,-0.11405,0,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.50337,-0.1128,-0.042652,0,0
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.079444,-0.1128,-0.099197,0,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.055956,-0.11294,-0.14272,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.03245,-0.11321,-0.15464,0,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10096,-0.11347,-0.10467,0,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.076492,-0.11351,-0.18911,0,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.070855,-0.11361,-0.11929,0,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.14769,-0.11364,-0.092679,0,0
1,GO RESPONSE TO VIRUS,0.054842,-0.11367,-0.12774,0,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.064293,-0.11381,-0.23493,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.11841,-0.11445,-0.08592,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.072231,-0.11459,-0.14293,0,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.12689,-0.11471,-0.18416,0,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.10465,-0.11511,-0.1057,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.0053338,-0.11516,-0.14856,0,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.17934,-0.11549,-0.074616,0,0
1,GO MESENCHYME MORPHOGENESIS,0.05824,-0.1155,-0.096758,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.11636,-0.11569,-0.12668,0,0
1,GO SYNAPTIC SIGNALING,0.085627,-0.1157,-0.06956,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.10654,-0.11583,-0.12185,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.057089,-0.1159,-0.17688,0,0
1,GO PHOSPHOLIPID HOMEOSTASIS,0.095625,-0.11597,-0.13727,0,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.4545,-0.11604,-0.081093,0,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.44402,-0.11651,0.0098965,0,0
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.14285,-0.1166,-0.12739,0,0
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.11434,-0.11672,-0.087672,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.16559,-0.1172,-0.084726,0,0
1,GO ORGAN GROWTH,0.0695,-0.11723,-0.075067,0,0
1,GO MITOCHONDRIAL FISSION,0.0090226,-0.11742,-0.12612,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.44924,-0.11778,-0.047419,0,0
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.087232,-0.11811,-0.09262,0,0
1,GO INTERLEUKIN 12 PRODUCTION,0.053746,-0.11827,-0.096928,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.088862,-0.11829,-0.13918,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.17374,-0.1183,-0.072582,0,0
1,GO PEPTIDYL HISTIDINE MODIFICATION,0.054842,-0.11835,-0.1376,0,0
1,GO REGULATION OF PROTEIN IMPORT,0.10465,-0.11866,-0.10331,0,0
1,GO INTERLEUKIN 10 PRODUCTION,0.054842,-0.11868,-0.1079,0,0
1,GO DENDRITE EXTENSION,0.13814,-0.11872,-0.0066498,0,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.059411,-0.11884,-0.14134,0,0
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.066855,-0.11887,-0.09614,0,0
1,GO REGULATION OF CHLORIDE TRANSPORT,0.37932,-0.11887,-0.080886,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.42855,-0.11895,-0.10862,0,0
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.073629,-0.11899,-0.11839,0,0
1,GO EPIDERMIS DEVELOPMENT,0.19393,-0.119,-0.06698,0,0
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.15264,-0.11905,-0.079641,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.0028141,-0.11906,-0.14835,0,0
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.072231,-0.11937,-0.1688,0,0
1,GO AXONEME ASSEMBLY,0.24643,-0.11939,-0.064973,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.23589,-0.11988,-0.077263,0,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.066855,-0.11992,-0.19329,0,0
1,GO ENERGY HOMEOSTASIS,0.070855,-0.11993,-0.11203,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.21579,-0.12019,-0.099795,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.27227,-0.12025,-0.070318,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.22235,-0.12025,-0.18817,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.11841,-0.12033,-0.1063,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.16828,-0.12049,-0.099692,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.22235,-0.12057,-0.084636,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.00021167,-0.12057,-0.11711,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.23245,-0.12063,-0.076125,0,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.12689,-0.12064,-0.11184,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.29992,-0.12071,-0.078539,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.36991,-0.12091,-0.0694,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.14526,-0.12098,-0.08709,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.022165,-0.12109,-0.11966,0,0
1,GO NEURAL CREST CELL DIFFERENTIATION,0.04854,-0.12112,-0.11057,0,0
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.073629,-0.12114,-0.082686,0,0
1,GO RESPONSE TO UV B,0.16032,-0.12122,-0.11753,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.2839,-0.12178,-0.066874,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.031059,-0.12178,-0.14579,0,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.014841,-0.12179,-0.16651,0,0
1,GO SYNAPTIC VESICLE PRIMING,0.29992,-0.12184,-0.027396,0,0
1,GO MALE MEIOSIS I,0.05161,-0.1219,-0.17458,0,0
1,GO LATERAL VENTRICLE DEVELOPMENT,0.38408,-0.12199,-0.048463,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.088862,-0.12221,-0.12749,0,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.73628,-0.12225,-0.0068849,0,0
1,GO REGULATION OF LIGASE ACTIVITY,0.049546,-0.12245,-0.13991,0,0
1,GO REGULATION OF PROTEIN TARGETING,0.0014299,-0.12251,-0.12562,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.10096,-0.1226,-0.14072,0,0
1,GO PIRNA METABOLIC PROCESS,0.060602,-0.12271,-0.15766,0,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,0.057089,-0.12282,-0.1509,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.055956,-0.12289,-0.13912,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.068167,-0.1229,-0.10756,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.072231,-0.12298,-0.14158,0,0
1,GO REGULATION OF SYMBIOTIC PROCESS,0.05824,-0.1231,-0.12805,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.068167,-0.12311,-0.1196,0,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.18508,-0.12336,-0.10552,0,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.076492,-0.12373,-0.19244,0,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.050569,-0.12384,-0.11352,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17374,-0.12387,-0.146,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.22568,-0.12402,-0.1029,0,0
1,GO OVULATION CYCLE PROCESS,0.0083534,-0.12447,-0.15097,0,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.16032,-0.12471,-0.090133,0,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.093897,-0.1248,-0.14247,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.23245,-0.12508,-0.074808,0,0
1,GO MATURATION OF SSU RRNA,0.073629,-0.12512,-0.1608,0,0
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.30815,-0.12515,-0.077993,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.41341,-0.12524,-0.075406,0,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.14769,-0.12526,-0.089233,0,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.47588,-0.12533,-0.066887,0,0
1,GO MITOCHONDRION ORGANIZATION,2.3418e-05,-0.12574,-0.12192,0,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.23245,-0.1259,-0.11049,0,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.097379,-0.12625,-0.11314,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.36064,-0.12681,-0.082146,0,0
1,GO AMMONIUM TRANSPORT,0.070855,-0.12687,-0.12899,0,0
1,GO REGULATION OF CELL KILLING,0.12259,-0.12689,-0.096267,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.1313,-0.1269,-0.13126,0,0
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.082489,-0.12696,-0.088055,0,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.15264,-0.12698,-0.096325,0,0
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.13814,-0.1271,-0.08565,0,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.19695,-0.12715,-0.083202,0,0
1,GO MAINTENANCE OF CELL POLARITY,0.035393,-0.12719,-0.13551,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.15015,-0.12722,-0.16519,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.0695,-0.12724,-0.16712,0,0
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.24288,-0.12727,-0.065743,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.088862,-0.12731,-0.09506,0,0
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.092194,-0.12739,-0.13691,0,0
1,GO KIDNEY MORPHOGENESIS,0.17099,-0.12747,-0.063789,0,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.090515,-0.12772,-0.12246,0,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.052669,-0.1278,-0.09793,0,0
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.40843,-0.12786,-0.10559,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.37932,-0.12794,-0.096845,0,0
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.084046,-0.12811,-0.20904,0,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0045306,-0.12825,-0.1408,0,0
1,GO RESPONSE TO VITAMIN A,0.092194,-0.12837,-0.14044,0,0
1,GO LYMPH NODE DEVELOPMENT,0.18508,-0.12843,-0.088241,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.053746,-0.12844,-0.099633,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.076492,-0.12848,-0.12659,0,0
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.10654,-0.12859,-0.094255,0,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.082489,-0.12883,-0.11145,0,0
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.12049,-0.12896,-0.21649,0,0
1,GO RESPONSE TO MURAMYL DIPEPTIDE,0.17934,-0.12914,-0.10631,0,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.10096,-0.12925,-0.072796,0,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.095625,-0.12937,-0.084579,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.12259,-0.12986,-0.14209,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.047551,-0.13016,-0.1631,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.10465,-0.13046,-0.19696,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.076492,-0.13114,-0.15903,0,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.34256,-0.13152,-0.047446,0,0
1,GO MATURATION OF LSU RRNA,0.15264,-0.13152,-0.14816,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.2,-0.13165,-0.060049,0,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.061812,-0.13186,-0.054864,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.20937,-0.13199,-0.080346,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.0018173,-0.13208,-0.14146,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.26471,-0.13233,-0.090117,0,0
1,GO SYNAPSE ASSEMBLY,0.14048,-0.13234,-0.060964,0,0
1,GO CGMP MEDIATED SIGNALING,0.0021689,-0.13261,-0.22143,0,0
1,GO ALPHA BETA T CELL PROLIFERATION,0.11434,-0.1327,-0.12451,0,0
1,GO PLACENTA DEVELOPMENT,0.075049,-0.13276,-0.10271,0,0
1,GO PROSTATE GLAND DEVELOPMENT,0.097379,-0.13292,-0.115,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.12259,-0.13327,-0.12957,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.12259,-0.13346,-0.11818,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.12908,-0.13358,-0.12233,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.14769,-0.13358,-0.060064,0,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.56666,-0.13364,-0.033264,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.32506,-0.13365,-0.14946,0,0
1,GO TRNA 5 LEADER REMOVAL,0.072231,-0.13378,-0.14319,0,0
1,GO RENAL SODIUM EXCRETION,0.021165,-0.13382,-0.13849,0,0
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.34702,-0.13401,-0.10288,0,0
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.15773,-0.13407,-0.15123,0,0
1,GO L GLUTAMATE IMPORT,0.0695,-0.13408,-0.15412,0,0
1,GO KERATINOCYTE PROLIFERATION,0.3746,-0.13417,-0.050017,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.070855,-0.1348,-0.10119,0,0
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.11841,-0.135,-0.15369,0,0
1,GO STEM CELL DIVISION,0.16559,-0.13547,-0.069346,0,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.10096,-0.13571,-0.11908,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.11841,-0.13591,-0.082673,0,0
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.068167,-0.13638,-0.19138,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.0049174,-0.13659,-0.16664,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.19393,-0.13686,-0.081727,0,0
1,GO BODY MORPHOGENESIS,0.16559,-0.1369,-0.069303,0,0
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.16559,-0.13711,-0.12282,0,0
1,GO LYSINE METABOLIC PROCESS,0.15773,-0.13744,-0.15151,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.26471,-0.13749,-0.077453,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.19393,-0.13764,-0.11115,0,0
1,GO OSTEOCLAST DEVELOPMENT,0.054842,-0.13825,-0.13091,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.1313,-0.13837,-0.11839,0,0
1,GO LAMELLIPODIUM MORPHOGENESIS,0.30815,-0.13856,-0.0667,0,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.19095,-0.13861,-0.058271,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.043763,-0.13922,-0.12955,0,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.35607,-0.14013,-0.12882,0,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.51459,-0.14017,-0.048313,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.31232,-0.14074,-0.14061,0,0
1,GO SYNAPTIC VESICLE RECYCLING,0.12049,-0.14118,-0.079272,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.080955,-0.14122,-0.11121,0,0
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.10845,-0.1413,-0.15159,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.24288,-0.14137,-0.13812,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.087232,-0.14149,-0.12331,0,0
1,GO METANEPHROS DEVELOPMENT,0.073629,-0.14155,-0.087791,0,0
1,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.30815,-0.14161,-0.1118,0,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.054842,-0.14162,-0.13294,0,0
1,GO REGULATION OF PLATELET AGGREGATION,0.055956,-0.14214,-0.21263,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.064293,-0.14303,-0.11724,0,0
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.10845,-0.14362,-0.1802,0,0
1,GO RESPONSE TO SALT STRESS,0.054842,-0.14363,-0.13841,0,0
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.15264,-0.14365,-0.14345,0,0
1,GO NOREPINEPHRINE TRANSPORT,0.21579,-0.14389,-0.075732,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.1313,-0.14396,-0.081526,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00050664,-0.14433,-0.15163,0,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.053746,-0.14436,-0.10369,0,0
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.060602,-0.14489,-0.12575,0,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.020205,-0.1452,-0.17008,0,0
1,GO DEVELOPMENTAL INDUCTION,0.066855,-0.14543,-0.097344,0,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.2839,-0.1455,-0.089446,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.15517,-0.14555,-0.099549,0,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.22568,-0.1456,-0.13967,0,0
1,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.061812,-0.14613,-0.1654,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.05161,-0.14619,-0.14384,0,0
1,GO CYTOPLASM ORGANIZATION,0.19393,-0.14645,-0.10391,0,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.21579,-0.14645,-0.088534,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.14285,-0.14659,-0.16448,0,0
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.2839,-0.14673,-0.15009,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.065563,-0.14689,-0.13219,0,0
1,GO POSTSYNAPSE ASSEMBLY,0.19393,-0.14695,-0.13273,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.063042,-0.14701,-0.18304,0,0
1,GO NEUROTRANSMITTER SECRETION,0.079444,-0.14707,-0.060682,0,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.42347,-0.14757,-0.057919,0,0
1,GO PREPULSE INHIBITION,0.22568,-0.14758,-0.13982,0,0
1,GO EXPLORATION BEHAVIOR,0.066855,-0.14765,-0.16752,0,0
1,GO BONE TRABECULA MORPHOGENESIS,0.12049,-0.14776,-0.16533,0,0
1,GO SKIN DEVELOPMENT,0.11434,-0.14792,-0.093385,0,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.10845,-0.14803,-0.11085,0,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.15015,-0.14803,-0.16644,0,0
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0695,-0.14868,-0.1342,0,0
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.057089,-0.14868,-0.20569,0,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.10845,-0.14908,-0.27773,0,0
1,GO ODONTOGENESIS,0.12259,-0.14919,-0.069262,0,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.14048,-0.14928,-0.13508,0,0
1,GO PLASMA MEMBRANE TUBULATION,0.093897,-0.14964,-0.11467,0,0
1,GO FACE DEVELOPMENT,0.064293,-0.14993,-0.12267,0,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.20309,-0.14995,-0.14975,0,0
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.073629,-0.15003,-0.15687,0,0
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.11039,-0.15024,-0.18783,0,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.059411,-0.15099,-0.14565,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.25729,-0.15155,-0.096001,0,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.1028,-0.15167,-0.22389,0,0
1,GO PSEUDOURIDINE SYNTHESIS,0.05824,-0.15172,-0.1739,0,0
1,GO MESODERM MORPHOGENESIS,0.05824,-0.15181,-0.12306,0,0
1,GO RESPONSE TO ANTIBIOTIC,0.060602,-0.15237,-0.1035,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.11235,-0.15238,-0.25608,0,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0017641,-0.15249,-0.13564,0,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.090515,-0.1526,-0.14845,0,0
1,GO AUTOPHAGIC CELL DEATH,0.042857,-0.15298,-0.13074,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00353,-0.15338,-0.19046,0,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0014738,-0.15342,-0.13673,0,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.02068,-0.15358,-0.14565,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.78289,-0.15382,-0.0066226,0,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.11434,-0.15404,-0.098451,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.0017641,-0.15409,-0.148,0,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.15264,-0.15445,-0.094557,0,0
1,GO AMINO ACID IMPORT,0.001986,-0.15479,-0.21632,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.050569,-0.155,-0.10223,0,0
1,GO CGMP METABOLIC PROCESS,0.10845,-0.15538,-0.15885,0,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,0.054842,-0.15582,-0.058288,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.15264,-0.15599,-0.085222,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.072231,-0.15617,-0.11081,0,0
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.34702,-0.1562,-0.05361,0,0
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.32506,-0.15626,-0.10692,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0039469,-0.1563,-0.18071,0,0
1,GO POSITIVE REGULATION OF URINE VOLUME,0.068167,-0.15646,-0.11477,0,0
1,GO CARDIOCYTE DIFFERENTIATION,0.041967,-0.15688,-0.097626,0,0
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.063042,-0.15689,-0.19793,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00022676,-0.15704,-0.16504,0,0
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.063042,-0.1572,-0.23551,0,0
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.13814,-0.15741,-0.18247,0,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.0054795,-0.158,-0.11969,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0071468,-0.15805,-0.1679,0,0
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.71658,-0.1585,-0.055585,0,0
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.085627,-0.1585,-0.093573,0,0
1,GO RESPONSE TO PROSTAGLANDIN E,0.017137,-0.15852,-0.13036,0,0
1,GO ADULT BEHAVIOR,0.050569,-0.15858,-0.073698,0,0
1,GO PIGMENT ACCUMULATION,0.099158,-0.15884,-0.10538,0,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.15517,-0.15901,-0.14429,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.10465,-0.15921,-0.10829,0,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.11039,-0.15926,-0.12286,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.13583,-0.15946,-0.12053,0,0
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.15015,-0.15995,-0.14343,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.0031536,-0.16039,-0.17072,0,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.05824,-0.16143,-0.14076,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0695,-0.1619,-0.10957,0,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,1.2308e-06,-0.16208,-0.17857,0,0
1,GO REPLACEMENT OSSIFICATION,0.32938,-0.16229,-0.049694,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.085627,-0.1623,-0.19289,0,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.064293,-0.16248,-0.11794,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.050569,-0.16286,-0.13135,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.095625,-0.16289,-0.15814,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0028141,-0.16293,-0.1331,0,0
1,GO MAST CELL MIGRATION,0.05161,-0.16329,-0.21428,0,0
1,GO RESPONSE TO ATP,0.00030804,-0.16344,-0.16907,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.41842,-0.16381,-0.10557,0,0
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.092194,-0.1643,-0.20013,0,0
1,GO THYROID GLAND DEVELOPMENT,0.34256,-0.16495,-0.059001,0,0
1,GO RESPONSE TO CAMP,0.00021167,-0.1651,-0.17603,0,0
1,GO KERATINIZATION,0.5726,-0.16516,-0.031298,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.016734,-0.16579,-0.15521,0,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,5.2139e-05,-0.16586,-0.17289,0,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0025817,-0.16598,-0.16441,0,0
1,GO VIRAL TRANSLATION,0.053746,-0.16613,-0.161,0,0
1,GO AUTOPHAGY OF NUCLEUS,0.04854,-0.1662,-0.13241,0,0
1,GO REGULATION OF MAST CELL ACTIVATION,0.11636,-0.16627,-0.10916,0,0
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.073629,-0.16667,-0.19311,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.00026903,-0.16717,-0.16464,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.068167,-0.16739,-0.10224,0,0
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.24643,-0.16771,-0.13369,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.085627,-0.16795,-0.19048,0,0
1,GO PIGMENT CELL DIFFERENTIATION,0.0023671,-0.16838,-0.16553,0,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.099158,-0.16857,-0.10775,0,0
1,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.079444,-0.16886,-0.18751,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.036164,-0.16897,-0.1967,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.013139,-0.16897,-0.13901,0,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.13583,-0.16907,-0.18687,0,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.15264,-0.1699,-0.11455,0,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.065563,-0.17024,-0.11943,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.11434,-0.17028,-0.11112,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.097379,-0.17042,-0.19204,0,0
1,GO GMP METABOLIC PROCESS,0.05161,-0.1706,-0.13506,0,0
1,GO KERATINOCYTE DIFFERENTIATION,0.29586,-0.17109,-0.061423,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.055956,-0.17121,-0.12558,0,0
1,GO NEGATIVE REGULATION OF CELL AGING,0.62732,-0.17142,-0.053718,0,0
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.10465,-0.17158,-0.12748,0,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.054842,-0.17159,-0.24404,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.0011199,-0.17173,-0.19189,0,0
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.23589,-0.17187,-0.13464,0,0
1,GO PRESYNAPTIC ENDOCYTOSIS,0.095625,-0.17239,-0.090767,0,0
1,GO GAP JUNCTION ASSEMBLY,0.099158,-0.17241,-0.16634,0,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.19095,-0.1728,-0.0932,0,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.17934,-0.17298,-0.11343,0,0
1,GO REGULATION OF HEART GROWTH,0.05161,-0.17305,-0.098255,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.35153,-0.17326,-0.049355,0,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.17374,-0.17381,-0.14346,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.05824,-0.17384,-0.18439,0,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.057089,-0.17394,-0.162,0,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.097379,-0.1745,-0.10258,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.16559,-0.17454,-0.092456,0,0
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.14285,-0.17465,-0.21367,0,0
1,GO HEART FIELD SPECIFICATION,0.16559,-0.17527,-0.11399,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.05824,-0.17531,-0.097628,0,0
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.05824,-0.17546,-0.16837,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.016734,-0.17582,-0.12309,0,0
1,GO RESPONSE TO POTASSIUM ION,0.075049,-0.17608,-0.15479,0,0
1,GO ASYMMETRIC CELL DIVISION,0.087232,-0.17617,-0.12846,0,0
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.13814,-0.17618,-0.11294,0,0
1,GO SYNAPTIC VESICLE MATURATION,0.16828,-0.1764,-0.093779,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.076492,-0.17681,-0.20723,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.080955,-0.17689,-0.095656,0,0
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.22235,-0.17925,-0.13179,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.001228,-0.17935,-0.21067,0,0
1,GO PRO B CELL DIFFERENTIATION,0.16559,-0.18022,-0.11358,0,0
1,GO CELLULAR RESPONSE TO ATP,0.00025131,-0.18067,-0.19934,0,0
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.060602,-0.18108,-0.1872,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.049546,-0.18122,-0.19257,0,0
1,GO NEUROBLAST DIVISION,0.043763,-0.18152,-0.18867,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.22905,-0.18206,-0.12537,0,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.012203,-0.18253,-0.21175,0,0
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.22905,-0.18257,-0.10653,0,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.065563,-0.18287,-0.16766,0,0
1,GO REGULATION OF RECEPTOR BINDING,0.10845,-0.18383,-0.16401,0,0
1,GO MUSCLE CELL FATE COMMITMENT,0.087232,-0.18395,-0.14301,0,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.019283,-0.18415,-0.18029,0,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.077957,-0.1845,-0.24256,0,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.31653,-0.18466,-0.048828,0,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.20937,-0.18517,-0.11057,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.05161,-0.18634,-0.15348,0,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.010506,-0.18645,-0.2113,0,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.11636,-0.18661,-0.18753,0,0
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.15015,-0.18674,-0.12246,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.38408,-0.1869,-0.13008,0,0
1,GO LIPID DROPLET FORMATION,0.17934,-0.18748,-0.17809,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.057089,-0.18753,-0.15257,0,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.075049,-0.18838,-0.13812,0,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.014486,-0.18848,-0.29539,0,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.05824,-0.19003,-0.18185,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0047853,-0.19005,-0.15896,0,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.39858,-0.19197,-0.088318,0,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.14048,-0.19218,-0.16874,0,0
1,GO APICAL JUNCTION ASSEMBLY,0.088862,-0.19225,-0.11285,0,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.17374,-0.19233,-0.080889,0,0
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.072231,-0.19242,-0.13799,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0087944,-0.1926,-0.15487,0,0
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.061812,-0.19323,-0.16455,0,0
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.063042,-0.19341,-0.13559,0,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.070855,-0.19345,-0.14592,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0018173,-0.19462,-0.22858,0,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0013872,-0.19592,-0.17344,0,0
1,GO HEMIDESMOSOME ASSEMBLY,0.1313,-0.19597,-0.26637,0,0
1,GO REGULATION OF SYNAPSE MATURATION,0.13583,-0.1961,-0.18095,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.20937,-0.19621,-0.14181,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.066855,-0.1965,-0.22319,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.12689,-0.19907,-0.17346,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.10465,-0.19938,-0.20243,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.077957,-0.20084,-0.12268,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.031748,-0.20176,-0.15922,0,0
1,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.018398,-0.20219,-0.18895,0,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.064293,-0.20312,-0.19193,0,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0031536,-0.2039,-0.22181,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,3.5759e-05,-0.20446,-0.18754,0,0
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.19695,-0.20507,-0.059889,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.0012662,-0.2055,-0.21314,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.12049,-0.20587,-0.14538,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.0079323,-0.20639,-0.1629,0,0
1,GO SEQUESTERING OF TRIGLYCERIDE,0.036164,-0.20696,-0.25957,0,0
1,GO RENAL FILTRATION,0.092194,-0.20792,-0.22228,0,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.13814,-0.20829,-0.15486,0,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0060989,-0.20891,-0.23603,0,0
1,GO ENDOCARDIAL CUSHION FORMATION,0.073629,-0.20928,-0.1446,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.061812,-0.20965,-0.15156,0,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,3.8583e-05,-0.20968,-0.21679,0,0
1,GO MEMBRANE BIOGENESIS,0.063042,-0.20984,-0.16635,0,0
1,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.0067808,-0.2099,-0.2498,0,0
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.11636,-0.2104,-0.26602,0,0
1,GO SARCOMERE ORGANIZATION,0.0075304,-0.21042,-0.15456,0,0
1,GO MITOTIC CELL CYCLE ARREST,0.15773,-0.21119,-0.099629,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0056288,-0.21142,-0.21254,0,0
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00063551,-0.21188,-0.22938,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,1.2962e-05,-0.21244,-0.21086,0,0
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.12259,-0.21253,-0.11174,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,6.5149e-05,-0.21258,-0.23933,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.021165,-0.2131,-0.16237,0,0
1,GO TUBULIN DEACETYLATION,0.070855,-0.21404,-0.11136,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.00021909,-0.21434,-0.228,0,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.054842,-0.21553,-0.1808,0,0
1,GO SYNAPSE MATURATION,0.060602,-0.21581,-0.25838,0,0
1,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.090515,-0.21607,-0.16803,0,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.22235,-0.21659,-0.12634,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.38408,-0.21731,-0.073417,0,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.085627,-0.21788,-0.11516,0,0
1,GO CORNIFICATION,0.39371,-0.21797,-0.071219,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.063042,-0.21802,-0.19135,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0018173,-0.21901,-0.18527,0,0
1,GO ETHANOL METABOLIC PROCESS,0.079444,-0.21947,-0.17065,0,0
1,GO CELLULAR RESPONSE TO SALT STRESS,0.054842,-0.22172,-0.19174,0,0
1,GO RESPONSE TO LIGHT INTENSITY,0.00069957,-0.22203,-0.26669,0,0
1,GO POSITIVE REGULATION OF MYELINATION,3.8583e-05,-0.22282,-0.24133,0,0
1,GO LOCOMOTOR RHYTHM,0.0038387,-0.22355,-0.23503,0,0
1,GO RESPONSE TO TYPE I INTERFERON,0.11636,-0.22394,-0.22087,0,0
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.053746,-0.22591,-0.13923,0,0
1,GO CARNITINE METABOLIC PROCESS,0.053746,-0.22646,-0.14113,0,0
1,GO REGULATION OF HAIR CYCLE,0.05161,-0.22647,-0.1323,0,0
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0695,-0.22698,-0.22126,0,0
1,GO STARTLE RESPONSE,0.12689,-0.22864,-0.12172,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.27611,-0.22896,-0.14694,0,0
1,GO SKIN MORPHOGENESIS,0.13583,-0.2293,-0.17061,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.010506,-0.22944,-0.2371,0,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.11841,-0.23142,-0.14298,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,1.8521e-05,-0.23305,-0.21553,0,0
1,GO NUCLEOTIDE PHOSPHORYLATION,3.9926e-07,-0.23372,-0.23779,0,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.00047456,-0.23544,-0.25014,0,0
1,GO NADPH REGENERATION,0.007729,-0.23648,-0.21053,0,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0019282,-0.23697,-0.20639,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.16032,-0.23739,-0.15452,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.0025083,-0.23797,-0.15864,0,0
1,GO CATECHOLAMINE METABOLIC PROCESS,0.0066042,-0.23882,-0.17374,0,0
1,GO T HELPER 1 CELL DIFFERENTIATION,0.073629,-0.24115,-0.20372,0,0
1,GO GROOMING BEHAVIOR,0.079444,-0.24218,-0.1196,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010245,-0.24238,-0.24262,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.00026903,-0.24358,-0.29995,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0011199,-0.24399,-0.1995,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.00079435,-0.24564,-0.28955,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.092194,-0.2457,-0.23888,0,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.095625,-0.24617,-0.099631,0,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.072231,-0.24695,-0.21636,0,0
1,GO L SERINE METABOLIC PROCESS,0.068167,-0.2471,-0.17374,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.25363,-0.24716,-0.093138,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00040247,-0.24972,-0.23957,0,0
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.1313,-0.25011,-0.194,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.049546,-0.25229,-0.24021,0,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.055956,-0.2525,-0.14324,0,0
1,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.023205,-0.25306,-0.20168,0,0
1,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.0007696,-0.25594,-0.23513,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.0013054,-0.25623,-0.18771,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.00032948,-0.2584,-0.27314,0,0
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.010773,-0.25862,-0.36175,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.099158,-0.26005,-0.205,0,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0031536,-0.26197,-0.2979,0,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.04854,-0.26248,-0.16206,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0022332,-0.26264,-0.28327,0,0
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.10654,-0.26277,-0.19074,0,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.026586,-0.26317,-0.14861,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.0025083,-0.26398,-0.27803,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,1.2454e-05,-0.26399,-0.27363,0,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.0018173,-0.26607,-0.29202,0,0
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.077957,-0.26783,-0.25091,0,0
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,8.7323e-05,-0.26875,-0.27786,0,0
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.085627,-0.26884,-0.23879,0,0
1,GO INNERVATION,0.061812,-0.26951,-0.14091,0,0
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.092194,-0.26997,-0.25884,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.029719,-0.27116,-0.20893,0,0
1,GO CELLULAR RESPONSE TO ETHANOL,0.0018173,-0.27567,-0.24151,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.053746,-0.27713,-0.16247,0,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.01282,-0.2785,-0.23621,0,0
1,GO REGULATION OF PODOSOME ASSEMBLY,0.084046,-0.28062,-0.17428,0,0
1,GO ENAMEL MINERALIZATION,0.093897,-0.281,-0.22929,0,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.084046,-0.28185,-0.1975,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.00079435,-0.28571,-0.24659,0,0
1,GO REGULATION OF GLOMERULAR FILTRATION,0.25729,-0.28702,-0.17181,0,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0695,-0.28864,-0.19094,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.001662,-0.28886,-0.25347,0,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.26098,-0.29146,-0.14503,0,0
1,GO PLASMA MEMBRANE REPAIR,0.087232,-0.29388,-0.15435,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,-0.29769,-0.29297,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,7.547e-05,-0.29888,-0.33202,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.00024286,-0.30473,-0.24621,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.12049,-0.30728,-0.37805,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.00017186,-0.31079,-0.30657,0,0
1,GO CYTIDINE TO URIDINE EDITING,0.0695,-0.31183,-0.31916,0,0
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.073629,-0.31247,-0.16878,0,0
1,GO TRNA CATABOLIC PROCESS,0.17099,-0.31884,-0.16079,0,0
1,GO PHOSPHOLIPID EFFLUX,8.1192e-05,-0.32177,-0.359,0,0
1,GO HEPARIN METABOLIC PROCESS,0.0045306,-0.32268,-0.31719,0,0
1,GO HEART VALVE FORMATION,0.1313,-0.3274,-0.19307,0,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.10465,-0.33021,-0.12221,0,0
1,GO INFLAMMATORY RESPONSE TO WOUNDING,0.050569,-0.33214,-0.29639,0,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0029794,-0.3375,-0.25712,0,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.061812,-0.3411,-0.23441,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.14526,-0.34247,-0.43933,0,0
1,GO INTERLEUKIN 13 PRODUCTION,0.0024367,-0.34582,-0.29723,0,0
1,GO GONADOTROPIN SECRETION,0.079444,-0.34589,-0.13679,0,0
1,GO RESPONSE TO HYDROPEROXIDE,0.0085714,-0.3492,-0.26804,0,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.055956,-0.35345,-0.27315,0,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,5.753e-07,-0.3549,-0.39183,0,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.0081404,-0.35907,-0.3318,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.00017186,-0.36143,-0.35534,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,3.6228e-06,-0.37319,-0.39906,0,0
1,GO INCLUSION BODY ASSEMBLY,7.013e-05,-0.37783,-0.33161,0,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,2.5308e-05,-0.38407,-0.35113,0,0
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,2.5774e-06,-0.38697,-0.41919,0,0
1,GO NADH METABOLIC PROCESS,4.4878e-05,-0.39041,-0.33293,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.31232,-0.39209,-0.12407,0,0
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00016023,-0.395,-0.43372,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.0045306,-0.39899,-0.3211,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,3.8583e-05,-0.40898,-0.38842,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,1.2454e-05,-0.42944,-0.39411,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.0027346,-0.44057,-0.45097,0,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00014935,-0.45628,-0.48164,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,6.7728e-06,-0.46281,-0.47988,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,1.7118e-05,-0.47012,-0.40397,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.00024286,-0.48708,-0.52581,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,6.7728e-06,-0.49026,-0.54751,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,7.9801e-06,-0.59382,-0.52168,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00017796,1.4705,1.17,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,8.4205e-05,1.3173,1.0187,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00026903,0.9206,0.65971,1,1
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,5.2139e-05,0.85973,0.91274,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0021689,0.84781,0.83089,1,1
2,GO CYTIDINE TO URIDINE EDITING,0.00055855,0.82178,0.62492,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00032948,0.78837,0.56721,1,1
2,GO TOLERANCE INDUCTION,3.7145e-05,0.78315,0.66158,1,1
2,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.7323e-05,0.77401,0.75079,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.389e-05,0.75104,0.57637,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,5.8301e-05,0.73405,0.67497,1,1
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0022332,0.73387,0.57588,1,1
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1.0184e-05,0.7143,0.57837,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00074557,0.69462,0.4364,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,4.2876e-06,0.68781,0.63371,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00095906,0.68012,0.49591,1,1
2,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00016595,0.67015,0.56536,1,1
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00026003,0.66963,0.58022,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,1.5201e-05,0.66155,0.60309,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0023671,0.65899,0.39752,1,1
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.035393,0.65647,0.41211,1,1
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00090094,0.65436,0.49711,1,1
2,GO RESPONSE TO TYPE I INTERFERON,5.4121e-05,0.65391,0.60068,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,4.4878e-05,0.6448,0.46354,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00050664,0.63881,0.44696,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0015653,0.63631,0.41989,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00098941,0.63355,0.5041,1,1
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,4.6597e-05,0.62823,0.50048,1,1
2,GO TYPE B PANCREATIC CELL PROLIFERATION,8.628e-07,0.61781,0.6616,1,1
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,8.1192e-05,0.61642,0.60146,1,1
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,5.7413e-06,0.6017,0.65024,1,1
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.013139,0.59631,0.36194,1,1
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00037661,0.59546,0.40519,1,1
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,9.3916e-06,0.5953,0.65177,1,1
2,GO SEROTONIN METABOLIC PROCESS,1.0184e-05,0.5912,0.60635,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,8.6584e-06,0.59022,0.51398,1,1
2,GO DETECTION OF TEMPERATURE STIMULUS,6.5149e-05,0.58922,0.45604,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.6307e-05,0.58844,0.70451,1,1
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,9.7801e-06,0.58839,0.5575,1,1
2,GO CORTICOSTEROID HORMONE SECRETION,0.00010845,0.58326,0.43273,1,1
2,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,2.2658e-06,0.57886,0.57453,1,1
2,GO DETECTION OF OTHER ORGANISM,0.00010462,0.57735,0.48483,1,1
2,GO LIPID DROPLET FORMATION,6.0504e-05,0.57423,0.58788,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0025817,0.5738,0.38816,1,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,1.4039e-05,0.57247,0.572,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.7728e-06,0.56884,0.48687,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.0226e-05,0.56637,0.4285,1,1
2,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001191,0.56603,0.50745,1,1
2,GO IMMUNOGLOBULIN SECRETION,0.00012964,0.56546,0.41118,1,1
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0010859,0.56488,0.45657,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.9263e-05,0.56463,0.51644,1,1
2,GO HISTAMINE SECRETION,0.0033369,0.56401,0.45405,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00095906,0.5616,0.39007,1,1
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.0604e-05,0.55875,0.5284,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,7.2754e-05,0.55828,0.40464,1,1
2,GO REGULATION OF VASCULOGENESIS,3.4421e-05,0.5562,0.52103,1,1
2,GO LIVER MORPHOGENESIS,2.7343e-05,0.55591,0.49829,1,1
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00012512,0.54847,0.43742,1,1
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.9532e-05,0.54804,0.51696,1,1
2,GO GLIAL CELL FATE COMMITMENT,0.00027832,0.54798,0.49336,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0016129,0.54291,0.39401,1,1
2,GO KERATINOCYTE DEVELOPMENT,0.00074557,0.54256,0.42705,1,1
2,GO EOSINOPHIL MIGRATION,0.0013872,0.54044,0.4402,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,9.389e-05,0.53865,0.5526,1,1
2,GO EOSINOPHIL CHEMOTAXIS,0.0017123,0.53797,0.4554,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.00072223,0.53139,0.3609,1,1
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.1964e-05,0.52962,0.48278,1,1
2,GO GERMINAL CENTER FORMATION,0.0014299,0.52748,0.47133,1,1
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,2.5774e-06,0.52674,0.6417,1,1
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0017641,0.52524,0.36785,1,1
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0011199,0.52522,0.52277,1,1
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,3.3132e-05,0.52481,0.5306,1,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,6.2786e-05,0.52306,0.36706,1,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0069616,0.5218,0.38273,1,1
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0017123,0.52172,0.43962,1,1
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00012074,0.52073,0.41251,1,1
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,5.8301e-05,0.5111,0.49415,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0050528,0.50976,0.55544,1,1
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,7.547e-05,0.50882,0.5464,1,1
2,GO O GLYCAN PROCESSING,0.00074557,0.50708,0.34327,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,0.0028957,0.50656,0.38528,1,1
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00029782,0.50648,0.4666,1,1
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.00072223,0.50509,0.39518,1,1
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0031536,0.50342,0.47591,1,1
2,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00021909,0.50141,0.52289,1,1
2,GO N GLYCAN PROCESSING,4.6623e-06,0.50059,0.47923,1,1
2,GO REGULATION OF PLATELET AGGREGATION,3.5759e-05,0.49994,0.4489,1,1
2,GO RESPONSE TO WATER,8.1192e-05,0.49941,0.42887,1,1
2,GO REGULATION OF RECEPTOR CLUSTERING,8.7323e-05,0.49909,0.46487,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00050664,0.49695,0.33042,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0045306,0.49589,0.33594,1,1
2,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.00012074,0.49531,0.50104,1,1
2,GO HISTAMINE TRANSPORT,0.0017123,0.4927,0.41872,1,1
2,GO REGULATORY T CELL DIFFERENTIATION,1.1267e-06,0.4917,0.48034,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,2.6902e-06,0.48967,0.45762,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0015653,0.48762,0.42928,1,1
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,4.6597e-05,0.48716,0.40076,1,1
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00063551,0.48588,0.44111,1,1
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,0.48396,0.35797,1,1
2,GO LIPOXYGENASE PATHWAY,0.00055855,0.48291,0.41117,1,1
2,GO REFLEX,0.0062634,0.48269,0.43445,1,1
2,GO DNA DEAMINATION,0.0097392,0.4824,0.31613,1,1
2,GO RESPONSE TO MUSCLE STRETCH,0.004408,0.48048,0.33436,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014418,0.47967,0.40374,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.4039e-05,0.47952,0.49599,1,1
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,3.1888e-05,0.47789,0.41491,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0022992,0.47606,0.32649,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0006154,0.4757,0.30777,1,1
2,GO PROSTATE GLAND MORPHOGENESIS,0.0090226,0.47519,0.33852,1,1
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,8.7323e-05,0.4712,0.45029,1,1
2,GO LUNG CELL DIFFERENTIATION,0.00012074,0.471,0.5018,1,1
2,GO REGULATION OF TRANSPOSITION,0.00052342,0.46589,0.37105,1,1
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00014418,0.46555,0.45466,1,1
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,3.8583e-05,0.46542,0.43374,1,1
2,GO T CELL MEDIATED IMMUNITY,0.00035231,0.46362,0.29606,1,1
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.00030804,0.46361,0.3358,1,1
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0090226,0.46329,0.32236,1,1
2,GO SYNAPSE MATURATION,0.00041602,0.46258,0.48323,1,1
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0022332,0.46216,0.39096,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0015653,0.46157,0.4813,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00019079,0.46141,0.39586,1,1
2,GO ENDOTHELIAL CELL CHEMOTAXIS,1.2454e-05,0.46048,0.44633,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0011199,0.46035,0.38469,1,1
2,GO RESPONSE TO INTERLEUKIN 18,0.0041716,0.46017,0.34641,1,1
2,GO MITOCHONDRIAL DEPOLARIZATION,0.00036427,0.45577,0.31599,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00026903,0.45403,0.42756,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.00072223,0.45299,0.41288,1,1
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,1.2454e-05,0.45188,0.41621,1,1
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,8.1192e-05,0.45171,0.31226,1,1
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.0012662,0.45098,0.3695,1,1
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.00095906,0.44926,0.39102,1,1
2,GO MYELIN MAINTENANCE,6.2367e-06,0.44886,0.45633,1,1
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0012662,0.44872,0.36669,1,1
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,4.1617e-05,0.44788,0.40945,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.01282,0.44746,0.31903,1,1
2,GO EPITHELIAL CELL MORPHOGENESIS,0.00030804,0.44739,0.4123,1,1
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,1.7118e-05,0.44678,0.37012,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0067808,0.44677,0.23859,1,1
2,GO MICROVILLUS ASSEMBLY,0.0011549,0.44592,0.37962,1,1
2,GO NEURONAL ION CHANNEL CLUSTERING,0.00017796,0.44495,0.45732,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0013872,0.44474,0.26376,1,1
2,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00090094,0.44457,0.45494,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00020448,0.44411,0.44191,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0007696,0.44321,0.41829,1,1
2,GO RESPONSE TO COLD,1.8521e-05,0.4426,0.38122,1,1
2,GO RESPONSE TO PAIN,0.0017123,0.44201,0.28913,1,1
2,GO GLIAL CELL APOPTOTIC PROCESS,0.00079435,0.44183,0.44899,1,1
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00022676,0.4413,0.37198,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00028792,0.44097,0.31138,1,1
2,GO MYOBLAST FUSION,0.00019753,0.43896,0.33289,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00036427,0.43886,0.27495,1,1
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.03245,0.43868,0.30757,1,1
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00092958,0.43627,0.30281,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00010462,0.43602,0.33867,1,1
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.0049174,0.43544,0.27156,1,1
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.7145e-05,0.4344,0.41149,1,1
2,GO TRANSPOSITION,7.013e-05,0.43392,0.39051,1,1
2,GO MINERALOCORTICOID METABOLIC PROCESS,0.011047,0.43358,0.33801,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.4878e-05,0.43325,0.40592,1,1
2,GO STEROID HORMONE SECRETION,0.00011241,0.43318,0.35223,1,1
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00040247,0.43136,0.30683,1,1
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,3.8583e-05,0.4295,0.35907,1,1
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,9.0179e-06,0.42898,0.52616,1,1
2,GO REGULATION OF EXOSOMAL SECRETION,0.0001547,0.42821,0.29734,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00030804,0.4266,0.36579,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0022992,0.42564,0.32049,1,1
2,GO ZYMOGEN ACTIVATION,0.00044439,0.42489,0.37464,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.9263e-05,0.42449,0.38888,1,1
2,GO REGULATION OF GLIAL CELL PROLIFERATION,2.0033e-05,0.42435,0.36588,1,1
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00065623,0.42349,0.4085,1,1
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0045306,0.42289,0.30769,1,1
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.00027832,0.42232,0.41997,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0042883,0.42215,0.26423,1,1
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00040247,0.42212,0.43602,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0021689,0.42139,0.37792,1,1
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0064317,0.42028,0.29,1,1
2,GO SIALYLATION,0.0015653,0.41957,0.31781,1,1
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.021165,0.41952,0.41683,1,1
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,1.2962e-05,0.41899,0.45396,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.013798,0.41874,0.27741,1,1
2,GO CAMP BIOSYNTHETIC PROCESS,2.6307e-05,0.41758,0.39945,1,1
2,GO CELLULAR DEFENSE RESPONSE,0.0031536,0.41631,0.23474,1,1
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,7.8282e-05,0.41601,0.4084,1,1
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00092958,0.41586,0.39684,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00011241,0.41575,0.3851,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00030804,0.41481,0.27609,1,1
2,GO FUCOSE METABOLIC PROCESS,0.00016023,0.41471,0.3092,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,7.2754e-05,0.41455,0.48196,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00028792,0.41361,0.42896,1,1
2,GO REGULATION OF MYOBLAST FUSION,0.0073363,0.41356,0.2911,1,1
2,GO REGULATION OF PLATELET ACTIVATION,7.2754e-05,0.4132,0.36905,1,1
2,GO REGULATION OF WATER LOSS VIA SKIN,0.00047456,0.4131,0.38867,1,1
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,5.2837e-06,0.41288,0.35073,1,1
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.0087944,0.41254,0.39114,1,1
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0028957,0.41241,0.28244,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00019753,0.40983,0.33835,1,1
2,GO MYELIN ASSEMBLY,0.00026003,0.40967,0.33067,1,1
2,GO LUNG EPITHELIUM DEVELOPMENT,2.9532e-05,0.40925,0.38996,1,1
2,GO RESPONSE TO DIETARY EXCESS,0.00017186,0.40908,0.41308,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00024286,0.40906,0.27366,1,1
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,7.547e-05,0.40891,0.32494,1,1
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,7.547e-05,0.40878,0.34322,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00059588,0.40766,0.29233,1,1
2,GO POSITIVE REGULATION OF WOUND HEALING,1.9263e-05,0.40622,0.39025,1,1
2,GO PROTEIN O LINKED GLYCOSYLATION,0.00037661,0.40593,0.25096,1,1
2,GO LUNG ALVEOLUS DEVELOPMENT,3.4728e-06,0.40589,0.37282,1,1
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,3.8583e-05,0.40557,0.34287,1,1
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0030654,0.40511,0.26942,1,1
2,GO REGULATION OF BONE REMODELING,9.7346e-05,0.40482,0.31747,1,1
2,GO GLIAL CELL PROLIFERATION,0.00038934,0.40442,0.27907,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0064317,0.40396,0.31311,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00022676,0.4039,0.31411,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.00012512,0.40359,0.39105,1,1
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.001191,0.40106,0.3758,1,1
2,GO RESPONSE TO AUDITORY STIMULUS,2.8418e-05,0.40039,0.42082,1,1
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00019753,0.40039,0.39171,1,1
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0006154,0.40012,0.33284,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.001986,0.39962,0.31609,1,1
2,GO CERAMIDE CATABOLIC PROCESS,0.0081404,0.39926,0.24616,1,1
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0012662,0.39915,0.37058,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0042883,0.39895,0.27908,1,1
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,1.4039e-05,0.39864,0.35101,1,1
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.4121e-05,0.39859,0.45841,1,1
2,GO MAGNESIUM ION TRANSPORT,0.00010092,0.39815,0.29342,1,1
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.001986,0.39804,0.39507,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.1904e-06,0.39744,0.50954,1,1
2,GO PROTEIN KINASE C SIGNALING,0.00013433,0.39736,0.35171,1,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,5.508e-06,0.3969,0.42055,1,1
2,GO STEROID ESTERIFICATION,0.00049035,0.39682,0.42797,1,1
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0054795,0.39459,0.25544,1,1
2,GO VIRAL GENOME REPLICATION,0.0026572,0.39392,0.25109,1,1
2,GO RELAXATION OF CARDIAC MUSCLE,0.0053338,0.39385,0.31638,1,1
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,2.6307e-05,0.39289,0.45814,1,1
2,GO NERVE DEVELOPMENT,3.1904e-06,0.39288,0.36064,1,1
2,GO AMYLOID FIBRIL FORMATION,0.0022332,0.39251,0.30383,1,1
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00045924,0.3925,0.34827,1,1
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,7.2754e-05,0.39235,0.4714,1,1
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012662,0.39135,0.34592,1,1
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00059588,0.39108,0.41953,1,1
2,GO NEGATIVE REGULATION OF LIPID STORAGE,2.0033e-05,0.3908,0.34295,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,7.6603e-06,0.39036,0.40141,1,1
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.00031859,0.3903,0.33778,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.023205,0.38998,0.2814,1,1
2,GO ALPHA BETA T CELL PROLIFERATION,0.0001165,0.38925,0.34348,1,1
2,GO VASCULAR WOUND HEALING,2.7343e-05,0.38848,0.46922,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.4421e-05,0.38827,0.31829,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.0021689,0.38803,0.34698,1,1
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0022992,0.38755,0.3689,1,1
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00014935,0.38748,0.39814,1,1
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00084609,0.38743,0.27421,1,1
2,GO DENDRITIC CELL DIFFERENTIATION,5.2139e-05,0.38693,0.37731,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,6.2786e-05,0.38668,0.37158,1,1
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00035231,0.38658,0.32987,1,1
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.2139e-05,0.38574,0.38658,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,6.7728e-06,0.38551,0.32446,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.018398,0.38543,0.26822,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.00038934,0.38528,0.29925,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00040247,0.38474,0.39884,1,1
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00049035,0.3847,0.34225,1,1
2,GO SMOOTH MUSCLE CELL MIGRATION,7.8282e-05,0.38462,0.33328,1,1
2,GO REGULATION OF TISSUE REMODELING,0.00017796,0.38448,0.28397,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,8.7323e-05,0.38431,0.31075,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00084609,0.38428,0.42754,1,1
2,GO DEFENSE RESPONSE TO VIRUS,0.0010528,0.3841,0.26066,1,1
2,GO GLAND MORPHOGENESIS,0.00013917,0.38335,0.32344,1,1
2,GO COCHLEA MORPHOGENESIS,0.0075304,0.3825,0.23959,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00026903,0.38244,0.26347,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.001191,0.38211,0.33651,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,2.0833e-05,0.382,0.35925,1,1
2,GO BONE RESORPTION,0.00054072,0.38143,0.25884,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00014418,0.38134,0.31262,1,1
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00021909,0.38126,0.32799,1,1
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0056288,0.38109,0.27557,1,1
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.1267e-06,0.38093,0.35498,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,5.0226e-05,0.37983,0.32228,1,1
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00065623,0.37975,0.28853,1,1
2,GO OLIGODENDROCYTE DEVELOPMENT,2.9301e-06,0.37887,0.32083,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,4.1617e-05,0.37837,0.35225,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.038561,0.37736,0.32114,1,1
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.017549,0.37709,0.52276,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,4.1617e-05,0.37684,0.30152,1,1
2,GO ESTROUS CYCLE,7.547e-05,0.37674,0.36999,1,1
2,GO B CELL APOPTOTIC PROCESS,0.0013054,0.3767,0.35004,1,1
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0039469,0.37666,0.32425,1,1
2,GO VOCALIZATION BEHAVIOR,0.0094949,0.37636,0.4099,1,1
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00035231,0.37608,0.30297,1,1
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.00067758,0.37596,0.42544,1,1
2,GO BRONCHUS DEVELOPMENT,0.0017641,0.37562,0.40139,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.0073e-05,0.37531,0.36127,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,6.2367e-06,0.37519,0.402,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,1.7806e-05,0.37481,0.32147,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00030804,0.37478,0.28367,1,1
2,GO EPITHELIAL CELL MATURATION,0.00010092,0.3744,0.37058,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.014841,0.37429,0.24854,1,1
2,GO CELLULAR RESPONSE TO COPPER ION,0.027803,0.37356,0.27108,1,1
2,GO LIPID DROPLET ORGANIZATION,1.104e-05,0.37349,0.34697,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.7343e-05,0.37334,0.35427,1,1
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00055855,0.37306,0.29438,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00021167,0.37291,0.44189,1,1
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0090226,0.37249,0.28847,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.031748,0.37205,0.21529,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0019282,0.37194,0.32606,1,1
2,GO TOXIN METABOLIC PROCESS,0.00090094,0.37189,0.34614,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.011047,0.37185,0.28572,1,1
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00079435,0.37184,0.37603,1,1
2,GO ASTROCYTE ACTIVATION,1.9263e-05,0.37182,0.37734,1,1
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.00017186,0.37165,0.37331,1,1
2,GO ASYMMETRIC CELL DIVISION,0.0038387,0.3715,0.26998,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00020448,0.37109,0.35703,1,1
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0010206,0.37075,0.38093,1,1
2,GO RENAL FILTRATION,0.011612,0.37062,0.33934,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00019079,0.37039,0.23697,1,1
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00023468,0.37021,0.28396,1,1
2,GO GALACTOSE METABOLIC PROCESS,0.0075304,0.36957,0.25916,1,1
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00028792,0.36918,0.29255,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.02068,0.36904,0.34142,1,1
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00037661,0.3688,0.27643,1,1
2,GO TONGUE DEVELOPMENT,0.031059,0.36861,0.2587,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00013433,0.36853,0.23759,1,1
2,GO REGULATION OF AMINO ACID TRANSPORT,0.00028792,0.36844,0.29059,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.00072223,0.36807,0.31695,1,1
2,GO OSTEOBLAST PROLIFERATION,2.6307e-05,0.36775,0.36192,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.4039e-05,0.36751,0.29313,1,1
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.018398,0.36749,0.26156,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.8418e-05,0.36693,0.3091,1,1
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.004408,0.36647,0.39811,1,1
2,GO CRANIAL NERVE DEVELOPMENT,5.508e-06,0.36617,0.34017,1,1
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.024288,0.36542,0.31032,1,1
2,GO OPTIC NERVE DEVELOPMENT,0.00090094,0.36464,0.37739,1,1
2,GO MESENCHYMAL CELL PROLIFERATION,0.0010206,0.36464,0.28377,1,1
2,GO VITAMIN D METABOLIC PROCESS,0.00054072,0.36423,0.30286,1,1
2,GO GLYCINE TRANSPORT,0.025414,0.3641,0.27049,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0010859,0.36368,0.26999,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.03939,0.36358,0.27892,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.018398,0.36182,0.25694,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0081404,0.36086,0.2717,1,1
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00022676,0.36048,0.31906,1,1
2,GO VASODILATION,0.00353,0.3604,0.24819,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0036303,0.36032,0.26472,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0099891,0.36005,0.3421,1,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,3.7791e-06,0.35932,0.3477,1,1
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00010462,0.35887,0.3106,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00040247,0.35876,0.2549,1,1
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00010845,0.3586,0.30849,1,1
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.012203,0.35831,0.28826,1,1
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0019282,0.3583,0.3037,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.001228,0.35803,0.28651,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00095906,0.35717,0.29763,1,1
2,GO RESPONSE TO THYROID HORMONE,0.0019282,0.35641,0.31157,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.042857,0.3563,0.2328,1,1
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0001165,0.35614,0.27993,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00010092,0.35606,0.36233,1,1
2,GO RESPONSE TO COPPER ION,0.0028141,0.35584,0.29646,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00017796,0.35571,0.27646,1,1
2,GO B CELL MEDIATED IMMUNITY,0.00021909,0.35547,0.33139,1,1
2,GO ACUTE INFLAMMATORY RESPONSE,1.4609e-05,0.35545,0.33507,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00067758,0.35516,0.22197,1,1
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0023671,0.35488,0.26507,1,1
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0071468,0.35479,0.25628,1,1
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0021062,0.35475,0.26796,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00035231,0.3546,0.22712,1,1
2,GO RETINAL ROD CELL DIFFERENTIATION,0.011612,0.35441,0.2695,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00092958,0.35398,0.32496,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,5.8301e-05,0.35358,0.27885,1,1
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,7.547e-05,0.35355,0.30694,1,1
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00040247,0.35335,0.32665,1,1
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00016023,0.35311,0.28733,1,1
2,GO ENDOCARDIUM DEVELOPMENT,9.7346e-05,0.35277,0.38677,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0090226,0.35274,0.2656,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.00013917,0.3525,0.28426,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00017186,0.35237,0.28745,1,1
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.7118e-05,0.35217,0.34147,1,1
2,GO AMMONIUM TRANSPORT,0.00010845,0.35196,0.33547,1,1
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00072223,0.3518,0.30341,1,1
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.00022676,0.35176,0.25343,1,1
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00028792,0.35142,0.46759,1,1
2,GO REGULATION OF VIRAL LIFE CYCLE,0.0090226,0.35083,0.24112,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.0226e-05,0.35082,0.27503,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00028792,0.35076,0.3317,1,1
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00079435,0.35074,0.24693,1,1
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0011549,0.3507,0.28244,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.5816e-05,0.3506,0.27944,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0031536,0.35049,0.28526,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0010528,0.35027,0.2992,1,1
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0012662,0.35021,0.26219,1,1
2,GO AMINE BIOSYNTHETIC PROCESS,0.00055855,0.35006,0.31487,1,1
2,GO FOAM CELL DIFFERENTIATION,0.00017186,0.34981,0.35755,1,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,1.1493e-05,0.34961,0.33545,1,1
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00084609,0.34945,0.27844,1,1
2,GO ENDOTHELIAL CELL DEVELOPMENT,2.7343e-05,0.34933,0.2798,1,1
2,GO GAMMA DELTA T CELL ACTIVATION,0.00035231,0.34931,0.36663,1,1
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0046564,0.34907,0.27653,1,1
2,GO CELLULAR RESPONSE TO NUTRIENT,0.00045924,0.34818,0.30055,1,1
2,GO REGULATION OF FAT CELL DIFFERENTIATION,8.628e-07,0.34817,0.31214,1,1
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00021909,0.34815,0.27545,1,1
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,7.5427e-07,0.34807,0.33252,1,1
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0021062,0.34807,0.21304,1,1
2,GO SYNCYTIUM FORMATION,0.00032948,0.34746,0.25646,1,1
2,GO T CELL CYTOKINE PRODUCTION,0.00047456,0.34742,0.22882,1,1
2,GO GABAERGIC NEURON DIFFERENTIATION,0.0050528,0.34738,0.46185,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00042998,0.34731,0.25587,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00042998,0.3473,0.31289,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.012203,0.34687,0.28805,1,1
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00027832,0.3465,0.3173,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0001165,0.34588,0.30944,1,1
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,3.8583e-05,0.34514,0.30951,1,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00023468,0.34409,0.28293,1,1
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.001228,0.3439,0.26129,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00072223,0.3438,0.29632,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.011326,0.34369,0.43345,1,1
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00098941,0.3431,0.35387,1,1
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0025817,0.34307,0.40714,1,1
2,GO LUNG MORPHOGENESIS,0.0028957,0.34264,0.22718,1,1
2,GO MAST CELL MEDIATED IMMUNITY,4.6597e-05,0.34231,0.30693,1,1
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00028792,0.3418,0.34329,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00032948,0.34169,0.27337,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.5759e-05,0.34156,0.39365,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,2.0033e-05,0.34134,0.28454,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0051916,0.34116,0.25457,1,1
2,GO PLASMINOGEN ACTIVATION,0.043763,0.34098,0.22933,1,1
2,GO MEMBRANE BIOGENESIS,0.00065623,0.34075,0.2782,1,1
2,GO MICROVILLUS ORGANIZATION,0.010245,0.33954,0.24374,1,1
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.0021689,0.3395,0.33896,1,1
2,GO ENDOTHELIUM DEVELOPMENT,3.0576e-06,0.33937,0.29298,1,1
2,GO SEQUESTERING OF ACTIN MONOMERS,0.00036427,0.33934,0.42919,1,1
2,GO CELL MIGRATION IN HINDBRAIN,0.00032948,0.33929,0.37399,1,1
2,GO MAST CELL ACTIVATION,1.104e-05,0.33885,0.30707,1,1
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00010092,0.33883,0.34835,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00095906,0.33874,0.27946,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00027832,0.33866,0.25581,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.014841,0.33845,0.26032,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,6.5149e-05,0.33828,0.28594,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0013872,0.33813,0.27838,1,1
2,GO RESPONSE TO INTERLEUKIN 2,0.00021167,0.33808,0.28073,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00037661,0.33742,0.26608,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0075304,0.33742,0.28368,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00034072,0.33721,0.21341,1,1
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0015653,0.33701,0.26453,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.0015653,0.33625,0.28619,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0013054,0.33603,0.29619,1,1
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,5.0226e-05,0.3359,0.28261,1,1
2,GO REGULATION OF B CELL ACTIVATION,3.7145e-05,0.33582,0.2666,1,1
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0064317,0.33569,0.2094,1,1
2,GO PROTEIN DEMANNOSYLATION,0.00042998,0.33557,0.2624,1,1
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0050528,0.33449,0.35865,1,1
2,GO FAT CELL DIFFERENTIATION,5.4977e-07,0.33447,0.28818,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0030654,0.33433,0.24687,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00020448,0.33433,0.29246,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.00098941,0.33423,0.31995,1,1
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00013433,0.33415,0.30198,1,1
2,GO GLIAL CELL DEVELOPMENT,3.4728e-06,0.33396,0.29701,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,6.2786e-05,0.33381,0.2772,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.00087311,0.33361,0.36309,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,7.8282e-05,0.33353,0.28174,1,1
2,GO LIPID TRANSLOCATION,2.8077e-06,0.33301,0.33719,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0015189,0.33282,0.30755,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00035231,0.33209,0.27396,1,1
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.015953,0.33172,0.15412,1,1
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0001165,0.33118,0.27748,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0021689,0.33114,0.28186,1,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.0020453,0.33085,0.30405,1,1
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0042883,0.33063,0.28297,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,9.7346e-05,0.33062,0.29018,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0090226,0.33054,0.20432,1,1
2,GO REGULATION OF ANOIKIS,0.00063551,0.33001,0.39069,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION,8.6584e-06,0.32978,0.27609,1,1
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.03245,0.32966,0.21536,1,1
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,6.7596e-05,0.32947,0.31583,1,1
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00011241,0.3294,0.2977,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0083534,0.32912,0.21827,1,1
2,GO REGULATION OF ENDOCRINE PROCESS,6.2367e-06,0.32865,0.29387,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0017641,0.32863,0.23712,1,1
2,GO PREPULSE INHIBITION,0.0085714,0.32819,0.36803,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.013798,0.32806,0.26052,1,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.00036427,0.32805,0.31201,1,1
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00025131,0.32802,0.31624,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00014935,0.32787,0.23997,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00047456,0.32771,0.28885,1,1
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00057693,0.32686,0.26736,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.5201e-05,0.32663,0.29744,1,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.017969,0.32631,0.17349,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00074557,0.32629,0.21199,1,1
2,GO MALE SEX DETERMINATION,0.0059384,0.32626,0.2741,1,1
2,GO REGULATION OF POSITIVE CHEMOTAXIS,4.4878e-05,0.32581,0.33067,1,1
2,GO GANGLION DEVELOPMENT,0.013139,0.32571,0.35929,1,1
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,5.6174e-05,0.32562,0.37021,1,1
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.00014418,0.32536,0.32793,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.00019079,0.32501,0.32564,1,1
2,GO BROWN FAT CELL DIFFERENTIATION,6.7728e-06,0.32498,0.33048,1,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00019753,0.3249,0.34851,1,1
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,3.4421e-05,0.32482,0.29338,1,1
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,3.6228e-06,0.32433,0.29785,1,1
2,GO BONE REMODELING,0.00013917,0.32424,0.29115,1,1
2,GO POSITIVE REGULATION OF OSSIFICATION,4.6597e-05,0.32416,0.32869,1,1
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00054072,0.32414,0.37937,1,1
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.025414,0.32404,0.22518,1,1
2,GO CELLULAR RESPONSE TO VITAMIN,0.0042883,0.32399,0.29312,1,1
2,GO EPOXYGENASE P450 PATHWAY,0.0060989,0.32398,0.30631,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.004408,0.32324,0.29158,1,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00014418,0.3225,0.27968,1,1
2,GO IMMUNOLOGICAL MEMORY PROCESS,8.1192e-05,0.32246,0.35239,1,1
2,GO REGULATION OF CELL MATRIX ADHESION,2.7343e-05,0.32238,0.29232,1,1
2,GO ENGULFMENT OF APOPTOTIC CELL,6.5149e-05,0.32224,0.32822,1,1
2,GO REGULATION OF ORGANIC ACID TRANSPORT,3.7145e-05,0.32223,0.27576,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.0081404,0.3222,0.24621,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00027832,0.32202,0.32585,1,1
2,GO NEURON CELL CELL ADHESION,0.0054795,0.32178,0.44689,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0018173,0.32155,0.1839,1,1
2,GO REGULATION OF SODIUM ION TRANSPORT,1.2454e-05,0.32148,0.27754,1,1
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.00092958,0.32141,0.36063,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00019079,0.32141,0.28946,1,1
2,GO POSITIVE REGULATION OF CHEMOTAXIS,4.6623e-06,0.32082,0.28893,1,1
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0026572,0.32065,0.27952,1,1
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0050528,0.3206,0.20565,1,1
2,GO SECONDARY PALATE DEVELOPMENT,1.104e-05,0.32037,0.36518,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,4.0073e-05,0.32021,0.28211,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00055855,0.31993,0.30008,1,1
2,GO POSITIVE REGULATION OF CILIUM MOVEMENT,8.1192e-05,0.31943,0.29909,1,1
2,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.00036427,0.31903,0.24952,1,1
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.8379e-05,0.31868,0.36006,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.014486,0.31823,0.36762,1,1
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0071468,0.31787,0.34107,1,1
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0038387,0.31779,0.35504,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.8379e-05,0.31759,0.27949,1,1
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.00049035,0.3174,0.43113,1,1
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00010092,0.31732,0.23275,1,1
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.001191,0.31721,0.2604,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,3.4421e-05,0.31719,0.30614,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00012074,0.31709,0.22533,1,1
2,GO REGULATION OF AMYLOID BETA FORMATION,0.00031859,0.31668,0.33012,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00013433,0.31653,0.2619,1,1
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0049174,0.31647,0.23002,1,1
2,GO ASTROCYTE DEVELOPMENT,0.00098941,0.31645,0.28293,1,1
2,GO TISSUE REMODELING,0.00024286,0.31632,0.25785,1,1
2,GO RESPONSE TO LITHIUM ION,0.00072223,0.31624,0.34386,1,1
2,GO EPITHELIAL CELL DEVELOPMENT,5.2837e-06,0.31623,0.26327,1,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00027832,0.3159,0.29704,1,1
2,GO PRO B CELL DIFFERENTIATION,0.0064317,0.31546,0.24538,1,1
2,GO REGULATION OF CELL KILLING,0.0006154,0.3154,0.24358,1,1
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0011549,0.31538,0.3619,1,1
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0020453,0.31535,0.30004,1,1
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0049174,0.31507,0.22391,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00095906,0.31492,0.20738,1,1
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.027803,0.31489,0.25546,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,3.8583e-05,0.31476,0.2661,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0045306,0.31459,0.20263,1,1
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00017796,0.31449,0.33717,1,1
2,GO ENERGY HOMEOSTASIS,2.8418e-05,0.31427,0.3083,1,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0021689,0.31413,0.26683,1,1
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00052342,0.31411,0.28369,1,1
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00023468,0.31355,0.28394,1,1
2,GO AMYLOID BETA FORMATION,0.00010845,0.3134,0.31247,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,3.1888e-05,0.31302,0.25448,1,1
2,GO DIGESTIVE SYSTEM DEVELOPMENT,1.1493e-05,0.31254,0.25724,1,1
2,GO RESPIRATORY SYSTEM DEVELOPMENT,4.6597e-05,0.31242,0.24878,1,1
2,GO AMYLOID BETA METABOLIC PROCESS,0.00014935,0.31236,0.26926,1,1
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,6.0198e-07,0.31227,0.31109,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.0184e-05,0.31206,0.26853,1,1
2,GO CELLULAR RESPONSE TO VITAMIN D,0.015203,0.31203,0.25275,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.00098941,0.31195,0.25431,1,1
2,GO RESPONSE TO VIRUS,0.0012662,0.31192,0.21354,1,1
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0038387,0.31187,0.23825,1,1
2,GO MECHANORECEPTOR DIFFERENTIATION,1.4039e-05,0.31181,0.25366,1,1
2,GO AMMONIUM ION METABOLIC PROCESS,0.00074557,0.31178,0.28887,1,1
2,GO APICAL JUNCTION ASSEMBLY,4.3218e-05,0.31176,0.30491,1,1
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0073363,0.31167,0.21532,1,1
2,GO INTERLEUKIN 10 PRODUCTION,9.0551e-05,0.31163,0.26943,1,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.025994,0.31141,0.19917,1,1
2,GO RESPONSE TO UV B,0.019283,0.31138,0.19544,1,1
2,GO REGULATION OF CARDIAC CONDUCTION,1.5201e-05,0.31135,0.27987,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0023671,0.31113,0.27181,1,1
2,GO ADRENAL GLAND DEVELOPMENT,9.389e-05,0.31078,0.37422,1,1
2,GO POLYSACCHARIDE METABOLIC PROCESS,1.0779e-06,0.31054,0.27246,1,1
2,GO SUPEROXIDE ANION GENERATION,0.00054072,0.31039,0.30314,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00028792,0.31027,0.22676,1,1
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.8301e-05,0.31007,0.29373,1,1
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,4.4878e-05,0.30996,0.31337,1,1
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.00014418,0.3096,0.3117,1,1
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,4.8379e-05,0.3096,0.32135,1,1
2,GO REGULATION OF GTP BINDING,0.023741,0.3094,0.2202,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00059588,0.30891,0.21807,1,1
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001986,0.30854,0.36681,1,1
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00011241,0.30853,0.4003,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0022332,0.30822,0.18367,1,1
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,6.2985e-07,0.30805,0.30656,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011326,0.30796,0.2346,1,1
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,2.6902e-06,0.30783,0.28055,1,1
2,GO INTERFERON BETA PRODUCTION,0.0011199,0.30783,0.21861,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0047853,0.30761,0.2685,1,1
2,GO LIPID STORAGE,3.5759e-05,0.30741,0.25138,1,1
2,GO RESPONSE TO PROTOZOAN,0.0047853,0.30731,0.23837,1,1
2,GO MIDGUT DEVELOPMENT,0.0026572,0.30715,0.33287,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016129,0.30659,0.1856,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.02166,0.30599,0.2765,1,1
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00044439,0.30596,0.25981,1,1
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00032948,0.30589,0.24199,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0028141,0.30588,0.29872,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00049035,0.30579,0.23671,1,1
2,GO NEPHRON MORPHOGENESIS,0.00017796,0.30562,0.22524,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00022676,0.30545,0.22667,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.0057817,0.30527,0.17571,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.0087944,0.30521,0.19113,1,1
2,GO KERATINOCYTE PROLIFERATION,0.018398,0.30475,0.18336,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00021909,0.30455,0.22213,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0028141,0.30432,0.21951,1,1
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0013457,0.30426,0.24847,1,1
2,GO SPINAL CORD PATTERNING,0.0049174,0.30404,0.29941,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00031859,0.30395,0.32678,1,1
2,GO DEVELOPMENTAL INDUCTION,7.9801e-06,0.30388,0.28868,1,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0001165,0.30354,0.23728,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00016023,0.30352,0.2417,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00037661,0.30335,0.30062,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00016595,0.30334,0.29489,1,1
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.0184e-05,0.30331,0.27788,1,1
2,GO REGULATION OF COAGULATION,0.0047853,0.30309,0.21791,1,1
2,GO MEMBRANE LIPID METABOLIC PROCESS,7.547e-05,0.30295,0.21742,1,1
2,GO REGULATION OF CELL CELL ADHESION,1.0184e-05,0.30238,0.25314,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0045306,0.30211,0.26826,1,1
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00012964,0.30211,0.24604,1,1
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.0033e-05,0.30203,0.26763,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0028141,0.30165,0.23392,1,1
2,GO REGULATION OF ODONTOGENESIS,0.0021062,0.30103,0.32689,1,1
2,GO SKIN EPIDERMIS DEVELOPMENT,0.00095906,0.30088,0.18485,1,1
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00032948,0.30078,0.27143,1,1
2,GO MACROPHAGE DIFFERENTIATION,7.2754e-05,0.30058,0.23987,1,1
2,GO B CELL PROLIFERATION,0.00065623,0.30054,0.22775,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,0.00012964,0.30053,0.28452,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00022676,0.30045,0.44657,1,1
2,GO EPITHELIAL CELL PROLIFERATION,2.7343e-05,0.30007,0.24526,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0011549,0.3,0.3264,1,1
2,GO ADIPOSE TISSUE DEVELOPMENT,3.9418e-06,0.29983,0.2856,1,1
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.4205e-05,0.29971,0.31019,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.007729,0.29967,0.2531,1,1
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00063551,0.29952,0.20086,1,1
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.29945,0.25123,1,1
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00013917,0.29903,0.29141,1,1
2,GO MYOTUBE DIFFERENTIATION,2.6307e-05,0.29893,0.23907,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.03245,0.29874,0.26619,1,1
2,GO REGULATION OF WOUND HEALING,0.00090094,0.29818,0.24381,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.02843,0.29798,0.17226,1,1
2,GO RENAL TUBULE DEVELOPMENT,0.00028792,0.29778,0.221,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.00050664,0.2975,0.27758,1,1
2,GO POSITIVE REGULATION OF GLIOGENESIS,1.9263e-05,0.29713,0.25804,1,1
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0017641,0.29692,0.36016,1,1
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.29637,0.23992,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,6.0504e-05,0.29608,0.31801,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0011199,0.29603,0.19634,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0028141,0.29562,0.19076,1,1
2,GO CHEMOKINE PRODUCTION,8.7323e-05,0.29549,0.2751,1,1
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.015953,0.29539,0.26865,1,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,7.547e-05,0.29537,0.21057,1,1
2,GO MUSCLE CELL MIGRATION,0.00025131,0.2953,0.28039,1,1
2,GO KETONE CATABOLIC PROCESS,0.012508,0.29524,0.29768,1,1
2,GO POSTSYNAPSE ASSEMBLY,0.038561,0.29501,0.28106,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0087944,0.29489,0.26386,1,1
2,GO INNATE IMMUNE RESPONSE,0.00055855,0.29469,0.20493,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.00081984,0.29439,0.28415,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.547e-05,0.29427,0.2579,1,1
2,GO RESPONSE TO MECHANICAL STIMULUS,4.8612e-06,0.29414,0.27329,1,1
2,GO RESPONSE TO AXON INJURY,0.00052342,0.29412,0.23164,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.009256,0.29407,0.24078,1,1
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0025083,0.29383,0.3444,1,1
2,GO OLIGODENDROCYTE DIFFERENTIATION,3.3287e-06,0.29362,0.28725,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.043763,0.29359,0.15857,1,1
2,GO MEMBRANE DEPOLARIZATION,0.00044439,0.2932,0.25747,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00021909,0.29309,0.26494,1,1
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00010092,0.29294,0.25681,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00023468,0.29292,0.24593,1,1
2,GO PROTEIN TARGETING TO LYSOSOME,0.010245,0.29289,0.23853,1,1
2,GO SKELETAL MUSCLE ADAPTATION,3.5759e-05,0.29268,0.30588,1,1
2,GO RESPONSE TO AMPHETAMINE,0.0010859,0.29257,0.27096,1,1
2,GO SPHINGOID METABOLIC PROCESS,0.00047456,0.29242,0.25638,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0034322,0.29235,0.21331,1,1
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,9.8628e-07,0.29192,0.28555,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00072223,0.29184,0.26336,1,1
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00074557,0.29151,0.2626,1,1
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0010528,0.29144,0.27636,1,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,8.1192e-05,0.29132,0.30246,1,1
2,GO COCHLEA DEVELOPMENT,0.0015653,0.29099,0.22852,1,1
2,GO RESPONSE TO IRON ION,0.00032948,0.29098,0.24474,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0094949,0.29087,0.22037,1,1
2,GO ENDOTHELIAL CELL PROLIFERATION,2.9532e-05,0.29081,0.26047,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,5.8301e-05,0.29057,0.24837,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,2.8418e-05,0.29029,0.23857,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.6603e-06,0.29011,0.27352,1,1
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.041093,0.28999,0.25877,1,1
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00011241,0.28992,0.22749,1,1
2,GO HEART VALVE FORMATION,0.041093,0.28986,0.2554,1,1
2,GO REGULATION OF RESPIRATORY BURST,0.0021689,0.28975,0.25532,1,1
2,GO REGULATION OF CARTILAGE DEVELOPMENT,1.8521e-05,0.28946,0.30693,1,1
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00084609,0.28931,0.38531,1,1
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00010462,0.28929,0.24129,1,1
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.011047,0.2892,0.176,1,1
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00087311,0.28919,0.23672,1,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,7.6603e-06,0.28911,0.26785,1,1
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,2.0833e-05,0.289,0.24428,1,1
2,GO KIDNEY MORPHOGENESIS,0.00029782,0.28899,0.22075,1,1
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00042998,0.28898,0.34849,1,1
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.5331e-06,0.28893,0.25232,1,1
2,GO PARAXIAL MESODERM DEVELOPMENT,0.0020453,0.28883,0.29262,1,1
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0013457,0.28849,0.22036,1,1
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,1.6455e-05,0.28841,0.35763,1,1
2,GO MAMMARY GLAND MORPHOGENESIS,0.00079435,0.28819,0.26073,1,1
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00013433,0.28802,0.24698,1,1
2,GO BEHAVIORAL RESPONSE TO PAIN,0.015953,0.28794,0.25581,1,1
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00010845,0.28767,0.23016,1,1
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.007729,0.28755,0.23905,1,1
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0060989,0.28748,0.32536,1,1
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00021909,0.28746,0.23913,1,1
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,2.2658e-06,0.28718,0.28908,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0025083,0.28687,0.31091,1,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00032948,0.28682,0.22928,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00034072,0.28678,0.22215,1,1
2,GO PLATELET ACTIVATION,0.00040247,0.28675,0.1978,1,1
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,7.547e-05,0.28672,0.25556,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00041602,0.28666,0.29062,1,1
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,6.2985e-07,0.28622,0.28546,1,1
2,GO GLYCOSYLATION,0.00011241,0.28621,0.21497,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,2.9532e-05,0.28603,0.21763,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00018427,0.28593,0.3002,1,1
2,GO LEUKOCYTE PROLIFERATION,5.6174e-05,0.28562,0.2327,1,1
2,GO TRANSMISSION OF NERVE IMPULSE,0.0007696,0.28526,0.27216,1,1
2,GO TOOTH MINERALIZATION,0.0030654,0.28524,0.25867,1,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00024286,0.28522,0.23795,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.004408,0.28507,0.2261,1,1
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00027832,0.28497,0.27604,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0066042,0.28467,0.29169,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,7.547e-05,0.28453,0.22072,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0006154,0.2845,0.20254,1,1
2,GO GLIAL CELL DIFFERENTIATION,5.508e-06,0.2844,0.26094,1,1
2,GO ANOIKIS,8.7323e-05,0.28438,0.34114,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,9.389e-05,0.28434,0.22725,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.001228,0.28408,0.24412,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,5.6174e-05,0.28397,0.22058,1,1
2,GO CAMP METABOLIC PROCESS,0.001662,0.2837,0.20921,1,1
2,GO REGULATION OF RESPONSE TO WOUNDING,0.00041602,0.28339,0.23525,1,1
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00025131,0.28328,0.22108,1,1
2,GO DORSAL AORTA DEVELOPMENT,0.019739,0.28318,0.23906,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0030654,0.28295,0.22147,1,1
2,GO OVARIAN FOLLICLE DEVELOPMENT,1.5201e-05,0.28282,0.26958,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00084609,0.28279,0.2055,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00012512,0.28247,0.23473,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00012512,0.28241,0.20913,1,1
2,GO LONG TERM SYNAPTIC POTENTIATION,0.0001547,0.28226,0.26802,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,3.7145e-05,0.28224,0.2138,1,1
2,GO PLACENTA DEVELOPMENT,0.00016595,0.28206,0.22308,1,1
2,GO PLASMA MEMBRANE FUSION,0.001986,0.28205,0.25666,1,1
2,GO SPHINGOLIPID METABOLIC PROCESS,5.8301e-05,0.28199,0.21431,1,1
2,GO REGULATION OF CELL ADHESION,5.6174e-05,0.28193,0.22844,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0090226,0.28162,0.23275,1,1
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,9.8628e-07,0.28153,0.26503,1,1
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0012662,0.28138,0.22814,1,1
2,GO REGULATION OF CELL ACTIVATION,4.1617e-05,0.28133,0.20372,1,1
2,GO B CELL ACTIVATION,7.547e-05,0.28122,0.20724,1,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00021167,0.28119,0.2137,1,1
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00037661,0.28116,0.24349,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,2.6307e-05,0.28106,0.24873,1,1
2,GO EMBRYONIC HEMOPOIESIS,0.00067758,0.28105,0.24297,1,1
2,GO ALPHA BETA T CELL ACTIVATION,7.2754e-05,0.28101,0.24058,1,1
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0027346,0.28047,0.20522,1,1
2,GO MONOCYTE CHEMOTAXIS,0.0075304,0.28038,0.17767,1,1
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00065623,0.28036,0.24397,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.0033369,0.28019,0.35565,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0025083,0.28008,0.16751,1,1
2,GO CELL CELL ADHESION,9.3916e-06,0.27989,0.22002,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00040247,0.27972,0.20771,1,1
2,GO CELL MATRIX ADHESION,7.013e-05,0.27968,0.23159,1,1
2,GO INNERVATION,0.0054795,0.27966,0.32557,1,1
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0073363,0.27946,0.21163,1,1
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0087944,0.2791,0.25039,1,1
2,GO RESPONSE TO MAGNESIUM ION,0.017969,0.27904,0.22997,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0038387,0.27879,0.24505,1,1
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,1.7118e-05,0.27849,0.2536,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.389e-05,0.27838,0.28156,1,1
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0037331,0.27832,0.50706,1,1
2,GO REGULATION OF STEM CELL DIVISION,0.00065623,0.27824,0.24984,1,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00021167,0.27816,0.23926,1,1
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0014299,0.27813,0.20861,1,1
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0047853,0.27799,0.23022,1,1
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.00069957,0.27798,0.2423,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0087944,0.27791,0.1745,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00090094,0.27777,0.22607,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0060989,0.27773,0.2169,1,1
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00092958,0.2774,0.32045,1,1
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0050528,0.27719,0.23302,1,1
2,GO CHONDROCYTE DIFFERENTIATION,0.0011199,0.27714,0.21146,1,1
2,GO ACYLGLYCEROL HOMEOSTASIS,0.00045924,0.27698,0.19867,1,1
2,GO REGULATION OF RESPONSE TO FOOD,2.2524e-05,0.27693,0.28258,1,1
2,GO AXIS ELONGATION,0.0073363,0.27678,0.20408,1,1
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00055855,0.27664,0.24771,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.016339,0.27652,0.2791,1,1
2,GO EPITHELIAL CELL FATE COMMITMENT,0.0031536,0.27646,0.34044,1,1
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00017186,0.27601,0.25805,1,1
2,GO GLIOGENESIS,1.1493e-05,0.27577,0.24013,1,1
2,GO EMBRYONIC BODY MORPHOGENESIS,0.0032441,0.27529,0.29061,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0026572,0.27502,0.23796,1,1
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00010462,0.27499,0.2052,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.4421e-05,0.27497,0.23059,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00014418,0.2749,0.27042,1,1
2,GO STARTLE RESPONSE,0.0010206,0.27443,0.29232,1,1
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00016595,0.27439,0.30129,1,1
2,GO RESPONSE TO ACIDIC PH,0.00079435,0.27438,0.27445,1,1
2,GO ADHESION OF SYMBIONT TO HOST,0.00081984,0.27428,0.34736,1,1
2,GO IMMUNE EFFECTOR PROCESS,0.00092958,0.27424,0.19445,1,1
2,GO CARDIAC CONDUCTION,6.5149e-05,0.27406,0.25394,1,1
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,7.3528e-06,0.27405,0.28127,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.00012074,0.27395,0.23014,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.036948,0.27391,0.20589,1,1
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0021062,0.27378,0.26346,1,1
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0029794,0.27367,0.28312,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.00010092,0.27362,0.27018,1,1
2,GO RECEPTOR CLUSTERING,0.00353,0.27355,0.1917,1,1
2,GO CGMP METABOLIC PROCESS,0.030383,0.27344,0.19253,1,1
2,GO CELL CHEMOTAXIS,4.0073e-05,0.27325,0.23973,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00063551,0.27313,0.24726,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0022992,0.27295,0.27619,1,1
2,GO REGULATION OF GLIOGENESIS,1.5816e-05,0.27293,0.24482,1,1
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,7.547e-05,0.27282,0.28552,1,1
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.00057693,0.2728,0.23163,1,1
2,GO LEUKOCYTE MIGRATION,4.4878e-05,0.27256,0.22729,1,1
2,GO REGULATION OF T CELL ACTIVATION,2.7343e-05,0.27254,0.22335,1,1
2,GO INTERLEUKIN 12 PRODUCTION,0.00016023,0.2725,0.25052,1,1
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,1.5201e-05,0.27239,0.24661,1,1
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00038934,0.27233,0.20831,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.0013457,0.27232,0.22112,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00044439,0.27221,0.22549,1,1
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00052342,0.27214,0.26922,1,1
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0001547,0.27207,0.29589,1,1
2,GO MEMBRANE REPOLARIZATION,0.0020453,0.27172,0.22851,1,1
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0026572,0.2712,0.20431,1,1
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0029794,0.27115,0.22258,1,1
2,GO STEROL HOMEOSTASIS,0.00010092,0.27086,0.22356,1,1
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00065623,0.2706,0.24247,1,1
2,GO REGULATION OF NEURON MATURATION,0.0042883,0.27049,0.26,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7145e-05,0.27041,0.22737,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00069957,0.26993,0.18789,1,1
2,GO HEART TRABECULA FORMATION,0.0040578,0.26985,0.27644,1,1
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00038934,0.26957,0.2229,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00052342,0.2694,0.19186,1,1
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00014418,0.26926,0.23693,1,1
2,GO METANEPHROS DEVELOPMENT,0.0011199,0.26921,0.19174,1,1
2,GO CELLULAR GLUCAN METABOLIC PROCESS,8.3127e-06,0.26902,0.25708,1,1
2,GO METANEPHROS MORPHOGENESIS,0.00016595,0.26893,0.27853,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0023671,0.26864,0.29191,1,1
2,GO ENAMEL MINERALIZATION,0.0085714,0.26863,0.2547,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00027832,0.26829,0.18242,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0085714,0.26817,0.23888,1,1
2,GO RESPONSE TO GROWTH HORMONE,0.0041716,0.26772,0.20526,1,1
2,GO LEUKOCYTE CHEMOTAXIS,0.00011241,0.26764,0.21195,1,1
2,GO FORELIMB MORPHOGENESIS,0.016734,0.26754,0.21457,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,5.2139e-05,0.26751,0.21203,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.004408,0.26749,0.17851,1,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0038387,0.26739,0.20326,1,1
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.4346e-05,0.26738,0.21367,1,1
2,GO WATER HOMEOSTASIS,5.8301e-05,0.26729,0.25736,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0075304,0.26702,0.25064,1,1
2,GO INTERACTION WITH HOST,0.0087944,0.26696,0.14251,1,1
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.012508,0.26682,0.20247,1,1
2,GO FUCOSYLATION,4.4878e-05,0.26661,0.26598,1,1
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,2.5308e-05,0.26644,0.30388,1,1
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.024288,0.26629,0.2955,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,9.0551e-05,0.2661,0.19872,1,1
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00020448,0.26607,0.22374,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,7.2754e-05,0.26594,0.20957,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0014738,0.26576,0.19289,1,1
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0017123,0.26565,0.1983,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.017137,0.26558,0.16861,1,1
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0034322,0.2654,0.31026,1,1
2,GO CERAMIDE METABOLIC PROCESS,0.00036427,0.26532,0.1969,1,1
2,GO SODIUM ION TRANSPORT,1.7474e-06,0.26528,0.23765,1,1
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.349e-05,0.26525,0.25837,1,1
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00012512,0.26506,0.24166,1,1
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00072223,0.26468,0.21025,1,1
2,GO HOMOTYPIC CELL CELL ADHESION,0.00069957,0.26465,0.24333,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0014738,0.26453,0.24767,1,1
2,GO MESONEPHROS DEVELOPMENT,1.5201e-05,0.26436,0.26639,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.014138,0.26426,0.252,1,1
2,GO T CELL ACTIVATION,5.6174e-05,0.26402,0.21389,1,1
2,GO RESPONSE TO CYTOKINE,0.0006154,0.26399,0.17942,1,1
2,GO TUBE MORPHOGENESIS,6.7596e-05,0.26397,0.19598,1,1
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00021167,0.26396,0.27531,1,1
2,GO STRIATED MUSCLE ADAPTATION,0.00057693,0.2639,0.23132,1,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0010859,0.26381,0.26315,1,1
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0033369,0.26381,0.27816,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,9.7346e-05,0.2638,0.21509,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00081984,0.26373,0.26181,1,1
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0062634,0.26355,0.20461,1,1
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,3.0689e-05,0.26334,0.2314,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.01282,0.26332,0.27881,1,1
2,GO REGULATION OF ACROSOME REACTION,0.030383,0.26266,0.17067,1,1
2,GO GLIAL CELL MIGRATION,0.0024367,0.26246,0.1872,1,1
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0094949,0.26242,0.20769,1,1
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00031859,0.26237,0.20556,1,1
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.00030804,0.26228,0.20397,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.00020448,0.26218,0.23477,1,1
2,GO RENAL SYSTEM PROCESS,1.2962e-05,0.26217,0.23315,1,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.00024286,0.26212,0.25306,1,1
2,GO REGULATION OF TUBULIN DEACETYLATION,0.011326,0.26211,0.24439,1,1
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,3.0689e-05,0.26189,0.23625,1,1
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,9.389e-05,0.26175,0.23395,1,1
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.01282,0.26174,0.21734,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0067808,0.26174,0.33147,1,1
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0007696,0.26107,0.18879,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.014138,0.26089,0.20812,1,1
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.033894,0.26081,0.12666,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00038934,0.26021,0.2236,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.016734,0.26021,0.30923,1,1
2,GO INTERLEUKIN 1 PRODUCTION,0.00092958,0.26017,0.22937,1,1
2,GO EATING BEHAVIOR,3.0576e-06,0.26015,0.2744,1,1
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.001191,0.26013,0.21941,1,1
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0051916,0.25997,0.21608,1,1
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.009256,0.25987,0.16421,1,1
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.00023468,0.25983,0.31694,1,1
2,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.012203,0.2596,0.32893,1,1
2,GO GONADOTROPIN SECRETION,0.0020453,0.25954,0.27889,1,1
2,GO SODIUM ION HOMEOSTASIS,0.0001165,0.25919,0.23685,1,1
2,GO BIOLOGICAL ADHESION,4.8379e-05,0.25917,0.20279,1,1
2,GO RESPONSE TO CORTICOSTERONE,0.011612,0.25911,0.22916,1,1
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0075304,0.2591,0.25615,1,1
2,GO BLOOD VESSEL MORPHOGENESIS,0.00028792,0.25882,0.19131,1,1
2,GO INFLAMMATORY RESPONSE,5.2139e-05,0.25875,0.2161,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,4.8379e-05,0.25852,0.24334,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,8.4205e-05,0.2585,0.23704,1,1
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00010462,0.2584,0.21154,1,1
2,GO INTERLEUKIN 6 PRODUCTION,1.5816e-05,0.25816,0.22463,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0032441,0.25802,0.17762,1,1
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.017549,0.25789,0.2287,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.004408,0.25785,0.16775,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00010845,0.25776,0.22935,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.0025817,0.25769,0.33929,1,1
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.036948,0.25765,0.22401,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.6307e-05,0.25751,0.245,1,1
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.00087311,0.25751,0.22145,1,1
2,GO RESPONSE TO INSECTICIDE,0.00353,0.25723,0.29188,1,1
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00017796,0.25702,0.21233,1,1
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00072223,0.25702,0.20919,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00095906,0.25702,0.24679,1,1
2,GO REGULATION OF FATTY ACID TRANSPORT,1.0604e-05,0.257,0.30285,1,1
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0030654,0.25673,0.22554,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.035393,0.25666,0.2635,1,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0054795,0.25663,0.20659,1,1
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0038387,0.25658,0.23536,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,5.2139e-05,0.25613,0.1895,1,1
2,GO REGULATION OF FLAGELLATED SPERM MOTILITY,7.547e-05,0.25611,0.22294,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.044685,0.25609,0.19012,1,1
2,GO RESPONSE TO NICOTINE,0.00013433,0.25606,0.25168,1,1
2,GO RESPONSE TO WOUNDING,0.00081984,0.25603,0.1905,1,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.3418e-05,0.25583,0.21151,1,1
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00017186,0.25579,0.25287,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0073363,0.25555,0.23196,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0049174,0.25548,0.19216,1,1
2,GO ODONTOGENESIS,0.0028957,0.25545,0.19795,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00014935,0.25524,0.29294,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.027188,0.25501,0.21947,1,1
2,GO SEX DETERMINATION,0.00027832,0.25492,0.2709,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00032948,0.25476,0.18327,1,1
2,GO DIOL METABOLIC PROCESS,0.0017641,0.25472,0.21068,1,1
2,GO OXALATE TRANSPORT,0.0081404,0.25468,0.16939,1,1
2,GO DEFENSE RESPONSE,0.00018427,0.25467,0.19714,1,1
2,GO LIPOPROTEIN METABOLIC PROCESS,1.6455e-05,0.25464,0.23809,1,1
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.00050664,0.25438,0.2799,1,1
2,GO ENDOCRINE HORMONE SECRETION,1.0779e-06,0.25436,0.31677,1,1
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,6.2786e-05,0.25424,0.23011,1,1
2,GO BASIC AMINO ACID TRANSPORT,0.024288,0.25398,0.10384,1,1
2,GO HAIR CELL DIFFERENTIATION,0.00019753,0.25397,0.21745,1,1
2,GO MACROPHAGE MIGRATION,0.00095906,0.2537,0.21249,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0066042,0.25364,0.13843,1,1
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0013054,0.2535,0.22261,1,1
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.1964e-05,0.25348,0.22559,1,1
2,GO INACTIVATION OF MAPK ACTIVITY,0.0029794,0.25332,0.26275,1,1
2,GO POSITIVE CHEMOTAXIS,0.00038934,0.25328,0.24017,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0023671,0.25305,0.2878,1,1
2,GO LYMPHOCYTE MIGRATION,0.0001165,0.25253,0.21187,1,1
2,GO CELL KILLING,0.00063551,0.25244,0.19153,1,1
2,GO MAST CELL MIGRATION,0.011047,0.25244,0.37182,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.0073363,0.25238,0.19079,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0014738,0.2523,0.24587,1,1
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,4.1617e-05,0.25219,0.19418,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00030804,0.25218,0.2281,1,1
2,GO LYMPHOCYTE ACTIVATION,6.0504e-05,0.25177,0.18662,1,1
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.037747,0.25177,0.18104,1,1
2,GO CYTOKINE PRODUCTION,0.00024286,0.25153,0.201,1,1
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.0027346,0.25153,0.20318,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.00084609,0.25149,0.19075,1,1
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.018398,0.25149,0.20885,1,1
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.001986,0.25148,0.21307,1,1
2,GO URETER DEVELOPMENT,0.023741,0.25135,0.23211,1,1
2,GO CELL ACTIVATION,0.00035231,0.25127,0.17682,1,1
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.021165,0.25123,0.18963,1,1
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0011549,0.25119,0.23144,1,1
2,GO REGULATION OF APPETITE,0.00017796,0.25076,0.23241,1,1
2,GO REGULATION OF DOPAMINE SECRETION,0.011612,0.25039,0.35299,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01282,0.25037,0.17152,1,1
2,GO NEGATIVE REGULATION OF GLIOGENESIS,3.1888e-05,0.25025,0.35078,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.004408,0.25001,0.24606,1,1
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0032441,0.24983,0.21829,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00074557,0.24963,0.37194,1,1
2,GO ACTIVATION OF JUN KINASE ACTIVITY,3.4728e-06,0.24923,0.24777,1,1
2,GO CELL CELL JUNCTION ASSEMBLY,0.00037661,0.24919,0.20881,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,5.2139e-05,0.24889,0.21414,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.00024286,0.24884,0.20779,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,6.7596e-05,0.2488,0.17724,1,1
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00063551,0.24871,0.24373,1,1
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,1.104e-05,0.2486,0.19852,1,1
2,GO DNA DEMETHYLATION,0.0042883,0.24851,0.18676,1,1
2,GO RESPONSE TO BMP,0.00010462,0.24841,0.21402,1,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00025131,0.24834,0.21475,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.034637,0.24804,0.17903,1,1
2,GO VIRAL LIFE CYCLE,0.016339,0.24789,0.14119,1,1
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.5149e-05,0.24786,0.21355,1,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,4.3218e-05,0.24778,0.22594,1,1
2,GO POSITIVE REGULATION OF CELL DIVISION,3.8583e-05,0.24777,0.22451,1,1
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0069616,0.24769,0.2947,1,1
2,GO KIDNEY EPITHELIUM DEVELOPMENT,6.7596e-05,0.24745,0.23239,1,1
2,GO ALANINE TRANSPORT,0.0075304,0.24733,0.17878,1,1
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,4.8379e-05,0.24731,0.23422,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.00092958,0.2473,0.20915,1,1
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00030804,0.24727,0.23619,1,1
2,GO BRAIN MORPHOGENESIS,0.0038387,0.2472,0.17336,1,1
2,GO ACTIVATION OF MAPK ACTIVITY,7.6603e-06,0.24718,0.24291,1,1
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,8.1192e-05,0.24716,0.19903,1,1
2,GO VASCULATURE DEVELOPMENT,0.00042998,0.24712,0.17086,1,1
2,GO T CELL PROLIFERATION,6.0504e-05,0.24674,0.23138,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,2.9532e-05,0.24662,0.20129,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.016339,0.24657,0.15749,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.004408,0.2464,0.19319,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,8.1192e-05,0.24636,0.18689,1,1
2,GO CARDIAC CELL DEVELOPMENT,0.00030804,0.24634,0.19009,1,1
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00026003,0.24613,0.22653,1,1
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.010245,0.24609,0.17829,1,1
2,GO MUSCLE ATROPHY,0.016339,0.24602,0.18798,1,1
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.9301e-06,0.24587,0.26779,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0075304,0.24587,0.32044,1,1
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,3.5759e-05,0.24575,0.21199,1,1
2,GO MYELOID LEUKOCYTE MIGRATION,0.00029782,0.24557,0.18266,1,1
2,GO STEM CELL DIVISION,0.012203,0.24549,0.16179,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.2786e-05,0.24542,0.20445,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00042998,0.24541,0.28444,1,1
2,GO ANION HOMEOSTASIS,0.0021689,0.24538,0.17734,1,1
2,GO REGULATION OF ICOSANOID SECRETION,0.00012074,0.2452,0.26696,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001872,0.24514,0.17007,1,1
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00047456,0.24512,0.24389,1,1
2,GO PROTEIN KINASE B SIGNALING,0.00017186,0.24484,0.18187,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0036303,0.24482,0.22038,1,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.011904,0.24441,0.23548,1,1
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.045624,0.24437,0.19353,1,1
2,GO MOLTING CYCLE,0.00074557,0.24433,0.16183,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.017137,0.24412,0.18147,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00031859,0.24389,0.23102,1,1
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0022992,0.24385,0.17904,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0010528,0.24376,0.28106,1,1
2,GO MULTICELLULAR ORGANISMAL SIGNALING,4.1617e-05,0.24375,0.24346,1,1
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0014299,0.24349,0.30067,1,1
2,GO LIPID LOCALIZATION,0.00014935,0.24345,0.17466,1,1
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0032441,0.24339,0.25234,1,1
2,GO REGULATION OF OSSIFICATION,3.8583e-05,0.24338,0.26371,1,1
2,GO NOTCH SIGNALING PATHWAY,1.0184e-05,0.24329,0.2309,1,1
2,GO ENERGY RESERVE METABOLIC PROCESS,1.1493e-05,0.24307,0.23849,1,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00013917,0.24292,0.1892,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00025131,0.24267,0.22267,1,1
2,GO AMELOGENESIS,0.0018173,0.24255,0.26638,1,1
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.6455e-05,0.24254,0.3466,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.001872,0.2424,0.15913,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00092958,0.2421,0.23483,1,1
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0030654,0.24209,0.23321,1,1
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0038387,0.24205,0.21359,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00042998,0.24192,0.25111,1,1
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00098941,0.24183,0.22164,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0090226,0.24178,0.1815,1,1
2,GO TUBE DEVELOPMENT,4.3218e-05,0.24173,0.1913,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0019282,0.24161,0.15993,1,1
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1.0184e-05,0.24144,0.19785,1,1
2,GO CALCINEURIN MEDIATED SIGNALING,0.00017186,0.24128,0.2102,1,1
2,GO REGULATION OF HISTONE DEACETYLATION,0.00035231,0.24114,0.22385,1,1
2,GO GLAND DEVELOPMENT,4.2876e-06,0.2411,0.21011,1,1
2,GO NEUROINFLAMMATORY RESPONSE,0.00059588,0.2411,0.21077,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00026903,0.24102,0.20506,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,9.0551e-05,0.24097,0.21313,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00019753,0.24076,0.22467,1,1
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,8.7323e-05,0.24067,0.2484,1,1
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00032948,0.24064,0.1771,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.0017123,0.2406,0.25089,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.02068,0.24058,0.1928,1,1
2,GO AMINOGLYCAN METABOLIC PROCESS,0.00057693,0.24049,0.20198,1,1
2,GO LACTATE METABOLIC PROCESS,0.0073363,0.24034,0.22478,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045924,0.24022,0.24429,1,1
2,GO RESPONSE TO INTERLEUKIN 6,0.00063551,0.24016,0.21179,1,1
2,GO RESPONSE TO CAFFEINE,0.0057817,0.24013,0.2042,1,1
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0013872,0.24011,0.16142,1,1
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0017641,0.23992,0.17815,1,1
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00084609,0.23992,0.20676,1,1
2,GO PROTEIN PROCESSING,0.00052342,0.23977,0.17699,1,1
2,GO B CELL DIFFERENTIATION,1.1964e-05,0.23959,0.19524,1,1
2,GO REGULATION OF MACROPHAGE MIGRATION,0.00024286,0.23952,0.21695,1,1
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0001547,0.23943,0.2186,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00012964,0.23941,0.19426,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0045306,0.23919,0.18239,1,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,4.8379e-05,0.23903,0.20529,1,1
2,GO INTESTINAL ABSORPTION,0.0049174,0.23872,0.20838,1,1
2,GO DIENCEPHALON DEVELOPMENT,1.5201e-05,0.23866,0.29775,1,1
2,GO BONE MINERALIZATION,0.00020448,0.23821,0.22994,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00017186,0.23821,0.26128,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0099891,0.23812,0.18162,1,1
2,GO PROTEIN N LINKED GLYCOSYLATION,0.0059384,0.23797,0.1807,1,1
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0046564,0.23789,0.22664,1,1
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00026903,0.23783,0.22366,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0021062,0.23775,0.21793,1,1
2,GO BODY MORPHOGENESIS,0.0049174,0.23758,0.18805,1,1
2,GO LEYDIG CELL DIFFERENTIATION,0.029719,0.23735,0.2516,1,1
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00029782,0.2373,0.27722,1,1
2,GO ORGANIC CATION TRANSPORT,0.00014418,0.23714,0.24618,1,1
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.00035231,0.23695,0.18274,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0046564,0.23689,0.21281,1,1
2,GO NEURAL CREST CELL DIFFERENTIATION,0.012203,0.23671,0.16013,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00012964,0.2367,0.23093,1,1
2,GO STEROID METABOLIC PROCESS,0.00042998,0.2366,0.17688,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0083534,0.23648,0.27983,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00081984,0.23644,0.17614,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0028957,0.23626,0.19193,1,1
2,GO CYTOKINE SECRETION,0.00034072,0.2362,0.20772,1,1
2,GO AMINE TRANSPORT,0.00084609,0.23618,0.28964,1,1
2,GO REGULATION OF MAP KINASE ACTIVITY,1.5201e-05,0.23616,0.21653,1,1
2,GO CELL SUBSTRATE ADHESION,0.00092958,0.23616,0.19701,1,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.2754e-05,0.23599,0.17313,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.011904,0.23597,0.298,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0064317,0.23596,0.27333,1,1
2,GO ADHERENS JUNCTION ASSEMBLY,0.00059588,0.23582,0.26258,1,1
2,GO WOUND HEALING,0.0017641,0.23575,0.17309,1,1
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00035231,0.23572,0.339,1,1
2,GO RESPONSE TO VITAMIN A,0.013798,0.23569,0.17799,1,1
2,GO LEUKOCYTE HOMEOSTASIS,0.0046564,0.23553,0.15418,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0034322,0.23545,0.16529,1,1
2,GO CATECHOLAMINE UPTAKE,0.0097392,0.23507,0.23318,1,1
2,GO RESPONSE TO POTASSIUM ION,0.00084609,0.23473,0.29307,1,1
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,7.8282e-05,0.23466,0.22816,1,1
2,GO INTERLEUKIN 4 PRODUCTION,0.00032948,0.23458,0.23734,1,1
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00040247,0.23451,0.21997,1,1
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.0012662,0.23434,0.21289,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0041716,0.23433,0.16272,1,1
2,GO CHLORIDE ION HOMEOSTASIS,0.0038387,0.23417,0.17703,1,1
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0014738,0.23416,0.18625,1,1
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,5.6174e-05,0.23388,0.21917,1,1
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,5.4121e-05,0.23383,0.18224,1,1
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,5.8301e-05,0.23377,0.2648,1,1
2,GO ENSHEATHMENT OF NEURONS,5.4121e-05,0.23369,0.20505,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.00018427,0.23351,0.17518,1,1
2,GO RESPONSE TO STEROL,0.001228,0.23346,0.20165,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,0.00072223,0.23343,0.19782,1,1
2,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.025994,0.23337,0.15421,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.00010092,0.23325,0.17514,1,1
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.014138,0.23308,0.18315,1,1
2,GO ACTIVATED T CELL PROLIFERATION,1.4609e-05,0.23305,0.24137,1,1
2,GO ACTIN CROSSLINK FORMATION,0.0057817,0.23304,0.20086,1,1
2,GO POTASSIUM ION HOMEOSTASIS,2.8418e-05,0.23292,0.25828,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00019079,0.23292,0.17915,1,1
2,GO ENDOCRINE SYSTEM DEVELOPMENT,8.7323e-05,0.23277,0.2277,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.001986,0.23257,0.20633,1,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,2.2524e-05,0.23233,0.17491,1,1
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.02068,0.23226,0.18688,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0018173,0.23226,0.17212,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0028957,0.23225,0.2213,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.001872,0.23187,0.17529,1,1
2,GO DIOL BIOSYNTHETIC PROCESS,0.0085714,0.23179,0.14803,1,1
2,GO NEURON MATURATION,3.3132e-05,0.23169,0.2816,1,1
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.00030804,0.23153,0.19749,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00019753,0.23151,0.23224,1,1
2,GO STEROL METABOLIC PROCESS,0.0033369,0.23137,0.15853,1,1
2,GO REGULATION OF CHEMOTAXIS,6.2786e-05,0.23108,0.21221,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0069616,0.23095,0.21575,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,4.0073e-05,0.23088,0.21537,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.009256,0.23078,0.22217,1,1
2,GO MUSCLE CELL DIFFERENTIATION,2.4346e-05,0.23074,0.19228,1,1
2,GO REGULATION OF IMMUNE RESPONSE,0.00052342,0.2306,0.16823,1,1
2,GO GRANULOCYTE MIGRATION,0.0022332,0.2306,0.15994,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0031536,0.23057,0.16029,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0087944,0.23054,0.22655,1,1
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.0062634,0.23049,0.18298,1,1
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.5816e-05,0.23046,0.21156,1,1
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00028792,0.23045,0.21866,1,1
2,GO DISACCHARIDE METABOLIC PROCESS,0.0016129,0.23043,0.21858,1,1
2,GO POSITIVE REGULATION OF JNK CASCADE,1.1493e-05,0.23041,0.20706,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0031536,0.23033,0.22688,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00087311,0.23023,0.23107,1,1
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.00027832,0.23011,0.24108,1,1
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.00017186,0.22994,0.24969,1,1
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0013054,0.22993,0.18886,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.009256,0.22991,0.20564,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0013054,0.22981,0.17111,1,1
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00018427,0.2298,0.16996,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.0041716,0.22978,0.19338,1,1
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00052342,0.22976,0.215,1,1
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00017796,0.22968,0.19539,1,1
2,GO ENDOCRINE PROCESS,0.00024286,0.2295,0.21856,1,1
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00067758,0.2295,0.31345,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0028141,0.22924,0.21753,1,1
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00016023,0.22912,0.20538,1,1
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.00010092,0.22907,0.21548,1,1
2,GO BIOMINERALIZATION,0.00010462,0.22907,0.21612,1,1
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0018173,0.22883,0.22935,1,1
2,GO CELLULAR RESPONSE TO STEROL,0.0017123,0.22872,0.2397,1,1
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.0016129,0.22871,0.24843,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.043763,0.22866,0.14812,1,1
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,9.7346e-05,0.22858,0.23179,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00069957,0.22845,0.18942,1,1
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0011199,0.22843,0.2116,1,1
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0027346,0.22829,0.26048,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.2281,0.22934,1,1
2,GO TISSUE REGENERATION,0.016339,0.22782,0.17146,1,1
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,2.3418e-05,0.22767,0.20217,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0007696,0.22763,0.17461,1,1
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045924,0.22752,0.1838,1,1
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0001165,0.22751,0.18345,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00030804,0.22749,0.17843,1,1
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0028141,0.22749,0.21354,1,1
2,GO REGULATION OF BLOOD CIRCULATION,5.2837e-06,0.22747,0.23018,1,1
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00016023,0.22708,0.20195,1,1
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0032441,0.22698,0.1935,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.037747,0.22681,0.28301,1,1
2,GO GROWTH HORMONE SECRETION,0.0007696,0.22673,0.33399,1,1
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00041602,0.22657,0.19185,1,1
2,GO NEUROPEPTIDE SIGNALING PATHWAY,8.1192e-05,0.2265,0.25219,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0021689,0.22645,0.2589,1,1
2,GO REGULATION OF ANION TRANSPORT,0.00025131,0.22644,0.18928,1,1
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,6.0504e-05,0.22638,0.17864,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.011047,0.22589,0.2159,1,1
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015653,0.22586,0.16607,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.00095906,0.22583,0.16318,1,1
2,GO STEROL TRANSPORT,0.0023671,0.22579,0.15756,1,1
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0023671,0.2257,0.17343,1,1
2,GO NEURON PROJECTION REGENERATION,0.001191,0.22567,0.20269,1,1
2,GO POSITIVE REGULATION OF HEART RATE,0.0051916,0.22559,0.26765,1,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.00353,0.2255,0.26495,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.023205,0.2255,0.19242,1,1
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0013457,0.2255,0.15845,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0015189,0.2255,0.19452,1,1
2,GO FIBROBLAST MIGRATION,0.0025083,0.22541,0.17796,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0016129,0.22528,0.17131,1,1
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00090094,0.22523,0.18824,1,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00017186,0.22475,0.16792,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.014841,0.22463,0.22851,1,1
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0083534,0.22456,0.1382,1,1
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.5759e-05,0.22453,0.22144,1,1
2,GO DECIDUALIZATION,0.010773,0.22444,0.20998,1,1
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0049174,0.22438,0.23615,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00045924,0.22435,0.20688,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0010859,0.2243,0.20271,1,1
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.02068,0.22408,0.23942,1,1
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00038934,0.22407,0.16536,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0054795,0.22386,0.19749,1,1
2,GO ENDOTHELIAL CELL MIGRATION,0.0020453,0.22362,0.19266,1,1
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00010462,0.22347,0.22141,1,1
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00028792,0.22334,0.26283,1,1
2,GO CARDIAC ATRIUM DEVELOPMENT,0.0049174,0.22333,0.19125,1,1
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00017796,0.22306,0.2067,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0036303,0.22285,0.21449,1,1
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0071468,0.22279,0.22274,1,1
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.001662,0.22269,0.18217,1,1
2,GO MYOTUBE CELL DEVELOPMENT,0.0015653,0.22265,0.20646,1,1
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00079435,0.22247,0.19239,1,1
2,GO NEPHRON DEVELOPMENT,0.00041602,0.22223,0.18726,1,1
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0022992,0.22215,0.20724,1,1
2,GO BILE ACID METABOLIC PROCESS,0.0026572,0.222,0.16361,1,1
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0001165,0.2218,0.17419,1,1
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00044439,0.22173,0.19466,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00037661,0.22164,0.19573,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00044439,0.22163,0.23465,1,1
2,GO MUSCLE HYPERTROPHY,0.001228,0.2215,0.17552,1,1
2,GO CELL MOTILITY,6.5149e-05,0.22149,0.17978,1,1
2,GO SPERM CAPACITATION,0.00024286,0.22134,0.20516,1,1
2,GO EPIDERMIS DEVELOPMENT,0.00020448,0.22121,0.18984,1,1
2,GO PANCREAS DEVELOPMENT,0.0014738,0.22112,0.2208,1,1
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0045306,0.22105,0.28257,1,1
2,GO PHOSPHOLIPID TRANSPORT,2.2524e-05,0.22097,0.20377,1,1
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.0026572,0.22094,0.15745,1,1
2,GO COAGULATION,0.00353,0.22048,0.14632,1,1
2,GO MAMMARY GLAND DEVELOPMENT,7.013e-05,0.22047,0.1937,1,1
2,GO CELL MATURATION,5.0194e-07,0.22044,0.21008,1,1
2,GO REGULATION OF MUSCLE ADAPTATION,0.00079435,0.22037,0.19167,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0087944,0.22037,0.19393,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,2.7343e-05,0.22035,0.18052,1,1
2,GO MESENCHYME DEVELOPMENT,0.001191,0.22022,0.15912,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0036303,0.22019,0.17776,1,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00063551,0.22014,0.17437,1,1
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.017137,0.21992,0.17228,1,1
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,3.3132e-05,0.21978,0.17941,1,1
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00010092,0.21965,0.19373,1,1
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.00024286,0.21964,0.15587,1,1
2,GO RESPONSE TO TUMOR CELL,0.0046564,0.2196,0.25262,1,1
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.00017796,0.2195,0.18537,1,1
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,5.8301e-05,0.21933,0.2679,1,1
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0075304,0.21931,0.20138,1,1
2,GO RESPONSE TO NUTRIENT,0.001191,0.21923,0.17414,1,1
2,GO REGULATION OF VASCULAR PERMEABILITY,6.7596e-05,0.21911,0.23801,1,1
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0029794,0.21908,0.19477,1,1
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.6623e-06,0.21908,0.20743,1,1
2,GO DRUG CATABOLIC PROCESS,0.0060989,0.21902,0.15274,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001872,0.21894,0.16824,1,1
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0040578,0.21852,0.20639,1,1
2,GO REGULATION OF MEMBRANE POTENTIAL,0.00017186,0.21818,0.20133,1,1
2,GO REGULATION OF FIBROBLAST MIGRATION,0.0031536,0.21818,0.17993,1,1
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0031536,0.21798,0.19873,1,1
2,GO PEPTIDE SECRETION,1.5331e-06,0.21792,0.2084,1,1
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.033894,0.21788,0.1472,1,1
2,GO REGULATION OF BIOMINERALIZATION,0.00074557,0.21779,0.18817,1,1
2,GO REGULATION OF HEMOPOIESIS,0.00011241,0.21759,0.16278,1,1
2,GO TRANSLESION SYNTHESIS,0.0013457,0.21758,0.1545,1,1
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00047456,0.21756,0.20651,1,1
2,GO RESPONSE TO FOOD,0.00065623,0.21724,0.16406,1,1
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0049174,0.21712,0.17742,1,1
2,GO CELL JUNCTION ASSEMBLY,8.4205e-05,0.21706,0.18396,1,1
2,GO REGULATION OF COLLATERAL SPROUTING,0.0081404,0.21702,0.22255,1,1
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.016339,0.21677,0.15468,1,1
2,GO GLYCOPROTEIN METABOLIC PROCESS,9.0551e-05,0.21669,0.18506,1,1
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.00074557,0.21647,0.18726,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.001986,0.21617,0.18903,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.004408,0.21612,0.20615,1,1
2,GO PHOSPHOLIPID HOMEOSTASIS,0.016734,0.21612,0.1683,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.02166,0.21602,0.18209,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,5.8301e-05,0.21588,0.20492,1,1
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.029068,0.21585,0.19047,1,1
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0017123,0.2158,0.18236,1,1
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.018398,0.21576,0.23477,1,1
2,GO REGULATION OF HEART RATE,0.00065623,0.21571,0.2194,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0020453,0.21561,0.15947,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.0013457,0.21538,0.22343,1,1
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,3.8131e-07,0.21536,0.2299,1,1
2,GO DETECTION OF MECHANICAL STIMULUS,3.0689e-05,0.21525,0.21922,1,1
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.1663e-05,0.21522,0.22781,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.046579,0.21521,0.17094,1,1
2,GO RESPONSE TO RETINOIC ACID,0.0045306,0.21519,0.1526,1,1
2,GO GPI ANCHOR METABOLIC PROCESS,0.0018173,0.21499,0.16972,1,1
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.001191,0.21483,0.19651,1,1
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.025994,0.21476,0.14218,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0054795,0.21456,0.16331,1,1
2,GO LEUKOCYTE DIFFERENTIATION,2.7343e-05,0.21443,0.18118,1,1
2,GO CELLULAR ANION HOMEOSTASIS,0.0056288,0.21439,0.23326,1,1
2,GO REGULATION OF DENDRITE EXTENSION,0.015953,0.21432,0.31846,1,1
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.0604e-05,0.21405,0.21337,1,1
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.9263e-05,0.21396,0.17978,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0010206,0.21363,0.20047,1,1
2,GO POSITIVE REGULATION OF SECRETION,2.1702e-06,0.21358,0.2143,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.0010528,0.21354,0.21551,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.025414,0.21334,0.11623,1,1
2,GO EXOCYTOSIS,0.00036427,0.2133,0.16015,1,1
2,GO MONONUCLEAR CELL MIGRATION,0.0049174,0.21291,0.17454,1,1
2,GO MONOAMINE TRANSPORT,0.0010206,0.21284,0.28002,1,1
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0075304,0.21281,0.36521,1,1
2,GO EAR DEVELOPMENT,0.00032948,0.21275,0.17149,1,1
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.031059,0.21269,0.21173,1,1
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,1.104e-05,0.2125,0.20679,1,1
2,GO PROTEIN PALMITOYLATION,0.00013433,0.21247,0.23356,1,1
2,GO REGULATION OF PEPTIDE SECRETION,1.0311e-06,0.21245,0.20819,1,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.017969,0.21241,0.15362,1,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00065623,0.21233,0.18086,1,1
2,GO SKIN DEVELOPMENT,0.00026903,0.2121,0.2002,1,1
2,GO IMPORT ACROSS PLASMA MEMBRANE,8.1192e-05,0.21209,0.19607,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.043763,0.21201,0.16889,1,1
2,GO REGULATION OF BODY FLUID LEVELS,0.00079435,0.21194,0.15347,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.00040247,0.21192,0.19724,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.019283,0.2119,0.23104,1,1
2,GO OSSIFICATION,9.389e-05,0.2119,0.22386,1,1
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.038561,0.21161,0.2203,1,1
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00069957,0.21153,0.20779,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.030383,0.2115,0.12242,1,1
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00067758,0.21147,0.22036,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0028957,0.2114,0.19603,1,1
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.001191,0.21133,0.22754,1,1
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.014486,0.21125,0.20086,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0054795,0.21116,0.16339,1,1
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.03245,0.21113,0.12801,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0029794,0.21104,0.15479,1,1
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0045306,0.21097,0.20796,1,1
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.026586,0.21094,0.21145,1,1
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00034072,0.21084,0.19985,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.041967,0.21074,0.16692,1,1
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.019739,0.21066,0.24102,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00067758,0.21063,0.1722,1,1
2,GO TUMOR NECROSIS FACTOR SECRETION,0.0015653,0.21062,0.15538,1,1
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00023468,0.21061,0.21172,1,1
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00012074,0.21031,0.1896,1,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,4.6597e-05,0.21017,0.18048,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0011199,0.21013,0.18538,1,1
2,GO ORGAN INDUCTION,0.0007696,0.2101,0.20659,1,1
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,7.8282e-05,0.21002,0.18428,1,1
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00025131,0.21001,0.17395,1,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0021062,0.21,0.18321,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.00019079,0.20999,0.17,1,1
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0033369,0.20997,0.18282,1,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.00042998,0.20988,0.22235,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION,3.7145e-05,0.20978,0.2106,1,1
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00065623,0.20974,0.18437,1,1
2,GO DEFENSE RESPONSE TO BACTERIUM,0.00017186,0.20956,0.18212,1,1
2,GO TISSUE MIGRATION,0.0031536,0.20941,0.1757,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,4.1617e-05,0.20922,0.16777,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,5.2139e-05,0.20902,0.17706,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0079323,0.20888,0.16432,1,1
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.010506,0.20863,0.34905,1,1
2,GO LYTIC VACUOLE ORGANIZATION,0.004408,0.20856,0.14661,1,1
2,GO ETHER METABOLIC PROCESS,0.043763,0.20851,0.14657,1,1
2,GO RETINOIC ACID METABOLIC PROCESS,0.0087944,0.20834,0.21009,1,1
2,GO REGULATION OF TUBE SIZE,0.00012964,0.20831,0.17675,1,1
2,GO REGULATION OF SYSTEM PROCESS,8.6584e-06,0.20822,0.18269,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0064317,0.20817,0.21199,1,1
2,GO FLUID TRANSPORT,0.0059384,0.20814,0.16356,1,1
2,GO LOCOMOTORY BEHAVIOR,0.0012662,0.20793,0.18379,1,1
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0090226,0.20792,0.16579,1,1
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0097392,0.20783,0.18475,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0062634,0.20777,0.16645,1,1
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,4.6597e-05,0.20762,0.20138,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0024367,0.20759,0.15375,1,1
2,GO RESPONSE TO CATECHOLAMINE,0.00050664,0.20752,0.19185,1,1
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,4.4878e-05,0.20743,0.185,1,1
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.00044439,0.20735,0.17765,1,1
2,GO STRESS FIBER ASSEMBLY,0.00065623,0.20731,0.19754,1,1
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00040247,0.20729,0.15397,1,1
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0075304,0.20726,0.19753,1,1
2,GO ACTIN FILAMENT BASED TRANSPORT,0.047551,0.20719,0.15998,1,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,9.0551e-05,0.20697,0.20062,1,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00031859,0.20677,0.2099,1,1
2,GO MEMORY,0.00049035,0.20669,0.19235,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0020453,0.20661,0.15196,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00057693,0.20641,0.19701,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.017549,0.20639,0.19262,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.023741,0.20636,0.1508,1,1
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,5.6174e-05,0.20636,0.17661,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.011612,0.20635,0.13476,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.6623e-06,0.20624,0.26106,1,1
2,GO NEURAL NUCLEUS DEVELOPMENT,0.00034072,0.20622,0.27455,1,1
2,GO T CELL DIFFERENTIATION,6.2786e-05,0.20616,0.17815,1,1
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00019079,0.20581,0.26599,1,1
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,2.2524e-05,0.20569,0.22352,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.035393,0.20547,0.17505,1,1
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00353,0.2054,0.25242,1,1
2,GO TISSUE HOMEOSTASIS,0.00021167,0.20529,0.15714,1,1
2,GO POSITIVE REGULATION OF HORMONE SECRETION,2.9532e-05,0.20515,0.22514,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.00095906,0.20495,0.17189,1,1
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00017186,0.2048,0.18943,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.001228,0.20443,0.23126,1,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00098941,0.2042,0.19486,1,1
2,GO REGULATION OF PROTEIN DEACETYLATION,6.0504e-05,0.20418,0.20923,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0025083,0.20417,0.20618,1,1
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0029794,0.2041,0.16775,1,1
2,GO TISSUE MORPHOGENESIS,0.00034072,0.20404,0.15136,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,1.7806e-05,0.20402,0.16768,1,1
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0001165,0.20381,0.20398,1,1
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.00019753,0.20369,0.19266,1,1
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00010462,0.20366,0.17268,1,1
2,GO INNER EAR MORPHOGENESIS,0.00035231,0.20352,0.17516,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.00035231,0.20341,0.19326,1,1
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00079435,0.20328,0.15697,1,1
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00059588,0.20324,0.14929,1,1
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0087944,0.20321,0.15964,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.012203,0.20296,0.14275,1,1
2,GO CELLULAR RESPONSE TO LIPID,0.0010528,0.20279,0.14789,1,1
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,4.8612e-06,0.2027,0.1885,1,1
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00042998,0.2025,0.18025,1,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.00013917,0.20238,0.15535,1,1
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00013917,0.20204,0.18023,1,1
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0010859,0.20185,0.21651,1,1
2,GO DEVELOPMENTAL MATURATION,2.2658e-06,0.20166,0.20511,1,1
2,GO FEMALE GENITALIA DEVELOPMENT,0.0025817,0.2016,0.20873,1,1
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00012964,0.20155,0.16019,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0007696,0.2013,0.16886,1,1
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,5.6174e-05,0.2013,0.2041,1,1
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0020453,0.2013,0.15602,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00026903,0.20129,0.15574,1,1
2,GO EPITHELIUM DEVELOPMENT,5.6174e-05,0.20116,0.17061,1,1
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00045924,0.20114,0.23898,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0075304,0.20099,0.20511,1,1
2,GO CARBOHYDRATE HOMEOSTASIS,1.349e-05,0.20089,0.1953,1,1
2,GO HEART PROCESS,1.1493e-05,0.20084,0.21775,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0027346,0.20075,0.15852,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.00032948,0.20074,0.17498,1,1
2,GO ACUTE PHASE RESPONSE,0.00030804,0.20065,0.19885,1,1
2,GO REPRODUCTIVE BEHAVIOR,0.030383,0.2005,0.14043,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0075304,0.2005,0.16503,1,1
2,GO STEROID BIOSYNTHETIC PROCESS,0.0081404,0.20043,0.12616,1,1
2,GO REGULATION OF JUN KINASE ACTIVITY,3.4421e-05,0.20042,0.19706,1,1
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.042857,0.20028,0.19418,1,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.017137,0.20024,0.15855,1,1
2,GO LOCALIZATION WITHIN MEMBRANE,0.0064317,0.20007,0.14579,1,1
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0019282,0.19999,0.1761,1,1
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.9263e-05,0.19996,0.19293,1,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION,8.1192e-05,0.1997,0.2034,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0024367,0.19957,0.20177,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.036164,0.19955,0.18481,1,1
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00027832,0.1993,0.23522,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.017969,0.19916,0.12534,1,1
2,GO B CELL HOMEOSTASIS,0.0045306,0.19915,0.22127,1,1
2,GO REGULATION OF BLOOD PRESSURE,0.00035231,0.19907,0.16476,1,1
2,GO GANGLIOSIDE METABOLIC PROCESS,0.001986,0.19892,0.18583,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0071468,0.19874,0.21448,1,1
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,2.8418e-05,0.19873,0.16399,1,1
2,GO REGULATION OF BONE MINERALIZATION,0.001228,0.1987,0.20811,1,1
2,GO POSITIVE REGULATION OF SIGNALING,1.0604e-05,0.19853,0.15884,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.041093,0.19844,0.16286,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.0019282,0.19841,0.18369,1,1
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0013054,0.19821,0.23122,1,1
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0018173,0.19814,0.22784,1,1
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0039469,0.19799,0.16,1,1
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00026003,0.19787,0.18041,1,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,6.2786e-05,0.1975,0.17851,1,1
2,GO CHLORIDE TRANSPORT,0.00010092,0.19736,0.18554,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0010528,0.19732,0.1376,1,1
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.043763,0.19722,0.15326,1,1
2,GO LIPID HOMEOSTASIS,0.00013917,0.19709,0.16132,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0023671,0.19707,0.17022,1,1
2,GO SECRETION,2.2524e-05,0.19689,0.16338,1,1
2,GO TERPENOID METABOLIC PROCESS,0.0018173,0.19687,0.15656,1,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00016595,0.19681,0.18042,1,1
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.011326,0.19677,0.15799,1,1
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0099891,0.19676,0.1351,1,1
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0054795,0.19666,0.17708,1,1
2,GO REGULATION OF LIPID STORAGE,0.00017796,0.19657,0.20596,1,1
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.001662,0.19652,0.1568,1,1
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,9.0551e-05,0.19648,0.15695,1,1
2,GO RESPONSE TO GONADOTROPIN,0.02166,0.19647,0.14258,1,1
2,GO INTEGRIN ACTIVATION,0.0046564,0.19647,0.19943,1,1
2,GO THYMIC T CELL SELECTION,0.00013433,0.19641,0.18969,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.001986,0.19641,0.30382,1,1
2,GO TUBULIN DEACETYLATION,0.0079323,0.19637,0.1903,1,1
2,GO NATURAL KILLER CELL ACTIVATION,0.0013457,0.19634,0.17054,1,1
2,GO CATECHOLAMINE SECRETION,0.0037331,0.19631,0.29504,1,1
2,GO CELL JUNCTION ORGANIZATION,7.547e-05,0.19627,0.17493,1,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00010845,0.19616,0.16866,1,1
2,GO MITOTIC CELL CYCLE ARREST,0.011326,0.19605,0.1848,1,1
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0090226,0.19568,0.16136,1,1
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0053338,0.19551,0.17339,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0001165,0.1955,0.18607,1,1
2,GO ANIMAL ORGAN MORPHOGENESIS,0.00010092,0.19537,0.16221,1,1
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0026572,0.19531,0.16159,1,1
2,GO MEMBRANE HYPERPOLARIZATION,0.0073363,0.19524,0.23413,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0081404,0.19524,0.11805,1,1
2,GO RESPONSE TO DEXAMETHASONE,0.0079323,0.1952,0.14482,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.015953,0.19519,0.1949,1,1
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,8.7323e-05,0.19517,0.16342,1,1
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00353,0.19505,0.13089,1,1
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,2.6307e-05,0.19502,0.20796,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.046579,0.19498,0.14592,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0013054,0.1949,0.16006,1,1
2,GO MYELOID CELL DIFFERENTIATION,0.00021167,0.19476,0.15314,1,1
2,GO RESPONSE TO FATTY ACID,0.0040578,0.19458,0.16262,1,1
2,GO REGULATION OF FERTILIZATION,0.029719,0.19446,0.12587,1,1
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00059588,0.19441,0.19839,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0079323,0.19435,0.21552,1,1
2,GO HUMORAL IMMUNE RESPONSE,1.8521e-05,0.19426,0.24589,1,1
2,GO MALE SEX DIFFERENTIATION,0.00042998,0.19425,0.16157,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.0045306,0.19411,0.16307,1,1
2,GO RESPONSE TO DRUG,0.00092958,0.1937,0.15244,1,1
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,6.0504e-05,0.19356,0.16321,1,1
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.1663e-05,0.19352,0.20889,1,1
2,GO REGULATION OF PROTEOLYSIS,0.001872,0.19349,0.15141,1,1
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00040247,0.19343,0.14715,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0046564,0.1934,0.17344,1,1
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.00045924,0.19334,0.26432,1,1
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.011904,0.19332,0.21971,1,1
2,GO DRINKING BEHAVIOR,0.011047,0.19328,0.33529,1,1
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0060989,0.19325,0.14131,1,1
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0032441,0.19285,0.27839,1,1
2,GO PROTEIN MATURATION,0.0020453,0.1927,0.1294,1,1
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0039469,0.19249,0.17193,1,1
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,8.7323e-05,0.19248,0.16048,1,1
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0019282,0.19243,0.16313,1,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00052342,0.19237,0.1588,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.00054072,0.19226,0.15891,1,1
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.00019753,0.19224,0.16416,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00079435,0.19212,0.17383,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0011549,0.19181,0.17766,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.026586,0.19155,0.21086,1,1
2,GO LYMPHOCYTE HOMEOSTASIS,0.0049174,0.19144,0.15614,1,1
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00040247,0.19136,0.15142,1,1
2,GO MULTICELLULAR ORGANISM AGING,0.00030804,0.19104,0.19546,1,1
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.00032948,0.1909,0.17155,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.004408,0.19086,0.15855,1,1
2,GO FOCAL ADHESION ASSEMBLY,0.001986,0.19086,0.17136,1,1
2,GO REGULATION OF SECRETION,3.1904e-06,0.19057,0.1849,1,1
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00012964,0.19044,0.17813,1,1
2,GO SLEEP,0.0019282,0.19032,0.15862,1,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.0033e-05,0.19029,0.18015,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.013465,0.19005,0.14179,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0051916,0.18997,0.15731,1,1
2,GO HORMONE TRANSPORT,7.3528e-06,0.18997,0.21933,1,1
2,GO RESPONSE TO UV C,0.0085714,0.18995,0.13549,1,1
2,GO HINDBRAIN MORPHOGENESIS,0.0073363,0.18974,0.1469,1,1
2,GO REGULATION OF CHROMATIN BINDING,0.0028141,0.18951,0.17595,1,1
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0062634,0.18938,0.15785,1,1
2,GO RELAXATION OF MUSCLE,0.015574,0.18932,0.17357,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0094949,0.18927,0.24858,1,1
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.013465,0.18926,0.16246,1,1
2,GO REGULATION OF HORMONE LEVELS,3.9418e-06,0.18924,0.19842,1,1
2,GO RESPONSE TO DOPAMINE,0.0011199,0.18919,0.18238,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.02166,0.18912,0.10779,1,1
2,GO REGULATION OF HORMONE SECRETION,1.7118e-05,0.18905,0.20632,1,1
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.0073e-05,0.18903,0.16578,1,1
2,GO RESPONSE TO CALCIUM ION,0.00087311,0.18892,0.16381,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00035231,0.18886,0.23594,1,1
2,GO RESPONSE TO ISCHEMIA,0.0013054,0.18878,0.17214,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.014841,0.18875,0.20981,1,1
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00016023,0.18849,0.15427,1,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.001228,0.18844,0.24409,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00067758,0.18839,0.16957,1,1
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00011241,0.18837,0.15328,1,1
2,GO REGULATION OF VASOCONSTRICTION,0.00054072,0.18832,0.16409,1,1
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0029794,0.18821,0.1747,1,1
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.018398,0.18818,0.12125,1,1
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.4994e-06,0.18812,0.19039,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.7118e-05,0.18797,0.1875,1,1
2,GO RESPONSE TO AMYLOID BETA,0.0013872,0.18796,0.18764,1,1
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.023741,0.18794,0.2389,1,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00010462,0.18791,0.17061,1,1
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00050664,0.18783,0.12916,1,1
2,GO MUSCLE CELL DEVELOPMENT,0.00028792,0.1878,0.18219,1,1
2,GO RESPONSE TO BACTERIUM,0.0014738,0.18759,0.15778,1,1
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00017186,0.18749,0.16376,1,1
2,GO PLASMA MEMBRANE ORGANIZATION,0.00072223,0.18745,0.18707,1,1
2,GO ERBB SIGNALING PATHWAY,0.0014299,0.18745,0.16711,1,1
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,3.7145e-05,0.18743,0.17059,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.0027346,0.18721,0.15006,1,1
2,GO ACTION POTENTIAL,0.001191,0.1871,0.18853,1,1
2,GO ENDOCYTIC RECYCLING,0.0006154,0.18693,0.1651,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010506,0.18691,0.13623,1,1
2,GO MUSCLE ADAPTATION,0.0021062,0.18688,0.16434,1,1
2,GO REGULATION OF PHOSPHORYLATION,5.4121e-05,0.18687,0.15061,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,4.3218e-05,0.18669,0.14461,1,1
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00079435,0.18666,0.19462,1,1
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00010845,0.18665,0.19479,1,1
2,GO BONE MATURATION,0.016339,0.18651,0.16777,1,1
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0039469,0.18648,0.15075,1,1
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,8.1192e-05,0.18641,0.17836,1,1
2,GO LIPID EXPORT FROM CELL,0.014841,0.18626,0.14966,1,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.0015189,0.18618,0.16622,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00017796,0.1861,0.20862,1,1
2,GO REGULATION OF CELL DIFFERENTIATION,1.9263e-05,0.18608,0.16169,1,1
2,GO P38MAPK CASCADE,0.0083534,0.18606,0.16673,1,1
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0079323,0.18598,0.17365,1,1
2,GO NEUTROPHIL MIGRATION,0.0051916,0.18587,0.11753,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0045306,0.18575,0.13572,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.02068,0.18573,0.12928,1,1
2,GO FIBROBLAST PROLIFERATION,0.0023671,0.1856,0.2364,1,1
2,GO ANATOMICAL STRUCTURE MATURATION,1.6729e-06,0.18544,0.17648,1,1
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,6.5149e-05,0.18525,0.15801,1,1
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.044685,0.1852,0.11618,1,1
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00013433,0.18514,0.15559,1,1
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,6.0504e-05,0.18514,0.15459,1,1
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00045924,0.18503,0.23168,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0023671,0.18501,0.17662,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.0059384,0.18496,0.18216,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.001872,0.18495,0.18765,1,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00047456,0.18483,0.18116,1,1
2,GO POTASSIUM ION TRANSPORT,0.00017186,0.18478,0.20405,1,1
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0001165,0.18477,0.16374,1,1
2,GO TAXIS,3.7145e-05,0.18462,0.17386,1,1
2,GO AMINE METABOLIC PROCESS,0.0056288,0.18453,0.13118,1,1
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00029782,0.18451,0.17667,1,1
2,GO REGULATION OF ION TRANSPORT,5.0226e-05,0.18447,0.1688,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.036164,0.18446,0.14895,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.040234,0.18444,0.099619,1,1
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,4.8379e-05,0.18402,0.17469,1,1
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0032441,0.18387,0.21417,1,1
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0023671,0.18382,0.2007,1,1
2,GO THYROID HORMONE METABOLIC PROCESS,0.001986,0.18378,0.1959,1,1
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.9263e-05,0.18376,0.15323,1,1
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0085714,0.18373,0.17176,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0054795,0.18348,0.22338,1,1
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.00057693,0.18328,0.15982,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00035231,0.18326,0.13961,1,1
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0059384,0.18311,0.17368,1,1
2,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.024288,0.183,0.16534,1,1
2,GO REGULATION OF EXIT FROM MITOSIS,0.014841,0.18297,0.12357,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0022332,0.18297,0.18775,1,1
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,9.0551e-05,0.18289,0.14127,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.010506,0.18288,0.16702,1,1
2,GO INORGANIC ANION TRANSPORT,0.00012964,0.18285,0.16508,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0050528,0.18267,0.13311,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0007696,0.18247,0.14302,1,1
2,GO MEMBRANE FUSION,0.0017641,0.18217,0.15563,1,1
2,GO SECOND MESSENGER MEDIATED SIGNALING,1.4039e-05,0.18181,0.16928,1,1
2,GO ADULT FEEDING BEHAVIOR,0.022165,0.18175,0.16982,1,1
2,GO NEGATIVE REGULATION OF GROWTH,6.2786e-05,0.18161,0.17308,1,1
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.001986,0.18151,0.25418,1,1
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.001191,0.1814,0.14349,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0073363,0.18138,0.1297,1,1
2,GO REGULATION OF MAPK CASCADE,0.00012964,0.18136,0.19184,1,1
2,GO CELL GROWTH,2.6307e-05,0.18126,0.17144,1,1
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0017641,0.18122,0.17975,1,1
2,GO ER OVERLOAD RESPONSE,0.040234,0.18122,0.1412,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0021062,0.18084,0.17763,1,1
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00032948,0.18075,0.23897,1,1
2,GO LIPID METABOLIC PROCESS,0.00021167,0.18073,0.14366,1,1
2,GO POSTSYNAPSE ORGANIZATION,0.011047,0.18067,0.16603,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.001872,0.18059,0.12942,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00014418,0.18025,0.14431,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00047456,0.17988,0.18149,1,1
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.00011241,0.17959,0.15365,1,1
2,GO REGULATION OF CELL SHAPE,0.00049035,0.1794,0.18096,1,1
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0019282,0.17934,0.15506,1,1
2,GO RESPONSE TO LIPID,0.0013457,0.17924,0.14365,1,1
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,2.4346e-05,0.17908,0.20057,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.013139,0.17885,0.19204,1,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00095906,0.17877,0.13664,1,1
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.00098941,0.17867,0.15674,1,1
2,GO TEMPERATURE HOMEOSTASIS,2.5774e-06,0.17865,0.2011,1,1
2,GO RESPONSE TO STEROID HORMONE,0.0010528,0.17861,0.14825,1,1
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00042998,0.1786,0.13391,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0034322,0.17839,0.2349,1,1
2,GO RESPONSE TO PROGESTERONE,0.0067808,0.17831,0.18274,1,1
2,GO EAR MORPHOGENESIS,0.00055855,0.17822,0.14571,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.004408,0.17813,0.1213,1,1
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0011199,0.17798,0.13992,1,1
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,2.0833e-05,0.17793,0.14878,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.018836,0.17785,0.12858,1,1
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0094949,0.17782,0.20393,1,1
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00072223,0.1776,0.12932,1,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00050664,0.17742,0.13779,1,1
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00028792,0.17741,0.18234,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING,0.0026572,0.1774,0.17042,1,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.012508,0.17728,0.19174,1,1
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.0023671,0.17724,0.14836,1,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00063551,0.17723,0.12954,1,1
2,GO FEEDING BEHAVIOR,0.00019753,0.17721,0.15956,1,1
2,GO RESPONSE TO ACETYLCHOLINE,0.011326,0.17708,0.21207,1,1
2,GO REGULATION OF PH,0.0020453,0.17693,0.10922,1,1
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.033894,0.1769,0.13446,1,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00013433,0.17686,0.14116,1,1
2,GO APOPTOTIC SIGNALING PATHWAY,0.00087311,0.17651,0.13711,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.023205,0.1761,0.10319,1,1
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,4.6597e-05,0.1761,0.14379,1,1
2,GO IMPORT INTO CELL,0.00044439,0.17609,0.17285,1,1
2,GO ACID SECRETION,0.00095906,0.17603,0.19304,1,1
2,GO PEPTIDE HORMONE SECRETION,4.6597e-05,0.176,0.20924,1,1
2,GO DIET INDUCED THERMOGENESIS,0.014138,0.17595,0.1519,1,1
2,GO LIPID MODIFICATION,0.00013433,0.17584,0.14606,1,1
2,GO CIRCULATORY SYSTEM PROCESS,7.6603e-06,0.1758,0.17974,1,1
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.015574,0.17561,0.21575,1,1
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0010528,0.1755,0.18365,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.010773,0.17543,0.10304,1,1
2,GO ANIMAL ORGAN MATURATION,0.00090094,0.17537,0.2217,1,1
2,GO SKELETAL MUSCLE CONTRACTION,0.0013054,0.17532,0.18664,1,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0016129,0.17505,0.15593,1,1
2,GO REGULATION OF HAIR CYCLE,0.0019282,0.17504,0.16969,1,1
2,GO CALCIUM MEDIATED SIGNALING,1.2962e-05,0.1749,0.15524,1,1
2,GO MONOVALENT INORGANIC CATION TRANSPORT,2.6307e-05,0.17488,0.1805,1,1
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0015653,0.17454,0.14682,1,1
2,GO RESPONSE TO GROWTH FACTOR,0.00037661,0.17452,0.1565,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,9.7346e-05,0.17449,0.14149,1,1
2,GO ER NUCLEUS SIGNALING PATHWAY,0.0069616,0.17447,0.14362,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.0184e-05,0.17443,0.16282,1,1
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.013465,0.17423,0.22614,1,1
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.015953,0.17408,0.11205,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019282,0.17406,0.19346,1,1
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0018173,0.17404,0.12912,1,1
2,GO REGULATION OF LIPID TRANSPORT,0.00041602,0.17375,0.16981,1,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.00026003,0.17374,0.13149,1,1
2,GO REGULATION OF LIPID LOCALIZATION,0.0010206,0.17373,0.15866,1,1
2,GO RESPONSE TO METAL ION,2.9532e-05,0.17365,0.18527,1,1
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00045924,0.17361,0.14677,1,1
2,GO CHEMICAL HOMEOSTASIS,6.2367e-06,0.17343,0.16235,1,1
2,GO LENS FIBER CELL DIFFERENTIATION,0.0028141,0.17342,0.20106,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0025083,0.17322,0.17617,1,1
2,GO ACROSOME REACTION,0.0069616,0.17312,0.15701,1,1
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00032948,0.17278,0.12561,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00012512,0.17267,0.1653,1,1
2,GO SENSORY PERCEPTION OF PAIN,0.0018173,0.17256,0.15593,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,2.0033e-05,0.17206,0.1505,1,1
2,GO EXCRETION,5.8301e-05,0.17204,0.19029,1,1
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.041093,0.1718,0.15307,1,1
2,GO INSULIN SECRETION,9.0551e-05,0.17172,0.19988,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0024367,0.1716,0.18684,1,1
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0017641,0.17125,0.23545,1,1
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.045624,0.17115,0.076891,1,1
2,GO DETECTION OF ABIOTIC STIMULUS,5.8301e-05,0.17114,0.16995,1,1
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.00087311,0.171,0.17602,1,1
2,GO POSITIVE T CELL SELECTION,0.00069957,0.17099,0.15425,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0006154,0.17077,0.18892,1,1
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.014486,0.17068,0.11668,1,1
2,GO RESPONSE TO ESTRADIOL,0.00084609,0.17066,0.14821,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00021167,0.17059,0.12285,1,1
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.00020448,0.17022,0.14626,1,1
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,9.0551e-05,0.17007,0.17478,1,1
2,GO MULTICELLULAR ORGANISM GROWTH,0.00028792,0.17004,0.12969,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.001191,0.16993,0.23999,1,1
2,GO STRIATED MUSCLE CONTRACTION,0.00049035,0.16984,0.15823,1,1
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00012512,0.1696,0.17049,1,1
2,GO MUSCLE FIBER DEVELOPMENT,0.011612,0.1692,0.14021,1,1
2,GO NEGATIVE REGULATION OF SIGNALING,9.389e-05,0.16911,0.14206,1,1
2,GO RESPONSE TO INSULIN,0.00030804,0.1691,0.13819,1,1
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0053338,0.16907,0.19381,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0085714,0.16888,0.1428,1,1
2,GO RESPONSE TO ENDOGENOUS STIMULUS,9.389e-05,0.16877,0.14186,1,1
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.3218e-05,0.16872,0.18289,1,1
2,GO CELL AGGREGATION,0.01282,0.16866,0.1717,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0025083,0.16841,0.15018,1,1
2,GO VACUOLAR TRANSPORT,0.004408,0.16838,0.11096,1,1
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,8.3127e-06,0.16817,0.23302,1,1
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0039469,0.16789,0.11835,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0038387,0.16772,0.14299,1,1
2,GO JNK CASCADE,0.00012964,0.16761,0.15501,1,1
2,GO T CELL SELECTION,0.00028792,0.16751,0.15927,1,1
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0011199,0.1674,0.13196,1,1
2,GO DETECTION OF STIMULUS,1.7118e-05,0.16735,0.14912,1,1
2,GO AUTOPHAGOSOME ORGANIZATION,0.00069957,0.16729,0.14375,1,1
2,GO TRANSFERRIN TRANSPORT,0.042857,0.16724,0.094828,1,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.017137,0.16707,0.13421,1,1
2,GO METAL ION HOMEOSTASIS,2.3418e-05,0.16707,0.14516,1,1
2,GO PIGMENTATION,0.0014738,0.16697,0.12165,1,1
2,GO ION HOMEOSTASIS,2.9532e-05,0.1664,0.14063,1,1
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.001872,0.16639,0.13033,1,1
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.00022676,0.16633,0.15871,1,1
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,8.1192e-05,0.16629,0.12981,1,1
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00012074,0.16619,0.14258,1,1
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.02068,0.16615,0.20227,1,1
2,GO LIPID OXIDATION,0.0018173,0.16612,0.16932,1,1
2,GO RHYTHMIC BEHAVIOR,0.0026572,0.1661,0.15178,1,1
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.013798,0.16605,0.19711,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.015574,0.16598,0.15419,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0040578,0.16597,0.12439,1,1
2,GO RESPONSE TO FUNGUS,0.00065623,0.16593,0.17523,1,1
2,GO T CELL DIFFERENTIATION IN THYMUS,0.00054072,0.16583,0.16574,1,1
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00014418,0.16576,0.14175,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.027803,0.16563,0.095492,1,1
2,GO SENSORY PERCEPTION OF SMELL,0.00063551,0.16555,0.13154,1,1
2,GO REGULATION OF TRANSPORT,1.6455e-05,0.1654,0.14297,1,1
2,GO HOMEOSTATIC PROCESS,5.2139e-05,0.16516,0.12608,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0023671,0.16498,0.14399,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.040234,0.16477,0.085509,1,1
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,9.7346e-05,0.16469,0.15946,1,1
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0015189,0.16456,0.14405,1,1
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.0030654,0.16456,0.16241,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0040578,0.1645,0.17256,1,1
2,GO REGULATION OF GLUTAMATE SECRETION,0.017969,0.16434,0.2396,1,1
2,GO COLLATERAL SPROUTING,0.011326,0.16433,0.17903,1,1
2,GO VACUOLE ORGANIZATION,0.00052342,0.16424,0.13116,1,1
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.019739,0.16421,0.16865,1,1
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.015574,0.1642,0.1281,1,1
2,GO CIRCADIAN RHYTHM,1.3441e-06,0.16407,0.1736,1,1
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0014738,0.16397,0.13303,1,1
2,GO CHOLESTEROL STORAGE,0.0026572,0.1639,0.22089,1,1
2,GO LYSOSOME LOCALIZATION,0.00042998,0.16388,0.15494,1,1
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.014138,0.16388,0.16402,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,0.0013872,0.16388,0.16197,1,1
2,GO CELLULAR RESPONSE TO PEPTIDE,9.389e-05,0.16374,0.13476,1,1
2,GO HINDBRAIN DEVELOPMENT,0.00020448,0.16368,0.20154,1,1
2,GO METAL ION TRANSPORT,4.6597e-05,0.16327,0.14645,1,1
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.011047,0.16315,0.11766,1,1
2,GO EXPLORATION BEHAVIOR,0.010245,0.16304,0.20654,1,1
2,GO CELL CELL SIGNALING,5.0226e-05,0.16288,0.14982,1,1
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.00047456,0.16269,0.12533,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00037661,0.16266,0.17562,1,1
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0011549,0.16256,0.12238,1,1
2,GO PROTEOLYSIS,0.0013872,0.16243,0.10365,1,1
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0031536,0.16238,0.10125,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.0066042,0.16232,0.18945,1,1
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.001662,0.16229,0.11897,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00090094,0.16213,0.2193,1,1
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.033894,0.16202,0.18034,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.024846,0.16194,0.12899,1,1
2,GO ORGANELLE MEMBRANE FUSION,0.013798,0.16127,0.12651,1,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00092958,0.16118,0.12871,1,1
2,GO POSITIVE REGULATION OF MAPK CASCADE,7.8282e-05,0.16106,0.19649,1,1
2,GO NEUROMUSCULAR PROCESS,0.0024367,0.16097,0.15703,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0020453,0.16087,0.18617,1,1
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00098941,0.1608,0.16496,1,1
2,GO POSITIVE THYMIC T CELL SELECTION,0.0011199,0.16079,0.24828,1,1
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.011047,0.16067,0.13811,1,1
2,GO GLUTAMATE METABOLIC PROCESS,0.0062634,0.16041,0.13204,1,1
2,GO REGULATION OF RESPONSE TO STRESS,0.0015189,0.16037,0.11027,1,1
2,GO NEGATIVE REGULATION OF NEURON DEATH,2.2524e-05,0.16014,0.14625,1,1
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.02068,0.16012,0.15812,1,1
2,GO ADULT LOCOMOTORY BEHAVIOR,0.0069616,0.16001,0.17739,1,1
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,4.0073e-05,0.15994,0.16759,1,1
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0062634,0.15982,0.18957,1,1
2,GO RESPONSE TO HORMONE,0.00055855,0.15957,0.12757,1,1
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00011241,0.15941,0.15579,1,1
2,GO NOTCH RECEPTOR PROCESSING,0.013798,0.15933,0.28707,1,1
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00029782,0.15906,0.13713,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.021165,0.15885,0.13133,1,1
2,GO CATION TRANSPORT,7.2754e-05,0.15877,0.14187,1,1
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0069616,0.15874,0.20836,1,1
2,GO VESICLE ORGANIZATION,0.0017123,0.15867,0.11485,1,1
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.001986,0.15857,0.1183,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0024367,0.15854,0.14501,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0019282,0.1584,0.13294,1,1
2,GO IRON ION TRANSPORT,0.014841,0.15829,0.085159,1,1
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.00012964,0.15824,0.12949,1,1
2,GO GLUCOSE METABOLIC PROCESS,5.4121e-05,0.15813,0.15747,1,1
2,GO OSTEOCLAST DIFFERENTIATION,0.0025083,0.15805,0.12903,1,1
2,GO CELLULAR RESPONSE TO FATTY ACID,0.0038387,0.15798,0.17807,1,1
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.037747,0.15797,0.13309,1,1
2,GO EMBRYONIC MORPHOGENESIS,0.00021909,0.15787,0.14837,1,1
2,GO EMBRYONIC ORGAN DEVELOPMENT,4.1617e-05,0.15781,0.16362,1,1
2,GO GROWTH,7.8282e-05,0.15779,0.14369,1,1
2,GO SCHWANN CELL DEVELOPMENT,0.0057817,0.15772,0.14207,1,1
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0006154,0.15762,0.1474,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0057817,0.15759,0.14324,1,1
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.0007696,0.15749,0.11494,1,1
2,GO SYNAPSE ORGANIZATION,0.0046564,0.15714,0.16291,1,1
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,5.4121e-05,0.15714,0.1698,1,1
2,GO CATION TRANSMEMBRANE TRANSPORT,0.00013917,0.1571,0.1383,1,1
2,GO CELLULAR RESPONSE TO STARVATION,0.00010092,0.15709,0.1734,1,1
2,GO DEFENSE RESPONSE TO FUNGUS,0.025994,0.15708,0.11248,1,1
2,GO BEHAVIOR,0.00042998,0.15692,0.15202,1,1
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0083534,0.15647,0.16685,1,1
2,GO DORSAL VENTRAL PATTERN FORMATION,0.0053338,0.15641,0.16785,1,1
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00063551,0.15637,0.15693,1,1
2,GO RESPONSE TO COCAINE,0.012508,0.15634,0.16009,1,1
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00065623,0.15632,0.16826,1,1
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.0085714,0.15627,0.16403,1,1
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.012203,0.15625,0.12998,1,1
2,GO REGULATION OF CELL MORPHOGENESIS,0.0025083,0.15606,0.1388,1,1
2,GO NEUTROPHIL CHEMOTAXIS,0.0097392,0.15585,0.10677,1,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.016734,0.15579,0.096959,1,1
2,GO PROTEIN DESTABILIZATION,0.0016129,0.15566,0.14682,1,1
2,GO REGULATION OF INSULIN SECRETION,0.00026903,0.1556,0.17726,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00057693,0.15558,0.17029,1,1
2,GO REGULATION OF INTEGRIN ACTIVATION,0.0075304,0.15554,0.18304,1,1
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,4.8379e-05,0.15549,0.16384,1,1
2,GO ACTIVATION OF MAPKK ACTIVITY,0.0022992,0.15545,0.19153,1,1
2,GO VESICLE BUDDING FROM MEMBRANE,0.041967,0.15528,0.086037,1,1
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00032948,0.15502,0.12993,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.014841,0.15472,0.20865,1,1
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0026572,0.15465,0.14969,1,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,9.7346e-05,0.15465,0.12541,1,1
2,GO RECEPTOR METABOLIC PROCESS,0.00081984,0.15453,0.1303,1,1
2,GO RESPONSE TO ACID CHEMICAL,0.0019282,0.15444,0.14697,1,1
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.00032948,0.15421,0.14049,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00031859,0.15409,0.16084,1,1
2,GO SINGLE FERTILIZATION,0.0015189,0.154,0.11106,1,1
2,GO ACTIN FILAMENT BASED PROCESS,0.00079435,0.15399,0.12733,1,1
2,GO LYSOSOMAL TRANSPORT,0.0025817,0.15394,0.1297,1,1
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00016595,0.15394,0.14042,1,1
2,GO CELLULAR RESPONSE TO ALKALOID,0.00098941,0.15381,0.18093,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.00049035,0.15359,0.13549,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.024846,0.15353,0.098757,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00045924,0.15351,0.16041,1,1
2,GO PRESYNAPSE ORGANIZATION,0.018836,0.15343,0.18272,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.036948,0.15341,0.13325,1,1
2,GO DIGESTION,0.001872,0.15317,0.15554,1,1
2,GO EXECUTION PHASE OF APOPTOSIS,6.0504e-05,0.15277,0.14802,1,1
2,GO HORMONE METABOLIC PROCESS,0.00040247,0.15274,0.15401,1,1
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0017641,0.1526,0.14571,1,1
2,GO ANION TRANSPORT,0.00013917,0.15257,0.12251,1,1
2,GO RESPONSE TO ABIOTIC STIMULUS,0.00049035,0.15237,0.10915,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0019282,0.15234,0.1299,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.0017123,0.15232,0.14751,1,1
2,GO NEGATIVE REGULATION OF CELL GROWTH,4.6597e-05,0.15226,0.17844,1,1
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0075304,0.15204,0.13318,1,1
2,GO CANONICAL WNT SIGNALING PATHWAY,0.001872,0.152,0.12055,1,1
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0020453,0.15194,0.15635,1,1
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00029782,0.15193,0.13953,1,1
2,GO DENDRITIC SPINE MAINTENANCE,0.0099891,0.15176,0.14411,1,1
2,GO REGULATION OF CELLULAR PH,0.014486,0.1511,0.084235,1,1
2,GO CELLULAR EXTRAVASATION,0.00353,0.15101,0.14139,1,1
2,GO APOPTOTIC PROCESS,0.00035231,0.15097,0.12144,1,1
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00098941,0.15088,0.19284,1,1
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.021165,0.15084,0.25942,1,1
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0045306,0.15081,0.22832,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0099891,0.15045,0.10779,1,1
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0033369,0.15008,0.15411,1,1
2,GO NEGATIVE T CELL SELECTION,0.0081404,0.14991,0.19907,1,1
2,GO REGULATION OF PEPTIDE TRANSPORT,6.4994e-06,0.14985,0.14542,1,1
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0081404,0.14982,0.14206,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.0031536,0.14971,0.12328,1,1
2,GO MUSCLE SYSTEM PROCESS,0.00054072,0.14968,0.12766,1,1
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0029794,0.1496,0.16065,1,1
2,GO ION TRANSPORT,4.6597e-05,0.14951,0.14138,1,1
2,GO ADAPTIVE THERMOGENESIS,1.5816e-05,0.14949,0.18931,1,1
2,GO NEURON APOPTOTIC PROCESS,8.1192e-05,0.14943,0.13646,1,1
2,GO POSITIVE REGULATION OF NEURON DEATH,0.00079435,0.14942,0.16843,1,1
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.00016023,0.14924,0.14298,1,1
2,GO REGULATION OF GROWTH,1.9263e-05,0.1492,0.15621,1,1
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00017796,0.14917,0.15224,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.012203,0.14893,0.1289,1,1
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00021909,0.14865,0.1274,1,1
2,GO GLUCOSE IMPORT,0.012203,0.14865,0.1136,1,1
2,GO ENDOSOME ORGANIZATION,0.030383,0.14856,0.082715,1,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0022332,0.14846,0.11997,1,1
2,GO RESPONSE TO KETONE,0.0059384,0.14829,0.12461,1,1
2,GO ZINC ION TRANSPORT,0.015203,0.14815,0.11726,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0033369,0.14803,0.096246,1,1
2,GO NEUROBLAST PROLIFERATION,0.0081404,0.14795,0.16121,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00353,0.1478,0.10196,1,1
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00021909,0.14779,0.13309,1,1
2,GO FACE DEVELOPMENT,0.040234,0.14776,0.12783,1,1
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0036303,0.14772,0.15164,1,1
2,GO RESPONSE TO PEPTIDE,0.00032948,0.14758,0.12687,1,1
2,GO MEMBRANE ORGANIZATION,0.0006154,0.14746,0.11821,1,1
2,GO REPRODUCTION,0.00012074,0.14743,0.12393,1,1
2,GO ION TRANSMEMBRANE TRANSPORT,5.8301e-05,0.14735,0.14289,1,1
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.00023468,0.14718,0.12706,1,1
2,GO SENSORY PERCEPTION,1.5816e-05,0.14709,0.13095,1,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0007696,0.14704,0.11825,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.019283,0.14702,0.11628,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION,0.00014418,0.14695,0.11893,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.0046564,0.14695,0.1044,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.036164,0.14694,0.18419,1,1
2,GO LIPID CATABOLIC PROCESS,0.0013054,0.1468,0.12661,1,1
2,GO CAMERA TYPE EYE DEVELOPMENT,0.00084609,0.14678,0.12201,1,1
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.001662,0.14662,0.12533,1,1
2,GO NERVOUS SYSTEM PROCESS,5.6174e-05,0.14661,0.14144,1,1
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00010845,0.14647,0.12251,1,1
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.00020448,0.14626,0.18009,1,1
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.024288,0.14625,0.10427,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.00055855,0.14618,0.12729,1,1
2,GO CELL VOLUME HOMEOSTASIS,0.0010859,0.14608,0.12738,1,1
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.0013054,0.14607,0.12088,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0025817,0.146,0.13439,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0042883,0.14595,0.13204,1,1
2,GO DEVELOPMENTAL CELL GROWTH,0.0014738,0.1459,0.16276,1,1
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0025083,0.14588,0.14011,1,1
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0010206,0.14574,0.1309,1,1
2,GO MAINTENANCE OF LOCATION,0.0014738,0.14556,0.12354,1,1
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.00072223,0.14552,0.13747,1,1
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00037661,0.14523,0.12521,1,1
2,GO REGULATION OF MUSCLE CONTRACTION,0.0014738,0.14516,0.12385,1,1
2,GO RESPONSE TO OXYGEN LEVELS,0.0011199,0.14508,0.13751,1,1
2,GO RESPONSE TO STARVATION,0.00012512,0.14495,0.1711,1,1
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.0020453,0.14482,0.13007,1,1
2,GO AGING,0.0037331,0.14481,0.111,1,1
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,6.5149e-05,0.14479,0.13102,1,1
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0023671,0.14469,0.15091,1,1
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,5.2139e-05,0.14468,0.13492,1,1
2,GO DEVELOPMENTAL GROWTH,0.00054072,0.14444,0.13343,1,1
2,GO REGULATION OF CELL DEATH,0.00065623,0.14434,0.11647,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.016339,0.14429,0.1146,1,1
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0010206,0.1441,0.13825,1,1
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0013054,0.14403,0.15212,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.016339,0.14398,0.14686,1,1
2,GO RESPONSE TO NITROGEN COMPOUND,0.00020448,0.14383,0.12108,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0015189,0.14383,0.12349,1,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.025414,0.1436,0.083046,1,1
2,GO RESPONSE TO MONOSACCHARIDE,0.00037661,0.14325,0.13379,1,1
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.001662,0.14299,0.16379,1,1
2,GO GOLGI RIBBON FORMATION,0.013798,0.14295,0.15403,1,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.025994,0.14283,0.11201,1,1
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00090094,0.14258,0.1374,1,1
2,GO REGULATION OF METAL ION TRANSPORT,0.00019079,0.14256,0.14071,1,1
2,GO MIDBRAIN DEVELOPMENT,0.00074557,0.14246,0.13128,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0007696,0.14245,0.11978,1,1
2,GO RHYTHMIC PROCESS,2.4346e-05,0.14233,0.13236,1,1
2,GO MUSCLE ORGAN MORPHOGENESIS,0.0019282,0.14228,0.14866,1,1
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0034322,0.14218,0.15683,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.0021062,0.14187,0.10548,1,1
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0017123,0.14145,0.13165,1,1
2,GO REGULATION OF GLUCOSE IMPORT,0.033894,0.14133,0.097754,1,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0031536,0.14131,0.12693,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.017137,0.14122,0.089112,1,1
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00035231,0.14101,0.14445,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0071468,0.1409,0.15982,1,1
2,GO SENSORY ORGAN MORPHOGENESIS,0.00049035,0.14085,0.13147,1,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.046579,0.14063,0.18223,1,1
2,GO ESTABLISHMENT OF CELL POLARITY,0.017549,0.1403,0.096688,1,1
2,GO NEGATIVE CHEMOTAXIS,0.041093,0.14027,0.14741,1,1
2,GO RESPONSE TO CARBOHYDRATE,0.00063551,0.13973,0.12516,1,1
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0037331,0.13954,0.20114,1,1
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.007729,0.13947,0.15789,1,1
2,GO ORGANIC ANION TRANSPORT,0.00036427,0.13941,0.11447,1,1
2,GO EYE MORPHOGENESIS,0.0011549,0.13921,0.13875,1,1
2,GO KERATINOCYTE MIGRATION,0.013798,0.13904,0.14526,1,1
2,GO TRANSMEMBRANE TRANSPORT,0.00021167,0.13898,0.11881,1,1
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00037661,0.13896,0.14291,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.007729,0.13884,0.24987,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0038387,0.13873,0.16295,1,1
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.023205,0.13871,0.13138,1,1
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00050664,0.13813,0.1469,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0028141,0.13782,0.12778,1,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.018836,0.13762,0.11588,1,1
2,GO WATER TRANSPORT,0.025414,0.13757,0.1186,1,1
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.030383,0.13756,0.15449,1,1
2,GO REGULATION OF T CELL MIGRATION,0.00050664,0.13754,0.19239,1,1
2,GO DEMETHYLATION,0.00010462,0.1375,0.14843,1,1
2,GO ANION TRANSMEMBRANE TRANSPORT,0.00012964,0.13736,0.13114,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0025083,0.13691,0.15033,1,1
2,GO HEART DEVELOPMENT,0.0023671,0.13688,0.11121,1,1
2,GO POSITIVE REGULATION OF CELL GROWTH,0.00011241,0.13657,0.15438,1,1
2,GO CELLULAR RESPONSE TO KETONE,0.027803,0.13644,0.11155,1,1
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0013457,0.13625,0.13128,1,1
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0033369,0.13619,0.12641,1,1
2,GO NEURON DEATH,9.7801e-06,0.13616,0.1497,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.011612,0.13566,0.14601,1,1
2,GO SMOOTH MUSCLE CONTRACTION,0.010506,0.13546,0.12683,1,1
2,GO POSTREPLICATION REPAIR,0.016734,0.13524,0.095953,1,1
2,GO SEX DIFFERENTIATION,0.00026003,0.13513,0.13127,1,1
2,GO HEART VALVE DEVELOPMENT,0.035393,0.13489,0.12321,1,1
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.010773,0.13483,0.14159,1,1
2,GO FEMALE SEX DIFFERENTIATION,0.00014418,0.13465,0.16421,1,1
2,GO RESPONSE TO PEPTIDE HORMONE,0.00092958,0.13464,0.1095,1,1
2,GO MUSCLE TISSUE DEVELOPMENT,0.0025817,0.13424,0.099444,1,1
2,GO NEGATIVE REGULATION OF SECRETION,0.00025131,0.1341,0.123,1,1
2,GO REGULATION OF PROTEIN STABILITY,0.043763,0.13402,0.06588,1,1
2,GO RESPONSE TO ETHANOL,0.0023671,0.13397,0.13309,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0015189,0.13392,0.10605,1,1
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0020453,0.13369,0.096778,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00020448,0.13367,0.11867,1,1
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.0045306,0.13359,0.11091,1,1
2,GO ROOF OF MOUTH DEVELOPMENT,0.024846,0.13355,0.12623,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0073363,0.13335,0.083333,1,1
2,GO CELLULAR ION HOMEOSTASIS,7.2754e-05,0.13322,0.12253,1,1
2,GO REGULATION OF ENDOCYTOSIS,0.0085714,0.13312,0.1018,1,1
2,GO RUFFLE ASSEMBLY,0.024846,0.13302,0.13952,1,1
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.022165,0.13292,0.085692,1,1
2,GO NATURAL KILLER CELL PROLIFERATION,0.018398,0.1329,0.21775,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.00032948,0.13288,0.13032,1,1
2,GO CELLULAR PIGMENTATION,0.020205,0.13286,0.094853,1,1
2,GO REGULATION OF CIRCADIAN RHYTHM,0.0032441,0.13275,0.12889,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0060989,0.13274,0.11162,1,1
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.009256,0.13258,0.13087,1,1
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,4.1617e-05,0.13256,0.14338,1,1
2,GO SIGNAL RELEASE,2.7343e-05,0.13255,0.17618,1,1
2,GO ENDOCYTOSIS,0.0022332,0.13251,0.11174,1,1
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00047456,0.1325,0.18211,1,1
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0025083,0.13223,0.10374,1,1
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0040578,0.13206,0.11965,1,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.0042883,0.13199,0.14072,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.036164,0.13197,0.097552,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0023671,0.1319,0.10559,1,1
2,GO SENSORY ORGAN DEVELOPMENT,0.00028792,0.13153,0.13574,1,1
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.00095906,0.13149,0.14656,1,1
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.018836,0.13145,0.10873,1,1
2,GO MACROPHAGE ACTIVATION,0.0017641,0.13142,0.20793,1,1
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0015189,0.13133,0.15497,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00012512,0.13128,0.11444,1,1
2,GO HEART MORPHOGENESIS,0.0050528,0.13089,0.11971,1,1
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0017123,0.1307,0.13128,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.001191,0.13041,0.11592,1,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.023205,0.13033,0.12214,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.016339,0.13033,0.089584,1,1
2,GO ADHERENS JUNCTION ORGANIZATION,0.0054795,0.13014,0.15774,1,1
2,GO REGIONALIZATION,0.00037661,0.13007,0.16152,1,1
2,GO STEM CELL PROLIFERATION,0.0021689,0.13003,0.14886,1,1
2,GO ONE CARBON COMPOUND TRANSPORT,0.0087944,0.13002,0.15772,1,1
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.0097392,0.12999,0.13914,1,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.0017641,0.12989,0.1106,1,1
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00021909,0.12954,0.13261,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0081404,0.12953,0.20977,1,1
2,GO APPENDAGE DEVELOPMENT,0.035393,0.12949,0.11655,1,1
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.02068,0.12946,0.15111,1,1
2,GO RETINOL METABOLIC PROCESS,0.030383,0.12944,0.10826,1,1
2,GO RESPONSE TO CHEMOKINE,0.0017641,0.12937,0.1243,1,1
2,GO PROTEIN AUTOUBIQUITINATION,0.00047456,0.12935,0.12111,1,1
2,GO REGULATION OF DNA BINDING,0.0011549,0.12931,0.12456,1,1
2,GO REGULATION OF AUTOPHAGY,0.00037661,0.12919,0.10707,1,1
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.024288,0.12895,0.15548,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0087944,0.12892,0.12596,1,1
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0041716,0.12872,0.1096,1,1
2,GO PHOSPHATE ION TRANSPORT,0.02268,0.12828,0.1179,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00022676,0.12827,0.14183,1,1
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0056288,0.12824,0.11016,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0013054,0.12817,0.12085,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0047853,0.12813,0.11261,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0059384,0.12807,0.15983,1,1
2,GO SKELETAL SYSTEM DEVELOPMENT,0.0020453,0.12801,0.11697,1,1
2,GO REGULATION OF CELL DEVELOPMENT,0.00044439,0.12788,0.14149,1,1
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0028141,0.12783,0.15053,1,1
2,GO REGULATION OF BINDING,0.00030804,0.12756,0.12312,1,1
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0011549,0.12743,0.12192,1,1
2,GO CARDIAC MUSCLE CONTRACTION,0.0064317,0.12732,0.13555,1,1
2,GO CELL CELL SIGNALING BY WNT,0.0014299,0.12725,0.11352,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0007696,0.12715,0.12793,1,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0083534,0.12702,0.12357,1,1
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.02843,0.12697,0.13068,1,1
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.030383,0.12679,0.15043,1,1
2,GO REGULATION OF VACUOLE ORGANIZATION,0.0097392,0.1265,0.11358,1,1
2,GO ACTIN MEDIATED CELL CONTRACTION,0.014486,0.12641,0.11399,1,1
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.025414,0.1264,0.092812,1,1
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0013054,0.12622,0.19131,1,1
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.042857,0.12621,0.11801,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,2.9532e-05,0.12607,0.12397,1,1
2,GO COGNITION,0.0036303,0.12595,0.13973,1,1
2,GO MUSCLE CONTRACTION,0.0010206,0.12544,0.12573,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0059384,0.12522,0.099093,1,1
2,GO SENSORY SYSTEM DEVELOPMENT,0.001228,0.125,0.12338,1,1
2,GO REGULATION OF CELL SIZE,0.0020453,0.12494,0.13447,1,1
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0066042,0.12481,0.083416,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.01282,0.12475,0.13813,1,1
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0010528,0.12456,0.11787,1,1
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0010859,0.12454,0.14634,1,1
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.00040247,0.1245,0.14802,1,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00098941,0.12438,0.10831,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0040578,0.12426,0.09731,1,1
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0019282,0.12424,0.12466,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0037331,0.1241,0.11744,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.025414,0.12405,0.15677,1,1
2,GO RETINA HOMEOSTASIS,0.018836,0.12394,0.082178,1,1
2,GO CELL MORPHOGENESIS,0.0031536,0.12394,0.11931,1,1
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.027803,0.1239,0.11371,1,1
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.00063551,0.12378,0.16679,1,1
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.00016023,0.12373,0.12716,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0013054,0.12351,0.14425,1,1
2,GO RESPONSE TO ALCOHOL,0.011326,0.12285,0.10118,1,1
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0094949,0.12264,0.083235,1,1
2,GO REGULATION OF NEURON DIFFERENTIATION,0.001872,0.12257,0.15053,1,1
2,GO T CELL LINEAGE COMMITMENT,0.0042883,0.12256,0.12849,1,1
2,GO NEGATIVE REGULATION OF BINDING,0.0007696,0.12242,0.12615,1,1
2,GO CALCIUM ION IMPORT,0.009256,0.12212,0.12935,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.013465,0.12212,0.12814,1,1
2,GO LEARNING,0.021165,0.12212,0.14576,1,1
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.011326,0.12208,0.12771,1,1
2,GO PEPTIDYL SERINE MODIFICATION,0.00067758,0.122,0.10059,1,1
2,GO SULFATE TRANSPORT,0.044685,0.12189,0.10984,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02843,0.12169,0.10349,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0069616,0.12118,0.088645,1,1
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.047551,0.12118,0.10644,1,1
2,GO TRANSITION METAL ION TRANSPORT,0.0094949,0.12113,0.079216,1,1
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00017796,0.12101,0.14901,1,1
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.036164,0.12096,0.12302,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0038387,0.12095,0.09687,1,1
2,GO FATTY ACID TRANSPORT,0.014138,0.12066,0.096458,1,1
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.00050664,0.12043,0.11898,1,1
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0010528,0.12009,0.092662,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.03245,0.11998,0.078329,1,1
2,GO REGULATION OF PROTEIN BINDING,0.00059588,0.11984,0.13629,1,1
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.013798,0.11976,0.13702,1,1
2,GO POSITIVE REGULATION OF GROWTH,0.00014935,0.11933,0.13725,1,1
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.015574,0.1187,0.10959,1,1
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.8379e-05,0.11865,0.11377,1,1
2,GO CELLULAR HOMEOSTASIS,0.00028792,0.11839,0.11027,1,1
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00063551,0.11839,0.13594,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0037331,0.11814,0.10585,1,1
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.004408,0.11811,0.087568,1,1
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0033369,0.11808,0.10319,1,1
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0024367,0.11808,0.098899,1,1
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.035393,0.11807,0.11501,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.012203,0.11798,0.095263,1,1
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.036164,0.11777,0.11835,1,1
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.00044439,0.11723,0.084994,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.026586,0.11696,0.08046,1,1
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.045624,0.11679,0.13857,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0028957,0.11679,0.13784,1,1
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.00041602,0.11672,0.12886,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00030804,0.11658,0.1087,1,1
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.027188,0.11626,0.10707,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0060989,0.11528,0.11777,1,1
2,GO ORGANELLE FUSION,0.024846,0.11519,0.092053,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00035231,0.11506,0.12879,1,1
2,GO ORGAN GROWTH,0.015953,0.11478,0.088219,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.009256,0.11478,0.10534,1,1
2,GO EMBRYO DEVELOPMENT,0.0007696,0.11454,0.11036,1,1
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.015203,0.11433,0.16663,1,1
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0099891,0.11426,0.13797,1,1
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.00037661,0.11411,0.13221,1,1
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.016339,0.11401,0.1237,1,1
2,GO DENDRITIC SPINE DEVELOPMENT,0.026586,0.11396,0.11736,1,1
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.036164,0.11386,0.12163,1,1
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0010859,0.1135,0.11481,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.031059,0.11325,0.14956,1,1
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00016023,0.11315,0.096433,1,1
2,GO RUFFLE ORGANIZATION,0.035393,0.11312,0.12255,1,1
2,GO CELLULAR RESPONSE TO CAMP,0.00045924,0.11312,0.16139,1,1
2,GO MULTI ORGANISM PROCESS,0.00092958,0.11298,0.094502,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0041716,0.11271,0.084959,1,1
2,GO PROTEIN DEPHOSPHORYLATION,0.0050528,0.11233,0.073777,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.5149e-05,0.11187,0.12497,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.015574,0.11169,0.11788,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.025994,0.11164,0.083676,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.040234,0.11158,0.11287,1,1
2,GO POSITIVE REGULATION OF BINDING,0.015953,0.11119,0.089664,1,1
2,GO EXOCYTIC PROCESS,0.02843,0.1106,0.13931,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00092958,0.11018,0.13503,1,1
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.038561,0.11015,0.14156,1,1
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.040234,0.10959,0.1318,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.011904,0.10933,0.11084,1,1
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.042857,0.10926,0.091935,1,1
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.0011199,0.10907,0.10352,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.010506,0.1085,0.10187,1,1
2,GO REGULATION OF AXONOGENESIS,0.025994,0.1076,0.14008,1,1
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00036427,0.10752,0.11683,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.026586,0.10733,0.13877,1,1
2,GO DEPHOSPHORYLATION,0.00092958,0.10732,0.090764,1,1
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.019739,0.10729,0.16013,1,1
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0045306,0.1067,0.12836,1,1
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00049035,0.10646,0.1048,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.012508,0.10642,0.12551,1,1
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0012662,0.10581,0.12681,1,1
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.011326,0.10579,0.076131,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.0087944,0.10496,0.10689,1,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.00035231,0.10494,0.084679,1,1
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.033166,0.10487,0.067062,1,1
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0037331,0.10408,0.11982,1,1
2,GO NEGATIVE REGULATION OF TRANSPORT,0.0028957,0.10393,0.090433,1,1
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.017549,0.10374,0.08488,1,1
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0047853,0.10367,0.084835,1,1
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001986,0.10361,0.13438,1,1
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.010245,0.10328,0.088268,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0047853,0.10326,0.093244,1,1
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.013465,0.103,0.10714,1,1
2,GO MUSCLE ORGAN DEVELOPMENT,0.0025083,0.10268,0.09334,1,1
2,GO REGULATION OF CELL DIVISION,0.007729,0.10237,0.093569,1,1
2,GO REGULATION OF CELLULAR LOCALIZATION,0.0021062,0.10229,0.084136,1,1
2,GO REGULATION OF TORC1 SIGNALING,0.027803,0.10203,0.077834,1,1
2,GO GOLGI LOCALIZATION,0.024846,0.10155,0.11424,1,1
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0057817,0.10149,0.082453,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.00095906,0.10134,0.12218,1,1
2,GO ORGANIC ACID TRANSPORT,0.0021689,0.10088,0.08458,1,1
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00098941,0.10027,0.09262,1,1
2,GO NEUROGENESIS,0.0013457,0.10027,0.12885,1,1
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.022165,0.10019,0.14495,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0075304,0.099633,0.10655,1,1
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.033894,0.099217,0.10097,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.043763,0.099079,0.062038,1,1
2,GO GOLGI ORGANIZATION,0.0097392,0.099056,0.080586,1,1
2,GO REGULATION OF GLUCONEOGENESIS,0.029719,0.098622,0.082797,1,1
2,GO OOGENESIS,0.013465,0.097786,0.092882,1,1
2,GO RECEPTOR INTERNALIZATION,0.025414,0.097638,0.097208,1,1
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.0014299,0.097315,0.095825,1,1
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.00098941,0.097202,0.080517,1,1
2,GO SEXUAL REPRODUCTION,0.001662,0.096918,0.084731,1,1
2,GO GERM CELL DEVELOPMENT,0.0027346,0.096506,0.097806,1,1
2,GO CELL FATE COMMITMENT,0.0029794,0.095949,0.133,1,1
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.041967,0.095341,0.090619,1,1
2,GO CELL PROJECTION ORGANIZATION,0.0017123,0.095264,0.11447,1,1
2,GO HEAD DEVELOPMENT,0.00049035,0.09502,0.13814,1,1
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0021689,0.094975,0.091476,1,1
2,GO REGULATION OF TOR SIGNALING,0.00092958,0.094837,0.099958,1,1
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.024288,0.094221,0.10012,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.014138,0.093983,0.08991,1,1
2,GO OVULATION CYCLE,0.027803,0.093737,0.10503,1,1
2,GO NEURON DIFFERENTIATION,0.0060989,0.093715,0.12459,1,1
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.023741,0.093447,0.15421,1,1
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0040578,0.092791,0.13677,1,1
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.013139,0.09272,0.08188,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.0099891,0.091482,0.13047,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.0075304,0.091469,0.095664,1,1
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0054795,0.090935,0.077563,1,1
2,GO NEURON DEVELOPMENT,0.007729,0.090341,0.12683,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.0069616,0.089397,0.1044,1,1
2,GO ENDOSOMAL TRANSPORT,0.022165,0.089267,0.066553,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0066042,0.088467,0.16927,1,1
2,GO REGULATION OF EXOCYTOSIS,0.0045306,0.088074,0.15913,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.013465,0.087673,0.064518,1,1
2,GO SYNAPTIC SIGNALING,0.013465,0.087229,0.14923,1,1
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.025414,0.086413,0.081984,1,1
2,GO MYOFIBRIL ASSEMBLY,0.043763,0.085067,0.085345,1,1
2,GO FERTILIZATION,0.0046564,0.084976,0.088313,1,1
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.031059,0.084329,0.083631,1,1
2,GO DNA CATABOLIC PROCESS,0.00090094,0.084224,0.12069,1,1
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.017969,0.083675,0.077681,1,1
2,GO PEPTIDYL THREONINE MODIFICATION,0.0085714,0.083224,0.093123,1,1
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.047551,0.083184,0.079806,1,1
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.007729,0.08264,0.079584,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.010773,0.082618,0.076646,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.035393,0.082563,0.097882,1,1
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.033166,0.082542,0.076344,1,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.019283,0.082209,0.077826,1,1
2,GO AXON DEVELOPMENT,0.041093,0.082023,0.11965,1,1
2,GO CELL CYCLE ARREST,0.015574,0.081973,0.066938,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.010506,0.08133,0.092676,1,1
2,GO MACROMOLECULE DEACYLATION,0.0085714,0.080842,0.07389,1,1
2,GO POLYOL METABOLIC PROCESS,0.026586,0.080833,0.071274,1,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.036948,0.080118,0.093659,1,1
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00353,0.079946,0.07145,1,1
2,GO PROTEIN HOMOOLIGOMERIZATION,0.0050528,0.079585,0.080516,1,1
2,GO GAMETE GENERATION,0.0049174,0.077942,0.078735,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.035393,0.076486,0.079101,1,1
2,GO CYTOSKELETON ORGANIZATION,0.0079323,0.074469,0.082076,1,1
2,GO TOR SIGNALING,0.0090226,0.074227,0.063033,1,1
2,GO REGULATION OF DEPHOSPHORYLATION,0.0012662,0.073658,0.08143,1,1
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0094949,0.072345,0.12382,1,1
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00098941,0.071512,0.087057,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.0053338,0.071464,0.11143,1,1
2,GO PROTEIN INSERTION INTO MEMBRANE,0.047551,0.071236,0.091191,1,1
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.025994,0.070707,0.053164,1,1
2,GO STEM CELL DIFFERENTIATION,0.03939,0.070398,0.074945,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.024846,0.068888,0.08946,1,1
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.033166,0.068522,0.10456,1,1
2,GO NEURON PROJECTION EXTENSION,0.023205,0.06844,0.13911,1,1
2,GO MALE GAMETE GENERATION,0.0099891,0.064423,0.072228,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.029719,0.063834,0.060896,1,1
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0075304,0.063583,0.084225,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.046579,0.060413,0.045525,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.041967,0.059879,0.072836,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE,0.015574,0.059172,0.058577,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.024846,0.058499,0.05431,1,1
2,GO FOREBRAIN DEVELOPMENT,0.0085714,0.05837,0.13542,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.033894,0.058245,0.057184,1,1
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.045624,0.057741,0.071811,1,1
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.027803,0.054909,0.043862,1,1
2,GO RESPONSE TO INTERFERON ALPHA,0.0032441,0.78827,0.5404,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0012662,0.75019,0.61145,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.0010528,0.66407,0.45624,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.017969,0.56945,0.36864,1,0
2,GO BLEB ASSEMBLY,0.0069616,0.52061,0.53485,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.020205,0.50601,0.24041,1,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00059588,0.48402,0.45871,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.012508,0.46686,0.26658,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.024288,0.46565,0.32544,1,0
2,GO RESPONSE TO INTERFERON BETA,0.025994,0.45369,0.40283,1,0
2,GO T CELL EXTRAVASATION,0.00026903,0.44719,0.46105,1,0
2,GO RENAL ABSORPTION,0.0011199,0.43644,0.38519,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0069616,0.4124,0.2867,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.001662,0.41214,0.37614,1,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0067808,0.40991,0.29837,1,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0079323,0.40589,0.2578,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.02843,0.39842,0.25472,1,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00059588,0.39551,0.35479,1,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.01282,0.39467,0.27517,1,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0041716,0.39131,0.32328,1,0
2,GO MECHANOSENSORY BEHAVIOR,0.0071468,0.3892,0.40214,1,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00024286,0.38757,0.39933,1,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0028957,0.37891,0.45669,1,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0011549,0.37702,0.32858,1,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0018173,0.37502,0.33217,1,0
2,GO EPIBOLY,0.03245,0.3729,0.19585,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.001872,0.3712,0.29062,1,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.0053338,0.36912,0.31287,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00026903,0.36351,0.29217,1,0
2,GO ENTRY INTO HOST,0.0045306,0.36283,0.20794,1,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0031536,0.36248,0.27146,1,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00021167,0.35925,0.45182,1,0
2,GO MEMBRANE RAFT ORGANIZATION,0.011612,0.35713,0.25152,1,0
2,GO RESPONSE TO FORSKOLIN,0.0025083,0.35395,0.32269,1,0
2,GO ADENOHYPOPHYSIS DEVELOPMENT,0.017549,0.35375,0.34332,1,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.010506,0.34444,0.24719,1,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.0041716,0.34355,0.31533,1,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00079435,0.34335,0.24843,1,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.004408,0.34277,0.25943,1,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0020453,0.34105,0.20368,1,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00025131,0.33995,0.24606,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0059384,0.33819,0.2115,1,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0057817,0.33661,0.26724,1,0
2,GO DETECTION OF CALCIUM ION,0.0053338,0.33444,0.30635,1,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.0017641,0.32944,0.26256,1,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.034637,0.32871,0.25435,1,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0006154,0.3256,0.32448,1,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0034322,0.32472,0.21256,1,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00021167,0.32392,0.28325,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00032948,0.3232,0.24047,1,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.010773,0.32139,0.22729,1,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0038387,0.32046,0.23356,1,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.036948,0.31881,0.26303,1,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0046564,0.31838,0.27866,1,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00022676,0.31678,0.24376,1,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0041716,0.3134,0.2172,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.029068,0.31142,0.23558,1,0
2,GO VASCULOGENESIS,0.0021062,0.30977,0.22947,1,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.013465,0.30805,0.19768,1,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0067808,0.30793,0.17539,1,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00069957,0.30566,0.26546,1,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0062634,0.30564,0.24429,1,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00017186,0.30495,0.24663,1,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.016339,0.30253,0.2238,1,0
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.042857,0.29655,0.24931,1,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.0015189,0.29638,0.26302,1,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0023671,0.29521,0.30977,1,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0069616,0.29395,0.33863,1,0
2,GO DETECTION OF BIOTIC STIMULUS,0.00063551,0.29146,0.33261,1,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.001191,0.28842,0.27636,1,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.0060989,0.28832,0.19554,1,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0083534,0.28642,0.31544,1,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0036303,0.28332,0.27113,1,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00059588,0.2829,0.2773,1,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.28287,0.29401,1,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0054795,0.27982,0.26985,1,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0066042,0.27973,0.2399,1,0
2,GO COLLAGEN CATABOLIC PROCESS,0.001228,0.27745,0.20475,1,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.016339,0.27499,0.24037,1,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.035393,0.27269,0.15434,1,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.02068,0.27211,0.28748,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0025083,0.2721,0.30267,1,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0011549,0.26705,0.21899,1,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.001662,0.26593,0.25281,1,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.0049174,0.26562,0.33828,1,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.023741,0.26234,0.18028,1,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.024288,0.26182,0.15288,1,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0049174,0.26182,0.22278,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.001662,0.26104,0.197,1,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0081404,0.2602,0.21534,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0011199,0.25765,0.24029,1,0
2,GO BLOOD VESSEL REMODELING,0.010506,0.25557,0.18041,1,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0032441,0.25534,0.21193,1,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.0040578,0.25513,0.23844,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0042883,0.25262,0.19865,1,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.038561,0.24996,0.14898,1,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.046579,0.24863,0.21215,1,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.015953,0.24844,0.25939,1,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.007729,0.24819,0.24998,1,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0019282,0.24532,0.18202,1,0
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.026586,0.24465,0.30806,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.001872,0.24406,0.19813,1,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.019739,0.24399,0.27534,1,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0081404,0.24276,0.16818,1,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0094949,0.24269,0.17308,1,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.02268,0.24181,0.28544,1,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0039469,0.24176,0.18314,1,0
2,GO T CELL MIGRATION,0.00044439,0.24124,0.21251,1,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.023205,0.24109,0.32262,1,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.0049174,0.24014,0.23572,1,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0037331,0.23967,0.57696,1,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.022165,0.23891,0.27251,1,0
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.026586,0.23865,0.20994,1,0
2,GO PLATELET DEGRANULATION,0.0026572,0.23782,0.22405,1,0
2,GO COLLAGEN METABOLIC PROCESS,0.024846,0.23349,0.13378,1,0
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.02843,0.23329,0.17977,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.019739,0.23309,0.21426,1,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00084609,0.23182,0.19022,1,0
2,GO ZYMOGEN INHIBITION,0.013798,0.2313,0.2003,1,0
2,GO STORE OPERATED CALCIUM ENTRY,0.0099891,0.23015,0.17067,1,0
2,GO PROTEIN OXIDATION,0.02843,0.22977,0.18136,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00024286,0.22925,0.3301,1,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0020453,0.2291,0.20208,1,0
2,GO REGULATION OF RECEPTOR BINDING,0.021165,0.22553,0.17987,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.023205,0.22528,0.18388,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.0015189,0.22492,0.23539,1,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.015203,0.2248,0.20106,1,0
2,GO COPPER ION HOMEOSTASIS,0.013465,0.22441,0.18268,1,0
2,GO VAGINA DEVELOPMENT,0.030383,0.22421,0.15451,1,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0045306,0.22415,0.16198,1,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.011904,0.22361,0.21974,1,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0069616,0.22352,0.2374,1,0
2,GO MACROPHAGE PROLIFERATION,0.041093,0.22301,0.25936,1,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.016339,0.22295,0.17198,1,0
2,GO MYELOID CELL APOPTOTIC PROCESS,0.0025083,0.22253,0.20885,1,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.03939,0.22178,0.1339,1,0
2,GO EPITHELIAL CELL CELL ADHESION,0.013139,0.22175,0.28361,1,0
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.02166,0.22168,0.12763,1,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.014841,0.22153,0.21503,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0051916,0.22152,0.19468,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.018836,0.22134,0.12351,1,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.0033369,0.22117,0.13412,1,0
2,GO VITAMIN CATABOLIC PROCESS,0.031059,0.21967,0.14875,1,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.020205,0.21959,0.13351,1,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010773,0.21883,0.1649,1,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.010773,0.21846,0.2931,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.019739,0.21837,0.32399,1,0
2,GO CELLULAR RESPONSE TO DSRNA,0.013465,0.21674,0.15879,1,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.034637,0.21489,0.15811,1,0
2,GO HYALURONAN METABOLIC PROCESS,0.023205,0.21479,0.12606,1,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0006154,0.21445,0.35998,1,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.0079323,0.21353,0.18472,1,0
2,GO NEURONAL ACTION POTENTIAL,0.029719,0.21343,0.25254,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.042857,0.21338,0.36004,1,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.013798,0.21313,0.17419,1,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.015953,0.21131,0.20389,1,0
2,GO PHAGOCYTOSIS,0.0054795,0.21043,0.14144,1,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.016734,0.20946,0.20913,1,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0025083,0.2088,0.15772,1,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.020205,0.20795,0.27117,1,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.001228,0.20741,0.21705,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0014738,0.20693,0.1672,1,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0051916,0.20645,0.24057,1,0
2,GO REGULATION OF PHAGOCYTOSIS,0.0056288,0.20565,0.17,1,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0015189,0.20401,0.23052,1,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.027188,0.20376,0.21469,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0079323,0.20253,0.18545,1,0
2,GO DOPAMINE TRANSPORT,0.01282,0.20249,0.3019,1,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.016339,0.20242,0.20862,1,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0053338,0.20225,0.19418,1,0
2,GO ANIMAL ORGAN REGENERATION,0.015203,0.20183,0.12762,1,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.0067808,0.20175,0.13369,1,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.017137,0.20162,0.1431,1,0
2,GO CYTOLYSIS,0.0083534,0.20097,0.20009,1,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.0079323,0.20071,0.15747,1,0
2,GO NECROTIC CELL DEATH,0.0015653,0.20011,0.24536,1,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.025994,0.19973,0.16338,1,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.0075304,0.19926,0.19598,1,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.033894,0.19912,0.10791,1,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.01282,0.1984,0.16353,1,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.025414,0.1979,0.12387,1,0
2,GO REGULATION OF PROTEIN MATURATION,0.033894,0.19728,0.11961,1,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.029068,0.19622,0.13151,1,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0025083,0.19599,0.18857,1,0
2,GO CHONDROCYTE DEVELOPMENT,0.0056288,0.19582,0.21478,1,0
2,GO PLATELET AGGREGATION,0.0028141,0.19462,0.20002,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.007729,0.19335,0.14013,1,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0006154,0.19293,0.18945,1,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.014138,0.19282,0.31865,1,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013465,0.1928,0.23073,1,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.031059,0.19246,0.13631,1,0
2,GO SALIVARY GLAND DEVELOPMENT,0.018398,0.19112,0.18732,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0066042,0.19093,0.23538,1,0
2,GO AMYLOID BETA CLEARANCE,0.041093,0.19046,0.12782,1,0
2,GO LEFT RIGHT PATTERN FORMATION,0.019739,0.18964,0.14489,1,0
2,GO NOTOCHORD DEVELOPMENT,0.046579,0.18889,0.18122,1,0
2,GO APOPTOTIC CELL CLEARANCE,0.0032441,0.18869,0.30856,1,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0031536,0.18858,0.20515,1,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.022165,0.18807,0.15633,1,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.031059,0.18722,0.18554,1,0
2,GO AXONEME ASSEMBLY,0.0032441,0.18703,0.17828,1,0
2,GO RESPONSE TO HYPEROXIA,0.027188,0.18697,0.17603,1,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.030383,0.18637,0.18275,1,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0073363,0.18497,0.14368,1,0
2,GO GLIAL CELL ACTIVATION,0.0028141,0.18386,0.20414,1,0
2,GO RESPONSE TO AMINE,0.016339,0.18372,0.14723,1,0
2,GO T CELL APOPTOTIC PROCESS,0.027188,0.1827,0.14192,1,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.0087944,0.18263,0.15592,1,0
2,GO RESPONSE TO CADMIUM ION,0.03939,0.18183,0.13327,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.019283,0.18103,0.15236,1,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.019283,0.18003,0.18552,1,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.031748,0.17999,0.10996,1,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.02166,0.1787,0.11993,1,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.041967,0.17868,0.14622,1,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.014138,0.17847,0.11943,1,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.023205,0.17843,0.14798,1,0
2,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.033166,0.17838,0.23386,1,0
2,GO SECRETION BY TISSUE,0.029719,0.17781,0.14264,1,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.01282,0.17625,0.1104,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0069616,0.17618,0.17032,1,0
2,GO DOPAMINE METABOLIC PROCESS,0.0046564,0.17548,0.2454,1,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.023205,0.17522,0.15228,1,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0051916,0.17373,0.2522,1,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.007729,0.1734,0.2038,1,0
2,GO SPROUTING ANGIOGENESIS,0.010506,0.17288,0.1289,1,0
2,GO RESPONSE TO CORTICOSTEROID,0.0040578,0.17288,0.14892,1,0
2,GO CELLULAR RESPONSE TO VIRUS,0.019283,0.17225,0.10842,1,0
2,GO COMPLEMENT ACTIVATION,0.0071468,0.17184,0.28169,1,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0053338,0.17181,0.15273,1,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.017969,0.17177,0.23797,1,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.027803,0.1715,0.13752,1,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.011047,0.17143,0.11948,1,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.011612,0.17138,0.13643,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.035393,0.17131,0.14109,1,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,1.4609e-05,0.17001,0.26118,1,0
2,GO MYOBLAST DIFFERENTIATION,0.0033369,0.16998,0.18692,1,0
2,GO REGENERATION,0.0057817,0.16979,0.1379,1,0
2,GO CELLULAR RESPONSE TO IRON ION,0.014138,0.16967,0.20269,1,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0034322,0.16842,0.12551,1,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.02068,0.16824,0.15867,1,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0027346,0.1676,0.20078,1,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.047551,0.16694,0.12645,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.029719,0.16694,0.11299,1,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.031059,0.16681,0.08233,1,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.023741,0.16567,0.29984,1,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00049035,0.16552,0.19064,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.02166,0.16459,0.18052,1,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.010506,0.16429,0.21963,1,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.034637,0.16415,0.092287,1,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.027188,0.16216,0.12383,1,0
2,GO OSTEOBLAST DIFFERENTIATION,0.0021062,0.16213,0.18483,1,0
2,GO KERATINIZATION,0.0079323,0.1618,0.17099,1,0
2,GO CHOLESTEROL EFFLUX,0.0013872,0.1618,0.14669,1,0
2,GO CORNIFICATION,0.02166,0.16158,0.16827,1,0
2,GO RECEPTOR CATABOLIC PROCESS,0.014486,0.16019,0.11675,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.047551,0.15866,0.19444,1,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0023671,0.15861,0.14506,1,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.03939,0.1585,0.12381,1,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.043763,0.15836,0.15726,1,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0097392,0.15834,0.12253,1,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0046564,0.15806,0.15557,1,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.047551,0.15787,0.086982,1,0
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.043763,0.15559,0.14114,1,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.046579,0.15519,0.15311,1,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0021062,0.15449,0.14458,1,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.016339,0.15419,0.089511,1,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.017137,0.15417,0.16077,1,0
2,GO CARTILAGE DEVELOPMENT,0.0046564,0.15413,0.13633,1,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.011904,0.15284,0.10118,1,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0016129,0.15281,0.1374,1,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.018836,0.1527,0.16549,1,0
2,GO FIBROBLAST APOPTOTIC PROCESS,0.047551,0.15254,0.13129,1,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0022992,0.15252,0.1331,1,0
2,GO RESPONSE TO PH,0.0030654,0.15108,0.16122,1,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0017123,0.15037,0.17683,1,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.010773,0.14953,0.1695,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.041967,0.14907,0.27805,1,0
2,GO ASSOCIATIVE LEARNING,0.0025817,0.14899,0.15388,1,0
2,GO MICROTUBULE BUNDLE FORMATION,0.0051916,0.14887,0.12946,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0099891,0.14799,0.11746,1,0
2,GO FOREBRAIN REGIONALIZATION,0.02068,0.14736,0.22886,1,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.033166,0.14697,0.14276,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.016339,0.14683,0.13826,1,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.024288,0.14638,0.1102,1,0
2,GO REGULATION OF CILIUM MOVEMENT,0.0013457,0.14597,0.14325,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.037747,0.14594,0.17376,1,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.015953,0.1451,0.11173,1,0
2,GO MUSCLE CELL PROLIFERATION,0.027188,0.14502,0.10491,1,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.017549,0.14402,0.10914,1,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.023205,0.14381,0.11967,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0073363,0.14376,0.13946,1,0
2,GO GASTRIC ACID SECRETION,0.022165,0.14289,0.178,1,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.02166,0.14208,0.10644,1,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.007729,0.14172,0.16706,1,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.045624,0.1389,0.26136,1,0
2,GO HEART TRABECULA MORPHOGENESIS,0.02068,0.13864,0.13427,1,0
2,GO MEMBRANE INVAGINATION,0.041967,0.13798,0.093388,1,0
2,GO ERK1 AND ERK2 CASCADE,0.0019282,0.13794,0.20384,1,0
2,GO MESODERM DEVELOPMENT,0.0051916,0.13757,0.11218,1,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.029719,0.13739,0.068154,1,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.044685,0.13687,0.14524,1,0
2,GO CARBOHYDRATE TRANSPORT,0.00029782,0.13588,0.15078,1,0
2,GO FEAR RESPONSE,0.027803,0.13497,0.10496,1,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0085714,0.13357,0.19039,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.017549,0.13355,0.14405,1,0
2,GO MANNOSYLATION,0.029068,0.13275,0.13609,1,0
2,GO NEURAL TUBE DEVELOPMENT,0.0083534,0.13261,0.11267,1,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.017969,0.13206,0.15323,1,0
2,GO RESPONSE TO INTERLEUKIN 1,0.046579,0.13176,0.078529,1,0
2,GO AMINE CATABOLIC PROCESS,0.03245,0.13041,0.15957,1,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.016339,0.1302,0.11689,1,0
2,GO GLOMERULUS DEVELOPMENT,0.020205,0.12937,0.16038,1,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.024846,0.12891,0.15691,1,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.013139,0.12873,0.1103,1,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.031748,0.12761,0.15314,1,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.036948,0.12659,0.10506,1,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.027803,0.12653,0.095167,1,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0032441,0.12631,0.10375,1,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.023741,0.12626,0.093421,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.036948,0.12564,0.19572,1,0
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.034637,0.12563,0.10814,1,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0045306,0.12505,0.12946,1,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.014486,0.12426,0.088792,1,0
2,GO SCHWANN CELL DIFFERENTIATION,0.010245,0.12355,0.12911,1,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0046564,0.12333,0.14329,1,0
2,GO RESPONSE TO LEPTIN,0.024288,0.12309,0.13798,1,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0083534,0.12295,0.13752,1,0
2,GO CHEMOSENSORY BEHAVIOR,0.017137,0.12253,0.20881,1,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.020205,0.12175,0.13731,1,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.045624,0.12174,0.21746,1,0
2,GO SECONDARY METABOLIC PROCESS,0.02166,0.12082,0.1141,1,0
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.031748,0.12061,0.10686,1,0
2,GO STEROID CATABOLIC PROCESS,0.03245,0.11967,0.16242,1,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.023205,0.11942,0.17138,1,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.014486,0.11923,0.096007,1,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.017549,0.11878,0.11954,1,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.02068,0.11774,0.092951,1,0
2,GO ADULT BEHAVIOR,0.017969,0.11736,0.15475,1,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.0071468,0.11735,0.10487,1,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.011047,0.11733,0.15058,1,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.018398,0.11688,0.090159,1,0
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.046579,0.11686,0.1177,1,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.045624,0.11684,0.17799,1,0
2,GO PROTEIN CATABOLIC PROCESS,0.022165,0.11656,0.060218,1,0
2,GO LONG TERM MEMORY,0.031059,0.11646,0.14792,1,0
2,GO GASTRULATION,0.036164,0.11603,0.10449,1,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.023205,0.11581,0.14155,1,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.045624,0.11581,0.097143,1,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.027803,0.11579,0.12564,1,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.033166,0.11562,0.12977,1,0
2,GO EPITHELIAL TUBE FORMATION,0.0026572,0.11509,0.12544,1,0
2,GO TUBE FORMATION,0.0021689,0.11483,0.1297,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0022332,0.11417,0.16894,1,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0032441,0.1137,0.13155,1,0
2,GO DNA DEALKYLATION,0.02268,0.11312,0.12451,1,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.044685,0.11285,0.14517,1,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.013465,0.11263,0.092694,1,0
2,GO CILIUM MOVEMENT,0.0060989,0.11221,0.091435,1,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.026586,0.11179,0.081757,1,0
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.013465,0.11047,0.063791,1,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0047853,0.11017,0.11332,1,0
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.013465,0.10996,0.088699,1,0
2,GO PHOTOPERIODISM,0.045624,0.10952,0.12985,1,0
2,GO DRUG METABOLIC PROCESS,0.010506,0.10945,0.1594,1,0
2,GO THYMUS DEVELOPMENT,0.044685,0.10895,0.11048,1,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.047551,0.10884,0.11635,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.025994,0.10878,0.14392,1,0
2,GO FATTY ACID CATABOLIC PROCESS,0.013465,0.10799,0.11569,1,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0075304,0.10701,0.11549,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001191,0.10678,0.13095,1,0
2,GO REGULATION OF STEROL TRANSPORT,0.033894,0.10642,0.096665,1,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.014486,0.10623,0.067292,1,0
2,GO RESPONSE TO ESTROGEN,0.030383,0.10614,0.094811,1,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0050528,0.10592,0.20748,1,0
2,GO REGULATION OF CELL MATURATION,0.036948,0.10573,0.09752,1,0
2,GO INTERFERON GAMMA PRODUCTION,0.007729,0.10572,0.12758,1,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.011326,0.10442,0.092816,1,0
2,GO RESPONSE TO ALKALOID,0.0067808,0.10356,0.12555,1,0
2,GO RESPONSE TO ANTIBIOTIC,0.0071468,0.10339,0.13756,1,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.045624,0.1032,0.081557,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.015953,0.10294,0.1056,1,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.037747,0.10221,0.088072,1,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.015203,0.10214,0.10854,1,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.043763,0.10169,0.079114,1,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.031059,0.10081,0.083517,1,0
2,GO SOMITOGENESIS,0.012203,0.09987,0.097518,1,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.009256,0.099562,0.091324,1,0
2,GO OXIDATION REDUCTION PROCESS,0.041093,0.097435,0.076162,1,0
2,GO CELL PROJECTION ASSEMBLY,0.0097392,0.0974,0.085565,1,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.023741,0.09653,0.10587,1,0
2,GO ANDROGEN METABOLIC PROCESS,0.023205,0.095772,0.12923,1,0
2,GO EXIT FROM MITOSIS,0.016734,0.095593,0.10277,1,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.027188,0.094166,0.19072,1,0
2,GO NEURAL TUBE FORMATION,0.015203,0.093297,0.10728,1,0
2,GO HEART GROWTH,0.025414,0.091478,0.096547,1,0
2,GO VISUAL BEHAVIOR,0.023205,0.091397,0.11668,1,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.024288,0.090836,0.17865,1,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.007729,0.09067,0.10713,1,0
2,GO BICARBONATE TRANSPORT,0.018836,0.089991,0.17371,1,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.027188,0.088371,0.10818,1,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.019739,0.086394,0.13321,1,0
2,GO CELL CELL RECOGNITION,0.042857,0.084249,0.089861,1,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.038561,0.083896,0.065332,1,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.025994,0.08268,0.097382,1,0
2,GO PATTERN SPECIFICATION PROCESS,0.0054795,0.081313,0.11966,1,0
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.015953,0.074425,0.068282,1,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.020205,0.072824,0.083866,1,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.033894,0.072588,0.03994,1,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.034637,0.071211,0.088937,1,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.0050528,0.070331,0.080049,1,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.043763,0.069995,0.04251,1,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.03245,0.067222,0.079114,1,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.016734,0.06319,0.11229,1,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.030383,0.055701,0.050468,1,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.02843,0.055635,0.068293,1,0
2,GO PROTEIN POLYUBIQUITINATION,0.046579,0.052886,0.052006,1,0
2,GO SPERMATID DIFFERENTIATION,0.033166,0.046911,0.07035,1,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.036948,0.04226,0.079782,1,0
2,GO MACROAUTOPHAGY,0.047551,0.03944,0.051062,1,0
2,GO REGULATION OF MACROAUTOPHAGY,0.040234,0.036481,0.062041,1,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.035393,-0.033786,-0.068968,1,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.035393,-0.057655,-0.042628,1,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,-0.058646,-0.10386,1,0
2,GO TRICARBOXYLIC ACID CYCLE,0.044685,-0.062217,-0.1383,1,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.018398,-0.063001,-0.049654,1,0
2,GO NUCLEAR TRANSPORT,0.029719,-0.065479,-0.07479,1,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.020205,-0.069405,-0.086417,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.044685,-0.071153,-0.08794,1,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0081404,-0.071305,-0.094393,1,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.027188,-0.072468,-0.10537,1,0
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0081404,-0.072769,-0.11519,1,0
2,GO CHROMOSOME LOCALIZATION,0.042857,-0.073693,-0.049888,1,0
2,GO DNA REPAIR,0.01282,-0.074353,-0.05645,1,0
2,GO SNRNA TRANSCRIPTION,0.00044439,-0.075716,-0.10409,1,0
2,GO BASE EXCISION REPAIR,0.0028957,-0.078868,-0.1067,1,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.017549,-0.079623,-0.11308,1,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.041093,-0.080933,-0.18349,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.029719,-0.081473,-0.074798,1,0
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.029719,-0.08194,-0.079304,1,0
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.020205,-0.082005,-0.097926,1,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0025083,-0.085615,-0.090285,1,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.03245,-0.085631,-0.085063,1,0
2,GO DNA DEPENDENT DNA REPLICATION,0.024288,-0.085829,-0.088683,1,0
2,GO PROTEIN TARGETING,0.031059,-0.087905,-0.090563,1,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.0069616,-0.088056,-0.095763,1,0
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0054795,-0.088486,-0.099133,1,0
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.018398,-0.089974,-0.099334,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.020205,-0.090605,-0.10826,1,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.02843,-0.092209,-0.069532,1,0
2,GO CHROMATIN REMODELING,0.038561,-0.094524,-0.059301,1,0
2,GO CHROMOSOME SEGREGATION,0.042857,-0.095017,-0.055151,1,0
2,GO PROTEIN SUMOYLATION,0.037747,-0.096234,-0.074717,1,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.011904,-0.096585,-0.13099,1,0
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.0049174,-0.097431,-0.092342,1,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.011904,-0.097434,-0.11224,1,0
2,GO REGULATION OF GENE SILENCING,0.018398,-0.097528,-0.11352,1,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0053338,-0.097633,-0.10533,1,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.027188,-0.098718,-0.089477,1,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.0049174,-0.099115,-0.1541,1,0
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.036948,-0.099672,-0.11048,1,0
2,GO NUCLEAR EXPORT,0.0069616,-0.10047,-0.10429,1,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.017549,-0.10048,-0.1326,1,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.023741,-0.10166,-0.13692,1,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0032441,-0.10331,-0.11907,1,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.040234,-0.10525,-0.12568,1,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.035393,-0.10567,-0.12481,1,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0033369,-0.1057,-0.13737,1,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.029068,-0.10618,-0.065598,1,0
2,GO RNA MODIFICATION,0.00040247,-0.10624,-0.16102,1,0
2,GO AEROBIC RESPIRATION,0.031748,-0.10651,-0.13277,1,0
2,GO DNA PACKAGING,0.030383,-0.10662,-0.067355,1,0
2,GO RECOMBINATIONAL REPAIR,0.015203,-0.10751,-0.07742,1,0
2,GO SPINDLE ASSEMBLY,0.026586,-0.10821,-0.072044,1,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.03245,-0.10942,-0.15949,1,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0051916,-0.11005,-0.11795,1,0
2,GO DNA CONFORMATION CHANGE,0.0033369,-0.11129,-0.087389,1,0
2,GO MRNA CLEAVAGE,0.007729,-0.11159,-0.10537,1,0
2,GO CELLULAR RESPIRATION,0.027188,-0.1126,-0.12511,1,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.0019282,-0.11303,-0.16147,1,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.045624,-0.11313,-0.12188,1,0
2,GO DNA GEOMETRIC CHANGE,0.0023671,-0.11408,-0.12148,1,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.031748,-0.1147,-0.14495,1,0
2,GO PENTOSE METABOLIC PROCESS,0.01282,-0.1147,-0.21304,1,0
2,GO MRNA 3 END PROCESSING,0.0013872,-0.11578,-0.1123,1,0
2,GO POSITIVE REGULATION OF TRANSLATION,0.010506,-0.11715,-0.13317,1,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00032948,-0.11783,-0.14249,1,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.010506,-0.11813,-0.1151,1,0
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0069616,-0.11822,-0.12404,1,0
2,GO SPINDLE ORGANIZATION,0.03245,-0.11822,-0.066004,1,0
2,GO RNA POLYADENYLATION,0.0046564,-0.11839,-0.11276,1,0
2,GO MRNA TRANSPORT,0.0046564,-0.11879,-0.11308,1,0
2,GO REGULATION OF RNA SPLICING,0.031059,-0.11887,-0.071399,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,1.4609e-05,-0.12002,-0.15826,1,0
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0022332,-0.1208,-0.11042,1,0
2,GO HISTONE EXCHANGE,0.044685,-0.12114,-0.081407,1,0
2,GO DNA METHYLATION,0.041967,-0.12222,-0.084953,1,0
2,GO NUCLEOTIDE EXCISION REPAIR,4.6597e-05,-0.12325,-0.12514,1,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.02166,-0.12414,-0.098456,1,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00010092,-0.1286,-0.1355,1,0
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.00021167,-0.12945,-0.14917,1,0
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.001872,-0.13023,-0.12357,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.010773,-0.1316,-0.17903,1,0
2,GO CHROMOSOME CONDENSATION,0.030383,-0.13171,-0.086673,1,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.025994,-0.1322,-0.15777,1,0
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0018173,-0.1327,-0.13362,1,0
2,GO HISTONE H3 K4 TRIMETHYLATION,0.038561,-0.13289,-0.098334,1,0
2,GO MRNA METHYLATION,0.021165,-0.13319,-0.13463,1,0
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.0057817,-0.13335,-0.11372,1,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.00028792,-0.1338,-0.19475,1,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0027346,-0.13448,-0.13051,1,0
2,GO PROTEIN NEDDYLATION,0.0036303,-0.13486,-0.13834,1,0
2,GO TRNA METHYLATION,0.00092958,-0.13644,-0.19857,1,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.0028957,-0.13659,-0.135,1,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.042857,-0.13688,-0.14198,1,0
2,GO RNA STABILIZATION,0.0018173,-0.13817,-0.15015,1,0
2,GO PEPTIDE METABOLIC PROCESS,0.0036303,-0.13823,-0.1271,1,0
2,GO MIRNA METABOLIC PROCESS,0.0017123,-0.13978,-0.17404,1,0
2,GO REGULATION OF MRNA PROCESSING,0.014138,-0.14058,-0.090402,1,0
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0041716,-0.1407,-0.14807,1,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.015953,-0.1412,-0.15068,1,0
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0021062,-0.14126,-0.22035,1,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0021689,-0.14155,-0.14189,1,0
2,GO OXIDATIVE PHOSPHORYLATION,0.046579,-0.14219,-0.12145,1,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.011904,-0.14409,-0.15593,1,0
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00034072,-0.1443,-0.17297,1,0
2,GO RNA INTERFERENCE,0.038561,-0.1448,-0.13159,1,0
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0012662,-0.14524,-0.11419,1,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.042857,-0.14589,-0.15596,1,0
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,4.8379e-05,-0.14634,-0.15194,1,0
2,GO NCRNA TRANSCRIPTION,5.9841e-06,-0.14643,-0.15972,1,0
2,GO CHROMOSOME SEPARATION,0.0011199,-0.14669,-0.12761,1,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.0028141,-0.14671,-0.10722,1,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0045306,-0.14754,-0.11908,1,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,3.4421e-05,-0.14778,-0.13916,1,0
2,GO HISTONE ARGININE METHYLATION,0.001986,-0.14942,-0.15775,1,0
2,GO TELOMERE ORGANIZATION,3.8583e-05,-0.14954,-0.14438,1,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.018398,-0.14976,-0.1359,1,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0017641,-0.14985,-0.14551,1,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.009256,-0.15004,-0.12076,1,0
2,GO NUCLEOSOME ORGANIZATION,0.0054795,-0.15149,-0.10166,1,0
2,GO MEMBRANE DISASSEMBLY,0.047551,-0.15201,-0.12575,1,0
2,GO MITOCHONDRIAL DNA REPLICATION,0.0023671,-0.15205,-0.18807,1,0
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00026003,-0.15218,-0.12945,1,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,5.508e-06,-0.15223,-0.17097,1,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.013139,-0.15236,-0.15651,1,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.015574,-0.15309,-0.10163,1,0
2,GO MRNA EXPORT FROM NUCLEUS,0.00026003,-0.15498,-0.1447,1,0
2,GO REGULATION OF CHROMOSOME SEPARATION,0.001986,-0.15551,-0.13991,1,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0022332,-0.15749,-0.14014,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0053338,-0.15798,-0.11203,1,0
2,GO TRANSLATIONAL TERMINATION,0.00065623,-0.1584,-0.24673,1,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.5331e-06,-0.15882,-0.18486,1,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0053338,-0.15958,-0.1791,1,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0013872,-0.16075,-0.24556,1,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.0025817,-0.16081,-0.21363,1,0
2,GO STRESS GRANULE ASSEMBLY,0.0031536,-0.16123,-0.16265,1,0
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.0024367,-0.16176,-0.14896,1,0
2,GO RNA LOCALIZATION,0.00012964,-0.16192,-0.15793,1,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0099891,-0.16229,-0.11258,1,0
2,GO PROTEIN NITROSYLATION,0.040234,-0.16238,-0.20265,1,0
2,GO MRNA PROCESSING,0.00018427,-0.16245,-0.12386,1,0
2,GO TRNA 5 LEADER REMOVAL,0.011612,-0.16348,-0.19909,1,0
2,GO REGULATION OF TELOMERE MAINTENANCE,7.9801e-06,-0.165,-0.18157,1,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.016734,-0.16513,-0.12801,1,0
2,GO MITOCHONDRIAL TRANSLATION,0.00063551,-0.16551,-0.24124,1,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.010245,-0.16561,-0.10305,1,0
2,GO RNA CAPPING,4.4878e-05,-0.16708,-0.15507,1,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.00087311,-0.16715,-0.12956,1,0
2,GO TRNA WOBBLE BASE MODIFICATION,0.0039469,-0.16751,-0.17772,1,0
2,GO RNA METHYLATION,1.8521e-05,-0.168,-0.20287,1,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0097392,-0.17072,-0.16724,1,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.0054795,-0.17081,-0.2168,1,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.033894,-0.17216,-0.14153,1,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0094949,-0.17294,-0.12496,1,0
2,GO RNA 5 END PROCESSING,0.0011199,-0.1734,-0.24661,1,0
2,GO MRNA METABOLIC PROCESS,5.8301e-05,-0.17395,-0.15962,1,0
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0032441,-0.17458,-0.11531,1,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,5.9841e-06,-0.17524,-0.20741,1,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.001872,-0.1754,-0.18887,1,0
2,GO RNA 3 END PROCESSING,9.7801e-06,-0.17551,-0.17094,1,0
2,GO TRNA MODIFICATION,4.3218e-05,-0.17585,-0.23873,1,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00019753,-0.17614,-0.19019,1,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.011326,-0.17619,-0.10509,1,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.02268,-0.17635,-0.14064,1,0
2,GO TRNA METABOLIC PROCESS,4.8379e-05,-0.17635,-0.2056,1,0
2,GO RNA SPLICING,0.00014935,-0.17662,-0.13381,1,0
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00026003,-0.17663,-0.14043,1,0
2,GO PROTEASOME ASSEMBLY,0.0039469,-0.17701,-0.19618,1,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.014486,-0.1773,-0.21807,1,0
2,GO SNRNA METABOLIC PROCESS,4.6623e-06,-0.17747,-0.23375,1,0
2,GO PEPTIDYL ARGININE METHYLATION,0.0011549,-0.17832,-0.16909,1,0
2,GO NCRNA EXPORT FROM NUCLEUS,0.0099891,-0.17843,-0.18027,1,0
2,GO NUCLEOBASE METABOLIC PROCESS,0.0007696,-0.17867,-0.20308,1,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.017137,-0.17987,-0.13423,1,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.009256,-0.1806,-0.15626,1,0
2,GO RNA EXPORT FROM NUCLEUS,7.8282e-05,-0.18272,-0.16909,1,0
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00017796,-0.18372,-0.14725,1,0
2,GO DNA STRAND ELONGATION,0.025994,-0.1838,-0.11827,1,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,1.7474e-06,-0.18427,-0.19799,1,0
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00045924,-0.18574,-0.1661,1,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.0075304,-0.18602,-0.15994,1,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0081404,-0.18768,-0.17706,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,2.3418e-05,-0.18772,-0.25242,1,0
2,GO HISTONE H2A ACETYLATION,0.0049174,-0.18801,-0.1372,1,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.02068,-0.18834,-0.13477,1,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,4.6623e-06,-0.1886,-0.18247,1,0
2,GO HISTONE DEUBIQUITINATION,0.00026003,-0.18904,-0.15358,1,0
2,GO HISTONE MRNA METABOLIC PROCESS,0.00010462,-0.18917,-0.18506,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0040578,-0.18998,-0.16569,1,0
2,GO MITOCHONDRIAL TRANSCRIPTION,0.022165,-0.19042,-0.19773,1,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0027346,-0.19057,-0.19502,1,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00042998,-0.19063,-0.24362,1,0
2,GO BLASTOCYST GROWTH,0.0016129,-0.19181,-0.1846,1,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0001547,-0.19205,-0.17973,1,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0067808,-0.19293,-0.13103,1,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0026572,-0.19494,-0.18744,1,0
2,GO TRANSLATIONAL ELONGATION,0.00057693,-0.19513,-0.22024,1,0
2,GO PEPTIDYL ARGININE N METHYLATION,0.004408,-0.196,-0.19688,1,0
2,GO DNA REPLICATION INITIATION,0.00021909,-0.19891,-0.20601,1,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0036303,-0.20146,-0.23738,1,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.042857,-0.20149,-0.13882,1,0
2,GO TRNA PROCESSING,9.3916e-06,-0.20205,-0.23319,1,0
2,GO RNA CATABOLIC PROCESS,0.00041602,-0.20206,-0.18821,1,0
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,2.9532e-05,-0.20267,-0.21066,1,0
2,GO RNA PROCESSING,2.0784e-06,-0.20349,-0.18576,1,0
2,GO TRNA TRANSPORT,0.0011199,-0.20625,-0.20693,1,0
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0073363,-0.20901,-0.13896,1,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0059384,-0.20989,-0.23564,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00040247,-0.21114,-0.27443,1,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.0056288,-0.21209,-0.19529,1,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.00012512,-0.21229,-0.18413,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0025817,-0.21371,-0.19759,1,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00072223,-0.21454,-0.3067,1,0
2,GO SNRNA PROCESSING,6.4994e-06,-0.21544,-0.27012,1,0
2,GO NUCLEAR PORE ORGANIZATION,0.0024367,-0.21568,-0.25612,1,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00098941,-0.21662,-0.18255,1,0
2,GO FOLIC ACID METABOLIC PROCESS,0.0087944,-0.21704,-0.20864,1,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00036427,-0.21715,-0.22446,1,0
2,GO GLUTAMINE METABOLIC PROCESS,0.0051916,-0.21723,-0.17895,1,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.016339,-0.21772,-0.17133,1,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.017137,-0.21795,-0.17784,1,0
2,GO KINETOCHORE ASSEMBLY,0.042857,-0.22235,-0.12287,1,0
2,GO TRNA 5 END PROCESSING,0.0017123,-0.22301,-0.23611,1,0
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.035393,-0.22439,-0.19016,1,0
2,GO PROTEIN DENEDDYLATION,0.00010462,-0.22537,-0.24069,1,0
2,GO PEPTIDYL METHIONINE MODIFICATION,0.001872,-0.22579,-0.2047,1,0
2,GO DNA REPLICATION CHECKPOINT,0.001228,-0.22675,-0.2236,1,0
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.00092958,-0.22681,-0.2145,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,1.5816e-05,-0.22827,-0.31105,1,0
2,GO PEPTIDYL HISTIDINE MODIFICATION,3.1888e-05,-0.22964,-0.26193,1,0
2,GO MRNA MODIFICATION,0.00037661,-0.23009,-0.21117,1,0
2,GO NCRNA METABOLIC PROCESS,2.0784e-06,-0.23019,-0.26347,1,0
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0021062,-0.23102,-0.19013,1,0
2,GO ADULT HEART DEVELOPMENT,0.021165,-0.232,-0.21231,1,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0025817,-0.23231,-0.24992,1,0
2,GO RRNA 3 END PROCESSING,0.00055855,-0.23412,-0.22931,1,0
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00092958,-0.23562,-0.24055,1,0
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,5.9841e-06,-0.23891,-0.21635,1,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,7.8282e-05,-0.24014,-0.25145,1,0
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0097392,-0.24066,-0.20438,1,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,3.8583e-05,-0.24119,-0.25082,1,0
2,GO NCRNA 3 END PROCESSING,3.1904e-06,-0.24125,-0.27597,1,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,1.6455e-05,-0.24137,-0.24179,1,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,4.4878e-05,-0.24446,-0.22564,1,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,2.5308e-05,-0.24614,-0.25682,1,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.00353,-0.24668,-0.21819,1,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0069616,-0.24748,-0.16551,1,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,2.4692e-06,-0.24934,-0.24854,1,0
2,GO REGULATION OF RNA BINDING,0.00014418,-0.25307,-0.24781,1,0
2,GO AMINO ACID ACTIVATION,0.00013917,-0.25475,-0.28488,1,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.0011199,-0.25568,-0.18699,1,0
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.0021062,-0.2564,-0.29666,1,0
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00034072,-0.25766,-0.28322,1,0
2,GO NCRNA PROCESSING,6.8936e-07,-0.25908,-0.29968,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,4.4712e-06,-0.25945,-0.22881,1,0
2,GO REGULATION OF MRNA BINDING,8.7323e-05,-0.26268,-0.2985,1,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00081984,-0.26271,-0.31202,1,0
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,7.2111e-07,-0.26438,-0.28715,1,0
2,GO IMP METABOLIC PROCESS,0.0017641,-0.26484,-0.32137,1,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,1.1493e-05,-0.265,-0.37081,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,3.4728e-06,-0.26517,-0.25053,1,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,4.4878e-05,-0.26563,-0.2936,1,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,5.508e-06,-0.27192,-0.27548,1,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,2.0033e-05,-0.27467,-0.33775,1,0
2,GO RRNA MODIFICATION,1.7474e-06,-0.27584,-0.33909,1,0
2,GO PSEUDOURIDINE SYNTHESIS,1.5201e-05,-0.27908,-0.38224,1,0
2,GO RRNA METHYLATION,1.906e-06,-0.27933,-0.30755,1,0
2,GO RRNA TRANSCRIPTION,5.7413e-06,-0.2794,-0.29958,1,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.012203,-0.27959,-0.18306,1,0
2,GO ETHANOL OXIDATION,0.029068,-0.28189,-0.30191,1,0
2,GO DENDRITIC TRANSPORT,0.041967,-0.28339,-0.1428,1,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.8583e-05,-0.28478,-0.33262,1,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,2.9532e-05,-0.28534,-0.27264,1,0
2,GO MATURATION OF 5 8S RRNA,9.0179e-06,-0.2886,-0.36079,1,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,6.2786e-05,-0.28965,-0.37431,1,0
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00041602,-0.29058,-0.35944,1,0
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.00016595,-0.29106,-0.28989,1,0
2,GO RRNA METABOLIC PROCESS,1.0779e-06,-0.29915,-0.33309,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,7.9801e-06,-0.30163,-0.31624,1,0
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,6.8936e-07,-0.30662,-0.29275,1,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00045924,-0.30877,-0.35721,1,0
2,GO MITOCHONDRIAL RNA PROCESSING,7.2754e-05,-0.31676,-0.32235,1,0
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00084609,-0.31799,-0.34667,1,0
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.019739,-0.31874,-0.25904,1,0
2,GO VIRAL GENE EXPRESSION,0.00021167,-0.3229,-0.32252,1,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,3.9418e-06,-0.32562,-0.31121,1,0
2,GO MITOCHONDRIAL TRNA PROCESSING,0.00018427,-0.32787,-0.30658,1,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,1.0604e-05,-0.32794,-0.38094,1,0
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,3.0264e-07,-0.33001,-0.33346,1,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,6.2786e-05,-0.33638,-0.46425,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00019079,-0.34693,-0.29859,1,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.0784e-06,-0.348,-0.38619,1,0
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.00081984,-0.35311,-0.28491,1,0
2,GO RIBOSOME BIOGENESIS,4.1802e-07,-0.35601,-0.37737,1,0
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,9.0179e-06,-0.36078,-0.38932,1,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,4.7955e-07,-0.36336,-0.42879,1,0
2,GO L SERINE METABOLIC PROCESS,0.019739,-0.36384,-0.27281,1,0
2,GO RNA SURVEILLANCE,1.2308e-06,-0.36464,-0.32169,1,0
2,GO MATURATION OF SSU RRNA,9.0221e-07,-0.3647,-0.40102,1,0
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,2.5774e-06,-0.36597,-0.39274,1,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,5.2533e-07,-0.37349,-0.37621,1,0
2,GO TELOMERASE RNA LOCALIZATION,5.4977e-07,-0.37586,-0.44421,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,6.8936e-07,-0.37691,-0.3921,1,0
2,GO RRNA PSEUDOURIDINE SYNTHESIS,1.7474e-06,-0.38206,-0.45697,1,0
2,GO TRANSLATIONAL INITIATION,0.00017796,-0.38598,-0.36524,1,0
2,GO CYTOPLASMIC TRANSLATION,1.5201e-05,-0.38871,-0.43176,1,0
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,1.349e-05,-0.39338,-0.38997,1,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,5.2837e-06,-0.39842,-0.4751,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00045924,-0.4004,-0.45196,1,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.025414,-0.4065,-0.25976,1,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,7.0571e-06,-0.41145,-0.41344,1,0
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,1.9873e-07,-0.418,-0.49986,1,0
2,GO RIBOSOME ASSEMBLY,6.0198e-07,-0.42011,-0.48878,1,0
2,GO SNORNA METABOLIC PROCESS,4.6623e-06,-0.42424,-0.3994,1,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,6.8936e-07,-0.42556,-0.45835,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,3.8131e-07,-0.42694,-0.50111,1,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.00050664,-0.43015,-0.31746,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00023468,-0.43128,-0.46026,1,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,9.0221e-07,-0.43192,-0.49335,1,0
2,GO VIRAL TRANSLATION,6.2367e-06,-0.43562,-0.42984,1,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,1.1964e-05,-0.43613,-0.39271,1,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,7.6603e-06,-0.43842,-0.46489,1,0
2,GO SNORNA 3 END PROCESSING,3.4728e-06,-0.43959,-0.44186,1,0
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,3.3132e-05,-0.45824,-0.45478,1,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00049035,-0.47353,-0.50333,1,0
2,GO MATURATION OF LSU RRNA,1.1776e-06,-0.49381,-0.4898,1,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,1.7474e-06,-0.49421,-0.5204,1,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,4.7955e-07,-0.49538,-0.54274,1,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,8.3127e-06,-0.52532,-0.54918,1,0
2,GO MUCUS SECRETION,0.052669,0.41241,0.28563,0,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.059411,0.41234,0.26026,0,1
2,GO ELASTIC FIBER ASSEMBLY,0.0695,0.36152,0.18746,0,1
2,GO NEPHRIC DUCT MORPHOGENESIS,0.082489,0.35784,0.17993,0,1
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.054842,0.32239,0.2951,0,1
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.064293,0.32137,0.24264,0,1
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.052669,0.32065,0.17734,0,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.055956,0.30952,0.1156,0,1
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.087232,0.2953,0.13084,0,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.29992,0.29373,0.075821,0,1
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.11636,0.29254,0.16921,0,1
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.15264,0.28913,0.22477,0,1
2,GO ACTIN FILAMENT NETWORK FORMATION,0.092194,0.28704,0.23024,0,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.093897,0.27335,0.2352,0,1
2,GO PROGESTERONE METABOLIC PROCESS,0.14526,0.26715,0.096648,0,1
2,GO PROSTATE GLAND DEVELOPMENT,0.052669,0.26535,0.15463,0,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.052669,0.26343,0.18129,0,1
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.04854,0.26278,0.2182,0,1
2,GO SHORT TERM MEMORY,0.1028,0.26272,0.1598,0,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.080955,0.25912,0.1362,0,1
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.079444,0.24909,0.13337,0,1
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.095625,0.24487,0.15596,0,1
2,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.050569,0.24007,0.20695,0,1
2,GO MITRAL VALVE DEVELOPMENT,0.085627,0.23315,0.14441,0,1
2,GO NOREPINEPHRINE SECRETION,0.064293,0.22859,0.17004,0,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.15015,0.22859,0.1275,0,1
2,GO TRACHEA DEVELOPMENT,0.050569,0.22843,0.21768,0,1
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.099158,0.22721,0.21916,0,1
2,GO SYNAPTIC VESICLE MATURATION,0.14048,0.22584,0.224,0,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.077957,0.22562,0.21767,0,1
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.085627,0.22502,0.17103,0,1
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.20621,0.22409,0.11995,0,1
2,GO CELL FATE DETERMINATION,0.075049,0.2224,0.13466,0,1
2,GO HYPOTONIC RESPONSE,0.188,0.21737,0.10529,0,1
2,GO AUTOPHAGY OF NUCLEUS,0.04854,0.21206,0.1319,0,1
2,GO RENAL VESICLE DEVELOPMENT,0.057089,0.21186,0.14261,0,1
2,GO PROTEIN LOCALIZATION TO AXON,0.054842,0.20875,0.28291,0,1
2,GO POSITIVE REGULATION OF FERTILIZATION,0.073629,0.20752,0.16835,0,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.063042,0.20441,0.11744,0,1
2,GO CORPUS CALLOSUM DEVELOPMENT,0.17099,0.20299,0.12366,0,1
2,GO I KAPPAB PHOSPHORYLATION,0.05824,0.20003,0.12578,0,1
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.075049,0.19927,0.10467,0,1
2,GO INSEMINATION,0.055956,0.19924,0.20472,0,1
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.12049,0.19859,0.11872,0,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.050569,0.19829,0.19318,0,1
2,GO DIVALENT METAL ION EXPORT,0.068167,0.19777,0.13852,0,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.28785,0.19615,0.1142,0,1
2,GO RESPONSE TO LEUCINE,0.066855,0.19556,0.17436,0,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.049546,0.19525,0.25167,0,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0695,0.19481,0.15166,0,1
2,GO HINDLIMB MORPHOGENESIS,0.17374,0.19462,0.10108,0,1
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.10845,0.19184,0.18359,0,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.16559,0.19176,0.17709,0,1
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.1313,0.19094,0.12701,0,1
2,GO LOCOMOTOR RHYTHM,0.088862,0.18461,0.11756,0,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.22905,0.18448,0.087291,0,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.057089,0.18426,0.11315,0,1
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.15517,0.18311,0.065448,0,1
2,GO MAGNESIUM ION HOMEOSTASIS,0.17934,0.18275,0.1069,0,1
2,GO SEROTONIN TRANSPORT,0.076492,0.17972,0.16512,0,1
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.087232,0.17929,0.15165,0,1
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.12049,0.17848,0.098812,0,1
2,GO NEUROTRANSMITTER REUPTAKE,0.14526,0.17748,0.11658,0,1
2,GO POSITIVE REGULATION OF CELL SIZE,0.12259,0.17712,0.089889,0,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.10654,0.17365,0.098411,0,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.054842,0.17198,0.12775,0,1
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.057089,0.17153,0.18536,0,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.073629,0.17123,0.10171,0,1
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.061812,0.171,0.17034,0,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.23937,0.16961,0.090261,0,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.16294,0.16839,0.10772,0,1
2,GO CARNITINE METABOLIC PROCESS,0.05824,0.16623,0.15929,0,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.080955,0.16483,0.15768,0,1
2,GO BLASTODERM SEGMENTATION,0.2,0.16,0.1293,0,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.087232,0.15986,0.10563,0,1
2,GO REGULATION OF EXCRETION,0.075049,0.15982,0.11509,0,1
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.25363,0.15708,0.050852,0,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.070855,0.15435,0.068434,0,1
2,GO NEUROTRANSMITTER UPTAKE,0.12049,0.15432,0.11054,0,1
2,GO PROTEIN DEMETHYLATION,0.093897,0.15402,0.08476,0,1
2,GO SEROTONIN SECRETION,0.05161,0.15141,0.20363,0,1
2,GO ARTERY MORPHOGENESIS,0.066855,0.15018,0.064178,0,1
2,GO CGMP MEDIATED SIGNALING,0.068167,0.1499,0.10431,0,1
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.18219,0.14892,0.16089,0,1
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.052669,0.14725,0.15246,0,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.090515,0.14617,0.058234,0,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.23245,0.14607,0.088621,0,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.068167,0.14551,0.071743,0,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.077957,0.14545,0.13702,0,1
2,GO RENAL SODIUM EXCRETION,0.070855,0.14501,0.1315,0,1
2,GO RESPONSE TO MINERALOCORTICOID,0.057089,0.14455,0.11725,0,1
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.16294,0.14441,0.11029,0,1
2,GO GOLGI VESICLE BUDDING,0.055956,0.14385,0.064943,0,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.12908,0.14296,0.19902,0,1
2,GO NEURAL CREST CELL MIGRATION,0.15773,0.14273,0.12655,0,1
2,GO REPLICATIVE SENESCENCE,0.049546,0.14199,0.14644,0,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.15264,0.13823,0.094064,0,1
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.12259,0.13814,0.090245,0,1
2,GO STRIATUM DEVELOPMENT,0.41341,0.13761,0.065795,0,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.063042,0.13655,0.11061,0,1
2,GO NUCLEOTIDE TRANSPORT,0.049546,0.13489,0.10548,0,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.054842,0.1331,0.16874,0,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.30815,0.13204,0.042075,0,1
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.055956,0.13041,0.1169,0,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.066855,0.13001,0.067616,0,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.066855,0.12984,0.094994,0,1
2,GO QUINONE METABOLIC PROCESS,0.10465,0.12909,0.046934,0,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.049546,0.12692,0.15288,0,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.12908,0.12668,0.057262,0,1
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.053746,0.12538,0.13603,0,1
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.15015,0.12513,0.055627,0,1
2,GO NEURON PROJECTION ORGANIZATION,0.13583,0.12484,0.087158,0,1
2,GO ALCOHOL CATABOLIC PROCESS,0.060602,0.12458,0.076594,0,1
2,GO COPII COATED VESICLE BUDDING,0.097379,0.12414,0.048231,0,1
2,GO HEAD MORPHOGENESIS,0.080955,0.1241,0.11753,0,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.22235,0.12301,0.073992,0,1
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.061812,0.12228,0.094727,0,1
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.055956,0.12198,0.068628,0,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.10465,0.12194,0.079068,0,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.052669,0.12057,0.1468,0,1
2,GO DEVELOPMENTAL PIGMENTATION,0.093897,0.12041,0.065342,0,1
2,GO MALE GENITALIA DEVELOPMENT,0.15517,0.11951,0.091809,0,1
2,GO PHAGOSOME MATURATION,0.12259,0.11928,0.061,0,1
2,GO PHAGOSOME ACIDIFICATION,0.17099,0.11918,0.060559,0,1
2,GO PH REDUCTION,0.10654,0.11873,0.056571,0,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.13583,0.11861,0.079682,0,1
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.19393,0.1184,0.053654,0,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.48131,0.11749,0.006821,0,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.10096,0.11714,0.096238,0,1
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.088862,0.11457,0.070123,0,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.21256,0.11365,0.075196,0,1
2,GO RESPONSE TO PROSTAGLANDIN,0.23245,0.1136,0.060634,0,1
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.059411,0.10886,0.12203,0,1
2,GO POSITIVE REGULATION OF MYELINATION,0.27227,0.10832,0.054824,0,1
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.053746,0.10831,0.067997,0,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.15517,0.10736,0.036483,0,1
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.17653,0.10573,0.11547,0,1
2,GO HEAT GENERATION,0.23937,0.10529,0.089188,0,1
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.18219,0.10529,0.062136,0,1
2,GO PURINE NUCLEOTIDE TRANSPORT,0.12473,0.10509,0.077904,0,1
2,GO MAINTENANCE OF CELL NUMBER,0.063042,0.1046,0.061778,0,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.57857,0.10326,0.0040925,0,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.090515,0.10314,0.10469,0,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.090515,0.10227,0.085187,0,1
2,GO SIGNAL PEPTIDE PROCESSING,0.25001,0.10156,0.081544,0,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.052669,0.10151,0.081842,0,1
2,GO TRABECULA MORPHOGENESIS,0.075049,0.099203,0.063122,0,1
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.27227,0.099013,0.087109,0,1
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.063042,0.098011,0.091979,0,1
2,GO LIMBIC SYSTEM DEVELOPMENT,0.064293,0.097302,0.10665,0,1
2,GO PROTEIN POLYGLUTAMYLATION,0.063042,0.095906,0.1097,0,1
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.14526,0.095702,0.078354,0,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.15773,0.094841,0.083813,0,1
2,GO RESPONSE TO GLUCAGON,0.057089,0.094395,0.082107,0,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.34256,0.093789,0.077056,0,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.10654,0.092436,0.10351,0,1
2,GO REGULATION OF STEM CELL PROLIFERATION,0.14526,0.090933,0.091659,0,1
2,GO ARACHIDONIC ACID SECRETION,0.076492,0.090907,0.066615,0,1
2,GO PROSTAGLANDIN TRANSPORT,0.20621,0.089146,0.066394,0,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.12473,0.089091,0.057441,0,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.29184,0.086868,0.05254,0,1
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.23245,0.086847,0.061221,0,1
2,GO HISTONE H3 K27 METHYLATION,0.36064,0.086841,0.060043,0,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.053746,0.086571,0.12149,0,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.67137,0.086277,-0.0016701,0,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.14526,0.086069,0.051081,0,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.063042,0.085655,0.060232,0,1
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.076492,0.084728,0.05161,0,1
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.11841,0.084206,0.10303,0,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.095625,0.083865,0.091739,0,1
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.16032,0.083475,0.091153,0,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.13814,0.081444,0.064047,0,1
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.097379,0.081121,0.11544,0,1
2,GO REGULATION OF HISTONE MODIFICATION,0.084046,0.080167,0.064997,0,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.092194,0.075855,0.055723,0,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.14526,0.075247,0.059208,0,1
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.24643,0.075126,0.054793,0,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.20621,0.074589,0.096929,0,1
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.27227,0.074133,0.043157,0,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.088862,0.071861,0.056162,0,1
2,GO REGULATION OF NEURON MIGRATION,0.4978,0.068903,0.047847,0,1
2,GO PIGMENT GRANULE ORGANIZATION,0.18508,0.067577,0.050238,0,1
2,GO REGULATION OF AXON GUIDANCE,0.56075,0.06691,0.057629,0,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.15773,0.066424,0.082405,0,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.18219,0.065169,0.054528,0,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.31232,0.064416,0.051674,0,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.063042,0.061885,0.078649,0,1
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.14048,0.061499,0.091799,0,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.065563,0.060637,0.047474,0,1
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.093897,0.059317,0.060229,0,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.11235,0.059255,0.038619,0,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.055956,0.059121,0.067148,0,1
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.89215,0.058856,-0.041162,0,1
2,GO CYTOSOLIC TRANSPORT,0.16559,0.057066,0.043021,0,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.19695,0.055,0.035697,0,1
2,GO POLYOL CATABOLIC PROCESS,0.10096,0.05466,0.10027,0,1
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.049546,0.054637,0.048224,0,1
2,GO HISTONE DEACETYLATION,0.075049,0.052903,0.0629,0,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.34256,0.052285,0.046301,0,1
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.060602,0.047276,0.066722,0,1
2,GO REGULATION OF CELL CYCLE,0.063042,0.04377,0.036222,0,1
2,GO AXON EXTENSION,0.21256,0.041297,0.090622,0,1
2,GO PROTEIN ACYLATION,0.21579,0.036149,0.031566,0,1
2,GO NEGATIVE REGULATION OF ANOIKIS,8.7323e-05,0.42355,0.55801,0,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.10654,0.41955,0.23704,0,0
2,GO PARENTAL BEHAVIOR,0.0034322,0.37898,0.27865,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.076492,0.37412,0.2267,0,0
2,GO THALAMUS DEVELOPMENT,0.00092958,0.3571,0.34225,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.095625,0.33961,0.19487,0,0
2,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.18508,0.33572,0.18289,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0010206,0.32647,0.3801,0,0
2,GO MEMBRANE RAFT ASSEMBLY,0.072231,0.32456,0.25177,0,0
2,GO PITUITARY GLAND DEVELOPMENT,8.4205e-05,0.32243,0.34525,0,0
2,GO PHOSPHOLIPID EFFLUX,0.0028957,0.31883,0.23088,0,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.10465,0.31213,0.16133,0,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.16559,0.30598,0.20951,0,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.080955,0.28358,0.20548,0,0
2,GO REGULATION OF SYNAPSE MATURATION,0.0075304,0.27883,0.31984,0,0
2,GO INTERLEUKIN 13 PRODUCTION,0.0087944,0.2785,0.25224,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00052342,0.27793,0.29153,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0050528,0.27758,0.24692,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.077957,0.26467,0.21489,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.079444,0.26151,0.10302,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.014841,0.26082,0.26415,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.064293,0.26058,0.2566,0,0
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.055956,0.259,0.26679,0,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.057089,0.25705,0.16789,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.073629,0.25554,0.15573,0,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0060989,0.25438,0.24108,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.04854,0.25317,0.12303,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.02068,0.2528,0.22506,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.025994,0.25182,0.25357,0,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.054842,0.24692,0.11275,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.0094949,0.24581,0.16693,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.070855,0.24579,0.15378,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.060602,0.24577,0.1662,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.072231,0.24529,0.16712,0,0
2,GO RESPONSE TO EPINEPHRINE,0.14285,0.24308,0.16205,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.17099,0.24238,0.13924,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.69707,0.24154,0.032248,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.023205,0.23866,0.25592,0,0
2,GO SKIN MORPHOGENESIS,0.084046,0.23779,0.14956,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.041967,0.23603,0.28978,0,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.080955,0.23591,0.15664,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.015203,0.23431,0.17709,0,0
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.18219,0.23145,0.27149,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.060602,0.23112,0.17635,0,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.42855,0.22852,0.083186,0,0
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.29992,0.22657,0.072815,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.0033369,0.22496,0.20147,0,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.13583,0.22284,0.10619,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.27999,0.21948,0.13791,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.057089,0.21948,0.14526,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.14285,0.21947,0.13365,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.044685,0.21453,0.35548,0,0
2,GO NOSE DEVELOPMENT,0.007729,0.21343,0.37776,0,0
2,GO RESPIRATORY BURST,0.10096,0.21315,0.12127,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.15517,0.21211,0.12803,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.073629,0.21187,0.17299,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.064293,0.21105,0.12404,0,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.21256,0.21088,0.17075,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.082489,0.20813,0.18791,0,0
2,GO RESPONSE TO VITAMIN,0.013139,0.20713,0.17053,0,0
2,GO RETINA LAYER FORMATION,0.047551,0.20656,0.26657,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.19393,0.20655,0.078907,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.16559,0.20462,0.10302,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00072223,0.20457,0.25627,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.10096,0.20378,0.13665,0,0
2,GO MEMBRANE FISSION,0.010245,0.20186,0.20546,0,0
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.10654,0.19928,0.12833,0,0
2,GO CEREBELLAR CORTEX FORMATION,0.036948,0.19661,0.17687,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.05824,0.19641,0.11645,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.36991,0.1964,0.045312,0,0
2,GO PARTURITION,0.029068,0.1961,0.22377,0,0
2,GO RETINAL METABOLIC PROCESS,0.092194,0.19571,0.12393,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.27611,0.1957,0.10837,0,0
2,GO ENDODERM DEVELOPMENT,0.05824,0.1939,0.13159,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.12049,0.19369,0.13504,0,0
2,GO CD40 SIGNALING PATHWAY,0.10096,0.19345,0.097722,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.15015,0.19323,0.087213,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.019739,0.19322,0.26305,0,0
2,GO TONGUE MORPHOGENESIS,0.076492,0.19294,0.26318,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.061812,0.19205,0.11744,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.12689,0.1913,0.084447,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.25729,0.19117,0.1341,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.26471,0.19103,0.097417,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.188,0.19013,0.06549,0,0
2,GO SEGMENT SPECIFICATION,0.052669,0.18995,0.21491,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.11636,0.18965,0.10208,0,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00026003,0.1889,0.24992,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.30402,0.18852,0.079176,0,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.064293,0.18775,0.2213,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.33812,0.18607,0.050246,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.080955,0.185,0.1961,0,0
2,GO NEUROBLAST DIVISION,0.075049,0.18473,0.16922,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.060602,0.18301,0.15327,0,0
2,GO NEURAL RETINA DEVELOPMENT,0.044685,0.18204,0.13689,0,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.14769,0.18068,0.19956,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.14285,0.1796,0.16477,0,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.04854,0.17884,0.074325,0,0
2,GO POLYOL TRANSPORT,0.10465,0.17846,0.11153,0,0
2,GO NEUTROPHIL HOMEOSTASIS,0.059411,0.17811,0.1143,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.14285,0.17767,0.16668,0,0
2,GO TRABECULA FORMATION,0.17934,0.17741,0.07142,0,0
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.27227,0.17708,0.11673,0,0
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.43883,0.17677,0.024747,0,0
2,GO HEPARIN METABOLIC PROCESS,0.36526,0.17638,0.064852,0,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.33373,0.17608,0.044339,0,0
2,GO MUSCLE CELL FATE COMMITMENT,0.13355,0.17498,0.11313,0,0
2,GO ENDODERM FORMATION,0.12473,0.17469,0.08924,0,0
2,GO ARGININE METABOLIC PROCESS,0.14285,0.17452,0.11004,0,0
2,GO FOREBRAIN MORPHOGENESIS,0.085627,0.17401,0.12624,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0099891,0.17384,0.22735,0,0
2,GO BILE ACID AND BILE SALT TRANSPORT,0.030383,0.17371,0.13314,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.049546,0.17206,0.11662,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.015953,0.17117,0.20907,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.053746,0.17041,0.12633,0,0
2,GO INCLUSION BODY ASSEMBLY,0.10654,0.17009,0.13719,0,0
2,GO AMINO ACID IMPORT,0.03939,0.17006,0.13207,0,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.095625,0.16936,0.088909,0,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.075049,0.16874,0.16065,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.14526,0.16587,0.09839,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.23589,0.16546,0.14846,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.061812,0.16532,0.19935,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.21579,0.16511,0.12282,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.073629,0.16454,0.14984,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.25001,0.16408,0.078672,0,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0059384,0.16379,0.21721,0,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.53742,0.16375,0.034323,0,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.0097392,0.16356,0.2838,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.015203,0.1632,0.16227,0,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.14526,0.16248,0.094846,0,0
2,GO RESPONSE TO TESTOSTERONE,0.070855,0.16246,0.13737,0,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0097392,0.16227,0.14619,0,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.10654,0.16102,0.22644,0,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.2,0.16075,0.064074,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.053746,0.16001,0.13526,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.18508,0.15991,0.17097,0,0
2,GO GDP METABOLIC PROCESS,0.11235,0.15834,0.15521,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.084046,0.15818,0.18835,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0057817,0.15789,0.16601,0,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.11235,0.15758,0.15375,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.070855,0.15586,0.10194,0,0
2,GO RIG I SIGNALING PATHWAY,0.16559,0.15582,0.062729,0,0
2,GO INTERLEUKIN 5 PRODUCTION,0.10654,0.15488,0.14579,0,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.059411,0.15408,0.2152,0,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.17099,0.15386,0.081897,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.15015,0.15327,0.020655,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.072231,0.15308,0.12037,0,0
2,GO VESICLE TARGETING,0.092194,0.15306,0.075166,0,0
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.17653,0.15275,0.17404,0,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.060602,0.15224,0.20057,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.25363,0.15215,0.061451,0,0
2,GO PHAGOCYTOSIS RECOGNITION,0.72313,0.15177,0.00010389,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.17374,0.1517,0.079351,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.0695,0.15094,0.09962,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.052669,0.15041,0.14221,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.10654,0.1503,0.11746,0,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.084046,0.15008,0.10451,0,0
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.19095,0.14974,0.059286,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.082489,0.14948,0.093126,0,0
2,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.17653,0.14908,0.094869,0,0
2,GO LIPID IMPORT INTO CELL,0.085627,0.14882,0.14136,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.57857,0.14843,0.025711,0,0
2,GO NEURON PROJECTION ARBORIZATION,0.02068,0.14821,0.20708,0,0
2,GO FIBRINOLYSIS,0.16559,0.14815,0.074266,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.070855,0.14806,0.16242,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.059411,0.14793,0.1207,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.095625,0.14792,0.1561,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.12259,0.14789,0.11131,0,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.11841,0.14739,0.11564,0,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.064293,0.14668,0.14987,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.11636,0.14659,0.08789,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.052669,0.14607,0.11277,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.14048,0.14553,0.11809,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.15773,0.14491,0.11374,0,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.052669,0.1449,0.16337,0,0
2,GO IMMATURE B CELL DIFFERENTIATION,0.15517,0.14488,0.099699,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.080955,0.14448,0.08991,0,0
2,GO BARBED END ACTIN FILAMENT CAPPING,0.15773,0.1443,0.080285,0,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.10845,0.14421,0.27629,0,0
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.10465,0.14417,0.1196,0,0
2,GO LEFT RIGHT AXIS SPECIFICATION,0.12259,0.14413,0.13142,0,0
2,GO GAP JUNCTION ASSEMBLY,0.070855,0.14391,0.17278,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.060602,0.14282,0.086462,0,0
2,GO NOREPINEPHRINE TRANSPORT,0.073629,0.14274,0.13564,0,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.23589,0.14259,0.056839,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.20937,0.14211,0.082837,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.20309,0.14181,0.10609,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.25363,0.14131,0.053933,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.25729,0.14082,0.14666,0,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.36064,0.14064,0.050418,0,0
2,GO IRON ION HOMEOSTASIS,0.075049,0.14044,0.089066,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.082489,0.14033,0.10806,0,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.25001,0.14021,0.099099,0,0
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.05161,0.14008,0.1003,0,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.32506,0.14002,0.098497,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.057089,0.13965,0.10806,0,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.11841,0.13947,0.13344,0,0
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.093897,0.13877,0.048797,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.050569,0.13827,0.11138,0,0
2,GO PROSTANOID METABOLIC PROCESS,0.33373,0.13825,0.04645,0,0
2,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.31232,0.13808,0.062878,0,0
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.28785,0.13804,0.096679,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.10096,0.13802,0.096231,0,0
2,GO RESPONSE TO DSRNA,0.050569,0.13747,0.089354,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.10096,0.13725,0.19117,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.049546,0.13641,0.14052,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.024288,0.13634,0.11899,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.41341,0.13603,0.098612,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.56666,0.13572,0.01843,0,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.075049,0.13571,0.12947,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0057817,0.13564,0.16815,0,0
2,GO MAINTENANCE OF CELL POLARITY,0.05824,0.13551,0.12705,0,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.33373,0.13548,0.048978,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.14285,0.13495,0.093977,0,0
2,GO PROTEIN AUTOPROCESSING,0.052669,0.13491,0.14615,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,0.43367,0.13485,-0.0089797,0,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0017641,0.13455,0.16693,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.34256,0.13421,0.11764,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.12689,0.13329,0.078558,0,0
2,GO NEURAL TUBE PATTERNING,0.070855,0.13316,0.094017,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.22235,0.13306,0.084425,0,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.11434,0.13303,0.10656,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.11434,0.13289,0.14049,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.18219,0.13283,0.095733,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.24643,0.1328,0.12917,0,0
2,GO PROTEIN HYDROXYLATION,0.073629,0.13279,0.12432,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.073629,0.13256,0.11359,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.16559,0.13252,0.072753,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.070855,0.13222,0.097668,0,0
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.064293,0.13207,0.091496,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.11841,0.13197,0.085093,0,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.30402,0.13177,0.026721,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.11039,0.13161,0.2097,0,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.40349,0.13159,0.050409,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.22905,0.13113,0.087463,0,0
2,GO CYTOPLASM ORGANIZATION,0.14285,0.13109,0.091328,0,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.26471,0.13093,0.091968,0,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0051916,0.13066,0.19615,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.054842,0.13049,0.10608,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.072231,0.13039,0.27175,0,0
2,GO REGULATION OF CILIUM BEAT FREQUENCY,0.31653,0.13034,0.039735,0,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.16559,0.13028,0.070902,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.034637,0.13009,0.20376,0,0
2,GO LAMELLIPODIUM MORPHOGENESIS,0.72313,0.12996,0.0095438,0,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.15517,0.12994,0.049646,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.079444,0.12962,0.082035,0,0
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.27227,0.1296,0.046336,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.055956,0.12951,0.21639,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.65866,0.12942,-0.12577,0,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.55487,0.12931,0.042899,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.026586,0.12929,0.1155,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.80989,0.12859,0.0041901,0,0
2,GO SYNAPSE ASSEMBLY,0.0040578,0.12828,0.19671,0,0
2,GO EXTRACELLULAR TRANSPORT,0.22568,0.12796,0.065059,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.29184,0.12762,0.12361,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.017549,0.1276,0.16289,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.16828,0.12727,0.10302,0,0
2,GO SARCOMERE ORGANIZATION,0.0056288,0.12718,0.14839,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.15264,0.127,0.07412,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.022165,0.1268,0.12979,0,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.085627,0.12667,0.28227,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.013798,0.12665,0.14885,0,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.20621,0.12663,0.089193,0,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0056288,0.1266,0.083756,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.065563,0.12582,0.24523,0,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.21579,0.12577,0.10992,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.095625,0.12561,0.12189,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.32077,0.12556,0.039502,0,0
2,GO POLYAMINE METABOLIC PROCESS,0.11434,0.12539,0.098341,0,0
2,GO MIDDLE EAR MORPHOGENESIS,0.40843,0.12472,0.040632,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.29184,0.12469,0.023768,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.15264,0.12466,0.088637,0,0
2,GO VITAMIN TRANSPORT,0.050569,0.12461,0.089263,0,0
2,GO DENDRITIC CELL MIGRATION,0.073629,0.12452,0.17011,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.11039,0.12449,0.11402,0,0
2,GO ERAD PATHWAY,0.049546,0.12429,0.04834,0,0
2,GO FAT CELL PROLIFERATION,0.31653,0.12404,0.13055,0,0
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.77618,0.12385,0.029571,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.065563,0.12325,0.081417,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.068167,0.12279,0.17092,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.057089,0.12242,0.12237,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.61497,0.1221,0.08129,0,0
2,GO SOMATIC STEM CELL DIVISION,0.20621,0.1221,0.16937,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.20309,0.12202,0.11115,0,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.20937,0.12196,0.073601,0,0
2,GO NEPHRON TUBULE FORMATION,0.18508,0.12167,0.12819,0,0
2,GO LEUKOCYTE AGGREGATION,0.93377,0.12127,-0.061361,0,0
2,GO L GLUTAMATE IMPORT,0.15264,0.1211,0.079915,0,0
2,GO FATTY ACYL COA METABOLIC PROCESS,0.076492,0.12107,0.10593,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.087232,0.12103,0.076997,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.11636,0.12086,0.16066,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.050569,0.12077,0.080841,0,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.13355,0.12066,0.096187,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.052669,0.1204,0.10612,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.40349,0.12037,0.015664,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.39371,0.12033,0.16583,0,0
2,GO EMBRYO IMPLANTATION,0.18508,0.12014,0.060202,0,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.43367,0.1196,0.030975,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.24288,0.11955,0.087648,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.14048,0.11941,0.065851,0,0
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.21905,0.11938,0.071322,0,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.15773,0.11913,0.066198,0,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.063042,0.11896,0.16883,0,0
2,GO CHYLOMICRON ASSEMBLY,0.11235,0.1187,0.051536,0,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.24643,0.11833,0.045285,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.049546,0.11832,0.18202,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0695,0.11817,0.12771,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,0.011612,0.11816,0.12646,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.12908,0.11802,0.12874,0,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.11235,0.11751,0.067122,0,0
2,GO SPERM AXONEME ASSEMBLY,0.025994,0.11743,0.18278,0,0
2,GO VESICLE DOCKING,0.068167,0.1167,0.097146,0,0
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.090515,0.11638,0.076388,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.29184,0.11638,0.09036,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.11235,0.11637,0.11236,0,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.15264,0.11624,0.10785,0,0
2,GO RESPONSE TO LIGHT INTENSITY,0.16294,0.11569,0.11117,0,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.075049,0.11566,0.1466,0,0
2,GO HEPATOCYTE DIFFERENTIATION,0.20937,0.11564,0.10746,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.0094949,0.11563,0.095553,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0695,0.11558,0.10324,0,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.12049,0.11519,0.10541,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.072231,0.11513,0.15603,0,0
2,GO AXONAL FASCICULATION,0.13814,0.11505,0.17476,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.079444,0.11441,0.078242,0,0
2,GO RENAL WATER HOMEOSTASIS,0.02268,0.11424,0.11353,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.16294,0.11424,0.087656,0,0
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.064293,0.11418,0.1834,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.099158,0.11383,0.094735,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.031748,0.11358,0.084451,0,0
2,GO BONE GROWTH,0.27227,0.11352,0.067541,0,0
2,GO MICROTUBULE SEVERING,0.17934,0.11344,0.08521,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.24643,0.11337,0.12749,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.031059,0.11337,0.36519,0,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.14285,0.1132,0.072598,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.079444,0.11317,0.04029,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.085627,0.11314,0.11239,0,0
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.20309,0.11295,0.09435,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.097379,0.11292,0.16794,0,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.088862,0.11286,0.086892,0,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,0.092194,0.11267,0.12326,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.087232,0.1124,0.15486,0,0
2,GO PERICARDIUM DEVELOPMENT,0.15517,0.11212,0.091559,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.63354,0.11179,0.012322,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.27999,0.11174,0.1026,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.045624,0.1117,0.085428,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.013139,0.1116,0.17916,0,0
2,GO BIOLOGICAL PHASE,0.40349,0.11147,0.084064,0,0
2,GO MATING BEHAVIOR,0.4978,0.11137,0.044637,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.068167,0.1111,0.116,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.1028,0.11107,0.067118,0,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.41341,0.11081,0.020587,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.066855,0.11064,0.16393,0,0
2,GO PYRUVATE METABOLIC PROCESS,0.05824,0.1106,0.082912,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.27999,0.11047,0.063636,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0042883,0.11046,0.10119,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.087232,0.11032,0.071848,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.053746,0.11026,0.11703,0,0
2,GO HORMONE CATABOLIC PROCESS,0.56666,0.11025,0.046625,0,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.015953,0.11004,0.097177,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.39858,0.11001,0.038711,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.19695,0.10975,0.11495,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39858,0.10952,0.04958,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.030383,0.10943,0.17084,0,0
2,GO CYTOKINETIC PROCESS,0.26098,0.1092,0.044956,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.12473,0.10897,0.40456,0,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.12049,0.10879,0.093237,0,0
2,GO CHONDROCYTE PROLIFERATION,0.20621,0.10876,0.071101,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.13583,0.10868,0.15152,0,0
2,GO REGULATION OF CHLORIDE TRANSPORT,0.47049,0.10858,0.038679,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.3746,0.10852,0.10801,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.22905,0.10852,0.12351,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.33373,0.10842,0.057246,0,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.47049,0.10821,0.025013,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.019739,0.10806,0.13469,0,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.11841,0.10804,0.12254,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0025817,0.10775,0.11658,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.092194,0.10708,0.19042,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.22905,0.10695,0.07161,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.18508,0.10683,0.093014,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.064293,0.10681,0.11445,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.5726,0.10679,0.046445,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0057817,0.10665,0.16643,0,0
2,GO NUCLEOTIDE PHOSPHORYLATION,0.041967,0.10651,0.089893,0,0
2,GO FOREGUT MORPHOGENESIS,0.188,0.10642,0.10041,0,0
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.14285,0.10642,0.11552,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.038561,0.10617,0.12154,0,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.47588,0.10591,0.093412,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.055956,0.1057,0.083164,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.67137,0.10565,-0.048408,0,0
2,GO INTERLEUKIN 2 PRODUCTION,0.079444,0.10559,0.071809,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.78962,0.10553,-0.0078263,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.31653,0.10533,0.075943,0,0
2,GO MIDBODY ABSCISSION,0.21905,0.10509,0.089554,0,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.22235,0.10452,0.040118,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.32077,0.10447,0.048895,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.188,0.10447,0.08436,0,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.25729,0.10437,0.082735,0,0
2,GO THIOESTER METABOLIC PROCESS,0.17934,0.10431,0.055717,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.20309,0.10423,0.11333,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.17099,0.10401,0.12459,0,0
2,GO CELLULAR RESPONSE TO PH,0.16032,0.10401,0.071311,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.17374,0.10386,0.099802,0,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.10096,0.10372,0.091008,0,0
2,GO TELENCEPHALON REGIONALIZATION,0.17934,0.10368,0.17741,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.17934,0.10361,0.076202,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.16032,0.1034,0.11994,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.19695,0.10325,0.12189,0,0
2,GO SPERM MOTILITY,0.0056288,0.10305,0.083456,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.055956,0.10302,0.090693,0,0
2,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.65866,0.10266,-0.0070355,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.22905,0.10262,0.042548,0,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.017549,0.10229,0.1657,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.038561,0.10226,0.09285,0,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.32938,0.10222,0.076785,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.070855,0.10221,0.093896,0,0
2,GO RESPONSE TO ACTIVITY,0.042857,0.10211,0.086785,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.088862,0.1016,0.096492,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.052669,0.10145,0.10535,0,0
2,GO HEART FIELD SPECIFICATION,0.52025,0.10142,0.065286,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.092194,0.10125,0.16717,0,0
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.24288,0.1011,0.12742,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.39858,0.10099,0.073244,0,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.20937,0.10098,0.1893,0,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.14048,0.10072,0.065606,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.38408,0.10072,0.050254,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.188,0.10057,0.088607,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.079444,0.10024,0.11917,0,0
2,GO MANGANESE ION TRANSPORT,0.29184,0.099668,0.026134,0,0
2,GO REGULATION OF HEAT GENERATION,0.29586,0.099511,0.10883,0,0
2,GO ANIMAL ORGAN FORMATION,0.088862,0.099489,0.071884,0,0
2,GO LYMPH NODE DEVELOPMENT,0.05161,0.099473,0.11806,0,0
2,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.25729,0.099471,0.032487,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.072231,0.099221,0.11223,0,0
2,GO TRANSCYTOSIS,0.054842,0.099156,0.09063,0,0
2,GO REGULATION OF URINE VOLUME,0.12473,0.099138,0.070054,0,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.050569,0.098741,0.15656,0,0
2,GO ARTERY DEVELOPMENT,0.41341,0.098711,0.00356,0,0
2,GO NIK NF KAPPAB SIGNALING,0.10096,0.098488,0.05596,0,0
2,GO BONE DEVELOPMENT,0.073629,0.098405,0.062756,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.14526,0.098386,0.13593,0,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.12049,0.098094,0.13219,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.53742,0.097917,0.0037623,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.55487,0.097626,0.044371,0,0
2,GO MESODERM MORPHOGENESIS,0.063042,0.097562,0.089526,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0057817,0.097481,0.084909,0,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.14769,0.097407,0.16632,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.39371,0.097346,0.048421,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.080955,0.097306,0.1383,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.74288,0.097043,0.030125,0,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.072231,0.097,0.089272,0,0
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.19095,0.096764,0.092865,0,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.29586,0.096722,0.033891,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0087944,0.096687,0.093783,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.39371,0.096667,0.11039,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.30815,0.096612,0.15798,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.052669,0.096448,0.077873,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.060602,0.09602,0.14191,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.10465,0.095685,0.053988,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.016339,0.09558,0.10252,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.19393,0.095118,0.071525,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.029068,0.095031,0.13356,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0695,0.095002,0.10753,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.48131,0.094761,0.05796,0,0
2,GO CELL FATE SPECIFICATION,0.041093,0.094561,0.16727,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.10096,0.09445,0.072675,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.34702,0.094172,0.041226,0,0
2,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.56075,0.094079,0.042874,0,0
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.088862,0.093997,0.14921,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.69061,0.093983,0.037101,0,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.11434,0.093955,0.11161,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.22568,0.093912,0.21194,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.46512,0.093809,0.036029,0,0
2,GO MESENCHYME MORPHOGENESIS,0.12259,0.093683,0.051693,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.4545,0.093669,0.076427,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.060602,0.093617,0.16856,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.27227,0.093227,0.10871,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.02843,0.093159,0.10564,0,0
2,GO BONE MORPHOGENESIS,0.10096,0.093151,0.078869,0,0
2,GO RNA DESTABILIZATION,0.29184,0.092738,0.021056,0,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.19695,0.092677,0.1189,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.20309,0.09256,0.12824,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.066855,0.092477,0.087917,0,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.033894,0.092293,0.25096,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.084046,0.092239,0.12894,0,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.11039,0.092218,0.069719,0,0
2,GO GLUTATHIONE METABOLIC PROCESS,0.44924,0.092201,0.022161,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.11636,0.092193,0.078044,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.14048,0.092049,0.23257,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.15517,0.092019,0.068906,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.029068,0.091626,0.084947,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0094949,0.090995,0.13403,0,0
2,GO AXIS SPECIFICATION,0.017969,0.090977,0.12044,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.17374,0.090939,0.085261,0,0
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.43883,0.090711,0.02789,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.58456,0.090625,0.0058893,0,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.85768,0.090244,-0.0082868,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.061812,0.09012,0.04713,0,0
2,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.76948,0.089965,0.027074,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.084046,0.089877,0.095946,0,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.02843,0.08973,0.090275,0,0
2,GO DETOXIFICATION,0.28785,0.089567,0.048687,0,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.15264,0.089553,0.19634,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.56075,0.089412,0.042952,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.2839,0.089347,0.069324,0,0
2,GO STEROL IMPORT,0.16294,0.089214,0.057464,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.40349,0.089144,0.038635,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.12908,0.088558,0.095844,0,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.26471,0.088289,0.053506,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.17934,0.088251,0.15443,0,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.12689,0.088234,0.16669,0,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.4598,0.088222,0.033061,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.084046,0.088188,0.092808,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.38888,0.087969,0.069762,0,0
2,GO CELL RECOGNITION,0.15773,0.087512,0.062821,0,0
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.19695,0.087432,0.062812,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.087232,0.087425,0.043093,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.22568,0.087245,0.10466,0,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.2,0.087123,0.046879,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.62732,0.086317,0.0048635,0,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.088862,0.086273,0.089783,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.22235,0.086256,0.072853,0,0
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.15015,0.086241,0.081342,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.02843,0.085727,0.10746,0,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.02068,0.085724,0.19013,0,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.27227,0.085627,0.058812,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.61497,0.085555,0.039637,0,0
2,GO CELLULAR RESPONSE TO ATP,0.059411,0.085345,0.091649,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.25001,0.085267,0.057299,0,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.39858,0.085169,0.037965,0,0
2,GO L AMINO ACID TRANSPORT,0.16294,0.084721,0.058708,0,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.63354,0.084513,0.017325,0,0
2,GO APPENDAGE MORPHOGENESIS,0.063042,0.084492,0.11692,0,0
2,GO RESPONSE TO CAMP,0.0042883,0.084362,0.11619,0,0
2,GO CILIUM ORGANIZATION,0.022165,0.084329,0.075076,0,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.14285,0.084304,0.061476,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.70355,0.083909,0.015965,0,0
2,GO METENCEPHALON DEVELOPMENT,0.019283,0.083795,0.15616,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.0695,0.08374,0.09508,0,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.041967,0.083608,0.086363,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.33373,0.083088,0.043796,0,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.3746,0.082764,0.034112,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.10096,0.082642,0.14954,0,0
2,GO PROSTATIC BUD FORMATION,0.33812,0.082584,0.15409,0,0
2,GO ACTIN FILAMENT SEVERING,0.48678,0.082578,0.043318,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.079444,0.082283,0.072714,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32506,0.082236,0.038423,0,0
2,GO RESPONSE TO INACTIVITY,0.5726,0.082077,0.019216,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.099158,0.082013,0.080168,0,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.084046,0.081947,0.08823,0,0
2,GO REGULATION OF HEART GROWTH,0.62732,0.081864,0.018021,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.11235,0.081836,0.11832,0,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.054842,0.081815,0.28401,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.068167,0.081739,0.093432,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.33373,0.081666,0.036774,0,0
2,GO ECTODERM DEVELOPMENT,0.03939,0.081501,0.10911,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.079444,0.081386,0.073392,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.16559,0.081288,0.11658,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.17653,0.081203,0.1039,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.092194,0.080767,0.11479,0,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.053746,0.08076,0.063893,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.38408,0.080758,0.077559,0,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.27227,0.080635,0.088398,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.4545,0.080619,0.081537,0,0
2,GO CELL JUNCTION MAINTENANCE,0.20309,0.080495,0.10512,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.12908,0.080447,0.036944,0,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.076492,0.080427,0.063562,0,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.10465,0.080385,0.059939,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.088862,0.080288,0.13066,0,0
2,GO SPERM EGG RECOGNITION,0.17099,0.080215,0.057535,0,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.12049,0.080148,0.077171,0,0
2,GO GENITALIA DEVELOPMENT,0.093897,0.080083,0.075605,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.78962,0.080047,-0.021153,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.079444,0.079979,0.13792,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.18219,0.079861,0.21095,0,0
2,GO RESPONSE TO REDOX STATE,0.28785,0.079814,0.10771,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.027188,0.07977,0.12667,0,0
2,GO REPLACEMENT OSSIFICATION,0.14769,0.07959,0.10058,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.11841,0.079515,0.13407,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.063042,0.079288,0.047853,0,0
2,GO RESPONSE TO SALT,0.11235,0.079115,0.074413,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.041093,0.079093,0.10026,0,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.19695,0.079032,0.14702,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.37932,0.078994,0.025426,0,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.3746,0.078974,0.095563,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.18219,0.078704,0.085641,0,0
2,GO CELL REDOX HOMEOSTASIS,0.68418,0.078584,0.010595,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.26471,0.078309,0.049944,0,0
2,GO CONVERGENT EXTENSION,0.56075,0.078081,0.051907,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.10096,0.07788,0.10863,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.24643,0.077869,0.059553,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.27611,0.077739,0.058262,0,0
2,GO GROOMING BEHAVIOR,0.98953,0.077682,0.011897,0,0
2,GO GOLGI VESICLE TRANSPORT,0.14285,0.077497,0.040051,0,0
2,GO REGULATION OF BONE DEVELOPMENT,0.41341,0.077347,0.040786,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.17653,0.077209,0.044467,0,0
2,GO SEGMENTATION,0.04854,0.077151,0.097494,0,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.27611,0.077007,0.032858,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.18219,0.076966,0.058035,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.42347,0.076938,0.047189,0,0
2,GO RESPONSE TO VITAMIN D,0.12689,0.076929,0.11806,0,0
2,GO NUCLEOTIDE SALVAGE,0.87833,0.076681,-0.026785,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.095625,0.076649,0.060463,0,0
2,GO ORGANIC ACID CATABOLIC PROCESS,0.13814,0.076559,0.049919,0,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.59059,0.076548,0.05883,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.47588,0.076101,0.045776,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.030383,0.076062,0.1048,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.18508,0.076035,0.068709,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.20937,0.075929,0.072734,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.12473,0.075815,0.038084,0,0
2,GO RESPONSE TO ZINC ION,0.063042,0.075812,0.12976,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.34256,0.0757,0.044739,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.35153,0.075597,0.052541,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.15773,0.075446,0.086315,0,0
2,GO GENITALIA MORPHOGENESIS,0.19695,0.075381,0.11372,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.34702,0.075349,0.058005,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.47049,0.075314,0.019603,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.30815,0.075225,0.051278,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.080955,0.074978,0.11511,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.097379,0.074932,0.054439,0,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.05824,0.074753,0.12126,0,0
2,GO OOCYTE DIFFERENTIATION,0.066855,0.07467,0.085704,0,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.064293,0.074587,0.092848,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.72969,0.074522,0.013196,0,0
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.054842,0.074517,0.051961,0,0
2,GO TRACHEA MORPHOGENESIS,0.20937,0.074356,0.13426,0,0
2,GO ESTROGEN BIOSYNTHETIC PROCESS,0.22235,0.074326,0.056222,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.030383,0.074304,0.16073,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.70355,0.074256,0.039804,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.7495,0.074222,0.071095,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.27999,0.074187,0.054622,0,0
2,GO AUTOPHAGIC CELL DEATH,0.044685,0.074035,0.14961,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.27999,0.074005,0.039789,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.97557,0.073822,0.032917,0,0
2,GO MUSCLE FILAMENT SLIDING,0.70355,0.073537,0.01788,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.31232,0.073518,0.081345,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.12259,0.073487,0.082098,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.39371,0.073393,0.018067,0,0
2,GO FIBROBLAST ACTIVATION,0.84397,0.073374,-0.0030734,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.10845,0.073279,0.099887,0,0
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.27227,0.073275,0.10569,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.39858,0.073257,0.075684,0,0
2,GO IMMATURE T CELL PROLIFERATION,0.82348,0.073221,-0.010064,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.15773,0.073194,0.11904,0,0
2,GO PROTEIN MANNOSYLATION,0.21579,0.073113,0.077438,0,0
2,GO NEURON PROJECTION GUIDANCE,0.13583,0.073028,0.1121,0,0
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.15517,0.072743,0.096231,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.73628,0.072728,0.064758,0,0
2,GO CELLULAR RESPONSE TO DRUG,0.31232,0.072451,0.048054,0,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.21905,0.072183,0.059913,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.27611,0.071925,0.052127,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.23245,0.071688,0.08422,0,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.47588,0.071326,0.028454,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.21256,0.071164,0.099179,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.41341,0.071132,0.082923,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.30402,0.070971,0.034928,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.057089,0.070928,0.074077,0,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.16559,0.070862,0.055255,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.13814,0.070802,0.11997,0,0
2,GO VIRAL BUDDING,0.24643,0.070671,0.058198,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.39858,0.07054,0.0466,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.32938,0.070531,0.061199,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.5726,0.070494,0.026979,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.37932,0.070345,0.0058804,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.2839,0.070261,0.10055,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.7495,0.069942,0.051621,0,0
2,GO HIPPO SIGNALING,0.74288,0.069923,-0.0042498,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.26098,0.06989,0.013799,0,0
2,GO VACUOLAR ACIDIFICATION,0.54321,0.06978,0.0033143,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.51459,0.069647,0.052842,0,0
2,GO INTERLEUKIN 17 PRODUCTION,0.10654,0.069584,0.076088,0,0
2,GO VIRAL RNA GENOME REPLICATION,0.11636,0.069201,0.072996,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.4545,0.069183,0.035872,0,0
2,GO SPECIFICATION OF SYMMETRY,0.097379,0.069092,0.052395,0,0
2,GO HISTONE H3 DEACETYLATION,0.39858,0.068993,0.034151,0,0
2,GO FOREBRAIN CELL MIGRATION,0.17374,0.068839,0.092956,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.060602,0.068827,0.076125,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.23589,0.068723,0.11852,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.065563,0.068705,0.074597,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.064293,0.068668,0.082324,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.97557,0.068214,0.0093672,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.47049,0.06812,0.02517,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.057089,0.067966,0.093251,0,0
2,GO SUCKLING BEHAVIOR,0.64605,0.067944,0.015182,0,0
2,GO RESPONSE TO HYDROPEROXIDE,0.79636,0.067651,-0.0020624,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.39371,0.067457,0.048975,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.36064,0.067333,0.10725,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,0.06733,0.010509,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.11235,0.066916,0.052909,0,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.30815,0.066857,0.065162,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.095625,0.066802,0.057533,0,0
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.17374,0.066768,0.050832,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.068167,0.066753,0.091221,0,0
2,GO SULFATION,0.35607,0.066227,0.049815,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.34702,0.066161,0.11267,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.34256,0.065981,0.037859,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.019283,0.06583,0.081286,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.34702,0.065675,0.063778,0,0
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.3746,0.065539,0.2341,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.28785,0.065472,0.060186,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.02166,0.065445,0.1403,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.017549,0.065392,0.081633,0,0
2,GO REGULATION OF MYELINATION,0.25729,0.065219,0.065729,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.188,0.06503,0.072897,0,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.05824,0.065025,0.12053,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.20621,0.064932,0.10525,0,0
2,GO SPINAL CORD DEVELOPMENT,0.1028,0.064899,0.12922,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.12908,0.064634,0.077283,0,0
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.48131,0.064441,0.031551,0,0
2,GO RECEPTOR RECYCLING,0.14285,0.064151,0.069131,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.31653,0.064042,0.051722,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.63978,0.063788,0.021936,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.16559,0.063723,0.060159,0,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.095625,0.06333,0.10603,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.33812,0.063083,0.064741,0,0
2,GO OXYGEN TRANSPORT,0.98953,0.063042,-0.06149,0,0
2,GO SEQUESTERING OF METAL ION,0.67776,0.062972,0.0033591,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.17099,0.062963,0.059213,0,0
2,GO AORTA MORPHOGENESIS,0.26847,0.062963,0.046807,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.62732,0.062835,0.03164,0,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.79636,0.062787,-0.0039878,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.17099,0.062783,0.086065,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.88523,0.062631,0.015164,0,0
2,GO LIPID DIGESTION,0.44402,0.062606,0.045913,0,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.49227,0.062597,0.031653,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.23589,0.062488,0.053381,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.14285,0.062355,0.08182,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.095625,0.062256,0.14704,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.47588,0.062031,0.067024,0,0
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.72313,0.061877,0.0065787,0,0
2,GO CELLULAR OXIDANT DETOXIFICATION,0.38888,0.061305,0.039834,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.54321,0.061085,0.051372,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.65866,0.061025,0.072783,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.12473,0.060856,0.073351,0,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.29184,0.060549,0.033343,0,0
2,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.31232,0.060373,0.043946,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.015574,0.060143,0.080846,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.17099,0.06014,0.06274,0,0
2,GO FATTY ACID BETA OXIDATION,0.088862,0.060055,0.06774,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.16828,0.060051,0.13378,0,0
2,GO RESPONSE TO ATP,0.057089,0.060021,0.099472,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.87144,0.059829,0.015955,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.4978,0.0594,0.015355,0,0
2,GO FEMALE GAMETE GENERATION,0.1313,0.059148,0.047709,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.036948,0.059138,0.061195,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.41842,0.059027,0.040418,0,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.18219,0.059018,0.094006,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.23937,0.058671,0.046447,0,0
2,GO AMINO ACID TRANSPORT,0.093897,0.058543,0.071368,0,0
2,GO PROTEIN STABILIZATION,0.21256,0.058511,0.045484,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.15015,0.057887,0.071218,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.075049,0.057568,0.11867,0,0
2,GO NEURON REMODELING,0.13814,0.057563,0.15081,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.62113,0.057092,0.042931,0,0
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.29586,0.056927,0.052413,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.48131,0.056911,0.019894,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.12259,0.0569,0.041321,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.93377,0.056812,-0.025067,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.32077,0.056652,0.043909,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.47588,0.056473,0.060194,0,0
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.38408,0.056313,0.041456,0,0
2,GO PANCREATIC JUICE SECRETION,0.33812,0.056164,0.080882,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.36064,0.056085,0.083111,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.32938,0.055999,0.046753,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.18219,0.055694,0.056524,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.16828,0.055602,0.11796,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.11841,0.055146,0.046284,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.21256,0.054902,0.092461,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.44402,0.054761,0.024013,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.090515,0.054758,0.064877,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.20937,0.054698,0.064731,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.86455,0.054287,-0.026139,0,0
2,GO DENDRITE EXTENSION,0.068167,0.054168,0.23074,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.74288,0.054071,0.015616,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.25363,0.054043,0.040056,0,0
2,GO UV PROTECTION,0.68418,0.053901,0.010486,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.099158,0.053881,0.028324,0,0
2,GO PROSTAGLANDIN SECRETION,0.63978,0.053791,0.026387,0,0
2,GO GENETIC IMPRINTING,0.17653,0.05366,0.098831,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.064293,0.053608,0.066925,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.26471,0.053428,0.059277,0,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.13355,0.053283,0.084131,0,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.23245,0.053034,0.060839,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.53742,0.052811,0.019016,0,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.47049,0.052775,0.097569,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.48131,0.052743,0.043894,0,0
2,GO PHOTOTRANSDUCTION,0.17374,0.052577,0.031167,0,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.35607,0.052569,0.07043,0,0
2,GO PROTEIN TETRAMERIZATION,0.12049,0.052543,0.059052,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.87833,0.052487,0.01335,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.26098,0.052223,0.090733,0,0
2,GO REGULATION OF BEHAVIOR,0.092194,0.05217,0.1001,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.16559,0.052138,0.051171,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.073629,0.052015,0.074213,0,0
2,GO VITAMIN METABOLIC PROCESS,0.29992,0.05201,0.038705,0,0
2,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.41341,0.051938,0.047937,0,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.79636,0.051785,0.018026,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.43883,0.051667,0.076238,0,0
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.36991,0.051608,0.037123,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.88523,0.051439,0.007103,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.14048,0.051438,0.081334,0,0
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.84397,0.051219,-0.044155,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.25363,0.051188,0.063461,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.3746,0.051143,0.068603,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.95466,0.051122,0.00021629,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.67137,0.051099,0.0040005,0,0
2,GO OVULATION,0.74288,0.051069,-0.017745,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.75615,0.050984,0.017244,0,0
2,GO INOSITOL METABOLIC PROCESS,0.19095,0.050748,0.080659,0,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.36064,0.050555,0.038942,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.14769,0.050258,0.11348,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.23937,0.050183,0.21194,0,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.54321,0.049982,0.017887,0,0
2,GO REGULATION OF ORGAN GROWTH,0.32938,0.049972,0.034765,0,0
2,GO BODY FLUID SECRETION,0.24288,0.049799,0.04039,0,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.082489,0.049746,0.16385,0,0
2,GO ZINC ION HOMEOSTASIS,0.21905,0.049719,0.07351,0,0
2,GO NEURON CELLULAR HOMEOSTASIS,0.76281,0.049616,0.0061612,0,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.22568,0.049607,0.070619,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.51459,0.049477,0.026405,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.15264,0.048884,0.048203,0,0
2,GO HISTONE H3 K36 METHYLATION,0.98255,0.048804,-0.014753,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.99651,0.048763,-0.038472,0,0
2,GO NEURAL CREST FORMATION,0.82348,0.048587,0.0070361,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.61497,0.048586,-0.0014926,0,0
2,GO HEART INDUCTION,0.39858,0.048584,0.13731,0,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.97557,0.048414,-0.0033,0,0
2,GO VIRION ASSEMBLY,0.35607,0.048248,0.03067,0,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.20937,0.048136,0.066826,0,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.78289,0.047745,0.022378,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.29992,0.047728,0.035258,0,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.65866,0.047353,-0.015368,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.088862,0.047271,0.10591,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.53742,0.04707,0.016412,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.48678,0.047041,0.014994,0,0
2,GO CELL PART MORPHOGENESIS,0.099158,0.046931,0.099067,0,0
2,GO ENDODERMAL CELL FATE COMMITMENT,0.73628,0.046899,-0.030458,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.32938,0.046859,0.049277,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.12473,0.046556,0.077069,0,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.36526,0.046474,0.037381,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.44402,0.04626,0.031089,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.76281,0.046188,0.046073,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.72313,0.046076,0.045451,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.5726,0.045793,0.07473,0,0
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.93377,0.045496,-0.012896,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.10096,0.045423,0.063464,0,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.13814,0.04522,0.1198,0,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.059411,0.04482,0.079052,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.073629,0.044524,0.093883,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.076492,0.044511,0.093181,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.36064,0.044434,0.023679,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.36064,0.044361,0.044778,0,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.32506,0.0443,0.030472,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.41842,0.044274,0.073965,0,0
2,GO SELECTIVE AUTOPHAGY,0.25001,0.044191,0.025783,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.16828,0.043994,0.076085,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.9686,0.043934,-0.016247,0,0
2,GO PEROXISOMAL TRANSPORT,0.15517,0.043716,0.080222,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.69061,0.043681,0.0062085,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.34702,0.043655,0.050353,0,0
2,GO RNA DECAPPING,0.50896,0.043558,0.017884,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.2839,0.043168,0.07059,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.79636,0.043035,-0.052597,0,0
2,GO REGULATION OF LIPASE ACTIVITY,0.1028,0.042974,0.070433,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.15517,0.042865,0.072548,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.63978,0.042813,0.068706,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.19695,0.042791,0.05141,0,0
2,GO SYNAPTIC VESICLE DOCKING,0.2,0.042725,0.17185,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.23245,0.042577,0.03867,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.12049,0.042332,0.029976,0,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.32506,0.042124,0.0878,0,0
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.12689,0.041753,0.12461,0,0
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.17653,0.041687,0.064577,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.60272,0.041422,0.02443,0,0
2,GO COPULATION,0.73628,0.041321,0.035652,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.80989,0.04123,0.015477,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.17653,0.040991,0.082263,0,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.19695,0.04098,0.12142,0,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.69707,0.04092,0.098251,0,0
2,GO MICROTUBULE ANCHORING,0.5726,0.040838,0.031345,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.27999,0.040785,0.13062,0,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.67776,0.040735,-0.0046399,0,0
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.37932,0.040702,0.03706,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.67776,0.040609,0.037687,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.53167,0.040537,0.0058185,0,0
2,GO ACROSOME ASSEMBLY,0.44402,0.040456,0.061767,0,0
2,GO RESPONSE TO MANGANESE ION,0.69707,0.040252,0.016095,0,0
2,GO PORE COMPLEX ASSEMBLY,0.67776,0.040108,0.019027,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.71006,0.040067,0.017534,0,0
2,GO ACIDIC AMINO ACID TRANSPORT,0.23589,0.039953,0.083051,0,0
2,GO BLASTOCYST DEVELOPMENT,0.21579,0.03985,0.032862,0,0
2,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.59664,0.039673,0.027816,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.21256,0.039641,0.08641,0,0
2,GO RESPONSE TO HEAT,0.86455,0.039528,-0.00042264,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.093897,0.039408,0.038465,0,0
2,GO SYMBIOTIC PROCESS,0.30402,0.039275,0.027486,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.23937,0.039236,0.041771,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.83713,0.039054,-0.0065371,0,0
2,GO NEURON FATE COMMITMENT,0.35607,0.038994,0.156,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.21256,0.038906,0.12705,0,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.48131,0.038905,0.022285,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.63354,0.038883,0.0070357,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.23937,0.038872,0.067101,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.38888,0.038832,0.12672,0,0
2,GO MICROTUBULE BASED MOVEMENT,0.43883,0.038822,0.019287,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.080955,0.03866,0.051851,0,0
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.10096,0.038644,0.071143,0,0
2,GO MATING,0.37932,0.038642,0.047506,0,0
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.69061,0.038162,-0.0039561,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.36064,0.03815,0.018144,0,0
2,GO MITOCHONDRIAL FISSION,0.34256,0.037327,0.033329,0,0
2,GO SYNAPTIC VESICLE RECYCLING,0.090515,0.037244,0.13868,0,0
2,GO HEART FORMATION,0.67137,0.037213,0.041145,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.7495,0.037207,0.0067256,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.98953,0.037127,-0.0070732,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.70355,0.037039,-0.0036608,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.44402,0.036443,0.0914,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.30815,0.036406,0.10324,0,0
2,GO RESPONSE TO UV,0.54903,0.036353,0.013504,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.21579,0.036322,0.064097,0,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.46512,0.036159,0.084738,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.76948,0.035827,0.0084292,0,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.32506,0.03574,0.031274,0,0
2,GO THYROID GLAND DEVELOPMENT,0.31653,0.035566,0.095407,0,0
2,GO LIPID PHOSPHORYLATION,0.27999,0.035384,0.042424,0,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.52025,0.035377,0.056166,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.76281,0.035349,-0.0022515,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.86455,0.035167,0.011978,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.4978,0.035008,0.017594,0,0
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.34256,0.034937,0.04245,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.79636,0.034611,-0.0010654,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.99651,0.034546,-0.03892,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.55487,0.034544,0.018195,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.51459,0.034345,0.037871,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.4978,0.034166,0.062523,0,0
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,0.034156,-0.02196,0,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.52025,0.034105,0.048801,0,0
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.4598,0.034091,0.014938,0,0
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.53742,0.034042,0.066185,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.44924,0.033978,0.10908,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.50896,0.033834,0.03068,0,0
2,GO CARNITINE SHUTTLE,0.44924,0.033548,0.054573,0,0
2,GO COENZYME A METABOLIC PROCESS,0.72313,0.033455,-0.021561,0,0
2,GO PROTEIN KINASE A SIGNALING,0.86455,0.033278,-0.020685,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.12473,0.032962,0.042981,0,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.22568,0.03283,0.063471,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.42347,0.032338,0.032082,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.76281,0.032312,0.0040912,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.60272,0.032183,0.0064638,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.17374,0.031918,0.078377,0,0
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.40843,0.031845,0.090221,0,0
2,GO DENDRITIC CELL CHEMOTAXIS,0.25363,0.031545,0.12364,0,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.84397,0.031319,-0.015622,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.22235,0.031249,0.10328,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.13583,0.031186,0.056947,0,0
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.20309,0.031017,0.05386,0,0
2,GO REGULATION OF MITOPHAGY,0.61497,0.031003,0.022735,0,0
2,GO TOXIN TRANSPORT,0.67776,0.030954,0.017133,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.52025,0.030894,0.042925,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.33812,0.030849,0.034162,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.49227,0.030739,0.0028656,0,0
2,GO T CELL HOMEOSTASIS,0.17934,0.03072,0.094467,0,0
2,GO PEROXISOME ORGANIZATION,0.18219,0.030465,0.071027,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.10465,0.030441,0.064955,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.56666,0.030424,0.010742,0,0
2,GO PROTEIN POLYMERIZATION,0.13355,0.03021,0.061118,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.78962,0.030196,-0.0056489,0,0
2,GO RESPONSE TO ANGIOTENSIN,0.59059,0.030014,0.013745,0,0
2,GO NON RECOMBINATIONAL REPAIR,0.36991,0.029963,0.030341,0,0
2,GO OTIC VESICLE MORPHOGENESIS,0.52594,0.029962,-0.094199,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.38888,0.02981,0.028025,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.75615,0.029673,0.04798,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.81668,0.029598,-0.064335,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,0.30815,0.02953,0.11403,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.72969,0.029522,0.033795,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.25729,0.029405,0.075341,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.69707,0.029403,0.06731,0,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.65866,0.029367,0.0043436,0,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.56075,0.029285,0.070626,0,0
2,GO SOMITE DEVELOPMENT,0.075049,0.029272,0.082947,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.42855,0.029237,0.04541,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.5726,0.029114,0.015098,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.53167,0.029114,0.032971,0,0
2,GO LIVER REGENERATION,0.36526,0.029069,0.0018735,0,0
2,GO NEURON FATE SPECIFICATION,0.16294,0.028971,0.26215,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.67776,0.028917,0.011806,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.66501,0.028917,0.025141,0,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.23937,0.028894,0.11759,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.92682,0.028775,0.006479,0,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.60272,0.02876,0.034491,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.85082,0.028541,0.0040606,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.54903,0.028537,0.090155,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.35607,0.028256,0.055493,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.53742,0.028151,0.057822,0,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.90599,0.028026,-0.03532,0,0
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.82348,0.027953,-0.0021507,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.36991,0.027936,0.053384,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.24643,0.02733,0.038383,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.2839,0.027319,0.018817,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.56666,0.02704,0.025999,0,0
2,GO NUCLEOSIDE SALVAGE,0.86455,0.026877,-0.024261,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.72969,0.026735,0.0077461,0,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.49227,0.026701,0.029229,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.76281,0.026662,-0.0096074,0,0
2,GO RESPONSE TO X RAY,0.85768,0.026498,-0.039768,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.52025,0.026439,0.037023,0,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.89907,0.026339,-0.052067,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.56075,0.026289,-0.064524,0,0
2,GO HISTONE H2A UBIQUITINATION,0.44924,0.026197,0.031309,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.17374,0.025743,0.044185,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.41341,0.025736,0.03387,0,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.75615,0.025639,0.0053169,0,0
2,GO AUTOPHAGOSOME MATURATION,0.29184,0.02556,0.05276,0,0
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.61497,0.025554,0.016424,0,0
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.19695,0.025493,0.12296,0,0
2,GO INTRACELLULAR TRANSPORT,0.4545,0.025459,0.0097598,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.50896,0.025401,0.034969,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.87144,0.025359,-0.0054163,0,0
2,GO NEURON RECOGNITION,0.65866,0.025274,0.056229,0,0
2,GO RESPONSE TO ETHER,0.52594,0.025033,0.025935,0,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.29992,0.024918,0.059099,0,0
2,GO NEUROTRANSMITTER TRANSPORT,0.21905,0.024732,0.11788,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.94769,0.02469,0.0027858,0,0
2,GO TORC1 SIGNALING,0.29184,0.024674,0.028885,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.35607,0.024612,0.14943,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.54903,0.024585,0.022029,0,0
2,GO RESPONSE TO RADIATION,0.064293,0.02458,0.041426,0,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.38888,0.024571,0.0333,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.18219,0.024294,0.086929,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.77618,0.024136,-0.0032999,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.2839,0.024034,0.07888,0,0
2,GO NUCLEAR MIGRATION,0.85082,0.023926,0.02534,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.72313,0.023779,-0.0097396,0,0
2,GO HISTONE H2B UBIQUITINATION,0.83713,0.023654,-0.007129,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.47588,0.023636,0.061817,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.30402,0.023486,0.03606,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.20937,0.023466,0.021411,0,0
2,GO MRNA TRANSCRIPTION,0.70355,0.023464,0.0088934,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.94073,0.023411,-0.062651,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.81668,0.023401,-0.057425,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.98953,0.023289,-0.015602,0,0
2,GO SPLEEN DEVELOPMENT,0.16559,0.023176,0.088269,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.74288,0.023174,0.034303,0,0
2,GO DENDRITE DEVELOPMENT,0.17653,0.022918,0.085711,0,0
2,GO MYOBLAST PROLIFERATION,0.66501,0.022907,-0.075241,0,0
2,GO COPPER ION TRANSPORT,0.44924,0.022775,0.10787,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.96163,0.022687,-0.038954,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.57857,0.022353,0.040703,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.69061,0.022066,-0.0072724,0,0
2,GO VESICLE LOCALIZATION,0.19393,0.022065,0.042752,0,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.36526,0.022035,0.042076,0,0
2,GO HEXOSE CATABOLIC PROCESS,0.80312,0.021931,-0.013332,0,0
2,GO MEMBRANE DOCKING,0.14285,0.021826,0.058293,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.36991,0.021807,0.12255,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.84397,0.021703,-0.0040607,0,0
2,GO DETECTION OF VISIBLE LIGHT,0.30402,0.02169,0.016797,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.80312,0.02163,0.0032759,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.93377,0.021619,0.0025533,0,0
2,GO MEIOTIC CELL CYCLE,0.43367,0.021587,0.031854,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.36064,0.021347,0.085705,0,0
2,GO REGULATION OF ACTIN NUCLEATION,0.62113,0.021282,0.042254,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.42855,0.021154,0.13982,0,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.35607,0.021072,0.068226,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.65866,0.021065,0.00012431,0,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.54321,0.021058,0.033515,0,0
2,GO REGULATION OF OOGENESIS,0.5726,0.020857,0.018396,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.41842,0.020535,0.052646,0,0
2,GO REGULATION OF MITOTIC CELL CYCLE,0.44402,0.020347,0.018045,0,0
2,GO NADPH REGENERATION,0.48131,0.020002,-0.079939,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.66501,0.01999,0.030871,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.20621,0.019818,0.084534,0,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.42855,0.019787,0.052752,0,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.70355,0.019713,0.0043547,0,0
2,GO TELENCEPHALON DEVELOPMENT,0.087232,0.019485,0.095807,0,0
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.70355,0.019483,0.0021153,0,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.5726,0.019477,0.039852,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.71658,0.019321,-0.044828,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.41842,0.019137,0.018283,0,0
2,GO REGULATION OF MICROTUBULE BINDING,0.93377,0.019124,0.0053665,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.59059,0.019081,0.033461,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.48678,0.01886,0.028067,0,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.42855,0.01876,0.051218,0,0
2,GO DENDRITE MORPHOGENESIS,0.24643,0.018677,0.074373,0,0
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.87144,0.018577,-0.099343,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.21579,0.018525,0.10848,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.24643,0.018499,0.032624,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.57857,0.018384,0.016118,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.4598,0.018222,0.020506,0,0
2,GO PLASMA MEMBRANE REPAIR,0.54903,0.017672,-0.067709,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.90599,0.017665,-0.034963,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.59664,0.017638,0.062955,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.5726,0.0174,0.054194,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.87144,0.017399,0.00063454,0,0
2,GO PROTEIN TRIMERIZATION,0.75615,0.017379,-0.044404,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.63978,0.017341,0.0075465,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.52594,0.017183,0.0197,0,0
2,GO ERBB2 SIGNALING PATHWAY,0.75615,0.017106,0.0058658,0,0
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.96163,0.017058,-0.010884,0,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.50896,0.016876,0.10504,0,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.80989,0.016818,0.016127,0,0
2,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.50896,0.016754,0.040387,0,0
2,GO ORGANELLE LOCALIZATION,0.16294,0.016307,0.043745,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.71006,0.016251,0.021762,0,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.15264,0.016245,0.25745,0,0
2,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1,0.016188,-0.018453,0,0
2,GO CELL CYCLE,0.4545,0.016136,0.017085,0,0
2,GO RESPONSE TO MUSCLE INACTIVITY,0.65866,0.016041,-0.053413,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.48678,0.015881,0.16109,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.78962,0.015758,0.030513,0,0
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.41341,0.01574,0.025217,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.8303,0.015606,0.0087375,0,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.96163,0.015577,-0.015808,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.72969,0.0153,0.028778,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.46512,0.015186,0.042096,0,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.99651,0.015049,-0.015794,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85082,0.014517,0.00062288,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.71006,0.014447,0.017619,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.44402,0.014397,0.099219,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.17099,0.014252,0.062986,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.19095,0.014251,0.064626,0,0
2,GO BONE CELL DEVELOPMENT,0.44924,0.014113,0.057123,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.8303,0.014085,-0.013488,0,0
2,GO MISMATCH REPAIR,0.17934,0.013756,0.059409,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.59059,0.013732,-0.05011,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.78962,0.0137,-0.031271,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.4598,0.013695,0.044748,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.76948,0.013645,0.019234,0,0
2,GO OVULATION CYCLE PROCESS,0.52025,0.013634,0.026597,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.30815,0.013592,-0.075831,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.27227,0.013588,0.054131,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.52025,0.013271,0.027564,0,0
2,GO PROTEIN DEPOLYMERIZATION,0.65234,0.013141,0.040997,0,0
2,GO T CELL CHEMOTAXIS,0.52594,0.012819,0.012279,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.67776,0.01268,0.069198,0,0
2,GO XENOBIOTIC TRANSPORT,0.32506,0.012551,0.029422,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.49227,0.012495,0.041616,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.73628,0.0121,-0.0027702,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.67137,0.012016,-0.0034712,0,0
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.62732,0.012005,-0.098802,0,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.11636,0.011928,0.12333,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.4598,0.011719,0.043132,0,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.60883,0.011713,0.024969,0,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.96163,0.011705,-0.032609,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.64605,0.011295,-0.02732,0,0
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.90599,0.01128,-0.0097236,0,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,1,0.01128,0.01749,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.98255,0.011273,-0.0079926,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.63978,0.011182,0.028281,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.37932,0.011084,0.040786,0,0
2,GO INTERACTION WITH SYMBIONT,0.76948,0.011052,-0.037094,0,0
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.76281,0.011019,0.019065,0,0
2,GO INTRACILIARY TRANSPORT,0.56666,0.010892,0.041437,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.80989,0.010734,-0.0047807,0,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.91293,0.010625,-0.0042193,0,0
2,GO MALE MEIOSIS I,0.8303,0.010377,-0.0059617,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.83713,0.01031,0.0050596,0,0
2,GO REGULATION OF VESICLE FUSION,0.74288,0.010249,0.034346,0,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.53167,0.010084,-0.064072,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.96163,0.0099293,-0.01568,0,0
2,GO DOSAGE COMPENSATION,0.96163,0.0098921,0.0027035,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.87144,0.0098216,0.00067262,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.69707,0.0097014,0.022047,0,0
2,GO PIGMENT METABOLIC PROCESS,0.52594,0.0095722,-0.060182,0,0
2,GO HISTONE H4 ACETYLATION,0.52594,0.009477,0.027382,0,0
2,GO MICROTUBULE BASED TRANSPORT,0.91987,0.0092962,-0.0038088,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.28785,0.0092647,0.085131,0,0
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.87833,0.0092427,-0.037579,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.33373,0.009234,0.090236,0,0
2,GO PIGMENT ACCUMULATION,0.76948,0.0088624,0.024511,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.16828,0.0088025,0.2092,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.43883,0.0082717,0.067466,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.92682,0.0080333,-0.0091375,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.91987,0.0078163,-0.0042513,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.54903,0.0076324,0.021952,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.38888,0.0074957,0.02258,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.66501,0.0073921,-0.037132,0,0
2,GO NADP METABOLIC PROCESS,0.97557,0.0073066,-0.037855,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.85768,0.0072095,0.014997,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.35607,0.007176,0.067197,0,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.98953,0.0071665,-0.016402,0,0
2,GO SPINDLE LOCALIZATION,0.67137,0.0069697,-0.013269,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.89215,0.0068909,0.00037987,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.88523,0.0068817,0.00020996,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.61497,0.0067553,-0.040121,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.8303,0.0064973,-0.004016,0,0
2,GO CELLULAR RESPONSE TO RADIATION,0.87144,0.0064157,0.0061709,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,0.59059,0.0062428,-0.06567,0,0
2,GO REGULATION OF PINOCYTOSIS,0.78962,0.0059322,-0.0078169,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.46512,0.0058046,0.089763,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.53167,0.0057259,0.016521,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.72969,0.0057238,-0.00235,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.43883,0.005699,0.062221,0,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.35153,0.0055944,0.10634,0,0
2,GO ORGANELLE DISASSEMBLY,0.76281,0.0053957,0.014451,0,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.71658,0.0052898,0.007928,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.78962,0.0052374,-0.021737,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.98255,0.0051207,-0.016298,0,0
2,GO PEPTIDE CROSS LINKING,0.59664,0.0049842,0.0062215,0,0
2,GO MITOPHAGY,0.75615,0.0049323,0.013085,0,0
2,GO CARDIOLIPIN METABOLIC PROCESS,0.77618,0.0048165,-0.065506,0,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.93377,0.0047992,0.0043346,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.4598,0.0047792,0.057976,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.89215,0.0042506,-0.008621,0,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.78289,0.0041395,0.0023207,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.27227,0.0038812,-0.047141,0,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.70355,0.0038577,0.0077743,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.55487,0.0037706,0.037452,0,0
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.75615,0.0035217,0.011524,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.65866,0.0031021,0.032384,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.57857,0.0030612,-0.049496,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.98953,0.0030553,-0.0069649,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.9686,0.002901,0.030675,0,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.42347,0.0028891,-0.028135,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.73628,0.0028243,0.010531,0,0
2,GO PROTEIN FOLDING,0.98255,0.002805,-0.015814,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.33812,0.0025956,0.045053,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.62732,0.0022928,-0.11565,0,0
2,GO CELL CYCLE PROCESS,0.90599,0.0021171,-0.0024342,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.65234,0.0018872,0.010432,0,0
2,GO RESPONSE TO HYDROXYUREA,0.69707,0.001651,0.036791,0,0
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.87144,0.0014581,-0.0141,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.54321,0.0014556,-0.04241,0,0
2,GO FILOPODIUM ASSEMBLY,0.33812,0.0014486,0.078015,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.67137,0.0011501,0.016902,0,0
2,GO ORGANELLE ASSEMBLY,0.57857,0.001036,0.013101,0,0
2,GO CYTOKINESIS,0.76948,0.00095921,-0.0067077,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.38408,0.00071604,-0.062751,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.87833,0.00069765,-0.028598,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.87144,0.00036575,-0.01612,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.59059,-0.00018876,-0.048749,0,0
2,GO DNA MODIFICATION,0.9686,-0.00020111,0.0018041,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.90599,-0.00027654,0.0025049,0,0
2,GO ACTIN NUCLEATION,0.71658,-0.00054639,0.027388,0,0
2,GO TELOMERIC LOOP DISASSEMBLY,0.30402,-0.00056186,-0.077052,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.89907,-0.00059464,0.03563,0,0
2,GO CEREBRAL CORTEX DEVELOPMENT,0.15517,-0.0008371,0.08814,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.72969,-0.00084315,0.010952,0,0
2,GO LYSINE METABOLIC PROCESS,0.4545,-0.0011099,-0.10099,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.98255,-0.0012411,0.013753,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.54903,-0.0012475,-0.055095,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.25729,-0.0012744,0.0469,0,0
2,GO CELL DIVISION,0.94073,-0.001294,0.0039233,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.98255,-0.0013363,0.0030863,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.61497,-0.0014527,0.034791,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.99651,-0.0016299,0.002859,0,0
2,GO GAS TRANSPORT,0.93377,-0.0018442,-0.043285,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.68418,-0.001848,0.026851,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.72969,-0.0028059,0.010938,0,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.68418,-0.0030396,-0.005202,0,0
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.90599,-0.0032092,-0.015917,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.26847,-0.0032472,0.085985,0,0
2,GO TRNA CATABOLIC PROCESS,0.29992,-0.0032864,0.14266,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.8303,-0.0033405,0.0071124,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.75615,-0.0033854,0.048069,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.55487,-0.0035175,-0.034525,0,0
2,GO NEUROTRANSMITTER SECRETION,0.4978,-0.0036791,0.10016,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.99651,-0.0038493,-0.0023859,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.67137,-0.003888,-0.05463,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.65866,-0.0041739,0.010007,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.98255,-0.0042844,-0.0029071,0,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.53742,-0.0044018,0.081143,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.41341,-0.00445,-0.049601,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.27611,-0.00451,0.082049,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.84397,-0.0045811,0.0084835,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.58456,-0.0048045,-0.02624,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.80312,-0.0048189,-0.034604,0,0
2,GO RESPONSE TO SALT STRESS,0.98255,-0.0048858,-0.01151,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.54903,-0.005046,0.032298,0,0
2,GO IMPORT INTO NUCLEUS,0.50896,-0.0052186,-0.03533,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.67776,-0.0053467,-0.013638,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.79636,-0.0054707,0.028781,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.37932,-0.0055621,0.061452,0,0
2,GO PODOSOME ASSEMBLY,0.60272,-0.0055789,0.036397,0,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.72969,-0.0056967,0.053652,0,0
2,GO NUCLEOSIDE METABOLIC PROCESS,0.98255,-0.005773,-0.0057883,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.78289,-0.0059611,-0.012455,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.70355,-0.0061375,0.008654,0,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.75615,-0.0062518,-0.0076729,0,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.56666,-0.0064841,0.068153,0,0
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.63978,-0.0065449,0.054829,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.86455,-0.0065975,-0.015052,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.87833,-0.0068369,0.01737,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.59059,-0.0072678,-0.033864,0,0
2,GO HISTONE MONOUBIQUITINATION,0.89907,-0.007345,0.0026867,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.98255,-0.0073488,-0.0052735,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.4598,-0.0077123,0.035602,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.83713,-0.0077878,-0.018693,0,0
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.97557,-0.007841,-0.0038045,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.68418,-0.0078671,0.03844,0,0
2,GO NEURON MIGRATION,0.34702,-0.0079104,0.08785,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.91987,-0.0083136,-0.0062278,0,0
2,GO PRIMARY MIRNA PROCESSING,0.93377,-0.0084191,-0.0095214,0,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.79636,-0.0084972,0.020205,0,0
2,GO CENTROSOME DUPLICATION,0.81668,-0.0086311,-8.4185e-05,0,0
2,GO HISTONE H4 DEACETYLATION,0.9686,-0.0086422,0.010749,0,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.93377,-0.0087841,-0.045825,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.87144,-0.0088232,-0.020578,0,0
2,GO COVALENT CHROMATIN MODIFICATION,0.72313,-0.0089901,0.014383,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.48131,-0.0089984,-0.032487,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.78289,-0.0090742,-0.0068197,0,0
2,GO HISTONE PHOSPHORYLATION,0.65234,-0.0091662,-0.034182,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.94073,-0.0092026,0.0068473,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.98255,-0.0092214,-0.015579,0,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.78962,-0.0095617,0.0032741,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.60272,-0.009654,0.033924,0,0
2,GO AORTA DEVELOPMENT,0.87833,-0.0097455,-0.030746,0,0
2,GO P BODY ASSEMBLY,0.76948,-0.0098878,-0.015736,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.60883,-0.0099167,0.046567,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.52025,-0.0099237,-0.046202,0,0
2,GO DE NOVO PROTEIN FOLDING,0.69707,-0.0099993,0.011952,0,0
2,GO NADH METABOLIC PROCESS,0.96163,-0.01004,-0.00053686,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.95466,-0.010177,-0.051821,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.87144,-0.010278,-0.031204,0,0
2,GO RESPONSE TO L GLUTAMATE,0.78289,-0.010308,0.026609,0,0
2,GO REGULATION OF CELL AGING,0.90599,-0.010402,-0.0037347,0,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.81668,-0.010489,0.045671,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.94769,-0.010538,-0.0088159,0,0
2,GO MYELOID CELL DEVELOPMENT,0.41341,-0.010613,0.044891,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.65866,-0.010866,-0.059339,0,0
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.82348,-0.010889,-0.006014,0,0
2,GO MITOCHONDRION ORGANIZATION,0.65234,-0.010955,-0.016418,0,0
2,GO GLUTAMATE SECRETION,0.63354,-0.011181,0.061965,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.67776,-0.011622,0.04117,0,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.76948,-0.011682,-0.0012706,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.46512,-0.011697,-0.099642,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.75615,-0.011802,-0.019034,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.56075,-0.011893,0.030003,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.38408,-0.012098,-0.089456,0,0
2,GO LACTATION,0.96163,-0.012147,-0.0025304,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.44402,-0.012214,-0.025747,0,0
2,GO MITOCHONDRION LOCALIZATION,0.83713,-0.012431,-0.0021504,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.16828,-0.012486,-0.054207,0,0
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.39858,-0.012576,0.049122,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.60272,-0.012626,0.038561,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.56666,-0.012663,0.038927,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.9686,-0.012722,-0.018138,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.25729,-0.0128,0.18415,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.93377,-0.012849,0.0058899,0,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.86455,-0.012852,0.018923,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.47049,-0.012954,0.11559,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.59664,-0.013056,0.0053111,0,0
2,GO ATP METABOLIC PROCESS,0.94769,-0.013062,-0.0011755,0,0
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.62732,-0.013074,-0.056722,0,0
2,GO REGULATION OF DNA REPLICATION,0.67137,-0.013593,0.011132,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.26098,-0.013761,0.09772,0,0
2,GO VIRAL RELEASE FROM HOST CELL,0.75615,-0.013896,0.0089381,0,0
2,GO REGULATION OF PROTEIN IMPORT,0.97557,-0.014296,-0.02531,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.28785,-0.01438,0.073786,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.86455,-0.014846,0.01149,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.91987,-0.015051,0.020694,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.91293,-0.015299,0.0093938,0,0
2,GO PROTEIN IMPORT,0.38408,-0.015317,-0.036338,0,0
2,GO MITOTIC CELL CYCLE,0.47049,-0.015553,-0.013086,0,0
2,GO CHROMATIN ORGANIZATION,0.92682,-0.015712,-0.00069979,0,0
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.64605,-0.016066,-0.031912,0,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.98953,-0.016121,0.011668,0,0
2,GO RESPONSE TO LEAD ION,0.65234,-0.016145,-0.023696,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.21579,-0.016419,-0.077362,0,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.89215,-0.016495,0.00091804,0,0
2,GO NUCLEUS LOCALIZATION,0.87833,-0.016545,0.019216,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.73628,-0.016782,0.02455,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.72313,-0.016795,0.030912,0,0
2,GO REGULATION OF CELL CYCLE PROCESS,0.7495,-0.016905,-0.0035637,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.99651,-0.016914,0.0057986,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.96163,-0.016971,0.022948,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.62732,-0.016979,0.02274,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.87144,-0.017333,-0.0078769,0,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.41842,-0.017432,-0.080399,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.98953,-0.017711,-0.023466,0,0
2,GO CYCLOOXYGENASE PATHWAY,0.63978,-0.017895,-0.077094,0,0
2,GO CELLULAR RESPONSE TO UV,0.80989,-0.017967,-0.011579,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.74288,-0.017999,-0.019562,0,0
2,GO NEGATIVE REGULATION OF CELL SIZE,0.71658,-0.018323,0.024353,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.88523,-0.018356,-0.01075,0,0
2,GO HEME METABOLIC PROCESS,0.72313,-0.018533,-0.07403,0,0
2,GO NUCLEUS ORGANIZATION,0.4598,-0.018586,-0.020804,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.86455,-0.018684,0.0026866,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.39371,-0.018989,-0.022503,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.39858,-0.019276,-0.026258,0,0
2,GO TRANSPORT ALONG MICROTUBULE,0.72313,-0.019371,-0.014125,0,0
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.52025,-0.019443,0.083098,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.60883,-0.019587,-0.029957,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.94769,-0.019672,-0.012688,0,0
2,GO MICROTUBULE BASED PROCESS,0.93377,-0.019751,0.014106,0,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.70355,-0.019926,-0.018066,0,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.60883,-0.019976,0.018276,0,0
2,GO PALLIUM DEVELOPMENT,0.41842,-0.020023,0.058772,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.52025,-0.020303,-0.03191,0,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.79636,-0.020399,-0.01661,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.83713,-0.020422,0.0075451,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1,-0.020585,-0.0014894,0,0
2,GO CELL CYCLE PHASE TRANSITION,0.51459,-0.020615,-0.016796,0,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.4978,-0.02069,0.041965,0,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.38408,-0.020751,-0.067653,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.71658,-0.021265,0.020801,0,0
2,GO REGULATION OF ERAD PATHWAY,0.86455,-0.021412,-0.0121,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.38408,-0.021506,-0.01437,0,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.69707,-0.021732,-0.029574,0,0
2,GO UTERUS DEVELOPMENT,0.76948,-0.021792,-0.020261,0,0
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.38888,-0.022029,-0.039595,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.8303,-0.022215,0.033456,0,0
2,GO ATP TRANSPORT,0.83713,-0.022221,-0.010997,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.78289,-0.022485,-0.010919,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.68418,-0.022485,-0.029997,0,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.78962,-0.022514,0.083202,0,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.4978,-0.02265,-0.06582,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.50896,-0.022937,-0.066257,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.94073,-0.022998,-0.002725,0,0
2,GO HISTONE METHYLATION,0.56666,-0.023196,-0.043654,0,0
2,GO HISTONE H3 K4 METHYLATION,0.4545,-0.023606,-0.052726,0,0
2,GO MITOCHONDRIAL FUSION,0.68418,-0.023615,-0.021989,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.7495,-0.023738,-0.0283,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.21905,-0.02389,-0.047534,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.62732,-0.023981,-0.029016,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.67776,-0.024062,0.023435,0,0
2,GO MYOBLAST MIGRATION,0.79636,-0.024067,0.01592,0,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.92682,-0.024215,-0.015846,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.85082,-0.024365,0.0083562,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.43883,-0.024452,-0.053042,0,0
2,GO CARTILAGE MORPHOGENESIS,0.70355,-0.024485,-0.050171,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.079444,-0.024626,-0.047144,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.89215,-0.024896,0.00604,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.98953,-0.025188,0.022566,0,0
2,GO OOCYTE MATURATION,0.99651,-0.025233,0.00046399,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.87144,-0.02526,0.0082625,0,0
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.63978,-0.02528,-0.029357,0,0
2,GO DNA INTEGRITY CHECKPOINT,0.43883,-0.025527,-0.020519,0,0
2,GO PROSTATE GLAND GROWTH,0.64605,-0.025614,-0.061658,0,0
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.58456,-0.025673,-0.091982,0,0
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.87833,-0.025694,-0.0082108,0,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.26471,-0.025895,-0.046862,0,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.90599,-0.026,-0.011833,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.31653,-0.026191,-0.037831,0,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.81668,-0.026192,-0.0091235,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.36526,-0.026435,-0.17355,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.95466,-0.026641,0.0071773,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.11636,-0.02685,-0.068573,0,0
2,GO MULTI ORGANISM LOCALIZATION,0.33373,-0.027113,-0.072926,0,0
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.36991,-0.027392,-0.028192,0,0
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.60272,-0.027625,-0.013359,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.82348,-0.027891,-0.016916,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.70355,-0.028449,-0.0020659,0,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.86455,-0.028513,0.055335,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.38888,-0.028797,-0.055718,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.85082,-0.028909,-0.030025,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.86455,-0.028945,-0.02142,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.62113,-0.029093,-0.05047,0,0
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.58456,-0.02921,-0.057249,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.26847,-0.029226,-0.08687,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.62732,-0.029358,-0.045235,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.26847,-0.029629,-0.089847,0,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.32077,-0.029878,-0.055655,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.56666,-0.029938,-0.026554,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.5726,-0.030216,-0.032315,0,0
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.2,-0.030236,-0.035685,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.29184,-0.030239,-0.022963,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.53167,-0.030633,-0.022689,0,0
2,GO PROTEIN MONOUBIQUITINATION,0.68418,-0.030666,-0.012991,0,0
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.73628,-0.030898,-0.068336,0,0
2,GO HISTONE H3 K9 METHYLATION,0.71006,-0.031406,0.042148,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.3746,-0.031538,-0.049223,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.36064,-0.031545,-0.043595,0,0
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.60883,-0.031686,-0.030034,0,0
2,GO HYPEROSMOTIC RESPONSE,0.94769,-0.031933,0.025576,0,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.87833,-0.031995,0.07307,0,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.94769,-0.032176,0.033283,0,0
2,GO DNA REPLICATION,0.53742,-0.032365,-0.016905,0,0
2,GO ERYTHROCYTE DEVELOPMENT,0.94769,-0.032566,0.0096211,0,0
2,GO CENTRIOLE ASSEMBLY,0.49227,-0.033316,-0.029563,0,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.76281,-0.033442,0.081291,0,0
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.43883,-0.033582,-0.064262,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.5726,-0.033647,-0.034101,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.65234,-0.033738,-0.083222,0,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.67776,-0.033742,0.010528,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.20621,-0.033763,-0.067924,0,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.81668,-0.033811,0.026938,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.70355,-0.033866,-0.032372,0,0
2,GO MITOTIC DNA REPLICATION,0.81668,-0.03396,0.014527,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.84397,-0.033979,0.012953,0,0
2,GO OTIC VESICLE DEVELOPMENT,0.69707,-0.034104,-0.041623,0,0
2,GO MICROTUBULE POLYMERIZATION,0.94769,-0.034105,0.025221,0,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.55487,-0.034116,-0.097315,0,0
2,GO HISTONE UBIQUITINATION,0.21579,-0.034142,-0.035012,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.62113,-0.034185,-0.047869,0,0
2,GO CENTROSOME SEPARATION,0.98255,-0.034272,0.017594,0,0
2,GO AXO DENDRITIC TRANSPORT,0.25729,-0.034439,-0.051647,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.81668,-0.034584,-0.029623,0,0
2,GO RESPONSE TO HISTAMINE,0.78289,-0.034639,0.036911,0,0
2,GO PROTEIN ACETYLATION,0.59664,-0.034726,-0.0030803,0,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.87833,-0.034786,0.013853,0,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.87144,-0.034798,0.014441,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.43883,-0.035028,-0.061765,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.16032,-0.035276,-0.085982,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.98953,-0.035394,0.012721,0,0
2,GO RESPONSE TO OXYGEN RADICAL,0.68418,-0.036026,0.019074,0,0
2,GO PIGMENT GRANULE MATURATION,0.52594,-0.036299,-0.055787,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.34256,-0.03634,-0.032995,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.43367,-0.036366,-0.017169,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.23245,-0.036646,-0.051673,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.67776,-0.036653,-0.022846,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.188,-0.037012,-0.034644,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.63978,-0.037069,-0.034474,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.76948,-0.037525,-0.0080489,0,0
2,GO REGULATION OF CYTOKINESIS,0.58456,-0.037552,-0.0086392,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.85082,-0.037606,-0.0096885,0,0
2,GO CELL AGING,0.96163,-0.037686,-0.0068527,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.188,-0.037817,-0.070707,0,0
2,GO VESICLE CARGO LOADING,0.74288,-0.038015,-0.038473,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.27999,-0.03814,-0.075911,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22905,-0.03839,-0.030953,0,0
2,GO DNA METABOLIC PROCESS,0.093897,-0.038397,-0.035059,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,0.48678,-0.038458,-0.03827,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.52025,-0.038671,-0.046076,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.89215,-0.038705,0.017179,0,0
2,GO LONG TERM SYNAPTIC DEPRESSION,0.80989,-0.038918,0.035544,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.91987,-0.038927,-0.0039349,0,0
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.48131,-0.038934,-0.04942,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.4978,-0.038963,-0.041679,0,0
2,GO ORGANELLE INHERITANCE,0.43883,-0.03902,-0.02834,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.94073,-0.039107,0.0044252,0,0
2,GO RESPONSE TO INTERLEUKIN 7,0.39858,-0.039467,-0.056375,0,0
2,GO MITOCHONDRIAL TRANSPORT,0.44924,-0.039634,-0.02701,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.093897,-0.039644,-0.050013,0,0
2,GO G0 TO G1 TRANSITION,0.53167,-0.040053,-0.026262,0,0
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.87833,-0.040098,0.030764,0,0
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.60883,-0.040882,-0.047426,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.49227,-0.040907,-0.049421,0,0
2,GO PROTEIN METHYLATION,0.3746,-0.041401,-0.040185,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.14285,-0.041669,-0.033128,0,0
2,GO METHIONINE METABOLIC PROCESS,0.50896,-0.042187,-0.038749,0,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.29184,-0.042266,-0.046529,0,0
2,GO SYNAPTIC VESICLE CLUSTERING,0.83713,-0.042321,0.11562,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.98255,-0.042693,-0.038901,0,0
2,GO FEVER GENERATION,0.41842,-0.042698,-0.056688,0,0
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.27611,-0.043136,-0.050721,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.34256,-0.043222,-0.030697,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.47588,-0.043504,-0.038673,0,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.29586,-0.043765,-0.073001,0,0
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.14285,-0.044045,-0.033655,0,0
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.50337,-0.044211,-0.052262,0,0
2,GO SYNAPTIC VESICLE LOCALIZATION,0.79636,-0.044264,0.027852,0,0
2,GO HAIR FOLLICLE MATURATION,0.85768,-0.044344,-0.046917,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.1028,-0.044471,-0.05901,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.44924,-0.044474,0.11892,0,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.21256,-0.04467,-0.059946,0,0
2,GO CELLULAR SENESCENCE,0.48678,-0.044736,-0.024629,0,0
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.31232,-0.045128,-0.10994,0,0
2,GO CELL CYCLE CHECKPOINT,0.16828,-0.045183,-0.030106,0,0
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.11434,-0.045213,-0.13749,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.1313,-0.045287,-0.072388,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.10845,-0.04537,-0.10266,0,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.59059,-0.045502,-0.042098,0,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.84397,-0.045708,0.016464,0,0
2,GO ORGANELLE FISSION,0.52025,-0.045726,-0.007069,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.27611,-0.045753,-0.10304,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.92682,-0.045813,0.0064968,0,0
2,GO PINOCYTOSIS,0.94769,-0.045867,-0.023341,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.51459,-0.046194,-0.08145,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.68418,-0.046227,-0.057163,0,0
2,GO AXONAL TRANSPORT,0.22235,-0.046407,-0.063355,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.28785,-0.046451,-0.034766,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.5726,-0.046498,-0.0064203,0,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.61497,-0.04653,-0.031836,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.69061,-0.046876,-0.031102,0,0
2,GO LYMPHANGIOGENESIS,0.51459,-0.046966,-0.054614,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0695,-0.047856,-0.070431,0,0
2,GO DNA RECOMBINATION,0.21579,-0.048002,-0.028811,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.67776,-0.048293,-0.018997,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.67137,-0.048553,-0.046865,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.72313,-0.04861,-0.023701,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.7495,-0.048611,-0.00021279,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.65234,-0.048726,-0.052804,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.41842,-0.048761,-0.02456,0,0
2,GO PLATELET MORPHOGENESIS,0.40843,-0.048831,-0.049233,0,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.63354,-0.048895,-0.039547,0,0
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.63354,-0.048992,-0.060006,0,0
2,GO COPII COATED VESICLE CARGO LOADING,0.61497,-0.049156,-0.03191,0,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.17099,-0.049879,-0.097088,0,0
2,GO SISTER CHROMATID COHESION,0.30815,-0.05002,-0.036448,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.11841,-0.050362,-0.070761,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.91987,-0.050842,-0.0020063,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.85768,-0.050899,-0.018113,0,0
2,GO REGULATION OF DNA REPAIR,0.12049,-0.051248,-0.053842,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27227,-0.052033,-0.05569,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.068167,-0.052047,-0.075185,0,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.91987,-0.052054,0.015011,0,0
2,GO MITOTIC RECOMBINATION,0.40349,-0.052105,-0.053533,0,0
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.24288,-0.052176,-0.047308,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.25729,-0.052371,-0.036534,0,0
2,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.35607,-0.052568,-0.083202,0,0
2,GO HISTONE H3 K14 ACETYLATION,0.44924,-0.052906,-0.03383,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.9686,-0.053052,-0.035431,0,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.89907,-0.053203,0.038247,0,0
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.23245,-0.053308,-0.049395,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.88523,-0.053592,0.017143,0,0
2,GO REGULATION OF GASTRULATION,0.55487,-0.053767,-0.047148,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.28785,-0.053864,-0.050909,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.52025,-0.053982,-0.022633,0,0
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.38408,-0.05433,-0.057677,0,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.9686,-0.054354,0.036231,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.30815,-0.054417,-0.068052,0,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.20621,-0.054609,-0.099531,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.12259,-0.054776,-0.058858,0,0
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.83713,-0.055154,-0.018105,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.66501,-0.05568,-0.047155,0,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.48131,-0.055751,0.088853,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.68418,-0.055897,-0.032172,0,0
2,GO BLASTOCYST FORMATION,0.41341,-0.055925,-0.043199,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.41842,-0.056418,-0.053726,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.25363,-0.056655,-0.082466,0,0
2,GO MICROTUBULE DEPOLYMERIZATION,0.65234,-0.056743,-0.029395,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.3746,-0.056791,-0.064573,0,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.41341,-0.056988,-0.04398,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.28785,-0.05701,-0.066075,0,0
2,GO RESPONSE TO INTERLEUKIN 12,0.25363,-0.057305,-0.087464,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.34702,-0.057842,-0.068705,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.16032,-0.05788,-0.06202,0,0
2,GO SYNAPTIC VESICLE PRIMING,0.98953,-0.057889,0.067462,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.061812,-0.058027,-0.16209,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.8303,-0.058357,0.001807,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.76948,-0.058922,-0.020651,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.5726,-0.058986,-0.052236,0,0
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.13814,-0.05906,-0.095152,0,0
2,GO ERYTHROCYTE MATURATION,0.32077,-0.059468,-0.068518,0,0
2,GO CERAMIDE TRANSPORT,0.59059,-0.059882,-0.034061,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.15773,-0.060135,-0.12098,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.37932,-0.060454,-0.03486,0,0
2,GO MITOCHONDRION DISTRIBUTION,0.38888,-0.060807,-0.017046,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.33812,-0.060965,-0.085071,0,0
2,GO NAD METABOLIC PROCESS,0.71658,-0.061372,-0.025533,0,0
2,GO LAMELLIPODIUM ORGANIZATION,0.88523,-0.061712,-0.0073083,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.48678,-0.061743,-0.044707,0,0
2,GO NCRNA CATABOLIC PROCESS,0.26098,-0.061832,-0.062437,0,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.50337,-0.062013,-0.077135,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.11039,-0.062655,-0.048883,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.24643,-0.062856,-0.057307,0,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.1313,-0.062867,-0.062847,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.057089,-0.062918,-0.067176,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.39858,-0.063616,-0.085623,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.87833,-0.063663,0.0041333,0,0
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.33812,-0.063775,-0.048386,0,0
2,GO ACETYL COA METABOLIC PROCESS,0.48131,-0.064024,-0.051483,0,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.084046,-0.06418,-0.044721,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.59059,-0.06425,-0.060642,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.11636,-0.06442,-0.11598,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.88523,-0.064666,0.0037075,0,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.13583,-0.064803,-0.068785,0,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.15773,-0.064821,-0.10821,0,0
2,GO ALDITOL METABOLIC PROCESS,0.62732,-0.064956,-0.03845,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.087232,-0.06503,-0.060617,0,0
2,GO RESPONSE TO GAMMA RADIATION,0.47049,-0.065099,-0.023621,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.27999,-0.065135,-0.077102,0,0
2,GO DOUBLE STRAND BREAK REPAIR,0.04854,-0.065398,-0.057558,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.76948,-0.065564,-0.01275,0,0
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.055956,-0.065749,-0.10573,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.95466,-0.06577,0.022296,0,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.16559,-0.065812,-0.050063,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.10845,-0.065885,-0.094371,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.22905,-0.066272,-0.052249,0,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.31653,-0.067293,-0.048313,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.10845,-0.067724,-0.10035,0,0
2,GO CELL CYCLE DNA REPLICATION,0.19393,-0.06782,-0.059637,0,0
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.97557,-0.067838,0.041045,0,0
2,GO GENE SILENCING,0.054842,-0.068295,-0.068468,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.29992,-0.068514,-0.078685,0,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.71658,-0.069482,-0.016557,0,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.78962,-0.069533,-0.0063915,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.053746,-0.069583,-0.05977,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.18508,-0.069613,-0.10773,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.075049,-0.070136,-0.090462,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.32077,-0.070465,-0.044646,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.35607,-0.070549,-0.093691,0,0
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.17934,-0.070579,-0.079807,0,0
2,GO MITOTIC CYTOKINESIS,0.32506,-0.07075,-0.039255,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.05161,-0.070977,-0.10024,0,0
2,GO REPLICATION FORK PROCESSING,0.04854,-0.071224,-0.098188,0,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.39858,-0.071319,-0.011835,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.14526,-0.071695,-0.10184,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.10654,-0.072273,-0.092078,0,0
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.4598,-0.072439,-0.020744,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.63978,-0.072499,-0.015663,0,0
2,GO METAPHASE PLATE CONGRESSION,0.077957,-0.073151,-0.040438,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.1313,-0.073545,-0.079555,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.23245,-0.073808,-0.059102,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.75615,-0.073809,0.006731,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.22235,-0.073822,-0.062876,0,0
2,GO GMP METABOLIC PROCESS,0.60272,-0.07441,-0.0077037,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.16032,-0.07536,-0.13834,0,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.17374,-0.075513,-0.10486,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.30402,-0.075594,-0.060516,0,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.23589,-0.075731,-0.11659,0,0
2,GO CHROMOSOME ORGANIZATION,0.11039,-0.075733,-0.036175,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.40349,-0.076057,-0.055947,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.86455,-0.076294,-0.0085825,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.32077,-0.076722,-0.072438,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.14526,-0.077084,-0.10423,0,0
2,GO PIRNA METABOLIC PROCESS,0.40843,-0.077604,-0.056308,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.87833,-0.077703,0.010895,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.89215,-0.077719,-0.024799,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.53167,-0.078069,-0.00877,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.20309,-0.078098,-0.077289,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.075049,-0.078695,-0.075,0,0
2,GO NUCLEOSOME ASSEMBLY,0.093897,-0.079701,-0.070766,0,0
2,GO VIRAL LATENCY,0.20937,-0.079806,-0.072162,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,0.59664,-0.079898,-0.07199,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.1313,-0.079982,-0.04939,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.054842,-0.080044,-0.048395,0,0
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.30402,-0.080124,-0.065559,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.25729,-0.081447,-0.069863,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.27227,-0.081654,-0.078532,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.34256,-0.081831,-0.12265,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.43883,-0.081867,-0.022522,0,0
2,GO CHROMATIN SILENCING,0.049546,-0.08261,-0.11843,0,0
2,GO NODAL SIGNALING PATHWAY,0.29586,-0.082713,-0.033807,0,0
2,GO CARDIOBLAST PROLIFERATION,0.76281,-0.082912,-0.068651,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.23589,-0.083289,-0.1333,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.35153,-0.083472,-0.082577,0,0
2,GO REGULATION OF SPINDLE ORGANIZATION,0.25363,-0.0837,-0.04143,0,0
2,GO HISTONE H3 ACETYLATION,0.17934,-0.083754,-0.033742,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.62113,-0.084203,-0.13317,0,0
2,GO MITOTIC SISTER CHROMATID COHESION,0.57857,-0.084881,-0.046802,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.41842,-0.086401,-0.0415,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.066855,-0.08693,-0.076368,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.072231,-0.087379,-0.044387,0,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.33373,-0.087599,-0.059185,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.20309,-0.087876,-0.061144,0,0
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.23245,-0.087971,-0.094372,0,0
2,GO AMP METABOLIC PROCESS,0.21579,-0.088274,-0.1194,0,0
2,GO METHYLATION,0.004408,-0.088499,-0.076673,0,0
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.13814,-0.088674,-0.079989,0,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.085627,-0.089143,-0.073674,0,0
2,GO V D J RECOMBINATION,0.37932,-0.089401,-0.050093,0,0
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.054842,-0.089446,-0.091572,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.79636,-0.090239,-0.01292,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.055956,-0.090429,-0.12123,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.68418,-0.090784,-0.0081718,0,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.52025,-0.091002,-0.010383,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.066855,-0.091125,-0.059819,0,0
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.073629,-0.091212,-0.064714,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.23589,-0.091485,-0.055071,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.24643,-0.091686,-0.086678,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.20309,-0.0922,-0.10761,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.27227,-0.092952,-0.078634,0,0
2,GO WALKING BEHAVIOR,0.21256,-0.093054,-0.061341,0,0
2,GO RRNA CATABOLIC PROCESS,0.90599,-0.09349,0.012272,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.4545,-0.094202,-0.071306,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.092194,-0.094261,-0.087509,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.30815,-0.094601,-0.04405,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.82348,-0.095144,-0.0098716,0,0
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.4545,-0.095245,-0.060966,0,0
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.68418,-0.095658,-0.049337,0,0
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.97557,-0.095659,-0.019914,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.66501,-0.095739,-0.012062,0,0
2,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.27227,-0.097403,-0.095319,0,0
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.51459,-0.097861,-0.080822,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.050569,-0.098205,-0.093716,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.36991,-0.098418,-0.020778,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.65234,-0.098992,-0.057543,0,0
2,GO OXIDATIVE DEMETHYLATION,0.05161,-0.099243,-0.07513,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.57857,-0.10051,-0.0079998,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.23937,-0.10078,-0.10744,0,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.88523,-0.10084,0.11756,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.17934,-0.10159,-0.0598,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.44402,-0.10171,-0.080364,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.3746,-0.10186,-0.096818,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.04854,-0.10211,-0.14198,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.31232,-0.10299,-0.041318,0,0
2,GO TELOMERE CAPPING,0.036164,-0.10321,-0.061101,0,0
2,GO PROTEIN REFOLDING,0.41341,-0.10327,-0.060971,0,0
2,GO MICROTUBULE NUCLEATION,0.13583,-0.10422,-0.030637,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.093897,-0.10567,-0.048701,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.40349,-0.10589,-0.082886,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.22905,-0.1066,-0.04007,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.61497,-0.10742,-0.024026,0,0
2,GO BONE TRABECULA FORMATION,0.55487,-0.10849,-0.13317,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.60883,-0.10867,-0.08162,0,0
2,GO CRISTAE FORMATION,0.082489,-0.10881,-0.12347,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.080955,-0.10917,-0.15658,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.25363,-0.10983,-0.12853,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.088862,-0.11009,-0.060586,0,0
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.18219,-0.11016,-0.17025,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.92682,-0.11064,0.046433,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0695,-0.11065,-0.16935,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.16032,-0.11084,-0.10598,0,0
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.045624,-0.11116,-0.11103,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11235,-0.11147,-0.10649,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.48131,-0.11154,-0.022604,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.038561,-0.11197,-0.080734,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.057089,-0.11212,-0.07957,0,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.70355,-0.11296,-0.064995,0,0
2,GO LIMB BUD FORMATION,0.78289,-0.11406,0.044176,0,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.19095,-0.11457,-0.049017,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.066855,-0.1155,-0.095496,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.075049,-0.11611,-0.083271,0,0
2,GO REGULATION OF HIPPO SIGNALING,0.22568,-0.1163,-0.11891,0,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.066855,-0.11638,-0.099274,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.02166,-0.11726,-0.12648,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.11636,-0.11753,-0.055664,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.063042,-0.11789,-0.10726,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.12908,-0.11867,-0.1102,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.052669,-0.11886,-0.14534,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.061812,-0.11934,-0.058976,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.093897,-0.12041,-0.083191,0,0
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.15264,-0.12074,-0.11108,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.20309,-0.12075,-0.08036,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.188,-0.12229,-0.050542,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.4545,-0.12292,-0.10197,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.092194,-0.12313,-0.06226,0,0
2,GO PRE MIRNA PROCESSING,0.13583,-0.1238,-0.11409,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.20621,-0.12393,-0.084026,0,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.15015,-0.12598,-0.05376,0,0
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.05824,-0.12603,-0.083314,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.065563,-0.12616,-0.1701,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.050569,-0.12703,-0.12169,0,0
2,GO SISTER CHROMATID SEGREGATION,0.0099891,-0.12721,-0.089569,0,0
2,GO PENILE ERECTION,0.27999,-0.12779,-0.1,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.10845,-0.12974,-0.1018,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.36064,-0.12982,-0.086051,0,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.56075,-0.1305,-0.05395,0,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.65866,-0.13145,-0.015579,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.12473,-0.13166,-0.073948,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.04854,-0.13171,-0.10096,0,0
2,GO GLYCINE METABOLIC PROCESS,0.049546,-0.13181,-0.19216,0,0
2,GO REGULATION OF DNA METHYLATION,0.057089,-0.13213,-0.099525,0,0
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.095625,-0.13224,-0.13711,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.1313,-0.13246,-0.10168,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.29586,-0.13302,-0.057868,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.18508,-0.1336,-0.074498,0,0
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.010773,-0.13747,-0.097691,0,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.88523,-0.13766,0.024863,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0695,-0.13793,-0.11787,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.27999,-0.13989,-0.10126,0,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.13583,-0.14336,-0.12738,0,0
2,GO VASCULAR TRANSPORT,0.69707,-0.14338,-0.10196,0,0
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.38888,-0.14494,-0.068112,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.015574,-0.14797,-0.11606,0,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.34702,-0.15173,-0.10675,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.04854,-0.15271,-0.10364,0,0
2,GO GTP METABOLIC PROCESS,0.22235,-0.15319,-0.094935,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.10465,-0.1533,-0.075512,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.064293,-0.15363,-0.23122,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.050569,-0.15441,-0.099831,0,0
2,GO DENDRITE SELF AVOIDANCE,0.34256,-0.15604,-0.083193,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.015574,-0.15939,-0.22263,0,0
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.036164,-0.16004,-0.1555,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.060602,-0.16156,-0.10608,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.72313,-0.16191,-0.00054022,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.085627,-0.1621,-0.070008,0,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.12473,-0.1634,-0.10294,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.82348,-0.16476,0.0052792,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.073629,-0.16557,-0.14685,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.066855,-0.16617,-0.10144,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.097379,-0.16645,-0.085623,0,0
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.11039,-0.16694,-0.089877,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.093897,-0.16818,-0.14199,0,0
2,GO MRNA SPLICE SITE SELECTION,0.2,-0.16963,-0.073695,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.26098,-0.17055,-0.1545,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.83713,-0.17374,0.098156,0,0
2,GO ETHANOL METABOLIC PROCESS,0.17934,-0.17466,-0.135,0,0
2,GO KINETOCHORE ORGANIZATION,0.12049,-0.17638,-0.087865,0,0
2,GO PYRAMIDAL NEURON DIFFERENTIATION,0.38888,-0.18069,-0.094636,0,0
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.46512,-0.18353,-0.073541,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.079444,-0.18452,-0.13251,0,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.19695,-0.18639,-0.1477,0,0
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.10096,-0.18784,-0.12872,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.05824,-0.19475,-0.11168,0,0
2,GO DNA LIGATION,0.064293,-0.19498,-0.12845,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.080955,-0.19577,-0.12153,0,0
2,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.18219,-0.19602,-0.11297,0,0
2,GO CYSTEINE METABOLIC PROCESS,0.11841,-0.20012,-0.21317,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.072231,-0.20066,-0.15715,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.24643,-0.20312,-0.15524,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.023205,-0.20324,-0.14814,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.025414,-0.2051,-0.17433,0,0
2,GO LATERAL VENTRICLE DEVELOPMENT,0.14526,-0.20844,-0.11721,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.42347,-0.21407,-0.052584,0,0
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.050569,-0.21518,-0.13382,0,0
2,GO DENSE CORE GRANULE TRANSPORT,0.25001,-0.21666,-0.12248,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.087232,-0.21686,-0.13982,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.024846,-0.21757,-0.18908,0,0
2,GO CHROMATIN DISASSEMBLY,0.076492,-0.21927,-0.12619,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.0087944,-0.21973,-0.18599,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.05161,-0.2217,-0.15265,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0022992,-0.23038,-0.35909,0,0
2,GO SECRETORY GRANULE LOCALIZATION,0.0695,-0.23802,-0.16204,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.17374,-0.24132,-0.090354,0,0
2,GO DISTAL TUBULE DEVELOPMENT,0.031059,-0.24157,-0.16652,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.010773,-0.24162,-0.14533,0,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.055956,-0.24419,-0.19169,0,0
2,GO PRENYLATION,0.010506,-0.24735,-0.17608,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.33812,-0.25828,-0.17528,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.0075304,-0.25877,-0.17769,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.0015653,-0.2721,-0.26811,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.027188,-0.28122,-0.24092,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0017123,-0.28482,-0.23453,0,0
2,GO CARDIAC VENTRICLE FORMATION,0.19695,-0.31892,-0.16218,0,0
2,GO CARDIAC CHAMBER FORMATION,0.15015,-0.44869,-0.1899,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.00059588,-0.68836,-0.45841,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,7.889e-07,1.2188,0.9552,1,1
3,GO ETHANOL OXIDATION,2.9301e-06,0.97262,0.82318,1,1
3,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00016023,0.96721,0.73654,1,1
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,7.8282e-05,0.82445,0.70794,1,1
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.6015e-06,0.82265,0.75691,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.1192e-05,0.799,0.54757,1,1
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.2879e-07,0.77703,0.70378,1,1
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,1.1493e-05,0.764,0.68603,1,1
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00034072,0.75365,0.63141,1,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.4609e-05,0.70935,0.69537,1,1
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.025414,0.69156,0.74252,1,1
3,GO RESPONSE TO INTERLEUKIN 18,9.7346e-05,0.68969,0.68465,1,1
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.8612e-06,0.68144,0.51343,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.6414e-07,0.68021,0.52869,1,1
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.4977e-07,0.67989,0.6221,1,1
3,GO T HELPER 1 CELL DIFFERENTIATION,4.8612e-06,0.67581,0.64131,1,1
3,GO BIOLOGICAL PHASE,2.1663e-05,0.67252,0.67402,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00020448,0.65356,0.53952,1,1
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00087311,0.65048,0.49737,1,1
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0021689,0.64671,0.48034,1,1
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00041602,0.63924,0.58755,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.389e-05,0.62672,0.52091,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,1.6455e-05,0.61743,0.5325,1,1
3,GO MYOBLAST MIGRATION,0.0037331,0.61589,0.53006,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.3287e-06,0.61141,0.56732,1,1
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,1.4674e-06,0.59842,0.5472,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,0.59147,0.46613,1,1
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019079,0.58885,0.54153,1,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0026572,0.58809,0.44817,1,1
3,GO PROSTATE GLAND GROWTH,1.0604e-05,0.58277,0.62851,1,1
3,GO HAIR FOLLICLE MATURATION,4.2876e-06,0.57317,0.50929,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.7791e-06,0.5727,0.42028,1,1
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0226e-05,0.5693,0.54481,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.3218e-05,0.56446,0.57641,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0040578,0.56154,0.40596,1,1
3,GO MUCUS SECRETION,0.0015189,0.5613,0.54353,1,1
3,GO ETHER METABOLIC PROCESS,1.1493e-05,0.55969,0.49063,1,1
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0010206,0.55619,0.51876,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0087944,0.54879,0.39014,1,1
3,GO OTIC VESICLE DEVELOPMENT,5.0226e-05,0.54762,0.49616,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,0.0028957,0.54436,0.38993,1,1
3,GO LYSINE METABOLIC PROCESS,0.00047456,0.54427,0.49105,1,1
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.1702e-06,0.53953,0.52154,1,1
3,GO PSEUDOPODIUM ORGANIZATION,0.0025083,0.539,0.417,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0032441,0.53516,0.40135,1,1
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00014935,0.53459,0.46176,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,7.0571e-06,0.53315,0.46472,1,1
3,GO ACTIN FILAMENT SEVERING,0.0067808,0.53247,0.37707,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0024367,0.52756,0.50617,1,1
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.906e-06,0.52628,0.49368,1,1
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0001547,0.52516,0.43691,1,1
3,GO PROSTANOID METABOLIC PROCESS,3.8583e-05,0.51843,0.45281,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00024286,0.51167,0.45479,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.4044e-06,0.50989,0.45644,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.0226e-05,0.50824,0.40987,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,3.3132e-05,0.50532,0.55247,1,1
3,GO REGULATION OF GASTRIC ACID SECRETION,7.547e-05,0.50048,0.46764,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0016129,0.49837,0.42673,1,1
3,GO CARDIOLIPIN METABOLIC PROCESS,7.547e-05,0.49801,0.3979,1,1
3,GO HEPATOCYTE DIFFERENTIATION,0.0057817,0.49763,0.39211,1,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00041602,0.48942,0.43739,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0016129,0.48346,0.35981,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.015574,0.48307,0.39056,1,1
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00044439,0.48059,0.46447,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.4728e-06,0.47901,0.42254,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,8.1192e-05,0.4752,0.43373,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.2962e-05,0.47187,0.43418,1,1
3,GO REGULATION OF HIPPO SIGNALING,0.020205,0.46834,0.2461,1,1
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7118e-05,0.46809,0.41513,1,1
3,GO NEURAL CREST FORMATION,0.00025131,0.46561,0.36549,1,1
3,GO MUSCLE ATROPHY,0.023741,0.4645,0.3159,1,1
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.046579,0.46191,0.30855,1,1
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,7.2754e-05,0.45356,0.33365,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,9.3916e-06,0.45162,0.42813,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0022992,0.45013,0.36154,1,1
3,GO NEPHRON TUBULE FORMATION,0.0027346,0.44818,0.31656,1,1
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,3.3132e-05,0.44716,0.41667,1,1
3,GO SKELETAL MUSCLE TISSUE REGENERATION,1.104e-05,0.44531,0.3719,1,1
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00057693,0.44499,0.4096,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.7596e-05,0.44416,0.38692,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.013798,0.44249,0.40489,1,1
3,GO OTIC VESICLE MORPHOGENESIS,0.00044439,0.43886,0.41696,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.00010092,0.43707,0.36734,1,1
3,GO DENDRITIC CELL MIGRATION,2.0833e-05,0.43567,0.3916,1,1
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0030654,0.43454,0.36715,1,1
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0038387,0.43358,0.35544,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00021909,0.43184,0.44266,1,1
3,GO REGULATION OF PROTEIN IMPORT,7.8282e-05,0.42768,0.30988,1,1
3,GO REGULATION OF GLOMERULAR FILTRATION,0.012508,0.42068,0.36337,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,2.3654e-06,0.41888,0.40362,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00035231,0.41597,0.3914,1,1
3,GO ETHANOL METABOLIC PROCESS,1.2454e-05,0.41328,0.49637,1,1
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.2524e-05,0.41126,0.32599,1,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0045306,0.40954,0.36044,1,1
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.001986,0.40915,0.33747,1,1
3,GO LEFT RIGHT AXIS SPECIFICATION,0.00017186,0.40752,0.45169,1,1
3,GO OXYGEN TRANSPORT,0.017137,0.40266,0.41156,1,1
3,GO CELLULAR RESPONSE TO COPPER ION,0.031059,0.40254,0.42595,1,1
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.031748,0.39751,0.26461,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00028792,0.39535,0.3855,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00063551,0.39496,0.38613,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.012203,0.39338,0.27462,1,1
3,GO MONONUCLEAR CELL DIFFERENTIATION,1.7806e-05,0.39275,0.35727,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0032441,0.39103,0.35845,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00014935,0.391,0.30692,1,1
3,GO PORE COMPLEX ASSEMBLY,5.0683e-06,0.39017,0.37634,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00024286,0.38945,0.35612,1,1
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.0032441,0.38886,0.36542,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.001986,0.38839,0.31981,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,2.5308e-05,0.38812,0.33751,1,1
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.035393,0.38807,0.22265,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,2.8891e-07,0.38804,0.4015,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00095906,0.38802,0.35929,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.021165,0.38378,0.33778,1,1
3,GO HEME METABOLIC PROCESS,0.00019079,0.38291,0.3461,1,1
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.013798,0.38097,0.2391,1,1
3,GO PENTOSE METABOLIC PROCESS,7.2754e-05,0.37984,0.3666,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00025131,0.379,0.32135,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0011549,0.3771,0.33166,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00098941,0.37689,0.34472,1,1
3,GO LIMB BUD FORMATION,0.0025817,0.37637,0.47345,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,4.2876e-06,0.37556,0.34868,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.00054072,0.3738,0.32363,1,1
3,GO RESPONSE TO CADMIUM ION,0.0041716,0.37301,0.26983,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00017186,0.37234,0.31354,1,1
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,5.9841e-06,0.3715,0.34682,1,1
3,GO LAMELLIPODIUM MORPHOGENESIS,0.001872,0.36948,0.28068,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00092958,0.36619,0.34981,1,1
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,7.2754e-05,0.36599,0.30981,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.5759e-05,0.36571,0.30245,1,1
3,GO MYELOID CELL APOPTOTIC PROCESS,0.007729,0.36497,0.25223,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.027188,0.36279,0.2515,1,1
3,GO REGULATION OF RIBOSOME BIOGENESIS,7.547e-05,0.35899,0.34698,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0054795,0.35869,0.25094,1,1
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00019753,0.35727,0.30906,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.034637,0.35712,0.28081,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,7.013e-05,0.35549,0.3547,1,1
3,GO HISTONE SERINE PHOSPHORYLATION,0.00017186,0.35413,0.28419,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00016595,0.35355,0.29327,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,7.6603e-06,0.35275,0.38288,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00023468,0.35038,0.32538,1,1
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,6.7728e-06,0.3499,0.31293,1,1
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0033369,0.34927,0.26525,1,1
3,GO FATTY ACID HOMEOSTASIS,0.014138,0.34829,0.20772,1,1
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00052342,0.34769,0.30775,1,1
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00019079,0.34747,0.26544,1,1
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00022676,0.34744,0.29864,1,1
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.023741,0.34735,0.27251,1,1
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0019282,0.34718,0.37952,1,1
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.7728e-06,0.34683,0.3541,1,1
3,GO RETINAL METABOLIC PROCESS,0.035393,0.34646,0.2657,1,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.017969,0.34269,0.24991,1,1
3,GO PRE MIRNA PROCESSING,0.001872,0.34144,0.22852,1,1
3,GO REGULATION OF DNA METHYLATION,4.6597e-05,0.34129,0.2736,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0011199,0.33906,0.29875,1,1
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0039469,0.33816,0.24768,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0007696,0.33813,0.29412,1,1
3,GO TONGUE MORPHOGENESIS,0.0060989,0.33749,0.34097,1,1
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.029068,0.33733,0.20486,1,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.0010528,0.33547,0.32311,1,1
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00013433,0.33505,0.4769,1,1
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0079323,0.33474,0.24572,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.029068,0.33405,0.20609,1,1
3,GO RNA DECAPPING,3.8583e-05,0.33388,0.23697,1,1
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0025083,0.3337,0.44137,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,5.2139e-05,0.33295,0.36286,1,1
3,GO MICROVILLUS ASSEMBLY,0.0019282,0.3326,0.35386,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0022992,0.33239,0.23539,1,1
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.024288,0.33166,0.34474,1,1
3,GO ERBB2 SIGNALING PATHWAY,0.0012662,0.33092,0.24905,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,8.6584e-06,0.33032,0.36231,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.001986,0.32972,0.32609,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.00017796,0.3288,0.27356,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,0.0081404,0.32827,0.20526,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00067758,0.32825,0.28442,1,1
3,GO FIBROBLAST APOPTOTIC PROCESS,0.00019079,0.3282,0.32944,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.014138,0.32789,0.29309,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00079435,0.32675,0.31189,1,1
3,GO ZINC ION HOMEOSTASIS,0.013798,0.32435,0.32015,1,1
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0025817,0.32427,0.21957,1,1
3,GO IMP METABOLIC PROCESS,0.034637,0.3242,0.27509,1,1
3,GO HEMOGLOBIN METABOLIC PROCESS,0.0022992,0.32379,0.22993,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00059588,0.32312,0.25202,1,1
3,GO RETINOL METABOLIC PROCESS,0.00069957,0.32205,0.24299,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.007729,0.3201,0.28802,1,1
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.0081404,0.3199,0.30841,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00016595,0.31908,0.42139,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0007696,0.31892,0.26076,1,1
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0032441,0.31862,0.3256,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.906e-06,0.31751,0.2648,1,1
3,GO NOTOCHORD DEVELOPMENT,0.00052342,0.3174,0.48821,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.5149e-05,0.31702,0.28095,1,1
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0028141,0.31633,0.26712,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0014299,0.31594,0.27115,1,1
3,GO PROTEIN DEMANNOSYLATION,0.0045306,0.31534,0.19096,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0083534,0.31384,0.29439,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0099891,0.31381,0.28726,1,1
3,GO GAS TRANSPORT,0.0064317,0.31363,0.35374,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0050528,0.31333,0.32658,1,1
3,GO CELLULAR RESPONSE TO SALT STRESS,0.0034322,0.31298,0.38202,1,1
3,GO CARNITINE SHUTTLE,5.6174e-05,0.31298,0.31693,1,1
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.8418e-05,0.31107,0.251,1,1
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0056288,0.31092,0.29792,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0007696,0.3107,0.28635,1,1
3,GO DETOXIFICATION,0.00019079,0.3095,0.26205,1,1
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.021165,0.30928,0.24237,1,1
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0069616,0.3082,0.24922,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,9.7801e-06,0.30811,0.31182,1,1
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0032441,0.30795,0.23311,1,1
3,GO AMP METABOLIC PROCESS,0.016734,0.30722,0.2298,1,1
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00019753,0.30708,0.39671,1,1
3,GO DNA LIGATION,0.0014738,0.30662,0.22878,1,1
3,GO INTERLEUKIN 2 PRODUCTION,3.8583e-05,0.30565,0.2651,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.043763,0.30557,0.18349,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00020448,0.3038,0.31849,1,1
3,GO RESPIRATORY BURST,0.0025083,0.30358,0.237,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00036427,0.30352,0.26929,1,1
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0021062,0.30294,0.24919,1,1
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0028141,0.30198,0.23833,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,9.7346e-05,0.3008,0.29486,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,7.013e-05,0.30064,0.32568,1,1
3,GO KERATINOCYTE PROLIFERATION,0.02843,0.30059,0.28596,1,1
3,GO FOREGUT MORPHOGENESIS,0.0025817,0.29939,0.34239,1,1
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00014418,0.29938,0.33314,1,1
3,GO OVULATION,0.0013872,0.29899,0.25418,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,2.7343e-05,0.29814,0.29384,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0015189,0.29678,0.24938,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00072223,0.29601,0.2591,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0017123,0.29582,0.19052,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001191,0.29556,0.20799,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0013457,0.29527,0.29306,1,1
3,GO NUCLEAR PORE ORGANIZATION,1.4039e-05,0.29527,0.34743,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,5.4121e-05,0.29466,0.25256,1,1
3,GO VIRAL TRANSLATION,0.00012512,0.29435,0.33713,1,1
3,GO REGULATION OF VIRAL TRANSCRIPTION,3.3202e-07,0.29425,0.27593,1,1
3,GO GLYCINE METABOLIC PROCESS,0.0017123,0.29374,0.26928,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00057693,0.29317,0.31209,1,1
3,GO PODOSOME ASSEMBLY,0.0010528,0.29268,0.27419,1,1
3,GO RESPONSE TO TUMOR CELL,0.0067808,0.29259,0.22318,1,1
3,GO GASTRIC ACID SECRETION,0.001228,0.29234,0.24359,1,1
3,GO RESPONSE TO ANGIOTENSIN,0.00049035,0.29142,0.25472,1,1
3,GO MATURATION OF LSU RRNA,0.0013457,0.29137,0.32786,1,1
3,GO RESPONSE TO COPPER ION,0.033894,0.28891,0.27089,1,1
3,GO URETER DEVELOPMENT,0.033166,0.28875,0.25547,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0050528,0.28853,0.2686,1,1
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.001228,0.28853,0.22133,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011904,0.28848,0.22255,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00026903,0.28826,0.26289,1,1
3,GO RIG I SIGNALING PATHWAY,4.0073e-05,0.2881,0.26385,1,1
3,GO RESPONSE TO STEROL DEPLETION,0.00065623,0.28801,0.27519,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00054072,0.2875,0.29619,1,1
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.00030804,0.28722,0.23232,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.00025131,0.28659,0.44109,1,1
3,GO BLASTODERM SEGMENTATION,0.019283,0.28649,0.2911,1,1
3,GO FIBROBLAST ACTIVATION,0.00081984,0.28636,0.32039,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00045924,0.28599,0.28621,1,1
3,GO T CELL CHEMOTAXIS,0.00011241,0.28576,0.25846,1,1
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00081984,0.28519,0.26861,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.28494,0.26199,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.7343e-05,0.28428,0.28317,1,1
3,GO MATURATION OF 5 8S RRNA,0.00040247,0.28384,0.29683,1,1
3,GO RESPONSE TO INTERLEUKIN 12,0.00016023,0.28381,0.25682,1,1
3,GO PROSTATE GLAND DEVELOPMENT,0.0025817,0.28291,0.34626,1,1
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.022165,0.28275,0.37956,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,4.0073e-05,0.28207,0.27596,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0027346,0.28166,0.22208,1,1
3,GO REGULATION OF LIPASE ACTIVITY,5.2139e-05,0.2814,0.22573,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00026903,0.28082,0.31561,1,1
3,GO HYPEROSMOTIC RESPONSE,0.00095906,0.28062,0.27633,1,1
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.3418e-05,0.28029,0.31852,1,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0066042,0.28016,0.20091,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.001191,0.2798,0.23862,1,1
3,GO TETRAPYRROLE METABOLIC PROCESS,0.00029782,0.27925,0.22482,1,1
3,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.007729,0.27922,0.25443,1,1
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0034322,0.27907,0.17663,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.0011549,0.27896,0.44222,1,1
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0007696,0.27849,0.21344,1,1
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00032948,0.27777,0.28294,1,1
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0019282,0.27752,0.24763,1,1
3,GO HIPPO SIGNALING,0.0006154,0.27723,0.34983,1,1
3,GO REGULATION OF TELOMERASE ACTIVITY,3.1888e-05,0.27718,0.24309,1,1
3,GO CHROMATIN DISASSEMBLY,0.00055855,0.2771,0.22681,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00065623,0.27632,0.25228,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.021165,0.27533,0.19528,1,1
3,GO VIRAL GENE EXPRESSION,0.00054072,0.27526,0.25999,1,1
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.001228,0.27447,0.18005,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.042857,0.27425,0.2203,1,1
3,GO ARACHIDONIC ACID SECRETION,7.8282e-05,0.274,0.28469,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00059588,0.27392,0.28376,1,1
3,GO MIRNA METABOLIC PROCESS,3.6228e-06,0.27377,0.23931,1,1
3,GO MUSCLE CELL FATE COMMITMENT,0.024288,0.2733,0.26082,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.035393,0.27318,0.23067,1,1
3,GO VESICLE CARGO LOADING,5.6174e-05,0.27306,0.27992,1,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.00041602,0.2726,0.39181,1,1
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.014138,0.27083,0.30597,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00017186,0.27047,0.35446,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0099891,0.2692,0.17031,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00055855,0.26874,0.25877,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.022165,0.26844,0.25348,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,9.0551e-05,0.26805,0.24172,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,0.0027346,0.26734,0.24392,1,1
3,GO GTP METABOLIC PROCESS,0.00084609,0.26711,0.28782,1,1
3,GO MRNA MODIFICATION,0.001986,0.26692,0.2032,1,1
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.00010092,0.26647,0.25791,1,1
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017549,0.26631,0.32264,1,1
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00037661,0.26616,0.3567,1,1
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00016023,0.26608,0.21856,1,1
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.0054795,0.26545,0.20872,1,1
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0056288,0.26544,0.31048,1,1
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.8418e-05,0.26504,0.24453,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0025083,0.26382,0.25223,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0025817,0.26369,0.21768,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0017123,0.26309,0.23199,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.021165,0.263,0.22577,1,1
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00052342,0.26278,0.24923,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0054795,0.26253,0.2678,1,1
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,1.6455e-05,0.26201,0.24882,1,1
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00016595,0.26186,0.22582,1,1
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0040578,0.26155,0.19656,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00026003,0.26047,0.26666,1,1
3,GO PROTEIN DEGLYCOSYLATION,0.0051916,0.2603,0.2011,1,1
3,GO FOREBRAIN MORPHOGENESIS,0.033166,0.25902,0.17177,1,1
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00032948,0.25894,0.24645,1,1
3,GO OSTEOBLAST DEVELOPMENT,0.00057693,0.25867,0.30394,1,1
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0011549,0.25857,0.20856,1,1
3,GO NUCLEAR MIGRATION,0.0032441,0.25854,0.19574,1,1
3,GO LAMELLIPODIUM ORGANIZATION,7.0571e-06,0.25798,0.27198,1,1
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.02268,0.25722,0.21145,1,1
3,GO MATURATION OF SSU RRNA,0.00063551,0.25673,0.29897,1,1
3,GO AMINE CATABOLIC PROCESS,0.0039469,0.25667,0.28814,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00017186,0.25637,0.25222,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,0.0067808,0.25616,0.18758,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.043763,0.25595,0.16439,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0014299,0.25469,0.29201,1,1
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.011326,0.25458,0.16623,1,1
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.8418e-05,0.2542,0.27233,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.7118e-05,0.25402,0.24833,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.001228,0.25355,0.22522,1,1
3,GO MICROVILLUS ORGANIZATION,0.010506,0.25289,0.29662,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0034322,0.25283,0.28348,1,1
3,GO HISTONE H3 K9 ACETYLATION,1.1964e-05,0.2527,0.25829,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.041967,0.25241,0.12555,1,1
3,GO PLATELET MORPHOGENESIS,0.00010092,0.2509,0.24738,1,1
3,GO TRNA METHYLATION,0.00018427,0.25004,0.2326,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,2.7343e-05,0.24997,0.21133,1,1
3,GO CELL REDOX HOMEOSTASIS,0.00049035,0.249,0.21458,1,1
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00045924,0.24878,0.22397,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0050528,0.24796,0.25006,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00084609,0.24754,0.28323,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.041093,0.247,0.21567,1,1
3,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.047551,0.24699,0.20009,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.033894,0.24699,0.21548,1,1
3,GO PEPTIDE CROSS LINKING,0.02166,0.2463,0.19565,1,1
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00021909,0.24535,0.22389,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.013139,0.24511,0.21954,1,1
3,GO GLUTATHIONE METABOLIC PROCESS,6.0504e-05,0.24489,0.27913,1,1
3,GO AMINO ACID ACTIVATION,0.00016023,0.2448,0.2837,1,1
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00353,0.24479,0.37055,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.00090094,0.24478,0.22728,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,7.547e-05,0.24431,0.20645,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.016339,0.24257,0.14627,1,1
3,GO CYTOPLASM ORGANIZATION,0.0016129,0.24231,0.29117,1,1
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0011549,0.2422,0.18878,1,1
3,GO NADP METABOLIC PROCESS,0.0047853,0.24197,0.2056,1,1
3,GO LAMELLIPODIUM ASSEMBLY,3.3132e-05,0.24152,0.23922,1,1
3,GO RESPONSE TO X RAY,0.00024286,0.24149,0.32402,1,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.2401,0.22733,1,1
3,GO HISTONE H4 DEACETYLATION,0.00050664,0.2399,0.29464,1,1
3,GO ERYTHROCYTE MATURATION,0.0045306,0.2397,0.30878,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.00090094,0.23959,0.18272,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00092958,0.23909,0.23647,1,1
3,GO CHONDROCYTE PROLIFERATION,0.013139,0.23834,0.3206,1,1
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.036948,0.2383,0.17781,1,1
3,GO MITOCHONDRIAL DNA REPLICATION,0.00020448,0.23789,0.22389,1,1
3,GO CELLULAR OXIDANT DETOXIFICATION,0.00021167,0.23774,0.2392,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0028141,0.23771,0.20837,1,1
3,GO PROTEASOME ASSEMBLY,0.0054795,0.23755,0.169,1,1
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0021689,0.23742,0.21593,1,1
3,GO L SERINE METABOLIC PROCESS,0.011047,0.23703,0.27423,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0006154,0.23666,0.24345,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0007696,0.23604,0.227,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00013917,0.23598,0.20923,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,4.8379e-05,0.23583,0.20121,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0017123,0.23472,0.25322,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0019282,0.23438,0.21695,1,1
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0032441,0.23371,0.23687,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0056288,0.23315,0.20294,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.00042998,0.2324,0.1869,1,1
3,GO RESPONSE TO MANGANESE ION,0.0013872,0.23176,0.22346,1,1
3,GO NIK NF KAPPAB SIGNALING,0.00037661,0.23138,0.19719,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,6.0504e-05,0.23121,0.20817,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.00098941,0.23059,0.21719,1,1
3,GO RNA STABILIZATION,0.00044439,0.23037,0.16942,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00057693,0.22963,0.21305,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,1.0604e-05,0.22963,0.20316,1,1
3,GO MALE GENITALIA DEVELOPMENT,0.0028141,0.22959,0.23036,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.011326,0.22907,0.19088,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00022676,0.22791,0.28044,1,1
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.016734,0.22789,0.18534,1,1
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.02268,0.22781,0.17166,1,1
3,GO REGULATION OF HAIR CYCLE,0.001872,0.22735,0.25656,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.024288,0.22724,0.20338,1,1
3,GO THYMUS DEVELOPMENT,0.00019753,0.22665,0.2155,1,1
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.001191,0.22652,0.17774,1,1
3,GO SECRETION BY TISSUE,0.0024367,0.22636,0.22809,1,1
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00035231,0.22558,0.23081,1,1
3,GO RIBOSOME BIOGENESIS,0.00016595,0.22553,0.26312,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001872,0.22512,0.16017,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.22422,0.20102,1,1
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.010245,0.22405,0.18815,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0010206,0.22342,0.23372,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0049174,0.22256,0.21257,1,1
3,GO NUCLEUS LOCALIZATION,0.00079435,0.22255,0.1868,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00079435,0.22102,0.23142,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.2454e-05,0.22099,0.22174,1,1
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00040247,0.22049,0.21836,1,1
3,GO MAGNESIUM ION HOMEOSTASIS,0.015953,0.21971,0.27628,1,1
3,GO MAINTENANCE OF CELL NUMBER,2.6307e-05,0.21917,0.21794,1,1
3,GO INTERLEUKIN 10 PRODUCTION,0.0028957,0.2176,0.18385,1,1
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.00081984,0.2173,0.24259,1,1
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.027188,0.21718,0.23403,1,1
3,GO STEM CELL DIVISION,0.0019282,0.21697,0.23401,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00049035,0.21673,0.19453,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00041602,0.21655,0.15771,1,1
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00041602,0.21534,0.22117,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0085714,0.21529,0.22025,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0015189,0.21507,0.15272,1,1
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0022992,0.21502,0.20257,1,1
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.038561,0.21489,0.21355,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0064317,0.21476,0.17098,1,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0040578,0.21452,0.15301,1,1
3,GO REGULATION OF B CELL PROLIFERATION,0.0023671,0.21432,0.1737,1,1
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.023741,0.21428,0.15194,1,1
3,GO B CELL HOMEOSTASIS,0.018836,0.21403,0.12761,1,1
3,GO INTESTINAL ABSORPTION,0.015574,0.2139,0.161,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.016339,0.21382,0.17499,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,2.3418e-05,0.21369,0.19953,1,1
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00049035,0.2133,0.218,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00026903,0.21311,0.18568,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00024286,0.21304,0.22839,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00092958,0.2129,0.17685,1,1
3,GO LIPID OXIDATION,0.0042883,0.21207,0.1526,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0087944,0.21191,0.20875,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0001547,0.21182,0.22917,1,1
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0057817,0.2118,0.19447,1,1
3,GO B CELL APOPTOTIC PROCESS,0.016339,0.21164,0.13949,1,1
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.047551,0.21123,0.13068,1,1
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0011549,0.21117,0.32387,1,1
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.0184e-05,0.21036,0.20298,1,1
3,GO RNA POLYADENYLATION,0.00031859,0.21025,0.16167,1,1
3,GO RRNA TRANSCRIPTION,0.00047456,0.21018,0.23609,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.033166,0.21012,0.178,1,1
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0028957,0.20965,0.15391,1,1
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.027803,0.20962,0.21634,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0012662,0.20928,0.2034,1,1
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.012203,0.2092,0.17019,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0073363,0.20875,0.17631,1,1
3,GO REGULATION OF CELL MATURATION,0.016339,0.20845,0.15292,1,1
3,GO MULTI ORGANISM LOCALIZATION,0.00040247,0.2083,0.16718,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.036164,0.20821,0.13773,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.018398,0.20819,0.13833,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.1964e-05,0.20772,0.1959,1,1
3,GO RRNA MODIFICATION,0.0022992,0.20725,0.22037,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.00041602,0.20714,0.26655,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0066042,0.20642,0.153,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0032441,0.20625,0.17197,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0032441,0.20555,0.21581,1,1
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.022165,0.20545,0.23801,1,1
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00020448,0.20513,0.18087,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.013139,0.20513,0.18246,1,1
3,GO GOLGI LOCALIZATION,0.041967,0.20466,0.15169,1,1
3,GO BLASTOCYST FORMATION,0.00028792,0.20426,0.19953,1,1
3,GO NCRNA PROCESSING,0.00021167,0.20423,0.22567,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,1.1493e-05,0.20398,0.2503,1,1
3,GO CORNIFICATION,0.0033369,0.20373,0.26876,1,1
3,GO SCHWANN CELL DIFFERENTIATION,0.0025083,0.20275,0.16388,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0039469,0.20256,0.21596,1,1
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.0083534,0.2022,0.17764,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.0081404,0.20207,0.20708,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.014841,0.202,0.14098,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,0.20191,0.2049,1,1
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00054072,0.20151,0.18924,1,1
3,GO TRNA 5 LEADER REMOVAL,0.00092958,0.20129,0.22494,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.037747,0.20016,0.12294,1,1
3,GO REGULATION OF CELLULAR RESPIRATION,0.024846,0.19993,0.16812,1,1
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0001547,0.19988,0.19481,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.001191,0.19911,0.25754,1,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.023205,0.1984,0.22334,1,1
3,GO RNA DESTABILIZATION,0.0081404,0.19819,0.13718,1,1
3,GO RNA METHYLATION,0.0013872,0.19798,0.15871,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.001872,0.19782,0.18255,1,1
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017796,0.1976,0.21277,1,1
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0059384,0.19753,0.20271,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.001662,0.19743,0.16348,1,1
3,GO HISTONE DEUBIQUITINATION,8.4205e-05,0.19705,0.18145,1,1
3,GO PEPTIDYL METHIONINE MODIFICATION,0.0056288,0.19613,0.20436,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.00036427,0.19609,0.16007,1,1
3,GO RESPONSE TO SALT STRESS,0.017549,0.19588,0.20532,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0064317,0.19572,0.156,1,1
3,GO LEFT RIGHT PATTERN FORMATION,0.0053338,0.19557,0.25304,1,1
3,GO FATTY ACID BETA OXIDATION,0.016339,0.19511,0.11874,1,1
3,GO RRNA METABOLIC PROCESS,0.00017796,0.1949,0.2428,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.031059,0.19474,0.2108,1,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.027188,0.19468,0.13298,1,1
3,GO PEPTIDYL ARGININE MODIFICATION,2.8418e-05,0.19463,0.22081,1,1
3,GO REGULATION OF GENE SILENCING,7.3528e-06,0.19462,0.19869,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011612,0.19441,0.16649,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.029719,0.19381,0.17445,1,1
3,GO TRANSLATIONAL TERMINATION,0.0020453,0.19306,0.21297,1,1
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00084609,0.19286,0.19104,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.036948,0.19285,0.13854,1,1
3,GO APICAL JUNCTION ASSEMBLY,0.0067808,0.19259,0.20547,1,1
3,GO INTERACTION WITH SYMBIONT,0.00026003,0.19257,0.21133,1,1
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.043763,0.19232,0.11543,1,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0031536,0.19195,0.14251,1,1
3,GO V D J RECOMBINATION,0.011047,0.19192,0.22247,1,1
3,GO AEROBIC RESPIRATION,0.0015189,0.19184,0.19142,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00040247,0.19153,0.23328,1,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.035393,0.19144,0.12765,1,1
3,GO TRNA TRANSPORT,1.2454e-05,0.19136,0.24443,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.00044439,0.19126,0.21118,1,1
3,GO B CELL PROLIFERATION,0.0022332,0.19115,0.15619,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.036948,0.19088,0.1628,1,1
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.015953,0.19062,0.1778,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0085714,0.19047,0.13959,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0099891,0.19038,0.176,1,1
3,GO TRNA METABOLIC PROCESS,0.00011241,0.19017,0.19466,1,1
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.031748,0.18975,0.14015,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.6902e-06,0.18902,0.20025,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00069957,0.18899,0.15451,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.037747,0.18875,0.11938,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.015574,0.18871,0.14948,1,1
3,GO NCRNA METABOLIC PROCESS,0.00021167,0.18855,0.20332,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0067808,0.18827,0.1506,1,1
3,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.018836,0.18819,0.18593,1,1
3,GO RESPONSE TO ZINC ION,0.047551,0.18803,0.20233,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0041716,0.18801,0.17313,1,1
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.00017796,0.18795,0.20671,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.015203,0.18787,0.16961,1,1
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.0023671,0.18686,0.17654,1,1
3,GO LIVER REGENERATION,0.037747,0.18645,0.13785,1,1
3,GO GLUTAMINE METABOLIC PROCESS,0.00063551,0.18622,0.24136,1,1
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.02843,0.18611,0.11896,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0060989,0.18602,0.17283,1,1
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.00012964,0.18602,0.19013,1,1
3,GO RNA INTERFERENCE,0.009256,0.18581,0.17558,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.024288,0.18579,0.17767,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00016595,0.18563,0.20033,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.047551,0.18537,0.14968,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.00012512,0.18527,0.22399,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.023741,0.18466,0.12192,1,1
3,GO AXIS ELONGATION,0.011904,0.18446,0.27909,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.00017186,0.18423,0.20917,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.02268,0.18404,0.13676,1,1
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.013139,0.18333,0.1907,1,1
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.021165,0.18281,0.18305,1,1
3,GO ICOSANOID METABOLIC PROCESS,0.0030654,0.18176,0.16886,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00050664,0.18169,0.17714,1,1
3,GO TRNA MODIFICATION,0.00065623,0.18139,0.17772,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,0.036164,0.18061,0.11407,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00016595,0.18052,0.19441,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.018836,0.1805,0.13101,1,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.029719,0.18044,0.13715,1,1
3,GO FEVER GENERATION,0.029068,0.18031,0.17002,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.0045306,0.18021,0.192,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.020205,0.18005,0.26963,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0046564,0.17973,0.17011,1,1
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00013433,0.17868,0.18281,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0011199,0.17842,0.16062,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00026903,0.17836,0.22362,1,1
3,GO PRIMARY MIRNA PROCESSING,0.0087944,0.17817,0.17025,1,1
3,GO RNA MODIFICATION,0.00034072,0.17762,0.16128,1,1
3,GO SYMBIOTIC PROCESS,8.7323e-05,0.17731,0.16324,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00087311,0.17713,0.17085,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010245,0.1771,0.14983,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.00034072,0.17669,0.1801,1,1
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00010845,0.17655,0.16698,1,1
3,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17624,0.24067,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,7.0571e-06,0.17621,0.16539,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0017641,0.17617,0.18807,1,1
3,GO FATTY ACID TRANSPORT,0.00074557,0.17603,0.14663,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00038934,0.17601,0.17811,1,1
3,GO TONGUE DEVELOPMENT,0.041967,0.176,0.18708,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00024286,0.17577,0.17109,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00026003,0.1756,0.21319,1,1
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0056288,0.17553,0.14183,1,1
3,GO TRANSLATIONAL ELONGATION,0.013465,0.17542,0.16158,1,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.027188,0.17509,0.13759,1,1
3,GO RESPONSE TO IRON ION,0.033894,0.17507,0.16452,1,1
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.034637,0.17498,0.13349,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.010773,0.17429,0.13354,1,1
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,7.013e-05,0.1737,0.18929,1,1
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.011326,0.17337,0.18942,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.001191,0.17325,0.2014,1,1
3,GO FATTY ACID CATABOLIC PROCESS,0.029719,0.17318,0.10427,1,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0059384,0.17227,0.16833,1,1
3,GO HISTONE H3 K4 TRIMETHYLATION,0.0011549,0.1718,0.17388,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0018173,0.17103,0.16244,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.023741,0.17074,0.14362,1,1
3,GO TRNA PROCESSING,0.00028792,0.17067,0.18298,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010506,0.17058,0.15908,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00047456,0.1704,0.19324,1,1
3,GO REGULATION OF PROTEIN SUMOYLATION,0.0047853,0.17033,0.16739,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00065623,0.17018,0.18945,1,1
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00067758,0.17004,0.16651,1,1
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.024288,0.16959,0.17512,1,1
3,GO HISTONE H3 K14 ACETYLATION,3.8583e-05,0.16925,0.19803,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.01282,0.16906,0.18254,1,1
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0011549,0.16896,0.19383,1,1
3,GO SIGNAL PEPTIDE PROCESSING,0.015574,0.16886,0.20077,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.044685,0.16862,0.13601,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00020448,0.16832,0.15555,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0037331,0.16819,0.1292,1,1
3,GO ERYTHROCYTE DEVELOPMENT,0.012203,0.16811,0.14494,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.040234,0.1681,0.11258,1,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.017549,0.16756,0.14457,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.001986,0.16732,0.14286,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02068,0.16725,0.14061,1,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.016339,0.16622,0.20905,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0029794,0.16586,0.1598,1,1
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0085714,0.16583,0.13942,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010245,0.16534,0.17512,1,1
3,GO PROTEIN IMPORT,0.0012662,0.1648,0.13747,1,1
3,GO FATTY ACID METABOLIC PROCESS,0.0010528,0.16474,0.14218,1,1
3,GO RNA CATABOLIC PROCESS,0.00014935,0.16465,0.1721,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.011612,0.16398,0.15501,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.013139,0.16388,0.12266,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.0017123,0.1636,0.14697,1,1
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0014299,0.16358,0.1406,1,1
3,GO RRNA 3 END PROCESSING,0.0099891,0.16344,0.16479,1,1
3,GO LIPID MODIFICATION,0.0041716,0.16339,0.11393,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.0011199,0.16319,0.14502,1,1
3,GO PHOTOPERIODISM,0.03939,0.163,0.10823,1,1
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.012203,0.16294,0.15343,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.011326,0.16221,0.10233,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0087944,0.16216,0.15047,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00055855,0.16207,0.19833,1,1
3,GO THIOESTER METABOLIC PROCESS,0.0034322,0.16194,0.18439,1,1
3,GO TRNA 5 END PROCESSING,0.0014738,0.16194,0.20031,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0039469,0.16178,0.15564,1,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0071468,0.16149,0.16946,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.018836,0.1614,0.1086,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00038934,0.16111,0.20516,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.040234,0.16054,0.14725,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.0067808,0.16039,0.12688,1,1
3,GO TERPENOID METABOLIC PROCESS,0.026586,0.16011,0.13546,1,1
3,GO P BODY ASSEMBLY,0.00063551,0.1601,0.14729,1,1
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.024288,0.1601,0.15318,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00054072,0.15975,0.16627,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.0028141,0.15952,0.15662,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0026572,0.15939,0.14108,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.031059,0.15928,0.13353,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0015189,0.15906,0.17625,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0071468,0.15846,0.22047,1,1
3,GO SKIN DEVELOPMENT,0.023741,0.15835,0.17089,1,1
3,GO EPIDERMIS DEVELOPMENT,0.010506,0.1582,0.17522,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0034322,0.15803,0.21994,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0079323,0.15797,0.16325,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.0099891,0.15793,0.13075,1,1
3,GO STEROL HOMEOSTASIS,0.040234,0.15773,0.099474,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0050528,0.15741,0.17989,1,1
3,GO DIGESTIVE SYSTEM PROCESS,0.0075304,0.15736,0.1316,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00019753,0.15679,0.19295,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.045624,0.15644,0.1865,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0025083,0.15635,0.15286,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00081984,0.15548,0.15897,1,1
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.043763,0.15543,0.098774,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.0017123,0.15536,0.13833,1,1
3,GO INTERLEUKIN 17 PRODUCTION,0.013465,0.15451,0.13066,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.03245,0.15448,0.10485,1,1
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.037747,0.15387,0.10327,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00054072,0.15353,0.19197,1,1
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00045924,0.15322,0.17236,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,0.0011549,0.15296,0.11773,1,1
3,GO RESPONSE TO GAMMA RADIATION,0.00079435,0.15283,0.1899,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0014299,0.15279,0.2028,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.5308e-05,0.15277,0.15972,1,1
3,GO CHYLOMICRON ASSEMBLY,0.020205,0.15267,0.10948,1,1
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.007729,0.15259,0.23371,1,1
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.001986,0.15244,0.17054,1,1
3,GO TOXIN TRANSPORT,0.011612,0.15187,0.13264,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0042883,0.15178,0.16581,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.15147,0.13985,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,2.3418e-05,0.15134,0.17493,1,1
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0081404,0.15133,0.23203,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,8.7323e-05,0.15103,0.14832,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.013798,0.15094,0.11287,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.0066042,0.15075,0.12867,1,1
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0012662,0.14967,0.14197,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0097392,0.14944,0.1116,1,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.025414,0.14926,0.12859,1,1
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00069957,0.14889,0.11609,1,1
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.009256,0.14849,0.15098,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.018836,0.14834,0.12912,1,1
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.0025083,0.14824,0.13442,1,1
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0045306,0.14791,0.18977,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0059384,0.14788,0.20213,1,1
3,GO B CELL DIFFERENTIATION,0.0087944,0.14779,0.11694,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0025083,0.14771,0.16408,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.037747,0.14767,0.096891,1,1
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.019283,0.14744,0.13175,1,1
3,GO STEROL METABOLIC PROCESS,0.024288,0.14728,0.092281,1,1
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.8583e-05,0.14657,0.14386,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.027803,0.14583,0.10977,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0083534,0.14582,0.18035,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0013457,0.14555,0.13664,1,1
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0013054,0.14554,0.15599,1,1
3,GO IMPORT INTO NUCLEUS,0.022165,0.14532,0.11197,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00092958,0.14511,0.13625,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.0059384,0.1451,0.11218,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0069616,0.1451,0.1561,1,1
3,GO GMP METABOLIC PROCESS,0.024846,0.14505,0.16515,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0033369,0.14488,0.1124,1,1
3,GO HISTONE PHOSPHORYLATION,0.00081984,0.14481,0.13203,1,1
3,GO INNER EAR MORPHOGENESIS,0.020205,0.14476,0.12936,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.00072223,0.14451,0.13866,1,1
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0030654,0.14404,0.12769,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0025083,0.14395,0.22883,1,1
3,GO DIGESTION,0.030383,0.14378,0.090594,1,1
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.001872,0.14324,0.14252,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0025817,0.14295,0.14807,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.012203,0.14273,0.10797,1,1
3,GO GOLGI RIBBON FORMATION,0.031059,0.14271,0.13085,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.0032441,0.14267,0.11376,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,4.1617e-05,0.14217,0.19552,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.013139,0.14184,0.12243,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0006154,0.14149,0.121,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0051916,0.14111,0.1198,1,1
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.0604e-05,0.14079,0.16829,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0019282,0.14069,0.1252,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.041093,0.14062,0.15157,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012508,0.14059,0.14893,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.025994,0.14045,0.14335,1,1
3,GO MALE SEX DIFFERENTIATION,0.015574,0.14021,0.13832,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.016734,0.14017,0.15993,1,1
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00353,0.13959,0.11711,1,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.010773,0.13947,0.11202,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.001986,0.13931,0.16377,1,1
3,GO NON RECOMBINATIONAL REPAIR,0.0014299,0.13901,0.11734,1,1
3,GO REGULATION OF ORGAN GROWTH,0.033894,0.13834,0.12596,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0022992,0.13778,0.12507,1,1
3,GO COPII COATED VESICLE CARGO LOADING,0.037747,0.13743,0.093374,1,1
3,GO ACTIN FILAMENT BASED MOVEMENT,0.015953,0.13733,0.11238,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,5.4121e-05,0.13709,0.13758,1,1
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.02068,0.13683,0.12415,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001986,0.13672,0.12658,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.018398,0.13665,0.13636,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0057817,0.13629,0.12634,1,1
3,GO BASE EXCISION REPAIR,0.0010206,0.13621,0.13639,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,8.1192e-05,0.13601,0.12954,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.041093,0.13541,0.098591,1,1
3,GO TISSUE HOMEOSTASIS,0.013139,0.1354,0.092127,1,1
3,GO REGULATION OF T CELL CHEMOTAXIS,0.025994,0.13531,0.16907,1,1
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00049035,0.13527,0.14849,1,1
3,GO NUCLEAR EXPORT,5.0226e-05,0.13523,0.16528,1,1
3,GO DNA GEOMETRIC CHANGE,1.6455e-05,0.13397,0.16783,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0050528,0.13364,0.15621,1,1
3,GO TELOMERE ORGANIZATION,0.00029782,0.13287,0.13882,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.0022332,0.13282,0.11892,1,1
3,GO MRNA 3 END PROCESSING,8.1192e-05,0.13165,0.15532,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.030383,0.13121,0.15578,1,1
3,GO MRNA TRANSCRIPTION,0.014138,0.13119,0.14171,1,1
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00012964,0.13118,0.13134,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.02268,0.13047,0.14898,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.022165,0.13007,0.098426,1,1
3,GO VIRAL RELEASE FROM HOST CELL,0.010773,0.12974,0.1335,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0014299,0.12965,0.13797,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.0033369,0.12951,0.12847,1,1
3,GO HISTONE UBIQUITINATION,0.031059,0.12923,0.081861,1,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.025994,0.12906,0.10994,1,1
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.036948,0.12901,0.12515,1,1
3,GO REGULATION OF HISTONE UBIQUITINATION,0.0037331,0.12848,0.13599,1,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0045306,0.128,0.13562,1,1
3,GO EXIT FROM MITOSIS,0.01282,0.1279,0.098681,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00017186,0.12781,0.12316,1,1
3,GO OXIDATIVE DEMETHYLATION,0.025994,0.12765,0.090446,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.038561,0.1275,0.1283,1,1
3,GO CELL CELL RECOGNITION,0.026586,0.12718,0.098306,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,0.011904,0.12678,0.18035,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.0024367,0.12657,0.10739,1,1
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.016734,0.12586,0.12472,1,1
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.041967,0.12579,0.12027,1,1
3,GO RNA PROCESSING,3.4421e-05,0.12572,0.16152,1,1
3,GO ALCOHOL METABOLIC PROCESS,0.00079435,0.12562,0.1332,1,1
3,GO KERATINIZATION,0.025994,0.12552,0.18132,1,1
3,GO KERATINOCYTE DIFFERENTIATION,0.0097392,0.12543,0.21557,1,1
3,GO POLYOL METABOLIC PROCESS,0.001191,0.12529,0.14861,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,7.547e-05,0.12488,0.11946,1,1
3,GO HISTONE H3 DEACETYLATION,0.011904,0.12442,0.12474,1,1
3,GO RESPONSE TO IONIZING RADIATION,0.0007696,0.12418,0.16681,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.0041716,0.12386,0.11172,1,1
3,GO GENE SILENCING,5.508e-06,0.12385,0.13907,1,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.023741,0.12359,0.09924,1,1
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00087311,0.12353,0.16414,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0015189,0.12331,0.12039,1,1
3,GO OXIDATION REDUCTION PROCESS,0.0045306,0.12301,0.11022,1,1
3,GO PROTEIN SUMOYLATION,3.4421e-05,0.12271,0.13421,1,1
3,GO MRNA METABOLIC PROCESS,1.7118e-05,0.12248,0.14894,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.0047853,0.12222,0.13145,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,0.0021689,0.12218,0.18815,1,1
3,GO MRNA CLEAVAGE,0.00021167,0.12208,0.14874,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00074557,0.12201,0.15557,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.018836,0.12185,0.11987,1,1
3,GO MRNA TRANSPORT,0.00022676,0.1215,0.14785,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.001986,0.12111,0.11249,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0010206,0.1211,0.11727,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0021062,0.12089,0.12252,1,1
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0038387,0.12049,0.10945,1,1
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.012203,0.1204,0.099253,1,1
3,GO EAR MORPHOGENESIS,0.0062634,0.12018,0.14534,1,1
3,GO LIPID METABOLIC PROCESS,0.0029794,0.12016,0.093843,1,1
3,GO LIPID CATABOLIC PROCESS,0.027188,0.12006,0.07731,1,1
3,GO ACTIN NUCLEATION,0.0085714,0.11917,0.12397,1,1
3,GO BODY FLUID SECRETION,0.0049174,0.11914,0.1296,1,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.02843,0.11904,0.11588,1,1
3,GO PROTEIN NEDDYLATION,0.02166,0.11873,0.10961,1,1
3,GO REGULATION OF MYELINATION,0.026586,0.11862,0.11447,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00019079,0.11822,0.14927,1,1
3,GO LIPID HOMEOSTASIS,0.023205,0.11811,0.084156,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00057693,0.11795,0.14871,1,1
3,GO NUCLEAR TRANSPORT,0.0012662,0.11762,0.12208,1,1
3,GO EPITHELIAL TUBE FORMATION,0.0071468,0.1167,0.14776,1,1
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0025083,0.11639,0.10776,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.020205,0.11613,0.12997,1,1
3,GO DNA BIOSYNTHETIC PROCESS,0.0013457,0.11565,0.096928,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0028141,0.11562,0.11311,1,1
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0014299,0.11549,0.11659,1,1
3,GO RESPONSE TO UV,0.001662,0.11535,0.13673,1,1
3,GO RNA CAPPING,0.0075304,0.11512,0.09999,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0022332,0.11423,0.12333,1,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.011612,0.11377,0.095786,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.041967,0.11371,0.11386,1,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.0025083,0.11348,0.12878,1,1
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0022992,0.1134,0.11392,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0029794,0.11337,0.14379,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.023205,0.11295,0.092148,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.0094949,0.11289,0.10223,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00084609,0.11254,0.13447,1,1
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.011047,0.11244,0.094214,1,1
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0067808,0.11242,0.089633,1,1
3,GO RESPONSE TO ALCOHOL,0.042857,0.11204,0.084471,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.00016595,0.11197,0.12128,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.029068,0.11173,0.09598,1,1
3,GO POLYAMINE METABOLIC PROCESS,0.027188,0.11154,0.12868,1,1
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0075304,0.11133,0.097153,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00084609,0.11121,0.13329,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0073363,0.11097,0.086476,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.011612,0.11083,0.080932,1,1
3,GO RNA EXPORT FROM NUCLEUS,9.0551e-05,0.11068,0.17069,1,1
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.0085714,0.11007,0.13481,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0034322,0.11001,0.12959,1,1
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.007729,0.10989,0.13571,1,1
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.020205,0.10979,0.11394,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.026586,0.10972,0.11891,1,1
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0001165,0.10956,0.14472,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.040234,0.10911,0.093241,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0069616,0.10818,0.12496,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.0019282,0.1079,0.27769,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0090226,0.10781,0.10079,1,1
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.004408,0.10774,0.080633,1,1
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.016734,0.107,0.10545,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.02268,0.10697,0.083028,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,0.0007696,0.10681,0.11294,1,1
3,GO MRNA PROCESSING,0.00013433,0.10673,0.12377,1,1
3,GO MITOCHONDRIAL TRANSPORT,0.0033369,0.10672,0.10286,1,1
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0067808,0.1067,0.10033,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.00035231,0.10664,0.11339,1,1
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00016023,0.10552,0.11528,1,1
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,4.1617e-05,0.10498,0.11054,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.045624,0.10488,0.10611,1,1
3,GO TUBE FORMATION,0.0087944,0.10442,0.13705,1,1
3,GO GOLGI VESICLE TRANSPORT,0.0028957,0.10273,0.087268,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.011326,0.1026,0.090222,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.022165,0.10246,0.078972,1,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.001872,0.10198,0.11746,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00084609,0.10158,0.11675,1,1
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.036948,0.1012,0.071555,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.043763,0.10086,0.14201,1,1
3,GO HISTONE H3 ACETYLATION,0.00038934,0.10023,0.10638,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00024286,0.099617,0.12281,1,1
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00016023,0.099248,0.10584,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.0013872,0.098422,0.13266,1,1
3,GO ACTIN MEDIATED CELL CONTRACTION,0.031748,0.098225,0.11822,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.038561,0.098218,0.077351,1,1
3,GO RNA LOCALIZATION,9.0551e-05,0.098195,0.15685,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.025414,0.097938,0.092131,1,1
3,GO DNA METHYLATION,0.001191,0.097405,0.11385,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.036164,0.097182,0.078226,1,1
3,GO MRNA EXPORT FROM NUCLEUS,0.00032948,0.097151,0.15323,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.031748,0.097136,0.0924,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.036164,0.097096,0.088946,1,1
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.018836,0.096858,0.064618,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0087944,0.096056,0.10869,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.010506,0.095767,0.11516,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.029719,0.095448,0.082843,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0017123,0.09529,0.11351,1,1
3,GO REGULATION OF DNA REPAIR,0.027803,0.095058,0.072378,1,1
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0059384,0.094865,0.11924,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0057817,0.094424,0.14149,1,1
3,GO STEM CELL DIFFERENTIATION,0.010773,0.094058,0.12095,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00353,0.093801,0.099404,1,1
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00072223,0.093578,0.089556,1,1
3,GO RNA SPLICING,0.00032948,0.093084,0.12073,1,1
3,GO PROTEIN POLYUBIQUITINATION,0.0094949,0.092643,0.08035,1,1
3,GO DNA CONFORMATION CHANGE,0.0022992,0.092533,0.094702,1,1
3,GO CHROMATIN REMODELING,0.00029782,0.092448,0.11632,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.023741,0.091637,0.084245,1,1
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,2.4346e-05,0.090771,0.1302,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.0051916,0.090737,0.078205,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.023741,0.089775,0.1034,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011904,0.08948,0.086803,1,1
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00047456,0.088858,0.12069,1,1
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.02166,0.088762,0.10133,1,1
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0075304,0.088757,0.10111,1,1
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.001228,0.087903,0.084858,1,1
3,GO CELLULAR RESPONSE TO UV,0.0060989,0.087743,0.11549,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.02843,0.08723,0.082009,1,1
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.041093,0.086364,0.078517,1,1
3,GO CELL CYCLE PHASE TRANSITION,0.0073363,0.086257,0.08139,1,1
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.041967,0.085751,0.082296,1,1
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0051916,0.085516,0.089922,1,1
3,GO SNRNA METABOLIC PROCESS,0.0022992,0.085496,0.10364,1,1
3,GO MACROMOLECULE CATABOLIC PROCESS,0.0038387,0.084422,0.077762,1,1
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.017969,0.083117,0.075529,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,0.02843,0.083088,0.072255,1,1
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00072223,0.0828,0.098703,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0039469,0.081934,0.09326,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.033894,0.081705,0.097138,1,1
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0019282,0.08097,0.10037,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.041967,0.080511,0.07287,1,1
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.014841,0.080452,0.10521,1,1
3,GO STEROID METABOLIC PROCESS,0.026586,0.08016,0.066894,1,1
3,GO SELECTIVE AUTOPHAGY,0.017969,0.079739,0.093905,1,1
3,GO DOUBLE STRAND BREAK REPAIR,0.0016129,0.079692,0.10174,1,1
3,GO CHROMOSOME SEPARATION,0.026586,0.078615,0.076513,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001986,0.078376,0.089469,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.017969,0.077976,0.11981,1,1
3,GO REGULATION OF CHROMOSOME SEPARATION,0.019739,0.077307,0.098388,1,1
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.018836,0.07674,0.095021,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.034637,0.075331,0.060103,1,1
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.014138,0.075052,0.091265,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0051916,0.072273,0.070045,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0090226,0.071385,0.10286,1,1
3,GO REGULATION OF RNA SPLICING,0.017137,0.071372,0.089751,1,1
3,GO RESPONSE TO RADIATION,0.0075304,0.071316,0.071314,1,1
3,GO DNA METABOLIC PROCESS,0.00065623,0.069042,0.076051,1,1
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0085714,0.06879,0.068234,1,1
3,GO REGULATION OF DNA METABOLIC PROCESS,0.0029794,0.068134,0.078725,1,1
3,GO DNA DEPENDENT DNA REPLICATION,0.041967,0.067885,0.086184,1,1
3,GO DNA MODIFICATION,0.0015653,0.06723,0.078711,1,1
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.009256,0.067219,0.079738,1,1
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.02843,0.065806,0.083378,1,1
3,GO DNA INTEGRITY CHECKPOINT,0.029068,0.065549,0.081761,1,1
3,GO MACROAUTOPHAGY,0.027803,0.065165,0.054319,1,1
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0020453,0.063603,0.10135,1,1
3,GO MITOTIC NUCLEAR DIVISION,0.03939,0.06225,0.069712,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.018398,0.061532,0.092842,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.027188,0.060788,0.066093,1,1
3,GO DNA REPAIR,0.0016129,0.060215,0.077932,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.004408,0.058792,0.059091,1,1
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.037747,0.057915,0.083609,1,1
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.042857,0.057435,0.049978,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.02068,0.056633,0.048629,1,1
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.023741,0.053938,0.075505,1,1
3,GO RESPONSE TO LIGHT STIMULUS,0.027188,0.053593,0.06027,1,1
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.03245,0.051571,0.06987,1,1
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0085714,0.049786,0.06961,1,1
3,GO DNA RECOMBINATION,0.017137,0.049753,0.079231,1,1
3,GO DNA METHYLATION OR DEMETHYLATION,0.033894,0.048029,0.064391,1,1
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.024288,0.047121,0.047038,1,1
3,GO CHROMOSOME ORGANIZATION,0.0099891,0.040902,0.062854,1,1
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.020205,0.040675,0.04923,1,1
3,GO COVALENT CHROMATIN MODIFICATION,0.033894,0.036669,0.05146,1,1
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.047551,0.035158,0.067746,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0047853,1.0935,0.83412,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0046564,0.93198,0.67111,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0014738,0.78829,0.58927,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0027346,0.72299,0.44713,1,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.00034072,0.71623,0.56991,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.007729,0.70136,0.32585,1,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.00027832,0.65953,0.46611,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.029068,0.65217,0.39426,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00024286,0.62238,0.48207,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0025083,0.6153,0.40231,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00067758,0.60615,0.38948,1,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.00055855,0.59988,0.47251,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0027346,0.59403,0.44583,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.024288,0.59266,0.33433,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00052342,0.5746,0.4175,1,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,5.4121e-05,0.5639,0.51084,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00055855,0.55842,0.37715,1,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.00011241,0.54863,0.55457,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.03245,0.54723,0.33319,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0013054,0.53424,0.38285,1,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0030654,0.53143,0.35165,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00028792,0.5091,0.38389,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0013054,0.49496,0.35703,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.00030804,0.47764,0.40799,1,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00050664,0.47722,0.42927,1,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0049174,0.47674,0.42337,1,0
3,GO RESPONSE TO INTERFERON BETA,0.0099891,0.46842,0.35115,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.2862e-06,0.46665,0.48481,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0013457,0.46238,0.34531,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0010859,0.44741,0.4971,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.7145e-05,0.44402,0.44577,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001872,0.44144,0.2784,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0036303,0.43261,0.29506,1,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00017796,0.43045,0.36444,1,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0049174,0.42459,0.33675,1,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0036303,0.41489,0.37695,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0045306,0.41386,0.36477,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00036427,0.40309,0.33092,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0025817,0.3999,0.39563,1,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0050528,0.38886,0.24038,1,0
3,GO NEUTROPHIL HOMEOSTASIS,0.0085714,0.38851,0.33522,1,0
3,GO TOLERANCE INDUCTION,0.015953,0.38541,0.26007,1,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00040247,0.38307,0.29639,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0010859,0.37187,0.23635,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0034322,0.37143,0.23402,1,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.012508,0.35986,0.36744,1,0
3,GO CYSTEINE METABOLIC PROCESS,0.001872,0.35924,0.35908,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.8418e-05,0.35784,0.31859,1,0
3,GO I KAPPAB PHOSPHORYLATION,0.001228,0.3574,0.22918,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00041602,0.3557,0.31329,1,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.013465,0.35094,0.23794,1,0
3,GO TYPE 2 IMMUNE RESPONSE,0.00042998,0.34998,0.26846,1,0
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00063551,0.34843,0.35516,1,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00029782,0.34839,0.3119,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00054072,0.34749,0.39512,1,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.019283,0.34352,0.31716,1,0
3,GO T CELL MEDIATED IMMUNITY,0.0010528,0.34174,0.25702,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0041716,0.33607,0.30784,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.023205,0.32977,0.29568,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00074557,0.32799,0.25551,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0087944,0.32616,0.20662,1,0
3,GO EPIBOLY,0.034637,0.32415,0.18403,1,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0062634,0.32299,0.25842,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.030383,0.31618,0.20965,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00028792,0.31551,0.28241,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.018836,0.31361,0.29639,1,0
3,GO PIGMENT GRANULE MATURATION,0.012203,0.31312,0.25517,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.0066042,0.31301,0.1932,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0036303,0.31111,0.21981,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0021062,0.31043,0.26669,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00063551,0.30986,0.21016,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010845,0.3076,0.28209,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0023671,0.30655,0.37875,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0016129,0.30612,0.26385,1,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.0090226,0.30593,0.24352,1,0
3,GO MONOCYTE CHEMOTAXIS,0.00055855,0.30575,0.26379,1,0
3,GO MONONUCLEAR CELL MIGRATION,9.7346e-05,0.3057,0.27038,1,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.004408,0.30532,0.29172,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00081984,0.30438,0.22969,1,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0007696,0.30237,0.24679,1,0
3,GO ENTRY INTO HOST,0.0019282,0.30169,0.22172,1,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0017641,0.29864,0.28391,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.01282,0.29792,0.19036,1,0
3,GO INTERLEUKIN 8 PRODUCTION,0.00057693,0.29755,0.24186,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0030654,0.2937,0.27438,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0064317,0.29291,0.17559,1,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0038387,0.29041,0.22133,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.034637,0.28904,0.17012,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.012203,0.28901,0.20823,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00028792,0.28845,0.28614,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0015189,0.28773,0.26772,1,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.016734,0.28737,0.23287,1,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.017549,0.28657,0.2425,1,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.037747,0.28563,0.14697,1,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0073363,0.2848,0.21557,1,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00022676,0.28472,0.21443,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.027803,0.28248,0.18709,1,0
3,GO RESPONSE TO TYPE I INTERFERON,0.035393,0.28208,0.18837,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010773,0.2812,0.21009,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00026903,0.27855,0.27879,1,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0028957,0.27671,0.21457,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0028141,0.27646,0.18976,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0019282,0.27515,0.24374,1,0
3,GO PHAGOCYTOSIS RECOGNITION,0.011047,0.27337,0.24005,1,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0013054,0.27208,0.20445,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0011549,0.27153,0.25688,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00095906,0.2714,0.25086,1,0
3,GO REGULATION OF CELL KILLING,0.0060989,0.27078,0.18864,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0012662,0.26947,0.21521,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.011047,0.26922,0.20271,1,0
3,GO RESPONSE TO INTERFERON GAMMA,0.0071468,0.26871,0.20565,1,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.016734,0.26689,0.15739,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.012508,0.26687,0.22116,1,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00074557,0.26667,0.2251,1,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0039469,0.26433,0.26018,1,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.02166,0.26376,0.19274,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.001986,0.26282,0.18957,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00017186,0.26265,0.23069,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,0.0015653,0.26198,0.20012,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.010506,0.26036,0.24739,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0007696,0.26031,0.21388,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.001228,0.26006,0.18818,1,0
3,GO RNA 5 END PROCESSING,0.00054072,0.25877,0.24139,1,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.029719,0.2579,0.19586,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0017123,0.25764,0.23167,1,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0018173,0.25744,0.20467,1,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.02843,0.25569,0.19065,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010773,0.25504,0.31234,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00067758,0.25468,0.25147,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.011326,0.25369,0.20407,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0062634,0.25361,0.25855,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.017969,0.25313,0.12963,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.020205,0.2524,0.21537,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0062634,0.25176,0.15598,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.010773,0.25126,0.18432,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0097392,0.25117,0.25537,1,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001872,0.25044,0.24803,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.022165,0.24866,0.15322,1,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00072223,0.24791,0.29233,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,0.2471,0.24016,1,0
3,GO TYPE I INTERFERON PRODUCTION,0.0015189,0.2469,0.20119,1,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.004408,0.24683,0.17847,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.037747,0.24593,0.30436,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.038561,0.24537,0.1164,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.013465,0.24397,0.22501,1,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.001191,0.24303,0.17099,1,0
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.01282,0.24172,0.22703,1,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.02068,0.24086,0.17471,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,0.00063551,0.24069,0.19014,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00087311,0.23939,0.2057,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,0.0037331,0.23817,0.23767,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0017123,0.23779,0.23085,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0023671,0.23774,0.16768,1,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0024367,0.23698,0.18731,1,0
3,GO REGULATION OF PLATELET ACTIVATION,0.040234,0.23696,0.15596,1,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.024288,0.23399,0.24526,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0045306,0.23315,0.18011,1,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.027188,0.232,0.22664,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.009256,0.23053,0.29304,1,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00055855,0.22916,0.2428,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0046564,0.22867,0.15022,1,0
3,GO APOPTOTIC CELL CLEARANCE,0.0056288,0.22855,0.13906,1,0
3,GO ZYMOGEN INHIBITION,0.024288,0.22834,0.21583,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00087311,0.22811,0.15602,1,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.0016129,0.22811,0.17565,1,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0045306,0.22699,0.1506,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00057693,0.22693,0.18435,1,0
3,GO PIGMENT METABOLIC PROCESS,0.0015653,0.22658,0.20479,1,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.038561,0.2261,0.14064,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.013465,0.22488,0.15005,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0022992,0.22478,0.20416,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0038387,0.22477,0.24672,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0026572,0.22434,0.18462,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001662,0.22269,0.16027,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.010773,0.22243,0.19285,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0022332,0.22167,0.19115,1,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0020453,0.22158,0.15786,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.02268,0.22068,0.17333,1,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0014299,0.21939,0.26816,1,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0050528,0.21931,0.18213,1,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,7.8282e-05,0.21882,0.18569,1,0
3,GO ENAMEL MINERALIZATION,0.033166,0.21831,0.30052,1,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.21796,0.18633,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0099891,0.21766,0.12924,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0034322,0.21729,0.19112,1,0
3,GO INTERFERON ALPHA PRODUCTION,0.019739,0.21655,0.20314,1,0
3,GO T CELL APOPTOTIC PROCESS,0.00021167,0.21578,0.24325,1,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.016339,0.21563,0.18642,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00036427,0.21554,0.23995,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,0.017969,0.21547,0.1857,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0013457,0.21381,0.18279,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0016129,0.21353,0.17232,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0015653,0.21348,0.16442,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.0010528,0.21185,0.20067,1,0
3,GO INTERACTION WITH HOST,0.0010206,0.21138,0.18325,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0037331,0.21046,0.1388,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00069957,0.21022,0.19874,1,0
3,GO LEUKOCYTE PROLIFERATION,0.00057693,0.20964,0.16711,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0006154,0.20857,0.20397,1,0
3,GO PIGMENT ACCUMULATION,0.0042883,0.20811,0.21453,1,0
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0006154,0.2075,0.27214,1,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.031748,0.20715,0.2287,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0041716,0.20711,0.17516,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.010245,0.20668,0.16088,1,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.012203,0.20661,0.20024,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.023741,0.20644,0.18316,1,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0097392,0.20598,0.21145,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.001986,0.20549,0.15385,1,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.015953,0.20548,0.15999,1,0
3,GO VIRAL GENOME REPLICATION,0.013139,0.2051,0.17025,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0062634,0.20473,0.27546,1,0
3,GO RESPONSE TO PROTOZOAN,0.037747,0.20346,0.13549,1,0
3,GO COPPER ION TRANSPORT,0.0083534,0.2032,0.18904,1,0
3,GO DEFENSE RESPONSE TO VIRUS,0.017137,0.20245,0.1518,1,0
3,GO CYTOPLASMIC TRANSLATION,0.025994,0.20244,0.19204,1,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.016734,0.20208,0.19384,1,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.017137,0.20196,0.15114,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0097392,0.2018,0.24301,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00044439,0.2018,0.19348,1,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.010245,0.20114,0.14867,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.033166,0.20108,0.14835,1,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.0071468,0.20095,0.26426,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.007729,0.20066,0.20563,1,0
3,GO PROTEIN ADP RIBOSYLATION,0.0053338,0.2001,0.20011,1,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0087944,0.19964,0.18318,1,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.042857,0.19931,0.12085,1,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,0.19921,0.13185,1,0
3,GO RIBOSOME ASSEMBLY,0.0045306,0.199,0.23771,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.018836,0.19848,0.14087,1,0
3,GO SERTOLI CELL DEVELOPMENT,0.0051916,0.19842,0.28271,1,0
3,GO VASCULOGENESIS,0.045624,0.1984,0.15471,1,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.019739,0.19643,0.1774,1,0
3,GO POSITIVE REGULATION OF COAGULATION,0.0075304,0.19637,0.20568,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.03245,0.19618,0.22964,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.03939,0.19613,0.12527,1,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.011904,0.19456,0.13933,1,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.045624,0.19402,0.1316,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0054795,0.19362,0.20584,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.012508,0.19358,0.15932,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,0.0034322,0.19339,0.19301,1,0
3,GO PINOCYTOSIS,0.0032441,0.19334,0.14961,1,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.026586,0.19272,0.14154,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0021062,0.19218,0.16557,1,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.015203,0.19184,0.18418,1,0
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0062634,0.19174,0.23677,1,0
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.042857,0.19158,0.17083,1,0
3,GO AMYLOID BETA CLEARANCE,0.016339,0.19123,0.15252,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00092958,0.191,0.15539,1,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.040234,0.19099,0.15912,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.012203,0.18946,0.12389,1,0
3,GO T CELL PROLIFERATION,0.0010528,0.1891,0.16864,1,0
3,GO TRANSLATIONAL INITIATION,0.019283,0.18881,0.19098,1,0
3,GO RESPONSE TO INTERLEUKIN 15,0.0071468,0.18863,0.15279,1,0
3,GO HYPOTONIC RESPONSE,0.041967,0.1885,0.15412,1,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.042857,0.1885,0.15079,1,0
3,GO RESPONSE TO INTERLEUKIN 1,0.00063551,0.18838,0.1691,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0049174,0.18782,0.14443,1,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0025083,0.18731,0.18374,1,0
3,GO COPPER ION HOMEOSTASIS,0.02068,0.18705,0.13995,1,0
3,GO NEGATIVE T CELL SELECTION,0.036164,0.18694,0.091995,1,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0007696,0.18571,0.1903,1,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0022332,0.18543,0.12667,1,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.18414,0.24377,1,0
3,GO INTERFERON BETA PRODUCTION,0.007729,0.18382,0.17168,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.0038387,0.18338,0.17894,1,0
3,GO RESPONSE TO GONADOTROPIN,0.0090226,0.18317,0.1929,1,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00079435,0.18306,0.15624,1,0
3,GO B CELL MEDIATED IMMUNITY,0.009256,0.1829,0.12908,1,0
3,GO CHEMOKINE PRODUCTION,0.0032441,0.18209,0.20343,1,0
3,GO RENAL TUBULE DEVELOPMENT,0.041967,0.18137,0.14458,1,0
3,GO NECROTIC CELL DEATH,0.012508,0.18127,0.17261,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.010506,0.18116,0.20325,1,0
3,GO INTERLEUKIN 1 PRODUCTION,0.0099891,0.18054,0.21593,1,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00095906,0.18026,0.15491,1,0
3,GO RESPONSE TO OSMOTIC STRESS,0.0011199,0.18012,0.1781,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.018836,0.18006,0.12433,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.027803,0.17979,0.18745,1,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.036164,0.17876,0.19281,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0050528,0.17863,0.17043,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.0067808,0.17854,0.13156,1,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0006154,0.17821,0.18389,1,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0024367,0.17801,0.21298,1,0
3,GO TRICARBOXYLIC ACID CYCLE,0.0039469,0.17768,0.22167,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.011904,0.1774,0.19314,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0034322,0.17656,0.13476,1,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.0067808,0.17631,0.11602,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00057693,0.17616,0.15202,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.016339,0.17591,0.1374,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0087944,0.17583,0.13553,1,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.025414,0.17464,0.13194,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.02843,0.17461,0.11306,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0064317,0.17424,0.14088,1,0
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.018398,0.1734,0.21404,1,0
3,GO VIRAL LIFE CYCLE,0.0014299,0.17329,0.16852,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0081404,0.1732,0.14886,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0022992,0.17269,0.17724,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0010859,0.17259,0.1763,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0021689,0.17254,0.19368,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0053338,0.17181,0.15754,1,0
3,GO PLACENTA DEVELOPMENT,0.025414,0.17178,0.13085,1,0
3,GO INTERFERON GAMMA PRODUCTION,0.0014299,0.17143,0.14822,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,0.018398,0.17105,0.15897,1,0
3,GO T CELL DIFFERENTIATION,0.001986,0.17001,0.14288,1,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.040234,0.1698,0.093254,1,0
3,GO METANEPHROS DEVELOPMENT,0.03245,0.16974,0.15369,1,0
3,GO MITOCHONDRIAL RNA PROCESSING,0.018398,0.16959,0.17415,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.0090226,0.16955,0.12382,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.015574,0.16839,0.11578,1,0
3,GO IRON ION HOMEOSTASIS,0.0062634,0.16724,0.14771,1,0
3,GO MACROPHAGE CHEMOTAXIS,0.031059,0.16607,0.14899,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0046564,0.16474,0.13857,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.001228,0.16389,0.17584,1,0
3,GO REGULATION OF PHAGOCYTOSIS,0.01282,0.1637,0.12406,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.0041716,0.16281,0.13644,1,0
3,GO CYTOKINE PRODUCTION,0.0047853,0.16274,0.12987,1,0
3,GO RESPONSE TO VIRUS,0.017969,0.16269,0.12297,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.024846,0.1624,0.13578,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0049174,0.16221,0.14647,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.043763,0.16185,0.15047,1,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.029068,0.16183,0.088742,1,0
3,GO POSITIVE CHEMOTAXIS,0.02166,0.16138,0.13505,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.017549,0.16112,0.10428,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.020205,0.16092,0.10877,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.02843,0.16082,0.1053,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0046564,0.16065,0.11612,1,0
3,GO INNATE IMMUNE RESPONSE,0.0047853,0.16021,0.13688,1,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.0025817,0.16009,0.18119,1,0
3,GO REGULATION OF IMMUNE RESPONSE,0.0032441,0.15981,0.12273,1,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0045306,0.1597,0.14624,1,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.011904,0.15959,0.14195,1,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0030654,0.15912,0.17973,1,0
3,GO REGULATION OF CELL CELL ADHESION,0.010506,0.1585,0.12545,1,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.045624,0.15776,0.13661,1,0
3,GO CELLULAR RESPONSE TO VIRUS,0.0041716,0.15723,0.15216,1,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.035393,0.1572,0.088486,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0057817,0.15673,0.23897,1,0
3,GO REGULATION OF CELL ACTIVATION,0.0031536,0.15647,0.12607,1,0
3,GO ERBB SIGNALING PATHWAY,0.0057817,0.1556,0.12517,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.019283,0.15533,0.16392,1,0
3,GO REGULATION OF DEFENSE RESPONSE,0.0042883,0.1552,0.11266,1,0
3,GO T CELL CYTOKINE PRODUCTION,0.0064317,0.15512,0.14959,1,0
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.02843,0.155,0.15954,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0073363,0.15477,0.1548,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0071468,0.15475,0.14191,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.029719,0.15335,0.26247,1,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0051916,0.15296,0.15748,1,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00042998,0.15295,0.15057,1,0
3,GO RESPONSE TO CYTOKINE,0.0090226,0.15167,0.11362,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.030383,0.15112,0.11379,1,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.024846,0.15084,0.1302,1,0
3,GO T CELL ACTIVATION,0.0042883,0.15054,0.13279,1,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0021689,0.14943,0.18399,1,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0036303,0.14938,0.11453,1,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0053338,0.14932,0.14643,1,0
3,GO PHAGOCYTOSIS,0.010245,0.14918,0.13454,1,0
3,GO COCHLEA MORPHOGENESIS,0.031059,0.14914,0.1519,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0069616,0.14907,0.12357,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.047551,0.14907,0.28731,1,0
3,GO REGULATION OF ACTION POTENTIAL,0.044685,0.14703,0.12209,1,0
3,GO REGULATION OF T CELL ACTIVATION,0.0045306,0.14699,0.13208,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.0037331,0.1469,0.14366,1,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0053338,0.14637,0.12007,1,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0085714,0.14602,0.11719,1,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00052342,0.1457,0.15615,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.0015653,0.14556,0.12959,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.001872,0.14556,0.13049,1,0
3,GO RECEPTOR CATABOLIC PROCESS,0.03245,0.14522,0.14506,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.017137,0.14507,0.13089,1,0
3,GO CELL KILLING,0.0094949,0.14501,0.12834,1,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0054795,0.14496,0.15685,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.02843,0.14491,0.12756,1,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0059384,0.14475,0.14674,1,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.011047,0.1447,0.20577,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.024288,0.14469,0.4073,1,0
3,GO SERTOLI CELL DIFFERENTIATION,0.017969,0.1445,0.20887,1,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.0097392,0.14415,0.1058,1,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.014486,0.14348,0.10733,1,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.035393,0.1434,0.13458,1,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0026572,0.1428,0.16588,1,0
3,GO CD40 SIGNALING PATHWAY,0.025414,0.14264,0.12147,1,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0083534,0.14243,0.20176,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.0062634,0.14227,0.12602,1,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0025083,0.14206,0.18039,1,0
3,GO HISTONE H2B UBIQUITINATION,0.014138,0.14186,0.13774,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,9.0551e-05,0.14169,0.15154,1,0
3,GO IMMUNE EFFECTOR PROCESS,0.0071468,0.14144,0.12292,1,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.013798,0.14105,0.17542,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.025414,0.14071,0.11566,1,0
3,GO CYTOKINETIC PROCESS,0.033894,0.14027,0.12855,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0079323,0.14016,0.12103,1,0
3,GO REGULATION OF B CELL ACTIVATION,0.014138,0.13947,0.11096,1,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.047551,0.13859,0.13394,1,0
3,GO PROTEIN KINASE B SIGNALING,0.047551,0.13855,0.086269,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0083534,0.13836,0.10469,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.031748,0.13821,0.11238,1,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0087944,0.13793,0.092534,1,0
3,GO ALPHA BETA T CELL ACTIVATION,0.0015189,0.13743,0.16443,1,0
3,GO MACROPHAGE MIGRATION,0.014841,0.13734,0.14811,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.001872,0.13732,0.14293,1,0
3,GO LEUKOCYTE HOMEOSTASIS,0.040234,0.1371,0.083054,1,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0053338,0.13708,0.19361,1,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0053338,0.13685,0.10992,1,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.031059,0.13678,0.1006,1,0
3,GO REGULATION OF HEMOPOIESIS,0.010245,0.13664,0.1148,1,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.013465,0.13643,0.12684,1,0
3,GO KERATINOCYTE MIGRATION,0.026586,0.13589,0.14024,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.014138,0.1355,0.1115,1,0
3,GO AMIDE BIOSYNTHETIC PROCESS,0.00052342,0.13545,0.15553,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.025414,0.13436,0.13781,1,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0020453,0.13316,0.17094,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.037747,0.13276,0.12785,1,0
3,GO LYMPHOCYTE ACTIVATION,0.0066042,0.13245,0.10937,1,0
3,GO VESICLE TARGETING,0.0062634,0.13223,0.10448,1,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0081404,0.13166,0.14947,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0075304,0.13125,0.14154,1,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.019283,0.13073,0.11449,1,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.017969,0.13047,0.24841,1,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.0054795,0.13031,0.14644,1,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00353,0.12974,0.12888,1,0
3,GO DEFENSE RESPONSE,0.017137,0.12953,0.085146,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,0.038561,0.12915,0.1139,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0069616,0.12886,0.16988,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.007729,0.12883,0.10134,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.045624,0.12877,0.10004,1,0
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.017549,0.12876,0.14172,1,0
3,GO RUFFLE ORGANIZATION,0.041093,0.12865,0.085359,1,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.014138,0.12839,0.10456,1,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.033166,0.12816,0.10108,1,0
3,GO REGULATION OF CELL ADHESION,0.033166,0.12796,0.10603,1,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.018836,0.12784,0.17201,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.015953,0.12783,0.090982,1,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.046579,0.12769,0.12112,1,0
3,GO RESPONSE TO BACTERIUM,0.02166,0.12668,0.092533,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.021165,0.12629,0.086477,1,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.021165,0.12617,0.094706,1,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.046579,0.12542,0.11777,1,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0062634,0.12522,0.14841,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0010206,0.12506,0.15564,1,0
3,GO RESPONSE TO ESTROGEN,0.023205,0.12488,0.13343,1,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.021165,0.12444,0.083458,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.025414,0.12427,0.098656,1,0
3,GO CELL ACTIVATION,0.016339,0.12343,0.095461,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.015574,0.12307,0.12466,1,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.044685,0.1228,0.11808,1,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0094949,0.12242,0.13812,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.047551,0.12194,0.12688,1,0
3,GO MYELOID CELL HOMEOSTASIS,0.017969,0.1218,0.11152,1,0
3,GO STRESS GRANULE ASSEMBLY,0.011326,0.12125,0.11766,1,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.046579,0.12124,0.10904,1,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.034637,0.12053,0.13567,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.021165,0.12052,0.19607,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.016734,0.11975,0.17436,1,0
3,GO GOLGI VESICLE BUDDING,0.00353,0.11956,0.09649,1,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.017137,0.11931,0.12803,1,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.023205,0.11866,0.086651,1,0
3,GO MOLTING CYCLE,0.027188,0.11816,0.15228,1,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.014138,0.11797,0.090691,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.021165,0.11793,0.085754,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.02166,0.11676,0.09689,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.03939,0.11632,0.10791,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.036948,0.11605,0.10613,1,0
3,GO LEUKOCYTE DIFFERENTIATION,0.010773,0.11272,0.09734,1,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.021165,0.11264,0.16842,1,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.017549,0.11256,0.095068,1,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.019739,0.11196,0.089363,1,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0006154,0.11191,0.13088,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.046579,0.11187,0.19069,1,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.043763,0.11167,0.076771,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0075304,0.11163,0.084019,1,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.038561,0.11132,0.070021,1,0
3,GO RESPONSE TO SALT,0.024288,0.11095,0.16747,1,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.015203,0.11089,0.13612,1,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.001228,0.11053,0.14689,1,0
3,GO MYOBLAST DIFFERENTIATION,0.030383,0.11043,0.16691,1,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0038387,0.10927,0.12839,1,0
3,GO CELLULAR RESPIRATION,0.015953,0.10918,0.13518,1,0
3,GO B CELL ACTIVATION,0.0046564,0.10902,0.10297,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.045624,0.10887,0.10684,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.042857,0.10864,0.085346,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.030383,0.10862,0.10562,1,0
3,GO COPII COATED VESICLE BUDDING,0.0027346,0.1082,0.10059,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.036164,0.10815,0.13529,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.02068,0.10612,0.1474,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.046579,0.10605,0.097911,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0073363,0.10562,0.12938,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0037331,0.10495,0.13495,1,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.023741,0.10381,0.12898,1,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.034637,0.1036,0.1171,1,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0033369,0.10225,0.12672,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.023205,0.10205,0.13596,1,0
3,GO RNA 3 END PROCESSING,0.0010859,0.10116,0.13378,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.019283,0.10107,0.11214,1,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0085714,0.10065,0.1843,1,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.024846,0.10003,0.082695,1,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.022165,0.099971,0.078876,1,0
3,GO REGULATION OF CELL SHAPE,0.02268,0.099748,0.13339,1,0
3,GO REGULATION OF RESPONSE TO STRESS,0.02268,0.099552,0.070269,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.023741,0.098407,0.14759,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.014138,0.097919,0.091327,1,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0025083,0.097412,0.15343,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.040234,0.097259,0.10641,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,0.033894,0.096531,0.099116,1,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.017549,0.096221,0.11338,1,0
3,GO REGULATION OF CATABOLIC PROCESS,0.0060989,0.096121,0.072845,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.033166,0.09567,0.094026,1,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.040234,0.09533,0.12404,1,0
3,GO ENDOCRINE PROCESS,0.018836,0.095323,0.11866,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.018398,0.094986,0.1221,1,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.036948,0.094327,0.078922,1,0
3,GO SNRNA PROCESSING,0.009256,0.093359,0.096868,1,0
3,GO RESPONSE TO HEAT,0.02268,0.093356,0.097181,1,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.019283,0.092965,0.10837,1,0
3,GO RESPONSE TO INTERLEUKIN 4,0.015574,0.09271,0.11053,1,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.009256,0.092202,0.098224,1,0
3,GO CELL AGING,0.012203,0.092119,0.088626,1,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.01282,0.0921,0.06739,1,0
3,GO ELECTRON TRANSPORT CHAIN,0.021165,0.09143,0.10984,1,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.022165,0.091224,0.094518,1,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.010773,0.090664,0.13724,1,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.042857,0.090515,0.12173,1,0
3,GO REGULATION OF PROTEIN STABILITY,0.011612,0.090253,0.072783,1,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.030383,0.090241,0.076051,1,0
3,GO NEURAL TUBE FORMATION,0.023205,0.09019,0.14562,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.031748,0.089925,0.10887,1,0
3,GO NCRNA CATABOLIC PROCESS,0.017137,0.088972,0.13617,1,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.02843,0.087968,0.060325,1,0
3,GO MYELOID CELL DIFFERENTIATION,0.027188,0.085905,0.087144,1,0
3,GO PEROXISOMAL TRANSPORT,0.014486,0.085778,0.11286,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.02268,0.085765,0.10049,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0057817,0.085542,0.083036,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.041093,0.085051,0.12291,1,0
3,GO POSTREPLICATION REPAIR,0.037747,0.085044,0.071008,1,0
3,GO CELLULAR RESPONSE TO HEAT,0.03939,0.08426,0.099183,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.015953,0.083406,0.11148,1,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012508,0.083066,0.075718,1,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.025414,0.082421,0.094417,1,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.007729,0.082147,0.11327,1,0
3,GO ERK1 AND ERK2 CASCADE,0.033894,0.081651,0.10355,1,0
3,GO RRNA METHYLATION,0.02843,0.081485,0.1597,1,0
3,GO ERAD PATHWAY,0.016734,0.081021,0.0811,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.018398,0.080462,0.053569,1,0
3,GO NCRNA TRANSCRIPTION,0.0079323,0.080268,0.098014,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.038561,0.080223,0.066305,1,0
3,GO HISTONE DEACETYLATION,0.0062634,0.079882,0.090372,1,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.041093,0.079717,0.069405,1,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.047551,0.078707,0.10895,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015203,0.078474,0.089141,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.025414,0.077301,0.065926,1,0
3,GO CELLULAR RESPONSE TO LIPID,0.031748,0.077143,0.089052,1,0
3,GO PEROXISOME ORGANIZATION,0.018398,0.075617,0.098051,1,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.018398,0.074118,0.074147,1,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.019283,0.073885,0.068889,1,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.033166,0.07269,0.0648,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.025414,0.0725,0.076027,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.046579,0.070156,0.17531,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.035393,0.069261,0.064537,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.023741,0.06894,0.13147,1,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.02068,0.068177,0.077531,1,0
3,GO ALCOHOL CATABOLIC PROCESS,0.046579,0.066806,0.11709,1,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.014138,0.066172,0.087766,1,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.041967,0.064935,0.057759,1,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.015574,0.061012,0.063124,1,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.041967,0.060539,0.091235,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.046579,0.058202,0.06435,1,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0049174,0.057979,0.066854,1,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.036164,0.057595,0.041506,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.038561,0.056371,0.050705,1,0
3,GO SNRNA TRANSCRIPTION,0.0090226,0.05122,0.078967,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.042857,0.05087,0.076788,1,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.027188,0.049354,0.066968,1,0
3,GO TISSUE MIGRATION,0.045624,0.045963,0.11694,1,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.02268,0.036689,0.053422,1,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.046579,0.035657,0.049754,1,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.034637,0.02977,0.046309,1,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.036948,-0.03721,-0.066589,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.029719,-0.043189,-0.06776,1,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.038561,-0.049313,-0.086107,1,0
3,GO AXON DEVELOPMENT,0.027188,-0.05,-0.11601,1,0
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.036948,-0.05111,-0.22259,1,0
3,GO CIRCADIAN RHYTHM,0.023205,-0.052637,-0.06337,1,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.042857,-0.054346,-0.10022,1,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.029068,-0.058558,-0.1074,1,0
3,GO NEURON PROJECTION GUIDANCE,0.042857,-0.0612,-0.11661,1,0
3,GO REGULATION OF VASOCONSTRICTION,0.035393,-0.062224,-0.1238,1,0
3,GO PEPTIDE SECRETION,0.026586,-0.062393,-0.092613,1,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.033166,-0.065196,-0.10164,1,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0060989,-0.066696,-0.13022,1,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.03939,-0.068924,-0.064548,1,0
3,GO CELL PROJECTION ORGANIZATION,0.029719,-0.069727,-0.08034,1,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.026586,-0.070177,-0.071244,1,0
3,GO METAL ION TRANSPORT,0.030383,-0.073308,-0.081459,1,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.013465,-0.074964,-0.11139,1,0
3,GO REGULATION OF DNA BINDING,0.03939,-0.075098,-0.097993,1,0
3,GO MICROTUBULE BASED MOVEMENT,0.0064317,-0.076697,-0.095808,1,0
3,GO CATION TRANSPORT,0.029719,-0.076805,-0.082139,1,0
3,GO REGULATION OF TORC1 SIGNALING,0.0025817,-0.077089,-0.12579,1,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.02268,-0.077243,-0.096808,1,0
3,GO GERM CELL DEVELOPMENT,0.004408,-0.077626,-0.09631,1,0
3,GO CELL CELL SIGNALING,0.0099891,-0.078327,-0.094155,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.027803,-0.079628,-0.11154,1,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0094949,-0.080302,-0.10934,1,0
3,GO REGULATION OF CELL DEVELOPMENT,0.017549,-0.08097,-0.093886,1,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.033166,-0.081976,-0.080843,1,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.025994,-0.082475,-0.14914,1,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.041967,-0.082943,-0.078209,1,0
3,GO CELL PART MORPHOGENESIS,0.0031536,-0.08337,-0.13165,1,0
3,GO POSITIVE REGULATION OF SECRETION,0.004408,-0.085082,-0.10615,1,0
3,GO MICROTUBULE BASED TRANSPORT,0.0060989,-0.08682,-0.095271,1,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.030383,-0.087304,-0.1128,1,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.024288,-0.087816,-0.11004,1,0
3,GO SUCKLING BEHAVIOR,0.041093,-0.088114,-0.18784,1,0
3,GO REGULATION OF SECRETION,0.018398,-0.088713,-0.09328,1,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.014841,-0.088718,-0.10032,1,0
3,GO REGULATION OF ANION TRANSPORT,0.036164,-0.08903,-0.1056,1,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0031536,-0.089809,-0.15562,1,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.02166,-0.090171,-0.11587,1,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0073363,-0.090757,-0.13376,1,0
3,GO CATION TRANSMEMBRANE TRANSPORT,0.019739,-0.090832,-0.09155,1,0
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.040234,-0.090954,-0.18739,1,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.029719,-0.09189,-0.086409,1,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.023741,-0.092091,-0.12079,1,0
3,GO CILIUM MOVEMENT,0.007729,-0.093585,-0.12342,1,0
3,GO REGULATION OF AXONOGENESIS,0.0045306,-0.095234,-0.16083,1,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.019283,-0.095444,-0.095967,1,0
3,GO REGULATION OF SYSTEM PROCESS,0.0087944,-0.095897,-0.10776,1,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.027803,-0.097954,-0.1281,1,0
3,GO NEUROGENESIS,0.0051916,-0.098197,-0.10678,1,0
3,GO REGULATION OF ION TRANSPORT,0.016339,-0.099181,-0.10115,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.037747,-0.099835,-0.14012,1,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0085714,-0.10069,-0.12893,1,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.017137,-0.10191,-0.13733,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.012508,-0.10199,-0.10979,1,0
3,GO REGULATION OF BLOOD CIRCULATION,0.02843,-0.10223,-0.10144,1,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.015203,-0.10244,-0.13722,1,0
3,GO SPERMATID DIFFERENTIATION,0.0045306,-0.10263,-0.10175,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,0.038561,-0.10279,-0.10337,1,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.046579,-0.10349,-0.12881,1,0
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.033166,-0.10401,-0.090215,1,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0099891,-0.10402,-0.1036,1,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.018398,-0.10428,-0.096031,1,0
3,GO REGULATION OF RESPONSE TO FOOD,0.02068,-0.10476,-0.15461,1,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.0079323,-0.10532,-0.11413,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.024288,-0.10569,-0.16067,1,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.016339,-0.10578,-0.073218,1,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.020205,-0.10793,-0.14959,1,0
3,GO CHLORIDE TRANSPORT,0.02843,-0.1081,-0.10098,1,0
3,GO NEURON DEVELOPMENT,0.0019282,-0.10935,-0.13927,1,0
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.035393,-0.1105,-0.10841,1,0
3,GO NERVOUS SYSTEM PROCESS,0.02268,-0.11061,-0.088964,1,0
3,GO MITOCHONDRION LOCALIZATION,0.011047,-0.111,-0.13528,1,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.015953,-0.11176,-0.11274,1,0
3,GO RESPONSE TO ALKALOID,0.0069616,-0.11263,-0.13927,1,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0025817,-0.11275,-0.15445,1,0
3,GO NEURON DIFFERENTIATION,0.0017123,-0.11306,-0.13152,1,0
3,GO DEVELOPMENTAL CELL GROWTH,0.0018173,-0.11368,-0.14946,1,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0079323,-0.11564,-0.11591,1,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.013798,-0.11585,-0.11178,1,0
3,GO L AMINO ACID TRANSPORT,0.025414,-0.11595,-0.083014,1,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.026586,-0.11649,-0.13226,1,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0054795,-0.11657,-0.11237,1,0
3,GO POSTSYNAPSE ORGANIZATION,0.019283,-0.1173,-0.1371,1,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0083534,-0.11764,-0.097916,1,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.013465,-0.11789,-0.14331,1,0
3,GO IMPORT INTO CELL,0.030383,-0.11792,-0.10902,1,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.007729,-0.11792,-0.13339,1,0
3,GO CELL MATURATION,0.0034322,-0.11822,-0.12282,1,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.021165,-0.11827,-0.15009,1,0
3,GO SENSORY PERCEPTION OF PAIN,0.0066042,-0.11848,-0.15034,1,0
3,GO HEAD DEVELOPMENT,0.0085714,-0.11897,-0.10579,1,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.027188,-0.11983,-0.097826,1,0
3,GO CRANIAL NERVE DEVELOPMENT,0.016734,-0.12134,-0.15224,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.001228,-0.12254,-0.15739,1,0
3,GO REGULATION OF NEURON MIGRATION,0.029719,-0.12298,-0.16213,1,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.0017123,-0.12577,-0.14336,1,0
3,GO REGULATION OF HORMONE SECRETION,0.0059384,-0.12654,-0.12072,1,0
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.0046564,-0.12736,-0.13702,1,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.025994,-0.12872,-0.17699,1,0
3,GO SPERM CAPACITATION,0.0057817,-0.12876,-0.17173,1,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.02268,-0.12902,-0.10574,1,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.018398,-0.13365,-0.10337,1,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0015189,-0.13543,-0.16831,1,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.007729,-0.13617,-0.12665,1,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.001662,-0.13722,-0.16202,1,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.0066042,-0.13819,-0.15059,1,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0039469,-0.13857,-0.099727,1,0
3,GO DENDRITE MORPHOGENESIS,0.0032441,-0.13885,-0.15684,1,0
3,GO REPRODUCTIVE BEHAVIOR,0.011047,-0.13916,-0.17873,1,0
3,GO COCHLEA DEVELOPMENT,0.02268,-0.14188,-0.13174,1,0
3,GO REGULATION OF APPETITE,0.0050528,-0.14222,-0.14492,1,0
3,GO SODIUM ION TRANSPORT,0.0036303,-0.14244,-0.13494,1,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.015953,-0.14244,-0.10344,1,0
3,GO CARDIAC CONDUCTION,0.026586,-0.1425,-0.13616,1,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.041093,-0.14539,-0.16528,1,0
3,GO HORMONE TRANSPORT,0.0060989,-0.14561,-0.12694,1,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.012203,-0.14724,-0.14138,1,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.02268,-0.14853,-0.12125,1,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,9.389e-05,-0.15014,-0.1736,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00057693,-0.15063,-0.17306,1,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0013872,-0.15076,-0.15712,1,0
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0051916,-0.15077,-0.27933,1,0
3,GO NEUROMUSCULAR PROCESS,0.031748,-0.1521,-0.12544,1,0
3,GO DENDRITE SELF AVOIDANCE,0.035393,-0.15251,-0.20665,1,0
3,GO TELENCEPHALON DEVELOPMENT,0.00055855,-0.15453,-0.15846,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0054795,-0.15462,-0.1517,1,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0039469,-0.15538,-0.12453,1,0
3,GO CELLULAR RESPONSE TO PH,0.0079323,-0.15695,-0.14887,1,0
3,GO RESPONSE TO CALCIUM ION,0.0019282,-0.15715,-0.16034,1,0
3,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.024846,-0.15755,-0.12081,1,0
3,GO REGULATION OF INSULIN SECRETION,0.010506,-0.15835,-0.12371,1,0
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.018836,-0.15953,-0.13448,1,0
3,GO SKELETAL MUSCLE CONTRACTION,0.041093,-0.16008,-0.12994,1,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.016339,-0.16064,-0.19673,1,0
3,GO HINDBRAIN DEVELOPMENT,0.00045924,-0.16078,-0.18774,1,0
3,GO SPINAL CORD DEVELOPMENT,0.0075304,-0.1611,-0.14967,1,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.0024367,-0.16153,-0.18813,1,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00059588,-0.16178,-0.18943,1,0
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0049174,-0.16203,-0.14691,1,0
3,GO LONG TERM MEMORY,0.027803,-0.16264,-0.14751,1,0
3,GO MEMBRANE BIOGENESIS,0.026586,-0.16319,-0.17376,1,0
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.014486,-0.16364,-0.14368,1,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.020205,-0.1638,-0.17084,1,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0007696,-0.16469,-0.18438,1,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.03939,-0.16504,-0.17528,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0073363,-0.16656,-0.17685,1,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00092958,-0.16698,-0.18606,1,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00067758,-0.16845,-0.14353,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.015953,-0.1686,-0.17602,1,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0050528,-0.16934,-0.1956,1,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.0053338,-0.16997,-0.15463,1,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.011047,-0.17113,-0.15492,1,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.014138,-0.17256,-0.17203,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0021062,-0.17397,-0.19351,1,0
3,GO FOREBRAIN CELL MIGRATION,0.001191,-0.17409,-0.18936,1,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.0033369,-0.17569,-0.15495,1,0
3,GO DENDRITE DEVELOPMENT,0.0022992,-0.17664,-0.15363,1,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0017123,-0.17712,-0.23775,1,0
3,GO BEHAVIOR,0.00020448,-0.17764,-0.1679,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.041093,-0.17792,-0.12738,1,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0081404,-0.17893,-0.26457,1,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.029068,-0.17897,-0.24151,1,0
3,GO ANDROGEN METABOLIC PROCESS,0.0053338,-0.17953,-0.1834,1,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.001228,-0.17982,-0.15853,1,0
3,GO INSULIN SECRETION,0.013139,-0.17994,-0.13275,1,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0073363,-0.18115,-0.2833,1,0
3,GO MEMORY,0.00037661,-0.18141,-0.19692,1,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0066042,-0.18272,-0.22384,1,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.011904,-0.18306,-0.13291,1,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0019282,-0.18401,-0.17976,1,0
3,GO SYNAPSE ORGANIZATION,0.0071468,-0.18421,-0.15646,1,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.010245,-0.18536,-0.1464,1,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.014841,-0.18565,-0.18024,1,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.013798,-0.18626,-0.21273,1,0
3,GO AMINO ACID TRANSPORT,0.00063551,-0.1863,-0.19484,1,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00065623,-0.18694,-0.20233,1,0
3,GO NEURON PROJECTION EXTENSION,0.00052342,-0.18718,-0.19068,1,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.033894,-0.18877,-0.13608,1,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.019283,-0.18978,-0.13722,1,0
3,GO COGNITION,0.00049035,-0.18983,-0.17907,1,0
3,GO PROTEIN KINASE C SIGNALING,0.0036303,-0.19075,-0.22443,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0059384,-0.19171,-0.20571,1,0
3,GO DEVELOPMENTAL MATURATION,0.00013433,-0.19179,-0.17704,1,0
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00095906,-0.19204,-0.18145,1,0
3,GO RESPONSE TO ACETYLCHOLINE,0.036164,-0.19337,-0.21023,1,0
3,GO ASSOCIATIVE LEARNING,0.0060989,-0.19361,-0.18346,1,0
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.012508,-0.19449,-0.16691,1,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00059588,-0.19557,-0.18503,1,0
3,GO SIGNAL RELEASE,0.00052342,-0.19617,-0.15669,1,0
3,GO FOREBRAIN DEVELOPMENT,0.00063551,-0.19685,-0.153,1,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0013054,-0.19823,-0.26044,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00087311,-0.19835,-0.18292,1,0
3,GO RESPONSE TO FUNGUS,0.011904,-0.19839,-0.13179,1,0
3,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.023741,-0.19901,-0.16128,1,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0030654,-0.19929,-0.21448,1,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.00055855,-0.20079,-0.17795,1,0
3,GO RESPONSE TO COCAINE,0.0056288,-0.20091,-0.19284,1,0
3,GO PEPTIDE HORMONE SECRETION,0.0010528,-0.20102,-0.16905,1,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0025083,-0.20133,-0.18267,1,0
3,GO SECONDARY PALATE DEVELOPMENT,0.033894,-0.20167,-0.18748,1,0
3,GO STRIATUM DEVELOPMENT,0.0024367,-0.20188,-0.25804,1,0
3,GO POTASSIUM ION TRANSPORT,0.00041602,-0.20209,-0.19948,1,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.001191,-0.20252,-0.16292,1,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00032948,-0.20405,-0.20879,1,0
3,GO CALCIUM ION IMPORT,0.00059588,-0.20609,-0.20042,1,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0099891,-0.20677,-0.18301,1,0
3,GO RESPONSE TO AMYLOID BETA,0.007729,-0.20699,-0.16052,1,0
3,GO REGULATION OF FERTILIZATION,5.2139e-05,-0.20823,-0.25471,1,0
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0047853,-0.20868,-0.18962,1,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0071468,-0.20897,-0.22032,1,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0047853,-0.20968,-0.20469,1,0
3,GO REGULATION OF CILIUM MOVEMENT,9.3916e-06,-0.2099,-0.21218,1,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.029719,-0.21052,-0.19791,1,0
3,GO DENDRITIC TRANSPORT,0.042857,-0.21053,-0.14966,1,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.00050664,-0.21056,-0.22945,1,0
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.033166,-0.21069,-0.21072,1,0
3,GO RESPONSE TO PH,0.010245,-0.21215,-0.15996,1,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0001547,-0.2131,-0.20208,1,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.00012074,-0.21445,-0.22122,1,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00025131,-0.21458,-0.24171,1,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.022165,-0.2148,-0.27049,1,0
3,GO DIVALENT METAL ION EXPORT,0.014486,-0.21757,-0.20642,1,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.0046564,-0.21902,-0.22337,1,0
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0057817,-0.21968,-0.18433,1,0
3,GO EPITHELIAL CELL MATURATION,0.02268,-0.22031,-0.23844,1,0
3,GO CAMP METABOLIC PROCESS,0.0083534,-0.22123,-0.21166,1,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0011199,-0.2218,-0.21194,1,0
3,GO FACIAL NERVE MORPHOGENESIS,0.035393,-0.22369,-0.3049,1,0
3,GO COPULATION,0.029719,-0.22384,-0.14349,1,0
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0062634,-0.22386,-0.18611,1,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.023205,-0.22605,-0.20727,1,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.009256,-0.22758,-0.20974,1,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.033894,-0.22761,-0.12306,1,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0049174,-0.22798,-0.17934,1,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0036303,-0.22963,-0.22529,1,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.007729,-0.2301,-0.1993,1,0
3,GO REGULATION OF EXOCYTOSIS,0.0067808,-0.2305,-0.18635,1,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.011047,-0.23113,-0.18656,1,0
3,GO RESPONSE TO POTASSIUM ION,0.007729,-0.23341,-0.22375,1,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00055855,-0.2363,-0.21409,1,0
3,GO VESICLE DOCKING,8.4205e-05,-0.23716,-0.24263,1,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0019282,-0.23742,-0.22486,1,0
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0013054,-0.23778,-0.271,1,0
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.023741,-0.23892,-0.24508,1,0
3,GO LEARNING,0.0022992,-0.23991,-0.20875,1,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0023671,-0.24055,-0.23122,1,0
3,GO CELL MIGRATION IN HINDBRAIN,0.037747,-0.24139,-0.20775,1,0
3,GO INSEMINATION,0.019739,-0.24222,-0.21931,1,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00072223,-0.2434,-0.21141,1,0
3,GO LONG TERM SYNAPTIC DEPRESSION,0.0015653,-0.24434,-0.2488,1,0
3,GO PROTEIN PALMITOYLATION,0.014841,-0.24462,-0.16771,1,0
3,GO VITAMIN CATABOLIC PROCESS,0.0066042,-0.24538,-0.27401,1,0
3,GO SECRETORY GRANULE LOCALIZATION,0.016339,-0.24624,-0.2997,1,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00065623,-0.24627,-0.27358,1,0
3,GO REGULATION OF MEMBRANE POTENTIAL,0.00024286,-0.24929,-0.21908,1,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0085714,-0.25051,-0.21344,1,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.00017796,-0.25131,-0.2831,1,0
3,GO PRESYNAPSE ORGANIZATION,0.0025817,-0.25142,-0.24451,1,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.004408,-0.25188,-0.3059,1,0
3,GO INNER DYNEIN ARM ASSEMBLY,0.007729,-0.25304,-0.31442,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00045924,-0.25537,-0.2592,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.010773,-0.25632,-0.2122,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.014841,-0.25755,-0.16415,1,0
3,GO MICROTUBULE BUNDLE FORMATION,6.7596e-05,-0.25836,-0.26072,1,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.00014935,-0.25952,-0.24699,1,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.0085714,-0.26083,-0.26862,1,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.0090226,-0.26098,-0.20008,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.010245,-0.26284,-0.22312,1,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.0079323,-0.26396,-0.2524,1,0
3,GO RESPONSE TO CATECHOLAMINE,8.1192e-05,-0.26455,-0.24133,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.001986,-0.26558,-0.27538,1,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.011047,-0.2669,-0.29912,1,0
3,GO NOTCH RECEPTOR PROCESSING,0.029068,-0.26756,-0.25231,1,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00047456,-0.2678,-0.31012,1,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1776e-06,-0.26834,-0.27515,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.037747,-0.2691,-0.24403,1,0
3,GO ACROSOME REACTION,4.3218e-05,-0.26936,-0.26173,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.0090226,-0.26986,-0.1886,1,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.01282,-0.27012,-0.21274,1,0
3,GO TUBULIN DEACETYLATION,0.0075304,-0.27037,-0.22164,1,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.015574,-0.27044,-0.26467,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0050528,-0.27139,-0.28017,1,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.010506,-0.27243,-0.33,1,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0010206,-0.27272,-0.29532,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.011612,-0.27352,-0.28858,1,0
3,GO NEURON MATURATION,0.0028957,-0.27384,-0.21133,1,0
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.027803,-0.27422,-0.25893,1,0
3,GO PYRAMIDAL NEURON DIFFERENTIATION,0.016339,-0.27433,-0.28305,1,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.044685,-0.27534,-0.18456,1,0
3,GO NERVE DEVELOPMENT,4.8379e-05,-0.27625,-0.28177,1,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,4.8379e-05,-0.27743,-0.31003,1,0
3,GO MEMBRANE DEPOLARIZATION,0.00024286,-0.27841,-0.28153,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.7118e-05,-0.27999,-0.27541,1,0
3,GO OPTIC NERVE DEVELOPMENT,0.0056288,-0.2801,-0.29784,1,0
3,GO DIENCEPHALON DEVELOPMENT,0.00035231,-0.28144,-0.25935,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.019739,-0.2815,-0.26656,1,0
3,GO NEURON CELLULAR HOMEOSTASIS,0.0028957,-0.28163,-0.30722,1,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.00019753,-0.28186,-0.25031,1,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00084609,-0.28237,-0.32809,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,7.2754e-05,-0.28243,-0.31888,1,0
3,GO NEURON RECOGNITION,0.0010206,-0.2826,-0.28251,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.001986,-0.28346,-0.31835,1,0
3,GO ALANINE TRANSPORT,0.015574,-0.28426,-0.19018,1,0
3,GO SYNAPTIC SIGNALING,0.00010845,-0.28428,-0.2449,1,0
3,GO SKELETAL MUSCLE ADAPTATION,0.023205,-0.2861,-0.20642,1,0
3,GO LOCOMOTORY BEHAVIOR,6.2786e-05,-0.28698,-0.24705,1,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.016734,-0.28714,-0.24216,1,0
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00021167,-0.28806,-0.2765,1,0
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0012662,-0.2914,-0.24557,1,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.010245,-0.2916,-0.22982,1,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.022165,-0.29231,-0.196,1,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0010206,-0.29337,-0.24955,1,0
3,GO CAMP BIOSYNTHETIC PROCESS,0.0012662,-0.2953,-0.30729,1,0
3,GO RESPONSE TO DOPAMINE,1.5201e-05,-0.29538,-0.26579,1,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.03245,-0.29651,-0.22642,1,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00021167,-0.29653,-0.25612,1,0
3,GO SYNAPTIC VESICLE TRANSPORT,8.1192e-05,-0.29679,-0.27793,1,0
3,GO NEURON MIGRATION,0.00025131,-0.30015,-0.25331,1,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00050664,-0.3014,-0.31495,1,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.0001165,-0.30148,-0.25428,1,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.00014418,-0.30255,-0.23676,1,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00021909,-0.304,-0.36586,1,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0041716,-0.30539,-0.23943,1,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0056288,-0.30581,-0.33342,1,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0045306,-0.30917,-0.28263,1,0
3,GO NOREPINEPHRINE TRANSPORT,0.00038934,-0.3096,-0.28459,1,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.018398,-0.31125,-0.24068,1,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.013465,-0.31189,-0.25954,1,0
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00098941,-0.31355,-0.25829,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.020205,-0.31398,-0.25263,1,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.015953,-0.31731,-0.3371,1,0
3,GO PROTEIN POLYGLUTAMYLATION,0.00021167,-0.31768,-0.26319,1,0
3,GO RESPONSE TO MUSCLE STRETCH,0.00069957,-0.32156,-0.35437,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.0184e-05,-0.32164,-0.3321,1,0
3,GO REGULATION OF CILIUM BEAT FREQUENCY,3.6228e-06,-0.32295,-0.32551,1,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0006154,-0.32321,-0.30721,1,0
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00049035,-0.32348,-0.30899,1,0
3,GO DORSAL AORTA DEVELOPMENT,0.00013917,-0.32349,-0.34635,1,0
3,GO REGULATION OF AMINO ACID TRANSPORT,4.6597e-05,-0.32373,-0.31778,1,0
3,GO EXOCYTIC PROCESS,0.00045924,-0.3242,-0.25854,1,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0023671,-0.32647,-0.31336,1,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00057693,-0.32843,-0.2827,1,0
3,GO DORSAL VENTRAL PATTERN FORMATION,0.0010206,-0.32902,-0.25897,1,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,2.0033e-05,-0.32927,-0.29634,1,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0021062,-0.32945,-0.37048,1,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.00013433,-0.32965,-0.27546,1,0
3,GO REGULATION OF ACROSOME REACTION,0.00017186,-0.33065,-0.3544,1,0
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.017549,-0.3314,-0.23062,1,0
3,GO PROTEIN LOCALIZATION TO SYNAPSE,7.2754e-05,-0.33144,-0.33873,1,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.00036427,-0.33336,-0.32851,1,0
3,GO REFLEX,0.0031536,-0.33447,-0.36126,1,0
3,GO FOREBRAIN REGIONALIZATION,5.2139e-05,-0.33698,-0.40563,1,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0017123,-0.33964,-0.38641,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.4609e-05,-0.34302,-0.3324,1,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00084609,-0.34441,-0.29044,1,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00023468,-0.34589,-0.303,1,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0049174,-0.34668,-0.24218,1,0
3,GO HEART INDUCTION,0.0059384,-0.34827,-0.50427,1,0
3,GO ADULT BEHAVIOR,3.1888e-05,-0.34936,-0.28256,1,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0012662,-0.35005,-0.35624,1,0
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,5.4121e-05,-0.35141,-0.3575,1,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00069957,-0.35143,-0.36649,1,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,5.6174e-05,-0.35298,-0.27815,1,0
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00079435,-0.35411,-0.31864,1,0
3,GO MOTILE CILIUM ASSEMBLY,0.0075304,-0.3543,-0.22714,1,0
3,GO SYNAPTIC VESICLE RECYCLING,3.4421e-05,-0.35485,-0.33623,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.5759e-05,-0.35759,-0.3858,1,0
3,GO NEUROTRANSMITTER TRANSPORT,0.00050664,-0.35804,-0.3358,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00079435,-0.35875,-0.34561,1,0
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00095906,-0.35917,-0.27045,1,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00023468,-0.36027,-0.33522,1,0
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0087944,-0.36049,-0.39278,1,0
3,GO EXPLORATION BEHAVIOR,3.0689e-05,-0.36184,-0.42087,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00054072,-0.36369,-0.30493,1,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,4.0073e-05,-0.36419,-0.42261,1,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.00092958,-0.36423,-0.48135,1,0
3,GO RESPONSE TO DIETARY EXCESS,0.00014418,-0.36612,-0.41439,1,0
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0067808,-0.3694,-0.27375,1,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00047456,-0.37017,-0.37428,1,0
3,GO TRANSMISSION OF NERVE IMPULSE,1.7806e-05,-0.37042,-0.36173,1,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00010845,-0.37203,-0.34103,1,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,2.0033e-05,-0.37254,-0.46369,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00012964,-0.3743,-0.35031,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0046564,-0.37514,-0.33052,1,0
3,GO CATECHOLAMINE UPTAKE,0.0046564,-0.3765,-0.26627,1,0
3,GO REGULATION OF VESICLE FUSION,0.0081404,-0.38038,-0.28864,1,0
3,GO AXONEME ASSEMBLY,3.4421e-05,-0.38059,-0.34053,1,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00018427,-0.38707,-0.30568,1,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0017641,-0.38708,-0.39581,1,0
3,GO NEURONAL ACTION POTENTIAL,0.00045924,-0.38967,-0.35591,1,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00041602,-0.3907,-0.25895,1,0
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0066042,-0.39075,-0.32556,1,0
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0033369,-0.39131,-0.33119,1,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.8521e-05,-0.39358,-0.34535,1,0
3,GO ADRENAL GLAND DEVELOPMENT,2.9532e-05,-0.39755,-0.41861,1,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,4.6597e-05,-0.39824,-0.37402,1,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.00011241,-0.40016,-0.36987,1,0
3,GO PRESYNAPTIC ENDOCYTOSIS,0.00010845,-0.40049,-0.33681,1,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.00014418,-0.4078,-0.40737,1,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0094949,-0.41315,-0.31802,1,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00045924,-0.41444,-0.36095,1,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,3.0689e-05,-0.41953,-0.40572,1,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,6.2786e-05,-0.4209,-0.33205,1,0
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00036427,-0.42106,-0.36199,1,0
3,GO STARTLE RESPONSE,0.00038934,-0.42577,-0.38571,1,0
3,GO OLFACTORY LOBE DEVELOPMENT,8.1192e-05,-0.42704,-0.38208,1,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00026003,-0.43007,-0.41267,1,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.0037331,-0.43651,-0.31257,1,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00013433,-0.4381,-0.34884,1,0
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.00023468,-0.43879,-0.35356,1,0
3,GO NEUROTRANSMITTER SECRETION,0.00032948,-0.43911,-0.37555,1,0
3,GO PROTEIN LOCALIZATION TO AXON,0.0075304,-0.44697,-0.47077,1,0
3,GO FOREBRAIN GENERATION OF NEURONS,7.6603e-06,-0.45012,-0.42152,1,0
3,GO NEURON FATE COMMITMENT,0.00038934,-0.45028,-0.36083,1,0
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00031859,-0.45114,-0.38953,1,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,2.7343e-05,-0.45131,-0.38639,1,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,6.2367e-06,-0.45535,-0.39191,1,0
3,GO SPINAL CORD PATTERNING,0.00012512,-0.45579,-0.43945,1,0
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.7346e-05,-0.45657,-0.45603,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.007729,-0.45936,-0.37279,1,0
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00098941,-0.4602,-0.33944,1,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0027346,-0.46083,-0.56064,1,0
3,GO PLASMA MEMBRANE REPAIR,0.00026003,-0.46581,-0.54237,1,0
3,GO RESPONSE TO HISTAMINE,0.00098941,-0.46764,-0.48239,1,0
3,GO POSTSYNAPSE ASSEMBLY,0.00067758,-0.46966,-0.44734,1,0
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.0604e-05,-0.47011,-0.4904,1,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,1.349e-05,-0.47385,-0.48564,1,0
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.001872,-0.47411,-0.49251,1,0
3,GO DENSE CORE GRANULE TRANSPORT,0.00016595,-0.47581,-0.55274,1,0
3,GO DETECTION OF CALCIUM ION,4.8379e-05,-0.47921,-0.43945,1,0
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.011612,-0.4825,-0.26419,1,0
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00079435,-0.48431,-0.35538,1,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0024367,-0.48435,-0.36658,1,0
3,GO TELENCEPHALON REGIONALIZATION,0.0010859,-0.48665,-0.42479,1,0
3,GO DOPAMINE METABOLIC PROCESS,0.00012512,-0.48807,-0.39637,1,0
3,GO DETECTION OF TEMPERATURE STIMULUS,1.7806e-05,-0.48987,-0.4636,1,0
3,GO RESPONSE TO LITHIUM ION,0.00017186,-0.48996,-0.39199,1,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.0017123,-0.50115,-0.38758,1,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,5.7413e-06,-0.50173,-0.50214,1,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0010528,-0.50502,-0.52338,1,0
3,GO SEROTONIN METABOLIC PROCESS,0.00026003,-0.50596,-0.45855,1,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0066042,-0.50635,-0.36939,1,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0085714,-0.50641,-0.44739,1,0
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00012512,-0.51125,-0.4357,1,0
3,GO ADENOHYPOPHYSIS DEVELOPMENT,0.0022332,-0.51477,-0.45491,1,0
3,GO GLUTAMATE SECRETION,4.8612e-06,-0.52196,-0.46084,1,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.4609e-05,-0.53818,-0.42839,1,0
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00016023,-0.54078,-0.51434,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0039469,-0.54333,-0.52374,1,0
3,GO GLIAL CELL FATE COMMITMENT,0.0015653,-0.54891,-0.44384,1,0
3,GO NEURONAL ION CHANNEL CLUSTERING,4.1617e-05,-0.5493,-0.57272,1,0
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00081984,-0.55378,-0.43883,1,0
3,GO AMINE TRANSPORT,2.7343e-05,-0.55393,-0.45855,1,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,3.6228e-06,-0.55775,-0.49852,1,0
3,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.013139,-0.56015,-0.45307,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,2.0833e-05,-0.56533,-0.56128,1,0
3,GO SUBPALLIUM DEVELOPMENT,3.6228e-06,-0.56698,-0.52343,1,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,6.2367e-06,-0.56804,-0.63466,1,0
3,GO REGULATION OF GLUTAMATE SECRETION,1.2962e-05,-0.5753,-0.50058,1,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,4.3218e-05,-0.57795,-0.45474,1,0
3,GO HEART FIELD SPECIFICATION,0.00014935,-0.57834,-0.5204,1,0
3,GO SYNAPTIC MEMBRANE ADHESION,4.3218e-05,-0.58357,-0.54784,1,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.1663e-05,-0.58792,-0.49029,1,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00014418,-0.58816,-0.42427,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,5.0226e-05,-0.58871,-0.57588,1,0
3,GO PREPULSE INHIBITION,0.0042883,-0.59001,-0.44761,1,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0050528,-0.59077,-0.54935,1,0
3,GO DENDRITE EXTENSION,6.7728e-06,-0.59498,-0.50986,1,0
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.9532e-05,-0.59663,-0.61714,1,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,1.7806e-05,-0.59905,-0.52503,1,0
3,GO MONOAMINE TRANSPORT,4.8379e-05,-0.61289,-0.47027,1,0
3,GO CALCIUM ION IMPORT INTO CYTOSOL,1.5816e-05,-0.61804,-0.51151,1,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,2.6902e-06,-0.6223,-0.57905,1,0
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,5.7413e-06,-0.62336,-0.60923,1,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,2.3418e-05,-0.63175,-0.58078,1,0
3,GO REGULATION OF DENDRITE EXTENSION,6.4994e-06,-0.63373,-0.64816,1,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.0027346,-0.63626,-0.52974,1,0
3,GO GROWTH HORMONE SECRETION,6.8936e-07,-0.64066,-0.57578,1,0
3,GO RESPONSE TO INSECTICIDE,1.1493e-05,-0.64525,-0.54813,1,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,7.013e-05,-0.64945,-0.5738,1,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.5816e-05,-0.6665,-0.62052,1,0
3,GO SYNAPSE MATURATION,0.00019079,-0.66908,-0.57202,1,0
3,GO NEURON CELL CELL ADHESION,7.547e-05,-0.67433,-0.62589,1,0
3,GO SYNAPTIC VESICLE PRIMING,4.1617e-05,-0.68553,-0.57212,1,0
3,GO SYNAPTIC VESICLE DOCKING,0.00036427,-0.68598,-0.56704,1,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00057693,-0.69392,-0.47901,1,0
3,GO INNERVATION,1.7474e-06,-0.69684,-0.69318,1,0
3,GO MECHANOSENSORY BEHAVIOR,0.0022992,-0.70331,-0.57914,1,0
3,GO SYNAPTIC VESICLE MATURATION,2.5308e-05,-0.70729,-0.74317,1,0
3,GO DOPAMINE TRANSPORT,0.00029782,-0.71466,-0.53243,1,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,3.0576e-06,-0.71975,-0.65879,1,0
3,GO VOCALIZATION BEHAVIOR,5.8301e-05,-0.71991,-0.62233,1,0
3,GO GANGLION DEVELOPMENT,4.6623e-06,-0.72491,-0.72524,1,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,4.8612e-06,-0.72655,-0.70448,1,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,5.9841e-06,-0.76196,-0.64503,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,2.9532e-05,-0.76375,-0.67236,1,0
3,GO CATECHOLAMINE SECRETION,0.00022676,-0.76913,-0.56227,1,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.9263e-05,-0.79706,-0.78369,1,0
3,GO REGULATION OF DOPAMINE SECRETION,0.0013457,-0.81198,-0.59623,1,0
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0011199,-0.81523,-0.6184,1,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00023468,-0.88588,-0.67055,1,0
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,2.5308e-05,-0.92275,-0.7472,1,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.6015e-06,-0.94969,-0.79829,1,0
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.2862e-06,-0.99956,-0.98187,1,0
3,GO GABAERGIC NEURON DIFFERENTIATION,4.6597e-05,-1.0677,-0.77311,1,0
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.012203,-1.0924,-0.83341,1,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,3.4728e-06,-1.3246,-1.241,1,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,6.0504e-05,-1.4303,-1.0716,1,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.076492,0.51854,0.4427,0,1
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.05824,0.4351,0.33785,0,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.077957,0.36104,0.31274,0,1
3,GO LIPID DROPLET FORMATION,0.13583,0.33649,0.20966,0,1
3,GO RESPONSE TO HYDROPEROXIDE,0.072231,0.32846,0.21761,0,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.099158,0.32508,0.12298,0,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0695,0.32157,0.14341,0,1
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.073629,0.31177,0.21178,0,1
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.04854,0.30058,0.16851,0,1
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.072231,0.29623,0.2157,0,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.055956,0.29077,0.37322,0,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.049546,0.28097,0.15917,0,1
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.084046,0.27972,0.22496,0,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.060602,0.27885,0.24118,0,1
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.061812,0.27104,0.13316,0,1
3,GO LATERAL MESODERM DEVELOPMENT,0.71658,0.26822,0.065851,0,1
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.10845,0.2557,0.18292,0,1
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.1028,0.24333,0.13809,0,1
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.057089,0.24267,0.15778,0,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.10654,0.24107,0.1504,0,1
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.052669,0.2334,0.1973,0,1
3,GO HEART VALVE FORMATION,0.13583,0.22788,0.18922,0,1
3,GO SOMATIC STEM CELL DIVISION,0.17934,0.22672,0.17662,0,1
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.15773,0.22586,0.13958,0,1
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.049546,0.22297,0.12435,0,1
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.44924,0.22167,0.057087,0,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.057089,0.21849,0.090822,0,1
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.28785,0.21838,0.11702,0,1
3,GO REGULATION OF NEURON MATURATION,0.04854,0.21638,0.20985,0,1
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.17653,0.2105,0.1462,0,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.093897,0.20802,0.15451,0,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.057089,0.20567,0.11243,0,1
3,GO EPITHELIAL CELL MORPHOGENESIS,0.095625,0.20394,0.18219,0,1
3,GO LEYDIG CELL DIFFERENTIATION,0.97557,0.2001,-0.075825,0,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.1313,0.19994,0.12627,0,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.05161,0.19981,0.13175,0,1
3,GO LIPOXYGENASE PATHWAY,0.10096,0.19901,0.18988,0,1
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.097379,0.19812,0.1129,0,1
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.068167,0.19752,0.14163,0,1
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.082489,0.19724,0.12313,0,1
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.053746,0.19604,0.1508,0,1
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.11636,0.19376,0.14205,0,1
3,GO PIGMENT CELL DIFFERENTIATION,0.057089,0.19319,0.097604,0,1
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.18508,0.19236,0.043618,0,1
3,GO VIRAL LATENCY,0.13355,0.19147,0.098042,0,1
3,GO HISTAMINE SECRETION,0.053746,0.19119,0.18718,0,1
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.05161,0.18685,0.29973,0,1
3,GO KETONE BODY METABOLIC PROCESS,0.11636,0.18683,0.1322,0,1
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.055956,0.18575,0.16665,0,1
3,GO GENITALIA MORPHOGENESIS,0.066855,0.18364,0.16524,0,1
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.21905,0.18192,0.076712,0,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.16032,0.18182,0.086555,0,1
3,GO HISTAMINE TRANSPORT,0.15517,0.1811,0.11734,0,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.11841,0.1774,0.090264,0,1
3,GO EMBRYO IMPLANTATION,0.060602,0.17722,0.12683,0,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.12908,0.17583,0.13829,0,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.093897,0.17551,0.096509,0,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.12473,0.1751,0.11231,0,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.14285,0.17504,0.21802,0,1
3,GO ARGININE METABOLIC PROCESS,0.085627,0.17404,0.16935,0,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.079444,0.17372,0.085207,0,1
3,GO CELL AGGREGATION,0.05824,0.1722,0.14802,0,1
3,GO MAST CELL ACTIVATION,0.061812,0.171,0.12634,0,1
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.31232,0.16972,0.12086,0,1
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.064293,0.16674,0.1256,0,1
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.05161,0.16655,0.15409,0,1
3,GO CERAMIDE TRANSPORT,0.2,0.16584,0.10881,0,1
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.088862,0.16556,0.18424,0,1
3,GO NEGATIVE REGULATION OF CELL AGING,0.29992,0.16551,0.1008,0,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.054842,0.16233,0.082445,0,1
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.063042,0.16197,0.19494,0,1
3,GO REGULATION OF EXIT FROM MITOSIS,0.04854,0.16062,0.10231,0,1
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.34256,0.16014,0.074279,0,1
3,GO COLLECTING DUCT DEVELOPMENT,0.10096,0.16001,0.13653,0,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.095625,0.15997,0.11328,0,1
3,GO DEVELOPMENTAL PIGMENTATION,0.14048,0.15818,0.06676,0,1
3,GO PERICARDIUM DEVELOPMENT,0.059411,0.1579,0.16733,0,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.070855,0.15653,0.15171,0,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.17934,0.15469,0.082429,0,1
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.088862,0.15352,0.092231,0,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.093897,0.15307,0.12882,0,1
3,GO MAST CELL MEDIATED IMMUNITY,0.12049,0.15239,0.11772,0,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.10096,0.15173,0.13767,0,1
3,GO GOLGI TO VACUOLE TRANSPORT,0.34256,0.15007,0.060904,0,1
3,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.055956,0.14923,0.16068,0,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.088862,0.14815,0.14231,0,1
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.075049,0.14753,0.16627,0,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.080955,0.1449,0.09778,0,1
3,GO MRNA METHYLATION,0.0695,0.14483,0.12837,0,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.070855,0.1439,0.14174,0,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.075049,0.14346,0.097057,0,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.19393,0.14053,0.070855,0,1
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.21256,0.14033,0.066417,0,1
3,GO HAIR CELL DIFFERENTIATION,0.079444,0.13999,0.1138,0,1
3,GO HISTONE MONOUBIQUITINATION,0.065563,0.13944,0.09156,0,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.5726,0.13933,0.018461,0,1
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.11039,0.13847,0.071765,0,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.082489,0.13814,0.077387,0,1
3,GO PLASMA MEMBRANE FUSION,0.13583,0.13713,0.098939,0,1
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.084046,0.13672,0.077145,0,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.1028,0.13616,0.10926,0,1
3,GO MITOTIC CYTOKINETIC PROCESS,0.14285,0.13486,0.094337,0,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.11235,0.13486,0.073338,0,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.080955,0.13458,0.12348,0,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.054842,0.13442,0.083947,0,1
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.11841,0.13418,0.083499,0,1
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.092194,0.13364,0.08355,0,1
3,GO PANCREATIC JUICE SECRETION,0.29992,0.13319,0.081989,0,1
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.14769,0.13217,0.08249,0,1
3,GO GDP METABOLIC PROCESS,0.24288,0.13079,0.10132,0,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.079444,0.13074,0.07637,0,1
3,GO REGULATION OF WATER LOSS VIA SKIN,0.11841,0.1307,0.17792,0,1
3,GO REGULATION OF SPINDLE ORGANIZATION,0.063042,0.12998,0.083354,0,1
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.073629,0.1291,0.13823,0,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.21905,0.12806,0.049426,0,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.099158,0.12671,0.069123,0,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.17934,0.12629,0.12896,0,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.079444,0.12583,0.10925,0,1
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.088862,0.12531,0.14107,0,1
3,GO RETINAL CONE CELL DIFFERENTIATION,0.59664,0.12482,0.080864,0,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.082489,0.12334,0.099562,0,1
3,GO RESPONSE TO VITAMIN A,0.14048,0.12268,0.099032,0,1
3,GO CELLULAR RESPONSE TO X RAY,0.088862,0.12252,0.18138,0,1
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.073629,0.12139,0.061902,0,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.15773,0.12137,0.072318,0,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.04854,0.1209,0.099132,0,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.60883,0.12081,-0.012764,0,1
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.13583,0.1196,0.082989,0,1
3,GO MAMMARY GLAND DEVELOPMENT,0.11235,0.11927,0.10056,0,1
3,GO RENAL ABSORPTION,0.29992,0.11918,0.11576,0,1
3,GO NEPHRON DEVELOPMENT,0.084046,0.1177,0.11855,0,1
3,GO CELLULAR PIGMENTATION,0.063042,0.11644,0.099707,0,1
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.13583,0.11481,0.090736,0,1
3,GO VIRION ASSEMBLY,0.17374,0.11481,0.053766,0,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.075049,0.11196,0.1083,0,1
3,GO AUTOPHAGIC CELL DEATH,0.48131,0.11038,0.03309,0,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.54903,0.11005,0.025219,0,1
3,GO NEURAL TUBE DEVELOPMENT,0.063042,0.11004,0.12345,0,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.095625,0.10954,0.14625,0,1
3,GO SPLEEN DEVELOPMENT,0.088862,0.10899,0.11594,0,1
3,GO REGULATION OF GASTRULATION,0.21905,0.10854,0.079461,0,1
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.054842,0.10839,0.075668,0,1
3,GO TRANSCYTOSIS,0.085627,0.10804,0.096796,0,1
3,GO BODY MORPHOGENESIS,0.9686,0.10764,-0.0088706,0,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.088862,0.10753,0.094676,0,1
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.13355,0.10583,0.08402,0,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.077957,0.10578,0.079365,0,1
3,GO INTERLEUKIN 12 PRODUCTION,0.053746,0.10427,0.10876,0,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.059411,0.10359,0.07857,0,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.12259,0.10279,0.10391,0,1
3,GO METHIONINE METABOLIC PROCESS,0.17099,0.102,0.058311,0,1
3,GO HISTONE H2A UBIQUITINATION,0.16032,0.10155,0.066811,0,1
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.22235,0.10154,0.077226,0,1
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.1028,0.10138,0.083988,0,1
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.088862,0.10015,0.083604,0,1
3,GO PROTEIN MONOUBIQUITINATION,0.060602,0.098914,0.066031,0,1
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.050569,0.098371,0.092757,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.085627,0.097706,0.084267,0,1
3,GO PIGMENTATION,0.188,0.097502,0.056976,0,1
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.78962,0.096537,0.011197,0,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.17374,0.095002,0.059714,0,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.12689,0.094591,0.091684,0,1
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.11841,0.093413,0.088175,0,1
3,GO OSTEOBLAST PROLIFERATION,0.14285,0.093068,0.12183,0,1
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.12689,0.092703,0.13129,0,1
3,GO DNA REPLICATION INITIATION,0.13355,0.092476,0.082918,0,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.63978,0.092287,0.034212,0,1
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.1028,0.091312,0.13107,0,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.60883,0.090465,0.051403,0,1
3,GO GLOMERULUS DEVELOPMENT,0.12689,0.090139,0.16513,0,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.17374,0.089962,0.062916,0,1
3,GO RESPONSE TO ACTIVITY,0.0695,0.089392,0.08218,0,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.62113,0.087567,0.038725,0,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.24288,0.087069,0.064318,0,1
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.24643,0.086725,0.066839,0,1
3,GO GENITALIA DEVELOPMENT,0.099158,0.085775,0.075034,0,1
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.10096,0.085706,0.084091,0,1
3,GO RNA SURVEILLANCE,0.070855,0.0839,0.10901,0,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.099158,0.08347,0.0853,0,1
3,GO MITOTIC SPINDLE ASSEMBLY,0.11434,0.082676,0.066856,0,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.093897,0.082229,0.057245,0,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.13355,0.082109,0.064882,0,1
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.65234,0.080931,0.017499,0,1
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.068167,0.079551,0.075541,0,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.188,0.079495,0.052328,0,1
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.11636,0.079117,0.09281,0,1
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.14048,0.079093,0.065798,0,1
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.43367,0.07855,0.027837,0,1
3,GO GLUCOSE METABOLIC PROCESS,0.049546,0.077599,0.048049,0,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.12473,0.075028,0.10346,0,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.090515,0.074584,0.071366,0,1
3,GO PHOSPHOLIPID TRANSPORT,0.27227,0.07446,0.035099,0,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.10845,0.074418,0.1164,0,1
3,GO ADHERENS JUNCTION ORGANIZATION,0.32506,0.073602,0.03892,0,1
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.17934,0.073177,0.093608,0,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.50337,0.07296,0.026552,0,1
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.068167,0.072033,0.075471,0,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.34702,0.071632,0.030942,0,1
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.64605,0.071068,0.011445,0,1
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.12908,0.070615,0.054605,0,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.095625,0.070512,0.11531,0,1
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.13814,0.070307,0.098118,0,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.50896,0.069351,0.0873,0,1
3,GO O GLYCAN PROCESSING,0.31232,0.06909,0.036689,0,1
3,GO PROTEIN INSERTION INTO MEMBRANE,0.30815,0.068981,0.031709,0,1
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.085627,0.068518,0.067519,0,1
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.22905,0.067564,0.058309,0,1
3,GO LIPID PHOSPHORYLATION,0.082489,0.066729,0.05841,0,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.28785,0.065404,0.06355,0,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.26098,0.065055,0.025599,0,1
3,GO GLYCOSYLATION,0.39371,0.063382,-0.005074,0,1
3,GO CELLULAR RESPONSE TO RADIATION,0.055956,0.062614,0.086124,0,1
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.69707,0.061722,0.012705,0,1
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.26471,0.060694,0.021496,0,1
3,GO G2 DNA DAMAGE CHECKPOINT,0.15773,0.059935,0.082187,0,1
3,GO CERAMIDE METABOLIC PROCESS,0.21256,0.059721,0.026578,0,1
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.43367,0.059544,0.061181,0,1
3,GO RECOMBINATIONAL REPAIR,0.097379,0.059424,0.07753,0,1
3,GO PROTEIN POLYMERIZATION,0.11039,0.05864,0.045393,0,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.26847,0.058502,0.021186,0,1
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.079444,0.057372,0.040873,0,1
3,GO EPITHELIAL CELL DIFFERENTIATION,0.24643,0.056532,0.07541,0,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.12689,0.056524,0.038078,0,1
3,GO REGULATION OF GTPASE ACTIVITY,0.092194,0.055906,0.058702,0,1
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.4545,0.055328,0.064995,0,1
3,GO LACTATION,0.060602,0.054089,0.10205,0,1
3,GO ARTERY MORPHOGENESIS,0.22905,0.053948,0.085609,0,1
3,GO NUCLEOSOME ORGANIZATION,0.40349,0.05388,0.045516,0,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.21905,0.053497,0.05327,0,1
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.082489,0.053195,0.060995,0,1
3,GO SPHINGOLIPID METABOLIC PROCESS,0.41341,0.05315,0.0088447,0,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.24288,0.052154,0.024749,0,1
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.50337,0.051655,0.024874,0,1
3,GO REGULATION OF MITOTIC CELL CYCLE,0.082489,0.051548,0.054792,0,1
3,GO HISTONE H3 K9 MODIFICATION,0.12049,0.05149,0.069702,0,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.188,0.051231,0.066854,0,1
3,GO PROTEIN AUTOUBIQUITINATION,0.15773,0.050581,0.039746,0,1
3,GO REGULATION OF NUCLEAR DIVISION,0.15773,0.049791,0.047505,0,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.58456,0.049513,0.0082399,0,1
3,GO MITOTIC CELL CYCLE,0.063042,0.049151,0.055821,0,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.065563,0.048844,0.074669,0,1
3,GO CENTRIOLE CENTRIOLE COHESION,0.77618,0.048754,0.015262,0,1
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.057089,0.047949,0.066243,0,1
3,GO MITOTIC SPINDLE ORGANIZATION,0.4598,0.04702,0.030973,0,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.32077,0.046656,0.030865,0,1
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.066855,0.046332,0.061176,0,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.38888,0.045936,0.040095,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.12049,0.04556,0.061274,0,1
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.21256,0.044901,0.031246,0,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.13355,0.043571,0.033044,0,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.36991,0.042686,0.016346,0,1
3,GO INTRACELLULAR TRANSPORT,0.092194,0.042005,0.037352,0,1
3,GO REGULATION OF CELL CYCLE PROCESS,0.04854,0.03906,0.059534,0,1
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.15773,0.039028,0.031976,0,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.25001,0.03854,0.051025,0,1
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.21905,0.03826,0.032762,0,1
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.15015,0.037673,0.030446,0,1
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.29184,0.037287,0.027541,0,1
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.1313,0.036837,0.028764,0,1
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.10845,0.036351,0.042738,0,1
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.4598,0.0359,0.021951,0,1
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.42347,0.032914,0.02443,0,1
3,GO REGULATION OF MACROAUTOPHAGY,0.12908,0.032126,0.037172,0,1
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.087232,0.032057,0.05545,0,1
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.12689,0.03058,0.053379,0,1
3,GO CHROMATIN ORGANIZATION,0.077957,0.0298,0.043052,0,1
3,GO CELL CYCLE PROCESS,0.059411,0.027887,0.048902,0,1
3,GO CELL CYCLE,0.11039,0.027347,0.038396,0,1
3,GO CELL JUNCTION ASSEMBLY,0.80989,0.025376,0.0072934,0,1
3,GO REGULATION OF CELL CYCLE,0.34702,0.024321,0.030868,0,1
3,GO MYOFIBRIL ASSEMBLY,0.34256,0.023967,0.040897,0,1
3,GO CELL DIVISION,0.15264,0.023158,0.057702,0,1
3,GO SPINDLE ORGANIZATION,0.48131,0.018041,0.024727,0,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0060989,0.39196,0.34619,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.050569,0.39146,0.18448,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00022676,0.3868,0.37012,0,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.05161,0.35217,0.2133,0,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.13355,0.33992,0.18597,0,0
3,GO BLEB ASSEMBLY,0.12689,0.33974,0.19859,0,0
3,GO INTERLEUKIN 13 PRODUCTION,0.001986,0.32514,0.35791,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.099158,0.32015,0.23488,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.013798,0.31389,0.23237,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.077957,0.31374,0.15279,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022332,0.31212,0.25561,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.0054795,0.30486,0.24629,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.0083534,0.30363,0.18841,0,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.1028,0.30145,0.17926,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.04854,0.30114,0.21181,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.57857,0.29797,0.034416,0,0
3,GO NADPH REGENERATION,0.0021689,0.28635,0.25457,0,0
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.070855,0.28096,0.21601,0,0
3,GO GERMINAL CENTER FORMATION,0.093897,0.28057,0.12898,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.092194,0.27839,0.25672,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.052669,0.2783,0.16494,0,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.092194,0.27371,0.19139,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.033894,0.27298,0.24783,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0028957,0.27225,0.18841,0,0
3,GO NEUROBLAST DIVISION,0.0017641,0.26468,0.3465,0,0
3,GO REGULATION OF TOLERANCE INDUCTION,0.061812,0.26118,0.15672,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.23937,0.2577,0.10686,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.27611,0.24414,0.064834,0,0
3,GO REPLICATIVE SENESCENCE,0.24288,0.24128,0.099938,0,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.24288,0.23828,0.066677,0,0
3,GO MEMBRANE RAFT ASSEMBLY,0.47049,0.23692,0.012974,0,0
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.084046,0.23499,0.1641,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.031059,0.23369,0.18083,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.17099,0.2316,0.1155,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.14048,0.22942,0.10616,0,0
3,GO TRACHEA DEVELOPMENT,0.026586,0.22787,0.19285,0,0
3,GO BILE ACID AND BILE SALT TRANSPORT,0.075049,0.22297,0.1031,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.059411,0.21984,0.20745,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.065563,0.21867,0.19108,0,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.21905,0.21861,0.14138,0,0
3,GO REGULATION OF ANOIKIS,0.12259,0.21851,0.13032,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.0038387,0.2183,0.23292,0,0
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.29586,0.21596,0.12111,0,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.063042,0.2142,0.20474,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.12259,0.21357,0.15373,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.059411,0.2133,0.14963,0,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.097379,0.21317,0.15968,0,0
3,GO RESPONSE TO UV B,0.20937,0.21293,0.12408,0,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.1028,0.21225,0.13597,0,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.099158,0.21155,0.14991,0,0
3,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.50896,0.21042,0.050278,0,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.084046,0.20974,0.12641,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.087232,0.20819,0.14165,0,0
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.14048,0.20656,0.15174,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.063042,0.20628,0.1509,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.11636,0.20626,0.16532,0,0
3,GO LIPID IMPORT INTO CELL,0.11434,0.20551,0.12182,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.16032,0.20521,0.10164,0,0
3,GO DETECTION OF OTHER ORGANISM,0.20309,0.20472,0.060443,0,0
3,GO GAP JUNCTION ASSEMBLY,0.36991,0.20448,0.066647,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.13355,0.20395,0.22646,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.075049,0.20182,0.16141,0,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.21256,0.20147,0.10552,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.11235,0.20133,0.16119,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0695,0.20119,0.10224,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.40349,0.20094,0.069965,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.16032,0.19993,0.22693,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.080955,0.19808,0.12942,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.15517,0.19668,0.081786,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.065563,0.19654,0.12072,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.088862,0.19479,0.12192,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.1028,0.19244,0.178,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.12473,0.1924,0.14951,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.35607,0.19149,0.048927,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.080955,0.19109,0.11879,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.001986,0.19051,0.18065,0,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.59664,0.19032,0.083642,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.065563,0.1896,0.16444,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.070855,0.18908,0.14709,0,0
3,GO CYTIDINE TO URIDINE EDITING,0.061812,0.18903,0.31052,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.10096,0.18848,0.17151,0,0
3,GO EPOXYGENASE P450 PATHWAY,0.061812,0.18786,0.15481,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.03245,0.18784,0.15501,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.10096,0.18711,0.15937,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.54903,0.18702,0.022063,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.32506,0.18519,0.10919,0,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0695,0.18487,0.17996,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.15517,0.18416,0.079552,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.055956,0.18337,0.15871,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.031059,0.17946,0.13126,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0036303,0.1791,0.23964,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.20621,0.17898,0.10209,0,0
3,GO POSITIVE REGULATION OF WOUND HEALING,0.072231,0.1789,0.15682,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.36526,0.17875,0.02479,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0695,0.1773,0.1863,0,0
3,GO MINERALOCORTICOID METABOLIC PROCESS,0.38888,0.17713,0.068642,0,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.085627,0.17672,0.12201,0,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.059411,0.17541,0.12466,0,0
3,GO INTERLEUKIN 5 PRODUCTION,0.11434,0.17493,0.16731,0,0
3,GO ZYMOGEN ACTIVATION,0.12473,0.17347,0.18151,0,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.12259,0.17281,0.21812,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.17374,0.17121,0.17414,0,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.065563,0.17062,0.10775,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16032,0.17057,0.13735,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.16294,0.1699,0.11235,0,0
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.21256,0.16986,0.14176,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.15264,0.1694,0.13898,0,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.14526,0.16906,0.081651,0,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.66501,0.16829,-0.00050559,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.50337,0.16721,0.043226,0,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.13355,0.16705,0.12816,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.15517,0.16669,0.10368,0,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.13583,0.16663,0.086763,0,0
3,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.090515,0.16636,0.20873,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.061812,0.16568,0.14709,0,0
3,GO BONE GROWTH,0.072231,0.1651,0.16245,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.2839,0.16501,0.094752,0,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.097379,0.16491,0.080095,0,0
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.055956,0.16487,0.13761,0,0
3,GO SKIN MORPHOGENESIS,0.38408,0.16451,0.086945,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.44924,0.16438,0.11756,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.11039,0.16435,0.089078,0,0
3,GO REGULATION OF PLATELET AGGREGATION,0.97557,0.1641,-0.0058543,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.070855,0.16396,0.15505,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.54903,0.16366,0.025659,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.079444,0.16304,0.13689,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0695,0.16212,0.13167,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.40349,0.16203,0.060027,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.072231,0.16119,0.13587,0,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.21579,0.16119,0.14094,0,0
3,GO NAD METABOLIC PROCESS,0.10845,0.16039,0.12996,0,0
3,GO ASTROCYTE DEVELOPMENT,0.33812,0.16033,0.070071,0,0
3,GO GRANULOCYTE CHEMOTAXIS,0.054842,0.1599,0.085825,0,0
3,GO MYELIN ASSEMBLY,0.16559,0.15982,0.11409,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.079444,0.15829,0.12427,0,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.10654,0.15829,0.14206,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.31653,0.15783,0.087136,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.082489,0.15621,0.12815,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.13583,0.15581,0.11506,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.32077,0.15557,0.14452,0,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.085627,0.15545,0.1895,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.10654,0.15496,0.15144,0,0
3,GO GONADOTROPIN SECRETION,0.23245,0.15449,0.092773,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.16032,0.15443,0.075873,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.17934,0.15367,0.19013,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0028957,0.15321,0.20756,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.13583,0.15261,0.13299,0,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.29586,0.15223,0.11109,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.38408,0.15205,0.099307,0,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.049546,0.15186,0.11553,0,0
3,GO MALE SEX DETERMINATION,0.12049,0.15167,0.13342,0,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.67776,0.15166,-0.00069196,0,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.052669,0.15158,0.10575,0,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.32938,0.15115,0.074441,0,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.13355,0.15107,0.1231,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0042883,0.15077,0.14092,0,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.10465,0.15066,0.12599,0,0
3,GO MIDGUT DEVELOPMENT,0.60272,0.15043,0.098326,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.11039,0.14993,0.10204,0,0
3,GO ASYMMETRIC CELL DIVISION,0.066855,0.1496,0.14195,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.076492,0.14909,0.1536,0,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.084046,0.14902,0.07251,0,0
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.26471,0.14901,0.070509,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.092194,0.14893,0.080321,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.15517,0.14869,0.075382,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.090515,0.14862,0.10481,0,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.2,0.14846,0.082641,0,0
3,GO RENAL FILTRATION,0.20309,0.14811,0.11824,0,0
3,GO RESPONSE TO THYROID HORMONE,0.082489,0.14797,0.14293,0,0
3,GO PROTEIN AUTOPROCESSING,0.36064,0.14778,0.040286,0,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.1313,0.1472,0.138,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.070855,0.14712,0.14137,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.045624,0.14632,0.19152,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.13355,0.14626,0.14875,0,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.16828,0.1459,0.10664,0,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.095625,0.14577,0.14198,0,0
3,GO TRACHEA MORPHOGENESIS,0.26098,0.14488,0.049606,0,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.22568,0.14428,0.089502,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.2839,0.14406,0.052526,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.063042,0.14405,0.097329,0,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.11039,0.14268,0.095797,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.12049,0.14171,0.098463,0,0
3,GO FILOPODIUM ASSEMBLY,0.19695,0.14163,0.07474,0,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.18508,0.14111,0.10037,0,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.099158,0.1411,0.14859,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.32077,0.1405,0.041122,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.092194,0.14021,0.10701,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.15773,0.13973,0.084943,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.12473,0.13914,0.17555,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0040578,0.13911,0.16199,0,0
3,GO ANOIKIS,0.19393,0.13864,0.08583,0,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.44924,0.13849,0.061648,0,0
3,GO NUCLEOTIDE SALVAGE,0.38408,0.13847,0.096841,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.11636,0.13829,0.10244,0,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.077957,0.13818,0.10586,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.013798,0.13782,0.17517,0,0
3,GO REGULATION OF GTP BINDING,0.092194,0.13777,0.15204,0,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.19695,0.13776,0.060715,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.059411,0.13776,0.11406,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.23245,0.13774,0.11829,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.53167,0.13768,0.037367,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.18508,0.13761,0.07405,0,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.22235,0.13738,0.078969,0,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.29586,0.13727,0.08713,0,0
3,GO RESPONSE TO UV C,0.1028,0.13699,0.14542,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.50896,0.13607,0.095289,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.14526,0.13592,0.10011,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.11039,0.13587,0.10573,0,0
3,GO GRANULOCYTE MIGRATION,0.088862,0.13552,0.074519,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.14048,0.13537,0.11013,0,0
3,GO MITOCHONDRIAL TRNA PROCESSING,0.049546,0.13522,0.14745,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.061812,0.1351,0.1135,0,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.14048,0.13494,0.064477,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.55487,0.13482,0.041488,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.66501,0.13437,-0.00039267,0,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.25001,0.13433,0.0094464,0,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.064293,0.13427,0.13013,0,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.20621,0.13391,0.12281,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.29586,0.13388,0.086432,0,0
3,GO ANIMAL ORGAN REGENERATION,0.060602,0.13374,0.092932,0,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.26098,0.13364,0.070871,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.073629,0.13357,0.14207,0,0
3,GO PLATELET ACTIVATION,0.057089,0.13345,0.086008,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.085627,0.13318,0.13489,0,0
3,GO CYTOLYSIS,0.46512,0.13231,0.050649,0,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.27611,0.1322,0.044988,0,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.22235,0.13206,0.14017,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.2,0.13205,0.075108,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.070855,0.13204,0.071719,0,0
3,GO POSITIVE REGULATION OF CELL SIZE,0.064293,0.13199,0.16831,0,0
3,GO ACTIN CROSSLINK FORMATION,0.47588,0.13198,0.025213,0,0
3,GO CELLULAR RESPONSE TO DSRNA,0.11636,0.13163,0.084397,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.98255,0.13139,0.074577,0,0
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.64605,0.13123,0.060634,0,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.11235,0.12996,0.068598,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.16828,0.12975,0.15559,0,0
3,GO LYMPHANGIOGENESIS,0.11636,0.12965,0.11565,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.080955,0.12949,0.087521,0,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.13355,0.12935,0.070897,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.079444,0.12919,0.10975,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.04854,0.12901,0.1769,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.35607,0.12893,0.069838,0,0
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.068167,0.12848,0.09973,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0097392,0.12848,0.14773,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.18508,0.12843,0.080965,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.049546,0.1283,0.1424,0,0
3,GO LEUKOCYTE AGGREGATION,0.39858,0.12819,0.093561,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.17653,0.12816,0.077301,0,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0037331,0.12779,0.18489,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.061812,0.12746,0.10151,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.18508,0.12726,0.1183,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.42855,0.12722,0.049742,0,0
3,GO RESPONSE TO HYPEROXIA,0.4598,0.12697,0.035696,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.12473,0.12666,0.13723,0,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.27611,0.12664,0.20489,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.057089,0.12644,0.33517,0,0
3,GO NEGATIVE REGULATION OF CELL SIZE,0.063042,0.12625,0.10772,0,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.092194,0.12577,0.13315,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.13355,0.125,0.09356,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0695,0.12482,0.12083,0,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.05161,0.1245,0.16765,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.066855,0.12434,0.12008,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.5726,0.1229,0.057672,0,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.076492,0.1225,0.12515,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.05824,0.12242,0.068775,0,0
3,GO PENILE ERECTION,0.44924,0.12159,0.035569,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.065563,0.12157,0.084914,0,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.33812,0.12105,0.096291,0,0
3,GO STRESS FIBER ASSEMBLY,0.05824,0.12101,0.12194,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.30402,0.12061,0.074164,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.070855,0.12041,0.11173,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.16828,0.12038,0.073312,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.045624,0.12022,0.087673,0,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.60883,0.12005,0.040613,0,0
3,GO PROTEIN MATURATION,0.10465,0.11988,0.060044,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.62732,0.1196,-0.002702,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.20309,0.11942,0.1188,0,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.27999,0.11925,0.054583,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.35607,0.11917,0.065899,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.15773,0.11916,0.050253,0,0
3,GO T CELL MIGRATION,0.34256,0.11896,0.05706,0,0
3,GO CARNITINE METABOLIC PROCESS,0.25001,0.11888,0.059096,0,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.34256,0.11884,0.084528,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.24288,0.11867,0.17894,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.084046,0.11787,0.10311,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.087232,0.11779,0.097305,0,0
3,GO IMMATURE B CELL DIFFERENTIATION,0.15517,0.11772,0.12007,0,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.13814,0.11768,0.080626,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.099158,0.11721,0.14355,0,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.68418,0.11714,-0.0011501,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.35607,0.11704,0.035484,0,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.082489,0.1169,0.053842,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.41842,0.11687,0.082641,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.063042,0.11685,0.14827,0,0
3,GO ANION HOMEOSTASIS,0.13355,0.11649,0.089598,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.2839,0.11635,0.057272,0,0
3,GO DENDRITIC SPINE MAINTENANCE,0.39371,0.11634,0.034191,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.46512,0.1163,0.019158,0,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.11636,0.11597,0.15871,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.053746,0.11596,0.18903,0,0
3,GO FORELIMB MORPHOGENESIS,0.53742,0.11567,0.034032,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.085627,0.11561,0.080609,0,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.15517,0.11526,0.1224,0,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.12259,0.11492,0.11163,0,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.092194,0.1149,0.066243,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.14526,0.11472,0.064464,0,0
3,GO NEPHRON MORPHOGENESIS,0.12259,0.11469,0.08245,0,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.26847,0.11466,0.052213,0,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.96163,0.11446,-0.00065455,0,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.69061,0.11428,-0.017449,0,0
3,GO WOUND HEALING,0.15264,0.1142,0.074278,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.10845,0.11417,0.077708,0,0
3,GO LIPID LOCALIZATION,0.088862,0.11397,0.052968,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.11039,0.11318,0.14059,0,0
3,GO REGULATION OF COAGULATION,0.69061,0.11302,0.015276,0,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.076492,0.113,0.084365,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0695,0.11292,0.14517,0,0
3,GO RESPONSE TO ETHANOL,0.070855,0.1124,0.085293,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.73628,0.11229,-0.0036445,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.29184,0.11227,0.092489,0,0
3,GO PYRUVATE METABOLIC PROCESS,0.092194,0.11227,0.075818,0,0
3,GO REGULATION OF WOUND HEALING,0.26847,0.11227,0.07198,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.30815,0.11221,0.0798,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.10465,0.11201,0.091201,0,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.065563,0.11197,0.080301,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.63978,0.11173,0.038603,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.51459,0.11157,0.024823,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.03939,0.11157,0.42822,0,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.22568,0.11153,0.072666,0,0
3,GO MEMBRANE RAFT ORGANIZATION,0.60272,0.11151,0.02431,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.061812,0.1114,0.12061,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.18508,0.11139,0.09019,0,0
3,GO MYOTUBE DIFFERENTIATION,0.13355,0.11131,0.061602,0,0
3,GO CRISTAE FORMATION,0.050569,0.1113,0.13952,0,0
3,GO OLIGOPEPTIDE TRANSPORT,0.23589,0.11127,0.11483,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.080955,0.11116,0.10492,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.018836,0.11092,0.14196,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.29992,0.11091,0.10143,0,0
3,GO ALPHA BETA T CELL PROLIFERATION,0.11039,0.11073,0.082718,0,0
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.31232,0.11065,0.044667,0,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.095625,0.11053,0.14854,0,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.47049,0.11021,0.053488,0,0
3,GO SEQUESTERING OF METAL ION,0.12473,0.11012,0.12577,0,0
3,GO PROTEIN PROCESSING,0.33812,0.11005,0.047524,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.014841,0.10997,0.11472,0,0
3,GO CELL CHEMOTAXIS,0.049546,0.10986,0.093034,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.25363,0.10965,0.066676,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.16828,0.10925,0.10749,0,0
3,GO PRO B CELL DIFFERENTIATION,0.2,0.10925,0.16111,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.072231,0.10895,0.073432,0,0
3,GO REGULATION OF PROTEOLYSIS,0.082489,0.10884,0.070333,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.58456,0.1088,0.0262,0,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.33812,0.10877,0.15622,0,0
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.71006,0.10849,0.010302,0,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.077957,0.10844,0.27385,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.77618,0.10798,-0.040852,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.22905,0.1079,0.093324,0,0
3,GO RESPONSE TO DSRNA,0.079444,0.10786,0.078146,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.44402,0.10764,0.074449,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.12908,0.10715,0.16987,0,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.62732,0.10701,0.0076206,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.34702,0.10693,0.10652,0,0
3,GO RESPONSE TO INACTIVITY,0.29184,0.10681,0.070624,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.10465,0.10676,0.10367,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.1067,0.057698,0,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.17934,0.10652,0.039096,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.063042,0.10633,0.23722,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.11636,0.10622,0.10281,0,0
3,GO SPROUTING ANGIOGENESIS,0.04854,0.10622,0.12267,0,0
3,GO NEURAL CREST CELL MIGRATION,0.26847,0.10617,0.076404,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.19095,0.10612,0.080146,0,0
3,GO RESPONSE TO ISCHEMIA,0.079444,0.10592,0.078048,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.25729,0.10587,0.061023,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.050569,0.10586,0.070356,0,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.079444,0.1055,0.10507,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.13814,0.10545,0.11124,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.22905,0.10529,0.074741,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.084046,0.10524,0.11741,0,0
3,GO RESPONSE TO LEPTIN,0.56075,0.10499,0.038264,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.19695,0.10499,0.044019,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.42347,0.10496,0.029511,0,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.053746,0.10479,0.081071,0,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.17653,0.10473,0.061179,0,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.13355,0.10459,0.065865,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.23245,0.1045,0.12133,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.30815,0.10439,0.058171,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.46512,0.10433,0.040884,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.27227,0.1042,0.075261,0,0
3,GO DIOL METABOLIC PROCESS,0.25363,0.10418,0.079834,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.35607,0.10414,0.033856,0,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.04854,0.1041,0.10621,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.18508,0.10405,0.10027,0,0
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.33373,0.10402,0.091372,0,0
3,GO IMMATURE T CELL PROLIFERATION,0.21256,0.104,0.069578,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0066042,0.10376,0.16795,0,0
3,GO CELL CELL ADHESION,0.12689,0.10372,0.061617,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.43883,0.10355,0.041084,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.36991,0.10354,0.060936,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.13355,0.10349,0.1502,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.30815,0.10341,0.038621,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.093897,0.10337,0.050929,0,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.12049,0.10323,0.073732,0,0
3,GO RESPONSE TO STEROID HORMONE,0.064293,0.10312,0.088366,0,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.10654,0.1031,0.089125,0,0
3,GO MUSCLE FILAMENT SLIDING,0.46512,0.10294,0.052478,0,0
3,GO CELLULAR DEFENSE RESPONSE,0.21256,0.10288,0.024876,0,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.059411,0.10285,0.081557,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.099158,0.10275,0.27408,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.27999,0.1027,0.11493,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.16294,0.10261,0.058407,0,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.76948,0.1026,-0.00054557,0,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.23245,0.10243,0.067527,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.065563,0.10232,0.16391,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.11039,0.10226,0.14346,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.23245,0.10226,0.092405,0,0
3,GO ENDODERM DEVELOPMENT,0.33812,0.10189,0.092926,0,0
3,GO LEUKOCYTE CHEMOTAXIS,0.061812,0.10188,0.078792,0,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.040234,0.1018,0.13191,0,0
3,GO COAGULATION,0.21579,0.10135,0.04442,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.60883,0.10131,0.01522,0,0
3,GO PLATELET AGGREGATION,0.11434,0.10113,0.10257,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.087232,0.1011,0.071028,0,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.057089,0.10091,0.10109,0,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.10845,0.10069,0.087169,0,0
3,GO DNA DEAMINATION,0.11235,0.10026,0.15703,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.1028,0.10013,0.080899,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.40843,0.09975,-0.074863,0,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.76281,0.099693,0.010192,0,0
3,GO RESPONSE TO NUTRIENT,0.55487,0.099491,0.024843,0,0
3,GO NATURAL KILLER CELL PROLIFERATION,0.11841,0.099439,0.13749,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.56075,0.099267,0.023993,0,0
3,GO LYMPHOCYTE MIGRATION,0.4978,0.099218,0.03237,0,0
3,GO EMBRYONIC HEMOPOIESIS,0.55487,0.099176,0.036996,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.72969,0.099032,0.015321,0,0
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.14048,0.099009,0.15152,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.52025,0.09897,0.017467,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.25001,0.098849,0.12259,0,0
3,GO GLIAL CELL APOPTOTIC PROCESS,0.44402,0.098846,0.066021,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.12689,0.098564,0.05625,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.13355,0.098529,0.074894,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.20937,0.098298,0.048385,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.060602,0.098234,0.10872,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.95466,0.098219,-0.017836,0,0
3,GO STEROL IMPORT,0.053746,0.098134,0.094196,0,0
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.31653,0.097921,0.10665,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.25363,0.097829,0.062092,0,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.23937,0.097736,0.035329,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.9686,0.097726,-0.028277,0,0
3,GO UV PROTECTION,0.24643,0.097526,0.089996,0,0
3,GO THYROID GLAND DEVELOPMENT,0.31232,0.097518,0.05079,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.34702,0.09748,0.040668,0,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.05824,0.097444,0.069279,0,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.24288,0.097122,0.048539,0,0
3,GO INTERLEUKIN 4 PRODUCTION,0.12049,0.097106,0.091308,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.099158,0.097102,0.082488,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.065563,0.097072,0.15581,0,0
3,GO INFLAMMATORY RESPONSE,0.11434,0.096851,0.054416,0,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.12049,0.096697,0.14593,0,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.19695,0.096531,0.055913,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.29184,0.096344,0.10869,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.064293,0.096202,0.15831,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.25729,0.096201,0.043257,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.13583,0.096189,0.065859,0,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.05161,0.096186,0.06984,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.13583,0.096082,0.081824,0,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.10096,0.096015,0.14962,0,0
3,GO TISSUE REGENERATION,0.066855,0.095834,0.11689,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.17374,0.095764,0.051142,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.36526,0.095636,0.071913,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.12689,0.095561,0.049276,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.42855,0.095442,0.055024,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.20937,0.095412,0.088988,0,0
3,GO LIPID STORAGE,0.2,0.095367,0.052031,0,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.076492,0.095261,0.054349,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.029068,0.094905,0.1139,0,0
3,GO MANGANESE ION TRANSPORT,0.26098,0.094835,0.081694,0,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.47049,0.094719,0.053722,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.1313,0.094649,0.10692,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.14048,0.094585,0.13657,0,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.38888,0.09445,0.017863,0,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.29184,0.094374,0.06814,0,0
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.11841,0.094219,0.13046,0,0
3,GO DENDRITIC CELL DIFFERENTIATION,0.46512,0.094125,0.024299,0,0
3,GO COENZYME A METABOLIC PROCESS,0.19393,0.094107,0.063144,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.36991,0.094103,0.078291,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.33812,0.094096,0.061567,0,0
3,GO RESPONSE TO FATTY ACID,0.17099,0.094021,0.069814,0,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.3746,0.093847,0.1088,0,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.049546,0.093738,0.097834,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.13814,0.093667,0.076279,0,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.076492,0.093614,0.067423,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.86455,0.093431,-0.0056016,0,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.15517,0.093351,0.090004,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.32077,0.093293,0.02567,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.19695,0.093256,0.078851,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.65866,0.092954,0.014381,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.60272,0.092866,0.017895,0,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.32938,0.092828,0.051674,0,0
3,GO GLUCOSE CATABOLIC PROCESS,0.14285,0.092678,0.12038,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.31232,0.092668,0.069205,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.29184,0.092409,0.039293,0,0
3,GO MESONEPHROS DEVELOPMENT,0.30815,0.092199,0.074426,0,0
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.34702,0.092106,0.067371,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.26098,0.092023,0.050364,0,0
3,GO HUMORAL IMMUNE RESPONSE,0.10654,0.091782,0.043769,0,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.22568,0.091709,0.088468,0,0
3,GO RESPONSE TO LIGHT INTENSITY,0.51459,0.091689,0.080547,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.17099,0.091681,0.042832,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.068167,0.091642,0.061983,0,0
3,GO LUNG MORPHOGENESIS,0.093897,0.091553,0.20556,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.44402,0.091438,0.075394,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.072231,0.091298,0.12484,0,0
3,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.076492,0.091289,0.22231,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.12689,0.091277,0.10912,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.038561,0.09126,0.16633,0,0
3,GO BRONCHUS DEVELOPMENT,0.47588,0.091162,0.056768,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.14048,0.090787,0.066882,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.093897,0.090322,0.10551,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.19393,0.090209,0.071089,0,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0695,0.090115,0.12673,0,0
3,GO REGULATION OF BODY FLUID LEVELS,0.15773,0.089802,0.048162,0,0
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.33373,0.089527,0.084876,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0695,0.089196,0.10661,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.052669,0.089171,0.12303,0,0
3,GO PROTEIN STABILIZATION,0.11235,0.089151,0.058041,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.066855,0.089093,0.058137,0,0
3,GO ORGANELLE INHERITANCE,0.063042,0.089061,0.061435,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.29992,0.088921,0.052342,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.24288,0.088799,0.087433,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.17653,0.088675,0.18268,0,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.087232,0.088419,0.10304,0,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.18508,0.088418,0.041267,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.99651,0.088383,-0.028314,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.89215,0.088299,0.00037367,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.20621,0.088017,0.060523,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.60883,0.087947,0.0067497,0,0
3,GO BILE ACID METABOLIC PROCESS,0.12259,0.087884,0.083811,0,0
3,GO AORTA MORPHOGENESIS,0.46512,0.087484,0.057372,0,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.75615,0.08732,-0.035032,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.35153,0.08728,0.048929,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.39858,0.087118,0.068366,0,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.24288,0.087117,0.050345,0,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.23245,0.087022,0.14275,0,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.15264,0.086829,0.064105,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.31232,0.086756,0.0028281,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.39371,0.08674,0.048899,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.38888,0.086494,0.033904,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.29992,0.086477,0.095705,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.41842,0.086439,0.078683,0,0
3,GO RESPONSE TO KETONE,0.12473,0.086286,0.068323,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.04854,0.086203,0.07307,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.53167,0.08618,0.020963,0,0
3,GO AGING,0.188,0.086057,0.047638,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14285,0.085984,0.065391,0,0
3,GO PROTEIN HYDROXYLATION,0.32077,0.08598,0.050912,0,0
3,GO LEUKOCYTE MIGRATION,0.12473,0.085586,0.060768,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1313,0.085503,0.079841,0,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.40349,0.085388,0.012975,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.53742,0.084925,0.0103,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.188,0.084876,0.052322,0,0
3,GO SEGMENTATION,0.11235,0.084866,0.074106,0,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.89215,0.084825,-0.00078325,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.063042,0.084611,0.086926,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.23589,0.084302,0.067185,0,0
3,GO PEPTIDYL ARGININE METHYLATION,0.20309,0.083961,0.085363,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.64605,0.083659,0.011648,0,0
3,GO MUSCLE CELL MIGRATION,0.13814,0.083517,0.10757,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.47588,0.083463,0.015076,0,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.92682,0.083423,0.0092788,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.11235,0.082969,0.075922,0,0
3,GO RENAL SYSTEM PROCESS,0.2,0.082937,0.05349,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.082489,0.082895,0.13446,0,0
3,GO TRNA CATABOLIC PROCESS,0.23245,0.082742,0.14071,0,0
3,GO MYOBLAST FUSION,0.34256,0.082319,0.039396,0,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.15015,0.082288,0.090074,0,0
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.55487,0.082174,0.04551,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.040234,0.082136,0.084889,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.14285,0.082068,0.11472,0,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.65234,0.081927,0.024439,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69061,0.08188,0.02041,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.20309,0.081828,0.12333,0,0
3,GO ELASTIC FIBER ASSEMBLY,0.23245,0.081781,0.15716,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.25001,0.081776,0.059038,0,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.093897,0.081764,0.081999,0,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.50337,0.08162,0.050838,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.084046,0.081609,0.043552,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,0.081489,0.070974,0,0
3,GO PROTEOLYSIS,0.077957,0.081447,0.052379,0,0
3,GO MACROPHAGE ACTIVATION,0.14285,0.081392,0.044558,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.22568,0.081075,0.049114,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.079444,0.081074,0.069088,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.48131,0.081065,0.025968,0,0
3,GO TRANSLESION SYNTHESIS,0.077957,0.081063,0.0621,0,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.94769,0.080988,0.062329,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.70355,0.080884,0.026257,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.10465,0.080585,0.11482,0,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.11434,0.080543,0.065671,0,0
3,GO RESPONSE TO LIPID,0.11434,0.080517,0.062965,0,0
3,GO REGULATION OF HEAT GENERATION,0.35153,0.080361,0.084545,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.097379,0.080181,0.05909,0,0
3,GO RESPONSE TO DRUG,0.14285,0.080113,0.060895,0,0
3,GO REGULATION OF CELL DEATH,0.0695,0.080025,0.063552,0,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.29586,0.079992,0.063942,0,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.36991,0.07987,0.036307,0,0
3,GO GLIAL CELL DEVELOPMENT,0.4978,0.079844,0.022521,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.21905,0.079784,0.058768,0,0
3,GO CHOLESTEROL STORAGE,0.36526,0.079746,0.071433,0,0
3,GO CELLULAR SENESCENCE,0.24288,0.079575,0.046859,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.077957,0.079399,0.1375,0,0
3,GO HOMOTYPIC CELL CELL ADHESION,0.079444,0.079372,0.15067,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.83713,0.079324,0.01423,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.057089,0.079249,0.12378,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.92682,0.079179,-0.0070681,0,0
3,GO RESPONSE TO TESTOSTERONE,0.22568,0.079028,0.085393,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.093897,0.079017,0.092457,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.73628,0.078934,0.051912,0,0
3,GO NEURAL TUBE PATTERNING,0.84397,0.07877,0.020775,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.20309,0.078723,0.12356,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.12908,0.078719,0.054498,0,0
3,GO REGENERATION,0.12908,0.078719,0.077648,0,0
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.095625,0.078706,0.070822,0,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.092194,0.078551,0.069626,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.48131,0.078228,0.062521,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.13355,0.077965,0.075981,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.34256,0.077943,0.083261,0,0
3,GO STEROID ESTERIFICATION,0.22235,0.077939,0.050429,0,0
3,GO T HELPER CELL LINEAGE COMMITMENT,0.17653,0.077864,0.10376,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.52025,0.077859,0.017871,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.054842,0.077711,0.093019,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.092194,0.077677,0.053148,0,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.066855,0.077643,0.049816,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0695,0.077561,0.068042,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.17653,0.077391,0.041093,0,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.47049,0.077381,0.020687,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.43883,0.077215,0.036978,0,0
3,GO BIOLOGICAL ADHESION,0.2,0.077152,0.049894,0,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.98255,0.077114,-0.043908,0,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.12908,0.076993,0.13995,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.12908,0.07689,0.038715,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.71658,0.076884,0.046381,0,0
3,GO LIPID DROPLET ORGANIZATION,0.25729,0.076472,0.07469,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.41341,0.076254,0.049391,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.075049,0.07619,0.057403,0,0
3,GO PLASMINOGEN ACTIVATION,0.27999,0.076178,0.080152,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.29992,0.076145,0.12715,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.36991,0.076113,0.07521,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.05824,0.076054,0.064507,0,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.37932,0.076,0.017198,0,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.054842,0.075743,0.077756,0,0
3,GO XENOBIOTIC TRANSPORT,0.73628,0.075706,-0.0096303,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.055956,0.075678,0.15302,0,0
3,GO TISSUE REMODELING,0.95466,0.075662,-0.013963,0,0
3,GO HISTONE H2A ACETYLATION,0.27611,0.07561,0.04532,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.80312,0.075582,0.066774,0,0
3,GO NCRNA 3 END PROCESSING,0.064293,0.075565,0.082329,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.40349,0.075529,0.0091241,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.56666,0.075435,0.078232,0,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.89215,0.075426,-0.030905,0,0
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.36991,0.075269,-0.14012,0,0
3,GO HISTONE ARGININE METHYLATION,0.2839,0.075256,0.056423,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.15015,0.075066,0.13399,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.27611,0.07503,0.023251,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.11434,0.075023,0.12963,0,0
3,GO DNA STRAND ELONGATION,0.12049,0.074949,0.083671,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.87144,0.074782,-0.0027689,0,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.32938,0.074234,0.028696,0,0
3,GO KIDNEY MORPHOGENESIS,0.14285,0.074182,0.075903,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.03939,0.074162,0.088346,0,0
3,GO PROTEIN OXIDATION,0.30402,0.074105,0.10376,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.073629,0.073954,0.14214,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.057089,0.073917,0.093119,0,0
3,GO REGULATION OF CELL AGING,0.18219,0.073724,0.054161,0,0
3,GO TRABECULA FORMATION,0.29586,0.073566,0.073231,0,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.1028,0.073543,0.14111,0,0
3,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.34702,0.073504,0.068626,0,0
3,GO REGULATION OF RESPONSE TO WOUNDING,0.26847,0.07345,0.070578,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.39858,0.073187,0.14402,0,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.19695,0.073116,0.062084,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.49227,0.073115,0.064222,0,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.19095,0.07291,0.043357,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.20937,0.072879,0.048538,0,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.097379,0.072794,0.09717,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.40843,0.072712,0.09829,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.049546,0.072709,0.099896,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.19393,0.072562,0.042668,0,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.070855,0.072401,0.10686,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.39858,0.072368,0.032692,0,0
3,GO RUFFLE ASSEMBLY,0.13355,0.072357,0.065431,0,0
3,GO REGULATION OF URINE VOLUME,0.25001,0.072355,0.10231,0,0
3,GO MEMBRANE INVAGINATION,0.32077,0.072228,0.048919,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.188,0.07219,0.050064,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.2,0.072177,0.057626,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.05161,0.072105,0.15886,0,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.1028,0.072074,0.06018,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.75615,0.071882,0.090745,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.13583,0.071748,0.08768,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.34256,0.071668,0.060181,0,0
3,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.57857,0.071665,0.044752,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.18508,0.071651,0.038724,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.32077,0.071639,0.022453,0,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.10845,0.071435,0.053841,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.3746,0.071197,0.037346,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.52594,0.071096,0.017712,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.87144,0.071084,-0.055823,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.94769,0.071039,-0.015882,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.26847,0.070911,0.060552,0,0
3,GO AUTOPHAGOSOME MATURATION,0.25001,0.070855,0.05014,0,0
3,GO GLIAL CELL ACTIVATION,0.23245,0.070847,0.054502,0,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.31232,0.070746,0.033979,0,0
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.4598,0.070742,0.063859,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.34702,0.070723,0.13238,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.18219,0.070701,0.085067,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.56075,0.070624,0.0085928,0,0
3,GO RESPONSE TO RETINOIC ACID,0.20621,0.070599,0.10298,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.49227,0.070572,0.026625,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.16828,0.0705,0.10903,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.063042,0.070349,0.091581,0,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.23937,0.070323,0.085673,0,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.28785,0.07025,0.074248,0,0
3,GO MACROPHAGE DIFFERENTIATION,0.47588,0.070244,0.025384,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.33373,0.070182,0.063594,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.12049,0.070162,0.12614,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.73628,0.070038,0.014572,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.14769,0.069992,0.054594,0,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.14285,0.06988,0.11294,0,0
3,GO MESODERM DEVELOPMENT,0.11636,0.069875,0.081004,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.47588,0.069698,0.046606,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.068167,0.069672,0.13641,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.29184,0.069567,0.10368,0,0
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.087232,0.069308,0.084981,0,0
3,GO OOCYTE DIFFERENTIATION,0.32077,0.069302,0.035667,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.94073,0.06929,-0.031282,0,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.20621,0.069282,0.0554,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.188,0.069256,0.056271,0,0
3,GO DEFENSE RESPONSE TO BACTERIUM,0.080955,0.069256,0.06202,0,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.054842,0.069083,0.084323,0,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.068167,0.068909,0.059835,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.38408,0.068886,0.037297,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.19393,0.068864,0.07713,0,0
3,GO INTERLEUKIN 6 PRODUCTION,0.11841,0.068808,0.069477,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.16559,0.068798,0.20495,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.94073,0.068724,-0.029288,0,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.10654,0.068642,0.075801,0,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.17099,0.068553,0.066003,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.28785,0.068537,0.044348,0,0
3,GO RESPONSE TO HORMONE,0.2839,0.068508,0.031936,0,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.4598,0.068389,0.073231,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.10465,0.068312,0.10531,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.18508,0.068216,0.087215,0,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.15517,0.068122,0.059303,0,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.4598,0.068109,0.016085,0,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.16032,0.068054,0.063058,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.24288,0.06802,0.054474,0,0
3,GO REGULATION OF MYOBLAST FUSION,0.60883,0.067874,-0.0076898,0,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.3746,0.067826,0.075463,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.10654,0.067819,0.10824,0,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.12908,0.067698,0.12618,0,0
3,GO EPITHELIUM DEVELOPMENT,0.37932,0.067398,0.054114,0,0
3,GO SUPEROXIDE ANION GENERATION,0.26847,0.067255,0.085879,0,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.13583,0.067186,0.23747,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.44924,0.067167,0.031801,0,0
3,GO NADH METABOLIC PROCESS,0.31232,0.067056,0.076871,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.63354,0.067043,0.095396,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.48131,0.066972,0.028519,0,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.28785,0.066958,0.037906,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.74288,0.066847,0.010147,0,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.16294,0.066842,0.055165,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.41842,0.066832,0.016901,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.25729,0.066805,0.075011,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.061812,0.066803,0.067828,0,0
3,GO ENDOSOME ORGANIZATION,0.188,0.066743,0.063612,0,0
3,GO RESPONSE TO WOUNDING,0.33812,0.066617,0.04742,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.73628,0.066378,-0.014514,0,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.39371,0.066363,0.057712,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.05161,0.066359,0.084532,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.54903,0.066333,0.018659,0,0
3,GO PROTEIN CATABOLIC PROCESS,0.050569,0.066325,0.045383,0,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.18219,0.066161,0.078695,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.20937,0.066119,0.0315,0,0
3,GO CORPUS CALLOSUM DEVELOPMENT,0.83713,0.066061,0.010927,0,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.29992,0.0658,0.029986,0,0
3,GO EXOCYTOSIS,0.26847,0.065642,0.02896,0,0
3,GO FIBROBLAST PROLIFERATION,0.33373,0.065585,0.065392,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.084046,0.06547,0.11296,0,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.59664,0.064931,0.0010018,0,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.34256,0.064908,0.081556,0,0
3,GO REGULATION OF LIPID STORAGE,0.26847,0.064867,0.04167,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.19095,0.064825,0.059533,0,0
3,GO NEUTROPHIL MIGRATION,0.20309,0.064782,0.025509,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.29586,0.064739,0.057349,0,0
3,GO REGULATION OF MRNA BINDING,0.16032,0.064513,0.096062,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.35153,0.064502,0.042028,0,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.1313,0.064498,0.071496,0,0
3,GO ER OVERLOAD RESPONSE,0.67137,0.06436,0.022374,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.27999,0.064247,0.061596,0,0
3,GO GAMMA DELTA T CELL ACTIVATION,0.15773,0.06417,0.1651,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.42347,0.064104,0.050888,0,0
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.065563,0.064047,0.069798,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.90599,0.064041,0.011561,0,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.099158,0.064012,0.065644,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.59059,0.063907,0.038627,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.095625,0.063775,0.13879,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.54903,0.063774,0.0094757,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.23245,0.063767,0.073559,0,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.74288,0.06364,0.018208,0,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.14048,0.063621,0.12402,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.80312,0.063472,-0.0099438,0,0
3,GO CYTOKINE SECRETION,0.23589,0.063468,0.051831,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.41341,0.063383,0.029246,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.75615,0.063251,-0.07041,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.19095,0.063073,0.087718,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.78289,0.063049,0.021578,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.038561,0.062912,0.12902,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.43883,0.062882,0.032327,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.075049,0.062876,0.092531,0,0
3,GO CENTRIOLE ASSEMBLY,0.18508,0.062835,0.068731,0,0
3,GO HORMONE METABOLIC PROCESS,0.23937,0.062731,0.044018,0,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.10654,0.06268,0.05586,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.33812,0.062631,0.053424,0,0
3,GO VASCULATURE DEVELOPMENT,0.23589,0.062578,0.070156,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.5726,0.062557,0.03104,0,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.80312,0.062531,0.005892,0,0
3,GO REGULATION OF RNA BINDING,0.24643,0.062378,0.071402,0,0
3,GO RESPONSE TO MISFOLDED PROTEIN,0.31232,0.062231,0.070977,0,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.05161,0.062204,0.058705,0,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.24643,0.062134,0.089325,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.11434,0.062107,0.12282,0,0
3,GO APOPTOTIC PROCESS,0.097379,0.062024,0.047401,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0083534,0.061894,0.11858,0,0
3,GO HOMEOSTATIC PROCESS,0.14769,0.06184,0.025671,0,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.37932,0.061795,0.060651,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.99651,0.06169,-0.026534,0,0
3,GO MAINTENANCE OF LOCATION,0.20621,0.06152,0.041074,0,0
3,GO DE NOVO PROTEIN FOLDING,0.80989,0.061453,0.005114,0,0
3,GO PROGESTERONE METABOLIC PROCESS,0.72313,0.061434,-0.01836,0,0
3,GO ORGAN GROWTH,0.14285,0.06143,0.10958,0,0
3,GO PROTEIN DESTABILIZATION,0.16828,0.061293,0.061793,0,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.2839,0.06123,0.064391,0,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.43367,0.061213,0.082464,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.17099,0.061073,0.11856,0,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.25363,0.061069,0.031648,0,0
3,GO CHROMOSOME CONDENSATION,0.061812,0.061065,0.073834,0,0
3,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.49227,0.060976,0.03809,0,0
3,GO SARCOMERE ORGANIZATION,0.41341,0.060936,0.046797,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.35153,0.060923,0.03215,0,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.31232,0.060897,0.025203,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.21579,0.060872,0.10583,0,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.22235,0.060831,0.092114,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.41842,0.06079,0.054398,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.059411,0.060705,0.11518,0,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.35153,0.060625,0.031009,0,0
3,GO RESPONSE TO CHEMOKINE,0.14769,0.060617,0.049582,0,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.23589,0.060208,0.054202,0,0
3,GO POLYOL CATABOLIC PROCESS,0.39371,0.060186,0.032053,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.12473,0.060158,0.091784,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.088862,0.060012,0.05434,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.50896,0.059866,0.018273,0,0
3,GO SPINDLE ASSEMBLY,0.11636,0.059852,0.048363,0,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.090515,0.059851,0.059646,0,0
3,GO VAGINA DEVELOPMENT,0.8303,0.059747,-0.043121,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.11841,0.059666,0.29971,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.26847,0.05951,0.097264,0,0
3,GO LIPID DIGESTION,0.94073,0.059464,-0.031255,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.40349,0.05942,0.01652,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.85082,0.059265,-0.011903,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.11636,0.059264,0.048717,0,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.20309,0.059228,0.047318,0,0
3,GO EPITHELIAL CELL DEVELOPMENT,0.50337,0.05905,0.05522,0,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.11235,0.05904,0.070532,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.4545,0.059025,0.034929,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.13814,0.058896,0.074757,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.18508,0.058738,0.058465,0,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.39371,0.058703,0.10958,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.47588,0.058629,0.041431,0,0
3,GO HINDLIMB MORPHOGENESIS,0.10096,0.058536,0.11967,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.1313,0.058521,0.14339,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.29184,0.05852,0.059612,0,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.47049,0.058494,0.11299,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.72313,0.058315,0.077082,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.66501,0.058302,0.002173,0,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.12689,0.058282,0.040072,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.27611,0.058189,0.054426,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.33812,0.058164,0.039268,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.58456,0.05816,0.017516,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.21256,0.05816,0.044633,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.21905,0.058115,0.084185,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.69707,0.05796,0.026983,0,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.10096,0.057862,0.066634,0,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.063042,0.057639,0.057341,0,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.35153,0.057503,0.041674,0,0
3,GO MITOTIC CYTOKINESIS,0.079444,0.057488,0.095263,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.15264,0.057446,0.092526,0,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.22905,0.057393,0.091158,0,0
3,GO RETINA HOMEOSTASIS,0.15015,0.057135,0.079949,0,0
3,GO BLASTOCYST GROWTH,0.13814,0.056992,0.0661,0,0
3,GO FEMALE GAMETE GENERATION,0.15773,0.056912,0.039131,0,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.16828,0.056906,0.062198,0,0
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.74288,0.056898,0.0017097,0,0
3,GO RESPONSE TO INSULIN,0.10845,0.056716,0.035724,0,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.3746,0.056661,0.066477,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.14769,0.056615,0.067678,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.1313,0.056201,0.038433,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.63354,0.056172,0.026991,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.32938,0.055956,0.13399,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.15015,0.055791,0.14778,0,0
3,GO CARTILAGE MORPHOGENESIS,0.51459,0.055791,0.058315,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.19393,0.055576,0.12522,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.34702,0.0555,0.059067,0,0
3,GO BONE REMODELING,0.8303,0.055495,-0.011648,0,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.26098,0.055475,0.070101,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.16828,0.055451,0.044807,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.74288,0.055363,0.0044657,0,0
3,GO METANEPHROS MORPHOGENESIS,0.59664,0.055324,0.021564,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.21905,0.055312,0.10803,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.25363,0.055305,0.12011,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.48131,0.055285,0.012916,0,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.74288,0.055266,0.0045132,0,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.49227,0.05498,0.011586,0,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.41341,0.054957,0.017058,0,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.36064,0.054847,0.042591,0,0
3,GO MEMBRANE DISASSEMBLY,0.69061,0.054697,0.020061,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.076492,0.054671,0.11618,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.41341,0.054538,0.037454,0,0
3,GO CELLULAR EXTRAVASATION,0.23245,0.054495,0.051801,0,0
3,GO RESPONSE TO VITAMIN,0.4598,0.054491,0.044464,0,0
3,GO REGULATION OF PROTEIN BINDING,0.31653,0.054481,0.039017,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.3746,0.054363,0.061758,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.18219,0.054282,0.048864,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.72969,0.054216,0.033028,0,0
3,GO PEPTIDYL ARGININE N METHYLATION,0.22235,0.054112,0.1113,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.13583,0.053983,0.074557,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.12473,0.053981,0.086866,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.13814,0.053939,0.047256,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.76948,0.053687,-0.017988,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.79636,0.053661,0.0033714,0,0
3,GO PROTEIN TARGETING,0.11636,0.053461,0.07056,0,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.70355,0.053241,-0.052804,0,0
3,GO FOAM CELL DIFFERENTIATION,0.5726,0.052945,0.0046793,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.24643,0.052857,0.031746,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.21256,0.05278,0.037122,0,0
3,GO ACUTE PHASE RESPONSE,0.27227,0.052761,0.051598,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.88523,0.052616,-0.018922,0,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.25363,0.052596,0.047676,0,0
3,GO BONE MORPHOGENESIS,0.11039,0.052551,0.11269,0,0
3,GO APPENDAGE DEVELOPMENT,0.10096,0.052534,0.10192,0,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.38888,0.052499,0.017291,0,0
3,GO ATP TRANSPORT,0.82348,0.052492,0.010466,0,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.92682,0.052474,-0.0029684,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.87144,0.052325,-0.038795,0,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.19695,0.052313,0.064728,0,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.24643,0.052285,0.056179,0,0
3,GO NEUTROPHIL CHEMOTAXIS,0.15773,0.052233,0.03027,0,0
3,GO SPERM EGG RECOGNITION,0.188,0.052163,0.054911,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.05161,0.05213,0.06606,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.81668,0.052062,0.0013288,0,0
3,GO HETEROCHROMATIN ORGANIZATION,0.19095,0.051863,0.038617,0,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.31232,0.051829,0.047114,0,0
3,GO SEX DIFFERENTIATION,0.51459,0.051757,0.026185,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.49227,0.051709,0.026878,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.82348,0.051702,-0.0029825,0,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.33373,0.051684,0.066866,0,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.38408,0.051607,0.012998,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.9686,0.051597,-0.046389,0,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.2,0.051585,0.076708,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.19393,0.051573,0.036724,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.42347,0.051282,0.051226,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.26471,0.051277,0.10498,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.097379,0.051068,0.10447,0,0
3,GO REGULATION OF PINOCYTOSIS,0.36526,0.051012,0.065152,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.72313,0.050841,0.0074296,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.64605,0.050764,0.022915,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.63978,0.050737,0.041633,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.56075,0.050544,0.050116,0,0
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.16828,0.050369,0.12375,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.91293,0.050211,-0.013079,0,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.50896,0.050179,0.0028097,0,0
3,GO MACROMOLECULE DEACYLATION,0.15773,0.050151,0.041132,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.35153,0.050057,0.031523,0,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.50337,0.049942,0.042177,0,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.061812,0.049854,0.074777,0,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.43883,0.049816,0.031106,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.35607,0.049815,0.080739,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.29992,0.049785,0.062412,0,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.080955,0.049709,0.11884,0,0
3,GO MYOBLAST PROLIFERATION,0.63354,0.049606,0.01973,0,0
3,GO SYNCYTIUM FORMATION,0.27227,0.049583,0.048953,0,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.188,0.049531,0.052918,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.35153,0.049472,0.057193,0,0
3,GO REPLICATION FORK PROCESSING,0.16294,0.049469,0.084256,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.14769,0.049405,0.044781,0,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.69061,0.04929,0.020832,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.43883,0.049059,0.026729,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.97557,0.049016,-0.033229,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.11841,0.048946,0.066571,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.32506,0.048945,0.068305,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.94769,0.048933,-0.00099045,0,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.83713,0.048812,-0.017979,0,0
3,GO REPLACEMENT OSSIFICATION,0.26847,0.048461,0.13405,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.18219,0.048443,0.05334,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.49227,0.048425,0.01732,0,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.33373,0.048398,0.035231,0,0
3,GO BRAIN MORPHOGENESIS,0.81668,0.048356,-0.0056329,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.52025,0.048118,0.031667,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.079444,0.048109,0.05916,0,0
3,GO MUSCLE HYPERTROPHY,0.85082,0.047933,0.012867,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.14526,0.047907,0.053649,0,0
3,GO SISTER CHROMATID COHESION,0.29184,0.047877,0.071291,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.51459,0.047805,0.027508,0,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.079444,0.047744,0.0837,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.73628,0.047669,0.012131,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.9686,0.047633,-0.0039583,0,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.4978,0.047607,0.031042,0,0
3,GO REGULATION OF ERAD PATHWAY,0.22235,0.047491,0.039703,0,0
3,GO RENAL SODIUM EXCRETION,0.66501,0.047487,0.055829,0,0
3,GO G0 TO G1 TRANSITION,0.49227,0.047383,0.0443,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.52025,0.047351,0.034159,0,0
3,GO REGULATION OF T CELL MIGRATION,0.31232,0.047276,0.043283,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.082489,0.047265,0.087916,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.23937,0.047132,0.057636,0,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.44924,0.046928,0.047211,0,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.16032,0.046921,0.080086,0,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.14769,0.046883,0.060456,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.41842,0.046872,0.12194,0,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.27999,0.046857,0.031499,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.63354,0.046802,0.021434,0,0
3,GO SMOOTH MUSCLE CELL MIGRATION,0.48678,0.046772,0.023072,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.71658,0.046764,-0.0098877,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.40843,0.046734,0.020418,0,0
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.068167,0.046702,0.074862,0,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.14526,0.046618,0.047379,0,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.36991,0.046607,0.060157,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.25001,0.046566,0.052838,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.44924,0.04654,0.014197,0,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.42855,0.046504,0.040547,0,0
3,GO RESPONSE TO AMINE,0.77618,0.046229,0.0089666,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.30402,0.046154,0.057096,0,0
3,GO GASTRULATION,0.36064,0.046065,0.075223,0,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.05161,0.045971,0.15185,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.56666,0.045867,0.063734,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.29992,0.045791,0.063869,0,0
3,GO TUBE MORPHOGENESIS,0.32077,0.045719,0.062161,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.087232,0.045625,0.063115,0,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.084046,0.045577,0.050273,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.085627,0.045497,0.059046,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.04854,0.045496,0.091348,0,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.32938,0.045474,0.029679,0,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.25363,0.045448,0.053881,0,0
3,GO AMMONIUM TRANSPORT,0.62113,0.045406,0.035089,0,0
3,GO PROSTATIC BUD FORMATION,0.65866,0.04529,0.042443,0,0
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.038561,0.045261,0.10592,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.057089,0.045243,0.071195,0,0
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.42855,0.045223,0.0065609,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.34702,0.045152,0.039928,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.31232,0.045139,0.078272,0,0
3,GO METHYLATION,0.004408,0.04502,0.072683,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.33812,0.044923,0.15179,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.31232,0.044901,0.027168,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.41842,0.044822,-0.093515,0,0
3,GO QUINONE METABOLIC PROCESS,0.5726,0.044673,-0.017713,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.23937,0.044517,0.075134,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.18219,0.044475,0.050218,0,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.29992,0.044383,0.073764,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.26471,0.044309,0.059175,0,0
3,GO MITOCHONDRION ORGANIZATION,0.038561,0.044294,0.060444,0,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.17653,0.044289,0.040489,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.44924,0.044273,0.031953,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.19695,0.044084,0.052081,0,0
3,GO JNK CASCADE,0.24643,0.043964,0.040204,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.48131,0.043887,0.049497,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.49227,0.043855,0.033974,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.85768,0.043477,0.046218,0,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.16032,0.043309,0.068905,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.59059,0.043299,-0.048605,0,0
3,GO LIPID EXPORT FROM CELL,0.3746,0.043223,0.038346,0,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.39858,0.04309,0.021377,0,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.48131,0.043035,0.088406,0,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.46512,0.043014,0.020461,0,0
3,GO MUSCLE CELL PROLIFERATION,0.33373,0.042991,0.05735,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.2,0.042985,0.049029,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.60883,0.042952,0.0087679,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.54321,0.042892,0.032828,0,0
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.095625,0.042833,0.11699,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.94769,0.042794,-0.0079984,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.075049,0.042751,0.14164,0,0
3,GO PIGMENT GRANULE LOCALIZATION,0.39858,0.042628,0.052247,0,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.11039,0.042564,0.090846,0,0
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.40349,0.042558,0.017796,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.25363,0.04255,0.080168,0,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.39858,0.042463,0.04091,0,0
3,GO REGULATION OF AUTOPHAGY,0.16294,0.042453,0.035331,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.14048,0.042412,0.068608,0,0
3,GO PH REDUCTION,0.34256,0.042369,0.03248,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.38408,0.042338,0.023134,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.63354,0.042106,0.027301,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.41842,0.042022,0.028828,0,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.38408,0.041995,0.042541,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.23245,0.041864,0.073452,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.72969,0.041845,0.009748,0,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.27999,0.04183,0.038212,0,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.33812,0.04181,0.033901,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.60883,0.041801,0.027013,0,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.79636,0.041646,0.0075,0,0
3,GO CELL SUBSTRATE ADHESION,0.28785,0.041455,0.07243,0,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.44402,0.041338,0.031534,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.5726,0.041223,-0.071673,0,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.17374,0.041015,0.052664,0,0
3,GO AMELOGENESIS,0.11841,0.041009,0.17526,0,0
3,GO FACE DEVELOPMENT,0.70355,0.040916,0.042102,0,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.36064,0.040885,0.076898,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.71006,0.040842,0.011822,0,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.60883,0.040832,0.048657,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.65866,0.040758,0.00048052,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.62113,0.040714,0.050416,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.5726,0.040671,0.031851,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.31653,0.040642,0.042778,0,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.11434,0.040341,0.087046,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.087232,0.040316,0.073451,0,0
3,GO PROTEIN NITROSYLATION,0.71006,0.040273,0.045299,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.73628,0.040271,-0.0021553,0,0
3,GO SISTER CHROMATID SEGREGATION,0.082489,0.040261,0.074869,0,0
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.61497,0.040175,0.031925,0,0
3,GO T CELL HOMEOSTASIS,0.79636,0.04007,0.001667,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.3746,0.04002,0.034657,0,0
3,GO NATURAL KILLER CELL ACTIVATION,0.54903,0.039991,0.034331,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.35153,0.039991,0.067395,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.20621,0.039869,0.28704,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.43367,0.039868,0.08237,0,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.50337,0.039667,0.018711,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.79636,0.039659,0.013651,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.27611,0.039652,0.068618,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.14285,0.039517,0.079624,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.22235,0.039502,0.039273,0,0
3,GO CELLULAR RESPONSE TO ATP,0.54903,0.0395,-0.053965,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.3746,0.039428,0.058661,0,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.59059,0.039216,0.050286,0,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.35153,0.039193,0.024067,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.60883,0.039032,0.023571,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.80989,0.03867,-0.023553,0,0
3,GO CELL MOTILITY,0.48131,0.038565,0.021913,0,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.36526,0.038557,0.018475,0,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.40349,0.038335,0.021489,0,0
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.64605,0.038324,0.070348,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.69707,0.038313,0.042673,0,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.43367,0.038056,0.01141,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.94073,0.03805,0.045376,0,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.29992,0.037788,0.045164,0,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.62732,0.037743,0.043855,0,0
3,GO REGULATION OF MRNA PROCESSING,0.13583,0.037671,0.05622,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.61497,0.03765,0.041798,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.26847,0.037582,0.075847,0,0
3,GO VIRAL BUDDING,0.90599,0.037544,0.022235,0,0
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.66501,0.037485,0.026042,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.12259,0.037446,0.29055,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.47588,0.037215,0.021039,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.16828,0.03715,0.033816,0,0
3,GO APOPTOTIC DNA FRAGMENTATION,0.50896,0.037112,0.020947,0,0
3,GO SECRETION,0.63354,0.037036,-0.0020831,0,0
3,GO LIVER MORPHOGENESIS,0.41842,0.036915,0.038533,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.85082,0.036865,0.0067225,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.53742,0.036794,0.011869,0,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.39858,0.036694,0.054044,0,0
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.4598,0.036654,0.039753,0,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.38888,0.03663,0.020665,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.77618,0.036604,-0.061092,0,0
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.32077,0.036552,0.056935,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.52025,0.036531,0.016336,0,0
3,GO EMBRYO DEVELOPMENT,0.26471,0.036525,0.048521,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.78289,0.036491,0.0055788,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.36991,0.036446,0.078624,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.90599,0.036392,0.017366,0,0
3,GO AXONAL FASCICULATION,0.65866,0.036389,0.025289,0,0
3,GO ATP METABOLIC PROCESS,0.099158,0.036376,0.064149,0,0
3,GO PROTEIN TRIMERIZATION,0.29586,0.036297,0.078671,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.86455,0.036247,0.00041853,0,0
3,GO DRUG CATABOLIC PROCESS,0.54321,0.036215,0.024317,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.85082,0.036143,-0.054905,0,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.64605,0.035892,0.030496,0,0
3,GO RESPONSE TO PROGESTERONE,0.44402,0.035701,0.07679,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.27611,0.035671,0.052746,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.48131,0.035671,0.057386,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.16828,0.035614,0.10596,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.86455,0.035332,0.042598,0,0
3,GO REGULATION OF CELL DIVISION,0.76948,0.035181,0.01653,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.73628,0.035167,0.042367,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.8303,0.035161,-0.0037604,0,0
3,GO TUBE DEVELOPMENT,0.63978,0.03512,0.038812,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.13583,0.035017,0.082066,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.52594,0.034913,0.018544,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.7495,0.034904,-0.041878,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.51459,0.034825,0.023561,0,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.67137,0.034796,0.053079,0,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.96163,0.034519,-0.027495,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.95466,0.034414,0.011796,0,0
3,GO REGULATION OF PHOSPHORYLATION,0.38888,0.034339,0.0246,0,0
3,GO DNA REPLICATION CHECKPOINT,0.20937,0.034293,0.095598,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.65234,0.034239,0.017871,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.23937,0.034182,0.069062,0,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.69061,0.034122,0.021403,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.2839,0.034092,0.03608,0,0
3,GO NODAL SIGNALING PATHWAY,0.43367,0.034061,0.040371,0,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.25729,0.034057,0.037246,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.25729,0.033946,0.057739,0,0
3,GO REGULATION OF PH,0.78962,0.03388,-0.01273,0,0
3,GO LYSOSOME LOCALIZATION,0.44924,0.033619,0.024405,0,0
3,GO PROTEIN KINASE A SIGNALING,0.26098,0.03345,0.042363,0,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.50896,0.033371,0.016285,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.78962,0.033339,-0.0047983,0,0
3,GO EAR DEVELOPMENT,0.44402,0.03324,0.031725,0,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.37932,0.033169,0.050946,0,0
3,GO BONE DEVELOPMENT,0.55487,0.033162,0.045902,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.80989,0.033141,-0.014117,0,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.5726,0.033078,0.014995,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.4978,0.033051,0.061301,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.5726,0.03301,0.063541,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.86455,0.032932,0.011669,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.24643,0.032909,0.09823,0,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.41842,0.032898,0.038681,0,0
3,GO MICROTUBULE ANCHORING,1,0.032815,-0.0093808,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.66501,0.032781,-0.042115,0,0
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.56075,0.032752,0.065188,0,0
3,GO HEAD MORPHOGENESIS,0.95466,0.032695,-0.016027,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.4598,0.032675,0.021053,0,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.2,0.03267,0.030845,0,0
3,GO HEAT GENERATION,0.26471,0.032605,0.075357,0,0
3,GO BLASTOCYST DEVELOPMENT,0.16032,0.032582,0.047057,0,0
3,GO GLAND DEVELOPMENT,0.80989,0.03255,0.025644,0,0
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.94073,0.032534,-0.018107,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.72969,0.032493,0.02342,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.20309,0.032262,0.070777,0,0
3,GO PHOSPHOLIPID EFFLUX,0.54903,0.032237,0.060411,0,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.62732,0.032053,0.019022,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.23589,0.032008,0.084091,0,0
3,GO CELL CYCLE CHECKPOINT,0.12908,0.031907,0.061234,0,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.57857,0.031905,0.038283,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.48678,0.03173,0.026306,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.59664,0.031658,0.027317,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.19095,0.031597,0.048329,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.055956,0.031532,0.053608,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.26847,0.031521,0.047979,0,0
3,GO PLATELET DEGRANULATION,0.8303,0.031469,-0.0082298,0,0
3,GO RESPONSE TO ESTRADIOL,0.53742,0.0312,0.022292,0,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.50896,0.031199,0.01324,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.4545,0.031131,0.024293,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.74288,0.031104,-0.0055599,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.30402,0.031,0.032081,0,0
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.13583,0.030974,0.23424,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.9686,0.03097,0.0022861,0,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.83713,0.030965,-0.019074,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.94073,0.030963,-0.0046669,0,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.67776,0.030908,0.0042182,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.38888,0.030673,0.069069,0,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.68418,0.030609,0.0096951,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.98255,0.030566,0.014679,0,0
3,GO PRENYLATION,0.52025,0.030561,0.06394,0,0
3,GO INTESTINAL LIPID ABSORPTION,0.81668,0.030472,-0.014808,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.22568,0.030447,0.044592,0,0
3,GO DECIDUALIZATION,0.86455,0.030409,-0.013648,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.44924,0.030378,0.041093,0,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.30815,0.030367,0.041542,0,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.53167,0.030289,0.028686,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.28785,0.03021,0.061859,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.068167,0.030202,0.076122,0,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.31232,0.030026,0.034959,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.36991,0.029981,0.068881,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.67776,0.029981,-0.037757,0,0
3,GO RESPONSE TO STEROL,0.46512,0.029937,0.026125,0,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.82348,0.029902,-0.025837,0,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.53742,0.029873,0.040777,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.65866,0.029843,0.052461,0,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.9686,0.029788,-0.038401,0,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.78962,0.029768,-0.004024,0,0
3,GO SINGLE FERTILIZATION,0.92682,0.029667,-0.016069,0,0
3,GO NEGATIVE REGULATION OF ANOIKIS,0.89907,0.029602,-0.0040761,0,0
3,GO RECEPTOR INTERNALIZATION,0.47588,0.029602,0.036779,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.43367,0.029547,0.036218,0,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.66501,0.029415,0.020412,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.22235,0.029375,0.037356,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.95466,0.029323,-0.022385,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.27227,0.029318,0.031763,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.89907,0.029277,0.010277,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.91987,0.029212,0.023306,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.43883,0.029187,0.059958,0,0
3,GO MIDBODY ABSCISSION,0.50337,0.029158,0.073767,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.5726,0.029015,0.012704,0,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.4978,0.028797,0.020276,0,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.62732,0.028782,0.0094842,0,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.26847,0.028665,0.11789,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.5726,0.028641,0.0070713,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.36064,0.028601,0.043228,0,0
3,GO CHROMATIN SILENCING,0.18219,0.028449,0.074907,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.44402,0.028448,0.027206,0,0
3,GO FERTILIZATION,0.67137,0.028316,0.0026147,0,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.35153,0.028173,0.02497,0,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.40843,0.027942,0.074033,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.28785,0.027841,0.04721,0,0
3,GO REGULATION OF CHEMOTAXIS,0.81668,0.027756,0.0016204,0,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.9686,0.027672,-0.022423,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.22235,0.027626,0.045317,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.49227,0.027481,0.011705,0,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.41842,0.027472,0.030717,0,0
3,GO CHOLESTEROL EFFLUX,0.51459,0.027359,0.036982,0,0
3,GO STEROL TRANSPORT,0.63978,0.02726,0.015795,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.33812,0.027256,0.053921,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.77618,0.027188,0.011942,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.53167,0.027138,0.0060814,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.68418,0.027137,-0.032406,0,0
3,GO RECEPTOR RECYCLING,0.85768,0.026881,0.0034264,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.84397,0.026824,0.0039897,0,0
3,GO VACUOLE ORGANIZATION,0.78962,0.026761,-0.0039865,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.75615,0.026755,-0.015934,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.41341,0.026603,0.02781,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.36064,0.026404,0.10711,0,0
3,GO RESPONSE TO NITRIC OXIDE,0.89215,0.026345,-8.2811e-05,0,0
3,GO RESPONSE TO VITAMIN D,0.81668,0.026294,-0.048248,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.96163,0.026175,-0.017757,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.25001,0.026081,0.034106,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.67776,0.025941,0.033861,0,0
3,GO PROTEIN ACYLATION,0.87833,0.025894,0.0041499,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.53742,0.025832,0.0163,0,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.59059,0.025738,0.034918,0,0
3,GO REGULATION OF MAPK CASCADE,0.36526,0.025712,0.032343,0,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.61497,0.025636,0.032559,0,0
3,GO NEGATIVE CHEMOTAXIS,0.9686,0.025563,-0.037356,0,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.23937,0.025503,0.10034,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.74288,0.025486,-0.034378,0,0
3,GO RESPONSE TO ATP,0.87833,0.025382,-0.011862,0,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.18508,0.025187,0.044034,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.40843,0.025151,0.059942,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.62732,0.025125,0.092484,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.92682,0.025079,-0.013365,0,0
3,GO NEURON REMODELING,0.83713,0.024973,0.018988,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.83713,0.024882,0.01876,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.62732,0.024824,0.0075785,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.91293,0.024784,-0.014398,0,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.80989,0.02477,-0.014278,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.48131,0.024756,0.012712,0,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.9686,0.024479,-0.0012045,0,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.73628,0.024192,-0.067395,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.50337,0.02416,0.015535,0,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.86455,0.024138,-0.075643,0,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.29184,0.023914,0.065447,0,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.67137,0.023721,0.02817,0,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.98255,0.023712,-0.0072966,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.78289,0.023672,-0.055391,0,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.85768,0.023668,-0.0032361,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.62113,0.023465,-0.042676,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.9686,0.02345,-0.028127,0,0
3,GO URONIC ACID METABOLIC PROCESS,0.58456,0.023439,0.019557,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.89215,0.023335,-0.050095,0,0
3,GO DNA PACKAGING,0.42855,0.023279,0.031242,0,0
3,GO BONE TRABECULA FORMATION,0.35607,0.023025,0.13848,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.52594,0.022929,0.008988,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.96163,0.022832,0.002417,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.82348,0.022795,0.0024769,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.15773,0.02277,0.039049,0,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.88523,0.02256,-0.017022,0,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.82348,0.02254,0.013111,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.59059,0.022534,-0.0010757,0,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.89215,0.022411,-0.014922,0,0
3,GO VACUOLAR ACIDIFICATION,0.92682,0.022273,-0.01213,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.62732,0.022176,0.019681,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.26847,0.022112,0.055381,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.35607,0.022072,0.087224,0,0
3,GO MATING BEHAVIOR,0.86455,0.022062,-0.0033528,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.87833,0.02204,0.0023024,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.5726,0.02195,0.023083,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.72969,0.021801,0.013041,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.92682,0.021796,-0.017403,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.5726,0.021724,0.030916,0,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.75615,0.021712,0.0011754,0,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.41341,0.021675,0.022768,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.39858,0.021638,0.038292,0,0
3,GO PEPTIDYL THREONINE MODIFICATION,0.27611,0.021629,0.040169,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.67137,0.021516,0.018986,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.21579,0.021488,0.028398,0,0
3,GO PROTEIN ACETYLATION,0.36526,0.021434,0.029627,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.90599,0.021431,0.00265,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.98255,0.021369,-0.012316,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.67776,0.021276,0.021803,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.54321,0.021251,0.033616,0,0
3,GO CHROMOSOME SEGREGATION,0.18219,0.021176,0.050064,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.59059,0.021146,0.047855,0,0
3,GO UTERUS DEVELOPMENT,0.78962,0.020986,-0.039375,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.61497,0.020916,0.035096,0,0
3,GO SEX DETERMINATION,0.7495,0.020867,-0.0030095,0,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.55487,0.020862,0.028692,0,0
3,GO METAPHASE PLATE CONGRESSION,0.35607,0.020765,0.051671,0,0
3,GO GOLGI ORGANIZATION,0.50896,0.02072,0.016268,0,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.49227,0.020627,0.022135,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.42855,0.02061,0.020482,0,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.94769,0.020562,0.002776,0,0
3,GO APPENDAGE MORPHOGENESIS,0.31232,0.020457,0.084527,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.53167,0.020394,0.031027,0,0
3,GO MUSCLE ADAPTATION,0.98953,0.020365,0.0083274,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.60883,0.020329,0.045949,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.81668,0.020293,-0.015168,0,0
3,GO TELOMERE CAPPING,0.48678,0.020199,0.023322,0,0
3,GO SPECIFICATION OF SYMMETRY,0.54321,0.020146,0.023239,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.74288,0.020108,-0.0029547,0,0
3,GO METAL ION HOMEOSTASIS,0.73628,0.020034,0.0099426,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.23937,0.019865,0.052937,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.53167,0.019819,0.026125,0,0
3,GO ENSHEATHMENT OF NEURONS,0.79636,0.019815,-0.0016946,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.88523,0.019763,-0.0040736,0,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.60883,0.01962,0.023639,0,0
3,GO MESODERM MORPHOGENESIS,0.36064,0.019545,0.067206,0,0
3,GO ACYLGLYCEROL HOMEOSTASIS,0.48131,0.019476,0.020467,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.85082,0.019403,-0.0016569,0,0
3,GO WALKING BEHAVIOR,0.95466,0.019265,-0.014496,0,0
3,GO BLOOD VESSEL REMODELING,0.71006,0.019247,-0.025714,0,0
3,GO CGMP MEDIATED SIGNALING,0.92682,0.019229,-0.022056,0,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.81668,0.019209,-0.045269,0,0
3,GO HISTONE EXCHANGE,0.58456,0.019187,0.025688,0,0
3,GO POSITIVE REGULATION OF SIGNALING,0.91987,0.019078,-0.0061867,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.31653,0.018993,0.066525,0,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.72969,0.018982,-0.025288,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.83713,0.018744,-0.0018584,0,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.78962,0.018742,0.053536,0,0
3,GO COMPLEMENT ACTIVATION,0.66501,0.018705,0.013863,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.48678,0.018696,0.021269,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.67137,0.018581,0.04462,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.91987,0.018508,-0.0010295,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.53742,0.018479,0.039571,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.72969,0.018444,0.019435,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.48131,0.018146,0.056931,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.27999,0.018131,0.037655,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.74288,0.018124,0.062647,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.51459,0.017962,0.012978,0,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.96163,0.017886,0.0023389,0,0
3,GO REGULATION OF CELLULAR PH,0.58456,0.017802,0.0019376,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.67137,0.017735,0.060251,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.80312,0.017733,0.019143,0,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.80312,0.017701,-0.0053639,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.50337,0.017621,0.011402,0,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.80312,0.017475,-0.042122,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.58456,0.017416,0.010545,0,0
3,GO LIPID TRANSLOCATION,0.80989,0.017406,-0.02895,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.46512,0.017278,0.040406,0,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.37932,0.016864,0.044605,0,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.7495,0.016771,0.012491,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.78289,0.016716,0.0066683,0,0
3,GO SENSORY PERCEPTION,0.89215,0.016695,0.0004651,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.70355,0.016672,-0.031028,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.7495,0.016662,-0.0097619,0,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.66501,0.016647,-0.012567,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.8303,0.016558,-0.00018159,0,0
3,GO PROTEIN REFOLDING,0.80989,0.016486,0.010819,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.40843,0.016356,0.039441,0,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.5726,0.016314,0.021497,0,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.25001,0.016293,0.080345,0,0
3,GO RESPONSE TO ETHER,0.31653,0.016208,0.056791,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.41341,0.015979,0.064861,0,0
3,GO T CELL SELECTION,0.56075,0.015962,0.040896,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.42347,0.015919,0.026646,0,0
3,GO CELL MATRIX ADHESION,0.41842,0.015913,0.056869,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.53167,0.015853,-0.03731,0,0
3,GO ORGANELLE ASSEMBLY,0.71006,0.015732,0.0038027,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.76281,0.015643,0.030383,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.41341,0.015485,0.022204,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.33373,0.015412,0.13269,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.75615,0.015398,0.0058541,0,0
3,GO TISSUE MORPHOGENESIS,0.44402,0.015253,0.046891,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.48131,0.01517,0.055067,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.58456,0.015062,0.058303,0,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.73628,0.015052,-0.025721,0,0
3,GO TAXIS,0.91987,0.014985,-0.0084573,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.74288,0.014858,0.005456,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.63978,0.014842,0.07023,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.76281,0.014839,0.077822,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.42855,0.014819,0.045228,0,0
3,GO CELLULAR HOMEOSTASIS,0.62113,0.014606,0.0094662,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.73628,0.014581,0.023886,0,0
3,GO CARDIOBLAST DIFFERENTIATION,0.89215,0.014438,0.0017735,0,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.56075,0.014087,0.014587,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.53167,0.014014,0.056533,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.93377,0.013951,-0.018158,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.49227,0.013943,0.044,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.77618,0.013651,-0.022381,0,0
3,GO MUSCLE CELL DEVELOPMENT,0.71658,0.013625,0.0053623,0,0
3,GO GLIAL CELL PROLIFERATION,0.36991,0.013621,0.049368,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.74288,0.013495,0.0012895,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.43367,0.013443,0.02111,0,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.80312,0.013291,-0.0056399,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.36064,0.013147,0.040981,0,0
3,GO RESPONSE TO LEAD ION,0.43367,0.013088,0.063661,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.99651,0.013078,0.013475,0,0
3,GO ARTERY DEVELOPMENT,0.63978,0.012857,0.05271,0,0
3,GO PHOTOTRANSDUCTION,0.39858,0.012838,0.134,0,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.3746,0.012765,0.079138,0,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.65866,0.012654,0.021415,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.51459,0.012652,0.01805,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.66501,0.012635,-0.032457,0,0
3,GO MYELOID CELL DEVELOPMENT,0.48131,0.012618,0.042586,0,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.59664,0.012544,0.077289,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.42347,0.012283,0.034255,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.91293,0.012203,0.0061826,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.59664,0.012192,0.024794,0,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.63978,0.012162,0.020457,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.71006,0.012091,0.0037145,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.60883,0.012039,0.034583,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.85768,0.012032,-0.015126,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.89215,0.012017,-0.048329,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.79636,0.012006,0.00096538,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.75615,0.011969,0.057695,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.56666,0.011882,0.029233,0,0
3,GO CELLULAR RESPONSE TO STARVATION,0.59664,0.011822,-0.036478,0,0
3,GO RESPONSE TO PEPTIDE,0.52594,0.011765,0.013631,0,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.76948,0.01175,0.010813,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.89215,0.011579,0.0061834,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.80312,0.01157,0.022543,0,0
3,GO GROWTH,0.9686,0.011482,-0.0043796,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.53167,0.011464,0.072573,0,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.77618,0.01144,-0.020374,0,0
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.14526,0.011381,0.054503,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.32077,0.011251,-0.080414,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.70355,0.011111,0.01236,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.87144,0.011109,-0.0093409,0,0
3,GO EPITHELIAL CELL PROLIFERATION,0.61497,0.011051,0.034827,0,0
3,GO CHEMICAL HOMEOSTASIS,0.89907,0.011002,-0.0064667,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.99651,0.010946,-0.015777,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.95466,0.01085,-0.0034728,0,0
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.35607,0.010745,0.056569,0,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.7495,0.010732,0.028464,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.76281,0.010728,0.024463,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.71006,0.010708,0.038792,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.89907,0.010683,-0.014508,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.91293,0.010589,0.00016149,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.76948,0.010525,0.0087662,0,0
3,GO RESPONSE TO L GLUTAMATE,0.89907,0.01036,0.010403,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.80312,0.010342,0.0017285,0,0
3,GO MISMATCH REPAIR,0.76281,0.010326,0.015222,0,0
3,GO REGULATION OF CHLORIDE TRANSPORT,0.86455,0.010318,-0.0021543,0,0
3,GO MEMBRANE ORGANIZATION,0.98255,0.010177,-0.0060445,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.83713,0.010171,0.012339,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.87144,0.010063,-0.0040671,0,0
3,GO ENDOSOMAL TRANSPORT,0.42855,0.0099629,0.030935,0,0
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.13814,0.0099098,0.082402,0,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.52025,0.0099087,-0.032786,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.48131,0.0098922,0.07091,0,0
3,GO CYTOSOLIC TRANSPORT,0.87833,0.0098905,0.0042568,0,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.78289,0.0096995,0.0023676,0,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.87144,0.0096623,0.0016199,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.65234,0.0096105,0.011384,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.98953,0.0094649,-0.012234,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.65866,0.0094318,0.06918,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.8303,0.009406,-0.012638,0,0
3,GO P38MAPK CASCADE,0.96163,0.0092738,-0.013171,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.91987,0.0092565,-0.02555,0,0
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.87144,0.0091789,-0.024134,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.43367,0.0090997,0.091241,0,0
3,GO MAGNESIUM ION TRANSPORT,0.70355,0.00906,-0.061826,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.76948,0.0089028,0.043178,0,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.82348,0.00886,0.017892,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.96163,0.0087607,-0.035539,0,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.47588,0.00876,0.042565,0,0
3,GO REGULATION OF TISSUE REMODELING,0.93377,0.0086779,-0.019777,0,0
3,GO REGULATION OF DNA REPLICATION,0.76281,0.0085241,0.030784,0,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.47588,0.0084861,0.055835,0,0
3,GO EXECUTION PHASE OF APOPTOSIS,1,0.0084836,-0.0057133,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.74288,0.0084545,0.0068427,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.79636,0.0083358,0.012237,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.73628,0.0081348,0.010196,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.56666,0.0080355,0.055684,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.77618,0.0080181,-0.043784,0,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.57857,0.0080104,0.025281,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.72969,0.0079577,0.0073943,0,0
3,GO ADAPTATION OF SIGNALING PATHWAY,0.55487,0.0077749,-0.037614,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.98953,0.0077517,-0.0013496,0,0
3,GO INOSITOL METABOLIC PROCESS,0.86455,0.0077052,-0.019355,0,0
3,GO CELL CYCLE DNA REPLICATION,0.60883,0.0075946,0.03359,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.90599,0.00751,-0.0037549,0,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.82348,0.0074276,-0.012368,0,0
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.87144,0.0073751,0.013248,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.33812,0.00734,0.14114,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.69061,0.0072565,0.015102,0,0
3,GO REGULATION OF AXON GUIDANCE,0.96163,0.0071827,-0.03107,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.80312,0.0071708,0.015357,0,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.56666,0.0071061,0.0010232,0,0
3,GO DEPHOSPHORYLATION,0.94073,0.0068665,-0.0035618,0,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.76281,0.0067867,0.011478,0,0
3,GO CYTOSKELETON ORGANIZATION,0.36991,0.0066741,0.026216,0,0
3,GO MACROPHAGE PROLIFERATION,0.56666,0.0065063,0.04362,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.80312,0.0063797,0.010479,0,0
3,GO FLUID TRANSPORT,0.74288,0.0062741,-0.032865,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.71006,0.0060849,0.0076353,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.4598,0.006082,0.057925,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.98953,0.0060804,-0.023312,0,0
3,GO BONE RESORPTION,0.98255,0.0060643,-0.032259,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.39371,0.005949,0.13353,0,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.56666,0.0058594,0.025411,0,0
3,GO SODIUM ION HOMEOSTASIS,0.81668,0.0057869,-0.024046,0,0
3,GO STEM CELL PROLIFERATION,0.96163,0.00577,0.0065672,0,0
3,GO KETONE CATABOLIC PROCESS,0.61497,0.005628,-0.017184,0,0
3,GO REPRODUCTION,0.89907,0.0055911,-0.0091368,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.73628,0.0053241,0.011311,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1,0.0053055,0.0037065,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.97557,0.005232,0.023973,0,0
3,GO DNA DEALKYLATION,0.38408,0.0051465,0.050198,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.94073,0.0051401,0.036093,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.8303,0.0050441,0.0052254,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.89215,0.0048482,-0.0176,0,0
3,GO MICROTUBULE NUCLEATION,0.94769,0.0048167,-0.035455,0,0
3,GO WATER HOMEOSTASIS,0.88523,0.0048013,-0.0056995,0,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.55487,0.0047843,0.032359,0,0
3,GO CARDIOCYTE DIFFERENTIATION,0.48131,0.0047193,0.0479,0,0
3,GO ENDOCARDIUM DEVELOPMENT,0.76281,0.0046956,0.052791,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.83713,0.0046943,0.0038409,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,1,0.0045322,0.0024773,0,0
3,GO FAT CELL DIFFERENTIATION,0.87833,0.0044176,0.012124,0,0
3,GO MIDBRAIN DEVELOPMENT,0.78289,0.0043856,0.052075,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.71658,0.0042397,-0.023401,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.81668,0.0041299,0.0083131,0,0
3,GO OOCYTE MATURATION,0.7495,0.0040174,-0.03816,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.47588,0.00398,0.073872,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.72969,0.0038717,-0.031951,0,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.42855,0.0038218,0.03874,0,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,1,0.0038125,-0.009967,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.94769,0.0037383,-0.0017274,0,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.90599,0.0036899,-0.055822,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.72969,0.003595,0.0042679,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.83713,0.0035051,0.011945,0,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.85768,0.0034267,0.00035933,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.67137,0.0033468,0.011695,0,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.79636,0.003297,-0.01656,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.92682,0.0031353,0.010254,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.22905,0.0027861,0.072655,0,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.61497,0.0027692,0.018648,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.33373,0.00266,-0.092995,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.87833,0.0026383,0.0066549,0,0
3,GO REGULATION OF BINDING,0.80312,0.0025468,-0.007104,0,0
3,GO BICARBONATE TRANSPORT,0.72969,0.0025355,0.017774,0,0
3,GO RESPONSE TO PAIN,0.89907,0.0022692,-0.034104,0,0
3,GO PEPTIDYL SERINE MODIFICATION,0.60883,0.0021851,-0.013474,0,0
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.69061,0.0021654,-0.039604,0,0
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.72969,0.002126,0.028948,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.75615,0.0021253,0.017278,0,0
3,GO WATER TRANSPORT,0.48131,0.0020258,-0.060896,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.87144,0.0019425,-0.0069768,0,0
3,GO TOR SIGNALING,0.54321,0.0019056,-0.02086,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.90599,0.0019009,0.004366,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.9686,0.0018274,0.0017194,0,0
3,GO ORGANELLE DISASSEMBLY,0.65234,0.0017757,0.0095502,0,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.78289,0.001766,0.0043845,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.15517,0.0015581,0.099224,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.68418,0.001533,-0.067591,0,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.84397,0.0014176,0.0070902,0,0
3,GO VESICLE ORGANIZATION,0.78289,0.0013084,0.00028221,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.87144,0.0012242,0.0033023,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.89907,0.0011973,0.011473,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.51459,0.00116,-0.044675,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.87144,0.0011231,0.01355,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.36064,0.0010619,-0.03466,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.61497,0.0010595,0.015184,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.66501,0.0010347,-0.012907,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.80312,0.00092343,0.039724,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.91987,0.00056386,0.1223,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.68418,0.00053261,-0.019411,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.81668,0.00045568,0.014667,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.75615,0.00036424,0.051242,0,0
3,GO EMBRYONIC MORPHOGENESIS,0.57857,0.00026735,0.039406,0,0
3,GO ADAPTIVE THERMOGENESIS,0.61497,0.00026167,-0.028232,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.76281,0.00024665,-0.014249,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.40349,0.0002208,0.1206,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.63354,0.00018928,0.028863,0,0
3,GO DNA REPLICATION,0.46512,7.0285e-05,0.049482,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.8303,-4.9541e-05,0.0044613,0,0
3,GO CELL CELL SIGNALING BY WNT,0.65866,-8.736e-05,0.035505,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.72969,-0.0001191,-0.027501,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.85082,-0.00012537,0.0075302,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.97557,-0.00047198,0.043064,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.32938,-0.0006517,-0.072399,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.91293,-0.0007684,0.011857,0,0
3,GO POSITIVE REGULATION OF BINDING,0.9686,-0.00089924,-0.0019886,0,0
3,GO POSITIVE T CELL SELECTION,0.72313,-0.0009085,0.028055,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.43367,-0.0010306,-0.069368,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.50896,-0.0010394,-0.10454,0,0
3,GO GLAND MORPHOGENESIS,0.36064,-0.0012119,0.12043,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.62732,-0.0012299,0.040425,0,0
3,GO MUSCLE CONTRACTION,0.65866,-0.0012409,-0.026152,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.4598,-0.00126,-0.075553,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.56075,-0.0013449,0.041338,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.51459,-0.0013866,0.018247,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.66501,-0.0014106,-0.034506,0,0
3,GO ION HOMEOSTASIS,0.88523,-0.0014913,0.00064221,0,0
3,GO HISTONE H4 ACETYLATION,0.92682,-0.0015084,0.0059071,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.66501,-0.0015183,0.037718,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.91293,-0.001591,0.020117,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.50337,-0.0017411,-0.036451,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.99651,-0.0017429,-0.0051699,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.60272,-0.0019414,0.089787,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.72313,-0.0020074,-0.042834,0,0
3,GO HISTONE H3 K9 METHYLATION,0.89215,-0.0020835,0.020255,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.85082,-0.0021736,0.032165,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.57857,-0.0021773,-0.015063,0,0
3,GO AMINE METABOLIC PROCESS,0.65866,-0.0022021,0.021726,0,0
3,GO SNORNA METABOLIC PROCESS,0.65234,-0.0022261,0.021478,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.79636,-0.0022879,-0.011191,0,0
3,GO ENDOCYTOSIS,0.67137,-0.0023516,0.0072655,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.50896,-0.0024489,0.11528,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.74288,-0.0024702,0.068178,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.43883,-0.0025183,-0.039399,0,0
3,GO RRNA CATABOLIC PROCESS,0.66501,-0.0027738,0.015592,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.59059,-0.0028035,-0.028975,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.83713,-0.0028604,-0.0025859,0,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.55487,-0.0028913,0.02713,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.85082,-0.0028998,-0.072088,0,0
3,GO AMYLOID BETA FORMATION,0.44924,-0.0029539,0.047613,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.9686,-0.002971,-0.0058354,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.77618,-0.0029781,-0.036471,0,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.75615,-0.0029798,-0.014653,0,0
3,GO SNORNA 3 END PROCESSING,0.90599,-0.0030298,-0.012817,0,0
3,GO ASTROCYTE ACTIVATION,0.87833,-0.0031401,-0.014759,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.91293,-0.0031724,-0.0055074,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.69707,-0.0032039,0.032522,0,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.71658,-0.0032594,-0.025127,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.87833,-0.0032754,0.044079,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.71006,-0.0033138,-0.022825,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.56075,-0.0033211,0.052969,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.72313,-0.0033442,0.011716,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.4545,-0.0033693,-0.047769,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.64605,-0.0033806,0.013814,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.47588,-0.0035456,0.057856,0,0
3,GO PROTEIN TETRAMERIZATION,0.85768,-0.0036673,0.0062736,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.93377,-0.0037123,-0.003999,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.30402,-0.0037298,-0.068021,0,0
3,GO NUCLEUS ORGANIZATION,0.66501,-0.0037733,0.0091453,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.68418,-0.003832,-0.023615,0,0
3,GO VASODILATION,0.72313,-0.0038696,-0.065333,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.72969,-0.0039408,0.038732,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.98953,-0.0040037,0.012826,0,0
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.76948,-0.0040478,-0.029922,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.73628,-0.0041763,0.018948,0,0
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.78289,-0.0042448,0.0073072,0,0
3,GO MANNOSYLATION,0.98953,-0.0042661,-0.02444,0,0
3,GO CYTOKINESIS,0.93377,-0.0042985,0.0054217,0,0
3,GO VITAMIN METABOLIC PROCESS,0.30815,-0.0043602,0.045781,0,0
3,GO BONE MATURATION,0.44402,-0.0044726,-0.058388,0,0
3,GO SULFATE TRANSPORT,0.94073,-0.0045515,0.015592,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.9686,-0.0046019,0.0057162,0,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.77618,-0.0047939,-0.012282,0,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.42347,-0.004795,-0.047915,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.78962,-0.0048028,-0.025903,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.65234,-0.0048152,0.018509,0,0
3,GO CELL JUNCTION ORGANIZATION,0.50337,-0.0050662,-0.03509,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.56075,-0.0050725,0.038182,0,0
3,GO LEUKOCYTE TETHERING OR ROLLING,0.76948,-0.0051075,0.012612,0,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.83713,-0.0054215,-0.030967,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.94073,-0.0054368,0.006086,0,0
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.47588,-0.0054495,-0.035082,0,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.90599,-0.0054609,0.014174,0,0
3,GO ENDOTHELIAL CELL MIGRATION,0.36064,-0.0054768,0.057251,0,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.70355,-0.0056226,-0.023508,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.7495,-0.0057147,-0.064709,0,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.71658,-0.005731,0.027173,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.99651,-0.0058966,0.0080598,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.92682,-0.0059073,0.058784,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.71658,-0.0059148,-0.03269,0,0
3,GO SECONDARY METABOLIC PROCESS,0.59059,-0.0059259,-0.050267,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.9686,-0.0059378,-0.00020582,0,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.93377,-0.0060723,-0.016654,0,0
3,GO CHROMOSOME LOCALIZATION,0.81668,-0.0062871,0.0041536,0,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.54903,-0.006407,0.030985,0,0
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.42347,-0.0065622,0.085423,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.73628,-0.0066685,-0.042374,0,0
3,GO AXIS SPECIFICATION,0.72969,-0.0067562,0.017448,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.61497,-0.0069095,-0.022153,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.4978,-0.0070185,-0.087467,0,0
3,GO L GLUTAMATE IMPORT,0.59664,-0.0070604,-0.058131,0,0
3,GO TOOTH MINERALIZATION,0.55487,-0.0071022,0.10424,0,0
3,GO LACTATE METABOLIC PROCESS,0.51459,-0.0072825,0.049836,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.57857,-0.0073265,-0.039642,0,0
3,GO ORGANELLE FISSION,0.67137,-0.0074995,0.014075,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.87833,-0.0076107,-0.013639,0,0
3,GO BROWN FAT CELL DIFFERENTIATION,0.7495,-0.0076962,-0.026369,0,0
3,GO NOTCH SIGNALING PATHWAY,0.42855,-0.0078258,-0.043735,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.82348,-0.0078298,0.0058407,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.86455,-0.0078352,0.012839,0,0
3,GO IRON ION TRANSPORT,0.99651,-0.0079143,-0.0060504,0,0
3,GO CENTROSOME DUPLICATION,0.96163,-0.0080788,0.016151,0,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.7495,-0.0080912,-0.01513,0,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.69707,-0.008264,0.017836,0,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.63978,-0.008273,-0.022757,0,0
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.95466,-0.0083756,-0.010181,0,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.92682,-0.0085292,0.014927,0,0
3,GO MEMBRANE FUSION,0.58456,-0.0085795,-0.030595,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.40843,-0.0086112,-0.049162,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.46512,-0.0086299,-0.059395,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.27611,-0.0086688,-0.11423,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.93377,-0.008701,0.0065878,0,0
3,GO TEMPERATURE HOMEOSTASIS,0.76948,-0.0087503,-0.019838,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.81668,-0.0088427,0.014968,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.59059,-0.0088635,-0.037339,0,0
3,GO OOGENESIS,0.87833,-0.0092334,-0.027197,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.59664,-0.0092886,-0.026783,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.89215,-0.0093159,-0.0095913,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.53742,-0.0096777,0.063334,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.53742,-0.0098818,0.039259,0,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.98255,-0.010051,0.0082096,0,0
3,GO EOSINOPHIL MIGRATION,0.91987,-0.01006,-0.052764,0,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.65234,-0.010098,-0.041412,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.95466,-0.010102,0.0015762,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.47049,-0.010201,-0.080964,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.70355,-0.01024,0.0049893,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.62113,-0.010267,-0.067388,0,0
3,GO VACUOLAR TRANSPORT,0.96163,-0.010383,-0.0066589,0,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.74288,-0.010426,0.042717,0,0
3,GO EYE MORPHOGENESIS,0.91293,-0.010561,0.012082,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.87144,-0.010636,-0.010995,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.63354,-0.010887,-0.017093,0,0
3,GO SOMITOGENESIS,0.73628,-0.010913,0.031784,0,0
3,GO MUSCLE SYSTEM PROCESS,0.89215,-0.010999,-0.01476,0,0
3,GO DETECTION OF STIMULUS,0.87833,-0.011115,-0.003388,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.31232,-0.011295,-0.044217,0,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.9686,-0.011568,0.0041237,0,0
3,GO EXCRETION,0.91987,-0.011851,-0.011747,0,0
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.85768,-0.011859,0.010733,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.98255,-0.012062,-0.038688,0,0
3,GO MUSCLE CELL DIFFERENTIATION,0.94769,-0.012099,0.010388,0,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.93377,-0.012111,-0.0070885,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.53167,-0.012366,0.036243,0,0
3,GO REGULATION OF BONE REMODELING,0.71658,-0.012425,-0.05832,0,0
3,GO CARTILAGE DEVELOPMENT,0.92682,-0.012518,0.0053434,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.81668,-0.012829,-0.017805,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.71658,-0.012924,-0.016035,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.98953,-0.01294,-0.0039555,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.76948,-0.012953,-0.024804,0,0
3,GO HISTONE H3 K9 DEMETHYLATION,0.76281,-0.013032,-0.010577,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.79636,-0.013042,-0.028944,0,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.82348,-0.013204,-0.00299,0,0
3,GO REGULATION OF RECEPTOR BINDING,0.72969,-0.013235,0.046592,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.54903,-0.013267,-0.026913,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.60883,-0.013369,-0.031527,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.95466,-0.01347,0.0050277,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.67776,-0.013481,-0.087073,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.37932,-0.013666,-0.041623,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.78289,-0.013686,-0.0080534,0,0
3,GO REGULATION OF ODONTOGENESIS,0.89215,-0.013859,-0.02389,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.73628,-0.013871,-0.0099123,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.82348,-0.013905,-0.030575,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.43883,-0.013952,-0.034782,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.75615,-0.014215,0.014835,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.99651,-0.014458,-0.00835,0,0
3,GO EATING BEHAVIOR,0.84397,-0.014476,0.0040688,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.29586,-0.014545,0.18821,0,0
3,GO CELL FATE COMMITMENT,0.34256,-0.014837,-0.046628,0,0
3,GO NEURON PROJECTION ORGANIZATION,0.20621,-0.014922,-0.064537,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.73628,-0.015522,0.062582,0,0
3,GO ZINC ION TRANSPORT,0.63978,-0.015523,0.025798,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.7495,-0.015719,0.025668,0,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.47049,-0.015822,-0.025028,0,0
3,GO MITOCHONDRIAL FUSION,0.87144,-0.015912,0.0038405,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.72313,-0.015941,0.0041594,0,0
3,GO VESICLE LOCALIZATION,0.85082,-0.016024,-0.018758,0,0
3,GO MULTI ORGANISM PROCESS,0.44402,-0.016092,-0.02788,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.31653,-0.016125,-0.043976,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.87144,-0.016205,0.0049678,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.95466,-0.016252,-0.0049767,0,0
3,GO SPINDLE LOCALIZATION,0.7495,-0.016421,-0.017228,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.75615,-0.01662,-0.020592,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.38408,-0.016694,-0.03476,0,0
3,GO DEVELOPMENTAL GROWTH,0.50896,-0.016748,-0.023465,0,0
3,GO RESPONSE TO STARVATION,0.4598,-0.016949,-0.039375,0,0
3,GO ORGANELLE FUSION,0.60883,-0.017171,-0.027475,0,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.77618,-0.017173,0.015513,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.34256,-0.017183,-0.083746,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.62732,-0.017257,-0.032857,0,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.69061,-0.017368,-0.027618,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.94073,-0.017592,0.0026307,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.25363,-0.017631,-0.04895,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.69707,-0.01768,-0.026646,0,0
3,GO APICAL PROTEIN LOCALIZATION,0.51459,-0.017693,-0.1172,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.96163,-0.017796,-0.0054831,0,0
3,GO REGULATION OF MRNA POLYADENYLATION,0.50896,-0.017808,-0.025397,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.9686,-0.017913,-0.01186,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.87144,-0.017935,0.025727,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.74288,-0.018273,-0.014848,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.85768,-0.018356,0.0038308,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.19695,-0.01842,-0.10992,0,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.60883,-0.018462,0.025553,0,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.22905,-0.018484,-0.06719,0,0
3,GO REGULATION OF HEART GROWTH,0.69061,-0.018521,0.01794,0,0
3,GO TRABECULA MORPHOGENESIS,0.77618,-0.018634,0.039966,0,0
3,GO DNA CATABOLIC PROCESS,0.97557,-0.018867,0.0020741,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.62113,-0.019001,-0.011619,0,0
3,GO REGULATION OF GROWTH,0.59059,-0.019136,-0.020384,0,0
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.82348,-0.019162,0.0069074,0,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.98953,-0.019299,-0.00019361,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.76948,-0.019308,0.045103,0,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.75615,-0.019467,-0.035096,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.48678,-0.019565,-0.061428,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.62113,-0.019648,-0.064379,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.79636,-0.019666,-0.02465,0,0
3,GO OSSIFICATION,0.65234,-0.019761,-0.01543,0,0
3,GO SHORT TERM MEMORY,0.89907,-0.019992,0.034855,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.85082,-0.020032,-0.0066922,0,0
3,GO SOMITE DEVELOPMENT,0.46512,-0.020136,-0.0088471,0,0
3,GO PROTEIN DENEDDYLATION,0.72969,-0.02029,-0.02793,0,0
3,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.60883,-0.020337,0.080373,0,0
3,GO HEART VALVE DEVELOPMENT,0.85082,-0.020363,-0.012814,0,0
3,GO ENDODERM FORMATION,0.67776,-0.020382,0.053993,0,0
3,GO REGULATION OF TRANSPORT,0.2,-0.020694,-0.044917,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.64605,-0.020734,-0.016077,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.34702,-0.020925,-0.033676,0,0
3,GO CENTROSOME SEPARATION,0.99651,-0.021151,0.010092,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.41842,-0.021249,-0.048628,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.26847,-0.021302,-0.047825,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.77618,-0.021326,-0.005266,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.89907,-0.021381,0.021659,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.47049,-0.021416,-0.057651,0,0
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.63978,-0.021446,-0.0013895,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.67776,-0.02147,0.066667,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.94769,-0.021563,0.02192,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.62113,-0.021674,-0.016308,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.4978,-0.021683,-0.012,0,0
3,GO HEART DEVELOPMENT,0.80312,-0.021917,0.007833,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.56075,-0.022033,0.034587,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.98255,-0.022262,0.089924,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.79636,-0.022302,-0.019647,0,0
3,GO REGULATION OF CELL CYCLE ARREST,0.70355,-0.022308,-0.0097195,0,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.59664,-0.022392,-0.011544,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.48678,-0.022409,-0.050255,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.74288,-0.022594,-0.012238,0,0
3,GO KINETOCHORE ASSEMBLY,0.76948,-0.022648,-0.013999,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.73628,-0.022757,-0.029755,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.78289,-0.022936,-0.044096,0,0
3,GO REGULATION OF TOR SIGNALING,0.39858,-0.02316,-0.029629,0,0
3,GO REGULATION OF CELL SIZE,0.26098,-0.023268,-0.057576,0,0
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.42855,-0.023286,-0.036705,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.72969,-0.023423,-0.0011874,0,0
3,GO RHYTHMIC BEHAVIOR,0.52594,-0.023578,-0.044433,0,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.92682,-0.02364,-0.016126,0,0
3,GO CELL PROJECTION ASSEMBLY,0.71006,-0.023994,-0.004016,0,0
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.95466,-0.024007,-0.019875,0,0
3,GO MITOCHONDRIAL FISSION,0.25363,-0.024205,-0.068821,0,0
3,GO GAMETE GENERATION,0.29992,-0.024278,-0.036864,0,0
3,GO SEXUAL REPRODUCTION,0.29992,-0.024443,-0.036946,0,0
3,GO PROTEIN FOLDING,0.94073,-0.024472,-0.005405,0,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.97557,-0.024497,0.008391,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.55487,-0.024572,-0.032902,0,0
3,GO ENDOCYTIC RECYCLING,0.9686,-0.024777,-0.0019488,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.36064,-0.024938,-0.029972,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.94073,-0.025025,0.035443,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.29184,-0.025364,-0.058327,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.90599,-0.025424,-0.0023006,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96163,-0.025741,-0.0050649,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.86455,-0.02576,0.00995,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.65234,-0.025788,-0.019837,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.16828,-0.02647,-0.11697,0,0
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.62732,-0.026487,-0.017879,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.48131,-0.026505,-0.041511,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.85768,-0.026586,-0.0053017,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.42347,-0.026618,0.041355,0,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.97557,-0.026846,0.0038558,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.35607,-0.026855,-0.021667,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.40349,-0.026921,-0.032566,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.59664,-0.027009,-0.062629,0,0
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.99651,-0.027086,0.0029926,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.95466,-0.027315,0.0011346,0,0
3,GO HISTONE H3 K36 METHYLATION,0.90599,-0.027321,0.033774,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.87144,-0.027322,-0.0076203,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.58456,-0.027356,-0.031217,0,0
3,GO NUCLEOSIDE SALVAGE,1,-0.027422,-0.0077333,0,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,1,-0.027458,-0.011208,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.9686,-0.027639,0.012745,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.41842,-0.027695,-0.035685,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.9686,-0.027728,-0.010332,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.48678,-0.027739,-0.083841,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.87833,-0.028138,-0.021331,0,0
3,GO ORGANIC ANION TRANSPORT,0.76948,-0.028141,-0.015844,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.74288,-0.028239,-0.0016117,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.52594,-0.028241,-0.057944,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.47588,-0.028264,-0.012564,0,0
3,GO CELL RECOGNITION,0.188,-0.028368,-0.059389,0,0
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.68418,-0.028589,-0.01309,0,0
3,GO GLUCOSE IMPORT,0.18219,-0.02869,-0.063799,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.62113,-0.02876,0.04753,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.56666,-0.028909,-0.012416,0,0
3,GO RESPONSE TO GLUCAGON,0.37932,-0.029117,-0.045042,0,0
3,GO HEART TRABECULA FORMATION,0.74288,-0.029148,-0.046726,0,0
3,GO MESENCHYME DEVELOPMENT,0.97557,-0.029185,0.02006,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.32938,-0.029197,0.059355,0,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.44924,-0.029283,-0.048383,0,0
3,GO MITOPHAGY,0.62732,-0.029367,-0.020582,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.21256,-0.029586,-0.042006,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.58456,-0.02959,-0.046437,0,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.62732,-0.029708,-0.029097,0,0
3,GO SULFATION,0.8303,-0.030031,0.035778,0,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.57857,-0.030076,-0.03305,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.36064,-0.030114,-0.024026,0,0
3,GO MALE GAMETE GENERATION,0.34256,-0.030132,-0.036712,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.38408,-0.030165,-0.033734,0,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.71658,-0.030294,0.010585,0,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.48131,-0.030451,-0.033881,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.11434,-0.030462,-0.076357,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.98953,-0.030539,-0.016438,0,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.56666,-0.030543,-0.042791,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.55487,-0.030547,0.023783,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.81668,-0.030586,0.012322,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.49227,-0.030682,-0.031055,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.20621,-0.030726,-0.04858,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.98255,-0.030886,0.052404,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.85768,-0.030907,0.029682,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.58456,-0.030932,0.10176,0,0
3,GO INORGANIC ANION TRANSPORT,0.2839,-0.030947,-0.039047,0,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.83713,-0.030971,0.0053893,0,0
3,GO CARDIAC CELL FATE COMMITMENT,0.63978,-0.031142,-0.087363,0,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.94073,-0.031273,0.010949,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.83713,-0.031472,0.0030399,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.92682,-0.031512,0.0049845,0,0
3,GO CELL GROWTH,0.12908,-0.031613,-0.058806,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.92682,-0.031616,-0.01564,0,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.68418,-0.031729,0.016292,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.58456,-0.031751,-0.037916,0,0
3,GO MYOTUBE CELL DEVELOPMENT,0.86455,-0.031898,0.0010697,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.27999,-0.031925,-0.06376,0,0
3,GO ACID SECRETION,0.89907,-0.031949,0.0025484,0,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.78289,-0.032064,-0.0023353,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.59059,-0.032205,-0.022278,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.60883,-0.032218,-0.026401,0,0
3,GO MATING,0.27611,-0.032222,-0.05983,0,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.76948,-0.032319,-0.028295,0,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.88523,-0.032696,-0.030556,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.31653,-0.032702,-0.029415,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.89215,-0.032709,0.0066327,0,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.65866,-0.032712,0.024905,0,0
3,GO NEURON DEATH,0.063042,-0.032799,-0.057668,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.47049,-0.032828,-0.031722,0,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.80312,-0.033057,0.046897,0,0
3,GO ANION TRANSPORT,0.57857,-0.033115,-0.023777,0,0
3,GO MEIOTIC CELL CYCLE,0.35153,-0.033216,-0.02207,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.56666,-0.033415,-0.025267,0,0
3,GO AORTA DEVELOPMENT,0.82348,-0.033787,-0.0069682,0,0
3,GO REGULATION OF BEHAVIOR,0.40349,-0.033868,-0.044169,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.28785,-0.033875,-0.050954,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.79636,-0.033971,0.035314,0,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.26471,-0.033978,-0.040538,0,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.59059,-0.03421,-0.031285,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.5726,-0.034227,-0.062791,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.27227,-0.03426,-0.046367,0,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.80989,-0.034335,-0.013961,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.62732,-0.034358,-0.079618,0,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.92682,-0.034429,-0.00085155,0,0
3,GO REGULATION OF CYTOKINESIS,0.69707,-0.034573,-0.013625,0,0
3,GO REGULATION OF PROTEIN TARGETING,0.87833,-0.034617,-0.001139,0,0
3,GO VASCULAR WOUND HEALING,0.67137,-0.03512,-0.048024,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.74288,-0.035198,-0.13211,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.95466,-0.03544,0.02591,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.35153,-0.035593,-0.04171,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.30815,-0.035853,-0.083014,0,0
3,GO DEMETHYLATION,0.7495,-0.036035,-0.0016498,0,0
3,GO CELL CYCLE ARREST,0.94769,-0.036188,0.0043449,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.67776,-0.036338,0.0028661,0,0
3,GO OXALATE TRANSPORT,0.36991,-0.03635,-0.073299,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.67776,-0.036477,-0.0069444,0,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.22235,-0.036518,-0.06511,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.39858,-0.036757,-0.023968,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.33812,-0.036764,-0.085618,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.52594,-0.037264,-0.041021,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.53167,-0.037285,-0.068386,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.91987,-0.037293,0.021636,0,0
3,GO OVULATION CYCLE PROCESS,0.29586,-0.037392,-0.066853,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.28785,-0.037407,-0.037762,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.54321,-0.037444,-0.035772,0,0
3,GO BIOMINERALIZATION,0.72313,-0.037551,-0.020229,0,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.63978,-0.03757,-0.02814,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.74288,-0.03759,0.02769,0,0
3,GO CONVERGENT EXTENSION,0.53742,-0.037648,0.093839,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.94073,-0.037755,0.042653,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.44924,-0.038084,0.12727,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.58456,-0.038117,-0.014262,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.74288,-0.038189,-0.020988,0,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.3746,-0.03824,-0.057171,0,0
3,GO PROTEIN METHYLATION,0.35153,-0.038343,-0.0023235,0,0
3,GO VASCULAR TRANSPORT,0.83713,-0.038771,-0.056258,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.11841,-0.038808,-0.050262,0,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.32077,-0.038879,-0.11814,0,0
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.76948,-0.038947,-0.024056,0,0
3,GO DRINKING BEHAVIOR,0.67776,-0.03898,-0.021519,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.85082,-0.03913,-0.013463,0,0
3,GO BONE MINERALIZATION,0.54321,-0.039265,-0.041039,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.30815,-0.039487,-0.034949,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.47588,-0.039529,0.083077,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.62113,-0.039694,-0.0076823,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.62113,-0.039878,-0.0085033,0,0
3,GO MICROTUBULE BASED PROCESS,0.059411,-0.039897,-0.053799,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.4598,-0.039905,-0.043306,0,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.92682,-0.039973,-0.00054065,0,0
3,GO FIBROBLAST MIGRATION,0.66501,-0.04003,-0.0031958,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.087232,-0.040161,-0.09229,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.052669,-0.040211,-0.091297,0,0
3,GO RESPONSE TO BMP,0.56075,-0.040383,-0.012051,0,0
3,GO RESPONSE TO MUSCLE INACTIVITY,0.65866,-0.040402,-0.021507,0,0
3,GO SENSORY ORGAN DEVELOPMENT,0.62732,-0.040516,-0.018611,0,0
3,GO HISTONE METHYLATION,0.62732,-0.040562,0.007613,0,0
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.74288,-0.040678,0.14302,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.83713,-0.040953,0.0048196,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.72969,-0.041013,-0.0092193,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.15264,-0.041051,-0.1424,0,0
3,GO NEURON APOPTOTIC PROCESS,0.15517,-0.041265,-0.045071,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.90599,-0.041279,0.022986,0,0
3,GO HEART GROWTH,0.63978,-0.04134,-0.0012359,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.47049,-0.041353,-0.041073,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.42855,-0.041376,-0.068246,0,0
3,GO RESPONSE TO NICOTINE,0.8303,-0.041397,-0.013962,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.56075,-0.041408,-0.096703,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.46512,-0.041419,-0.043169,0,0
3,GO ANATOMICAL STRUCTURE REGRESSION,0.14048,-0.041497,-0.19022,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.91987,-0.041505,-0.0047314,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.62732,-0.041556,-0.042587,0,0
3,GO REGULATION OF TUBE SIZE,0.090515,-0.041671,-0.094235,0,0
3,GO RESPONSE TO PROSTAGLANDIN E,0.76948,-0.041764,-0.012519,0,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.8303,-0.042196,-0.030476,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.43883,-0.042332,-0.048422,0,0
3,GO RESPONSE TO HYDROXYUREA,0.67776,-0.042466,0.064806,0,0
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.24288,-0.042648,-0.042295,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.56666,-0.042656,-0.017121,0,0
3,GO IMMUNOGLOBULIN SECRETION,0.35153,-0.042681,-0.10178,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.23245,-0.042688,-0.060059,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.64605,-0.042759,-0.051666,0,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.12908,-0.042767,-0.046912,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.29184,-0.042776,-0.040407,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.37932,-0.042777,-0.071257,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.9686,-0.042829,0.010893,0,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.19393,-0.043006,-0.091415,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.24288,-0.043095,-0.094169,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.188,-0.043108,-0.038699,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.52594,-0.043119,0.065409,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.26471,-0.043124,-0.03211,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.29992,-0.043126,-0.053331,0,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.46512,-0.04328,-0.031461,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.22568,-0.043329,-0.087702,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,0.63354,-0.043511,0.093846,0,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.48131,-0.04352,-0.18563,0,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.30402,-0.043753,-0.031607,0,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.60883,-0.04377,-0.036521,0,0
3,GO VITAMIN TRANSPORT,0.5726,-0.043911,-0.032751,0,0
3,GO T CELL EXTRAVASATION,0.53742,-0.044242,-0.11609,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.33812,-0.044317,-0.07286,0,0
3,GO NUCLEOTIDE TRANSPORT,0.35607,-0.044327,-0.058104,0,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.80989,-0.044465,-0.014862,0,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.31653,-0.044658,-0.046312,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.29184,-0.044716,-0.052618,0,0
3,GO MEGAKARYOCYTE DEVELOPMENT,0.96163,-0.044845,0.028676,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.75615,-0.044921,-0.031363,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.73628,-0.045561,0.0099406,0,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.076492,-0.045595,-0.079691,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.53167,-0.045813,-0.018454,0,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.78962,-0.045905,-0.070768,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.78962,-0.046144,0.014306,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.44402,-0.046309,-0.076337,0,0
3,GO SLEEP,0.90599,-0.04635,0.015661,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.31653,-0.046361,-0.078942,0,0
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.085627,-0.046407,-0.074577,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.64605,-0.046539,-0.031003,0,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.94769,-0.046753,0.053765,0,0
3,GO STEROID HORMONE SECRETION,0.81668,-0.046811,-0.0034402,0,0
3,GO GLIAL CELL MIGRATION,0.60272,-0.046915,-0.03668,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.94073,-0.046986,0.0025958,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.35607,-0.047091,-0.057023,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.12049,-0.047461,-0.07392,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.76281,-0.047479,-0.071572,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20309,-0.047515,-0.060863,0,0
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.36526,-0.047807,-0.12861,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.26098,-0.04785,-0.076417,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.73628,-0.047918,0.0024697,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.65234,-0.047973,-0.076357,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.59664,-0.048114,-0.064801,0,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.25001,-0.04812,-0.10515,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.44402,-0.048197,-0.022639,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.36064,-0.048275,-0.050733,0,0
3,GO REGULATION OF EXOSOMAL SECRETION,0.78962,-0.048321,-0.021271,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.32938,-0.048366,-0.025031,0,0
3,GO REGULATION OF CYCLASE ACTIVITY,0.32077,-0.048452,-0.08072,0,0
3,GO EOSINOPHIL CHEMOTAXIS,0.78289,-0.048464,-0.069727,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.61497,-0.048585,-0.0081955,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.21579,-0.048606,-0.048249,0,0
3,GO ORGANIC ACID TRANSPORT,0.39858,-0.04865,-0.032892,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.57857,-0.048882,-0.047604,0,0
3,GO REGULATION OF VASCULOGENESIS,0.43367,-0.048933,-0.093609,0,0
3,GO PHOSPHATE ION TRANSPORT,0.17374,-0.049287,-0.064524,0,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.072231,-0.049316,-0.11286,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.3746,-0.04933,-0.019956,0,0
3,GO POSITIVE REGULATION OF HEART RATE,0.34256,-0.04952,-0.069631,0,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.32506,-0.049604,-0.058278,0,0
3,GO MRNA SPLICE SITE SELECTION,0.30815,-0.04968,-0.074057,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.72313,-0.049702,-0.010827,0,0
3,GO ORGANELLE LOCALIZATION,0.41842,-0.049821,-0.02336,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.35153,-0.049876,-0.07581,0,0
3,GO FEAR RESPONSE,0.17653,-0.049974,-0.086328,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.25363,-0.049981,-0.042491,0,0
3,GO REGULATION OF MITOPHAGY,0.38408,-0.050176,-0.041551,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.10654,-0.050204,-0.093228,0,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29586,-0.050284,-0.083042,0,0
3,GO VISUAL BEHAVIOR,0.65866,-0.050588,-0.041894,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.23589,-0.050746,-0.041812,0,0
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.27999,-0.050831,-0.073485,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.24643,-0.050863,-0.15608,0,0
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.12049,-0.051029,-0.16651,0,0
3,GO RHYTHMIC PROCESS,0.17934,-0.051278,-0.037433,0,0
3,GO GLIOGENESIS,0.33812,-0.051301,-0.04807,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.16032,-0.051408,-0.059323,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.34702,-0.051486,-0.045499,0,0
3,GO CARBOHYDRATE PHOSPHORYLATION,0.62732,-0.051598,-0.029285,0,0
3,GO HEART MORPHOGENESIS,0.74288,-0.051725,0.0065058,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.91987,-0.051915,-0.0023221,0,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.21579,-0.052116,-0.122,0,0
3,GO FUCOSE METABOLIC PROCESS,0.83713,-0.052126,0.010346,0,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.98953,-0.052147,0.0001915,0,0
3,GO REGULATION OF EXCRETION,0.92682,-0.052292,0.02275,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.84397,-0.052333,0.023461,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.47049,-0.05234,-0.030538,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.23937,-0.052366,-0.070511,0,0
3,GO GENETIC IMPRINTING,0.54903,-0.052394,-0.029883,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.15015,-0.052667,-0.0041501,0,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.17099,-0.052686,-0.068813,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.39371,-0.05283,-0.099401,0,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.51459,-0.052842,-0.025487,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.52025,-0.05297,-0.02871,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.20937,-0.05302,-0.063677,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.88523,-0.053109,0.075423,0,0
3,GO RESPONSE TO REDOX STATE,0.83713,-0.053199,-0.035364,0,0
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.69061,-0.053209,-0.032671,0,0
3,GO SEGMENT SPECIFICATION,0.47588,-0.053396,-0.073367,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.17653,-0.053648,-0.11972,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26471,-0.054117,-0.061617,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.18219,-0.054231,-0.091229,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.61497,-0.054273,-0.018718,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.56666,-0.054518,-0.0049012,0,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.55487,-0.054544,-0.02049,0,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.91987,-0.054681,-0.0060025,0,0
3,GO FUCOSYLATION,0.76281,-0.054727,-0.024176,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.46512,-0.054766,-0.048431,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.49227,-0.054816,-0.019358,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.65234,-0.054866,-0.015468,0,0
3,GO MITOTIC RECOMBINATION,0.59664,-0.054928,-0.0135,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.19695,-0.05523,-0.097568,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.66501,-0.055476,-0.015374,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.70355,-0.055477,-0.078541,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.49227,-0.055647,-0.040412,0,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.36991,-0.055798,-0.050289,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.32938,-0.055891,-0.060499,0,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.42347,-0.055975,-0.088756,0,0
3,GO TRANSFERRIN TRANSPORT,0.16828,-0.056007,-0.089237,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.23937,-0.056098,-0.078395,0,0
3,GO REGULATION OF LYASE ACTIVITY,0.40843,-0.056118,-0.066943,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.95466,-0.056143,0.062333,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.63354,-0.056165,-0.041181,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.079444,-0.056255,-0.085288,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.47049,-0.056256,0.0013533,0,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0695,-0.056357,-0.082793,0,0
3,GO THYMIC T CELL SELECTION,0.35607,-0.056415,-0.034567,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.15015,-0.056496,-0.059368,0,0
3,GO T CELL LINEAGE COMMITMENT,0.69707,-0.056604,0.04526,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.85082,-0.056683,0.012197,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.38888,-0.057385,-0.062773,0,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.12049,-0.057401,-0.07608,0,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.63978,-0.057588,-0.039618,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.48131,-0.057799,-0.046698,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.15015,-0.058063,-0.12741,0,0
3,GO CARBOHYDRATE TRANSPORT,0.11235,-0.058121,-0.07518,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.21256,-0.058171,-0.075738,0,0
3,GO DENDRITIC SPINE DEVELOPMENT,0.25363,-0.058238,-0.052013,0,0
3,GO CELL MORPHOGENESIS,0.18508,-0.058274,-0.060732,0,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.33812,-0.058322,-0.040414,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.67776,-0.058476,-0.00038622,0,0
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.35153,-0.058538,-0.059904,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.33373,-0.058543,-0.032744,0,0
3,GO RESPONSE TO METAL ION,0.38888,-0.058676,-0.038335,0,0
3,GO NUCLEOSOME ASSEMBLY,0.28785,-0.058719,-0.029281,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.080955,-0.058789,-0.13867,0,0
3,GO RESPONSE TO LEUCINE,0.2,-0.058793,-0.13906,0,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.40349,-0.058825,-0.048915,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.76281,-0.05898,-0.019204,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39858,-0.059078,-0.044626,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.69061,-0.05919,-0.0090011,0,0
3,GO SPERM MOTILITY,0.011047,-0.059231,-0.12238,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.19393,-0.059266,-0.09481,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.40349,-0.0593,-0.058973,0,0
3,GO RESPONSE TO FOOD,0.12259,-0.059567,-0.074421,0,0
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.8303,-0.059622,-0.045867,0,0
3,GO REGULATION OF GONAD DEVELOPMENT,0.41842,-0.06011,-0.089681,0,0
3,GO DRUG METABOLIC PROCESS,0.44402,-0.060116,-0.030207,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.91293,-0.060124,-0.012635,0,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.17099,-0.060165,-0.074423,0,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.71006,-0.060185,0.033064,0,0
3,GO DOSAGE COMPENSATION,0.82348,-0.060471,0.036966,0,0
3,GO DNA DEMETHYLATION,0.36991,-0.060559,-0.037285,0,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.28785,-0.060697,-0.049294,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.28785,-0.060964,-0.11029,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.90599,-0.061029,0.077876,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.90599,-0.061175,0.011151,0,0
3,GO CELL FATE SPECIFICATION,0.32938,-0.061208,-0.067401,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.8303,-0.061412,0.0039516,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.94073,-0.061426,0.043455,0,0
3,GO RESPONSE TO WATER,0.86455,-0.061494,-0.0039454,0,0
3,GO LYSOSOMAL TRANSPORT,0.54321,-0.061674,-0.028724,0,0
3,GO AXON EXTENSION,0.047551,-0.0617,-0.12079,0,0
3,GO REGULATION OF HORMONE LEVELS,0.13355,-0.061874,-0.071426,0,0
3,GO PROSTAGLANDIN SECRETION,0.93377,-0.061884,-0.0055076,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.05824,-0.061962,-0.081488,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.61497,-0.061967,-0.018121,0,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.20621,-0.062208,-0.070945,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.40349,-0.06223,-0.084241,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.14526,-0.062234,-0.062208,0,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.52594,-0.062237,-0.032572,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.46512,-0.062704,-0.053821,0,0
3,GO AMYLOID FIBRIL FORMATION,0.21256,-0.062709,-0.12213,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.76281,-0.062951,-0.028025,0,0
3,GO RECEPTOR CLUSTERING,0.36526,-0.063017,-0.062479,0,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.67776,-0.06305,0.0023569,0,0
3,GO REGULATION OF OSSIFICATION,0.87833,-0.063279,0.015308,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.4598,-0.063321,-0.051239,0,0
3,GO REGULATION OF PEPTIDE SECRETION,0.12473,-0.063335,-0.069012,0,0
3,GO MEMBRANE REPOLARIZATION,0.12908,-0.063438,-0.10516,0,0
3,GO FIBRINOLYSIS,0.39371,-0.06357,-0.10365,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.54321,-0.063727,-0.026126,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.43367,-0.063816,-0.029598,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.39858,-0.063827,-0.050873,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.42347,-0.063894,-0.023601,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.077957,-0.063938,-0.064654,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.38888,-0.064142,-0.058166,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.8303,-0.064185,0.007146,0,0
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.17653,-0.064187,-0.053701,0,0
3,GO BONE CELL DEVELOPMENT,0.42347,-0.06423,-0.030892,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.61497,-0.064419,-0.075831,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.44402,-0.064531,-0.077703,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.2,-0.064583,-0.087977,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.30402,-0.064641,-0.043484,0,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.91987,-0.064742,-0.018855,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.11841,-0.064745,-0.09419,0,0
3,GO ACTIVATED T CELL PROLIFERATION,0.8303,-0.065233,0.011237,0,0
3,GO HISTONE H3 K27 METHYLATION,0.26471,-0.065842,-0.043383,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.37932,-0.065867,-0.11975,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.31232,-0.066085,-0.074268,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.36526,-0.066175,-0.082852,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.56666,-0.066247,-0.03021,0,0
3,GO ION TRANSPORT,0.11841,-0.066432,-0.054666,0,0
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.40843,-0.066576,-0.034388,0,0
3,GO PHAGOSOME ACIDIFICATION,0.34702,-0.066644,-0.05983,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.084046,-0.066655,-0.071699,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.60883,-0.066681,0.0036353,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.54903,-0.066759,-0.021923,0,0
3,GO INTEGRIN ACTIVATION,0.66501,-0.067115,-0.05459,0,0
3,GO RESPONSE TO COLD,0.080955,-0.067722,-0.15856,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.43883,-0.067756,-0.039545,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.066855,-0.06778,-0.075099,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.52594,-0.067937,-0.037146,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.79636,-0.067942,0.037378,0,0
3,GO MESENCHYME MORPHOGENESIS,0.50896,-0.067983,-0.015512,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.85768,-0.068004,-0.0058731,0,0
3,GO AROMATIC AMINO ACID TRANSPORT,0.43367,-0.068006,-0.049576,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.52594,-0.068165,-0.012873,0,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.084046,-0.068441,-0.11927,0,0
3,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.81668,-0.068683,0.012217,0,0
3,GO PROTEIN DEMETHYLATION,0.87144,-0.069229,-0.00071634,0,0
3,GO ANIMAL ORGAN MATURATION,0.42855,-0.069337,-0.033435,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.27227,-0.069449,-0.049235,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.054842,-0.069796,-0.10508,0,0
3,GO HISTONE H3 K4 METHYLATION,0.92682,-0.069888,0.032452,0,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.188,-0.069904,-0.055566,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.30402,-0.069981,-0.13486,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.69061,-0.070035,-0.0033915,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.090515,-0.070104,-0.14274,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.52025,-0.070137,-0.051949,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.077957,-0.070235,-0.061064,0,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.16559,-0.070246,-0.092238,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.21256,-0.070428,-0.067536,0,0
3,GO ECTODERM DEVELOPMENT,0.22568,-0.070568,-0.037931,0,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0030654,-0.070686,-0.12969,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.085627,-0.070754,-0.06516,0,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.62113,-0.070772,-0.013928,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.3746,-0.07093,-0.034389,0,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.1313,-0.07118,-0.095478,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.30815,-0.071273,-0.066993,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.27611,-0.071309,-0.077487,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.26847,-0.07136,-0.076054,0,0
3,GO RESPONSE TO CAMP,0.17374,-0.071387,-0.076767,0,0
3,GO DIET INDUCED THERMOGENESIS,0.11434,-0.071429,-0.13541,0,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.36526,-0.071749,-0.042204,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.47049,-0.071909,-0.049592,0,0
3,GO ODONTOGENESIS,0.98255,-0.071949,0.022524,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.1313,-0.072038,-0.097283,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.097379,-0.07222,-0.10355,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.26471,-0.072229,-0.074008,0,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.39858,-0.072324,-0.15827,0,0
3,GO CELL JUNCTION MAINTENANCE,0.64605,-0.072356,0.00049972,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.27999,-0.072785,-0.052788,0,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.090515,-0.072846,-0.08593,0,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.22905,-0.073045,-0.20508,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.42855,-0.07312,-0.038369,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.75615,-0.073257,-0.011674,0,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.088862,-0.073317,-0.10543,0,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.58456,-0.073666,-0.029965,0,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.29586,-0.073904,-0.061276,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.84397,-0.073952,0.017877,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.50337,-0.074043,-0.024404,0,0
3,GO ONE CARBON COMPOUND TRANSPORT,0.71006,-0.074057,-0.032444,0,0
3,GO PIRNA METABOLIC PROCESS,0.12259,-0.074253,-0.16493,0,0
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.10654,-0.074542,-0.071821,0,0
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.86455,-0.07459,0.039198,0,0
3,GO PROTEIN MANNOSYLATION,0.22905,-0.074832,-0.088045,0,0
3,GO KINETOCHORE ORGANIZATION,0.41341,-0.074957,-0.046109,0,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.28785,-0.075694,-0.12642,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.16294,-0.075881,-0.05764,0,0
3,GO REGULATION OF TRANSPOSITION,0.76281,-0.076174,0.0034603,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.70355,-0.07647,-0.0037593,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.3746,-0.076593,-0.043037,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.04854,-0.077137,-0.11034,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.81668,-0.077329,0.030608,0,0
3,GO REGULATION OF GLIOGENESIS,0.32938,-0.077357,-0.056142,0,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.19393,-0.07738,-0.083842,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.16559,-0.077435,-0.078343,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.39858,-0.077507,-0.043413,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0056288,-0.077544,-0.18101,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.54903,-0.077611,-0.040971,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.16559,-0.077632,-0.11681,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.52594,-0.077686,-0.0077949,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.35153,-0.077771,-0.098723,0,0
3,GO RESPONSE TO AMPHETAMINE,0.37932,-0.077881,-0.046712,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.36526,-0.078016,-0.032147,0,0
3,GO REGIONALIZATION,0.21905,-0.078053,-0.059805,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.36526,-0.0781,-0.056543,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.99651,-0.078245,0.011173,0,0
3,GO RENAL WATER HOMEOSTASIS,0.2839,-0.078432,-0.057563,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.23937,-0.078542,-0.062674,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.64605,-0.07924,-0.031308,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.1313,-0.079517,-0.04816,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.16032,-0.07958,-0.055923,0,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.26471,-0.079661,-0.078798,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.20937,-0.079728,-0.099014,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.12908,-0.079781,-0.076325,0,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.78289,-0.079878,0.033862,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.21905,-0.080014,-0.047885,0,0
3,GO MICROTUBULE POLYMERIZATION,0.12259,-0.080307,-0.099593,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.44402,-0.08032,-0.044395,0,0
3,GO CELLULAR ANION HOMEOSTASIS,0.32938,-0.08037,-0.069209,0,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.23245,-0.080373,-0.085206,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.39371,-0.080883,-0.03514,0,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.43367,-0.081153,-0.046809,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.15773,-0.081179,-0.062468,0,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.33373,-0.081275,-0.12444,0,0
3,GO ENDOCRINE HORMONE SECRETION,0.35153,-0.081647,-0.049547,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.44924,-0.082113,-0.043179,0,0
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.79636,-0.082126,-0.051814,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.22235,-0.082405,0.073161,0,0
3,GO DENDRITIC SPINE MORPHOGENESIS,0.26847,-0.082588,-0.06767,0,0
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.32938,-0.083142,-0.055598,0,0
3,GO DEVELOPMENTAL INDUCTION,0.1028,-0.083171,-0.13337,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.22235,-0.0832,-0.063513,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.61497,-0.083432,-0.028535,0,0
3,GO REGULATION OF RESPIRATORY BURST,0.53742,-0.08362,-0.057749,0,0
3,GO HEART PROCESS,0.059411,-0.083676,-0.086449,0,0
3,GO RESPONSE TO INTERLEUKIN 6,0.05161,-0.083912,-0.13526,0,0
3,GO AMINO ACID IMPORT,0.36526,-0.083962,-0.025843,0,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.26471,-0.084116,-0.099346,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.38408,-0.084333,-0.081126,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.15773,-0.0847,-0.10594,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.48131,-0.084862,-0.0257,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.060602,-0.08489,-0.074278,0,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.11039,-0.08512,-0.078282,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.095625,-0.085132,-0.053184,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.29992,-0.085278,-0.10449,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.060602,-0.085285,-0.075663,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.29992,-0.085793,-0.069012,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.13814,-0.085879,-0.080272,0,0
3,GO HEPARIN METABOLIC PROCESS,0.50896,-0.086115,-0.072655,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.17099,-0.086158,-0.089138,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.85768,-0.08632,-0.034243,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.0062634,-0.08669,-0.089772,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.51459,-0.086828,-0.029669,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.85082,-0.087032,0.031978,0,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.29586,-0.087145,-0.067516,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.32077,-0.087957,-0.050434,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.19095,-0.087964,-0.093406,0,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.087232,-0.088046,-0.13302,0,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.40349,-0.088122,-0.092263,0,0
3,GO AXO DENDRITIC TRANSPORT,0.027188,-0.08822,-0.092793,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.097379,-0.088323,-0.097057,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.52594,-0.088426,-0.056623,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.044685,-0.088659,-0.081907,0,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.24288,-0.088728,-0.065243,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.58456,-0.088881,-0.036773,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.70355,-0.088961,-0.043729,0,0
3,GO ENERGY HOMEOSTASIS,0.065563,-0.089324,-0.14088,0,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.34702,-0.089375,-0.12395,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.94769,-0.089452,0.051183,0,0
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.2839,-0.089595,-0.074824,0,0
3,GO CILIUM ORGANIZATION,0.0099891,-0.089797,-0.10144,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.20309,-0.090186,-0.13271,0,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.11039,-0.090298,-0.074736,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.13814,-0.090673,-0.15105,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.082489,-0.09106,-0.064619,0,0
3,GO CHEMOSENSORY BEHAVIOR,0.079444,-0.09163,-0.1203,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.21256,-0.091747,-0.05296,0,0
3,GO REGULATION OF ICOSANOID SECRETION,0.19695,-0.091799,-0.085274,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.092194,-0.092051,-0.10884,0,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.090515,-0.092497,-0.14385,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.26098,-0.092509,-0.078134,0,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.2,-0.092517,-0.098011,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.27227,-0.092612,-0.063258,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.23589,-0.093177,-0.11066,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.39371,-0.093276,-0.082669,0,0
3,GO COLLATERAL SPROUTING,0.085627,-0.093495,-0.15539,0,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.12473,-0.093766,-0.12771,0,0
3,GO ANIMAL ORGAN FORMATION,0.30815,-0.094013,-0.039168,0,0
3,GO N GLYCAN PROCESSING,0.093897,-0.094133,-0.17837,0,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.14285,-0.09424,-0.097322,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.037747,-0.094331,-0.15279,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.065563,-0.094471,-0.11673,0,0
3,GO MYELIN MAINTENANCE,0.092194,-0.094505,-0.1618,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.27611,-0.094654,-0.16255,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.53742,-0.094871,-0.040409,0,0
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.054842,-0.094911,-0.1035,0,0
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.064293,-0.095324,-0.11169,0,0
3,GO STEROID CATABOLIC PROCESS,0.11841,-0.095932,-0.11305,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.8303,-0.096206,0.0040578,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.15264,-0.096873,-0.070582,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.059411,-0.097119,-0.13924,0,0
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.11235,-0.097186,-0.099812,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.53742,-0.097388,-0.050615,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.072231,-0.097555,-0.12898,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.65234,-0.097601,0.0046579,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.11235,-0.097875,-0.085659,0,0
3,GO RESPONSE TO AXON INJURY,0.13583,-0.098014,-0.099957,0,0
3,GO PATTERN SPECIFICATION PROCESS,0.097379,-0.098039,-0.080186,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.15517,-0.098206,-0.061658,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.25729,-0.09848,-0.11052,0,0
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.11636,-0.09865,-0.093201,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.19393,-0.098799,-0.076522,0,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.41842,-0.098933,0.18174,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.66501,-0.098958,-0.031871,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.43883,-0.099052,-0.02682,0,0
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.24288,-0.099141,-0.14661,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.56666,-0.099435,-0.085178,0,0
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.14048,-0.09944,-0.050669,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.2,-0.099545,-0.09223,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.12689,-0.099707,-0.14774,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.04854,-0.099758,-0.094063,0,0
3,GO ENDOTHELIUM DEVELOPMENT,0.1313,-0.099881,-0.087136,0,0
3,GO NEUROBLAST PROLIFERATION,0.065563,-0.1,-0.13132,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.26847,-0.10011,-0.039065,0,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.43367,-0.10012,-0.12131,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.63978,-0.10014,-0.021791,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.17374,-0.10024,-0.076932,0,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.068167,-0.10036,-0.086183,0,0
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.14769,-0.10043,-0.087137,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.035393,-0.10046,-0.089247,0,0
3,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.16294,-0.10077,-0.17336,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.3746,-0.10086,-0.071361,0,0
3,GO PARTURITION,0.26471,-0.10091,-0.11502,0,0
3,GO REGULATION OF HEART RATE,0.1028,-0.10117,-0.089009,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.16828,-0.10128,-0.075038,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.21905,-0.10135,-0.05965,0,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.78289,-0.10185,-0.020188,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.87833,-0.10188,0.012128,0,0
3,GO ADULT FEEDING BEHAVIOR,0.052669,-0.10199,-0.14423,0,0
3,GO RESPONSE TO EPINEPHRINE,0.64605,-0.10213,-0.031207,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.29184,-0.10233,-0.09382,0,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.2,-0.10245,-0.12623,0,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.36526,-0.10284,-0.048422,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.072231,-0.10315,-0.076243,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.56666,-0.10374,-0.056877,0,0
3,GO MICROTUBULE SEVERING,0.14526,-0.10412,-0.13436,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.67776,-0.10421,-0.029774,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.009256,-0.10435,-0.20613,0,0
3,GO TORC1 SIGNALING,0.017549,-0.10456,-0.084651,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.30815,-0.10496,-0.11001,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.093897,-0.10499,-0.10487,0,0
3,GO ORGANIC CATION TRANSPORT,0.34702,-0.10543,-0.054027,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.055956,-0.10584,-0.097105,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.39858,-0.10618,-0.10503,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0075304,-0.10626,-0.1482,0,0
3,GO RELAXATION OF MUSCLE,0.20621,-0.10667,-0.098049,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.15773,-0.10712,-0.12259,0,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.15517,-0.10715,-0.090363,0,0
3,GO PANCREAS DEVELOPMENT,0.15264,-0.1072,-0.093905,0,0
3,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.13583,-0.10747,-0.0637,0,0
3,GO ORGAN INDUCTION,0.12259,-0.10798,-0.12214,0,0
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.12473,-0.10802,-0.19197,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.31232,-0.10811,-0.11409,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.080955,-0.10847,-0.081786,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.42347,-0.10864,-0.035184,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.36991,-0.1087,-0.10601,0,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,0.20621,-0.10884,-0.058291,0,0
3,GO NEUROTRANSMITTER UPTAKE,0.26098,-0.10918,-0.10774,0,0
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.55487,-0.10946,-0.050482,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.42855,-0.10962,-0.048535,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.2,-0.11005,-0.11908,0,0
3,GO BASIC AMINO ACID TRANSPORT,0.16032,-0.11013,-0.11419,0,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.29586,-0.11015,-0.071262,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.20309,-0.11028,-0.070412,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.54903,-0.11075,-0.039061,0,0
3,GO ESTROUS CYCLE,0.38408,-0.11138,-0.074696,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.1028,-0.11191,-0.088509,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0056288,-0.11212,-0.20565,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.59059,-0.11253,-0.038544,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.061812,-0.11321,-0.14976,0,0
3,GO OVULATION CYCLE,0.3746,-0.11331,-0.049759,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.29586,-0.11336,-0.085588,0,0
3,GO FEEDING BEHAVIOR,0.053746,-0.11338,-0.092453,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.4978,-0.11395,-0.028467,0,0
3,GO REGULATION OF RECEPTOR CLUSTERING,0.18219,-0.11398,-0.12792,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.23937,-0.11409,-0.10284,0,0
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.10845,-0.11416,-0.12725,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.52025,-0.11427,-0.0058229,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.052669,-0.11428,-0.088349,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.53167,-0.11464,-0.10743,0,0
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.065563,-0.11473,-0.22654,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.5726,-0.11493,-0.049902,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.24288,-0.1152,-0.058774,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.029719,-0.11525,-0.079576,0,0
3,GO ACTION POTENTIAL,0.065563,-0.1155,-0.10579,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.28785,-0.11633,-0.092056,0,0
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.22568,-0.11652,-0.13399,0,0
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.24643,-0.1168,-0.063665,0,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.3746,-0.11741,-0.076794,0,0
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.94769,-0.11756,0.0040028,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.037747,-0.1178,-0.092463,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.14769,-0.11795,-0.088882,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.066855,-0.11797,-0.08671,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.25363,-0.11903,-0.056627,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.095625,-0.11913,-0.098124,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.3746,-0.11939,-0.082515,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.77618,-0.11941,0.01629,0,0
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.15264,-0.11962,-0.054246,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.070855,-0.11963,-0.0847,0,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.065563,-0.11971,-0.23502,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.023741,-0.12014,-0.0010532,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.29992,-0.12021,-0.038826,0,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.10845,-0.12043,-0.1075,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.19695,-0.12072,-0.1338,0,0
3,GO MITOTIC DNA REPLICATION,0.088862,-0.121,-0.078633,0,0
3,GO MEMBRANE DOCKING,0.0014738,-0.12124,-0.10438,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.17934,-0.12154,-0.059277,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.67776,-0.12171,-0.068097,0,0
3,GO PHAGOSOME MATURATION,0.10096,-0.12281,-0.091038,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.061812,-0.12291,-0.14037,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.18219,-0.12331,-0.069971,0,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.070855,-0.12408,-0.087007,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.51459,-0.12442,-0.050798,0,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.43367,-0.12475,-0.074349,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.62113,-0.12545,0.067738,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.05824,-0.12554,-0.14082,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.090515,-0.12592,-0.11655,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.15517,-0.12607,-0.13574,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.022165,-0.12617,-0.16624,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.049546,-0.12649,-0.10952,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.22235,-0.12665,-0.14007,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.96163,-0.12679,0.0093432,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.076492,-0.12768,-0.12262,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.18219,-0.12774,-0.089097,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.010773,-0.12785,-0.11846,0,0
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.092194,-0.12841,-0.096748,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.31653,-0.12919,-0.066759,0,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.37932,-0.12924,-0.093896,0,0
3,GO EXTRACELLULAR TRANSPORT,0.14048,-0.12951,-0.11626,0,0
3,GO NEURON PROJECTION REGENERATION,0.11235,-0.12984,-0.10481,0,0
3,GO MITOCHONDRION DISTRIBUTION,0.12689,-0.13075,-0.14622,0,0
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.22235,-0.13148,-0.10074,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.10845,-0.13173,-0.09986,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.016339,-0.13234,-0.2109,0,0
3,GO AXONAL TRANSPORT,0.012203,-0.13237,-0.12528,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.14526,-0.13273,-0.068723,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.37932,-0.13324,-0.055189,0,0
3,GO TRANSPOSITION,0.35153,-0.13347,-0.09833,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.1313,-0.13373,-0.11991,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.4545,-0.13375,-0.062264,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.050569,-0.13416,-0.082218,0,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.077957,-0.13482,-0.11841,0,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.064293,-0.13572,-0.11269,0,0
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.42347,-0.13589,-0.036377,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.96163,-0.13596,0.074661,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.54903,-0.1361,-0.028147,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.30402,-0.13623,-0.047756,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.92682,-0.13659,0.065792,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.4978,-0.13706,-0.088108,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.18219,-0.13793,-0.071636,0,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.21579,-0.13849,-0.076694,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.076492,-0.1394,-0.14104,0,0
3,GO LOCOMOTOR RHYTHM,0.31653,-0.13949,-0.074566,0,0
3,GO POLYOL TRANSPORT,0.12049,-0.13966,-0.11352,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.11235,-0.14091,-0.11076,0,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.27999,-0.14137,-0.080348,0,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.066855,-0.14155,-0.17658,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.40843,-0.14174,-0.094223,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.05161,-0.14183,-0.11,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.072231,-0.14216,-0.24311,0,0
3,GO CARDIAC VENTRICLE FORMATION,0.43883,-0.14283,-0.11842,0,0
3,GO NEUROTRANSMITTER REUPTAKE,0.11235,-0.14363,-0.14795,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.16032,-0.14379,-0.14586,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.36526,-0.14418,-0.072774,0,0
3,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.099158,-0.14445,-0.1379,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0064317,-0.14452,-0.15153,0,0
3,GO ADULT HEART DEVELOPMENT,0.188,-0.14493,-0.10864,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.15264,-0.1456,-0.072488,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.1313,-0.14565,-0.1463,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.16294,-0.14591,-0.13753,0,0
3,GO LYMPH NODE DEVELOPMENT,0.0054795,-0.14679,-0.19679,0,0
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.076492,-0.14684,-0.15905,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.20309,-0.14692,-0.12076,0,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.26098,-0.14701,-0.10159,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.4598,-0.14714,-0.1015,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.13814,-0.14727,-0.13389,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.11841,-0.14773,-0.14182,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.042857,-0.14797,-0.15023,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.29184,-0.14837,-0.076838,0,0
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.068167,-0.15047,-0.18969,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.10845,-0.15123,-0.12227,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12908,-0.15216,-0.14626,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.088862,-0.15233,-0.11641,0,0
3,GO SEROTONIN TRANSPORT,0.072231,-0.15256,-0.1502,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.080955,-0.15285,-0.20337,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.015953,-0.15355,-0.16147,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.11434,-0.15388,-0.23924,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.2839,-0.15525,-0.047982,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.0050528,-0.15588,-0.19041,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.22905,-0.15631,-0.067598,0,0
3,GO RESPONSE TO INTERLEUKIN 2,0.26847,-0.15742,-0.051292,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.13583,-0.15784,-0.22537,0,0
3,GO REGULATION OF OOGENESIS,0.0064317,-0.15987,-0.16671,0,0
3,GO CGMP METABOLIC PROCESS,0.088862,-0.16022,-0.18154,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.17374,-0.16033,-0.086828,0,0
3,GO REVERSE CHOLESTEROL TRANSPORT,0.11636,-0.16212,-0.10515,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.30815,-0.1627,-0.042584,0,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.10654,-0.16368,-0.15458,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.057089,-0.16414,-0.11863,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.017549,-0.16417,-0.14253,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.15015,-0.16536,-0.15492,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.021165,-0.16641,-0.15652,0,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.43883,-0.16769,-0.07779,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.015203,-0.16814,-0.1613,0,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.057089,-0.16827,-0.22606,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15015,-0.16831,-0.1265,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.093897,-0.16898,-0.15925,0,0
3,GO CARDIAC CHAMBER FORMATION,0.59664,-0.16921,-0.072117,0,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0059384,-0.16946,-0.16507,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.0040578,-0.16946,-0.25782,0,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.24643,-0.17009,-0.091487,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.20937,-0.17013,-0.15406,0,0
3,GO RESPONSE TO FORSKOLIN,0.16294,-0.1702,-0.18278,0,0
3,GO RESPONSE TO ACIDIC PH,0.21256,-0.17072,-0.075048,0,0
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.12473,-0.17136,-0.25829,0,0
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.066855,-0.17161,-0.23609,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.095625,-0.17249,-0.21678,0,0
3,GO FAT CELL PROLIFERATION,0.036164,-0.17292,-0.16883,0,0
3,GO ACROSOME ASSEMBLY,0.0083534,-0.17352,-0.19573,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.30815,-0.17428,-0.033504,0,0
3,GO PALLIUM DEVELOPMENT,0.0015653,-0.17567,-0.14705,0,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.13355,-0.17615,-0.10735,0,0
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.070855,-0.17745,-0.18714,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.36064,-0.17825,-0.05041,0,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.20621,-0.17842,-0.18358,0,0
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.068167,-0.17932,-0.18819,0,0
3,GO SEROTONIN SECRETION,0.14769,-0.1808,-0.14028,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.17374,-0.18088,-0.11426,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.050569,-0.18235,-0.11761,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0071468,-0.18535,-0.22766,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00069957,-0.18536,-0.1909,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.072231,-0.18568,-0.12709,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.14769,-0.18571,-0.093435,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.1313,-0.18582,-0.11611,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.47049,-0.18869,-0.044765,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.063042,-0.18951,-0.13265,0,0
3,GO THALAMUS DEVELOPMENT,0.034637,-0.19188,-0.18599,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.043763,-0.19244,-0.2046,0,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.015203,-0.19252,-0.25942,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.13355,-0.19306,-0.20037,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.11235,-0.19393,-0.12321,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.099158,-0.19448,-0.11954,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.23589,-0.19481,-0.076242,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.011904,-0.19533,-0.15912,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.070855,-0.19537,-0.1644,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.00024286,-0.1956,-0.21812,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.04854,-0.19607,-0.12202,0,0
3,GO RESPONSE TO CAFFEINE,0.2,-0.19619,-0.081134,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.0021062,-0.19639,-0.15376,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.072231,-0.19783,-0.18831,0,0
3,GO GLYCINE TRANSPORT,0.16828,-0.19857,-0.11215,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.32077,-0.19871,-0.1085,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.025994,-0.19873,-0.12033,0,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.31232,-0.20125,-0.11076,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.075049,-0.20219,-0.19945,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.14769,-0.20318,-0.25056,0,0
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.14769,-0.20486,-0.1663,0,0
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.070855,-0.20529,-0.25252,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.24288,-0.20747,-0.062903,0,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.32938,-0.20928,-0.085681,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.072231,-0.20931,-0.12411,0,0
3,GO METENCEPHALON DEVELOPMENT,0.00024286,-0.20958,-0.21474,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.059411,-0.20975,-0.22862,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.084046,-0.21006,-0.13761,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00090094,-0.21099,-0.22898,0,0
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0011199,-0.21193,-0.15183,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23589,-0.21357,-0.17754,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0019282,-0.21561,-0.20128,0,0
3,GO MEMBRANE FISSION,0.027188,-0.21853,-0.17776,0,0
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.12689,-0.22088,-0.16998,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.1028,-0.22333,-0.13178,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0062634,-0.22368,-0.26946,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00055855,-0.22428,-0.20221,0,0
3,GO REGULATION OF MICROTUBULE BINDING,5.4121e-05,-0.22612,-0.30663,0,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.064293,-0.22825,-0.16631,0,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00050664,-0.23064,-0.25715,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.092194,-0.23087,-0.14966,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.17653,-0.23097,-0.1239,0,0
3,GO SYNAPSE ASSEMBLY,0.0036303,-0.23157,-0.18532,0,0
3,GO MALE MEIOSIS I,0.0037331,-0.23344,-0.24029,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.62732,-0.23429,-0.085272,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.5726,-0.23449,-0.042311,0,0
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.053746,-0.23517,-0.20494,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.00034072,-0.23614,-0.29599,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.64605,-0.23701,-0.10036,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.14526,-0.23703,-0.21982,0,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.15015,-0.23978,-0.14812,0,0
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.092194,-0.2423,-0.17733,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.033894,-0.24343,-0.25084,0,0
3,GO SIALYLATION,0.079444,-0.24466,-0.17385,0,0
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.001228,-0.24626,-0.19075,0,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.013798,-0.2513,-0.19657,0,0
3,GO CELL FATE DETERMINATION,0.0042883,-0.2516,-0.20779,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.00010845,-0.25222,-0.25972,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.25001,-0.25362,-0.10568,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.019283,-0.25741,-0.24244,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.001191,-0.2593,-0.21367,0,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.15517,-0.25951,-0.16165,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.0071468,-0.26726,-0.23054,0,0
3,GO INTRACILIARY TRANSPORT,0.0036303,-0.27263,-0.22285,0,0
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.015953,-0.27494,-0.22759,0,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.11039,-0.27672,-0.17588,0,0
3,GO RETINA LAYER FORMATION,0.0050528,-0.27678,-0.28371,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.073629,-0.27972,-0.17909,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0022332,-0.28015,-0.22576,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0026572,-0.28148,-0.29187,0,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.13583,-0.28436,-0.19438,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.001228,-0.28675,-0.22839,0,0
3,GO HORMONE CATABOLIC PROCESS,0.02068,-0.29056,-0.24386,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.01282,-0.29809,-0.19251,0,0
3,GO GROOMING BEHAVIOR,0.0085714,-0.29981,-0.25225,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,5.4121e-05,-0.302,-0.30495,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.088862,-0.30236,-0.21449,0,0
3,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.25363,-0.30284,-0.22861,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0060989,-0.30568,-0.1973,0,0
3,GO KERATINOCYTE DEVELOPMENT,0.17934,-0.30645,-0.1702,0,0
3,GO TOXIN METABOLIC PROCESS,0.05824,-0.3095,-0.19951,0,0
3,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.014841,-0.31029,-0.39114,0,0
3,GO HEART FORMATION,0.0013872,-0.31205,-0.32478,0,0
3,GO MAST CELL MIGRATION,0.30815,-0.32279,-0.10288,0,0
3,GO NOREPINEPHRINE SECRETION,0.00012964,-0.32373,-0.34996,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0011199,-0.32514,-0.33104,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0054795,-0.32695,-0.2334,0,0
3,GO ACIDIC AMINO ACID TRANSPORT,1.1964e-05,-0.34653,-0.32267,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.29992,-0.34683,-0.035639,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00029782,-0.34831,-0.34391,0,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.095625,-0.35229,-0.23167,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,1.5816e-05,-0.35697,-0.35393,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.025414,-0.36232,-0.257,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.00081984,-0.37208,-0.38575,0,0
3,GO LUNG CELL DIFFERENTIATION,0.23937,-0.37364,-0.16087,0,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00016023,-0.37882,-0.31114,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0066042,-0.38511,-0.25758,0,0
3,GO CEREBELLAR CORTEX FORMATION,5.0226e-05,-0.38593,-0.34616,0,0
3,GO SPERM AXONEME ASSEMBLY,0.00026003,-0.38965,-0.32646,0,0
3,GO CARDIOBLAST PROLIFERATION,0.033894,-0.39484,-0.36108,0,0
3,GO PITUITARY GLAND DEVELOPMENT,0.00025131,-0.40645,-0.35278,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00079435,-0.41032,-0.46631,0,0
3,GO INCLUSION BODY ASSEMBLY,0.00018427,-0.41345,-0.3703,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0059384,-0.4163,-0.39774,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0067808,-0.41804,-0.33631,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.017549,-0.42591,-0.33704,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00034072,-0.43245,-0.43805,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.001986,-0.43263,-0.40151,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0021689,-0.43689,-0.30675,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,5.0226e-05,-0.44506,-0.40873,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.00040247,-0.44954,-0.48373,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,8.7323e-05,-0.4634,-0.5653,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00021167,-0.46975,-0.51629,0,0
3,GO PARENTAL BEHAVIOR,0.0001165,-0.4833,-0.42934,0,0
3,GO REGULATION OF SYNAPSE MATURATION,0.0028141,-0.49399,-0.37768,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.00098941,-0.49417,-0.38242,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,9.0179e-06,-0.51025,-0.46609,0,0
3,GO NEURON FATE SPECIFICATION,0.0022332,-0.5165,-0.3905,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00065623,-0.52796,-0.41199,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,3.9418e-06,-0.56376,-0.51056,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,7.0571e-06,-0.64924,-0.59559,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0028957,-0.65138,-0.48739,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,9.7346e-05,-0.66093,-0.50387,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,3.6228e-06,-0.67931,-0.61885,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00040247,-0.68225,-0.57906,0,0
3,GO NOSE DEVELOPMENT,0.00092958,-0.68387,-0.49443,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.6623e-06,-0.69416,-0.66073,0,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,5.508e-06,-0.84992,-0.78528,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00019753,-1.2367,-0.91664,0,0
4,GO BLEB ASSEMBLY,1.1237e-07,1.6202,1.4836,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.3218e-05,1.537,1.3321,1,1
4,GO MEMBRANE RAFT ASSEMBLY,9.4334e-07,1.4257,1.6075,1,1
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,6.8936e-07,1.2317,1.0334,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,7.8282e-05,1.2056,1.0142,1,1
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,1.071e-07,1.1934,1.1733,1,1
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.6603e-06,1.1702,1.1577,1,1
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,6.5896e-07,1.1589,1.0076,1,1
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.8084e-07,1.134,1.0144,1,1
4,GO TROPHOBLAST CELL MIGRATION,1.0207e-07,1.0912,0.96928,1,1
4,GO RESPONSE TO INTERFERON ALPHA,4.5813e-07,1.076,1.1429,1,1
4,GO T HELPER 2 CELL DIFFERENTIATION,3.9926e-07,1.0692,1.0034,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.6228e-06,1.0476,1.0026,1,1
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.8251e-06,1.0451,0.9169,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00017796,1.0416,0.74827,1,1
4,GO NEUTROPHIL HOMEOSTASIS,3.9926e-07,1.0348,0.98055,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,1.8084e-07,1.0286,1.0431,1,1
4,GO HYALURONAN CATABOLIC PROCESS,3.6563e-08,1.0272,1.1005,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,8.1192e-05,1.0145,0.8732,1,1
4,GO RESPONSE TO INTERFERON BETA,1.4044e-06,1.0058,1.0056,1,1
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,1.8958e-07,0.99939,1.0022,1,1
4,GO GLYCOPROTEIN CATABOLIC PROCESS,8.4155e-08,0.99651,0.92658,1,1
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,7.9801e-06,0.97653,0.82404,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.4878e-05,0.96933,0.81612,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,3.4772e-07,0.93268,0.98915,1,1
4,GO NEGATIVE REGULATION OF CELL KILLING,7.9801e-06,0.92892,0.80681,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,2.0033e-05,0.92141,0.81434,1,1
4,GO REGULATION OF METANEPHROS DEVELOPMENT,5.4272e-08,0.92007,0.9478,1,1
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,9.8628e-07,0.91994,0.86583,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,1.5201e-05,0.9193,0.8749,1,1
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,1.5816e-05,0.91599,0.78809,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00016595,0.91524,0.68482,1,1
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.2424e-08,0.91414,0.94863,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,3.4728e-06,0.90936,0.87337,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,6.5896e-07,0.90321,0.82466,1,1
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.6228e-06,0.89257,1.0796,1,1
4,GO HEMIDESMOSOME ASSEMBLY,1.6455e-05,0.88469,1.1712,1,1
4,GO T HELPER 1 CELL DIFFERENTIATION,3.0264e-07,0.87942,0.82221,1,1
4,GO ENDODERMAL CELL DIFFERENTIATION,4.9191e-08,0.87035,0.93596,1,1
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,8.628e-07,0.86993,0.81337,1,1
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00016023,0.8676,0.79602,1,1
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,1.4044e-06,0.86521,0.72344,1,1
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,8.0176e-08,0.86182,0.87975,1,1
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,5.0683e-06,0.85999,0.77134,1,1
4,GO COLLAGEN BIOSYNTHETIC PROCESS,6.2859e-08,0.85508,0.85239,1,1
4,GO MEMBRANE RAFT ORGANIZATION,1.3441e-06,0.85217,0.95192,1,1
4,GO BONE TRABECULA FORMATION,0.00011241,0.84028,0.79195,1,1
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,2.5122e-07,0.83422,0.79977,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.4994e-06,0.83326,0.67467,1,1
4,GO CD40 SIGNALING PATHWAY,9.2696e-08,0.82693,0.78863,1,1
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.5691e-07,0.82175,0.78534,1,1
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.8084e-07,0.81999,0.76049,1,1
4,GO INFLAMMATORY RESPONSE TO WOUNDING,1.0311e-06,0.81759,0.93372,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,9.4334e-07,0.81364,0.87121,1,1
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,5.2837e-06,0.80982,0.86645,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,1.9904e-06,0.80446,0.63411,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.9301e-06,0.80137,0.65367,1,1
4,GO ZYMOGEN INHIBITION,5.753e-07,0.79652,0.80434,1,1
4,GO PLASMINOGEN ACTIVATION,0.00010092,0.79105,0.62348,1,1
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.3763e-07,0.79033,0.73223,1,1
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.4728e-06,0.78315,0.65368,1,1
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.0829e-07,0.78271,0.78567,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,1.8521e-05,0.7774,0.63198,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,9.8628e-07,0.77482,0.67983,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.77167,0.65046,1,1
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.0033e-05,0.76869,0.61658,1,1
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.4044e-06,0.76756,0.72141,1,1
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.5122e-07,0.76737,0.74242,1,1
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00081984,0.76704,0.61104,1,1
4,GO CHRONIC INFLAMMATORY RESPONSE,4.4572e-08,0.76567,0.81147,1,1
4,GO ENDODERM FORMATION,6.6003e-08,0.76452,0.82532,1,1
4,GO HIPPO SIGNALING,2.0784e-06,0.75833,0.62243,1,1
4,GO CHAPERONE MEDIATED AUTOPHAGY,5.8301e-05,0.75597,0.61384,1,1
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,8.2505e-07,0.75166,0.72035,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00012512,0.75149,0.63767,1,1
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.8077e-06,0.74902,0.80662,1,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.1776e-06,0.74323,0.65467,1,1
4,GO CYSTEINE METABOLIC PROCESS,7.547e-05,0.74235,0.59077,1,1
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.2308e-06,0.74179,0.68499,1,1
4,GO EPIBOLY,9.2696e-08,0.73565,0.79916,1,1
4,GO LATERAL MESODERM DEVELOPMENT,9.3916e-06,0.73191,0.60779,1,1
4,GO GAP JUNCTION ASSEMBLY,8.628e-07,0.73129,0.67873,1,1
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.2366e-07,0.72952,0.67823,1,1
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,5.6999e-08,0.72741,0.72055,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.6455e-05,0.72536,0.70767,1,1
4,GO CELLULAR RESPONSE TO X RAY,3.1888e-05,0.72155,0.55245,1,1
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.5774e-06,0.72044,0.66677,1,1
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.2424e-08,0.71993,0.71921,1,1
4,GO RESPONSE TO MURAMYL DIPEPTIDE,4.3763e-07,0.71959,0.66344,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.4674e-06,0.71211,0.66611,1,1
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.3441e-06,0.70893,0.67334,1,1
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,2.3418e-05,0.70463,0.61357,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,4.4712e-06,0.70343,0.72451,1,1
4,GO LEUKOCYTE AGGREGATION,0.00023468,0.69722,0.5829,1,1
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,2.2879e-07,0.69195,0.66353,1,1
4,GO MULTI ORGANISM CELLULAR PROCESS,3.4772e-07,0.68664,0.84811,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,5.2837e-06,0.68636,0.60558,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00044439,0.68562,0.62353,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,9.3916e-06,0.68372,0.6945,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,4.0073e-05,0.68327,0.5481,1,1
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.8131e-07,0.68278,0.6349,1,1
4,GO VASCULOGENESIS,3.6563e-08,0.68204,0.6538,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,7.889e-07,0.67903,0.81183,1,1
4,GO FIBRINOLYSIS,6.5896e-07,0.67892,0.82778,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.5331e-06,0.67604,0.59747,1,1
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.906e-06,0.66631,0.71738,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,4.0073e-05,0.66583,0.57596,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,4.3763e-07,0.66483,0.71001,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.5816e-05,0.66109,0.47875,1,1
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.5759e-05,0.66063,0.59806,1,1
4,GO T CELL EXTRAVASATION,7.6603e-06,0.66048,0.67073,1,1
4,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.1964e-05,0.66029,0.73701,1,1
4,GO REGULATION OF PINOCYTOSIS,3.9418e-06,0.65699,0.66586,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,6.0504e-05,0.65196,0.59068,1,1
4,GO SKIN MORPHOGENESIS,1.7118e-05,0.65191,0.78369,1,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,8.3127e-06,0.64875,0.61738,1,1
4,GO SALIVARY GLAND DEVELOPMENT,2.4692e-06,0.64757,0.62551,1,1
4,GO APOPTOTIC CELL CLEARANCE,1.3605e-07,0.64512,0.72745,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,2.3654e-06,0.64366,0.64371,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,5.4121e-05,0.6423,0.51051,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00011241,0.64199,0.61132,1,1
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0001165,0.64162,0.53407,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.7578e-07,0.64148,0.62761,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.2111e-07,0.64007,0.6592,1,1
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,1.6729e-06,0.6392,0.59043,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,5.0226e-05,0.63898,0.52941,1,1
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,6.4994e-06,0.63626,0.71843,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.9841e-06,0.63346,0.67457,1,1
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,7.2754e-05,0.63336,0.53998,1,1
4,GO PIGMENT GRANULE MATURATION,5.0226e-05,0.63062,0.46882,1,1
4,GO NEGATIVE REGULATION OF CELL AGING,2.7104e-08,0.62907,0.63903,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.6603e-06,0.62864,0.53364,1,1
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.9301e-06,0.62737,0.71842,1,1
4,GO REGULATION OF AMYLOID BETA CLEARANCE,1.104e-05,0.62689,0.52799,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.1617e-05,0.62645,0.52547,1,1
4,GO NOTOCHORD DEVELOPMENT,6.2985e-07,0.62633,0.70423,1,1
4,GO ENDODERM DEVELOPMENT,1.6452e-07,0.62469,0.66681,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.6452e-07,0.62358,0.678,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,2.4346e-05,0.62346,0.50282,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,3.0689e-05,0.62256,0.57686,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,9.7801e-06,0.62202,0.65902,1,1
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,7.5427e-07,0.61556,0.56702,1,1
4,GO DNA DEAMINATION,1.5816e-05,0.61555,0.60349,1,1
4,GO AMYLOID BETA CLEARANCE,8.4155e-08,0.61524,0.54825,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,9.389e-05,0.61339,0.55027,1,1
4,GO VAGINA DEVELOPMENT,3.3202e-07,0.61256,0.65971,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,2.1663e-05,0.61217,0.53119,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.4044e-06,0.61151,0.55407,1,1
4,GO REGULATION OF ISOTYPE SWITCHING,3.0576e-06,0.61138,0.49239,1,1
4,GO SNRNA PROCESSING,0.00055855,0.60934,0.62006,1,1
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0081404,0.60817,0.41231,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00016595,0.60764,0.55067,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,7.9801e-06,0.60628,0.69415,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,5.0683e-06,0.60619,0.49758,1,1
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.2658e-06,0.60537,0.57039,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,1.4609e-05,0.60305,0.62135,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,1.8251e-06,0.60224,0.65497,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,9.0221e-07,0.60223,0.61496,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.17e-07,0.60211,0.64619,1,1
4,GO COLLAGEN METABOLIC PROCESS,7.889e-07,0.60033,0.59808,1,1
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.2366e-07,0.59871,0.52701,1,1
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,5.2837e-06,0.59842,0.57506,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.8251e-06,0.5982,0.58861,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,6.2985e-07,0.59693,0.70293,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,5.508e-06,0.59621,0.47806,1,1
4,GO LIVER REGENERATION,5.6999e-08,0.59611,0.6007,1,1
4,GO BIOLOGICAL PHASE,0.00030804,0.59458,0.58572,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,1.8251e-06,0.59451,0.52684,1,1
4,GO HEME METABOLIC PROCESS,1.2308e-06,0.59409,0.53114,1,1
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.001872,0.59369,0.71041,1,1
4,GO REGULATION OF FIBRINOLYSIS,3.5759e-05,0.59308,0.60062,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,2.7343e-05,0.59277,0.51514,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.8958e-07,0.59276,0.61529,1,1
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.2308e-06,0.59159,0.654,1,1
4,GO CELLULAR RESPONSE TO IRON ION,1.2962e-05,0.59125,0.54788,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,1.2962e-05,0.58993,0.51416,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.349e-05,0.58951,0.57788,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.0689e-05,0.58926,0.65964,1,1
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,1.7118e-05,0.5891,0.56174,1,1
4,GO MUCUS SECRETION,0.0028957,0.58748,0.46948,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.6228e-06,0.58588,0.6777,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,4.8612e-06,0.58529,0.60886,1,1
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,5.0226e-05,0.58365,0.46739,1,1
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,8.6584e-06,0.58286,0.49544,1,1
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.0829e-07,0.58243,0.58483,1,1
4,GO MACROPHAGE PROLIFERATION,4.0073e-05,0.57999,0.56675,1,1
4,GO ELASTIC FIBER ASSEMBLY,0.00016595,0.57954,0.70907,1,1
4,GO BONE TRABECULA MORPHOGENESIS,0.0022332,0.57928,0.47339,1,1
4,GO MODULATION BY HOST OF VIRAL PROCESS,8.8325e-08,0.57919,0.6336,1,1
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,1.3605e-07,0.57918,0.63182,1,1
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,6.2367e-06,0.57865,0.60154,1,1
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00013433,0.57848,0.48403,1,1
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.9904e-06,0.57823,0.50676,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.2837e-06,0.57606,0.63028,1,1
4,GO AORTIC VALVE DEVELOPMENT,9.3916e-06,0.57598,0.53352,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,4.1112e-06,0.57423,0.62196,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,1.0184e-05,0.57321,0.5496,1,1
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00026903,0.57251,0.61432,1,1
4,GO ENTRY INTO HOST,3.17e-07,0.57198,0.59247,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.4674e-06,0.57079,0.49872,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.104e-05,0.56938,0.502,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,2.9532e-05,0.56806,0.73866,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.6455e-05,0.56519,0.46243,1,1
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,5.0194e-07,0.5628,0.61117,1,1
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0022992,0.56159,0.39377,1,1
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.6307e-05,0.55988,0.46954,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.0784e-06,0.55959,0.50843,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4712e-06,0.55853,0.53271,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.2862e-06,0.55774,0.48513,1,1
4,GO CELLULAR RESPONSE TO DSRNA,1.725e-07,0.557,0.57794,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.042857,0.55357,0.34697,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,9.7346e-05,0.55336,0.48007,1,1
4,GO REGULATION OF GLOMERULAR FILTRATION,0.00024286,0.5528,0.58782,1,1
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.0207e-07,0.55218,0.53285,1,1
4,GO TYPE 2 IMMUNE RESPONSE,7.9801e-06,0.5506,0.54977,1,1
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,2.0784e-06,0.5505,0.52172,1,1
4,GO CYTOLYSIS,1.2862e-06,0.54962,0.4966,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.4977e-07,0.5495,0.64045,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.17e-07,0.54697,0.52031,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.0576e-06,0.54645,0.5054,1,1
4,GO RESPONSE TO X RAY,5.4977e-07,0.54565,0.5777,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00042998,0.54443,0.45712,1,1
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00026903,0.54429,0.45909,1,1
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0007696,0.54281,0.3958,1,1
4,GO INTERLEUKIN 1 PRODUCTION,5.2837e-06,0.53987,0.48705,1,1
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,7.9801e-06,0.53874,0.50146,1,1
4,GO COLLAGEN CATABOLIC PROCESS,1.8251e-06,0.53677,0.57596,1,1
4,GO MESODERMAL CELL DIFFERENTIATION,1.5331e-06,0.53434,0.46425,1,1
4,GO ZYMOGEN ACTIVATION,1.9263e-05,0.53383,0.52862,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.7955e-07,0.5333,0.57902,1,1
4,GO TOLERANCE INDUCTION,0.00020448,0.53304,0.48451,1,1
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.8084e-07,0.53268,0.54957,1,1
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.5816e-05,0.53094,0.54671,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,8.1192e-05,0.53002,0.51754,1,1
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,3.8131e-07,0.5296,0.53414,1,1
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.033166,0.52838,0.29197,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,1.4674e-06,0.52806,0.50398,1,1
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,5.2837e-06,0.52665,0.47363,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,7.2754e-05,0.52653,0.442,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.2971e-07,0.52641,0.6023,1,1
4,GO XENOBIOTIC CATABOLIC PROCESS,0.0012662,0.52614,0.54319,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.025414,0.52405,0.29166,1,1
4,GO FORMATION OF PRIMARY GERM LAYER,1.2971e-07,0.52372,0.52548,1,1
4,GO SKELETAL MUSCLE TISSUE REGENERATION,2.4692e-06,0.52328,0.47487,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.8077e-06,0.52287,0.43441,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.2533e-07,0.52137,0.50961,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0001165,0.52076,0.45073,1,1
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0311e-06,0.51992,0.47903,1,1
4,GO VIRAL GENOME REPLICATION,1.5331e-06,0.51779,0.45913,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,0.51762,0.50648,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,6.5896e-07,0.51749,0.45881,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00023468,0.51714,0.43271,1,1
4,GO CELLULAR RESPONSE TO SALT STRESS,2.9301e-06,0.51547,0.55253,1,1
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00034072,0.51399,0.49181,1,1
4,GO RESPONSE TO INTERFERON GAMMA,3.1904e-06,0.51373,0.51566,1,1
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,3.3287e-06,0.51344,0.4293,1,1
4,GO RESPONSE TO TYPE I INTERFERON,7.2754e-05,0.51342,0.60157,1,1
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0007696,0.51309,0.42695,1,1
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.001986,0.51179,0.468,1,1
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,7.5427e-07,0.51143,0.51989,1,1
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.51114,0.43642,1,1
4,GO REGULATION OF MEMBRANE INVAGINATION,4.8379e-05,0.51054,0.50322,1,1
4,GO PULMONARY VALVE DEVELOPMENT,2.9532e-05,0.51006,0.52798,1,1
4,GO COLLAGEN FIBRIL ORGANIZATION,4.1802e-07,0.50975,0.75103,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,3.9418e-06,0.50831,0.45685,1,1
4,GO SEMI LUNAR VALVE DEVELOPMENT,7.0571e-06,0.5083,0.51712,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.986e-08,0.50793,0.51951,1,1
4,GO T CELL MEDIATED IMMUNITY,5.7413e-06,0.50749,0.46847,1,1
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.8131e-07,0.50644,0.445,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,8.4205e-05,0.50559,0.48982,1,1
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,2.8418e-05,0.50512,0.6686,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,2.1702e-06,0.50384,0.64394,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,1.5201e-05,0.50369,0.49493,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,3.5759e-05,0.50344,0.39801,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,2.7578e-07,0.50231,0.50057,1,1
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.9904e-06,0.50181,0.43838,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.4044e-06,0.50099,0.59299,1,1
4,GO NCRNA 3 END PROCESSING,0.0023671,0.50049,0.41998,1,1
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,3.1904e-06,0.49913,0.51372,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00055855,0.49904,0.43655,1,1
4,GO PEPTIDE CROSS LINKING,9.0551e-05,0.49844,0.51113,1,1
4,GO POSITIVE REGULATION OF ERAD PATHWAY,3.4772e-07,0.49818,0.48082,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,1.1267e-06,0.49778,0.5467,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.2862e-06,0.49739,0.54362,1,1
4,GO SNRNA METABOLIC PROCESS,0.00014935,0.49715,0.50159,1,1
4,GO LYMPHANGIOGENESIS,6.8936e-07,0.49659,0.49766,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00021909,0.49644,0.44276,1,1
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.013e-05,0.49636,0.51062,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0024367,0.49603,0.40703,1,1
4,GO RESPONSE TO HYPEROXIA,3.1888e-05,0.49576,0.50399,1,1
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,2.3418e-05,0.4957,0.60339,1,1
4,GO STORE OPERATED CALCIUM ENTRY,9.7801e-06,0.49539,0.40482,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00042998,0.49536,0.45955,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0006154,0.49409,0.42515,1,1
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0006154,0.49387,0.4633,1,1
4,GO PHAGOCYTOSIS RECOGNITION,4.6597e-05,0.49342,0.56282,1,1
4,GO DETECTION OF BIOTIC STIMULUS,5.9841e-06,0.49201,0.48496,1,1
4,GO GERMINAL CENTER FORMATION,0.00014935,0.49189,0.45072,1,1
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.3654e-06,0.48985,0.42737,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,8.3127e-06,0.48682,0.50153,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.0194e-07,0.4858,0.48739,1,1
4,GO PINOCYTOSIS,6.0198e-07,0.48579,0.6063,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,6.2859e-08,0.48568,0.49808,1,1
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.9904e-06,0.48502,0.45136,1,1
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00014418,0.48496,0.38321,1,1
4,GO PROTEIN OXIDATION,0.00028792,0.48447,0.48241,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,3.3287e-06,0.48156,0.47304,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.7801e-06,0.48118,0.48285,1,1
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.8583e-05,0.48084,0.41102,1,1
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00040247,0.48059,0.3766,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00013433,0.48017,0.48185,1,1
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,4.2876e-06,0.47981,0.5046,1,1
4,GO RESPONSE TO ANGIOTENSIN,6.0198e-07,0.47974,0.47927,1,1
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00037661,0.4782,0.39544,1,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.6174e-05,0.47789,0.43376,1,1
4,GO VIRAL RNA GENOME REPLICATION,8.8325e-08,0.47778,0.45863,1,1
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00014418,0.47666,0.37759,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,9.2696e-08,0.4766,0.42306,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00025131,0.47632,0.37753,1,1
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.00069957,0.47561,0.34712,1,1
4,GO PEPTIDYL PROLINE MODIFICATION,9.8628e-07,0.47554,0.39637,1,1
4,GO NIK NF KAPPAB SIGNALING,4.7955e-07,0.4751,0.42039,1,1
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.2862e-06,0.47487,0.50251,1,1
4,GO CYTOKINE METABOLIC PROCESS,1.5331e-06,0.47403,0.41655,1,1
4,GO BLOOD VESSEL REMODELING,2.0833e-05,0.47379,0.43883,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00021909,0.47378,0.45168,1,1
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00011241,0.47378,0.46108,1,1
4,GO REGULATION OF TRANSPOSITION,0.00014418,0.47325,0.46463,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,2.5122e-07,0.47301,0.53275,1,1
4,GO HYALURONAN METABOLIC PROCESS,1.1237e-07,0.47297,0.52167,1,1
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0047853,0.4729,0.35353,1,1
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,5.753e-07,0.47243,0.4334,1,1
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.7955e-07,0.47221,0.49545,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.5308e-05,0.47181,0.44513,1,1
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.2962e-05,0.47136,0.48344,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.9904e-06,0.47106,0.45275,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0087944,0.47047,0.40213,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0010528,0.46949,0.46298,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0014738,0.46929,0.37036,1,1
4,GO ENAMEL MINERALIZATION,0.00072223,0.4692,0.423,1,1
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,1.7806e-05,0.46886,0.43651,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.5308e-05,0.46844,0.45581,1,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,4.4878e-05,0.46829,0.42022,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,4.3763e-07,0.46814,0.50586,1,1
4,GO DEFENSE RESPONSE TO VIRUS,9.3916e-06,0.46678,0.41691,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,4.6597e-05,0.46674,0.43498,1,1
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,5.4977e-07,0.46666,0.50854,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.9418e-06,0.4665,0.41569,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.6455e-05,0.46553,0.46816,1,1
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.001662,0.46536,0.31918,1,1
4,GO MATURATION OF LSU RRNA,2.9532e-05,0.46526,0.46768,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,3.1904e-06,0.46434,0.45831,1,1
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.5308e-05,0.46346,0.50702,1,1
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0012662,0.46336,0.39519,1,1
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,6.7728e-06,0.46328,0.52107,1,1
4,GO RESPONSE TO INTERLEUKIN 12,2.7578e-07,0.4632,0.44563,1,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0024367,0.4632,0.38962,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.9904e-06,0.46315,0.41691,1,1
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00045924,0.46295,0.33024,1,1
4,GO REGULATION OF MRNA BINDING,3.3287e-06,0.4627,0.41994,1,1
4,GO OSTEOBLAST DEVELOPMENT,0.00022676,0.46245,0.40815,1,1
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,3.4421e-05,0.46232,0.46111,1,1
4,GO BONE GROWTH,7.0571e-06,0.4616,0.52384,1,1
4,GO PROTEIN ACTIVATION CASCADE,5.0683e-06,0.46127,0.40035,1,1
4,GO LYMPH VESSEL MORPHOGENESIS,1.1964e-05,0.46093,0.43354,1,1
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00010845,0.4598,0.52745,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.020205,0.4594,0.23727,1,1
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,6.2985e-07,0.45774,0.50017,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00022676,0.45763,0.41872,1,1
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.033166,0.45761,0.29427,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,5.2837e-06,0.45696,0.45234,1,1
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.5427e-07,0.45695,0.43908,1,1
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.8521e-05,0.45626,0.40839,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,6.2367e-06,0.45585,0.4609,1,1
4,GO RESPONSE TO PROGESTERONE,0.0017641,0.45583,0.32059,1,1
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.2658e-06,0.4558,0.46274,1,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.45573,0.4068,1,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00016023,0.45571,0.4926,1,1
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.00081984,0.4554,0.34936,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,4.2876e-06,0.45535,0.36981,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,3.4421e-05,0.45525,0.39758,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,8.3127e-06,0.45515,0.49197,1,1
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.5774e-06,0.45481,0.39375,1,1
4,GO ANIMAL ORGAN REGENERATION,2.3975e-07,0.45455,0.50144,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.6322e-07,0.45439,0.3975,1,1
4,GO PROTEASOME ASSEMBLY,4.1617e-05,0.45437,0.3364,1,1
4,GO REGULATION OF MYOBLAST FUSION,0.00023468,0.45363,0.50937,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.4268e-07,0.45311,0.41291,1,1
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,1.2962e-05,0.45257,0.48879,1,1
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,2.2879e-07,0.4525,0.50145,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.628e-07,0.45234,0.47687,1,1
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,8.2505e-07,0.45233,0.44963,1,1
4,GO MRNA TRANSCRIPTION,1.4039e-05,0.45148,0.38383,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.3654e-06,0.45052,0.39493,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,1.5331e-06,0.45007,0.39722,1,1
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.889e-07,0.44967,0.50353,1,1
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00017796,0.44966,0.36998,1,1
4,GO MUSCLE CELL FATE COMMITMENT,0.00027832,0.44965,0.41466,1,1
4,GO REPLICATIVE SENESCENCE,0.00353,0.44847,0.39897,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,5.4121e-05,0.44817,0.48627,1,1
4,GO CYTOPLASMIC TRANSLATION,0.00010845,0.44817,0.37787,1,1
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,9.4334e-07,0.44781,0.41043,1,1
4,GO VIRAL TRANSLATION,1.3441e-06,0.44742,0.46639,1,1
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00019079,0.44657,0.48508,1,1
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00010845,0.44599,0.40653,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9904e-06,0.44516,0.41648,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,2.2658e-06,0.44452,0.37293,1,1
4,GO PARAXIAL MESODERM DEVELOPMENT,7.8282e-05,0.44444,0.4301,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.6902e-06,0.44436,0.45121,1,1
4,GO CELLULAR COPPER ION HOMEOSTASIS,2.5308e-05,0.44397,0.53678,1,1
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00014935,0.4436,0.4002,1,1
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,4.4712e-06,0.44329,0.41603,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00031859,0.44306,0.32562,1,1
4,GO REGULATION OF TRANSLATIONAL TERMINATION,1.8521e-05,0.44305,0.39401,1,1
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.725e-07,0.4425,0.43634,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.3287e-06,0.44232,0.48818,1,1
4,GO MYELOID CELL APOPTOTIC PROCESS,7.547e-05,0.44199,0.42664,1,1
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.0012662,0.44186,0.37157,1,1
4,GO IRON ION TRANSMEMBRANE TRANSPORT,4.5813e-07,0.44172,0.37855,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.1663e-05,0.44164,0.43129,1,1
4,GO EMBRYO IMPLANTATION,2.6322e-07,0.44132,0.5358,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,4.8612e-06,0.44108,0.53545,1,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.1904e-06,0.44026,0.40879,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00050664,0.43989,0.47689,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.6015e-06,0.43934,0.44559,1,1
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,6.4994e-06,0.43912,0.42886,1,1
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.011047,0.43852,0.43959,1,1
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0014299,0.43804,0.52162,1,1
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0014299,0.43786,0.51255,1,1
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00063551,0.4374,0.51307,1,1
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00063551,0.4374,0.63563,1,1
4,GO RESPONSE TO FLUID SHEAR STRESS,5.0194e-07,0.43604,0.48761,1,1
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,6.2786e-05,0.43596,0.39399,1,1
4,GO INTERLEUKIN 2 PRODUCTION,5.753e-07,0.43407,0.45456,1,1
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,5.2533e-07,0.43302,0.41205,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,3.3132e-05,0.43244,0.39143,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00029782,0.43191,0.44502,1,1
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.7343e-05,0.43171,0.38489,1,1
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.4121e-05,0.43024,0.3901,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00069957,0.43016,0.44846,1,1
4,GO RECEPTOR CATABOLIC PROCESS,2.5774e-06,0.42956,0.43152,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00040247,0.4288,0.41113,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.6015e-06,0.42879,0.42076,1,1
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.906e-06,0.42869,0.58892,1,1
4,GO MAMMARY GLAND MORPHOGENESIS,1.104e-05,0.42862,0.4467,1,1
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,6.0504e-05,0.42837,0.37197,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00016595,0.42826,0.4472,1,1
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.7343e-05,0.42797,0.32597,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00045924,0.42784,0.37855,1,1
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.027188,0.42765,0.24147,1,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0045306,0.42732,0.38713,1,1
4,GO RIBOSOME ASSEMBLY,0.00021909,0.42689,0.37441,1,1
4,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0010859,0.42653,0.33772,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.5759e-05,0.42639,0.37995,1,1
4,GO FIBROBLAST MIGRATION,1.5331e-06,0.42632,0.42232,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,2.0033e-05,0.4263,0.43865,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.2366e-07,0.42609,0.46131,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00041602,0.42578,0.43941,1,1
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0031536,0.42541,0.3265,1,1
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.2366e-07,0.42501,0.39274,1,1
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,2.5122e-07,0.42457,0.54563,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,1.8521e-05,0.42362,0.38165,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,7.0571e-06,0.42352,0.41672,1,1
4,GO REGULATION OF FIBROBLAST MIGRATION,4.1112e-06,0.42312,0.44122,1,1
4,GO REGULATION OF HIPPO SIGNALING,0.00025131,0.42276,0.3656,1,1
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.045624,0.42165,0.24348,1,1
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.8301e-05,0.42162,0.37248,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0010859,0.42149,0.38134,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00045924,0.42118,0.48267,1,1
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0001547,0.42069,0.34638,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,3.1888e-05,0.42058,0.38257,1,1
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,2.1663e-05,0.42048,0.38773,1,1
4,GO CERAMIDE CATABOLIC PROCESS,6.0504e-05,0.4201,0.38148,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1776e-06,0.42008,0.42852,1,1
4,GO VIRAL LIFE CYCLE,3.0264e-07,0.41928,0.42543,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0001547,0.41923,0.36848,1,1
4,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.0038387,0.41914,0.53671,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.2454e-05,0.41881,0.36178,1,1
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,8.6584e-06,0.4188,0.38209,1,1
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,3.0689e-05,0.41844,0.39791,1,1
4,GO REGULATION OF RIBOSOME BIOGENESIS,7.6603e-06,0.41807,0.49516,1,1
4,GO VASCULAR TRANSPORT,0.0028141,0.41798,0.51373,1,1
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00020448,0.41777,0.40296,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00014935,0.41754,0.59989,1,1
4,GO MULTI ORGANISM LOCALIZATION,4.9191e-08,0.41721,0.4244,1,1
4,GO TELOMERASE RNA LOCALIZATION,0.00010845,0.41699,0.36499,1,1
4,GO REGULATION OF GASTRULATION,2.3975e-07,0.41601,0.41245,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00032948,0.41595,0.33092,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.2524e-05,0.4159,0.39301,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00030804,0.41575,0.33338,1,1
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,4.6623e-06,0.41524,0.44584,1,1
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.4143,0.36184,1,1
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,3.4772e-07,0.4132,0.40957,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,9.3916e-06,0.4132,0.36957,1,1
4,GO IMMATURE T CELL PROLIFERATION,3.8583e-05,0.41288,0.45111,1,1
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.349e-05,0.41274,0.38678,1,1
4,GO REGULATION OF STEROL TRANSPORT,6.2985e-07,0.41259,0.38198,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0015653,0.41227,0.31667,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,9.8628e-07,0.41222,0.40637,1,1
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,2.5308e-05,0.41174,0.33445,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00069957,0.41129,0.29911,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4044e-06,0.41099,0.39983,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00019079,0.41069,0.37711,1,1
4,GO I KAPPAB PHOSPHORYLATION,3.3132e-05,0.41068,0.3092,1,1
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,9.0221e-07,0.41033,0.42967,1,1
4,GO RESPONSE TO SALT STRESS,2.6902e-06,0.41028,0.3857,1,1
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0028141,0.41024,0.33095,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00019753,0.40996,0.35024,1,1
4,GO MATURATION OF SSU RRNA,9.0551e-05,0.40983,0.37767,1,1
4,GO COPPER ION HOMEOSTASIS,2.0784e-06,0.40959,0.50766,1,1
4,GO REGULATION OF STEM CELL DIFFERENTIATION,1.5331e-06,0.40922,0.37514,1,1
4,GO PLATELET AGGREGATION,5.0683e-06,0.40867,0.36513,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00012964,0.40854,0.45453,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.00029782,0.40834,0.342,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,2.2658e-06,0.40805,0.45816,1,1
4,GO INTERLEUKIN 17 PRODUCTION,8.2505e-07,0.40798,0.48558,1,1
4,GO HISTONE SERINE PHOSPHORYLATION,4.1112e-06,0.40748,0.44665,1,1
4,GO INTERACTION WITH SYMBIONT,5.508e-06,0.40735,0.35444,1,1
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,2.0033e-05,0.40725,0.58454,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.1617e-05,0.40626,0.43064,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,5.7413e-06,0.40615,0.41037,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.0604e-05,0.40562,0.39872,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.9801e-06,0.4053,0.47221,1,1
4,GO EXOCRINE SYSTEM DEVELOPMENT,7.013e-05,0.40486,0.43489,1,1
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,2.2524e-05,0.40417,0.49295,1,1
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00023468,0.40416,0.33159,1,1
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0036303,0.40393,0.40015,1,1
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,5.7413e-06,0.40352,0.48342,1,1
4,GO INTERLEUKIN 8 PRODUCTION,1.4609e-05,0.40344,0.37777,1,1
4,GO TRANSLATIONAL INITIATION,5.2139e-05,0.403,0.3605,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.3441e-06,0.40259,0.38901,1,1
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00037661,0.40258,0.356,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.1617e-05,0.40231,0.4844,1,1
4,GO CELL SUBSTRATE ADHESION,1.4044e-06,0.40222,0.41372,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.628e-07,0.40216,0.40876,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,6.7728e-06,0.40163,0.34615,1,1
4,GO FOREGUT MORPHOGENESIS,1.349e-05,0.40157,0.45945,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,5.4121e-05,0.40103,0.33543,1,1
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.0030654,0.40084,0.57233,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,7.8282e-05,0.39932,0.38795,1,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00065623,0.39931,0.39145,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,2.6902e-06,0.39927,0.36682,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00017186,0.39849,0.49779,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.5813e-07,0.39777,0.43334,1,1
4,GO INTERFERON BETA PRODUCTION,0.0001165,0.39715,0.2995,1,1
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00014935,0.39707,0.28036,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.7728e-06,0.39685,0.33904,1,1
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.023741,0.39657,0.31789,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,5.2139e-05,0.39652,0.36547,1,1
4,GO PRIMARY MIRNA PROCESSING,8.7323e-05,0.39624,0.38327,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.3441e-06,0.39594,0.33394,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.2308e-06,0.39547,0.50288,1,1
4,GO SPROUTING ANGIOGENESIS,1.2962e-05,0.3953,0.35812,1,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,2.1702e-06,0.39518,0.33824,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2454e-05,0.39516,0.43612,1,1
4,GO HAIR FOLLICLE MATURATION,0.0015653,0.39467,0.32374,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00030804,0.39438,0.35727,1,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00090094,0.39437,0.32512,1,1
4,GO PULMONARY VALVE MORPHOGENESIS,0.001191,0.39434,0.51396,1,1
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0019282,0.39327,0.3967,1,1
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.023741,0.39315,0.30851,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,2.9532e-05,0.39301,0.46268,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0030654,0.39272,0.38591,1,1
4,GO B CELL MEDIATED IMMUNITY,2.5774e-06,0.39219,0.35276,1,1
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00016595,0.39211,0.31308,1,1
4,GO PLATELET DEGRANULATION,2.6902e-06,0.39201,0.45925,1,1
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,3.3287e-06,0.39165,0.3422,1,1
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.104e-05,0.39129,0.34261,1,1
4,GO OSTEOCLAST DEVELOPMENT,5.9841e-06,0.39084,0.41501,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.9418e-06,0.39052,0.43315,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.029719,0.39009,0.47437,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00021909,0.38987,0.34272,1,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0079323,0.38965,0.30906,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,8.0176e-08,0.38928,0.37665,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.4712e-06,0.38909,0.35891,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00013433,0.38888,0.32394,1,1
4,GO INTERACTION WITH HOST,6.2985e-07,0.38851,0.43434,1,1
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.9301e-06,0.38821,0.40493,1,1
4,GO CHONDROCYTE DEVELOPMENT,0.00017186,0.38817,0.39047,1,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.3287e-06,0.38815,0.35503,1,1
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00059588,0.38813,0.34016,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,9.7801e-06,0.38778,0.35051,1,1
4,GO T CELL APOPTOTIC PROCESS,1.6729e-06,0.38743,0.36383,1,1
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.6455e-05,0.38722,0.39392,1,1
4,GO REGULATION OF PROTEIN IMPORT,8.3127e-06,0.38711,0.37908,1,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.4039e-05,0.38665,0.37537,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00098941,0.38633,0.40189,1,1
4,GO MUSCLE FILAMENT SLIDING,9.4334e-07,0.38628,0.41839,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,2.3975e-07,0.38616,0.38284,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00092958,0.3861,0.30747,1,1
4,GO RESPONSE TO ESTROGEN,1.9904e-06,0.38605,0.3778,1,1
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.001662,0.38604,0.4903,1,1
4,GO BASEMENT MEMBRANE ASSEMBLY,6.0504e-05,0.38559,0.56029,1,1
4,GO MATURATION OF 5 8S RRNA,0.00012512,0.38425,0.32521,1,1
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.00012074,0.38399,0.3414,1,1
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00029782,0.38396,0.30278,1,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00028792,0.38394,0.35911,1,1
4,GO ERBB2 SIGNALING PATHWAY,0.0001547,0.38381,0.29597,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00028792,0.38332,0.32387,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0022992,0.38332,0.331,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.018836,0.3829,0.29875,1,1
4,GO POSITIVE REGULATION OF TRANSLATION,4.9191e-08,0.38225,0.38719,1,1
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00054072,0.3818,0.35158,1,1
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0067808,0.38149,0.37362,1,1
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0010528,0.3813,0.38381,1,1
4,GO ARGININE METABOLIC PROCESS,0.00021909,0.38098,0.39643,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.0184e-05,0.38043,0.33361,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00028792,0.37978,0.38542,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0047853,0.37968,0.27982,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,1.104e-05,0.37912,0.34024,1,1
4,GO MEMBRANE INVAGINATION,1.0207e-07,0.37863,0.40224,1,1
4,GO NEGATIVE REGULATION OF CELL SIZE,4.6623e-06,0.37795,0.33384,1,1
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0015189,0.37771,0.42536,1,1
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,1.1964e-05,0.3776,0.31284,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.8251e-06,0.37732,0.36546,1,1
4,GO TYPE I INTERFERON PRODUCTION,1.4609e-05,0.37726,0.32799,1,1
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00020448,0.37719,0.3185,1,1
4,GO REGULATION OF PHAGOCYTOSIS,3.17e-07,0.37716,0.40851,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0038387,0.37671,0.42188,1,1
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0022332,0.37628,0.2832,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.1964e-05,0.37625,0.32639,1,1
4,GO GLAND MORPHOGENESIS,4.3218e-05,0.37522,0.41221,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,2.8418e-05,0.37495,0.38061,1,1
4,GO POSITIVE REGULATION OF HEART GROWTH,0.00026003,0.37486,0.31498,1,1
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00010845,0.37483,0.30565,1,1
4,GO REGULATION OF KIDNEY DEVELOPMENT,3.7145e-05,0.37481,0.35205,1,1
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,4.3218e-05,0.37455,0.41245,1,1
4,GO CARNITINE METABOLIC PROCESS,0.00040247,0.37435,0.34468,1,1
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00016023,0.37418,0.3585,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,3.7145e-05,0.37396,0.46547,1,1
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,7.8282e-05,0.37373,0.33779,1,1
4,GO VIRAL GENE EXPRESSION,1.7118e-05,0.37334,0.37695,1,1
4,GO POSITIVE REGULATION OF ORGAN GROWTH,1.9263e-05,0.37273,0.34379,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00029782,0.37209,0.29398,1,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,3.7791e-06,0.37192,0.39776,1,1
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.001872,0.3718,0.32209,1,1
4,GO FIBROBLAST PROLIFERATION,3.7145e-05,0.37164,0.3409,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,7.3528e-06,0.37147,0.36544,1,1
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,1.5201e-05,0.37096,0.33116,1,1
4,GO TRABECULA FORMATION,0.00052342,0.37094,0.45107,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.036948,0.37062,0.21831,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,3.0689e-05,0.36943,0.34969,1,1
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00065623,0.36932,0.33428,1,1
4,GO MEMBRANE DISASSEMBLY,0.00027832,0.36932,0.29925,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.5427e-07,0.36891,0.36789,1,1
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,4.0073e-05,0.3687,0.3934,1,1
4,GO RIG I SIGNALING PATHWAY,3.4421e-05,0.36825,0.37021,1,1
4,GO REGULATION OF LIPASE ACTIVITY,1.4609e-05,0.36824,0.2794,1,1
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00081984,0.36805,0.36957,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.0041716,0.3679,0.29498,1,1
4,GO GLIAL CELL ACTIVATION,3.3132e-05,0.36788,0.36745,1,1
4,GO CHONDROCYTE DIFFERENTIATION,7.0571e-06,0.36766,0.33175,1,1
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0006154,0.36671,0.35586,1,1
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.36639,0.27119,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.013e-05,0.366,0.32724,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.3127e-06,0.36579,0.42378,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0054795,0.36563,0.38914,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0034322,0.36536,0.29737,1,1
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00034072,0.36523,0.39902,1,1
4,GO ERAD PATHWAY,1.2308e-06,0.36505,0.30767,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00069957,0.36504,0.34157,1,1
4,GO REGULATION OF COAGULATION,2.7343e-05,0.3648,0.4143,1,1
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,2.9532e-05,0.36479,0.3134,1,1
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0015653,0.36442,0.38977,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,5.2837e-06,0.36359,0.35386,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.8521e-05,0.36351,0.39524,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.9418e-06,0.36329,0.49364,1,1
4,GO FOCAL ADHESION ASSEMBLY,7.3528e-06,0.36329,0.40534,1,1
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.4712e-06,0.36285,0.40413,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00016595,0.36279,0.272,1,1
4,GO MESODERM MORPHOGENESIS,2.8891e-07,0.36274,0.38224,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.4609e-05,0.36256,0.31787,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00095906,0.36245,0.35396,1,1
4,GO GENITALIA MORPHOGENESIS,0.0017641,0.36221,0.33722,1,1
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.349e-05,0.3622,0.37599,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00079435,0.36213,0.36151,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.001228,0.36203,0.28489,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00010092,0.36198,0.29342,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,2.4346e-05,0.36163,0.35248,1,1
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00079435,0.36051,0.35195,1,1
4,GO VASCULATURE DEVELOPMENT,4.1112e-06,0.36033,0.31669,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.045624,0.36024,0.21688,1,1
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.0015189,0.36023,0.33471,1,1
4,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0051916,0.36023,0.28318,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00049035,0.36016,0.43747,1,1
4,GO GASTRULATION,2.1831e-07,0.35998,0.38701,1,1
4,GO RESPONSE TO VIRUS,4.2876e-06,0.3591,0.36356,1,1
4,GO NEGATIVE REGULATION OF GENE SILENCING,7.2754e-05,0.35868,0.29828,1,1
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.0604e-05,0.35848,0.4102,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.5308e-05,0.35847,0.29108,1,1
4,GO FOREBRAIN MORPHOGENESIS,0.027188,0.35829,0.19678,1,1
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,9.7346e-05,0.35799,0.29216,1,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00021909,0.35799,0.26595,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,9.7801e-06,0.35757,0.39709,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0010206,0.35754,0.31076,1,1
4,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.027188,0.35714,0.23848,1,1
4,GO HYPOTONIC RESPONSE,0.00016595,0.35712,0.32895,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,6.2786e-05,0.35696,0.29233,1,1
4,GO WOUND HEALING,8.6584e-06,0.35685,0.33441,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.0833e-05,0.35633,0.32695,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.0036303,0.3562,0.31111,1,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0024367,0.35608,0.43759,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,5.2837e-06,0.35555,0.37305,1,1
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.3441e-06,0.35527,0.37314,1,1
4,GO REGULATION OF PROTEIN MATURATION,2.6902e-06,0.35515,0.36714,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00034072,0.35492,0.39162,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0062634,0.35477,0.27362,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.7118e-05,0.35458,0.31043,1,1
4,GO EPOXYGENASE P450 PATHWAY,0.0021689,0.3545,0.29184,1,1
4,GO ENDOTHELIAL CELL MIGRATION,1.5201e-05,0.35421,0.3406,1,1
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.5308e-05,0.35415,0.33292,1,1
4,GO SERTOLI CELL DEVELOPMENT,0.0023671,0.35364,0.31022,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,8.3127e-06,0.35336,0.36198,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.6174e-05,0.35295,0.32769,1,1
4,GO MATERNAL PLACENTA DEVELOPMENT,5.2139e-05,0.35283,0.38232,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,7.9801e-06,0.35225,0.31169,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0015189,0.3522,0.35896,1,1
4,GO RESPONSE TO MANGANESE ION,7.6603e-06,0.3521,0.34046,1,1
4,GO PIGMENT ACCUMULATION,0.0001547,0.35138,0.32351,1,1
4,GO NUCLEOSIDE SALVAGE,0.00095906,0.35108,0.43139,1,1
4,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00044439,0.35092,0.31778,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,1.9263e-05,0.35072,0.3416,1,1
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0056288,0.3507,0.28609,1,1
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.3654e-06,0.35015,0.34466,1,1
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.1888e-05,0.34969,0.26324,1,1
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.4421e-05,0.34844,0.38486,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.00038934,0.34802,0.30143,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.0571e-06,0.3479,0.32981,1,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.7323e-05,0.34714,0.43855,1,1
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00031859,0.34688,0.34565,1,1
4,GO L GLUTAMATE IMPORT,0.00038934,0.34672,0.35787,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,2.6902e-06,0.34652,0.36698,1,1
4,GO LENS FIBER CELL DEVELOPMENT,0.001872,0.34601,0.37409,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00045924,0.34569,0.39439,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00011241,0.34546,0.31263,1,1
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.0375e-08,0.34525,0.34067,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0007696,0.34498,0.27082,1,1
4,GO NCRNA PROCESSING,2.5308e-05,0.34461,0.30403,1,1
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.3418e-05,0.34451,0.37511,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.9904e-06,0.34431,0.34938,1,1
4,GO TISSUE MIGRATION,3.8583e-05,0.34364,0.30732,1,1
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,2.0033e-05,0.34364,0.3351,1,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.00022676,0.34331,0.37889,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0075304,0.3431,0.2846,1,1
4,GO BLOOD VESSEL MORPHOGENESIS,2.5774e-06,0.34289,0.32212,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.6729e-06,0.34281,0.39055,1,1
4,GO INNER CELL MASS CELL PROLIFERATION,0.00021909,0.34226,0.37044,1,1
4,GO PEPTIDE CATABOLIC PROCESS,1.104e-05,0.34213,0.29851,1,1
4,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0016129,0.34158,0.34907,1,1
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0090226,0.34122,0.24725,1,1
4,GO REGULATION OF HISTONE PHOSPHORYLATION,6.7596e-05,0.34108,0.34712,1,1
4,GO PROTEIN HYDROXYLATION,0.0046564,0.34105,0.3742,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.010245,0.34058,0.29353,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.0779e-06,0.34036,0.42456,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00059588,0.33985,0.30223,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.33959,0.27452,1,1
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00054072,0.33946,0.30081,1,1
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,4.4878e-05,0.33939,0.34297,1,1
4,GO T CELL MIGRATION,4.8379e-05,0.33927,0.30731,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00054072,0.33911,0.36866,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.33876,0.30838,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0023671,0.33853,0.39066,1,1
4,GO NATURAL KILLER CELL ACTIVATION,4.4712e-06,0.33817,0.33046,1,1
4,GO CARTILAGE DEVELOPMENT,2.1663e-05,0.33751,0.29274,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.5201e-05,0.33746,0.27946,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.349e-05,0.33712,0.45658,1,1
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0604e-05,0.33709,0.33633,1,1
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,4.5813e-07,0.33696,0.32253,1,1
4,GO REGULATION OF PROTEIN FOLDING,0.00013433,0.33692,0.27269,1,1
4,GO CORTICAL CYTOSKELETON ORGANIZATION,4.5813e-07,0.33631,0.34936,1,1
4,GO PROSTATIC BUD FORMATION,0.00087311,0.33585,0.45168,1,1
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,3.9418e-06,0.33546,0.31306,1,1
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021062,0.3352,0.31817,1,1
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0059384,0.33518,0.39457,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,9.3916e-06,0.3351,0.30708,1,1
4,GO FIBROBLAST ACTIVATION,0.0010859,0.3347,0.35971,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,3.3287e-06,0.33466,0.40503,1,1
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,9.7346e-05,0.33419,0.30144,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,5.4121e-05,0.3341,0.2725,1,1
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.7806e-05,0.3341,0.39181,1,1
4,GO REGULATION OF CALCIUM ION IMPORT,0.00081984,0.33395,0.21264,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00021167,0.33394,0.27285,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,4.4712e-06,0.33393,0.3397,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.3418e-05,0.33349,0.40185,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,4.5813e-07,0.33348,0.40688,1,1
4,GO IRON ION HOMEOSTASIS,1.9904e-06,0.33337,0.29119,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.00012964,0.33307,0.2633,1,1
4,GO DECIDUALIZATION,0.0028141,0.33303,0.3997,1,1
4,GO LENS FIBER CELL DIFFERENTIATION,0.00012964,0.33299,0.35197,1,1
4,GO ENDOCARDIAL CUSHION FORMATION,0.010245,0.3324,0.25072,1,1
4,GO MYOBLAST DIFFERENTIATION,7.9801e-06,0.33197,0.34007,1,1
4,GO AMYLOID FIBRIL FORMATION,0.0037331,0.33182,0.31092,1,1
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00044439,0.33181,0.33212,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00057693,0.3317,0.37076,1,1
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,7.547e-05,0.33161,0.29919,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00081984,0.33142,0.23567,1,1
4,GO REGULATION OF VASCULATURE DEVELOPMENT,6.4994e-06,0.33124,0.3086,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0041716,0.33107,0.28048,1,1
4,GO PROTEIN TARGETING TO VACUOLE,9.7801e-06,0.331,0.28905,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,5.2837e-06,0.33076,0.32005,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.33076,0.24713,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.7145e-05,0.33059,0.28758,1,1
4,GO RESPONSE TO WOUNDING,9.7801e-06,0.33042,0.28797,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,4.3218e-05,0.33019,0.26161,1,1
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.00016023,0.33008,0.29939,1,1
4,GO TISSUE REGENERATION,5.6174e-05,0.32996,0.316,1,1
4,GO SPINDLE MIDZONE ASSEMBLY,5.0226e-05,0.32992,0.32222,1,1
4,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.00035231,0.32987,0.34705,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.7413e-06,0.32971,0.2984,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00049035,0.32957,0.31638,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,3.7791e-06,0.32946,0.39779,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,8.1192e-05,0.32881,0.26985,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.8612e-06,0.3284,0.31024,1,1
4,GO PIGMENT METABOLIC PROCESS,6.2367e-06,0.32794,0.31283,1,1
4,GO REGENERATION,5.753e-07,0.32782,0.31146,1,1
4,GO TOOTH MINERALIZATION,0.0038387,0.32768,0.28371,1,1
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00081984,0.32768,0.29554,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00026903,0.327,0.31905,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0022992,0.32691,0.34381,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,2.2658e-06,0.32652,0.35008,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.00041602,0.3263,0.36731,1,1
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.0007696,0.32583,0.25501,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0032441,0.32576,0.32374,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00044439,0.32549,0.35337,1,1
4,GO MACROPHAGE APOPTOTIC PROCESS,0.00049035,0.3253,0.38365,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,2.0033e-05,0.32525,0.30646,1,1
4,GO MUSCLE CELL PROLIFERATION,5.9841e-06,0.32517,0.32699,1,1
4,GO COMPLEMENT ACTIVATION,2.6902e-06,0.32499,0.32038,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.2454e-05,0.32487,0.28297,1,1
4,GO ASYMMETRIC CELL DIVISION,0.00036427,0.32482,0.28376,1,1
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0025083,0.32481,0.30746,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00045924,0.32476,0.26561,1,1
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0021062,0.32454,0.25603,1,1
4,GO CELL REDOX HOMEOSTASIS,1.4609e-05,0.32449,0.29923,1,1
4,GO MACROPHAGE DIFFERENTIATION,8.4205e-05,0.32447,0.35753,1,1
4,GO REGULATION OF HEART GROWTH,2.6307e-05,0.32407,0.27893,1,1
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.3441e-06,0.32407,0.28376,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00029782,0.3239,0.30095,1,1
4,GO MONOCYTE CHEMOTAXIS,0.00026903,0.32306,0.33732,1,1
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00030804,0.32259,0.28955,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.02843,0.32249,0.18206,1,1
4,GO LYMPH VESSEL DEVELOPMENT,0.0021689,0.32248,0.33873,1,1
4,GO RESPONSE TO INTERLEUKIN 1,3.0576e-06,0.32236,0.35341,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00037661,0.32232,0.33249,1,1
4,GO REGULATION OF RNA BINDING,1.8251e-06,0.32229,0.32726,1,1
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0024367,0.32228,0.31841,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.015953,0.32214,0.31562,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.3287e-06,0.32205,0.35429,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.322,0.34007,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.023205,0.32195,0.22463,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.001191,0.32189,0.28596,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.2876e-06,0.32185,0.31692,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0011549,0.32181,0.23169,1,1
4,GO NEURAL CREST CELL MIGRATION,0.0042883,0.32181,0.25404,1,1
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0010206,0.32125,0.31164,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.00021909,0.3212,0.30991,1,1
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00036427,0.32043,0.21272,1,1
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00042998,0.32013,0.28712,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00021167,0.319,0.3633,1,1
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.9301e-06,0.31874,0.33197,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0027346,0.31856,0.29315,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0064317,0.31838,0.19883,1,1
4,GO ACTIVATION OF MAPKK ACTIVITY,2.5308e-05,0.31838,0.3141,1,1
4,GO HISTONE PHOSPHORYLATION,1.3441e-06,0.31819,0.30491,1,1
4,GO RESPONSE TO PARATHYROID HORMONE,9.389e-05,0.31814,0.35779,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00030804,0.31799,0.33109,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.4728e-06,0.31778,0.32173,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,9.0179e-06,0.31755,0.40472,1,1
4,GO NECROTIC CELL DEATH,7.8282e-05,0.31738,0.39379,1,1
4,GO RECEPTOR BIOSYNTHETIC PROCESS,1.349e-05,0.31729,0.3179,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,5.9841e-06,0.31723,0.40967,1,1
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0025083,0.31703,0.29035,1,1
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0097392,0.31662,0.27932,1,1
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.4044e-06,0.31659,0.35182,1,1
4,GO ASTROCYTE ACTIVATION,0.0010206,0.31652,0.31038,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00032948,0.31639,0.26239,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00047456,0.31617,0.30627,1,1
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0067808,0.3156,0.43487,1,1
4,GO CYTOKINETIC PROCESS,3.0689e-05,0.31522,0.29585,1,1
4,GO SYNCYTIUM FORMATION,5.4121e-05,0.31517,0.32681,1,1
4,GO PROTEIN DEGLYCOSYLATION,0.00014418,0.31509,0.32332,1,1
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0021062,0.31497,0.36082,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,2.0033e-05,0.31461,0.32994,1,1
4,GO INNATE IMMUNE RESPONSE,1.4039e-05,0.31441,0.27788,1,1
4,GO REGULATION OF SPROUTING ANGIOGENESIS,5.6174e-05,0.31417,0.33699,1,1
4,GO PLASMA MEMBRANE TUBULATION,1.1776e-06,0.31413,0.37146,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.1112e-06,0.31412,0.29353,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00016595,0.31346,0.23128,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.5816e-05,0.31333,0.3292,1,1
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.03939,0.31279,0.1933,1,1
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00036427,0.3127,0.29517,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00018427,0.31232,0.31437,1,1
4,GO LIPOPROTEIN LOCALIZATION,0.00013917,0.31231,0.39721,1,1
4,GO RNA 5 END PROCESSING,0.00026903,0.31199,0.28801,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,5.9841e-06,0.31172,0.30218,1,1
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00010462,0.31172,0.29202,1,1
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00013433,0.31169,0.28328,1,1
4,GO KERATINOCYTE MIGRATION,8.7323e-05,0.31165,0.3432,1,1
4,GO INTRACELLULAR MRNA LOCALIZATION,2.2524e-05,0.31153,0.37744,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,1.3441e-06,0.31129,0.28248,1,1
4,GO VESICLE CARGO LOADING,0.00010845,0.31075,0.29275,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.00038934,0.31035,0.26265,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,8.1192e-05,0.30967,0.27815,1,1
4,GO RRNA METABOLIC PROCESS,0.00012964,0.30964,0.30083,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00063551,0.30959,0.29875,1,1
4,GO CELLULAR HYPEROSMOTIC RESPONSE,9.0551e-05,0.30957,0.37805,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4039e-05,0.30918,0.29374,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,1.7118e-05,0.30894,0.43469,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,6.5149e-05,0.30894,0.29085,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.001872,0.30877,0.28226,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.2658e-06,0.30865,0.35243,1,1
4,GO GONADOTROPIN SECRETION,0.0071468,0.30838,0.26456,1,1
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.017137,0.30809,0.26241,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,2.3418e-05,0.30748,0.25106,1,1
4,GO REGULATION OF HEART MORPHOGENESIS,0.0025817,0.30672,0.30695,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00031859,0.3067,0.34436,1,1
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,7.3528e-06,0.30614,0.29803,1,1
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,4.4712e-06,0.30588,0.28108,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,6.0504e-05,0.30587,0.29954,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00049035,0.30567,0.27372,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.1192e-05,0.30565,0.33582,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00012074,0.30545,0.25859,1,1
4,GO TRNA 5 LEADER REMOVAL,0.0001547,0.30539,0.31858,1,1
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.007729,0.30531,0.20372,1,1
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,4.0073e-05,0.30525,0.25966,1,1
4,GO RESPONSE TO DSRNA,9.8628e-07,0.30518,0.37605,1,1
4,GO MACROPHAGE MIGRATION,3.9418e-06,0.30506,0.36068,1,1
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,4.3218e-05,0.30485,0.3339,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.001872,0.30485,0.26523,1,1
4,GO NCRNA METABOLIC PROCESS,5.2139e-05,0.30479,0.26796,1,1
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,3.9418e-06,0.30478,0.307,1,1
4,GO CELL MATRIX ADHESION,1.7118e-05,0.30469,0.34271,1,1
4,GO NUCLEAR ENVELOPE REASSEMBLY,1.2454e-05,0.30468,0.26794,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.6902e-06,0.30461,0.29689,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.046579,0.30444,0.39175,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,8.1192e-05,0.30437,0.34894,1,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2962e-05,0.304,0.40382,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00029782,0.30389,0.29192,1,1
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.00019753,0.30383,0.29042,1,1
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.889e-07,0.30344,0.24135,1,1
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.2524e-05,0.30341,0.28314,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00044439,0.30304,0.3445,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.906e-06,0.30251,0.44456,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0014738,0.30227,0.30753,1,1
4,GO TRANSLATIONAL TERMINATION,0.00057693,0.30227,0.24308,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0081404,0.30201,0.24022,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00012074,0.30194,0.32051,1,1
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,4.1617e-05,0.30191,0.34806,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,2.1702e-06,0.30181,0.35084,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.3441e-06,0.30171,0.3822,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.00055855,0.30164,0.26104,1,1
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.001191,0.30159,0.27792,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00014418,0.30158,0.24673,1,1
4,GO SELECTIVE AUTOPHAGY,3.17e-07,0.30121,0.32186,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,2.2524e-05,0.30117,0.30233,1,1
4,GO MUSCLE CELL MIGRATION,0.023205,0.30077,0.22351,1,1
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.7145e-05,0.30073,0.26853,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,1.0604e-05,0.30055,0.31976,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00067758,0.30023,0.27416,1,1
4,GO CARDIOBLAST DIFFERENTIATION,0.0037331,0.30007,0.31925,1,1
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,6.4994e-06,0.30003,0.29449,1,1
4,GO T CELL CYTOKINE PRODUCTION,9.3916e-06,0.29996,0.40732,1,1
4,GO URETER DEVELOPMENT,0.011904,0.29983,0.23486,1,1
4,GO LIPID IMPORT INTO CELL,0.0032441,0.29972,0.25292,1,1
4,GO STEROL TRANSPORT,2.5308e-05,0.29969,0.26096,1,1
4,GO SPERM EGG RECOGNITION,1.3441e-06,0.29954,0.27761,1,1
4,GO ETHANOL OXIDATION,0.031059,0.2994,0.30429,1,1
4,GO RRNA MODIFICATION,0.0021689,0.2993,0.22642,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.02843,0.29922,0.36721,1,1
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.1112e-06,0.29899,0.25283,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,8.6584e-06,0.29871,0.3205,1,1
4,GO FOAM CELL DIFFERENTIATION,0.00034072,0.29858,0.28637,1,1
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0056288,0.29853,0.36097,1,1
4,GO LYMPHOCYTE MIGRATION,5.6174e-05,0.29851,0.24202,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00026003,0.29845,0.36124,1,1
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00084609,0.29836,0.27165,1,1
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0041716,0.29829,0.22142,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0011199,0.29795,0.27465,1,1
4,GO AMINO SUGAR METABOLIC PROCESS,7.9801e-06,0.29783,0.28569,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.001872,0.29761,0.31318,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00026003,0.29748,0.25978,1,1
4,GO REGULATION OF MESODERM DEVELOPMENT,0.020205,0.29705,0.24385,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.6455e-05,0.2969,0.34688,1,1
4,GO RIBOSOME BIOGENESIS,0.00010092,0.29663,0.31796,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00010845,0.29605,0.31195,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.2879e-07,0.296,0.29876,1,1
4,GO RNA CATABOLIC PROCESS,4.5813e-07,0.29577,0.27874,1,1
4,GO AMEBOIDAL TYPE CELL MIGRATION,5.7413e-06,0.29555,0.2837,1,1
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.4421e-05,0.29543,0.27075,1,1
4,GO CHOLESTEROL EFFLUX,4.2876e-06,0.29542,0.32058,1,1
4,GO RESPONSE TO CYTOKINE,7.6603e-06,0.29539,0.30307,1,1
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00067758,0.2953,0.26988,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.2524e-05,0.29524,0.31439,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00032948,0.29502,0.23839,1,1
4,GO REGULATION OF MRNA CATABOLIC PROCESS,2.6902e-06,0.29489,0.25646,1,1
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0013457,0.29486,0.2767,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,3.9418e-06,0.2947,0.3112,1,1
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00021909,0.29444,0.35579,1,1
4,GO CYTOKINE PRODUCTION,1.2454e-05,0.2941,0.26883,1,1
4,GO REGULATION OF CELL AGING,1.4268e-07,0.29407,0.33608,1,1
4,GO INTERLEUKIN 5 PRODUCTION,0.014486,0.29383,0.26868,1,1
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.0779e-06,0.29365,0.25265,1,1
4,GO T CELL CHEMOTAXIS,4.6597e-05,0.29304,0.27183,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00012512,0.29295,0.34201,1,1
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,8.7323e-05,0.2926,0.26392,1,1
4,GO PIGMENT BIOSYNTHETIC PROCESS,9.0179e-06,0.29254,0.2905,1,1
4,GO COAGULATION,1.0604e-05,0.29223,0.29182,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00038934,0.29203,0.23173,1,1
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,6.0504e-05,0.29202,0.33534,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0031536,0.29199,0.23119,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0036303,0.29141,0.2024,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.014486,0.29138,0.3076,1,1
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00012512,0.29119,0.28939,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.628e-07,0.29105,0.33379,1,1
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00055855,0.29089,0.32118,1,1
4,GO NUCLEOSIDE METABOLIC PROCESS,1.4039e-05,0.29078,0.25405,1,1
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0053338,0.29072,0.23229,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0007696,0.29044,0.34819,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,8.3127e-06,0.29034,0.31033,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00065623,0.29023,0.18154,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.02166,0.2901,0.25645,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00035231,0.29,0.24499,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0001165,0.28977,0.30431,1,1
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00013917,0.28974,0.29384,1,1
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00018427,0.28965,0.41056,1,1
4,GO TRACHEA MORPHOGENESIS,0.0020453,0.28909,0.25979,1,1
4,GO TRNA 5 END PROCESSING,0.00010845,0.28894,0.3013,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.2139e-05,0.2886,0.28375,1,1
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00012964,0.28779,0.30882,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.6597e-05,0.28766,0.26542,1,1
4,GO SERTOLI CELL DIFFERENTIATION,0.0028141,0.28759,0.26741,1,1
4,GO COPPER ION TRANSPORT,6.2786e-05,0.28722,0.31354,1,1
4,GO RESPONSE TO BACTERIUM,1.7806e-05,0.2872,0.26679,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.2962e-05,0.28709,0.25178,1,1
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,5.508e-06,0.28707,0.2629,1,1
4,GO SYMBIOTIC PROCESS,1.6452e-07,0.28705,0.28642,1,1
4,GO HYPEROSMOTIC RESPONSE,0.00035231,0.2865,0.27454,1,1
4,GO MITRAL VALVE DEVELOPMENT,0.044685,0.28646,0.31554,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,9.0551e-05,0.28628,0.34389,1,1
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00013917,0.28627,0.28142,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.001662,0.28595,0.2762,1,1
4,GO OSTEOBLAST DIFFERENTIATION,1.7806e-05,0.28589,0.29213,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0069616,0.28584,0.47379,1,1
4,GO CELL CELL RECOGNITION,5.4977e-07,0.28569,0.30051,1,1
4,GO TRNA WOBBLE BASE MODIFICATION,0.0025083,0.2856,0.19463,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.00040247,0.28499,0.26649,1,1
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00045924,0.28445,0.31518,1,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.00021167,0.28443,0.42295,1,1
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00016023,0.28441,0.32742,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,5.0226e-05,0.28405,0.28948,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00090094,0.28405,0.20127,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,8.3127e-06,0.28401,0.25233,1,1
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.2786e-05,0.28401,0.33848,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.2454e-05,0.2838,0.26806,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.1888e-05,0.28378,0.24471,1,1
4,GO CORONARY VASCULATURE DEVELOPMENT,7.2754e-05,0.28367,0.31239,1,1
4,GO CHEMOKINE PRODUCTION,0.0019282,0.2836,0.25622,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00090094,0.28352,0.27363,1,1
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.0264e-07,0.28314,0.2503,1,1
4,GO MYOBLAST FUSION,0.00042998,0.28309,0.32007,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,2.3418e-05,0.28291,0.2761,1,1
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00019079,0.28284,0.26959,1,1
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,7.8282e-05,0.28274,0.27209,1,1
4,GO ASTROCYTE DEVELOPMENT,0.00019753,0.28267,0.31259,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.022165,0.28263,0.22768,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,3.9418e-06,0.28244,0.25902,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00016595,0.28222,0.21555,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.349e-05,0.2822,0.27405,1,1
4,GO RESPONSE TO PROTOZOAN,0.0013457,0.28213,0.28525,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,0.013465,0.28171,0.1997,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013917,0.28144,0.31943,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.011904,0.28094,0.20273,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,4.4878e-05,0.28075,0.29044,1,1
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.2754e-05,0.28061,0.36608,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00029782,0.28031,0.19958,1,1
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00010845,0.2803,0.29885,1,1
4,GO REGULATION OF GENE SILENCING,3.6228e-06,0.28012,0.24958,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.0060989,0.27924,0.2909,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0019282,0.27913,0.23043,1,1
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0021062,0.2791,0.2719,1,1
4,GO TISSUE REMODELING,0.00024286,0.27882,0.26365,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.031059,0.27824,0.17693,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0054795,0.27822,0.21743,1,1
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00054072,0.27804,0.22018,1,1
4,GO REGULATION OF ORGAN GROWTH,3.8131e-07,0.27763,0.32653,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00087311,0.2776,0.2834,1,1
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00019079,0.27752,0.34228,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.021165,0.27745,0.32363,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.2837e-06,0.27713,0.28953,1,1
4,GO PROTEIN FOLDING,3.3287e-06,0.27687,0.26021,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.00024286,0.27682,0.25774,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00092958,0.2768,0.20452,1,1
4,GO NEGATIVE REGULATION OF DNA REPAIR,8.3127e-06,0.27674,0.26394,1,1
4,GO ERK1 AND ERK2 CASCADE,1.4039e-05,0.27594,0.24463,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.00059588,0.27529,0.19027,1,1
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00021167,0.27523,0.30172,1,1
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.046579,0.27522,0.23118,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00022676,0.27517,0.25052,1,1
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00045924,0.27502,0.29665,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,9.7346e-05,0.27492,0.28283,1,1
4,GO CELLULAR RESPONSE TO LIPID,8.4205e-05,0.27488,0.2049,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00017186,0.27479,0.28495,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.2754e-05,0.27396,0.34051,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.7118e-05,0.27379,0.41789,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,1.5201e-05,0.27378,0.22928,1,1
4,GO RESPONSE TO IONIZING RADIATION,3.9418e-06,0.27378,0.27594,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.00034072,0.2735,0.28797,1,1
4,GO TRANSPOSITION,0.017137,0.27334,0.22313,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.3654e-06,0.2732,0.2455,1,1
4,GO LYMPHOCYTE CHEMOTAXIS,4.4712e-06,0.27312,0.30196,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.1192e-05,0.273,0.27723,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00069957,0.27278,0.3624,1,1
4,GO NUCLEOBASE METABOLIC PROCESS,0.00079435,0.27238,0.26115,1,1
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.015953,0.27228,0.21594,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.7346e-05,0.27212,0.23555,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00031859,0.27188,0.20007,1,1
4,GO MESODERM DEVELOPMENT,7.3528e-06,0.27184,0.23371,1,1
4,GO DNA LIGATION,0.00010462,0.27181,0.3051,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,7.547e-05,0.27171,0.22488,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00036427,0.27157,0.29141,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.00011241,0.27149,0.22639,1,1
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.031748,0.27144,0.3077,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00057693,0.27143,0.31548,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION,3.6414e-07,0.27113,0.28569,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,8.4205e-05,0.27105,0.21603,1,1
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.3441e-06,0.27062,0.34139,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.0571e-06,0.27041,0.31506,1,1
4,GO PEPTIDE BIOSYNTHETIC PROCESS,4.8612e-06,0.27039,0.24794,1,1
4,GO BONE MORPHOGENESIS,0.00020448,0.27018,0.27187,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00034072,0.26968,0.28374,1,1
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.001228,0.26909,0.30736,1,1
4,GO ACUTE PHASE RESPONSE,0.0085714,0.26901,0.26263,1,1
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.020205,0.26879,0.20972,1,1
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0037331,0.26864,0.25061,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00045924,0.26843,0.22655,1,1
4,GO PHAGOCYTOSIS,1.0311e-06,0.26827,0.3337,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.0013054,0.26819,0.2135,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.2962e-05,0.26815,0.27566,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,5.8301e-05,0.268,0.2303,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,9.0551e-05,0.26768,0.43824,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00010092,0.26759,0.25239,1,1
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00052342,0.26751,0.28039,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,5.2837e-06,0.2675,0.29041,1,1
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,1.5816e-05,0.26748,0.2561,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0014299,0.26717,0.31539,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.0779e-06,0.26716,0.2717,1,1
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00013433,0.26705,0.2505,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0036303,0.26677,0.28222,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.2754e-05,0.26676,0.24832,1,1
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00030804,0.26664,0.28785,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0016129,0.26639,0.21985,1,1
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,1.7118e-05,0.2662,0.28269,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0041716,0.26596,0.26727,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,7.013e-05,0.2657,0.37263,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001228,0.26549,0.23186,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0024367,0.26525,0.26204,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0071468,0.26523,0.279,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,4.3763e-07,0.26522,0.2728,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0045306,0.2651,0.28188,1,1
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0049174,0.26495,0.24024,1,1
4,GO GTP METABOLIC PROCESS,0.00011241,0.26495,0.32762,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00050664,0.26473,0.2916,1,1
4,GO REGULATION OF PROTEOLYSIS,1.349e-05,0.26473,0.21005,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.00055855,0.2647,0.19294,1,1
4,GO SEQUESTERING OF METAL ION,0.0039469,0.26461,0.23234,1,1
4,GO CELL AGING,2.8077e-06,0.26455,0.22643,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.0013457,0.26451,0.43266,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.26443,0.23141,1,1
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.0079323,0.26441,0.24154,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0040578,0.2644,0.22187,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00010845,0.26425,0.24193,1,1
4,GO TOXIN TRANSPORT,0.0022332,0.26416,0.18484,1,1
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0025817,0.26397,0.21574,1,1
4,GO DETECTION OF OTHER ORGANISM,0.0064317,0.26393,0.28754,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.7474e-06,0.26387,0.29351,1,1
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00029782,0.26345,0.24997,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00095906,0.26343,0.22679,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.027803,0.26329,0.16236,1,1
4,GO PROTEIN KINASE B SIGNALING,2.2524e-05,0.26305,0.21807,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00017796,0.26292,0.20864,1,1
4,GO VIRION ASSEMBLY,0.00050664,0.26279,0.18733,1,1
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0011199,0.26272,0.28011,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00050664,0.26264,0.25771,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.023741,0.26256,0.30675,1,1
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.016734,0.26253,0.23149,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.3418e-05,0.26219,0.24309,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.5774e-06,0.26207,0.25923,1,1
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00021909,0.26194,0.24287,1,1
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0013457,0.26187,0.21405,1,1
4,GO XENOBIOTIC TRANSPORT,0.00055855,0.26183,0.258,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00019079,0.2616,0.24078,1,1
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.00016595,0.26157,0.27308,1,1
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.00010092,0.26154,0.23798,1,1
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0094949,0.2611,0.3145,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,4.4878e-05,0.261,0.21933,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,6.7596e-05,0.261,0.19902,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.018836,0.26097,0.1915,1,1
4,GO REGULATION OF STEM CELL PROLIFERATION,0.016734,0.26096,0.15377,1,1
4,GO AUTOPHAGOSOME MATURATION,3.8583e-05,0.26078,0.26899,1,1
4,GO FATTY ACID BETA OXIDATION,0.00026903,0.26068,0.2486,1,1
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,4.1802e-07,0.26052,0.23059,1,1
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0083534,0.26052,0.20388,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.0047853,0.2604,0.21311,1,1
4,GO TRANSEPITHELIAL TRANSPORT,0.00035231,0.26035,0.25813,1,1
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.0045306,0.26021,0.19797,1,1
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011326,0.26015,0.29195,1,1
4,GO RNA 3 END PROCESSING,0.00016023,0.26012,0.20803,1,1
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.012203,0.25969,0.26277,1,1
4,GO RNA DESTABILIZATION,2.8418e-05,0.25959,0.25233,1,1
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00030804,0.2593,0.27285,1,1
4,GO CHYLOMICRON ASSEMBLY,0.010245,0.25909,0.23147,1,1
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00022676,0.2588,0.20508,1,1
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0094949,0.25865,0.33269,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00050664,0.25858,0.23649,1,1
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.044685,0.25853,0.35487,1,1
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.2837e-06,0.25824,0.25679,1,1
4,GO IMMUNE EFFECTOR PROCESS,9.3916e-06,0.25819,0.28073,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.6228e-06,0.25786,0.23765,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,5.0683e-06,0.25781,0.26207,1,1
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00012074,0.25738,0.23465,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,4.4878e-05,0.25729,0.21329,1,1
4,GO NUCLEAR PORE ORGANIZATION,0.00035231,0.25727,0.27444,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00012964,0.25725,0.24706,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,1.1267e-06,0.25672,0.28241,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.0013054,0.25651,0.23903,1,1
4,GO CHONDROCYTE PROLIFERATION,0.0046564,0.25635,0.39489,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00010462,0.25612,0.29357,1,1
4,GO DE NOVO PROTEIN FOLDING,0.00042998,0.25611,0.20853,1,1
4,GO PEPTIDE METABOLIC PROCESS,1.6729e-06,0.25568,0.23244,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00040247,0.25562,0.21628,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,2.4692e-06,0.25531,0.24124,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00021167,0.25529,0.26062,1,1
4,GO MACROPHAGE CHEMOTAXIS,2.7343e-05,0.25482,0.3462,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.015203,0.25475,0.24057,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.6455e-05,0.2547,0.29413,1,1
4,GO PROSTATE GLAND DEVELOPMENT,0.00052342,0.25454,0.37431,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.00047456,0.25446,0.27334,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.3132e-05,0.2544,0.23957,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.029068,0.25432,0.19462,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00050664,0.25428,0.21171,1,1
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0017641,0.25408,0.25202,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.5774e-06,0.2537,0.31297,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00057693,0.25364,0.31053,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00026003,0.25364,0.24404,1,1
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0097392,0.25352,0.24873,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0026572,0.25345,0.28558,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,9.7801e-06,0.25303,0.25075,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,3.9926e-07,0.25298,0.25389,1,1
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,2.9532e-05,0.25276,0.29501,1,1
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,7.0571e-06,0.25242,0.22575,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5308e-05,0.25221,0.22122,1,1
4,GO TRANSLATIONAL ELONGATION,0.0013054,0.25147,0.20506,1,1
4,GO INFLAMMATORY RESPONSE,6.0504e-05,0.25125,0.25003,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.00023468,0.25104,0.24269,1,1
4,GO REGULATION OF VASOCONSTRICTION,0.00012074,0.25096,0.25952,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00013433,0.25094,0.23384,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.027188,0.25089,0.21473,1,1
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0024367,0.25077,0.21169,1,1
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.508e-06,0.25066,0.24796,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00012512,0.2499,0.28194,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.0033369,0.24977,0.19764,1,1
4,GO RRNA METHYLATION,0.0038387,0.24974,0.20013,1,1
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.044685,0.24946,0.22732,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.001986,0.24934,0.25232,1,1
4,GO CERAMIDE TRANSPORT,0.0051916,0.24917,0.23399,1,1
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00081984,0.2481,0.20718,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00027832,0.24798,0.26553,1,1
4,GO OSTEOCLAST DIFFERENTIATION,3.8583e-05,0.24794,0.2167,1,1
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0029794,0.24757,0.22647,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.045624,0.24744,0.26618,1,1
4,GO FACE DEVELOPMENT,0.00019753,0.24712,0.26851,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00038934,0.24708,0.21103,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.033894,0.24701,0.19671,1,1
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.014486,0.24699,0.2645,1,1
4,GO REGULATION OF VIRAL TRANSCRIPTION,2.3418e-05,0.24693,0.25389,1,1
4,GO INTERLEUKIN 4 PRODUCTION,0.0012662,0.24666,0.20636,1,1
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.017969,0.24652,0.32456,1,1
4,GO PODOSOME ASSEMBLY,0.00014935,0.24635,0.35735,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00017796,0.24615,0.23006,1,1
4,GO CARDIOLIPIN METABOLIC PROCESS,0.023741,0.24609,0.16462,1,1
4,GO RESPONSE TO TESTOSTERONE,0.00012512,0.24601,0.25949,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.8379e-05,0.24585,0.23346,1,1
4,GO MITOCHONDRIAL DNA REPLICATION,0.00027832,0.24564,0.2019,1,1
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00069957,0.24532,0.19117,1,1
4,GO PROTEIN TARGETING TO MEMBRANE,0.0015653,0.24528,0.22923,1,1
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.020205,0.24469,0.17548,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00019753,0.24461,0.21987,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.4039e-05,0.24432,0.24738,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0010206,0.24424,0.24016,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.00049035,0.24414,0.24841,1,1
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.00027832,0.24414,0.23153,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0006154,0.24362,0.41866,1,1
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00012512,0.24347,0.23648,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0010206,0.24322,0.27225,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.00353,0.24287,0.25971,1,1
4,GO RESPONSE TO STEROID HORMONE,0.00032948,0.24275,0.19098,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.037747,0.24242,0.14342,1,1
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0036303,0.24221,0.23287,1,1
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.0033369,0.2422,0.2106,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0012662,0.24212,0.24947,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0015189,0.242,0.18954,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,1.1964e-05,0.24185,0.28568,1,1
4,GO REGULATION OF MITOPHAGY,0.015574,0.24166,0.19585,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.00042998,0.24163,0.22332,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0015189,0.24144,0.16769,1,1
4,GO DNA DEALKYLATION,0.00090094,0.24115,0.22595,1,1
4,GO CELLULAR IRON ION HOMEOSTASIS,2.7343e-05,0.24098,0.21455,1,1
4,GO METANEPHROS DEVELOPMENT,0.00067758,0.24092,0.22046,1,1
4,GO NEURAL TUBE PATTERNING,0.0017123,0.2407,0.23859,1,1
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,2.0033e-05,0.24064,0.21516,1,1
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00041602,0.24056,0.24421,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.029719,0.24051,0.16689,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001191,0.24048,0.22184,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.24023,0.22474,1,1
4,GO HEART VALVE DEVELOPMENT,0.00040247,0.23972,0.29763,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,5.8301e-05,0.23944,0.23673,1,1
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.3654e-06,0.23932,0.25068,1,1
4,GO DEFENSE RESPONSE,4.0073e-05,0.2391,0.22623,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,9.389e-05,0.23904,0.21096,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00063551,0.23885,0.25566,1,1
4,GO MITOTIC CYTOKINETIC PROCESS,0.0021689,0.23881,0.22263,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014935,0.2387,0.35059,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00036427,0.23868,0.24054,1,1
4,GO MEMBRANE BIOGENESIS,0.0049174,0.23859,0.23502,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.4346e-05,0.23845,0.30052,1,1
4,GO TUBE MORPHOGENESIS,6.7596e-05,0.23845,0.22029,1,1
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,5.2139e-05,0.23811,0.21855,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00069957,0.23806,0.18497,1,1
4,GO CELLULAR DEFENSE RESPONSE,0.0032441,0.23782,0.2735,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00031859,0.23766,0.25083,1,1
4,GO TONGUE DEVELOPMENT,0.011326,0.23753,0.26438,1,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0010206,0.23747,0.32472,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,4.6597e-05,0.23722,0.32263,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.019283,0.2372,0.18478,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00017796,0.23709,0.22861,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.6455e-05,0.23703,0.27242,1,1
4,GO PLATELET ACTIVATION,0.00057693,0.23675,0.22268,1,1
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,6.7596e-05,0.23633,0.20332,1,1
4,GO STRESS FIBER ASSEMBLY,0.00090094,0.23576,0.22714,1,1
4,GO PEPTIDYL ARGININE N METHYLATION,0.029719,0.23566,0.16109,1,1
4,GO RESPONSE TO RETINOIC ACID,7.013e-05,0.2356,0.25855,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0047853,0.23473,0.19888,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0067808,0.23455,0.20173,1,1
4,GO AMINE CATABOLIC PROCESS,0.00050664,0.23447,0.32449,1,1
4,GO TRNA PROCESSING,0.00049035,0.23411,0.18611,1,1
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.024288,0.23397,0.35347,1,1
4,GO CANONICAL WNT SIGNALING PATHWAY,0.00018427,0.23384,0.18895,1,1
4,GO LIPID STORAGE,0.00059588,0.23358,0.23299,1,1
4,GO PROTEIN TARGETING,3.0689e-05,0.23319,0.20101,1,1
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,2.9301e-06,0.23313,0.25943,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0038387,0.23311,0.17584,1,1
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.4728e-06,0.2331,0.26174,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.00013917,0.23293,0.2282,1,1
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,8.7323e-05,0.23279,0.26466,1,1
4,GO NCRNA EXPORT FROM NUCLEUS,0.0014738,0.23279,0.21045,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.1493e-05,0.23268,0.35401,1,1
4,GO P38MAPK CASCADE,9.7346e-05,0.23257,0.31846,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,4.6597e-05,0.23253,0.2062,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00011241,0.23229,0.24078,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00052342,0.23176,0.34295,1,1
4,GO MYELOID CELL HOMEOSTASIS,1.349e-05,0.23169,0.22021,1,1
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,3.0689e-05,0.23146,0.36514,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.023741,0.23124,0.1539,1,1
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.0067808,0.23099,0.23929,1,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00036427,0.23093,0.2591,1,1
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.009256,0.23089,0.19531,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,8.628e-07,0.23084,0.22357,1,1
4,GO SCHWANN CELL DIFFERENTIATION,0.00041602,0.2308,0.20351,1,1
4,GO POSITIVE CHEMOTAXIS,0.0041716,0.23075,0.22772,1,1
4,GO CRISTAE FORMATION,0.025414,0.23065,0.18741,1,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.0027346,0.23029,0.23109,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.010773,0.23012,0.35613,1,1
4,GO MITOPHAGY,0.00019079,0.2301,0.23929,1,1
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,3.6228e-06,0.22991,0.22802,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,2.2658e-06,0.22984,0.24722,1,1
4,GO REGULATION OF MRNA 3 END PROCESSING,0.00014935,0.2298,0.21116,1,1
4,GO REGULATION OF IMMUNE RESPONSE,1.9263e-05,0.22979,0.2163,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00017796,0.22927,0.33993,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0007696,0.22915,0.17588,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.00090094,0.22889,0.25738,1,1
4,GO NUCLEAR EXPORT,5.7413e-06,0.22858,0.21112,1,1
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.7596e-05,0.22768,0.29144,1,1
4,GO TRABECULA MORPHOGENESIS,0.00081984,0.22732,0.27815,1,1
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,5.8301e-05,0.22731,0.20156,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00014418,0.22728,0.24797,1,1
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0024367,0.22693,0.19282,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,8.1192e-05,0.22691,0.21576,1,1
4,GO REGULATION OF HEMOPOIESIS,5.6174e-05,0.22687,0.19816,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00087311,0.22681,0.22472,1,1
4,GO AGING,1.5816e-05,0.22677,0.20055,1,1
4,GO TRNA MODIFICATION,0.00069957,0.22664,0.19317,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0041716,0.22631,0.22911,1,1
4,GO STEROL IMPORT,0.00054072,0.22611,0.41555,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00010845,0.22582,0.21368,1,1
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0033369,0.22574,0.20098,1,1
4,GO REGULATION OF MACROPHAGE MIGRATION,9.0551e-05,0.2257,0.26549,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.019739,0.2255,0.18337,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.00065623,0.22529,0.17424,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00050664,0.22526,0.20777,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,9.8628e-07,0.2252,0.19916,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.00021167,0.22515,0.19671,1,1
4,GO CELL PROLIFERATION IN HINDBRAIN,0.010773,0.22489,0.20424,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0001165,0.22483,0.22212,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.001228,0.22459,0.22025,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,9.0551e-05,0.22457,0.26763,1,1
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00059588,0.22453,0.26205,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,6.0504e-05,0.22409,0.20911,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0083534,0.22404,0.17624,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00017186,0.22367,0.23643,1,1
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00021167,0.22364,0.18372,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.00074557,0.22337,0.16108,1,1
4,GO CELL KILLING,0.00353,0.22321,0.15694,1,1
4,GO LEUKOCYTE PROLIFERATION,0.0016129,0.22312,0.17812,1,1
4,GO T CELL PROLIFERATION,0.00049035,0.22309,0.20584,1,1
4,GO RESPONSE TO ISCHEMIA,0.00020448,0.22309,0.20778,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.0011199,0.22304,0.18797,1,1
4,GO ASTROCYTE DIFFERENTIATION,0.010506,0.2228,0.16056,1,1
4,GO PLATELET MORPHOGENESIS,0.00059588,0.22279,0.22458,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0020453,0.22265,0.21424,1,1
4,GO REGULATION OF DNA RECOMBINATION,0.00011241,0.22209,0.21219,1,1
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.010773,0.22193,0.16857,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,4.1617e-05,0.22182,0.21175,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0083534,0.2217,0.18214,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00055855,0.22142,0.17329,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00028792,0.22106,0.16628,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0016129,0.22086,0.19128,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,6.0504e-05,0.22078,0.18192,1,1
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0079323,0.22059,0.2959,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.1617e-05,0.21995,0.2163,1,1
4,GO BODY FLUID SECRETION,0.00024286,0.21983,0.21425,1,1
4,GO NUCLEUS LOCALIZATION,0.031059,0.2198,0.13251,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.004408,0.21975,0.20282,1,1
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,5.0194e-07,0.21971,0.20108,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00084609,0.21958,0.19592,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,3.1888e-05,0.21957,0.19601,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00050664,0.21924,0.2112,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0021062,0.2191,0.26958,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.4609e-05,0.21904,0.23487,1,1
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,3.5759e-05,0.21884,0.21656,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0087944,0.21884,0.15379,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.017137,0.2188,0.18169,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00012074,0.21856,0.26116,1,1
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.2366e-07,0.21854,0.18213,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0038387,0.21852,0.19732,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.046579,0.21813,0.1638,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0011199,0.2181,0.20968,1,1
4,GO EMBRYONIC EYE MORPHOGENESIS,0.011326,0.21793,0.21866,1,1
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,2.5308e-05,0.2176,0.20256,1,1
4,GO TRNA METABOLIC PROCESS,0.00081984,0.21758,0.17844,1,1
4,GO INTERFERON GAMMA PRODUCTION,4.1617e-05,0.21747,0.26656,1,1
4,GO RNA MODIFICATION,0.00010462,0.21727,0.1981,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00042998,0.21723,0.31674,1,1
4,GO CARDIAC SEPTUM DEVELOPMENT,0.00036427,0.21677,0.2428,1,1
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00024286,0.21654,0.19111,1,1
4,GO REGULATION OF URINE VOLUME,0.00027832,0.21647,0.24044,1,1
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,8.628e-07,0.21628,0.21255,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00019079,0.216,0.20061,1,1
4,GO REGULATION OF CENTRIOLE REPLICATION,0.02268,0.21565,0.14186,1,1
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.015953,0.21551,0.26259,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0099891,0.21541,0.16482,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,6.2367e-06,0.21526,0.1974,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0028957,0.21509,0.222,1,1
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,9.389e-05,0.21501,0.26076,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0069616,0.21454,0.28703,1,1
4,GO GRANULOCYTE MIGRATION,0.00018427,0.21445,0.27623,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0011549,0.21418,0.18974,1,1
4,GO NEURAL CREST CELL DIFFERENTIATION,0.024288,0.2141,0.19236,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00353,0.2141,0.15204,1,1
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0010528,0.214,0.21006,1,1
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0067808,0.21346,0.18073,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0016129,0.21295,0.22479,1,1
4,GO T CELL ACTIVATION,0.00011241,0.21262,0.20769,1,1
4,GO REGULATION OF CELL ACTIVATION,0.00012074,0.21229,0.19659,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00055855,0.21222,0.21259,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.012203,0.2118,0.19708,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00072223,0.21173,0.19311,1,1
4,GO CELL ACTIVATION,2.4346e-05,0.21138,0.23077,1,1
4,GO POSITIVE REGULATION OF VIRAL PROCESS,2.4692e-06,0.21113,0.24364,1,1
4,GO FIBROBLAST APOPTOTIC PROCESS,0.027803,0.21105,0.21071,1,1
4,GO AMIDE BIOSYNTHETIC PROCESS,2.2524e-05,0.21076,0.19654,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.0011199,0.21067,0.21199,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0066042,0.21061,0.18612,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0023671,0.21055,0.23087,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7145e-05,0.21022,0.21092,1,1
4,GO HEAD MORPHOGENESIS,0.001228,0.21003,0.25997,1,1
4,GO BLASTOCYST GROWTH,0.0011549,0.20993,0.25414,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,7.547e-05,0.20992,0.17176,1,1
4,GO FATTY ACID CATABOLIC PROCESS,0.0020453,0.2099,0.17151,1,1
4,GO CIRCULATORY SYSTEM DEVELOPMENT,2.0833e-05,0.20966,0.22543,1,1
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,7.2754e-05,0.20944,0.1976,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,7.8282e-05,0.20914,0.21995,1,1
4,GO MESENCHYME DEVELOPMENT,0.00018427,0.20907,0.22643,1,1
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0075304,0.20905,0.17936,1,1
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0013457,0.20895,0.24051,1,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00021167,0.20871,0.19465,1,1
4,GO PROTEIN DENEDDYLATION,0.0028957,0.2087,0.18314,1,1
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0011549,0.20869,0.18418,1,1
4,GO MACROMOLECULE CATABOLIC PROCESS,7.2756e-08,0.20857,0.19434,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.2454e-05,0.20805,0.20492,1,1
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.019283,0.20772,0.26496,1,1
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.014841,0.20766,0.16415,1,1
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,2.5774e-06,0.20742,0.26238,1,1
4,GO RESPONSE TO KETONE,0.0025817,0.2073,0.16483,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0034322,0.20702,0.16825,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,3.8583e-05,0.20697,0.27622,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,2.0833e-05,0.20677,0.22,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00084609,0.20671,0.22566,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.027803,0.2067,0.17768,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.010506,0.2065,0.20352,1,1
4,GO LEUKOCYTE MIGRATION,0.0018173,0.20628,0.19037,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,7.013e-05,0.20545,0.19957,1,1
4,GO CELLULAR RESPONSE TO HEAT,0.00065623,0.20544,0.17946,1,1
4,GO RETINOL METABOLIC PROCESS,0.0030654,0.20526,0.20344,1,1
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,5.8301e-05,0.20521,0.20799,1,1
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.023205,0.20499,0.16649,1,1
4,GO RUFFLE ORGANIZATION,0.0049174,0.20481,0.14416,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00017186,0.2047,0.18396,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00035231,0.20436,0.16841,1,1
4,GO MYELOID CELL DIFFERENTIATION,3.1888e-05,0.20436,0.17745,1,1
4,GO RESPONSE TO INTERLEUKIN 7,0.036164,0.20434,0.1784,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,1.0184e-05,0.2041,0.19524,1,1
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.019283,0.20391,0.2282,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.015953,0.20391,0.13791,1,1
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.016339,0.2033,0.11167,1,1
4,GO RESPONSE TO CHEMOKINE,0.0046564,0.20321,0.21045,1,1
4,GO NEUROINFLAMMATORY RESPONSE,0.0030654,0.20285,0.25006,1,1
4,GO RRNA 3 END PROCESSING,0.0007696,0.20283,0.21338,1,1
4,GO CELLULAR AMIDE METABOLIC PROCESS,7.9801e-06,0.2026,0.18922,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00011241,0.20259,0.24387,1,1
4,GO REGULATION OF LIPID STORAGE,0.00098941,0.2024,0.23675,1,1
4,GO RESPONSE TO LIPID,0.00050664,0.20226,0.17103,1,1
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0014738,0.20221,0.21435,1,1
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,9.0221e-07,0.20184,0.21059,1,1
4,GO RESPONSE TO VITAMIN A,0.033166,0.2018,0.17107,1,1
4,GO COENZYME A METABOLIC PROCESS,0.0081404,0.20169,0.16161,1,1
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.009256,0.20168,0.16842,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,2.0833e-05,0.20137,0.20105,1,1
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,9.8628e-07,0.20085,0.19278,1,1
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.20079,0.23505,1,1
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00353,0.20072,0.22242,1,1
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00059588,0.20058,0.15261,1,1
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0037331,0.20055,0.14382,1,1
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.017969,0.20052,0.22345,1,1
4,GO OSSIFICATION,0.00035231,0.20032,0.20839,1,1
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00090094,0.20027,0.21205,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.042857,0.2002,0.21202,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,6.2786e-05,0.20019,0.23458,1,1
4,GO RESPONSE TO TUMOR CELL,0.02068,0.19979,0.18965,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00054072,0.19975,0.21189,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.00059588,0.19966,0.20134,1,1
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.00098941,0.19961,0.21676,1,1
4,GO HISTONE H2B UBIQUITINATION,0.03245,0.19959,0.14264,1,1
4,GO REGULATION OF CELL ADHESION,0.0018173,0.19957,0.18596,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,2.8418e-05,0.19935,0.22296,1,1
4,GO MITOTIC CYTOKINESIS,0.00098941,0.19935,0.20065,1,1
4,GO RNA LOCALIZATION,0.00014418,0.19924,0.1994,1,1
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.046579,0.19912,0.13684,1,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0011199,0.19894,0.2288,1,1
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0010206,0.19888,0.14647,1,1
4,GO LYMPHOCYTE ACTIVATION,6.0504e-05,0.19873,0.19493,1,1
4,GO MIDBODY ABSCISSION,0.036948,0.19861,0.15932,1,1
4,GO ANIMAL ORGAN FORMATION,0.011612,0.19861,0.17696,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,3.8583e-05,0.19829,0.23625,1,1
4,GO DENDRITIC SPINE MAINTENANCE,0.0097392,0.19811,0.21452,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.0001547,0.19803,0.19568,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.013798,0.19799,0.13291,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.0075304,0.19784,0.20477,1,1
4,GO RNA METHYLATION,0.00036427,0.19755,0.19289,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,1.4039e-05,0.19732,0.21747,1,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.047551,0.19702,0.20995,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.8301e-05,0.19652,0.22774,1,1
4,GO HEART TRABECULA MORPHOGENESIS,0.0099891,0.19631,0.19245,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0013054,0.19624,0.22164,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,3.4421e-05,0.1959,0.17428,1,1
4,GO VESICLE TARGETING,0.00022676,0.19585,0.20778,1,1
4,GO RESPONSE TO PH,0.0059384,0.1958,0.22017,1,1
4,GO BODY MORPHOGENESIS,0.0034322,0.1955,0.18575,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00087311,0.19549,0.18451,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0011199,0.19541,0.16215,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00017796,0.19523,0.19532,1,1
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0017123,0.19516,0.20363,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00059588,0.1951,0.19527,1,1
4,GO PROTEIN PROCESSING,0.00026003,0.195,0.20121,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,1.4609e-05,0.19489,0.17723,1,1
4,GO ORGAN GROWTH,0.00035231,0.19464,0.20728,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.0016129,0.19399,0.29642,1,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00014935,0.19373,0.17788,1,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0017123,0.1935,0.16075,1,1
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.020205,0.1932,0.20995,1,1
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.0085714,0.19307,0.14719,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.011047,0.19275,0.1393,1,1
4,GO PROTEIN STABILIZATION,2.5308e-05,0.19262,0.16595,1,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.0067808,0.19166,0.33297,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0022992,0.19149,0.16246,1,1
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00021909,0.19129,0.15629,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00026003,0.19102,0.18544,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0014299,0.1906,0.18118,1,1
4,GO REGULATION OF BIOMINERALIZATION,0.0010859,0.19057,0.25392,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00059588,0.19048,0.18427,1,1
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00045924,0.19045,0.17865,1,1
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00031859,0.19045,0.23669,1,1
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.0011549,0.19036,0.15651,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00011241,0.19027,0.18405,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018427,0.19026,0.17321,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.0029794,0.19014,0.244,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00022676,0.19012,0.15191,1,1
4,GO SECRETION BY TISSUE,0.035393,0.18996,0.14018,1,1
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00044439,0.18992,0.16934,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.00010092,0.18989,0.18737,1,1
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00012512,0.18969,0.19343,1,1
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.00087311,0.18956,0.20799,1,1
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.011612,0.18919,0.17235,1,1
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00031859,0.18913,0.2035,1,1
4,GO RESPONSE TO REDOX STATE,0.043763,0.18902,0.19195,1,1
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.001986,0.18883,0.19264,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0013457,0.18867,0.17886,1,1
4,GO PEPTIDYL ARGININE MODIFICATION,0.00065623,0.18864,0.15251,1,1
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0023671,0.18811,0.16059,1,1
4,GO PROTEIN HOMOTETRAMERIZATION,1.5816e-05,0.1879,0.19314,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0029794,0.18769,0.15195,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,6.5149e-05,0.18746,0.15525,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00013917,0.18744,0.17949,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.8418e-05,0.18716,0.15285,1,1
4,GO NEURAL TUBE DEVELOPMENT,0.0017641,0.18715,0.18699,1,1
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00054072,0.18713,0.22555,1,1
4,GO HISTONE DEACETYLATION,0.00084609,0.18712,0.12623,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0054795,0.18689,0.18642,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.00031859,0.18651,0.18943,1,1
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00087311,0.18644,0.18778,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001986,0.18639,0.1638,1,1
4,GO PROTEIN DEMANNOSYLATION,0.014841,0.18607,0.18077,1,1
4,GO ENDOTHELIAL CELL PROLIFERATION,0.00047456,0.18591,0.19967,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0016129,0.18588,0.21972,1,1
4,GO DRUG METABOLIC PROCESS,0.0033369,0.18571,0.15632,1,1
4,GO PROTEIN MATURATION,0.00012074,0.18535,0.15531,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,6.5896e-07,0.18526,0.17336,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.753e-07,0.18517,0.16516,1,1
4,GO RNA PROCESSING,8.4205e-05,0.18508,0.17478,1,1
4,GO ORGANELLE INHERITANCE,0.0018173,0.18502,0.17036,1,1
4,GO SULFUR COMPOUND TRANSPORT,4.0073e-05,0.18493,0.21395,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.019739,0.1848,0.14375,1,1
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00031859,0.1848,0.20281,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.0046564,0.18468,0.27762,1,1
4,GO CELLULAR RESPONSE TO UV,0.00072223,0.18438,0.16825,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.029719,0.1843,0.11571,1,1
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0014299,0.18419,0.17225,1,1
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0010859,0.18419,0.15436,1,1
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00024286,0.18407,0.24352,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0085714,0.18393,0.15841,1,1
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.025994,0.18383,0.14087,1,1
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.029719,0.18369,0.13253,1,1
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00055855,0.18354,0.20198,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0024367,0.18333,0.15258,1,1
4,GO BONE DEVELOPMENT,9.0551e-05,0.18328,0.22452,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0038387,0.18328,0.21917,1,1
4,GO STEROL HOMEOSTASIS,0.026586,0.18324,0.1038,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0028141,0.18322,0.19665,1,1
4,GO REGULATION OF T CELL CHEMOTAXIS,0.02166,0.18316,0.16209,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0051916,0.18289,0.16357,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.389e-05,0.18279,0.17211,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.906e-06,0.18255,0.19007,1,1
4,GO CELLULAR RESPONSE TO RADIATION,0.00011241,0.18229,0.17343,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0040578,0.18224,0.12682,1,1
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,6.7596e-05,0.18187,0.21036,1,1
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.6455e-05,0.18183,0.19656,1,1
4,GO OVULATION,0.045624,0.18151,0.21515,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0015653,0.18143,0.14491,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.0012662,0.18141,0.15887,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.022165,0.18114,0.14393,1,1
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0085714,0.18102,0.14807,1,1
4,GO PROTEIN NEDDYLATION,0.0013457,0.18063,0.18757,1,1
4,GO PEPTIDYL ARGININE METHYLATION,0.016339,0.18038,0.13803,1,1
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,2.0033e-05,0.18001,0.21106,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,2.7578e-07,0.17974,0.18268,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0028141,0.17962,0.17746,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0030654,0.17955,0.20751,1,1
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,6.0504e-05,0.1795,0.21432,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00092958,0.17948,0.14115,1,1
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0090226,0.17942,0.19612,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00042998,0.17925,0.21327,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0027346,0.17916,0.17754,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.044685,0.17914,0.15418,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0025083,0.17912,0.15965,1,1
4,GO PEROXISOMAL TRANSPORT,0.0017641,0.17852,0.18946,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,1.1493e-05,0.17749,0.17449,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0007696,0.17733,0.15447,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00021167,0.17714,0.15731,1,1
4,GO SCHWANN CELL DEVELOPMENT,0.0017123,0.177,0.1736,1,1
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0014738,0.1764,0.13026,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00047456,0.1761,0.19009,1,1
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00087311,0.1761,0.21891,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00020448,0.17599,0.16436,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0083534,0.17584,0.13091,1,1
4,GO T CELL DIFFERENTIATION IN THYMUS,7.8282e-05,0.17575,0.18998,1,1
4,GO TRNA TRANSPORT,0.0075304,0.17573,0.16343,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.00047456,0.17562,0.18106,1,1
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.2533e-07,0.17557,0.17718,1,1
4,GO RESPONSE TO HEAT,0.00014418,0.17537,0.18386,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.001662,0.17533,0.15365,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00016023,0.17514,0.19241,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,2.5774e-06,0.17487,0.17479,1,1
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,7.8282e-05,0.17459,0.20051,1,1
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00069957,0.17452,0.31239,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00072223,0.17438,0.13207,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0013457,0.17438,0.22613,1,1
4,GO GOLGI VESICLE TRANSPORT,1.1964e-05,0.17426,0.17047,1,1
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.0025083,0.17392,0.15294,1,1
4,GO RNA POLYADENYLATION,0.0013054,0.17382,0.15341,1,1
4,GO FOLIC ACID METABOLIC PROCESS,0.037747,0.17377,0.15295,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00050664,0.17367,0.17396,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0020453,0.17358,0.16878,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.023205,0.17357,0.12839,1,1
4,GO MITOTIC RECOMBINATION,0.0028957,0.17352,0.1951,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00031859,0.17309,0.18345,1,1
4,GO CELLULAR EXTRAVASATION,0.00079435,0.17306,0.20085,1,1
4,GO ANION HOMEOSTASIS,0.015203,0.17264,0.13523,1,1
4,GO REGULATION OF MAPK CASCADE,0.00023468,0.17259,0.15864,1,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.0010528,0.17242,0.1718,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.001191,0.17233,0.18895,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,0.0025817,0.17231,0.16563,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.019283,0.17217,0.13673,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,4.5813e-07,0.17186,0.17112,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0018173,0.17184,0.15918,1,1
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.03939,0.17179,0.24763,1,1
4,GO LYSOSOMAL TRANSPORT,0.00010845,0.17172,0.18502,1,1
4,GO PROTEIN IMPORT,7.2754e-05,0.1717,0.16619,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.001872,0.17148,0.16919,1,1
4,GO PEROXISOME ORGANIZATION,0.0010859,0.17129,0.18302,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.015203,0.17095,0.11923,1,1
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.5427e-07,0.17084,0.18106,1,1
4,GO REGULATION OF RESPONSE TO STRESS,2.7343e-05,0.17084,0.16487,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.023741,0.17062,0.14843,1,1
4,GO TRANSLESION SYNTHESIS,0.0015653,0.17043,0.15589,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,5.0226e-05,0.17043,0.18213,1,1
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.001191,0.17034,0.13539,1,1
4,GO VACUOLAR TRANSPORT,0.00034072,0.17011,0.15288,1,1
4,GO TUBE DEVELOPMENT,0.00052342,0.17006,0.17617,1,1
4,GO SPINDLE LOCALIZATION,8.1192e-05,0.16972,0.18164,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00079435,0.16955,0.15913,1,1
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0046564,0.1695,0.22304,1,1
4,GO REGULATION OF CATABOLIC PROCESS,5.4977e-07,0.1695,0.16452,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00023468,0.16919,0.13692,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00010092,0.16891,0.20301,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.001986,0.16882,0.15204,1,1
4,GO MRNA METABOLIC PROCESS,2.9532e-05,0.16862,0.16557,1,1
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0014738,0.16852,0.17512,1,1
4,GO INTERMEMBRANE LIPID TRANSFER,0.001191,0.16847,0.18006,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0085714,0.16846,0.12952,1,1
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.0576e-06,0.16817,0.16602,1,1
4,GO REGULATION OF NUCLEAR DIVISION,0.00019079,0.16809,0.13753,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.011904,0.16808,0.18896,1,1
4,GO NEUTROPHIL MIGRATION,0.0021062,0.16772,0.24021,1,1
4,GO AEROBIC RESPIRATION,0.036164,0.1676,0.098627,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.019283,0.16759,0.18154,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.013798,0.16757,0.13045,1,1
4,GO COPII COATED VESICLE CARGO LOADING,0.001228,0.16756,0.19716,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,7.5427e-07,0.16748,0.16734,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00034072,0.16718,0.18579,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00041602,0.16683,0.18232,1,1
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0027346,0.1665,0.14795,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.001872,0.16628,0.16832,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.0034322,0.16628,0.12961,1,1
4,GO OXALATE TRANSPORT,0.031748,0.16623,0.1071,1,1
4,GO ENDODERMAL CELL FATE COMMITMENT,0.029068,0.16599,0.17541,1,1
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022992,0.16567,0.18533,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0001547,0.16563,0.1419,1,1
4,GO PROTEIN REFOLDING,0.042857,0.1656,0.1569,1,1
4,GO NUCLEAR TRANSPORT,3.3132e-05,0.1655,0.15444,1,1
4,GO PROTEIN KINASE A SIGNALING,0.00016595,0.16514,0.21289,1,1
4,GO RNA CAPPING,0.00026003,0.16511,0.16282,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.001662,0.16474,0.1302,1,1
4,GO REGULATION OF MYELINATION,0.0094949,0.16445,0.14529,1,1
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.0041716,0.16433,0.21881,1,1
4,GO RESPONSE TO GONADOTROPIN,0.0059384,0.16422,0.27755,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.0571e-06,0.16403,0.20062,1,1
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0099891,0.16399,0.13145,1,1
4,GO VACUOLE ORGANIZATION,7.8282e-05,0.16375,0.15452,1,1
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,5.6174e-05,0.16367,0.15591,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00057693,0.16347,0.21328,1,1
4,GO RECEPTOR RECYCLING,0.0069616,0.16318,0.12983,1,1
4,GO RNA DECAPPING,0.00055855,0.16313,0.18146,1,1
4,GO POSITIVE REGULATION OF BINDING,0.00011241,0.16287,0.16396,1,1
4,GO REGULATION OF BONE MINERALIZATION,0.0057817,0.16279,0.23497,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,1.9904e-06,0.16278,0.15446,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0085714,0.16242,0.1752,1,1
4,GO TELOMERE ORGANIZATION,0.0006154,0.16219,0.13455,1,1
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.014486,0.16215,0.15314,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0020453,0.16205,0.17778,1,1
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.012508,0.16186,0.13872,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.00030804,0.16177,0.22715,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00030804,0.16169,0.15709,1,1
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.004408,0.16141,0.1827,1,1
4,GO ERBB SIGNALING PATHWAY,0.00041602,0.16126,0.22356,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.029719,0.16117,0.13968,1,1
4,GO PROTEIN POLYUBIQUITINATION,8.4205e-05,0.161,0.1464,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00047456,0.16094,0.14943,1,1
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00038934,0.16085,0.14692,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.019283,0.16063,0.088191,1,1
4,GO MUSCLE ADAPTATION,0.015203,0.1606,0.11148,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017969,0.16051,0.19455,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.16045,0.16635,1,1
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0022992,0.16038,0.16967,1,1
4,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0051916,0.16024,0.27498,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.0020453,0.15997,0.12801,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.041093,0.15987,0.13846,1,1
4,GO NEURAL TUBE FORMATION,0.0053338,0.15981,0.17645,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0099891,0.1596,0.17829,1,1
4,GO PROTEOLYSIS,1.104e-05,0.15947,0.14891,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00030804,0.159,0.14214,1,1
4,GO REGULATION OF OSSIFICATION,0.0024367,0.15895,0.19695,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0011199,0.15852,0.17148,1,1
4,GO THYROID HORMONE METABOLIC PROCESS,0.025414,0.15842,0.14062,1,1
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0071468,0.15839,0.17502,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0057817,0.15826,0.13239,1,1
4,GO RESPONSE TO UV,0.00014418,0.15756,0.17273,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0085714,0.15752,0.16111,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00021909,0.15735,0.13334,1,1
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0081404,0.15712,0.2453,1,1
4,GO TISSUE MORPHOGENESIS,0.00026903,0.15708,0.17354,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.017969,0.15703,0.128,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00027832,0.15682,0.14603,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0025083,0.15681,0.1229,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00059588,0.1568,0.15164,1,1
4,GO REGULATION OF RECEPTOR RECYCLING,0.00095906,0.15647,0.21339,1,1
4,GO SKELETAL SYSTEM DEVELOPMENT,0.0031536,0.15631,0.16135,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,8.7323e-05,0.15616,0.1751,1,1
4,GO MAINTENANCE OF LOCATION,3.4421e-05,0.156,0.17106,1,1
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.0030654,0.15593,0.19531,1,1
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0039469,0.15571,0.16732,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013465,0.15539,0.16702,1,1
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00098941,0.15513,0.13555,1,1
4,GO MITOTIC SPINDLE ORGANIZATION,0.001872,0.1551,0.15889,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0037331,0.15509,0.14149,1,1
4,GO PROTEIN CATABOLIC PROCESS,1.1267e-06,0.15492,0.1538,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.00353,0.15468,0.20365,1,1
4,GO POSTREPLICATION REPAIR,0.00079435,0.15468,0.13962,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0029794,0.15427,0.11791,1,1
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.033894,0.15404,0.092987,1,1
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,5.2139e-05,0.154,0.15608,1,1
4,GO LACTATION,0.0049174,0.15374,0.18083,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00072223,0.15358,0.17483,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.001986,0.15344,0.15305,1,1
4,GO RESPONSE TO DRUG,0.01282,0.15335,0.11107,1,1
4,GO MRNA TRANSPORT,0.00034072,0.15332,0.17623,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,8.2505e-07,0.15325,0.16724,1,1
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,3.0689e-05,0.15305,0.1769,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,9.0551e-05,0.15291,0.18315,1,1
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0050528,0.15287,0.25269,1,1
4,GO UV DAMAGE EXCISION REPAIR,0.0022332,0.15269,0.16893,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,2.0033e-05,0.15265,0.13936,1,1
4,GO REGULATION OF ERAD PATHWAY,9.0551e-05,0.1523,0.16679,1,1
4,GO REPLACEMENT OSSIFICATION,0.016734,0.15222,0.23853,1,1
4,GO HEART GROWTH,0.0046564,0.15184,0.1689,1,1
4,GO REGULATION OF CELL DEATH,0.00017796,0.15169,0.13612,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.036164,0.15166,0.13402,1,1
4,GO B CELL ACTIVATION,0.001191,0.15151,0.14117,1,1
4,GO RESPONSE TO GROWTH FACTOR,0.00087311,0.15137,0.15736,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00037661,0.15137,0.13301,1,1
4,GO REGULATION OF BINDING,0.00038934,0.15112,0.13773,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00069957,0.15091,0.13695,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.8418e-05,0.15067,0.16131,1,1
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.001872,0.15055,0.11492,1,1
4,GO HUMORAL IMMUNE RESPONSE,0.0079323,0.15051,0.12664,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0013054,0.15048,0.15639,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.014138,0.15044,0.10252,1,1
4,GO RESPONSE TO LEPTIN,0.030383,0.15038,0.17542,1,1
4,GO MACROPHAGE ACTIVATION,0.015574,0.14995,0.15745,1,1
4,GO GOLGI VESICLE BUDDING,0.0011199,0.14979,0.17165,1,1
4,GO VACUOLAR ACIDIFICATION,0.0026572,0.14956,0.16886,1,1
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0031536,0.14927,0.13185,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00079435,0.14923,0.14819,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00030804,0.14921,0.14229,1,1
4,GO DNA BIOSYNTHETIC PROCESS,1.0311e-06,0.14876,0.16786,1,1
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.021165,0.14857,0.15604,1,1
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00018427,0.14825,0.1409,1,1
4,GO REGULATION OF PROTEIN BINDING,0.00036427,0.14769,0.15361,1,1
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00059588,0.14727,0.15713,1,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0060989,0.14723,0.10864,1,1
4,GO RECEPTOR METABOLIC PROCESS,0.00037661,0.14712,0.14854,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.007729,0.14709,0.1382,1,1
4,GO NCRNA CATABOLIC PROCESS,0.026586,0.14695,0.15928,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0094949,0.14694,0.11495,1,1
4,GO POSITIVE REGULATION OF DNA BINDING,0.033166,0.14691,0.11648,1,1
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0022992,0.14677,0.18254,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.043763,0.14642,0.16522,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.024288,0.14612,0.16179,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00057693,0.14579,0.11465,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0066042,0.14541,0.16472,1,1
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.016339,0.14505,0.13921,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.00079435,0.14483,0.15391,1,1
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0094949,0.14467,0.14752,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.036164,0.1446,0.11369,1,1
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0033369,0.14453,0.17456,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00045924,0.1445,0.16244,1,1
4,GO REGULATION OF CHEMOTAXIS,0.001872,0.14433,0.1479,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00021167,0.1443,0.12773,1,1
4,GO CHROMOSOME LOCALIZATION,0.043763,0.14391,0.11104,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.0031536,0.14365,0.10986,1,1
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.026586,0.14317,0.16542,1,1
4,GO LAMELLIPODIUM ASSEMBLY,0.0083534,0.14304,0.16937,1,1
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0010528,0.14264,0.19171,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0064317,0.14253,0.1057,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00059588,0.14245,0.1825,1,1
4,GO COPII COATED VESICLE BUDDING,0.0029794,0.14234,0.16748,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.0049174,0.142,0.17805,1,1
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.14185,0.14042,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00044439,0.14181,0.13253,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0019282,0.14163,0.13483,1,1
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.020205,0.14161,0.15743,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.03245,0.14156,0.078346,1,1
4,GO GENITALIA DEVELOPMENT,0.0056288,0.14131,0.12734,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.0038387,0.14115,0.15157,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013465,0.1411,0.11921,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0062634,0.14109,0.10622,1,1
4,GO PROTEIN LOCALIZATION TO ORGANELLE,6.2985e-07,0.14107,0.13724,1,1
4,GO LIPID CATABOLIC PROCESS,0.0034322,0.14087,0.10094,1,1
4,GO GOLGI ORGANIZATION,0.00069957,0.14082,0.13405,1,1
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0038387,0.14052,0.11408,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00026003,0.14043,0.13401,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00030804,0.13999,0.14349,1,1
4,GO MEIOTIC SPINDLE ORGANIZATION,0.024846,0.13973,0.12393,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,2.0033e-05,0.13946,0.13714,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.03939,0.13934,0.16737,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.0017123,0.13918,0.1302,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0022992,0.13909,0.16923,1,1
4,GO MESENCHYME MORPHOGENESIS,0.0032441,0.13908,0.30352,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00020448,0.13874,0.16069,1,1
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.033166,0.13863,0.12871,1,1
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.007729,0.1384,0.13802,1,1
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0039469,0.13829,0.1451,1,1
4,GO CELL CELL SIGNALING BY WNT,0.0050528,0.13812,0.12281,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.00095906,0.13811,0.1162,1,1
4,GO NUCLEUS ORGANIZATION,0.0006154,0.13804,0.12879,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.00079435,0.1377,0.11917,1,1
4,GO OUTFLOW TRACT MORPHOGENESIS,0.0042883,0.13749,0.26856,1,1
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00032948,0.13733,0.18307,1,1
4,GO APOPTOTIC PROCESS,8.4205e-05,0.13719,0.13308,1,1
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0050528,0.13715,0.1844,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.0504e-05,0.13711,0.14588,1,1
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.0019282,0.13704,0.10455,1,1
4,GO MYOTUBE DIFFERENTIATION,0.038561,0.13701,0.12585,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,2.4346e-05,0.13689,0.16824,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,4.1617e-05,0.1366,0.17834,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00050664,0.13641,0.12096,1,1
4,GO REGULATION OF GLIAL CELL MIGRATION,0.023205,0.13631,0.16326,1,1
4,GO ENDOSOME ORGANIZATION,0.0022992,0.13593,0.14671,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.00032948,0.13557,0.18446,1,1
4,GO SULFATE TRANSPORT,0.00069957,0.13554,0.14245,1,1
4,GO RNA SURVEILLANCE,0.00069957,0.13536,0.2054,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00036427,0.1353,0.14715,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.00034072,0.1351,0.11821,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00057693,0.13508,0.12335,1,1
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00090094,0.13452,0.13898,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.13449,0.13233,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,5.9841e-06,0.13425,0.13309,1,1
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.041967,0.1342,0.20415,1,1
4,GO REGULATION OF MITOTIC CELL CYCLE,0.0016129,0.13385,0.1127,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0024367,0.13337,0.18637,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.00095906,0.13325,0.10309,1,1
4,GO CELL CYCLE PHASE TRANSITION,0.0031536,0.13314,0.10457,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00031859,0.13283,0.14611,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0012662,0.13253,0.14007,1,1
4,GO STEM CELL DIFFERENTIATION,0.00021167,0.13218,0.17719,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.034637,0.13208,0.17067,1,1
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.033894,0.13204,0.095095,1,1
4,GO VIRAL BUDDING,0.013465,0.13148,0.1175,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.0046564,0.1312,0.205,1,1
4,GO REGULATION OF CENTROSOME DUPLICATION,0.017969,0.13082,0.12895,1,1
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.00092958,0.1301,0.1192,1,1
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00011241,0.13004,0.11411,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0060989,0.1297,0.11017,1,1
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.026586,0.12968,0.11388,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00016023,0.12951,0.1844,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00037661,0.12896,0.11847,1,1
4,GO GENE SILENCING,0.00010462,0.12893,0.13271,1,1
4,GO ORGANELLE DISASSEMBLY,5.8301e-05,0.12868,0.13596,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00014935,0.1286,0.13625,1,1
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.0001547,0.12799,0.13751,1,1
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0013872,0.12772,0.12044,1,1
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.016339,0.12767,0.13858,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00079435,0.12744,0.11966,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0069616,0.12684,0.18514,1,1
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0099891,0.12646,0.12961,1,1
4,GO EXOCYTOSIS,0.0011199,0.12645,0.13749,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00030804,0.12629,0.13249,1,1
4,GO NON RECOMBINATIONAL REPAIR,0.0018173,0.12626,0.13275,1,1
4,GO REGULATION OF CHROMOSOME SEPARATION,0.0062634,0.12624,0.16516,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0014299,0.12615,0.1125,1,1
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.045624,0.12612,0.092082,1,1
4,GO RESPONSE TO HORMONE,0.00092958,0.12561,0.12393,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017796,0.12559,0.21496,1,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.047551,0.12551,0.14491,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.010506,0.12549,0.1282,1,1
4,GO MEMBRANE ORGANIZATION,0.00074557,0.12522,0.1104,1,1
4,GO NUCLEOTIDE EXCISION REPAIR,0.00016023,0.12504,0.13887,1,1
4,GO CENTRIOLE CENTRIOLE COHESION,0.016734,0.12489,0.16986,1,1
4,GO HEART DEVELOPMENT,0.0017641,0.12473,0.14399,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.001191,0.12398,0.11453,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,2.4346e-05,0.12394,0.12828,1,1
4,GO CELLULAR SENESCENCE,0.00092958,0.12384,0.13602,1,1
4,GO ENDOCYTOSIS,0.00030804,0.12359,0.14079,1,1
4,GO CELL DIVISION,0.0025083,0.12332,0.10628,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00081984,0.12304,0.093322,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.021165,0.12303,0.095374,1,1
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00057693,0.12281,0.14934,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.014138,0.12254,0.085709,1,1
4,GO REGULATION OF DNA REPAIR,0.0083534,0.12235,0.094956,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0042883,0.12232,0.099417,1,1
4,GO FLUID TRANSPORT,0.0037331,0.12221,0.1533,1,1
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.011612,0.12199,0.1263,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.00353,0.12187,0.10535,1,1
4,GO FAT CELL DIFFERENTIATION,0.035393,0.12163,0.090244,1,1
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.4121e-05,0.12139,0.13948,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.001662,0.12047,0.10153,1,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.00021167,0.11983,0.12367,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0028141,0.11973,0.13848,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0028957,0.11934,0.093252,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0013457,0.11933,0.14714,1,1
4,GO RESPONSE TO PEPTIDE,0.00059588,0.11882,0.11342,1,1
4,GO CYTOKINESIS,0.0085714,0.11861,0.10996,1,1
4,GO LAMELLIPODIUM ORGANIZATION,0.0046564,0.11799,0.18098,1,1
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0054795,0.11787,0.11109,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00012964,0.11735,0.15591,1,1
4,GO REGULATION OF DNA REPLICATION,0.0031536,0.11709,0.11091,1,1
4,GO CHROMOSOME SEPARATION,0.011047,0.11668,0.133,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.011904,0.11617,0.087073,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,5.2139e-05,0.11605,0.14524,1,1
4,GO REGULATION OF ATPASE ACTIVITY,0.0057817,0.11598,0.11393,1,1
4,GO REGULATION OF AUTOPHAGY,6.0504e-05,0.11411,0.13573,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00010845,0.11372,0.122,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00021909,0.11368,0.12092,1,1
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.019283,0.1135,0.1069,1,1
4,GO EMBRYONIC MORPHOGENESIS,0.0054795,0.11333,0.11892,1,1
4,GO APOPTOTIC DNA FRAGMENTATION,0.0010206,0.11315,0.11398,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0045306,0.11299,0.088532,1,1
4,GO ORGANELLE FISSION,0.0039469,0.11284,0.091543,1,1
4,GO SPINDLE ORGANIZATION,0.0047853,0.11271,0.11735,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.017969,0.11216,0.10068,1,1
4,GO MACROAUTOPHAGY,1.349e-05,0.11204,0.1404,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.033894,0.11183,0.13326,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0010859,0.11173,0.16527,1,1
4,GO FEMALE GAMETE GENERATION,0.0032441,0.11153,0.098412,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02268,0.11145,0.10073,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.00052342,0.11135,0.10608,1,1
4,GO MITOTIC CELL CYCLE,0.0018173,0.11133,0.10611,1,1
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.013139,0.11055,0.1361,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00081984,0.11018,0.13918,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0022332,0.11003,0.11418,1,1
4,GO METAPHASE PLATE CONGRESSION,0.047551,0.11002,0.10185,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.023741,0.10979,0.074936,1,1
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.013139,0.10969,0.13352,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.017969,0.10963,0.1815,1,1
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.030383,0.10947,0.10946,1,1
4,GO REGULATION OF CELL CYCLE PROCESS,0.001872,0.10946,0.096889,1,1
4,GO CHROMOSOME CONDENSATION,0.0042883,0.10909,0.1303,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.014486,0.10837,0.13675,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0013872,0.10813,0.10278,1,1
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,3.1888e-05,0.10751,0.11115,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.018398,0.10726,0.071363,1,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,2.3418e-05,0.10621,0.10747,1,1
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.00013917,0.10604,0.087885,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.029068,0.10572,0.088847,1,1
4,GO CARDIAC CHAMBER DEVELOPMENT,0.017137,0.10418,0.1412,1,1
4,GO MUSCLE ORGAN DEVELOPMENT,0.0014738,0.1039,0.13318,1,1
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0011549,0.10375,0.11415,1,1
4,GO MIRNA METABOLIC PROCESS,0.0085714,0.10365,0.13932,1,1
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.03245,0.10354,0.097241,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.02843,0.10328,0.12874,1,1
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.011047,0.10287,0.10008,1,1
4,GO PROTEIN TETRAMERIZATION,0.0025817,0.10143,0.11286,1,1
4,GO SNRNA TRANSCRIPTION,0.001986,0.10116,0.10652,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.012203,0.10063,0.12057,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.024846,0.10034,0.063311,1,1
4,GO NEGATIVE REGULATION OF BINDING,0.025414,0.10024,0.096378,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.027188,0.10013,0.078171,1,1
4,GO TUBE FORMATION,0.034637,0.099443,0.11719,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.043763,0.09936,0.080727,1,1
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0066042,0.098738,0.10349,1,1
4,GO NCRNA TRANSCRIPTION,0.022165,0.098729,0.091303,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0097392,0.098269,0.086968,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0028957,0.097498,0.11183,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.024846,0.097413,0.074603,1,1
4,GO CELL CYCLE PROCESS,0.0022332,0.097231,0.08863,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0012662,0.09651,0.10311,1,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0087944,0.096474,0.09702,1,1
4,GO REGULATION OF DNA METABOLIC PROCESS,0.00021167,0.096419,0.11056,1,1
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00028792,0.096304,0.1058,1,1
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.00084609,0.096052,0.1549,1,1
4,GO IRON ION TRANSPORT,0.004408,0.095384,0.099605,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0053338,0.095001,0.083618,1,1
4,GO MACROMOLECULE DEACYLATION,0.014486,0.094987,0.075986,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.012508,0.094728,0.073052,1,1
4,GO REGULATION OF CELL CYCLE,0.0050528,0.094704,0.075655,1,1
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.037747,0.094133,0.079676,1,1
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.00065623,0.093972,0.084718,1,1
4,GO G2 DNA DAMAGE CHECKPOINT,0.030383,0.093569,0.10741,1,1
4,GO HEART MORPHOGENESIS,0.018836,0.093436,0.13754,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.0071468,0.093215,0.090313,1,1
4,GO MULTI ORGANISM PROCESS,0.0018173,0.093044,0.074631,1,1
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036164,0.092595,0.089066,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.016339,0.090739,0.084969,1,1
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.016339,0.09071,0.094423,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0030654,0.090629,0.10176,1,1
4,GO LIPID METABOLIC PROCESS,0.013465,0.090616,0.064994,1,1
4,GO NEGATIVE REGULATION OF GROWTH,0.041093,0.090583,0.074688,1,1
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00028792,0.090572,0.10451,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.033894,0.090494,0.088325,1,1
4,GO DNA METABOLIC PROCESS,0.00032948,0.090433,0.095284,1,1
4,GO MITOTIC NUCLEAR DIVISION,0.0038387,0.089101,0.10667,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.015953,0.088978,0.088637,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.010773,0.088328,0.12562,1,1
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.041093,0.088072,0.14517,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.03939,0.088046,0.052093,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00019753,0.087704,0.094827,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.001986,0.087693,0.10511,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.025414,0.087178,0.064114,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.015203,0.087098,0.085005,1,1
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.02843,0.086378,0.084402,1,1
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.029719,0.08636,0.088331,1,1
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00353,0.086264,0.064463,1,1
4,GO CELL CYCLE,0.0034322,0.085642,0.074152,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.029719,0.085261,0.04751,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00014418,0.085186,0.095811,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.004408,0.084723,0.075421,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0042883,0.084109,0.10169,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.029068,0.083987,0.081845,1,1
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.011326,0.083256,0.071316,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0075304,0.082353,0.075734,1,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.023205,0.081517,0.099039,1,1
4,GO RESPONSE TO RADIATION,0.0047853,0.081251,0.082213,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.012203,0.079508,0.06525,1,1
4,GO SPINDLE ASSEMBLY,0.010245,0.078785,0.089603,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00037661,0.077573,0.078478,1,1
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0017641,0.077566,0.081889,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.00079435,0.07732,0.13055,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.02843,0.076661,0.085266,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.033166,0.074179,0.081529,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.00049035,0.072895,0.095778,1,1
4,GO INTRACELLULAR TRANSPORT,0.00049035,0.072534,0.081128,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.03939,0.071957,0.073794,1,1
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.010245,0.070289,0.10369,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.018398,0.070249,0.07561,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0025083,0.069076,0.089662,1,1
4,GO POLYOL METABOLIC PROCESS,0.02843,0.069025,0.066218,1,1
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.019739,0.068697,0.051409,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.036164,0.064064,0.06263,1,1
4,GO DOUBLE STRAND BREAK REPAIR,0.012508,0.063461,0.09116,1,1
4,GO DNA REPAIR,0.0083534,0.062813,0.078005,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.033166,0.061943,0.046509,1,1
4,GO DNA RECOMBINATION,0.02843,0.060878,0.088485,1,1
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0087944,0.060013,0.11721,1,1
4,GO DNA MODIFICATION,0.042857,0.054972,0.070704,1,1
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.104e-05,0.52173,0.4982,1,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00074557,0.46854,0.37522,1,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.001228,0.44661,0.47166,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00092958,0.44392,0.34085,1,0
4,GO RETINAL METABOLIC PROCESS,0.0060989,0.44287,0.33196,1,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,8.1192e-05,0.42292,0.43619,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.0034322,0.40512,0.38304,1,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,2.1663e-05,0.40265,0.44973,1,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0018173,0.37538,0.35835,1,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00065623,0.37077,0.36764,1,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0015189,0.36667,0.43241,1,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0011549,0.35931,0.45513,1,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.00014418,0.35531,0.34179,1,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,3.1888e-05,0.35343,0.31825,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0041716,0.34776,0.30921,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.03245,0.34653,0.25048,1,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00042998,0.34519,0.37271,1,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00010462,0.33824,0.41043,1,0
4,GO PROSTANOID METABOLIC PROCESS,0.0001547,0.33415,0.35904,1,0
4,GO PSEUDOURIDINE SYNTHESIS,0.0042883,0.32629,0.25695,1,0
4,GO PENTOSE METABOLIC PROCESS,0.0041716,0.31918,0.20968,1,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.0059384,0.31628,0.27659,1,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0085714,0.31575,0.30611,1,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0010206,0.31534,0.31495,1,0
4,GO EOSINOPHIL MIGRATION,0.0036303,0.31021,0.35949,1,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.30883,0.30611,1,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0032441,0.30794,0.22841,1,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0010859,0.30333,0.28202,1,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00098941,0.29649,0.28806,1,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.025414,0.29646,0.18417,1,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.043763,0.29582,0.3832,1,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0054795,0.28967,0.27972,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0031536,0.28801,0.2376,1,0
4,GO REGULATION OF WOUND HEALING,0.00034072,0.28669,0.29517,1,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.012508,0.28563,0.34061,1,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00079435,0.28472,0.2809,1,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.007729,0.28268,0.23585,1,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0049174,0.27928,0.31259,1,0
4,GO RESPONSE TO THYROID HORMONE,7.2754e-05,0.27749,0.3498,1,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0047853,0.27632,0.26325,1,0
4,GO GLYCINE METABOLIC PROCESS,0.019283,0.27465,0.2243,1,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.034637,0.27253,0.27901,1,0
4,GO MIDGUT DEVELOPMENT,0.035393,0.26564,0.2437,1,0
4,GO EOSINOPHIL CHEMOTAXIS,0.026586,0.26561,0.34202,1,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00014418,0.2653,0.34472,1,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00016595,0.26312,0.25072,1,0
4,GO LUNG MORPHOGENESIS,0.0024367,0.26306,0.25877,1,0
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0046564,0.26107,0.3407,1,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.010506,0.26089,0.18674,1,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0069616,0.25772,0.22689,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0022992,0.25344,0.27368,1,0
4,GO REGULATION OF RESPONSE TO WOUNDING,0.00034072,0.25227,0.2501,1,0
4,GO TRNA METHYLATION,0.00026903,0.24895,0.22958,1,0
4,GO RRNA TRANSCRIPTION,0.001872,0.24808,0.19946,1,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0094949,0.24674,0.22534,1,0
4,GO NADP METABOLIC PROCESS,0.016339,0.24624,0.18485,1,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0020453,0.24574,0.21514,1,0
4,GO REGULATION OF CELL KILLING,0.0024367,0.24247,0.20972,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.001191,0.24189,0.25848,1,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0040578,0.24166,0.24182,1,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,3.4421e-05,0.24009,0.25435,1,0
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0026572,0.23997,0.23432,1,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.041967,0.23925,0.37819,1,0
4,GO BEHAVIORAL RESPONSE TO PAIN,0.013465,0.23846,0.23891,1,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0013457,0.23751,0.2494,1,0
4,GO LIPID OXIDATION,0.0020453,0.23544,0.18661,1,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00019753,0.23541,0.23322,1,0
4,GO REGULATION OF ANOIKIS,0.047551,0.23482,0.21286,1,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.0018173,0.23404,0.30037,1,0
4,GO CELL JUNCTION DISASSEMBLY,0.0059384,0.23111,0.22275,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0083534,0.23088,0.22763,1,0
4,GO HISTONE H4 DEACETYLATION,0.0071468,0.22953,0.22424,1,0
4,GO PLACENTA DEVELOPMENT,0.0010528,0.22933,0.20752,1,0
4,GO SUPEROXIDE ANION GENERATION,0.0023671,0.22601,0.27071,1,0
4,GO MITOCHONDRIAL TRANSLATION,0.0017641,0.22429,0.19892,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.01282,0.22344,0.19403,1,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0014299,0.22089,0.37989,1,0
4,GO HOMOTYPIC CELL CELL ADHESION,0.0010859,0.22029,0.25296,1,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.0028141,0.22019,0.19724,1,0
4,GO REGULATION OF VASCULOGENESIS,0.0071468,0.22017,0.30944,1,0
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.024846,0.21586,0.155,1,0
4,GO PORE COMPLEX ASSEMBLY,0.0038387,0.21566,0.19658,1,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.022165,0.21516,0.13492,1,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0013457,0.21495,0.20475,1,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0047853,0.2117,0.16501,1,0
4,GO FATTY ACID HOMEOSTASIS,0.044685,0.21042,0.16108,1,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0033369,0.20959,0.24908,1,0
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.023205,0.20847,0.2341,1,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.0031536,0.20744,0.17695,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.011612,0.20613,0.21261,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00016595,0.20541,0.25169,1,0
4,GO RENAL FILTRATION,0.020205,0.20527,0.33674,1,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.0025817,0.20483,0.18759,1,0
4,GO RESPONSE TO GAMMA RADIATION,6.0504e-05,0.20319,0.24147,1,0
4,GO AMINO ACID ACTIVATION,0.014138,0.20154,0.18203,1,0
4,GO ETHANOL METABOLIC PROCESS,0.0097392,0.19997,0.26106,1,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.021165,0.19945,0.18406,1,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0029794,0.19813,0.26308,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.013139,0.19733,0.14533,1,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.015203,0.19375,0.14972,1,0
4,GO ALDITOL METABOLIC PROCESS,0.001228,0.19338,0.206,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015203,0.19106,0.13831,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.029719,0.19097,0.1667,1,0
4,GO GLOMERULUS DEVELOPMENT,0.00035231,0.1907,0.36498,1,0
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.011326,0.18892,0.19149,1,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0067808,0.18825,0.21016,1,0
4,GO EPITHELIAL CELL PROLIFERATION,0.0012662,0.1882,0.19061,1,0
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.023741,0.18616,0.14857,1,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0046564,0.1858,0.2674,1,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0099891,0.18385,0.1559,1,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.024846,0.18372,0.21599,1,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0036303,0.18367,0.22349,1,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0022992,0.18244,0.26006,1,0
4,GO CAMP METABOLIC PROCESS,0.043763,0.18229,0.20689,1,0
4,GO AMYLOID BETA METABOLIC PROCESS,0.012508,0.18059,0.16335,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0013457,0.17778,0.22002,1,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.030383,0.17493,0.20312,1,0
4,GO AXIS ELONGATION,0.030383,0.1735,0.22014,1,0
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.030383,0.17268,0.12115,1,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00065623,0.17184,0.18891,1,0
4,GO RESPONSE TO MINERALOCORTICOID,0.0075304,0.1699,0.23762,1,0
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.017969,0.16959,0.23968,1,0
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0094949,0.16958,0.17495,1,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.00054072,0.16827,0.17205,1,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.041967,0.16747,0.2234,1,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00055855,0.1671,0.15103,1,0
4,GO REGULATION OF B CELL ACTIVATION,0.010506,0.16617,0.12901,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00059588,0.16537,0.22105,1,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00010092,0.16495,0.28751,1,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00079435,0.1648,0.1912,1,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0047853,0.16261,0.15956,1,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.001191,0.16216,0.14945,1,0
4,GO MATURE B CELL DIFFERENTIATION,0.014841,0.16176,0.20074,1,0
4,GO BONE REMODELING,0.0028141,0.16144,0.18439,1,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0025817,0.16095,0.4305,1,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0054795,0.16002,0.18112,1,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.045624,0.15992,0.35232,1,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.033894,0.15927,0.16249,1,0
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.024846,0.15781,0.17897,1,0
4,GO DETOXIFICATION,0.013465,0.15753,0.13762,1,0
4,GO AMYLOID BETA FORMATION,0.0064317,0.15602,0.19334,1,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0015189,0.15598,0.13184,1,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.012203,0.1552,0.25176,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.027803,0.15454,0.20689,1,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.033166,0.15415,0.19779,1,0
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.014841,0.15383,0.18772,1,0
4,GO POSITIVE REGULATION OF COAGULATION,0.012203,0.15371,0.24159,1,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.01282,0.15298,0.18527,1,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.019283,0.15289,0.10075,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0020453,0.15039,0.20837,1,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0094949,0.14874,0.15687,1,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.036164,0.14767,0.24068,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.017969,0.14759,0.13234,1,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0037331,0.14722,0.1459,1,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.027188,0.14697,0.12425,1,0
4,GO IMPORT INTO NUCLEUS,0.00045924,0.14596,0.13361,1,0
4,GO INTEGRIN ACTIVATION,0.034637,0.14543,0.14923,1,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.00041602,0.14389,0.17786,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0064317,0.14388,0.20742,1,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.0062634,0.14338,0.11829,1,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.023741,0.14186,0.18576,1,0
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0028141,0.14165,0.14792,1,0
4,GO RESPONSE TO UV C,0.017549,0.14159,0.19112,1,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.021165,0.14132,0.11087,1,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.011904,0.14074,0.2006,1,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.03245,0.14059,0.18866,1,0
4,GO REGULATION OF MAP KINASE ACTIVITY,0.00092958,0.14058,0.13383,1,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.013139,0.13972,0.13112,1,0
4,GO GLIAL CELL MIGRATION,0.035393,0.13905,0.16948,1,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.047551,0.13797,0.11361,1,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0028957,0.13779,0.21075,1,0
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.025994,0.13727,0.14518,1,0
4,GO POSITIVE REGULATION OF CELL KILLING,0.041967,0.13724,0.12701,1,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.0030654,0.13679,0.20769,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.024846,0.13608,0.17338,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.023205,0.13578,0.11766,1,0
4,GO CELL CHEMOTAXIS,0.0041716,0.13548,0.18541,1,0
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.019739,0.13522,0.10769,1,0
4,GO CELLULAR RESPIRATION,0.02068,0.13309,0.10232,1,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.018836,0.13302,0.1737,1,0
4,GO GOLGI TO ENDOSOME TRANSPORT,0.0040578,0.13271,0.17646,1,0
4,GO REGULATION OF CELL CELL ADHESION,0.0060989,0.13034,0.13922,1,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.037747,0.13034,0.15905,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0017123,0.12972,0.16471,1,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.029068,0.12968,0.24939,1,0
4,GO LIPID HOMEOSTASIS,0.011904,0.12884,0.083537,1,0
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.018836,0.12847,0.14073,1,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.044685,0.12759,0.11756,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.012203,0.12687,0.13338,1,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.013465,0.12632,0.14395,1,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.02166,0.12629,0.29111,1,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.012508,0.12584,0.12223,1,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.026586,0.12563,0.10721,1,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.012508,0.12507,0.097319,1,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.014138,0.12504,0.10923,1,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0013872,0.12489,0.32379,1,0
4,GO BLASTOCYST FORMATION,0.0081404,0.12461,0.13915,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.010245,0.12381,0.11296,1,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0066042,0.12249,0.17059,1,0
4,GO OXIDATION REDUCTION PROCESS,0.0038387,0.12231,0.10345,1,0
4,GO AMINE METABOLIC PROCESS,0.017137,0.12209,0.0953,1,0
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.0071468,0.12099,0.095825,1,0
4,GO T CELL DIFFERENTIATION,0.0079323,0.12035,0.12249,1,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.019283,0.11912,0.09173,1,0
4,GO MAMMARY GLAND DEVELOPMENT,0.040234,0.11908,0.13059,1,0
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.026586,0.11757,0.15628,1,0
4,GO RESPONSE TO NUTRIENT,0.036164,0.11721,0.13005,1,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.03939,0.11677,0.21285,1,0
4,GO BIOLOGICAL ADHESION,0.016339,0.11652,0.11922,1,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.012508,0.11446,0.082696,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0073363,0.11443,0.12396,1,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.030383,0.11229,0.14186,1,0
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0040578,0.11225,0.088591,1,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.001228,0.11223,0.13113,1,0
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.02068,0.11039,0.1415,1,0
4,GO OVULATION CYCLE,0.017137,0.11029,0.14867,1,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0030654,0.10974,0.10612,1,0
4,GO LIPID LOCALIZATION,0.029068,0.10962,0.069183,1,0
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.0094949,0.10914,0.087216,1,0
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.010245,0.10748,0.077632,1,0
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.046579,0.10696,0.095753,1,0
4,GO LYMPHOCYTE DIFFERENTIATION,0.0021062,0.10679,0.13185,1,0
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.011326,0.1066,0.095613,1,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020205,0.10621,0.15414,1,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0011549,0.10407,0.10852,1,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.022165,0.10322,0.18225,1,0
4,GO MRNA CLEAVAGE,0.0057817,0.10301,0.11052,1,0
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.042857,0.10277,0.11,1,0
4,GO ELECTRON TRANSPORT CHAIN,0.017969,0.10215,0.094669,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0075304,0.10021,0.17427,1,0
4,GO ENDOCRINE PROCESS,0.029719,0.099355,0.12656,1,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.02068,0.098958,0.12584,1,0
4,GO HORMONE METABOLIC PROCESS,0.0081404,0.097909,0.11633,1,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0075304,0.09764,0.17115,1,0
4,GO CELL MOTILITY,0.015203,0.097111,0.10456,1,0
4,GO LIPID MODIFICATION,0.016339,0.096851,0.088125,1,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.047551,0.096648,0.25173,1,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.01282,0.096579,0.10427,1,0
4,GO KERATINOCYTE PROLIFERATION,0.015203,0.096294,0.31457,1,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.03245,0.095908,0.10018,1,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.024288,0.095801,0.089758,1,0
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.02268,0.093959,0.09118,1,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0087944,0.09351,0.16475,1,0
4,GO MRNA 3 END PROCESSING,0.017137,0.093093,0.10761,1,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0031536,0.092272,0.1241,1,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.004408,0.091877,0.12622,1,0
4,GO CELLULAR RESPONSE TO DRUG,0.041967,0.091736,0.10198,1,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.011326,0.090522,0.12035,1,0
4,GO AORTA DEVELOPMENT,0.023741,0.090089,0.24806,1,0
4,GO POLYOL BIOSYNTHETIC PROCESS,0.017137,0.088611,0.0918,1,0
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.016339,0.088142,0.060474,1,0
4,GO ANTIMICROBIAL HUMORAL RESPONSE,0.013465,0.087675,0.12865,1,0
4,GO RNA EXPORT FROM NUCLEUS,0.014841,0.08742,0.1188,1,0
4,GO VESICLE ORGANIZATION,0.017137,0.087253,0.088447,1,0
4,GO REGULATION OF CELL SHAPE,0.016734,0.087109,0.1521,1,0
4,GO REGULATION OF CENTROSOME CYCLE,0.033166,0.087053,0.095422,1,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.018836,0.086486,0.090732,1,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00090094,0.084343,0.14786,1,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.011904,0.082631,0.095918,1,0
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.044685,0.082531,0.092382,1,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.033166,0.079488,0.082786,1,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.040234,0.079459,0.062077,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.024288,0.079178,0.093045,1,0
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.043763,0.07915,0.050442,1,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.045624,0.079118,0.13307,1,0
4,GO ATP METABOLIC PROCESS,0.029719,0.07909,0.07495,1,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.035393,0.078562,0.11506,1,0
4,GO POSITIVE REGULATION OF SIGNALING,0.02843,0.078446,0.069587,1,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0064317,0.078248,0.11349,1,0
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.041093,0.077962,0.099068,1,0
4,GO REGULATION OF TUBE SIZE,0.007729,0.077524,0.13778,1,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.020205,0.076802,0.11526,1,0
4,GO CELL CYCLE ARREST,0.040234,0.074587,0.06205,1,0
4,GO VITAMIN METABOLIC PROCESS,0.026586,0.073716,0.10658,1,0
4,GO ODONTOGENESIS,0.015953,0.072419,0.19457,1,0
4,GO ACTIN FILAMENT BASED PROCESS,0.03939,0.070808,0.086259,1,0
4,GO MRNA EXPORT FROM NUCLEUS,0.037747,0.067912,0.089757,1,0
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.012203,0.060807,0.089537,1,0
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0097392,0.060432,0.087471,1,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.019283,0.05775,0.083183,1,0
4,GO DNA CATABOLIC PROCESS,0.037747,0.054712,0.060438,1,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.040234,0.052268,0.055236,1,0
4,GO MITOCHONDRIAL TRANSPORT,0.036948,0.051881,0.063414,1,0
4,GO SECRETION,0.037747,0.04739,0.063146,1,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.017549,-0.04239,-0.069698,1,0
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0081404,-0.047688,-0.10675,1,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.044685,-0.052999,-0.088747,1,0
4,GO PROTEIN ACETYLATION,0.026586,-0.058454,-0.068731,1,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.029719,-0.064034,-0.085857,1,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.026586,-0.067037,-0.12414,1,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.044685,-0.069778,-0.10768,1,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.016339,-0.071158,-0.1175,1,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0040578,-0.073284,-0.10591,1,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.047551,-0.073285,-0.075834,1,0
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.029719,-0.076672,-0.094895,1,0
4,GO REGULATION OF CILIUM MOVEMENT,0.017137,-0.077314,-0.11831,1,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.029719,-0.080221,-0.090536,1,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.024846,-0.082457,-0.18198,1,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.03939,-0.082757,-0.064394,1,0
4,GO PH REDUCTION,0.045624,-0.082842,-0.087074,1,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.046579,-0.084835,-0.092453,1,0
4,GO CIRCADIAN RHYTHM,0.0010528,-0.087676,-0.11046,1,0
4,GO CELL PROJECTION ORGANIZATION,0.012508,-0.088703,-0.089397,1,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.033894,-0.090265,-0.099867,1,0
4,GO VESICLE LOCALIZATION,0.030383,-0.090324,-0.061618,1,0
4,GO METAL ION TRANSPORT,0.0064317,-0.091256,-0.093703,1,0
4,GO CARBOHYDRATE HOMEOSTASIS,0.015953,-0.094651,-0.10097,1,0
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.022165,-0.09468,-0.13592,1,0
4,GO POSITIVE REGULATION OF SECRETION,0.0040578,-0.095025,-0.10532,1,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0045306,-0.095171,-0.091079,1,0
4,GO ANATOMICAL STRUCTURE MATURATION,0.022165,-0.095581,-0.088589,1,0
4,GO REGULATION OF CELL DEVELOPMENT,0.012508,-0.095759,-0.11042,1,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.025414,-0.095826,-0.10106,1,0
4,GO SENSORY PERCEPTION OF SMELL,0.0047853,-0.097677,-0.096812,1,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.018836,-0.098105,-0.086819,1,0
4,GO CHROMATIN REMODELING,0.047551,-0.098232,-0.080105,1,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.033894,-0.099015,-0.11186,1,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0022332,-0.099592,-0.15392,1,0
4,GO PEPTIDE SECRETION,0.0021689,-0.099981,-0.10925,1,0
4,GO MULTICELLULAR ORGANISM AGING,0.045624,-0.10013,-0.10656,1,0
4,GO DETECTION OF STIMULUS,0.0028957,-0.10016,-0.087217,1,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.041967,-0.10024,-0.079814,1,0
4,GO FEAR RESPONSE,0.0032441,-0.1021,-0.16266,1,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.020205,-0.10333,-0.092524,1,0
4,GO REGULATION OF CELL CYCLE ARREST,0.029719,-0.10516,-0.074353,1,0
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.041093,-0.10543,-0.077868,1,0
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0083534,-0.10615,-0.12691,1,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.011326,-0.10647,-0.097479,1,0
4,GO ADIPOSE TISSUE DEVELOPMENT,0.025994,-0.10785,-0.1841,1,0
4,GO REGULATION OF CARDIAC CONDUCTION,0.040234,-0.10913,-0.10911,1,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.036948,-0.10952,-0.13104,1,0
4,GO NEURON APOPTOTIC PROCESS,0.0066042,-0.10999,-0.10076,1,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.019283,-0.11052,-0.10842,1,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.0097392,-0.1126,-0.14954,1,0
4,GO SOMITOGENESIS,0.034637,-0.11326,-0.081634,1,0
4,GO ION TRANSPORT,0.0040578,-0.1142,-0.094076,1,0
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.021165,-0.11465,-0.14757,1,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.020205,-0.11586,-0.077629,1,0
4,GO CELL JUNCTION ORGANIZATION,0.047551,-0.11597,-0.083167,1,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.02068,-0.11677,-0.14498,1,0
4,GO REGULATION OF HORMONE LEVELS,0.0040578,-0.11735,-0.12126,1,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.040234,-0.11815,-0.139,1,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0047853,-0.11876,-0.12102,1,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.03245,-0.11901,-0.10851,1,0
4,GO REGULATION OF PEPTIDE SECRETION,0.0040578,-0.11992,-0.10525,1,0
4,GO MOTOR NEURON AXON GUIDANCE,0.043763,-0.12006,-0.11408,1,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.025414,-0.12082,-0.16526,1,0
4,GO REGULATION OF RESPONSE TO FOOD,0.02068,-0.12087,-0.14408,1,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.043763,-0.12105,-0.15073,1,0
4,GO CELL FATE COMMITMENT,0.017549,-0.12116,-0.13743,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.041093,-0.12188,-0.11166,1,0
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.027188,-0.12249,-0.11403,1,0
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.031748,-0.12298,-0.09855,1,0
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.0045306,-0.12299,-0.10305,1,0
4,GO REGULATION OF ACTIN NUCLEATION,0.004408,-0.12337,-0.18947,1,0
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0013457,-0.12405,-0.12219,1,0
4,GO MICROTUBULE POLYMERIZATION,0.013139,-0.12438,-0.13803,1,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0022332,-0.12501,-0.14581,1,0
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0010528,-0.12579,-0.13129,1,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.035393,-0.12608,-0.17036,1,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.034637,-0.12677,-0.12592,1,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.013139,-0.12711,-0.12989,1,0
4,GO DEVELOPMENTAL CELL GROWTH,0.0042883,-0.12721,-0.14284,1,0
4,GO ADULT FEEDING BEHAVIOR,0.0067808,-0.1273,-0.20657,1,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.02843,-0.12823,-0.15957,1,0
4,GO CELL CELL SIGNALING,0.0010206,-0.12945,-0.10966,1,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.019283,-0.12999,-0.18237,1,0
4,GO REGULATION OF BEHAVIOR,0.0097392,-0.13047,-0.1541,1,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0022332,-0.13115,-0.128,1,0
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.029068,-0.13156,-0.15321,1,0
4,GO HEAD DEVELOPMENT,0.0021062,-0.13237,-0.14562,1,0
4,GO PEPTIDYL LYSINE METHYLATION,0.035393,-0.13319,-0.11058,1,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.02268,-0.13363,-0.12825,1,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.025994,-0.13372,-0.11592,1,0
4,GO ION TRANSMEMBRANE TRANSPORT,0.0027346,-0.13392,-0.1095,1,0
4,GO REGULATION OF TORC1 SIGNALING,0.0054795,-0.1341,-0.128,1,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.040234,-0.13411,-0.217,1,0
4,GO CHLORIDE TRANSPORT,0.0094949,-0.13774,-0.10707,1,0
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.001986,-0.13797,-0.17385,1,0
4,GO CELL MATURATION,0.0010859,-0.13811,-0.1299,1,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0075304,-0.13832,-0.16289,1,0
4,GO OLIGODENDROCYTE DEVELOPMENT,0.0041716,-0.13896,-0.21026,1,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.021165,-0.13963,-0.1782,1,0
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0012662,-0.13993,-0.12664,1,0
4,GO CATION TRANSPORT,0.00049035,-0.14003,-0.12643,1,0
4,GO OXIDATIVE DEMETHYLATION,0.010773,-0.14045,-0.12803,1,0
4,GO INNER EAR MORPHOGENESIS,0.023205,-0.14064,-0.15504,1,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0010528,-0.14157,-0.14829,1,0
4,GO HINDBRAIN MORPHOGENESIS,0.0042883,-0.14161,-0.16047,1,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0025083,-0.14348,-0.15145,1,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0028141,-0.14387,-0.12945,1,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0025817,-0.14472,-0.15699,1,0
4,GO REGULATION OF SYSTEM PROCESS,0.0013457,-0.14496,-0.12491,1,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.00047456,-0.14518,-0.15205,1,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0097392,-0.14578,-0.13215,1,0
4,GO LIPID DROPLET ORGANIZATION,0.007729,-0.14594,-0.16971,1,0
4,GO REGULATION OF APPETITE,0.0030654,-0.14599,-0.15257,1,0
4,GO SENSORY PERCEPTION OF TASTE,0.0049174,-0.14698,-0.17465,1,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.02268,-0.14708,-0.18067,1,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0050528,-0.14763,-0.23513,1,0
4,GO COCHLEA DEVELOPMENT,0.012508,-0.14783,-0.22229,1,0
4,GO FOREBRAIN CELL MIGRATION,0.012508,-0.14783,-0.19009,1,0
4,GO SENSORY PERCEPTION,0.00087311,-0.14818,-0.11908,1,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.029719,-0.1489,-0.1488,1,0
4,GO STRIATUM DEVELOPMENT,0.0075304,-0.14941,-0.23216,1,0
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.001662,-0.14961,-0.17586,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.025994,-0.14969,-0.16333,1,0
4,GO REGULATION OF SECRETION,3.7145e-05,-0.15007,-0.14916,1,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0059384,-0.15193,-0.13788,1,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.046579,-0.15203,-0.14896,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.043763,-0.15224,-0.22567,1,0
4,GO CATION TRANSMEMBRANE TRANSPORT,0.00087311,-0.15228,-0.12872,1,0
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00027832,-0.15358,-0.16167,1,0
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0047853,-0.15387,-0.17362,1,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00057693,-0.15408,-0.15843,1,0
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0037331,-0.15512,-0.12655,1,0
4,GO RESPONSE TO POTASSIUM ION,0.046579,-0.15523,-0.24763,1,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0024367,-0.15532,-0.1789,1,0
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.044685,-0.15577,-0.16624,1,0
4,GO NEUROGENESIS,0.00074557,-0.15641,-0.15381,1,0
4,GO SODIUM ION TRANSPORT,0.00090094,-0.15864,-0.15385,1,0
4,GO TELENCEPHALON DEVELOPMENT,0.00072223,-0.15892,-0.17423,1,0
4,GO REGULATION OF RESPIRATORY BURST,0.046579,-0.15911,-0.19582,1,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.015203,-0.15917,-0.12335,1,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.03245,-0.15931,-0.12118,1,0
4,GO IMPORT INTO CELL,0.042857,-0.15942,-0.096739,1,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.035393,-0.16042,-0.21842,1,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.019739,-0.16226,-0.15605,1,0
4,GO REGULATION OF ION TRANSPORT,0.00021909,-0.16317,-0.15237,1,0
4,GO REGULATION OF GLIOGENESIS,0.018836,-0.16327,-0.12233,1,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.019739,-0.16335,-0.14476,1,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.00044439,-0.1635,-0.17565,1,0
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00067758,-0.16379,-0.13113,1,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00044439,-0.16411,-0.2019,1,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0036303,-0.16476,-0.14243,1,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.011326,-0.16486,-0.19088,1,0
4,GO MECHANORECEPTOR DIFFERENTIATION,0.011612,-0.16535,-0.17638,1,0
4,GO HISTONE H4 ACETYLATION,0.0021062,-0.1661,-0.1413,1,0
4,GO CELL PART MORPHOGENESIS,0.00029782,-0.16633,-0.19539,1,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.02843,-0.16702,-0.14174,1,0
4,GO HISTONE H4 K16 ACETYLATION,0.00067758,-0.16885,-0.23445,1,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.043763,-0.16889,-0.21831,1,0
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.030383,-0.1689,-0.11564,1,0
4,GO REGULATION OF BLOOD CIRCULATION,0.0023671,-0.16908,-0.14164,1,0
4,GO NEURON PROJECTION GUIDANCE,0.009256,-0.16917,-0.16906,1,0
4,GO AXON DEVELOPMENT,0.001986,-0.16958,-0.18423,1,0
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0069616,-0.17006,-0.16807,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0051916,-0.17065,-0.18108,1,0
4,GO HEART PROCESS,0.0033369,-0.1712,-0.14142,1,0
4,GO REGULATION OF AXONOGENESIS,0.00087311,-0.17133,-0.18794,1,0
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00055855,-0.17151,-0.17507,1,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00034072,-0.1718,-0.14226,1,0
4,GO RESPONSE TO ALKALOID,2.2524e-05,-0.17279,-0.19924,1,0
4,GO STRIATED MUSCLE CONTRACTION,0.018836,-0.17285,-0.1228,1,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0085714,-0.17344,-0.29607,1,0
4,GO DIGESTIVE SYSTEM PROCESS,0.015203,-0.17362,-0.14104,1,0
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.00037661,-0.17485,-0.18432,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.027803,-0.17496,-0.2095,1,0
4,GO RHYTHMIC BEHAVIOR,0.036948,-0.17518,-0.14917,1,0
4,GO SECONDARY PALATE DEVELOPMENT,0.025414,-0.17646,-0.16045,1,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.033894,-0.17683,-0.19438,1,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0018173,-0.17686,-0.21621,1,0
4,GO RESPONSE TO INTERLEUKIN 2,0.017137,-0.17733,-0.20377,1,0
4,GO VESICLE DOCKING,0.00047456,-0.17778,-0.18095,1,0
4,GO MICROTUBULE BUNDLE FORMATION,0.02166,-0.18,-0.12299,1,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.025414,-0.18018,-0.12321,1,0
4,GO EATING BEHAVIOR,0.0007696,-0.18045,-0.17663,1,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0017123,-0.18186,-0.18457,1,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,9.7346e-05,-0.18218,-0.19467,1,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0025083,-0.18267,-0.15569,1,0
4,GO HYPOTHALAMUS DEVELOPMENT,0.020205,-0.1827,-0.18481,1,0
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.020205,-0.18302,-0.16665,1,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.035393,-0.18351,-0.15716,1,0
4,GO HISTONE H3 K4 METHYLATION,0.0079323,-0.18389,-0.19252,1,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0025083,-0.18395,-0.15729,1,0
4,GO DEVELOPMENTAL INDUCTION,0.03939,-0.18433,-0.13334,1,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.0094949,-0.18441,-0.17615,1,0
4,GO NEURON PROJECTION ORGANIZATION,0.0051916,-0.18455,-0.18711,1,0
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.024288,-0.18552,-0.14708,1,0
4,GO EAR DEVELOPMENT,0.0067808,-0.18571,-0.16991,1,0
4,GO NEUROMUSCULAR PROCESS,0.00047456,-0.18582,-0.19533,1,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.0047853,-0.18663,-0.16676,1,0
4,GO PHAGOSOME ACIDIFICATION,0.0085714,-0.18711,-0.16489,1,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0010206,-0.18738,-0.18526,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0094949,-0.18749,-0.17732,1,0
4,GO RESPONSE TO FOOD,9.389e-05,-0.18771,-0.18901,1,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.0001547,-0.18787,-0.20532,1,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.004408,-0.18847,-0.17279,1,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.001662,-0.18861,-0.20247,1,0
4,GO NERVOUS SYSTEM PROCESS,1.5201e-05,-0.18872,-0.17779,1,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00029782,-0.18876,-0.18983,1,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.025414,-0.18885,-0.21724,1,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.017969,-0.1898,-0.19657,1,0
4,GO NEURON DEVELOPMENT,0.00012512,-0.18983,-0.19276,1,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0075304,-0.19062,-0.18839,1,0
4,GO POSTSYNAPSE ORGANIZATION,0.00065623,-0.19071,-0.22229,1,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0083534,-0.19209,-0.20439,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.024846,-0.1924,-0.19375,1,0
4,GO REPRODUCTIVE BEHAVIOR,0.00079435,-0.1926,-0.21906,1,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.0053338,-0.19303,-0.22985,1,0
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.017969,-0.19487,-0.17553,1,0
4,GO REGULATION OF CIRCADIAN RHYTHM,7.6603e-06,-0.19511,-0.19391,1,0
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00022676,-0.19517,-0.19484,1,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00034072,-0.19555,-0.16161,1,0
4,GO DIGESTION,0.0041716,-0.19629,-0.16824,1,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0025817,-0.19681,-0.33578,1,0
4,GO FOREBRAIN DEVELOPMENT,0.00017796,-0.1974,-0.1944,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.024288,-0.198,-0.18417,1,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.0050528,-0.19837,-0.17815,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0014738,-0.1989,-0.21567,1,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0056288,-0.19973,-0.20355,1,0
4,GO RESPONSE TO AMPHETAMINE,0.00081984,-0.20037,-0.26149,1,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.013798,-0.20096,-0.14932,1,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.024288,-0.20219,-0.22637,1,0
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0017123,-0.20226,-0.20657,1,0
4,GO ORGANIC CATION TRANSPORT,0.00047456,-0.20231,-0.22369,1,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00024286,-0.2027,-0.19565,1,0
4,GO LIPID TRANSLOCATION,0.0079323,-0.20292,-0.18425,1,0
4,GO DEVELOPMENTAL MATURATION,6.2786e-05,-0.20359,-0.19082,1,0
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0010859,-0.20416,-0.28759,1,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.00014418,-0.20422,-0.18034,1,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.00081984,-0.20475,-0.2217,1,0
4,GO NEURON DIFFERENTIATION,5.4121e-05,-0.20557,-0.19862,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00090094,-0.20596,-0.2575,1,0
4,GO REGULATION OF CHROMATIN BINDING,0.001228,-0.2063,-0.21695,1,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0099891,-0.20647,-0.15471,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.011326,-0.20767,-0.19841,1,0
4,GO NEURON PROJECTION EXTENSION,0.0030654,-0.20769,-0.17259,1,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0007696,-0.20786,-0.20599,1,0
4,GO PROTEIN POLYGLUTAMYLATION,0.00034072,-0.20791,-0.26213,1,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.025414,-0.20849,-0.20315,1,0
4,GO HAIR CELL DIFFERENTIATION,0.0045306,-0.20932,-0.24711,1,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.035393,-0.2094,-0.16626,1,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00059588,-0.21075,-0.16174,1,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00050664,-0.21077,-0.17973,1,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,2.9532e-05,-0.21122,-0.23424,1,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.00087311,-0.21159,-0.20346,1,0
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.012203,-0.21225,-0.19486,1,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0016129,-0.21249,-0.21152,1,0
4,GO ACROSOME REACTION,0.0099891,-0.21332,-0.16141,1,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0028141,-0.21339,-0.21704,1,0
4,GO THYMUS DEVELOPMENT,0.041093,-0.21346,-0.12548,1,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0006154,-0.21384,-0.17432,1,0
4,GO ACID SECRETION,0.00027832,-0.21393,-0.20627,1,0
4,GO MEMORY,0.00022676,-0.21395,-0.19021,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0047853,-0.21519,-0.20607,1,0
4,GO SODIUM ION HOMEOSTASIS,0.00092958,-0.21594,-0.25441,1,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0083534,-0.21806,-0.28135,1,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,6.7596e-05,-0.2184,-0.2288,1,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.0056288,-0.2194,-0.19524,1,0
4,GO SLEEP,0.00050664,-0.22016,-0.20245,1,0
4,GO REGULATION OF ORGANIC ACID TRANSPORT,3.8583e-05,-0.22057,-0.24326,1,0
4,GO COGNITION,4.4878e-05,-0.22067,-0.20422,1,0
4,GO RESPONSE TO PAIN,0.0051916,-0.22152,-0.21247,1,0
4,GO VISUAL BEHAVIOR,0.00013917,-0.22191,-0.19853,1,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0071468,-0.22211,-0.24405,1,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.00353,-0.22263,-0.25621,1,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.038561,-0.2228,-0.14494,1,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.018836,-0.22316,-0.18269,1,0
4,GO MITOCHONDRION LOCALIZATION,0.0040578,-0.22395,-0.2312,1,0
4,GO REGULATION OF CELL MATURATION,0.00035231,-0.2244,-0.23742,1,0
4,GO REGULATION OF HORMONE SECRETION,2.5774e-06,-0.22532,-0.2427,1,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.0036303,-0.22656,-0.14291,1,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.0031536,-0.2272,-0.17862,1,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,8.4205e-05,-0.22735,-0.27144,1,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00014935,-0.22764,-0.3191,1,0
4,GO TUBULIN DEACETYLATION,0.015203,-0.2279,-0.2507,1,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.001986,-0.2298,-0.16929,1,0
4,GO AMINO ACID TRANSPORT,0.00057693,-0.2305,-0.18009,1,0
4,GO RESPONSE TO CATECHOLAMINE,3.8583e-05,-0.23128,-0.22032,1,0
4,GO MITOCHONDRION DISTRIBUTION,0.0069616,-0.23166,-0.24471,1,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.0026572,-0.23206,-0.15772,1,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.044685,-0.23387,-0.29412,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0090226,-0.234,-0.20436,1,0
4,GO HORMONE TRANSPORT,1.2862e-06,-0.23408,-0.25355,1,0
4,GO REGULATION OF ICOSANOID SECRETION,0.02068,-0.23447,-0.15714,1,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.018836,-0.23491,-0.26904,1,0
4,GO SPINAL CORD DEVELOPMENT,0.00023468,-0.23521,-0.2561,1,0
4,GO MONOVALENT INORGANIC CATION TRANSPORT,2.9301e-06,-0.23566,-0.21776,1,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,2.2524e-05,-0.23659,-0.28432,1,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,7.3528e-06,-0.23676,-0.22538,1,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0081404,-0.23684,-0.23171,1,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.029068,-0.23693,-0.17875,1,0
4,GO BEHAVIOR,3.0576e-06,-0.23774,-0.22722,1,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00353,-0.23841,-0.159,1,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.00012964,-0.24141,-0.31128,1,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041093,-0.24193,-0.13258,1,0
4,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.00030804,-0.24213,-0.18869,1,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00016595,-0.24266,-0.25509,1,0
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.047551,-0.24295,-0.16983,1,0
4,GO BILE ACID METABOLIC PROCESS,0.004408,-0.24305,-0.19518,1,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00021909,-0.24361,-0.31529,1,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00081984,-0.24438,-0.17754,1,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.00010092,-0.24679,-0.28578,1,0
4,GO CRANIAL NERVE DEVELOPMENT,0.0007696,-0.24739,-0.26609,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00063551,-0.2475,-0.21409,1,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.00016023,-0.24909,-0.26132,1,0
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0007696,-0.24962,-0.20541,1,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00013433,-0.25075,-0.26971,1,0
4,GO CARDIAC CONDUCTION,0.00034072,-0.25079,-0.24279,1,0
4,GO DETECTION OF ABIOTIC STIMULUS,2.2524e-05,-0.25245,-0.20449,1,0
4,GO FILOPODIUM ASSEMBLY,0.001191,-0.25245,-0.226,1,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0097392,-0.25402,-0.28936,1,0
4,GO FEEDING BEHAVIOR,3.9926e-07,-0.25467,-0.27215,1,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.017137,-0.25481,-0.21294,1,0
4,GO MICROTUBULE DEPOLYMERIZATION,5.6174e-05,-0.25483,-0.33389,1,0
4,GO REGULATION OF ACTION POTENTIAL,0.025414,-0.25497,-0.16261,1,0
4,GO RESPONSE TO DOPAMINE,2.6902e-06,-0.25522,-0.2476,1,0
4,GO SEX DETERMINATION,0.0013872,-0.2562,-0.25913,1,0
4,GO REGULATION OF HEART RATE,0.0015189,-0.25768,-0.20987,1,0
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00092958,-0.25787,-0.24408,1,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.010773,-0.25798,-0.31171,1,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0014738,-0.25824,-0.21955,1,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0012662,-0.25889,-0.25984,1,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0029794,-0.25915,-0.22741,1,0
4,GO DENDRITIC TRANSPORT,0.0099891,-0.25969,-0.26482,1,0
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.011904,-0.25972,-0.22104,1,0
4,GO GENETIC IMPRINTING,0.0024367,-0.26005,-0.19143,1,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00055855,-0.26042,-0.30426,1,0
4,GO ADHERENS JUNCTION ORGANIZATION,0.00059588,-0.26053,-0.25471,1,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0027346,-0.26083,-0.27143,1,0
4,GO CAMP BIOSYNTHETIC PROCESS,0.012203,-0.26083,-0.24378,1,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.02843,-0.26093,-0.16802,1,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.0053338,-0.26399,-0.22026,1,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,4.2876e-06,-0.26457,-0.22997,1,0
4,GO AMINE BIOSYNTHETIC PROCESS,0.007729,-0.26678,-0.20231,1,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00026903,-0.26718,-0.27179,1,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00026903,-0.26735,-0.21451,1,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.017137,-0.27258,-0.32306,1,0
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00014935,-0.27399,-0.29327,1,0
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00052342,-0.27463,-0.31207,1,0
4,GO PANCREAS DEVELOPMENT,0.00034072,-0.27529,-0.24106,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.022165,-0.27616,-0.23195,1,0
4,GO RELAXATION OF MUSCLE,0.041093,-0.27847,-0.17946,1,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.00057693,-0.27912,-0.20084,1,0
4,GO CORTICOSTEROID HORMONE SECRETION,0.0032441,-0.2795,-0.29586,1,0
4,GO SIGNAL RELEASE,3.17e-07,-0.28052,-0.26837,1,0
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0059384,-0.28073,-0.32712,1,0
4,GO PRESYNAPSE ORGANIZATION,0.0010206,-0.28242,-0.26826,1,0
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0013457,-0.28276,-0.25674,1,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0087944,-0.28297,-0.2408,1,0
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0046564,-0.28303,-0.22866,1,0
4,GO HISTONE H4 K5 ACETYLATION,0.001228,-0.28421,-0.24492,1,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.016339,-0.28539,-0.30039,1,0
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,5.0683e-06,-0.28568,-0.2574,1,0
4,GO PEPTIDE HORMONE SECRETION,4.5813e-07,-0.28632,-0.30753,1,0
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.4346e-05,-0.28664,-0.28185,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.9263e-05,-0.28934,-0.31502,1,0
4,GO REGULATION OF INSULIN SECRETION,3.4728e-06,-0.28997,-0.28229,1,0
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,4.5813e-07,-0.29115,-0.29768,1,0
4,GO SYNAPSE ORGANIZATION,4.0073e-05,-0.29118,-0.27941,1,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0042883,-0.29157,-0.29249,1,0
4,GO SENSORY PERCEPTION OF PAIN,5.2533e-07,-0.29383,-0.2854,1,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00052342,-0.29634,-0.26894,1,0
4,GO HINDBRAIN DEVELOPMENT,5.0683e-06,-0.29671,-0.28689,1,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0028141,-0.29675,-0.25219,1,0
4,GO LIPOXYGENASE PATHWAY,0.0057817,-0.29682,-0.31292,1,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.001662,-0.29715,-0.32045,1,0
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,4.3218e-05,-0.29722,-0.2731,1,0
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.00026003,-0.29733,-0.2695,1,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0015189,-0.29809,-0.24697,1,0
4,GO CELL MIGRATION IN HINDBRAIN,0.00023468,-0.29885,-0.37899,1,0
4,GO PROTEIN PALMITOYLATION,1.7806e-05,-0.29964,-0.28933,1,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,9.7801e-06,-0.29983,-0.28564,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.023741,-0.30127,-0.25113,1,0
4,GO RDNA HETEROCHROMATIN ASSEMBLY,1.5816e-05,-0.30185,-0.27375,1,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00021167,-0.303,-0.30788,1,0
4,GO POTASSIUM ION HOMEOSTASIS,0.0017641,-0.30379,-0.23026,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.9263e-05,-0.30427,-0.28214,1,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,6.0504e-05,-0.30615,-0.26789,1,0
4,GO DENDRITE DEVELOPMENT,2.0833e-05,-0.30649,-0.27792,1,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.011904,-0.30711,-0.20219,1,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.031059,-0.30827,-0.22951,1,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00038934,-0.30841,-0.52722,1,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00084609,-0.30872,-0.28408,1,0
4,GO SKELETAL MUSCLE ADAPTATION,0.0023671,-0.3092,-0.23974,1,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.013139,-0.30929,-0.26402,1,0
4,GO ENERGY HOMEOSTASIS,0.0022992,-0.30937,-0.25599,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.022165,-0.31009,-0.21595,1,0
4,GO INSULIN SECRETION,1.4674e-06,-0.3103,-0.30265,1,0
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0028957,-0.31074,-0.25254,1,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.5201e-05,-0.31077,-0.2894,1,0
4,GO RESPONSE TO MAGNESIUM ION,0.0040578,-0.31211,-0.28833,1,0
4,GO MULTICELLULAR ORGANISMAL SIGNALING,8.3127e-06,-0.31241,-0.31541,1,0
4,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.00018427,-0.31341,-0.25721,1,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,7.8282e-05,-0.31449,-0.26481,1,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.0026572,-0.31503,-0.2978,1,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00025131,-0.31505,-0.35936,1,0
4,GO POSITIVE REGULATION OF EXOCYTOSIS,3.17e-07,-0.31759,-0.31801,1,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00012512,-0.31903,-0.31394,1,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,1.0604e-05,-0.32062,-0.29583,1,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.00081984,-0.32265,-0.25015,1,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0025817,-0.32313,-0.42419,1,0
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.020205,-0.32414,-0.36839,1,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,2.6307e-05,-0.32417,-0.3718,1,0
4,GO ACTION POTENTIAL,4.3218e-05,-0.32453,-0.30551,1,0
4,GO ASSOCIATIVE LEARNING,4.8379e-05,-0.32529,-0.25736,1,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00055855,-0.32543,-0.24489,1,0
4,GO DENDRITE MORPHOGENESIS,2.6307e-05,-0.32593,-0.30377,1,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,4.4878e-05,-0.32726,-0.27128,1,0
4,GO SYNAPTIC VESICLE RECYCLING,4.2876e-06,-0.32967,-0.34272,1,0
4,GO NERVE DEVELOPMENT,8.1192e-05,-0.33006,-0.29638,1,0
4,GO NOREPINEPHRINE TRANSPORT,0.00092958,-0.33174,-0.27312,1,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,1.4044e-06,-0.33419,-0.38533,1,0
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,5.508e-06,-0.33433,-0.33617,1,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.00047456,-0.33436,-0.31399,1,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.013139,-0.33443,-0.24061,1,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0010206,-0.33468,-0.35895,1,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,8.3127e-06,-0.33472,-0.332,1,0
4,GO SYNAPTIC VESICLE TRANSPORT,9.0179e-06,-0.33722,-0.36097,1,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0036303,-0.33985,-0.36538,1,0
4,GO FOREBRAIN REGIONALIZATION,0.00040247,-0.34079,-0.36147,1,0
4,GO REGULATION OF MEMBRANE POTENTIAL,7.889e-07,-0.34233,-0.32763,1,0
4,GO RESPONSE TO DIETARY EXCESS,0.00044439,-0.34245,-0.36527,1,0
4,GO MEMBRANE DEPOLARIZATION,7.8282e-05,-0.3426,-0.28919,1,0
4,GO ADRENAL GLAND DEVELOPMENT,8.4205e-05,-0.34487,-0.37108,1,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.009256,-0.34672,-0.30147,1,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,9.3916e-06,-0.34713,-0.38551,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0006154,-0.3473,-0.30442,1,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0039469,-0.34781,-0.293,1,0
4,GO LEARNING,9.7801e-06,-0.34827,-0.30329,1,0
4,GO NEUROTRANSMITTER REUPTAKE,0.00014935,-0.34906,-0.33557,1,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.030383,-0.34925,-0.3214,1,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.0060989,-0.34953,-0.23891,1,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.02843,-0.35022,-0.25159,1,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,9.3916e-06,-0.35044,-0.32381,1,0
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.9263e-05,-0.35184,-0.32008,1,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0025083,-0.35248,-0.28078,1,0
4,GO EPITHELIAL STRUCTURE MAINTENANCE,1.7806e-05,-0.35324,-0.3457,1,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,8.7323e-05,-0.3536,-0.3877,1,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,3.8583e-05,-0.35543,-0.37053,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00057693,-0.35616,-0.32691,1,0
4,GO REGULATION OF EXOCYTOSIS,9.4334e-07,-0.35666,-0.3134,1,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.001228,-0.35679,-0.28916,1,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0094949,-0.35882,-0.28904,1,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.00032948,-0.36004,-0.29266,1,0
4,GO LOCOMOTORY BEHAVIOR,1.4963e-07,-0.36024,-0.39219,1,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.00017796,-0.36178,-0.33731,1,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,7.2754e-05,-0.36214,-0.33621,1,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.024288,-0.36281,-0.22426,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0036303,-0.36408,-0.28771,1,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0012662,-0.36429,-0.26219,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,5.7413e-06,-0.36563,-0.40715,1,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,1.7806e-05,-0.36675,-0.4033,1,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0024367,-0.36716,-0.27152,1,0
4,GO SYNAPTIC SIGNALING,8.628e-07,-0.3675,-0.32588,1,0
4,GO POTASSIUM ION TRANSPORT,1.0311e-06,-0.36758,-0.32478,1,0
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.001228,-0.37293,-0.33592,1,0
4,GO DETECTION OF MECHANICAL STIMULUS,1.7118e-05,-0.37388,-0.31484,1,0
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0027346,-0.37421,-0.25251,1,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,2.0784e-06,-0.37423,-0.34543,1,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0067808,-0.37478,-0.27086,1,0
4,GO WALKING BEHAVIOR,0.00011241,-0.37669,-0.33973,1,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00047456,-0.3772,-0.33427,1,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00010092,-0.37749,-0.37194,1,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,7.547e-05,-0.37872,-0.32707,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.009256,-0.38066,-0.42135,1,0
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,4.2876e-06,-0.38225,-0.36383,1,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,7.9801e-06,-0.38337,-0.35508,1,0
4,GO RESPONSE TO NICOTINE,0.00036427,-0.38374,-0.27602,1,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00018427,-0.38397,-0.43228,1,0
4,GO OTIC VESICLE MORPHOGENESIS,0.024288,-0.38421,-0.36256,1,0
4,GO RESPONSE TO ACETYLCHOLINE,0.00024286,-0.38529,-0.3438,1,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,1.6455e-05,-0.38559,-0.40204,1,0
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0056288,-0.38565,-0.25323,1,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00074557,-0.38679,-0.43069,1,0
4,GO RESPONSE TO INSECTICIDE,0.00030804,-0.38749,-0.36839,1,0
4,GO LIPID DROPLET FORMATION,0.0019282,-0.38829,-0.38895,1,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,6.7728e-06,-0.38882,-0.39237,1,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.0013872,-0.39162,-0.42413,1,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.0001547,-0.39182,-0.35189,1,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,5.2139e-05,-0.395,-0.3991,1,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.9801e-06,-0.39515,-0.39764,1,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0038387,-0.39576,-0.3136,1,0
4,GO NEURON MIGRATION,1.9263e-05,-0.39576,-0.36784,1,0
4,GO PRESYNAPTIC ENDOCYTOSIS,4.2876e-06,-0.39751,-0.37477,1,0
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,9.7346e-05,-0.3981,-0.38308,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0087944,-0.39973,-0.28397,1,0
4,GO MRNA SPLICE SITE SELECTION,1.8521e-05,-0.39984,-0.3636,1,0
4,GO POSTSYNAPSE ASSEMBLY,0.001872,-0.4,-0.40829,1,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00032948,-0.40055,-0.34926,1,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0021062,-0.40175,-0.36356,1,0
4,GO RESPONSE TO COCAINE,1.8958e-07,-0.40183,-0.4432,1,0
4,GO NEUROTRANSMITTER METABOLIC PROCESS,5.9841e-06,-0.40284,-0.41833,1,0
4,GO NEUROPEPTIDE SIGNALING PATHWAY,1.0779e-06,-0.40323,-0.3676,1,0
4,GO NEURON RECOGNITION,4.4878e-05,-0.40331,-0.42754,1,0
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,9.0551e-05,-0.4045,-0.48556,1,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00081984,-0.40705,-0.36804,1,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00017186,-0.40913,-0.36171,1,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0034322,-0.40918,-0.29233,1,0
4,GO SECRETORY GRANULE LOCALIZATION,7.2754e-05,-0.41139,-0.6171,1,0
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,6.2786e-05,-0.41413,-0.38736,1,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0007696,-0.41427,-0.36115,1,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.0032441,-0.41594,-0.3781,1,0
4,GO N GLYCAN PROCESSING,2.6307e-05,-0.41834,-0.3964,1,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.017969,-0.41897,-0.36374,1,0
4,GO REGULATION OF AMINO ACID TRANSPORT,2.8077e-06,-0.42072,-0.4087,1,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.0050528,-0.42284,-0.28005,1,0
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,1.4039e-05,-0.42312,-0.42175,1,0
4,GO MALE SEX DETERMINATION,0.001662,-0.42581,-0.35079,1,0
4,GO RESPONSE TO L GLUTAMATE,0.0051916,-0.42703,-0.40315,1,0
4,GO ADULT LOCOMOTORY BEHAVIOR,8.8325e-08,-0.4272,-0.44756,1,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.0075304,-0.42721,-0.32684,1,0
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00019079,-0.43056,-0.31412,1,0
4,GO SEGMENT SPECIFICATION,8.1192e-05,-0.4322,-0.47412,1,0
4,GO TRANSMISSION OF NERVE IMPULSE,6.8936e-07,-0.43317,-0.45998,1,0
4,GO SEROTONIN TRANSPORT,1.4044e-06,-0.43436,-0.55173,1,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0024367,-0.4347,-0.38653,1,0
4,GO OPTIC NERVE DEVELOPMENT,0.00032948,-0.43491,-0.42176,1,0
4,GO ADULT BEHAVIOR,4.9191e-08,-0.43592,-0.49751,1,0
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.6729e-06,-0.43624,-0.39906,1,0
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.0006154,-0.43768,-0.35486,1,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,3.8131e-07,-0.43851,-0.50672,1,0
4,GO EXOCYTIC PROCESS,3.0264e-07,-0.43991,-0.42476,1,0
4,GO NEUROTRANSMITTER UPTAKE,0.00026003,-0.44363,-0.31269,1,0
4,GO SUCKLING BEHAVIOR,0.00014935,-0.44493,-0.42672,1,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0064317,-0.4456,-0.29595,1,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00074557,-0.44595,-0.34491,1,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,1.6455e-05,-0.44647,-0.52229,1,0
4,GO REGULATION OF VESICLE FUSION,0.00037661,-0.44691,-0.40914,1,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00031859,-0.45103,-0.4312,1,0
4,GO DIENCEPHALON DEVELOPMENT,3.0576e-06,-0.45163,-0.39658,1,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,8.628e-07,-0.45289,-0.42162,1,0
4,GO SYNAPTIC VESICLE LOCALIZATION,1.9904e-06,-0.45302,-0.47709,1,0
4,GO NEURON MATURATION,4.6623e-06,-0.45356,-0.43745,1,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,3.3287e-06,-0.45635,-0.4616,1,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.024846,-0.45647,-0.41362,1,0
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,9.7801e-06,-0.45869,-0.46969,1,0
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.071e-07,-0.46281,-0.44281,1,0
4,GO SUBPALLIUM DEVELOPMENT,6.5149e-05,-0.46445,-0.42459,1,0
4,GO AMMONIUM ION METABOLIC PROCESS,0.00035231,-0.46566,-0.38693,1,0
4,GO OTIC VESICLE DEVELOPMENT,0.0060989,-0.47142,-0.34423,1,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,9.7801e-06,-0.47642,-0.45627,1,0
4,GO REGULATION OF CELL PROJECTION SIZE,3.4728e-06,-0.47781,-0.49878,1,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0017641,-0.47838,-0.36378,1,0
4,GO PYRAMIDAL NEURON DIFFERENTIATION,0.01282,-0.47917,-0.46048,1,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00067758,-0.47981,-0.35482,1,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.031059,-0.48016,-0.3206,1,0
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,4.3218e-05,-0.48067,-0.58227,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,7.8282e-05,-0.48187,-0.52661,1,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,5.4977e-07,-0.48368,-0.48117,1,0
4,GO ENDOCARDIUM DEVELOPMENT,0.007729,-0.4843,-0.32572,1,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.6902e-06,-0.48487,-0.42869,1,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,1.4039e-05,-0.48667,-0.43757,1,0
4,GO CATECHOLAMINE UPTAKE,6.5149e-05,-0.4908,-0.39543,1,0
4,GO AXONAL FASCICULATION,0.00026903,-0.49154,-0.49463,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.004408,-0.49498,-0.4995,1,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.5774e-06,-0.50169,-0.4406,1,0
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,1.2971e-07,-0.50635,-0.48296,1,0
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00044439,-0.50684,-0.47206,1,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0090226,-0.50717,-0.38279,1,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.019283,-0.50915,-0.31479,1,0
4,GO CGMP METABOLIC PROCESS,2.4346e-05,-0.51359,-0.48995,1,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,5.4977e-07,-0.51573,-0.50703,1,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,1.4609e-05,-0.51597,-0.51537,1,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.753e-07,-0.51629,-0.4797,1,0
4,GO EPITHELIAL CELL MATURATION,2.0833e-05,-0.51645,-0.50643,1,0
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00092958,-0.51969,-0.4152,1,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,2.4346e-05,-0.52055,-0.5437,1,0
4,GO GLUTAMATE SECRETION,5.9841e-06,-0.52209,-0.44843,1,0
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,1.0779e-06,-0.52512,-0.51598,1,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,7.5427e-07,-0.52845,-0.49894,1,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,3.9418e-06,-0.53045,-0.50838,1,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,8.2505e-07,-0.5333,-0.58149,1,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,8.2505e-07,-0.53377,-0.56898,1,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00054072,-0.53871,-0.48683,1,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00020448,-0.54045,-0.44026,1,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,2.6307e-05,-0.54165,-0.46789,1,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.00014418,-0.54493,-0.50024,1,0
4,GO MAST CELL MIGRATION,0.00067758,-0.5468,-0.46037,1,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,4.2876e-06,-0.54756,-0.55939,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00031859,-0.5476,-0.4452,1,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,3.17e-07,-0.54818,-0.51019,1,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,4.1802e-07,-0.55192,-0.52934,1,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0001165,-0.55403,-0.42037,1,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,1.349e-05,-0.55406,-0.56107,1,0
4,GO REGULATION OF NEURON MATURATION,6.5149e-05,-0.5574,-0.53457,1,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.9841e-06,-0.55845,-0.55743,1,0
4,GO REFLEX,3.3132e-05,-0.56442,-0.54172,1,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,6.4994e-06,-0.56683,-0.53019,1,0
4,GO DETECTION OF TEMPERATURE STIMULUS,4.5813e-07,-0.56965,-0.61318,1,0
4,GO DOPAMINE METABOLIC PROCESS,2.3975e-07,-0.57283,-0.5763,1,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00013917,-0.57347,-0.39674,1,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,5.753e-07,-0.57696,-0.55641,1,0
4,GO GROWTH HORMONE SECRETION,7.889e-07,-0.57949,-0.54441,1,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,8.0176e-08,-0.58284,-0.63668,1,0
4,GO NEURAL NUCLEUS DEVELOPMENT,6.2985e-07,-0.5896,-0.49624,1,0
4,GO DETECTION OF CALCIUM ION,1.1493e-05,-0.58999,-0.56105,1,0
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00037661,-0.59264,-0.53252,1,0
4,GO GLIAL CELL FATE COMMITMENT,0.00016023,-0.59393,-0.60077,1,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,3.7791e-06,-0.59485,-0.51529,1,0
4,GO LUNG CELL DIFFERENTIATION,0.001191,-0.59552,-0.47345,1,0
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,1.2971e-07,-0.59617,-0.56701,1,0
4,GO SIALYLATION,3.9418e-06,-0.59905,-0.55149,1,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,5.2533e-07,-0.59964,-0.57798,1,0
4,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.00042998,-0.60275,-0.44502,1,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.4878e-05,-0.60278,-0.54555,1,0
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,7.0571e-06,-0.60295,-0.57762,1,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00032948,-0.60377,-0.56276,1,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.00065623,-0.60694,-0.58143,1,0
4,GO NEUROTRANSMITTER TRANSPORT,8.628e-07,-0.60784,-0.54325,1,0
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,1.9263e-05,-0.60931,-0.50677,1,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,9.4334e-07,-0.60951,-0.52589,1,0
4,GO SPINAL CORD PATTERNING,3.1904e-06,-0.61927,-0.60146,1,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,9.0179e-06,-0.61995,-0.6302,1,0
4,GO REGULATION OF GLUTAMATE SECRETION,9.8628e-07,-0.62414,-0.57039,1,0
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,5.2837e-06,-0.62931,-0.63606,1,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.4268e-07,-0.63093,-0.64636,1,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.7728e-06,-0.63154,-0.54437,1,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,1.9904e-06,-0.63515,-0.69405,1,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00013433,-0.63525,-0.47645,1,0
4,GO NEURONAL ACTION POTENTIAL,1.1237e-07,-0.63973,-0.68881,1,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.036164,-0.64071,-0.35819,1,0
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.00011241,-0.6433,-0.5499,1,0
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.5691e-07,-0.65216,-0.64735,1,0
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.0604e-05,-0.66146,-0.5797,1,0
4,GO STARTLE RESPONSE,8.2505e-07,-0.66452,-0.56212,1,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,3.9926e-07,-0.66527,-0.65289,1,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,2.3654e-06,-0.6665,-0.73384,1,0
4,GO NEUROTRANSMITTER SECRETION,6.8936e-07,-0.66729,-0.601,1,0
4,GO SYNAPTIC VESICLE MATURATION,1.8521e-05,-0.67292,-0.74302,1,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS,1.5331e-06,-0.67601,-0.63584,1,0
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.7474e-06,-0.67671,-0.5598,1,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,3.17e-07,-0.67863,-0.65138,1,0
4,GO RESPONSE TO LITHIUM ION,3.7791e-06,-0.68229,-0.61168,1,0
4,GO NEURON FATE COMMITMENT,6.2985e-07,-0.68474,-0.71284,1,0
4,GO RESPONSE TO HISTAMINE,2.2658e-06,-0.68626,-0.68134,1,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,1.8084e-07,-0.68947,-0.72631,1,0
4,GO ADENOHYPOPHYSIS DEVELOPMENT,1.5201e-05,-0.69226,-0.67675,1,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,2.3975e-07,-0.7019,-0.6771,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,7.547e-05,-0.70575,-0.61421,1,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,9.8628e-07,-0.71008,-0.63641,1,0
4,GO DENSE CORE GRANULE TRANSPORT,2.4692e-06,-0.7241,-0.95158,1,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.4963e-07,-0.73184,-0.73151,1,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,5.4977e-07,-0.75499,-0.71319,1,0
4,GO MONOAMINE TRANSPORT,1.2971e-07,-0.75601,-0.68029,1,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.029719,-0.76739,-0.44953,1,0
4,GO AMINE TRANSPORT,1.2971e-07,-0.76842,-0.63954,1,0
4,GO INNERVATION,3.9418e-06,-0.76895,-0.62589,1,0
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.628e-07,-0.77378,-0.7813,1,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,1.4609e-05,-0.78338,-0.75742,1,0
4,GO SYNAPTIC VESICLE DOCKING,5.753e-07,-0.78581,-0.77385,1,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.00072223,-0.7859,-0.6657,1,0
4,GO RESPONSE TO AUDITORY STIMULUS,1.5201e-05,-0.78722,-0.60825,1,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00067758,-0.78731,-0.6168,1,0
4,GO SEROTONIN METABOLIC PROCESS,1.2308e-06,-0.80773,-0.70294,1,0
4,GO PROTEIN LOCALIZATION TO AXON,4.6623e-06,-0.80917,-0.91561,1,0
4,GO SYNAPSE MATURATION,5.0683e-06,-0.81147,-0.78314,1,0
4,GO NEURON CELL CELL ADHESION,5.753e-07,-0.82878,-0.93974,1,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,1.1964e-05,-0.83173,-0.79208,1,0
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,7.2756e-08,-0.83399,-0.88345,1,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,3.7791e-06,-0.8381,-0.72208,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,3.3287e-06,-0.85528,-0.80292,1,0
4,GO EPITHELIAL CELL FATE COMMITMENT,4.0073e-05,-0.8649,-0.76849,1,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,1.2971e-07,-0.86819,-0.83372,1,0
4,GO VOCALIZATION BEHAVIOR,2.2658e-06,-0.86899,-0.83892,1,0
4,GO DENDRITE EXTENSION,8.4155e-08,-0.88462,-0.7895,1,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.1776e-06,-0.88749,-0.81773,1,0
4,GO SYNAPTIC VESICLE PRIMING,6.5896e-07,-0.89151,-0.80372,1,0
4,GO REGULATION OF DENDRITE EXTENSION,1.5691e-07,-0.89271,-0.85146,1,0
4,GO PREPULSE INHIBITION,1.8958e-07,-0.92547,-0.8487,1,0
4,GO DOPAMINE TRANSPORT,1.4963e-07,-0.92813,-0.80285,1,0
4,GO NEURONAL ION CHANNEL CLUSTERING,1.1493e-05,-0.93,-0.77386,1,0
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.8131e-07,-0.94395,-0.96679,1,0
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.071e-07,-0.97149,-0.89677,1,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,2.4346e-05,-0.97649,-0.81148,1,0
4,GO CATECHOLAMINE SECRETION,1.725e-07,-0.98425,-0.82346,1,0
4,GO SYNAPTIC VESICLE CLUSTERING,9.8628e-07,-0.99067,-0.92249,1,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,2.5774e-06,-0.9965,-0.85668,1,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.0311e-06,-1.0061,-0.82011,1,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,9.4334e-07,-1.0216,-0.97465,1,0
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,8.2505e-07,-1.0254,-1.0155,1,0
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,5.2533e-07,-1.0721,-0.96372,1,0
4,GO GANGLION DEVELOPMENT,2.5122e-07,-1.0795,-0.92764,1,0
4,GO REGULATION OF DOPAMINE SECRETION,2.0829e-07,-1.1147,-0.99016,1,0
4,GO GABAERGIC NEURON DIFFERENTIATION,9.8628e-07,-1.1203,-1.0187,1,0
4,GO MECHANOSENSORY BEHAVIOR,8.6584e-06,-1.1257,-0.94412,1,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,3.6228e-06,-1.3746,-1.1683,1,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,2.3654e-06,-1.5983,-1.5061,1,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,2.5122e-07,-1.6695,-1.4739,1,0
4,GO PHOSPHOLIPID EFFLUX,0.092194,0.41091,0.27229,0,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.05161,0.3604,0.16368,0,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.14048,0.34732,0.19124,0,1
4,GO DISTAL TUBULE DEVELOPMENT,0.10654,0.3259,0.24579,0,1
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.060602,0.32291,0.28294,0,1
4,GO CYCLOOXYGENASE PATHWAY,0.049546,0.32232,0.29605,0,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.049546,0.30564,0.16412,0,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.23245,0.30051,0.18787,0,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.25363,0.29855,0.1522,0,1
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.084046,0.28694,0.20339,0,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.10465,0.28208,0.16545,0,1
4,GO L SERINE METABOLIC PROCESS,0.12689,0.2806,0.13234,0,1
4,GO TONGUE MORPHOGENESIS,0.066855,0.27758,0.23927,0,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.10096,0.27359,0.17615,0,1
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.05824,0.27244,0.14538,0,1
4,GO ACTIN FILAMENT SEVERING,0.061812,0.26758,0.1701,0,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.10465,0.25701,0.15372,0,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.2,0.24383,0.1178,0,1
4,GO UV PROTECTION,0.073629,0.23838,0.19308,0,1
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.13355,0.23573,0.15056,0,1
4,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.088862,0.23563,0.15035,0,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12259,0.23509,0.23784,0,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.25729,0.23138,0.15456,0,1
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.26847,0.22619,0.19352,0,1
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.16294,0.22283,0.11014,0,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.061812,0.22203,0.1124,0,1
4,GO POSITIVE REGULATION OF CELL SIZE,0.16032,0.22055,0.18248,0,1
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.064293,0.21642,0.14372,0,1
4,GO KINETOCHORE ASSEMBLY,0.0695,0.21428,0.15868,0,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.079444,0.21291,0.26194,0,1
4,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.077957,0.21291,0.099801,0,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.090515,0.21167,0.12375,0,1
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.30402,0.2103,0.10118,0,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.060602,0.20735,0.12404,0,1
4,GO STEROID ESTERIFICATION,0.053746,0.20559,0.20482,0,1
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.15015,0.20472,0.085778,0,1
4,GO NEGATIVE T CELL SELECTION,0.05161,0.20383,0.1673,0,1
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.05824,0.2038,0.15727,0,1
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.04854,0.19853,0.15831,0,1
4,GO RESPONSE TO CADMIUM ION,0.26847,0.19549,0.096188,0,1
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.11434,0.19504,0.16247,0,1
4,GO PROTEIN AUTOPROCESSING,0.076492,0.1944,0.11378,0,1
4,GO MITOTIC CELL CYCLE ARREST,0.076492,0.19367,0.14055,0,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.055956,0.19337,0.17604,0,1
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.066855,0.19333,0.12531,0,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.10845,0.1911,0.1489,0,1
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.33812,0.19091,0.094013,0,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.075049,0.19031,0.095579,0,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.097379,0.19028,0.13818,0,1
4,GO NUCLEAR MIGRATION,0.37932,0.18881,0.066509,0,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.21905,0.18505,0.24953,0,1
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.052669,0.18376,0.18849,0,1
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.065563,0.17856,0.077773,0,1
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.0695,0.17798,0.14099,0,1
4,GO RESPONSE TO INTERLEUKIN 6,0.13583,0.17758,0.088768,0,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.090515,0.17675,0.15758,0,1
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.15015,0.17641,0.12187,0,1
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.19095,0.17576,0.12042,0,1
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.084046,0.17362,0.11158,0,1
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.16032,0.17099,0.15932,0,1
4,GO POSITIVE REGULATION OF CELL DIVISION,0.10654,0.16954,0.11224,0,1
4,GO KINETOCHORE ORGANIZATION,0.15264,0.16938,0.10314,0,1
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.065563,0.16932,0.1555,0,1
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.063042,0.1691,0.11849,0,1
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.13355,0.16795,0.087969,0,1
4,GO ATP TRANSPORT,0.10845,0.16733,0.072705,0,1
4,GO MICROVILLUS ASSEMBLY,0.26847,0.16733,0.1087,0,1
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.087232,0.16629,0.091314,0,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.47049,0.16538,0.071281,0,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.068167,0.16396,0.13194,0,1
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.053746,0.16273,0.169,0,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.18508,0.16246,0.13948,0,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.080955,0.16126,0.18416,0,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.27227,0.15908,0.093904,0,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.088862,0.15898,0.1841,0,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.62113,0.15896,0.053574,0,1
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.24643,0.15862,0.076678,0,1
4,GO REGULATION OF GTP BINDING,0.12259,0.15858,0.16147,0,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.064293,0.1581,0.18494,0,1
4,GO AMP METABOLIC PROCESS,0.095625,0.15618,0.2216,0,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.080955,0.15612,0.12798,0,1
4,GO TRICARBOXYLIC ACID CYCLE,0.23589,0.15604,0.047051,0,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.11434,0.15559,0.079452,0,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.050569,0.15508,0.09393,0,1
4,GO PROTEIN ADP RIBOSYLATION,0.065563,0.15502,0.12628,0,1
4,GO REGULATION OF T CELL MIGRATION,0.087232,0.15274,0.11183,0,1
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.36526,0.15208,0.070108,0,1
4,GO ACETYL COA METABOLIC PROCESS,0.17099,0.15113,0.054375,0,1
4,GO CELLULAR RESPONSE TO PH,0.10465,0.15087,0.10067,0,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.12689,0.15067,0.082765,0,1
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.050569,0.14778,0.12018,0,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.049546,0.1468,0.096097,0,1
4,GO DENDRITIC CELL MIGRATION,0.40843,0.1466,0.089538,0,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.24643,0.14559,0.069412,0,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.080955,0.14491,0.12327,0,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.090515,0.14476,0.074886,0,1
4,GO PLASMA MEMBRANE FUSION,0.065563,0.14401,0.16588,0,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.11235,0.14353,0.090093,0,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.10654,0.14347,0.14286,0,1
4,GO REGULATION OF DNA BINDING,0.054842,0.14296,0.075835,0,1
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.10654,0.14211,0.11646,0,1
4,GO RESPONSE TO STEROL,0.054842,0.14152,0.12321,0,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.29586,0.14134,0.074414,0,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.099158,0.1408,0.074406,0,1
4,GO EXTRACELLULAR TRANSPORT,0.188,0.14052,0.099282,0,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.068167,0.13789,0.10196,0,1
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.17099,0.13651,0.15928,0,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.20621,0.13559,0.12664,0,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.29992,0.13535,0.096652,0,1
4,GO CENTRIOLE ASSEMBLY,0.05161,0.13348,0.093568,0,1
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.33812,0.13306,0.060001,0,1
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.19393,0.13289,0.083251,0,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.13583,0.13063,0.11134,0,1
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.56075,0.12995,-0.012385,0,1
4,GO REGULATION OF CELL DIVISION,0.065563,0.12814,0.078163,0,1
4,GO MUSCLE ORGAN MORPHOGENESIS,0.068167,0.12809,0.12619,0,1
4,GO MEIOTIC CHROMOSOME SEPARATION,0.32077,0.12792,0.097814,0,1
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.24288,0.12767,0.082818,0,1
4,GO MUSCLE HYPERTROPHY,0.31653,0.12741,0.054268,0,1
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.080955,0.1273,0.15667,0,1
4,GO CELL PROLIFERATION IN FOREBRAIN,0.40349,0.12702,0.041698,0,1
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.16294,0.12676,0.12724,0,1
4,GO REGULATION OF SENSORY PERCEPTION,0.11636,0.12648,0.086323,0,1
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.50337,0.12452,0.053258,0,1
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.061812,0.12445,0.062575,0,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.087232,0.12444,0.086419,0,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.05824,0.12402,0.22491,0,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.56666,0.12393,0.083784,0,1
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.17653,0.12381,0.19437,0,1
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.14048,0.12339,0.078942,0,1
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.11841,0.12287,0.14307,0,1
4,GO PIRNA METABOLIC PROCESS,0.23589,0.12242,0.15848,0,1
4,GO SPHINGOID METABOLIC PROCESS,0.060602,0.12236,0.080864,0,1
4,GO PROTEIN MONOUBIQUITINATION,0.088862,0.12216,0.062077,0,1
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.082489,0.12126,0.090493,0,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.40843,0.12121,0.026977,0,1
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16294,0.12098,0.19018,0,1
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.36526,0.12082,0.064178,0,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.76948,0.11964,-0.0088294,0,1
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.10845,0.11961,0.10526,0,1
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.3746,0.11907,0.039231,0,1
4,GO HISTONE ARGININE METHYLATION,0.093897,0.11902,0.082759,0,1
4,GO RESPIRATORY SYSTEM PROCESS,0.4978,0.11532,0.044628,0,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.16294,0.11385,0.060955,0,1
4,GO PYRUVATE METABOLIC PROCESS,0.15517,0.11358,0.064171,0,1
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.05161,0.11243,0.14607,0,1
4,GO HISTONE H3 DEACETYLATION,0.095625,0.11159,0.09058,0,1
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.24288,0.11149,0.07647,0,1
4,GO NEUTROPHIL CHEMOTAXIS,0.050569,0.10966,0.19158,0,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.087232,0.1096,0.094184,0,1
4,GO POSITIVE REGULATION OF URINE VOLUME,0.0695,0.10891,0.17957,0,1
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.061812,0.1068,0.11833,0,1
4,GO RRNA CATABOLIC PROCESS,0.40349,0.10596,0.047524,0,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.40349,0.1057,0.01829,0,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.11235,0.10147,0.19395,0,1
4,GO MITOCHONDRIAL DEPOLARIZATION,0.21256,0.10073,0.11396,0,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.21579,0.1007,0.062891,0,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.40349,0.10016,0.041657,0,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.087232,0.10005,0.082377,0,1
4,GO REGULATION OF PROTEIN SUMOYLATION,0.17934,0.097492,0.10078,0,1
4,GO STEROL METABOLIC PROCESS,0.18219,0.097022,0.035726,0,1
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.080955,0.095356,0.080615,0,1
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.099158,0.095028,0.064236,0,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.13583,0.095015,0.055094,0,1
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.36064,0.093846,0.039058,0,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15015,0.093582,0.047035,0,1
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.15773,0.092227,0.08648,0,1
4,GO POSITIVE REGULATION OF MYELINATION,0.20621,0.091914,0.11009,0,1
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.19095,0.091655,0.075665,0,1
4,GO DNA REPLICATION INITIATION,0.20621,0.091601,0.04509,0,1
4,GO MUSCLE FIBER DEVELOPMENT,0.17934,0.091383,0.055078,0,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.30402,0.090656,0.050346,0,1
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.22568,0.090074,0.10959,0,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.055956,0.089743,0.1094,0,1
4,GO RESPONSE TO IRON ION,0.1313,0.089142,0.080458,0,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.092194,0.088455,0.071833,0,1
4,GO OOCYTE MATURATION,0.28785,0.088046,0.043114,0,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.060602,0.08795,0.15695,0,1
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.21905,0.086169,0.062498,0,1
4,GO REGULATION OF PROTEIN TARGETING,0.068167,0.085933,0.06816,0,1
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.060602,0.084909,0.064357,0,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.23937,0.081959,0.037269,0,1
4,GO SEQUESTERING OF CALCIUM ION,0.0695,0.08151,0.084882,0,1
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.14526,0.080895,0.083546,0,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.066855,0.080703,0.065644,0,1
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.10465,0.0805,0.075437,0,1
4,GO FERTILIZATION,0.077957,0.079374,0.056512,0,1
4,GO REGULATION OF CYTOKINESIS,0.21905,0.078712,0.043404,0,1
4,GO CENTROMERE COMPLEX ASSEMBLY,0.29184,0.077648,0.077306,0,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.98255,0.077465,-0.037101,0,1
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.079444,0.076531,0.057242,0,1
4,GO RESPONSE TO INSULIN,0.13583,0.076314,0.034484,0,1
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.25001,0.075809,0.12966,0,1
4,GO HISTONE EXCHANGE,0.35153,0.075341,0.058418,0,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.061812,0.074589,0.048758,0,1
4,GO DNA INTEGRITY CHECKPOINT,0.12908,0.07389,0.068491,0,1
4,GO PEPTIDYL SERINE MODIFICATION,0.049546,0.073604,0.059685,0,1
4,GO CELL VOLUME HOMEOSTASIS,0.14285,0.0719,0.060031,0,1
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.29586,0.071716,0.077305,0,1
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.49227,0.069735,0.037069,0,1
4,GO CYTOSKELETON ORGANIZATION,0.10096,0.069453,0.059627,0,1
4,GO CELLULAR ION HOMEOSTASIS,0.10845,0.069289,0.045481,0,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.33812,0.069168,0.028534,0,1
4,GO REGULATION OF SPINDLE CHECKPOINT,0.079444,0.069039,0.13149,0,1
4,GO REGULATION OF MRNA POLYADENYLATION,0.28785,0.068683,0.066811,0,1
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.31653,0.068503,0.039961,0,1
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.18508,0.068211,0.039988,0,1
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.052669,0.066769,0.090084,0,1
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.39858,0.065299,0.030571,0,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.16032,0.064621,0.10545,0,1
4,GO MISMATCH REPAIR,0.25363,0.064453,0.047312,0,1
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.049546,0.064103,0.055365,0,1
4,GO CELL PROJECTION ASSEMBLY,0.18219,0.062635,0.051186,0,1
4,GO CELL CYCLE CHECKPOINT,0.049546,0.059245,0.065995,0,1
4,GO REGULATION OF CELL SIZE,0.23937,0.059036,0.03351,0,1
4,GO CELLULAR HOMEOSTASIS,0.082489,0.055036,0.04658,0,1
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.05824,0.054589,0.056425,0,1
4,GO EXECUTION PHASE OF APOPTOSIS,0.11039,0.054178,0.051417,0,1
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.27227,0.053109,0.047921,0,1
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.32077,0.052499,0.070887,0,1
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.12259,0.051904,0.067015,0,1
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.05161,0.049955,0.065985,0,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.32938,0.049088,0.061688,0,1
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.092194,0.048493,0.064057,0,1
4,GO CHROMOSOME SEGREGATION,0.054842,0.048147,0.078296,0,1
4,GO MRNA PROCESSING,0.24643,0.047,0.044769,0,1
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.1028,0.045137,0.065512,0,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.32077,0.043256,0.017842,0,1
4,GO RNA SPLICING,0.18219,0.039613,0.044479,0,1
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.10465,0.039092,0.13514,0,1
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.72313,0.036822,0.002507,0,1
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.36526,0.035552,0.029641,0,1
4,GO DNA REPLICATION,0.13355,0.032934,0.052199,0,1
4,GO MEIOTIC CELL CYCLE PROCESS,0.32938,0.029743,0.052059,0,1
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.0015189,0.40023,0.38848,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.001191,0.39217,0.51684,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00065623,0.3808,0.47279,0,0
4,GO INTERLEUKIN 13 PRODUCTION,0.00038934,0.36215,0.45525,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00012512,0.35638,0.38539,0,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.012508,0.34348,0.37386,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00014418,0.3428,0.46021,0,0
4,GO NADPH REGENERATION,0.00022676,0.33842,0.31369,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0015653,0.32766,0.35193,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0033369,0.31751,0.41124,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0062634,0.30949,0.36333,0,0
4,GO HEPARIN METABOLIC PROCESS,0.0032441,0.29926,0.36888,0,0
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.05161,0.28464,0.19095,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.00045924,0.27725,0.29284,0,0
4,GO MYOBLAST PROLIFERATION,0.053746,0.27701,0.15233,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.061812,0.27628,0.21871,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.00040247,0.27599,0.30532,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,2.8418e-05,0.27309,0.34204,0,0
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0028957,0.2695,0.22305,0,0
4,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.0066042,0.26309,0.30141,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.0046564,0.2558,0.26926,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.064293,0.25216,0.31284,0,0
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.20937,0.24979,0.16608,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.1028,0.2492,0.16385,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.12049,0.24512,0.26749,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.43883,0.24453,0.20795,0,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.057089,0.24318,0.15918,0,0
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.24643,0.24278,0.13998,0,0
4,GO OXYGEN TRANSPORT,0.59664,0.23956,0.086522,0,0
4,GO NUCLEOTIDE SALVAGE,0.050569,0.23881,0.29862,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.0695,0.22955,0.24288,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.085627,0.22893,0.22052,0,0
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.019283,0.22833,0.33345,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.050569,0.22679,0.20549,0,0
4,GO TRACHEA DEVELOPMENT,0.0079323,0.22186,0.24842,0,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.013139,0.22156,0.19935,0,0
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.049546,0.22087,0.36547,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.21905,0.22048,0.082017,0,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.11039,0.21476,0.15522,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.42347,0.21102,0.10939,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.011904,0.21096,0.35243,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.033166,0.20826,0.23744,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.20621,0.20562,0.20303,0,0
4,GO CELLULAR RESPONSE TO ATP,0.00055855,0.20366,0.20191,0,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.69061,0.20354,-0.0055454,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.095625,0.20203,0.28972,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.092194,0.19991,0.15857,0,0
4,GO HINDLIMB MORPHOGENESIS,0.068167,0.19666,0.17699,0,0
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.063042,0.19424,0.12207,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.05161,0.19334,0.13184,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.14048,0.19239,0.25909,0,0
4,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.075049,0.19145,0.25063,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.17934,0.19132,0.16355,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.042857,0.19062,0.20585,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.066855,0.18885,0.141,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.018398,0.18789,0.19833,0,0
4,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.0041716,0.18589,0.21394,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.019739,0.18451,0.16485,0,0
4,GO DNA DEMETHYLATION,0.063042,0.1819,0.13178,0,0
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.18508,0.1814,0.16455,0,0
4,GO REGULATION OF PLATELET ACTIVATION,0.077957,0.1795,0.13069,0,0
4,GO GAS TRANSPORT,0.20937,0.17923,0.16146,0,0
4,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.090515,0.17916,0.17478,0,0
4,GO TRNA CATABOLIC PROCESS,0.076492,0.17911,0.21913,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.33373,0.17727,0.11087,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.33373,0.17648,0.08274,0,0
4,GO HEPATOCYTE DIFFERENTIATION,0.26098,0.17548,0.15475,0,0
4,GO MYOBLAST MIGRATION,0.077957,0.1749,0.24952,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0066042,0.17301,0.1936,0,0
4,GO VITAMIN D METABOLIC PROCESS,0.11636,0.17298,0.1818,0,0
4,GO BILE ACID AND BILE SALT TRANSPORT,0.077957,0.17286,0.10552,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.20621,0.17225,0.24893,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.41341,0.17193,0.20216,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.073629,0.16894,0.15653,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.075049,0.16876,0.1331,0,0
4,GO AMELOGENESIS,0.05161,0.16861,0.20183,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.26098,0.16848,0.058405,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.055956,0.16814,0.15057,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.014486,0.1675,0.22063,0,0
4,GO NEGATIVE REGULATION OF ANOIKIS,0.14769,0.1672,0.18624,0,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.02843,0.16674,0.13176,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.065563,0.16573,0.19639,0,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.05161,0.16432,0.18166,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.077957,0.16088,0.15083,0,0
4,GO ETHER METABOLIC PROCESS,0.053746,0.1593,0.14514,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.092194,0.15917,0.11636,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0013872,0.15881,0.16718,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.21256,0.15864,0.085998,0,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.18219,0.15781,0.10786,0,0
4,GO NEUROBLAST DIVISION,0.19695,0.15779,0.19496,0,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.26471,0.15701,0.21888,0,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.052669,0.15674,0.18897,0,0
4,GO HEART TRABECULA FORMATION,0.16294,0.15432,0.21458,0,0
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.066855,0.15368,0.10676,0,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.16828,0.15205,0.088799,0,0
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.095625,0.15129,0.089573,0,0
4,GO STEM CELL DIVISION,0.084046,0.15108,0.17001,0,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.31653,0.151,0.12156,0,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.075049,0.15036,0.18929,0,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.061812,0.14889,0.17047,0,0
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.099158,0.14819,0.13231,0,0
4,GO LIPID DIGESTION,0.27227,0.14786,0.049082,0,0
4,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.92682,0.14767,-0.014322,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.13814,0.14717,0.084886,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.70355,0.14709,-0.0072114,0,0
4,GO PERICARDIUM DEVELOPMENT,0.0069616,0.147,0.23352,0,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.39858,0.14571,0.086969,0,0
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.23245,0.1452,0.062835,0,0
4,GO REGULATION OF FATTY ACID OXIDATION,0.25363,0.14451,0.075036,0,0
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.20309,0.14369,0.11409,0,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.10465,0.14349,0.13253,0,0
4,GO HEART VALVE FORMATION,0.66501,0.14343,0.076057,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.24643,0.14269,0.094734,0,0
4,GO LIVER MORPHOGENESIS,0.16559,0.1414,0.12836,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.033166,0.14051,0.12168,0,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.29992,0.14025,0.06122,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.12908,0.14,0.091905,0,0
4,GO MYELIN MAINTENANCE,0.17653,0.13982,0.1213,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.072231,0.13885,0.18379,0,0
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.90599,0.13668,-0.0030229,0,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.090515,0.13613,0.11186,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.44924,0.13597,0.036541,0,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.24643,0.13591,0.042303,0,0
4,GO CELLULAR RESPONSE TO KETONE,0.05161,0.13503,0.1119,0,0
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.1313,0.13495,0.069388,0,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.16828,0.13463,0.097051,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.29992,0.13289,0.081423,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.21905,0.13238,0.11641,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.052669,0.13238,0.15677,0,0
4,GO INTESTINAL LIPID ABSORPTION,0.10654,0.13235,0.10818,0,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.51459,0.1323,0.061387,0,0
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.087232,0.13225,0.12324,0,0
4,GO MANGANESE ION TRANSPORT,0.066855,0.132,0.1528,0,0
4,GO MINERALOCORTICOID METABOLIC PROCESS,0.21256,0.13182,0.19766,0,0
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.61497,0.13176,0.038952,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.060602,0.13175,0.11507,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.016339,0.13161,0.2838,0,0
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.11039,0.13152,0.089862,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.0056288,0.13089,0.13595,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.20309,0.1297,0.11222,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.35153,0.12957,0.13862,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.018398,0.12938,0.17737,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.31653,0.12912,0.060518,0,0
4,GO ARTERY DEVELOPMENT,0.0036303,0.12903,0.27149,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.29992,0.12852,0.095607,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.40843,0.12808,0.11379,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.42855,0.12805,0.048854,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.015203,0.12737,0.12739,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.057089,0.12702,0.181,0,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.55487,0.12665,0.10076,0,0
4,GO TERPENOID METABOLIC PROCESS,0.05161,0.12653,0.14244,0,0
4,GO INTRACELLULAR STEROL TRANSPORT,0.21579,0.12487,0.10851,0,0
4,GO ENGULFMENT OF APOPTOTIC CELL,0.090515,0.12443,0.096655,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.2,0.12409,0.15523,0,0
4,GO THIOESTER METABOLIC PROCESS,0.05161,0.1229,0.089181,0,0
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.05824,0.12176,0.12152,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.027803,0.1217,0.1232,0,0
4,GO PROTEIN KINASE C SIGNALING,0.28785,0.12144,0.049925,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.21905,0.12107,0.094457,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.50896,0.12101,0.055224,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.29992,0.12093,0.10555,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.16032,0.12091,0.12074,0,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.19393,0.12067,0.1292,0,0
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.13814,0.12016,0.049563,0,0
4,GO ADHESION OF SYMBIONT TO HOST,0.070855,0.12015,0.22893,0,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.26098,0.11979,0.11047,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.34702,0.11917,0.14999,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.12259,0.11864,0.12592,0,0
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.04854,0.11798,0.13077,0,0
4,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.14526,0.11794,0.14647,0,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.19695,0.11782,0.13988,0,0
4,GO LYSINE METABOLIC PROCESS,0.15015,0.11698,0.15391,0,0
4,GO GOLGI LOCALIZATION,0.46512,0.11647,0.037685,0,0
4,GO REGULATION OF HAIR CYCLE,0.22568,0.11642,0.16823,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.25729,0.11586,0.16869,0,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.26847,0.11575,0.060988,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.22905,0.11524,0.26604,0,0
4,GO COCHLEA MORPHOGENESIS,0.54903,0.11435,0.011362,0,0
4,GO UBIQUINONE METABOLIC PROCESS,0.22235,0.1142,0.058009,0,0
4,GO PEPTIDYL HISTIDINE MODIFICATION,0.065563,0.1141,0.1657,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.10096,0.11409,0.094823,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.11636,0.1139,0.22433,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.4545,0.11386,0.03644,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.29992,0.11376,0.029412,0,0
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.26847,0.11342,0.082365,0,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.17099,0.11337,0.079145,0,0
4,GO RNA INTERFERENCE,0.47588,0.11313,0.047255,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.1028,0.11306,0.082174,0,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.28785,0.11261,0.2921,0,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.11039,0.11248,0.11532,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.064293,0.11225,0.20822,0,0
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.079444,0.11149,0.058275,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.095625,0.11112,0.092937,0,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.10096,0.11109,0.092675,0,0
4,GO REGULATION OF TISSUE REMODELING,0.10845,0.11089,0.067974,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.11235,0.10985,0.09228,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.63354,0.10974,0.083614,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.12908,0.10919,0.12059,0,0
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.60272,0.10919,0.03262,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.35153,0.10889,0.073543,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15264,0.10835,0.092693,0,0
4,GO L PHENYLALANINE METABOLIC PROCESS,0.3746,0.10809,0.037697,0,0
4,GO RESPONSE TO MUSCLE STRETCH,0.58456,0.10801,0.096262,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.26471,0.10778,0.074414,0,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.063042,0.10777,0.10637,0,0
4,GO INTRACELLULAR LIPID TRANSPORT,0.063042,0.10765,0.12903,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.13355,0.10764,0.12969,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.20621,0.10752,0.1184,0,0
4,GO CELLULAR PIGMENTATION,0.065563,0.10743,0.080771,0,0
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.17934,0.10704,0.17857,0,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.052669,0.10698,0.18789,0,0
4,GO LEUKOCYTE CHEMOTAXIS,0.050569,0.10668,0.14072,0,0
4,GO REGULATION OF HISTONE DEACETYLATION,0.12908,0.10638,0.091202,0,0
4,GO OVULATION CYCLE PROCESS,0.22905,0.10602,0.072839,0,0
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.084046,0.10553,0.098468,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.22568,0.10522,0.07195,0,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.32938,0.10515,0.1223,0,0
4,GO NAD METABOLIC PROCESS,0.17934,0.1047,0.11278,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.16828,0.10463,0.059157,0,0
4,GO REGULATION OF CHLORIDE TRANSPORT,0.54321,0.10383,0.055805,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.46512,0.10377,0.13561,0,0
4,GO ACTIVATED T CELL PROLIFERATION,0.14526,0.10369,0.091179,0,0
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.052669,0.10365,0.096021,0,0
4,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.40843,0.10361,0.14011,0,0
4,GO RESPONSE TO ATP,0.021165,0.10339,0.10377,0,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.25363,0.10312,0.050288,0,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.055956,0.10225,0.14638,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0007696,0.10224,0.088563,0,0
4,GO CARNITINE SHUTTLE,0.088862,0.10222,0.13629,0,0
4,GO INOSITOL METABOLIC PROCESS,0.32938,0.10174,0.052231,0,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.15015,0.10166,0.10904,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.052669,0.10153,0.097665,0,0
4,GO ANOIKIS,0.33812,0.10151,0.091582,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.32506,0.1012,0.096503,0,0
4,GO GLIAL CELL DEVELOPMENT,0.19095,0.10116,0.048737,0,0
4,GO LYTIC VACUOLE ORGANIZATION,0.21256,0.10115,0.041098,0,0
4,GO REGULATION OF MAST CELL ACTIVATION,0.32506,0.10111,0.080235,0,0
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.33373,0.10069,0.038125,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.14048,0.10057,0.15163,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.11434,0.10048,0.091041,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.046579,0.099836,0.14041,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.35607,0.099449,0.07044,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.05161,0.099418,0.071503,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0695,0.099125,0.19374,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.44924,0.097877,0.049624,0,0
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.78289,0.097818,0.043535,0,0
4,GO CENTROSOME SEPARATION,0.17653,0.09774,0.090906,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.012203,0.097529,0.15793,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.23937,0.097413,0.057131,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.15015,0.097103,0.11877,0,0
4,GO EPITHELIAL TUBE FORMATION,0.1028,0.096634,0.10247,0,0
4,GO RESPONSE TO AMYLOID BETA,0.061812,0.095805,0.18055,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.12908,0.09568,0.19478,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.084046,0.095263,0.14685,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.049546,0.095163,0.18687,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.27227,0.094963,0.11673,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.22235,0.094639,0.11711,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.050569,0.094014,0.089433,0,0
4,GO B CELL APOPTOTIC PROCESS,0.54903,0.093761,0.021358,0,0
4,GO RESPONSE TO VITAMIN,0.082489,0.093502,0.1481,0,0
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.35607,0.093484,0.045313,0,0
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.10465,0.093473,0.052043,0,0
4,GO ERYTHROCYTE MATURATION,0.079444,0.093218,0.15604,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.47588,0.093159,0.070614,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.29184,0.092844,0.046102,0,0
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.37932,0.092743,0.060216,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.4545,0.092194,0.054966,0,0
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.19695,0.091926,0.095835,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.26098,0.09183,0.038251,0,0
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.30402,0.091529,0.022505,0,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.11235,0.091513,0.10768,0,0
4,GO REGULATION OF WATER LOSS VIA SKIN,0.62732,0.091265,0.052572,0,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.22905,0.091168,0.093017,0,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.12473,0.091034,0.055683,0,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.082489,0.090946,0.052284,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0695,0.090336,0.13925,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.063042,0.090062,0.14228,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.079444,0.090014,0.12171,0,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.11841,0.089624,0.27458,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.14769,0.089528,0.12054,0,0
4,GO BASE EXCISION REPAIR,0.05161,0.089125,0.10091,0,0
4,GO PURINE NUCLEOTIDE TRANSPORT,0.43883,0.089069,0.029924,0,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0695,0.088713,0.15202,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.050569,0.088447,0.10241,0,0
4,GO RNA STABILIZATION,0.082489,0.088289,0.089638,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.14285,0.087887,0.098153,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.4598,0.087698,0.014549,0,0
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.81668,0.087647,0.035025,0,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.67137,0.087562,0.032072,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.077957,0.087435,0.1164,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.5726,0.087336,0.043311,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.085627,0.087195,0.080802,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.4545,0.086978,0.048519,0,0
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.15015,0.086947,0.064393,0,0
4,GO PHOSPHOLIPID HOMEOSTASIS,0.21256,0.086524,0.13186,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.29992,0.086393,0.10574,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.48678,0.086149,0.045766,0,0
4,GO STEM CELL PROLIFERATION,0.51459,0.085335,0.011101,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.56075,0.085216,0.059834,0,0
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.41842,0.084528,0.065976,0,0
4,GO NUCLEOTIDE PHOSPHORYLATION,0.21579,0.084435,0.048922,0,0
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.73628,0.084386,0.035248,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.037747,0.083992,0.15852,0,0
4,GO IMP METABOLIC PROCESS,0.20309,0.083899,0.18821,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.17653,0.083799,0.10775,0,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.25363,0.083694,0.071184,0,0
4,GO OXIDATIVE PHOSPHORYLATION,0.11841,0.083581,0.083122,0,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.40843,0.082734,0.059478,0,0
4,GO ACTIVATION OF GTPASE ACTIVITY,0.11841,0.082716,0.077355,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.3746,0.082681,0.064785,0,0
4,GO B CELL PROLIFERATION,0.63978,0.082598,0.0089042,0,0
4,GO VIRAL LATENCY,0.47049,0.082292,0.043815,0,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.26847,0.082247,0.056436,0,0
4,GO NOTCH RECEPTOR PROCESSING,0.20937,0.082075,0.14072,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.12473,0.081955,0.097859,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.79636,0.081862,0.024609,0,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.52025,0.0812,0.064994,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.16294,0.081199,0.10016,0,0
4,GO RESPONSE TO COPPER ION,0.39371,0.081006,0.085446,0,0
4,GO RESPONSE TO WATER,0.49227,0.080941,0.085625,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.16032,0.080811,0.087124,0,0
4,GO CENTROSOME DUPLICATION,0.26847,0.080706,0.053602,0,0
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.39371,0.080675,0.032345,0,0
4,GO HEXOSE CATABOLIC PROCESS,0.24288,0.080633,0.045143,0,0
4,GO STEROID METABOLIC PROCESS,0.13355,0.080366,0.037702,0,0
4,GO FATTY ACID TRANSPORT,0.10654,0.080255,0.059611,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.33373,0.080209,0.073529,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.58456,0.080006,0.012092,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.31232,0.079948,0.066678,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.35153,0.079901,0.06039,0,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.42347,0.079836,0.05005,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.40349,0.079801,0.03219,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.11039,0.07979,0.077525,0,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.83713,0.079714,-0.10542,0,0
4,GO LACTATE METABOLIC PROCESS,0.26098,0.079638,0.068918,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.23245,0.079595,0.08073,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.36526,0.079467,0.081924,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.099158,0.079139,0.084821,0,0
4,GO RESPONSE TO BMP,0.087232,0.07895,0.10828,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.17099,0.078466,0.097691,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.8303,0.078313,-0.0070772,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.14285,0.078291,0.095358,0,0
4,GO REGULATION OF INTEGRIN ACTIVATION,0.8303,0.078073,-0.0045399,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.19095,0.077882,0.096981,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.14769,0.077431,0.067339,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.43367,0.077208,0.07622,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.4978,0.077045,0.042733,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.072231,0.076946,0.11722,0,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.33373,0.076827,0.031614,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.11039,0.076803,0.12885,0,0
4,GO MITOCHONDRION ORGANIZATION,0.0017123,0.076636,0.082978,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.52025,0.076624,0.022213,0,0
4,GO MALE SEX DIFFERENTIATION,0.25001,0.076574,0.067975,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.38408,0.076511,0.054051,0,0
4,GO SULFATION,0.25363,0.076201,0.13664,0,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.13814,0.076138,0.075613,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.23245,0.076027,0.075274,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.4545,0.076024,0.18113,0,0
4,GO RESPONSE TO MUSCLE INACTIVITY,0.13583,0.075588,0.14312,0,0
4,GO KERATINOCYTE DIFFERENTIATION,0.38888,0.07555,0.11008,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.59664,0.075548,0.014989,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.29586,0.075541,0.060076,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.17374,0.07532,0.080383,0,0
4,GO RESPONSE TO UV B,0.25001,0.075283,0.13822,0,0
4,GO NEURON PROJECTION REGENERATION,0.27611,0.075272,0.056957,0,0
4,GO MAINTENANCE OF CELL NUMBER,0.17374,0.075258,0.09713,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.32938,0.075218,0.094291,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.15517,0.075194,0.106,0,0
4,GO BLASTODERM SEGMENTATION,0.2,0.074614,0.18134,0,0
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.34702,0.074333,0.022137,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.65866,0.074193,0.036886,0,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.14769,0.074001,0.067773,0,0
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.38888,0.073401,0.062909,0,0
4,GO PROTEIN SUMOYLATION,0.093897,0.0731,0.070712,0,0
4,GO RECEPTOR INTERNALIZATION,0.059411,0.072695,0.082769,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.22568,0.072555,0.050026,0,0
4,GO RESPIRATORY BURST,0.54321,0.072495,0.021371,0,0
4,GO KETONE CATABOLIC PROCESS,0.52025,0.072333,0.10867,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.27227,0.072232,0.057003,0,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.2839,0.072214,0.1214,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.66501,0.072031,0.034868,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.42347,0.071977,0.048391,0,0
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.47049,0.071956,0.07738,0,0
4,GO T CELL LINEAGE COMMITMENT,0.066855,0.071521,0.098866,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.15517,0.071422,0.067833,0,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.05161,0.071315,0.090302,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.049546,0.071161,0.13307,0,0
4,GO DISACCHARIDE METABOLIC PROCESS,0.18219,0.071149,0.10391,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.015574,0.071122,0.15394,0,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.4978,0.071064,0.018704,0,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.10465,0.070707,0.13286,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.83713,0.070555,0.065928,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.25001,0.070513,0.12136,0,0
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.053746,0.070384,0.099734,0,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.32506,0.070378,0.045585,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.18508,0.07032,0.098441,0,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.31653,0.06994,0.053991,0,0
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.34256,0.069895,0.013918,0,0
4,GO DNA GEOMETRIC CHANGE,0.055956,0.069823,0.10365,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.15264,0.0698,0.080001,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.57857,0.069384,0.053335,0,0
4,GO AMINO ACID IMPORT,0.4978,0.069211,0.092712,0,0
4,GO TAXIS,0.23245,0.06896,0.038442,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.11235,0.068915,0.16265,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.031059,0.068911,0.077172,0,0
4,GO NEGATIVE CHEMOTAXIS,0.088862,0.068751,0.16457,0,0
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.15015,0.068668,0.089587,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.21905,0.068451,0.096423,0,0
4,GO RUFFLE ASSEMBLY,0.12473,0.068166,0.08178,0,0
4,GO CHOLESTEROL STORAGE,0.18508,0.067769,0.14357,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.11636,0.067423,0.051112,0,0
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.23589,0.067345,0.099048,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.31232,0.067239,0.061028,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.36526,0.066711,0.048392,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.52025,0.066645,0.072396,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.4598,0.066549,0.063913,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.40349,0.06641,0.018665,0,0
4,GO DIOL METABOLIC PROCESS,0.4545,0.066356,0.031391,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.34702,0.066338,0.049893,0,0
4,GO NADH METABOLIC PROCESS,0.20309,0.066191,0.095729,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.12689,0.066185,0.087015,0,0
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.22568,0.06614,0.1502,0,0
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.13814,0.066134,0.055366,0,0
4,GO ACTIN FILAMENT ORGANIZATION,0.10654,0.065829,0.079107,0,0
4,GO NUCLEOTIDE TRANSPORT,0.40349,0.065817,0.020325,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.075049,0.065695,0.066043,0,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.8303,0.065672,0.018032,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.81668,0.065117,0.05265,0,0
4,GO RESPONSE TO ESTRADIOL,0.084046,0.065103,0.096916,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.30402,0.064887,0.026821,0,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.04854,0.064838,0.073677,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.22905,0.064784,0.084844,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.53167,0.064772,0.05594,0,0
4,GO VITAMIN TRANSPORT,0.35153,0.064652,0.0513,0,0
4,GO ENSHEATHMENT OF NEURONS,0.11434,0.064603,0.060257,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.29586,0.064383,0.073934,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.068167,0.064174,0.095211,0,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.10845,0.063779,0.065475,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.014486,0.063483,0.19215,0,0
4,GO RESPONSE TO CAMP,0.080955,0.063429,0.12597,0,0
4,GO GLYCEROLIPID METABOLIC PROCESS,0.077957,0.063351,0.040766,0,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.14048,0.063242,0.063586,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.35153,0.063124,0.081262,0,0
4,GO HOMEOSTATIC PROCESS,0.10465,0.062829,0.034016,0,0
4,GO TISSUE HOMEOSTASIS,0.093897,0.062816,0.061123,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.17653,0.062748,0.097543,0,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.188,0.062551,0.041185,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.18508,0.062181,0.057661,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.44924,0.062151,0.022368,0,0
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.19695,0.062121,0.099585,0,0
4,GO GOLGI RIBBON FORMATION,0.4598,0.062114,0.085967,0,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.5726,0.062038,0.091759,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.60272,0.061868,0.07907,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.35153,0.061701,0.037186,0,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.023741,0.061656,0.13007,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.47588,0.061298,0.056106,0,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.070855,0.061222,0.07239,0,0
4,GO EPITHELIUM DEVELOPMENT,0.085627,0.060936,0.081422,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.007729,0.060909,0.1275,0,0
4,GO MUSCLE SYSTEM PROCESS,0.19695,0.060645,0.05144,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.32077,0.060584,0.12824,0,0
4,GO RESPONSE TO CORTICOSTERONE,0.14526,0.060474,0.19562,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.092194,0.060463,0.16485,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.21579,0.060444,0.066981,0,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.5726,0.06035,0.025762,0,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.057089,0.06006,0.070313,0,0
4,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.94073,0.059943,0.030611,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.46512,0.059861,0.030407,0,0
4,GO MEMBRANE FUSION,0.31653,0.059833,0.031151,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.70355,0.059643,0.040359,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.14526,0.059543,0.075951,0,0
4,GO PANCREATIC JUICE SECRETION,0.72313,0.05948,0.039394,0,0
4,GO CELL CELL ADHESION,0.22905,0.059292,0.051552,0,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.29184,0.05929,0.11467,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4545,0.059125,0.047574,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.43883,0.058957,0.032558,0,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.14048,0.058788,0.038471,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.51459,0.058786,0.023884,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.70355,0.058707,0.019551,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16294,0.058516,0.074805,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.11434,0.058469,0.048716,0,0
4,GO INCLUSION BODY ASSEMBLY,0.92682,0.058464,-0.042246,0,0
4,GO ENERGY RESERVE METABOLIC PROCESS,0.33373,0.058376,0.036211,0,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.090515,0.058204,0.05691,0,0
4,GO NEPHRON DEVELOPMENT,0.072231,0.058185,0.14623,0,0
4,GO REPRODUCTION,0.049546,0.05788,0.051281,0,0
4,GO NEPHRON TUBULE FORMATION,0.23245,0.057821,0.12818,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17099,0.057408,0.072689,0,0
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.25363,0.057302,0.028094,0,0
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.17934,0.057254,0.079338,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.26098,0.05711,0.16945,0,0
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.34256,0.057029,0.041942,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.073629,0.056916,0.13325,0,0
4,GO CYTOKINE SECRETION,0.44924,0.056803,0.049403,0,0
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.049546,0.056039,0.098058,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.26847,0.056009,0.058916,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.088862,0.055917,0.062911,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.35607,0.05568,0.069116,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.076492,0.0556,0.15043,0,0
4,GO BONE RESORPTION,0.0695,0.055497,0.097856,0,0
4,GO AMMONIUM TRANSPORT,0.075049,0.055347,0.15286,0,0
4,GO TRANSCYTOSIS,0.20309,0.055251,0.10446,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.41341,0.055073,0.078582,0,0
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.19393,0.055,0.055469,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.25729,0.054999,0.1023,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.54321,0.054994,0.048884,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.66501,0.054851,0.0015478,0,0
4,GO ION HOMEOSTASIS,0.18508,0.054803,0.036744,0,0
4,GO BIOMINERALIZATION,0.065563,0.054662,0.14125,0,0
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.27611,0.054578,0.024836,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.21579,0.054531,0.050534,0,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.99651,0.054505,-0.022039,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.054842,0.05439,0.11547,0,0
4,GO ARTERY MORPHOGENESIS,0.32077,0.054315,0.18312,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.57857,0.054103,0.077347,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.55487,0.05398,0.020692,0,0
4,GO RESPONSE TO ACIDIC PH,0.29586,0.0539,0.089002,0,0
4,GO MICROTUBULE ANCHORING,0.33812,0.053065,0.044721,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.59664,0.052938,0.019751,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.22568,0.052901,0.070799,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.068167,0.052887,0.059528,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.40349,0.052883,0.047754,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.060602,0.052815,0.1292,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.12473,0.052215,0.061475,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.17653,0.052113,0.10665,0,0
4,GO RESPONSE TO MECHANICAL STIMULUS,0.21905,0.052079,0.080233,0,0
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.26847,0.051288,0.059017,0,0
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.14048,0.051219,0.06226,0,0
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.13355,0.051216,0.061464,0,0
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.22235,0.051116,0.054363,0,0
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.051115,0.059581,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.2,0.051076,0.044251,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.12689,0.05103,0.050526,0,0
4,GO REGULATION OF PROTEIN DEACETYLATION,0.8303,0.05094,0.00031261,0,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.088862,0.050509,0.058303,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.47588,0.050414,0.087098,0,0
4,GO RETROGRADE AXONAL TRANSPORT,0.85082,0.049971,-0.025855,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.35607,0.049963,0.082686,0,0
4,GO PROTEIN DESTABILIZATION,0.44402,0.04981,0.025839,0,0
4,GO HISTONE H3 K27 METHYLATION,0.56075,0.049807,0.030621,0,0
4,GO JNK CASCADE,0.070855,0.049803,0.055413,0,0
4,GO APPENDAGE DEVELOPMENT,0.33812,0.049546,0.070219,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.10845,0.049425,0.067792,0,0
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.29586,0.049376,0.031138,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.064293,0.048978,0.097548,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.42347,0.048794,0.060063,0,0
4,GO RESPONSE TO STEROL DEPLETION,0.9686,0.048757,-0.036671,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.068167,0.048684,0.082257,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.4978,0.048417,0.046349,0,0
4,GO EMBRYONIC BODY MORPHOGENESIS,0.91293,0.048383,0.0041499,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.39858,0.048339,0.051533,0,0
4,GO METAL ION HOMEOSTASIS,0.1313,0.048226,0.043729,0,0
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.11841,0.047968,0.034469,0,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.54903,0.047909,0.019642,0,0
4,GO RESPONSE TO GROWTH HORMONE,0.29184,0.047564,0.086407,0,0
4,GO POSITIVE REGULATION OF FERTILIZATION,0.98953,0.047498,-0.032463,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.39371,0.047304,0.0645,0,0
4,GO INTERLEUKIN 6 PRODUCTION,0.22235,0.047199,0.086118,0,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.9686,0.047057,-0.0066608,0,0
4,GO SKIN DEVELOPMENT,0.27611,0.047054,0.1266,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.075049,0.046846,0.18032,0,0
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.099158,0.046568,0.059426,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.17653,0.046535,0.052488,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.66501,0.046496,0.003916,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.38408,0.04648,0.039842,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.14526,0.046147,0.10604,0,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.25001,0.046115,0.066336,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.92682,0.045993,-0.013209,0,0
4,GO PRO B CELL DIFFERENTIATION,0.98255,0.045908,0.051957,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.48678,0.045846,0.045397,0,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.54321,0.045615,0.033795,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.71006,0.045492,0.018999,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.80312,0.045369,-0.052893,0,0
4,GO GROWTH,0.095625,0.045223,0.054926,0,0
4,GO TRANSFERRIN TRANSPORT,0.60272,0.045175,0.0091535,0,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.56075,0.044999,0.02806,0,0
4,GO ORGANELLE ASSEMBLY,0.0079323,0.044611,0.066039,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.68418,0.044512,0.035779,0,0
4,GO RECOMBINATIONAL REPAIR,0.48131,0.044478,0.047326,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.25363,0.044339,0.028945,0,0
4,GO EMBRYO DEVELOPMENT,0.065563,0.043884,0.070105,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.59059,0.043797,0.0074132,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.32077,0.04379,0.045679,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.47049,0.043754,0.068255,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.32077,0.043531,0.052586,0,0
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.26847,0.043266,0.047714,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.38408,0.04326,0.03406,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.41842,0.043041,0.086615,0,0
4,GO REGULATION OF GROWTH,0.11235,0.042678,0.047409,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.44924,0.042468,0.025226,0,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.97557,0.042384,-0.012269,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.23245,0.042254,0.051243,0,0
4,GO RESPONSE TO TOXIC SUBSTANCE,0.48678,0.042183,0.024964,0,0
4,GO METHIONINE METABOLIC PROCESS,0.70355,0.042082,-0.019495,0,0
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.2839,0.042066,0.018463,0,0
4,GO RESPONSE TO ALCOHOL,0.47049,0.042002,0.028232,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.12908,0.041559,0.077696,0,0
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.43367,0.041551,0.010499,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.75615,0.041251,0.045325,0,0
4,GO DNA CONFORMATION CHANGE,0.38408,0.041136,0.040981,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.53742,0.041054,0.026295,0,0
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.099158,0.040681,0.10492,0,0
4,GO PROTEIN TRIMERIZATION,0.62732,0.040629,0.050821,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.77618,0.040465,0.073182,0,0
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.34702,0.040354,0.10398,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.17099,0.040283,0.049729,0,0
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.55487,0.040038,0.018325,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.94769,0.039926,-0.00112,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.88523,0.039896,0.027284,0,0
4,GO RESPONSE TO ZINC ION,0.63354,0.03988,0.028807,0,0
4,GO MICROTUBULE NUCLEATION,0.36064,0.039848,0.053801,0,0
4,GO MRNA METHYLATION,0.50896,0.039841,0.053989,0,0
4,GO MITOCHONDRIAL FISSION,0.31653,0.039614,0.04677,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.79636,0.039598,-0.00047171,0,0
4,GO MIDBRAIN DEVELOPMENT,0.23589,0.039485,0.071921,0,0
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.41842,0.039242,0.082822,0,0
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.33373,0.0392,0.10489,0,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.26847,0.039004,0.047965,0,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.72313,0.038999,0.063417,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.56666,0.038977,-0.043841,0,0
4,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.60883,0.038865,0.095034,0,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.65866,0.0388,0.015657,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.72969,0.038643,0.041742,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.39858,0.038523,0.043817,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.52025,0.038074,-0.0012138,0,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.67776,0.037951,-0.046386,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.94769,0.037924,0.015094,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.67137,0.037844,0.061106,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.59059,0.037783,0.041022,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.38888,0.037345,0.025942,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.21579,0.037183,0.035413,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.9686,0.037055,0.019646,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.48678,0.037054,0.04506,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.48131,0.036966,0.027743,0,0
4,GO ENDOSOMAL TRANSPORT,0.10654,0.036785,0.057604,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.25001,0.036614,0.078055,0,0
4,GO PROTEIN POLYMERIZATION,0.20937,0.036515,0.038404,0,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.24288,0.036487,0.03292,0,0
4,GO CERAMIDE METABOLIC PROCESS,0.29992,0.036385,0.008518,0,0
4,GO REGULATION OF B CELL PROLIFERATION,0.75615,0.036169,-0.0085888,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.72969,0.036134,0.020272,0,0
4,GO LOCOMOTOR RHYTHM,0.80989,0.036037,0.032337,0,0
4,GO HISTONE H3 ACETYLATION,0.41341,0.035782,0.031008,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.23245,0.035723,0.092212,0,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.67137,0.035562,0.043533,0,0
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.46512,0.035487,0.0039001,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.42855,0.035388,0.057214,0,0
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.19695,0.035019,0.04465,0,0
4,GO POSITIVE REGULATION OF TRANSPORT,0.26847,0.03497,0.028593,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.85082,0.03485,-0.017118,0,0
4,GO ONE CARBON COMPOUND TRANSPORT,0.54321,0.034774,0.08125,0,0
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.32938,0.034721,0.037417,0,0
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.68418,0.034685,-0.0060057,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.7495,0.034492,0.010329,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.25729,0.034261,0.11267,0,0
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.20937,0.03415,0.036192,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.35153,0.03407,0.050242,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION,0.21905,0.033958,0.031688,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.52025,0.033559,0.063437,0,0
4,GO SPECIFICATION OF SYMMETRY,0.14526,0.033546,0.057825,0,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.25729,0.033433,0.038323,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.63354,0.033408,0.029261,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.21905,0.03321,0.050776,0,0
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.21905,0.033088,0.086087,0,0
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.94769,0.033073,-0.024108,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.51459,0.032865,0.047868,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.94769,0.032646,0.013024,0,0
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16294,0.032605,0.058073,0,0
4,GO ENDOCRINE HORMONE SECRETION,0.71658,0.032526,0.025042,0,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.15773,0.03234,0.031136,0,0
4,GO REGULATION OF JUN KINASE ACTIVITY,0.53742,0.03221,0.034325,0,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.50896,0.032148,0.063976,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.53167,0.03173,0.12637,0,0
4,GO POSITIVE REGULATION OF DNA REPAIR,0.29992,0.031086,0.03566,0,0
4,GO PHOSPHATE ION TRANSPORT,0.94769,0.030929,0.0057611,0,0
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.51459,0.030895,0.0047151,0,0
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.77618,0.030814,0.0049586,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.22235,0.030803,0.055859,0,0
4,GO PROTEIN AUTOUBIQUITINATION,0.56075,0.030727,0.019229,0,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.84397,0.030713,-0.0013921,0,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.36064,0.030688,0.028432,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.85082,0.030653,0.023896,0,0
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.92682,0.030506,-0.0237,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.62113,0.030501,-0.038528,0,0
4,GO MUSCLE CONTRACTION,0.31232,0.030212,0.044545,0,0
4,GO RETINA HOMEOSTASIS,0.69061,0.030009,0.040449,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.13583,0.029968,0.098098,0,0
4,GO PROSTAGLANDIN SECRETION,0.20309,0.029937,0.096352,0,0
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.97557,0.029486,-0.018988,0,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.4978,0.029399,0.046809,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.84397,0.029383,-0.010967,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.34702,0.029192,0.080672,0,0
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.17099,0.029191,0.13671,0,0
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.48131,0.029166,0.024113,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.89215,0.029123,0.02185,0,0
4,GO SINGLE FERTILIZATION,0.49227,0.029053,0.020016,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.82348,0.028968,0.011766,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.42855,0.028793,0.027457,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.18219,0.028494,0.046244,0,0
4,GO NEGATIVE REGULATION OF SECRETION,0.11636,0.028455,0.065334,0,0
4,GO THYROID GLAND DEVELOPMENT,0.9686,0.028396,-0.0091341,0,0
4,GO SECONDARY METABOLIC PROCESS,0.42855,0.028233,0.063218,0,0
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.24643,0.028118,0.042911,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.67137,0.028081,0.033478,0,0
4,GO DNA METHYLATION,0.79636,0.027913,0.002889,0,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.87144,0.027909,0.039433,0,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.42347,0.027669,0.041962,0,0
4,GO ESTROUS CYCLE,0.50337,0.027641,0.070549,0,0
4,GO MRNA MODIFICATION,0.5726,0.027591,0.051628,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.43367,0.027292,0.027073,0,0
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.24288,0.027286,0.048593,0,0
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.98255,0.027115,-0.0061949,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.23245,0.026993,0.05407,0,0
4,GO PHOSPHOLIPID TRANSPORT,0.60883,0.026986,0.007109,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.11039,0.026973,0.086602,0,0
4,GO MUSCLE ATROPHY,0.68418,0.026889,0.057823,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.54321,0.026834,0.067389,0,0
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.78289,0.026739,0.015383,0,0
4,GO CELLULAR RESPONSE TO ALCOHOL,0.50896,0.026671,0.043759,0,0
4,GO ICOSANOID METABOLIC PROCESS,0.25729,0.026669,0.070497,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.70355,0.026561,0.044592,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.27227,0.026336,0.072834,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.47049,0.026299,0.071542,0,0
4,GO MUSCLE CELL DEVELOPMENT,0.39371,0.026251,0.063216,0,0
4,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.56666,0.026094,0.064362,0,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.67137,0.026086,0.0025581,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.14048,0.026057,0.055319,0,0
4,GO SISTER CHROMATID SEGREGATION,0.34256,0.025995,0.045972,0,0
4,GO MACROMOLECULE DEPALMITOYLATION,0.54321,0.025992,0.042632,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.87144,0.025909,-0.01485,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.47049,0.025704,0.036548,0,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.67137,0.025665,0.03054,0,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.50337,0.025638,0.043857,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.51459,0.025521,0.034521,0,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.59664,0.025494,0.037213,0,0
4,GO OSTEOBLAST PROLIFERATION,0.27999,0.025463,0.13897,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.18508,0.025185,0.16049,0,0
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.44924,0.02478,0.091054,0,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.12908,0.024546,0.070017,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.16032,0.024521,0.0347,0,0
4,GO APPENDAGE MORPHOGENESIS,0.59059,0.024411,0.040027,0,0
4,GO GLUCOSE IMPORT,0.77618,0.024316,0.0044689,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION,0.69707,0.024289,0.044137,0,0
4,GO TEMPERATURE HOMEOSTASIS,0.68418,0.024265,0.012929,0,0
4,GO RESPONSE TO ACTIVITY,0.63354,0.024097,0.011429,0,0
4,GO QUINONE METABOLIC PROCESS,0.44402,0.024087,0.052219,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.76281,0.023973,0.0052292,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.36991,0.023827,-0.062711,0,0
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.66501,0.023612,0.032232,0,0
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.97557,0.023596,0.016205,0,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.95466,0.023568,0.017864,0,0
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.48678,0.023449,-0.057772,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.72313,0.023215,-0.014819,0,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.4545,0.023156,0.059532,0,0
4,GO B CELL DIFFERENTIATION,0.12049,0.022996,0.081668,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.71658,0.022558,0.011868,0,0
4,GO LIPID BIOSYNTHETIC PROCESS,0.40349,0.022432,0.0013372,0,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.24643,0.022398,0.062535,0,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.93377,0.022252,-0.0048352,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.9686,0.02218,0.026876,0,0
4,GO DRUG CATABOLIC PROCESS,0.52594,0.02181,0.026801,0,0
4,GO PROTEIN O LINKED GLYCOSYLATION,0.84397,0.021805,-0.04598,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.80312,0.021674,-0.028188,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.20937,0.021547,0.091639,0,0
4,GO DNA REPLICATION CHECKPOINT,0.72969,0.021498,0.018642,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.63978,0.021329,0.024712,0,0
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.56075,0.021115,0.095686,0,0
4,GO AUTOPHAGIC CELL DEATH,0.4978,0.021031,0.078329,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.91987,0.020979,0.011838,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.60272,0.020908,0.02744,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.63354,0.020706,0.034423,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.41341,0.020524,0.029424,0,0
4,GO RESPONSE TO LEAD ION,0.30402,0.020473,0.077328,0,0
4,GO GLAND DEVELOPMENT,0.20937,0.020279,0.063067,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.62732,0.020045,0.047548,0,0
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.4978,0.020039,0.021872,0,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.65234,0.01988,0.016642,0,0
4,GO FUCOSE METABOLIC PROCESS,0.82348,0.019839,-0.0087712,0,0
4,GO SEXUAL REPRODUCTION,0.47049,0.019806,0.01523,0,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.64605,0.019774,0.034644,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.87144,0.01895,0.017443,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.96163,0.01884,0.0010446,0,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.80312,0.018377,0.016078,0,0
4,GO LIPOPROTEIN METABOLIC PROCESS,0.87144,0.01833,-0.014707,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.65234,0.01798,-0.057669,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.63978,0.017933,-0.024299,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.55487,0.017855,0.026044,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.27611,0.01762,0.099651,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.69707,0.017549,0.039095,0,0
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.74288,0.017512,-0.0059652,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.67776,0.017366,0.055923,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25729,0.017127,0.067781,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.17099,0.017122,0.047461,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.95466,0.016968,-0.025477,0,0
4,GO PROSTAGLANDIN TRANSPORT,0.72969,0.016917,-0.041416,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.9686,0.016864,-0.011658,0,0
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.56666,0.016751,0.012132,0,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.87144,0.016669,0.042527,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.26847,0.016498,0.083072,0,0
4,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.69707,0.016278,-0.073643,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.89907,0.015978,0.018638,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.65866,0.015828,0.12139,0,0
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.32938,0.01538,0.063176,0,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.87144,0.015333,-0.050946,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.71658,0.015298,-0.03555,0,0
4,GO ACTIN NUCLEATION,0.99651,0.015165,-0.03037,0,0
4,GO INTERLEUKIN 12 PRODUCTION,0.26847,0.015127,0.075362,0,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.65866,0.014732,0.040651,0,0
4,GO PHOTOPERIODISM,0.98255,0.014614,-0.017117,0,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.93377,0.014569,0.017334,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.94073,0.014371,0.018608,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.72313,0.014292,0.020574,0,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.58456,0.01424,0.015304,0,0
4,GO APICAL JUNCTION ASSEMBLY,0.3746,0.014209,0.088813,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.29184,0.014097,0.044873,0,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.69707,0.01409,0.0024343,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.30402,0.014047,0.076663,0,0
4,GO GLYCOSYLATION,0.98953,0.013578,-0.035192,0,0
4,GO BONE MATURATION,0.62732,0.013274,-0.00048586,0,0
4,GO EPIDERMIS DEVELOPMENT,0.67137,0.013151,0.081349,0,0
4,GO POSITIVE REGULATION OF CELL GROWTH,0.86455,0.013063,0.0090635,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.89215,0.013025,0.0269,0,0
4,GO ENDOCYTIC RECYCLING,0.34702,0.012798,0.038255,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.86455,0.012742,-0.008032,0,0
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.72313,0.012742,0.023101,0,0
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.41842,0.012336,0.036997,0,0
4,GO ANDROGEN METABOLIC PROCESS,0.68418,0.012216,-0.0039007,0,0
4,GO REGULATION OF BLOOD PRESSURE,0.80989,0.012151,0.022339,0,0
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.7495,0.011855,0.038286,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.87833,0.011755,-0.00093614,0,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.54903,0.011485,0.018662,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.5726,0.011242,0.022298,0,0
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.76948,0.011217,-0.043937,0,0
4,GO CHLORIDE ION HOMEOSTASIS,0.78962,0.011175,0.017189,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.36526,0.011008,0.026413,0,0
4,GO REGULATION OF MUSCLE CONTRACTION,0.63354,0.010834,0.019728,0,0
4,GO CHEMICAL HOMEOSTASIS,0.91293,0.010753,-0.0046869,0,0
4,GO REGULATION OF AXON GUIDANCE,0.88523,0.010747,-0.0017526,0,0
4,GO STRIATED MUSCLE ADAPTATION,0.82348,0.010629,-0.0006052,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.75615,0.010615,0.033859,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.42347,0.010583,0.074711,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.21256,0.010535,0.077667,0,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.79636,0.010494,-0.0045202,0,0
4,GO POSITIVE REGULATION OF WOUND HEALING,0.19095,0.010349,0.15732,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.63978,0.01034,0.020192,0,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.57857,0.010126,0.040206,0,0
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.88523,0.010101,-0.022333,0,0
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.84397,0.010018,-0.016458,0,0
4,GO MEIOTIC CELL CYCLE,0.67137,0.0098627,0.030904,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.43883,0.0094518,0.042136,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.83713,0.0093284,0.032557,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.88523,0.0093235,0.052737,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.31232,0.0089747,0.068486,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.53167,0.0088195,0.046216,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.87833,0.0087746,0.015708,0,0
4,GO HISTONE H2A ACETYLATION,0.97557,0.0087376,-5.7908e-05,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.5726,0.0086995,0.031191,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.37932,0.0086265,0.10933,0,0
4,GO ORGAN INDUCTION,0.38888,0.0084935,0.072143,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.47588,0.0084504,0.054788,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.77618,0.0083381,0.031444,0,0
4,GO ZINC ION HOMEOSTASIS,0.9686,0.0082495,-0.013564,0,0
4,GO HISTONE H3 K9 ACETYLATION,0.76281,0.0082186,0.021722,0,0
4,GO SKIN EPIDERMIS DEVELOPMENT,0.62732,0.0081392,0.1127,0,0
4,GO ORGANELLE MEMBRANE FUSION,0.92682,0.0080999,-0.010409,0,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.19393,0.0080051,0.07778,0,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.9686,0.0079761,-0.007411,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.82348,0.0079322,0.0078949,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.90599,0.0075917,0.021219,0,0
4,GO REGULATION OF CELLULAR PH,0.7495,0.0072173,-0.00074996,0,0
4,GO ADAPTIVE THERMOGENESIS,0.76948,0.0071635,0.012138,0,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.44924,0.0071624,0.041268,0,0
4,GO REGULATION OF VASCULAR PERMEABILITY,1,0.0069352,-0.0012087,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.76281,0.006897,0.016856,0,0
4,GO ARACHIDONIC ACID SECRETION,0.37932,0.0068792,-0.10951,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.68418,0.0068765,0.016013,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.62732,0.0067251,0.028581,0,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.88523,0.0064278,0.031091,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.82348,0.0063894,0.060252,0,0
4,GO CARBOHYDRATE TRANSPORT,0.62732,0.0062451,0.0019552,0,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.52025,0.0061204,-0.025308,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.91293,0.0058778,0.014158,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.72969,0.0057878,0.0091933,0,0
4,GO MICROTUBULE SEVERING,0.47588,0.0057291,-0.046514,0,0
4,GO STRESS GRANULE ASSEMBLY,0.56666,0.0056795,-0.031833,0,0
4,GO VASODILATION,0.7495,0.0056344,-0.062696,0,0
4,GO CELL RECOGNITION,0.90599,0.0055472,-0.010308,0,0
4,GO ZINC ION TRANSPORT,0.52594,0.0053888,0.041273,0,0
4,GO DEPHOSPHORYLATION,0.53167,0.0053724,-0.023432,0,0
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.91987,0.0052955,0.0057979,0,0
4,GO CELL GROWTH,0.69061,0.005276,0.022295,0,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.75615,0.0051197,0.015785,0,0
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.69707,0.0049806,-0.045266,0,0
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.55487,0.0048039,0.078177,0,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.78289,0.0046735,-0.0072192,0,0
4,GO LYMPH NODE DEVELOPMENT,0.69707,0.0045066,0.087621,0,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.62113,0.0044527,0.038925,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.78962,0.0044289,0.016802,0,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.95466,0.0041688,-0.0014232,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.80312,0.0041372,0.014973,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.80312,0.00371,0.034984,0,0
4,GO RESPONSE TO AXON INJURY,0.89215,0.0035183,-0.0064923,0,0
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.98255,0.0032863,-0.0076068,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.56666,0.0032315,-0.037784,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.34256,0.0028349,-0.10178,0,0
4,GO ADULT HEART DEVELOPMENT,0.80989,0.0028305,-0.045466,0,0
4,GO STEROID BIOSYNTHETIC PROCESS,0.72969,0.0027542,-0.046168,0,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.92682,0.0027275,-0.0034792,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.7495,0.0023355,0.018217,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.98255,0.0021805,-0.022444,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.54321,0.0019989,-0.084078,0,0
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.99651,0.0019248,-0.022669,0,0
4,GO REGULATION OF GLUCONEOGENESIS,0.53167,0.0018253,0.0082078,0,0
4,GO BONE CELL DEVELOPMENT,0.65866,0.0015974,0.033761,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.47588,0.0014784,-0.0074061,0,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.59664,0.0013746,0.029297,0,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.94073,0.0013543,0.063092,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.8303,0.0012256,0.012845,0,0
4,GO MYELIN ASSEMBLY,0.78962,0.0008571,0.033023,0,0
4,GO EYE MORPHOGENESIS,0.91987,0.00071635,-0.0049472,0,0
4,GO MYELOID CELL DEVELOPMENT,0.44402,0.00042426,0.04944,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.71658,8.629e-05,0.061358,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.63354,-0.00014662,0.045546,0,0
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.72969,-0.00032005,-0.021766,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.72969,-0.00032378,-0.0033755,0,0
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.78962,-0.00035819,0.02935,0,0
4,GO REGULATION OF PH,0.87144,-0.00093359,-0.0018085,0,0
4,GO PRE MIRNA PROCESSING,0.79636,-0.0011086,0.016213,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.98953,-0.001125,0.039099,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.69707,-0.0013098,0.031358,0,0
4,GO P BODY ASSEMBLY,0.88523,-0.0014077,0.0016891,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.70355,-0.0014248,0.017529,0,0
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.85768,-0.0014574,0.0036518,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.1313,-0.0014924,0.097874,0,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.40843,-0.0016425,0.08442,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.73628,-0.0021463,0.042753,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.62732,-0.0021606,0.047602,0,0
4,GO REGULATION OF LYASE ACTIVITY,0.48678,-0.0023118,0.041605,0,0
4,GO MOLTING CYCLE,0.56666,-0.0023157,0.11901,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.70355,-0.0023462,0.027439,0,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.50896,-0.0024082,0.048539,0,0
4,GO DEVELOPMENTAL PIGMENTATION,0.63354,-0.0024347,-0.025469,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.59059,-0.0024722,-0.12135,0,0
4,GO ALANINE TRANSPORT,0.87144,-0.0025644,0.001537,0,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.93377,-0.0026689,-0.00047555,0,0
4,GO HISTONE DEUBIQUITINATION,0.54321,-0.0027848,0.041969,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.69707,-0.0029491,0.014106,0,0
4,GO METHYLATION,0.91293,-0.0031648,0.0089425,0,0
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.87833,-0.0034284,-0.022724,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.52594,-0.0034603,0.10178,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.9686,-0.0034768,0.0059624,0,0
4,GO TOR SIGNALING,0.81668,-0.0036529,0.0037114,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.91987,-0.0037452,0.0021366,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.67137,-0.0040181,0.050439,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.55487,-0.0040953,-0.060728,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.43883,-0.0042239,0.069119,0,0
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.78289,-0.0044433,0.00061644,0,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.84397,-0.0046696,-0.040497,0,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.80312,-0.0049831,0.0059153,0,0
4,GO NEUROBLAST PROLIFERATION,0.4978,-0.0050239,-0.092343,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.83713,-0.0053613,-0.025244,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.84397,-0.0054378,-0.022239,0,0
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.51459,-0.0058327,0.049873,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.91987,-0.0059212,0.11141,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.63354,-0.0060417,0.04379,0,0
4,GO RESPONSE TO COLD,0.51459,-0.0061696,-0.071563,0,0
4,GO TELOMERIC LOOP DISASSEMBLY,0.52025,-0.0063449,-0.051595,0,0
4,GO GAMETE GENERATION,0.65866,-0.0064943,0.012383,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.76948,-0.0065039,-0.0076451,0,0
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.93377,-0.0065943,-0.041022,0,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.87833,-0.0069237,0.015861,0,0
4,GO REGULATION OF ODONTOGENESIS,0.96163,-0.0071364,0.033539,0,0
4,GO RESPONSE TO GLUCAGON,0.78289,-0.0073071,-0.016426,0,0
4,GO REGULATION OF RNA SPLICING,0.87833,-0.0076035,-0.020393,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.99651,-0.0077819,-0.0014634,0,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.87833,-0.0077865,0.017426,0,0
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.86455,-0.0078124,-0.0077478,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.92682,-0.0078851,0.0045878,0,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.53167,-0.007992,-0.01908,0,0
4,GO CHROMOSOME ORGANIZATION,0.85082,-0.0082947,0.019175,0,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.80989,-0.0083239,0.01492,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.35153,-0.0084851,-0.039055,0,0
4,GO PRENYLATION,0.99651,-0.0085747,0.030935,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.40843,-0.0087254,-0.11456,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.60272,-0.0088543,-0.040868,0,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.76948,-0.0089133,0.083223,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.68418,-0.008991,0.07102,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.92682,-0.0094784,0.0031951,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.64605,-0.0095609,-0.030874,0,0
4,GO L AMINO ACID TRANSPORT,0.98255,-0.0099714,0.043139,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.48678,-0.0099767,0.048362,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.69061,-0.010135,-0.04811,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.69707,-0.01028,0.028088,0,0
4,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.97557,-0.010309,-0.0022323,0,0
4,GO RESPONSE TO STARVATION,0.87144,-0.010607,-0.014396,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.83713,-0.010708,0.027054,0,0
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.47588,-0.010739,-0.048486,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.8303,-0.010744,-0.0374,0,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.85082,-0.010858,0.0040744,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.91987,-0.010887,-0.0068452,0,0
4,GO PROSTATE GLAND GROWTH,0.71658,-0.010952,0.15103,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.73628,-0.01138,0.073648,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.46512,-0.011467,-0.092438,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.76948,-0.011482,0.051228,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.91293,-0.011534,-0.015393,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.71006,-0.011546,-0.02029,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.43883,-0.011572,0.12359,0,0
4,GO DEVELOPMENTAL GROWTH,0.83713,-0.011574,0.0092621,0,0
4,GO RESPONSE TO FATTY ACID,0.83713,-0.011587,0.03662,0,0
4,GO DNA STRAND ELONGATION,0.4545,-0.011679,-0.061559,0,0
4,GO PARTURITION,0.79636,-0.011709,-0.047612,0,0
4,GO OOGENESIS,0.65866,-0.011883,-0.019255,0,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.90599,-0.011898,0.040048,0,0
4,GO REGULATION OF MRNA PROCESSING,0.84397,-0.012012,-0.018016,0,0
4,GO RESPONSE TO VITAMIN D,0.97557,-0.01243,0.003025,0,0
4,GO CELLULAR RESPONSE TO STEROL,0.3746,-0.012553,-0.070236,0,0
4,GO HISTAMINE TRANSPORT,0.80989,-0.012581,-0.060585,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.68418,-0.012883,0.047702,0,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.69061,-0.013291,-0.017363,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.77618,-0.013465,-0.0051469,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.91293,-0.013892,0.0088972,0,0
4,GO BICARBONATE TRANSPORT,0.47049,-0.014092,0.05168,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.67776,-0.014218,-0.039093,0,0
4,GO REGULATION OF OOGENESIS,0.62732,-0.014448,-0.010605,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.47049,-0.014502,-0.015232,0,0
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.30402,-0.014565,-0.18488,0,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.84397,-0.014569,0.018628,0,0
4,GO CYTOSOLIC TRANSPORT,0.63978,-0.014764,0.027011,0,0
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.87833,-0.014805,0.016529,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76948,-0.01509,0.043473,0,0
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.86455,-0.015104,0.029619,0,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.89215,-0.015148,0.0094771,0,0
4,GO REGULATION OF PEPTIDE TRANSPORT,0.50337,-0.015204,-0.024178,0,0
4,GO LIPID PHOSPHORYLATION,0.60272,-0.015309,-0.025637,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.73628,-0.015488,0.016596,0,0
4,GO REGULATION OF FATTY ACID TRANSPORT,0.79636,-0.015509,-0.0087078,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.97557,-0.015699,0.0011866,0,0
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.66501,-0.015725,0.0020463,0,0
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.91293,-0.01585,0.023709,0,0
4,GO GLUCOSE METABOLIC PROCESS,0.84397,-0.01589,-0.016928,0,0
4,GO GMP METABOLIC PROCESS,0.9686,-0.015894,-0.0065054,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.24288,-0.016013,0.19271,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.41842,-0.016039,-0.10975,0,0
4,GO SNORNA 3 END PROCESSING,0.69061,-0.016105,0.010598,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.75615,-0.016181,-0.033231,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.79636,-0.016411,0.0097475,0,0
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.89907,-0.016949,-0.02049,0,0
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.26847,-0.016952,-0.059761,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.78289,-0.016959,0.016352,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.42347,-0.017165,-0.095474,0,0
4,GO CELL CELL JUNCTION ASSEMBLY,0.65866,-0.01728,0.01943,0,0
4,GO MICROVILLUS ORGANIZATION,0.20937,-0.017527,-0.13267,0,0
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.70355,-0.017891,-0.022049,0,0
4,GO EXPLORATION BEHAVIOR,0.29586,-0.018083,-0.11944,0,0
4,GO RENAL ABSORPTION,0.93377,-0.018212,0.01712,0,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.44402,-0.018372,-0.10032,0,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.52594,-0.018417,-0.02081,0,0
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.62113,-0.018488,-0.083249,0,0
4,GO GPI ANCHOR METABOLIC PROCESS,0.40843,-0.018857,-0.048535,0,0
4,GO PLASMA MEMBRANE REPAIR,0.89215,-0.018946,-0.0095235,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.95466,-0.018999,0.017064,0,0
4,GO SEX DIFFERENTIATION,0.99651,-0.019303,0.0067072,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.19095,-0.019605,-0.071354,0,0
4,GO MITOCHONDRIAL FUSION,0.49227,-0.019718,0.031667,0,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.67137,-0.01992,-0.02607,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.56666,-0.020034,0.035853,0,0
4,GO CELL CYCLE DNA REPLICATION,0.63354,-0.020157,-0.040676,0,0
4,GO O GLYCAN PROCESSING,0.38408,-0.0203,-0.091679,0,0
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.059411,-0.020545,-0.10352,0,0
4,GO TELOMERE CAPPING,0.94073,-0.020676,0.0048974,0,0
4,GO GLIOGENESIS,0.97557,-0.020838,-0.0055475,0,0
4,GO REGULATION OF ENDOCRINE PROCESS,0.76281,-0.020866,0.019664,0,0
4,GO CELLULAR RESPONSE TO STARVATION,0.53167,-0.021174,-0.030331,0,0
4,GO CGMP MEDIATED SIGNALING,0.74288,-0.021307,-0.023633,0,0
4,GO STEROID CATABOLIC PROCESS,0.63978,-0.021345,0.025208,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.87833,-0.021439,0.0031397,0,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.66501,-0.021829,-0.028512,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.86455,-0.022097,0.029349,0,0
4,GO ANION TRANSPORT,0.32077,-0.022255,-0.031252,0,0
4,GO ORGANELLE FUSION,0.87833,-0.022544,-0.0083574,0,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.40843,-0.022562,-0.092328,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.94073,-0.022634,0.16876,0,0
4,GO MICROTUBULE BASED PROCESS,0.63978,-0.022933,-0.019494,0,0
4,GO ER OVERLOAD RESPONSE,0.59664,-0.023044,0.052632,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.30815,-0.023069,-0.058463,0,0
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.99651,-0.023156,-0.00011301,0,0
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.99651,-0.02325,0.00090104,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.86455,-0.023836,0.041798,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.44402,-0.023837,0.059961,0,0
4,GO REGULATION OF METAL ION TRANSPORT,0.69061,-0.02403,-0.0077309,0,0
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.97557,-0.024101,0.0051449,0,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.94073,-0.024104,0.0066388,0,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.52594,-0.024606,-0.050182,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.87144,-0.025062,-0.01684,0,0
4,GO ORGANIC ANION TRANSPORT,0.35607,-0.025167,-0.037054,0,0
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.23937,-0.025207,-0.12883,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.86455,-0.025231,0.0069601,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.95466,-0.025314,0.014436,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.87833,-0.025347,0.013183,0,0
4,GO PIGMENTATION,0.71006,-0.025498,0.0002878,0,0
4,GO AXON EXTENSION,0.62732,-0.025526,-0.025401,0,0
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.40843,-0.025529,-0.064141,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.63354,-0.025614,-0.010339,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.26847,-0.025693,-0.020627,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.83713,-0.025702,0.0015859,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.62113,-0.025755,0.10123,0,0
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.58456,-0.026097,-0.047231,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.30815,-0.026187,-0.022484,0,0
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.30402,-0.026303,-0.062469,0,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.54321,-0.026349,-0.011681,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.62732,-0.026431,-0.0065238,0,0
4,GO CONVERGENT EXTENSION,0.71006,-0.02683,-0.039926,0,0
4,GO MALE GAMETE GENERATION,0.87144,-0.027407,-0.00037547,0,0
4,GO HISTONE MONOUBIQUITINATION,0.75615,-0.027411,-0.01593,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.78289,-0.027633,0.0061745,0,0
4,GO BONE MINERALIZATION,0.44924,-0.028439,0.099119,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.96163,-0.028642,-0.06515,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.71006,-0.028757,-0.010384,0,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.48678,-0.028854,-0.062351,0,0
4,GO INORGANIC ANION TRANSPORT,0.55487,-0.028993,-0.017156,0,0
4,GO PROTEIN NITROSYLATION,0.74288,-0.02903,-0.038024,0,0
4,GO NEPHRON MORPHOGENESIS,0.95466,-0.029077,0.014064,0,0
4,GO RESPONSE TO CALCIUM ION,0.54321,-0.029673,-0.03378,0,0
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.97557,-0.029707,0.05016,0,0
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.31653,-0.02981,-0.057335,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.39858,-0.029938,-0.024396,0,0
4,GO HISTAMINE SECRETION,0.96163,-0.030177,-0.012065,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.42855,-0.030444,-0.051019,0,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.61497,-0.03059,-0.032552,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.68418,-0.030614,0.049354,0,0
4,GO THYMIC T CELL SELECTION,0.53742,-0.030702,-0.0089489,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.18219,-0.030868,-0.12544,0,0
4,GO HISTONE UBIQUITINATION,0.88523,-0.031098,0.016836,0,0
4,GO EXIT FROM MITOSIS,0.7495,-0.031313,-0.0075684,0,0
4,GO MANNOSYLATION,0.82348,-0.031358,-0.014985,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.80312,-0.031547,0.0025171,0,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.77618,-0.031783,-0.016684,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.38888,-0.032118,-0.034874,0,0
4,GO LYSOSOME LOCALIZATION,0.32506,-0.032155,-0.039979,0,0
4,GO ORGANELLE LOCALIZATION,0.18508,-0.032192,-0.028938,0,0
4,GO ECTODERM DEVELOPMENT,0.86455,-0.032253,0.053127,0,0
4,GO SNORNA METABOLIC PROCESS,0.73628,-0.032256,0.016425,0,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.32938,-0.032297,-0.11542,0,0
4,GO GLIAL CELL PROLIFERATION,0.70355,-0.032607,0.049365,0,0
4,GO AORTA MORPHOGENESIS,0.87833,-0.032652,0.095754,0,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.71006,-0.032654,0.0088795,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.24288,-0.032693,-0.18443,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.74288,-0.032948,-0.054706,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.74288,-0.033019,-0.0040894,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.2839,-0.033052,-0.022264,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.70355,-0.033192,-0.010677,0,0
4,GO SIGNAL PEPTIDE PROCESSING,0.50337,-0.033521,0.065389,0,0
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.43883,-0.033559,-0.044743,0,0
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.71006,-0.033665,-0.026287,0,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.38408,-0.033976,-0.073955,0,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.65866,-0.034003,0.030562,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.54321,-0.03401,-0.034218,0,0
4,GO BLASTOCYST DEVELOPMENT,0.43883,-0.034196,-0.023284,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.44402,-0.034277,-0.069209,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.76281,-0.034279,-0.00096573,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.36526,-0.034528,-0.099192,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.22905,-0.034541,-0.057712,0,0
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.15264,-0.034656,-0.063962,0,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.97557,-0.034792,0.022704,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.91293,-0.034813,0.0095113,0,0
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.43367,-0.034859,-0.10098,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.30402,-0.035,-0.067903,0,0
4,GO MEMBRANE HYPERPOLARIZATION,0.54903,-0.035175,-0.07478,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.39371,-0.035381,-0.034452,0,0
4,GO B CELL HOMEOSTASIS,0.63978,-0.035535,-0.039942,0,0
4,GO RESPONSE TO METAL ION,0.66501,-0.035558,-0.017491,0,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.29184,-0.035599,-0.065316,0,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.95466,-0.035647,0.03226,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.71006,-0.035779,0.02266,0,0
4,GO PIGMENT GRANULE LOCALIZATION,0.26098,-0.036086,-0.066628,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.78289,-0.036289,-0.0091225,0,0
4,GO REPLICATION FORK PROCESSING,0.96163,-0.036658,0.045153,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.42855,-0.036705,0.073101,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.36064,-0.036863,-0.051454,0,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.72969,-0.037016,-0.012127,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.39858,-0.037136,-0.041867,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.72313,-0.037282,-0.03043,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.85082,-0.037535,-0.023302,0,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.92682,-0.038251,0.053161,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.67137,-0.038286,0.0036856,0,0
4,GO RESPONSE TO CARBOHYDRATE,0.63354,-0.038445,-0.0073568,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.4598,-0.038515,-0.019622,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.53167,-0.038618,-0.071777,0,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.89907,-0.038638,0.021422,0,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.32938,-0.038727,-0.065269,0,0
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.9686,-0.038751,0.0032909,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.70355,-0.038812,0.012875,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.23589,-0.038924,-0.049109,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.71006,-0.039276,-0.016678,0,0
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.98953,-0.039457,0.031451,0,0
4,GO REGULATION OF FERTILIZATION,0.54903,-0.039479,-0.055307,0,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.15773,-0.039592,-0.1263,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.27227,-0.039825,-0.20215,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.10654,-0.040362,-0.16399,0,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.69061,-0.041595,-0.015751,0,0
4,GO LINOLEIC ACID METABOLIC PROCESS,0.35153,-0.041848,-0.14103,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.87833,-0.041972,0.060245,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.40349,-0.042022,-0.077811,0,0
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.14285,-0.042151,-0.071573,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.092194,-0.042256,-0.054397,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.53742,-0.042322,-0.016824,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.73628,-0.042398,-0.14836,0,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.23937,-0.042439,-0.046716,0,0
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.13583,-0.042849,-0.057455,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.98255,-0.043184,0.024098,0,0
4,GO NODAL SIGNALING PATHWAY,0.89907,-0.043425,-0.0087826,0,0
4,GO REGULATION OF B CELL DIFFERENTIATION,0.64605,-0.043719,-0.018962,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.63354,-0.043721,-0.028675,0,0
4,GO RESPONSE TO SALT,0.98255,-0.043846,-0.036631,0,0
4,GO CIRCULATORY SYSTEM PROCESS,0.29586,-0.044178,-0.038873,0,0
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.72313,-0.044343,-0.023747,0,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.29992,-0.044582,-0.03003,0,0
4,GO MITOTIC DNA REPLICATION,0.59664,-0.044731,-0.03312,0,0
4,GO OOCYTE DIFFERENTIATION,0.13583,-0.044948,-0.06304,0,0
4,GO CELLULAR RESPONSE TO ALKALOID,0.16828,-0.045065,-0.080563,0,0
4,GO T CELL SELECTION,0.63354,-0.045103,-0.003448,0,0
4,GO CALCIUM ION IMPORT,0.065563,-0.045308,-0.091995,0,0
4,GO SPERM MOTILITY,0.17374,-0.045486,-0.054944,0,0
4,GO REGULATION OF EXCRETION,0.56666,-0.045878,-0.044144,0,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.87144,-0.045914,-0.018473,0,0
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.23589,-0.046041,-0.062916,0,0
4,GO REGULATION OF ANION TRANSPORT,0.0695,-0.046227,-0.096598,0,0
4,GO MALE MEIOSIS I,0.48131,-0.046327,-0.074654,0,0
4,GO EPIDERMAL CELL DIFFERENTIATION,0.78962,-0.046362,0.033497,0,0
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.80989,-0.046363,0.11221,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.29586,-0.046398,-0.061973,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.68418,-0.046627,0.0005039,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.84397,-0.046683,-0.0050589,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.41341,-0.046698,-0.03446,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.31653,-0.046918,-0.047551,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.12689,-0.047028,-0.093959,0,0
4,GO ALCOHOL CATABOLIC PROCESS,0.49227,-0.047119,-0.0060786,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.71658,-0.047157,-0.019695,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.98255,-0.047212,0.028255,0,0
4,GO SPHINGOLIPID METABOLIC PROCESS,0.12908,-0.04773,-0.067679,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.27227,-0.047742,-0.063204,0,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.61497,-0.047763,-0.02638,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.39371,-0.047941,-0.099313,0,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.36064,-0.047946,-0.062323,0,0
4,GO WATER TRANSPORT,0.35153,-0.048059,-0.042344,0,0
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.75615,-0.048364,-0.0050303,0,0
4,GO PENILE ERECTION,0.52025,-0.048603,-0.061274,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.73628,-0.048631,-0.00066691,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.67137,-0.04867,0.0087962,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.39371,-0.048908,-0.064449,0,0
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.46512,-0.048919,-0.048265,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.2,-0.05027,-0.073115,0,0
4,GO SEGMENTATION,0.49227,-0.050397,-0.020663,0,0
4,GO CILIUM ORGANIZATION,0.63354,-0.050495,-0.0038867,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.04854,-0.050601,-0.098303,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.3746,-0.050688,-0.098011,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.16032,-0.050834,-0.12924,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.51459,-0.050903,-0.0059819,0,0
4,GO NUCLEOSOME ORGANIZATION,0.25729,-0.051362,-0.044342,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.95466,-0.05169,0.03858,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.25729,-0.051753,-0.067448,0,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.41341,-0.051929,-0.085244,0,0
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.20621,-0.052189,-0.08511,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.41842,-0.052237,-0.072077,0,0
4,GO PROTEIN O LINKED MANNOSYLATION,0.48131,-0.05228,-0.048752,0,0
4,GO NEURON DEATH,0.21579,-0.052422,-0.034396,0,0
4,GO DEMETHYLATION,0.46512,-0.05315,-0.013046,0,0
4,GO CILIUM MOVEMENT,0.25363,-0.053531,-0.047778,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.21579,-0.053638,-0.0664,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.51459,-0.05437,-0.070568,0,0
4,GO CALCIUM MEDIATED SIGNALING,0.19695,-0.05439,-0.043676,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.37932,-0.054545,-0.03039,0,0
4,GO DNA PACKAGING,0.47588,-0.054598,-0.023981,0,0
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.10465,-0.054681,-0.11608,0,0
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.42855,-0.055028,-0.10955,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.13583,-0.055176,-0.11362,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.91987,-0.05554,0.03489,0,0
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.53742,-0.05556,-0.10049,0,0
4,GO RESPONSE TO MONOSACCHARIDE,0.39371,-0.055878,-0.021496,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.92682,-0.056099,0.20545,0,0
4,GO LONG TERM MEMORY,0.52025,-0.056364,-0.047945,0,0
4,GO FRUCTOSE METABOLIC PROCESS,0.31653,-0.056419,-0.1608,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.54903,-0.05658,-0.060788,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.97557,-0.056677,0.012487,0,0
4,GO REGULATION OF TRANSPORT,0.088862,-0.057008,-0.047764,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.88523,-0.057047,0.018552,0,0
4,GO RHYTHMIC PROCESS,0.093897,-0.057207,-0.051444,0,0
4,GO GERM CELL DEVELOPMENT,0.16294,-0.057315,-0.044433,0,0
4,GO ANION TRANSMEMBRANE TRANSPORT,0.53742,-0.057428,-0.0087465,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.48678,-0.057707,-0.048798,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.62732,-0.05777,-0.032899,0,0
4,GO MEMBRANE REPOLARIZATION,0.25363,-0.057917,-0.090092,0,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.16032,-0.058065,-0.0769,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.11235,-0.058347,-0.10902,0,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.061812,-0.058366,-0.16475,0,0
4,GO MEMBRANE DOCKING,0.23245,-0.058383,-0.040113,0,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.23937,-0.058497,-0.068885,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.7495,-0.05871,-0.012515,0,0
4,GO ORGANIC ACID TRANSPORT,0.072231,-0.058854,-0.06459,0,0
4,GO REGULATION OF BONE REMODELING,0.65234,-0.059218,-0.033349,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.24643,-0.059632,-0.072559,0,0
4,GO RESPONSE TO INACTIVITY,0.59059,-0.059873,-0.052567,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.86455,-0.060035,0.023647,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.70355,-0.060146,-0.023411,0,0
4,GO INTERLEUKIN 10 PRODUCTION,0.47588,-0.060283,-0.013887,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.89907,-0.060544,0.062547,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.69707,-0.060598,0.083278,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.37932,-0.060692,-0.053912,0,0
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.14285,-0.060941,-0.10322,0,0
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.18508,-0.061341,-0.1101,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.78289,-0.061478,0.043452,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.64605,-0.062254,-0.029978,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.24288,-0.062299,-0.053978,0,0
4,GO PHAGOSOME MATURATION,0.94073,-0.062975,-0.0089723,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.46512,-0.063364,-0.050298,0,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.51459,-0.063669,-0.056709,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.34702,-0.063895,-0.066288,0,0
4,GO ACTIN CROSSLINK FORMATION,0.38408,-0.064066,-0.13,0,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.36064,-0.064241,-0.077395,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.46512,-0.064434,-0.060854,0,0
4,GO REGULATION OF PLATELET AGGREGATION,0.33373,-0.064487,-0.11161,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.35153,-0.064744,-0.046168,0,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.26847,-0.065104,-0.10746,0,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.8303,-0.065254,-0.0023344,0,0
4,GO HISTONE H3 K36 METHYLATION,0.32077,-0.065263,-0.076193,0,0
4,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23589,-0.06542,-0.2275,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.20309,-0.065431,-0.080038,0,0
4,GO FUCOSYLATION,0.2839,-0.065618,-0.071242,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.32506,-0.065682,-0.028292,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.188,-0.0657,-0.10929,0,0
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.62113,-0.065717,-0.046737,0,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.12049,-0.06573,-0.16876,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.22568,-0.065735,-0.079115,0,0
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.43367,-0.065788,-0.044999,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.30815,-0.065882,-0.04425,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.87833,-0.065934,-0.02319,0,0
4,GO CHROMATIN ORGANIZATION,0.084046,-0.066084,-0.038112,0,0
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.070855,-0.066268,-0.099741,0,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.10096,-0.06677,-0.085383,0,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.38408,-0.066974,-0.039072,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.91987,-0.066981,0.019941,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.15015,-0.067302,-0.19504,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.24288,-0.067493,-0.06132,0,0
4,GO RESPONSE TO ETHANOL,0.11636,-0.067817,-0.070071,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.84397,-0.067966,0.017486,0,0
4,GO REGULATION OF DNA METHYLATION,0.41842,-0.068081,-0.056813,0,0
4,GO FEMALE SEX DIFFERENTIATION,0.35153,-0.068178,-0.037984,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.20621,-0.068279,-0.046442,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.88523,-0.06841,0.045747,0,0
4,GO DIVALENT METAL ION EXPORT,0.94769,-0.068692,-0.0081165,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.11039,-0.068727,-0.1308,0,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.36064,-0.068858,-0.075591,0,0
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.87833,-0.06895,0.012385,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.26098,-0.069402,-0.12677,0,0
4,GO POSITIVE T CELL SELECTION,0.52594,-0.069519,0.012704,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.080955,-0.069727,-0.1074,0,0
4,GO DRINKING BEHAVIOR,0.13583,-0.069884,-0.13533,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.71006,-0.070081,0.0036348,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.63354,-0.07125,0.021189,0,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.2839,-0.071275,-0.0229,0,0
4,GO MATING BEHAVIOR,0.15015,-0.071333,-0.097774,0,0
4,GO NUCLEOSOME ASSEMBLY,0.18508,-0.071962,-0.069742,0,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.48678,-0.071979,-0.084626,0,0
4,GO CARDIAC CHAMBER FORMATION,0.29992,-0.072027,-0.2204,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.13355,-0.072032,-0.060055,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.33373,-0.072268,-0.035558,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.98953,-0.072491,-0.043896,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.41341,-0.072524,-0.020337,0,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.14526,-0.072697,-0.050387,0,0
4,GO ANIMAL ORGAN MATURATION,0.9686,-0.073221,0.0028945,0,0
4,GO RENAL SODIUM EXCRETION,0.34256,-0.073406,-0.06281,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.21256,-0.073532,-0.11173,0,0
4,GO CYTOPLASM ORGANIZATION,0.94769,-0.073681,0.025045,0,0
4,GO CELL MORPHOGENESIS,0.12473,-0.073809,-0.061307,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.62732,-0.074325,-0.039947,0,0
4,GO DIET INDUCED THERMOGENESIS,0.054842,-0.074351,-0.14903,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.31232,-0.075087,-0.053578,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.25363,-0.075105,-0.080992,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.46512,-0.075208,-0.047968,0,0
4,GO T CELL HOMEOSTASIS,0.082489,-0.075576,-0.076248,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.24643,-0.075926,-0.051943,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.94769,-0.076207,0.0073796,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.41341,-0.076904,-0.027489,0,0
4,GO TRANSMEMBRANE TRANSPORT,0.055956,-0.076905,-0.056706,0,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.097379,-0.077231,-0.14344,0,0
4,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.65234,-0.077796,-0.034769,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.65234,-0.07788,0.050104,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.44402,-0.07798,-0.0019227,0,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.16828,-0.07856,-0.050066,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.31232,-0.078721,-0.067178,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.11636,-0.078871,-0.10278,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.19393,-0.079109,-0.080728,0,0
4,GO REGULATION OF TOR SIGNALING,0.13583,-0.079197,-0.039798,0,0
4,GO PROTEIN ACYLATION,0.0034322,-0.079405,-0.092299,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.96163,-0.079533,0.0044596,0,0
4,GO MITOCHONDRIAL TRNA PROCESSING,0.80989,-0.079617,0.034151,0,0
4,GO SISTER CHROMATID COHESION,0.2,-0.079684,-0.061342,0,0
4,GO CELL JUNCTION ASSEMBLY,0.51459,-0.0798,-0.023826,0,0
4,GO INTRACILIARY TRANSPORT,0.4598,-0.080075,-0.050061,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.11039,-0.080177,-0.067137,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.12689,-0.080422,-0.087075,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.20621,-0.080718,-0.11517,0,0
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.11636,-0.08072,-0.056741,0,0
4,GO EAR MORPHOGENESIS,0.084046,-0.080731,-0.10292,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.29992,-0.081144,-0.076852,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.25001,-0.081647,-0.05569,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.56075,-0.082091,-0.044147,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.059411,-0.082387,-0.10333,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.83713,-0.082432,0.0037183,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20309,-0.082666,-0.13673,0,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.22235,-0.082799,-0.070165,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.22905,-0.083063,-0.048466,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.77618,-0.08354,0.026494,0,0
4,GO MAST CELL ACTIVATION,0.072231,-0.083649,-0.12973,0,0
4,GO BRAIN MORPHOGENESIS,0.17653,-0.083676,-0.098152,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.59664,-0.083882,-0.048732,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.15773,-0.083988,-0.079089,0,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.21579,-0.084044,-0.083726,0,0
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.12259,-0.084298,-0.065593,0,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.049546,-0.084312,-0.10173,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.15264,-0.084438,-0.07167,0,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.093897,-0.084565,-0.13475,0,0
4,GO CHROMATIN DISASSEMBLY,0.78289,-0.08462,-0.041801,0,0
4,GO RECEPTOR CLUSTERING,0.064293,-0.085227,-0.13764,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.50337,-0.085515,-0.051623,0,0
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.34256,-0.086391,-0.11581,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.14285,-0.086441,-0.065124,0,0
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.34702,-0.08665,-0.11204,0,0
4,GO REGULATION OF CILIUM BEAT FREQUENCY,0.62113,-0.086837,-0.033915,0,0
4,GO DOSAGE COMPENSATION,0.35607,-0.086906,-0.027478,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.52594,-0.087089,-0.030968,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.059411,-0.087115,-0.083636,0,0
4,GO MAGNESIUM ION TRANSPORT,0.15773,-0.087865,-0.08832,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.036164,-0.087938,-0.075493,0,0
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.090515,-0.088025,-0.11623,0,0
4,GO SPERM CAPACITATION,0.2839,-0.088133,-0.058808,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.62113,-0.088448,-0.019282,0,0
4,GO TELENCEPHALON REGIONALIZATION,0.40349,-0.088897,-0.11938,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.11039,-0.089683,-0.075363,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.41341,-0.090271,-0.020193,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.10845,-0.090304,-0.068864,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.67137,-0.090305,-0.0043268,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.29992,-0.090341,-0.045053,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.41341,-0.090348,-0.059007,0,0
4,GO RENAL SYSTEM PROCESS,0.36526,-0.090364,-0.036694,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.48131,-0.090493,-0.039901,0,0
4,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.37932,-0.090779,0.126,0,0
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.1028,-0.091076,-0.086992,0,0
4,GO SPLEEN DEVELOPMENT,0.53167,-0.091086,-0.010201,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.34256,-0.092502,-0.13622,0,0
4,GO EPITHELIAL CELL CELL ADHESION,0.99651,-0.092564,0.073317,0,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.25363,-0.092866,-0.14301,0,0
4,GO HORMONE CATABOLIC PROCESS,0.75615,-0.0929,-0.027047,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.52594,-0.092963,-0.039248,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.36064,-0.093351,-0.081074,0,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.42855,-0.093464,-0.02611,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.10845,-0.094324,-0.07239,0,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.11235,-0.094679,-0.17751,0,0
4,GO HISTONE H2A UBIQUITINATION,0.56666,-0.095113,-0.021238,0,0
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.25001,-0.095186,-0.050999,0,0
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.060602,-0.095351,-0.073073,0,0
4,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.51459,-0.095395,-0.060263,0,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.63978,-0.095541,-0.0064688,0,0
4,GO REGULATORY T CELL DIFFERENTIATION,0.23589,-0.095753,-0.095574,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.25729,-0.095895,-0.060457,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.084046,-0.095932,-0.13627,0,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.22905,-0.096121,-0.022132,0,0
4,GO REGULATION OF NEURON MIGRATION,0.16294,-0.096182,-0.11467,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.7495,-0.096413,-0.011406,0,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.093897,-0.096597,-0.097091,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.031748,-0.09704,-0.095746,0,0
4,GO MATING,0.082489,-0.097115,-0.073023,0,0
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.52025,-0.0974,-0.032324,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.065563,-0.097649,-0.15042,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.1028,-0.097832,-0.1767,0,0
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.15517,-0.09784,-0.10132,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.42347,-0.098628,-0.023244,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.052669,-0.098725,0.033529,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.14769,-0.098798,-0.10415,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.40349,-0.098819,-0.06601,0,0
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.060602,-0.099251,-0.12345,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.061812,-0.099387,-0.055266,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.070855,-0.099401,-0.10119,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.51459,-0.099856,-0.030096,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.32938,-0.10008,-0.055141,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.061812,-0.10023,-0.095863,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.38408,-0.10049,-0.059109,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.15773,-0.10102,-0.094554,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.36526,-0.10133,-0.08367,0,0
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.55487,-0.10147,-0.037983,0,0
4,GO FORELIMB MORPHOGENESIS,0.29992,-0.10163,-0.072863,0,0
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.19095,-0.102,-0.052831,0,0
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.44402,-0.10218,-0.062069,0,0
4,GO CHROMATIN SILENCING,0.10845,-0.10233,-0.049267,0,0
4,GO AXO DENDRITIC TRANSPORT,0.035393,-0.10283,-0.14809,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.67776,-0.10348,-0.041814,0,0
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.44402,-0.1035,-0.060627,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.3746,-0.10401,-0.105,0,0
4,GO CELLULAR ANION HOMEOSTASIS,0.26847,-0.10425,-0.065376,0,0
4,GO NEURAL CREST FORMATION,0.35607,-0.10437,-0.061088,0,0
4,GO EXCRETION,0.188,-0.10493,-0.054331,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.075049,-0.10525,-0.09605,0,0
4,GO HEART INDUCTION,0.88523,-0.10538,0.0034153,0,0
4,GO RESPONSE TO FUNGUS,0.11039,-0.10566,-0.10748,0,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.38408,-0.10627,-0.064746,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.11841,-0.10637,-0.16668,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.68418,-0.10639,0.076351,0,0
4,GO MYOFIBRIL ASSEMBLY,0.72969,-0.10655,0.028138,0,0
4,GO UTERUS DEVELOPMENT,0.11636,-0.1068,-0.15649,0,0
4,GO MESONEPHROS DEVELOPMENT,0.68418,-0.10682,0.0071364,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.92682,-0.10692,-0.0037485,0,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.53167,-0.10736,0.01351,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.72969,-0.10774,0.0080665,0,0
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.080955,-0.10777,-0.08441,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.068167,-0.10811,-0.090142,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.11039,-0.10849,-0.11321,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.21579,-0.10852,-0.097115,0,0
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.068167,-0.10865,-0.15945,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.40843,-0.10914,-0.053435,0,0
4,GO REGIONALIZATION,0.20937,-0.10926,-0.089261,0,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21905,-0.10936,-0.099286,0,0
4,GO DENDRITE SELF AVOIDANCE,0.65234,-0.10974,-0.013857,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.024846,-0.10978,-0.11254,0,0
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.079444,-0.10988,-0.090947,0,0
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.26098,-0.11009,-0.046736,0,0
4,GO AXIS SPECIFICATION,0.090515,-0.11015,-0.1147,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.48131,-0.11027,-0.067503,0,0
4,GO TORC1 SIGNALING,0.070855,-0.11076,-0.065706,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.17374,-0.11101,-0.089051,0,0
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.080955,-0.11114,-0.10415,0,0
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.093897,-0.11188,-0.098918,0,0
4,GO CELL CELL JUNCTION ORGANIZATION,0.52025,-0.11192,-0.026644,0,0
4,GO G0 TO G1 TRANSITION,0.088862,-0.11201,-0.067666,0,0
4,GO SOMITE DEVELOPMENT,0.0075304,-0.11212,-0.11797,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.092194,-0.11215,-0.14005,0,0
4,GO PROTEIN MANNOSYLATION,0.32077,-0.11223,-0.054855,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.27611,-0.11254,-0.039674,0,0
4,GO SARCOMERE ORGANIZATION,0.89907,-0.1126,0.030828,0,0
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.12473,-0.11318,-0.1092,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.83713,-0.11327,0.044938,0,0
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.055956,-0.11334,-0.12322,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.18508,-0.11395,-0.058417,0,0
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.22568,-0.11435,-0.091661,0,0
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.063042,-0.11439,-0.11528,0,0
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.52025,-0.11458,-0.078662,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.070855,-0.11492,-0.060521,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.10096,-0.11493,-0.14774,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.41842,-0.11564,-0.045744,0,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.082489,-0.11606,-0.13512,0,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.35153,-0.11608,-0.05792,0,0
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.50896,-0.11638,0.00095405,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.19695,-0.11652,-0.12473,0,0
4,GO SPERMATID DIFFERENTIATION,0.16032,-0.11684,-0.060121,0,0
4,GO PROTEIN DEMETHYLATION,0.065563,-0.11686,-0.13576,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.68418,-0.11792,0.15623,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.28785,-0.11804,-0.11237,0,0
4,GO REGULATION OF ACROSOME REACTION,0.21905,-0.11829,-0.11919,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.23245,-0.11833,-0.068577,0,0
4,GO BROWN FAT CELL DIFFERENTIATION,0.42347,-0.11844,-0.053988,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.27611,-0.1187,-0.074682,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.41341,-0.11898,-0.034044,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.16559,-0.1192,-0.063749,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.099158,-0.11958,-0.13425,0,0
4,GO COLLATERAL SPROUTING,0.21256,-0.11966,-0.073271,0,0
4,GO LEUKOTRIENE METABOLIC PROCESS,0.23937,-0.11968,-0.09618,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.17653,-0.11979,-0.12478,0,0
4,GO SECRETORY GRANULE ORGANIZATION,0.018398,-0.12068,-0.1268,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.48131,-0.12089,-0.030724,0,0
4,GO RESPONSE TO CAFFEINE,0.54903,-0.12231,-0.039991,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.17653,-0.12368,-0.063913,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.41341,-0.1238,-0.096143,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.16828,-0.12404,-0.078712,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.59059,-0.12418,-0.059399,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.12259,-0.12425,0.044579,0,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.20621,-0.12467,-0.1167,0,0
4,GO MAST CELL MEDIATED IMMUNITY,0.061812,-0.12504,-0.12405,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.092194,-0.12521,-0.13867,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0695,-0.12554,-0.10158,0,0
4,GO SNARE COMPLEX ASSEMBLY,0.39858,-0.12615,-0.048778,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.11841,-0.12625,-0.07555,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.65234,-0.12799,0.034252,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.39858,-0.12868,-0.066454,0,0
4,GO HISTONE METHYLATION,0.013465,-0.1288,-0.11275,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.15773,-0.1298,-0.060609,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.12908,-0.13075,-0.079266,0,0
4,GO LIPID EXPORT FROM CELL,0.30815,-0.13106,-0.062172,0,0
4,GO GLUTAMATE METABOLIC PROCESS,0.13355,-0.13113,-0.082797,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.073629,-0.1315,-0.11789,0,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.11636,-0.13159,-0.10803,0,0
4,GO PHOTOTRANSDUCTION,0.004408,-0.13223,-0.014165,0,0
4,GO RESPONSE TO ETHER,0.10845,-0.13289,-0.13561,0,0
4,GO NEUTRAL AMINO ACID TRANSPORT,0.17934,-0.1335,-0.062973,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.26471,-0.13546,-0.0834,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19393,-0.13555,-0.28685,0,0
4,GO POLYOL CATABOLIC PROCESS,0.02843,-0.13598,-0.12298,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.51459,-0.13606,-0.06858,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16294,-0.13622,-0.11239,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.58456,-0.1364,-0.028252,0,0
4,GO BRONCHUS DEVELOPMENT,0.71006,-0.13662,-0.068777,0,0
4,GO RESPONSE TO AMINE,0.075049,-0.13686,-0.12334,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.045624,-0.13779,-0.23504,0,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.014841,-0.13847,-0.12462,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.080955,-0.13849,-0.094576,0,0
4,GO WATER HOMEOSTASIS,0.052669,-0.13851,-0.10502,0,0
4,GO KIDNEY MORPHOGENESIS,0.28785,-0.13888,-0.046796,0,0
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.11636,-0.13889,-0.087677,0,0
4,GO FEVER GENERATION,0.16828,-0.13906,-0.022644,0,0
4,GO METANEPHROS MORPHOGENESIS,0.34702,-0.14022,-0.089168,0,0
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29992,-0.14118,-0.10117,0,0
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.015203,-0.14154,-0.15201,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.38888,-0.14206,-0.093658,0,0
4,GO NOTCH SIGNALING PATHWAY,0.085627,-0.14254,-0.081489,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.055956,-0.14365,-0.11843,0,0
4,GO RENAL WATER HOMEOSTASIS,0.04854,-0.14368,-0.098269,0,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.15517,-0.14586,-0.13776,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.0056288,-0.14648,-0.13561,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.085627,-0.14668,-0.16492,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.25729,-0.14683,-0.087027,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.27999,-0.14684,-0.045212,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.23589,-0.14684,-0.095623,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.32077,-0.14851,-0.11744,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.099158,-0.14943,-0.086141,0,0
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.087232,-0.15023,-0.11459,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12473,-0.15129,-0.18077,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.12049,-0.15148,-0.11566,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.14048,-0.15151,-0.071366,0,0
4,GO STEROID HORMONE SECRETION,0.13814,-0.15313,-0.12498,0,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.34256,-0.15315,-0.072262,0,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.32506,-0.15323,-0.091807,0,0
4,GO V D J RECOMBINATION,0.19695,-0.15332,-0.075713,0,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.35153,-0.15523,-0.060104,0,0
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.188,-0.15526,-0.12114,0,0
4,GO AXONEME ASSEMBLY,0.084046,-0.15541,-0.13233,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.16294,-0.15581,-0.11575,0,0
4,GO COPULATION,0.34256,-0.15589,-0.07769,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0695,-0.15614,-0.12216,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.21579,-0.1563,-0.080026,0,0
4,GO AXONAL TRANSPORT,0.010773,-0.1574,-0.19024,0,0
4,GO RESPONSE TO EPINEPHRINE,0.18508,-0.15785,-0.14905,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.070855,-0.15788,-0.11522,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.0025817,-0.15811,-0.03683,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.17374,-0.15816,-0.1008,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.05161,-0.15868,-0.14378,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.030383,-0.15886,-0.11083,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.097379,-0.15904,-0.10593,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.05824,-0.15913,-0.11806,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.11235,-0.15976,-0.19639,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.052669,-0.15979,-0.071651,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.00067758,-0.16027,-0.049026,0,0
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.21579,-0.16082,-0.049556,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.05824,-0.16091,-0.21801,0,0
4,GO PROTEIN METHYLATION,0.019283,-0.16261,-0.11422,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.065563,-0.16327,-0.092134,0,0
4,GO CARDIAC VENTRICLE FORMATION,0.076492,-0.16412,-0.40022,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.080955,-0.16429,-0.12669,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.070855,-0.16535,-0.13217,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.010506,-0.1654,-0.14492,0,0
4,GO LUNG ALVEOLUS DEVELOPMENT,0.19095,-0.16553,-0.094257,0,0
4,GO NEURON REMODELING,0.85082,-0.16691,0.010241,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.034637,-0.16726,-0.20242,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.050569,-0.16881,-0.20332,0,0
4,GO GASTRIC ACID SECRETION,0.23589,-0.16948,-0.078835,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.32506,-0.16954,-0.073736,0,0
4,GO INTESTINAL ABSORPTION,0.05161,-0.16999,-0.15892,0,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.10845,-0.17162,-0.11145,0,0
4,GO DORSAL AORTA DEVELOPMENT,0.21579,-0.17178,-0.10345,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.20937,-0.17218,-0.056542,0,0
4,GO MAINTENANCE OF CELL POLARITY,0.01282,-0.17269,-0.15532,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.15015,-0.1736,-0.098323,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.20309,-0.17521,-0.13325,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.001228,-0.17569,-0.18237,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.038561,-0.17729,-0.20001,0,0
4,GO POSITIVE REGULATION OF HEART RATE,0.33812,-0.17763,-0.053961,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.088862,-0.17807,-0.10622,0,0
4,GO TOXIN METABOLIC PROCESS,0.12259,-0.17859,-0.16124,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.063042,-0.17891,-0.15951,0,0
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.027803,-0.179,-0.15265,0,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.055956,-0.17905,-0.098807,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.065563,-0.17906,-0.10127,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.12259,-0.17968,-0.086796,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.76948,-0.1797,-0.031484,0,0
4,GO VASCULAR WOUND HEALING,0.17653,-0.17973,-0.16086,0,0
4,GO MEMBRANE FISSION,0.0046564,-0.17975,-0.2324,0,0
4,GO POLYOL TRANSPORT,0.073629,-0.18007,-0.1426,0,0
4,GO GDP METABOLIC PROCESS,0.037747,-0.18017,-0.23359,0,0
4,GO NEPHRIC DUCT DEVELOPMENT,0.34256,-0.18059,-0.084726,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.4978,-0.18216,0.1119,0,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.030383,-0.18279,-0.12421,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.0075304,-0.18282,-0.1244,0,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.17934,-0.18338,-0.11737,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.052669,-0.18474,-0.090528,0,0
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.16294,-0.18485,-0.18225,0,0
4,GO SPERM AXONEME ASSEMBLY,0.12908,-0.18489,-0.11089,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.064293,-0.18524,-0.1783,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.092194,-0.18535,-0.17915,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.32077,-0.18569,-0.059182,0,0
4,GO CELL AGGREGATION,0.16032,-0.18579,-0.1006,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.18219,-0.18608,-0.075173,0,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.13814,-0.18622,-0.16351,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.034637,-0.18691,-0.18194,0,0
4,GO HISTONE H3 K9 METHYLATION,0.00353,-0.18833,-0.15521,0,0
4,GO HEART FORMATION,0.061812,-0.18863,-0.15104,0,0
4,GO PHAGOLYSOSOME ASSEMBLY,0.10845,-0.18966,-0.14647,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0024367,-0.19214,-0.13063,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.054842,-0.19233,-0.14826,0,0
4,GO RESPONSE TO FORSKOLIN,0.11235,-0.19247,-0.16376,0,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.14048,-0.1934,-0.20057,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0090226,-0.19403,-0.19404,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.02268,-0.19663,-0.24247,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00041602,-0.19737,-0.26418,0,0
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0022332,-0.19916,-0.16526,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.087232,-0.19986,-0.14757,0,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.00047456,-0.20068,-0.17451,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.063042,-0.20111,-0.15321,0,0
4,GO KERATINIZATION,0.14769,-0.20154,-0.076541,0,0
4,GO PROTEIN DEPOLYMERIZATION,0.00027832,-0.20159,-0.2124,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0028141,-0.20208,-0.17352,0,0
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.17653,-0.20328,-0.15377,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.009256,-0.20329,-0.18855,0,0
4,GO PALLIUM DEVELOPMENT,0.00072223,-0.20428,-0.20083,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.090515,-0.21025,-0.232,0,0
4,GO CORNIFICATION,0.23937,-0.21143,-0.051658,0,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0018173,-0.21268,-0.2147,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.015953,-0.2138,-0.19964,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.11636,-0.21549,-0.13527,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0010859,-0.21805,-0.28265,0,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.33812,-0.21958,-0.1972,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0030654,-0.21973,-0.18567,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.12049,-0.22149,-0.10539,0,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.10465,-0.22188,-0.18525,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.0032441,-0.22278,-0.18304,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.11039,-0.22283,-0.17364,0,0
4,GO CARTILAGE MORPHOGENESIS,0.20621,-0.22499,-0.16244,0,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.1313,-0.22749,-0.24518,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.17934,-0.22797,-0.15244,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.12049,-0.23005,-0.16996,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.00025131,-0.2308,-0.24996,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.034637,-0.23129,-0.18982,0,0
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.10845,-0.23265,-0.15688,0,0
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.27611,-0.23486,-0.098964,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.011904,-0.23525,-0.19766,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.0021689,-0.23587,-0.24983,0,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.11434,-0.23662,-0.15046,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00024286,-0.23746,-0.24717,0,0
4,GO RESPONSE TO HYDROXYUREA,0.0056288,-0.23848,-0.21112,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.2839,-0.24395,-0.11455,0,0
4,GO SHORT TERM MEMORY,0.015203,-0.24447,-0.23969,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00069957,-0.24832,-0.21345,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00023468,-0.24868,-0.24913,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00034072,-0.25661,-0.28255,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.031059,-0.25777,-0.18002,0,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.093897,-0.25824,-0.18336,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,2.3418e-05,-0.25832,-0.24584,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.060602,-0.26044,-0.15073,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.00020448,-0.26256,-0.30004,0,0
4,GO INSEMINATION,0.13583,-0.26515,-0.13594,0,0
4,GO HEAT GENERATION,0.053746,-0.26551,-0.17596,0,0
4,GO GLYCINE TRANSPORT,0.072231,-0.26565,-0.16923,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00065623,-0.26954,-0.28059,0,0
4,GO RESPONSE TO LIGHT INTENSITY,0.0011199,-0.27026,-0.25942,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.17099,-0.27306,-0.17658,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.012508,-0.27336,-0.21137,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00044439,-0.27424,-0.22575,0,0
4,GO CELL FATE DETERMINATION,0.0062634,-0.27637,-0.24206,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.31653,-0.27747,-0.12107,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.016734,-0.27864,-0.22767,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.057089,-0.28037,-0.41905,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00040247,-0.28199,-0.30126,0,0
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.066855,-0.28221,-0.23249,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.054842,-0.28697,-0.23211,0,0
4,GO ACROSOME ASSEMBLY,0.00027832,-0.28782,-0.25328,0,0
4,GO CELL JUNCTION MAINTENANCE,0.0040578,-0.28811,-0.26278,0,0
4,GO POSITIVE REGULATION OF CELL MATURATION,0.079444,-0.28871,-0.18902,0,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00050664,-0.29328,-0.35707,0,0
4,GO NOREPINEPHRINE SECRETION,0.00026903,-0.29641,-0.28632,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,1.4609e-05,-0.29805,-0.31081,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.00012512,-0.29979,-0.25334,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.13355,-0.30034,-0.15198,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00014418,-0.30396,-0.3342,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.12473,-0.30416,-0.13712,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.11039,-0.30564,-0.20269,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.12473,-0.30796,-0.17464,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,8.1192e-05,-0.31322,-0.26398,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0022992,-0.31613,-0.2781,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.011904,-0.31657,-0.18976,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00353,-0.31818,-0.30072,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0017123,-0.31859,-0.30819,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.04854,-0.3189,-0.21783,0,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,2.6902e-06,-0.3212,-0.32737,0,0
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.082489,-0.32191,-0.15509,0,0
4,GO IMMATURE B CELL DIFFERENTIATION,0.0081404,-0.32446,-0.20113,0,0
4,GO CELL FATE SPECIFICATION,0.00012074,-0.32505,-0.35332,0,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.001662,-0.33752,-0.24121,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.0094949,-0.34055,-0.24649,0,0
4,GO EPITHELIAL CELL MORPHOGENESIS,0.073629,-0.35007,-0.18916,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.0015653,-0.35115,-0.28398,0,0
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0007696,-0.35315,-0.3076,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,6.7596e-05,-0.35335,-0.39252,0,0
4,GO NEURAL RETINA DEVELOPMENT,5.6174e-05,-0.35603,-0.39614,0,0
4,GO METENCEPHALON DEVELOPMENT,7.5427e-07,-0.35615,-0.3744,0,0
4,GO RESPONSE TO LEUCINE,0.011326,-0.35627,-0.33549,0,0
4,GO LEYDIG CELL DIFFERENTIATION,0.14285,-0.36109,-0.17585,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.8521e-05,-0.36275,-0.43211,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0050528,-0.36372,-0.32176,0,0
4,GO PITUITARY GLAND DEVELOPMENT,2.2524e-05,-0.36823,-0.43749,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.6455e-05,-0.36957,-0.33504,0,0
4,GO PARENTAL BEHAVIOR,0.00090094,-0.37643,-0.3526,0,0
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.9263e-05,-0.3841,-0.44529,0,0
4,GO FAT CELL PROLIFERATION,0.00035231,-0.38476,-0.36049,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00055855,-0.38826,-0.33326,0,0
4,GO HEART FIELD SPECIFICATION,0.04854,-0.40383,-0.23151,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0056288,-0.40953,-0.28659,0,0
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00090094,-0.41307,-0.30816,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00010462,-0.41398,-0.32103,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,1.6729e-06,-0.41481,-0.4277,0,0
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,9.0221e-07,-0.41814,-0.41715,0,0
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00052342,-0.43363,-0.33332,0,0
4,GO CARDIOBLAST PROLIFERATION,0.018398,-0.43478,-0.38682,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.009256,-0.44307,-0.30449,0,0
4,GO GROOMING BEHAVIOR,1.2962e-05,-0.44832,-0.42683,0,0
4,GO SOMATIC STEM CELL DIVISION,0.12908,-0.44943,-0.1843,0,0
4,GO SYNAPSE ASSEMBLY,7.2111e-07,-0.44959,-0.44293,0,0
4,GO LIMB BUD FORMATION,0.061812,-0.46115,-0.26233,0,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00010462,-0.46242,-0.55984,0,0
4,GO MEGAKARYOCYTE DEVELOPMENT,0.00031859,-0.46746,-0.39514,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.00065623,-0.46871,-0.39661,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.0038387,-0.47635,-0.41696,0,0
4,GO CEREBELLAR CORTEX FORMATION,4.3763e-07,-0.48788,-0.52267,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.063042,-0.51574,-0.24549,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.0311e-06,-0.52774,-0.54284,0,0
4,GO RETROGRADE TRANS SYNAPTIC SIGNALING,2.8418e-05,-0.53557,-0.6326,0,0
4,GO REGULATION OF HEAT GENERATION,0.0047853,-0.55323,-0.36926,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,2.6307e-05,-0.57941,-0.47478,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,5.4121e-05,-0.58472,-0.54965,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,1.8521e-05,-0.58637,-0.57317,0,0
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,1.6455e-05,-0.59767,-0.56592,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.0042883,-0.60603,-0.39844,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,2.1831e-07,-0.61244,-0.55571,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,2.7578e-07,-0.62089,-0.5525,0,0
4,GO REGULATION OF SYNAPSE MATURATION,3.1888e-05,-0.62295,-0.61507,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.00037661,-0.64548,-0.53971,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,3.3287e-06,-0.69069,-0.74121,0,0
4,GO THALAMUS DEVELOPMENT,1.5816e-05,-0.72111,-0.58827,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,2.3975e-07,-0.72341,-0.69549,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,2.5308e-05,-0.72507,-0.62334,0,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00063551,-0.73424,-0.52344,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,2.5122e-07,-0.73801,-0.7011,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.0689e-05,-0.74826,-0.67701,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.7118e-05,-0.74999,-0.78632,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,9.3916e-06,-0.76701,-0.68967,0,0
4,GO SEROTONIN SECRETION,3.9926e-07,-0.79114,-0.6722,0,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.9418e-06,-0.79143,-0.71145,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,9.0221e-07,-0.84183,-0.77933,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,2.0829e-07,-0.88784,-0.78535,0,0
4,GO RETINA LAYER FORMATION,2.0033e-05,-0.89975,-0.66826,0,0
4,GO NEURON FATE SPECIFICATION,3.17e-07,-1.0126,-0.9849,0,0
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,1.0779e-06,-1.0573,-0.82442,0,0
4,GO NOSE DEVELOPMENT,1.3441e-06,-1.1182,-0.90361,0,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,3.3202e-07,-1.3533,-1.214,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.001228,1.595,1.1082,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0014738,1.2785,0.87372,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,3.5759e-05,1.1534,1.0164,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0049174,0.86861,0.63146,1,1
5,GO TOLERANCE INDUCTION,9.0551e-05,0.79848,0.65319,1,1
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.0184e-05,0.79225,0.76963,1,1
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,7.013e-05,0.76741,0.67909,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.0198e-07,0.76209,0.72414,1,1
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00026003,0.7586,0.60176,1,1
5,GO CYTIDINE TO URIDINE EDITING,9.7346e-05,0.75695,0.69284,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0045306,0.74103,0.47151,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.1617e-05,0.73465,0.60251,1,1
5,GO HISTAMINE SECRETION,3.8131e-07,0.72337,0.73754,1,1
5,GO INTESTINAL LIPID ABSORPTION,3.7791e-06,0.7002,0.72519,1,1
5,GO LIPID DROPLET FORMATION,4.1112e-06,0.68312,0.66798,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00024286,0.67863,0.67598,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00019753,0.67254,0.58923,1,1
5,GO PROGESTERONE METABOLIC PROCESS,0.00011241,0.66483,0.83595,1,1
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,2.2658e-06,0.66398,0.61389,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0034322,0.65551,0.42978,1,1
5,GO GERMINAL CENTER FORMATION,0.00028792,0.65307,0.48635,1,1
5,GO ACTIN FILAMENT NETWORK FORMATION,0.00045924,0.64318,0.48715,1,1
5,GO GLYCOSIDE METABOLIC PROCESS,0.0050528,0.6351,0.73378,1,1
5,GO LIPID DIGESTION,1.8521e-05,0.63109,0.63657,1,1
5,GO HISTAMINE TRANSPORT,7.5427e-07,0.62544,0.69388,1,1
5,GO T CELL MEDIATED CYTOTOXICITY,0.001986,0.6241,0.40034,1,1
5,GO RESPONSE TO TYPE I INTERFERON,5.6174e-05,0.62117,0.56919,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0060989,0.62052,0.49202,1,1
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00026903,0.61038,0.53316,1,1
5,GO DOPAMINE BIOSYNTHETIC PROCESS,5.6174e-05,0.60329,0.6517,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,8.7323e-05,0.60164,0.46818,1,1
5,GO FRUCTOSE METABOLIC PROCESS,0.00012074,0.601,0.59376,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,2.0833e-05,0.59551,0.55942,1,1
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00010462,0.59431,0.53866,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,5.6174e-05,0.5878,0.44741,1,1
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.8418e-05,0.58705,0.63466,1,1
5,GO KETONE CATABOLIC PROCESS,0.0010859,0.5768,0.44009,1,1
5,GO INTESTINAL ABSORPTION,1.4268e-07,0.56542,0.66905,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.00017796,0.56022,0.47149,1,1
5,GO RENAL ABSORPTION,8.1192e-05,0.55776,0.60535,1,1
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00028792,0.55518,0.51692,1,1
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0010528,0.55424,0.45749,1,1
5,GO MUCUS SECRETION,0.0010206,0.54137,0.56132,1,1
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00013433,0.5404,0.48555,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00014418,0.53496,0.47167,1,1
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.013465,0.53226,0.36655,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0001165,0.53182,0.50749,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,4.8379e-05,0.53059,0.59967,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.5201e-05,0.52584,0.42336,1,1
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00010092,0.52234,0.51027,1,1
5,GO RESPONSE TO NITROSATIVE STRESS,0.00042998,0.52216,0.45078,1,1
5,GO RESPONSE TO INTERLEUKIN 18,0.0030654,0.52105,0.46733,1,1
5,GO SPHINGOMYELIN METABOLIC PROCESS,2.4692e-06,0.51774,0.47307,1,1
5,GO DETECTION OF OTHER ORGANISM,7.2754e-05,0.51251,0.50962,1,1
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00011241,0.51147,0.51198,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0033369,0.5105,0.3203,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0020453,0.50922,0.40564,1,1
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0013054,0.50882,0.39476,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.9841e-06,0.50785,0.51604,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00081984,0.50693,0.44981,1,1
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00012074,0.50689,0.45679,1,1
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.7578e-07,0.50437,0.56719,1,1
5,GO RESPONSE TO IMMOBILIZATION STRESS,6.0504e-05,0.50359,0.39755,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00035231,0.50336,0.38358,1,1
5,GO O GLYCAN PROCESSING,5.9841e-06,0.50276,0.46731,1,1
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,2.7343e-05,0.50249,0.4584,1,1
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0014299,0.50157,0.42259,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.4346e-05,0.50041,0.50008,1,1
5,GO PHAGOLYSOSOME ASSEMBLY,1.3441e-06,0.49854,0.50941,1,1
5,GO ACTIN FILAMENT SEVERING,0.00067758,0.49705,0.42133,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,4.6597e-05,0.49381,0.45899,1,1
5,GO LEYDIG CELL DIFFERENTIATION,0.00081984,0.4922,0.48268,1,1
5,GO RETINAL METABOLIC PROCESS,0.001986,0.49188,0.52796,1,1
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.011612,0.48947,0.51972,1,1
5,GO RESPONSE TO EPINEPHRINE,0.042857,0.48808,0.26761,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.0683e-06,0.48662,0.42751,1,1
5,GO REGULATION OF INTEGRIN ACTIVATION,3.0264e-07,0.48327,0.53978,1,1
5,GO EOSINOPHIL MIGRATION,0.0014299,0.47488,0.36962,1,1
5,GO BARBED END ACTIN FILAMENT CAPPING,0.0010528,0.47485,0.40612,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,0.00030804,0.47484,0.52464,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.6307e-05,0.47188,0.47517,1,1
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00055855,0.47018,0.48307,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,7.013e-05,0.46993,0.46538,1,1
5,GO TOXIN METABOLIC PROCESS,2.1663e-05,0.46698,0.45058,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00049035,0.46398,0.40456,1,1
5,GO RESPONSE TO COLD,7.9801e-06,0.46218,0.41448,1,1
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0056288,0.46153,0.44468,1,1
5,GO RESPONSE TO PAIN,3.1888e-05,0.45858,0.40482,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00030804,0.45851,0.43903,1,1
5,GO SIGNAL PEPTIDE PROCESSING,1.8521e-05,0.45727,0.44363,1,1
5,GO L PHENYLALANINE METABOLIC PROCESS,0.00012512,0.45549,0.61832,1,1
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,9.0551e-05,0.45388,0.4722,1,1
5,GO REGULATION OF NEURON MATURATION,7.547e-05,0.45111,0.3883,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00047456,0.4481,0.39227,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00017796,0.44663,0.45397,1,1
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00017186,0.44564,0.42333,1,1
5,GO GALACTOSE METABOLIC PROCESS,0.00032948,0.44547,0.49353,1,1
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00095906,0.44317,0.36414,1,1
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.0689e-05,0.44309,0.49486,1,1
5,GO REGULATION OF PLATELET AGGREGATION,0.00047456,0.44262,0.38037,1,1
5,GO QUINONE METABOLIC PROCESS,0.00017186,0.44188,0.60099,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0010528,0.43887,0.44065,1,1
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00021909,0.4379,0.38644,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,3.4421e-05,0.43506,0.43057,1,1
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.104e-05,0.43454,0.40746,1,1
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,8.6584e-06,0.43392,0.43303,1,1
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0045306,0.43366,0.43595,1,1
5,GO ZYMOGEN ACTIVATION,0.0011199,0.43288,0.34615,1,1
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,7.547e-05,0.43264,0.43139,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00069957,0.42911,0.36709,1,1
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00019753,0.4289,0.35909,1,1
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.00031859,0.42826,0.41661,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0013457,0.42803,0.40118,1,1
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00063551,0.42742,0.47377,1,1
5,GO STEROID ESTERIFICATION,0.00057693,0.42618,0.44161,1,1
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00092958,0.42492,0.45874,1,1
5,GO RESPONSE TO DIETARY EXCESS,0.00024286,0.42341,0.40412,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00037661,0.42238,0.35749,1,1
5,GO BONE RESORPTION,1.0604e-05,0.41918,0.40198,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.4044e-06,0.41896,0.47625,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00050664,0.41676,0.34899,1,1
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00069957,0.41668,0.32637,1,1
5,GO REGULATION OF PLATELET ACTIVATION,5.6174e-05,0.41524,0.3829,1,1
5,GO CELLULAR DEFENSE RESPONSE,5.7413e-06,0.41362,0.40672,1,1
5,GO NEGATIVE REGULATION OF BONE REMODELING,8.1192e-05,0.41214,0.46545,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,5.4121e-05,0.41074,0.42419,1,1
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00030804,0.41051,0.2772,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0006154,0.40981,0.39689,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.001228,0.40557,0.36528,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00022676,0.40535,0.32619,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,2.4346e-05,0.40424,0.36678,1,1
5,GO RESPONSE TO REDOX STATE,0.00013433,0.40371,0.34136,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0037331,0.40342,0.3067,1,1
5,GO AMINE BIOSYNTHETIC PROCESS,8.628e-07,0.40273,0.41913,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.013139,0.40209,0.3146,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.8612e-06,0.40096,0.42054,1,1
5,GO AMMONIUM ION METABOLIC PROCESS,9.0551e-05,0.39978,0.43684,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.0075304,0.39944,0.36235,1,1
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00042998,0.39914,0.46557,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0031536,0.3968,0.31806,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00022676,0.39488,0.37825,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,0.00057693,0.39478,0.32956,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0032441,0.39441,0.41761,1,1
5,GO B CELL APOPTOTIC PROCESS,4.1617e-05,0.39426,0.37509,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,1.2962e-05,0.39393,0.32402,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0050528,0.39184,0.29555,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,1.9263e-05,0.39175,0.36445,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0011199,0.39108,0.34979,1,1
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0028957,0.39027,0.34664,1,1
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0013054,0.38964,0.33267,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0019282,0.38922,0.40662,1,1
5,GO MUSCLE ATROPHY,0.014486,0.38846,0.25192,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.014486,0.38547,0.24938,1,1
5,GO SECONDARY METABOLIC PROCESS,0.00045924,0.38505,0.37219,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00024286,0.3804,0.37632,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,6.7728e-06,0.37974,0.34782,1,1
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0007696,0.37956,0.32038,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00035231,0.37869,0.28868,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00026003,0.37828,0.40162,1,1
5,GO UBIQUINONE METABOLIC PROCESS,1.2962e-05,0.37784,0.33519,1,1
5,GO CELLULAR RESPONSE TO COPPER ION,0.009256,0.37731,0.4486,1,1
5,GO N GLYCAN PROCESSING,0.0027346,0.37707,0.28529,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00057693,0.37651,0.44756,1,1
5,GO PROTEIN DEMANNOSYLATION,0.00012964,0.37576,0.37107,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00049035,0.3757,0.31813,1,1
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0038387,0.37543,0.34254,1,1
5,GO ACUTE PHASE RESPONSE,0.00050664,0.37529,0.31419,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0025817,0.37376,0.30106,1,1
5,GO SEROTONIN METABOLIC PROCESS,0.00038934,0.37333,0.44811,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00023468,0.37295,0.33619,1,1
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0045306,0.3729,0.35744,1,1
5,GO DEFENSE RESPONSE TO VIRUS,0.00049035,0.37246,0.24669,1,1
5,GO REGULATION OF BONE REMODELING,2.1663e-05,0.37214,0.40465,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00065623,0.37136,0.28481,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00072223,0.3709,0.35599,1,1
5,GO VASODILATION,0.0019282,0.37029,0.34479,1,1
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00067758,0.37023,0.34526,1,1
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00045924,0.36998,0.28181,1,1
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0083534,0.36985,0.41914,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,7.013e-05,0.36856,0.41137,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.00024286,0.36847,0.37118,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0097392,0.368,0.31805,1,1
5,GO DIGESTION,2.2524e-05,0.36779,0.32442,1,1
5,GO POSITIVE REGULATION OF CELL SIZE,3.1888e-05,0.36769,0.39111,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00090094,0.36693,0.35493,1,1
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.2308e-06,0.36681,0.36379,1,1
5,GO METHIONINE METABOLIC PROCESS,1.8521e-05,0.36572,0.34464,1,1
5,GO DIGESTIVE SYSTEM PROCESS,1.4039e-05,0.36568,0.30343,1,1
5,GO LUNG CELL DIFFERENTIATION,0.0031536,0.3648,0.38648,1,1
5,GO VITAMIN D METABOLIC PROCESS,0.00041602,0.36476,0.32099,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.00011241,0.36464,0.43125,1,1
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00041602,0.3645,0.33746,1,1
5,GO PHAGOSOME ACIDIFICATION,3.0264e-07,0.36432,0.40446,1,1
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0018173,0.36391,0.30017,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.00092958,0.36387,0.25644,1,1
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0018173,0.36363,0.37597,1,1
5,GO REGULATION OF ICOSANOID SECRETION,2.3654e-06,0.36362,0.40815,1,1
5,GO CORTICOSTEROID HORMONE SECRETION,0.0097392,0.36263,0.30502,1,1
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.00012512,0.36254,0.40627,1,1
5,GO RESPONSE TO COPPER ION,0.00045924,0.36221,0.4471,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,5.2139e-05,0.36186,0.36155,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.00013917,0.3605,0.35251,1,1
5,GO CYCLOOXYGENASE PATHWAY,0.0030654,0.35993,0.43109,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,0.00014935,0.35971,0.32602,1,1
5,GO RESPONSE TO INTERLEUKIN 2,3.8583e-05,0.35966,0.304,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0028141,0.35902,0.37902,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,5.6174e-05,0.35866,0.3568,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00072223,0.35842,0.35951,1,1
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00095906,0.35821,0.31433,1,1
5,GO RESPONSE TO PEPTIDOGLYCAN,8.1192e-05,0.35799,0.2916,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.010773,0.35755,0.26061,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,4.8379e-05,0.35748,0.34444,1,1
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0039469,0.35686,0.45027,1,1
5,GO ETHER METABOLIC PROCESS,0.00079435,0.35661,0.25756,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0007696,0.35647,0.42804,1,1
5,GO PLASMINOGEN ACTIVATION,0.0066042,0.35479,0.36225,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0045306,0.35421,0.40305,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.014841,0.35301,0.26511,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0073363,0.35295,0.20588,1,1
5,GO T CELL MEDIATED IMMUNITY,0.0031536,0.35209,0.24712,1,1
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00014935,0.35156,0.33417,1,1
5,GO ETHANOL OXIDATION,0.0073363,0.35129,0.4518,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00036427,0.35023,0.25939,1,1
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0010206,0.35001,0.32516,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.0001547,0.34972,0.28019,1,1
5,GO PROSTANOID METABOLIC PROCESS,0.0037331,0.34924,0.3598,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00021909,0.34699,0.26545,1,1
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0012662,0.34606,0.21633,1,1
5,GO LYTIC VACUOLE ORGANIZATION,6.2985e-07,0.3459,0.35296,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0029794,0.34547,0.48018,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00059588,0.34508,0.31461,1,1
5,GO RESPONSE TO LITHIUM ION,6.7596e-05,0.34401,0.44157,1,1
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00084609,0.34301,0.35981,1,1
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0025083,0.34252,0.3106,1,1
5,GO FOAM CELL DIFFERENTIATION,0.00041602,0.34185,0.28263,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00019079,0.34168,0.27563,1,1
5,GO DETERMINATION OF ADULT LIFESPAN,0.00024286,0.34148,0.29761,1,1
5,GO INTRACELLULAR STEROL TRANSPORT,7.2754e-05,0.34116,0.35287,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.00032948,0.34078,0.30163,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.0032441,0.34047,0.42809,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,6.2786e-05,0.33995,0.3421,1,1
5,GO TISSUE REMODELING,0.00012074,0.33875,0.27436,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,3.0689e-05,0.33872,0.32333,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.00023468,0.33843,0.31497,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00025131,0.33837,0.27271,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0047853,0.33821,0.25471,1,1
5,GO STEROL METABOLIC PROCESS,0.00013433,0.33812,0.25991,1,1
5,GO INTEGRIN ACTIVATION,1.1964e-05,0.33812,0.32942,1,1
5,GO INSEMINATION,0.0010528,0.33772,0.32375,1,1
5,GO DIET INDUCED THERMOGENESIS,0.00098941,0.33721,0.26846,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0059384,0.33715,0.27802,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0050528,0.33698,0.32112,1,1
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00025131,0.33669,0.26342,1,1
5,GO RESPONSE TO INTERFERON GAMMA,0.0010528,0.33637,0.28898,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00038934,0.33635,0.29456,1,1
5,GO IMMUNOGLOBULIN SECRETION,0.00079435,0.33585,0.29532,1,1
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,6.2786e-05,0.33568,0.31106,1,1
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0062634,0.33558,0.22531,1,1
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0025083,0.33547,0.21868,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00023468,0.33538,0.31544,1,1
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0010528,0.3352,0.27264,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,6.5149e-05,0.33492,0.26524,1,1
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0087944,0.33439,0.32806,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.0226e-05,0.33416,0.34418,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.3418e-05,0.33401,0.33539,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0017123,0.33369,0.2582,1,1
5,GO RESPONSE TO THYROID HORMONE,0.0036303,0.33354,0.25199,1,1
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.0049174,0.33281,0.29301,1,1
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0050528,0.33239,0.24251,1,1
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.017137,0.33182,0.21152,1,1
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0056288,0.33161,0.26893,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00016595,0.33112,0.30004,1,1
5,GO REGULATION OF TISSUE REMODELING,4.4878e-05,0.33003,0.34407,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0034322,0.32974,0.32185,1,1
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.0041716,0.32937,0.3547,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00017186,0.3282,0.24665,1,1
5,GO LIVER MORPHOGENESIS,0.0045306,0.32806,0.26302,1,1
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0014738,0.32806,0.24463,1,1
5,GO SNARE COMPLEX ASSEMBLY,0.001228,0.32791,0.24923,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.4878e-05,0.32754,0.43116,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.00041602,0.32748,0.27563,1,1
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00040247,0.3268,0.3652,1,1
5,GO KETONE BIOSYNTHETIC PROCESS,0.00095906,0.32632,0.28205,1,1
5,GO VACUOLAR ACIDIFICATION,9.4334e-07,0.32598,0.38137,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,0.0001165,0.32526,0.32325,1,1
5,GO NATURAL KILLER CELL PROLIFERATION,0.0081404,0.32523,0.29142,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0015653,0.32517,0.34156,1,1
5,GO REGULATION OF LIGASE ACTIVITY,0.001872,0.32473,0.22931,1,1
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.0551e-05,0.3242,0.34054,1,1
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00057693,0.324,0.22407,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,2.8418e-05,0.32373,0.31214,1,1
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.009256,0.32364,0.22943,1,1
5,GO REGULATION OF PROSTAGLANDIN SECRETION,8.1192e-05,0.32356,0.35428,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0059384,0.32331,0.25916,1,1
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0025817,0.32253,0.26609,1,1
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0081404,0.32237,0.31962,1,1
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00016023,0.32182,0.33725,1,1
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00045924,0.32144,0.2766,1,1
5,GO STEROID METABOLIC PROCESS,3.7145e-05,0.32077,0.28562,1,1
5,GO EPITHELIAL CELL CELL ADHESION,0.00353,0.32076,0.39401,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,3.1888e-05,0.31964,0.31004,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.014138,0.3196,0.21199,1,1
5,GO PLATELET DEGRANULATION,0.0025817,0.31951,0.21585,1,1
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.0022992,0.31902,0.36161,1,1
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0023671,0.31891,0.30124,1,1
5,GO REGULATION OF FIBRINOLYSIS,0.0016129,0.31856,0.36137,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0006154,0.31829,0.32873,1,1
5,GO VIRAL GENOME REPLICATION,0.0010206,0.31749,0.2135,1,1
5,GO REGULATION OF COAGULATION,0.0020453,0.31742,0.26559,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0097392,0.31738,0.25224,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00042998,0.31634,0.29601,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0031536,0.31629,0.19452,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00095906,0.31607,0.22435,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00049035,0.31549,0.28265,1,1
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012512,0.31542,0.25856,1,1
5,GO PROTEIN DEGLYCOSYLATION,0.00017796,0.31471,0.36127,1,1
5,GO BONE REMODELING,0.00017186,0.31465,0.31798,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00026903,0.31463,0.30291,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0011199,0.31441,0.26403,1,1
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.00353,0.3141,0.20406,1,1
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0083534,0.3139,0.22265,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0010528,0.31388,0.29678,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.021165,0.31328,0.2521,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.00021167,0.31243,0.37474,1,1
5,GO LIPID TRANSLOCATION,0.00010092,0.31241,0.27833,1,1
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00079435,0.31219,0.3257,1,1
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,5.0226e-05,0.31186,0.35138,1,1
5,GO OSTEOBLAST PROLIFERATION,0.0010859,0.31181,0.27671,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.001872,0.31106,0.27125,1,1
5,GO RESPONSE TO CORTICOSTERONE,0.0054795,0.3108,0.2618,1,1
5,GO MITOCHONDRIAL RNA PROCESSING,0.03245,0.31077,0.18466,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.010773,0.31065,0.19376,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00014418,0.31065,0.29524,1,1
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0012662,0.31023,0.26461,1,1
5,GO INNATE IMMUNE RESPONSE,0.00013917,0.30926,0.2254,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00353,0.30873,0.24209,1,1
5,GO CELL KILLING,3.4421e-05,0.3084,0.25053,1,1
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.010245,0.30823,0.25535,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,6.5149e-05,0.30815,0.25637,1,1
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.037747,0.30809,0.19097,1,1
5,GO APICAL JUNCTION ASSEMBLY,2.9532e-05,0.30793,0.35254,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00079435,0.30776,0.28592,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.00054072,0.30743,0.20286,1,1
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00041602,0.30716,0.25465,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0001165,0.30665,0.23209,1,1
5,GO NADP METABOLIC PROCESS,0.0046564,0.30661,0.27088,1,1
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0015653,0.30637,0.31415,1,1
5,GO ICOSANOID METABOLIC PROCESS,6.0504e-05,0.30553,0.33174,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.0020453,0.30543,0.36541,1,1
5,GO PHAGOSOME MATURATION,9.3916e-06,0.30491,0.31638,1,1
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0010528,0.30474,0.24271,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.4878e-05,0.30444,0.26026,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.1663e-05,0.3044,0.32786,1,1
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00084609,0.30423,0.33873,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.015574,0.30417,0.227,1,1
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.0087944,0.30324,0.2926,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.2786e-05,0.30316,0.27202,1,1
5,GO STEROID HORMONE SECRETION,0.01282,0.30312,0.23023,1,1
5,GO IMMUNE EFFECTOR PROCESS,0.00019753,0.3028,0.21876,1,1
5,GO RESPONSE TO MINERALOCORTICOID,0.00042998,0.30248,0.27275,1,1
5,GO MAGNESIUM ION TRANSPORT,0.00038934,0.30229,0.27854,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.010245,0.30194,0.22058,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,9.0551e-05,0.3018,0.22063,1,1
5,GO KERATINIZATION,2.1663e-05,0.30131,0.28563,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.30119,0.26562,1,1
5,GO CORNIFICATION,2.7343e-05,0.30041,0.32396,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,1.7806e-05,0.2996,0.30815,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,8.1192e-05,0.29933,0.27584,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.001191,0.29919,0.23922,1,1
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00081984,0.29821,0.24265,1,1
5,GO REGULATION OF EXOSOMAL SECRETION,0.00018427,0.29816,0.27373,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00017186,0.298,0.37212,1,1
5,GO MAST CELL ACTIVATION,9.7346e-05,0.29759,0.26852,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0060989,0.29704,0.23705,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.8282e-05,0.29679,0.2427,1,1
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00016595,0.29661,0.30331,1,1
5,GO REGULATION OF B CELL PROLIFERATION,4.3218e-05,0.29626,0.29402,1,1
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.00059588,0.29626,0.2636,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0046564,0.29585,0.24639,1,1
5,GO ARACHIDONIC ACID SECRETION,0.00014935,0.29571,0.26792,1,1
5,GO GOLGI TO ENDOSOME TRANSPORT,0.00026903,0.29541,0.2877,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00042998,0.29521,0.27359,1,1
5,GO RESPONSE TO VIRUS,0.00065623,0.29501,0.20697,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.547e-05,0.29489,0.24074,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0028957,0.29443,0.23994,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0027346,0.29426,0.2122,1,1
5,GO SMOOTH MUSCLE CELL MIGRATION,0.016734,0.29423,0.21863,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020448,0.29311,0.22879,1,1
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00017186,0.29306,0.39052,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,6.2786e-05,0.293,0.27206,1,1
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0064317,0.29142,0.26437,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00055855,0.2909,0.28981,1,1
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0014738,0.2909,0.21697,1,1
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00037661,0.29062,0.4777,1,1
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.011047,0.29061,0.27665,1,1
5,GO REGULATION OF RESPIRATORY BURST,8.4205e-05,0.29029,0.34377,1,1
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.001986,0.28972,0.32533,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0024367,0.28967,0.26528,1,1
5,GO HYPOTHALAMUS DEVELOPMENT,0.0014738,0.28963,0.2506,1,1
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00014418,0.28946,0.34636,1,1
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0053338,0.28941,0.22922,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0032441,0.28932,0.2974,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.00026903,0.28903,0.30081,1,1
5,GO REGULATION OF ACROSOME REACTION,0.041093,0.28886,0.2877,1,1
5,GO PURINE NUCLEOTIDE TRANSPORT,1.5201e-05,0.28882,0.25766,1,1
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00090094,0.28852,0.27805,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0037331,0.28657,0.2902,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.5759e-05,0.28616,0.31218,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,8.1192e-05,0.28593,0.28014,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,2.2658e-06,0.28585,0.30316,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,4.4878e-05,0.28581,0.33616,1,1
5,GO EXTRACELLULAR VESICLE BIOGENESIS,8.4205e-05,0.28579,0.24809,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.00059588,0.28556,0.26191,1,1
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0013054,0.28468,0.2015,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.014486,0.28467,0.20068,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00044439,0.2845,0.26346,1,1
5,GO PANCREATIC JUICE SECRETION,0.027188,0.28428,0.17685,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.00017186,0.28416,0.23172,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,8.1192e-05,0.28356,0.28587,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.02843,0.28344,0.1754,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0006154,0.28314,0.23192,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.011047,0.2831,0.29182,1,1
5,GO RESPIRATORY BURST,0.00036427,0.28287,0.26082,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.0025083,0.28271,0.31412,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00035231,0.28236,0.31859,1,1
5,GO OLIGOPEPTIDE TRANSPORT,0.00098941,0.28233,0.36122,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,0.00019079,0.28193,0.27366,1,1
5,GO ADRENAL GLAND DEVELOPMENT,0.00067758,0.28144,0.34788,1,1
5,GO PROSTAGLANDIN TRANSPORT,0.00072223,0.28119,0.32742,1,1
5,GO REGULATION OF CELL KILLING,0.00029782,0.28088,0.27949,1,1
5,GO MAST CELL MEDIATED IMMUNITY,0.00059588,0.28068,0.24409,1,1
5,GO PH REDUCTION,1.349e-05,0.28021,0.25938,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00013433,0.27992,0.22942,1,1
5,GO NUCLEOTIDE SALVAGE,0.022165,0.27959,0.23192,1,1
5,GO POLYOL TRANSPORT,0.0034322,0.27931,0.29303,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,0.00353,0.27903,0.38843,1,1
5,GO TYPE I INTERFERON PRODUCTION,0.00030804,0.279,0.22823,1,1
5,GO STEROL HOMEOSTASIS,0.00092958,0.2788,0.29376,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0045306,0.27804,0.17556,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0032441,0.27776,0.27927,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00030804,0.2773,0.28179,1,1
5,GO LIPID DROPLET ORGANIZATION,5.4121e-05,0.27719,0.28233,1,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.011612,0.27715,0.33825,1,1
5,GO RESPONSE TO ACIDIC PH,0.0067808,0.27704,0.25642,1,1
5,GO HAIR CELL DIFFERENTIATION,0.00021167,0.27699,0.24485,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0036303,0.27679,0.1906,1,1
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,4.1617e-05,0.27672,0.23271,1,1
5,GO STEROL BIOSYNTHETIC PROCESS,0.00028792,0.27651,0.25395,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00025131,0.27624,0.24942,1,1
5,GO RESPONSE TO GROWTH HORMONE,4.6597e-05,0.2762,0.33554,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0013457,0.27588,0.24612,1,1
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00014418,0.27587,0.29703,1,1
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0001165,0.27562,0.26726,1,1
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0020453,0.27525,0.24862,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028141,0.27509,0.28011,1,1
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0094949,0.27499,0.20236,1,1
5,GO ETHANOL METABOLIC PROCESS,0.011612,0.27489,0.23299,1,1
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,5.2139e-05,0.27476,0.24581,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0015653,0.27445,0.19522,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00067758,0.2741,0.2362,1,1
5,GO INTERLEUKIN 8 PRODUCTION,0.00035231,0.27402,0.25211,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.001228,0.27394,0.20717,1,1
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0085714,0.27322,0.29862,1,1
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.00020448,0.27307,0.2906,1,1
5,GO INTERLEUKIN 10 PRODUCTION,0.00014935,0.27291,0.23048,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.015953,0.27288,0.23499,1,1
5,GO RESPONSE TO DEXAMETHASONE,0.0042883,0.27285,0.2128,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0015653,0.27246,0.22745,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0031536,0.2724,0.24466,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00050664,0.27238,0.32273,1,1
5,GO REGULATION OF WOUND HEALING,0.00090094,0.27212,0.25133,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.036164,0.27207,0.23186,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.010506,0.27199,0.23084,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,7.9801e-06,0.271,0.25446,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.018836,0.27092,0.16558,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00092958,0.2706,0.23643,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00017796,0.27017,0.2455,1,1
5,GO ENDOCRINE PROCESS,0.00072223,0.26982,0.24261,1,1
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0028141,0.26971,0.30632,1,1
5,GO DIOL METABOLIC PROCESS,0.00037661,0.26943,0.31667,1,1
5,GO CHEMOKINE PRODUCTION,0.0033369,0.2693,0.18532,1,1
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00047456,0.26917,0.33952,1,1
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.007729,0.26892,0.19188,1,1
5,GO RETINOL METABOLIC PROCESS,0.0022992,0.26806,0.36166,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.02068,0.268,0.36813,1,1
5,GO RESPONSE TO PROGESTERONE,0.0019282,0.26796,0.22251,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.2677,0.18704,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00092958,0.26766,0.27667,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,4.0073e-05,0.26765,0.2486,1,1
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.02268,0.26735,0.17901,1,1
5,GO PHOSPHOLIPID TRANSPORT,0.00010845,0.26702,0.21542,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00020448,0.2664,0.27192,1,1
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.011326,0.26636,0.27508,1,1
5,GO DOPAMINE TRANSPORT,0.0059384,0.26585,0.29574,1,1
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00014418,0.26582,0.21174,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00038934,0.26493,0.22303,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.041967,0.26416,0.22869,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00067758,0.26347,0.31313,1,1
5,GO CATECHOLAMINE UPTAKE,0.010245,0.26334,0.25017,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0090226,0.26317,0.23519,1,1
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00016023,0.26314,0.25681,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0011199,0.26295,0.26971,1,1
5,GO INTERLEUKIN 12 PRODUCTION,1.2454e-05,0.26287,0.28614,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00084609,0.26272,0.23414,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,4.0073e-05,0.26211,0.31186,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.00020448,0.26194,0.22719,1,1
5,GO DEFENSE RESPONSE,0.00016023,0.26191,0.20323,1,1
5,GO GLYCOSYLATION,0.00016023,0.26164,0.24991,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.042857,0.26163,0.15744,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0013872,0.26159,0.17711,1,1
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.1493e-05,0.26154,0.26822,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00014418,0.26145,0.23398,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.00095906,0.26127,0.28217,1,1
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0017641,0.26097,0.30467,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00054072,0.26047,0.21696,1,1
5,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.010773,0.26035,0.21384,1,1
5,GO ADAPTIVE IMMUNE RESPONSE,0.00065623,0.26028,0.22172,1,1
5,GO SECRETION BY TISSUE,0.001228,0.25991,0.22575,1,1
5,GO LIPID LOCALIZATION,5.0226e-05,0.25988,0.24733,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00040247,0.25968,0.21854,1,1
5,GO OXALATE TRANSPORT,0.0023671,0.25907,0.18355,1,1
5,GO FATTY ACID CATABOLIC PROCESS,3.5759e-05,0.25898,0.26439,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0033369,0.25894,0.19761,1,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.027803,0.25865,0.30783,1,1
5,GO LYMPHOCYTE MIGRATION,0.0022332,0.25851,0.17523,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00045924,0.25827,0.24039,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00041602,0.25826,0.29628,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0083534,0.25823,0.25781,1,1
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.019739,0.25802,0.24526,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0022992,0.25794,0.17087,1,1
5,GO VITAMIN TRANSPORT,0.031748,0.25776,0.18818,1,1
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0030654,0.25773,0.20329,1,1
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0049174,0.25772,0.25298,1,1
5,GO RESPONSE TO PROTOZOAN,0.0039469,0.25771,0.18082,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00095906,0.25765,0.19642,1,1
5,GO PLASMA MEMBRANE FUSION,0.0085714,0.25726,0.22916,1,1
5,GO TRANSFERRIN TRANSPORT,2.3654e-06,0.25715,0.33681,1,1
5,GO TRANSCYTOSIS,0.00010092,0.25705,0.28904,1,1
5,GO HORMONE METABOLIC PROCESS,0.0011549,0.25697,0.25233,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,4.2876e-06,0.25673,0.24262,1,1
5,GO WATER HOMEOSTASIS,0.00032948,0.25618,0.25305,1,1
5,GO RESPONSE TO CADMIUM ION,0.0028141,0.25583,0.25395,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,7.2754e-05,0.25525,0.22634,1,1
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00034072,0.25523,0.20584,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00014418,0.25513,0.25464,1,1
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0042883,0.25495,0.2849,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,0.00029782,0.25493,0.18367,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.4878e-05,0.25483,0.24887,1,1
5,GO BONE CELL DEVELOPMENT,0.020205,0.25453,0.16607,1,1
5,GO REGULATION OF FATTY ACID TRANSPORT,2.6307e-05,0.25342,0.37322,1,1
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.03245,0.253,0.22602,1,1
5,GO REGULATION OF B CELL ACTIVATION,0.00013433,0.25295,0.22491,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.013465,0.25255,0.31236,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,0.0001165,0.25242,0.24108,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.001662,0.25239,0.301,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00017186,0.25211,0.21794,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0051916,0.25182,0.28944,1,1
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0010528,0.25125,0.2748,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0025083,0.25122,0.21956,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0062634,0.25094,0.20749,1,1
5,GO NEUTROPHIL MIGRATION,0.00011241,0.25093,0.20653,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0037331,0.25083,0.17706,1,1
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00098941,0.25033,0.19148,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.03245,0.25027,0.26914,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0033369,0.2501,0.21393,1,1
5,GO TRANSPOSITION,0.010506,0.24996,0.2284,1,1
5,GO BILE ACID METABOLIC PROCESS,1.2454e-05,0.2499,0.36335,1,1
5,GO CYTOPLASM ORGANIZATION,0.00065623,0.2494,0.29273,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,5.0226e-05,0.24914,0.24111,1,1
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0064317,0.24897,0.36112,1,1
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0020453,0.24889,0.20419,1,1
5,GO NUCLEOTIDE TRANSPORT,9.0179e-06,0.24847,0.25147,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.8583e-05,0.24831,0.28572,1,1
5,GO DOPAMINE METABOLIC PROCESS,0.0032441,0.24764,0.27093,1,1
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0045306,0.24736,0.17238,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0015189,0.24733,0.19762,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00021167,0.24726,0.21624,1,1
5,GO AMELOGENESIS,0.014486,0.2471,0.21311,1,1
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.001662,0.24706,0.28805,1,1
5,GO SPLEEN DEVELOPMENT,0.00098941,0.24694,0.20995,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00011241,0.24649,0.21768,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0046564,0.24639,0.25771,1,1
5,GO HEXOSE CATABOLIC PROCESS,0.012203,0.24629,0.18672,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00012074,0.24625,0.23907,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00044439,0.24618,0.24263,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0028141,0.24616,0.15451,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0025817,0.24599,0.22301,1,1
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.031748,0.24559,0.2459,1,1
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00059588,0.24553,0.22889,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0006154,0.24503,0.30822,1,1
5,GO B CELL PROLIFERATION,5.8301e-05,0.24475,0.23827,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.001228,0.24451,0.15943,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0067808,0.24415,0.22906,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00098941,0.2441,0.19641,1,1
5,GO REGULATION OF ACTIN NUCLEATION,0.00010845,0.24365,0.29114,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00012074,0.24362,0.21168,1,1
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00095906,0.24353,0.19093,1,1
5,GO GRANULOCYTE MIGRATION,0.00035231,0.24218,0.19574,1,1
5,GO MACROMOLECULE DEPALMITOYLATION,8.4205e-05,0.24216,0.28294,1,1
5,GO INOSITOL METABOLIC PROCESS,8.1192e-05,0.24192,0.28492,1,1
5,GO PROTEIN HYDROXYLATION,0.027188,0.24171,0.18516,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0014299,0.24157,0.19887,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.0053338,0.24101,0.28238,1,1
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0019282,0.24063,0.19096,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.8583e-05,0.24063,0.23035,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.00047456,0.24044,0.24951,1,1
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,5.6174e-05,0.24035,0.22593,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0083534,0.24021,0.17041,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.1617e-05,0.24018,0.23594,1,1
5,GO ZINC ION HOMEOSTASIS,0.01282,0.2401,0.27938,1,1
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00014935,0.24006,0.28179,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00040247,0.23999,0.25019,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.025414,0.23961,0.19399,1,1
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.011047,0.23954,0.17152,1,1
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.4878e-05,0.23909,0.28176,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0064317,0.2388,0.17491,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00030804,0.23878,0.19691,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00029782,0.23868,0.26859,1,1
5,GO T HELPER CELL LINEAGE COMMITMENT,0.0013457,0.23847,0.20395,1,1
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0042883,0.23843,0.22036,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00019753,0.23835,0.2844,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00020448,0.23803,0.23446,1,1
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.014841,0.23797,0.22836,1,1
5,GO STEROID CATABOLIC PROCESS,0.015574,0.23794,0.25614,1,1
5,GO AUTOPHAGY OF NUCLEUS,0.02068,0.23755,0.19229,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0032441,0.2367,0.2125,1,1
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.010506,0.23666,0.20213,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,7.8282e-05,0.23643,0.19665,1,1
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0059384,0.23577,0.19898,1,1
5,GO RESPONSE TO CYTOKINE,0.00052342,0.23564,0.17878,1,1
5,GO ER OVERLOAD RESPONSE,0.0053338,0.23538,0.23825,1,1
5,GO REGULATION OF CELL PROJECTION SIZE,0.014138,0.23503,0.26482,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,6.2786e-05,0.2346,0.22926,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0054795,0.23459,0.17812,1,1
5,GO AMINE METABOLIC PROCESS,5.9841e-06,0.23456,0.27067,1,1
5,GO CELL CHEMOTAXIS,0.00035231,0.23395,0.18494,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0013872,0.23365,0.19946,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.00065623,0.2336,0.19767,1,1
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00040247,0.23356,0.31272,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.8583e-05,0.23268,0.24029,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.024288,0.23237,0.19172,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.23211,0.23726,1,1
5,GO PROTEIN AUTOPROCESSING,0.00095906,0.23172,0.3113,1,1
5,GO MITOCHONDRIAL TRNA PROCESSING,0.031748,0.23165,0.18529,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0013054,0.23116,0.21196,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,6.2786e-05,0.23115,0.23524,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,6.7728e-06,0.23109,0.30506,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0010528,0.23098,0.20005,1,1
5,GO REGULATION OF FERTILIZATION,0.0064317,0.23082,0.26249,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00050664,0.23058,0.22326,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0011199,0.23056,0.19728,1,1
5,GO RESPONSE TO BACTERIUM,0.00063551,0.22978,0.18277,1,1
5,GO B CELL HOMEOSTASIS,0.0013872,0.22922,0.23195,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.025994,0.2287,0.19321,1,1
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.3132e-05,0.22834,0.29643,1,1
5,GO RESPONSE TO ISCHEMIA,0.00050664,0.2282,0.22996,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0015653,0.22814,0.18495,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.00029782,0.22791,0.21903,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.018836,0.22788,0.20651,1,1
5,GO TISSUE HOMEOSTASIS,0.0001547,0.22779,0.19855,1,1
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.018836,0.22768,0.21907,1,1
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00055855,0.22744,0.25557,1,1
5,GO MEMBRANE FUSION,0.001662,0.22715,0.1704,1,1
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00030804,0.2271,0.1839,1,1
5,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0073363,0.22649,0.19137,1,1
5,GO LEUKOCYTE PROLIFERATION,0.00072223,0.22647,0.18518,1,1
5,GO STEROL TRANSPORT,0.00018427,0.22606,0.25475,1,1
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0064317,0.2259,0.18096,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.011047,0.22588,0.23746,1,1
5,GO INTRACELLULAR LIPID TRANSPORT,0.0010859,0.22557,0.22665,1,1
5,GO LIPID STORAGE,0.0028957,0.22532,0.2097,1,1
5,GO RESPONSE TO PH,0.0079323,0.22501,0.16785,1,1
5,GO INFLAMMATORY RESPONSE,0.00044439,0.22501,0.18155,1,1
5,GO LEUKOCYTE MIGRATION,0.00079435,0.22495,0.18563,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0097392,0.22472,0.20437,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0050528,0.22464,0.22782,1,1
5,GO REGULATION OF CELLULAR PH,1.0604e-05,0.22449,0.21942,1,1
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0006154,0.22446,0.20203,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.0013457,0.22445,0.2362,1,1
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0011199,0.2243,0.22958,1,1
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00018427,0.22425,0.28403,1,1
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0099891,0.22423,0.20755,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00024286,0.22377,0.24808,1,1
5,GO INSULIN SECRETION,0.00065623,0.2234,0.1778,1,1
5,GO INTERLEUKIN 1 PRODUCTION,0.0033369,0.22339,0.18604,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0046564,0.22337,0.26138,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00059588,0.22317,0.19741,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.00012512,0.22264,0.18804,1,1
5,GO RESPONSE TO CAFFEINE,0.013465,0.22238,0.19745,1,1
5,GO DENDRITIC CELL MIGRATION,0.045624,0.22226,0.12522,1,1
5,GO CELLULAR RESPONSE TO STARVATION,3.0689e-05,0.22215,0.22478,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0011549,0.2218,0.1944,1,1
5,GO CELLULAR KETONE METABOLIC PROCESS,0.0006154,0.22177,0.21417,1,1
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0045306,0.22124,0.19663,1,1
5,GO CYTOKINE PRODUCTION,0.00059588,0.221,0.18224,1,1
5,GO PIRNA METABOLIC PROCESS,0.0025083,0.22081,0.27728,1,1
5,GO REGULATION OF NUCLEASE ACTIVITY,0.0018173,0.22077,0.187,1,1
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.010245,0.2206,0.15086,1,1
5,GO INTERLEUKIN 6 PRODUCTION,0.00024286,0.22038,0.20823,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0025083,0.2203,0.21662,1,1
5,GO REGULATION OF GLUCONEOGENESIS,2.3418e-05,0.21997,0.2692,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,7.9801e-06,0.21996,0.24413,1,1
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.016734,0.21993,0.14011,1,1
5,GO VESICLE BUDDING FROM MEMBRANE,0.011326,0.21992,0.163,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0024367,0.21983,0.2288,1,1
5,GO INTERFERON ALPHA PRODUCTION,0.00041602,0.21978,0.2205,1,1
5,GO SKIN DEVELOPMENT,0.00065623,0.21965,0.17429,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0013054,0.21919,0.1983,1,1
5,GO REGULATION OF PH,2.4346e-05,0.21885,0.21161,1,1
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.7346e-05,0.21876,0.22664,1,1
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00084609,0.21827,0.30421,1,1
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00353,0.21799,0.21346,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.0047853,0.21795,0.17863,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.027188,0.21767,0.15092,1,1
5,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.017549,0.21764,0.22708,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.014486,0.21762,0.14241,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,2.2524e-05,0.21719,0.22685,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.00026903,0.21701,0.20577,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0085714,0.217,0.16699,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00023468,0.2168,0.19128,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00353,0.21637,0.16787,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0025083,0.21635,0.239,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.016734,0.21634,0.18681,1,1
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00012512,0.21627,0.21217,1,1
5,GO MYOBLAST FUSION,0.010245,0.21617,0.1859,1,1
5,GO DIOL BIOSYNTHETIC PROCESS,0.0016129,0.21614,0.3262,1,1
5,GO REGULATION OF ACTION POTENTIAL,0.029068,0.21524,0.16222,1,1
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0014299,0.21524,0.18217,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.8583e-05,0.21512,0.19224,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0015653,0.21504,0.16892,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0017123,0.2148,0.17141,1,1
5,GO EPIDERMIS DEVELOPMENT,0.00049035,0.21447,0.18021,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0099891,0.21434,0.16059,1,1
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.047551,0.21426,0.095456,1,1
5,GO POSITIVE CHEMOTAXIS,0.011612,0.21394,0.14272,1,1
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0013457,0.21382,0.17187,1,1
5,GO RESPONSE TO NUTRIENT,0.031059,0.21369,0.12431,1,1
5,GO RENAL SYSTEM PROCESS,0.0057817,0.21364,0.16174,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00072223,0.21355,0.206,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,0.0042883,0.21351,0.19742,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.014841,0.21314,0.15226,1,1
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0097392,0.21297,0.20229,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.029068,0.21274,0.16029,1,1
5,GO MUSCLE HYPERTROPHY,0.0028141,0.21248,0.15483,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00098941,0.21226,0.24961,1,1
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0032441,0.21215,0.24502,1,1
5,GO HETEROTYPIC CELL CELL ADHESION,0.022165,0.2121,0.16159,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.0087944,0.2118,0.17685,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00098941,0.21174,0.18914,1,1
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0025817,0.21173,0.17681,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,0.0069616,0.21123,0.17394,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0023671,0.21064,0.16572,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0081404,0.21063,0.23015,1,1
5,GO T CELL MIGRATION,0.036164,0.21061,0.14731,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.019739,0.21051,0.1657,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00042998,0.21041,0.18562,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.001191,0.21027,0.14728,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0013457,0.21023,0.21478,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00081984,0.21015,0.21664,1,1
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0067808,0.2099,0.19937,1,1
5,GO SODIUM ION HOMEOSTASIS,0.011904,0.20987,0.15365,1,1
5,GO MANGANESE ION TRANSPORT,0.00055855,0.20972,0.22699,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0040578,0.20958,0.20814,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.013465,0.20917,0.21625,1,1
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.017969,0.20841,0.20662,1,1
5,GO PROSTAGLANDIN SECRETION,0.0051916,0.2082,0.23687,1,1
5,GO ENERGY HOMEOSTASIS,0.011904,0.20812,0.18023,1,1
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,7.8282e-05,0.20807,0.23706,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0025817,0.20789,0.17376,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,0.0014738,0.20768,0.21792,1,1
5,GO LIPID OXIDATION,0.0015189,0.20755,0.18368,1,1
5,GO WOUND HEALING,0.013139,0.20755,0.12551,1,1
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.0029794,0.20678,0.26057,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0087944,0.20673,0.13314,1,1
5,GO ALANINE TRANSPORT,0.02843,0.20669,0.23264,1,1
5,GO PIGMENTATION,0.0014738,0.20668,0.14268,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.00010845,0.20664,0.23767,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,0.00037661,0.20656,0.19339,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.045624,0.20639,0.12033,1,1
5,GO CYTOKINE SECRETION,0.00031859,0.20609,0.20188,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00036427,0.20586,0.19106,1,1
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.013465,0.20564,0.18664,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,3.8583e-05,0.20535,0.25272,1,1
5,GO CERAMIDE METABOLIC PROCESS,0.00022676,0.20504,0.22156,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.00052342,0.20502,0.19451,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.2139e-05,0.2044,0.20599,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.033166,0.20415,0.11885,1,1
5,GO EXOCYTOSIS,0.00050664,0.20403,0.17241,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.043763,0.20384,0.12934,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,4.6597e-05,0.20381,0.2247,1,1
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.021165,0.20362,0.1503,1,1
5,GO REGULATION OF PEPTIDE SECRETION,5.6174e-05,0.20307,0.18571,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.0023671,0.20276,0.19335,1,1
5,GO XENOBIOTIC TRANSPORT,0.0021062,0.20258,0.28098,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.029719,0.20258,0.20444,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.0013054,0.20203,0.17763,1,1
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.010506,0.20191,0.18162,1,1
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0022332,0.20179,0.16384,1,1
5,GO LEUKOCYTE CHEMOTAXIS,0.00069957,0.2017,0.17664,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0047853,0.20133,0.13265,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.0085714,0.20098,0.17376,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0023671,0.20086,0.15139,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0017641,0.20063,0.17318,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0013054,0.20061,0.17139,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.027803,0.20061,0.14432,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.02166,0.20058,0.16463,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00010462,0.20052,0.23285,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0040578,0.20045,0.2191,1,1
5,GO PLATELET MORPHOGENESIS,0.0069616,0.2003,0.17895,1,1
5,GO GPI ANCHOR METABOLIC PROCESS,0.0018173,0.20009,0.21422,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.0016129,0.19955,0.15103,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0081404,0.19923,0.1615,1,1
5,GO FLUID TRANSPORT,0.001662,0.1989,0.18216,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,0.015203,0.19889,0.16152,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.013798,0.19877,0.13898,1,1
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.025414,0.19871,0.2558,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.0024367,0.19855,0.15137,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.020205,0.19848,0.21323,1,1
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0010859,0.19841,0.16906,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,8.1192e-05,0.19839,0.24006,1,1
5,GO ANDROGEN METABOLIC PROCESS,0.0020453,0.19835,0.34705,1,1
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0023671,0.19813,0.15343,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00059588,0.19809,0.16742,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0046564,0.19775,0.20029,1,1
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.010245,0.19752,0.16138,1,1
5,GO CELL ACTIVATION,0.0007696,0.19749,0.16178,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00012964,0.19706,0.22934,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.0069616,0.19698,0.15337,1,1
5,GO ENDOCYTIC RECYCLING,0.0054795,0.19645,0.13056,1,1
5,GO MONOCYTE CHEMOTAXIS,0.029719,0.19628,0.14171,1,1
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.017137,0.1959,0.19561,1,1
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0056288,0.19581,0.14386,1,1
5,GO T CELL DIFFERENTIATION,0.0006154,0.19552,0.14542,1,1
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.013139,0.19547,0.14052,1,1
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.023205,0.19543,0.14855,1,1
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.043763,0.19533,0.19829,1,1
5,GO ALPHA BETA T CELL ACTIVATION,0.00038934,0.1952,0.19967,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00090094,0.19511,0.22925,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.041093,0.19501,0.17895,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0090226,0.19491,0.15299,1,1
5,GO CELLULAR RESPONSE TO ALKALOID,0.00047456,0.1948,0.20134,1,1
5,GO REGULATION OF DEFENSE RESPONSE,0.00023468,0.19476,0.18269,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00079435,0.19473,0.18704,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.0049174,0.19466,0.20802,1,1
5,GO RESPONSE TO CHEMOKINE,0.00055855,0.19381,0.17008,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.013139,0.19368,0.13512,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.00074557,0.19303,0.23461,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0018173,0.1929,0.17494,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.001872,0.19276,0.15239,1,1
5,GO ADAPTIVE THERMOGENESIS,4.0073e-05,0.19274,0.19495,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0046564,0.19265,0.15308,1,1
5,GO MANNOSYLATION,9.389e-05,0.19248,0.237,1,1
5,GO B CELL ACTIVATION,0.00023468,0.19246,0.17771,1,1
5,GO PROTEIN N LINKED GLYCOSYLATION,0.00037661,0.19227,0.22955,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.029068,0.19224,0.22076,1,1
5,GO B CELL DIFFERENTIATION,0.00016023,0.19222,0.18799,1,1
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.041967,0.19208,0.12225,1,1
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00010462,0.19204,0.21478,1,1
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.0010206,0.19201,0.15824,1,1
5,GO REGULATION OF TUBE SIZE,0.010506,0.19152,0.14446,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.001228,0.19148,0.16561,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00055855,0.19148,0.17753,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.021165,0.19136,0.17225,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0021062,0.19135,0.15958,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.004408,0.19128,0.13195,1,1
5,GO FATTY ACID TRANSPORT,0.00029782,0.19122,0.21129,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.19117,0.20296,1,1
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.046579,0.19048,0.11241,1,1
5,GO RESPONSE TO ALCOHOL,0.0040578,0.19008,0.1309,1,1
5,GO PEPTIDE SECRETION,0.00021167,0.18936,0.17735,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.00065623,0.18933,0.20526,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00041602,0.18924,0.19521,1,1
5,GO RESPONSE TO DSRNA,0.0015189,0.18921,0.15628,1,1
5,GO PEPTIDE HORMONE SECRETION,0.0006154,0.18902,0.17128,1,1
5,GO PROTEIN KINASE B SIGNALING,0.021165,0.18885,0.10458,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0046564,0.18789,0.12942,1,1
5,GO GOLGI VESICLE BUDDING,0.00055855,0.18785,0.19255,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.00059588,0.18766,0.16247,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00067758,0.18756,0.18688,1,1
5,GO RESPONSE TO FATTY ACID,0.0051916,0.18725,0.18384,1,1
5,GO VITAMIN METABOLIC PROCESS,0.010506,0.18715,0.1901,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.017969,0.18694,0.15402,1,1
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,6.0504e-05,0.18693,0.21754,1,1
5,GO MEMBRANE DEPOLARIZATION,0.041093,0.18687,0.13738,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0025083,0.18686,0.13589,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00027832,0.1866,0.17389,1,1
5,GO GLUTAMATE METABOLIC PROCESS,0.0071468,0.1865,0.16551,1,1
5,GO CARBOHYDRATE TRANSPORT,2.9532e-05,0.18637,0.2338,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0015653,0.18636,0.20073,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0046564,0.18603,0.16685,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0042883,0.186,0.17605,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,0.00042998,0.18595,0.17079,1,1
5,GO HUMORAL IMMUNE RESPONSE,0.00016595,0.18547,0.19416,1,1
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.027188,0.18546,0.10646,1,1
5,GO RESPONSE TO TUMOR CELL,0.012508,0.18509,0.24446,1,1
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00055855,0.18505,0.25845,1,1
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0050528,0.18503,0.22842,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00095906,0.18464,0.14599,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,9.389e-05,0.18436,0.15782,1,1
5,GO REGULATION OF HORMONE LEVELS,0.00030804,0.18423,0.1962,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.0022332,0.18398,0.14508,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.016734,0.18393,0.13882,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,3.3132e-05,0.18382,0.2438,1,1
5,GO REGULATION OF INSULIN SECRETION,0.0013457,0.18372,0.15971,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.0017123,0.18338,0.15163,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0066042,0.183,0.14519,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.036948,0.18294,0.16187,1,1
5,GO PLATELET ACTIVATION,0.0028141,0.18276,0.15408,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.023741,0.18272,0.12438,1,1
5,GO SUPEROXIDE METABOLIC PROCESS,0.0028141,0.18252,0.19897,1,1
5,GO OXIDATION REDUCTION PROCESS,0.00052342,0.18239,0.18113,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00029782,0.18234,0.1721,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.00050664,0.1823,0.15238,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00079435,0.18225,0.15974,1,1
5,GO SEQUESTERING OF CALCIUM ION,0.0069616,0.18212,0.14141,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.0025083,0.1821,0.16805,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0054795,0.18207,0.17494,1,1
5,GO PROTON TRANSMEMBRANE TRANSPORT,1.0604e-05,0.18201,0.21909,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0040578,0.18135,0.1207,1,1
5,GO RESPONSE TO WOUNDING,0.029719,0.18134,0.10248,1,1
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.031059,0.18127,0.1254,1,1
5,GO REGULATION OF CELL CELL ADHESION,0.0020453,0.18111,0.16323,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00020448,0.18069,0.17096,1,1
5,GO T CELL ACTIVATION,0.0013457,0.18052,0.15344,1,1
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.0083534,0.18034,0.17202,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.00012512,0.18001,0.1836,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,0.0045306,0.17991,0.15615,1,1
5,GO IRON ION TRANSPORT,0.00016023,0.17984,0.22826,1,1
5,GO REGULATION OF CELL ACTIVATION,0.0067808,0.17976,0.12326,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00063551,0.17973,0.17906,1,1
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0090226,0.17926,0.19996,1,1
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.018836,0.17891,0.11009,1,1
5,GO VACUOLE ORGANIZATION,2.0833e-05,0.17877,0.21386,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0025083,0.1785,0.1941,1,1
5,GO MUSCLE ADAPTATION,0.0075304,0.17813,0.12896,1,1
5,GO RESPONSE TO KETONE,0.0047853,0.17806,0.14423,1,1
5,GO HORMONE TRANSPORT,0.00067758,0.17802,0.17457,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0010206,0.17785,0.14467,1,1
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.02843,0.1778,0.1781,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.00045924,0.1777,0.17335,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.0011549,0.1777,0.14964,1,1
5,GO VESICLE TARGETING,0.0071468,0.17762,0.17558,1,1
5,GO RESPONSE TO METAL ION,0.00012512,0.17748,0.1923,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.02068,0.17741,0.2731,1,1
5,GO PROTEIN REFOLDING,0.0081404,0.17737,0.20564,1,1
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0010206,0.1769,0.20251,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.00045924,0.17685,0.20732,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0012662,0.17684,0.15209,1,1
5,GO ACTIN NUCLEATION,0.00018427,0.17668,0.18363,1,1
5,GO CHOLESTEROL STORAGE,0.023205,0.17658,0.17158,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0010859,0.17649,0.30123,1,1
5,GO T CELL LINEAGE COMMITMENT,0.0015653,0.17639,0.16855,1,1
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.001228,0.17635,0.1806,1,1
5,GO CELLULAR PIGMENTATION,0.0010206,0.17593,0.17422,1,1
5,GO LIPID METABOLIC PROCESS,0.00063551,0.17583,0.1703,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.0029794,0.17574,0.14191,1,1
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0034322,0.17561,0.2096,1,1
5,GO VASCULAR WOUND HEALING,0.037747,0.17554,0.26176,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.020205,0.17533,0.13686,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.017137,0.17523,0.14556,1,1
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.00024286,0.17502,0.22283,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.042857,0.17485,0.13788,1,1
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00098941,0.17468,0.15197,1,1
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.013139,0.17446,0.17864,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0020453,0.17446,0.16643,1,1
5,GO LYMPHOCYTE ACTIVATION,0.0037331,0.17441,0.12344,1,1
5,GO LIPID HOMEOSTASIS,0.0036303,0.17434,0.20163,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0010859,0.17424,0.15013,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.0011549,0.17421,0.15782,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.014841,0.17385,0.13494,1,1
5,GO TRANSITION METAL ION HOMEOSTASIS,0.0087944,0.17374,0.13977,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0059384,0.17372,0.12269,1,1
5,GO ORGANIC ANION TRANSPORT,0.00035231,0.17355,0.17745,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.022165,0.17348,0.11786,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,0.0016129,0.17346,0.12083,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,9.7346e-05,0.17334,0.19616,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0006154,0.17316,0.19033,1,1
5,GO PANCREAS DEVELOPMENT,0.031059,0.17308,0.14136,1,1
5,GO T CELL HOMEOSTASIS,0.011612,0.173,0.13676,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.8282e-05,0.17293,0.174,1,1
5,GO RESPONSE TO GONADOTROPIN,0.0069616,0.17287,0.19012,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.7343e-05,0.17264,0.19056,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00092958,0.17256,0.13877,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.035393,0.17249,0.16572,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.001662,0.17248,0.17149,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0007696,0.17245,0.15462,1,1
5,GO ISOPRENOID METABOLIC PROCESS,0.014138,0.17218,0.17746,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0011549,0.17216,0.16207,1,1
5,GO RESPONSE TO STARVATION,7.013e-05,0.17201,0.20796,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0050528,0.17188,0.12845,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,0.0031536,0.17169,0.1257,1,1
5,GO RESPONSE TO ETHER,0.0042883,0.17168,0.17156,1,1
5,GO POLYOL BIOSYNTHETIC PROCESS,0.0014738,0.17159,0.20643,1,1
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00038934,0.17099,0.17491,1,1
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.02268,0.17087,0.16965,1,1
5,GO REGULATION OF HORMONE SECRETION,0.00092958,0.17049,0.1645,1,1
5,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0060989,0.17048,0.37114,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.03245,0.17046,0.094167,1,1
5,GO METAL ION HOMEOSTASIS,0.0025083,0.17028,0.11768,1,1
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.021165,0.17012,0.13241,1,1
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0010859,0.17,0.20553,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0030654,0.16985,0.15968,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.024846,0.16932,0.21878,1,1
5,GO RESPONSE TO FUNGUS,0.00052342,0.16914,0.16709,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.015953,0.16913,0.1812,1,1
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.019283,0.16825,0.16261,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.047551,0.16822,0.1331,1,1
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0064317,0.16801,0.16302,1,1
5,GO ORGANELLE FUSION,0.0036303,0.16774,0.14043,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00098941,0.16772,0.18635,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0064317,0.16753,0.14146,1,1
5,GO REGULATION OF BONE DEVELOPMENT,0.040234,0.16751,0.12357,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0083534,0.16749,0.12124,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0028957,0.16732,0.12509,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0025083,0.16684,0.16511,1,1
5,GO REGULATION OF LIPID STORAGE,0.012203,0.1666,0.15364,1,1
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.017549,0.16644,0.13224,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,0.0015189,0.16619,0.15652,1,1
5,GO PEROXISOME ORGANIZATION,0.00095906,0.16595,0.1872,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,0.015574,0.16559,0.11582,1,1
5,GO REGULATION OF ANION TRANSPORT,0.0028141,0.16548,0.20503,1,1
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0029794,0.16548,0.21365,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00010845,0.16508,0.20645,1,1
5,GO FATTY ACID BETA OXIDATION,0.0040578,0.16475,0.18441,1,1
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00047456,0.16468,0.16361,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0062634,0.16452,0.1089,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0049174,0.1645,0.18042,1,1
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.02268,0.16418,0.21689,1,1
5,GO LEUKOCYTE DIFFERENTIATION,0.00098941,0.16396,0.13833,1,1
5,GO COPII COATED VESICLE BUDDING,0.00098941,0.16374,0.18146,1,1
5,GO PROTEIN MATURATION,0.00049035,0.16372,0.18017,1,1
5,GO T CELL PROLIFERATION,0.0017123,0.16368,0.17664,1,1
5,GO PROTEIN PROCESSING,0.00020448,0.16338,0.22712,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0010206,0.1633,0.15214,1,1
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0050528,0.16327,0.19613,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.034637,0.16238,0.1149,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0054795,0.1623,0.1292,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0015189,0.16209,0.14029,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.01282,0.16178,0.13099,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,7.3528e-06,0.16131,0.19479,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.0022992,0.16105,0.13282,1,1
5,GO LIPID CATABOLIC PROCESS,0.00011241,0.16072,0.20844,1,1
5,GO REGULATION OF HEMOPOIESIS,0.0016129,0.16063,0.12366,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0024367,0.16041,0.14254,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0021062,0.16025,0.14959,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0073363,0.1598,0.15526,1,1
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.034637,0.15954,0.094751,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.02068,0.15946,0.16672,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0026572,0.15933,0.15704,1,1
5,GO TEMPERATURE HOMEOSTASIS,0.00063551,0.15927,0.1562,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00074557,0.15927,0.12876,1,1
5,GO ION HOMEOSTASIS,0.0025817,0.15913,0.12237,1,1
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0010206,0.15895,0.1594,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0037331,0.15866,0.11294,1,1
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.045624,0.1586,0.15163,1,1
5,GO GLUCOSE METABOLIC PROCESS,5.4121e-05,0.15841,0.21158,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0062634,0.15814,0.16473,1,1
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0006154,0.15808,0.19125,1,1
5,GO RETINA HOMEOSTASIS,0.013465,0.15804,0.086411,1,1
5,GO PEROXISOMAL TRANSPORT,0.0010859,0.1578,0.19567,1,1
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0014299,0.15757,0.19373,1,1
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.014138,0.15731,0.13913,1,1
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.023741,0.15722,0.13037,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0051916,0.15688,0.14793,1,1
5,GO RESPONSE TO STEROL,0.019283,0.15683,0.16427,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0006154,0.15638,0.17574,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,6.5149e-05,0.15634,0.1849,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.00017796,0.15629,0.15386,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0031536,0.15628,0.15427,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012203,0.15628,0.11642,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.001872,0.15603,0.14535,1,1
5,GO GLOMERULUS DEVELOPMENT,0.011047,0.15573,0.17121,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,5.2139e-05,0.15567,0.2189,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.010773,0.15566,0.1252,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,0.035393,0.15559,0.10463,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0038387,0.15553,0.14946,1,1
5,GO DEFENSE RESPONSE TO FUNGUS,0.0024367,0.1552,0.15377,1,1
5,GO SECRETION,0.0011199,0.1552,0.14562,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0022992,0.15473,0.15692,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0030654,0.15465,0.1285,1,1
5,GO OOCYTE DIFFERENTIATION,0.0039469,0.15421,0.13059,1,1
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.031059,0.15419,0.12799,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,0.001872,0.15356,0.16019,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0087944,0.15335,0.13735,1,1
5,GO LIPID EXPORT FROM CELL,0.017549,0.15325,0.22148,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.042857,0.15316,0.15622,1,1
5,GO RESPONSE TO LIPID,0.013139,0.1531,0.10695,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0015189,0.15309,0.2163,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00353,0.15272,0.12875,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0032441,0.15251,0.15237,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,0.00057693,0.1525,0.17123,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.007729,0.15246,0.23876,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,0.00087311,0.15212,0.11392,1,1
5,GO REGULATION OF PROTEOLYSIS,0.0030654,0.15178,0.12789,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,0.011612,0.15133,0.12534,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,0.0014299,0.15129,0.15735,1,1
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0049174,0.15094,0.16553,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.012203,0.15039,0.14093,1,1
5,GO ORGANIC ACID CATABOLIC PROCESS,0.0023671,0.15028,0.17941,1,1
5,GO AGING,0.00353,0.15011,0.11297,1,1
5,GO ENDOSOME ORGANIZATION,0.0015189,0.14987,0.16091,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.03939,0.14963,0.098944,1,1
5,GO KILLING OF CELLS OF OTHER ORGANISM,8.7323e-05,0.14959,0.19819,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.017137,0.14945,0.12436,1,1
5,GO TERPENOID METABOLIC PROCESS,0.036164,0.14937,0.15135,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.02843,0.14919,0.099202,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0051916,0.14888,0.13929,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,0.012203,0.14872,0.14195,1,1
5,GO ANION TRANSPORT,0.00055855,0.14867,0.15739,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.018398,0.14855,0.16449,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0010206,0.14847,0.16428,1,1
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0066042,0.14839,0.16224,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.017549,0.14822,0.1404,1,1
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.0087944,0.14791,0.1112,1,1
5,GO REGULATION OF CELL ADHESION,0.011904,0.14791,0.12435,1,1
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.029719,0.14709,0.21293,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,0.001228,0.14701,0.15675,1,1
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.035393,0.14694,0.23029,1,1
5,GO REGULATION OF LIPID TRANSPORT,0.001662,0.14636,0.2108,1,1
5,GO RUFFLE ORGANIZATION,0.011047,0.14629,0.16156,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0060989,0.14613,0.12185,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.02166,0.14598,0.11251,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,0.0015189,0.14598,0.16463,1,1
5,GO EPITHELIUM DEVELOPMENT,0.00353,0.14597,0.10948,1,1
5,GO CHEMICAL HOMEOSTASIS,0.00065623,0.14585,0.14127,1,1
5,GO FC RECEPTOR SIGNALING PATHWAY,0.0027346,0.14571,0.12392,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.01282,0.14537,0.21217,1,1
5,GO BICARBONATE TRANSPORT,0.036948,0.14484,0.11017,1,1
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.027803,0.14384,0.11958,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0051916,0.1438,0.14415,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0083534,0.14369,0.13494,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.02268,0.14359,0.21309,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.027188,0.14343,0.17987,1,1
5,GO RESPONSE TO DRUG,0.015953,0.14342,0.11739,1,1
5,GO ALCOHOL CATABOLIC PROCESS,0.0033369,0.14341,0.16321,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.0053338,0.14341,0.1537,1,1
5,GO CHLORIDE TRANSPORT,0.0064317,0.14306,0.12034,1,1
5,GO REGULATION OF APPETITE,0.037747,0.14274,0.10477,1,1
5,GO ORGANIC ACID TRANSPORT,0.0010859,0.14266,0.17627,1,1
5,GO GLUCOSE IMPORT,0.012203,0.14231,0.14501,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.031059,0.14187,0.20066,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0042883,0.1417,0.14483,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.001662,0.14165,0.12292,1,1
5,GO MYOTUBE DIFFERENTIATION,0.0087944,0.14153,0.11972,1,1
5,GO CELL CELL ADHESION,0.026586,0.14152,0.10623,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00081984,0.14149,0.14657,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00028792,0.14125,0.15712,1,1
5,GO POSITIVE REGULATION OF SECRETION,0.00032948,0.14092,0.16704,1,1
5,GO REGULATION OF GLUCOSE IMPORT,0.0099891,0.14085,0.14415,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0062634,0.14082,0.13051,1,1
5,GO MACROPHAGE ACTIVATION,0.0046564,0.14042,0.13833,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.021165,0.13993,0.090873,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0041716,0.13984,0.12225,1,1
5,GO RESPONSE TO HORMONE,0.0097392,0.13961,0.11007,1,1
5,GO RESPONSE TO CALCIUM ION,0.0042883,0.13945,0.16354,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.010506,0.13929,0.13828,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0025083,0.13891,0.12064,1,1
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0081404,0.13886,0.16764,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0075304,0.13818,0.16378,1,1
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0056288,0.13817,0.16063,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0040578,0.13772,0.14685,1,1
5,GO REGULATION OF CELL MATURATION,0.02843,0.13751,0.12766,1,1
5,GO LYSOSOME LOCALIZATION,0.0056288,0.13734,0.13469,1,1
5,GO RESPONSE TO STEROID HORMONE,0.01282,0.13727,0.11867,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00037661,0.13643,0.1456,1,1
5,GO PROTEIN MANNOSYLATION,0.02166,0.13642,0.14684,1,1
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0051916,0.13632,0.17425,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0069616,0.13625,0.11594,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0038387,0.13573,0.11213,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.0062634,0.13563,0.10523,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.012508,0.13544,0.099211,1,1
5,GO VESICLE ORGANIZATION,0.0049174,0.13508,0.14123,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.023205,0.13472,0.1089,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.0039469,0.13458,0.11098,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00074557,0.13435,0.15021,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.00025131,0.13427,0.12333,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.038561,0.13386,0.12799,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.025414,0.13354,0.22498,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.03939,0.13345,0.13241,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.013139,0.13292,0.12861,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0073363,0.13288,0.14095,1,1
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.009256,0.13285,0.1547,1,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0041716,0.13283,0.17298,1,1
5,GO ORGANELLE DISASSEMBLY,0.0022992,0.13216,0.14329,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030804,0.1319,0.15407,1,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0057817,0.13187,0.20485,1,1
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.015574,0.13183,0.096047,1,1
5,GO CELL MATURATION,0.0067808,0.13174,0.10707,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00047456,0.13163,0.15005,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0013457,0.13153,0.15684,1,1
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.004408,0.13131,0.12035,1,1
5,GO REGULATION OF T CELL ACTIVATION,0.0047853,0.13116,0.13419,1,1
5,GO NOTCH SIGNALING PATHWAY,0.0024367,0.13085,0.1498,1,1
5,GO SPERM CAPACITATION,0.0075304,0.13052,0.19378,1,1
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.024846,0.1302,0.09784,1,1
5,GO T CELL SELECTION,0.0029794,0.13011,0.12654,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.031059,0.13,0.10313,1,1
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.007729,0.12949,0.11775,1,1
5,GO DETECTION OF STIMULUS,0.00044439,0.12943,0.11189,1,1
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.0010859,0.12907,0.17645,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.001986,0.12904,0.1535,1,1
5,GO RESPONSE TO ANTIBIOTIC,0.026586,0.12845,0.10922,1,1
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0029794,0.12834,0.17856,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0041716,0.12751,0.10841,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,0.024846,0.12742,0.12377,1,1
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0064317,0.12728,0.13325,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.041093,0.12703,0.14879,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00353,0.12683,0.13161,1,1
5,GO ENDOCRINE HORMONE SECRETION,0.02843,0.12666,0.11493,1,1
5,GO GOLGI ORGANIZATION,0.00029782,0.12648,0.15547,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.035393,0.12625,0.26063,1,1
5,GO RESPONSE TO SALT,0.027188,0.12624,0.11463,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.038561,0.12525,0.092534,1,1
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.011326,0.12494,0.12343,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.010773,0.12491,0.12364,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.017969,0.12442,0.13,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.031748,0.12431,0.12671,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0090226,0.12427,0.14075,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.017137,0.12427,0.10569,1,1
5,GO REGULATION OF CHEMOTAXIS,0.034637,0.12418,0.08489,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0081404,0.12395,0.11293,1,1
5,GO ORGANIC ACID METABOLIC PROCESS,0.0030654,0.1239,0.15497,1,1
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.043763,0.12383,0.14731,1,1
5,GO INORGANIC ANION TRANSPORT,0.0040578,0.12351,0.12003,1,1
5,GO PROTEOLYSIS,0.0006154,0.1234,0.12484,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,0.00034072,0.12338,0.12816,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.00055855,0.12326,0.14275,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0010859,0.12317,0.11643,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.029068,0.12301,0.091045,1,1
5,GO CARNITINE SHUTTLE,0.027803,0.1229,0.1727,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0006154,0.12213,0.14559,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.017549,0.122,0.12812,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,0.029068,0.12197,0.10204,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.038561,0.12195,0.088431,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0013054,0.12176,0.151,1,1
5,GO TISSUE MIGRATION,0.043763,0.12168,0.10444,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0017123,0.12166,0.11586,1,1
5,GO GLAND DEVELOPMENT,0.0067808,0.12154,0.10051,1,1
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.014486,0.12096,0.096356,1,1
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0026572,0.12083,0.10144,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.00034072,0.12063,0.20355,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.014138,0.12043,0.11484,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,0.011612,0.12006,0.099414,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0054795,0.11988,0.10818,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.041093,0.11949,0.092124,1,1
5,GO ACTIVATION OF GTPASE ACTIVITY,0.0066042,0.11927,0.098682,1,1
5,GO REGULATION OF CELL DEATH,0.014486,0.11905,0.083207,1,1
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.014486,0.11893,0.12607,1,1
5,GO AUTOPHAGY OF MITOCHONDRION,0.011904,0.11863,0.1419,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.029068,0.11837,0.089178,1,1
5,GO HOMEOSTATIC PROCESS,0.00069957,0.11836,0.11617,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028141,0.1183,0.11803,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0036303,0.11824,0.11887,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.015953,0.11737,0.089085,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.015574,0.11729,0.14621,1,1
5,GO ACID SECRETION,0.043763,0.11727,0.10267,1,1
5,GO REGULATION OF TOR SIGNALING,0.00079435,0.1169,0.11259,1,1
5,GO TOR SIGNALING,0.00017186,0.11657,0.1027,1,1
5,GO PIGMENT GRANULE LOCALIZATION,0.011904,0.11653,0.13549,1,1
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.026586,0.11645,0.13682,1,1
5,GO RESPONSE TO INSULIN,0.0014738,0.11637,0.14527,1,1
5,GO REGULATION OF SECRETION,0.0027346,0.11612,0.12459,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.024288,0.11599,0.1386,1,1
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.0038387,0.11597,0.11928,1,1
5,GO PROTEIN DESTABILIZATION,0.0031536,0.11572,0.13854,1,1
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0013054,0.11567,0.15131,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0049174,0.11548,0.13873,1,1
5,GO CIRCULATORY SYSTEM PROCESS,0.011326,0.11543,0.10121,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.012203,0.11504,0.10729,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.0034322,0.11449,0.13789,1,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.043763,0.11428,0.18742,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.007729,0.11396,0.13514,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0099891,0.11327,0.11742,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.0057817,0.11264,0.104,1,1
5,GO APOPTOTIC PROCESS,0.009256,0.11227,0.087336,1,1
5,GO DNA CATABOLIC PROCESS,0.0013457,0.11206,0.11895,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0037331,0.11159,0.11216,1,1
5,GO MULTICELLULAR ORGANISM AGING,0.0073363,0.11083,0.11939,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,0.011612,0.11066,0.080677,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.01282,0.11053,0.099778,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.025994,0.11049,0.11733,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.010773,0.11019,0.10737,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.024846,0.10963,0.10072,1,1
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0013054,0.10927,0.14069,1,1
5,GO LIPID MODIFICATION,0.007729,0.1092,0.12482,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0056288,0.10896,0.16603,1,1
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.027188,0.10872,0.06607,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.0062634,0.1086,0.10884,1,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0099891,0.10803,0.13959,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,0.02268,0.10741,0.10597,1,1
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.02268,0.10726,0.098575,1,1
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.018398,0.10723,0.12137,1,1
5,GO REGULATION OF PROTEIN BINDING,0.045624,0.10695,0.089897,1,1
5,GO ELECTRON TRANSPORT CHAIN,0.0049174,0.10666,0.18681,1,1
5,GO SOMITOGENESIS,0.0083534,0.10662,0.11581,1,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.025994,0.10659,0.076665,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.016339,0.1063,0.087591,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.009256,0.10567,0.097975,1,1
5,GO COPULATION,0.044685,0.10553,0.14981,1,1
5,GO RESPONSE TO PEPTIDE,0.015953,0.1055,0.09001,1,1
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.017549,0.10525,0.12662,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0026572,0.10517,0.13835,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0012662,0.10476,0.11107,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0026572,0.10445,0.11162,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0079323,0.10435,0.10268,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.0032441,0.10361,0.11942,1,1
5,GO RESPONSE TO INTERLEUKIN 4,0.029719,0.10346,0.10948,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.027803,0.10264,0.091698,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.036948,0.10258,0.074682,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.026586,0.10254,0.093188,1,1
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0097392,0.10214,0.13757,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.012508,0.1018,0.091728,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,0.018398,0.10106,0.091516,1,1
5,GO BIOMINERALIZATION,0.038561,0.10063,0.10094,1,1
5,GO POSITIVE REGULATION OF SIGNALING,0.0079323,0.10057,0.089231,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.02068,0.10028,0.10505,1,1
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.029068,0.10015,0.10875,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0071468,0.099483,0.10894,1,1
5,GO REGULATION OF MAPK CASCADE,0.041093,0.099178,0.087104,1,1
5,GO ION TRANSPORT,0.0033369,0.099175,0.12184,1,1
5,GO CELLULAR HOMEOSTASIS,0.011047,0.098054,0.096008,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.016734,0.098044,0.0857,1,1
5,GO CALCIUM MEDIATED SIGNALING,0.011047,0.097807,0.076248,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.030383,0.097399,0.09324,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.040234,0.097285,0.075554,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.012203,0.096242,0.098265,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.027188,0.096205,0.074728,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.027803,0.095282,0.075004,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.022165,0.094645,0.08995,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.026586,0.093963,0.089689,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.026586,0.093785,0.11694,1,1
5,GO CYTOSOLIC TRANSPORT,0.0053338,0.093246,0.09342,1,1
5,GO THIOESTER METABOLIC PROCESS,0.0083534,0.092179,0.15416,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.031748,0.091296,0.083947,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.021165,0.091116,0.073563,1,1
5,GO BLASTOCYST DEVELOPMENT,0.0039469,0.090379,0.099227,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.014841,0.090048,0.085673,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.015574,0.089968,0.082417,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.045624,0.089935,0.11153,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.034637,0.089694,0.07346,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.033166,0.089531,0.14521,1,1
5,GO MITOCHONDRIAL TRANSPORT,0.01282,0.089046,0.079461,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.009256,0.089029,0.089044,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.024846,0.088533,0.083444,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0053338,0.087897,0.10118,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.02843,0.087258,0.08894,1,1
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.033166,0.086627,0.153,1,1
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0051916,0.085158,0.10601,1,1
5,GO CATION TRANSPORT,0.017549,0.084517,0.096406,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.03939,0.083621,0.10373,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.027803,0.08291,0.16147,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.010245,0.082358,0.15993,1,1
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.042857,0.082147,0.12879,1,1
5,GO SENSORY PERCEPTION,0.029068,0.079775,0.062783,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.015953,0.079585,0.08823,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.0099891,0.077557,0.091261,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.027803,0.077348,0.07539,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.046579,0.076584,0.064806,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.025414,0.076461,0.075029,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.037747,0.072115,0.081091,1,1
5,GO MYELOID CELL DEVELOPMENT,0.02268,0.06812,0.1015,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.033894,0.065166,0.10125,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.034637,0.056118,0.067794,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.037747,0.055313,0.064386,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.018398,0.053464,0.065435,1,1
5,GO INTRACELLULAR TRANSPORT,0.023741,0.053311,0.057337,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.02268,0.051353,0.087305,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.019739,0.048722,0.064724,1,1
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.02843,0.81089,0.48964,1,0
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00038934,0.68964,0.61277,1,0
5,GO RESPONSE TO INTERFERON BETA,0.0032441,0.59599,0.3825,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00031859,0.5861,0.44447,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00032948,0.53253,0.46026,1,0
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0032441,0.52372,0.39109,1,0
5,GO GLYCOLIPID CATABOLIC PROCESS,0.00095906,0.51763,0.4719,1,0
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00041602,0.50777,0.42163,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00353,0.48778,0.33103,1,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0010206,0.43959,0.3637,1,0
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00079435,0.43284,0.34972,1,0
5,GO GAP JUNCTION ASSEMBLY,0.0041716,0.43228,0.32555,1,0
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.0023671,0.43046,0.4327,1,0
5,GO EOSINOPHIL CHEMOTAXIS,0.0011549,0.41604,0.37969,1,0
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0011199,0.41463,0.32556,1,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.024288,0.40904,0.29508,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.001872,0.40538,0.35197,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.020205,0.4053,0.33773,1,0
5,GO REGULATION OF ANOIKIS,0.00069957,0.39621,0.36338,1,0
5,GO REFLEX,0.0014299,0.3814,0.36728,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0026572,0.38139,0.32098,1,0
5,GO RESPONSE TO INTERFERON ALPHA,0.014841,0.37464,0.26644,1,0
5,GO T CELL EXTRAVASATION,0.022165,0.37424,0.39388,1,0
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0010528,0.37095,0.38249,1,0
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0059384,0.36576,0.23301,1,0
5,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.016734,0.36513,0.30125,1,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00072223,0.35958,0.26894,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.001662,0.35635,0.30433,1,0
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0007696,0.35632,0.291,1,0
5,GO TYPE B PANCREATIC CELL PROLIFERATION,0.025414,0.35454,0.27732,1,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.036164,0.35386,0.21609,1,0
5,GO REGULATION OF MYOBLAST FUSION,0.00069957,0.35276,0.32337,1,0
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0071468,0.35168,0.35445,1,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0019282,0.34278,0.25211,1,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0045306,0.33992,0.26635,1,0
5,GO ANOIKIS,0.00012512,0.33982,0.30076,1,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0014299,0.33864,0.24817,1,0
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.014486,0.3357,0.32291,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.011612,0.33372,0.19974,1,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0042883,0.32905,0.25984,1,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,8.1192e-05,0.32464,0.28002,1,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0011199,0.32238,0.29863,1,0
5,GO ENTRY INTO HOST,0.0024367,0.32066,0.22058,1,0
5,GO B CELL MEDIATED IMMUNITY,0.00069957,0.31966,0.22814,1,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0022992,0.31693,0.19695,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0045306,0.3161,0.2103,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0057817,0.31602,0.2004,1,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0090226,0.31475,0.27029,1,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.016339,0.31404,0.26164,1,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.015574,0.3128,0.31383,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.01282,0.31241,0.20803,1,0
5,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.011904,0.31044,0.33104,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0010859,0.31002,0.2823,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.011904,0.30968,0.28899,1,0
5,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.001872,0.30828,0.2846,1,0
5,GO BLOOD VESSEL REMODELING,0.0013457,0.30548,0.23622,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.001986,0.30489,0.23401,1,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.017969,0.30428,0.30241,1,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0079323,0.30161,0.19337,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00069957,0.2987,0.20992,1,0
5,GO REGULATION OF VIRAL LIFE CYCLE,0.0006154,0.29868,0.25086,1,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.027803,0.29817,0.22569,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00059588,0.29628,0.2461,1,0
5,GO REGULATION OF TRANSPOSITION,0.020205,0.29572,0.22744,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.001662,0.29518,0.185,1,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0045306,0.29501,0.30333,1,0
5,GO MOVEMENT IN HOST ENVIRONMENT,0.0019282,0.294,0.20535,1,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0039469,0.29372,0.3076,1,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00040247,0.2924,0.21413,1,0
5,GO MEMBRANE RAFT ORGANIZATION,0.018836,0.29057,0.22535,1,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.0032441,0.28994,0.21021,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,0.015203,0.2899,0.25409,1,0
5,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0066042,0.28756,0.31337,1,0
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.001986,0.28704,0.28557,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.0024367,0.2867,0.21838,1,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0041716,0.2858,0.22259,1,0
5,GO THYMOCYTE APOPTOTIC PROCESS,0.013139,0.28349,0.21633,1,0
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0059384,0.28325,0.19012,1,0
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00098941,0.27897,0.36818,1,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00087311,0.27824,0.17934,1,0
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.011612,0.27749,0.23799,1,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.012508,0.27626,0.25212,1,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0041716,0.27381,0.24683,1,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0014738,0.27263,0.28172,1,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,0.013798,0.27178,0.25537,1,0
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0075304,0.27153,0.27753,1,0
5,GO CYTOKINE METABOLIC PROCESS,0.0014738,0.26685,0.16858,1,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0020453,0.26665,0.28407,1,0
5,GO RESPONSE TO WATER,0.024846,0.26608,0.22474,1,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0071468,0.26568,0.25023,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0036303,0.26456,0.17494,1,0
5,GO RESPONSE TO MAGNESIUM ION,0.0014299,0.26441,0.3649,1,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0085714,0.26389,0.17031,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00081984,0.26215,0.20677,1,0
5,GO ZYMOGEN INHIBITION,0.0042883,0.26144,0.22283,1,0
5,GO VASCULAR TRANSPORT,0.016339,0.26004,0.26822,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.011612,0.25911,0.16947,1,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.012203,0.25809,0.25024,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.027188,0.25808,0.16186,1,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.011047,0.2557,0.22446,1,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.031059,0.25507,0.24164,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.02268,0.25292,0.20487,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0060989,0.25261,0.24346,1,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.019739,0.25241,0.29887,1,0
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.024846,0.25115,0.29019,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.031748,0.24974,0.14319,1,0
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.014841,0.24943,0.25818,1,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0054795,0.24842,0.2258,1,0
5,GO RELAXATION OF CARDIAC MUSCLE,0.014138,0.24777,0.23621,1,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.02166,0.24737,0.30694,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0079323,0.24491,0.21267,1,0
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.033894,0.24358,0.25758,1,0
5,GO DETECTION OF BIOTIC STIMULUS,0.011326,0.24229,0.23001,1,0
5,GO DETECTION OF CALCIUM ION,0.015203,0.24213,0.28586,1,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.024288,0.23975,0.15586,1,0
5,GO PROGRAMMED NECROTIC CELL DEATH,0.00054072,0.23876,0.26264,1,0
5,GO REGULATION OF VASCULOGENESIS,0.029068,0.23854,0.19685,1,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0013457,0.23852,0.29573,1,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.015203,0.2369,0.12881,1,0
5,GO MICROVILLUS ORGANIZATION,0.0037331,0.23678,0.30163,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.011612,0.23661,0.21508,1,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.040234,0.23657,0.17692,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0062634,0.23583,0.16937,1,0
5,GO CELLULAR RESPONSE TO DSRNA,0.0081404,0.23578,0.17546,1,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00036427,0.23451,0.207,1,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.031748,0.2328,0.25847,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0047853,0.23205,0.1708,1,0
5,GO ORGANELLE MEMBRANE FUSION,0.0032441,0.23041,0.17088,1,0
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00031859,0.23037,0.22095,1,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.010245,0.22805,0.23095,1,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0012662,0.22767,0.26735,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.014138,0.22635,0.19019,1,0
5,GO HYALURONAN METABOLIC PROCESS,0.0023671,0.22585,0.15941,1,0
5,GO AMYLOID FIBRIL FORMATION,0.026586,0.2255,0.18177,1,0
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.00013433,0.22474,0.30588,1,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.037747,0.2234,0.12139,1,0
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.02843,0.22173,0.30969,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.031059,0.22162,0.17431,1,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0025817,0.22136,0.25306,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0042883,0.22108,0.185,1,0
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0049174,0.22042,0.25355,1,0
5,GO CD40 SIGNALING PATHWAY,0.0049174,0.22024,0.16372,1,0
5,GO TRNA 5 LEADER REMOVAL,0.0060989,0.2201,0.17911,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.029068,0.21935,0.21991,1,0
5,GO LUNG EPITHELIUM DEVELOPMENT,0.018836,0.21783,0.22232,1,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00067758,0.21591,0.23272,1,0
5,GO REGULATION OF ISOTYPE SWITCHING,0.013465,0.21546,0.11279,1,0
5,GO COAGULATION,0.0071468,0.21492,0.13693,1,0
5,GO RESPONSE TO MUSCLE STRETCH,0.0060989,0.2149,0.29419,1,0
5,GO AMYLOID BETA CLEARANCE,0.0056288,0.21441,0.18111,1,0
5,GO PROTEIN TARGETING TO LYSOSOME,0.029719,0.21416,0.1986,1,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.017137,0.2137,0.20495,1,0
5,GO INTERACTION WITH HOST,0.0025817,0.21316,0.1645,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0056288,0.21257,0.15989,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.040234,0.21208,0.11106,1,0
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.031059,0.21161,0.13296,1,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0064317,0.21146,0.16474,1,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0083534,0.21044,0.18764,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.024846,0.20935,0.20778,1,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.016339,0.20851,0.14148,1,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00079435,0.20843,0.2528,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.044685,0.20824,0.23478,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.001872,0.20823,0.24142,1,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.027803,0.2074,0.25442,1,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.02068,0.20615,0.1352,1,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0032441,0.20325,0.18518,1,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0064317,0.20322,0.1338,1,0
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.010773,0.20242,0.19691,1,0
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.017969,0.20092,0.16505,1,0
5,GO DNA DEAMINATION,0.015953,0.19978,0.25449,1,0
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.010773,0.19975,0.14625,1,0
5,GO RESPONSE TO INTERLEUKIN 1,0.00090094,0.19974,0.16149,1,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.023205,0.19857,0.24616,1,0
5,GO CELLULAR RESPONSE TO VIRUS,0.0017123,0.19793,0.18326,1,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0037331,0.19761,0.17532,1,0
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028957,0.19701,0.18326,1,0
5,GO CELL REDOX HOMEOSTASIS,0.0030654,0.19553,0.21778,1,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.035393,0.19508,0.16932,1,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.022165,0.1948,0.16167,1,0
5,GO RESPONSE TO INTERLEUKIN 15,0.031748,0.19468,0.20984,1,0
5,GO NECROTIC CELL DEATH,0.0007696,0.19418,0.24287,1,0
5,GO NEURONAL ACTION POTENTIAL,0.0083534,0.19396,0.30782,1,0
5,GO SYNCYTIUM FORMATION,0.015574,0.1933,0.1359,1,0
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0041716,0.19202,0.13272,1,0
5,GO NATURAL KILLER CELL ACTIVATION,0.0016129,0.1917,0.15952,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00081984,0.1909,0.17934,1,0
5,GO PLATELET AGGREGATION,0.014841,0.19067,0.14246,1,0
5,GO LYMPHOCYTE CHEMOTAXIS,0.031748,0.19021,0.091726,1,0
5,GO SPHINGOID METABOLIC PROCESS,0.0050528,0.1889,0.23788,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.036948,0.18791,0.11857,1,0
5,GO AUTOPHAGOSOME MATURATION,0.0029794,0.1875,0.19114,1,0
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.036164,0.18707,0.16238,1,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00049035,0.18609,0.18636,1,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.016339,0.18579,0.13838,1,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.027188,0.18397,0.1449,1,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.017969,0.18392,0.15448,1,0
5,GO REGULATION OF SYMBIOTIC PROCESS,0.0013457,0.18374,0.1779,1,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0054795,0.18335,0.20553,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0042883,0.18256,0.24929,1,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.02268,0.18156,0.17358,1,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.021165,0.18147,0.16955,1,0
5,GO LAMELLIPODIUM MORPHOGENESIS,0.037747,0.18144,0.18745,1,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.007729,0.18116,0.14608,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0087944,0.18094,0.27291,1,0
5,GO VIRION ASSEMBLY,0.0015653,0.1799,0.14326,1,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0020453,0.17932,0.17177,1,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.040234,0.17918,0.24446,1,0
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.02843,0.1788,0.16986,1,0
5,GO VIRAL LIFE CYCLE,0.0021062,0.17845,0.14968,1,0
5,GO BASIC AMINO ACID TRANSPORT,0.025414,0.17819,0.28795,1,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.018398,0.1778,0.17803,1,0
5,GO BROWN FAT CELL DIFFERENTIATION,0.0057817,0.17769,0.18379,1,0
5,GO NIK NF KAPPAB SIGNALING,0.0033369,0.17749,0.13581,1,0
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.024288,0.17734,0.16486,1,0
5,GO KERATINOCYTE PROLIFERATION,0.03245,0.1773,0.1235,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0062634,0.17727,0.12835,1,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0067808,0.17664,0.17801,1,0
5,GO HEPATOCYTE DIFFERENTIATION,0.017969,0.17645,0.21153,1,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00042998,0.17573,0.19835,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0059384,0.17439,0.17361,1,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.023741,0.17413,0.24752,1,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0018173,0.17387,0.18938,1,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0042883,0.1718,0.14347,1,0
5,GO SELECTIVE AUTOPHAGY,0.00074557,0.17151,0.19323,1,0
5,GO RESPONSE TO ANGIOTENSIN,0.026586,0.17139,0.1819,1,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0097392,0.17105,0.15469,1,0
5,GO IMMUNOGLOBULIN PRODUCTION,0.0011199,0.17093,0.13874,1,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.035393,0.16929,0.14703,1,0
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00353,0.16919,0.17161,1,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.027188,0.16911,0.13122,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.047551,0.16856,0.10089,1,0
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.0046564,0.16695,0.19109,1,0
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.01282,0.16681,0.12772,1,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0046564,0.16597,0.25371,1,0
5,GO ANIMAL ORGAN REGENERATION,0.009256,0.16579,0.13789,1,0
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.042857,0.16471,0.10785,1,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0067808,0.16444,0.1983,1,0
5,GO AMINO SUGAR CATABOLIC PROCESS,0.00049035,0.16305,0.30809,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.016339,0.16276,0.17632,1,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0099891,0.16117,0.13574,1,0
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0027346,0.16056,0.16413,1,0
5,GO INTERFERON BETA PRODUCTION,0.015953,0.1591,0.13869,1,0
5,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.017969,0.15899,0.29436,1,0
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.031748,0.15761,0.11105,1,0
5,GO SULFUR COMPOUND TRANSPORT,0.0013872,0.15702,0.186,1,0
5,GO COPPER ION TRANSPORT,0.036948,0.15645,0.16124,1,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.016339,0.15615,0.19185,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.012203,0.15574,0.14318,1,0
5,GO SYMBIOTIC PROCESS,0.0051916,0.15557,0.10542,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.022165,0.15537,0.1558,1,0
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.022165,0.15515,0.18775,1,0
5,GO PHAGOCYTOSIS,0.017137,0.15495,0.11567,1,0
5,GO RIG I SIGNALING PATHWAY,0.023741,0.15429,0.11646,1,0
5,GO REGULATION OF HEART RATE,0.037747,0.15391,0.13765,1,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.011612,0.1538,0.14702,1,0
5,GO REGULATION OF MITOPHAGY,0.036164,0.15345,0.11822,1,0
5,GO MIDBODY ABSCISSION,0.0015653,0.15344,0.23015,1,0
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.043763,0.15263,0.13493,1,0
5,GO REGULATION OF LIPID LOCALIZATION,0.0031536,0.15207,0.18353,1,0
5,GO VIRAL RNA GENOME REPLICATION,0.034637,0.15184,0.089925,1,0
5,GO T CELL APOPTOTIC PROCESS,0.031059,0.15121,0.13912,1,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00098941,0.15064,0.23869,1,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.033166,0.15054,0.23439,1,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.0041716,0.15031,0.13146,1,0
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.025414,0.14948,0.099151,1,0
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.009256,0.14822,0.17853,1,0
5,GO VIRAL RELEASE FROM HOST CELL,0.0033369,0.14725,0.16483,1,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0042883,0.14694,0.20142,1,0
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.025994,0.14677,0.16195,1,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0045306,0.14667,0.16775,1,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0021689,0.14602,0.13856,1,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,0.017137,0.14578,0.18025,1,0
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.011612,0.14572,0.14234,1,0
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.045624,0.14482,0.11552,1,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0045306,0.14416,0.24046,1,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.016734,0.14393,0.14176,1,0
5,GO PEPTIDE CATABOLIC PROCESS,0.040234,0.14385,0.17354,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.014138,0.14378,0.13057,1,0
5,GO CELL CELL RECOGNITION,0.0081404,0.14375,0.15344,1,0
5,GO ACTIN FILAMENT BASED TRANSPORT,0.025414,0.14296,0.19541,1,0
5,GO ER NUCLEUS SIGNALING PATHWAY,0.007729,0.14286,0.22422,1,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.030383,0.14174,0.17452,1,0
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0047853,0.14145,0.15384,1,0
5,GO REGULATION OF STEROL TRANSPORT,0.015203,0.14094,0.14651,1,0
5,GO MITOPHAGY,0.011047,0.14069,0.14439,1,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.010506,0.14014,0.17582,1,0
5,GO REPLICATIVE SENESCENCE,0.031059,0.13981,0.18886,1,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0066042,0.13931,0.17376,1,0
5,GO GOLGI RIBBON FORMATION,0.016734,0.13862,0.15527,1,0
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.014841,0.13841,0.20629,1,0
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.041093,0.13758,0.11999,1,0
5,GO EATING BEHAVIOR,0.0090226,0.13756,0.15227,1,0
5,GO ERAD PATHWAY,0.011326,0.13733,0.1269,1,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.03939,0.13731,0.1871,1,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.023741,0.13642,0.096275,1,0
5,GO CHOLESTEROL EFFLUX,0.024846,0.13527,0.15178,1,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.019739,0.13524,0.10684,1,0
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0026572,0.13391,0.1903,1,0
5,GO NCRNA CATABOLIC PROCESS,0.023741,0.13308,0.11627,1,0
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.02268,0.13291,0.11221,1,0
5,GO CELLULAR RESPIRATION,0.019283,0.13199,0.13899,1,0
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00353,0.13048,0.16366,1,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0053338,0.13041,0.15744,1,0
5,GO POSITIVE REGULATION OF MITOPHAGY,0.019739,0.12694,0.17655,1,0
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.029068,0.12625,0.21771,1,0
5,GO REGULATION OF MACROPHAGE MIGRATION,0.026586,0.12552,0.11477,1,0
5,GO TETRAPYRROLE METABOLIC PROCESS,0.033166,0.12545,0.18974,1,0
5,GO RESPONSE TO ALKALOID,0.037747,0.12484,0.099889,1,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0033369,0.12458,0.16059,1,0
5,GO REGULATION OF DENDRITE EXTENSION,0.023205,0.12452,0.2779,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.0037331,0.12425,0.1447,1,0
5,GO REGULATION OF VASOCONSTRICTION,0.025414,0.12394,0.13362,1,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.041967,0.12336,0.11825,1,0
5,GO OXIDATIVE PHOSPHORYLATION,0.027803,0.12298,0.14099,1,0
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.031748,0.12279,0.13196,1,0
5,GO RESPONSE TO OXYGEN RADICAL,0.001986,0.12233,0.18634,1,0
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.013139,0.12213,0.14364,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.024846,0.12147,0.14927,1,0
5,GO PROTEASOME ASSEMBLY,0.03939,0.12095,0.13358,1,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.044685,0.12002,0.24645,1,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.045624,0.11957,0.12112,1,0
5,GO MAINTENANCE OF LOCATION,0.024288,0.11925,0.089269,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,0.015953,0.11741,0.088729,1,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0099891,0.11728,0.2269,1,0
5,GO ORGANELLE INHERITANCE,0.010245,0.11621,0.12316,1,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.027188,0.11572,0.19986,1,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.015953,0.11536,0.11568,1,0
5,GO CYTOKINETIC PROCESS,0.033166,0.11501,0.10292,1,0
5,GO VIRAL BUDDING,0.0028957,0.11466,0.15079,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.038561,0.11464,0.12943,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0057817,0.11435,0.10141,1,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0071468,0.11388,0.15092,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.046579,0.11358,0.15689,1,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0036303,0.11357,0.19336,1,0
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.014841,0.11338,0.21892,1,0
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.033166,0.11286,0.094322,1,0
5,GO DE NOVO PROTEIN FOLDING,0.0099891,0.11283,0.14772,1,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.017137,0.11114,0.17077,1,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.022165,0.11114,0.13208,1,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.03245,0.1095,0.15649,1,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.024288,0.10948,0.1077,1,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.041093,0.1091,0.13682,1,0
5,GO RESPONSE TO MISFOLDED PROTEIN,0.033894,0.10714,0.14086,1,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.036948,0.1067,0.078832,1,0
5,GO AMINE CATABOLIC PROCESS,0.043763,0.10464,0.22914,1,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.011904,0.10414,0.16213,1,0
5,GO TRANSLESION SYNTHESIS,0.02268,0.10386,0.085167,1,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.010773,0.10372,0.13031,1,0
5,GO ATP METABOLIC PROCESS,0.036164,0.10359,0.09282,1,0
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.10167,0.095165,1,0
5,GO ERYTHROCYTE HOMEOSTASIS,0.011904,0.10121,0.10456,1,0
5,GO ACTIVATED T CELL PROLIFERATION,0.041967,0.10009,0.12401,1,0
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.043763,0.099634,0.1455,1,0
5,GO DRUG METABOLIC PROCESS,0.0054795,0.099314,0.24237,1,0
5,GO NEGATIVE REGULATION OF CELL DEATH,0.027188,0.09854,0.07937,1,0
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.027803,0.098326,0.12111,1,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.041093,0.097895,0.14083,1,0
5,GO SPERM EGG RECOGNITION,0.025994,0.097501,0.11202,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0027346,0.096755,0.11059,1,0
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.030383,0.096602,0.12971,1,0
5,GO AUTOPHAGOSOME ORGANIZATION,0.0046564,0.096335,0.15665,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.027803,0.095766,0.098724,1,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.027188,0.095537,0.14366,1,0
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.018836,0.09481,0.17592,1,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.034637,0.094693,0.22273,1,0
5,GO RESPONSE TO ACID CHEMICAL,0.033894,0.094034,0.087075,1,0
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.02268,0.093297,0.093807,1,0
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.029719,0.093086,0.093306,1,0
5,GO METAL ION TRANSPORT,0.02843,0.090733,0.087934,1,0
5,GO AEROBIC RESPIRATION,0.017549,0.090649,0.1543,1,0
5,GO VACUOLAR TRANSPORT,0.011612,0.090557,0.12253,1,0
5,GO FAT CELL DIFFERENTIATION,0.03939,0.089341,0.094298,1,0
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0039469,0.089064,0.12814,1,0
5,GO MEMBRANE ORGANIZATION,0.037747,0.089023,0.076353,1,0
5,GO PROTEIN CATABOLIC PROCESS,0.0057817,0.088285,0.087093,1,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.029068,0.088186,0.11336,1,0
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.015953,0.08744,0.13802,1,0
5,GO CIRCADIAN RHYTHM,0.022165,0.087399,0.073137,1,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.038561,0.0867,0.18192,1,0
5,GO PROTEIN POLYUBIQUITINATION,0.00065623,0.086591,0.10254,1,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.011612,0.086574,0.11148,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.027188,0.086123,0.066759,1,0
5,GO SIGNAL RELEASE,0.014486,0.085658,0.10491,1,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.025414,0.085655,0.091547,1,0
5,GO MACROMOLECULE CATABOLIC PROCESS,0.033166,0.085064,0.058718,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0066042,0.08496,0.1318,1,0
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0034322,0.08443,0.090862,1,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.024846,0.081873,0.074546,1,0
5,GO POSITIVE REGULATION OF JNK CASCADE,0.018398,0.081867,0.10228,1,0
5,GO POSITIVE T CELL SELECTION,0.016339,0.081498,0.10412,1,0
5,GO REGULATION OF ATP METABOLIC PROCESS,0.038561,0.081357,0.091067,1,0
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.033894,0.080818,0.10618,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.018836,0.079081,0.10392,1,0
5,GO ENDOSOMAL TRANSPORT,0.0042883,0.078663,0.082004,1,0
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.031059,0.078546,0.10373,1,0
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.016734,0.07845,0.11161,1,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.033894,0.077405,0.056143,1,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.034637,0.076364,0.10845,1,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0042883,0.075383,0.15914,1,0
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.033894,0.075103,0.092038,1,0
5,GO MYELOID CELL HOMEOSTASIS,0.02843,0.072106,0.090697,1,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0073363,0.070429,0.1072,1,0
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.038561,0.06914,0.069814,1,0
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.025994,0.068067,0.10589,1,0
5,GO RESPONSE TO MONOSACCHARIDE,0.030383,0.064685,0.10154,1,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.043763,0.063635,0.083999,1,0
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.014138,0.062181,0.084309,1,0
5,GO PROTEIN TARGETING TO VACUOLE,0.036164,0.06184,0.12819,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.023205,0.059997,0.085238,1,0
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.023741,0.059948,0.10933,1,0
5,GO POSITIVE REGULATION OF TRANSPORT,0.025994,0.056822,0.079045,1,0
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0021062,0.056576,0.11508,1,0
5,GO REGULATION OF AUTOPHAGY,0.0071468,0.056537,0.099925,1,0
5,GO REGULATION OF TRANSPORT,0.025994,0.053307,0.070013,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.01282,0.050616,0.054944,1,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.013798,0.04657,0.067712,1,0
5,GO MACROAUTOPHAGY,0.0050528,0.045227,0.10812,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.029068,0.034463,0.04616,1,0
5,GO CHROMATIN ORGANIZATION,0.044685,-0.015812,-0.047568,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.038561,-0.032342,-0.049909,1,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.038561,-0.036943,-0.079562,1,0
5,GO CELL DIVISION,0.041093,-0.043389,-0.058496,1,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,-0.045618,-0.06672,1,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.034637,-0.046473,-0.057033,1,0
5,GO REGULATION OF RNA SPLICING,0.040234,-0.048226,-0.050568,1,0
5,GO REGULATION OF DNA METABOLIC PROCESS,0.014841,-0.055222,-0.063037,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.033894,-0.057352,-0.083435,1,0
5,GO DNA CONFORMATION CHANGE,0.041093,-0.058341,-0.059172,1,0
5,GO CELL CYCLE DNA REPLICATION,0.034637,-0.059636,-0.087263,1,0
5,GO PROTEIN ACETYLATION,0.02843,-0.060877,-0.04114,1,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.045624,-0.062944,-0.13878,1,0
5,GO MRNA EXPORT FROM NUCLEUS,0.036164,-0.064015,-0.081428,1,0
5,GO MRNA PROCESSING,0.010506,-0.064286,-0.070211,1,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.022165,-0.064389,-0.11057,1,0
5,GO SPINDLE LOCALIZATION,0.038561,-0.065569,-0.084649,1,0
5,GO DNA PACKAGING,0.020205,-0.067465,-0.066048,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.042857,-0.068412,-0.10153,1,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.030383,-0.068558,-0.11211,1,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0067808,-0.068796,-0.089396,1,0
5,GO RNA SPLICING,0.0030654,-0.071689,-0.08479,1,0
5,GO RECOMBINATIONAL REPAIR,0.02068,-0.072603,-0.080571,1,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0021062,-0.074229,-0.080386,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE,0.016734,-0.074953,-0.099593,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.011904,-0.075353,-0.093645,1,0
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.034637,-0.07771,-0.10788,1,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.036164,-0.078113,-0.073993,1,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00087311,-0.078352,-0.096624,1,0
5,GO CHROMOSOME SEGREGATION,0.036164,-0.078446,-0.056576,1,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.03245,-0.078668,-0.10002,1,0
5,GO NUCLEOSOME ORGANIZATION,0.0067808,-0.079477,-0.096782,1,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.027803,-0.07955,-0.06285,1,0
5,GO MUSCLE ORGAN DEVELOPMENT,0.026586,-0.080863,-0.074111,1,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0049174,-0.081188,-0.090209,1,0
5,GO MICROTUBULE BASED MOVEMENT,0.018398,-0.083386,-0.069608,1,0
5,GO MICROTUBULE BASED PROCESS,0.001986,-0.08421,-0.07689,1,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.046579,-0.084674,-0.12895,1,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.01282,-0.085532,-0.088511,1,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.042857,-0.086775,-0.13669,1,0
5,GO CELL PROJECTION ORGANIZATION,0.018398,-0.086806,-0.081638,1,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.019739,-0.087184,-0.075744,1,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0087944,-0.087242,-0.082315,1,0
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.038561,-0.088835,-0.086139,1,0
5,GO REPLICATION FORK PROCESSING,0.029719,-0.088971,-0.13267,1,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.040234,-0.089141,-0.10218,1,0
5,GO SPINDLE ORGANIZATION,0.0094949,-0.089541,-0.075844,1,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0081404,-0.091284,-0.091552,1,0
5,GO CELL MORPHOGENESIS,0.019739,-0.091498,-0.10055,1,0
5,GO HEAD DEVELOPMENT,0.019283,-0.092123,-0.080025,1,0
5,GO REGULATION OF BEHAVIOR,0.045624,-0.092251,-0.11563,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.027188,-0.092652,-0.10409,1,0
5,GO CHROMATIN REMODELING,0.001986,-0.09292,-0.086295,1,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.031059,-0.093107,-0.16043,1,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0060989,-0.09388,-0.093148,1,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.02268,-0.095244,-0.1422,1,0
5,GO REGULATION OF ORGAN GROWTH,0.046579,-0.095835,-0.10642,1,0
5,GO CHROMOSOME CONDENSATION,0.038561,-0.096135,-0.088712,1,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,-0.096581,-0.14873,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.027188,-0.097068,-0.1708,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.041093,-0.097187,-0.13296,1,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0099891,-0.097705,-0.13383,1,0
5,GO MITOTIC DNA REPLICATION CHECKPOINT,0.02068,-0.099002,-0.16734,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.001872,-0.099869,-0.10295,1,0
5,GO MUSCLE FILAMENT SLIDING,0.0064317,-0.099935,-0.2233,1,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.030383,-0.10006,-0.11965,1,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.018398,-0.10031,-0.10121,1,0
5,GO REGULATION OF CELL DEVELOPMENT,0.024846,-0.10178,-0.085572,1,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.044685,-0.10194,-0.1286,1,0
5,GO LYMPH VESSEL DEVELOPMENT,0.029719,-0.10202,-0.16472,1,0
5,GO NEGATIVE REGULATION OF DNA BINDING,0.0030654,-0.10221,-0.15131,1,0
5,GO STRESS GRANULE ASSEMBLY,0.026586,-0.10231,-0.12557,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.025414,-0.10351,-0.13348,1,0
5,GO NEUROGENESIS,0.020205,-0.10384,-0.092185,1,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,-0.10389,-0.10858,1,0
5,GO CELLULAR RESPONSE TO X RAY,0.00353,-0.10525,-0.2215,1,0
5,GO APPENDAGE DEVELOPMENT,0.029719,-0.10553,-0.11056,1,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.018398,-0.10602,-0.091911,1,0
5,GO REGULATION OF MRNA POLYADENYLATION,0.046579,-0.10615,-0.095337,1,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.00026903,-0.10654,-0.11571,1,0
5,GO DNA REPLICATION INITIATION,0.0023671,-0.10811,-0.14748,1,0
5,GO REGULATION OF CELL MORPHOGENESIS,0.011612,-0.10828,-0.10981,1,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0021062,-0.10841,-0.099386,1,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.019739,-0.1088,-0.15013,1,0
5,GO DNA DEPENDENT DNA REPLICATION,0.011904,-0.10933,-0.09225,1,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.041093,-0.1095,-0.11828,1,0
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.047551,-0.11018,-0.20389,1,0
5,GO REGULATION OF DNA REPAIR,0.00013917,-0.11029,-0.12118,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.029719,-0.11058,-0.12146,1,0
5,GO SMOOTHENED SIGNALING PATHWAY,0.0079323,-0.1121,-0.11889,1,0
5,GO DNA REPLICATION CHECKPOINT,0.011047,-0.11268,-0.14522,1,0
5,GO LONG TERM SYNAPTIC POTENTIATION,0.047551,-0.11357,-0.1341,1,0
5,GO MICROTUBULE POLYMERIZATION,0.0021062,-0.11378,-0.15108,1,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.017969,-0.11428,-0.136,1,0
5,GO MUSCLE FIBER DEVELOPMENT,0.041967,-0.11446,-0.094603,1,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.042857,-0.11521,-0.19413,1,0
5,GO LIMBIC SYSTEM DEVELOPMENT,0.019739,-0.11545,-0.11601,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0010528,-0.11576,-0.12295,1,0
5,GO POSITIVE REGULATION OF DNA REPAIR,0.00025131,-0.11585,-0.1265,1,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.029719,-0.11709,-0.14808,1,0
5,GO BONE MORPHOGENESIS,0.010506,-0.11894,-0.16632,1,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.023741,-0.11898,-0.077472,1,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.00353,-0.1194,-0.13127,1,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0075304,-0.1195,-0.1246,1,0
5,GO G0 TO G1 TRANSITION,0.014138,-0.11971,-0.11072,1,0
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.023205,-0.11984,-0.14449,1,0
5,GO NEURON DEVELOPMENT,0.0099891,-0.1199,-0.11616,1,0
5,GO COGNITION,0.037747,-0.12049,-0.10091,1,0
5,GO LONG TERM MEMORY,0.02268,-0.12057,-0.17052,1,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0032441,-0.12073,-0.19435,1,0
5,GO BONE MATURATION,0.035393,-0.12226,-0.16068,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.03245,-0.12292,-0.15022,1,0
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.015203,-0.12316,-0.097225,1,0
5,GO MITOCHONDRION LOCALIZATION,0.0011549,-0.12403,-0.13208,1,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.0041716,-0.12438,-0.13002,1,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.040234,-0.12485,-0.18031,1,0
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.01282,-0.1253,-0.11026,1,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0090226,-0.12747,-0.22464,1,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,8.1192e-05,-0.12757,-0.1414,1,0
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.021165,-0.12835,-0.14589,1,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.036948,-0.12841,-0.11457,1,0
5,GO NEURON DIFFERENTIATION,0.010773,-0.12848,-0.11285,1,0
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0034322,-0.12879,-0.16335,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0038387,-0.12993,-0.13397,1,0
5,GO REGULATION OF CELL SIZE,0.012203,-0.12999,-0.12855,1,0
5,GO MITOTIC CHROMOSOME CONDENSATION,0.027803,-0.13018,-0.12733,1,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.014138,-0.13067,-0.10106,1,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.019739,-0.13176,-0.16613,1,0
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.03939,-0.13181,-0.12807,1,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.01282,-0.13248,-0.14985,1,0
5,GO REGULATION OF MRNA PROCESSING,0.0012662,-0.13263,-0.10987,1,0
5,GO DEVELOPMENTAL CELL GROWTH,0.015203,-0.13359,-0.13181,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.001872,-0.13424,-0.14867,1,0
5,GO MICROTUBULE BASED TRANSPORT,0.0022332,-0.13446,-0.11942,1,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.013798,-0.13455,-0.13474,1,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00353,-0.13478,-0.14829,1,0
5,GO MYOBLAST PROLIFERATION,0.030383,-0.13637,-0.16422,1,0
5,GO TELOMERIC LOOP DISASSEMBLY,0.0057817,-0.13728,-0.16878,1,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0064317,-0.13764,-0.1563,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001662,-0.13838,-0.12734,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.015574,-0.1385,-0.17743,1,0
5,GO REGULATION OF CYCLASE ACTIVITY,0.0019282,-0.13853,-0.2047,1,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.0023671,-0.13927,-0.14978,1,0
5,GO ADULT HEART DEVELOPMENT,0.041967,-0.13998,-0.18717,1,0
5,GO REGULATION OF LYASE ACTIVITY,0.012508,-0.14043,-0.15402,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0027346,-0.14068,-0.13586,1,0
5,GO NEURAL CREST CELL DIFFERENTIATION,0.029719,-0.14116,-0.14809,1,0
5,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.041967,-0.14141,-0.21527,1,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00018427,-0.14151,-0.13403,1,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0094949,-0.14164,-0.15261,1,0
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0021689,-0.14176,-0.16904,1,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0013457,-0.14206,-0.1976,1,0
5,GO COCHLEA MORPHOGENESIS,0.0090226,-0.14236,-0.20675,1,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.010773,-0.14302,-0.18109,1,0
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.02843,-0.14323,-0.14857,1,0
5,GO L GLUTAMATE IMPORT,0.031059,-0.14326,-0.15208,1,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.034637,-0.14368,-0.092493,1,0
5,GO MOTOR NEURON AXON GUIDANCE,0.019283,-0.1442,-0.20422,1,0
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.013139,-0.14503,-0.12016,1,0
5,GO REGULATION OF MYELINATION,0.00081984,-0.14533,-0.16855,1,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.004408,-0.14553,-0.18362,1,0
5,GO EMBRYONIC HEMOPOIESIS,0.035393,-0.14653,-0.1501,1,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00042998,-0.1468,-0.14592,1,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.037747,-0.14696,-0.17539,1,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.016734,-0.14696,-0.15297,1,0
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.02166,-0.14742,-0.11214,1,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.013465,-0.14757,-0.23764,1,0
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.024846,-0.14848,-0.13618,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.019739,-0.14885,-0.15407,1,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.041967,-0.14905,-0.22972,1,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0017123,-0.14989,-0.15628,1,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,4.4878e-05,-0.14994,-0.13307,1,0
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.010506,-0.15005,-0.12639,1,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.044685,-0.15015,-0.14937,1,0
5,GO FOREBRAIN DEVELOPMENT,0.001662,-0.15064,-0.13008,1,0
5,GO HISTONE H3 K9 DEMETHYLATION,0.0090226,-0.15149,-0.19507,1,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.02068,-0.15278,-0.23491,1,0
5,GO NEURAL CREST CELL MIGRATION,0.0042883,-0.15297,-0.24177,1,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.041093,-0.15371,-0.13704,1,0
5,GO ROOF OF MOUTH DEVELOPMENT,0.037747,-0.15411,-0.13515,1,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.011047,-0.1549,-0.17919,1,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00057693,-0.15555,-0.14198,1,0
5,GO COLLAGEN FIBRIL ORGANIZATION,0.018398,-0.15559,-0.23047,1,0
5,GO PROTEIN POLYGLUTAMYLATION,0.0033369,-0.15624,-0.15104,1,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.004408,-0.15631,-0.11926,1,0
5,GO HISTONE H3 K9 TRIMETHYLATION,0.017137,-0.15734,-0.11022,1,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.027803,-0.15805,-0.10589,1,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00087311,-0.15813,-0.17678,1,0
5,GO NEURAL TUBE PATTERNING,0.0051916,-0.15853,-0.18098,1,0
5,GO REGULATION OF STEM CELL PROLIFERATION,0.0028957,-0.15894,-0.17056,1,0
5,GO NEUROTRANSMITTER SECRETION,0.041093,-0.15966,-0.081171,1,0
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0036303,-0.16057,-0.21751,1,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.021165,-0.16102,-0.22875,1,0
5,GO HISTONE H4 K16 ACETYLATION,0.033894,-0.16104,-0.10329,1,0
5,GO REGULATION OF NEURON DIFFERENTIATION,0.0097392,-0.1613,-0.12186,1,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.018398,-0.16186,-0.12286,1,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0025817,-0.1624,-0.29032,1,0
5,GO CELL PART MORPHOGENESIS,0.00084609,-0.16319,-0.17957,1,0
5,GO LEARNING,0.02068,-0.16367,-0.15063,1,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.022165,-0.16434,-0.14008,1,0
5,GO REGULATION OF HEART GROWTH,0.0054795,-0.16494,-0.15263,1,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0031536,-0.16499,-0.13869,1,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00079435,-0.16695,-0.12977,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.021165,-0.16706,-0.13659,1,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0023671,-0.16858,-0.15609,1,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0026572,-0.17043,-0.17516,1,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.036948,-0.17149,-0.12107,1,0
5,GO TELENCEPHALON DEVELOPMENT,0.00035231,-0.17172,-0.16271,1,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.041093,-0.17226,-0.14641,1,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0013872,-0.17335,-0.23099,1,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0016129,-0.17382,-0.1456,1,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0060989,-0.1742,-0.19122,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0006154,-0.17444,-0.13225,1,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.009256,-0.17461,-0.22436,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0042883,-0.17538,-0.17042,1,0
5,GO LYMPHANGIOGENESIS,0.0037331,-0.17635,-0.23308,1,0
5,GO OUTFLOW TRACT MORPHOGENESIS,0.035393,-0.17675,-0.14684,1,0
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.019739,-0.17693,-0.12954,1,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.0090226,-0.17721,-0.16753,1,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0079323,-0.17726,-0.20055,1,0
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0090226,-0.17845,-0.12935,1,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.0010528,-0.17909,-0.16777,1,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.019739,-0.17939,-0.1666,1,0
5,GO PROTEIN DEMETHYLATION,0.00092958,-0.18124,-0.18758,1,0
5,GO REPLACEMENT OSSIFICATION,0.041093,-0.18135,-0.16901,1,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.010245,-0.18165,-0.22475,1,0
5,GO MEMBRANE BIOGENESIS,0.03939,-0.18209,-0.16989,1,0
5,GO FOREBRAIN CELL MIGRATION,0.0017641,-0.18268,-0.21676,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00019753,-0.18272,-0.14739,1,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.034637,-0.18383,-0.20178,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.00095906,-0.18422,-0.19745,1,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.02268,-0.18427,-0.1977,1,0
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.024846,-0.18582,-0.17362,1,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00019753,-0.18669,-0.20532,1,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.010506,-0.18698,-0.12792,1,0
5,GO NEURON PROJECTION EXTENSION,0.0064317,-0.18713,-0.17412,1,0
5,GO LATERAL MESODERM DEVELOPMENT,0.0047853,-0.1884,-0.31848,1,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0011549,-0.18875,-0.24665,1,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.03939,-0.19,-0.17114,1,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0062634,-0.19093,-0.16912,1,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0050528,-0.19093,-0.21386,1,0
5,GO NEUROBLAST PROLIFERATION,0.0015189,-0.19184,-0.19693,1,0
5,GO REGULATION OF HIPPO SIGNALING,0.046579,-0.19228,-0.19786,1,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0017641,-0.1931,-0.17117,1,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.027803,-0.19323,-0.22733,1,0
5,GO CELLULAR RESPONSE TO VITAMIN D,0.036948,-0.19339,-0.18244,1,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.047551,-0.19478,-0.1777,1,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.0090226,-0.19602,-0.16239,1,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00028792,-0.19668,-0.21495,1,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.01282,-0.1971,-0.16092,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0071468,-0.19713,-0.19654,1,0
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,-0.19837,-0.24201,1,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.045624,-0.19858,-0.22159,1,0
5,GO DENDRITE DEVELOPMENT,0.0011199,-0.19936,-0.17044,1,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.011612,-0.20297,-0.15426,1,0
5,GO NEURON PROJECTION REGENERATION,0.0045306,-0.20325,-0.19357,1,0
5,GO SYNAPTIC SIGNALING,0.040234,-0.20388,-0.11207,1,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0010206,-0.20438,-0.17343,1,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0090226,-0.2047,-0.20422,1,0
5,GO SPINAL CORD DEVELOPMENT,0.0071468,-0.20543,-0.16973,1,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.015574,-0.20647,-0.34637,1,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.013465,-0.20652,-0.19646,1,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0016129,-0.20764,-0.17865,1,0
5,GO PROSTATE GLAND GROWTH,0.036948,-0.20889,-0.2031,1,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.013139,-0.20892,-0.28815,1,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.038561,-0.20895,-0.20123,1,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.0097392,-0.20926,-0.25415,1,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0047853,-0.20957,-0.25366,1,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.03245,-0.21003,-0.1611,1,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.013465,-0.2102,-0.24433,1,0
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0069616,-0.21039,-0.15824,1,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.038561,-0.21066,-0.22327,1,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0014738,-0.21111,-0.20288,1,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0066042,-0.21175,-0.30239,1,0
5,GO FOREBRAIN REGIONALIZATION,0.015953,-0.213,-0.22263,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00028792,-0.21305,-0.27546,1,0
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.00057693,-0.21379,-0.19626,1,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00084609,-0.21434,-0.18257,1,0
5,GO MITOCHONDRION DISTRIBUTION,0.0019282,-0.21457,-0.18097,1,0
5,GO SYNAPSE ORGANIZATION,0.0039469,-0.21477,-0.17561,1,0
5,GO NEURAL CREST FORMATION,0.041967,-0.21498,-0.18871,1,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.033894,-0.21554,-0.15893,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0015189,-0.21699,-0.19224,1,0
5,GO NEGATIVE CHEMOTAXIS,0.011904,-0.21812,-0.23757,1,0
5,GO REGULATION OF COLLATERAL SPROUTING,0.016339,-0.21829,-0.2406,1,0
5,GO LOCALIZATION WITHIN MEMBRANE,4.1617e-05,-0.21861,-0.23882,1,0
5,GO GTP METABOLIC PROCESS,0.011904,-0.21904,-0.21057,1,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.018836,-0.22059,-0.20399,1,0
5,GO CARDIOBLAST DIFFERENTIATION,0.0057817,-0.22197,-0.25857,1,0
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011047,-0.22217,-0.23358,1,0
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0020453,-0.22245,-0.16276,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.021165,-0.22252,-0.16127,1,0
5,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.011326,-0.22283,-0.24283,1,0
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.026586,-0.22465,-0.16198,1,0
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0046564,-0.22488,-0.21584,1,0
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00084609,-0.22514,-0.18187,1,0
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0066042,-0.22521,-0.20576,1,0
5,GO FORELIMB MORPHOGENESIS,0.0028957,-0.22523,-0.25441,1,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00041602,-0.22581,-0.24534,1,0
5,GO HIPPO SIGNALING,0.00092958,-0.22621,-0.27825,1,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0033369,-0.22686,-0.14945,1,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0010528,-0.22763,-0.24986,1,0
5,GO AXON DEVELOPMENT,0.00045924,-0.22843,-0.22839,1,0
5,GO COCHLEA DEVELOPMENT,0.0057817,-0.22905,-0.20475,1,0
5,GO CHROMATIN REMODELING AT CENTROMERE,0.011326,-0.22907,-0.1573,1,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.019283,-0.22954,-0.21595,1,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,8.3127e-06,-0.22978,-0.29084,1,0
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.014486,-0.22987,-0.24278,1,0
5,GO MRNA SPLICE SITE SELECTION,0.0017641,-0.23015,-0.19551,1,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00069957,-0.2318,-0.21202,1,0
5,GO HIPPOCAMPUS DEVELOPMENT,0.00018427,-0.23206,-0.21665,1,0
5,GO DENDRITE SELF AVOIDANCE,0.044685,-0.23344,-0.21129,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0094949,-0.23514,-0.18462,1,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.011612,-0.2353,-0.25159,1,0
5,GO CGMP METABOLIC PROCESS,0.043763,-0.23535,-0.18461,1,0
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.011904,-0.23544,-0.15307,1,0
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.029068,-0.2355,-0.20204,1,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.004408,-0.23572,-0.18299,1,0
5,GO NEURON PROJECTION GUIDANCE,0.00023468,-0.23768,-0.25795,1,0
5,GO MITRAL VALVE DEVELOPMENT,0.0022992,-0.23809,-0.32294,1,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,8.4205e-05,-0.24056,-0.21403,1,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0073363,-0.24061,-0.22392,1,0
5,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.031748,-0.24063,-0.23375,1,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0054795,-0.24078,-0.17653,1,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,9.7346e-05,-0.24113,-0.26809,1,0
5,GO NEURON MIGRATION,0.001228,-0.24151,-0.23925,1,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00084609,-0.24299,-0.31919,1,0
5,GO MUSCLE CELL FATE COMMITMENT,0.0015653,-0.24321,-0.28767,1,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.016734,-0.24328,-0.2149,1,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.043763,-0.24447,-0.24691,1,0
5,GO NEPHRON TUBULE FORMATION,0.02166,-0.24464,-0.25987,1,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,7.547e-05,-0.24484,-0.33728,1,0
5,GO BONE GROWTH,0.00045924,-0.24498,-0.31238,1,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,2.4346e-05,-0.24538,-0.32566,1,0
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.02068,-0.24575,-0.20707,1,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.0021689,-0.24605,-0.22701,1,0
5,GO PYRAMIDAL NEURON DIFFERENTIATION,0.011904,-0.24636,-0.28352,1,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0062634,-0.24777,-0.26423,1,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.2962e-05,-0.2496,-0.23552,1,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.015953,-0.25172,-0.27705,1,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.00035231,-0.25223,-0.25868,1,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0067808,-0.25303,-0.1606,1,0
5,GO ELASTIC FIBER ASSEMBLY,0.025994,-0.25485,-0.30925,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0014738,-0.25567,-0.28976,1,0
5,GO DNA LIGATION,0.0030654,-0.25733,-0.21757,1,0
5,GO REGULATION OF AXONOGENESIS,0.00069957,-0.25808,-0.2468,1,0
5,GO SYNAPTIC VESICLE LOCALIZATION,0.00074557,-0.25837,-0.2343,1,0
5,GO POSTSYNAPSE ORGANIZATION,9.0551e-05,-0.25855,-0.25975,1,0
5,GO DENDRITE MORPHOGENESIS,0.00020448,-0.2604,-0.22387,1,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.023205,-0.2605,-0.21777,1,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0011199,-0.26067,-0.28875,1,0
5,GO TONGUE DEVELOPMENT,0.0064317,-0.26131,-0.28644,1,0
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,5.2837e-06,-0.26146,-0.32705,1,0
5,GO RECEPTOR CLUSTERING,0.0001547,-0.26316,-0.26003,1,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0017123,-0.26441,-0.20565,1,0
5,GO MYOBLAST MIGRATION,0.024846,-0.26515,-0.31378,1,0
5,GO DENDRITIC SPINE DEVELOPMENT,0.00016595,-0.26646,-0.24024,1,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.00069957,-0.26805,-0.25286,1,0
5,GO BRAIN MORPHOGENESIS,1.7806e-05,-0.26847,-0.25039,1,0
5,GO CELL PROLIFERATION IN FOREBRAIN,6.2786e-05,-0.27005,-0.29071,1,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,2.5308e-05,-0.27033,-0.24538,1,0
5,GO UV PROTECTION,0.020205,-0.27124,-0.20894,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.016339,-0.27243,-0.24354,1,0
5,GO EXPLORATION BEHAVIOR,0.023741,-0.27251,-0.25317,1,0
5,GO MICROTUBULE DEPOLYMERIZATION,0.0013457,-0.27251,-0.23841,1,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,1.7118e-05,-0.27401,-0.26393,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0062634,-0.27552,-0.20118,1,0
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.007729,-0.27569,-0.25316,1,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.016734,-0.27656,-0.19492,1,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.0015189,-0.27851,-0.29316,1,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00020448,-0.27981,-0.36351,1,0
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,9.0551e-05,-0.27988,-0.25247,1,0
5,GO REGULATION OF NEURON MIGRATION,9.0179e-06,-0.28036,-0.35762,1,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0033369,-0.28118,-0.34612,1,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,3.1888e-05,-0.28274,-0.3032,1,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0021062,-0.28523,-0.33369,1,0
5,GO RETINAL ROD CELL DIFFERENTIATION,0.025414,-0.28574,-0.23954,1,0
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0083534,-0.28634,-0.20548,1,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.009256,-0.28636,-0.20521,1,0
5,GO BONE TRABECULA FORMATION,0.010506,-0.28649,-0.39941,1,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.012203,-0.28898,-0.28594,1,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0013872,-0.28985,-0.26489,1,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.00036427,-0.29056,-0.36293,1,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.00016595,-0.29062,-0.29464,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0021062,-0.29117,-0.31715,1,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0041716,-0.29476,-0.26819,1,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0032441,-0.29531,-0.23778,1,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,7.2754e-05,-0.29725,-0.35779,1,0
5,GO NEURON RECOGNITION,0.015574,-0.29822,-0.25247,1,0
5,GO NEURON CELLULAR HOMEOSTASIS,0.0032441,-0.30167,-0.29364,1,0
5,GO NEURON PROJECTION ORGANIZATION,0.00010462,-0.30303,-0.25891,1,0
5,GO RESPONSE TO L GLUTAMATE,0.0060989,-0.30437,-0.29274,1,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.025994,-0.30493,-0.20561,1,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00024286,-0.30513,-0.36296,1,0
5,GO FOREBRAIN MORPHOGENESIS,0.00067758,-0.30669,-0.26618,1,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.001191,-0.30823,-0.25301,1,0
5,GO RESPIRATORY SYSTEM PROCESS,7.013e-05,-0.30917,-0.26794,1,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00017186,-0.30947,-0.27787,1,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.0001165,-0.31077,-0.2847,1,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00067758,-0.31121,-0.31899,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.043763,-0.31203,-0.17122,1,0
5,GO RESPONSE TO ACETYLCHOLINE,0.0031536,-0.31261,-0.28355,1,0
5,GO PRESYNAPSE ORGANIZATION,0.023741,-0.31354,-0.20811,1,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00049035,-0.31549,-0.3616,1,0
5,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.0018173,-0.31654,-0.36723,1,0
5,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.0049174,-0.31937,-0.32541,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00069957,-0.31968,-0.25253,1,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,6.5149e-05,-0.32202,-0.31123,1,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00020448,-0.32295,-0.31946,1,0
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0045306,-0.32437,-0.33418,1,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.016339,-0.32575,-0.32609,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.019283,-0.32596,-0.3179,1,0
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0010528,-0.32669,-0.24777,1,0
5,GO PHAGOCYTOSIS RECOGNITION,0.0012662,-0.32746,-0.33563,1,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.031059,-0.3283,-0.21489,1,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0013457,-0.32888,-0.24006,1,0
5,GO CHROMATIN DISASSEMBLY,1.7806e-05,-0.32947,-0.31105,1,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,8.7323e-05,-0.32968,-0.50187,1,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0001165,-0.33111,-0.28617,1,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.00016595,-0.33338,-0.3583,1,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,2.9532e-05,-0.33351,-0.30801,1,0
5,GO TONGUE MORPHOGENESIS,0.029719,-0.33382,-0.27696,1,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.001662,-0.33922,-0.22932,1,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,5.2837e-06,-0.34084,-0.35036,1,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,3.1888e-05,-0.34254,-0.34057,1,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00037661,-0.34357,-0.29025,1,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.1617e-05,-0.34363,-0.29748,1,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,1.2962e-05,-0.34553,-0.33126,1,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00057693,-0.34796,-0.3507,1,0
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00029782,-0.3508,-0.32088,1,0
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.0011199,-0.35087,-0.29513,1,0
5,GO DENDRITIC TRANSPORT,0.00012964,-0.35104,-0.33986,1,0
5,GO EMBRYONIC EYE MORPHOGENESIS,4.6597e-05,-0.35143,-0.31713,1,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00032948,-0.3519,-0.29701,1,0
5,GO LIMB BUD FORMATION,0.021165,-0.35687,-0.30567,1,0
5,GO TELENCEPHALON REGIONALIZATION,0.020205,-0.36,-0.33685,1,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,2.0833e-05,-0.36056,-0.40134,1,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00084609,-0.36166,-0.27843,1,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,3.7145e-05,-0.36532,-0.39621,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,5.9841e-06,-0.36831,-0.40413,1,0
5,GO CENTRIOLE CENTRIOLE COHESION,9.0179e-06,-0.37393,-0.36019,1,0
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.00079435,-0.37614,-0.44998,1,0
5,GO HEART VALVE FORMATION,0.009256,-0.37628,-0.32213,1,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0050528,-0.38084,-0.29707,1,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00027832,-0.38892,-0.33807,1,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.001191,-0.39912,-0.3288,1,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,3.3132e-05,-0.40257,-0.36494,1,0
5,GO SYNAPTIC MEMBRANE ADHESION,0.0042883,-0.40621,-0.37345,1,0
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.0007696,-0.40623,-0.33886,1,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,5.7413e-06,-0.40753,-0.42583,1,0
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0023671,-0.40803,-0.42771,1,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,8.3127e-06,-0.41589,-0.40346,1,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.025994,-0.41807,-0.26067,1,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.022165,-0.42004,-0.31755,1,0
5,GO DENDRITIC SPINE MORPHOGENESIS,3.4421e-05,-0.4224,-0.33108,1,0
5,GO LONG TERM SYNAPTIC DEPRESSION,7.2754e-05,-0.42408,-0.38378,1,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,9.7801e-06,-0.43152,-0.49872,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00027832,-0.43414,-0.4092,1,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.00081984,-0.43454,-0.47707,1,0
5,GO SYNAPTIC VESICLE MATURATION,0.0028141,-0.43645,-0.3094,1,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00079435,-0.44005,-0.32593,1,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0013872,-0.44821,-0.39319,1,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.00014935,-0.45047,-0.34288,1,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00098941,-0.45199,-0.41633,1,0
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.0059384,-0.4536,-0.40959,1,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0056288,-0.45431,-0.39908,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0013872,-0.45548,-0.39085,1,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00021167,-0.45836,-0.43352,1,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00054072,-0.46764,-0.3812,1,0
5,GO LATERAL VENTRICLE DEVELOPMENT,0.0022992,-0.46877,-0.35632,1,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0016129,-0.47479,-0.35415,1,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,7.2111e-07,-0.48476,-0.57473,1,0
5,GO CORPUS CALLOSUM DEVELOPMENT,2.0833e-05,-0.50373,-0.43588,1,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,8.4205e-05,-0.51085,-0.50583,1,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00024286,-0.52052,-0.44862,1,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,6.7728e-06,-0.53596,-0.55068,1,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,1.104e-05,-0.53612,-0.64038,1,0
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,1.7118e-05,-0.55437,-0.54237,1,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.56336,-0.64111,1,0
5,GO VOCALIZATION BEHAVIOR,0.0032441,-0.56509,-0.47131,1,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,2.1663e-05,-0.58407,-0.52274,1,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,5.7413e-06,-0.59939,-0.60708,1,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,1.4044e-06,-0.63199,-0.70357,1,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,9.0179e-06,-0.64402,-0.54169,1,0
5,GO CARDIAC CHAMBER FORMATION,0.00023468,-0.66975,-0.54133,1,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,3.3132e-05,-0.68062,-0.63643,1,0
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0027346,-0.68927,-0.51183,1,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,6.7728e-06,-0.69867,-0.85721,1,0
5,GO CARDIAC VENTRICLE FORMATION,0.00041602,-0.72391,-0.56811,1,0
5,GO POSTSYNAPSE ASSEMBLY,1.8521e-05,-0.768,-0.63581,1,0
5,GO SYNAPTIC VESICLE CLUSTERING,4.0073e-05,-0.79277,-0.69616,1,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.6015e-06,-0.90402,-0.90261,1,0
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.065563,0.46831,0.26065,0,1
5,GO CELLULAR RESPONSE TO ZINC ION,0.080955,0.37664,0.37161,0,1
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.053746,0.36095,0.24214,0,1
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.13583,0.34582,0.25014,0,1
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.11235,0.34354,0.18152,0,1
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.04854,0.33786,0.24012,0,1
5,GO POSITIVE REGULATION OF FERTILIZATION,0.050569,0.3351,0.18703,0,1
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.072231,0.32774,0.24238,0,1
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.060602,0.30518,0.29341,0,1
5,GO NADPH REGENERATION,0.15773,0.30417,0.14044,0,1
5,GO EPITHELIAL CELL FATE COMMITMENT,0.064293,0.28892,0.19476,0,1
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.054842,0.28067,0.16762,0,1
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.060602,0.27741,0.15474,0,1
5,GO HEART INDUCTION,0.13583,0.26883,0.19397,0,1
5,GO CARNITINE METABOLIC PROCESS,0.05824,0.26116,0.17727,0,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.095625,0.25347,0.18424,0,1
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.055956,0.24686,0.12521,0,1
5,GO MEMBRANE FISSION,0.072231,0.24417,0.15697,0,1
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0695,0.24278,0.16823,0,1
5,GO DETOXIFICATION,0.060602,0.24259,0.16514,0,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.11841,0.23518,0.21007,0,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.11039,0.23356,0.20398,0,1
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.12473,0.23225,0.1387,0,1
5,GO GDP METABOLIC PROCESS,0.076492,0.23138,0.17071,0,1
5,GO REGULATION OF CHLORIDE TRANSPORT,0.05161,0.23102,0.24975,0,1
5,GO CAMP BIOSYNTHETIC PROCESS,0.087232,0.23005,0.16436,0,1
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.092194,0.22897,0.12804,0,1
5,GO FUCOSE METABOLIC PROCESS,0.15015,0.22729,0.20991,0,1
5,GO ETHER BIOSYNTHETIC PROCESS,0.082489,0.22376,0.10902,0,1
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.16559,0.2172,0.14229,0,1
5,GO VITAMIN CATABOLIC PROCESS,0.055956,0.2168,0.24117,0,1
5,GO FUCOSYLATION,0.055956,0.2156,0.18573,0,1
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.053746,0.21194,0.15387,0,1
5,GO CHLORIDE ION HOMEOSTASIS,0.073629,0.21102,0.11999,0,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.076492,0.20829,0.081328,0,1
5,GO TRNA CATABOLIC PROCESS,0.053746,0.20425,0.22011,0,1
5,GO CHYLOMICRON ASSEMBLY,0.079444,0.20264,0.20819,0,1
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.049546,0.20241,0.17142,0,1
5,GO INTERLEUKIN 13 PRODUCTION,0.092194,0.20094,0.14671,0,1
5,GO REGULATION OF RECEPTOR BINDING,0.188,0.19822,0.13917,0,1
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.2839,0.19784,0.17241,0,1
5,GO SEQUESTERING OF TRIGLYCERIDE,0.066855,0.19776,0.15962,0,1
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.10654,0.19738,0.11021,0,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.2,0.19715,0.088667,0,1
5,GO PODOSOME ASSEMBLY,0.29992,0.19357,0.046782,0,1
5,GO CARDIOLIPIN METABOLIC PROCESS,0.10845,0.19321,0.0844,0,1
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.29184,0.19234,0.11767,0,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.05824,0.19201,0.1393,0,1
5,GO PARENTAL BEHAVIOR,0.093897,0.19182,0.18558,0,1
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.093897,0.19179,0.12923,0,1
5,GO MAINTENANCE OF CELL POLARITY,0.19095,0.1899,0.1018,0,1
5,GO AMMONIUM TRANSPORT,0.11636,0.18932,0.0942,0,1
5,GO GLIAL CELL PROLIFERATION,0.17099,0.18703,0.10845,0,1
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.057089,0.18588,0.13141,0,1
5,GO REGULATION OF T CELL MIGRATION,0.087232,0.18337,0.13708,0,1
5,GO RESPONSE TO UV B,0.31232,0.17994,0.056934,0,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.093897,0.17881,0.092398,0,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.15015,0.17267,0.12984,0,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.057089,0.17155,0.11792,0,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.05161,0.17129,0.13309,0,1
5,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.20937,0.16967,0.1115,0,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.090515,0.16899,0.13042,0,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.41842,0.16684,0.079905,0,1
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.095625,0.1667,0.18884,0,1
5,GO CAMP METABOLIC PROCESS,0.38888,0.1659,0.073511,0,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.057089,0.16586,0.092924,0,1
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.057089,0.16574,0.16949,0,1
5,GO ERK1 AND ERK2 CASCADE,0.05824,0.16487,0.098152,0,1
5,GO AMYLOID BETA FORMATION,0.10654,0.16401,0.11447,0,1
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.066855,0.16391,0.208,0,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.063042,0.16324,0.16155,0,1
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.22235,0.16254,0.14218,0,1
5,GO ENGULFMENT OF APOPTOTIC CELL,0.061812,0.16155,0.1121,0,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.084046,0.1614,0.1276,0,1
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.082489,0.16022,0.13889,0,1
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.077957,0.15991,0.13096,0,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.097379,0.15987,0.10138,0,1
5,GO AMINO ACID ACTIVATION,0.064293,0.15896,0.13321,0,1
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.35153,0.15792,0.064774,0,1
5,GO ACETYL COA METABOLIC PROCESS,0.068167,0.15774,0.12344,0,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.22568,0.1575,0.077339,0,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.060602,0.15738,0.11131,0,1
5,GO MUSCLE CELL MIGRATION,0.054842,0.15687,0.12989,0,1
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.19393,0.15647,0.21359,0,1
5,GO DRINKING BEHAVIOR,0.17934,0.15481,0.085857,0,1
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.13814,0.15273,0.065419,0,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.057089,0.15218,0.13867,0,1
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.079444,0.14827,0.10968,0,1
5,GO FIBROBLAST PROLIFERATION,0.13583,0.14784,0.08357,0,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.087232,0.14768,0.12574,0,1
5,GO ATP TRANSPORT,0.063042,0.14664,0.092346,0,1
5,GO RENAL TUBULE DEVELOPMENT,0.052669,0.14549,0.087844,0,1
5,GO RESPONSE TO MUSCLE ACTIVITY,0.53167,0.14547,0.061811,0,1
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.14048,0.14518,0.11139,0,1
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.066855,0.14496,0.1245,0,1
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.19095,0.14476,0.10201,0,1
5,GO ESTROGEN BIOSYNTHETIC PROCESS,0.075049,0.14456,0.19505,0,1
5,GO RESPONSE TO VITAMIN,0.69061,0.144,0.0096289,0,1
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.188,0.14282,0.085601,0,1
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.26098,0.14238,0.076923,0,1
5,GO RESPONSE TO LIGHT INTENSITY,0.14285,0.14031,0.08737,0,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.088862,0.13859,0.19096,0,1
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.13583,0.13837,0.09776,0,1
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.065563,0.13729,0.13768,0,1
5,GO CALCIUM ION IMPORT,0.11039,0.13675,0.062469,0,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.064293,0.1366,0.13451,0,1
5,GO MONONUCLEAR CELL MIGRATION,0.068167,0.13406,0.087213,0,1
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.055956,0.13404,0.091798,0,1
5,GO RESPONSE TO ETHANOL,0.087232,0.13209,0.075634,0,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11039,0.13142,0.086332,0,1
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.052669,0.13093,0.11399,0,1
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.15517,0.13017,0.076032,0,1
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.16828,0.12981,0.11559,0,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.15517,0.12928,0.086596,0,1
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.064293,0.12872,0.22554,0,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.11841,0.12837,0.090478,0,1
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.075049,0.12834,0.13025,0,1
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.25729,0.12809,0.053727,0,1
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.13583,0.12808,0.06628,0,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.42855,0.12728,0.036288,0,1
5,GO RRNA CATABOLIC PROCESS,0.063042,0.12599,0.10647,0,1
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.18508,0.12507,0.1274,0,1
5,GO KERATINOCYTE MIGRATION,0.15015,0.12486,0.079348,0,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.17374,0.12462,0.054626,0,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.059411,0.12354,0.11443,0,1
5,GO RNA INTERFERENCE,0.11841,0.12339,0.095883,0,1
5,GO EPITHELIAL CELL PROLIFERATION,0.0695,0.12266,0.068202,0,1
5,GO MITOTIC DNA REPLICATION,0.17934,0.12255,0.08951,0,1
5,GO REGULATION OF DNA METHYLATION,0.14526,0.12251,0.079487,0,1
5,GO RESPONSE TO IRON ION,0.090515,0.12238,0.12616,0,1
5,GO REGULATION OF ION TRANSPORT,0.070855,0.12111,0.076178,0,1
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.080955,0.12098,0.10681,0,1
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.095625,0.11965,0.088195,0,1
5,GO BIOLOGICAL ADHESION,0.087232,0.11952,0.074127,0,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.11841,0.11923,0.063953,0,1
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.059411,0.11858,0.14931,0,1
5,GO EXCRETION,0.053746,0.11782,0.092701,0,1
5,GO RESPONSE TO NITRIC OXIDE,0.20937,0.11765,0.048268,0,1
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.2,0.11708,0.069382,0,1
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.16828,0.11695,0.071492,0,1
5,GO ERBB SIGNALING PATHWAY,0.23245,0.11667,0.065306,0,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.18219,0.11627,0.080983,0,1
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.12259,0.11516,0.074339,0,1
5,GO SODIUM ION TRANSPORT,0.05161,0.11482,0.09849,0,1
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.22568,0.11286,0.056665,0,1
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.2839,0.11082,0.14128,0,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.057089,0.1105,0.07997,0,1
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.13355,0.11038,0.11046,0,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.054842,0.11033,0.13992,0,1
5,GO DENDRITIC CELL CHEMOTAXIS,0.11841,0.11032,0.093113,0,1
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.17099,0.10912,0.061364,0,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.04854,0.10847,0.081442,0,1
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.19393,0.10846,0.090642,0,1
5,GO SULFATE TRANSPORT,0.14769,0.10824,0.070744,0,1
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.18219,0.10742,0.0958,0,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.27227,0.10732,0.058778,0,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.17934,0.10613,0.074919,0,1
5,GO INTERFERON GAMMA PRODUCTION,0.075049,0.1059,0.090594,0,1
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.15015,0.10586,0.109,0,1
5,GO BODY FLUID SECRETION,0.04854,0.10578,0.080711,0,1
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.060602,0.10577,0.10817,0,1
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.04854,0.10518,0.11129,0,1
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.05824,0.10439,0.073449,0,1
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.41341,0.10363,0.042349,0,1
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.13814,0.10253,0.11583,0,1
5,GO MAMMARY GLAND DEVELOPMENT,0.059411,0.10216,0.086007,0,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.21256,0.10199,0.066655,0,1
5,GO DRUG CATABOLIC PROCESS,0.092194,0.10046,0.15382,0,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.085627,0.099789,0.068256,0,1
5,GO HEMOGLOBIN METABOLIC PROCESS,0.43367,0.099191,0.036484,0,1
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.25001,0.098278,0.064373,0,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.072231,0.098195,0.12084,0,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.080955,0.098169,0.10366,0,1
5,GO POSITIVE REGULATION OF CELL AGING,0.10845,0.098087,0.13963,0,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.097379,0.098015,0.10597,0,1
5,GO GLIAL CELL DEVELOPMENT,0.36526,0.097947,0.0424,0,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.076492,0.09777,0.098771,0,1
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.075049,0.097191,0.11279,0,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.099158,0.096324,0.067827,0,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.17934,0.096217,0.056011,0,1
5,GO POSITIVE REGULATION OF CELL DEATH,0.059411,0.095617,0.072622,0,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.32077,0.094988,0.15437,0,1
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.12049,0.094601,0.090855,0,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.11636,0.094408,0.058287,0,1
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.25363,0.093787,0.080181,0,1
5,GO CELL MOTILITY,0.12689,0.093749,0.055256,0,1
5,GO NEGATIVE REGULATION OF SECRETION,0.075049,0.093619,0.065361,0,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.14526,0.093525,0.043357,0,1
5,GO ESTROGEN METABOLIC PROCESS,0.15773,0.092566,0.13153,0,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.44924,0.092268,0.028914,0,1
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.188,0.0922,0.06536,0,1
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.22235,0.090177,0.051956,0,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.38408,0.089895,0.038321,0,1
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.054842,0.089756,0.1244,0,1
5,GO RESPONSE TO ESTRADIOL,0.2839,0.089352,0.036819,0,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.25363,0.089125,0.034628,0,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.14048,0.088868,0.052215,0,1
5,GO STRESS FIBER ASSEMBLY,0.4545,0.088722,0.030419,0,1
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.1028,0.0887,0.093614,0,1
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.053746,0.088563,0.12661,0,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.079444,0.088519,0.099546,0,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.56075,0.088484,0.023539,0,1
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.21905,0.087323,0.08776,0,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.05161,0.087003,0.059024,0,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.188,0.086526,0.039315,0,1
5,GO ENDOCYTOSIS,0.188,0.085587,0.055172,0,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.049546,0.084608,0.080319,0,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.188,0.084203,0.039795,0,1
5,GO PROTEIN PALMITOYLATION,0.22235,0.082938,0.078881,0,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.084046,0.081907,0.060537,0,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.052669,0.080916,0.05688,0,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.29184,0.080495,0.039162,0,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.049546,0.079875,0.070722,0,1
5,GO FATTY ACYL COA METABOLIC PROCESS,0.059411,0.07985,0.14507,0,1
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.12908,0.079524,0.086011,0,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.17374,0.079401,0.052501,0,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.050569,0.079241,0.088054,0,1
5,GO RENAL SODIUM EXCRETION,0.057089,0.079045,0.1409,0,1
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.23937,0.078892,0.039574,0,1
5,GO JNK CASCADE,0.080955,0.078653,0.070423,0,1
5,GO VISUAL BEHAVIOR,0.17934,0.077815,0.086907,0,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.15517,0.077512,0.044293,0,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.188,0.07696,0.048431,0,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.12259,0.076613,0.064805,0,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.050569,0.074835,0.064336,0,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.093897,0.074796,0.061813,0,1
5,GO POLYOL METABOLIC PROCESS,0.052669,0.073453,0.095435,0,1
5,GO NEGATIVE T CELL SELECTION,0.35607,0.071921,0.033349,0,1
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.52594,0.071274,0.011838,0,1
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.090515,0.070842,0.053892,0,1
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.061812,0.070735,0.13157,0,1
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.188,0.069638,0.067254,0,1
5,GO PEPTIDYL METHIONINE MODIFICATION,0.61497,0.068317,0.10833,0,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.1028,0.068098,0.053829,0,1
5,GO DNA MODIFICATION,0.061812,0.067586,0.04598,0,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.28785,0.067036,0.035682,0,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.075049,0.066688,0.056543,0,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.088862,0.066524,0.04787,0,1
5,GO SINGLE FERTILIZATION,0.075049,0.064767,0.067315,0,1
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.1028,0.064715,0.099017,0,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.21579,0.063947,0.043547,0,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.055956,0.063884,0.065306,0,1
5,GO REPRODUCTION,0.077957,0.06355,0.048401,0,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.26471,0.062963,0.032782,0,1
5,GO LYSINE METABOLIC PROCESS,0.23937,0.061798,0.12945,0,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.052669,0.060799,0.045962,0,1
5,GO TUBE DEVELOPMENT,0.22568,0.059573,0.038515,0,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.082489,0.056129,0.06994,0,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.14526,0.0554,0.047876,0,1
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.59059,0.054887,0.0058967,0,1
5,GO FERTILIZATION,0.10654,0.052085,0.05483,0,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.054842,0.051493,0.092242,0,1
5,GO TORC1 SIGNALING,0.061812,0.050162,0.06832,0,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.23937,0.049766,0.023075,0,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.24643,0.04824,0.030988,0,1
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.188,0.047217,0.040534,0,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.26471,0.046075,0.0369,0,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.29184,0.042807,0.027764,0,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.17653,0.039763,0.033677,0,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.2,0.036502,0.027958,0,1
5,GO RESPONSE TO RADIATION,0.28785,0.035787,0.018681,0,1
5,GO METHYLATION,0.30815,0.03475,0.010667,0,1
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.15517,0.033123,0.050316,0,1
5,GO MALE GAMETE GENERATION,0.23245,0.031707,0.029762,0,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.063042,0.64118,0.37915,0,0
5,GO NEGATIVE REGULATION OF CELL KILLING,0.068167,0.54616,0.32368,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.0695,0.52689,0.5135,0,0
5,GO NEGATIVE REGULATION OF ANOIKIS,0.00034072,0.49059,0.46751,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00057693,0.36019,0.41759,0,0
5,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.065563,0.33528,0.24426,0,0
5,GO PHOSPHOLIPID EFFLUX,0.00081984,0.33175,0.35753,0,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.11039,0.32941,0.20934,0,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.049546,0.31955,0.28959,0,0
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.055956,0.31818,0.19468,0,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.021165,0.30769,0.29417,0,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.0094949,0.29346,0.2838,0,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.12473,0.29115,0.18316,0,0
5,GO KETONE BODY METABOLIC PROCESS,0.011904,0.29081,0.29213,0,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0094949,0.27288,0.2192,0,0
5,GO PHOSPHOLIPID HOMEOSTASIS,0.060602,0.26391,0.1956,0,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.016339,0.26268,0.39046,0,0
5,GO BASEMENT MEMBRANE ORGANIZATION,0.1313,0.26178,0.15046,0,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.090515,0.26017,0.14815,0,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.065563,0.25914,0.18208,0,0
5,GO BEHAVIORAL RESPONSE TO PAIN,0.072231,0.25769,0.17251,0,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.001228,0.25593,0.23608,0,0
5,GO BILE ACID AND BILE SALT TRANSPORT,0.0025817,0.25172,0.51342,0,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.25729,0.24757,0.09834,0,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.050569,0.24678,0.15895,0,0
5,GO RESPONSE TO HISTAMINE,0.054842,0.24619,0.2875,0,0
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.010773,0.24554,0.24838,0,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.12473,0.24452,0.1334,0,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.080955,0.24426,0.13,0,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.16032,0.24421,0.11656,0,0
5,GO CYSTEINE METABOLIC PROCESS,0.36991,0.24404,0.14111,0,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.022165,0.23806,0.23862,0,0
5,GO HYALURONAN CATABOLIC PROCESS,0.063042,0.23469,0.090336,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0026572,0.23311,0.295,0,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.85768,0.23125,0.050943,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.092194,0.22971,0.18242,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.22568,0.22869,0.10182,0,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.073629,0.22665,0.1497,0,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.085627,0.22597,0.15471,0,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0085714,0.22471,0.20369,0,0
5,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.37932,0.22465,0.052784,0,0
5,GO HORMONE CATABOLIC PROCESS,0.0059384,0.22317,0.34458,0,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.13355,0.223,0.083405,0,0
5,GO T CELL CYTOKINE PRODUCTION,0.076492,0.21659,0.15366,0,0
5,GO KERATINOCYTE DEVELOPMENT,0.049546,0.21602,0.22246,0,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.13355,0.21576,0.10259,0,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.077957,0.21527,0.14907,0,0
5,GO HEPARIN METABOLIC PROCESS,0.26471,0.21443,0.10737,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.12049,0.2131,0.14025,0,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.052669,0.21174,0.1774,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.064293,0.20965,0.14718,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.17934,0.20875,0.17121,0,0
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.36064,0.20634,0.12247,0,0
5,GO ENAMEL MINERALIZATION,0.15015,0.20554,0.14592,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00095906,0.2055,0.22692,0,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.15517,0.20546,0.1773,0,0
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.12689,0.20397,0.099238,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.39371,0.20051,0.079839,0,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.057089,0.19965,0.1795,0,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.087232,0.19883,0.21653,0,0
5,GO TYPE 2 IMMUNE RESPONSE,0.10096,0.19755,0.11122,0,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.079444,0.19748,0.28619,0,0
5,GO RESPONSE TO FORSKOLIN,0.24288,0.1958,0.14201,0,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.32077,0.19508,0.11537,0,0
5,GO T HELPER 2 CELL DIFFERENTIATION,0.48678,0.19428,-0.032403,0,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.021165,0.1929,0.18058,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.064293,0.19185,0.2147,0,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.41341,0.19169,0.085676,0,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.068167,0.19132,0.094412,0,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.22235,0.19096,0.092562,0,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.24288,0.19059,0.074406,0,0
5,GO SEGMENT SPECIFICATION,0.48131,0.18937,0.08344,0,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.053746,0.18911,0.14507,0,0
5,GO INCLUSION BODY ASSEMBLY,0.042857,0.18901,0.20462,0,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.11039,0.18779,0.18867,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.065563,0.18769,0.10915,0,0
5,GO MYELIN MAINTENANCE,0.11636,0.18319,0.17308,0,0
5,GO EPOXYGENASE P450 PATHWAY,0.085627,0.18204,0.16701,0,0
5,GO CATECHOLAMINE METABOLIC PROCESS,0.0045306,0.18192,0.24071,0,0
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.075049,0.18095,0.12894,0,0
5,GO CYTOLYSIS,0.085627,0.18053,0.12671,0,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.082489,0.17707,0.10005,0,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.27227,0.17664,0.11181,0,0
5,GO POSITIVE REGULATION OF HEART RATE,0.05824,0.17611,0.18142,0,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.25729,0.17606,0.1209,0,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.10096,0.17545,0.19412,0,0
5,GO RESPONSE TO TESTOSTERONE,0.080955,0.17535,0.10338,0,0
5,GO MEGAKARYOCYTE DEVELOPMENT,0.0039469,0.17513,0.28476,0,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.40843,0.17463,0.078708,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.073629,0.17434,0.10372,0,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.075049,0.17294,0.11172,0,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.057089,0.17223,0.18394,0,0
5,GO ADENOHYPOPHYSIS DEVELOPMENT,0.32077,0.17219,0.13858,0,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.52025,0.1719,-0.0045807,0,0
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.085627,0.17073,0.12335,0,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.070855,0.16967,0.11397,0,0
5,GO PARAXIAL MESODERM DEVELOPMENT,0.32938,0.16889,0.080258,0,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.068167,0.16817,0.13643,0,0
5,GO RECEPTOR CATABOLIC PROCESS,0.095625,0.16681,0.085129,0,0
5,GO STORE OPERATED CALCIUM ENTRY,0.52594,0.16443,0.076744,0,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.053746,0.16434,0.15288,0,0
5,GO LACTATE METABOLIC PROCESS,0.17374,0.16432,0.085232,0,0
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.044685,0.16333,0.19186,0,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.78962,0.16318,0.033577,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.029068,0.16308,0.23157,0,0
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.052669,0.16279,0.11861,0,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.035393,0.16263,0.21261,0,0
5,GO IMMATURE T CELL PROLIFERATION,0.19095,0.16255,0.13943,0,0
5,GO LIPOXYGENASE PATHWAY,0.1028,0.16231,0.18165,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.14526,0.16224,0.14267,0,0
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.060602,0.1616,0.1308,0,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.10845,0.1592,0.10527,0,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.080955,0.15903,0.17855,0,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.3746,0.15891,-0.002369,0,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.066855,0.15862,0.22213,0,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0038387,0.15861,0.18578,0,0
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.46512,0.15842,0.010621,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.10654,0.15617,0.20425,0,0
5,GO INTERLEUKIN 5 PRODUCTION,0.32077,0.15611,0.092623,0,0
5,GO LOCOMOTOR RHYTHM,0.12908,0.15592,0.10016,0,0
5,GO SKIN MORPHOGENESIS,0.8303,0.1558,-0.04216,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.073629,0.15531,0.11575,0,0
5,GO PARTURITION,0.076492,0.15514,0.15882,0,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.24288,0.15479,0.079997,0,0
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.48131,0.15442,0.081365,0,0
5,GO DEVELOPMENTAL PIGMENTATION,0.017969,0.15396,0.1132,0,0
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.05161,0.15382,0.1055,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.095625,0.15381,0.12772,0,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.44402,0.15343,0.054962,0,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.25001,0.15326,0.10591,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.20621,0.15305,0.20589,0,0
5,GO WHITE FAT CELL DIFFERENTIATION,0.05161,0.15214,0.1074,0,0
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.20937,0.15187,0.081025,0,0
5,GO MALE MEIOSIS I,0.20937,0.1514,0.14186,0,0
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.42347,0.15114,0.092794,0,0
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.14769,0.15113,0.075503,0,0
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.059411,0.15102,0.18602,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.2839,0.15065,0.088369,0,0
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.50896,0.15048,0.044664,0,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00035231,0.15046,0.26359,0,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.23245,0.15031,0.070882,0,0
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.092194,0.14996,0.19845,0,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.061812,0.14973,0.14943,0,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.11039,0.1494,0.12159,0,0
5,GO MACROPHAGE MIGRATION,0.070855,0.14906,0.086098,0,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.097379,0.14896,0.21803,0,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.18508,0.14878,0.10532,0,0
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.23245,0.14847,0.046142,0,0
5,GO REGULATION OF AMYLOID BETA FORMATION,0.13355,0.14782,0.12141,0,0
5,GO RESPONSE TO HYPEROXIA,0.33373,0.14758,0.036833,0,0
5,GO REGULATION OF GLIAL CELL PROLIFERATION,0.087232,0.14719,0.12293,0,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.2839,0.14695,0.059372,0,0
5,GO HORMONE BIOSYNTHETIC PROCESS,0.17099,0.14676,0.1114,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.13814,0.14668,0.09674,0,0
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.099158,0.1463,0.1452,0,0
5,GO OXYGEN TRANSPORT,0.9686,0.14567,-0.035907,0,0
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.4545,0.14528,0.011104,0,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.28785,0.1449,0.066151,0,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.3746,0.14384,0.044037,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.011047,0.1437,0.18536,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.033894,0.1434,0.13322,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.019283,0.14327,0.10642,0,0
5,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.25729,0.14312,0.073989,0,0
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.084046,0.1426,0.24327,0,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.13814,0.14223,0.088521,0,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.064293,0.14089,0.11227,0,0
5,GO RNA 5 END PROCESSING,0.25729,0.14082,0.072024,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.11235,0.14039,0.1155,0,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.62113,0.14035,0.01667,0,0
5,GO PIGMENT ACCUMULATION,0.15015,0.14031,0.086648,0,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.045624,0.14024,0.20583,0,0
5,GO REGULATION OF PODOSOME ASSEMBLY,0.30815,0.13975,0.058399,0,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.53167,0.13975,-0.0022403,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.063042,0.13955,0.1004,0,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.085627,0.13928,0.17194,0,0
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.10096,0.13913,0.15801,0,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.0695,0.13848,0.14268,0,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.66501,0.13804,0.052292,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.10654,0.13801,0.11299,0,0
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.10465,0.13742,0.074169,0,0
5,GO MONOAMINE TRANSPORT,0.073629,0.1374,0.18396,0,0
5,GO LIPID IMPORT INTO CELL,0.092194,0.13702,0.15933,0,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.22568,0.13686,0.070638,0,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.17934,0.13676,0.1384,0,0
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.073629,0.13648,0.10296,0,0
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.31232,0.13619,0.088833,0,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.21256,0.13546,0.095889,0,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.05161,0.13542,0.13941,0,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.29586,0.13502,0.097946,0,0
5,GO ENDOTHELIAL CELL MIGRATION,0.05824,0.13457,0.098078,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.35607,0.13411,0.060297,0,0
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.36064,0.13306,0.079729,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.67776,0.13208,0.009992,0,0
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.16559,0.13157,0.092538,0,0
5,GO STRIATED MUSCLE ADAPTATION,0.14285,0.13134,0.09475,0,0
5,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.21905,0.13132,0.090527,0,0
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.26098,0.13072,0.071191,0,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.085627,0.13069,0.12251,0,0
5,GO ENDOCARDIUM DEVELOPMENT,0.14526,0.13017,0.15156,0,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.69061,0.12994,0.0029589,0,0
5,GO RESPONSE TO MUSCLE INACTIVITY,0.077957,0.12959,0.18822,0,0
5,GO POLYAMINE METABOLIC PROCESS,0.053746,0.12954,0.14234,0,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.053746,0.1295,0.11509,0,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.67776,0.12935,-0.025647,0,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.17653,0.12906,0.11906,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.50337,0.12889,0.047716,0,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.080955,0.12844,0.14475,0,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.33373,0.12839,0.058753,0,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.22235,0.12815,0.045865,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.24288,0.12801,0.11933,0,0
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.084046,0.12763,0.099312,0,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.15773,0.12758,0.10993,0,0
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.19393,0.12707,0.073086,0,0
5,GO PENILE ERECTION,0.53167,0.12666,0.038089,0,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.21579,0.1257,0.041677,0,0
5,GO REGULATION OF DOPAMINE SECRETION,0.13814,0.12567,0.24929,0,0
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.2,0.12546,0.10059,0,0
5,GO RESPONSE TO ESTROGEN,0.54903,0.12516,0.030003,0,0
5,GO REGULATION OF AMINO ACID TRANSPORT,0.19695,0.12497,0.10583,0,0
5,GO CELLULAR RESPONSE TO IRON ION,0.27999,0.12497,0.089315,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.17099,0.12495,0.08758,0,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.060602,0.12494,0.094157,0,0
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.05824,0.12487,0.11192,0,0
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.088862,0.12439,0.20883,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.32938,0.12307,0.064851,0,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.17374,0.12296,0.083238,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.16828,0.12243,0.061148,0,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.087232,0.1224,0.11434,0,0
5,GO MUSCLE CELL PROLIFERATION,0.075049,0.12193,0.071669,0,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.11841,0.12104,0.11174,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.32077,0.12076,0.057462,0,0
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.053746,0.12066,0.12673,0,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.21256,0.12061,0.035026,0,0
5,GO FIBRINOLYSIS,0.50896,0.12057,0.10011,0,0
5,GO PROTEIN KINASE C SIGNALING,0.14285,0.12048,0.12251,0,0
5,GO GLIAL CELL ACTIVATION,0.30815,0.1203,0.043784,0,0
5,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.16559,0.12003,0.10317,0,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.51459,0.12003,0.069834,0,0
5,GO TRNA 5 END PROCESSING,0.093897,0.11963,0.09695,0,0
5,GO ENDODERMAL CELL FATE COMMITMENT,0.25729,0.11959,0.057396,0,0
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.052669,0.11933,0.27046,0,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11841,0.11891,0.07418,0,0
5,GO CELL MATRIX ADHESION,0.099158,0.11824,0.076833,0,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.075049,0.11793,0.099659,0,0
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.32077,0.11773,0.042847,0,0
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.092194,0.11771,0.11572,0,0
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.16559,0.1175,0.11099,0,0
5,GO I KAPPAB PHOSPHORYLATION,0.23245,0.11743,0.083429,0,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.11039,0.11732,0.17818,0,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.10096,0.11702,0.077546,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.10845,0.11668,0.19474,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.095625,0.11628,0.19353,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.092194,0.116,0.11762,0,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.22235,0.11593,0.07106,0,0
5,GO COLLAGEN CATABOLIC PROCESS,0.38408,0.11569,0.023518,0,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.24288,0.11555,0.047007,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.34702,0.11543,0.06851,0,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.084046,0.11541,0.087436,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.03939,0.11525,0.18804,0,0
5,GO OSTEOBLAST DEVELOPMENT,0.16032,0.1149,0.046354,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.095625,0.11482,0.098657,0,0
5,GO AMINE TRANSPORT,0.090515,0.1147,0.16162,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.076492,0.11468,0.10337,0,0
5,GO OSTEOCLAST DEVELOPMENT,0.32938,0.11467,0.060572,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.24643,0.11464,0.065653,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.22568,0.11463,0.06078,0,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.19393,0.11419,0.065378,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.26471,0.11402,0.13574,0,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.87144,0.11352,-0.0029292,0,0
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.11434,0.11308,0.088624,0,0
5,GO MACROPHAGE CHEMOTAXIS,0.093897,0.11289,0.069864,0,0
5,GO GROOMING BEHAVIOR,0.14048,0.11288,0.13407,0,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.070855,0.11282,0.092232,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.52594,0.11239,-0.014029,0,0
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.25001,0.11233,0.066277,0,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.88523,0.11229,0.029262,0,0
5,GO OSTEOCLAST DIFFERENTIATION,0.11434,0.11214,0.07218,0,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.21905,0.11207,0.048625,0,0
5,GO NAD BIOSYNTHETIC PROCESS,0.2,0.112,0.095112,0,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.055956,0.11166,0.09449,0,0
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.47049,0.11161,0.055457,0,0
5,GO DNA DEMETHYLATION,0.22905,0.11146,0.065807,0,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.17374,0.11124,0.074613,0,0
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.17374,0.11083,0.079677,0,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.27227,0.11073,0.070779,0,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.12049,0.1104,0.11742,0,0
5,GO GLYCINE TRANSPORT,0.93377,0.11037,0.0071356,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.30815,0.11031,0.052881,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.12689,0.11025,0.10369,0,0
5,GO STEROL IMPORT,0.061812,0.11024,0.18749,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.065563,0.11002,0.069953,0,0
5,GO ANION HOMEOSTASIS,0.32506,0.10925,0.073835,0,0
5,GO REGULATION OF RESPONSE TO FOOD,0.53167,0.10855,0.023023,0,0
5,GO REGENERATION,0.32077,0.10809,0.028951,0,0
5,GO PROTEIN ACTIVATION CASCADE,0.2,0.10787,0.14701,0,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.16294,0.10755,0.094912,0,0
5,GO LUNG MORPHOGENESIS,0.29586,0.10751,0.043872,0,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.038561,0.10739,0.12266,0,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.67776,0.10738,0.032316,0,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.072231,0.10728,0.17885,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.092194,0.10709,0.12936,0,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,0.064293,0.10704,0.16738,0,0
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.13355,0.10697,0.048832,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.12259,0.10676,0.093536,0,0
5,GO WATER TRANSPORT,0.1028,0.10671,0.066991,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0090226,0.10628,0.11282,0,0
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.10096,0.10618,0.2348,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.19695,0.106,0.071829,0,0
5,GO PLACENTA DEVELOPMENT,0.14526,0.10593,0.075406,0,0
5,GO DEVELOPMENTAL INDUCTION,0.11235,0.10584,0.086121,0,0
5,GO P38MAPK CASCADE,0.13355,0.1057,0.092555,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.22235,0.10553,0.10093,0,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.087232,0.10547,0.09555,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.12049,0.10533,0.073918,0,0
5,GO ENDODERM DEVELOPMENT,0.47049,0.10532,0.023516,0,0
5,GO REGULATION OF BLOOD CIRCULATION,0.084046,0.10495,0.075956,0,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.025994,0.10472,0.16151,0,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.62113,0.10465,0.019908,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.12049,0.10442,0.082267,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.079444,0.1044,0.10912,0,0
5,GO PEPTIDYL PROLINE MODIFICATION,0.10465,0.10425,0.094167,0,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.81668,0.10418,0.046989,0,0
5,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.19695,0.10417,0.082321,0,0
5,GO RESPONSE TO RETINOIC ACID,0.31653,0.10411,0.043591,0,0
5,GO COMPLEMENT ACTIVATION,0.082489,0.10396,0.11698,0,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.19695,0.10395,0.067955,0,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.40843,0.10375,0.086588,0,0
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.51459,0.10371,0.03456,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.78962,0.10325,0.011987,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.20937,0.10324,0.069176,0,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.19393,0.10304,0.072471,0,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.14526,0.10302,0.10606,0,0
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.057089,0.10283,0.082259,0,0
5,GO CELLULAR EXTRAVASATION,0.26471,0.10273,0.05251,0,0
5,GO NOTOCHORD DEVELOPMENT,0.51459,0.10273,-0.012973,0,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.05824,0.10272,0.11114,0,0
5,GO MALE SEX DETERMINATION,0.16032,0.10223,0.12396,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.29586,0.10221,0.042947,0,0
5,GO POSTREPLICATION REPAIR,0.066855,0.1022,0.053756,0,0
5,GO NOREPINEPHRINE TRANSPORT,0.25729,0.10179,0.080017,0,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.22905,0.10142,0.052572,0,0
5,GO RESPONSE TO UV C,0.14526,0.10124,0.082797,0,0
5,GO REGULATION OF PROTEIN FOLDING,0.11039,0.10059,0.075033,0,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.080955,0.10058,0.21077,0,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.83713,0.1004,0.0092249,0,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.2,0.10027,0.038622,0,0
5,GO INTERLEUKIN 4 PRODUCTION,0.14048,0.10025,0.11802,0,0
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.7495,0.10023,0.014009,0,0
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.50896,0.1002,0.033685,0,0
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.65866,0.099857,0.034822,0,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.17374,0.099714,0.096047,0,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.35607,0.099653,-0.0023921,0,0
5,GO GLUTATHIONE METABOLIC PROCESS,0.11235,0.099574,0.19656,0,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.50337,0.099499,0.021565,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.10654,0.099491,0.11323,0,0
5,GO NEPHRON DEVELOPMENT,0.1028,0.09927,0.066812,0,0
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.12259,0.099088,0.086886,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.085627,0.098997,0.086504,0,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.2,0.098909,0.060648,0,0
5,GO PRE MIRNA PROCESSING,0.96163,0.098802,-0.0097885,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.3746,0.098495,0.043088,0,0
5,GO NEPHRIC DUCT DEVELOPMENT,0.24643,0.098468,0.08881,0,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.36991,0.098428,0.075739,0,0
5,GO URONIC ACID METABOLIC PROCESS,0.04854,0.098422,0.13004,0,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.44924,0.098323,0.0086931,0,0
5,GO TRICARBOXYLIC ACID CYCLE,0.057089,0.097923,0.16596,0,0
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.27611,0.097821,0.086731,0,0
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.20621,0.09777,0.093708,0,0
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.33373,0.09765,0.066636,0,0
5,GO REGULATION OF VESICLE FUSION,0.29586,0.097437,0.10934,0,0
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.14048,0.097116,0.085526,0,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.88523,0.096907,-0.077975,0,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.16828,0.096808,0.076919,0,0
5,GO CARDIAC CELL DEVELOPMENT,0.17653,0.096597,0.056767,0,0
5,GO PINOCYTOSIS,0.20309,0.096393,0.042538,0,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.48678,0.096319,0.067721,0,0
5,GO COENZYME A METABOLIC PROCESS,0.15517,0.096273,0.10095,0,0
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.079444,0.09584,0.10749,0,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.12689,0.095814,0.13252,0,0
5,GO REGULATION OF MEMBRANE INVAGINATION,0.53167,0.095648,0.086299,0,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.20309,0.095609,0.10863,0,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.40843,0.095485,0.04605,0,0
5,GO RESPONSE TO INSECTICIDE,0.072231,0.095395,0.20565,0,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.037747,0.095335,0.12583,0,0
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.16294,0.095188,0.074846,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.22905,0.094731,0.075542,0,0
5,GO MAMMARY GLAND MORPHOGENESIS,0.10654,0.094683,0.11393,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.21256,0.09468,0.11613,0,0
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.27227,0.094618,0.062298,0,0
5,GO PIGMENT CELL DIFFERENTIATION,0.2,0.094601,0.049154,0,0
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.39371,0.094589,0.044101,0,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.12049,0.094385,0.08303,0,0
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.20621,0.094284,0.04217,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.23245,0.094272,0.033524,0,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.11841,0.094182,0.08031,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.34702,0.093748,0.22457,0,0
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.15015,0.093685,0.085648,0,0
5,GO MACROPHAGE DIFFERENTIATION,0.23245,0.093529,0.0765,0,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.41842,0.093498,0.034307,0,0
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.23937,0.093484,0.089271,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.50337,0.093254,0.017219,0,0
5,GO AMINO SUGAR METABOLIC PROCESS,0.29184,0.093236,0.074846,0,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.061812,0.093187,0.091725,0,0
5,GO ORGANIC CATION TRANSPORT,0.053746,0.093108,0.13676,0,0
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.27227,0.092655,0.037933,0,0
5,GO PENTOSE METABOLIC PROCESS,0.53742,0.092298,0.066648,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.63978,0.092151,0.0088083,0,0
5,GO ASTROCYTE ACTIVATION,0.94769,0.091998,-0.043595,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.088862,0.09198,0.072665,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.17653,0.091671,0.082872,0,0
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.50896,0.091617,0.012102,0,0
5,GO RETINOIC ACID METABOLIC PROCESS,0.60883,0.091595,0.024739,0,0
5,GO PYRUVATE METABOLIC PROCESS,0.15264,0.091545,0.067517,0,0
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.082489,0.091373,0.086336,0,0
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0054795,0.091289,0.10075,0,0
5,GO EPIDERMIS MORPHOGENESIS,0.14526,0.091191,0.069103,0,0
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.10654,0.09104,0.12485,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.088862,0.090807,0.05903,0,0
5,GO MACROPHAGE PROLIFERATION,0.20621,0.09078,0.13996,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.10096,0.090749,0.10472,0,0
5,GO CELL JUNCTION DISASSEMBLY,0.73628,0.090371,0.014362,0,0
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.082489,0.09036,0.070083,0,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.16559,0.090161,0.1295,0,0
5,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.68418,0.090152,0.0093849,0,0
5,GO FORMATION OF PRIMARY GERM LAYER,0.41842,0.09006,0.034159,0,0
5,GO COBALAMIN METABOLIC PROCESS,0.013798,0.089916,0.22435,0,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.12908,0.089814,0.087244,0,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.18219,0.089746,0.042005,0,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.40349,0.089591,-0.033552,0,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.39371,0.089514,0.060123,0,0
5,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.71658,0.089452,0.0070911,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.78289,0.089442,0.00053091,0,0
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13355,0.089214,0.076126,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.26471,0.089167,0.078279,0,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.053746,0.089096,0.20356,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.30815,0.088935,0.0099497,0,0
5,GO ORGAN INDUCTION,0.39858,0.088732,0.025605,0,0
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.43883,0.088724,0.042443,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.4545,0.088537,0.078776,0,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.46512,0.088371,0.053368,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.19095,0.088369,0.076017,0,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.053746,0.088194,0.16148,0,0
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.17374,0.088115,0.087704,0,0
5,GO MULTI ORGANISM CELLULAR PROCESS,0.19695,0.087734,0.046951,0,0
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.51459,0.087729,0.021556,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.81668,0.087606,-0.0098104,0,0
5,GO POTASSIUM ION HOMEOSTASIS,0.4598,0.087527,0.041301,0,0
5,GO SYNAPTIC VESICLE BUDDING,0.34256,0.087509,0.078757,0,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.73628,0.087492,-0.056898,0,0
5,GO CARDIAC CONDUCTION,0.35153,0.087326,0.045441,0,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.54903,0.087296,0.09038,0,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.36991,0.087047,0.069631,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.92682,0.086691,-0.03244,0,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.13583,0.086564,0.059011,0,0
5,GO GLIAL CELL MIGRATION,0.83713,0.085892,-0.01534,0,0
5,GO PSEUDOPODIUM ORGANIZATION,0.16559,0.085604,0.15743,0,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.25363,0.08535,0.050437,0,0
5,GO REGULATION OF CELL MATRIX ADHESION,0.066855,0.085226,0.11864,0,0
5,GO THYROID HORMONE METABOLIC PROCESS,0.16559,0.084984,0.075892,0,0
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.16294,0.084961,0.055251,0,0
5,GO REGULATION OF HAIR CYCLE,0.11841,0.0847,0.11055,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.079444,0.08464,0.12395,0,0
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.78289,0.084532,-0.038039,0,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.18508,0.084408,0.10367,0,0
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.077957,0.084301,0.099564,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.21579,0.084257,0.057716,0,0
5,GO RESPONSE TO INTERLEUKIN 12,0.26098,0.084215,0.062531,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.072231,0.084093,0.099347,0,0
5,GO CATION TRANSMEMBRANE TRANSPORT,0.049546,0.084089,0.078353,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.14285,0.084071,0.080982,0,0
5,GO SEX DETERMINATION,0.42855,0.083932,0.03942,0,0
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.15773,0.083886,0.054688,0,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.10654,0.083864,0.054726,0,0
5,GO RESPONSE TO INACTIVITY,0.079444,0.08386,0.16668,0,0
5,GO CARBOHYDRATE PHOSPHORYLATION,0.39371,0.083731,0.055141,0,0
5,GO AMINO ACID IMPORT,0.23937,0.083664,0.087611,0,0
5,GO MESONEPHROS DEVELOPMENT,0.072231,0.083485,0.086245,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.19095,0.083461,0.083576,0,0
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.080955,0.083202,0.11099,0,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.20937,0.082962,0.074972,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.31232,0.082901,0.03883,0,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.061812,0.082748,0.080934,0,0
5,GO PROTEIN LOCALIZATION TO AXON,0.54321,0.082685,0.098597,0,0
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.11039,0.082348,0.039554,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.14048,0.082256,0.074967,0,0
5,GO T CELL DIFFERENTIATION IN THYMUS,0.30402,0.082011,0.04619,0,0
5,GO INTRACELLULAR MRNA LOCALIZATION,0.63978,0.081683,0.011374,0,0
5,GO NERVE DEVELOPMENT,0.27611,0.081531,0.067868,0,0
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.49227,0.081495,0.045007,0,0
5,GO PROTEIN OXIDATION,0.59664,0.081473,-0.0014352,0,0
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.36064,0.081406,0.067567,0,0
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.076492,0.081338,0.17321,0,0
5,GO OOCYTE MATURATION,0.54903,0.081327,0.030394,0,0
5,GO CELLULAR IRON ION HOMEOSTASIS,0.16559,0.081291,0.10173,0,0
5,GO MACROPHAGE APOPTOTIC PROCESS,0.23937,0.080992,0.099246,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.71658,0.080975,0.060387,0,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.11235,0.080664,0.075771,0,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.11039,0.080451,0.13805,0,0
5,GO RESPONSE TO LEPTIN,0.065563,0.080318,0.15247,0,0
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.67776,0.080311,0.014189,0,0
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.14769,0.080271,0.056568,0,0
5,GO PRESYNAPTIC ENDOCYTOSIS,0.65234,0.080243,0.024846,0,0
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.097379,0.080068,0.077964,0,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.36526,0.080027,0.036153,0,0
5,GO PIGMENT GRANULE ORGANIZATION,0.092194,0.079827,0.078289,0,0
5,GO NEPHRIC DUCT MORPHOGENESIS,0.94073,0.079713,-0.035523,0,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.72969,0.079613,-0.038274,0,0
5,GO POSITIVE REGULATION OF MYELINATION,0.27999,0.079499,0.049689,0,0
5,GO PIGMENT METABOLIC PROCESS,0.12473,0.07944,0.097071,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.36064,0.079438,0.042235,0,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.14285,0.079256,0.072432,0,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.066855,0.079228,0.11014,0,0
5,GO RESPONSE TO HYDROXYUREA,0.073629,0.078982,0.11308,0,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.30815,0.07884,0.067237,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.23589,0.078836,0.055926,0,0
5,GO COPPER ION HOMEOSTASIS,0.41842,0.078737,0.060482,0,0
5,GO CARDIAC ATRIUM DEVELOPMENT,0.42855,0.078554,0.052425,0,0
5,GO RESPONSE TO ZINC ION,0.19695,0.078497,0.1397,0,0
5,GO T HELPER 1 CELL DIFFERENTIATION,0.97557,0.078298,-0.01955,0,0
5,GO ENDOTHELIUM DEVELOPMENT,0.15015,0.078201,0.068243,0,0
5,GO TUMOR NECROSIS FACTOR SECRETION,0.20937,0.077766,0.057286,0,0
5,GO NEUROINFLAMMATORY RESPONSE,0.41842,0.077761,0.036027,0,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.049546,0.077637,0.07654,0,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.092194,0.077618,0.12776,0,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.25001,0.077603,0.076463,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.44402,0.077595,0.0546,0,0
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.15773,0.077536,0.13776,0,0
5,GO PEPTIDYL TYROSINE MODIFICATION,0.054842,0.077522,0.083091,0,0
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.18508,0.077379,0.058422,0,0
5,GO MELANOCYTE DIFFERENTIATION,0.12049,0.077352,0.056879,0,0
5,GO ENDOTHELIAL CELL DEVELOPMENT,0.48131,0.077264,0.033076,0,0
5,GO IMMATURE B CELL DIFFERENTIATION,0.34256,0.07723,0.072204,0,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.087232,0.077098,0.15829,0,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.98255,0.076716,-0.024636,0,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.32506,0.076703,0.013508,0,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.13814,0.076676,0.13277,0,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.52025,0.076643,0.042844,0,0
5,GO MIDGUT DEVELOPMENT,0.2,0.076437,0.14711,0,0
5,GO PEPTIDE METABOLIC PROCESS,0.32938,0.076267,0.037962,0,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.15264,0.076263,0.056921,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.17099,0.076252,0.078627,0,0
5,GO PHOTOTRANSDUCTION,0.093897,0.075914,0.057534,0,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.7495,0.075867,-0.033279,0,0
5,GO INTERACTION WITH SYMBIONT,0.188,0.075834,0.032224,0,0
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.11434,0.075785,0.066127,0,0
5,GO ACROSOME REACTION,0.14048,0.075477,0.13445,0,0
5,GO RESPONSE TO INTERLEUKIN 7,0.079444,0.075447,0.091204,0,0
5,GO RNA MODIFICATION,0.33373,0.075212,0.038871,0,0
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.23937,0.075186,0.050059,0,0
5,GO REGULATION OF CELLULAR RESPIRATION,0.10654,0.075083,0.16296,0,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.20937,0.074985,0.079157,0,0
5,GO RESPONSE TO PROSTAGLANDIN,0.188,0.07498,0.1304,0,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.60272,0.074264,0.045172,0,0
5,GO REGULATION OF CALCIUM ION IMPORT,0.38888,0.074129,0.071943,0,0
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.62732,0.074108,0.044097,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.19393,0.073895,0.052974,0,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.63978,0.07372,0.027899,0,0
5,GO PERICARDIUM DEVELOPMENT,0.82348,0.073507,-0.016338,0,0
5,GO CELLULAR ANION HOMEOSTASIS,0.81668,0.07339,-0.023047,0,0
5,GO METANEPHROS MORPHOGENESIS,0.36526,0.073339,0.0624,0,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.36991,0.073329,0.025569,0,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.43883,0.07321,0.034271,0,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.070855,0.073128,0.063158,0,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.17653,0.072896,0.093056,0,0
5,GO REGULATION OF SODIUM ION TRANSPORT,0.26471,0.072879,0.0729,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.32077,0.07277,0.049903,0,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0695,0.072659,0.081423,0,0
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.19695,0.072621,0.031117,0,0
5,GO TRANSMISSION OF NERVE IMPULSE,0.13814,0.072556,0.13141,0,0
5,GO ANATOMICAL STRUCTURE MATURATION,0.05161,0.072392,0.068856,0,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.69707,0.072369,0.036801,0,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.4978,0.072338,0.045515,0,0
5,GO TOXIN TRANSPORT,0.11235,0.072312,0.10845,0,0
5,GO REGULATION OF PHAGOCYTOSIS,0.21905,0.07218,0.061039,0,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,0.25363,0.0721,0.091662,0,0
5,GO DNA DEALKYLATION,0.53742,0.072052,0.015274,0,0
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.14285,0.071881,0.054071,0,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.63978,0.071402,0.026705,0,0
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.17653,0.071239,0.041659,0,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.17653,0.071109,0.10509,0,0
5,GO REGULATION OF EXOCYTOSIS,0.15517,0.071015,0.075553,0,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.16032,0.071002,0.03824,0,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.23937,0.070931,0.082087,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.23589,0.070608,0.05549,0,0
5,GO RESPONSE TO ACTIVITY,0.047551,0.070482,0.12335,0,0
5,GO PROTEIN TARGETING,0.40349,0.070337,0.02957,0,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.33373,0.070227,0.032928,0,0
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.14769,0.070012,0.074202,0,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.32077,0.070008,0.057757,0,0
5,GO ARGININE METABOLIC PROCESS,0.20621,0.069962,0.22186,0,0
5,GO RNA METHYLATION,0.59059,0.069944,0.018323,0,0
5,GO FEEDING BEHAVIOR,0.16828,0.069941,0.077849,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,0.65866,0.069933,0.020913,0,0
5,GO RENAL WATER HOMEOSTASIS,0.66501,0.069817,0.014838,0,0
5,GO POSITIVE REGULATION OF CELL GROWTH,0.21905,0.069776,0.041431,0,0
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.076492,0.069754,0.19659,0,0
5,GO GLAND MORPHOGENESIS,0.26471,0.069372,0.051015,0,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.28785,0.069153,0.083117,0,0
5,GO OOGENESIS,0.38888,0.069136,0.035058,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10845,0.069087,0.099433,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.92682,0.068696,-0.010061,0,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.10096,0.06864,0.067999,0,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.14769,0.068633,0.062874,0,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.35153,0.068325,0.032049,0,0
5,GO GLIAL CELL APOPTOTIC PROCESS,0.23589,0.068085,0.11298,0,0
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.050569,0.067993,0.068866,0,0
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.56666,0.067965,0.029549,0,0
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.25363,0.067873,0.092103,0,0
5,GO HYPEROSMOTIC RESPONSE,0.48678,0.067744,0.052431,0,0
5,GO AORTA MORPHOGENESIS,0.56666,0.067731,0.030121,0,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.58456,0.067439,-0.0012616,0,0
5,GO VESICLE LOCALIZATION,0.12259,0.067281,0.069352,0,0
5,GO CELLULAR OXIDANT DETOXIFICATION,0.25363,0.067104,0.095513,0,0
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.12259,0.067058,0.091237,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.41842,0.066945,0.089754,0,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.38408,0.066931,0.093496,0,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.073629,0.066927,0.12168,0,0
5,GO LYMPH NODE DEVELOPMENT,0.076492,0.066807,0.1316,0,0
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.88523,0.066753,-0.011451,0,0
5,GO TUBE MORPHOGENESIS,0.36526,0.066751,0.022966,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.10096,0.066736,0.1585,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.56666,0.066627,0.019061,0,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.12259,0.066584,0.098153,0,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.54321,0.066546,0.0087755,0,0
5,GO BLOOD VESSEL MORPHOGENESIS,0.38408,0.066523,0.022326,0,0
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.98255,0.066495,0.011753,0,0
5,GO REGULATION OF PROTEIN MATURATION,0.12473,0.066379,0.074513,0,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.066855,0.066262,0.18636,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.21579,0.06605,0.0847,0,0
5,GO GMP METABOLIC PROCESS,0.54903,0.065959,0.032239,0,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.12049,0.065942,0.02873,0,0
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.11434,0.065855,0.065197,0,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.54903,0.065736,0.026077,0,0
5,GO PROTEIN FOLDING,0.064293,0.065715,0.086416,0,0
5,GO NOREPINEPHRINE SECRETION,0.44924,0.065628,0.065724,0,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.53167,0.065568,0.0058868,0,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.57857,0.065521,-0.04623,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.27999,0.065517,0.053557,0,0
5,GO REGULATION OF CELL FATE COMMITMENT,0.19393,0.06539,0.073933,0,0
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.73628,0.065336,-0.0086295,0,0
5,GO HEMIDESMOSOME ASSEMBLY,0.53742,0.065231,0.08187,0,0
5,GO RESPONSE TO CAMP,0.25729,0.065226,0.062687,0,0
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.29992,0.065195,0.03318,0,0
5,GO HEME METABOLIC PROCESS,0.22235,0.065083,0.1313,0,0
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.20309,0.065033,0.051457,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY,0.10096,0.064913,0.053943,0,0
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.54321,0.064868,0.035036,0,0
5,GO REGULATION OF ODONTOGENESIS,0.99651,0.064855,-0.05059,0,0
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.42347,0.064787,0.043209,0,0
5,GO UV DAMAGE EXCISION REPAIR,0.52025,0.064778,0.025368,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.78289,0.064773,-0.006834,0,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.47588,0.064717,0.010323,0,0
5,GO RESPONSE TO NICOTINE,0.73628,0.064548,0.01047,0,0
5,GO THYMUS DEVELOPMENT,0.67776,0.064391,0.015061,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.90599,0.064289,-0.020117,0,0
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.35153,0.064146,0.085827,0,0
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.14048,0.064105,0.0624,0,0
5,GO NEGATIVE REGULATION OF TRANSPORT,0.25729,0.064058,0.04008,0,0
5,GO REPRODUCTIVE BEHAVIOR,0.60272,0.064038,0.024641,0,0
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.65234,0.064028,0.056522,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.17653,0.063947,0.13018,0,0
5,GO ADAPTATION OF SIGNALING PATHWAY,0.59664,0.063928,0.024386,0,0
5,GO RESPONSE TO AMINE,0.90599,0.063928,0.0075997,0,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.69061,0.063896,0.0058055,0,0
5,GO GOLGI LOCALIZATION,0.3746,0.063887,0.055745,0,0
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.87144,0.063806,-0.014342,0,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.082489,0.063753,0.13777,0,0
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.070855,0.06363,0.060425,0,0
5,GO GLUCOSE CATABOLIC PROCESS,0.36991,0.063468,0.074368,0,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.74288,0.063455,0.062652,0,0
5,GO KIDNEY MORPHOGENESIS,0.3746,0.063367,0.034842,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.31653,0.063256,0.23769,0,0
5,GO ALDITOL METABOLIC PROCESS,0.59059,0.063249,0.025257,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.38408,0.063196,0.0059033,0,0
5,GO SECRETORY GRANULE ORGANIZATION,0.22568,0.063168,0.074727,0,0
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.10465,0.063089,0.0711,0,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.14048,0.06301,0.049181,0,0
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.25729,0.062863,0.053744,0,0
5,GO AMP METABOLIC PROCESS,0.23245,0.062829,0.12356,0,0
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.67137,0.062817,-0.019936,0,0
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.16828,0.062716,0.077862,0,0
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.22905,0.0627,0.046076,0,0
5,GO DIENCEPHALON DEVELOPMENT,0.3746,0.062678,0.061779,0,0
5,GO REGULATION OF PROTEIN SUMOYLATION,0.20309,0.062624,0.068965,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.50896,0.062549,0.048504,0,0
5,GO LYSOSOMAL TRANSPORT,0.082489,0.062484,0.10543,0,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.82348,0.062205,0.0064088,0,0
5,GO CERAMIDE TRANSPORT,0.32077,0.061779,0.14178,0,0
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.24288,0.0617,0.089768,0,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.74288,0.061602,-0.010161,0,0
5,GO CELLULAR SENESCENCE,0.14769,0.061552,0.050792,0,0
5,GO GASTRULATION,0.39858,0.061538,0.034172,0,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.23245,0.061526,0.076637,0,0
5,GO ACTION POTENTIAL,0.19393,0.06143,0.083271,0,0
5,GO CELL AGING,0.18508,0.06133,0.043554,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.063042,0.061087,0.063819,0,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.35607,0.06079,0.077472,0,0
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.38408,0.06061,0.018342,0,0
5,GO MEMBRANE INVAGINATION,0.15264,0.06052,0.070751,0,0
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.38408,0.060517,0.036081,0,0
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.064293,0.06037,0.042678,0,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.89215,0.060262,-0.0121,0,0
5,GO TISSUE REGENERATION,0.2,0.060171,0.075444,0,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.82348,0.060129,-0.024219,0,0
5,GO PULMONARY VALVE MORPHOGENESIS,0.41341,0.060036,0.073745,0,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.94073,0.060009,-0.027722,0,0
5,GO MALE SEX DIFFERENTIATION,0.16032,0.059969,0.047607,0,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.076492,0.059874,0.11889,0,0
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.11434,0.059854,0.065128,0,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.099158,0.059795,0.098829,0,0
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.14526,0.05976,0.072379,0,0
5,GO ARTERY MORPHOGENESIS,0.19095,0.059703,0.027248,0,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.52594,0.059423,0.15499,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.33812,0.059384,0.046676,0,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.75615,0.059284,-0.0093924,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.20937,0.059275,0.042894,0,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.72313,0.059262,-0.085988,0,0
5,GO AMIDE BIOSYNTHETIC PROCESS,0.43367,0.059236,0.025277,0,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.21579,0.058939,0.091731,0,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.8303,0.05879,0.0054406,0,0
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.11636,0.058636,0.06761,0,0
5,GO APOPTOTIC CELL CLEARANCE,0.72969,0.058413,-0.058235,0,0
5,GO SERTOLI CELL DIFFERENTIATION,0.46512,0.058372,0.027907,0,0
5,GO RESPONSE TO HYDROPEROXIDE,0.78289,0.05835,0.030038,0,0
5,GO LEUKOCYTE TETHERING OR ROLLING,0.12689,0.058242,0.063294,0,0
5,GO PIGMENT GRANULE MATURATION,0.40843,0.058115,0.030616,0,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.52594,0.05811,0.0086294,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.12259,0.058073,0.062287,0,0
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.83713,0.058055,-0.051032,0,0
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.59059,0.057976,0.027268,0,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.25729,0.057874,0.031817,0,0
5,GO RESPONSE TO LEUCINE,0.35607,0.057728,0.08183,0,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.18508,0.057713,0.041066,0,0
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.16294,0.057552,0.060465,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.69707,0.057521,0.0065363,0,0
5,GO ENDODERM FORMATION,0.85082,0.057449,-0.034544,0,0
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.51459,0.057387,0.025944,0,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,0.23245,0.057223,0.024419,0,0
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.072231,0.057132,0.066508,0,0
5,GO INTERMEMBRANE LIPID TRANSFER,0.23937,0.057123,0.050579,0,0
5,GO HEART PROCESS,0.23937,0.057098,0.047579,0,0
5,GO MESODERM MORPHOGENESIS,0.43367,0.057064,0.022215,0,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.22568,0.057064,0.08426,0,0
5,GO VESICLE CARGO LOADING,0.85082,0.057016,0.043147,0,0
5,GO MYOFIBRIL ASSEMBLY,0.093897,0.056969,0.065781,0,0
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.36526,0.056909,0.031078,0,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.40349,0.056824,0.021358,0,0
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.188,0.056647,0.061527,0,0
5,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.23937,0.056524,0.08463,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.80989,0.0565,0.0070924,0,0
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.20937,0.056366,0.074665,0,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.088862,0.056315,0.026861,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.13814,0.056269,0.17171,0,0
5,GO MYELIN ASSEMBLY,0.4545,0.056032,0.050171,0,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.25363,0.055954,0.049581,0,0
5,GO REGULATION OF ERAD PATHWAY,0.82348,0.055932,0.0069404,0,0
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.092194,0.055877,0.073387,0,0
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.47588,0.055678,0.064729,0,0
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.14769,0.05563,0.086813,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.14526,0.05554,0.068585,0,0
5,GO SECONDARY PALATE DEVELOPMENT,0.55487,0.055538,0.043995,0,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.11235,0.055432,0.071133,0,0
5,GO NCRNA 3 END PROCESSING,0.60272,0.055362,-0.013008,0,0
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.29184,0.055303,0.05564,0,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.93377,0.055299,-0.031259,0,0
5,GO DETECTION OF MECHANICAL STIMULUS,0.54321,0.055265,0.038197,0,0
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.32506,0.055265,0.021994,0,0
5,GO TRNA METABOLIC PROCESS,0.53167,0.055208,0.029085,0,0
5,GO REGULATION OF OSSIFICATION,0.12473,0.055149,0.063351,0,0
5,GO FIBROBLAST ACTIVATION,0.47588,0.055124,0.035732,0,0
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.10465,0.055081,0.05242,0,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.52594,0.055054,0.038447,0,0
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.85082,0.05499,-0.006154,0,0
5,GO FEVER GENERATION,0.62113,0.0549,0.020101,0,0
5,GO GLIAL CELL FATE COMMITMENT,0.47588,0.054884,0.11501,0,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.05824,0.054812,0.043436,0,0
5,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.98953,0.054667,0.022934,0,0
5,GO AXONEME ASSEMBLY,0.42347,0.054544,0.055559,0,0
5,GO THYMIC T CELL SELECTION,0.38408,0.054393,0.040588,0,0
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16828,0.054322,0.077279,0,0
5,GO OSSIFICATION,0.20621,0.054308,0.040809,0,0
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.20621,0.054276,0.060428,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.61497,0.054225,0.029494,0,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.075049,0.054164,0.058203,0,0
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.18508,0.054159,0.082986,0,0
5,GO AUTOPHAGIC CELL DEATH,0.1313,0.054046,0.097013,0,0
5,GO EPITHELIAL TUBE FORMATION,0.76948,0.053958,-0.0060804,0,0
5,GO REGULATION OF VACUOLE ORGANIZATION,0.054842,0.05394,0.098607,0,0
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.92682,0.053873,-0.006909,0,0
5,GO NEGATIVE REGULATION OF SIGNALING,0.27227,0.053821,0.034861,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.54903,0.053658,0.037871,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.23937,0.053308,0.038825,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.69061,0.05311,0.18479,0,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.34702,0.052934,0.028458,0,0
5,GO MITOCHONDRIAL TRANSLATION,0.35607,0.052854,0.054064,0,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.20621,0.052792,0.03137,0,0
5,GO INACTIVATION OF MAPK ACTIVITY,0.48678,0.052688,0.060108,0,0
5,GO MOLTING CYCLE,0.21579,0.052637,0.039058,0,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.068167,0.052553,0.039063,0,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.39858,0.052525,0.064711,0,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.15015,0.052495,0.045698,0,0
5,GO IRON ION HOMEOSTASIS,0.090515,0.052424,0.1055,0,0
5,GO TISSUE MORPHOGENESIS,0.29586,0.052415,0.021147,0,0
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.3746,0.052305,0.035003,0,0
5,GO ONE CARBON METABOLIC PROCESS,0.50337,0.052214,0.018603,0,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.5726,0.052016,0.040501,0,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.15773,0.052005,0.043502,0,0
5,GO NUCLEOTIDE PHOSPHORYLATION,0.3746,0.051964,0.038583,0,0
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.16294,0.051916,0.055149,0,0
5,GO PLASMA MEMBRANE TUBULATION,0.78289,0.051907,0.006249,0,0
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.33373,0.051897,0.06073,0,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.38888,0.051885,0.036568,0,0
5,GO CATECHOLAMINE SECRETION,0.14048,0.051772,0.19159,0,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.15773,0.051584,0.098558,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.14769,0.051507,0.044878,0,0
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.92682,0.051498,-0.019862,0,0
5,GO SOMITE DEVELOPMENT,0.099158,0.051469,0.064601,0,0
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.98255,0.051461,0.0044831,0,0
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.33812,0.051338,0.020283,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.47588,0.051307,0.10099,0,0
5,GO MUSCLE SYSTEM PROCESS,0.27227,0.051305,0.037238,0,0
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.81668,0.051045,0.039583,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.60272,0.050914,0.019449,0,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.33373,0.050818,0.040029,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.89907,0.050572,-0.026404,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.79636,0.050519,-0.0093306,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.26847,0.050497,0.031283,0,0
5,GO REGULATION OF CATABOLIC PROCESS,0.077957,0.050468,0.052681,0,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.68418,0.050376,0.030019,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.29992,0.050354,0.07155,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.33373,0.050329,0.033264,0,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.4545,0.050303,0.02565,0,0
5,GO LAMELLIPODIUM ORGANIZATION,0.65866,0.050256,0.010311,0,0
5,GO VASCULATURE DEVELOPMENT,0.59664,0.050166,0.0054961,0,0
5,GO RNA DECAPPING,0.85082,0.050027,0.0088028,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.97557,0.049784,-0.098716,0,0
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.52025,0.049561,0.0051407,0,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.41842,0.049516,0.060411,0,0
5,GO SNRNA METABOLIC PROCESS,0.36064,0.049449,0.0159,0,0
5,GO CELL SUBSTRATE ADHESION,0.53742,0.049312,0.0029396,0,0
5,GO RESPONSE TO AMPHETAMINE,0.85768,0.049241,-0.0024878,0,0
5,GO DEPHOSPHORYLATION,0.14285,0.04916,0.039505,0,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.92682,0.048986,-0.072061,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.15015,0.048981,0.070646,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.52025,0.04892,0.028613,0,0
5,GO RESPONSE TO ATP,0.62732,0.048789,0.035517,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.62732,0.048511,0.014453,0,0
5,GO POLYOL CATABOLIC PROCESS,0.070855,0.048456,0.097068,0,0
5,GO PRENYLATION,0.78289,0.048443,-0.0049114,0,0
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.39858,0.048414,0.027376,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.80989,0.048367,0.013692,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.40349,0.048274,0.11553,0,0
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.25363,0.048134,0.060623,0,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.56666,0.048109,0.036467,0,0
5,GO REGULATION OF SYSTEM PROCESS,0.3746,0.04797,0.030127,0,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.095625,0.047834,0.07431,0,0
5,GO RELAXATION OF MUSCLE,0.63978,0.047772,0.030868,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.34702,0.04777,0.0396,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.39371,0.04758,0.0382,0,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.99651,0.047538,-0.0051558,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.64605,0.047419,0.014342,0,0
5,GO ENDOTHELIAL CELL PROLIFERATION,0.18219,0.047197,0.054945,0,0
5,GO SEGMENTATION,0.52025,0.047012,0.034121,0,0
5,GO RESPONSE TO IONIZING RADIATION,0.19695,0.046872,0.022883,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.84397,0.04659,0.0047737,0,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.22568,0.046547,0.12321,0,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.54321,0.046535,0.027174,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1,0.046509,-0.092131,0,0
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.47049,0.046482,0.021413,0,0
5,GO CHEMOSENSORY BEHAVIOR,0.74288,0.046481,0.0052081,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.093897,0.046418,0.15429,0,0
5,GO P BODY ASSEMBLY,0.32938,0.046369,0.037428,0,0
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.36526,0.046332,0.099237,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.30402,0.046319,0.062267,0,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.29184,0.0463,0.033233,0,0
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.26471,0.04627,0.061565,0,0
5,GO EXOCYTIC PROCESS,0.085627,0.046168,0.11986,0,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.29586,0.046009,0.016274,0,0
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.24288,0.045965,0.094496,0,0
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.080955,0.045851,0.059429,0,0
5,GO ADHERENS JUNCTION ORGANIZATION,0.33373,0.045754,0.065372,0,0
5,GO CRISTAE FORMATION,0.55487,0.045743,0.049185,0,0
5,GO NUCLEOSIDE SALVAGE,0.62113,0.045716,0.013949,0,0
5,GO MITOCHONDRION ORGANIZATION,0.018836,0.045591,0.082019,0,0
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.80989,0.045388,0.010503,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.62732,0.04526,0.019765,0,0
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0695,0.045244,0.066544,0,0
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.076492,0.045233,0.066153,0,0
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.61497,0.045186,0.036309,0,0
5,GO PRO B CELL DIFFERENTIATION,0.21256,0.045148,0.096048,0,0
5,GO MULTI ORGANISM PROCESS,0.17653,0.045006,0.038764,0,0
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.17099,0.044976,0.067547,0,0
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.48678,0.044959,0.015281,0,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.87833,0.04492,0.0069318,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.67776,0.044778,0.00081667,0,0
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.13814,0.044488,0.048199,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.2839,0.044319,0.028213,0,0
5,GO MEMBRANE HYPERPOLARIZATION,0.38888,0.044108,0.056545,0,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.53167,0.044086,0.019418,0,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.35607,0.044035,0.054142,0,0
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.25729,0.043954,0.041471,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.12908,0.043913,0.079007,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.054842,0.043911,0.077929,0,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.27227,0.043718,0.030398,0,0
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.21256,0.043617,0.049768,0,0
5,GO REGULATION OF GASTRULATION,0.80989,0.043568,-0.011749,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.29992,0.043489,0.042532,0,0
5,GO REGULATION OF PROTEIN DEACETYLATION,0.49227,0.043445,0.063104,0,0
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.18219,0.043373,0.045767,0,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.17099,0.04333,0.11305,0,0
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.30815,0.043288,0.027525,0,0
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.42855,0.043217,0.027868,0,0
5,GO ANIMAL ORGAN MATURATION,0.48131,0.04321,0.03476,0,0
5,GO REGULATION OF CHROMATIN BINDING,0.4545,0.042949,0.044313,0,0
5,GO REGULATION OF PINOCYTOSIS,0.73628,0.04282,-0.028405,0,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.076492,0.042734,0.047934,0,0
5,GO SKIN EPIDERMIS DEVELOPMENT,0.48678,0.042477,0.01932,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.40843,0.042438,0.032783,0,0
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.32506,0.042326,0.034225,0,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.26847,0.042252,0.12584,0,0
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.29586,0.042242,0.17538,0,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.64605,0.042238,0.00051,0,0
5,GO NEURON MATURATION,0.27611,0.042201,0.095829,0,0
5,GO POSITIVE REGULATION OF NEURON DEATH,0.10465,0.042134,0.081867,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.60272,0.042107,0.03261,0,0
5,GO NUCLEOSIDE METABOLIC PROCESS,0.44924,0.041653,0.022524,0,0
5,GO ZINC ION TRANSPORT,0.075049,0.041584,0.13233,0,0
5,GO STRIATED MUSCLE CONTRACTION,0.63354,0.041539,0.023583,0,0
5,GO BONE MINERALIZATION,0.16294,0.041468,0.067201,0,0
5,GO PRIMARY MIRNA PROCESSING,0.76281,0.041446,0.00085711,0,0
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.70355,0.04136,0.0099065,0,0
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.33373,0.041356,0.031644,0,0
5,GO MYOBLAST DIFFERENTIATION,0.76948,0.041219,-0.011667,0,0
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.36064,0.041208,0.067417,0,0
5,GO POSITIVE REGULATION OF OSSIFICATION,0.35607,0.041124,0.057641,0,0
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.68418,0.040929,0.015591,0,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.34256,0.040792,0.040189,0,0
5,GO DEFINITIVE HEMOPOIESIS,0.5726,0.040753,0.0093419,0,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21256,0.040732,0.048236,0,0
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.87144,0.040659,0.010281,0,0
5,GO DNA METHYLATION OR DEMETHYLATION,0.13814,0.040656,0.041404,0,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.85082,0.040487,-0.018813,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.89215,0.040471,-0.02009,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.47049,0.040395,0.047659,0,0
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.19695,0.040316,0.043789,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.48678,0.040248,0.028848,0,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.070855,0.040138,0.05715,0,0
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.17099,0.040104,0.065251,0,0
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.15517,0.040079,0.075034,0,0
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.40349,0.039975,0.086482,0,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.63354,0.03994,0.0020453,0,0
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.61497,0.039867,0.019489,0,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.4545,0.039107,0.070212,0,0
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.188,0.039036,0.053468,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.59059,0.038767,0.029383,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.91987,0.038749,-0.00044939,0,0
5,GO PORE COMPLEX ASSEMBLY,0.62113,0.038711,0.031095,0,0
5,GO PROTEIN HOMOTETRAMERIZATION,0.63978,0.038705,0.012733,0,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.90599,0.038681,-0.066173,0,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.59059,0.038431,0.017901,0,0
5,GO REGULATION OF JUN KINASE ACTIVITY,0.18219,0.038374,0.0535,0,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.25729,0.038344,0.058889,0,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.67776,0.038293,0.026633,0,0
5,GO CRANIAL NERVE DEVELOPMENT,0.53742,0.038207,0.04309,0,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.42347,0.038102,0.045151,0,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.36991,0.038012,0.027672,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.32077,0.037978,0.043094,0,0
5,GO FEAR RESPONSE,0.55487,0.037967,0.036232,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.31232,0.037678,0.041066,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.52594,0.037663,0.036563,0,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.32077,0.037661,0.031702,0,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.59059,0.03766,0.02253,0,0
5,GO REGULATION OF BINDING,0.29184,0.037617,0.036088,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.27227,0.037598,0.081584,0,0
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.3746,0.037592,0.036122,0,0
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.70355,0.037303,-0.0067835,0,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.21256,0.037163,0.058957,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.25363,0.036816,0.032889,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.28785,0.036517,0.032373,0,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.93377,0.036476,-0.054679,0,0
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.29586,0.036365,0.062731,0,0
5,GO SEX DIFFERENTIATION,0.62113,0.036358,0.014161,0,0
5,GO MUSCLE CELL DEVELOPMENT,0.23589,0.036349,0.035944,0,0
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.36526,0.036186,0.045343,0,0
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.87144,0.036167,0.032405,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.188,0.035978,0.13738,0,0
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.27999,0.035825,0.027149,0,0
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.82348,0.035754,0.078093,0,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.98953,0.03571,-0.0050582,0,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.98255,0.035641,-0.028507,0,0
5,GO METANEPHROS DEVELOPMENT,0.87144,0.035544,0.0014425,0,0
5,GO CARDIAC MUSCLE CONTRACTION,0.67776,0.03547,0.019258,0,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.70355,0.03545,0.041711,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61497,0.035146,0.013559,0,0
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.26847,0.035045,0.046743,0,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.7495,0.034922,-0.027476,0,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.74288,0.034853,-0.067394,0,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.62732,0.034839,-0.0055654,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.18508,0.03482,0.056615,0,0
5,GO FEMALE SEX DIFFERENTIATION,0.75615,0.034582,0.00057162,0,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.60883,0.034476,-0.010979,0,0
5,GO ETHANOL CATABOLIC PROCESS,0.97557,0.03442,-0.011514,0,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.41341,0.034332,0.059643,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.96163,0.034231,0.0056188,0,0
5,GO ACTIN FILAMENT BASED MOVEMENT,0.78289,0.034163,0.0088231,0,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.88523,0.034137,-0.011136,0,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.20621,0.034125,0.10325,0,0
5,GO RESPONSE TO GAMMA RADIATION,0.21905,0.034016,0.054443,0,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.93377,0.034001,-0.021611,0,0
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.14769,0.033862,0.08764,0,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.91987,0.033829,-0.012846,0,0
5,GO PEPTIDE CROSS LINKING,0.44924,0.033795,0.022875,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.69707,0.033565,0.020655,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.2839,0.033557,0.040452,0,0
5,GO MEMBRANE REPOLARIZATION,0.61497,0.033532,0.033635,0,0
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.36526,0.033458,0.057298,0,0
5,GO REGULATION OF LIPASE ACTIVITY,0.65234,0.033401,0.0023515,0,0
5,GO HETEROCHROMATIN ORGANIZATION,0.89215,0.033398,-0.015096,0,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.37932,0.033288,0.0289,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.92682,0.033286,-0.038675,0,0
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.38888,0.033278,0.030951,0,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.48131,0.033273,0.07589,0,0
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.75615,0.033255,0.011595,0,0
5,GO L AMINO ACID TRANSPORT,0.47588,0.033251,0.072213,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.082489,0.033251,0.076734,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.5726,0.033146,0.079877,0,0
5,GO REGULATION OF GTPASE ACTIVITY,0.19095,0.033062,0.043713,0,0
5,GO POTASSIUM ION TRANSPORT,0.29992,0.033022,0.06461,0,0
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.74288,0.032985,0.017927,0,0
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.44402,0.032903,0.056133,0,0
5,GO PROTEIN HOMOOLIGOMERIZATION,0.36526,0.032882,0.024681,0,0
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.26847,0.032796,0.046674,0,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.66501,0.03258,0.072104,0,0
5,GO REGULATION OF ENDOCYTOSIS,0.40349,0.032516,0.031145,0,0
5,GO REGULATION OF RECEPTOR RECYCLING,0.62732,0.032442,0.01884,0,0
5,GO HISTONE DEACETYLATION,0.70355,0.032323,0.0085055,0,0
5,GO REGULATION OF METAL ION TRANSPORT,0.52025,0.032277,0.020761,0,0
5,GO REGULATION OF CELLULAR LOCALIZATION,0.36526,0.032099,0.019141,0,0
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.9686,0.03201,-0.0081849,0,0
5,GO NAD METABOLIC PROCESS,0.47588,0.031909,0.053764,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.79636,0.031811,-0.021274,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.4598,0.031785,0.024322,0,0
5,GO GOLGI VESICLE TRANSPORT,0.052669,0.031774,0.079953,0,0
5,GO RESPONSE TO LIGHT STIMULUS,0.67137,0.031679,0.00024819,0,0
5,GO POSITIVE REGULATION OF CELL DIVISION,0.59664,0.031635,0.014193,0,0
5,GO TRABECULA MORPHOGENESIS,0.85768,0.031577,-0.031995,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.14526,0.031521,0.16564,0,0
5,GO POSITIVE REGULATION OF BINDING,0.36526,0.031452,0.03144,0,0
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.81668,0.031333,-0.023162,0,0
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.53742,0.0313,0.014725,0,0
5,GO REGULATION OF MUSCLE CONTRACTION,0.19695,0.031184,0.054133,0,0
5,GO HISTONE H2B UBIQUITINATION,0.22905,0.031119,0.056051,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.78289,0.031043,0.0093198,0,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.20309,0.030726,0.1167,0,0
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.35153,0.030696,0.035516,0,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.63978,0.030676,0.0060337,0,0
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.67137,0.030645,0.053297,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.52025,0.03053,0.061269,0,0
5,GO GERM CELL DEVELOPMENT,0.40349,0.030517,0.023608,0,0
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.25363,0.030422,0.051688,0,0
5,GO RUFFLE ASSEMBLY,0.30402,0.030404,0.073291,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.56666,0.030385,0.010877,0,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.65866,0.030373,-0.022156,0,0
5,GO CELL JUNCTION ASSEMBLY,0.40349,0.030335,0.036284,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.21256,0.030282,0.088883,0,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.89215,0.030087,-0.024683,0,0
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.40349,0.030016,0.050895,0,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.30402,0.029967,0.046935,0,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.96163,0.029959,0.0017294,0,0
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.40843,0.029927,0.027444,0,0
5,GO FATTY ACID HOMEOSTASIS,0.72313,0.029899,0.040737,0,0
5,GO MEIOTIC CELL CYCLE,0.19393,0.029775,0.030514,0,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.48678,0.02975,0.068089,0,0
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.66501,0.029575,0.019596,0,0
5,GO NCRNA METABOLIC PROCESS,0.72313,0.029538,0.0042418,0,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.69061,0.029467,-0.065344,0,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.16294,0.029433,0.11409,0,0
5,GO ORGANELLE FISSION,0.77618,0.02926,0.0039022,0,0
5,GO ACTIN FILAMENT ORGANIZATION,0.27611,0.029255,0.033617,0,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.4978,0.029245,-0.091965,0,0
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.38888,0.029206,0.031638,0,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.78289,0.0292,-0.067686,0,0
5,GO ASSOCIATIVE LEARNING,0.76948,0.029171,0.013537,0,0
5,GO BLASTOCYST FORMATION,0.26847,0.02916,0.08226,0,0
5,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.94073,0.029132,0.004659,0,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.23245,0.029132,0.028746,0,0
5,GO REGULATION OF MRNA BINDING,0.95466,0.029121,-0.033571,0,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.53167,0.029067,0.013979,0,0
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.31232,0.028988,0.021997,0,0
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.80312,0.028984,0.028275,0,0
5,GO COLLAGEN METABOLIC PROCESS,0.82348,0.028969,-0.057135,0,0
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.34256,0.028875,0.054167,0,0
5,GO MATURATION OF 5 8S RRNA,0.80312,0.028711,-0.044554,0,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.188,0.028674,0.036949,0,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.72969,0.028664,0.063375,0,0
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.65866,0.028633,-0.10967,0,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.56666,0.028496,-0.083936,0,0
5,GO CELL CELL JUNCTION MAINTENANCE,0.98953,0.028484,-0.015034,0,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.95466,0.028458,-0.017953,0,0
5,GO MUSCLE CONTRACTION,0.50337,0.028326,0.018242,0,0
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.64605,0.028195,0.026203,0,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.40843,0.028065,0.020212,0,0
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.63354,0.028053,0.093752,0,0
5,GO SEXUAL REPRODUCTION,0.21905,0.028047,0.02885,0,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.97557,0.028023,-0.010774,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.42347,0.027993,0.034496,0,0
5,GO LACTATION,0.85768,0.027991,0.012893,0,0
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.73628,0.027977,-0.036773,0,0
5,GO PROTEIN STABILIZATION,0.11434,0.027969,0.057933,0,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.2839,0.027623,0.090727,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.63354,0.027522,0.0052195,0,0
5,GO PSEUDOURIDINE SYNTHESIS,0.87833,0.027514,-0.0080521,0,0
5,GO EPITHELIAL CELL MATURATION,0.56075,0.027377,0.073438,0,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.83713,0.027343,-0.0019635,0,0
5,GO REGULATION OF EXCRETION,0.81668,0.027246,0.0069316,0,0
5,GO SPERM AXONEME ASSEMBLY,0.76281,0.027162,-0.012512,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.48678,0.027,0.024443,0,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.62113,0.026994,0.021891,0,0
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.88523,0.026787,-0.009282,0,0
5,GO SARCOMERE ORGANIZATION,0.29992,0.026711,0.059801,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.4978,0.026606,0.0141,0,0
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.72969,0.026564,0.011319,0,0
5,GO FACE DEVELOPMENT,0.86455,0.026484,-0.015919,0,0
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.74288,0.026439,0.00087595,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.19095,0.026427,0.051452,0,0
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.31653,0.026418,0.056134,0,0
5,GO REGULATION OF GLIAL CELL MIGRATION,0.30402,0.026403,0.053753,0,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.97557,0.026056,-0.040993,0,0
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.70355,0.025958,0.0082437,0,0
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.15517,0.025803,0.057,0,0
5,GO AXIS SPECIFICATION,0.66501,0.025794,0.019176,0,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.4598,0.025715,0.0064488,0,0
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.58456,0.025694,0.025493,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.89215,0.025573,-0.014426,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.39371,0.02555,0.056664,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.53742,0.025528,0.083221,0,0
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.22235,0.025492,0.077805,0,0
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.68418,0.025375,-0.020919,0,0
5,GO CELLULAR RESPONSE TO ATP,0.40843,0.025225,0.064999,0,0
5,GO PEPTIDYL HISTIDINE MODIFICATION,0.85082,0.025184,-0.0095506,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.55487,0.025084,0.029979,0,0
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.47049,0.025076,0.019346,0,0
5,GO DETECTION OF ABIOTIC STIMULUS,0.59664,0.02488,0.01654,0,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.59059,0.024858,0.010152,0,0
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.38888,0.024829,0.072825,0,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.53167,0.024623,0.011546,0,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.40349,0.024601,0.041075,0,0
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.35607,0.02453,0.037697,0,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.52594,0.024521,0.011405,0,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.88523,0.024415,-0.013577,0,0
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.59664,0.024281,0.026701,0,0
5,GO MITOCHONDRIAL FUSION,0.69707,0.024112,0.046308,0,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.34702,0.02411,0.061696,0,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.43883,0.024084,0.013592,0,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.80312,0.024077,0.003582,0,0
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.72313,0.024002,0.0059565,0,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.98255,0.02387,-0.030417,0,0
5,GO TRANSEPITHELIAL TRANSPORT,0.38408,0.023844,0.069942,0,0
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.49227,0.02381,0.028917,0,0
5,GO ORGANELLE LOCALIZATION,0.68418,0.023763,0.0056754,0,0
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.076492,0.023684,0.092717,0,0
5,GO NON RECOMBINATIONAL REPAIR,0.89215,0.023625,-0.006262,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.34702,0.023474,0.062795,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.90599,0.023472,-0.0039959,0,0
5,GO REGULATION OF T CELL CHEMOTAXIS,0.26098,0.023455,0.077002,0,0
5,GO DENDRITE EXTENSION,0.59664,0.023334,0.10103,0,0
5,GO AMINO ACID TRANSPORT,0.36991,0.023212,0.081665,0,0
5,GO PROTEIN TETRAMERIZATION,0.87144,0.023174,-0.013425,0,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.72969,0.023112,0.040212,0,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.63354,0.023037,0.028438,0,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.97557,0.022938,-0.0071673,0,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.85082,0.022918,0.0055341,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.53742,0.022867,0.030246,0,0
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.23937,0.022833,0.051813,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.7495,0.022587,0.056983,0,0
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.39858,0.022515,0.032983,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.76281,0.022487,0.011936,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.9686,0.02247,-0.029783,0,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.90599,0.022411,-0.018953,0,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.15015,0.022272,0.03238,0,0
5,GO RESPONSE TO BMP,0.29586,0.022149,0.03053,0,0
5,GO PHOSPHATE ION TRANSPORT,0.33373,0.02211,0.054076,0,0
5,GO GAS TRANSPORT,0.80312,0.022044,-0.06951,0,0
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.82348,0.021989,0.006336,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.44402,0.021963,0.013997,0,0
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.41341,0.021885,0.015954,0,0
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.41341,0.021813,0.076501,0,0
5,GO ADULT LOCOMOTORY BEHAVIOR,0.61497,0.02179,0.047034,0,0
5,GO RESPONSE TO GROWTH FACTOR,0.38888,0.021763,0.027072,0,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.36991,0.021652,0.06696,0,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.53742,0.021632,0.024365,0,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.34702,0.021561,0.056116,0,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.30402,0.021547,0.060215,0,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.91987,0.021489,-0.040058,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.75615,0.021467,0.018642,0,0
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.98255,0.021391,-0.015308,0,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.72313,0.021386,-0.057696,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.35153,0.021328,0.046167,0,0
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.97557,0.021322,-0.019079,0,0
5,GO NEURAL TUBE DEVELOPMENT,0.85768,0.021316,-0.024068,0,0
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.26471,0.021179,0.067259,0,0
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.15517,0.021151,0.086684,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.79636,0.021127,-0.044008,0,0
5,GO LENS FIBER CELL DEVELOPMENT,0.75615,0.02108,-0.04657,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.43883,0.020951,0.037597,0,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.72313,0.020836,0.023325,0,0
5,GO TRNA METHYLATION,0.96163,0.020624,-0.0016923,0,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.99651,0.020619,-0.03833,0,0
5,GO NEUROTRANSMITTER REUPTAKE,0.43883,0.020591,0.071155,0,0
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.30402,0.020525,0.10037,0,0
5,GO REGULATION OF MACROAUTOPHAGY,0.10465,0.020521,0.071373,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.83713,0.020346,-0.015841,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.48678,0.020235,0.064576,0,0
5,GO FEMALE GAMETE GENERATION,0.65234,0.020124,0.016935,0,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.95466,0.01981,-0.0049505,0,0
5,GO RESPONSE TO GLUCAGON,0.73628,0.019594,0.033674,0,0
5,GO PROTEIN INSERTION INTO MEMBRANE,0.34702,0.019542,0.036744,0,0
5,GO GAMETE GENERATION,0.29992,0.019532,0.024885,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE,0.23937,0.019411,0.030868,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.43367,0.019394,0.014734,0,0
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.48131,0.019158,0.01803,0,0
5,GO REGULATION OF MITOTIC CELL CYCLE,0.49227,0.019155,0.01043,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.67776,0.019148,0.0026963,0,0
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.75615,0.019101,0.022351,0,0
5,GO HEAD MORPHOGENESIS,0.78962,0.018931,-0.047403,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.85768,0.018889,-0.04868,0,0
5,GO REGULATION OF EXIT FROM MITOSIS,0.4978,0.018843,0.036675,0,0
5,GO FOLIC ACID METABOLIC PROCESS,0.96163,0.018833,-0.037217,0,0
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.11039,0.018815,0.10878,0,0
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.34702,0.018731,0.040656,0,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.80989,0.018641,-0.0016874,0,0
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.99651,0.018594,-0.020039,0,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.79636,0.01858,-0.021745,0,0
5,GO MUSCLE CELL DIFFERENTIATION,0.53742,0.018493,0.012471,0,0
5,GO TRANSLATIONAL TERMINATION,0.56666,0.018398,0.026816,0,0
5,GO SPERMATID DIFFERENTIATION,0.72313,0.018394,0.011503,0,0
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.65866,0.018361,-0.0016014,0,0
5,GO CELL FATE DETERMINATION,0.50337,0.018261,0.047317,0,0
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.95466,0.01822,-0.0063928,0,0
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.56075,0.01819,0.020473,0,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,0.82348,0.018158,-0.0036592,0,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.72969,0.018117,0.025972,0,0
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.85082,0.01795,0.0018766,0,0
5,GO SPROUTING ANGIOGENESIS,0.81668,0.017933,-0.031728,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.70355,0.017878,-0.041668,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.58456,0.017767,0.019862,0,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.4598,0.017743,0.032163,0,0
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.92682,0.017653,-0.014568,0,0
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.19695,0.017652,0.06311,0,0
5,GO HEART TRABECULA FORMATION,0.29586,0.017559,0.14697,0,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.58456,0.01745,0.027781,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.91987,0.017176,0.0015766,0,0
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.50337,0.01712,0.066305,0,0
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.24643,0.017044,0.065728,0,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.97557,0.017008,-0.0092367,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.91987,0.016964,-0.006346,0,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.76948,0.016904,0.020454,0,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.91987,0.016872,-0.022271,0,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.94769,0.016745,0.0046641,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.83713,0.016701,-0.0063081,0,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.37932,0.016689,0.037449,0,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.60883,0.016553,0.047837,0,0
5,GO MITOCHONDRIAL FISSION,0.40843,0.016455,0.076289,0,0
5,GO PHOTOPERIODISM,0.56666,0.016444,0.06303,0,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.77618,0.016273,0.095087,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.23589,0.016249,0.059609,0,0
5,GO ACTIN MEDIATED CELL CONTRACTION,0.81668,0.016183,-0.011666,0,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.95466,0.016127,-0.016288,0,0
5,GO MIRNA METABOLIC PROCESS,0.86455,0.0161,-0.017214,0,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.86455,0.016043,0.00024087,0,0
5,GO TRNA PROCESSING,0.90599,0.015953,-0.016877,0,0
5,GO RHYTHMIC PROCESS,0.36991,0.015741,0.029427,0,0
5,GO MEMBRANE RAFT ASSEMBLY,0.26847,0.015503,0.12759,0,0
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.36064,0.01538,0.048027,0,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.62732,0.015201,0.053093,0,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.42347,0.015191,0.048414,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.73628,0.01516,-0.023484,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.27999,0.014969,0.068078,0,0
5,GO POSITIVE REGULATION OF GROWTH,0.65234,0.014916,0.012177,0,0
5,GO ONE CARBON COMPOUND TRANSPORT,0.53167,0.014859,0.048128,0,0
5,GO RESPONSE TO HEAT,0.69061,0.014784,0.034867,0,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.80989,0.014737,0.055331,0,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.79636,0.014718,0.014304,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.53742,0.014571,0.062719,0,0
5,GO REGULATION OF GROWTH,0.59059,0.014547,0.014367,0,0
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.93377,0.014506,-0.0081687,0,0
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.9686,0.014365,-0.029276,0,0
5,GO MACROMOLECULE DEACYLATION,0.54903,0.014309,0.015851,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.90599,0.014279,0.0084629,0,0
5,GO TUBE FORMATION,0.91293,0.014069,-0.02308,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.60272,0.013975,0.0091052,0,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.67137,0.013925,-0.14646,0,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.1313,0.013914,0.055633,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.65866,0.013835,0.0088854,0,0
5,GO NEGATIVE REGULATION OF GROWTH,0.39371,0.013818,0.037566,0,0
5,GO REGULATION OF CELL DIFFERENTIATION,0.89215,0.013689,-0.0065074,0,0
5,GO PROTEIN IMPORT,0.47049,0.013686,0.035996,0,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.85768,0.01362,-0.017564,0,0
5,GO RNA CATABOLIC PROCESS,0.90599,0.013597,-0.0025114,0,0
5,GO CELL CYCLE ARREST,0.87144,0.013531,0.007592,0,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.29586,0.013478,0.056719,0,0
5,GO REGULATION OF CIRCADIAN RHYTHM,0.62732,0.013377,0.032491,0,0
5,GO BLEB ASSEMBLY,0.96163,0.013363,-0.14906,0,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.94073,0.013355,-0.0089323,0,0
5,GO CELLULAR RESPONSE TO CAMP,0.65866,0.013243,0.027573,0,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.80312,0.013174,-0.0038312,0,0
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.8303,0.013122,-0.0031839,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.80989,0.013106,-0.0040646,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.87144,0.012978,0.010578,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.62732,0.012962,0.023477,0,0
5,GO HISTONE ARGININE METHYLATION,0.84397,0.012871,0.010395,0,0
5,GO ESTABLISHMENT OF CELL POLARITY,0.72969,0.012793,-0.012469,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.83713,0.012737,0.086677,0,0
5,GO ERYTHROCYTE DEVELOPMENT,0.91987,0.012524,-0.00049237,0,0
5,GO REGULATION OF BIOMINERALIZATION,0.59059,0.012468,0.018253,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.60883,0.012396,0.036165,0,0
5,GO ENDODERMAL CELL DIFFERENTIATION,0.9686,0.012379,-0.05684,0,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.44402,0.012357,0.078669,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.53167,0.012266,0.017614,0,0
5,GO RECEPTOR METABOLIC PROCESS,0.90599,0.012241,-0.008066,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.58456,0.012239,-0.062059,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.63978,0.012222,-0.047759,0,0
5,GO NEURAL TUBE FORMATION,0.91987,0.012027,-0.006623,0,0
5,GO ESTROUS CYCLE,0.87833,0.012015,-0.0083643,0,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.91987,0.011993,-0.031992,0,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.50896,0.011958,0.066724,0,0
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.68418,0.011769,0.037367,0,0
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.79636,0.011755,0.0052098,0,0
5,GO C4 DICARBOXYLATE TRANSPORT,0.76281,0.011682,0.006298,0,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.4545,0.011678,0.031728,0,0
5,GO DECIDUALIZATION,0.31653,0.011634,-0.12284,0,0
5,GO MITOTIC CELL CYCLE ARREST,0.79636,0.011412,0.027306,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,0.22235,0.011315,0.091418,0,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.96163,0.011248,0.025005,0,0
5,GO DEVELOPMENTAL MATURATION,0.55487,0.011247,0.0303,0,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.16559,0.011099,0.060703,0,0
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.78962,0.011071,0.021356,0,0
5,GO IMPORT INTO NUCLEUS,0.97557,0.01102,0.0066571,0,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.9686,0.010939,0.0081011,0,0
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.58456,0.010889,0.021413,0,0
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.75615,0.010846,-0.043832,0,0
5,GO DETECTION OF LIGHT STIMULUS,0.77618,0.010779,-0.013845,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.54321,0.010752,0.12076,0,0
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.76281,0.010639,0.0089958,0,0
5,GO NEURON DEATH,0.26471,0.010589,0.030551,0,0
5,GO TAXIS,0.52594,0.01056,-0.034939,0,0
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.81668,0.010464,0.0098386,0,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.39858,0.010364,0.033757,0,0
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.59664,0.010233,0.078873,0,0
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.66501,0.010183,-0.00079031,0,0
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.86455,0.01017,0.010218,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.72969,0.010019,0.005374,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.85082,0.0098461,-0.025999,0,0
5,GO BLASTODERM SEGMENTATION,0.77618,0.0098449,-0.07242,0,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.92682,0.0097054,0.0040331,0,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.85768,0.0095508,-0.025043,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.89215,0.0095027,-0.019659,0,0
5,GO MRNA MODIFICATION,0.78289,0.0093752,-0.036159,0,0
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.59059,0.0092559,0.034098,0,0
5,GO REGULATION OF GLUTAMATE SECRETION,0.99651,0.0092298,0.024973,0,0
5,GO POSITIVE REGULATION OF TRANSLATION,0.84397,0.0092108,-0.036234,0,0
5,GO GLIOGENESIS,0.94073,0.0091959,-0.001549,0,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.82348,0.0090486,-0.055498,0,0
5,GO PROTEIN DEPHOSPHORYLATION,0.86455,0.0089976,-0.010109,0,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.72313,0.0089955,0.050595,0,0
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.46512,0.0089722,0.07536,0,0
5,GO EMBRYONIC MORPHOGENESIS,0.97557,0.0089251,-0.0091553,0,0
5,GO URETER DEVELOPMENT,0.96163,0.0088026,-0.032347,0,0
5,GO NUCLEUS LOCALIZATION,0.53167,0.0085506,-0.050237,0,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.81668,0.0085082,0.0083566,0,0
5,GO ACTIN FILAMENT BASED PROCESS,0.5726,0.0084755,0.012945,0,0
5,GO DOSAGE COMPENSATION,0.52025,0.0084009,0.032445,0,0
5,GO CARTILAGE DEVELOPMENT,0.66501,0.0082319,-0.037923,0,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.31653,0.0080775,0.078829,0,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.60272,0.0080701,0.054389,0,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.75615,0.0080232,0.018505,0,0
5,GO REGULATION OF URINE VOLUME,0.43883,0.0079359,-0.052011,0,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.31232,0.0077152,0.10397,0,0
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.59059,0.0077102,-0.11453,0,0
5,GO VESICLE DOCKING,0.69707,0.0077093,0.027906,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.71658,0.0076733,-0.020235,0,0
5,GO SMOOTH MUSCLE CONTRACTION,0.89215,0.0076712,-0.004433,0,0
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.76948,0.0076186,0.00079709,0,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.3746,0.0075902,-0.069512,0,0
5,GO NADH METABOLIC PROCESS,0.73628,0.0075794,0.037559,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.71658,0.0075068,0.0044176,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.62113,0.0074925,0.010324,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.77618,0.0074613,-0.023495,0,0
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.7495,0.0073974,-0.00028167,0,0
5,GO ENSHEATHMENT OF NEURONS,0.86455,0.0073013,0.0068617,0,0
5,GO EAR DEVELOPMENT,0.63354,0.0072526,0.01091,0,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.26098,0.0071725,0.094594,0,0
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.61497,0.0070854,0.020853,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.82348,0.006985,-0.081829,0,0
5,GO REGULATION OF TORC1 SIGNALING,0.43883,0.0069714,0.050593,0,0
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.64605,0.0069594,0.02918,0,0
5,GO T CELL CHEMOTAXIS,0.9686,0.0069262,0.0030778,0,0
5,GO ANIMAL ORGAN MORPHOGENESIS,0.90599,0.0068524,-0.016259,0,0
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.51459,0.0068301,0.018989,0,0
5,GO LEFT RIGHT PATTERN FORMATION,0.9686,0.0066312,0.0027909,0,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.81668,0.0065645,-0.01394,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.78289,0.006543,-0.050489,0,0
5,GO RNA DESTABILIZATION,0.85768,0.0065352,-0.027701,0,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.70355,0.0065002,-0.011969,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.69061,0.0064053,0.056631,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.96163,0.0063606,-0.0094084,0,0
5,GO NCRNA PROCESSING,0.84397,0.0062505,-0.028573,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.35607,0.0062454,-0.044512,0,0
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.91293,0.0061978,-0.0024563,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.77618,0.0061817,-0.018126,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.98953,0.0061784,0.0021528,0,0
5,GO GLIAL CELL DIFFERENTIATION,0.69707,0.0061545,-0.015947,0,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.64605,0.0061475,-0.06231,0,0
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.67776,0.006049,0.018532,0,0
5,GO REGULATION OF DEPHOSPHORYLATION,0.87144,0.0059025,0.0033809,0,0
5,GO ASTROCYTE DEVELOPMENT,0.60883,0.0056306,-0.049487,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.13355,0.0055791,0.040701,0,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.70355,0.005478,-0.015829,0,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.55487,0.0054555,-0.061917,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,0.91293,0.0054495,0.019984,0,0
5,GO NEURONAL ION CHANNEL CLUSTERING,0.84397,0.0050705,0.036924,0,0
5,GO CELL GROWTH,0.64605,0.0050246,-0.019003,0,0
5,GO CENTROSOME SEPARATION,0.91293,0.0049136,0.017658,0,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.67137,0.0049073,0.016108,0,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.54321,0.0048875,0.059838,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.71006,0.0048396,-0.053659,0,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.63978,0.0048334,0.0083592,0,0
5,GO NEGATIVE REGULATION OF BINDING,0.75615,0.0047877,0.017366,0,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.49227,0.0047622,0.055747,0,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.94769,0.004734,0.0023835,0,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.78289,0.0043363,-0.015245,0,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.81668,0.0041994,-0.0449,0,0
5,GO CANONICAL WNT SIGNALING PATHWAY,0.44402,0.0041961,-0.041722,0,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.35607,0.0039251,0.044932,0,0
5,GO MAINTENANCE OF CELL NUMBER,0.14526,0.0039167,-0.080426,0,0
5,GO GENE SILENCING,0.64605,0.0038318,0.00026588,0,0
5,GO TRANSLATIONAL ELONGATION,0.91987,0.0037865,-0.0078148,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.8303,0.0037764,-0.040678,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.28785,0.0036031,0.078174,0,0
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.91987,0.0033906,0.003598,0,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.90599,0.0033489,-0.018469,0,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.76948,0.0031326,0.053554,0,0
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.80989,0.0030511,-0.003853,0,0
5,GO PULMONARY VALVE DEVELOPMENT,0.56666,0.0028385,0.060071,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.82348,0.0025368,-0.010578,0,0
5,GO SNRNA PROCESSING,0.80312,0.0024191,-0.01918,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.9686,0.0023917,-0.026557,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.8303,0.0021391,0.044246,0,0
5,GO REGULATION OF HISTONE MODIFICATION,0.63978,0.0021311,0.011935,0,0
5,GO MITOTIC CYTOKINESIS,0.62732,0.0020523,-0.02448,0,0
5,GO EMBRYO DEVELOPMENT,0.84397,0.0018891,-0.011612,0,0
5,GO RESPONSE TO VITAMIN A,0.63354,0.001889,-0.058251,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.78289,0.0017938,-0.039418,0,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.81668,0.0016742,-0.0362,0,0
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.57857,0.0013996,-0.022757,0,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.27611,0.0011281,-0.13372,0,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.86455,0.0011253,0.049752,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.98953,0.0010451,0.0058457,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.32506,0.00099899,-0.064621,0,0
5,GO PROTEIN NITROSYLATION,0.55487,0.00099404,-0.084298,0,0
5,GO SPERM MOTILITY,0.76948,0.00093353,-0.010718,0,0
5,GO RENAL VESICLE DEVELOPMENT,0.87833,0.00064562,-0.037509,0,0
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.70355,0.00056326,0.01632,0,0
5,GO REGULATION OF CELL SHAPE,0.5726,0.00034061,0.0066151,0,0
5,GO IMPORT INTO CELL,0.41842,0.00030582,0.046463,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.84397,0.00026113,0.0078795,0,0
5,GO DNA BIOSYNTHETIC PROCESS,0.58456,0.00019282,-0.022886,0,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.96163,0.00010629,-0.0093455,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.72313,-9.4616e-05,-0.014102,0,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.84397,-9.7957e-05,-0.032963,0,0
5,GO SYNAPTIC VESICLE RECYCLING,0.88523,-0.00023073,-0.0027163,0,0
5,GO NEPHRON MORPHOGENESIS,0.79636,-0.00026506,0.010716,0,0
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.94769,-0.00049884,-0.0093525,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.80312,-0.00059937,0.0032055,0,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.83713,-0.00062576,-0.01536,0,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.76281,-0.00086761,0.042172,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.73628,-0.00088807,-0.023964,0,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.71006,-0.00089449,0.021664,0,0
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.71006,-0.00095972,-0.017103,0,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.82348,-0.0010097,0.023761,0,0
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.89215,-0.0010542,0.027572,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.71006,-0.0011078,-0.055763,0,0
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.68418,-0.0012005,-0.0028254,0,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.8303,-0.0012204,-0.01796,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.54903,-0.0012732,0.045196,0,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.85082,-0.0012966,-0.025731,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.50337,-0.0013502,-0.029042,0,0
5,GO VAGINA DEVELOPMENT,0.92682,-0.0013627,-0.024021,0,0
5,GO HYPOTONIC RESPONSE,0.4978,-0.0013745,-0.076195,0,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.59059,-0.0013791,0.0093004,0,0
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.77618,-0.0013971,0.0092044,0,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.53167,-0.0014446,-0.070671,0,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.66501,-0.0014587,-0.076929,0,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.4978,-0.0015043,0.033632,0,0
5,GO CELL CYCLE CHECKPOINT,0.69707,-0.0017607,-0.013512,0,0
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.98255,-0.0017996,-0.0034052,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.55487,-0.0018082,0.022264,0,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.99651,-0.0018616,-0.012508,0,0
5,GO REGULATION OF CILIUM MOVEMENT,0.8303,-0.0018792,0.00125,0,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.7495,-0.0019052,-0.023166,0,0
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.80989,-0.0019638,-0.024656,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.84397,-0.0019861,0.053815,0,0
5,GO TRNA MODIFICATION,0.86455,-0.0019923,-0.021696,0,0
5,GO MATING,0.63978,-0.0020032,0.020256,0,0
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.74288,-0.0022044,0.014398,0,0
5,GO GENITALIA DEVELOPMENT,0.89215,-0.0022159,-0.0083392,0,0
5,GO RECEPTOR INTERNALIZATION,0.44924,-0.0022673,-0.051475,0,0
5,GO SUBPALLIUM DEVELOPMENT,0.77618,-0.0024308,0.059436,0,0
5,GO EMBRYONIC PATTERN SPECIFICATION,0.9686,-0.002492,0.00011988,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.26847,-0.0025586,-0.22392,0,0
5,GO INNERVATION,0.97557,-0.0028264,0.043606,0,0
5,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.8303,-0.0030053,-0.019803,0,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.36064,-0.0030575,-0.035915,0,0
5,GO PEPTIDYL SERINE MODIFICATION,0.36064,-0.00315,0.027005,0,0
5,GO PROTEIN TRIMERIZATION,0.94073,-0.0031809,-0.026368,0,0
5,GO PEPTIDYL THREONINE MODIFICATION,0.56666,-0.00325,0.032943,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.90599,-0.0033493,-0.0083016,0,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.71658,-0.0034763,-0.04369,0,0
5,GO RESPONSE TO SALT STRESS,0.67776,-0.0034885,-0.060653,0,0
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.87833,-0.0034902,-0.011531,0,0
5,GO MULTI ORGANISM LOCALIZATION,0.60272,-0.0035149,-0.048942,0,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.44402,-0.0035245,0.098479,0,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.63354,-0.0035256,-0.051903,0,0
5,GO HISTONE H3 ACETYLATION,0.90599,-0.0035999,-0.013577,0,0
5,GO FAT CELL PROLIFERATION,0.86455,-0.0039363,0.0033248,0,0
5,GO CHONDROCYTE DIFFERENTIATION,0.91293,-0.0039985,-0.007185,0,0
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.53742,-0.0040778,-0.034002,0,0
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.44402,-0.0040826,-0.055469,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.79636,-0.0041523,-0.078796,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.59059,-0.0041873,0.016881,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.72313,-0.0042473,0.025006,0,0
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.86455,-0.0045131,-0.0077489,0,0
5,GO RESPONSE TO COCAINE,0.77618,-0.0045301,-0.011452,0,0
5,GO INTERLEUKIN 17 PRODUCTION,0.40843,-0.0046792,0.062753,0,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.95466,-0.0049184,0.019834,0,0
5,GO REGULATION OF PROTEIN IMPORT,0.37932,-0.0049491,0.040682,0,0
5,GO RESPONSE TO MANGANESE ION,0.50337,-0.0050432,0.067413,0,0
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.76948,-0.0051216,-0.01398,0,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.74288,-0.0051394,-0.039093,0,0
5,GO DNA METHYLATION,0.66501,-0.0052058,0.023549,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.44402,-0.0052619,0.030186,0,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.8303,-0.0054865,-0.022326,0,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.78962,-0.0055118,0.0067693,0,0
5,GO POSITIVE THYMIC T CELL SELECTION,0.67776,-0.0055898,0.020445,0,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.62113,-0.0056127,-0.022097,0,0
5,GO CELLULAR RESPONSE TO DRUG,0.8303,-0.0056467,-0.0031605,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.89907,-0.0056893,-0.011066,0,0
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.39371,-0.0057638,-0.04457,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.71006,-0.0058936,0.069184,0,0
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.60272,-0.0059077,-0.031499,0,0
5,GO ANATOMICAL STRUCTURE REGRESSION,0.79636,-0.0059258,-0.04858,0,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.66501,-0.0061566,-0.028182,0,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.27227,-0.00616,0.052932,0,0
5,GO RRNA TRANSCRIPTION,0.2839,-0.0062005,-0.085566,0,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.54321,-0.0062157,-0.028404,0,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.51459,-0.006267,-0.084486,0,0
5,GO OVULATION CYCLE,0.72313,-0.0063929,-0.01898,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.60272,-0.0063978,-0.03314,0,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.35153,-0.0064352,-0.031276,0,0
5,GO HISTONE H3 K14 ACETYLATION,0.98255,-0.0065845,0.0069497,0,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.52594,-0.006763,-0.030313,0,0
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.42855,-0.0068238,-0.035947,0,0
5,GO HEART TRABECULA MORPHOGENESIS,0.48131,-0.0069089,0.046552,0,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.9686,-0.0070064,-0.0099843,0,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.83713,-0.0070764,0.024606,0,0
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.85768,-0.0071375,-0.0094783,0,0
5,GO MUSCLE TISSUE DEVELOPMENT,0.62732,-0.0071418,-0.023867,0,0
5,GO TRANSLATIONAL INITIATION,0.51459,-0.007184,-0.068424,0,0
5,GO EMBRYONIC BODY MORPHOGENESIS,0.67137,-0.0072399,-0.0051565,0,0
5,GO TROPHOBLAST CELL MIGRATION,0.65234,-0.0072477,-0.09539,0,0
5,GO CILIUM MOVEMENT,0.48131,-0.0073267,0.0086493,0,0
5,GO SENSORY PERCEPTION OF PAIN,0.73628,-0.007721,0.028105,0,0
5,GO GROWTH,0.67776,-0.0077548,-0.02023,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.55487,-0.0077853,-0.027019,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.68418,-0.0078163,-0.013506,0,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.80989,-0.0078195,-0.002204,0,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.52594,-0.0078565,-0.049993,0,0
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.87144,-0.0078673,-0.0071055,0,0
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.72313,-0.0079734,-0.037432,0,0
5,GO MESENCHYME DEVELOPMENT,0.25363,-0.0080495,-0.076603,0,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.71006,-0.0082026,-0.023067,0,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.48131,-0.0082221,-0.097169,0,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.43367,-0.0082541,-0.030365,0,0
5,GO DNA METABOLIC PROCESS,0.40349,-0.0082761,-0.022034,0,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.72313,-0.0082929,0.0055162,0,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.76948,-0.0086672,0.169,0,0
5,GO TOOTH MINERALIZATION,0.76948,-0.0086739,-0.034516,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.73628,-0.0087918,-0.0091127,0,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.76281,-0.0089284,-0.04495,0,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.44924,-0.0089398,0.040616,0,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.79636,-0.0090009,0.031636,0,0
5,GO DNA INTEGRITY CHECKPOINT,0.50896,-0.0090552,-0.023307,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.35153,-0.0090851,0.066938,0,0
5,GO ERBB2 SIGNALING PATHWAY,0.99651,-0.0092926,0.017342,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.51459,-0.0093739,0.034427,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.71006,-0.0093986,-0.027636,0,0
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.90599,-0.009529,0.0037006,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.94073,-0.0095869,0.0046373,0,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.57857,-0.0095894,0.037007,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.89907,-0.0097287,-0.018478,0,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.91293,-0.0097649,0.0088822,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.54903,-0.0099063,-0.018268,0,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.67776,-0.0099259,-0.076329,0,0
5,GO RESPONSE TO AMINO ACID STARVATION,0.59664,-0.010028,0.033199,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.55487,-0.010061,-0.014026,0,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.66501,-0.010114,0.037484,0,0
5,GO REGULATION OF SYNAPSE MATURATION,0.67776,-0.010176,-0.094938,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.8303,-0.010209,-0.010234,0,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,0.85768,-0.01032,-0.012463,0,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.9686,-0.010398,0.013597,0,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.90599,-0.010434,-0.033272,0,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.69061,-0.010523,0.024441,0,0
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.37932,-0.010547,-0.076787,0,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.92682,-0.010628,0.0017099,0,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.77618,-0.0108,-0.0010692,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.54321,-0.011097,-0.034944,0,0
5,GO NODAL SIGNALING PATHWAY,0.80989,-0.011144,-0.016918,0,0
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.74288,-0.011466,-0.011521,0,0
5,GO NUCLEUS ORGANIZATION,0.97557,-0.011556,0.0088123,0,0
5,GO NOTCH RECEPTOR PROCESSING,0.69707,-0.01169,0.07034,0,0
5,GO FACIAL NERVE MORPHOGENESIS,0.48678,-0.011709,-0.13068,0,0
5,GO INTERLEUKIN 2 PRODUCTION,0.63978,-0.011818,-0.062569,0,0
5,GO OLIGODENDROCYTE DIFFERENTIATION,0.76948,-0.012101,0.023595,0,0
5,GO CELLULAR RESPONSE TO NUTRIENT,0.69061,-0.012191,-0.041011,0,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.77618,-0.012194,0.0055108,0,0
5,GO RECEPTOR RECYCLING,0.61497,-0.012315,0.039362,0,0
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.94073,-0.012342,-0.01902,0,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.31653,-0.012524,-0.049088,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.80989,-0.01255,0.031865,0,0
5,GO ACTIN CROSSLINK FORMATION,0.30402,-0.012591,-0.09033,0,0
5,GO VIRAL LATENCY,0.19695,-0.012848,-0.11257,0,0
5,GO METAPHASE PLATE CONGRESSION,0.63354,-0.012878,-0.011488,0,0
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.64605,-0.013049,-0.019392,0,0
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.59059,-0.013237,-0.039705,0,0
5,GO CELL JUNCTION ORGANIZATION,0.65866,-0.013254,-0.023985,0,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.52025,-0.013293,-0.064879,0,0
5,GO REGULATION OF PROTEIN TARGETING,0.73628,-0.013363,-0.0072515,0,0
5,GO RNA PROCESSING,0.30815,-0.013411,-0.043938,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.62113,-0.013417,-0.071732,0,0
5,GO HISTONE MONOUBIQUITINATION,0.42855,-0.01352,-0.033868,0,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.85082,-0.01358,-0.065362,0,0
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.63978,-0.013582,0.027949,0,0
5,GO NOSE DEVELOPMENT,0.97557,-0.013647,0.10778,0,0
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.80989,-0.013701,-0.028892,0,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.9686,-0.013732,-0.0028494,0,0
5,GO REGULATION OF MRNA 3 END PROCESSING,0.44924,-0.013751,-0.043175,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.87833,-0.013783,-0.01785,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.92682,-0.0138,0.069063,0,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.90599,-0.013829,-0.011731,0,0
5,GO POSITIVE REGULATION OF RNA SPLICING,0.67137,-0.01384,0.047253,0,0
5,GO MYELOID CELL APOPTOTIC PROCESS,0.64605,-0.013926,0.020251,0,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.88523,-0.01412,-0.0096339,0,0
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.63978,-0.01412,0.015023,0,0
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.61497,-0.014195,-0.036693,0,0
5,GO LAMELLIPODIUM ASSEMBLY,0.65234,-0.014215,-0.027267,0,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.98255,-0.014319,-0.015721,0,0
5,GO CELL CELL SIGNALING,0.77618,-0.014346,-0.01026,0,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.40843,-0.014349,0.059707,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.52594,-0.014529,-0.01837,0,0
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.89215,-0.014678,0.0038557,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.87833,-0.014707,-0.0032992,0,0
5,GO CELL FATE COMMITMENT,0.50337,-0.014725,-0.022835,0,0
5,GO CYTOKINESIS,0.38408,-0.01479,-0.030636,0,0
5,GO TELOMERE ORGANIZATION,0.38408,-0.014811,-0.041701,0,0
5,GO RRNA METHYLATION,0.89215,-0.014975,-0.007622,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.98953,-0.015203,-0.013867,0,0
5,GO PROTEIN DENEDDYLATION,0.57857,-0.015244,-0.034825,0,0
5,GO REGULATION OF CELL CYCLE,0.8303,-0.015417,0.0022615,0,0
5,GO GROWTH HORMONE SECRETION,0.93377,-0.015544,0.041766,0,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.88523,-0.015651,-0.017876,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.9686,-0.015676,0.020422,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.73628,-0.015688,-0.0098733,0,0
5,GO REGULATION OF GENE SILENCING,0.85768,-0.015886,-0.02262,0,0
5,GO PROTEIN SUMOYLATION,0.44402,-0.015912,-0.022907,0,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.81668,-0.015944,0.013706,0,0
5,GO CELL CYCLE,0.80312,-0.016015,-0.010331,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.99651,-0.016074,-0.020194,0,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.99651,-0.016084,-0.0038403,0,0
5,GO MISMATCH REPAIR,0.43883,-0.016267,-0.035956,0,0
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.90599,-0.016268,-0.010515,0,0
5,GO EXTRACELLULAR TRANSPORT,0.63978,-0.016396,0.031432,0,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.10096,-0.016525,-0.04675,0,0
5,GO OSTEOBLAST DIFFERENTIATION,0.94769,-0.01667,-0.0042203,0,0
5,GO NEURON REMODELING,0.95466,-0.016771,-0.034189,0,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.94769,-0.016814,-0.011169,0,0
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.76281,-0.016941,0.010746,0,0
5,GO REGULATION OF TELOMERASE ACTIVITY,0.48678,-0.01695,-0.052113,0,0
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.5726,-0.016966,-0.042948,0,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.21905,-0.016996,-0.051082,0,0
5,GO LIVER REGENERATION,0.79636,-0.01707,0.0057256,0,0
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.57857,-0.017132,0.072547,0,0
5,GO CYTOPLASMIC TRANSLATION,0.5726,-0.017163,-0.075498,0,0
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.36064,-0.017257,-0.078327,0,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.89907,-0.017284,-0.0007665,0,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.8303,-0.017357,-0.0060106,0,0
5,GO POST EMBRYONIC DEVELOPMENT,0.18508,-0.017421,-0.057202,0,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.85768,-0.017456,-0.0099522,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.94769,-0.017487,0.013775,0,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.44402,-0.017502,-0.066235,0,0
5,GO RESPONSE TO PROSTAGLANDIN E,0.87144,-0.01774,-0.0019812,0,0
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.59664,-0.01776,-0.031346,0,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.73628,-0.017848,-0.0056299,0,0
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.13355,-0.017918,-0.073311,0,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.33373,-0.017937,-0.034189,0,0
5,GO NUCLEAR EXPORT,0.48678,-0.017963,-0.040385,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.52594,-0.017971,-0.08227,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.52594,-0.017982,-0.04175,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.57857,-0.01799,-0.032762,0,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.67137,-0.018022,-0.061393,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.56075,-0.018063,-0.050074,0,0
5,GO SKELETAL MUSCLE ADAPTATION,0.62732,-0.018164,0.053194,0,0
5,GO RIBOSOME ASSEMBLY,0.89907,-0.018196,-0.027959,0,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.54903,-0.018373,-0.03001,0,0
5,GO RNA LOCALIZATION,0.16032,-0.018488,-0.068544,0,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.093897,-0.018624,-0.075788,0,0
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.27999,-0.018651,-0.02503,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.71658,-0.018759,-0.01943,0,0
5,GO MICROTUBULE BUNDLE FORMATION,0.92682,-0.018776,-0.0066997,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.97557,-0.018821,-0.0015198,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.60883,-0.018888,0.032943,0,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.96163,-0.01891,0.0013553,0,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.92682,-0.019009,-0.010676,0,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.51459,-0.019063,-0.030648,0,0
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.57857,-0.019383,-0.027697,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.91987,-0.01965,0.00083419,0,0
5,GO MALE GENITALIA DEVELOPMENT,0.67776,-0.019656,0.038039,0,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.58456,-0.019675,-0.011578,0,0
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.90599,-0.019683,-0.011054,0,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.82348,-0.01969,0.010768,0,0
5,GO COVALENT CHROMATIN MODIFICATION,0.052669,-0.019762,-0.048992,0,0
5,GO RESPONSE TO FOOD,0.9686,-0.020122,-0.0067337,0,0
5,GO RHYTHMIC BEHAVIOR,0.72313,-0.020152,-0.006774,0,0
5,GO CELL PROJECTION ASSEMBLY,0.25363,-0.020157,-0.035931,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.87833,-0.020659,0.010948,0,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.87833,-0.020799,0.030082,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.41341,-0.021072,-0.061456,0,0
5,GO DENDRITIC SPINE MAINTENANCE,0.3746,-0.021133,-0.073482,0,0
5,GO CELL CELL SIGNALING BY WNT,0.39371,-0.021332,-0.03494,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.54903,-0.02136,-0.052367,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.59059,-0.021381,0.06063,0,0
5,GO FOCAL ADHESION ASSEMBLY,0.93377,-0.021547,-0.025624,0,0
5,GO ORGANELLE ASSEMBLY,0.47588,-0.021554,-0.018448,0,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.28785,-0.021589,-0.066748,0,0
5,GO MULTICELLULAR ORGANISM GROWTH,0.60883,-0.021608,-0.016438,0,0
5,GO SKELETAL SYSTEM DEVELOPMENT,0.71006,-0.021625,-0.025554,0,0
5,GO MESODERM DEVELOPMENT,0.36526,-0.021905,-0.051218,0,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.56666,-0.022122,-0.027682,0,0
5,GO MICROVILLUS ASSEMBLY,0.63354,-0.022222,0.033542,0,0
5,GO PEPTIDYL LYSINE MODIFICATION,0.050569,-0.022278,-0.038082,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.47049,-0.022309,-0.041007,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.30815,-0.022356,-0.10219,0,0
5,GO MITOTIC CELL CYCLE,0.36064,-0.022356,-0.022627,0,0
5,GO BRONCHUS DEVELOPMENT,0.87833,-0.022403,0.031243,0,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.9686,-0.022514,0.0016254,0,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.90599,-0.022531,-0.02344,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.29586,-0.022622,-0.02508,0,0
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.2839,-0.022679,-0.058074,0,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.48678,-0.022729,-0.052194,0,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.78289,-0.022882,-0.014039,0,0
5,GO REGULATION OF CELL CYCLE ARREST,0.56075,-0.022951,-0.012734,0,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.26098,-0.023164,-0.03656,0,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.61497,-0.023164,-0.027117,0,0
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.78289,-0.023423,-0.030323,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.20309,-0.023494,-0.12677,0,0
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.69707,-0.02351,-0.021277,0,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.81668,-0.02364,0.088662,0,0
5,GO RRNA MODIFICATION,0.78962,-0.023728,-0.03333,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.81668,-0.023767,-0.031182,0,0
5,GO CELL CYCLE PROCESS,0.188,-0.023909,-0.026444,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.63354,-0.023935,-0.011105,0,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.12473,-0.023936,-0.066511,0,0
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.59059,-0.02399,-0.046066,0,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.93377,-0.024185,0.0088929,0,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.68418,-0.024231,0.0028421,0,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.51459,-0.024253,-0.022306,0,0
5,GO SENSORY ORGAN MORPHOGENESIS,0.32938,-0.024459,-0.048054,0,0
5,GO CYTOSKELETON ORGANIZATION,0.56666,-0.024675,-0.020283,0,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.91293,-0.024823,-0.0021612,0,0
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.9686,-0.02483,0.00079889,0,0
5,GO REGULATION OF CELL DIVISION,0.72969,-0.024876,-0.012973,0,0
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.98953,-0.025074,0.028617,0,0
5,GO SENSORY ORGAN DEVELOPMENT,0.31232,-0.025157,-0.041555,0,0
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.94073,-0.025241,-0.025422,0,0
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.20937,-0.025316,-0.03902,0,0
5,GO MRNA TRANSCRIPTION,0.48131,-0.025321,-0.047762,0,0
5,GO SNRNA TRANSCRIPTION,0.21905,-0.025427,-0.047048,0,0
5,GO SLEEP,0.88523,-0.025636,0.00046508,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.62113,-0.025727,-0.017505,0,0
5,GO HEART DEVELOPMENT,0.40349,-0.02577,-0.040407,0,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.42855,-0.025798,-0.06359,0,0
5,GO PROTEIN ACYLATION,0.20937,-0.025839,-0.021459,0,0
5,GO REGULATION OF CENTROSOME CYCLE,0.43883,-0.025936,-0.015657,0,0
5,GO RIBOSOME BIOGENESIS,0.67776,-0.026022,-0.043287,0,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,0.4978,-0.026073,-0.078328,0,0
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.90599,-0.026098,0.0069708,0,0
5,GO REGIONALIZATION,0.92682,-0.02633,0.0024615,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.15015,-0.026379,-0.05956,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.89215,-0.026387,-0.017079,0,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.94073,-0.0266,-0.018174,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.53742,-0.026615,0.047789,0,0
5,GO CHROMOSOME LOCALIZATION,0.39371,-0.026631,-0.029487,0,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.99651,-0.026676,-0.021151,0,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.74288,-0.026689,0.021031,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.42855,-0.026698,-0.028647,0,0
5,GO ECTODERM DEVELOPMENT,0.84397,-0.026739,-0.018272,0,0
5,GO REGULATION OF CELL AGING,0.65866,-0.026795,-0.032098,0,0
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.51459,-0.02685,-0.029112,0,0
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.32077,-0.026887,-0.092006,0,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.27611,-0.026952,-0.0666,0,0
5,GO HISTONE H4 ACETYLATION,0.43367,-0.027173,-0.019179,0,0
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.53167,-0.027233,-0.043973,0,0
5,GO ODONTOGENESIS,0.31653,-0.027247,-0.08539,0,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.23589,-0.027349,-0.027563,0,0
5,GO BODY MORPHOGENESIS,0.65866,-0.027493,-0.034079,0,0
5,GO MESENCHYME MORPHOGENESIS,0.59059,-0.027499,-0.062542,0,0
5,GO PROTEIN NEDDYLATION,0.23937,-0.027543,-0.064834,0,0
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.90599,-0.027651,-0.012186,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.69061,-0.027674,-0.020256,0,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.49227,-0.028214,-0.041858,0,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.30815,-0.028321,-0.052631,0,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.89215,-0.028342,0.039202,0,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.49227,-0.028375,-0.012245,0,0
5,GO NEUROTRANSMITTER UPTAKE,0.65234,-0.028385,0.042514,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.23589,-0.028439,-0.096322,0,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.30815,-0.02848,-0.049962,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.47049,-0.028494,-0.028786,0,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.76281,-0.028502,-0.091175,0,0
5,GO DNA REPAIR,0.12259,-0.028518,-0.037738,0,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.4598,-0.028615,-0.040443,0,0
5,GO SPINDLE ASSEMBLY,0.25729,-0.028632,-0.033257,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.27999,-0.028695,-0.099378,0,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.48678,-0.028732,-0.059473,0,0
5,GO NUCLEAR TRANSPORT,0.67137,-0.028767,-0.017814,0,0
5,GO THYROID GLAND DEVELOPMENT,0.42855,-0.028839,-0.098979,0,0
5,GO GONADOTROPIN SECRETION,0.80989,-0.029054,-0.030437,0,0
5,GO NEURON APOPTOTIC PROCESS,0.56666,-0.029175,-0.013557,0,0
5,GO REGULATION OF PROTEIN ACETYLATION,0.62732,-0.029515,-0.0026105,0,0
5,GO PROTEIN KINASE A SIGNALING,0.24643,-0.029519,-0.066507,0,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.63354,-0.029529,-0.010994,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.98255,-0.029641,0.025638,0,0
5,GO NCRNA TRANSCRIPTION,0.19393,-0.029674,-0.056156,0,0
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.52594,-0.029798,-0.017267,0,0
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.87833,-0.029855,0.0068016,0,0
5,GO EMBRYO IMPLANTATION,0.60272,-0.030245,-0.065958,0,0
5,GO NERVOUS SYSTEM PROCESS,1,-0.030493,0.0001273,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.28785,-0.030564,-0.040729,0,0
5,GO MRNA CLEAVAGE,0.38888,-0.030582,-0.03517,0,0
5,GO REGULATION OF GLIOGENESIS,0.94769,-0.030614,0.007991,0,0
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.48131,-0.030682,-0.08138,0,0
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.94073,-0.030689,-0.014292,0,0
5,GO RNA SURVEILLANCE,0.48131,-0.030699,-0.039056,0,0
5,GO REGULATION OF GTP BINDING,0.80989,-0.030724,-0.043696,0,0
5,GO STARTLE RESPONSE,0.79636,-0.030845,-0.030668,0,0
5,GO REGULATION OF ATPASE ACTIVITY,0.15264,-0.030917,-0.045127,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.71658,-0.031067,-0.0065566,0,0
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.87833,-0.031074,0.0057213,0,0
5,GO DEMETHYLATION,0.79636,-0.03114,-0.013014,0,0
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.31232,-0.031168,-0.039083,0,0
5,GO RRNA METABOLIC PROCESS,0.76948,-0.031452,-0.028141,0,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.20621,-0.031872,-0.029582,0,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.97557,-0.031879,0.0025962,0,0
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.92682,-0.031959,0.010287,0,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.15517,-0.031982,-0.050807,0,0
5,GO NCRNA EXPORT FROM NUCLEUS,0.41842,-0.032045,-0.0584,0,0
5,GO HISTONE PHOSPHORYLATION,0.85082,-0.032227,-0.011015,0,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.54321,-0.032309,-0.056515,0,0
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.56075,-0.03236,-0.019754,0,0
5,GO COPII COATED VESICLE CARGO LOADING,0.44924,-0.032403,-0.026402,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.53167,-0.032452,-0.040209,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.94769,-0.032492,-0.061582,0,0
5,GO CAMERA TYPE EYE DEVELOPMENT,0.13583,-0.03254,-0.065419,0,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.43883,-0.032719,-0.13925,0,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.47049,-0.032815,-0.032645,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.28785,-0.032852,-0.05211,0,0
5,GO LENS FIBER CELL DIFFERENTIATION,0.61497,-0.033022,-0.025572,0,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.53167,-0.033064,-0.032533,0,0
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.3746,-0.033173,-0.091963,0,0
5,GO OVULATION,0.91293,-0.033183,0.0086665,0,0
5,GO MINERALOCORTICOID METABOLIC PROCESS,0.47588,-0.033254,-0.10622,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS,0.94073,-0.033365,0.0054396,0,0
5,GO PROTEIN POLYMERIZATION,0.59664,-0.033862,-0.022046,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.76281,-0.033881,0.012167,0,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.32077,-0.033968,-0.097066,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.67776,-0.034319,-0.023724,0,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.4545,-0.034335,-0.038481,0,0
5,GO RNA EXPORT FROM NUCLEUS,0.12049,-0.034338,-0.068081,0,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.65234,-0.034425,-0.037903,0,0
5,GO NEUTROPHIL HOMEOSTASIS,0.60272,-0.03452,-0.10759,0,0
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.79636,-0.034716,-0.016078,0,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.44924,-0.034749,-0.065895,0,0
5,GO MRNA METHYLATION,0.27611,-0.034825,-0.08139,0,0
5,GO REGULATION OF RNA BINDING,0.36064,-0.034835,-0.074281,0,0
5,GO PROTEIN DEPOLYMERIZATION,0.98953,-0.034901,0.0081486,0,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.26471,-0.035011,-0.078668,0,0
5,GO RNA POLYADENYLATION,0.15264,-0.035341,-0.06077,0,0
5,GO HEART FIELD SPECIFICATION,0.67776,-0.035363,-0.039086,0,0
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.67137,-0.035388,-0.046543,0,0
5,GO FEMALE GENITALIA DEVELOPMENT,0.48678,-0.035471,-0.059689,0,0
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.91293,-0.035505,-0.030471,0,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.23589,-0.035847,-0.027666,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.068167,-0.035979,-0.082131,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.59059,-0.036018,-0.04663,0,0
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.62113,-0.036027,-0.019873,0,0
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.68418,-0.036399,-0.024518,0,0
5,GO REGULATION OF CYTOKINESIS,0.27227,-0.03642,-0.03351,0,0
5,GO HISTONE UBIQUITINATION,0.17099,-0.036652,-0.048372,0,0
5,GO SULFATION,0.72313,-0.036682,-0.020232,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.40349,-0.036709,-0.023932,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.39858,-0.036725,-0.044076,0,0
5,GO EXIT FROM MITOSIS,0.67137,-0.03679,-0.015104,0,0
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.5726,-0.036898,-0.024125,0,0
5,GO NEURAL NUCLEUS DEVELOPMENT,0.94769,-0.036901,0.032746,0,0
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.56075,-0.036928,-0.023725,0,0
5,GO BONE DEVELOPMENT,0.11434,-0.036974,-0.086657,0,0
5,GO MESENCHYMAL CELL PROLIFERATION,0.90599,-0.037084,-0.049916,0,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.63978,-0.03782,0.10738,0,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.76281,-0.038225,-0.047405,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.23937,-0.038456,-0.032171,0,0
5,GO FOREGUT MORPHOGENESIS,0.31653,-0.038503,-0.086445,0,0
5,GO CHROMOSOME ORGANIZATION,0.0695,-0.038659,-0.03896,0,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.64605,-0.03879,-0.03061,0,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.44402,-0.03882,-0.056186,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.82348,-0.038889,-0.01027,0,0
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.14285,-0.038952,-0.072819,0,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.26847,-0.039172,-0.046893,0,0
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.90599,-0.03931,0.019493,0,0
5,GO ACTIVATION OF MAPKK ACTIVITY,0.63978,-0.039443,-0.027367,0,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.17374,-0.039469,-0.038793,0,0
5,GO VASCULOGENESIS,0.49227,-0.039498,-0.080346,0,0
5,GO CLATHRIN COAT ASSEMBLY,0.60883,-0.039571,-0.034842,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.60883,-0.039835,-0.023978,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.60883,-0.039863,-0.059839,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.98953,-0.040276,0.0064131,0,0
5,GO STRIATUM DEVELOPMENT,0.89907,-0.040299,0.0022805,0,0
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.59059,-0.040407,-0.019271,0,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.33373,-0.040504,-0.061846,0,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.38888,-0.040665,-0.12998,0,0
5,GO CELLULAR RESPONSE TO RADIATION,0.34702,-0.040757,-0.033936,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.9686,-0.040776,0.029815,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.67137,-0.040953,-0.0030403,0,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.56075,-0.041052,-0.055601,0,0
5,GO PROSTATE GLAND MORPHOGENESIS,0.21579,-0.041181,-0.18803,0,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.42855,-0.041221,-0.1244,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.58456,-0.041296,-0.025772,0,0
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.71006,-0.041455,-0.056844,0,0
5,GO PEPTIDYL LYSINE ACETYLATION,0.05161,-0.041613,-0.049553,0,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.4598,-0.042036,-0.023653,0,0
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.32938,-0.042105,-0.034085,0,0
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.18508,-0.042187,-0.068516,0,0
5,GO VIRAL GENE EXPRESSION,0.76948,-0.042486,-0.03696,0,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.13583,-0.042647,-0.086416,0,0
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.59059,-0.042688,-0.038602,0,0
5,GO GLUTAMINE METABOLIC PROCESS,0.17099,-0.042704,-0.096766,0,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.32506,-0.042799,-0.047055,0,0
5,GO LIPOPROTEIN LOCALIZATION,0.12473,-0.043138,-0.11003,0,0
5,GO PROTEIN METHYLATION,0.2,-0.04314,-0.024358,0,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.69707,-0.043379,-0.036714,0,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.65866,-0.04339,-0.047349,0,0
5,GO SPECIFICATION OF SYMMETRY,0.24643,-0.04352,-0.052854,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.53742,-0.043681,-0.044798,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.070855,-0.043697,-0.092489,0,0
5,GO TRNA TRANSPORT,0.3746,-0.043769,-0.066131,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.42855,-0.044241,-0.0407,0,0
5,GO PROTEIN MONOUBIQUITINATION,0.16828,-0.044289,-0.038606,0,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.56075,-0.044312,-0.055736,0,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.60272,-0.044474,-0.093951,0,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.19393,-0.044487,-0.05442,0,0
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.29586,-0.044618,-0.053461,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.99651,-0.044677,-0.0072914,0,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.17653,-0.044751,-0.072007,0,0
5,GO CENTROSOME DUPLICATION,0.60272,-0.044841,-0.014978,0,0
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.38888,-0.044974,-0.025538,0,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.33812,-0.045169,-0.043974,0,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.61497,-0.045199,-0.041743,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.36526,-0.045292,-0.09549,0,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.32938,-0.045302,-0.075601,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.72969,-0.045424,-0.030401,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.63354,-0.045523,-0.024715,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.16828,-0.045621,-0.054072,0,0
5,GO THALAMUS DEVELOPMENT,0.39371,-0.045637,-0.055788,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.60272,-0.045672,-0.032424,0,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.65234,-0.045844,0.046118,0,0
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.49227,-0.045862,-0.037907,0,0
5,GO FIBROBLAST MIGRATION,0.71658,-0.045862,-0.031752,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.90599,-0.045903,0.0085818,0,0
5,GO HISTONE H2A ACETYLATION,0.60272,-0.04595,-0.035502,0,0
5,GO PROSTATE GLAND DEVELOPMENT,0.25001,-0.046026,-0.13296,0,0
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.47588,-0.046074,-0.10791,0,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.71006,-0.046097,-0.034907,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.66501,-0.04662,-0.033767,0,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.16294,-0.046719,-0.060037,0,0
5,GO MRNA METABOLIC PROCESS,0.17653,-0.046781,-0.048174,0,0
5,GO EAR MORPHOGENESIS,0.48131,-0.046932,-0.04243,0,0
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.52594,-0.047407,-0.020992,0,0
5,GO ACTIVATION OF JNKK ACTIVITY,0.67137,-0.047572,-0.023311,0,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.46512,-0.047627,-0.095115,0,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.78962,-0.047661,-0.044595,0,0
5,GO HISTONE H2A UBIQUITINATION,0.2839,-0.047778,-0.052866,0,0
5,GO PATTERN SPECIFICATION PROCESS,0.42347,-0.047808,-0.027176,0,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.29992,-0.047916,-0.067901,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.19393,-0.048078,-0.13539,0,0
5,GO MIDBRAIN DEVELOPMENT,0.31232,-0.048133,-0.039813,0,0
5,GO CEREBELLAR CORTEX FORMATION,0.23245,-0.04814,-0.071949,0,0
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.20937,-0.048185,-0.053555,0,0
5,GO SALIVARY GLAND DEVELOPMENT,0.91987,-0.048219,-0.016112,0,0
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.35607,-0.048344,-0.08411,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0695,-0.04838,-0.091679,0,0
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.47588,-0.048442,-0.033631,0,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.58456,-0.048559,-0.050718,0,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.48678,-0.048567,-0.032249,0,0
5,GO OVULATION CYCLE PROCESS,0.85082,-0.04867,0.0040588,0,0
5,GO OTIC VESICLE DEVELOPMENT,0.54903,-0.048683,-0.08033,0,0
5,GO REGULATION OF BONE MINERALIZATION,0.93377,-0.049023,-0.011128,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.65234,-0.049417,-0.059488,0,0
5,GO PEPTIDYL ARGININE MODIFICATION,0.27611,-0.049465,-0.045229,0,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.81668,-0.049641,-0.039936,0,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.41341,-0.049642,-0.072497,0,0
5,GO RNA 3 END PROCESSING,0.26847,-0.049772,-0.055293,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.76281,-0.049855,-0.03597,0,0
5,GO SCHWANN CELL DEVELOPMENT,0.32077,-0.049936,-0.048025,0,0
5,GO DOUBLE STRAND BREAK REPAIR,0.049546,-0.050154,-0.065182,0,0
5,GO RNA CAPPING,0.42347,-0.050249,-0.034913,0,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.23245,-0.050446,-0.054027,0,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.12473,-0.050499,-0.081411,0,0
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.87144,-0.050655,0.035324,0,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.39858,-0.05066,-0.1164,0,0
5,GO REGULATION OF CILIUM BEAT FREQUENCY,0.31653,-0.050713,-0.07363,0,0
5,GO PEPTIDYL LYSINE METHYLATION,0.057089,-0.050733,-0.050951,0,0
5,GO HINDBRAIN MORPHOGENESIS,0.21905,-0.050881,-0.065556,0,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.20309,-0.051036,-0.06991,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.16559,-0.051251,-0.065877,0,0
5,GO SERTOLI CELL DEVELOPMENT,0.29184,-0.05134,-0.13416,0,0
5,GO CARDIOCYTE DIFFERENTIATION,0.50337,-0.051594,-0.040373,0,0
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.60883,-0.051821,-0.049618,0,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.51459,-0.051997,-0.069224,0,0
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.27227,-0.052054,-0.036577,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.065563,-0.052289,-0.10995,0,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.20621,-0.052392,-0.11068,0,0
5,GO REGULATION OF HEAT GENERATION,0.89907,-0.052398,0.011596,0,0
5,GO SENSORY SYSTEM DEVELOPMENT,0.10096,-0.052401,-0.06444,0,0
5,GO MUSCLE ORGAN MORPHOGENESIS,0.47588,-0.05242,-0.050048,0,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.44924,-0.052475,-0.01248,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.5726,-0.052516,-0.069036,0,0
5,GO HISTONE METHYLATION,0.05824,-0.052533,-0.044643,0,0
5,GO CELL VOLUME HOMEOSTASIS,0.75615,-0.052698,0.0088776,0,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.4598,-0.052748,-0.02431,0,0
5,GO APICAL PROTEIN LOCALIZATION,0.96163,-0.052792,0.0062417,0,0
5,GO NEGATIVE REGULATION OF CELL SIZE,0.62732,-0.053009,-0.055815,0,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.26471,-0.053316,-0.081839,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.28785,-0.053426,-0.057126,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.31653,-0.053575,-0.1144,0,0
5,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.89215,-0.053788,0.053727,0,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.22905,-0.05385,-0.13436,0,0
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.17099,-0.053898,-0.091537,0,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.14048,-0.054056,-0.10628,0,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.38408,-0.054086,-0.090739,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.22235,-0.054311,-0.085655,0,0
5,GO GRANULOCYTE DIFFERENTIATION,0.65234,-0.0545,-0.0083976,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.53742,-0.054562,-0.066677,0,0
5,GO STEM CELL DIFFERENTIATION,0.25363,-0.05465,-0.04199,0,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.14769,-0.054774,-0.10986,0,0
5,GO PEPTIDYL ARGININE METHYLATION,0.4978,-0.055076,-0.03252,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.23589,-0.055175,-0.04473,0,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.061812,-0.055396,-0.09736,0,0
5,GO LOCOMOTORY BEHAVIOR,0.60883,-0.055406,-0.0031042,0,0
5,GO REGULATION OF FEEDING BEHAVIOR,0.27227,-0.055438,-0.084805,0,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.080955,-0.05547,-0.083094,0,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.98953,-0.055533,-0.063824,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.27227,-0.055536,-0.19901,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.16032,-0.055584,-0.069395,0,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.10096,-0.055618,-0.11421,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.18219,-0.05563,-0.055119,0,0
5,GO MRNA 3 END PROCESSING,0.076492,-0.055661,-0.070432,0,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.46512,-0.055693,-0.049528,0,0
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.35153,-0.055994,-0.073181,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.20309,-0.056041,-0.065436,0,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.22235,-0.056149,-0.086935,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.2839,-0.056196,-0.069377,0,0
5,GO EYE MORPHOGENESIS,0.18508,-0.056271,-0.064142,0,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.58456,-0.056338,-0.047403,0,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.14526,-0.056346,-0.054187,0,0
5,GO LIPID PHOSPHORYLATION,0.85082,-0.056625,0.016617,0,0
5,GO HISTONE H3 K4 METHYLATION,0.16559,-0.05663,-0.035226,0,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.079444,-0.057195,-0.068758,0,0
5,GO SISTER CHROMATID SEGREGATION,0.10465,-0.057279,-0.04565,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.38408,-0.057307,-0.036343,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.51459,-0.057404,-0.066407,0,0
5,GO MEMBRANE DOCKING,0.085627,-0.057482,-0.045843,0,0
5,GO MATING BEHAVIOR,0.69061,-0.057594,-0.049107,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.90599,-0.057786,-0.019567,0,0
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.63978,-0.057849,-0.017288,0,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.85082,-0.057851,-0.011529,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.15264,-0.057896,-0.054527,0,0
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.53742,-0.057917,-0.017331,0,0
5,GO REGULATION OF RECEPTOR CLUSTERING,0.69061,-0.058024,-0.028234,0,0
5,GO RENAL FILTRATION,0.69707,-0.05813,-0.019353,0,0
5,GO ARTERY DEVELOPMENT,0.17099,-0.058181,-0.08991,0,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.41341,-0.058194,-0.045875,0,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.053746,-0.058345,-0.059699,0,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.61497,-0.058402,-0.065323,0,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.67137,-0.058489,-0.042534,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.42347,-0.05852,-0.091866,0,0
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.15773,-0.058521,-0.057513,0,0
5,GO REGULATION OF OOGENESIS,0.34702,-0.058528,-0.032594,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.33812,-0.058653,-0.025319,0,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.14769,-0.058779,-0.06633,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.44402,-0.058954,-0.062036,0,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.14526,-0.059053,-0.093471,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.15773,-0.05906,-0.05748,0,0
5,GO CHROMOSOME SEPARATION,0.12259,-0.059125,-0.057478,0,0
5,GO RESPONSE TO CATECHOLAMINE,0.99651,-0.059138,0.0098898,0,0
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.63354,-0.059192,-0.029047,0,0
5,GO G2 DNA DAMAGE CHECKPOINT,0.10096,-0.059207,-0.090424,0,0
5,GO EPIBOLY,0.50896,-0.059423,-0.12209,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.47588,-0.060176,-0.085069,0,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.14769,-0.060378,-0.097825,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.25729,-0.06055,-0.054276,0,0
5,GO INNER EAR MORPHOGENESIS,0.31232,-0.060621,-0.051124,0,0
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.25729,-0.060742,-0.038345,0,0
5,GO REGULATION OF DNA BINDING,0.11841,-0.061013,-0.045952,0,0
5,GO RETINA LAYER FORMATION,0.4545,-0.061236,-0.031658,0,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.56075,-0.06124,-0.028743,0,0
5,GO REGULATION OF HEART MORPHOGENESIS,0.22905,-0.061612,-0.11393,0,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.077957,-0.061653,-0.043758,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.64605,-0.062051,-0.02969,0,0
5,GO HISTONE H3 K36 METHYLATION,0.12908,-0.062074,-0.10032,0,0
5,GO CELLULAR RESPONSE TO HEAT,0.28785,-0.06226,-0.042578,0,0
5,GO CELL AGGREGATION,0.31653,-0.062405,-0.085159,0,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.090515,-0.062519,-0.079661,0,0
5,GO GENITALIA MORPHOGENESIS,0.25001,-0.062695,-0.13191,0,0
5,GO HISTONE H3 K9 METHYLATION,0.13814,-0.062924,-0.08324,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.85082,-0.063059,0.052989,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.43883,-0.063154,-0.037628,0,0
5,GO DNA GEOMETRIC CHANGE,0.04854,-0.06364,-0.080988,0,0
5,GO HISTONE H3 K9 MODIFICATION,0.12689,-0.063773,-0.071178,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.54903,-0.063868,-0.039916,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.33812,-0.064016,-0.06191,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.65234,-0.06414,-0.0056985,0,0
5,GO LYMPH VESSEL MORPHOGENESIS,0.23245,-0.064302,-0.10495,0,0
5,GO SEQUESTERING OF METAL ION,0.58456,-0.064592,-0.066525,0,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.33373,-0.06461,-0.041856,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.53742,-0.064611,0.0038025,0,0
5,GO CHROMATIN SILENCING,0.188,-0.064657,-0.04427,0,0
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.3746,-0.064926,-0.10047,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.4598,-0.064972,-0.03831,0,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.087232,-0.064981,-0.084544,0,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.29184,-0.064994,-0.039514,0,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.80312,-0.06521,-0.050936,0,0
5,GO STEM CELL DIVISION,0.1313,-0.065346,-0.098871,0,0
5,GO REGULATION OF MEMBRANE POTENTIAL,0.55487,-0.065431,-0.02057,0,0
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.26471,-0.065447,-0.073937,0,0
5,GO CARDIAC CHAMBER DEVELOPMENT,0.25729,-0.06546,-0.055152,0,0
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.10654,-0.065566,-0.13743,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.31232,-0.065693,-0.082284,0,0
5,GO DNA REPLICATION,0.04854,-0.065912,-0.063003,0,0
5,GO BASE EXCISION REPAIR,0.064293,-0.065935,-0.079788,0,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.070855,-0.066231,-0.1274,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.38888,-0.06628,-0.044639,0,0
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.188,-0.06678,-0.061391,0,0
5,GO RESPONSE TO UV,0.14285,-0.06685,-0.051091,0,0
5,GO PROSTATIC BUD FORMATION,0.38888,-0.06703,-0.16064,0,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.23589,-0.067097,-0.045197,0,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.11434,-0.067115,-0.12766,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.10465,-0.067175,-0.067857,0,0
5,GO DEVELOPMENTAL GROWTH,0.092194,-0.067364,-0.07136,0,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.9686,-0.067688,0.018071,0,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.16032,-0.067871,-0.09792,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.053746,-0.067956,-0.091939,0,0
5,GO NEUROMUSCULAR PROCESS,0.087232,-0.068103,-0.093867,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.76948,-0.068406,0.001089,0,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.11039,-0.068677,-0.054306,0,0
5,GO GASTRIC ACID SECRETION,0.91987,-0.068788,0.007642,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.90599,-0.068866,-0.020053,0,0
5,GO HISTONE H3 K4 TRIMETHYLATION,0.13583,-0.068884,-0.065256,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.28785,-0.069452,-0.079208,0,0
5,GO HISTONE H4 K5 ACETYLATION,0.71006,-0.069515,-0.0084386,0,0
5,GO HEART MORPHOGENESIS,0.12908,-0.069578,-0.075954,0,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.20309,-0.069612,-0.076682,0,0
5,GO SKELETAL MUSCLE CONTRACTION,0.29184,-0.069928,-0.064461,0,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.084046,-0.069962,-0.10543,0,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.11039,-0.070101,-0.061145,0,0
5,GO ACROSOME ASSEMBLY,0.13355,-0.070122,-0.10425,0,0
5,GO DNA RECOMBINATION,0.10654,-0.070145,-0.044151,0,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.082489,-0.070188,-0.081802,0,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.54321,-0.070238,-0.069698,0,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.60883,-0.070476,0.020733,0,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.061812,-0.070527,-0.075592,0,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.43883,-0.070888,-0.079493,0,0
5,GO VIRAL TRANSLATION,0.25363,-0.07099,-0.11051,0,0
5,GO ORGAN GROWTH,0.070855,-0.071005,-0.086191,0,0
5,GO AORTIC VALVE DEVELOPMENT,0.25001,-0.071029,-0.11388,0,0
5,GO HEAT GENERATION,0.93377,-0.071157,0.0073566,0,0
5,GO MATURATION OF SSU RRNA,0.44924,-0.071262,-0.082903,0,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.099158,-0.071384,-0.10896,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.8303,-0.071436,-0.0098309,0,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.38408,-0.071476,-0.081716,0,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.34256,-0.07158,-0.014853,0,0
5,GO CELL RECOGNITION,0.35153,-0.071583,-0.059521,0,0
5,GO MICROTUBULE ANCHORING,0.11841,-0.071716,-0.065759,0,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.26098,-0.072061,-0.061855,0,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.20937,-0.072204,-0.17231,0,0
5,GO MRNA TRANSPORT,0.10465,-0.072223,-0.06959,0,0
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.72313,-0.072611,-0.027197,0,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.017549,-0.072629,-0.14494,0,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.12049,-0.072738,-0.085345,0,0
5,GO MITOTIC RECOMBINATION,0.23245,-0.072836,-0.075105,0,0
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0695,-0.072976,-0.10648,0,0
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.053746,-0.072998,-0.084121,0,0
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.30402,-0.073091,-0.062754,0,0
5,GO CORONARY VASCULATURE DEVELOPMENT,0.05824,-0.073169,-0.14916,0,0
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.63978,-0.073205,-0.071404,0,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.30815,-0.073293,-0.068066,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,-0.073314,-0.031493,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.30815,-0.073386,-0.077921,0,0
5,GO CGMP MEDIATED SIGNALING,0.25363,-0.073443,-0.06624,0,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.63354,-0.073667,-0.034187,0,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.36064,-0.073714,-0.059801,0,0
5,GO BEHAVIOR,0.38888,-0.073769,-0.03223,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.96163,-0.073974,-0.026919,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.14048,-0.073982,-0.087064,0,0
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.18219,-0.074096,-0.068847,0,0
5,GO CALCINEURIN MEDIATED SIGNALING,0.31653,-0.074571,-0.04471,0,0
5,GO HINDBRAIN DEVELOPMENT,0.44402,-0.075077,-0.032105,0,0
5,GO RESPONSE TO AMYLOID BETA,0.29992,-0.075264,-0.046662,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.48131,-0.075466,-0.08949,0,0
5,GO CELLULAR COMPONENT MAINTENANCE,0.43367,-0.075558,-0.039287,0,0
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.62732,-0.075602,-0.028268,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.066855,-0.075603,-0.11134,0,0
5,GO SNORNA METABOLIC PROCESS,0.14526,-0.075645,-0.11638,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.57857,-0.075758,-0.045517,0,0
5,GO HISTONE H3 DEACETYLATION,0.19695,-0.075824,-0.064758,0,0
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.066855,-0.076033,-0.064198,0,0
5,GO ANIMAL ORGAN FORMATION,0.11434,-0.076058,-0.1011,0,0
5,GO SCHWANN CELL DIFFERENTIATION,0.30402,-0.076061,-0.059039,0,0
5,GO MATERNAL PLACENTA DEVELOPMENT,0.064293,-0.076178,-0.18747,0,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.3746,-0.076215,-0.047092,0,0
5,GO OTIC VESICLE MORPHOGENESIS,0.35153,-0.076231,-0.106,0,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.95466,-0.076237,0.057094,0,0
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.4978,-0.076507,-0.06321,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.14526,-0.076809,-0.051082,0,0
5,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.87833,-0.077066,-0.056719,0,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.21579,-0.077115,-0.087407,0,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.066855,-0.077229,-0.080003,0,0
5,GO RESPONSE TO DOPAMINE,0.48131,-0.077659,-0.028266,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.90599,-0.077816,0.02528,0,0
5,GO HAIR FOLLICLE MATURATION,0.41341,-0.077855,-0.066549,0,0
5,GO CELLULAR RESPONSE TO PH,0.19095,-0.078242,-0.081774,0,0
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.26471,-0.078464,-0.081871,0,0
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.43883,-0.078524,-0.079276,0,0
5,GO HISTONE DEUBIQUITINATION,0.21256,-0.078587,-0.047403,0,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.037747,-0.078624,-0.065679,0,0
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.34702,-0.078657,-0.058516,0,0
5,GO ASYMMETRIC CELL DIVISION,0.47049,-0.078832,-0.065572,0,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.088862,-0.079286,-0.16089,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.22905,-0.079414,-0.052401,0,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.25729,-0.079437,-0.078926,0,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.44924,-0.07963,-0.038486,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.48678,-0.079735,-0.063115,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.19695,-0.07985,-0.10693,0,0
5,GO FIBROBLAST APOPTOTIC PROCESS,0.63978,-0.079879,-0.051881,0,0
5,GO DETECTION OF VISIBLE LIGHT,0.061812,-0.080132,-0.099606,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.55487,-0.080307,-0.071567,0,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.065563,-0.080384,-0.068194,0,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.188,-0.080443,-0.11735,0,0
5,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.94769,-0.08051,0.06649,0,0
5,GO NUCLEAR MIGRATION,0.14048,-0.080513,-0.10567,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.41842,-0.080835,-0.042511,0,0
5,GO WALKING BEHAVIOR,0.049546,-0.081294,-0.14027,0,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.47588,-0.081298,-0.071033,0,0
5,GO DNA STRAND ELONGATION,0.16032,-0.081395,-0.060626,0,0
5,GO HEART VALVE DEVELOPMENT,0.188,-0.081473,-0.094783,0,0
5,GO RRNA PSEUDOURIDINE SYNTHESIS,0.59059,-0.081579,-0.077578,0,0
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.30402,-0.081849,-0.052633,0,0
5,GO MICROTUBULE NUCLEATION,0.05161,-0.081905,-0.084203,0,0
5,GO REGULATION OF HISTONE METHYLATION,0.12908,-0.082174,-0.043716,0,0
5,GO MEMORY,0.26098,-0.082593,-0.053581,0,0
5,GO REGULATION OF DNA RECOMBINATION,0.072231,-0.082767,-0.077679,0,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.38888,-0.083042,-0.078464,0,0
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.67776,-0.083142,-0.084319,0,0
5,GO CILIUM ORGANIZATION,0.049546,-0.083263,-0.071464,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.50896,-0.083371,-0.081631,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.46512,-0.083494,-0.046897,0,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.25001,-0.08351,-0.085321,0,0
5,GO CELLULAR RESPONSE TO SALT STRESS,0.088862,-0.083784,-0.22174,0,0
5,GO CONVERGENT EXTENSION,0.47588,-0.084125,-0.058044,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.39858,-0.084418,-0.068313,0,0
5,GO NUCLEOSOME ASSEMBLY,0.092194,-0.084481,-0.079413,0,0
5,GO SEROTONIN SECRETION,0.62732,-0.084524,-0.011969,0,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.58456,-0.084534,-0.017741,0,0
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.084046,-0.08466,-0.068407,0,0
5,GO CELLULAR RESPONSE TO UV,0.11039,-0.084906,-0.065529,0,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.095625,-0.084943,-0.08777,0,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0075304,-0.084979,-0.12757,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.29184,-0.085379,-0.046051,0,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.69061,-0.085441,0.031338,0,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.088862,-0.085709,-0.093892,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.21579,-0.085773,-0.13483,0,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.084046,-0.08612,-0.080041,0,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.71006,-0.086276,0.0085918,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.65234,-0.086793,0.045639,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.23245,-0.086952,-0.048441,0,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.39858,-0.087027,-0.11681,0,0
5,GO RNA STABILIZATION,0.15264,-0.087536,-0.074106,0,0
5,GO REGULATION OF TELOMERE CAPPING,0.046579,-0.087626,-0.085988,0,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.064293,-0.08783,-0.12881,0,0
5,GO HEART GROWTH,0.077957,-0.087875,-0.081166,0,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.64605,-0.088076,-0.058284,0,0
5,GO MAST CELL MIGRATION,0.50337,-0.088381,-0.088718,0,0
5,GO REGULATION OF DNA REPLICATION,0.21905,-0.088667,-0.046175,0,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.28785,-0.088824,-0.10583,0,0
5,GO HISTONE H2A MONOUBIQUITINATION,0.014138,-0.088868,-0.12633,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.19695,-0.08899,-0.06898,0,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.13583,-0.089028,-0.093258,0,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.13814,-0.089053,-0.041323,0,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23245,-0.089318,-0.096257,0,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.29992,-0.089553,-0.11071,0,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.61497,-0.089783,-0.021576,0,0
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.12049,-0.089976,-0.083573,0,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.10654,-0.090071,-0.092438,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.2839,-0.090645,-0.08501,0,0
5,GO ASTROCYTE DIFFERENTIATION,0.43883,-0.090667,-0.028295,0,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0695,-0.090892,-0.070726,0,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.71006,-0.090986,-0.075303,0,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.064293,-0.091041,-0.09544,0,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.17653,-0.091058,-0.087282,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.39858,-0.091517,-0.053765,0,0
5,GO HEART FORMATION,0.36064,-0.093138,-0.070699,0,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.18508,-0.09332,-0.08835,0,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.35153,-0.094323,-0.06439,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.088862,-0.094633,-0.099575,0,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.32506,-0.094704,-0.039423,0,0
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.29992,-0.094744,-0.098294,0,0
5,GO MEMBRANE DISASSEMBLY,0.18219,-0.094751,-0.09154,0,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.62732,-0.09483,-0.056655,0,0
5,GO OXIDATIVE DEMETHYLATION,0.19393,-0.095048,-0.048158,0,0
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.41842,-0.095356,-0.062361,0,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.20309,-0.095549,-0.065517,0,0
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.26847,-0.095748,-0.056912,0,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.17374,-0.096071,-0.088199,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.32938,-0.096222,-0.068448,0,0
5,GO AORTA DEVELOPMENT,0.090515,-0.096866,-0.12768,0,0
5,GO REGULATION OF GONAD DEVELOPMENT,0.22905,-0.096935,-0.092212,0,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.16294,-0.096987,-0.090253,0,0
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.15015,-0.097016,-0.11002,0,0
5,GO GANGLION DEVELOPMENT,0.61497,-0.097521,0.0048156,0,0
5,GO REGULATION OF TUBULIN DEACETYLATION,0.41341,-0.097769,-0.041328,0,0
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.32077,-0.097827,-0.058076,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.22235,-0.098122,-0.058224,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.25001,-0.098139,-0.053658,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.068167,-0.098625,-0.11422,0,0
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.31232,-0.098821,-0.084684,0,0
5,GO POSITIVE REGULATION OF URINE VOLUME,0.22235,-0.098914,-0.089712,0,0
5,GO TELOMERE CAPPING,0.059411,-0.098918,-0.060501,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.11841,-0.099917,-0.088406,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.31653,-0.09994,-0.07243,0,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.43883,-0.10011,-0.104,0,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.055956,-0.10017,-0.12579,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.90599,-0.10035,0.00081628,0,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.054842,-0.10048,-0.12742,0,0
5,GO CELLULAR RESPONSE TO ETHANOL,0.4598,-0.10153,-0.061413,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.049546,-0.10218,-0.18256,0,0
5,GO HISTONE H3 K9 ACETYLATION,0.049546,-0.10236,-0.090463,0,0
5,GO ADULT FEEDING BEHAVIOR,0.2839,-0.1025,-0.089345,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.17374,-0.10266,-0.095026,0,0
5,GO ATRIAL SEPTUM DEVELOPMENT,0.99651,-0.1029,0.013733,0,0
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.55487,-0.10348,-0.13049,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.38408,-0.10399,-0.075472,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.30402,-0.10405,-0.12895,0,0
5,GO TUBULIN DEACETYLATION,0.14769,-0.10411,-0.082424,0,0
5,GO RRNA 3 END PROCESSING,0.63354,-0.10453,-0.024777,0,0
5,GO MESODERMAL CELL DIFFERENTIATION,0.082489,-0.10478,-0.13743,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.22235,-0.10499,-0.064349,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.076492,-0.10505,-0.1016,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.057089,-0.10519,-0.085623,0,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.19393,-0.10557,-0.06889,0,0
5,GO HISTONE EXCHANGE,0.052669,-0.10585,-0.085733,0,0
5,GO ERYTHROCYTE MATURATION,0.21256,-0.10592,-0.10045,0,0
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.31232,-0.10609,-0.080818,0,0
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.16559,-0.10658,-0.073861,0,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.88523,-0.10668,0.024964,0,0
5,GO DORSAL VENTRAL PATTERN FORMATION,0.12908,-0.10723,-0.039872,0,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.35153,-0.10758,-0.08042,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.44402,-0.10766,-0.061073,0,0
5,GO AXIS ELONGATION,0.10465,-0.10784,-0.13996,0,0
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.24288,-0.10798,-0.076384,0,0
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.064293,-0.10857,-0.080164,0,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.53742,-0.1086,-0.066714,0,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.050569,-0.10861,-0.07502,0,0
5,GO BLASTOCYST GROWTH,0.35153,-0.10881,-0.035038,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.48678,-0.10888,-0.001216,0,0
5,GO NEUROTRANSMITTER TRANSPORT,0.16294,-0.10938,-0.045497,0,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.072231,-0.10942,-0.14341,0,0
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.11636,-0.10943,-0.099467,0,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.50337,-0.10954,-0.043711,0,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.19095,-0.11004,-0.14106,0,0
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.72969,-0.11023,-0.018085,0,0
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.12908,-0.11025,-0.15682,0,0
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.17653,-0.11032,-0.098558,0,0
5,GO SOMATIC STEM CELL DIVISION,0.22235,-0.1104,-0.16782,0,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.066855,-0.11075,-0.067284,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.033894,-0.11111,-0.15843,0,0
5,GO LEFT RIGHT AXIS SPECIFICATION,0.72969,-0.11126,-0.04958,0,0
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.15015,-0.11136,-0.15486,0,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0025817,-0.11139,-0.12519,0,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.60883,-0.11327,-0.13037,0,0
5,GO STEM CELL PROLIFERATION,0.17099,-0.11334,-0.065448,0,0
5,GO TRABECULA FORMATION,0.54321,-0.11354,-0.067923,0,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.12689,-0.1137,-0.066327,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.24288,-0.11421,-0.03509,0,0
5,GO SHORT TERM MEMORY,0.34702,-0.11453,-0.11426,0,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.2,-0.11486,-0.053211,0,0
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.10465,-0.11611,-0.10207,0,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.12689,-0.11626,-0.079496,0,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.26098,-0.11657,-0.10021,0,0
5,GO PEPTIDYL ARGININE N METHYLATION,0.2839,-0.11681,-0.077009,0,0
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.188,-0.11687,-0.063094,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.015574,-0.11721,-0.10478,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.41842,-0.11733,-0.083721,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.070855,-0.11772,-0.16087,0,0
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.0695,-0.11779,-0.11213,0,0
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.093897,-0.11848,-0.11712,0,0
5,GO CARDIAC SEPTUM DEVELOPMENT,0.1313,-0.11875,-0.10112,0,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.075049,-0.11875,-0.12032,0,0
5,GO SEROTONIN TRANSPORT,0.2839,-0.11924,-0.062235,0,0
5,GO GENETIC IMPRINTING,0.15264,-0.11929,-0.084919,0,0
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.14769,-0.12015,-0.088109,0,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.097379,-0.12019,-0.13716,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.16828,-0.1205,-0.086714,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.36064,-0.12104,-0.070283,0,0
5,GO CARDIOBLAST PROLIFERATION,0.19095,-0.12168,-0.23188,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.13583,-0.12173,-0.092246,0,0
5,GO REGULATION OF STEM CELL DIVISION,0.13355,-0.12201,-0.11345,0,0
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.69707,-0.1222,0.027078,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.26847,-0.12235,-0.1038,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.32938,-0.12245,-0.05293,0,0
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.11434,-0.12295,-0.091904,0,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.23245,-0.12344,-0.10696,0,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.22568,-0.12356,-0.12302,0,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.16032,-0.12375,-0.1004,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.11039,-0.12385,-0.10928,0,0
5,GO BIOLOGICAL PHASE,0.84397,-0.12401,0.0018514,0,0
5,GO MATURATION OF LSU RRNA,0.33812,-0.12426,-0.11207,0,0
5,GO TRANSPORT ALONG MICROTUBULE,0.00014418,-0.12465,-0.13598,0,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.03939,-0.12526,-0.26675,0,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.15015,-0.12538,-0.075695,0,0
5,GO CELLULAR RESPONSE TO VITAMIN,0.054842,-0.12548,-0.15,0,0
5,GO ADULT BEHAVIOR,0.25729,-0.12557,-0.023854,0,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.28785,-0.12609,-0.084948,0,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0022332,-0.12623,-0.13481,0,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.12473,-0.12649,-0.13377,0,0
5,GO MOTILE CILIUM ASSEMBLY,0.34256,-0.12652,-0.077185,0,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.15773,-0.12693,-0.10625,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.00063551,-0.12712,-0.14828,0,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.13355,-0.12713,-0.061618,0,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.1028,-0.12726,-0.11735,0,0
5,GO L SERINE METABOLIC PROCESS,0.39371,-0.12759,-0.095632,0,0
5,GO REGULATION OF FIBROBLAST MIGRATION,0.073629,-0.12783,-0.11875,0,0
5,GO CHONDROCYTE DEVELOPMENT,0.12259,-0.12809,-0.12954,0,0
5,GO SNORNA 3 END PROCESSING,0.0695,-0.12868,-0.13781,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.064293,-0.12871,-0.17929,0,0
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0039469,-0.12897,-0.18973,0,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.026586,-0.12922,-0.13173,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.30815,-0.13005,-0.084311,0,0
5,GO CENTRIOLE ASSEMBLY,0.019283,-0.13039,-0.097597,0,0
5,GO RESPONSE TO AUDITORY STIMULUS,0.36064,-0.13049,-0.069294,0,0
5,GO METENCEPHALON DEVELOPMENT,0.15264,-0.13105,-0.054696,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.40349,-0.13122,-0.015546,0,0
5,GO RESPONSE TO AXON INJURY,0.1028,-0.13169,-0.090293,0,0
5,GO CELL FATE SPECIFICATION,0.12049,-0.13171,-0.080458,0,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.084046,-0.13183,-0.19563,0,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.061812,-0.13244,-0.10908,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.11841,-0.13268,-0.11679,0,0
5,GO DISTAL TUBULE DEVELOPMENT,0.2,-0.13283,-0.11952,0,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.029068,-0.13317,-0.11917,0,0
5,GO ADHERENS JUNCTION ASSEMBLY,0.26471,-0.13327,-0.068028,0,0
5,GO BONE TRABECULA MORPHOGENESIS,0.093897,-0.13356,-0.22321,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.12689,-0.13398,-0.12294,0,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.066855,-0.13461,-0.15259,0,0
5,GO TELOMERASE RNA LOCALIZATION,0.10654,-0.13471,-0.15967,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.072231,-0.13501,-0.091739,0,0
5,GO REGULATION OF CILIUM ASSEMBLY,0.0011199,-0.13549,-0.13361,0,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.049546,-0.13581,-0.15859,0,0
5,GO NEURON CELL CELL ADHESION,0.62113,-0.13653,-0.03106,0,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.14526,-0.13705,-0.11945,0,0
5,GO NEURAL RETINA DEVELOPMENT,0.057089,-0.13715,-0.097046,0,0
5,GO CHONDROCYTE PROLIFERATION,0.10096,-0.13745,-0.1793,0,0
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.065563,-0.13752,-0.09238,0,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.0695,-0.13794,-0.053579,0,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.12689,-0.13803,-0.095787,0,0
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.25001,-0.13805,-0.080486,0,0
5,GO IRON COORDINATION ENTITY TRANSPORT,0.72969,-0.1383,0.012592,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.052669,-0.13843,-0.086362,0,0
5,GO FILOPODIUM ASSEMBLY,0.049546,-0.13873,-0.1268,0,0
5,GO TRACHEA MORPHOGENESIS,0.34256,-0.13896,-0.066836,0,0
5,GO SPINAL CORD PATTERNING,0.58456,-0.13918,-0.026333,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.13814,-0.14013,-0.099532,0,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.00098941,-0.1403,-0.19217,0,0
5,GO GLYCINE METABOLIC PROCESS,0.33812,-0.14146,-0.050808,0,0
5,GO CELL PROLIFERATION IN HINDBRAIN,0.084046,-0.14153,-0.16858,0,0
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.35153,-0.14177,-0.064236,0,0
5,GO BASEMENT MEMBRANE ASSEMBLY,0.2,-0.14183,-0.1754,0,0
5,GO NEURON PROJECTION ARBORIZATION,0.041093,-0.14237,-0.16449,0,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.5726,-0.14237,-0.072401,0,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.12473,-0.14288,-0.18013,0,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.036948,-0.14318,-0.1273,0,0
5,GO MYOTUBE CELL DEVELOPMENT,0.079444,-0.14346,-0.11586,0,0
5,GO APPENDAGE MORPHOGENESIS,0.014486,-0.14475,-0.13905,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.46512,-0.14487,-0.084557,0,0
5,GO AXONAL FASCICULATION,0.064293,-0.14564,-0.2378,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.2839,-0.14592,-0.098951,0,0
5,GO CELL JUNCTION MAINTENANCE,0.29992,-0.14599,-0.065933,0,0
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.20937,-0.14621,-0.15324,0,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.063042,-0.147,-0.098906,0,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.0071468,-0.14712,-0.13901,0,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.16032,-0.14762,-0.099074,0,0
5,GO SISTER CHROMATID COHESION,0.009256,-0.14776,-0.10286,0,0
5,GO SYNAPTIC VESICLE DOCKING,0.64605,-0.1479,0.021962,0,0
5,GO COLLECTING DUCT DEVELOPMENT,0.019283,-0.14798,-0.21433,0,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.21905,-0.14802,-0.23562,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.12689,-0.14889,-0.092593,0,0
5,GO CELL MIGRATION IN HINDBRAIN,0.12259,-0.14944,-0.15381,0,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.53742,-0.14988,-0.071952,0,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0021062,-0.15033,-0.16435,0,0
5,GO CEREBRAL CORTEX DEVELOPMENT,0.0017641,-0.15129,-0.12374,0,0
5,GO RESPONSE TO LEAD ION,0.025414,-0.15156,-0.12088,0,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.16294,-0.1516,-0.19583,0,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.079444,-0.15207,-0.13515,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.26098,-0.15209,-0.057405,0,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.11841,-0.1521,-0.16684,0,0
5,GO HISTONE H3 K27 METHYLATION,0.0069616,-0.1546,-0.15179,0,0
5,GO CRANIAL NERVE MORPHOGENESIS,0.16294,-0.15499,-0.12768,0,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.033166,-0.15501,-0.15176,0,0
5,GO PROTEIN LOCALIZATION TO CILIUM,0.00032948,-0.15503,-0.20005,0,0
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.095625,-0.15513,-0.15221,0,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.16559,-0.15613,-0.085434,0,0
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.029719,-0.15649,-0.16356,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.17934,-0.1565,-0.11095,0,0
5,GO COLLATERAL SPROUTING,0.04854,-0.15665,-0.16464,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.47588,-0.15707,-0.05392,0,0
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0014738,-0.15816,-0.14916,0,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.065563,-0.15862,-0.1359,0,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.052669,-0.15923,-0.1827,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.066855,-0.15945,-0.18366,0,0
5,GO REGULATION OF MICROTUBULE BINDING,0.031748,-0.16007,-0.16741,0,0
5,GO PREPULSE INHIBITION,0.44402,-0.16057,-0.086327,0,0
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.15015,-0.16073,-0.12099,0,0
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.21579,-0.16127,-0.097349,0,0
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.11235,-0.16166,-0.11068,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.16828,-0.16173,-0.087951,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.1028,-0.16264,-0.15065,0,0
5,GO HISTONE H4 DEACETYLATION,0.084046,-0.16285,-0.14638,0,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.90599,-0.16307,-0.010754,0,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.063042,-0.16359,-0.1585,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.15264,-0.16398,-0.11299,0,0
5,GO V D J RECOMBINATION,0.10096,-0.16458,-0.13914,0,0
5,GO RESPONSE TO X RAY,0.053746,-0.1648,-0.14856,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.054842,-0.16503,-0.10549,0,0
5,GO SUCKLING BEHAVIOR,0.097379,-0.16586,-0.14988,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0014299,-0.16586,-0.20279,0,0
5,GO AXO DENDRITIC TRANSPORT,0.00045924,-0.1659,-0.16399,0,0
5,GO MAGNESIUM ION HOMEOSTASIS,0.076492,-0.16637,-0.14242,0,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.05824,-0.16687,-0.13532,0,0
5,GO PALLIUM DEVELOPMENT,0.00030804,-0.16735,-0.15531,0,0
5,GO NEURON FATE COMMITMENT,0.17374,-0.16894,-0.095277,0,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.19095,-0.16919,-0.14732,0,0
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.23589,-0.1695,-0.083317,0,0
5,GO GLUTAMATE SECRETION,0.054842,-0.1701,-0.11434,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.53742,-0.17056,-0.046905,0,0
5,GO REGULATION OF SENSORY PERCEPTION,0.0064317,-0.1727,-0.15499,0,0
5,GO INTRACILIARY TRANSPORT,0.011047,-0.17341,-0.17421,0,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.11235,-0.1735,-0.07677,0,0
5,GO SYNAPTIC VESICLE PRIMING,0.26847,-0.17442,-0.026843,0,0
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.033894,-0.17491,-0.11128,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.34256,-0.17524,-0.060205,0,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.024846,-0.17642,-0.25813,0,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.060602,-0.17697,-0.13597,0,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0013457,-0.1772,-0.21324,0,0
5,GO RESPONSE TO POTASSIUM ION,0.11841,-0.17818,-0.13056,0,0
5,GO KINETOCHORE ASSEMBLY,0.095625,-0.1784,-0.12833,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.04854,-0.18024,-0.14826,0,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.010773,-0.18069,-0.21377,0,0
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.28785,-0.18092,-0.072008,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.085627,-0.18099,-0.087314,0,0
5,GO KINETOCHORE ORGANIZATION,0.064293,-0.18174,-0.12525,0,0
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.56075,-0.18187,-0.046569,0,0
5,GO NUCLEAR PORE ORGANIZATION,0.05824,-0.18296,-0.13755,0,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15264,-0.18331,-0.18936,0,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.27999,-0.18354,-0.13363,0,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.12259,-0.18357,-0.11128,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00095906,-0.18372,-0.20442,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.079444,-0.18452,-0.14057,0,0
5,GO AXONAL TRANSPORT,0.00054072,-0.18595,-0.17149,0,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0036303,-0.18625,-0.16773,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.084046,-0.18705,-0.15439,0,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0073363,-0.18763,-0.1834,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.097379,-0.18779,-0.15385,0,0
5,GO DENSE CORE GRANULE TRANSPORT,0.37932,-0.18781,-0.073537,0,0
5,GO UTERUS DEVELOPMENT,0.188,-0.18809,-0.1232,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.049546,-0.18915,-0.12693,0,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.052669,-0.18937,-0.2154,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.188,-0.19086,-0.098104,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.23589,-0.19131,-0.12812,0,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.0695,-0.19579,-0.19555,0,0
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.093897,-0.19599,-0.10426,0,0
5,GO IMP METABOLIC PROCESS,0.37932,-0.19649,-0.1112,0,0
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.20621,-0.19819,-0.21685,0,0
5,GO RESPONSE TO VITAMIN D,0.099158,-0.19974,-0.1536,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.13355,-0.20064,-0.17979,0,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.11235,-0.20107,-0.14151,0,0
5,GO SYNAPSE MATURATION,0.093897,-0.20362,-0.23296,0,0
5,GO MITOTIC SISTER CHROMATID COHESION,0.012508,-0.2038,-0.14608,0,0
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.40349,-0.20395,-0.035638,0,0
5,GO REGULATION OF AXON GUIDANCE,0.0094949,-0.20443,-0.20854,0,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.015953,-0.2051,-0.2126,0,0
5,GO NEUROBLAST DIVISION,0.068167,-0.20514,-0.18928,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.095625,-0.20538,-0.23649,0,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,2.7343e-05,-0.20544,-0.24783,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.066855,-0.20677,-0.12888,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0022332,-0.20755,-0.19344,0,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.0014738,-0.20758,-0.17362,0,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.027188,-0.20773,-0.2076,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.072231,-0.21214,-0.16815,0,0
5,GO SIALYLATION,0.16828,-0.21479,-0.15507,0,0
5,GO SECRETORY GRANULE LOCALIZATION,0.080955,-0.21518,-0.18305,0,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.024846,-0.21634,-0.26928,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.10096,-0.21649,-0.1793,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.25729,-0.22013,-0.085178,0,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.05824,-0.22162,-0.15855,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.072231,-0.22234,-0.15421,0,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00012512,-0.2231,-0.25809,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,0.00047456,-0.22353,-0.23085,0,0
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.21256,-0.22382,-0.10979,0,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.00052342,-0.22421,-0.25265,0,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.11039,-0.22501,-0.12601,0,0
5,GO SYNAPSE ASSEMBLY,0.054842,-0.22626,-0.12864,0,0
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.072231,-0.22969,-0.19172,0,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.024846,-0.23028,-0.24633,0,0
5,GO DIVALENT METAL ION EXPORT,0.050569,-0.2319,-0.24061,0,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.097379,-0.23426,-0.22947,0,0
5,GO LEUKOCYTE AGGREGATION,0.04854,-0.23928,-0.27828,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.087232,-0.24053,-0.21393,0,0
5,GO RETROGRADE AXONAL TRANSPORT,0.00041602,-0.24161,-0.27565,0,0
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0022332,-0.24363,-0.22765,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.33373,-0.24378,-0.09682,0,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.12689,-0.24395,-0.15162,0,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0030654,-0.24687,-0.22182,0,0
5,GO HINDLIMB MORPHOGENESIS,0.0062634,-0.24821,-0.2078,0,0
5,GO AXON EXTENSION,0.00014935,-0.24934,-0.27016,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.029068,-0.24972,-0.26711,0,0
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.36526,-0.25033,-0.079725,0,0
5,GO TRACHEA DEVELOPMENT,0.023205,-0.25053,-0.18937,0,0
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0022992,-0.2573,-0.24159,0,0
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.10654,-0.25915,-0.20488,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0014299,-0.26045,-0.26565,0,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.12689,-0.26329,-0.16566,0,0
5,GO NEURON FATE SPECIFICATION,0.42855,-0.26726,-0.053532,0,0
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.049546,-0.26916,-0.28087,0,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0014299,-0.27197,-0.27677,0,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.013798,-0.27204,-0.22296,0,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0037331,-0.28802,-0.20139,0,0
5,GO MICROTUBULE SEVERING,0.013465,-0.28877,-0.17265,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.035393,-0.28891,-0.16868,0,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.020205,-0.29218,-0.31015,0,0
5,GO PLASMA MEMBRANE REPAIR,0.066855,-0.29357,-0.18,0,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.061812,-0.31143,-0.17497,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,1.2962e-05,-0.31349,-0.32191,0,0
5,GO DENTATE GYRUS DEVELOPMENT,0.0069616,-0.3199,-0.26058,0,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.00063551,-0.3239,-0.3096,0,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.014138,-0.33134,-0.25954,0,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,1.0184e-05,-0.33181,-0.37841,0,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0039469,-0.33573,-0.29734,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019283,-0.34356,-0.24065,0,0
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0001547,-0.34446,-0.37555,0,0
5,GO MECHANOSENSORY BEHAVIOR,0.35607,-0.38273,-0.14192,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,6.2786e-05,-0.4183,-0.37878,0,0
5,GO CARTILAGE MORPHOGENESIS,0.0012662,-0.42192,-0.39626,0,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.00032948,-0.4356,-0.39726,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0051916,-0.48216,-0.38004,0,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00059588,-0.50231,-0.44896,0,0
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0071468,-0.50783,-0.35166,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,6.0504e-05,-0.57459,-0.59225,0,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,8.7323e-05,-0.62244,-0.53393,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,2.1663e-05,-0.70204,-0.64132,0,0
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
6,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
6,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
6,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
6,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
6,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
6,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
6,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
6,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3418e-05,0.58202,0.62154,1,1
6,GO DENSE CORE GRANULE TRANSPORT,0.00041602,0.57831,0.51559,1,1
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
6,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00059588,0.56333,0.5821,1,1
6,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
6,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
6,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.1617e-05,0.52422,0.50849,1,1
6,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
6,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
6,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
6,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
6,GO NEURON CELLULAR HOMEOSTASIS,1.5331e-06,0.49745,0.49407,1,1
6,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
6,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
6,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
6,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
6,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
6,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
6,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
6,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
6,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
6,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
6,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.0047853,0.45378,0.36699,1,1
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
6,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
6,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
6,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
6,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
6,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
6,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
6,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
6,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
6,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
6,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
6,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
6,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
6,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
6,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
6,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
6,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
6,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
6,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
6,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
6,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
6,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
6,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
6,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
6,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
6,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
6,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,1,1
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
6,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
6,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
6,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
6,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.00028792,0.37316,0.34224,1,1
6,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
6,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
6,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
6,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
6,GO REGULATION OF VESICLE FUSION,4.4878e-05,0.36279,0.4105,1,1
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
6,GO PROTEIN TRIMERIZATION,0.00022676,0.3573,0.36141,1,1
6,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.013e-05,0.3558,0.41317,1,1
6,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
6,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
6,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
6,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
6,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
6,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
6,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
6,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
6,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
6,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
6,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
6,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
6,GO DENDRITIC SPINE MORPHOGENESIS,2.1663e-05,0.32993,0.32988,1,1
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00031859,0.32762,0.38047,1,1
6,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
6,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
6,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
6,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
6,GO NEUROTRANSMITTER REUPTAKE,0.00029782,0.31881,0.30582,1,1
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
6,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.027188,0.31677,0.24137,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
6,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
6,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
6,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
6,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00042998,0.30979,0.37234,1,1
6,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
6,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
6,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
6,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
6,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
6,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
6,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
6,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,4.4878e-05,0.2951,0.38378,1,1
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
6,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
6,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
6,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
6,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
6,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.013465,0.29312,0.23126,1,1
6,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
6,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
6,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
6,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
6,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
6,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,1,1
6,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
6,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
6,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
6,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.2876e-06,0.28722,0.38318,1,1
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
6,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
6,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,1
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9263e-05,0.2812,0.29651,1,1
6,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,9.389e-05,0.27784,0.31439,1,1
6,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
6,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
6,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
6,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
6,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
6,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,9.0551e-05,0.2694,0.31875,1,1
6,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.013465,0.26825,0.30375,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
6,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
6,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
6,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
6,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
6,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
6,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
6,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
6,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
6,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
6,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
6,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
6,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
6,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019753,0.25151,0.27618,1,1
6,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
6,GO MITOCHONDRION LOCALIZATION,3.4421e-05,0.24872,0.21481,1,1
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
6,GO REGULATION OF SYNAPTIC PLASTICITY,0.00035231,0.24686,0.23419,1,1
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
6,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
6,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
6,GO REGULATION OF DOPAMINE SECRETION,0.025414,0.24193,0.30834,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0015653,0.2416,0.24139,1,1
6,GO REGULATION OF DENDRITE MORPHOGENESIS,2.0033e-05,0.2415,0.25324,1,1
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
6,GO NEUROTRANSMITTER UPTAKE,0.0012662,0.23757,0.23734,1,1
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0056288,0.23754,0.21434,1,1
6,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
6,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
6,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
6,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
6,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
6,GO NEGATIVE REGULATION OF AXONOGENESIS,0.034637,0.2307,0.16896,1,1
6,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
6,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
6,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
6,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
6,GO EXPLORATION BEHAVIOR,0.0081404,0.22547,0.28578,1,1
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.7596e-05,0.22515,0.29582,1,1
6,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00019753,0.22483,0.2524,1,1
6,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
6,GO LATERAL VENTRICLE DEVELOPMENT,0.0083534,0.22406,0.22513,1,1
6,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
6,GO SYNAPTIC VESICLE EXOCYTOSIS,3.1888e-05,0.22368,0.30447,1,1
6,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
6,GO SYNAPSE ORGANIZATION,9.0551e-05,0.22201,0.22157,1,1
6,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
6,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
6,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
6,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
6,GO CELLULAR RESPONSE TO PH,0.00013433,0.21743,0.2188,1,1
6,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
6,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
6,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
6,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
6,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
6,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
6,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
6,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
6,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
6,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
6,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
6,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
6,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
6,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
6,GO DENDRITIC SPINE DEVELOPMENT,0.00016023,0.20566,0.23771,1,1
6,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
6,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
6,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
6,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,1,1
6,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
6,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
6,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
6,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
6,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
6,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
6,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
6,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
6,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
6,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
6,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
6,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
6,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
6,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
6,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
6,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
6,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0006154,0.18942,0.15551,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
6,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
6,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
6,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
6,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
6,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0013054,0.18509,0.20822,1,1
6,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.011047,0.18468,0.17127,1,1
6,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016129,0.18413,0.17665,1,1
6,GO CALCIUM ION IMPORT INTO CYTOSOL,0.024846,0.18345,0.22184,1,1
6,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
6,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00026003,0.18249,0.2041,1,1
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
6,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
6,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0099891,0.18129,0.18737,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
6,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
6,GO NEUROTRANSMITTER TRANSPORT,0.00084609,0.17881,0.23235,1,1
6,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
6,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
6,GO NEURON PROJECTION EXTENSION,0.00065623,0.1778,0.17702,1,1
6,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
6,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
6,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0028957,0.17417,0.18703,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
6,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
6,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
6,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
6,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
6,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
6,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
6,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00353,0.16997,0.15308,1,1
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
6,GO NEUROTRANSMITTER SECRETION,0.0013054,0.16961,0.24314,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
6,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
6,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
6,GO DENDRITIC TRANSPORT,0.010506,0.16695,0.24093,1,1
6,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
6,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0079323,0.16511,0.13868,1,1
6,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
6,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
6,GO CARDIAC CONDUCTION,0.010773,0.16145,0.15299,1,1
6,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0059384,0.16057,0.19391,1,1
6,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
6,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,1
6,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.033894,0.15562,0.12154,1,1
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
6,GO IMPORT INTO CELL,0.00031859,0.15268,0.16949,1,1
6,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
6,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.029068,0.15185,0.30318,1,1
6,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
6,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.044685,0.1478,0.14767,1,1
6,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
6,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
6,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
6,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
6,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
6,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,1
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
6,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
6,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.03939,0.13858,0.17548,1,1
6,GO SYNAPTIC VESICLE RECYCLING,0.029719,0.13856,0.14167,1,1
6,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,1
6,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.041093,0.13814,0.09988,1,1
6,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
6,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
6,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0026572,0.13362,0.13974,1,1
6,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
6,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
6,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
6,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
6,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
6,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
6,GO COCHLEA DEVELOPMENT,0.0085714,0.12808,0.14509,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,1,1
6,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
6,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
6,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
6,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
6,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
6,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
6,GO MATING,0.033166,0.12237,0.091484,1,1
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
6,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.11938,0.12948,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
6,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
6,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
6,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.014486,0.11788,0.11892,1,1
6,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
6,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.036164,0.11708,0.11111,1,1
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,1
6,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
6,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
6,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,1
6,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
6,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.043763,0.1138,0.13072,1,1
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.015574,0.11325,0.13457,1,1
6,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
6,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.033166,0.1119,0.10784,1,1
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
6,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0094949,0.10875,0.096243,1,1
6,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.047551,0.1078,0.085432,1,1
6,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.016734,0.10328,0.12458,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
6,GO REGULATION OF SYSTEM PROCESS,0.016734,0.10271,0.089714,1,1
6,GO MITOTIC RECOMBINATION,0.03939,0.10239,0.12336,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
6,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
6,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
6,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
6,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
6,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
6,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
6,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
6,GO CATION TRANSMEMBRANE TRANSPORT,0.020205,0.095754,0.083423,1,1
6,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
6,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
6,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
6,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,1,1
6,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
6,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.02843,0.089345,0.091656,1,1
6,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.045624,0.089295,0.096514,1,1
6,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,1,1
6,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.033894,0.086043,0.089639,1,1
6,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
6,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,1,1
6,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
6,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
6,GO CELL CYCLE DNA REPLICATION,0.044685,0.07298,0.079722,1,1
6,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
6,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.024288,0.065336,0.096793,1,1
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
6,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
6,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,0
6,GO SYNAPTIC MEMBRANE ADHESION,0.00038934,0.44341,0.47686,1,0
6,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.020205,0.4197,0.32519,1,0
6,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,0
6,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,0
6,GO ANATOMICAL STRUCTURE REGRESSION,0.0049174,0.37793,0.30971,1,0
6,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,9.0551e-05,0.37466,0.4369,1,0
6,GO SYNAPTIC VESICLE CLUSTERING,0.00090094,0.36122,0.49279,1,0
6,GO CHAPERONE MEDIATED AUTOPHAGY,0.0081404,0.35604,0.31425,1,0
6,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,1,0
6,GO REGULATION OF NEURON MIGRATION,0.00036427,0.32467,0.28077,1,0
6,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0067808,0.32231,0.3593,1,0
6,GO PREPULSE INHIBITION,0.011047,0.31329,0.33627,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0073363,0.30895,0.2251,1,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.01282,0.30544,0.21362,1,0
6,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.18672,1,0
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.031748,0.29573,0.37958,1,0
6,GO BONE TRABECULA FORMATION,0.016339,0.29217,0.28867,1,0
6,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0027346,0.28208,0.29485,1,0
6,GO VOCALIZATION BEHAVIOR,0.030383,0.27735,0.35457,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.029068,0.27701,0.172,1,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0064317,0.27528,0.21508,1,0
6,GO ARGININE METABOLIC PROCESS,0.0079323,0.27497,0.29089,1,0
6,GO GLUTAMATE SECRETION,0.00029782,0.27482,0.30144,1,0
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00016023,0.27422,0.2883,1,0
6,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.018398,0.27165,0.20893,1,0
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.012203,0.2705,0.32617,1,0
6,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0031536,0.26779,0.27331,1,0
6,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,1,0
6,GO COLLAGEN BIOSYNTHETIC PROCESS,0.03245,0.26305,0.1703,1,0
6,GO GTP METABOLIC PROCESS,0.0021689,0.26286,0.23585,1,0
6,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,0
6,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,0
6,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,0
6,GO COLLAGEN METABOLIC PROCESS,0.020205,0.24009,0.14035,1,0
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.033166,0.2364,0.23571,1,0
6,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,0
6,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,0
6,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0026572,0.23251,0.2819,1,0
6,GO POLYOL TRANSPORT,0.0079323,0.23114,0.18719,1,0
6,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.03939,0.22828,0.26749,1,0
6,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0016129,0.22746,0.18799,1,0
6,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,1,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,0
6,GO POSTSYNAPSE ORGANIZATION,7.8282e-05,0.22101,0.24513,1,0
6,GO LONG TERM SYNAPTIC DEPRESSION,0.0087944,0.2208,0.20689,1,0
6,GO HISTONE SERINE PHOSPHORYLATION,0.0037331,0.21351,0.17163,1,0
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.033894,0.21116,0.18694,1,0
6,GO NEURON RECOGNITION,0.014841,0.21085,0.20202,1,0
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,0
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00021909,0.20953,0.26645,1,0
6,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.031059,0.20867,0.18668,1,0
6,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.019283,0.20829,0.13889,1,0
6,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,0
6,GO REGULATION OF SYNAPSE ASSEMBLY,0.00087311,0.20663,0.2178,1,0
6,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0056288,0.20426,0.24748,1,0
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0062634,0.20156,0.21024,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0079323,0.20082,0.20231,1,0
6,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.047551,0.19713,0.17411,1,0
6,GO CELLULAR COPPER ION HOMEOSTASIS,0.014486,0.19694,0.17506,1,0
6,GO CORONARY VASCULATURE MORPHOGENESIS,0.015203,0.19653,0.20902,1,0
6,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.014138,0.19562,0.16247,1,0
6,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,0
6,GO DENDRITE SELF AVOIDANCE,0.041967,0.19194,0.1856,1,0
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00024286,0.19188,0.24956,1,0
6,GO REGULATION OF DENDRITE DEVELOPMENT,0.00012074,0.19017,0.20882,1,0
6,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,0
6,GO FOREBRAIN CELL MIGRATION,0.00049035,0.18415,0.23235,1,0
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.045624,0.18289,0.16825,1,0
6,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013798,0.18278,0.18877,1,0
6,GO NEURON PROJECTION GUIDANCE,0.0056288,0.18235,0.16389,1,0
6,GO CORONARY VASCULATURE DEVELOPMENT,0.013798,0.18198,0.12879,1,0
6,GO PRESYNAPSE ORGANIZATION,0.007729,0.18186,0.20793,1,0
6,GO MICROTUBULE DEPOLYMERIZATION,0.030383,0.18146,0.16576,1,0
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.045624,0.18131,0.1476,1,0
6,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.011904,0.18024,0.16927,1,0
6,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.045624,0.17967,0.12845,1,0
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.014841,0.17909,0.14522,1,0
6,GO MOTOR NEURON AXON GUIDANCE,0.012203,0.17899,0.17322,1,0
6,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17726,0.17885,1,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0030654,0.17692,0.23384,1,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00069957,0.17671,0.2571,1,0
6,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0081404,0.17668,0.20275,1,0
6,GO LONG TERM MEMORY,0.0041716,0.17645,0.19976,1,0
6,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.02166,0.1762,0.13534,1,0
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,0
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0011549,0.17007,0.27365,1,0
6,GO POSITIVE REGULATION OF HEART RATE,0.040234,0.16813,0.18861,1,0
6,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,0
6,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16648,0.13209,1,0
6,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,0
6,GO FATTY ACID HOMEOSTASIS,0.044685,0.16644,0.20355,1,0
6,GO FOLIC ACID METABOLIC PROCESS,0.041967,0.16632,0.17031,1,0
6,GO REGULATION OF TRANSLATIONAL TERMINATION,0.010506,0.16562,0.19049,1,0
6,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,0
6,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,0
6,GO DENDRITE MORPHOGENESIS,0.0014738,0.16149,0.18245,1,0
6,GO RESPONSE TO AMINE,0.0094949,0.16148,0.17707,1,0
6,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.041967,0.16069,0.13783,1,0
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00081984,0.15747,0.20098,1,0
6,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.015203,0.15686,0.17096,1,0
6,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.042857,0.15679,0.097057,1,0
6,GO COPPER ION HOMEOSTASIS,0.024846,0.15663,0.14424,1,0
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.046579,0.15659,0.12563,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.02068,0.15485,0.11071,1,0
6,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.015203,0.15295,0.097831,1,0
6,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.042857,0.15178,0.12137,1,0
6,GO DENDRITE DEVELOPMENT,0.00087311,0.15132,0.17742,1,0
6,GO REGULATION OF CARDIAC CONDUCTION,0.024846,0.15042,0.12439,1,0
6,GO RESPIRATORY SYSTEM PROCESS,0.010506,0.14997,0.14022,1,0
6,GO MEMBRANE REPOLARIZATION,0.014138,0.14965,0.13738,1,0
6,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0069616,0.14894,0.15764,1,0
6,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0087944,0.14827,0.14805,1,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.017137,0.14759,0.15602,1,0
6,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,1,0
6,GO COLLATERAL SPROUTING,0.02843,0.14592,0.15473,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.047551,0.14515,0.10055,1,0
6,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.013798,0.14497,0.14402,1,0
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0026572,0.14459,0.15038,1,0
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,0
6,GO DEVELOPMENTAL CELL GROWTH,0.00074557,0.14342,0.149,1,0
6,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,0
6,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,0
6,GO REGULATION OF AXONOGENESIS,0.012203,0.13962,0.14762,1,0
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0011549,0.13884,0.15637,1,0
6,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,0
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0033369,0.13635,0.21006,1,0
6,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0094949,0.13631,0.16419,1,0
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.009256,0.13573,0.11999,1,0
6,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043763,0.13544,0.12947,1,0
6,GO LIVER REGENERATION,0.040234,0.13541,0.077176,1,0
6,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0090226,0.13417,0.19615,1,0
6,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0038387,0.13277,0.1505,1,0
6,GO NEUROMUSCULAR PROCESS,0.0060989,0.13239,0.14602,1,0
6,GO MODULATION BY HOST OF VIRAL PROCESS,0.0087944,0.13195,0.11512,1,0
6,GO REGULATION OF EXTENT OF CELL GROWTH,0.0030654,0.13151,0.15901,1,0
6,GO PRESYNAPTIC ENDOCYTOSIS,0.034637,0.13006,0.14386,1,0
6,GO REGULATION OF MEMBRANE POTENTIAL,0.02166,0.12912,0.12848,1,0
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0010528,0.12762,0.16732,1,0
6,GO SYNAPTIC SIGNALING,0.001986,0.12747,0.172,1,0
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0025083,0.12726,0.12677,1,0
6,GO MEMORY,0.0067808,0.12525,0.13818,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,0
6,GO MRNA SPLICE SITE SELECTION,0.042857,0.123,0.13568,1,0
6,GO PROTEOGLYCAN METABOLIC PROCESS,0.041093,0.12291,0.091021,1,0
6,GO GLUTAMINE METABOLIC PROCESS,0.0031536,0.12242,0.15681,1,0
6,GO SYNAPTIC VESICLE LOCALIZATION,0.014841,0.11988,0.19226,1,0
6,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.011904,0.11981,0.10207,1,0
6,GO PEPTIDE METABOLIC PROCESS,0.024846,0.11942,0.091635,1,0
6,GO MAINTENANCE OF PROTEIN LOCATION,0.015574,0.11796,0.081204,1,0
6,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.026586,0.11785,0.1383,1,0
6,GO AXON DEVELOPMENT,0.0050528,0.11594,0.15111,1,0
6,GO RNA 5 END PROCESSING,0.035393,0.11506,0.12281,1,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.022165,0.11502,0.13665,1,0
6,GO CELL PART MORPHOGENESIS,0.0024367,0.11485,0.1479,1,0
6,GO REGULATION OF TRANSPORTER ACTIVITY,0.010506,0.11484,0.11228,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,0
6,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,0
6,GO POSITIVE REGULATION OF AXONOGENESIS,0.017137,0.11306,0.15792,1,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.03245,0.11289,0.1031,1,0
6,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,0
6,GO NUCLEOBASE METABOLIC PROCESS,0.0037331,0.11212,0.17851,1,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.018836,0.11181,0.17577,1,0
6,GO COGNITION,0.0031536,0.11159,0.15657,1,0
6,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,0
6,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.11156,0.096039,1,0
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,0
6,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.045624,0.11137,0.11873,1,0
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0069616,0.11107,0.10628,1,0
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,0
6,GO NEURON MIGRATION,0.042857,0.11025,0.14875,1,0
6,GO TRNA METABOLIC PROCESS,0.0034322,0.10892,0.14407,1,0
6,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.10831,0.12606,1,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.004408,0.10765,0.16898,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.009256,0.1067,0.12313,1,0
6,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.029068,0.10605,0.11104,1,0
6,GO CELLULAR IRON ION HOMEOSTASIS,0.015953,0.10552,0.11118,1,0
6,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,0
6,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,0
6,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.016734,0.1037,0.11503,1,0
6,GO RESPONSE TO AMYLOID BETA,0.0094949,0.10326,0.1324,1,0
6,GO POTASSIUM ION TRANSPORT,0.035393,0.10273,0.1169,1,0
6,GO WALKING BEHAVIOR,0.004408,0.10242,0.20944,1,0
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,0
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.024846,0.10018,0.11791,1,0
6,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.024846,0.099707,0.083464,1,0
6,GO METAL ION TRANSPORT,0.031059,0.098552,0.068972,1,0
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.031059,0.098422,0.099572,1,0
6,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0060989,0.098297,0.099857,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015953,0.09826,0.081023,1,0
6,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,1,0
6,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.029068,0.097005,0.08091,1,0
6,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,0
6,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.038561,0.096255,0.11449,1,0
6,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,0
6,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0079323,0.09519,0.12173,1,0
6,GO RNA MODIFICATION,0.0075304,0.09438,0.12402,1,0
6,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.021165,0.093074,0.086229,1,0
6,GO CELLULAR COMPONENT MORPHOGENESIS,0.010773,0.092962,0.11854,1,0
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.036164,0.089277,0.11426,1,0
6,GO RESPONSE TO HEAT,0.017969,0.088863,0.079789,1,0
6,GO REGULATION OF CALCIUM ION TRANSPORT,0.029068,0.08883,0.090382,1,0
6,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.010245,0.088589,0.06583,1,0
6,GO PIGMENT BIOSYNTHETIC PROCESS,0.033166,0.088546,0.11543,1,0
6,GO ORGANIC CATION TRANSPORT,0.02268,0.085963,0.1203,1,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0099891,0.085126,0.18506,1,0
6,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.016734,0.083355,0.11394,1,0
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.013139,0.083289,0.099556,1,0
6,GO LACTATION,0.036948,0.081867,0.11724,1,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.041093,0.080665,0.085237,1,0
6,GO DICARBOXYLIC ACID TRANSPORT,0.043763,0.077645,0.10789,1,0
6,GO REGULATION OF NEURON DIFFERENTIATION,0.026586,0.073598,0.10531,1,0
6,GO LOCOMOTORY BEHAVIOR,0.036164,0.072435,0.13478,1,0
6,GO NUCLEAR EXPORT,0.024846,0.070434,0.06326,1,0
6,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.047551,0.068477,0.092842,1,0
6,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.024846,0.067091,0.096255,1,0
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.03245,0.066848,0.090725,1,0
6,GO NEURON DEVELOPMENT,0.015574,0.066648,0.10551,1,0
6,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.016734,0.063443,0.10185,1,0
6,GO RNA EXPORT FROM NUCLEUS,0.041967,0.063385,0.083155,1,0
6,GO BEHAVIOR,0.013139,0.062013,0.11244,1,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.036164,0.061913,0.066182,1,0
6,GO NEURON DIFFERENTIATION,0.033166,0.061143,0.09311,1,0
6,GO REGULATION OF CELL SIZE,0.027803,0.06009,0.078054,1,0
6,GO DIVALENT INORGANIC CATION TRANSPORT,0.044685,0.060003,0.063979,1,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031059,0.056379,0.062983,1,0
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,0
6,GO NUCLEAR TRANSPORT,0.023741,0.052646,0.053247,1,0
6,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.035393,0.052448,0.055266,1,0
6,GO MICROTUBULE POLYMERIZATION,0.044685,0.045838,0.11001,1,0
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.038561,0.038589,0.066038,1,0
6,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.041093,0.036656,0.074008,1,0
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.031748,0.035939,0.067457,1,0
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.019739,-0.024923,-0.086715,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.031059,-0.036167,-0.13545,1,0
6,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.047551,-0.037358,-0.049977,1,0
6,GO CYTOKINESIS,0.046579,-0.038365,-0.070188,1,0
6,GO TISSUE MORPHOGENESIS,0.047551,-0.042047,-0.080539,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION,0.027803,-0.046405,-0.057805,1,0
6,GO PROTEIN O LINKED GLYCOSYLATION,0.025414,-0.046584,-0.13269,1,0
6,GO METAPHASE PLATE CONGRESSION,0.014138,-0.047354,-0.09609,1,0
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.030383,-0.047395,-0.0479,1,0
6,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.025994,-0.047781,-0.15593,1,0
6,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.042857,-0.048096,-0.056265,1,0
6,GO NON RECOMBINATIONAL REPAIR,0.029719,-0.049058,-0.070112,1,0
6,GO ACTIN FILAMENT BASED PROCESS,0.036948,-0.05139,-0.072544,1,0
6,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.047551,-0.052509,-0.059863,1,0
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.036948,-0.052873,-0.041961,1,0
6,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.037747,-0.053669,-0.068959,1,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.014138,-0.053852,-0.15297,1,0
6,GO PHOSPHOLIPID METABOLIC PROCESS,0.037747,-0.055403,-0.066143,1,0
6,GO POSITIVE REGULATION OF SIGNALING,0.033166,-0.055813,-0.065149,1,0
6,GO MALE GAMETE GENERATION,0.0045306,-0.056225,-0.08556,1,0
6,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.009256,-0.056332,-0.085675,1,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.03245,-0.056358,-0.056157,1,0
6,GO MACROAUTOPHAGY,0.0054795,-0.057538,-0.080368,1,0
6,GO REGULATION OF CELL POPULATION PROLIFERATION,0.019283,-0.057979,-0.084699,1,0
6,GO ACTIN FILAMENT ORGANIZATION,0.017549,-0.058128,-0.094691,1,0
6,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.038561,-0.058545,-0.10222,1,0
6,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.019739,-0.058587,-0.081149,1,0
6,GO SEXUAL REPRODUCTION,0.0025817,-0.059443,-0.071044,1,0
6,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024288,-0.059497,-0.077715,1,0
6,GO ORGANELLE FISSION,0.019283,-0.060777,-0.053453,1,0
6,GO HISTONE UBIQUITINATION,0.041093,-0.061309,-0.066636,1,0
6,GO PROTEIN AUTOUBIQUITINATION,0.027188,-0.061491,-0.065572,1,0
6,GO MORPHOGENESIS OF AN EPITHELIUM,0.013139,-0.061745,-0.099152,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.03939,-0.061936,-0.17826,1,0
6,GO REGULATION OF HYDROLASE ACTIVITY,0.012203,-0.062843,-0.080199,1,0
6,GO HUMORAL IMMUNE RESPONSE,0.0013872,-0.063414,-0.13611,1,0
6,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.042857,-0.06359,-0.11612,1,0
6,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.023741,-0.063699,-0.12651,1,0
6,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0067808,-0.064341,-0.1042,1,0
6,GO CELL MOTILITY,0.036948,-0.064481,-0.079393,1,0
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.024288,-0.065264,-0.08581,1,0
6,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.042857,-0.065369,-0.13007,1,0
6,GO TUBE MORPHOGENESIS,0.041093,-0.06564,-0.099175,1,0
6,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.033894,-0.065921,-0.067849,1,0
6,GO LEUKOCYTE DIFFERENTIATION,0.011047,-0.066015,-0.10214,1,0
6,GO MULTICELLULAR ORGANISM AGING,0.017549,-0.066565,-0.12547,1,0
6,GO SECRETION,0.012508,-0.067035,-0.08332,1,0
6,GO REGULATION OF ACTIN FILAMENT LENGTH,0.03245,-0.067433,-0.079096,1,0
6,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.026586,-0.06747,-0.092176,1,0
6,GO GLYCEROLIPID METABOLIC PROCESS,0.024846,-0.067811,-0.070702,1,0
6,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.030383,-0.067849,-0.11162,1,0
6,GO TUBE DEVELOPMENT,0.033894,-0.069626,-0.094207,1,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0079323,-0.070156,-0.080998,1,0
6,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.001872,-0.070793,-0.12646,1,0
6,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.02166,-0.071389,-0.099685,1,0
6,GO REGULATION OF MEIOTIC CELL CYCLE,0.025994,-0.071424,-0.085065,1,0
6,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.014138,-0.071536,-0.11367,1,0
6,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0038387,-0.072065,-0.074907,1,0
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.03245,-0.072305,-0.11245,1,0
6,GO LYMPHOCYTE ACTIVATION,0.0075304,-0.072443,-0.11104,1,0
6,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0085714,-0.072665,-0.087308,1,0
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.013139,-0.074079,-0.11156,1,0
6,GO MULTI ORGANISM PROCESS,0.009256,-0.074202,-0.06881,1,0
6,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.015203,-0.074726,-0.069842,1,0
6,GO PEPTIDE SECRETION,0.025414,-0.074792,-0.08505,1,0
6,GO NEGATIVE T CELL SELECTION,0.0027346,-0.075183,-0.16075,1,0
6,GO REGULATION OF RESPONSE TO STRESS,0.0064317,-0.075297,-0.092052,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.038561,-0.076032,-0.079738,1,0
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.017969,-0.07604,-0.099561,1,0
6,GO EAR DEVELOPMENT,0.035393,-0.0763,-0.099769,1,0
6,GO DNA METHYLATION OR DEMETHYLATION,0.023205,-0.076905,-0.071375,1,0
6,GO DEPHOSPHORYLATION,0.021165,-0.077657,-0.058171,1,0
6,GO REGULATION OF PEPTIDE TRANSPORT,0.0097392,-0.07785,-0.076389,1,0
6,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011326,-0.077982,-0.078376,1,0
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.041967,-0.078097,-0.11692,1,0
6,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.041967,-0.078222,-0.095114,1,0
6,GO POSITIVE REGULATION OF SECRETION,0.031748,-0.078364,-0.079138,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.03245,-0.078499,-0.10286,1,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0039469,-0.078562,-0.08408,1,0
6,GO EXOCYTOSIS,0.011047,-0.078638,-0.10281,1,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.018836,-0.078865,-0.058864,1,0
6,GO MACROPHAGE DIFFERENTIATION,0.045624,-0.079261,-0.13395,1,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.017549,-0.079405,-0.10827,1,0
6,GO IMMUNE SYSTEM DEVELOPMENT,0.0015653,-0.079454,-0.10403,1,0
6,GO CHROMOSOME LOCALIZATION,0.0025817,-0.079572,-0.11324,1,0
6,GO DETECTION OF STIMULUS,0.0010859,-0.079666,-0.097326,1,0
6,GO REGULATION OF CIRCADIAN RHYTHM,0.027188,-0.080418,-0.06057,1,0
6,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.015574,-0.080753,-0.10773,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.037747,-0.080788,-0.11695,1,0
6,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.019739,-0.080956,-0.12703,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.042857,-0.081063,-0.10309,1,0
6,GO GAMETE GENERATION,0.0010206,-0.081244,-0.088169,1,0
6,GO TUBE FORMATION,0.023205,-0.081475,-0.096162,1,0
6,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0021062,-0.081483,-0.10326,1,0
6,GO REGULATION OF HEMOPOIESIS,0.010773,-0.081738,-0.105,1,0
6,GO MEIOTIC CELL CYCLE PROCESS,0.0018173,-0.081769,-0.08676,1,0
6,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.044685,-0.081822,-0.10828,1,0
6,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0064317,-0.08192,-0.10728,1,0
6,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.045624,-0.081921,-0.088216,1,0
6,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.016339,-0.081932,-0.096147,1,0
6,GO ENDOSOMAL TRANSPORT,0.00028792,-0.082157,-0.10138,1,0
6,GO REGULATION OF IMMUNE RESPONSE,0.010773,-0.082422,-0.11106,1,0
6,GO VACUOLAR TRANSPORT,0.0094949,-0.082562,-0.1011,1,0
6,GO FATTY ACID METABOLIC PROCESS,0.031059,-0.082955,-0.10209,1,0
6,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038561,-0.083001,-0.11834,1,0
6,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.012508,-0.083325,-0.12337,1,0
6,GO FAT CELL DIFFERENTIATION,0.0067808,-0.083727,-0.12377,1,0
6,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014486,-0.084075,-0.1136,1,0
6,GO MAST CELL MEDIATED IMMUNITY,0.019739,-0.084268,-0.18989,1,0
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.027803,-0.08431,-0.14589,1,0
6,GO GLUCOSE METABOLIC PROCESS,0.044685,-0.084349,-0.067101,1,0
6,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0075304,-0.084664,-0.10493,1,0
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.035393,-0.084752,-0.069618,1,0
6,GO EXIT FROM MITOSIS,0.022165,-0.084988,-0.10847,1,0
6,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.010773,-0.085104,-0.11029,1,0
6,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.013139,-0.085154,-0.12442,1,0
6,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0056288,-0.08531,-0.10888,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.011904,-0.08548,-0.080851,1,0
6,GO RESPONSE TO ANTIBIOTIC,0.037747,-0.085625,-0.11302,1,0
6,GO CILIUM MOVEMENT,0.0020453,-0.085741,-0.127,1,0
6,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.011047,-0.085863,-0.17353,1,0
6,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0094949,-0.086271,-0.12897,1,0
6,GO REGULATION OF PROTEOLYSIS,0.0057817,-0.086679,-0.112,1,0
6,GO GOLGI TO VACUOLE TRANSPORT,0.014486,-0.086788,-0.13458,1,0
6,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.041967,-0.08685,-0.069253,1,0
6,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.009256,-0.087266,-0.095113,1,0
6,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.013798,-0.087488,-0.13861,1,0
6,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.036948,-0.08754,-0.090013,1,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00081984,-0.087676,-0.10881,1,0
6,GO REGULATION OF ERBB SIGNALING PATHWAY,0.033166,-0.087948,-0.13159,1,0
6,GO EMBRYONIC MORPHOGENESIS,0.012203,-0.088139,-0.10272,1,0
6,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.047551,-0.088301,-0.081081,1,0
6,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.014841,-0.088522,-0.1165,1,0
6,GO LYMPHOCYTE DIFFERENTIATION,0.0021062,-0.088558,-0.11587,1,0
6,GO CELLULAR SENESCENCE,0.017549,-0.088653,-0.11054,1,0
6,GO PROTEOLYSIS,0.00044439,-0.089362,-0.10478,1,0
6,GO NATURAL KILLER CELL ACTIVATION,0.011904,-0.089745,-0.13561,1,0
6,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.043763,-0.089812,-0.09272,1,0
6,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.02268,-0.089912,-0.090142,1,0
6,GO REGULATION OF T CELL DIFFERENTIATION,0.018398,-0.090064,-0.10809,1,0
6,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.030383,-0.090119,-0.20065,1,0
6,GO ACTIVATION OF GTPASE ACTIVITY,0.0064317,-0.090415,-0.098557,1,0
6,GO REGULATION OF CELLULAR PH,0.0049174,-0.090578,-0.097889,1,0
6,GO CELL CELL ADHESION,0.004408,-0.09071,-0.12249,1,0
6,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0069616,-0.09084,-0.1134,1,0
6,GO CELLULAR PIGMENTATION,0.0036303,-0.09092,-0.13554,1,0
6,GO REGULATION OF NUCLEAR DIVISION,0.0050528,-0.091131,-0.08089,1,0
6,GO CELL MATRIX ADHESION,0.038561,-0.091166,-0.1199,1,0
6,GO MEIOSIS I CELL CYCLE PROCESS,0.0087944,-0.091301,-0.11058,1,0
6,GO GERM CELL DEVELOPMENT,0.0056288,-0.091316,-0.088962,1,0
6,GO REGULATION OF PH,0.0062634,-0.091444,-0.094954,1,0
6,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02268,-0.091575,-0.10198,1,0
6,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.010245,-0.091642,-0.12579,1,0
6,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.030383,-0.091662,-0.14272,1,0
6,GO MEIOTIC CELL CYCLE,0.00037661,-0.091734,-0.09741,1,0
6,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.015953,-0.091744,-0.12223,1,0
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.016339,-0.092052,-0.097263,1,0
6,GO MALE SEX DIFFERENTIATION,0.0069616,-0.092178,-0.10836,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.012508,-0.092218,-0.10432,1,0
6,GO RESPONSE TO GAMMA RADIATION,0.036948,-0.092257,-0.093986,1,0
6,GO GLAND DEVELOPMENT,0.013139,-0.092267,-0.099714,1,0
6,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0099891,-0.092299,-0.10271,1,0
6,GO ERBB SIGNALING PATHWAY,0.02843,-0.092544,-0.11082,1,0
6,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.042857,-0.092571,-0.14696,1,0
6,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.012203,-0.092747,-0.12479,1,0
6,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0028957,-0.092966,-0.091004,1,0
6,GO PROTEIN MATURATION,0.015574,-0.092989,-0.10116,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.017137,-0.093242,-0.1859,1,0
6,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.019739,-0.093259,-0.14598,1,0
6,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.018836,-0.093434,-0.18171,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0024367,-0.093456,-0.1471,1,0
6,GO LIPID LOCALIZATION,0.0079323,-0.09371,-0.11778,1,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.017969,-0.093974,-0.093809,1,0
6,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0042883,-0.09409,-0.12622,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.013798,-0.094359,-0.11699,1,0
6,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.010245,-0.094843,-0.12706,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0025083,-0.094888,-0.15669,1,0
6,GO PEPTIDYL ASPARAGINE MODIFICATION,0.02268,-0.095105,-0.13525,1,0
6,GO RESPONSE TO ALCOHOL,0.044685,-0.095276,-0.077525,1,0
6,GO GOLGI VESICLE BUDDING,0.0081404,-0.095367,-0.11661,1,0
6,GO ACTIVATION OF IMMUNE RESPONSE,0.0097392,-0.095573,-0.10692,1,0
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0013872,-0.095585,-0.121,1,0
6,GO POSTREPLICATION REPAIR,0.011904,-0.096376,-0.08894,1,0
6,GO COPII COATED VESICLE BUDDING,0.0053338,-0.096385,-0.11379,1,0
6,GO RESPONSE TO BMP,0.042857,-0.096422,-0.11419,1,0
6,GO REGULATION OF BODY FLUID LEVELS,0.0010859,-0.096588,-0.1364,1,0
6,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.038561,-0.09677,-0.13006,1,0
6,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.03939,-0.096774,-0.14335,1,0
6,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.041967,-0.097474,-0.17357,1,0
6,GO GENITALIA DEVELOPMENT,0.031748,-0.097801,-0.11878,1,0
6,GO GOLGI ORGANIZATION,0.0025083,-0.097875,-0.11643,1,0
6,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.015574,-0.098282,-0.13644,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.027803,-0.098302,-0.10269,1,0
6,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.017549,-0.098956,-0.093767,1,0
6,GO ORGANELLE DISASSEMBLY,0.0087944,-0.099028,-0.092583,1,0
6,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.023205,-0.099219,-0.1092,1,0
6,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0069616,-0.099376,-0.12092,1,0
6,GO COAGULATION,0.0051916,-0.099857,-0.13878,1,0
6,GO REGULATION OF INNATE IMMUNE RESPONSE,0.009256,-0.099859,-0.13181,1,0
6,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00044439,-0.099918,-0.12903,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.022165,-0.099988,-0.15007,1,0
6,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.010773,-0.099989,-0.13459,1,0
6,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0023671,-0.1002,-0.15959,1,0
6,GO APOPTOTIC SIGNALING PATHWAY,0.0041716,-0.10043,-0.1099,1,0
6,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.022165,-0.1009,-0.15697,1,0
6,GO ERAD PATHWAY,0.010506,-0.10131,-0.11486,1,0
6,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.011904,-0.10153,-0.12119,1,0
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00050664,-0.1016,-0.097924,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.03939,-0.10185,-0.078305,1,0
6,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00054072,-0.10187,-0.1406,1,0
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0060989,-0.10191,-0.14091,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0013054,-0.10192,-0.14426,1,0
6,GO RESPONSE TO XENOBIOTIC STIMULUS,0.014486,-0.10213,-0.14414,1,0
6,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.034637,-0.10216,-0.10785,1,0
6,GO POSITIVE REGULATION OF OSSIFICATION,0.047551,-0.10217,-0.13505,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.045624,-0.10218,-0.10611,1,0
6,GO REGULATION OF CELL ADHESION,0.0026572,-0.10247,-0.1538,1,0
6,GO REGULATION OF CELL ACTIVATION,0.0022992,-0.10248,-0.13089,1,0
6,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023671,-0.10265,-0.10487,1,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.015574,-0.10293,-0.1546,1,0
6,GO ENDOCYTIC RECYCLING,0.0020453,-0.10297,-0.1284,1,0
6,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0053338,-0.10314,-0.1281,1,0
6,GO EAR MORPHOGENESIS,0.012203,-0.1035,-0.12465,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0085714,-0.10358,-0.137,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00092958,-0.10358,-0.14937,1,0
6,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0025083,-0.10375,-0.13773,1,0
6,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00092958,-0.10393,-0.11064,1,0
6,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.026586,-0.10435,-0.085846,1,0
6,GO PH REDUCTION,0.0021689,-0.10437,-0.14997,1,0
6,GO CELL ACTIVATION,0.0027346,-0.10443,-0.13744,1,0
6,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.033166,-0.10445,-0.079391,1,0
6,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.015574,-0.10467,-0.13052,1,0
6,GO REGULATION OF CELL SUBSTRATE ADHESION,0.03245,-0.10489,-0.13769,1,0
6,GO ADAPTIVE THERMOGENESIS,0.02268,-0.10497,-0.09286,1,0
6,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.043763,-0.10516,-0.10536,1,0
6,GO REGULATION OF CENTRIOLE REPLICATION,0.0060989,-0.10518,-0.13486,1,0
6,GO HISTONE MONOUBIQUITINATION,0.00026903,-0.10577,-0.13101,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.02166,-0.10578,-0.18634,1,0
6,GO DIGESTIVE SYSTEM PROCESS,0.033894,-0.10582,-0.12398,1,0
6,GO T CELL DIFFERENTIATION,0.0046564,-0.10597,-0.12217,1,0
6,GO PROTEIN POLYUBIQUITINATION,7.547e-05,-0.10635,-0.12601,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.10682,-0.21834,1,0
6,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.038561,-0.10693,-0.11031,1,0
6,GO SPERMATID DIFFERENTIATION,0.0087944,-0.1071,-0.10775,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.011326,-0.10731,-0.18883,1,0
6,GO RESPONSE TO OSMOTIC STRESS,0.023205,-0.10739,-0.11405,1,0
6,GO SEX DETERMINATION,0.033894,-0.10741,-0.13898,1,0
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0069616,-0.10748,-0.13913,1,0
6,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.040234,-0.10761,-0.18224,1,0
6,GO DETECTION OF MECHANICAL STIMULUS,0.012508,-0.10772,-0.16527,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.033894,-0.10795,-0.1079,1,0
6,GO IMMUNOGLOBULIN PRODUCTION,0.00049035,-0.10805,-0.13497,1,0
6,GO PROTEIN KINASE B SIGNALING,0.0042883,-0.10819,-0.13353,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0049174,-0.10864,-0.10882,1,0
6,GO LIPID DIGESTION,0.012508,-0.10865,-0.28191,1,0
6,GO INTERLEUKIN 17 PRODUCTION,0.030383,-0.10907,-0.14524,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.026586,-0.10914,-0.17042,1,0
6,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.025414,-0.1093,-0.17811,1,0
6,GO PEPTIDYL TYROSINE MODIFICATION,0.0037331,-0.10936,-0.13087,1,0
6,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.042857,-0.10946,-0.09126,1,0
6,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,8.7323e-05,-0.10953,-0.14344,1,0
6,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.016734,-0.1097,-0.10881,1,0
6,GO REPRODUCTION,0.0007696,-0.10999,-0.092536,1,0
6,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.016734,-0.11011,-0.10868,1,0
6,GO REGULATION OF PEPTIDE SECRETION,0.0083534,-0.11015,-0.099042,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.031748,-0.11072,-0.18395,1,0
6,GO VESICLE BUDDING FROM MEMBRANE,0.00087311,-0.11132,-0.14441,1,0
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.041093,-0.1115,-0.082264,1,0
6,GO REPLACEMENT OSSIFICATION,0.035393,-0.11165,-0.16091,1,0
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.00095906,-0.11176,-0.15167,1,0
6,GO RESPONSE TO BIOTIC STIMULUS,0.0023671,-0.11176,-0.13851,1,0
6,GO LYMPHOCYTE CHEMOTAXIS,0.020205,-0.11203,-0.13579,1,0
6,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00042998,-0.11209,-0.15393,1,0
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.041093,-0.1121,-0.089285,1,0
6,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0071468,-0.11215,-0.088894,1,0
6,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00087311,-0.11217,-0.14572,1,0
6,GO EMBRYONIC ORGAN DEVELOPMENT,0.0023671,-0.11228,-0.11441,1,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00090094,-0.11244,-0.15274,1,0
6,GO HEMOGLOBIN METABOLIC PROCESS,0.010506,-0.11274,-0.16972,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014486,-0.11296,-0.11908,1,0
6,GO INNATE IMMUNE RESPONSE,0.00092958,-0.11297,-0.16868,1,0
6,GO LEUKOCYTE CELL CELL ADHESION,0.001662,-0.11298,-0.15534,1,0
6,GO CARBOHYDRATE TRANSPORT,0.0067808,-0.11335,-0.10615,1,0
6,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00052342,-0.11337,-0.19464,1,0
6,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.014138,-0.11384,-0.10532,1,0
6,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.031748,-0.11388,-0.22195,1,0
6,GO REGULATION OF MEMBRANE INVAGINATION,0.044685,-0.11432,-0.19369,1,0
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0037331,-0.11433,-0.10729,1,0
6,GO MYELOID CELL DIFFERENTIATION,0.00025131,-0.11435,-0.12563,1,0
6,GO MITOTIC CYTOKINESIS,0.0030654,-0.11455,-0.12727,1,0
6,GO MEIOTIC CHROMOSOME SEGREGATION,0.0085714,-0.1146,-0.11829,1,0
6,GO PLATELET MORPHOGENESIS,0.0051916,-0.11539,-0.20988,1,0
6,GO RESPONSE TO UV C,0.030383,-0.11551,-0.1629,1,0
6,GO REGULATION OF T CELL ACTIVATION,0.00087311,-0.11577,-0.14916,1,0
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0019282,-0.11619,-0.11366,1,0
6,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.042857,-0.11675,-0.12906,1,0
6,GO ANTIMICROBIAL HUMORAL RESPONSE,0.017969,-0.11697,-0.13148,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0064317,-0.11699,-0.1915,1,0
6,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.02268,-0.11734,-0.11495,1,0
6,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0036303,-0.11734,-0.21546,1,0
6,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.02166,-0.11741,-0.21897,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0021689,-0.11744,-0.21493,1,0
6,GO MYOBLAST DIFFERENTIATION,0.00353,-0.1177,-0.18566,1,0
6,GO DENDRITIC CELL MIGRATION,0.03939,-0.11815,-0.17082,1,0
6,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0042883,-0.11821,-0.15809,1,0
6,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.020205,-0.11829,-0.15136,1,0
6,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0030654,-0.1183,-0.175,1,0
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0071468,-0.11846,-0.13149,1,0
6,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00079435,-0.11849,-0.1507,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0046564,-0.11865,-0.10903,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE,0.00037661,-0.11881,-0.14684,1,0
6,GO LYMPHOCYTE COSTIMULATION,0.016734,-0.1192,-0.12062,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00012074,-0.11925,-0.16242,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.014138,-0.11938,-0.17878,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.030383,-0.1196,-0.11207,1,0
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00057693,-0.1198,-0.17694,1,0
6,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0062634,-0.12015,-0.103,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00065623,-0.12034,-0.1434,1,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.036948,-0.12079,-0.19372,1,0
6,GO ROOF OF MOUTH DEVELOPMENT,0.016339,-0.12098,-0.13489,1,0
6,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.036948,-0.12122,-0.16682,1,0
6,GO DIGESTION,0.0037331,-0.12135,-0.15953,1,0
6,GO NOTCH SIGNALING PATHWAY,0.0041716,-0.12161,-0.12592,1,0
6,GO T CELL ACTIVATION,0.00084609,-0.1218,-0.15324,1,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.010245,-0.12181,-0.091078,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.027188,-0.12199,-0.11447,1,0
6,GO RESPONSE TO WOUNDING,0.0097392,-0.12206,-0.13851,1,0
6,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.043763,-0.12209,-0.13789,1,0
6,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.036164,-0.12218,-0.12394,1,0
6,GO SPINDLE LOCALIZATION,0.001228,-0.12219,-0.14155,1,0
6,GO RESPONSE TO BACTERIUM,0.011612,-0.12235,-0.12854,1,0
6,GO PROTEIN DESTABILIZATION,0.0045306,-0.1224,-0.12012,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.036164,-0.12245,-0.17099,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0073363,-0.1225,-0.12381,1,0
6,GO CYTOKINE PRODUCTION,0.00021167,-0.12282,-0.17499,1,0
6,GO AUTOPHAGY OF MITOCHONDRION,0.0045306,-0.1229,-0.11055,1,0
6,GO TISSUE HOMEOSTASIS,5.508e-06,-0.12321,-0.18363,1,0
6,GO EPITHELIUM DEVELOPMENT,4.6597e-05,-0.12322,-0.15616,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00014418,-0.12327,-0.15893,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0045306,-0.12336,-0.10713,1,0
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.012508,-0.12338,-0.14282,1,0
6,GO AUTOPHAGOSOME ORGANIZATION,0.00041602,-0.12341,-0.1536,1,0
6,GO BONE CELL DEVELOPMENT,0.021165,-0.12346,-0.13918,1,0
6,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00010845,-0.12354,-0.12675,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.015203,-0.12356,-0.19931,1,0
6,GO REGULATION OF DEFENSE RESPONSE,0.00049035,-0.12387,-0.14928,1,0
6,GO VIRAL LATENCY,0.024288,-0.12407,-0.12119,1,0
6,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.038561,-0.12409,-0.20943,1,0
6,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00013433,-0.12422,-0.14223,1,0
6,GO MYELOID LEUKOCYTE ACTIVATION,0.0026572,-0.12426,-0.16489,1,0
6,GO REGULATION OF ISOTYPE SWITCHING,0.0028141,-0.12432,-0.19311,1,0
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0036303,-0.12448,-0.13972,1,0
6,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0085714,-0.1248,-0.21404,1,0
6,GO TRANSLESION SYNTHESIS,0.004408,-0.12481,-0.11409,1,0
6,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.031748,-0.12484,-0.12044,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0037331,-0.1252,-0.19543,1,0
6,GO ACUTE INFLAMMATORY RESPONSE,0.0064317,-0.12528,-0.19474,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.042857,-0.12547,-0.24358,1,0
6,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0014738,-0.12559,-0.16921,1,0
6,GO EPITHELIAL TUBE MORPHOGENESIS,0.00017186,-0.12589,-0.15114,1,0
6,GO VESICLE TARGETING,0.0010859,-0.12596,-0.15258,1,0
6,GO DEFENSE RESPONSE,0.00067758,-0.12607,-0.14936,1,0
6,GO POSITIVE REGULATION OF BEHAVIOR,0.036948,-0.12609,-0.18719,1,0
6,GO RESPIRATORY BURST,0.0030654,-0.12709,-0.24633,1,0
6,GO DNA DEALKYLATION,0.021165,-0.12709,-0.13663,1,0
6,GO REGULATION OF MUSCLE ADAPTATION,0.0073363,-0.12709,-0.13064,1,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0050528,-0.12729,-0.17163,1,0
6,GO REGULATION OF PEPTIDASE ACTIVITY,0.00024286,-0.12733,-0.1873,1,0
6,GO REGULATION OF PINOCYTOSIS,0.0049174,-0.12742,-0.21435,1,0
6,GO VIRAL LIFE CYCLE,0.0006154,-0.12754,-0.18525,1,0
6,GO INFLAMMATORY RESPONSE,0.0010528,-0.12767,-0.14813,1,0
6,GO GOLGI TO ENDOSOME TRANSPORT,0.029719,-0.1277,-0.13862,1,0
6,GO RESPONSE TO IRON ION,0.017969,-0.12784,-0.15696,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0014738,-0.12842,-0.14968,1,0
6,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.013465,-0.12854,-0.12884,1,0
6,GO KILLING OF CELLS OF OTHER ORGANISM,0.0046564,-0.12856,-0.12382,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01282,-0.1286,-0.17838,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023468,-0.12895,-0.16558,1,0
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.042857,-0.12913,-0.2315,1,0
6,GO WOUND HEALING,0.0054795,-0.1293,-0.15726,1,0
6,GO FIBROBLAST MIGRATION,0.007729,-0.12942,-0.17907,1,0
6,GO REGULATION OF CELL SHAPE,0.007729,-0.12957,-0.13399,1,0
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.014138,-0.12982,-0.14473,1,0
6,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00084609,-0.12995,-0.18643,1,0
6,GO RESPONSE TO INTERLEUKIN 6,0.0012662,-0.13027,-0.18833,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00042998,-0.13033,-0.17338,1,0
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.017549,-0.13045,-0.11113,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.024288,-0.13054,-0.14495,1,0
6,GO PHAGOSOME ACIDIFICATION,0.011047,-0.13061,-0.16997,1,0
6,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.004408,-0.13062,-0.18148,1,0
6,GO ACTIN FILAMENT DEPOLYMERIZATION,0.019739,-0.13104,-0.13652,1,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.042857,-0.13113,-0.13624,1,0
6,GO SPECIFICATION OF SYMMETRY,0.001986,-0.13171,-0.11453,1,0
6,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00050664,-0.132,-0.16849,1,0
6,GO REGULATION OF CHEMOTAXIS,0.0025817,-0.13201,-0.13346,1,0
6,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0083534,-0.13223,-0.22541,1,0
6,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.042857,-0.13227,-0.10183,1,0
6,GO NEURAL TUBE DEVELOPMENT,0.00079435,-0.13232,-0.14758,1,0
6,GO REGULATION OF LEUKOCYTE MIGRATION,0.013465,-0.13233,-0.11869,1,0
6,GO SENSORY PERCEPTION OF BITTER TASTE,0.00067758,-0.13237,-0.17463,1,0
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0032441,-0.13243,-0.12134,1,0
6,GO PEPTIDE CROSS LINKING,0.031059,-0.1329,-0.19153,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0031536,-0.1334,-0.14323,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0083534,-0.13365,-0.18128,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION,0.004408,-0.13383,-0.18717,1,0
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.00067758,-0.13394,-0.14216,1,0
6,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00079435,-0.13405,-0.18566,1,0
6,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00037661,-0.1343,-0.18074,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0071468,-0.13466,-0.25989,1,0
6,GO PEPTIDYL THREONINE MODIFICATION,0.0010206,-0.13467,-0.13057,1,0
6,GO LEUKOCYTE MEDIATED IMMUNITY,0.00045924,-0.13472,-0.18616,1,0
6,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.01282,-0.1348,-0.14885,1,0
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.03245,-0.13487,-0.15042,1,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0073363,-0.13507,-0.13492,1,0
6,GO MYELOID DENDRITIC CELL ACTIVATION,0.0034322,-0.1352,-0.20747,1,0
6,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0010206,-0.13529,-0.18728,1,0
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00012512,-0.13531,-0.11985,1,0
6,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028957,-0.13533,-0.18301,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.017549,-0.1354,-0.11915,1,0
6,GO SENSORY ORGAN MORPHOGENESIS,0.00044439,-0.13553,-0.14304,1,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.035393,-0.13556,-0.122,1,0
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00040247,-0.13585,-0.15198,1,0
6,GO DIOL BIOSYNTHETIC PROCESS,0.018398,-0.13599,-0.16919,1,0
6,GO B CELL ACTIVATION,1.349e-05,-0.13627,-0.16989,1,0
6,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00034072,-0.13627,-0.17261,1,0
6,GO REGULATION OF MAST CELL ACTIVATION,0.025994,-0.13635,-0.1584,1,0
6,GO PIGMENT GRANULE LOCALIZATION,0.01282,-0.13658,-0.1564,1,0
6,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0057817,-0.13663,-0.16375,1,0
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.044685,-0.13707,-0.10245,1,0
6,GO RESPONSE TO CYTOKINE,0.0015653,-0.13722,-0.15304,1,0
6,GO LEUKOCYTE PROLIFERATION,5.2139e-05,-0.13752,-0.18262,1,0
6,GO CYTOKINE SECRETION,0.00036427,-0.13774,-0.16718,1,0
6,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.00059588,-0.13782,-0.13632,1,0
6,GO REGULATION OF T CELL CHEMOTAXIS,0.017969,-0.13784,-0.13105,1,0
6,GO ATP BIOSYNTHETIC PROCESS,0.017137,-0.13838,-0.12921,1,0
6,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015653,-0.13838,-0.16625,1,0
6,GO CELLULAR RESPONSE TO ALCOHOL,0.0036303,-0.13851,-0.13108,1,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0022992,-0.13857,-0.19007,1,0
6,GO B CELL PROLIFERATION,0.0047853,-0.13915,-0.14366,1,0
6,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.025414,-0.13941,-0.14385,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION,0.0013457,-0.13943,-0.17667,1,0
6,GO RESPONSE TO PEPTIDOGLYCAN,0.0011199,-0.13949,-0.21885,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.13965,-0.1945,1,0
6,GO LEUKOCYTE APOPTOTIC PROCESS,0.019283,-0.14022,-0.1494,1,0
6,GO REGULATION OF NEUTROPHIL MIGRATION,0.0085714,-0.14029,-0.15571,1,0
6,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0081404,-0.14034,-0.14479,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0011549,-0.14036,-0.19254,1,0
6,GO AMINO SUGAR CATABOLIC PROCESS,0.019739,-0.14046,-0.16668,1,0
6,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0001547,-0.14116,-0.15776,1,0
6,GO T CELL PROLIFERATION,0.00047456,-0.14122,-0.17393,1,0
6,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0028141,-0.14125,-0.16001,1,0
6,GO GRANULOCYTE MIGRATION,0.0039469,-0.14139,-0.1513,1,0
6,GO ARACHIDONIC ACID METABOLIC PROCESS,0.030383,-0.14149,-0.14655,1,0
6,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.016734,-0.14167,-0.18334,1,0
6,GO RESPONSE TO ETHER,0.024288,-0.14185,-0.11441,1,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0057817,-0.14203,-0.15264,1,0
6,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00035231,-0.14214,-0.22517,1,0
6,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00012512,-0.14214,-0.20648,1,0
6,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.013465,-0.14252,-0.17536,1,0
6,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00029782,-0.14289,-0.16849,1,0
6,GO VIRAL RNA GENOME REPLICATION,0.0025083,-0.14291,-0.18684,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057817,-0.14298,-0.17715,1,0
6,GO V D J RECOMBINATION,0.011904,-0.14309,-0.19634,1,0
6,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0047853,-0.14328,-0.23072,1,0
6,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0024367,-0.14331,-0.18293,1,0
6,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.035393,-0.14355,-0.18871,1,0
6,GO BLOOD VESSEL REMODELING,0.0053338,-0.14366,-0.2213,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0028957,-0.1439,-0.19045,1,0
6,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011549,-0.14393,-0.18759,1,0
6,GO PROTEIN K48 LINKED UBIQUITINATION,0.00013917,-0.14424,-0.15291,1,0
6,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.02068,-0.14432,-0.21244,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.009256,-0.14442,-0.18871,1,0
6,GO OVARIAN FOLLICLE DEVELOPMENT,0.014486,-0.14453,-0.12149,1,0
6,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.042857,-0.14456,-0.15514,1,0
6,GO INTERLEUKIN 4 PRODUCTION,0.0014299,-0.14457,-0.20697,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0037331,-0.14465,-0.17389,1,0
6,GO EPITHELIAL TUBE FORMATION,0.00022676,-0.14479,-0.15709,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14492,-0.17924,1,0
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00022676,-0.14503,-0.1583,1,0
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.014841,-0.14516,-0.13223,1,0
6,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.035393,-0.14517,-0.18809,1,0
6,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.017137,-0.14525,-0.11333,1,0
6,GO CHEMOKINE PRODUCTION,0.00035231,-0.14531,-0.21654,1,0
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.0018173,-0.14548,-0.14576,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0014738,-0.14601,-0.16132,1,0
6,GO MAST CELL ACTIVATION,0.0090226,-0.14638,-0.18771,1,0
6,GO ER NUCLEUS SIGNALING PATHWAY,0.017549,-0.14655,-0.14279,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0010528,-0.14678,-0.18093,1,0
6,GO MYELOID CELL DEVELOPMENT,0.00041602,-0.14679,-0.14912,1,0
6,GO SENSORY PERCEPTION OF TASTE,0.00087311,-0.14694,-0.17863,1,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,-0.14704,-0.21074,1,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00019079,-0.14753,-0.18056,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00027832,-0.14789,-0.19066,1,0
6,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001872,-0.14792,-0.17967,1,0
6,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.033166,-0.14877,-0.19191,1,0
6,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.9904e-06,-0.14883,-0.18084,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0015653,-0.14894,-0.18765,1,0
6,GO ENDOTHELIUM DEVELOPMENT,0.0013872,-0.14899,-0.16446,1,0
6,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.011904,-0.14926,-0.19602,1,0
6,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.015574,-0.1494,-0.12683,1,0
6,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.009256,-0.14942,-0.17523,1,0
6,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00353,-0.14945,-0.15172,1,0
6,GO ENDOTHELIAL CELL DEVELOPMENT,0.00057693,-0.14947,-0.2105,1,0
6,GO LYMPHOCYTE APOPTOTIC PROCESS,0.013465,-0.14956,-0.1439,1,0
6,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.6174e-05,-0.14956,-0.17964,1,0
6,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00059588,-0.14964,-0.12514,1,0
6,GO MICROTUBULE BUNDLE FORMATION,0.00087311,-0.14969,-0.16357,1,0
6,GO RENAL TUBULE DEVELOPMENT,0.001191,-0.14991,-0.17985,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0025817,-0.14994,-0.20246,1,0
6,GO POSITIVE REGULATION OF NEURON DEATH,0.0075304,-0.14999,-0.11888,1,0
6,GO NUCLEOTIDE TRANSPORT,0.033166,-0.15011,-0.098094,1,0
6,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00032948,-0.15014,-0.18851,1,0
6,GO SECRETION BY TISSUE,0.013465,-0.15017,-0.16291,1,0
6,GO SECONDARY METABOLIC PROCESS,0.0029794,-0.15038,-0.21197,1,0
6,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.02166,-0.15049,-0.19718,1,0
6,GO REGULATION OF B CELL ACTIVATION,0.00028792,-0.15059,-0.17344,1,0
6,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0038387,-0.15116,-0.14668,1,0
6,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00027832,-0.15117,-0.17891,1,0
6,GO REGULATION OF FIBROBLAST MIGRATION,0.0075304,-0.1512,-0.1891,1,0
6,GO UROGENITAL SYSTEM DEVELOPMENT,0.0015653,-0.15155,-0.14694,1,0
6,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0032441,-0.15164,-0.14705,1,0
6,GO LEUKOCYTE MIGRATION,0.00052342,-0.15167,-0.16869,1,0
6,GO CYTOKINE METABOLIC PROCESS,0.0007696,-0.15171,-0.20216,1,0
6,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013433,-0.15188,-0.18461,1,0
6,GO CELL PROJECTION ASSEMBLY,5.4121e-05,-0.15189,-0.12875,1,0
6,GO PINOCYTOSIS,0.017549,-0.15217,-0.18144,1,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.023205,-0.15258,-0.1816,1,0
6,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00037661,-0.15284,-0.21262,1,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019079,-0.15285,-0.22724,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.007729,-0.15288,-0.25354,1,0
6,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.031748,-0.15312,-0.2892,1,0
6,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.045624,-0.15342,-0.1403,1,0
6,GO DETERMINATION OF ADULT LIFESPAN,0.03939,-0.15348,-0.13741,1,0
6,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0039469,-0.15351,-0.21867,1,0
6,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00012074,-0.15356,-0.20431,1,0
6,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0049174,-0.15376,-0.16147,1,0
6,GO REGULATION OF CELL CELL ADHESION,0.00019753,-0.15387,-0.18583,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00036427,-0.15402,-0.19018,1,0
6,GO MYOFIBRIL ASSEMBLY,0.0013054,-0.15403,-0.1654,1,0
6,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.15411,-0.20674,1,0
6,GO INTESTINAL LIPID ABSORPTION,0.0057817,-0.15426,-0.30133,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0066042,-0.15435,-0.18217,1,0
6,GO GRANULOCYTE CHEMOTAXIS,0.004408,-0.15444,-0.14176,1,0
6,GO DEFENSE RESPONSE TO BACTERIUM,5.0226e-05,-0.15451,-0.18967,1,0
6,GO IMMUNE EFFECTOR PROCESS,0.00027832,-0.15462,-0.18866,1,0
6,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0010528,-0.15478,-0.19313,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0032441,-0.15482,-0.23943,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.01282,-0.15482,-0.17457,1,0
6,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00027832,-0.15485,-0.20869,1,0
6,GO ACTIN NUCLEATION,9.3916e-06,-0.15517,-0.17974,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0054795,-0.15535,-0.19323,1,0
6,GO INTRA S DNA DAMAGE CHECKPOINT,0.00084609,-0.15538,-0.14248,1,0
6,GO EYE MORPHOGENESIS,0.0007696,-0.15573,-0.15378,1,0
6,GO GENETIC IMPRINTING,0.001662,-0.1559,-0.18531,1,0
6,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.012508,-0.15608,-0.25662,1,0
6,GO T HELPER 1 CELL DIFFERENTIATION,0.020205,-0.15641,-0.32179,1,0
6,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.001191,-0.15661,-0.24229,1,0
6,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0056288,-0.15663,-0.43877,1,0
6,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.020205,-0.15667,-0.12284,1,0
6,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00021909,-0.15674,-0.17691,1,0
6,GO RESPONSE TO REDOX STATE,0.042857,-0.15686,-0.15179,1,0
6,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00074557,-0.15704,-0.18448,1,0
6,GO INTERACTION WITH HOST,0.00019079,-0.15709,-0.20914,1,0
6,GO NEURAL NUCLEUS DEVELOPMENT,0.019739,-0.1571,-0.15153,1,0
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.0037331,-0.15743,-0.14227,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION,0.00079435,-0.15766,-0.18699,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0014299,-0.15773,-0.2157,1,0
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.014486,-0.15774,-0.12947,1,0
6,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00057693,-0.15783,-0.1292,1,0
6,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00016023,-0.15786,-0.21085,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00067758,-0.15788,-0.18079,1,0
6,GO PURINE NUCLEOTIDE TRANSPORT,0.035393,-0.15803,-0.10595,1,0
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0026572,-0.15807,-0.2037,1,0
6,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0087944,-0.15853,-0.16251,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0038387,-0.15858,-0.15479,1,0
6,GO LINOLEIC ACID METABOLIC PROCESS,0.041967,-0.15888,-0.19555,1,0
6,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00034072,-0.1591,-0.19399,1,0
6,GO FOAM CELL DIFFERENTIATION,0.019283,-0.15919,-0.17345,1,0
6,GO RESPONSE TO DSRNA,0.0051916,-0.1593,-0.15298,1,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00016023,-0.15932,-0.20877,1,0
6,GO HISTAMINE TRANSPORT,0.02843,-0.15977,-0.22185,1,0
6,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0060989,-0.15995,-0.27992,1,0
6,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010092,-0.16008,-0.19963,1,0
6,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00017796,-0.16016,-0.18245,1,0
6,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.8379e-05,-0.16017,-0.21337,1,0
6,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.020205,-0.16021,-0.17337,1,0
6,GO MALE GENITALIA DEVELOPMENT,0.036164,-0.16024,-0.16504,1,0
6,GO CELL KILLING,0.00074557,-0.16039,-0.18127,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,-0.16045,-0.19554,1,0
6,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.5816e-05,-0.16078,-0.24415,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.017549,-0.16089,-0.24785,1,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0025083,-0.16094,-0.13679,1,0
6,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.033894,-0.16114,-0.19282,1,0
6,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00026903,-0.16179,-0.2271,1,0
6,GO ENDOTHELIAL CELL MIGRATION,0.017137,-0.16179,-0.13681,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0036303,-0.16222,-0.20852,1,0
6,GO RESPONSE TO VIRUS,7.2754e-05,-0.16236,-0.22056,1,0
6,GO REPRODUCTIVE SYSTEM DEVELOPMENT,8.7323e-05,-0.16304,-0.15477,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.023205,-0.16307,-0.22829,1,0
6,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0037331,-0.16314,-0.18802,1,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00024286,-0.16323,-0.17159,1,0
6,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0039469,-0.16341,-0.16958,1,0
6,GO LEUKOTRIENE METABOLIC PROCESS,0.017549,-0.16375,-0.15881,1,0
6,GO BONE RESORPTION,0.001662,-0.16393,-0.2021,1,0
6,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0050528,-0.16395,-0.16202,1,0
6,GO EPITHELIAL CELL DEVELOPMENT,4.0073e-05,-0.16412,-0.20926,1,0
6,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,-0.16446,-0.21357,1,0
6,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0033369,-0.16459,-0.23974,1,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.014138,-0.16466,-0.14851,1,0
6,GO PROTEIN K63 LINKED UBIQUITINATION,8.6584e-06,-0.16481,-0.16849,1,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.019739,-0.16498,-0.16212,1,0
6,GO PROTEIN PROCESSING,0.00031859,-0.16503,-0.17643,1,0
6,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.016339,-0.16508,-0.20976,1,0
6,GO POSITIVE REGULATION OF BONE RESORPTION,0.030383,-0.16509,-0.17813,1,0
6,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0099891,-0.16521,-0.21723,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00035231,-0.16611,-0.20067,1,0
6,GO PROTEIN DEMANNOSYLATION,0.016734,-0.16667,-0.1826,1,0
6,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00012512,-0.16682,-0.20585,1,0
6,GO REGULATION OF ICOSANOID SECRETION,0.043763,-0.16685,-0.13495,1,0
6,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0053338,-0.16686,-0.18038,1,0
6,GO REGULATION OF LEUKOCYTE PROLIFERATION,5.4121e-05,-0.16691,-0.21403,1,0
6,GO MEGAKARYOCYTE DIFFERENTIATION,4.4712e-06,-0.1672,-0.18873,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0090226,-0.16723,-0.18053,1,0
6,GO ALPHA BETA T CELL ACTIVATION,1.5816e-05,-0.16759,-0.22358,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00072223,-0.16822,-0.19688,1,0
6,GO RESPONSE TO ISCHEMIA,0.001986,-0.16838,-0.16397,1,0
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0042883,-0.1685,-0.20823,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0087944,-0.16857,-0.18176,1,0
6,GO T CELL CYTOKINE PRODUCTION,0.0037331,-0.16864,-0.19095,1,0
6,GO RESPONSE TO PROGESTERONE,0.0049174,-0.1687,-0.22083,1,0
6,GO MESONEPHROS DEVELOPMENT,0.012508,-0.16888,-0.15112,1,0
6,GO REGULATION OF CHROMATIN BINDING,0.00095906,-0.16935,-0.21586,1,0
6,GO MYELOID LEUKOCYTE MIGRATION,0.0014299,-0.16935,-0.16125,1,0
6,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.6455e-05,-0.16944,-0.1757,1,0
6,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0033369,-0.16957,-0.33203,1,0
6,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.038561,-0.17029,-0.16591,1,0
6,GO ZYMOGEN ACTIVATION,0.0051916,-0.17036,-0.27421,1,0
6,GO RIG I SIGNALING PATHWAY,0.0025083,-0.17043,-0.18276,1,0
6,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0010859,-0.17043,-0.23775,1,0
6,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.024846,-0.17045,-0.16178,1,0
6,GO EXECUTION PHASE OF APOPTOSIS,1.0184e-05,-0.17048,-0.1646,1,0
6,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025414,-0.17053,-0.3756,1,0
6,GO ENTRY INTO HOST,0.00050664,-0.17066,-0.26205,1,0
6,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00035231,-0.17079,-0.15974,1,0
6,GO ACUTE PHASE RESPONSE,0.0031536,-0.17081,-0.1885,1,0
6,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.013465,-0.17095,-0.14719,1,0
6,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0022332,-0.17123,-0.19664,1,0
6,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0028141,-0.17125,-0.20777,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.1617e-05,-0.17141,-0.24649,1,0
6,GO RESPONSE TO ANGIOTENSIN,0.0024367,-0.17178,-0.21932,1,0
6,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0015653,-0.17192,-0.16732,1,0
6,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00037661,-0.17193,-0.21364,1,0
6,GO DIOL METABOLIC PROCESS,0.019739,-0.17195,-0.17019,1,0
6,GO CENTROSOME DUPLICATION,9.389e-05,-0.17204,-0.17864,1,0
6,GO REGULATION OF CHROMATIN ASSEMBLY,0.00055855,-0.17215,-0.159,1,0
6,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0025817,-0.17218,-0.21653,1,0
6,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00063551,-0.17254,-0.21976,1,0
6,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.033894,-0.17272,-0.17615,1,0
6,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0029794,-0.17299,-0.21201,1,0
6,GO REGULATION OF B CELL PROLIFERATION,0.0017123,-0.17333,-0.18159,1,0
6,GO SKELETAL MUSCLE CELL PROLIFERATION,0.036164,-0.17361,-0.19823,1,0
6,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0028957,-0.17377,-0.17369,1,0
6,GO ICOSANOID BIOSYNTHETIC PROCESS,0.012508,-0.17408,-0.20794,1,0
6,GO ERYTHROCYTE DEVELOPMENT,0.0032441,-0.17411,-0.13457,1,0
6,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0051916,-0.1742,-0.17726,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0014738,-0.17422,-0.17904,1,0
6,GO PROSTANOID BIOSYNTHETIC PROCESS,0.019283,-0.17445,-0.2578,1,0
6,GO REGULATION OF GOLGI ORGANIZATION,0.044685,-0.17453,-0.14119,1,0
6,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0075304,-0.17471,-0.2284,1,0
6,GO CYTOLYSIS,0.0054795,-0.17473,-0.22888,1,0
6,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0013872,-0.17476,-0.1755,1,0
6,GO DORSAL VENTRAL PATTERN FORMATION,0.0037331,-0.17487,-0.14148,1,0
6,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0045306,-0.17502,-0.19628,1,0
6,GO T HELPER 17 TYPE IMMUNE RESPONSE,6.7596e-05,-0.17559,-0.19025,1,0
6,GO MYOTUBE CELL DEVELOPMENT,0.016339,-0.17563,-0.15797,1,0
6,GO ENDOCRINE HORMONE SECRETION,0.0056288,-0.17573,-0.15316,1,0
6,GO O GLYCAN PROCESSING,0.0031536,-0.17579,-0.2369,1,0
6,GO REGULATION OF RUFFLE ASSEMBLY,0.00079435,-0.17596,-0.1982,1,0
6,GO RETINA HOMEOSTASIS,0.00032948,-0.17619,-0.14676,1,0
6,GO DNA DEMETHYLATION,0.00029782,-0.17626,-0.19988,1,0
6,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.001228,-0.17636,-0.17727,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,5.2139e-05,-0.17658,-0.2252,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.015574,-0.17694,-0.22061,1,0
6,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0047853,-0.17737,-0.19456,1,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001165,-0.17743,-0.194,1,0
6,GO CAMERA TYPE EYE MORPHOGENESIS,0.00052342,-0.17744,-0.15958,1,0
6,GO EPOXYGENASE P450 PATHWAY,0.03939,-0.17744,-0.19399,1,0
6,GO PLATELET ACTIVATION,4.1617e-05,-0.17749,-0.21602,1,0
6,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.018836,-0.17791,-0.15795,1,0
6,GO CELL ADHESION MEDIATED BY INTEGRIN,0.013465,-0.17804,-0.23875,1,0
6,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.17827,-0.19891,1,0
6,GO B CELL DIFFERENTIATION,4.1112e-06,-0.17886,-0.20911,1,0
6,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.1663e-05,-0.1789,-0.24823,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.17895,-0.21136,1,0
6,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00036427,-0.17899,-0.16736,1,0
6,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7806e-05,-0.17912,-0.19717,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00017186,-0.17933,-0.24299,1,0
6,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.036164,-0.17974,-0.1366,1,0
6,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0036303,-0.17976,-0.23816,1,0
6,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00067758,-0.1798,-0.18452,1,0
6,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0034322,-0.17994,-0.15644,1,0
6,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0011549,-0.18011,-0.26679,1,0
6,GO REGULATION OF CILIUM BEAT FREQUENCY,0.013139,-0.18018,-0.17527,1,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0018173,-0.18039,-0.20622,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0031536,-0.18041,-0.17537,1,0
6,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0056288,-0.1806,-0.16351,1,0
6,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0067808,-0.18146,-0.20684,1,0
6,GO PHOSPHOLIPID TRANSPORT,9.7346e-05,-0.18173,-0.18523,1,0
6,GO NEPHRON DEVELOPMENT,0.00034072,-0.18181,-0.18869,1,0
6,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00052342,-0.18189,-0.2359,1,0
6,GO CELLULAR RESPONSE TO VIRUS,3.5759e-05,-0.18208,-0.22268,1,0
6,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0081404,-0.18208,-0.18681,1,0
6,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00081984,-0.18246,-0.19194,1,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0029794,-0.18274,-0.23216,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.8301e-05,-0.18284,-0.21292,1,0
6,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00019753,-0.18286,-0.20857,1,0
6,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00017796,-0.18323,-0.26212,1,0
6,GO RESPONSE TO INACTIVITY,0.02166,-0.18324,-0.15967,1,0
6,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0053338,-0.1835,-0.18746,1,0
6,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00049035,-0.18353,-0.2607,1,0
6,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0046564,-0.18402,-0.23911,1,0
6,GO MYELOID CELL HOMEOSTASIS,1.7806e-05,-0.18416,-0.19416,1,0
6,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00090094,-0.18552,-0.17905,1,0
6,GO DEFENSE RESPONSE TO VIRUS,3.6228e-06,-0.18591,-0.29096,1,0
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.0011549,-0.18602,-0.16315,1,0
6,GO ENDOSOME ORGANIZATION,5.7413e-06,-0.18602,-0.1872,1,0
6,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0027346,-0.18632,-0.20252,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.7118e-05,-0.18636,-0.21519,1,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00032948,-0.18658,-0.16686,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0056288,-0.18666,-0.16861,1,0
6,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0046564,-0.18693,-0.22136,1,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0028957,-0.18694,-0.3128,1,0
6,GO REGULATION OF TISSUE REMODELING,0.00353,-0.18727,-0.18813,1,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,6.2786e-05,-0.18748,-0.24241,1,0
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.00017796,-0.18756,-0.15865,1,0
6,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00010845,-0.18759,-0.23729,1,0
6,GO HYPOTHALAMUS DEVELOPMENT,0.010245,-0.18772,-0.19643,1,0
6,GO PRO B CELL DIFFERENTIATION,0.03939,-0.18773,-0.17599,1,0
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0069616,-0.18822,-0.15997,1,0
6,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0039469,-0.18868,-0.22033,1,0
6,GO ACTIN FILAMENT NETWORK FORMATION,0.029068,-0.18875,-0.28838,1,0
6,GO ALPHA BETA T CELL DIFFERENTIATION,3.6228e-06,-0.18876,-0.24018,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0087944,-0.18891,-0.22537,1,0
6,GO IMMUNOGLOBULIN SECRETION,5.8301e-05,-0.18902,-0.32871,1,0
6,GO KERATINOCYTE PROLIFERATION,0.023741,-0.18905,-0.1901,1,0
6,GO MATERNAL PLACENTA DEVELOPMENT,0.020205,-0.18916,-0.18951,1,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0053338,-0.18936,-0.20841,1,0
6,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00026003,-0.18937,-0.20372,1,0
6,GO MULTIVESICULAR BODY SORTING PATHWAY,4.6597e-05,-0.18985,-0.20809,1,0
6,GO REGULATION OF SYMBIOTIC PROCESS,2.3418e-05,-0.19054,-0.23827,1,0
6,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.042857,-0.19116,-0.1446,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.1617e-05,-0.19125,-0.20666,1,0
6,GO MATURE B CELL DIFFERENTIATION,0.0079323,-0.19127,-0.24139,1,0
6,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00042998,-0.19132,-0.18364,1,0
6,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00045924,-0.19145,-0.25472,1,0
6,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.033166,-0.19155,-0.18675,1,0
6,GO MYELOID CELL APOPTOTIC PROCESS,0.0039469,-0.19155,-0.20908,1,0
6,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.009256,-0.1917,-0.21063,1,0
6,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0014738,-0.19173,-0.19582,1,0
6,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0007696,-0.19186,-0.24411,1,0
6,GO CELL MIGRATION IN HINDBRAIN,0.041093,-0.19215,-0.19747,1,0
6,GO HISTONE H4 DEACETYLATION,0.0083534,-0.19221,-0.18168,1,0
6,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0011549,-0.19228,-0.17259,1,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.019283,-0.19244,-0.19172,1,0
6,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.025994,-0.19261,-0.19316,1,0
6,GO MACROPHAGE MIGRATION,0.016734,-0.19285,-0.15018,1,0
6,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,-0.19285,-0.19495,1,0
6,GO REGULATION OF GASTRULATION,0.0036303,-0.19303,-0.19391,1,0
6,GO TYPE I INTERFERON PRODUCTION,0.00012512,-0.19307,-0.22172,1,0
6,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.0073e-05,-0.19317,-0.20567,1,0
6,GO SEGMENT SPECIFICATION,0.016734,-0.1934,-0.22752,1,0
6,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0094949,-0.19414,-0.17633,1,0
6,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,-0.19418,-0.24207,1,0
6,GO FEMALE GENITALIA DEVELOPMENT,0.0030654,-0.19429,-0.21205,1,0
6,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0053338,-0.1944,-0.18269,1,0
6,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.030383,-0.19452,-0.19046,1,0
6,GO RESPONSE TO INTERLEUKIN 2,0.0024367,-0.19464,-0.21173,1,0
6,GO LEUKOCYTE CHEMOTAXIS,0.00034072,-0.19467,-0.17473,1,0
6,GO RESPONSE TO INTERFERON GAMMA,0.0022992,-0.19468,-0.25638,1,0
6,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00020448,-0.19474,-0.22513,1,0
6,GO LIPID DROPLET ORGANIZATION,0.00057693,-0.19506,-0.24384,1,0
6,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0083534,-0.19517,-0.14355,1,0
6,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00052342,-0.19534,-0.26544,1,0
6,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0041716,-0.19545,-0.23709,1,0
6,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.013798,-0.19553,-0.16904,1,0
6,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0028141,-0.19558,-0.17657,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0011549,-0.19644,-0.24342,1,0
6,GO B CELL MEDIATED IMMUNITY,4.1617e-05,-0.19658,-0.25168,1,0
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.013465,-0.19668,-0.20185,1,0
6,GO ENDODERMAL CELL FATE COMMITMENT,0.0027346,-0.19669,-0.18498,1,0
6,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0053338,-0.19672,-0.37465,1,0
6,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0001165,-0.19674,-0.23763,1,0
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0025817,-0.19709,-0.1548,1,0
6,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,-0.1971,-0.17857,1,0
6,GO REGULATION OF MEMBRANE PERMEABILITY,2.8418e-05,-0.19715,-0.20872,1,0
6,GO RESPONSE TO OXYGEN RADICAL,0.00031859,-0.19742,-0.19113,1,0
6,GO ADAPTIVE IMMUNE RESPONSE,1.5201e-05,-0.19811,-0.24424,1,0
6,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024367,-0.19818,-0.25076,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,-0.19822,-0.26604,1,0
6,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.021165,-0.19857,-0.19446,1,0
6,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0031536,-0.19869,-0.15963,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0034322,-0.19925,-0.25923,1,0
6,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00035231,-0.1996,-0.20529,1,0
6,GO VIRAL GENOME REPLICATION,0.00019079,-0.19966,-0.25058,1,0
6,GO IMMUNE RESPONSE TO TUMOR CELL,0.017549,-0.19969,-0.24726,1,0
6,GO CELL CHEMOTAXIS,0.00014935,-0.19992,-0.19702,1,0
6,GO MICROVILLUS ORGANIZATION,0.0040578,-0.20036,-0.24987,1,0
6,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0047853,-0.20082,-0.23713,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0038387,-0.20094,-0.21145,1,0
6,GO VASCULAR WOUND HEALING,0.047551,-0.20094,-0.1695,1,0
6,GO MOVEMENT IN HOST ENVIRONMENT,4.0073e-05,-0.20127,-0.26159,1,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00010092,-0.20136,-0.21635,1,0
6,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.0689e-05,-0.20164,-0.24896,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0027346,-0.20192,-0.23749,1,0
6,GO ERYTHROCYTE HOMEOSTASIS,3.1888e-05,-0.20196,-0.18645,1,0
6,GO ETHANOL METABOLIC PROCESS,0.018836,-0.20221,-0.22088,1,0
6,GO ENDOCRINE PROCESS,0.0021689,-0.20277,-0.19742,1,0
6,GO MONONUCLEAR CELL MIGRATION,0.0015189,-0.2029,-0.20107,1,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014486,-0.20301,-0.21454,1,0
6,GO VIRION ASSEMBLY,4.8612e-06,-0.20303,-0.20821,1,0
6,GO T CELL MEDIATED CYTOTOXICITY,0.019739,-0.20305,-0.31241,1,0
6,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.018836,-0.2032,-0.29272,1,0
6,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0032441,-0.20377,-0.19792,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1702e-06,-0.20405,-0.22395,1,0
6,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00090094,-0.20412,-0.23801,1,0
6,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0016129,-0.20414,-0.21579,1,0
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.035393,-0.20415,-0.19456,1,0
6,GO RESPONSE TO COPPER ION,0.0094949,-0.20454,-0.28372,1,0
6,GO MACROPHAGE CHEMOTAXIS,0.015574,-0.20459,-0.15958,1,0
6,GO POSITIVE REGULATION OF CELL KILLING,0.00027832,-0.20468,-0.24762,1,0
6,GO ACTIN CYTOSKELETON REORGANIZATION,8.3127e-06,-0.20517,-0.19981,1,0
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00090094,-0.20534,-0.19398,1,0
6,GO BONE REMODELING,0.0067808,-0.20576,-0.18857,1,0
6,GO REGULATION OF PROTEIN SUMOYLATION,0.043763,-0.20577,-0.115,1,0
6,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.036948,-0.2058,-0.3584,1,0
6,GO CELLULAR DEFENSE RESPONSE,3.0576e-06,-0.20588,-0.28847,1,0
6,GO REGULATION OF RESPIRATORY BURST,0.0011549,-0.20635,-0.22913,1,0
6,GO CYTOKINETIC PROCESS,1.1493e-05,-0.20698,-0.2535,1,0
6,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.001872,-0.20732,-0.23,1,0
6,GO RESPONSE TO MECHANICAL STIMULUS,4.3218e-05,-0.20756,-0.21244,1,0
6,GO LIPID STORAGE,0.0019282,-0.20795,-0.18547,1,0
6,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.0016129,-0.20814,-0.22175,1,0
6,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0006154,-0.20853,-0.23021,1,0
6,GO SUPEROXIDE METABOLIC PROCESS,0.00031859,-0.2086,-0.20416,1,0
6,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,-0.2088,-0.23571,1,0
6,GO REPLICATIVE SENESCENCE,0.037747,-0.2091,-0.18202,1,0
6,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00072223,-0.20911,-0.22309,1,0
6,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015653,-0.20922,-0.2255,1,0
6,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0034322,-0.20965,-0.15386,1,0
6,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010092,-0.20979,-0.26298,1,0
6,GO REGULATORY T CELL DIFFERENTIATION,0.0024367,-0.21051,-0.25494,1,0
6,GO REGULATION OF ACTIN NUCLEATION,7.013e-05,-0.21059,-0.23706,1,0
6,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010462,-0.21082,-0.26754,1,0
6,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.026586,-0.21085,-0.2233,1,0
6,GO MONOCYTE CHEMOTAXIS,0.00098941,-0.21086,-0.24741,1,0
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001662,-0.21109,-0.17954,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00022676,-0.21165,-0.21018,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.017969,-0.21172,-0.29752,1,0
6,GO B CELL APOPTOTIC PROCESS,0.00049035,-0.21179,-0.25333,1,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00081984,-0.21195,-0.26482,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,-0.21209,-0.27498,1,0
6,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0013054,-0.2125,-0.18284,1,0
6,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.024846,-0.21262,-0.19456,1,0
6,GO POSITIVE T CELL SELECTION,0.0020453,-0.21266,-0.17666,1,0
6,GO REGULATION OF CENTROSOME CYCLE,7.6603e-06,-0.21304,-0.1946,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00016595,-0.21323,-0.23457,1,0
6,GO ACTIVATED T CELL PROLIFERATION,0.00090094,-0.21349,-0.20102,1,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030804,-0.21379,-0.2708,1,0
6,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.8301e-05,-0.21386,-0.22757,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0033e-05,-0.21438,-0.24567,1,0
6,GO CELLULAR RESPONSE TO DSRNA,0.0015189,-0.21458,-0.24055,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0027346,-0.21505,-0.19654,1,0
6,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0022332,-0.21511,-0.20742,1,0
6,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0073363,-0.21563,-0.22312,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00023468,-0.21583,-0.2611,1,0
6,GO NEURAL TUBE FORMATION,5.508e-06,-0.21605,-0.21581,1,0
6,GO ERBB2 SIGNALING PATHWAY,2.0833e-05,-0.21644,-0.26576,1,0
6,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,7.547e-05,-0.21684,-0.28659,1,0
6,GO APICAL PROTEIN LOCALIZATION,0.0049174,-0.21697,-0.17376,1,0
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0028141,-0.21714,-0.20972,1,0
6,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,-0.21721,-0.20417,1,0
6,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.036948,-0.21748,-0.15889,1,0
6,GO EMBRYONIC BODY MORPHOGENESIS,0.00026903,-0.21769,-0.26574,1,0
6,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00024286,-0.21769,-0.26093,1,0
6,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.018836,-0.21834,-0.1872,1,0
6,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0067808,-0.2186,-0.188,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.023741,-0.21892,-0.25559,1,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.040234,-0.21923,-0.20719,1,0
6,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.044685,-0.21924,-0.23152,1,0
6,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00024286,-0.21992,-0.23488,1,0
6,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.018836,-0.22005,-0.2922,1,0
6,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0085714,-0.22029,-0.24136,1,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.013139,-0.22034,-0.24011,1,0
6,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0020453,-0.22041,-0.21338,1,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00014935,-0.22042,-0.22091,1,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00074557,-0.22052,-0.23118,1,0
6,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,6.7596e-05,-0.22062,-0.24206,1,0
6,GO RESPONSE TO IMMOBILIZATION STRESS,0.0014738,-0.22117,-0.26106,1,0
6,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0042883,-0.22129,-0.15994,1,0
6,GO REGULATION OF MACROPHAGE MIGRATION,0.0050528,-0.22173,-0.1835,1,0
6,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,-0.22194,-0.24205,1,0
6,GO INTERLEUKIN 12 PRODUCTION,3.4728e-06,-0.22211,-0.29373,1,0
6,GO REGULATION OF CELL KILLING,4.8379e-05,-0.22214,-0.25679,1,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0032441,-0.22215,-0.3142,1,0
6,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00063551,-0.22233,-0.19661,1,0
6,GO MALE SEX DETERMINATION,0.0038387,-0.22247,-0.24751,1,0
6,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,5.8301e-05,-0.22287,-0.2445,1,0
6,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.011326,-0.22309,-0.29545,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.046579,-0.2238,-0.16822,1,0
6,GO CELLULAR RESPONSE TO LITHIUM ION,0.017137,-0.22444,-0.21637,1,0
6,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.508e-06,-0.22459,-0.26358,1,0
6,GO MAMMARY GLAND MORPHOGENESIS,0.016734,-0.22463,-0.21877,1,0
6,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.012203,-0.2247,-0.24322,1,0
6,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0038387,-0.2247,-0.22273,1,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00021167,-0.22558,-0.22814,1,0
6,GO REGULATION OF CENTROSOME DUPLICATION,9.0179e-06,-0.22561,-0.22652,1,0
6,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.00084609,-0.22566,-0.24754,1,0
6,GO MEMBRANE RAFT ORGANIZATION,0.015203,-0.22589,-0.30842,1,0
6,GO AUTOPHAGOSOME MATURATION,8.3127e-06,-0.22632,-0.24604,1,0
6,GO AMYLOID BETA CLEARANCE,0.00098941,-0.22633,-0.22719,1,0
6,GO POSITIVE REGULATION OF CHEMOTAXIS,3.5759e-05,-0.22635,-0.21966,1,0
6,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.8583e-05,-0.22652,-0.25966,1,0
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00011241,-0.22664,-0.19871,1,0
6,GO PANCREAS DEVELOPMENT,0.00079435,-0.22667,-0.21684,1,0
6,GO ICOSANOID METABOLIC PROCESS,4.8612e-06,-0.22668,-0.29497,1,0
6,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.011326,-0.2269,-0.28724,1,0
6,GO HAIR CELL DIFFERENTIATION,0.00067758,-0.22705,-0.30225,1,0
6,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00018427,-0.22775,-0.31642,1,0
6,GO CELLULAR RESPONSE TO INTERFERON BETA,0.034637,-0.22817,-0.22697,1,0
6,GO EOSINOPHIL CHEMOTAXIS,0.015574,-0.22819,-0.32833,1,0
6,GO EPITHELIAL CELL DIFFERENTIATION,1.349e-05,-0.22914,-0.21975,1,0
6,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0025083,-0.22917,-0.21106,1,0
6,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00019079,-0.22951,-0.28921,1,0
6,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013433,-0.22958,-0.24524,1,0
6,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00018427,-0.22973,-0.26764,1,0
6,GO INTERFERON BETA PRODUCTION,7.8282e-05,-0.22975,-0.2223,1,0
6,GO REGULATION OF CELL MATRIX ADHESION,0.0011199,-0.23004,-0.21837,1,0
6,GO SPERM CAPACITATION,0.00035231,-0.23005,-0.20641,1,0
6,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0014299,-0.23007,-0.22609,1,0
6,GO TISSUE REMODELING,0.00045924,-0.23097,-0.22321,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8282e-05,-0.23157,-0.25202,1,0
6,GO ESTROUS CYCLE,0.0071468,-0.23163,-0.24358,1,0
6,GO T CELL MEDIATED IMMUNITY,0.00022676,-0.23181,-0.28114,1,0
6,GO LIVER MORPHOGENESIS,0.0060989,-0.23202,-0.26133,1,0
6,GO POLYAMINE BIOSYNTHETIC PROCESS,0.001872,-0.23253,-0.22796,1,0
6,GO SMOOTH MUSCLE CELL MIGRATION,6.5149e-05,-0.23294,-0.30385,1,0
6,GO PLACENTA DEVELOPMENT,5.2837e-06,-0.23308,-0.24538,1,0
6,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.011612,-0.23334,-0.22078,1,0
6,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.4346e-05,-0.23393,-0.25058,1,0
6,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.02268,-0.23406,-0.20338,1,0
6,GO REGULATION OF COAGULATION,0.00042998,-0.23454,-0.28661,1,0
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0018173,-0.23487,-0.22772,1,0
6,GO GLOMERULUS DEVELOPMENT,0.00040247,-0.23508,-0.27223,1,0
6,GO PIGMENT ACCUMULATION,0.00069957,-0.23533,-0.24213,1,0
6,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00011241,-0.23554,-0.26285,1,0
6,GO REGULATION OF RESPONSE TO WOUNDING,0.00016595,-0.2363,-0.24885,1,0
6,GO SPHINGOMYELIN METABOLIC PROCESS,0.0032441,-0.23642,-0.22832,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.011326,-0.23688,-0.29969,1,0
6,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00084609,-0.23692,-0.31663,1,0
6,GO RESPONSE TO LEPTIN,0.014841,-0.23696,-0.21683,1,0
6,GO BILE ACID METABOLIC PROCESS,0.0001547,-0.23739,-0.24479,1,0
6,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0040578,-0.23753,-0.29836,1,0
6,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0099891,-0.23757,-0.19277,1,0
6,GO MULTIVESICULAR BODY ORGANIZATION,1.0311e-06,-0.23775,-0.24534,1,0
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.029068,-0.23779,-0.17505,1,0
6,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.6455e-05,-0.23804,-0.24279,1,0
6,GO REGULATION OF BONE REMODELING,0.0059384,-0.23806,-0.20804,1,0
6,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.013798,-0.23846,-0.24683,1,0
6,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0011549,-0.2385,-0.23034,1,0
6,GO REGULATION OF B CELL DIFFERENTIATION,0.0016129,-0.23864,-0.21939,1,0
6,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0024367,-0.2387,-0.29907,1,0
6,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.6584e-06,-0.23954,-0.27036,1,0
6,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0014738,-0.24015,-0.29273,1,0
6,GO REGULATION OF VIRAL LIFE CYCLE,9.3916e-06,-0.24069,-0.31282,1,0
6,GO RUFFLE ORGANIZATION,5.753e-07,-0.2416,-0.25942,1,0
6,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0066042,-0.24254,-0.23492,1,0
6,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00023468,-0.24255,-0.22243,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.007729,-0.24275,-0.27836,1,0
6,GO REGULATION OF VIRAL GENOME REPLICATION,5.2139e-05,-0.24295,-0.32085,1,0
6,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.4421e-05,-0.24328,-0.26399,1,0
6,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00044439,-0.24388,-0.23842,1,0
6,GO REGULATION OF RECEPTOR BINDING,0.0051916,-0.24406,-0.24122,1,0
6,GO CELL CELL JUNCTION ORGANIZATION,3.4728e-06,-0.24465,-0.27055,1,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0047853,-0.24528,-0.28865,1,0
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00049035,-0.24546,-0.21638,1,0
6,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.017549,-0.24561,-0.25071,1,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.027188,-0.24568,-0.13963,1,0
6,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0053338,-0.24622,-0.29305,1,0
6,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0031536,-0.24657,-0.19922,1,0
6,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00069957,-0.2476,-0.32612,1,0
6,GO RUFFLE ASSEMBLY,7.889e-07,-0.24772,-0.25036,1,0
6,GO MAGNESIUM ION TRANSPORT,5.7413e-06,-0.24806,-0.30052,1,0
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00011241,-0.24842,-0.29403,1,0
6,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00032948,-0.24865,-0.22503,1,0
6,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0013457,-0.24887,-0.22264,1,0
6,GO GLYCEROL ETHER METABOLIC PROCESS,0.00092958,-0.24896,-0.26571,1,0
6,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00084609,-0.24956,-0.22203,1,0
6,GO NEGATIVE REGULATION OF CELL KILLING,0.016734,-0.24956,-0.38989,1,0
6,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00018427,-0.24982,-0.23766,1,0
6,GO INTERLEUKIN 6 PRODUCTION,1.0311e-06,-0.24986,-0.25164,1,0
6,GO SKIN DEVELOPMENT,3.1888e-05,-0.25008,-0.24267,1,0
6,GO REGULATION OF POSITIVE CHEMOTAXIS,0.014486,-0.25132,-0.20024,1,0
6,GO INTERLEUKIN 8 PRODUCTION,3.4421e-05,-0.25161,-0.26375,1,0
6,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0067808,-0.25167,-0.24715,1,0
6,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,-0.25182,-0.21858,1,0
6,GO CELLULAR RESPONSE TO CADMIUM ION,0.040234,-0.25236,-0.22468,1,0
6,GO REGULATION OF EXOSOMAL SECRETION,5.7413e-06,-0.25266,-0.30234,1,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00016023,-0.25312,-0.30547,1,0
6,GO EOSINOPHIL MIGRATION,0.0039469,-0.25314,-0.33673,1,0
6,GO GLYCOSIDE METABOLIC PROCESS,0.040234,-0.25318,-0.31809,1,0
6,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.031748,-0.2535,-0.21394,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,8.2505e-07,-0.25363,-0.32642,1,0
6,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.03245,-0.25371,-0.31817,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,4.8379e-05,-0.25406,-0.28955,1,0
6,GO EPIDERMIS DEVELOPMENT,2.2524e-05,-0.2541,-0.2431,1,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00041602,-0.25555,-0.29162,1,0
6,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0038387,-0.25562,-0.29218,1,0
6,GO SPINAL CORD PATTERNING,0.0087944,-0.25563,-0.24283,1,0
6,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.0015189,-0.25565,-0.26237,1,0
6,GO BIOLOGICAL PHASE,0.033166,-0.2559,-0.32727,1,0
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00036427,-0.25617,-0.26599,1,0
6,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0045306,-0.25629,-0.38517,1,0
6,GO EMBRYONIC HEMOPOIESIS,0.001228,-0.2566,-0.21903,1,0
6,GO GERMINAL CENTER FORMATION,0.017969,-0.25681,-0.28634,1,0
6,GO TRANSCYTOSIS,6.7596e-05,-0.25794,-0.24346,1,0
6,GO VIRAL RELEASE FROM HOST CELL,4.5813e-07,-0.25822,-0.27857,1,0
6,GO T CELL SELECTION,0.0025817,-0.25841,-0.17252,1,0
6,GO BROWN FAT CELL DIFFERENTIATION,5.0226e-05,-0.25842,-0.31036,1,0
6,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0016129,-0.25925,-0.26186,1,0
6,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.5331e-06,-0.25932,-0.29812,1,0
6,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.016734,-0.26101,-0.26029,1,0
6,GO NECROTIC CELL DEATH,0.00069957,-0.26175,-0.24807,1,0
6,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0007696,-0.2618,-0.30188,1,0
6,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00013917,-0.26277,-0.25581,1,0
6,GO RDNA HETEROCHROMATIN ASSEMBLY,7.013e-05,-0.26277,-0.25226,1,0
6,GO EXTRACELLULAR VESICLE BIOGENESIS,4.4712e-06,-0.26339,-0.28481,1,0
6,GO ER OVERLOAD RESPONSE,0.033166,-0.26405,-0.20384,1,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00042998,-0.26408,-0.32444,1,0
6,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00012074,-0.26412,-0.24638,1,0
6,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.012203,-0.26518,-0.2249,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00029782,-0.26547,-0.32186,1,0
6,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.015574,-0.26558,-0.25503,1,0
6,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0010528,-0.26567,-0.28976,1,0
6,GO WATER HOMEOSTASIS,0.0010859,-0.2666,-0.24307,1,0
6,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0030654,-0.26752,-0.26249,1,0
6,GO ACTIN FILAMENT BASED TRANSPORT,0.00087311,-0.26765,-0.27725,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0099891,-0.26796,-0.43197,1,0
6,GO REGULATION OF WOUND HEALING,6.5149e-05,-0.26837,-0.28992,1,0
6,GO INTERLEUKIN 10 PRODUCTION,1.1964e-05,-0.26843,-0.2883,1,0
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.029719,-0.26862,-0.19443,1,0
6,GO ENDOCARDIUM DEVELOPMENT,0.018398,-0.2693,-0.2307,1,0
6,GO LEFT RIGHT AXIS SPECIFICATION,0.0006154,-0.26939,-0.31114,1,0
6,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.3218e-05,-0.27,-0.25704,1,0
6,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.0046564,-0.27219,-0.35907,1,0
6,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0018173,-0.27289,-0.32491,1,0
6,GO ECTODERMAL PLACODE DEVELOPMENT,0.036164,-0.2733,-0.22995,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.0576e-06,-0.27331,-0.32003,1,0
6,GO PROGRAMMED NECROTIC CELL DEATH,0.00036427,-0.27386,-0.27448,1,0
6,GO SIGNAL PEPTIDE PROCESSING,6.2786e-05,-0.27455,-0.35918,1,0
6,GO CELL CELL JUNCTION ASSEMBLY,1.8251e-06,-0.2747,-0.28631,1,0
6,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.2533e-07,-0.27599,-0.30411,1,0
6,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0060989,-0.27599,-0.27453,1,0
6,GO TYPE B PANCREATIC CELL PROLIFERATION,0.043763,-0.2761,-0.25581,1,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,4.1112e-06,-0.27697,-0.2946,1,0
6,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.019739,-0.27818,-0.22433,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.9532e-05,-0.27823,-0.2547,1,0
6,GO INTERLEUKIN 1 BETA PRODUCTION,6.2367e-06,-0.27843,-0.31747,1,0
6,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.02068,-0.2801,-0.36336,1,0
6,GO REGULATION OF PLATELET ACTIVATION,6.0504e-05,-0.28027,-0.3648,1,0
6,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0010528,-0.28029,-0.33755,1,0
6,GO INTERLEUKIN 5 PRODUCTION,0.011047,-0.28092,-0.21074,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00072223,-0.28173,-0.30843,1,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.7145e-05,-0.2822,-0.29097,1,0
6,GO ACTIN FILAMENT SEVERING,0.0047853,-0.2824,-0.31525,1,0
6,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.4674e-06,-0.28415,-0.31777,1,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.7596e-05,-0.28487,-0.29067,1,0
6,GO CELLULAR RESPONSE TO ALKALOID,0.00014418,-0.2852,-0.26135,1,0
6,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00019079,-0.28537,-0.35242,1,0
6,GO DENDRITIC CELL DIFFERENTIATION,2.7343e-05,-0.28633,-0.34976,1,0
6,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.041967,-0.28645,-0.22356,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0075304,-0.28692,-0.30594,1,0
6,GO EXTRACELLULAR TRANSPORT,1.104e-05,-0.28703,-0.35817,1,0
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0081404,-0.28721,-0.20979,1,0
6,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00026903,-0.28802,-0.26272,1,0
6,GO INTERLEUKIN 1 PRODUCTION,2.2658e-06,-0.2884,-0.34316,1,0
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0024367,-0.28859,-0.21119,1,0
6,GO PLATELET AGGREGATION,2.6307e-05,-0.28918,-0.28722,1,0
6,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.1702e-06,-0.28972,-0.2868,1,0
6,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00019079,-0.28997,-0.36913,1,0
6,GO POSITIVE REGULATION OF CELL SIZE,0.00012512,-0.29019,-0.33138,1,0
6,GO MUSCLE CELL MIGRATION,5.0226e-05,-0.29145,-0.2889,1,0
6,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00013433,-0.29179,-0.3439,1,0
6,GO INTESTINAL ABSORPTION,0.00014935,-0.29193,-0.32136,1,0
6,GO OLIGOPEPTIDE TRANSPORT,0.0013872,-0.29235,-0.36432,1,0
6,GO HETEROTYPIC CELL CELL ADHESION,3.0576e-06,-0.29252,-0.34378,1,0
6,GO REGULATION OF INTEGRIN ACTIVATION,0.00010462,-0.29321,-0.32558,1,0
6,GO HOMOTYPIC CELL CELL ADHESION,4.1617e-05,-0.29375,-0.31832,1,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.018836,-0.29395,-0.20767,1,0
6,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.027803,-0.29423,-0.30208,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00067758,-0.29434,-0.31884,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,7.0571e-06,-0.29463,-0.30316,1,0
6,GO SPLEEN DEVELOPMENT,1.4044e-06,-0.29584,-0.28265,1,0
6,GO OSTEOBLAST PROLIFERATION,0.00010462,-0.29629,-0.3177,1,0
6,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,9.0179e-06,-0.29686,-0.29205,1,0
6,GO DECIDUALIZATION,0.0038387,-0.29723,-0.29606,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.9904e-06,-0.29804,-0.33319,1,0
6,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00038934,-0.2983,-0.32016,1,0
6,GO ANOIKIS,1.104e-05,-0.29847,-0.32652,1,0
6,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.020205,-0.29852,-0.27063,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00054072,-0.29897,-0.33388,1,0
6,GO CELLULAR RESPONSE TO COPPER ION,0.019283,-0.29926,-0.345,1,0
6,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.023205,-0.29949,-0.23421,1,0
6,GO T HELPER CELL LINEAGE COMMITMENT,4.8379e-05,-0.30004,-0.27867,1,0
6,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0075304,-0.30162,-0.26013,1,0
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0028957,-0.3024,-0.25799,1,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.0184e-05,-0.30264,-0.28678,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0054795,-0.30381,-0.29111,1,0
6,GO ALPHA BETA T CELL PROLIFERATION,1.7806e-05,-0.30409,-0.34839,1,0
6,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0059384,-0.30429,-0.41633,1,0
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00042998,-0.30511,-0.32144,1,0
6,GO INDOLALKYLAMINE METABOLIC PROCESS,0.02843,-0.30537,-0.18731,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.9926e-07,-0.3054,-0.31235,1,0
6,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.017137,-0.30542,-0.47191,1,0
6,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,-0.30585,-0.29082,1,0
6,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0079323,-0.30608,-0.25945,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.7145e-05,-0.30622,-0.36877,1,0
6,GO AXONEME ASSEMBLY,3.1888e-05,-0.30878,-0.31671,1,0
6,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,3.3132e-05,-0.30958,-0.33903,1,0
6,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0087944,-0.31152,-0.43355,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.0504e-05,-0.31164,-0.4274,1,0
6,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,6.2367e-06,-0.31241,-0.29558,1,0
6,GO RESPONSE TO NITROSATIVE STRESS,0.00010092,-0.31387,-0.41922,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.00052342,-0.31439,-0.28122,1,0
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.011612,-0.3153,-0.23936,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,-0.316,-0.30444,1,0
6,GO T CELL LINEAGE COMMITMENT,3.7145e-05,-0.31675,-0.28651,1,0
6,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010528,-0.31782,-0.3985,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.014138,-0.31831,-0.24614,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.2754e-05,-0.3189,-0.30745,1,0
6,GO NATURAL KILLER CELL PROLIFERATION,0.00022676,-0.31933,-0.35296,1,0
6,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012512,-0.31948,-0.27264,1,0
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,9.7346e-05,-0.32053,-0.26301,1,0
6,GO EMBRYONIC PLACENTA DEVELOPMENT,2.5774e-06,-0.32067,-0.35368,1,0
6,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,-0.32067,-0.4067,1,0
6,GO ETHER METABOLIC PROCESS,0.00024286,-0.32158,-0.3238,1,0
6,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0081404,-0.32171,-0.29305,1,0
6,GO ESCRT COMPLEX DISASSEMBLY,0.00013433,-0.32177,-0.30842,1,0
6,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00010092,-0.32231,-0.41032,1,0
6,GO REGULATION OF NECROTIC CELL DEATH,0.00022676,-0.32293,-0.31857,1,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,-0.32306,-0.3267,1,0
6,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0053338,-0.32368,-0.23044,1,0
6,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00087311,-0.32478,-0.33323,1,0
6,GO NEGATIVE REGULATION OF VIRAL PROCESS,2.4346e-05,-0.32514,-0.37414,1,0
6,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.17e-07,-0.32574,-0.36739,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.906e-06,-0.32644,-0.35873,1,0
6,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,9.0551e-05,-0.32649,-0.49659,1,0
6,GO LIPOXYGENASE PATHWAY,0.0015653,-0.32839,-0.35137,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0062634,-0.32858,-0.25416,1,0
6,GO LEFT RIGHT PATTERN FORMATION,0.00012964,-0.32909,-0.30426,1,0
6,GO KERATINOCYTE DEVELOPMENT,0.025414,-0.33042,-0.28399,1,0
6,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.031059,-0.33255,-0.23364,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.3916e-06,-0.33422,-0.36738,1,0
6,GO PROGESTERONE METABOLIC PROCESS,0.00044439,-0.3345,-0.46742,1,0
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.3528e-06,-0.33772,-0.40042,1,0
6,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,-0.33785,-0.39231,1,0
6,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.8301e-05,-0.33818,-0.3144,1,0
6,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.4044e-06,-0.33845,-0.33214,1,0
6,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0010206,-0.33953,-0.36921,1,0
6,GO SUPEROXIDE ANION GENERATION,0.00017186,-0.34021,-0.32774,1,0
6,GO TRANSPOSITION,1.7118e-05,-0.34022,-0.41665,1,0
6,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0019282,-0.34024,-0.27362,1,0
6,GO ZYMOGEN INHIBITION,0.00018427,-0.34126,-0.40275,1,0
6,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00054072,-0.3422,-0.34746,1,0
6,GO RESPONSE TO INTERFERON ALPHA,0.0024367,-0.34261,-0.46016,1,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.3218e-05,-0.34314,-0.35544,1,0
6,GO PROSTANOID METABOLIC PROCESS,2.3418e-05,-0.34391,-0.43093,1,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.017969,-0.34458,-0.29141,1,0
6,GO DETECTION OF OTHER ORGANISM,4.3218e-05,-0.34508,-0.39188,1,0
6,GO IMMUNOLOGICAL MEMORY PROCESS,8.1192e-05,-0.34512,-0.34359,1,0
6,GO REFLEX,0.00087311,-0.34684,-0.36676,1,0
6,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.0069616,-0.34711,-0.41594,1,0
6,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.7596e-05,-0.34729,-0.42145,1,0
6,GO LIPID TRANSLOCATION,1.8251e-06,-0.34769,-0.32187,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.1192e-05,-0.34789,-0.33195,1,0
6,GO EPIDERMAL CELL DIFFERENTIATION,9.7801e-06,-0.34994,-0.32441,1,0
6,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0031536,-0.3503,-0.31511,1,0
6,GO HISTAMINE SECRETION,0.004408,-0.35224,-0.34449,1,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT,5.2533e-07,-0.35314,-0.34367,1,0
6,GO MITOTIC CYTOKINETIC PROCESS,5.1671e-08,-0.35462,-0.38135,1,0
6,GO KERATINOCYTE DIFFERENTIATION,1.104e-05,-0.35542,-0.33714,1,0
6,GO GONADOTROPIN SECRETION,0.00055855,-0.35713,-0.35836,1,0
6,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0021062,-0.35735,-0.34442,1,0
6,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.8891e-07,-0.35749,-0.37725,1,0
6,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0016129,-0.35752,-0.4848,1,0
6,GO ENDOTHELIAL CELL CHEMOTAXIS,7.2754e-05,-0.35926,-0.38583,1,0
6,GO PROTEIN ADP RIBOSYLATION,1.1493e-05,-0.35936,-0.31088,1,0
6,GO POSITIVE REGULATION OF COAGULATION,2.8077e-06,-0.35968,-0.36426,1,0
6,GO AMINE BIOSYNTHETIC PROCESS,0.0039469,-0.35989,-0.27633,1,0
6,GO VIRAL BUDDING,4.1802e-07,-0.36018,-0.30959,1,0
6,GO REGULATION OF ANOIKIS,3.5759e-05,-0.36079,-0.41494,1,0
6,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0014299,-0.36235,-0.41913,1,0
6,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0021062,-0.36436,-0.37608,1,0
6,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00016595,-0.36442,-0.39438,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0079323,-0.36585,-0.46838,1,0
6,GO HEPATOCYTE DIFFERENTIATION,0.00072223,-0.36744,-0.33667,1,0
6,GO MOTILE CILIUM ASSEMBLY,0.00059588,-0.36813,-0.30731,1,0
6,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,4.0073e-05,-0.36865,-0.39858,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0021062,-0.36881,-0.41526,1,0
6,GO RESPONSE TO INTERFERON BETA,0.0015189,-0.36925,-0.47942,1,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,5.2837e-06,-0.36938,-0.38245,1,0
6,GO ADRENAL GLAND DEVELOPMENT,0.00045924,-0.36996,-0.30908,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00016595,-0.3702,-0.37092,1,0
6,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0099891,-0.37217,-0.32764,1,0
6,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.3528e-06,-0.37291,-0.4365,1,0
6,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00027832,-0.37409,-0.36678,1,0
6,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.6455e-05,-0.37503,-0.39173,1,0
6,GO LUNG EPITHELIUM DEVELOPMENT,0.0010528,-0.37541,-0.29342,1,0
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,2.9532e-05,-0.37623,-0.38386,1,0
6,GO GAP JUNCTION ASSEMBLY,3.8583e-05,-0.37954,-0.47572,1,0
6,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.4039e-05,-0.37995,-0.37162,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.9263e-05,-0.3813,-0.36927,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,3.3132e-05,-0.38141,-0.47901,1,0
6,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0014738,-0.38151,-0.48088,1,0
6,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.5201e-05,-0.3827,-0.38461,1,0
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0017641,-0.38506,-0.33924,1,0
6,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00017186,-0.38724,-0.38847,1,0
6,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.2879e-07,-0.38762,-0.46097,1,0
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0059384,-0.3883,-0.31908,1,0
6,GO POSITIVE REGULATION OF CELL MATURATION,7.8282e-05,-0.38891,-0.42751,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,6.0504e-05,-0.38909,-0.49545,1,0
6,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00092958,-0.39007,-0.34123,1,0
6,GO INTERFERON ALPHA PRODUCTION,9.4334e-07,-0.39028,-0.38184,1,0
6,GO TOXIN METABOLIC PROCESS,0.010506,-0.39189,-0.28136,1,0
6,GO DNA DEAMINATION,0.001191,-0.39408,-0.37956,1,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,1.5816e-05,-0.3966,-0.39359,1,0
6,GO RESPONSE TO TYPE I INTERFERON,1.5816e-05,-0.3972,-0.51811,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.0194e-07,-0.40082,-0.44143,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,3.0689e-05,-0.40384,-0.38688,1,0
6,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,2.5774e-06,-0.40399,-0.41128,1,0
6,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.3287e-06,-0.40454,-0.44126,1,0
6,GO INFLAMMATORY RESPONSE TO WOUNDING,0.038561,-0.40676,-0.32394,1,0
6,GO PARAXIAL MESODERM DEVELOPMENT,0.00040247,-0.4106,-0.35141,1,0
6,GO GLIAL CELL FATE COMMITMENT,0.0079323,-0.41107,-0.33351,1,0
6,GO VASCULAR TRANSPORT,0.00032948,-0.41351,-0.43145,1,0
6,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,-0.41442,-0.5307,1,0
6,GO REGULATION OF PLATELET AGGREGATION,7.8282e-05,-0.41461,-0.4927,1,0
6,GO REGULATION OF TRANSPOSITION,7.9801e-06,-0.4174,-0.47822,1,0
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.1888e-05,-0.41765,-0.35528,1,0
6,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,2.2879e-07,-0.41917,-0.37594,1,0
6,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0025817,-0.41948,-0.3296,1,0
6,GO TOLERANCE INDUCTION,0.00035231,-0.41976,-0.4532,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,6.4994e-06,-0.42159,-0.52534,1,0
6,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,6.2786e-05,-0.42252,-0.46546,1,0
6,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0085714,-0.42279,-0.3354,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.6015e-06,-0.4252,-0.49017,1,0
6,GO KERATINIZATION,2.7343e-05,-0.42753,-0.36981,1,0
6,GO POSITIVE REGULATION OF WOUND HEALING,5.2533e-07,-0.42842,-0.47284,1,0
6,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,3.7145e-05,-0.4294,-0.39364,1,0
6,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012512,-0.43125,-0.3942,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,8.1192e-05,-0.4321,-0.41443,1,0
6,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.2366e-07,-0.43419,-0.49423,1,0
6,GO GLIAL CELL APOPTOTIC PROCESS,0.00017796,-0.43898,-0.42635,1,0
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0019282,-0.43953,-0.34183,1,0
6,GO LEYDIG CELL DIFFERENTIATION,0.001986,-0.44113,-0.40441,1,0
6,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00016595,-0.44235,-0.4661,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00074557,-0.44239,-0.4068,1,0
6,GO REGULATION OF TOLERANCE INDUCTION,2.6902e-06,-0.44317,-0.50979,1,0
6,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.4268e-07,-0.44578,-0.45789,1,0
6,GO RESPONSE TO INTERLEUKIN 18,0.00017796,-0.44644,-0.5171,1,0
6,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,6.7728e-06,-0.44842,-0.39402,1,0
6,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012662,-0.45043,-0.52504,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7801e-06,-0.45496,-0.55607,1,0
6,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00042998,-0.45839,-0.45926,1,0
6,GO CORNIFICATION,3.5759e-05,-0.45883,-0.41776,1,0
6,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,5.0226e-05,-0.45926,-0.63387,1,0
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.2754e-05,-0.46042,-0.40321,1,0
6,GO CELLULAR RESPONSE TO NITROGEN STARVATION,5.7413e-06,-0.46129,-0.46877,1,0
6,GO LABYRINTHINE LAYER DEVELOPMENT,1.2962e-05,-0.46211,-0.39934,1,0
6,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00017186,-0.46555,-0.43602,1,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00065623,-0.46852,-0.37734,1,0
6,GO RESPONSE TO WATER,6.7596e-05,-0.46905,-0.42596,1,0
6,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0013872,-0.4696,-0.39297,1,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,-0.47305,-0.4793,1,0
6,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.508e-06,-0.47602,-0.47528,1,0
6,GO CELL CELL JUNCTION MAINTENANCE,0.00036427,-0.48016,-0.39339,1,0
6,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0050528,-0.48127,-0.48072,1,0
6,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,1.1964e-05,-0.48384,-0.45744,1,0
6,GO MIDBODY ABSCISSION,1.5691e-07,-0.48641,-0.48507,1,0
6,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.038561,-0.49499,-0.24544,1,0
6,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.9418e-06,-0.49691,-0.52259,1,0
6,GO RESPONSE TO LITHIUM ION,3.7145e-05,-0.49709,-0.47986,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00095906,-0.50367,-0.36502,1,0
6,GO RESPONSE TO FORSKOLIN,4.2876e-06,-0.50527,-0.46257,1,0
6,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,9.3916e-06,-0.50832,-0.45937,1,0
6,GO SEROTONIN METABOLIC PROCESS,0.011326,-0.50881,-0.31563,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.4692e-06,-0.51142,-0.47635,1,0
6,GO NOTCH RECEPTOR PROCESSING,8.6584e-06,-0.52724,-0.48523,1,0
6,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00050664,-0.52989,-0.49198,1,0
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,4.6597e-05,-0.5309,-0.47422,1,0
6,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0045306,-0.53873,-0.35833,1,0
6,GO INNER DYNEIN ARM ASSEMBLY,5.7413e-06,-0.53986,-0.59671,1,0
6,GO REGULATION OF RECEPTOR CLUSTERING,0.00024286,-0.54336,-0.47666,1,0
6,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,5.2837e-06,-0.55036,-0.52776,1,0
6,GO EPITHELIAL CELL MORPHOGENESIS,4.1112e-06,-0.5572,-0.53601,1,0
6,GO APICAL JUNCTION ASSEMBLY,4.9191e-08,-0.56098,-0.52845,1,0
6,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.00021909,-0.56212,-0.45463,1,0
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00016595,-0.56502,-0.52614,1,0
6,GO REGULATION OF WATER LOSS VIA SKIN,0.00032948,-0.57307,-0.47633,1,0
6,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.4712e-06,-0.57605,-0.58621,1,0
6,GO ENTRY OF BACTERIUM INTO HOST CELL,2.3418e-05,-0.57882,-0.57934,1,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00049035,-0.5793,-0.43966,1,0
6,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,-0.58673,-0.52029,1,0
6,GO PSEUDOPODIUM ORGANIZATION,0.00020448,-0.5905,-0.44339,1,0
6,GO GAMMA DELTA T CELL ACTIVATION,1.4044e-06,-0.59862,-0.56138,1,0
6,GO MUCUS SECRETION,0.00084609,-0.60014,-0.52376,1,0
6,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,2.1702e-06,-0.61866,-0.60316,1,0
6,GO CYTIDINE TO URIDINE EDITING,0.0001165,-0.61921,-0.65655,1,0
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0025817,-0.63422,-0.53362,1,0
6,GO PARAXIAL MESODERM MORPHOGENESIS,6.4994e-06,-0.63775,-0.59594,1,0
6,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.3218e-05,-0.64222,-0.63275,1,0
6,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,7.2754e-05,-0.64706,-0.7541,1,0
6,GO LUNG CELL DIFFERENTIATION,0.00012074,-0.65646,-0.51701,1,0
6,GO GAMMA DELTA T CELL DIFFERENTIATION,8.3127e-06,-0.66246,-0.65678,1,0
6,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,9.4334e-07,-0.67958,-0.63089,1,0
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,7.6603e-06,-0.72682,-0.57253,1,0
6,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.6322e-07,-0.74931,-0.65572,1,0
6,GO EPITHELIAL CELL CELL ADHESION,1.5691e-07,-0.7504,-0.79986,1,0
6,GO LIPID DROPLET FORMATION,7.3528e-06,-0.767,-0.68572,1,0
6,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,3.1904e-06,-0.77652,-0.71411,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,6.0504e-05,-0.8094,-0.88752,1,0
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.8891e-07,-0.92382,-0.82664,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,5.0194e-07,-0.96787,-0.81736,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,7.8282e-05,-0.99536,-1.0952,1,0
6,GO HEPATOCYTE APOPTOTIC PROCESS,1.8084e-07,-0.99605,-1.0676,1,0
6,GO LABYRINTHINE LAYER MORPHOGENESIS,3.0264e-07,-1.0047,-0.89157,1,0
6,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.2308e-06,-1.1075,-0.9977,1,0
6,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.14048,0.3332,0.13527,0,1
6,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.060602,0.30348,0.18271,0,1
6,GO GLYCINE METABOLIC PROCESS,0.054842,0.29931,0.20115,0,1
6,GO TOOTH MINERALIZATION,0.075049,0.29597,0.14282,0,1
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.054842,0.29297,0.1712,0,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.10465,0.27498,0.12566,0,1
6,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.077957,0.2721,0.20978,0,1
6,GO POSITIVE REGULATION OF VESICLE FUSION,0.11235,0.2487,0.20634,0,1
6,GO ACTIVATION OF MAPKKK ACTIVITY,0.054842,0.24402,0.13174,0,1
6,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.079444,0.23858,0.17847,0,1
6,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.097379,0.21014,0.1369,0,1
6,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.05824,0.2088,0.19463,0,1
6,GO NEUROBLAST DIVISION,0.10465,0.20113,0.16202,0,1
6,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.14285,0.19643,0.11303,0,1
6,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,0,1
6,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.10654,0.19335,0.18023,0,1
6,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.30402,0.18828,0.071766,0,1
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.2839,0.18712,0.13208,0,1
6,GO COCHLEA MORPHOGENESIS,0.070855,0.185,0.11256,0,1
6,GO RESPONSE TO VITAMIN A,0.15015,0.18388,0.10886,0,1
6,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,0,1
6,GO DETECTION OF TEMPERATURE STIMULUS,0.15264,0.18144,0.16619,0,1
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.065563,0.17947,0.11335,0,1
6,GO MIDDLE EAR MORPHOGENESIS,0.41341,0.17478,0.035279,0,1
6,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.092194,0.1745,0.11047,0,1
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.51459,0.17098,0.078423,0,1
6,GO MINERALOCORTICOID METABOLIC PROCESS,0.22905,0.17035,0.096224,0,1
6,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20937,0.16977,0.091043,0,1
6,GO FIBROBLAST APOPTOTIC PROCESS,0.099158,0.1652,0.11653,0,1
6,GO RESPONSE TO ACETYLCHOLINE,0.04854,0.16384,0.18446,0,1
6,GO ODONTOGENESIS,0.13814,0.16051,0.075846,0,1
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.061812,0.15431,0.10314,0,1
6,GO NUCLEUS LOCALIZATION,0.082489,0.15271,0.095375,0,1
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.072231,0.14838,0.1029,0,1
6,GO BONE MORPHOGENESIS,0.10654,0.1475,0.072442,0,1
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.10096,0.13825,0.077172,0,1
6,GO T CELL HOMEOSTASIS,0.12689,0.13464,0.053061,0,1
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.17374,0.13022,0.10472,0,1
6,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.075049,0.12975,0.11657,0,1
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.20937,0.12905,0.064557,0,1
6,GO AORTIC VALVE DEVELOPMENT,0.18508,0.12903,0.083409,0,1
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.13583,0.12709,0.104,0,1
6,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.12908,0.1266,0.11207,0,1
6,GO REGULATION OF ODONTOGENESIS,0.40843,0.12506,0.031587,0,1
6,GO SMOOTH MUSCLE CONTRACTION,0.11636,0.12434,0.063471,0,1
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.11039,0.12311,0.08545,0,1
6,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.093897,0.12094,0.068757,0,1
6,GO MONOSACCHARIDE CATABOLIC PROCESS,0.19695,0.12009,0.063184,0,1
6,GO RESPONSE TO LIGHT INTENSITY,0.14769,0.12009,0.1245,0,1
6,GO LYMPH VESSEL DEVELOPMENT,0.14769,0.11937,0.073455,0,1
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.16294,0.11889,0.09017,0,1
6,GO MITOCHONDRIAL RNA PROCESSING,0.070855,0.11661,0.15768,0,1
6,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.066855,0.11658,0.080127,0,1
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.053746,0.11627,0.18126,0,1
6,GO SLEEP,0.29184,0.10954,0.05629,0,1
6,GO HEART VALVE DEVELOPMENT,0.27227,0.10804,0.063939,0,1
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.21905,0.1076,0.065025,0,1
6,GO SECRETORY GRANULE ORGANIZATION,0.22568,0.10553,0.055856,0,1
6,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.075049,0.10372,0.095769,0,1
6,GO SPINDLE MIDZONE ASSEMBLY,0.60272,0.1027,0.03177,0,1
6,GO REGULATION OF METAL ION TRANSPORT,0.082489,0.10141,0.067514,0,1
6,GO RESPONSE TO LEAD ION,0.2,0.099167,0.066486,0,1
6,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.068167,0.09548,0.080124,0,1
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.2,0.093725,0.074412,0,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.070855,0.093583,0.11512,0,1
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.072231,0.09215,0.069895,0,1
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.11636,0.092058,0.10672,0,1
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.095625,0.091975,0.14316,0,1
6,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.27999,0.091737,0.027537,0,1
6,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.073629,0.090744,0.0655,0,1
6,GO RRNA 3 END PROCESSING,0.1313,0.090271,0.099363,0,1
6,GO CELLULAR RESPONSE TO UV,0.090515,0.086893,0.060283,0,1
6,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.30815,0.085366,0.044127,0,1
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.075049,0.084777,0.056319,0,1
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.38408,0.084446,0.047501,0,1
6,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.088862,0.084073,0.16487,0,1
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.11434,0.082719,0.083548,0,1
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.095625,0.080499,0.080015,0,1
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.3746,0.078174,0.024524,0,1
6,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.082489,0.076793,0.056017,0,1
6,GO MAINTENANCE OF CELL POLARITY,0.23937,0.076611,0.073465,0,1
6,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.55487,0.076436,0.026264,0,1
6,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.17653,0.075733,0.040967,0,1
6,GO ASTRAL MICROTUBULE ORGANIZATION,0.37932,0.075513,0.046886,0,1
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.068167,0.073734,0.06478,0,1
6,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.33812,0.072441,0.057914,0,1
6,GO HISTONE H3 K36 METHYLATION,0.51459,0.07244,0.031562,0,1
6,GO REGULATION OF HISTONE PHOSPHORYLATION,0.37932,0.069578,0.054866,0,1
6,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.059411,0.068576,0.062462,0,1
6,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.055956,0.064814,0.067937,0,1
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.063042,0.064006,0.038941,0,1
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.58456,0.062265,0.054427,0,1
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.3746,0.06199,0.028828,0,1
6,GO MISMATCH REPAIR,0.26098,0.061634,0.040266,0,1
6,GO RNA CAPPING,0.087232,0.061067,0.064207,0,1
6,GO HISTONE DEUBIQUITINATION,0.22905,0.058474,0.029267,0,1
6,GO PEPTIDYL LYSINE DIMETHYLATION,0.088862,0.057756,0.05304,0,1
6,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.56666,0.056407,0.022729,0,1
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.079444,0.055331,0.075593,0,1
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.32506,0.052067,0.043894,0,1
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.25363,0.050937,0.02684,0,1
6,GO REGULATION OF HISTONE UBIQUITINATION,0.33373,0.048465,0.043883,0,1
6,GO RESPONSE TO NERVE GROWTH FACTOR,0.082489,0.045935,0.10175,0,1
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.14285,0.041947,0.040574,0,1
6,GO ESTABLISHMENT OF RNA LOCALIZATION,0.092194,0.041691,0.050936,0,1
6,GO PROTEIN ACYLATION,0.13583,0.026497,0.027667,0,1
6,GO SNRNA TRANSCRIPTION,0.23937,0.020297,0.025213,0,1
6,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,0,0
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00081984,0.49751,0.48283,0,0
6,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,0,0
6,GO SHORT TERM MEMORY,0.0022332,0.35017,0.32134,0,0
6,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,0,0
6,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.079444,0.32819,0.20651,0,0
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.013798,0.32666,0.44768,0,0
6,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.053746,0.31706,0.17246,0,0
6,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,0,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0047853,0.3128,0.27844,0,0
6,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00017186,0.30909,0.303,0,0
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0010528,0.30801,0.47087,0,0
6,GO REGULATION OF HIPPO SIGNALING,0.087232,0.30609,0.1616,0,0
6,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.21256,0.29727,0.11575,0,0
6,GO PHAGOCYTOSIS RECOGNITION,0.052669,0.29655,0.16095,0,0
6,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0075304,0.28483,0.24571,0,0
6,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0010859,0.28339,0.25764,0,0
6,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.015953,0.28339,0.195,0,0
6,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0010859,0.27257,0.30115,0,0
6,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019739,0.2609,0.27203,0,0
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.2,0.25982,0.18244,0,0
6,GO HOMOCYSTEINE METABOLIC PROCESS,0.0038387,0.25753,0.34078,0,0
6,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,0,0
6,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0059384,0.24118,0.17636,0,0
6,GO RESPONSE TO HYPEROXIA,0.21905,0.23675,0.093777,0,0
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,0,0
6,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.097379,0.22447,0.14673,0,0
6,GO ENAMEL MINERALIZATION,0.19393,0.22049,0.12673,0,0
6,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,0,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.05824,0.21712,0.14067,0,0
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0027346,0.2165,0.26938,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.095625,0.21504,0.16926,0,0
6,GO THALAMUS DEVELOPMENT,0.42347,0.211,0.095315,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.1028,0.20502,0.1412,0,0
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00044439,0.20471,0.21521,0,0
6,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,0,0
6,GO AXO DENDRITIC PROTEIN TRANSPORT,0.036948,0.20256,0.14063,0,0
6,GO NEPHRIC DUCT MORPHOGENESIS,0.0695,0.20112,0.27288,0,0
6,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.29586,0.20077,0.089066,0,0
6,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.3746,0.20026,0.1234,0,0
6,GO SEROTONIN TRANSPORT,0.092194,0.19987,0.13843,0,0
6,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.066855,0.19852,0.15497,0,0
6,GO SALIVARY GLAND DEVELOPMENT,0.12689,0.19843,0.1108,0,0
6,GO AMP METABOLIC PROCESS,0.14769,0.19832,0.097326,0,0
6,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,0,0
6,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0022332,0.1974,0.26312,0,0
6,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.064293,0.197,0.15482,0,0
6,GO CGMP MEDIATED SIGNALING,0.022165,0.19695,0.13884,0,0
6,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,0,0
6,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.15773,0.19313,0.1908,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.26471,0.19306,0.087065,0,0
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.01282,0.18917,0.28102,0,0
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.31232,0.18914,0.10494,0,0
6,GO AXONAL FASCICULATION,0.066855,0.18785,0.20241,0,0
6,GO RESPONSE TO MANGANESE ION,0.095625,0.18754,0.10711,0,0
6,GO NEURAL CREST CELL MIGRATION,0.064293,0.18719,0.12956,0,0
6,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.18219,0.18645,0.15957,0,0
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.25001,0.18443,0.067083,0,0
6,GO RESPONSE TO MUSCLE ACTIVITY,0.11434,0.18411,0.11316,0,0
6,GO TETRAHYDROFOLATE INTERCONVERSION,0.12908,0.18381,0.11776,0,0
6,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,0,0
6,GO ONE CARBON METABOLIC PROCESS,0.013139,0.18303,0.13074,0,0
6,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0695,0.18298,0.16604,0,0
6,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0045306,0.18258,0.17858,0,0
6,GO BEHAVIORAL RESPONSE TO PAIN,0.18508,0.18137,0.13887,0,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.049546,0.18136,0.15569,0,0
6,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.12473,0.18122,0.10465,0,0
6,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.19095,0.1812,0.11729,0,0
6,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.055956,0.17964,0.1357,0,0
6,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.1313,0.17674,0.16827,0,0
6,GO ACIDIC AMINO ACID TRANSPORT,0.00014935,0.17661,0.21319,0,0
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.1313,0.17567,0.12315,0,0
6,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.092194,0.17496,0.12255,0,0
6,GO BASIC AMINO ACID TRANSPORT,0.13583,0.17471,0.16587,0,0
6,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.21256,0.17362,0.047425,0,0
6,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.20309,0.17338,0.15988,0,0
6,GO RELAXATION OF MUSCLE,0.082489,0.17281,0.12867,0,0
6,GO PROSTATE GLAND GROWTH,0.17099,0.17216,0.068806,0,0
6,GO LEUKOCYTE AGGREGATION,0.077957,0.17168,0.13519,0,0
6,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.077957,0.17053,0.092339,0,0
6,GO KIDNEY MESENCHYME DEVELOPMENT,0.027803,0.17038,0.1883,0,0
6,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,0,0
6,GO NADH METABOLIC PROCESS,0.0020453,0.16892,0.23118,0,0
6,GO HEME METABOLIC PROCESS,0.13814,0.16832,0.099533,0,0
6,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0073363,0.1681,0.19008,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.059411,0.16806,0.13846,0,0
6,GO TONIC SMOOTH MUSCLE CONTRACTION,0.092194,0.16715,0.09528,0,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0075304,0.16634,0.16894,0,0
6,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,0,0
6,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10654,0.163,0.088909,0,0
6,GO POST ANAL TAIL MORPHOGENESIS,0.13583,0.16295,0.09286,0,0
6,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.082489,0.16141,0.11853,0,0
6,GO RECEPTOR CLUSTERING,0.065563,0.16141,0.10745,0,0
6,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.12908,0.16023,0.13459,0,0
6,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.18508,0.16014,0.11315,0,0
6,GO RESPONSE TO PROTOZOAN,0.55487,0.15933,0.020455,0,0
6,GO FOREBRAIN NEURON DEVELOPMENT,0.11235,0.1591,0.15054,0,0
6,GO HEPARIN METABOLIC PROCESS,0.045624,0.15858,0.22973,0,0
6,GO NEURONAL ION CHANNEL CLUSTERING,0.1313,0.15494,0.20744,0,0
6,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.060602,0.15474,0.11877,0,0
6,GO NEPHRIC DUCT DEVELOPMENT,0.20937,0.15455,0.1298,0,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.30815,0.15376,0.0535,0,0
6,GO THYROID GLAND DEVELOPMENT,0.022165,0.15356,0.18117,0,0
6,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.13814,0.15332,0.096099,0,0
6,GO VASCULOGENESIS,0.32077,0.15279,0.034338,0,0
6,GO RESPONSE TO CAFFEINE,0.10096,0.15263,0.1189,0,0
6,GO NERVE DEVELOPMENT,0.11841,0.15175,0.09633,0,0
6,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,0,0
6,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.15517,0.14983,0.13446,0,0
6,GO XENOBIOTIC TRANSPORT,0.23937,0.14962,0.036327,0,0
6,GO AXON EXTENSION,0.0028957,0.14933,0.15833,0,0
6,GO SYNAPSE ASSEMBLY,0.012203,0.1488,0.16867,0,0
6,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.043763,0.14864,0.13656,0,0
6,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.12908,0.14773,0.09882,0,0
6,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,0,0
6,GO BASEMENT MEMBRANE ASSEMBLY,0.054842,0.14706,0.17956,0,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.68418,0.14644,0.042439,0,0
6,GO CELLULAR HYPEROSMOTIC RESPONSE,0.26098,0.14593,0.088138,0,0
6,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.34702,0.14582,0.067119,0,0
6,GO BONE TRABECULA MORPHOGENESIS,0.12259,0.14555,0.1142,0,0
6,GO MUSCLE CELL FATE COMMITMENT,0.2839,0.14515,0.061047,0,0
6,GO FIBRINOLYSIS,0.27227,0.14489,-0.014555,0,0
6,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.084046,0.14438,0.14979,0,0
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.16294,0.14334,0.094518,0,0
6,GO BEHAVIORAL RESPONSE TO COCAINE,0.20621,0.14262,0.15547,0,0
6,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.47588,0.14236,-0.15827,0,0
6,GO PROTEIN ACTIVATION CASCADE,0.68418,0.14226,-0.019158,0,0
6,GO REGULATION OF AXON GUIDANCE,0.059411,0.14205,0.091043,0,0
6,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.18219,0.14187,0.077712,0,0
6,GO LIPID IMPORT INTO CELL,0.27999,0.14127,0.061506,0,0
6,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.24643,0.14089,0.051468,0,0
6,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.04854,0.13973,0.12553,0,0
6,GO REGULATION OF RIBOSOME BIOGENESIS,0.11235,0.13913,0.10017,0,0
6,GO CELL AGGREGATION,0.073629,0.13892,0.10884,0,0
6,GO ALANINE TRANSPORT,0.14048,0.13877,0.13747,0,0
6,GO RESPONSE TO UV B,0.89215,0.13872,-0.044541,0,0
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.26471,0.13871,0.055067,0,0
6,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.097379,0.13833,0.14589,0,0
6,GO MESODERMAL CELL FATE COMMITMENT,0.28785,0.13813,0.055579,0,0
6,GO CELLULAR RESPONSE TO MANGANESE ION,0.060602,0.13743,0.11847,0,0
6,GO REGULATION OF PLASMINOGEN ACTIVATION,0.47049,0.13733,-0.044057,0,0
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.033894,0.13709,0.18228,0,0
6,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,0,0
6,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13583,0.13599,0.14502,0,0
6,GO PARENTAL BEHAVIOR,0.27611,0.13494,0.093322,0,0
6,GO STARTLE RESPONSE,0.22235,0.13404,0.12204,0,0
6,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.092194,0.1338,0.0909,0,0
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.18219,0.13362,0.096613,0,0
6,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,0,0
6,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.15773,0.13179,0.072583,0,0
6,GO LIMBIC SYSTEM DEVELOPMENT,0.04854,0.13163,0.11612,0,0
6,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.064293,0.1315,0.14118,0,0
6,GO COLLAGEN FIBRIL ORGANIZATION,0.11841,0.13124,0.05568,0,0
6,GO PROTEIN OXIDATION,0.12049,0.13088,0.072808,0,0
6,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.20621,0.12996,0.08712,0,0
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.085627,0.12959,0.12237,0,0
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.054842,0.12954,0.15753,0,0
6,GO REGULATION OF STEROL TRANSPORT,0.49227,0.12951,0.027337,0,0
6,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.27999,0.1293,0.10607,0,0
6,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54903,0.12856,0.062475,0,0
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.52594,0.12846,0.04104,0,0
6,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0695,0.1279,0.11656,0,0
6,GO CATECHOLAMINE UPTAKE,0.16828,0.12781,0.13783,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27611,0.12734,0.10221,0,0
6,GO REGULATION OF BMP SIGNALING PATHWAY,0.8303,0.1273,0.00708,0,0
6,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.077957,0.12711,0.08124,0,0
6,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.064293,0.12701,0.11209,0,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.077957,0.127,0.090624,0,0
6,GO CARDIOLIPIN METABOLIC PROCESS,0.23589,0.12658,0.067219,0,0
6,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.29184,0.12632,0.084081,0,0
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.20937,0.1263,0.14382,0,0
6,GO ENDODERM DEVELOPMENT,0.2839,0.12617,0.025249,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.099158,0.12532,0.16393,0,0
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.13355,0.12514,0.23131,0,0
6,GO METENCEPHALON DEVELOPMENT,0.0054795,0.12488,0.16011,0,0
6,GO REGULATION OF CELLULAR RESPIRATION,0.097379,0.12458,0.11837,0,0
6,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.057089,0.12452,0.17914,0,0
6,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.070855,0.12428,0.11219,0,0
6,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.53167,0.12415,0.026669,0,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS,0.10096,0.12406,0.11849,0,0
6,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.59059,0.12406,0.0070754,0,0
6,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,0,0
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.10654,0.12351,0.24502,0,0
6,GO REGULATION OF HEART RATE,0.10465,0.12348,0.095051,0,0
6,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.39858,0.12348,0.09055,0,0
6,GO REGULATION OF CELLULAR EXTRAVASATION,0.11235,0.12275,0.11146,0,0
6,GO NEURAL CREST FORMATION,0.36991,0.12272,0.07721,0,0
6,GO CAMP METABOLIC PROCESS,0.31232,0.12264,0.054026,0,0
6,GO NEUROBLAST PROLIFERATION,0.14048,0.12256,0.087126,0,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.17099,0.12222,0.077015,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.34702,0.12148,0.1034,0,0
6,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.20937,0.12099,0.079371,0,0
6,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.070855,0.12077,0.10228,0,0
6,GO RESPONSE TO NITRIC OXIDE,0.0060989,0.11975,0.1029,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.099158,0.11908,0.091544,0,0
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.12689,0.11897,0.11581,0,0
6,GO COMMISSURAL NEURON AXON GUIDANCE,0.20937,0.11875,0.13745,0,0
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.188,0.11867,0.089562,0,0
6,GO MECHANOSENSORY BEHAVIOR,0.36526,0.1182,0.17894,0,0
6,GO REGULATION OF POTASSIUM ION TRANSPORT,0.10096,0.11796,0.079862,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.080955,0.1175,0.098141,0,0
6,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.23245,0.11711,0.078572,0,0
6,GO CELLULAR RESPONSE TO RETINOIC ACID,0.11235,0.11693,0.064552,0,0
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.014138,0.1168,0.11783,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.14285,0.11668,0.19877,0,0
6,GO STORE OPERATED CALCIUM ENTRY,0.44402,0.11647,0.034577,0,0
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.91987,0.11642,0.029245,0,0
6,GO LONG TERM SYNAPTIC POTENTIATION,0.14526,0.11641,0.08259,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.059411,0.11573,0.1537,0,0
6,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.11532,0.078129,0,0
6,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.21256,0.11469,0.12975,0,0
6,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.066855,0.11431,0.13884,0,0
6,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.1313,0.11422,0.1157,0,0
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.26098,0.11301,0.14473,0,0
6,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12908,0.11274,0.14697,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.35607,0.11239,0.068419,0,0
6,GO GLIAL CELL MIGRATION,0.052669,0.11218,0.13199,0,0
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.17653,0.11182,0.05138,0,0
6,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.20621,0.11179,0.051553,0,0
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.25729,0.1117,0.072017,0,0
6,GO URETER DEVELOPMENT,0.41842,0.11161,0.072538,0,0
6,GO SEQUESTERING OF METAL ION,0.11841,0.11155,0.077539,0,0
6,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.30402,0.11099,0.064195,0,0
6,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.34256,0.11099,0.048058,0,0
6,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.061812,0.11097,0.13005,0,0
6,GO RESPONSE TO PARATHYROID HORMONE,0.16828,0.11045,0.16887,0,0
6,GO UBIQUINONE METABOLIC PROCESS,0.2,0.11014,0.02765,0,0
6,GO TRIGLYCERIDE CATABOLIC PROCESS,0.25001,0.11002,0.084059,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.26471,0.10971,0.089985,0,0
6,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.088862,0.10951,0.10544,0,0
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.015203,0.10934,0.19385,0,0
6,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,0,0
6,GO MYELIN MAINTENANCE,0.46512,0.10871,0.05417,0,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10845,0.10842,0.17539,0,0
6,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.066855,0.10823,0.083208,0,0
6,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.30402,0.10773,0.091316,0,0
6,GO ALDEHYDE CATABOLIC PROCESS,0.064293,0.10773,0.10406,0,0
6,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.079444,0.10761,0.13606,0,0
6,GO DORSAL AORTA DEVELOPMENT,0.24288,0.10736,0.086646,0,0
6,GO ANION HOMEOSTASIS,0.17934,0.10723,0.076362,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.19393,0.10666,0.1672,0,0
6,GO DOPAMINE TRANSPORT,0.33812,0.10662,0.15678,0,0
6,GO ASYMMETRIC CELL DIVISION,0.39371,0.10648,0.0629,0,0
6,GO CEREBELLAR CORTEX MORPHOGENESIS,0.14526,0.10629,0.11146,0,0
6,GO PHOSPHOLIPID HOMEOSTASIS,0.39858,0.10609,0.041172,0,0
6,GO COENZYME A BIOSYNTHETIC PROCESS,0.26847,0.10608,0.07133,0,0
6,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.15264,0.10543,0.064202,0,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.20621,0.10501,0.038164,0,0
6,GO CELLULAR RESPONSE TO ETHANOL,0.11434,0.105,0.12598,0,0
6,GO TOXIN TRANSPORT,0.10096,0.10474,0.067394,0,0
6,GO GROWTH HORMONE SECRETION,0.16294,0.10466,0.10545,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.27227,0.10464,0.079484,0,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12908,0.10451,0.12432,0,0
6,GO POSITIVE REGULATION OF ION TRANSPORT,0.076492,0.1043,0.078154,0,0
6,GO SKELETAL SYSTEM MORPHOGENESIS,0.36064,0.10427,0.032545,0,0
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.59059,0.10414,0.032692,0,0
6,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.34702,0.10387,0.057386,0,0
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19695,0.10371,0.094687,0,0
6,GO OUTFLOW TRACT MORPHOGENESIS,0.19095,0.10319,0.058589,0,0
6,GO TRNA 5 END PROCESSING,0.12473,0.10284,0.079239,0,0
6,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.084046,0.10254,0.11759,0,0
6,GO CELLULAR RESPONSE TO CALCIUM ION,0.097379,0.10248,0.094569,0,0
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.05824,0.10243,0.090781,0,0
6,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0023671,0.10243,0.09872,0,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.26098,0.10238,0.15396,0,0
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.060602,0.10188,0.083724,0,0
6,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38408,0.10184,0.054856,0,0
6,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.44924,0.1016,0.14169,0,0
6,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.32506,0.10158,0.057278,0,0
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.011047,0.10155,0.11642,0,0
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.049546,0.10137,0.11162,0,0
6,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.17099,0.10112,0.059583,0,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.19393,0.10101,-0.010585,0,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.22235,0.10099,0.074943,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.14048,0.1007,0.081393,0,0
6,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.23589,0.10064,0.1404,0,0
6,GO AXO DENDRITIC TRANSPORT,0.043763,0.10041,0.10129,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.65866,0.10026,0.046327,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.57857,0.10015,-0.021418,0,0
6,GO PROSTAGLANDIN SECRETION,0.17099,0.10012,0.085141,0,0
6,GO NAD BIOSYNTHETIC PROCESS,0.5726,0.099913,0.02916,0,0
6,GO PHAGOLYSOSOME ASSEMBLY,0.29992,0.099778,0.059685,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.63978,0.099585,0.039394,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.41341,0.099415,0.015277,0,0
6,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.17653,0.099388,0.090573,0,0
6,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.22235,0.099251,0.049878,0,0
6,GO ACROSOME ASSEMBLY,0.15773,0.098843,0.14126,0,0
6,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.14285,0.098716,0.046371,0,0
6,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.70355,0.098621,0.01751,0,0
6,GO REGULATION OF MIRNA METABOLIC PROCESS,0.4545,0.097984,0.073768,0,0
6,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.25363,0.097836,0.044028,0,0
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.16032,0.097756,0.10818,0,0
6,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.31653,0.097516,0.041001,0,0
6,GO REGULATION OF ATP METABOLIC PROCESS,0.065563,0.097368,0.064835,0,0
6,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.23245,0.097273,0.072781,0,0
6,GO RENAL VESICLE DEVELOPMENT,0.18219,0.09686,0.12136,0,0
6,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17374,0.09671,0.085387,0,0
6,GO LATERAL MESODERM DEVELOPMENT,0.99651,0.096493,-0.042264,0,0
6,GO REVERSE CHOLESTEROL TRANSPORT,0.72969,0.096301,-0.0135,0,0
6,GO RENAL SODIUM EXCRETION,0.095625,0.096118,0.077543,0,0
6,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.10654,0.096015,0.079689,0,0
6,GO BICARBONATE TRANSPORT,0.16828,0.095931,0.057661,0,0
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.36526,0.095619,0.024502,0,0
6,GO AXONAL TRANSPORT OF MITOCHONDRION,0.18508,0.095579,0.15747,0,0
6,GO ENDODERM FORMATION,0.25363,0.095455,0.025382,0,0
6,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.05824,0.095351,0.080819,0,0
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.070855,0.095187,0.082986,0,0
6,GO TRANSEPITHELIAL TRANSPORT,0.060602,0.095126,0.071842,0,0
6,GO PIGMENT METABOLIC PROCESS,0.13355,0.094987,0.079327,0,0
6,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.18219,0.094937,0.063127,0,0
6,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.29586,0.094911,0.033694,0,0
6,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011326,0.094873,0.17996,0,0
6,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.4978,0.094615,0.011696,0,0
6,GO CELL RECOGNITION,0.057089,0.094592,0.072826,0,0
6,GO MITOCHONDRIAL GENOME MAINTENANCE,0.041967,0.09449,0.13653,0,0
6,GO DENDRITIC SPINE MAINTENANCE,0.14048,0.094365,0.078247,0,0
6,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.54903,0.09376,0.037638,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.32938,0.093651,0.17063,0,0
6,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.27227,0.0934,0.11352,0,0
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.44402,0.093148,0.037235,0,0
6,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0024367,0.092894,0.131,0,0
6,GO NOREPINEPHRINE METABOLIC PROCESS,0.44402,0.092883,0.11071,0,0
6,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.054842,0.092556,0.08351,0,0
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.092194,0.09236,0.080909,0,0
6,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.0695,0.091905,0.040213,0,0
6,GO MEMBRANE DEPOLARIZATION,0.14769,0.091862,0.10733,0,0
6,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.12908,0.091841,0.068493,0,0
6,GO SNARE COMPLEX ASSEMBLY,0.63354,0.09169,0.023899,0,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.85768,0.091628,-0.035297,0,0
6,GO AMELOGENESIS,0.72313,0.091497,0.017454,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.29992,0.091025,0.062368,0,0
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.079444,0.090943,0.089883,0,0
6,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.12908,0.090858,0.07639,0,0
6,GO REGULATION OF LIPID CATABOLIC PROCESS,0.19393,0.090771,0.067024,0,0
6,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.42855,0.090715,0.051687,0,0
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.36526,0.090547,0.066859,0,0
6,GO NUCLEOTIDE SALVAGE,0.16032,0.090474,0.12384,0,0
6,GO EXPORT ACROSS PLASMA MEMBRANE,0.14769,0.090338,0.086928,0,0
6,GO SODIUM ION TRANSPORT,0.04854,0.090093,0.07834,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.089731,0.099952,0,0
6,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.15264,0.089392,0.1084,0,0
6,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.079444,0.089231,0.081202,0,0
6,GO AMINO ACID ACTIVATION,0.17099,0.089177,0.096164,0,0
6,GO REGULATION OF GLUTAMATE SECRETION,0.17653,0.089087,0.13757,0,0
6,GO RESPONSE TO CALCIUM ION,0.050569,0.088902,0.089481,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.2,0.088542,0.06317,0,0
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.064293,0.088449,0.097257,0,0
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.43367,0.088351,0.053667,0,0
6,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.15773,0.088278,0.063281,0,0
6,GO CATECHOLAMINE SECRETION,0.070855,0.088274,0.21533,0,0
6,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.94769,0.088241,-0.017123,0,0
6,GO RECEPTOR INTERNALIZATION,0.049546,0.088196,0.094469,0,0
6,GO RNA STABILIZATION,0.13583,0.088143,0.071223,0,0
6,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.060602,0.088074,0.064686,0,0
6,GO GROOMING BEHAVIOR,0.20621,0.088031,0.11623,0,0
6,GO COPPER ION TRANSPORT,0.19695,0.087859,0.074573,0,0
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.47588,0.087791,0.047237,0,0
6,GO DENDRITIC CELL APOPTOTIC PROCESS,0.39371,0.087635,0.037074,0,0
6,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.25363,0.087382,0.067867,0,0
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.72969,0.087255,0.00042408,0,0
6,GO REGULATION OF STEM CELL DIFFERENTIATION,0.32938,0.087207,0.028107,0,0
6,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.39858,0.086961,0.037733,0,0
6,GO PALLIUM DEVELOPMENT,0.011612,0.086703,0.12236,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.047551,0.086679,0.097788,0,0
6,GO SKELETAL MUSCLE CONTRACTION,0.11039,0.086276,0.085481,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.36526,0.085893,0.021861,0,0
6,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.13814,0.08582,0.079721,0,0
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.17099,0.085525,0.043005,0,0
6,GO REGULATION OF ION TRANSPORT,0.14285,0.085163,0.060629,0,0
6,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.28785,0.085014,0.067548,0,0
6,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.74288,0.084953,-0.011379,0,0
6,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.5726,0.084937,0.0074552,0,0
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.25729,0.084792,0.1637,0,0
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.14526,0.084508,0.05929,0,0
6,GO HORMONE BIOSYNTHETIC PROCESS,0.10845,0.084391,0.088945,0,0
6,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.38408,0.084332,0.03121,0,0
6,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.34256,0.084212,0.065424,0,0
6,GO BLASTOCYST FORMATION,0.10465,0.083901,0.07186,0,0
6,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.29184,0.083715,0.0484,0,0
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.093897,0.083683,0.095142,0,0
6,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.67776,0.083643,-0.0021424,0,0
6,GO POSITIVE REGULATION OF LIPID STORAGE,0.3746,0.083425,0.053785,0,0
6,GO MESODERMAL CELL DIFFERENTIATION,0.31232,0.082899,0.010792,0,0
6,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,0,0
6,GO PLASMINOGEN ACTIVATION,0.46512,0.082181,-0.039713,0,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.75615,0.082149,-0.074696,0,0
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.25363,0.081677,0.04365,0,0
6,GO PODOSOME ASSEMBLY,0.67137,0.081675,-0.064838,0,0
6,GO ZINC ION TRANSPORT,0.23937,0.081671,0.059316,0,0
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.28785,0.081668,0.10687,0,0
6,GO PROSTATE GLAND MORPHOGENESIS,0.25001,0.081626,0.029616,0,0
6,GO ENDOTHELIAL CELL PROLIFERATION,0.74288,0.08162,0.0065297,0,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.23937,0.081615,0.073582,0,0
6,GO TONGUE MORPHOGENESIS,0.4598,0.081393,0.12758,0,0
6,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.17934,0.081261,0.082883,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.064293,0.081174,0.14722,0,0
6,GO REGULATION OF AMYLOID BETA FORMATION,0.60272,0.080998,0.035328,0,0
6,GO REGULATION OF PROTEIN TARGETING,0.059411,0.080954,0.067854,0,0
6,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.42347,0.080935,0.03634,0,0
6,GO OTIC VESICLE MORPHOGENESIS,0.22235,0.080834,0.17572,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.32077,0.080806,0.049153,0,0
6,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.32077,0.080729,0.029259,0,0
6,GO PULMONARY VALVE MORPHOGENESIS,0.50896,0.080652,0.027984,0,0
6,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.31232,0.08065,0.072418,0,0
6,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.55487,0.080271,0.037342,0,0
6,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.2,0.080203,0.10426,0,0
6,GO GLIAL CELL ACTIVATION,0.69707,0.080002,0.010975,0,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.14526,0.079913,0.088509,0,0
6,GO ENDOCARDIAL CUSHION FORMATION,0.52594,0.079881,0.033788,0,0
6,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.23245,0.079584,0.11512,0,0
6,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.36991,0.079189,0.044649,0,0
6,GO REGULATION OF DNA METHYLATION,0.55487,0.078676,0.022381,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.18508,0.078595,0.066106,0,0
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.12049,0.078554,0.08366,0,0
6,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.31653,0.078538,0.044265,0,0
6,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.5726,0.07847,0.015,0,0
6,GO CELL GROWTH,0.075049,0.078358,0.049189,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0695,0.078322,0.089378,0,0
6,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.11039,0.078308,0.051503,0,0
6,GO SEQUESTERING OF CALCIUM ION,0.30402,0.078271,0.048713,0,0
6,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.10845,0.078262,0.069084,0,0
6,GO REGULATION OF NEURON PROJECTION REGENERATION,0.60272,0.078197,0.048157,0,0
6,GO MITOTIC CHROMOSOME CONDENSATION,0.084046,0.078058,0.085615,0,0
6,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.21905,0.07805,0.047038,0,0
6,GO NUCLEAR MIGRATION,0.093897,0.077994,0.098162,0,0
6,GO TRABECULA FORMATION,0.22568,0.077658,0.066652,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.25729,0.077515,0.06121,0,0
6,GO AMINO SUGAR METABOLIC PROCESS,0.29184,0.077403,0.034278,0,0
6,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.87833,0.077391,-0.031794,0,0
6,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.4598,0.077289,0.012326,0,0
6,GO ADULT BEHAVIOR,0.055956,0.077249,0.14414,0,0
6,GO DRUG CATABOLIC PROCESS,0.085627,0.077231,0.084308,0,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.070855,0.077169,0.095196,0,0
6,GO AXONAL TRANSPORT,0.070855,0.077143,0.10062,0,0
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.26098,0.077094,0.10614,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.56075,0.077027,0.080368,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.4545,0.076803,0.039002,0,0
6,GO PROTEIN CONTAINING COMPLEX REMODELING,0.19095,0.076794,0.038257,0,0
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.47049,0.076733,0.087098,0,0
6,GO POSITIVE REGULATION OF HEART CONTRACTION,0.46512,0.076668,0.05701,0,0
6,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.61497,0.076578,0.019408,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.52594,0.076353,0.023953,0,0
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.67776,0.076184,0.045548,0,0
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.88523,0.076182,-0.051929,0,0
6,GO MONONUCLEAR CELL DIFFERENTIATION,0.31653,0.075882,0.091314,0,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.32938,0.075861,0.085015,0,0
6,GO REGULATION OF EXCRETION,0.12259,0.075844,0.11051,0,0
6,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.3746,0.075674,0.0491,0,0
6,GO GANGLIOSIDE METABOLIC PROCESS,0.35607,0.075559,0.08742,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.082489,0.07523,0.11739,0,0
6,GO CATION TRANSPORT,0.05824,0.075116,0.060237,0,0
6,GO PLASMA MEMBRANE ORGANIZATION,0.30815,0.07504,0.048406,0,0
6,GO IRON ION HOMEOSTASIS,0.20309,0.074902,0.055373,0,0
6,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.14769,0.074629,0.10781,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.76281,0.074518,0.0086407,0,0
6,GO 3 UTR MEDIATED MRNA STABILIZATION,0.77618,0.074206,-0.012709,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.66501,0.074091,-0.012677,0,0
6,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.085627,0.074082,0.062271,0,0
6,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.11636,0.07407,0.079286,0,0
6,GO REGULATION OF SENSORY PERCEPTION,0.1313,0.073811,0.11994,0,0
6,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.21905,0.073492,0.093333,0,0
6,GO THIOESTER METABOLIC PROCESS,0.25729,0.073276,0.052488,0,0
6,GO PROTEIN KINASE A SIGNALING,0.2839,0.07278,0.047207,0,0
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.94073,0.072656,-0.016114,0,0
6,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.23245,0.072351,0.14897,0,0
6,GO MITOTIC SISTER CHROMATID COHESION,0.48131,0.072182,0.03863,0,0
6,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.085627,0.07167,0.091229,0,0
6,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.27999,0.071191,0.043413,0,0
6,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.12049,0.071179,0.052823,0,0
6,GO ESTROGEN BIOSYNTHETIC PROCESS,0.60272,0.070872,0.029586,0,0
6,GO REGULATION OF BLOOD CIRCULATION,0.17099,0.07079,0.06219,0,0
6,GO RESPONSE TO COCAINE,0.47049,0.070694,0.053782,0,0
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.32506,0.070677,0.023749,0,0
6,GO CELLULAR AMIDE METABOLIC PROCESS,0.054842,0.070652,0.070367,0,0
6,GO CELL JUNCTION ORGANIZATION,0.188,0.07046,0.04718,0,0
6,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.17934,0.070351,0.051365,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.34702,0.070264,0.030359,0,0
6,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.4545,0.070237,0.023566,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.14526,0.070001,0.11623,0,0
6,GO PROTEIN HOMOTETRAMERIZATION,0.075049,0.069941,0.066948,0,0
6,GO MESENCHYMAL CELL PROLIFERATION,0.090515,0.069754,0.13252,0,0
6,GO TRABECULA MORPHOGENESIS,0.68418,0.069601,0.00042882,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.32506,0.069519,0.047766,0,0
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.065563,0.069382,0.070423,0,0
6,GO NEGATIVE REGULATION OF CELL AGING,0.78962,0.069356,-0.046214,0,0
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12908,0.069332,0.057547,0,0
6,GO RESPONSE TO ACIDIC PH,0.61497,0.069269,-0.0041426,0,0
6,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.33812,0.068977,0.040546,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32506,0.068946,0.054595,0,0
6,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.05824,0.068821,0.071223,0,0
6,GO POSITIVE REGULATION OF FERTILIZATION,0.22905,0.068786,0.12685,0,0
6,GO REGULATION OF DNA BINDING,0.32506,0.068703,0.035944,0,0
6,GO MULTICELLULAR ORGANISMAL SIGNALING,0.092194,0.068576,0.10112,0,0
6,GO RESPONSE TO INTERLEUKIN 12,0.40349,0.068368,0.034789,0,0
6,GO FATTY ACYL COA METABOLIC PROCESS,0.054842,0.06832,0.13079,0,0
6,GO LENS FIBER CELL DEVELOPMENT,0.40349,0.067964,0.057793,0,0
6,GO INTRACELLULAR LIPID TRANSPORT,0.32506,0.067907,0.051331,0,0
6,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.39371,0.067675,0.031582,0,0
6,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.16559,0.067378,0.083294,0,0
6,GO MITOCHONDRIAL FISSION,0.17934,0.066962,0.067096,0,0
6,GO ACTION POTENTIAL,0.31653,0.066927,0.062919,0,0
6,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.092194,0.066661,0.065468,0,0
6,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.11039,0.066519,0.060207,0,0
6,GO RECOMBINATIONAL REPAIR,0.084046,0.066379,0.049275,0,0
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.4545,0.066267,0.05857,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.22235,0.066172,0.060251,0,0
6,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.63354,0.066041,-0.0040107,0,0
6,GO ATP DEPENDENT CHROMATIN REMODELING,0.060602,0.065935,0.06487,0,0
6,GO MULTICELLULAR ORGANISM GROWTH,0.14048,0.065507,0.039674,0,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.85768,0.065444,-0.0028137,0,0
6,GO HIPPO SIGNALING,0.68418,0.065365,-0.024942,0,0
6,GO HEXOSE CATABOLIC PROCESS,0.4598,0.065182,0.035594,0,0
6,GO RESPONSE TO AMINO ACID STARVATION,0.17653,0.065071,0.077566,0,0
6,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.3746,0.064971,0.040328,0,0
6,GO CELLULAR RESPONSE TO X RAY,0.41842,0.064863,0.016317,0,0
6,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.073629,0.064843,0.15596,0,0
6,GO HISTONE H3 K27 METHYLATION,0.40349,0.064767,0.041694,0,0
6,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.30402,0.064586,0.12124,0,0
6,GO CELLULAR RESPONSE TO AMYLOID BETA,0.12689,0.064443,0.07886,0,0
6,GO POSITIVE REGULATION OF AXON EXTENSION,0.21905,0.064149,0.10092,0,0
6,GO SYNAPTIC VESICLE TRANSPORT,0.11434,0.063924,0.11139,0,0
6,GO EMBRYONIC AXIS SPECIFICATION,0.42855,0.063734,0.056971,0,0
6,GO DERMATAN SULFATE METABOLIC PROCESS,0.93377,0.063732,-0.0072338,0,0
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.72969,0.063652,0.0051246,0,0
6,GO CEREBRAL CORTEX DEVELOPMENT,0.082489,0.063571,0.083382,0,0
6,GO ION TRANSMEMBRANE TRANSPORT,0.05824,0.063493,0.061114,0,0
6,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.39371,0.063293,0.046665,0,0
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.54903,0.063118,0.086518,0,0
6,GO METHIONINE BIOSYNTHETIC PROCESS,0.32938,0.062669,0.024869,0,0
6,GO RESPONSE TO SALT,0.92682,0.062643,0.00048644,0,0
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.22235,0.06263,0.0745,0,0
6,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.28785,0.062444,0.041102,0,0
6,GO NEURON MATURATION,0.073629,0.062192,0.1618,0,0
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.50337,0.062074,0.015222,0,0
6,GO GLUCOCORTICOID METABOLIC PROCESS,0.90599,0.062055,-0.0055476,0,0
6,GO REGULATION OF CAMP MEDIATED SIGNALING,0.31232,0.062028,0.069046,0,0
6,GO COLLAGEN CATABOLIC PROCESS,0.52025,0.062015,0.00011165,0,0
6,GO MULTI ORGANISM LOCALIZATION,0.15264,0.061525,0.032862,0,0
6,GO SNRNA PROCESSING,0.15773,0.061408,-0.0063667,0,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.63978,0.061342,0.018724,0,0
6,GO MEMBRANE HYPERPOLARIZATION,0.44924,0.061284,0.069574,0,0
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.58456,0.061271,0.021532,0,0
6,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.76281,0.061217,0.038906,0,0
6,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.13355,0.061175,0.11112,0,0
6,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.40349,0.061015,0.054946,0,0
6,GO HEART PROCESS,0.12259,0.06089,0.068836,0,0
6,GO LOCALIZATION WITHIN MEMBRANE,0.2,0.060871,0.062917,0,0
6,GO CERAMIDE TRANSPORT,0.11434,0.060835,0.045107,0,0
6,GO OPTIC NERVE DEVELOPMENT,0.32938,0.060655,0.088409,0,0
6,GO PRENYLATION,0.43883,0.060469,0.026651,0,0
6,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10654,0.060355,0.045853,0,0
6,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.060279,-0.055547,0,0
6,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.049546,0.060199,0.081212,0,0
6,GO POSITIVE REGULATION OF URINE VOLUME,0.5726,0.060194,0.011848,0,0
6,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.041093,0.060038,0.10921,0,0
6,GO REGULATION OF MRNA 3 END PROCESSING,0.12049,0.060029,0.062462,0,0
6,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,0,0
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.36526,0.059805,0.094879,0,0
6,GO NUCLEOSIDE METABOLIC PROCESS,0.12908,0.059782,0.047589,0,0
6,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.26098,0.059782,0.039865,0,0
6,GO NEURON PROJECTION ARBORIZATION,0.49227,0.059684,0.069472,0,0
6,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.87144,0.059626,-0.016596,0,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.12689,0.059588,0.062803,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.38888,0.059495,0.059975,0,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.96163,0.059474,0.0074326,0,0
6,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.1028,0.059414,0.067347,0,0
6,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.71006,0.059403,-0.061317,0,0
6,GO REGULATION OF EXOCYTOSIS,0.12908,0.059169,0.083328,0,0
6,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.69061,0.059045,0.016918,0,0
6,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.23245,0.058912,0.051956,0,0
6,GO PROTEIN FOLDING,0.19695,0.058895,0.037073,0,0
6,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.21905,0.05883,0.18293,0,0
6,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.39858,0.058732,0.057713,0,0
6,GO REGULATION OF SODIUM ION TRANSPORT,0.36991,0.058589,0.04793,0,0
6,GO NEUTRAL LIPID CATABOLIC PROCESS,0.48678,0.058587,0.043292,0,0
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.42855,0.058445,0.01996,0,0
6,GO PROTEIN O LINKED MANNOSYLATION,0.40349,0.058248,0.034762,0,0
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.17934,0.057919,0.052955,0,0
6,GO MRNA EXPORT FROM NUCLEUS,0.059411,0.057863,0.069993,0,0
6,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.188,0.057766,0.070135,0,0
6,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.67137,0.057761,-0.0024584,0,0
6,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32938,0.057662,0.027942,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41341,0.057564,0.03109,0,0
6,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.12908,0.057514,0.096921,0,0
6,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.83713,0.057268,-0.011995,0,0
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.045624,0.057252,0.082736,0,0
6,GO REGULATION OF FATTY ACID BETA OXIDATION,0.25001,0.057197,0.081448,0,0
6,GO APOPTOTIC DNA FRAGMENTATION,0.12689,0.056973,0.054069,0,0
6,GO FEEDING BEHAVIOR,0.088862,0.056843,0.084705,0,0
6,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.92682,0.056737,-0.0044084,0,0
6,GO MITOCHONDRIAL DNA REPLICATION,0.44924,0.056697,0.032179,0,0
6,GO RESPONSE TO MISFOLDED PROTEIN,0.72969,0.05629,-0.0008014,0,0
6,GO MONOVALENT INORGANIC CATION TRANSPORT,0.11636,0.05621,0.064125,0,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.14526,0.056149,0.057714,0,0
6,GO CHROMOSOME CONDENSATION,0.10465,0.056019,0.064779,0,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.85768,0.056012,-0.042994,0,0
6,GO ACTIN MEDIATED CELL CONTRACTION,0.47049,0.055942,0.047177,0,0
6,GO REGULATION OF MRNA CATABOLIC PROCESS,0.16032,0.055811,0.040261,0,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.48678,0.055774,-0.077812,0,0
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.05573,0.0054114,0,0
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.23589,0.055727,0.111,0,0
6,GO NEPHRON TUBULE FORMATION,0.79636,0.055653,0.036197,0,0
6,GO NOREPINEPHRINE SECRETION,0.37932,0.055307,0.052206,0,0
6,GO REGULATION OF HEART GROWTH,0.23589,0.055286,0.066202,0,0
6,GO DNA GEOMETRIC CHANGE,0.054842,0.055228,0.060255,0,0
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.25729,0.055025,0.049114,0,0
6,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.065563,0.055002,0.04809,0,0
6,GO ANIMAL ORGAN REGENERATION,0.4978,0.054878,-0.0026538,0,0
6,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.81668,0.054837,-0.034905,0,0
6,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.71006,0.054812,0.0049911,0,0
6,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.68418,0.0548,0.015893,0,0
6,GO G0 TO G1 TRANSITION,0.43367,0.05475,0.036869,0,0
6,GO CYTOCHROME COMPLEX ASSEMBLY,0.24643,0.054744,0.073746,0,0
6,GO PROTEIN DEPOLYMERIZATION,0.40349,0.054687,0.035538,0,0
6,GO TRACHEA DEVELOPMENT,0.4598,0.054649,0.060868,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.34702,0.054639,0.074693,0,0
6,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.29992,0.054492,0.03947,0,0
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.56666,0.054206,0.020814,0,0
6,GO PROSTAGLANDIN TRANSPORT,0.58456,0.05399,0.016902,0,0
6,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.26471,0.053979,0.072737,0,0
6,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.71658,0.053975,0.017606,0,0
6,GO OSTEOBLAST DEVELOPMENT,0.71658,0.053807,-0.021909,0,0
6,GO PROTEASOME ASSEMBLY,0.2,0.053773,0.053468,0,0
6,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.76948,0.053703,0.016269,0,0
6,GO ANTEROGRADE AXONAL TRANSPORT,0.11841,0.053664,0.080307,0,0
6,GO STRIATED MUSCLE CONTRACTION,0.14526,0.053577,0.068468,0,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.42347,0.053419,0.04701,0,0
6,GO NEGATIVE REGULATION OF RNA SPLICING,0.14526,0.053381,0.070599,0,0
6,GO PROTEIN NEDDYLATION,0.12049,0.053309,0.067427,0,0
6,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.26098,0.053132,0.13369,0,0
6,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.14048,0.05306,0.053304,0,0
6,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.33373,0.052918,0.067288,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.1313,0.052863,0.075474,0,0
6,GO MAINTENANCE OF LOCATION IN CELL,0.29184,0.052824,0.043541,0,0
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.41842,0.05282,0.050627,0,0
6,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.84397,0.052755,-0.028331,0,0
6,GO NEURON CELL CELL ADHESION,0.61497,0.052642,0.10326,0,0
6,GO PROTEIN POLYGLUTAMYLATION,0.36064,0.052559,0.035699,0,0
6,GO MYELIN ASSEMBLY,0.49227,0.052436,0.042426,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.83713,0.05231,-0.055094,0,0
6,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.63354,0.052278,0.024987,0,0
6,GO NUCLEOSOME ORGANIZATION,0.14526,0.052174,0.050352,0,0
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.72969,0.052144,0.013265,0,0
6,GO RESPONSE TO CATECHOLAMINE,0.47588,0.051724,0.0425,0,0
6,GO MUSCLE CONTRACTION,0.13814,0.051623,0.053266,0,0
6,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.63978,0.05139,0.023118,0,0
6,GO IRON SULFUR CLUSTER ASSEMBLY,0.14769,0.05134,0.11065,0,0
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.2839,0.051251,0.057719,0,0
6,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.59664,0.051103,-0.044502,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.71658,0.051083,0.0022241,0,0
6,GO MONOAMINE TRANSPORT,0.55487,0.051073,0.10533,0,0
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.16294,0.051029,0.064254,0,0
6,GO RESPONSE TO POTASSIUM ION,0.59059,0.050913,0.052922,0,0
6,GO GRANULOCYTE DIFFERENTIATION,0.96163,0.050771,-0.026791,0,0
6,GO PROTEIN LOCALIZATION TO MEMBRANE,0.11434,0.050566,0.041946,0,0
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.24288,0.050528,0.091945,0,0
6,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.38408,0.050521,0.079565,0,0
6,GO ADHESION OF SYMBIONT TO HOST,0.5726,0.050321,0.033531,0,0
6,GO PEPTIDYL METHIONINE MODIFICATION,0.15015,0.050316,0.06293,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE,0.33812,0.050176,0.083192,0,0
6,GO REGULATION OF CELL PROJECTION SIZE,0.94769,0.050105,-0.0076313,0,0
6,GO CARDIAC CHAMBER DEVELOPMENT,0.53167,0.050087,0.016322,0,0
6,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.40349,0.049989,0.026336,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.25363,0.049893,0.036914,0,0
6,GO RHYTHMIC BEHAVIOR,0.47049,0.049745,0.042894,0,0
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.11434,0.049733,0.11575,0,0
6,GO DEFENSE RESPONSE TO FUNGUS,0.69061,0.049532,0.0085766,0,0
6,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.98953,0.049408,-0.006554,0,0
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.15015,0.049344,0.041168,0,0
6,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.70355,0.049297,-0.011863,0,0
6,GO TRANSMEMBRANE TRANSPORT,0.11841,0.049215,0.040787,0,0
6,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.98255,0.049192,-0.017618,0,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.16294,0.049185,0.099555,0,0
6,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.83713,0.049162,-0.0024512,0,0
6,GO RESPONSE TO CORTICOSTERONE,0.91987,0.049093,-0.019411,0,0
6,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.42347,0.049075,0.01986,0,0
6,GO SCHWANN CELL DEVELOPMENT,0.72313,0.048968,0.017815,0,0
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.86455,0.048931,0.016773,0,0
6,GO CHROMATIN DISASSEMBLY,0.22235,0.048408,0.125,0,0
6,GO ACYLGLYCEROL HOMEOSTASIS,0.42347,0.048374,0.038189,0,0
6,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.33812,0.048365,0.058467,0,0
6,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.43883,0.048133,0.06176,0,0
6,GO REGULATION OF CELL MORPHOGENESIS,0.087232,0.048035,0.062806,0,0
6,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.17099,0.048005,0.046503,0,0
6,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.81668,0.047761,0.0094245,0,0
6,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.38888,0.04765,0.031904,0,0
6,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.42855,0.047545,0.038869,0,0
6,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.58456,0.04754,0.013204,0,0
6,GO REGULATION OF ORGAN GROWTH,0.35607,0.04754,0.035379,0,0
6,GO INNER CELL MASS CELL PROLIFERATION,0.25729,0.047341,0.061132,0,0
6,GO CARBOHYDRATE CATABOLIC PROCESS,0.23937,0.047273,0.047214,0,0
6,GO MRNA TRANSPORT,0.095625,0.047191,0.05429,0,0
6,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.62732,0.047146,0.030781,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.62113,0.047105,0.047123,0,0
6,GO CARDIAC CHAMBER MORPHOGENESIS,0.69061,0.04698,0.0037934,0,0
6,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.86455,0.046963,-0.036538,0,0
6,GO OSTEOCLAST DEVELOPMENT,0.22905,0.046955,0.076249,0,0
6,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.62113,0.046823,0.028654,0,0
6,GO KERATAN SULFATE CATABOLIC PROCESS,0.9686,0.046602,-0.055373,0,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43883,0.046447,0.052152,0,0
6,GO ACROSOME REACTION,0.54321,0.046437,0.028279,0,0
6,GO FORMATION OF PRIMARY GERM LAYER,0.65234,0.046422,-0.0089847,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.41842,0.046411,0.052284,0,0
6,GO NEUROGENESIS,0.075049,0.046395,0.071918,0,0
6,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.55487,0.046293,0.032767,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.15773,0.046282,0.068317,0,0
6,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.60883,0.046193,0.036286,0,0
6,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.35153,0.046032,0.060186,0,0
6,GO MITOTIC CELL CYCLE ARREST,0.60883,0.04592,0.03141,0,0
6,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25729,0.045851,0.068885,0,0
6,GO CEREBELLAR CORTEX FORMATION,0.63978,0.045735,0.048536,0,0
6,GO POSITIVE REGULATION OF DNA BINDING,0.10465,0.045604,0.064125,0,0
6,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.71006,0.045453,-0.0036157,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.33812,0.045402,0.066379,0,0
6,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.21905,0.045383,0.045223,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.95466,0.045349,-0.026062,0,0
6,GO MYOBLAST FUSION,0.89215,0.045198,-0.025843,0,0
6,GO REGULATION OF PROTEIN GLYCOSYLATION,0.69707,0.045174,0.0098476,0,0
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.31232,0.044919,0.059493,0,0
6,GO SULFUR COMPOUND CATABOLIC PROCESS,0.093897,0.044885,0.10197,0,0
6,GO RESPONSE TO DOPAMINE,0.61497,0.044837,0.033992,0,0
6,GO CHROMATIN SILENCING,0.46512,0.044804,0.026672,0,0
6,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.71006,0.044783,0.016251,0,0
6,GO ORGAN GROWTH,0.54903,0.044716,0.018631,0,0
6,GO BASEMENT MEMBRANE ORGANIZATION,0.86455,0.044645,-0.072866,0,0
6,GO RRNA CATABOLIC PROCESS,0.62732,0.044437,0.04833,0,0
6,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.78962,0.044324,0.0072863,0,0
6,GO HEART TRABECULA FORMATION,0.95466,0.044239,-0.0041626,0,0
6,GO HISTONE METHYLATION,0.1028,0.044139,0.047003,0,0
6,GO CORTICOSTEROID HORMONE SECRETION,0.81668,0.044039,-0.020328,0,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.16828,0.043899,0.12862,0,0
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.061812,0.043714,0.131,0,0
6,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.32077,0.043609,0.049395,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.95466,0.043547,-0.012278,0,0
6,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.42347,0.04348,0.037169,0,0
6,GO PHOTORECEPTOR CELL DEVELOPMENT,0.38888,0.043411,0.05894,0,0
6,GO MICROTUBULE NUCLEATION,0.67137,0.043043,0.030211,0,0
6,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.10654,0.042921,0.09844,0,0
6,GO REGULATION OF LIPID KINASE ACTIVITY,0.22905,0.042914,0.041127,0,0
6,GO EXOCRINE SYSTEM DEVELOPMENT,0.48678,0.042716,0.033185,0,0
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.88523,0.042581,0.023569,0,0
6,GO REGULATION OF PODOSOME ASSEMBLY,0.50896,0.042552,-0.11406,0,0
6,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.20621,0.042531,0.072654,0,0
6,GO PROTEIN HYDROXYLATION,0.78289,0.042499,0.014227,0,0
6,GO PROTEIN PALMITOYLATION,0.30815,0.042405,0.061275,0,0
6,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.21256,0.04236,0.096539,0,0
6,GO BONE DEVELOPMENT,0.3746,0.042278,0.014209,0,0
6,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.89907,0.042198,-0.021191,0,0
6,GO TRNA 5 LEADER REMOVAL,0.63354,0.041775,0.01211,0,0
6,GO PROTEIN STABILIZATION,0.52025,0.041628,0.017604,0,0
6,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.69707,0.041617,0.042231,0,0
6,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1,0.041609,-0.013308,0,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.60272,0.04137,-0.015169,0,0
6,GO LYMPHANGIOGENESIS,0.26098,0.041195,0.057051,0,0
6,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.41341,0.041186,0.027773,0,0
6,GO NADP METABOLIC PROCESS,0.70355,0.041152,-0.016033,0,0
6,GO PROTEIN LOCALIZATION TO ORGANELLE,0.05824,0.041143,0.037228,0,0
6,GO ELECTRON TRANSPORT CHAIN,0.37932,0.040798,0.031763,0,0
6,GO REGULATION OF DEVELOPMENTAL GROWTH,0.10654,0.040787,0.053955,0,0
6,GO CARTILAGE MORPHOGENESIS,0.35153,0.04077,0.14204,0,0
6,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.4598,0.040627,0.046269,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.75615,0.040613,-0.040405,0,0
6,GO SNRNA METABOLIC PROCESS,0.25001,0.040524,-0.0053469,0,0
6,GO PROTEIN IMPORT,0.58456,0.040337,0.0071906,0,0
6,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.64605,0.039969,-0.042298,0,0
6,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.91987,0.039865,-0.0085776,0,0
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.86455,0.039813,-0.0023915,0,0
6,GO PROTON TRANSMEMBRANE TRANSPORT,0.78962,0.039672,-0.0087641,0,0
6,GO RESPONSE TO UV,0.12259,0.039584,0.042676,0,0
6,GO EMBRYONIC EYE MORPHOGENESIS,0.99651,0.039419,-0.019693,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.80989,0.03933,0.024745,0,0
6,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.84397,0.039168,-0.0045513,0,0
6,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.91293,0.039067,-0.013666,0,0
6,GO CELL MORPHOGENESIS,0.14526,0.038997,0.058199,0,0
6,GO REGULATION OF URINE VOLUME,0.65234,0.038963,0.011216,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.95466,0.038951,-0.010853,0,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29184,0.038797,0.040875,0,0
6,GO POLYOL METABOLIC PROCESS,0.24288,0.038771,0.036067,0,0
6,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.96163,0.03877,-0.010743,0,0
6,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.42855,0.038761,0.046427,0,0
6,GO OXIDATIVE DEMETHYLATION,0.15517,0.038625,0.072435,0,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.20621,0.038547,0.030599,0,0
6,GO ION TRANSPORT,0.23937,0.038322,0.031685,0,0
6,GO CARDIAC MUSCLE CELL CONTRACTION,0.25729,0.038216,0.080229,0,0
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.76948,0.038215,0.0055821,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.78962,0.03819,-0.0078515,0,0
6,GO SECOND MESSENGER MEDIATED SIGNALING,0.33373,0.038161,0.031432,0,0
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.76948,0.038053,0.035254,0,0
6,GO MITOCHONDRION ORGANIZATION,0.17653,0.038028,0.029368,0,0
6,GO IMMATURE T CELL PROLIFERATION,0.72969,0.038013,-0.01894,0,0
6,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.30402,0.037981,0.042514,0,0
6,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.9686,0.037969,-0.025374,0,0
6,GO VITAMIN BIOSYNTHETIC PROCESS,0.41842,0.03795,0.046741,0,0
6,GO CELL CELL SIGNALING,0.13355,0.037895,0.047582,0,0
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.17099,0.037849,0.099701,0,0
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.50896,0.037847,0.02657,0,0
6,GO REGULATION OF GENE SILENCING,0.28785,0.037828,0.031926,0,0
6,GO PROTEIN KINASE C SIGNALING,0.98953,0.037794,-0.0076044,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.090515,0.037701,0.056622,0,0
6,GO CEREBRAL CORTEX CELL MIGRATION,0.073629,0.037433,0.12602,0,0
6,GO DNA REPAIR,0.077957,0.037393,0.035463,0,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.68418,0.037332,0.015243,0,0
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.67137,0.037196,0.016443,0,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.49227,0.037067,0.057624,0,0
6,GO DEVELOPMENTAL GROWTH,0.14285,0.037026,0.047565,0,0
6,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.38888,0.037015,0.016176,0,0
6,GO NEGATIVE REGULATION OF DNA REPAIR,0.78289,0.036885,0.008726,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.71658,0.036778,-0.0092596,0,0
6,GO BLASTOCYST GROWTH,0.47049,0.036748,0.016377,0,0
6,GO COENZYME A METABOLIC PROCESS,0.80312,0.03672,0.013962,0,0
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56075,0.036493,0.040761,0,0
6,GO RESPONSE TO RETINOIC ACID,0.76948,0.036452,-0.016635,0,0
6,GO RESPONSE TO LEUCINE,0.4978,0.03628,0.078433,0,0
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.52025,0.036273,0.026461,0,0
6,GO GMP METABOLIC PROCESS,0.80989,0.03627,0.042603,0,0
6,GO REGULATION OF HISTONE METHYLATION,0.15773,0.036244,0.048961,0,0
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.8303,0.036212,0.032197,0,0
6,GO REGULATION OF DNA REPAIR,0.7495,0.036026,0.0030106,0,0
6,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.67776,0.036019,0.00746,0,0
6,GO REGULATION OF ACROSOME REACTION,0.39371,0.035938,0.070154,0,0
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.13814,0.035896,0.10478,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.4598,0.035834,0.062649,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.89907,0.035827,-0.026239,0,0
6,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.21905,0.035753,0.10856,0,0
6,GO SKELETAL MUSCLE TISSUE REGENERATION,0.69707,0.035704,-0.011069,0,0
6,GO CRANIAL NERVE DEVELOPMENT,0.67137,0.035667,-0.061516,0,0
6,GO CHLORIDE TRANSPORT,0.49227,0.035636,0.025545,0,0
6,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.29184,0.035526,0.036014,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.47588,0.03537,0.020826,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.34702,0.035361,0.020919,0,0
6,GO VENTRICULAR SEPTUM DEVELOPMENT,0.47049,0.035198,0.041503,0,0
6,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.98953,0.035074,-0.014027,0,0
6,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.63354,0.035062,0.0040174,0,0
6,GO CHROMATIN REMODELING AT CENTROMERE,0.17099,0.034998,0.078447,0,0
6,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.61497,0.034779,-0.010887,0,0
6,GO RESPONSE TO ESTROGEN,0.48678,0.034711,0.0087973,0,0
6,GO I KAPPAB PHOSPHORYLATION,0.98953,0.034662,-0.030051,0,0
6,GO AMYLOID BETA FORMATION,0.84397,0.034629,0.0047639,0,0
6,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.16828,0.034385,0.030482,0,0
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.11434,0.034342,0.062309,0,0
6,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.71006,0.034128,0.023519,0,0
6,GO SULFUR COMPOUND METABOLIC PROCESS,0.36991,0.034056,0.024522,0,0
6,GO AORTA MORPHOGENESIS,0.89215,0.034007,-0.028269,0,0
6,GO GROWTH,0.51459,0.033947,0.014628,0,0
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.63978,0.033925,0.0085486,0,0
6,GO REGULATION OF FERTILIZATION,0.39371,0.033886,0.034041,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.50337,0.033874,-0.070401,0,0
6,GO INACTIVATION OF MAPK ACTIVITY,0.89907,0.033782,0.011946,0,0
6,GO TORC1 SIGNALING,0.088862,0.033763,0.062223,0,0
6,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.26847,0.033624,0.05577,0,0
6,GO CELL CYCLE G2 M PHASE TRANSITION,0.17099,0.0333,0.029814,0,0
6,GO NEUROTROPHIN SIGNALING PATHWAY,0.48678,0.03326,0.034975,0,0
6,GO CHOLESTEROL EFFLUX,0.70355,0.033257,-0.045448,0,0
6,GO REGULATION OF CELL DEVELOPMENT,0.12473,0.033246,0.058581,0,0
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.43367,0.033047,0.036882,0,0
6,GO CELLULAR HOMEOSTASIS,0.23589,0.033012,0.031681,0,0
6,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.74288,0.032724,-0.042776,0,0
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.050569,0.032713,0.064769,0,0
6,GO CARTILAGE DEVELOPMENT,0.73628,0.032683,-0.0058453,0,0
6,GO PORE COMPLEX ASSEMBLY,0.80989,0.032664,-0.034393,0,0
6,GO LYTIC VACUOLE ORGANIZATION,0.85768,0.032642,-0.01039,0,0
6,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.56075,0.032546,0.027683,0,0
6,GO DNA CONFORMATION CHANGE,0.16032,0.032404,0.03942,0,0
6,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.70355,0.032357,-0.046804,0,0
6,GO RNA INTERFERENCE,0.20621,0.03234,0.069483,0,0
6,GO METHYLATION,0.033166,0.032322,0.058393,0,0
6,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.47588,0.032237,0.011778,0,0
6,GO LUNG ALVEOLUS DEVELOPMENT,0.4978,0.032095,0.0372,0,0
6,GO REGULATION OF PROTON TRANSPORT,0.55487,0.03197,0.044068,0,0
6,GO PROTEIN ACETYLATION,0.26847,0.031965,0.017669,0,0
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.52594,0.031952,0.059015,0,0
6,GO NEGATIVE REGULATION OF BINDING,0.3746,0.031909,0.033044,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.59664,0.031803,0.021365,0,0
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.71658,0.031783,0.0052435,0,0
6,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.24643,0.031667,0.018889,0,0
6,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.85082,0.031627,9.4196e-05,0,0
6,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.75615,0.031621,-0.0013877,0,0
6,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.097379,0.031562,0.062583,0,0
6,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.53167,0.031557,0.022321,0,0
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.2,0.031533,0.02891,0,0
6,GO NADPH REGENERATION,0.97557,0.03146,-0.014396,0,0
6,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.68418,0.031428,0.018659,0,0
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.86455,0.031386,0.010408,0,0
6,GO FOREBRAIN DEVELOPMENT,0.15773,0.031358,0.064155,0,0
6,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.25001,0.031311,0.038895,0,0
6,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.44402,0.031263,0.018939,0,0
6,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.67137,0.031137,0.014411,0,0
6,GO REGULATION OF TORC1 SIGNALING,0.26847,0.030901,0.038266,0,0
6,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.42855,0.030871,0.025901,0,0
6,GO MEIOTIC SPINDLE ORGANIZATION,0.92682,0.030773,0.0029153,0,0
6,GO SEMI LUNAR VALVE DEVELOPMENT,0.80989,0.030645,-0.0048553,0,0
6,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.78962,0.030489,0.0047626,0,0
6,GO CELLULAR RESPONSE TO VITAMIN,0.51459,0.030433,0.023195,0,0
6,GO MUSCLE SYSTEM PROCESS,0.23937,0.030397,0.038068,0,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.78962,0.030362,0.0039012,0,0
6,GO ION HOMEOSTASIS,0.53742,0.030339,0.017595,0,0
6,GO CARDIAC MUSCLE CONTRACTION,0.20937,0.030078,0.067402,0,0
6,GO OVULATION CYCLE PROCESS,0.40349,0.030026,0.040106,0,0
6,GO DNA PACKAGING,0.33373,0.029913,0.028574,0,0
6,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.81668,0.029894,-0.012265,0,0
6,GO ENERGY HOMEOSTASIS,0.55487,0.029863,0.050136,0,0
6,GO QUINONE METABOLIC PROCESS,0.32938,0.029856,-0.15592,0,0
6,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.50896,0.029631,0.028245,0,0
6,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.58456,0.029594,0.057225,0,0
6,GO NEGATIVE REGULATION OF CELL DIVISION,0.94769,0.029519,0.0078431,0,0
6,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96163,0.029503,-0.013801,0,0
6,GO RESPONSE TO TEMPERATURE STIMULUS,0.14769,0.02944,0.043423,0,0
6,GO RESPONSE TO MAGNESIUM ION,0.9686,0.029394,-0.0081614,0,0
6,GO T CELL DIFFERENTIATION IN THYMUS,0.44924,0.029312,0.026918,0,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.91987,0.029294,-0.067343,0,0
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.71006,0.029261,-0.043304,0,0
6,GO SENSORY PERCEPTION OF PAIN,0.82348,0.029227,0.024267,0,0
6,GO RESPONSE TO GONADOTROPIN,0.92682,0.029167,-0.018143,0,0
6,GO MIRNA METABOLIC PROCESS,0.95466,0.029152,-0.00043178,0,0
6,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.66501,0.029119,0.0058449,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.94073,0.029071,-0.037658,0,0
6,GO DEVELOPMENTAL MATURATION,0.22905,0.028994,0.059102,0,0
6,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.96163,0.028993,0.013514,0,0
6,GO HISTONE EXCHANGE,0.31653,0.028887,0.039289,0,0
6,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.62113,0.028843,-0.063157,0,0
6,GO LYMPH NODE DEVELOPMENT,0.87144,0.028811,-0.013562,0,0
6,GO ACTIVATION OF MAPKK ACTIVITY,0.94769,0.028809,-0.0032546,0,0
6,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.67137,0.028734,0.051423,0,0
6,GO CONVERGENT EXTENSION,0.56666,0.028632,0.041216,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.4978,0.028512,0.02142,0,0
6,GO CHYLOMICRON ASSEMBLY,0.78962,0.028507,-0.019807,0,0
6,GO DNA REPLICATION,0.17653,0.028502,0.033985,0,0
6,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29184,0.028124,0.017059,0,0
6,GO MIDBRAIN DEVELOPMENT,0.76281,0.028068,-0.035876,0,0
6,GO OXIDATION REDUCTION PROCESS,0.68418,0.028046,0.0095475,0,0
6,GO INORGANIC ANION TRANSPORT,0.42347,0.027832,0.015758,0,0
6,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.42855,0.027774,0.047455,0,0
6,GO METAL ION HOMEOSTASIS,0.84397,0.02774,0.0037628,0,0
6,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.23245,0.027726,0.10127,0,0
6,GO REGULATION OF LIGASE ACTIVITY,0.94073,0.027714,0.004058,0,0
6,GO CELL CYCLE ARREST,0.33373,0.027653,0.025913,0,0
6,GO PEROXISOMAL MEMBRANE TRANSPORT,0.42347,0.027639,0.031295,0,0
6,GO RESPONSE TO MONOSACCHARIDE,0.61497,0.027606,0.0067171,0,0
6,GO STRIATED MUSCLE CELL PROLIFERATION,0.89907,0.027545,-0.023932,0,0
6,GO CELLULAR RESPONSE TO CHOLESTEROL,0.56075,0.027486,0.042877,0,0
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.52594,0.027418,0.038913,0,0
6,GO IRON ION TRANSPORT,0.77618,0.027225,-0.0098631,0,0
6,GO CHONDROCYTE DEVELOPMENT,0.47049,0.027036,0.011729,0,0
6,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.46512,0.027007,0.03849,0,0
6,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.36526,0.026823,0.032309,0,0
6,GO NEGATIVE REGULATION OF AUTOPHAGY,0.5726,0.026772,0.026549,0,0
6,GO LAMELLIPODIUM MORPHOGENESIS,0.22568,0.026735,-0.14412,0,0
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.42347,0.026586,0.049709,0,0
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.25363,0.026583,0.047106,0,0
6,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.42347,0.026536,0.024151,0,0
6,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.80989,0.026417,0.0048714,0,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.88523,0.026403,-0.0021909,0,0
6,GO MRNA CLEAVAGE,0.22235,0.026381,0.051584,0,0
6,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.72969,0.026187,0.014482,0,0
6,GO CELLULAR RESPONSE TO RADIATION,0.72313,0.026019,-0.0023432,0,0
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.56075,0.026014,0.010009,0,0
6,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.12689,0.025895,0.046954,0,0
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.55487,0.025797,0.023933,0,0
6,GO NEURAL CREST CELL DIFFERENTIATION,0.55487,0.025671,0.027042,0,0
6,GO SEGMENTATION,0.48678,0.025492,0.021605,0,0
6,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.87833,0.025299,-0.040874,0,0
6,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.92682,0.025244,-0.012407,0,0
6,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.41842,0.025238,0.03403,0,0
6,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.87144,0.025062,-0.039824,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.58456,0.024944,-0.06273,0,0
6,GO NERVOUS SYSTEM PROCESS,0.34702,0.024861,0.038292,0,0
6,GO REGULATION OF GLIOGENESIS,0.78289,0.024815,0.012054,0,0
6,GO MUSCLE ORGAN DEVELOPMENT,0.38408,0.024716,0.01842,0,0
6,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.54321,0.02446,0.042752,0,0
6,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.82348,0.024273,0.004358,0,0
6,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.9686,0.02426,-0.035691,0,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.70355,0.02423,-0.006168,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.81668,0.024143,-0.031975,0,0
6,GO REGULATION OF FIBRINOLYSIS,0.68418,0.024101,-0.09294,0,0
6,GO FILOPODIUM ASSEMBLY,0.46512,0.023969,0.037676,0,0
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.88523,0.023937,-0.016667,0,0
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.63978,0.02391,0.020487,0,0
6,GO CHROMOSOME SEPARATION,0.42855,0.02386,0.025272,0,0
6,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.98255,0.023852,-0.025406,0,0
6,GO ALCOHOL BIOSYNTHETIC PROCESS,0.39371,0.023753,0.024745,0,0
6,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.72969,0.023648,0.032474,0,0
6,GO CHROMATIN SILENCING AT TELOMERE,0.34256,0.023635,0.060195,0,0
6,GO HISTONE H3 K4 METHYLATION,0.95466,0.023547,0.0012104,0,0
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.65234,0.023542,0.012827,0,0
6,GO REGULATION OF TELOMERASE ACTIVITY,0.83713,0.023357,-0.018905,0,0
6,GO REGULATION OF GROWTH,0.90599,0.023354,-0.00044268,0,0
6,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.96163,0.023258,-0.033939,0,0
6,GO THIOESTER BIOSYNTHETIC PROCESS,0.13814,0.023166,0.084946,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.96163,0.02307,-0.010031,0,0
6,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86455,0.023017,-0.017188,0,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.13583,0.022928,0.060352,0,0
6,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.70355,0.022912,0.010331,0,0
6,GO INTERACTION WITH SYMBIONT,0.4545,0.022889,0.0019219,0,0
6,GO LYMPH VESSEL MORPHOGENESIS,0.72313,0.022857,-0.06373,0,0
6,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.62732,0.022769,0.022613,0,0
6,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.98953,0.022752,-0.017444,0,0
6,GO WATER TRANSPORT,0.91293,0.022676,-0.0035743,0,0
6,GO REGULATION OF RECEPTOR RECYCLING,0.61497,0.022614,-0.038741,0,0
6,GO REGULATION OF CHROMOSOME ORGANIZATION,0.16828,0.022592,0.024635,0,0
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.64605,0.022425,0.03981,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.61497,0.022396,0.049255,0,0
6,GO REGULATION OF RNA SPLICING,0.2,0.021959,0.036933,0,0
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.61497,0.021905,0.09446,0,0
6,GO INTERMEMBRANE LIPID TRANSFER,0.95466,0.021783,-0.0027989,0,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.37932,0.02162,0.035968,0,0
6,GO DNA METABOLIC PROCESS,0.39858,0.021597,0.015568,0,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.60272,0.021583,0.044211,0,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.72313,0.021456,0.004522,0,0
6,GO RETINAL CONE CELL DIFFERENTIATION,0.60272,0.021411,-0.075543,0,0
6,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.79636,0.021405,-0.0081328,0,0
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.71006,0.021397,-0.059285,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.73628,0.021363,-0.015008,0,0
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.26471,0.021339,0.07162,0,0
6,GO PROTEIN METHYLATION,0.59059,0.021317,0.020162,0,0
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.39371,0.021265,0.10921,0,0
6,GO REGULATION OF BEHAVIOR,0.67137,0.021183,0.017133,0,0
6,GO PROTEIN LOCALIZATION TO CHROMATIN,0.98953,0.021103,0.002342,0,0
6,GO PEPTIDYL ARGININE MODIFICATION,0.13814,0.020855,0.082401,0,0
6,GO CARDIAC SEPTUM DEVELOPMENT,0.53167,0.020774,0.023525,0,0
6,GO PEPTIDYL CYSTEINE MODIFICATION,0.70355,0.020711,0.020402,0,0
6,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.36064,0.020512,0.024503,0,0
6,GO ORGANELLE MEMBRANE FUSION,0.70355,0.020481,0.0053225,0,0
6,GO DNA RECOMBINATION,0.50896,0.020447,0.011395,0,0
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.17653,0.020436,0.12032,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.32938,0.02037,-0.10796,0,0
6,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.85082,0.02027,0.0037798,0,0
6,GO FOREGUT MORPHOGENESIS,0.8303,0.02027,-0.019063,0,0
6,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.72313,0.020237,-0.00023766,0,0
6,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.39371,0.020216,0.097113,0,0
6,GO CHROMATIN REMODELING,0.23589,0.020082,0.036679,0,0
6,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.36991,0.020018,0.057893,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.57857,0.019838,0.017424,0,0
6,GO HEART TRABECULA MORPHOGENESIS,0.94769,0.019723,-0.004214,0,0
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.56666,0.01962,-0.096087,0,0
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.68418,0.019617,0.028103,0,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.66501,0.019419,0.0024772,0,0
6,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.27999,0.019343,0.048686,0,0
6,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.42347,0.019231,0.069953,0,0
6,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.31653,0.01916,0.034708,0,0
6,GO NEURAL TUBE PATTERNING,0.98953,0.019061,-0.0099716,0,0
6,GO REGULATION OF MYELINATION,0.51459,0.019049,0.051814,0,0
6,GO NEGATIVE REGULATION OF GLIOGENESIS,0.78962,0.018996,-0.01939,0,0
6,GO SECONDARY PALATE DEVELOPMENT,0.53167,0.018966,-0.057617,0,0
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.91293,0.018898,0.0007021,0,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.30402,0.018874,0.14205,0,0
6,GO CONNECTIVE TISSUE DEVELOPMENT,0.95466,0.018871,-0.019809,0,0
6,GO BRAIN MORPHOGENESIS,0.67776,0.018857,0.044687,0,0
6,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.67776,0.018855,0.01276,0,0
6,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.48678,0.018828,0.059431,0,0
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.50896,0.018781,0.026803,0,0
6,GO TRIGLYCERIDE METABOLIC PROCESS,0.92682,0.0187,0.014684,0,0
6,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.67776,0.018616,-0.066419,0,0
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.42855,0.018591,0.029812,0,0
6,GO DENDRITE EXTENSION,0.34702,0.018508,0.14333,0,0
6,GO CARDIAC MUSCLE CELL PROLIFERATION,0.43883,0.018494,0.025655,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.42347,0.018441,0.05027,0,0
6,GO CARBOHYDRATE HOMEOSTASIS,0.4598,0.018052,0.021581,0,0
6,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.94073,0.018001,0.039363,0,0
6,GO HISTONE H3 K4 TRIMETHYLATION,0.87833,0.017889,-0.011816,0,0
6,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.24643,0.017792,0.042424,0,0
6,GO CELLULAR COMPONENT DISASSEMBLY,0.47588,0.017532,0.01762,0,0
6,GO DNA DOUBLE STRAND BREAK PROCESSING,0.86455,0.017507,-0.0079791,0,0
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.27611,0.017285,0.039654,0,0
6,GO PROSTATIC BUD FORMATION,0.83713,0.017271,-0.094231,0,0
6,GO ENDODERMAL CELL DIFFERENTIATION,0.63354,0.017071,-0.059135,0,0
6,GO CANONICAL WNT SIGNALING PATHWAY,0.80312,0.017066,-0.0033325,0,0
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.85768,0.017032,-0.022861,0,0
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.46512,0.016925,0.02599,0,0
6,GO TRANSITION METAL ION HOMEOSTASIS,0.56075,0.016895,0.015071,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.84397,0.016853,0.0044396,0,0
6,GO REGULATION OF CHROMOSOME SEGREGATION,0.26847,0.016798,0.038712,0,0
6,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.27611,0.016703,0.053101,0,0
6,GO REGULATION OF OOGENESIS,0.44924,0.01662,-0.056119,0,0
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.90599,0.01645,0.007407,0,0
6,GO EMBRYONIC PATTERN SPECIFICATION,0.71006,0.016362,0.020384,0,0
6,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.53167,0.016183,0.025218,0,0
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.63354,0.016057,0.035845,0,0
6,GO DETECTION OF VISIBLE LIGHT,0.48131,0.0159,0.044241,0,0
6,GO ORGANELLE FUSION,0.80989,0.015796,-0.0066239,0,0
6,GO CHONDROCYTE DIFFERENTIATION,0.89215,0.015664,-0.032996,0,0
6,GO NODAL SIGNALING PATHWAY,0.9686,0.015654,-0.016513,0,0
6,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.42347,0.015603,0.049487,0,0
6,GO VESICLE DOCKING,0.48678,0.015435,0.035588,0,0
6,GO HORMONE MEDIATED SIGNALING PATHWAY,0.85082,0.015429,-0.010858,0,0
6,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.35607,0.015387,0.027589,0,0
6,GO ENSHEATHMENT OF NEURONS,0.75615,0.015249,0.0062892,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.38888,0.015212,0.045411,0,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.38888,0.015163,0.026909,0,0
6,GO SOMATIC STEM CELL DIVISION,0.87144,0.015116,0.024833,0,0
6,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.95466,0.015107,-0.01713,0,0
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.69707,0.015035,-0.00017288,0,0
6,GO RESPONSE TO CAMP,0.29184,0.014955,0.047401,0,0
6,GO CARDIAC VENTRICLE DEVELOPMENT,0.64605,0.014931,0.018597,0,0
6,GO REGULATION OF PROTEIN MATURATION,0.78289,0.014886,-0.048514,0,0
6,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.99651,0.014794,-0.053607,0,0
6,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.82348,0.014788,0.015365,0,0
6,GO COMPLEMENT ACTIVATION,0.8303,0.014705,-0.056068,0,0
6,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.4598,0.014615,0.040127,0,0
6,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.94073,0.014529,-0.013746,0,0
6,GO LYSOSOME LOCALIZATION,0.43883,0.014507,-0.054235,0,0
6,GO RESPONSE TO PROSTAGLANDIN,0.54903,0.014507,0.016201,0,0
6,GO INTRACELLULAR MRNA LOCALIZATION,0.93377,0.014461,-0.018421,0,0
6,GO POSITIVE REGULATION OF ANION TRANSPORT,0.92682,0.014395,-0.020453,0,0
6,GO HISTONE DEACETYLATION,0.86455,0.014311,-0.0095593,0,0
6,GO RETINOIC ACID METABOLIC PROCESS,0.81668,0.014272,-0.058788,0,0
6,GO SYNCYTIUM FORMATION,0.91293,0.014208,-0.00773,0,0
6,GO CELLULAR ION HOMEOSTASIS,0.78962,0.014174,0.0070492,0,0
6,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.98953,0.014172,-0.014974,0,0
6,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.63354,0.014161,0.030027,0,0
6,GO REGULATION OF MICROTUBULE BINDING,0.36064,0.014122,0.06788,0,0
6,GO CELL CYCLE PHASE TRANSITION,0.91987,0.01403,-0.0022613,0,0
6,GO AMINOGLYCAN METABOLIC PROCESS,0.73628,0.014016,-0.00043295,0,0
6,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.78962,0.013994,-0.0028564,0,0
6,GO MEMBRANE BIOGENESIS,0.91293,0.013919,-0.016019,0,0
6,GO ALPHA AMINO ACID METABOLIC PROCESS,0.56075,0.013905,0.031828,0,0
6,GO REGULATION OF ENDOCYTOSIS,0.97557,0.013786,-0.000796,0,0
6,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.98953,0.013741,9.2521e-05,0,0
6,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.99651,0.013716,0.0016867,0,0
6,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.23937,0.013563,0.0867,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.63354,0.013491,0.030871,0,0
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.48131,0.013438,0.010475,0,0
6,GO OLIGODENDROCYTE DEVELOPMENT,0.49227,0.013319,-0.052704,0,0
6,GO REGULATION OF CELLULAR LOCALIZATION,0.41341,0.013302,0.020149,0,0
6,GO RESPONSE TO MUSCLE STRETCH,0.65234,0.012963,0.019026,0,0
6,GO TERPENOID METABOLIC PROCESS,0.53167,0.012959,-0.048455,0,0
6,GO CELL CELL SIGNALING BY WNT,0.67776,0.012924,0.0040329,0,0
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,1,0.012924,-0.010853,0,0
6,GO SOMITOGENESIS,0.75615,0.012884,-0.013891,0,0
6,GO NCRNA CATABOLIC PROCESS,0.92682,0.012874,-0.00061769,0,0
6,GO POST EMBRYONIC DEVELOPMENT,0.50337,0.012845,-0.03428,0,0
6,GO RESPONSE TO CARBOHYDRATE,0.8303,0.012791,-0.0018795,0,0
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.68418,0.012757,0.015022,0,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.93377,0.012426,-0.011165,0,0
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.5726,0.012155,-0.022016,0,0
6,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.22905,0.01208,0.023931,0,0
6,GO HINDBRAIN DEVELOPMENT,0.34702,0.012054,0.056454,0,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.97557,0.011896,-0.010103,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.85768,0.011887,0.0023157,0,0
6,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.82348,0.01186,0.010332,0,0
6,GO CELL CYCLE G1 S PHASE TRANSITION,0.79636,0.011832,-0.0006604,0,0
6,GO VASODILATION,0.30402,0.011816,0.058037,0,0
6,GO MITOCHONDRIAL TRNA PROCESSING,0.29184,0.011812,0.1047,0,0
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.68418,0.011693,0.037641,0,0
6,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.72313,0.011683,0.0096705,0,0
6,GO POSITIVE REGULATION OF T CELL MIGRATION,0.62732,0.011669,-0.044504,0,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.52025,0.011663,-0.060471,0,0
6,GO MANNOSYLATION,0.72313,0.01166,-0.041711,0,0
6,GO MITOCHONDRIAL TRANSPORT,0.57857,0.011623,0.0083721,0,0
6,GO MESENCHYME DEVELOPMENT,0.92682,0.011533,-0.017653,0,0
6,GO HEAD DEVELOPMENT,0.38888,0.011522,0.035896,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE,0.85768,0.011515,-0.0063422,0,0
6,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.97557,0.011501,-0.0084849,0,0
6,GO DOUBLE STRAND BREAK REPAIR,0.70355,0.011466,0.010564,0,0
6,GO PEPTIDYL PROLINE MODIFICATION,0.76948,0.011348,0.00081077,0,0
6,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.40843,0.011263,-0.051516,0,0
6,GO CIRCULATORY SYSTEM PROCESS,0.95466,0.011262,-0.0044998,0,0
6,GO RESPONSE TO ATP,0.54321,0.011184,0.023555,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.90599,0.011106,-0.077073,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.57857,0.011054,-0.021601,0,0
6,GO VISUAL BEHAVIOR,0.48678,0.011038,0.036199,0,0
6,GO REGULATION OF LIPASE ACTIVITY,0.76948,0.011037,-0.010956,0,0
6,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.9686,0.010961,-0.042987,0,0
6,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.92682,0.010889,-0.0036678,0,0
6,GO DNA LIGATION,0.97557,0.010881,-0.0011536,0,0
6,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.71006,0.010711,0.0058404,0,0
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.9686,0.0107,-0.01829,0,0
6,GO SOMITE DEVELOPMENT,0.72969,0.010665,0.01032,0,0
6,GO REGULATION OF FILOPODIUM ASSEMBLY,0.57857,0.010611,0.05109,0,0
6,GO RECEPTOR METABOLIC PROCESS,0.69707,0.010605,0.01992,0,0
6,GO CELL FATE COMMITMENT,0.77618,0.01056,-0.019383,0,0
6,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.56666,0.010495,0.017299,0,0
6,GO REGULATION OF CELL DIFFERENTIATION,0.98953,0.010484,-0.0071665,0,0
6,GO HINDBRAIN MORPHOGENESIS,0.5726,0.010333,0.045606,0,0
6,GO REGULATION OF FEEDING BEHAVIOR,0.19095,0.010159,0.10225,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.87833,0.010127,-0.010742,0,0
6,GO MITOTIC DNA REPLICATION,0.90599,0.010126,-0.013772,0,0
6,GO THYMUS DEVELOPMENT,0.93377,0.010049,-0.0022784,0,0
6,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.78289,0.010027,0.0062207,0,0
6,GO RHYTHMIC PROCESS,0.90599,0.0097994,0.002983,0,0
6,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76281,0.0097513,0.011355,0,0
6,GO STEM CELL DIFFERENTIATION,0.76281,0.0096906,-0.018138,0,0
6,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.76948,0.0096897,-0.0073922,0,0
6,GO INTRACELLULAR PROTEIN TRANSPORT,0.65866,0.0095956,0.0069814,0,0
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.81668,0.0094596,0.0014535,0,0
6,GO GLIAL CELL PROLIFERATION,0.72969,0.0093701,-0.038691,0,0
6,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.59059,0.0093476,0.01958,0,0
6,GO RESPONSE TO DRUG,0.57857,0.0091927,0.020593,0,0
6,GO INTRACELLULAR TRANSPORT,0.9686,0.0091498,-0.0026833,0,0
6,GO LYMPHOCYTE HOMEOSTASIS,0.89907,0.0091333,-0.010242,0,0
6,GO ESTABLISHMENT OF TISSUE POLARITY,0.91987,0.0091104,0.0022079,0,0
6,GO HEAD MORPHOGENESIS,0.73628,0.0090675,-0.054164,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.82348,0.0090306,0.012044,0,0
6,GO INSEMINATION,0.56666,0.0090097,-0.071983,0,0
6,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.83713,0.0088583,-0.029768,0,0
6,GO RESPONSE TO IONIZING RADIATION,0.60272,0.0086388,-0.036803,0,0
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.78289,0.0085554,-0.042887,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.86455,0.0083696,-0.047653,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,0.0083209,-0.041158,0,0
6,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.63978,0.0083131,-0.031907,0,0
6,GO NEGATIVE REGULATION OF NEURON DEATH,0.73628,0.0082851,0.011449,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.52594,0.0082561,0.044908,0,0
6,GO REGULATION OF ATPASE ACTIVITY,0.9686,0.0081832,-0.010798,0,0
6,GO REGULATION OF MACROAUTOPHAGY,0.87144,0.0081344,-0.0070383,0,0
6,GO FIBROBLAST ACTIVATION,0.80312,0.0081279,-0.041497,0,0
6,GO NUCLEOSOME ASSEMBLY,0.55487,0.0080678,0.024743,0,0
6,GO RESPONSE TO FATTY ACID,0.63354,0.007977,0.014849,0,0
6,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.32077,0.0079634,-0.06499,0,0
6,GO CALCIUM MEDIATED SIGNALING,0.5726,0.0078482,0.013017,0,0
6,GO CELLULAR LIPID CATABOLIC PROCESS,0.39858,0.0078203,-0.050042,0,0
6,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.96163,0.0078085,-0.0010393,0,0
6,GO REGULATION OF DENDRITE EXTENSION,0.5726,0.0077551,0.11384,0,0
6,GO REGULATION OF SULFUR METABOLIC PROCESS,0.62732,0.0077524,0.039512,0,0
6,GO REGULATION OF VACUOLE ORGANIZATION,0.61497,0.0077184,-0.037848,0,0
6,GO POSITIVE REGULATION OF BINDING,0.89215,0.0076239,0.005204,0,0
6,GO ANIMAL ORGAN MORPHOGENESIS,0.76948,0.0075946,-0.023653,0,0
6,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.59059,0.007441,-0.043833,0,0
6,GO ENDOCYTOSIS,0.73628,0.0073062,0.0071156,0,0
6,GO REGULATION OF CHROMOSOME SEPARATION,0.41341,0.0072445,0.032636,0,0
6,GO TETRAPYRROLE METABOLIC PROCESS,0.78289,0.0070853,0.00025501,0,0
6,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.91987,0.0070363,-0.024636,0,0
6,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.43883,0.0069035,0.021505,0,0
6,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.96163,0.0068807,-0.025694,0,0
6,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.91987,0.0068506,-0.020342,0,0
6,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.72969,0.0068365,0.021299,0,0
6,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.90599,0.0067852,-0.0039021,0,0
6,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.73628,0.0067294,-0.0023183,0,0
6,GO DNA STRAND ELONGATION,0.79636,0.0066817,0.033476,0,0
6,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.40349,0.006628,0.032395,0,0
6,GO SPINAL CORD DEVELOPMENT,0.56666,0.0065917,0.036106,0,0
6,GO REGULATION OF DEACETYLASE ACTIVITY,0.8303,0.0064893,-0.02342,0,0
6,GO ISOPRENOID METABOLIC PROCESS,0.41842,0.0064745,-0.050097,0,0
6,GO TRIPARTITE REGIONAL SUBDIVISION,0.39858,0.0064415,-0.082113,0,0
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.71006,0.0064107,-0.062065,0,0
6,GO PEPTIDYL LYSINE MODIFICATION,0.81668,0.0064007,-0.0014967,0,0
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3746,0.0063876,0.036079,0,0
6,GO TRANSITION METAL ION TRANSPORT,0.9686,0.0062893,-0.012317,0,0
6,GO GLYCEROLIPID CATABOLIC PROCESS,0.69707,0.0062535,-0.03318,0,0
6,GO PEPTIDYL LYSINE METHYLATION,0.9686,0.0061402,0.0075368,0,0
6,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.85768,0.0060765,-0.0030939,0,0
6,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.71658,0.0059511,-0.039991,0,0
6,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.50337,0.0059337,-0.048614,0,0
6,GO CELLULAR SODIUM ION HOMEOSTASIS,0.96163,0.0058761,-0.011583,0,0
6,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.74288,0.005827,0.038529,0,0
6,GO AMINOGLYCAN CATABOLIC PROCESS,0.74288,0.005808,-0.056682,0,0
6,GO NEURAL PRECURSOR CELL PROLIFERATION,0.98953,0.0056344,0.0085193,0,0
6,GO VESICLE CARGO LOADING,0.96163,0.0055976,-0.034602,0,0
6,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.47049,0.0055959,-0.076542,0,0
6,GO STEROL TRANSPORT,0.5726,0.0055668,-0.042278,0,0
6,GO COVALENT CHROMATIN MODIFICATION,0.84397,0.0055293,0.0032237,0,0
6,GO ASTROCYTE DIFFERENTIATION,0.98953,0.0053946,0.0052026,0,0
6,GO MITOCHONDRION MORPHOGENESIS,0.85768,0.0053581,-0.0010191,0,0
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.79636,0.005149,-0.026913,0,0
6,GO MIDGUT DEVELOPMENT,0.96163,0.0051445,-0.015151,0,0
6,GO CHONDROCYTE PROLIFERATION,0.91987,0.0051153,0.0016201,0,0
6,GO CELLULAR RESPONSE TO ATP,0.3746,0.0050817,0.047175,0,0
6,GO ANION TRANSMEMBRANE TRANSPORT,0.41842,0.0050806,0.031823,0,0
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.72969,0.0050624,-0.043073,0,0
6,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.94073,0.0050359,-0.0048989,0,0
6,GO HEART GROWTH,0.2839,0.0050315,0.056927,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.30815,0.0050261,0.037477,0,0
6,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.63354,0.0049954,0.013793,0,0
6,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.61497,0.0049698,0.037935,0,0
6,GO REGULATION OF PROTEIN ACETYLATION,0.97557,0.0049425,-0.0017851,0,0
6,GO CHROMATIN ORGANIZATION,0.98255,0.004924,-0.0017387,0,0
6,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.85082,0.0049136,-0.061184,0,0
6,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.48131,0.0048492,0.023663,0,0
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.52025,0.0048344,0.01364,0,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.66501,0.0047222,-0.063692,0,0
6,GO MACROMOLECULE DEACYLATION,0.65866,0.0047171,0.015379,0,0
6,GO CELL CYCLE PROCESS,0.89215,0.0046228,-0.003076,0,0
6,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.74288,0.0046221,-0.027191,0,0
6,GO RECEPTOR RECYCLING,0.91293,0.004562,-0.012386,0,0
6,GO ADULT LOCOMOTORY BEHAVIOR,0.38408,0.0044266,0.080401,0,0
6,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.31653,0.0043766,0.044046,0,0
6,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.69061,0.0042673,-0.0027631,0,0
6,GO REGULATION OF BINDING,0.62732,0.0042594,-0.01871,0,0
6,GO HYPEROSMOTIC RESPONSE,0.78289,0.0042529,-0.031204,0,0
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.90599,0.004252,0.011128,0,0
6,GO PEPTIDYL SERINE MODIFICATION,0.33812,0.0041312,-0.028558,0,0
6,GO REGULATION OF PROTEIN STABILITY,0.62732,0.0041212,-0.016858,0,0
6,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.90599,0.0039969,-0.011779,0,0
6,GO VENTRICULAR SYSTEM DEVELOPMENT,0.52594,0.0038315,0.034647,0,0
6,GO ACTIN FILAMENT BASED MOVEMENT,0.85082,0.0037939,-0.0089701,0,0
6,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.7495,0.0037598,0.0014151,0,0
6,GO DRUG METABOLIC PROCESS,0.7495,0.0037539,-0.0068088,0,0
6,GO METHIONINE METABOLIC PROCESS,0.91293,0.0036902,-0.018883,0,0
6,GO ENGULFMENT OF APOPTOTIC CELL,0.73628,0.0036781,-0.043312,0,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.63978,0.0034803,-0.040616,0,0
6,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.63354,0.0034268,0.01767,0,0
6,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.72313,0.0033832,0.014453,0,0
6,GO REGULATION OF CELL CYCLE PROCESS,0.97557,0.0033497,-0.0034348,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.33812,0.0033183,0.048085,0,0
6,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.77618,0.0032772,-0.0396,0,0
6,GO POSITIVE REGULATION OF MYELINATION,0.53167,0.0032278,0.045445,0,0
6,GO SKELETAL SYSTEM DEVELOPMENT,0.91293,0.0032274,-0.017486,0,0
6,GO MAST CELL MIGRATION,0.79636,0.0030541,-0.057608,0,0
6,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.9686,0.0030387,-0.0057029,0,0
6,GO NEGATIVE REGULATION OF ION TRANSPORT,0.72969,0.0030025,0.01727,0,0
6,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.75615,0.0029931,0.03214,0,0
6,GO MITOTIC CELL CYCLE,0.87144,0.0029303,-0.009113,0,0
6,GO DOPAMINE METABOLIC PROCESS,0.96163,0.0028974,0.028137,0,0
6,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.93377,0.0028891,-0.0074689,0,0
6,GO ACTIVATION OF JNKK ACTIVITY,0.89215,0.0028527,-0.012984,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.59059,0.0027225,-0.033148,0,0
6,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.68418,0.0026018,0.0055043,0,0
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.75615,0.0024251,0.011794,0,0
6,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.56666,0.0021858,0.027748,0,0
6,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.66501,0.0021491,-0.012893,0,0
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.96163,0.0020983,-0.00019962,0,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.42855,0.0020975,0.092799,0,0
6,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.65234,0.0019754,0.060867,0,0
6,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.49227,0.0019008,-0.065546,0,0
6,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.76948,0.0018088,-0.0023158,0,0
6,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91987,0.0017719,0.0062413,0,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.69061,0.001762,0.016804,0,0
6,GO CELL PROJECTION ORGANIZATION,0.66501,0.0017527,0.018766,0,0
6,GO VESICLE CYTOSKELETAL TRAFFICKING,0.71658,0.0017109,0.023363,0,0
6,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.75615,0.0015939,-0.042717,0,0
6,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.9686,0.0014908,-0.0014358,0,0
6,GO REGULATION OF WNT SIGNALING PATHWAY,0.9686,0.0014733,-0.0091945,0,0
6,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.85082,0.0014074,-0.034616,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.52025,0.0012349,0.026247,0,0
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.89907,0.0012121,-0.012278,0,0
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.31232,0.0011984,-0.059052,0,0
6,GO RESPONSE TO INTERLEUKIN 4,0.59059,0.0011784,-0.036901,0,0
6,GO IMPORT INTO NUCLEUS,0.93377,0.0011547,-0.0035695,0,0
6,GO HYPEROSMOTIC SALINITY RESPONSE,0.78289,0.0011132,-0.048874,0,0
6,GO LIPID PHOSPHORYLATION,0.50337,0.0010831,0.041144,0,0
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.53167,0.0010643,-0.039973,0,0
6,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.65866,0.0010595,0.033711,0,0
6,GO RESPONSE TO ORGANOPHOSPHORUS,0.44402,0.00094454,0.029056,0,0
6,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.78962,0.00092425,-0.029875,0,0
6,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.72969,0.00085306,-0.076354,0,0
6,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.87144,0.00066066,0.0056869,0,0
6,GO HOMOLOGOUS RECOMBINATION,0.97557,0.00061569,-0.001468,0,0
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.80312,0.00058415,0.013009,0,0
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.83713,0.00054748,-0.013983,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.85768,0.00049936,-0.030225,0,0
6,GO RESPONSE TO NICOTINE,0.69061,0.00045567,0.027831,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.54321,0.00034335,-0.014881,0,0
6,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.41341,0.00014907,0.021634,0,0
6,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91293,0.00013118,0.00040004,0,0
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.75615,0.00011039,0.014211,0,0
6,GO IRON ION TRANSMEMBRANE TRANSPORT,0.83713,5.2757e-05,-0.039116,0,0
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.5726,-4.8057e-05,-0.016782,0,0
6,GO MAINTENANCE OF LOCATION,0.78289,-6.148e-05,0.0098354,0,0
6,GO PROTEIN AUTOPROCESSING,0.98953,-0.00016379,-0.022545,0,0
6,GO PIRNA METABOLIC PROCESS,0.48131,-0.0002303,-0.10914,0,0
6,GO REGULATION OF MUSCLE CONTRACTION,0.52025,-0.00023226,-0.028183,0,0
6,GO POSITIVE REGULATION OF AUTOPHAGY,0.77618,-0.00036335,0.0048093,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.63354,-0.000428,-0.044165,0,0
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.96163,-0.00048452,0.0017186,0,0
6,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.80312,-0.00049308,-0.05234,0,0
6,GO MUSCLE HYPERTROPHY,0.72969,-0.00058105,-0.028925,0,0
6,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.41842,-0.0007005,-0.034803,0,0
6,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1,-0.00076563,-0.031239,0,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.76948,-0.00085104,-0.029858,0,0
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.62732,-0.00086836,0.019572,0,0
6,GO FEVER GENERATION,0.53742,-0.0010039,0.030955,0,0
6,GO REGULATION OF RESPONSE TO FOOD,0.69061,-0.001153,-0.019731,0,0
6,GO MITOTIC SISTER CHROMATID SEGREGATION,0.80989,-0.0011931,-0.0028538,0,0
6,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0012676,-0.044833,0,0
6,GO THYROID HORMONE METABOLIC PROCESS,0.79636,-0.0012742,0.0056948,0,0
6,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.96163,-0.0012755,-0.0061296,0,0
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.52594,-0.0013027,0.025534,0,0
6,GO NUCLEAR BODY ORGANIZATION,0.78962,-0.001415,-0.014481,0,0
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.89215,-0.0014205,0.011426,0,0
6,GO BODY FLUID SECRETION,0.81668,-0.0014761,0.0029811,0,0
6,GO RESPONSE TO GLUCAGON,0.91987,-0.0015068,-0.014708,0,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.60883,-0.0015098,-0.030795,0,0
6,GO OVULATION CYCLE,0.4978,-0.0015213,0.032306,0,0
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.97557,-0.0016361,0.0037829,0,0
6,GO REGULATION OF REPRODUCTIVE PROCESS,0.63354,-0.0016612,-0.02543,0,0
6,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.85768,-0.0016885,-0.0014084,0,0
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.94769,-0.0017264,-0.012812,0,0
6,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.67137,-0.0017465,-0.066126,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.59664,-0.0019113,-0.030114,0,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.39858,-0.0019951,0.039776,0,0
6,GO C21 STEROID HORMONE METABOLIC PROCESS,0.85768,-0.0020953,-0.059625,0,0
6,GO REGULATION OF CARTILAGE DEVELOPMENT,0.78962,-0.0021106,-0.043574,0,0
6,GO REGULATION OF CYTOKINESIS,0.43883,-0.002141,-0.032988,0,0
6,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.78289,-0.0021447,0.0050345,0,0
6,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.97557,-0.0021541,-0.011407,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.7495,-0.0021752,-0.039342,0,0
6,GO NUCLEOSIDE SALVAGE,0.36991,-0.0022156,0.039444,0,0
6,GO EXOCYTIC PROCESS,0.56666,-0.002245,0.062948,0,0
6,GO PIGMENT GRANULE MATURATION,0.85768,-0.0023048,-0.054706,0,0
6,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.97557,-0.0023323,-0.0083782,0,0
6,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.84397,-0.0023651,-0.025005,0,0
6,GO TAXIS,0.7495,-0.0024014,-0.010814,0,0
6,GO NEURON DEATH,0.92682,-0.0025196,-0.0017035,0,0
6,GO POSITIVE REGULATION OF TOR SIGNALING,0.95466,-0.0026231,-0.013383,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.83713,-0.0030017,0.0066233,0,0
6,GO DOSAGE COMPENSATION,0.8303,-0.0030349,-0.013877,0,0
6,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.58456,-0.0030703,-0.15633,0,0
6,GO CHROMOSOME ORGANIZATION,0.87833,-0.0030851,0.0056816,0,0
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.37932,-0.0032129,-0.048803,0,0
6,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.40349,-0.003424,0.021385,0,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.93377,-0.0035655,-0.017228,0,0
6,GO RESPONSE TO LIGHT STIMULUS,0.60883,-0.0037699,0.020089,0,0
6,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.80989,-0.0038033,0.010839,0,0
6,GO PEPTIDYL LYSINE ACETYLATION,0.68418,-0.0038524,-0.013559,0,0
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.53742,-0.0038826,0.035653,0,0
6,GO CHEMICAL HOMEOSTASIS,0.95466,-0.003967,-0.0080533,0,0
6,GO HEART MORPHOGENESIS,0.99651,-0.0041449,-0.018148,0,0
6,GO HISTONE H4 K16 ACETYLATION,0.54903,-0.0041466,-0.019115,0,0
6,GO ORGANIC ACID TRANSPORT,0.55487,-0.0042215,0.017458,0,0
6,GO REGULATION OF CATABOLIC PROCESS,0.94073,-0.004325,-0.0048182,0,0
6,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.97557,-0.0043475,-0.013154,0,0
6,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.94769,-0.0043516,-0.016717,0,0
6,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.80312,-0.0043878,-0.024818,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.67776,-0.0045072,0.0046049,0,0
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.52025,-0.0047153,-0.030987,0,0
6,GO RESPONSE TO PH,0.76948,-0.004738,-0.027486,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEUS,0.69707,-0.0047639,-0.021699,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.71658,-0.0048014,-0.013175,0,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.80312,-0.0048961,-0.015413,0,0
6,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.75615,-0.0049049,-0.025801,0,0
6,GO REGULATION OF DNA CATABOLIC PROCESS,0.97557,-0.005009,0.0067403,0,0
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.72313,-0.005061,-0.052126,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.55487,-0.0050735,0.08997,0,0
6,GO MACROMOLECULE CATABOLIC PROCESS,0.90599,-0.0050959,-0.0070516,0,0
6,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.61497,-0.0051145,-0.021377,0,0
6,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.87144,-0.0051889,0.013658,0,0
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.72313,-0.0052208,-0.050558,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.82348,-0.0052434,-0.0048747,0,0
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.65866,-0.0052449,-0.048825,0,0
6,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.66501,-0.005382,-0.043445,0,0
6,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.20621,-0.0057439,-0.059669,0,0
6,GO CELLULAR OXIDANT DETOXIFICATION,0.87144,-0.0061845,-0.014707,0,0
6,GO LIPID CATABOLIC PROCESS,0.47588,-0.0062484,-0.037588,0,0
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.65234,-0.0063962,-0.022471,0,0
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.56666,-0.0064213,-0.021922,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.3746,-0.0064736,0.045386,0,0
6,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.91293,-0.0065886,-0.010019,0,0
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.95466,-0.0066102,-0.030804,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.85768,-0.0067242,0.0015205,0,0
6,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.48131,-0.0067761,0.044148,0,0
6,GO HEAT GENERATION,0.62113,-0.0067979,-0.041792,0,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.76281,-0.0068298,-0.040138,0,0
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.49227,-0.0068596,-0.061985,0,0
6,GO BLASTODERM SEGMENTATION,0.4978,-0.0069007,0.08959,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.44402,-0.0069391,-0.061373,0,0
6,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.31232,-0.006964,-0.10786,0,0
6,GO MUSCLE STRUCTURE DEVELOPMENT,0.58456,-0.0069784,-0.030028,0,0
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.76948,-0.0071088,-0.0088894,0,0
6,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.86455,-0.0071364,0.018294,0,0
6,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.87833,-0.007325,-0.045401,0,0
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.7495,-0.0073674,-0.011251,0,0
6,GO HINDLIMB MORPHOGENESIS,0.66501,-0.0074091,0.010561,0,0
6,GO POLYOL BIOSYNTHETIC PROCESS,0.86455,-0.0074578,-0.016199,0,0
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.84397,-0.0076558,-0.01464,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.76281,-0.0076769,-0.0092746,0,0
6,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.92682,-0.0077309,-0.018139,0,0
6,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.80989,-0.008001,-0.01596,0,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89907,-0.0080193,-0.0045908,0,0
6,GO MICROTUBULE ANCHORING AT CENTROSOME,0.70355,-0.0080197,-0.011913,0,0
6,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.65234,-0.0080541,-0.025212,0,0
6,GO SERTOLI CELL DEVELOPMENT,0.89215,-0.0080773,0.020725,0,0
6,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.83713,-0.0081249,-0.022048,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.71006,-0.0081736,-0.041355,0,0
6,GO SULFUR AMINO ACID METABOLIC PROCESS,0.61497,-0.008546,0.029044,0,0
6,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.80989,-0.0085715,-0.015401,0,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.54321,-0.0086583,-0.029287,0,0
6,GO APOPTOTIC CELL CLEARANCE,0.82348,-0.0088617,-0.082832,0,0
6,GO ERK1 AND ERK2 CASCADE,0.51459,-0.0089105,-0.046951,0,0
6,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.85768,-0.0089968,-0.012245,0,0
6,GO TRACHEA MORPHOGENESIS,0.89907,-0.0091072,-0.018687,0,0
6,GO DRINKING BEHAVIOR,0.7495,-0.0093318,-0.0030326,0,0
6,GO PIGMENT GRANULE ORGANIZATION,0.97557,-0.0093498,0.0090277,0,0
6,GO REGULATION OF MICROTUBULE BASED PROCESS,0.69707,-0.009508,-0.004935,0,0
6,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.87144,-0.00953,-0.011361,0,0
6,GO RESPONSE TO X RAY,0.60272,-0.0096007,-0.065705,0,0
6,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.50896,-0.0096237,-0.068419,0,0
6,GO FIBROBLAST PROLIFERATION,0.54903,-0.0097005,0.024163,0,0
6,GO MITRAL VALVE DEVELOPMENT,0.59664,-0.00975,-0.0624,0,0
6,GO PERICARDIUM DEVELOPMENT,0.94073,-0.0097832,-0.011658,0,0
6,GO RESPONSE TO ETHANOL,0.99651,-0.0098929,-0.00047781,0,0
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.60883,-0.010035,-0.049841,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.65866,-0.01009,-0.037508,0,0
6,GO POSITIVE REGULATION OF GLIOGENESIS,0.62732,-0.010112,-0.030351,0,0
6,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.53167,-0.010163,-0.041355,0,0
6,GO PROSTATE GLAND DEVELOPMENT,0.69707,-0.010221,-0.027857,0,0
6,GO CENTROMERE COMPLEX ASSEMBLY,0.49227,-0.010278,0.037499,0,0
6,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.8303,-0.010279,-0.010079,0,0
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.73628,-0.010351,-0.018502,0,0
6,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.81668,-0.010369,0.0030049,0,0
6,GO REGULATION OF PROTEIN FOLDING,0.65234,-0.010619,-0.0232,0,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.97557,-0.010684,-0.013915,0,0
6,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.60272,-0.010713,-0.10836,0,0
6,GO HEART DEVELOPMENT,0.48678,-0.010727,-0.037599,0,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.36064,-0.010749,-0.084745,0,0
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.99651,-0.010795,-0.023231,0,0
6,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.31653,-0.010802,-0.029142,0,0
6,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.80989,-0.010999,-0.0041155,0,0
6,GO BASE EXCISION REPAIR AP SITE FORMATION,0.95466,-0.011084,0.01409,0,0
6,GO GENE SILENCING,0.40843,-0.011122,-0.021814,0,0
6,GO SENSORY PERCEPTION OF SMELL,0.44924,-0.011182,-0.034949,0,0
6,GO CELLULAR RESPONSE TO ZINC ION,0.67776,-0.011203,-0.1668,0,0
6,GO COLLECTING DUCT DEVELOPMENT,0.68418,-0.011264,-0.036411,0,0
6,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.64605,-0.011307,0.058723,0,0
6,GO BLOOD VESSEL MORPHOGENESIS,0.19095,-0.011431,-0.080238,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.4545,-0.011468,-0.032258,0,0
6,GO RESPONSE TO AXON INJURY,0.91293,-0.011778,-0.0012456,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.62113,-0.011837,-0.034786,0,0
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.44402,-0.011893,0.12852,0,0
6,GO VESICLE LOCALIZATION,0.26847,-0.012029,-0.033037,0,0
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.47049,-0.012085,-0.032097,0,0
6,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.69061,-0.012213,-0.018482,0,0
6,GO CELLULAR RESPONSE TO STARVATION,0.40843,-0.012282,-0.041562,0,0
6,GO MUSCLE TISSUE DEVELOPMENT,0.44924,-0.012391,-0.031789,0,0
6,GO MESODERM DEVELOPMENT,0.44924,-0.012459,-0.050142,0,0
6,GO FEMALE SEX DIFFERENTIATION,0.56075,-0.012515,-0.022809,0,0
6,GO NEUTRAL AMINO ACID TRANSPORT,0.62732,-0.012588,0.025694,0,0
6,GO PROTEIN SUMOYLATION,0.77618,-0.012736,-0.0075734,0,0
6,GO NEGATIVE REGULATION OF SIGNALING,0.50337,-0.012781,-0.022183,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.87833,-0.012867,-0.0079675,0,0
6,GO BIOMINERALIZATION,0.89215,-0.012871,-0.020201,0,0
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.34256,-0.012913,-0.031051,0,0
6,GO CELLULAR RESPONSE TO VITAMIN D,0.55487,-0.012973,0.085402,0,0
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.17934,-0.013086,-0.058279,0,0
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.21579,-0.013223,-0.045768,0,0
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.33812,-0.01325,-0.059833,0,0
6,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.93377,-0.013264,0.0035065,0,0
6,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.57857,-0.013331,-0.027579,0,0
6,GO DNA BIOSYNTHETIC PROCESS,0.65866,-0.013388,-0.013358,0,0
6,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.76948,-0.013403,0.024341,0,0
6,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.20309,-0.013471,-0.05008,0,0
6,GO PROTEIN TARGETING TO LYSOSOME,0.56666,-0.013499,-0.066469,0,0
6,GO POLYOL CATABOLIC PROCESS,0.78962,-0.013535,-0.024826,0,0
6,GO GASTRULATION,0.65866,-0.013544,-0.044904,0,0
6,GO MICROTUBULE ANCHORING,0.63978,-0.013549,-0.024947,0,0
6,GO GLYCOPROTEIN METABOLIC PROCESS,0.56666,-0.013641,-0.035936,0,0
6,GO PHOTOPERIODISM,0.88523,-0.013648,-0.015083,0,0
6,GO BLASTOCYST DEVELOPMENT,0.60272,-0.013652,-0.018421,0,0
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.98255,-0.013772,-0.0020253,0,0
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.36064,-0.013815,-0.055739,0,0
6,GO REGULATION OF GLIAL CELL PROLIFERATION,0.7495,-0.013861,-0.027981,0,0
6,GO SERTOLI CELL DIFFERENTIATION,0.96163,-0.013871,-5.346e-05,0,0
6,GO RETROGRADE AXONAL TRANSPORT,0.93377,-0.013925,0.012308,0,0
6,GO REGULATION OF FATTY ACID OXIDATION,0.65866,-0.013971,0.046057,0,0
6,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.8303,-0.013999,0.0024329,0,0
6,GO HISTONE H3 K9 MODIFICATION,0.36526,-0.014096,-0.039662,0,0
6,GO NEUROINFLAMMATORY RESPONSE,0.72969,-0.014098,-0.032344,0,0
6,GO REGULATION OF BIOMINERALIZATION,0.59664,-0.014158,-0.038722,0,0
6,GO MITOPHAGY,0.33812,-0.014368,-0.059769,0,0
6,GO VITAMIN TRANSPORT,0.78289,-0.01444,0.035671,0,0
6,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.96163,-0.014539,-0.053293,0,0
6,GO HISTONE PHOSPHORYLATION,0.5726,-0.014694,-0.040065,0,0
6,GO HISTONE H3 K9 METHYLATION,0.59664,-0.01473,-0.027067,0,0
6,GO CELL DIVISION,0.48131,-0.014868,-0.022416,0,0
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.80312,-0.015031,-0.031949,0,0
6,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.60272,-0.015053,-0.043052,0,0
6,GO CELLULAR MACROMOLECULE LOCALIZATION,0.60272,-0.015136,-0.0088106,0,0
6,GO REGULATION OF HISTONE MODIFICATION,0.89215,-0.015318,-0.0092663,0,0
6,GO REGULATION OF T CELL MIGRATION,0.42347,-0.015403,-0.054232,0,0
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.40843,-0.015546,-0.019983,0,0
6,GO G2 DNA DAMAGE CHECKPOINT,0.87144,-0.015547,-0.015575,0,0
6,GO OSTEOBLAST DIFFERENTIATION,0.81668,-0.015593,-0.0057824,0,0
6,GO POSITIVE REGULATION OF CELL GROWTH,0.15517,-0.015865,-0.045594,0,0
6,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.98255,-0.015901,-0.023011,0,0
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.39371,-0.015977,-0.05669,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.4545,-0.016055,-0.03357,0,0
6,GO SPINDLE ORGANIZATION,0.39858,-0.016137,-0.028088,0,0
6,GO GLIOGENESIS,0.74288,-0.016142,-0.017504,0,0
6,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.59664,-0.016208,-0.068997,0,0
6,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.61497,-0.016301,0.028317,0,0
6,GO RESPONSE TO STEROL,0.77618,-0.016342,-0.017548,0,0
6,GO POSITIVE REGULATION OF DNA REPAIR,0.56666,-0.016354,-0.024477,0,0
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.39371,-0.016433,-0.052615,0,0
6,GO ORGAN INDUCTION,0.4978,-0.016484,-0.074804,0,0
6,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.15264,-0.016519,-0.058883,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.24288,-0.016529,-0.032371,0,0
6,GO REGULATION OF ORGANELLE ORGANIZATION,0.50337,-0.016546,-0.015016,0,0
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.50896,-0.016593,-0.053644,0,0
6,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.20937,-0.016604,-0.065645,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.44924,-0.016703,-0.027995,0,0
6,GO SISTER CHROMATID COHESION,0.92682,-0.016719,0.0106,0,0
6,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.68418,-0.016808,-0.052488,0,0
6,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.72313,-0.016871,-0.073009,0,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.46512,-0.016947,-0.030799,0,0
6,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.80312,-0.01708,-0.062657,0,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.4545,-0.017094,-0.030825,0,0
6,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.83713,-0.017231,-0.034079,0,0
6,GO SMOOTHENED SIGNALING PATHWAY,0.33373,-0.017298,-0.048122,0,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.72969,-0.017307,-0.013092,0,0
6,GO AUTOPHAGIC CELL DEATH,0.52594,-0.017344,-0.05563,0,0
6,GO REGULATION OF VASCULAR PERMEABILITY,0.70355,-0.017345,-0.030833,0,0
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.76281,-0.017359,-0.012146,0,0
6,GO REGULATION OF TRANSPORT,0.61497,-0.017377,-0.014246,0,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.53742,-0.017379,-0.029342,0,0
6,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.5726,-0.01739,-0.0339,0,0
6,GO GLAND MORPHOGENESIS,0.46512,-0.017413,-0.092293,0,0
6,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.27611,-0.017446,-0.045449,0,0
6,GO CALCIUM ION IMPORT,0.65866,-0.017459,0.027533,0,0
6,GO TRANSPORT ALONG MICROTUBULE,0.89907,-0.01748,0.01167,0,0
6,GO REGULATION OF CHROMATIN ORGANIZATION,0.53167,-0.017485,-0.019121,0,0
6,GO KERATAN SULFATE METABOLIC PROCESS,0.77618,-0.017605,-0.041129,0,0
6,GO CARDIAC SEPTUM MORPHOGENESIS,0.86455,-0.017617,-0.029001,0,0
6,GO ACETYL COA METABOLIC PROCESS,0.74288,-0.017803,0.024424,0,0
6,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.58456,-0.017903,-0.012086,0,0
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.72313,-0.017932,-0.0043403,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.47049,-0.017987,-0.049102,0,0
6,GO AMMONIUM ION METABOLIC PROCESS,0.36991,-0.01823,-0.09678,0,0
6,GO SISTER CHROMATID SEGREGATION,0.60272,-0.018329,-0.011517,0,0
6,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.91293,-0.01838,-0.080202,0,0
6,GO ANION TRANSPORT,0.7495,-0.018423,-0.010151,0,0
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.94769,-0.018629,0.018076,0,0
6,GO SKIN EPIDERMIS DEVELOPMENT,0.88523,-0.018726,-0.024389,0,0
6,GO RESPONSE TO ZINC ION,0.62113,-0.018737,-0.069647,0,0
6,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.58456,-0.018831,0.020753,0,0
6,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.53742,-0.018839,-0.060528,0,0
6,GO REGULATION OF DNA METABOLIC PROCESS,0.71006,-0.018859,-0.010004,0,0
6,GO PROTEIN N LINKED GLYCOSYLATION,0.34702,-0.018873,-0.071356,0,0
6,GO DIACYLGLYCEROL METABOLIC PROCESS,0.32506,-0.018886,-0.078006,0,0
6,GO REGULATION OF STEM CELL PROLIFERATION,0.53167,-0.01915,-0.046456,0,0
6,GO REGULATION OF CELL CYCLE,0.30815,-0.019229,-0.020215,0,0
6,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.41341,-0.019283,-0.022807,0,0
6,GO ORGANELLE INHERITANCE,0.49227,-0.019439,-0.037226,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.48131,-0.019447,-0.032394,0,0
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.49227,-0.019517,-0.042666,0,0
6,GO VASCULATURE DEVELOPMENT,0.25363,-0.019522,-0.066452,0,0
6,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.48678,-0.019665,-0.050587,0,0
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.58456,-0.019705,0.028858,0,0
6,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.23589,-0.019711,-0.054555,0,0
6,GO REGULATION OF LYMPHOCYTE MIGRATION,0.39858,-0.019807,-0.060449,0,0
6,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.56666,-0.019892,-0.028081,0,0
6,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.2,-0.019967,-0.071375,0,0
6,GO REGULATION OF AUTOPHAGY,0.4978,-0.019997,-0.022612,0,0
6,GO REGULATION OF CELLULAR COMPONENT SIZE,0.68418,-0.020077,-0.014108,0,0
6,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.50896,-0.020125,0.067618,0,0
6,GO POSITIVE REGULATION OF GROWTH,0.67776,-0.020305,-0.012599,0,0
6,GO REGULATION OF PHOSPHORYLATION,0.20937,-0.020325,-0.042632,0,0
6,GO CELL VOLUME HOMEOSTASIS,0.15264,-0.020357,-0.080097,0,0
6,GO LAMELLIPODIUM ORGANIZATION,0.23245,-0.020431,-0.059592,0,0
6,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.77618,-0.02049,-0.033878,0,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.65234,-0.020664,-0.02965,0,0
6,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.24643,-0.020679,-0.10669,0,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.65866,-0.021099,-0.030584,0,0
6,GO MEMBRANE FUSION,0.27999,-0.021176,-0.048341,0,0
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.89907,-0.021317,0.071593,0,0
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25363,-0.02133,-0.028237,0,0
6,GO MICROTUBULE BASED MOVEMENT,0.27227,-0.021344,-0.033256,0,0
6,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.89907,-0.021446,-0.0045247,0,0
6,GO MUSCLE FILAMENT SLIDING,0.91987,-0.021468,-0.016047,0,0
6,GO ORGANIC ACID METABOLIC PROCESS,0.81668,-0.021567,-0.016558,0,0
6,GO NUCLEAR ENVELOPE REASSEMBLY,0.4598,-0.021573,-0.051162,0,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67776,-0.021645,-0.032571,0,0
6,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.51459,-0.021663,-0.03962,0,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.4545,-0.021732,-0.015393,0,0
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.53167,-0.021734,-0.026713,0,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.67776,-0.021846,-0.0047164,0,0
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.70355,-0.021862,-0.021587,0,0
6,GO REGULATION OF VASCULOGENESIS,0.33373,-0.021997,-0.093101,0,0
6,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.50337,-0.022015,-0.027923,0,0
6,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.78289,-0.022044,-0.03604,0,0
6,GO VITAMIN D BIOSYNTHETIC PROCESS,0.67137,-0.022119,-0.031084,0,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.72313,-0.02213,-0.051099,0,0
6,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.59664,-0.022203,-0.017086,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.21905,-0.022287,-0.090021,0,0
6,GO PEPTIDYL LYSINE TRIMETHYLATION,0.47588,-0.022386,-0.021315,0,0
6,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.80312,-0.022407,-0.038593,0,0
6,GO RESPONSE TO OXYGEN LEVELS,0.93377,-0.022455,-0.013078,0,0
6,GO FERTILIZATION,0.26098,-0.022487,-0.028927,0,0
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.188,-0.022569,-0.04408,0,0
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.29586,-0.022607,-0.034894,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.18219,-0.02268,-0.13403,0,0
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.50337,-0.022701,-0.035619,0,0
6,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.89907,-0.022744,-0.020357,0,0
6,GO POLYSACCHARIDE CATABOLIC PROCESS,0.92682,-0.022747,-0.0033542,0,0
6,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.77618,-0.02277,-0.02659,0,0
6,GO GLIAL CELL DIFFERENTIATION,0.61497,-0.02287,-0.023392,0,0
6,GO CELLULAR RESPONSE TO KETONE,0.32938,-0.022926,-0.066363,0,0
6,GO BODY MORPHOGENESIS,0.31653,-0.022946,-0.081159,0,0
6,GO INTERLEUKIN 2 PRODUCTION,0.72313,-0.023015,-0.049528,0,0
6,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.59664,-0.023039,-0.081571,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.21579,-0.023048,-0.1047,0,0
6,GO P BODY ASSEMBLY,0.61497,-0.023064,-0.018746,0,0
6,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.95466,-0.023077,0.00022288,0,0
6,GO PROTEIN TARGETING TO VACUOLE,0.36991,-0.023133,-0.057583,0,0
6,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.32506,-0.023137,-0.056151,0,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.78962,-0.023186,-0.082528,0,0
6,GO DNA INTEGRITY CHECKPOINT,0.29586,-0.023214,-0.038719,0,0
6,GO RECEPTOR BIOSYNTHETIC PROCESS,0.36064,-0.02324,-0.063778,0,0
6,GO ORGANIC ACID CATABOLIC PROCESS,0.40349,-0.023243,-0.049346,0,0
6,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.17374,-0.023355,-0.046619,0,0
6,GO FATTY ACID TRANSPORT,0.72969,-0.023384,-0.024542,0,0
6,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.49227,-0.023425,-0.050692,0,0
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.49227,-0.023635,-0.021057,0,0
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.38408,-0.023652,-0.068116,0,0
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.15773,-0.024099,-0.049024,0,0
6,GO AMINE CATABOLIC PROCESS,0.44924,-0.024209,-0.093456,0,0
6,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.30402,-0.024269,-0.1025,0,0
6,GO POLYSACCHARIDE METABOLIC PROCESS,0.27611,-0.024315,-0.054826,0,0
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.32938,-0.024508,-0.030476,0,0
6,GO RESPONSE TO ABIOTIC STIMULUS,0.52025,-0.024594,-0.023625,0,0
6,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35607,-0.024607,-0.033533,0,0
6,GO CARBOHYDRATE METABOLIC PROCESS,0.80989,-0.024674,-0.0090311,0,0
6,GO REGULATION OF DNA REPLICATION,0.92682,-0.02468,-0.0045385,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.65866,-0.024829,-0.01931,0,0
6,GO NEGATIVE REGULATION OF OSSIFICATION,0.36064,-0.024879,-0.07039,0,0
6,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.41341,-0.024891,-0.055045,0,0
6,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.67137,-0.024914,-0.030866,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.30815,-0.024951,-0.031347,0,0
6,GO C4 DICARBOXYLATE TRANSPORT,0.98255,-0.024992,0.01505,0,0
6,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.35153,-0.025158,-0.071753,0,0
6,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.38888,-0.025203,-0.024403,0,0
6,GO REGULATION OF DEPHOSPHORYLATION,0.41842,-0.025215,-0.021795,0,0
6,GO MELANOCYTE DIFFERENTIATION,0.43367,-0.025222,-0.056351,0,0
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.78962,-0.025276,-0.01593,0,0
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.2839,-0.025285,-0.029132,0,0
6,GO PATTERN SPECIFICATION PROCESS,0.44924,-0.025338,-0.030402,0,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.60272,-0.025653,-0.045093,0,0
6,GO AMINE TRANSPORT,0.99651,-0.025839,0.064469,0,0
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.98953,-0.025852,0.045742,0,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.53742,-0.025889,-0.011043,0,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.99651,-0.025897,0.0025506,0,0
6,GO CELLULAR KETONE METABOLIC PROCESS,0.5726,-0.02593,-0.053479,0,0
6,GO REGULATION OF ORGANELLE ASSEMBLY,0.11841,-0.025953,-0.040729,0,0
6,GO CELL CYCLE,0.25001,-0.025977,-0.022523,0,0
6,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.27227,-0.026075,-0.049069,0,0
6,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.24288,-0.026102,-0.018355,0,0
6,GO POSITIVE REGULATION OF EXOCYTOSIS,0.72313,-0.02615,0.0020184,0,0
6,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.87144,-0.026156,-0.015939,0,0
6,GO MEMBRANE DOCKING,0.20309,-0.026247,-0.029645,0,0
6,GO MAMMARY GLAND DEVELOPMENT,0.20621,-0.026289,-0.071253,0,0
6,GO RESPONSE TO RADIATION,0.65866,-0.02629,-0.0067871,0,0
6,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.24643,-0.026311,-0.028875,0,0
6,GO MUSCLE CELL DIFFERENTIATION,0.40349,-0.026345,-0.042672,0,0
6,GO MACROPHAGE ACTIVATION,0.84397,-0.026365,-0.024553,0,0
6,GO MESENCHYMAL CELL DIFFERENTIATION,0.56075,-0.026375,-0.047339,0,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,1,-0.026387,-0.012159,0,0
6,GO T CELL MIGRATION,0.43367,-0.026446,-0.06959,0,0
6,GO TRANSMISSION OF NERVE IMPULSE,0.9686,-0.026471,0.027409,0,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.25363,-0.026567,-0.076366,0,0
6,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.36064,-0.026647,-0.055413,0,0
6,GO BLEB ASSEMBLY,0.33373,-0.026684,-0.25347,0,0
6,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15773,-0.026729,-0.097364,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.43367,-0.026904,-0.028678,0,0
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.50337,-0.026967,-0.044751,0,0
6,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.36064,-0.027007,-0.033968,0,0
6,GO AXIS SPECIFICATION,0.69707,-0.027023,-0.00131,0,0
6,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.46512,-0.027051,-0.040504,0,0
6,GO COPII COATED VESICLE CARGO LOADING,0.62732,-0.027099,-0.023682,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.87144,-0.027157,-0.0027098,0,0
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.85082,-0.02721,-0.0089129,0,0
6,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.17934,-0.027252,-0.048935,0,0
6,GO HOMEOSTATIC PROCESS,0.26847,-0.02729,-0.030685,0,0
6,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15264,-0.027331,-0.13456,0,0
6,GO MUSCLE ATROPHY,0.51459,-0.027353,-0.093716,0,0
6,GO FACE DEVELOPMENT,0.2,-0.027398,-0.098459,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.81668,-0.02754,-0.022786,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.34256,-0.027581,-0.03578,0,0
6,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33373,-0.027635,-0.03034,0,0
6,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.67776,-0.027651,-0.017569,0,0
6,GO REGULATION OF ACTION POTENTIAL,0.78289,-0.027837,-0.022079,0,0
6,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.56075,-0.027854,-0.10173,0,0
6,GO RESPONSE TO INSULIN,0.23937,-0.027872,-0.040946,0,0
6,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.95466,-0.027884,0.0057815,0,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.7495,-0.027931,-0.0022154,0,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.96163,-0.028046,-0.020998,0,0
6,GO REGULATION OF INTRACELLULAR TRANSPORT,0.34256,-0.028056,-0.028641,0,0
6,GO SMOOTH MUSCLE CELL PROLIFERATION,0.61497,-0.028077,-0.044532,0,0
6,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.68418,-0.028218,-0.021905,0,0
6,GO RESPONSE TO STARVATION,0.69707,-0.028266,-0.019755,0,0
6,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32077,-0.028559,-0.044567,0,0
6,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.32938,-0.028631,-0.061288,0,0
6,GO CHROMOSOME SEGREGATION,0.4598,-0.028657,-0.022158,0,0
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.12473,-0.028662,-0.054169,0,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.83713,-0.028844,-0.0091235,0,0
6,GO REGULATION OF MEMBRANE REPOLARIZATION,0.67776,-0.028846,0.028935,0,0
6,GO ORGANIC ANION TRANSPORT,0.52594,-0.028995,-0.022643,0,0
6,GO EPIDERMIS MORPHOGENESIS,0.87144,-0.029194,-0.039638,0,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.69707,-0.0292,-0.0099276,0,0
6,GO CELL SUBSTRATE ADHESION,0.56666,-0.029225,-0.050192,0,0
6,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.88523,-0.029295,-0.023462,0,0
6,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.5726,-0.029314,-0.027981,0,0
6,GO OSSIFICATION,0.33373,-0.029494,-0.057957,0,0
6,GO REGULATION OF CELL DIVISION,0.25729,-0.029523,-0.04194,0,0
6,GO MUSCLE CELL PROLIFERATION,0.61497,-0.029577,-0.039756,0,0
6,GO FOCAL ADHESION ASSEMBLY,0.43883,-0.029639,-0.064164,0,0
6,GO LEUKOCYTE HOMEOSTASIS,0.28785,-0.02964,-0.067543,0,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.20937,-0.029771,-0.10267,0,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.27227,-0.029816,-0.030102,0,0
6,GO CIRCULATORY SYSTEM DEVELOPMENT,0.25729,-0.029835,-0.058054,0,0
6,GO NUCLEAR ENVELOPE ORGANIZATION,0.25729,-0.029843,-0.056505,0,0
6,GO NIK NF KAPPAB SIGNALING,0.27227,-0.029898,-0.085049,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.059411,-0.02991,-0.065,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.070855,-0.030125,-0.036356,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.25001,-0.030207,-0.042938,0,0
6,GO MOLTING CYCLE,0.63354,-0.030221,-0.044955,0,0
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.31653,-0.03029,-0.057567,0,0
6,GO LONG CHAIN FATTY ACID TRANSPORT,0.62113,-0.030407,-0.03705,0,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.21256,-0.030434,-0.071756,0,0
6,GO CELL JUNCTION ASSEMBLY,0.31232,-0.030441,-0.050339,0,0
6,GO STEM CELL DIVISION,0.94769,-0.03047,-0.0068845,0,0
6,GO ALCOHOL CATABOLIC PROCESS,0.4978,-0.030495,-0.053634,0,0
6,GO ACID SECRETION,0.90599,-0.030511,-0.0013233,0,0
6,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.77618,-0.030557,-0.010788,0,0
6,GO CELLULAR EXTRAVASATION,0.56075,-0.030612,-0.031455,0,0
6,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.50896,-0.030648,-0.056695,0,0
6,GO GLUTATHIONE METABOLIC PROCESS,0.91987,-0.030648,-0.02002,0,0
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.40349,-0.030654,-0.052955,0,0
6,GO REGULATION OF CHOLESTEROL EFFLUX,0.30402,-0.030756,-0.068411,0,0
6,GO T CELL RECEPTOR SIGNALING PATHWAY,0.080955,-0.030783,-0.083591,0,0
6,GO REGULATION OF GLUCONEOGENESIS,0.76948,-0.030822,-0.021881,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.69707,-0.030851,-0.027205,0,0
6,GO RESPIRATORY SYSTEM DEVELOPMENT,0.14526,-0.03092,-0.079507,0,0
6,GO REGULATION OF CELL AGING,0.32506,-0.030984,-0.064828,0,0
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.14526,-0.031013,-0.041615,0,0
6,GO INOSITOL LIPID MEDIATED SIGNALING,0.20621,-0.031033,-0.058887,0,0
6,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.22568,-0.031154,-0.053133,0,0
6,GO AGING,0.1028,-0.031162,-0.074528,0,0
6,GO REGULATION OF CALCIUM ION IMPORT,0.54321,-0.031173,-0.040351,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.23589,-0.031365,-0.062076,0,0
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.69707,-0.031397,-0.026546,0,0
6,GO MITOTIC CELL CYCLE CHECKPOINT,0.049546,-0.031431,-0.054434,0,0
6,GO HAIR FOLLICLE MATURATION,0.27611,-0.031505,-0.10466,0,0
6,GO PROTEIN CATABOLIC PROCESS,0.095625,-0.031539,-0.052693,0,0
6,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.47588,-0.031565,-0.039208,0,0
6,GO SKIN MORPHOGENESIS,0.39371,-0.031647,-0.14764,0,0
6,GO SULFATE TRANSPORT,0.073629,-0.031684,-0.062673,0,0
6,GO POSITIVE REGULATION OF HEAT GENERATION,0.69061,-0.03171,-0.032563,0,0
6,GO CORTICAL CYTOSKELETON ORGANIZATION,0.38888,-0.031726,-0.06098,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.068167,-0.031776,-0.037793,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.4545,-0.031787,-0.045034,0,0
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0695,-0.031794,-0.043171,0,0
6,GO LAMELLIPODIUM ASSEMBLY,0.44402,-0.031798,-0.036458,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.65234,-0.031911,-0.028526,0,0
6,GO DNA CATABOLIC PROCESS,0.15773,-0.032259,-0.067355,0,0
6,GO SMALL MOLECULE CATABOLIC PROCESS,0.23245,-0.032418,-0.05419,0,0
6,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.78962,-0.032572,-0.052148,0,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.15264,-0.03268,-0.16772,0,0
6,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.51459,-0.032754,-0.026166,0,0
6,GO REGULATION OF PHAGOCYTOSIS,0.22235,-0.032766,-0.090831,0,0
6,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.24643,-0.032795,-0.071503,0,0
6,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.90599,-0.032901,-0.019411,0,0
6,GO SODIUM ION HOMEOSTASIS,0.27999,-0.032947,-0.046438,0,0
6,GO REGULATION OF PROTEIN BINDING,0.36064,-0.03295,-0.037602,0,0
6,GO REGULATION OF GROWTH HORMONE SECRETION,0.89907,-0.033011,0.01014,0,0
6,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.22568,-0.033062,-0.068204,0,0
6,GO NEUTRAL LIPID METABOLIC PROCESS,0.61497,-0.033134,-0.010585,0,0
6,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.23245,-0.033202,-0.07845,0,0
6,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.11039,-0.033212,-0.03158,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.60272,-0.033233,-0.022539,0,0
6,GO HISTONE H2B UBIQUITINATION,0.19095,-0.033276,-0.077911,0,0
6,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.36064,-0.033339,-0.15957,0,0
6,GO REGULATION OF TRANSFERASE ACTIVITY,0.15517,-0.033368,-0.037576,0,0
6,GO DNA METHYLATION,0.59664,-0.033528,-0.014798,0,0
6,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.60883,-0.033558,-0.077682,0,0
6,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.85768,-0.03357,0.0008337,0,0
6,GO LYSOSOMAL TRANSPORT,0.32506,-0.033694,-0.053499,0,0
6,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.46512,-0.033767,-0.044268,0,0
6,GO HISTONE H3 K9 ACETYLATION,0.32938,-0.033798,-0.055461,0,0
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.5726,-0.033834,-0.029344,0,0
6,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.22905,-0.033836,-0.080209,0,0
6,GO RESPONSE TO METAL ION,0.29184,-0.033855,-0.042174,0,0
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17099,-0.033886,-0.03698,0,0
6,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.89907,-0.033909,0.016014,0,0
6,GO ALCOHOL METABOLIC PROCESS,0.69707,-0.033941,-0.029167,0,0
6,GO DETOXIFICATION,0.53167,-0.033965,-0.044965,0,0
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.48678,-0.033968,-0.067663,0,0
6,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.35607,-0.034059,-0.10266,0,0
6,GO FLUID TRANSPORT,0.25363,-0.034061,-0.074638,0,0
6,GO SIGNAL RELEASE,0.65866,-0.034071,-0.0010474,0,0
6,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.20309,-0.034174,-0.10134,0,0
6,GO INTRACELLULAR STEROL TRANSPORT,0.57857,-0.034258,-0.055949,0,0
6,GO MICROTUBULE BASED PROCESS,0.38408,-0.034271,-0.014227,0,0
6,GO NUCLEAR CHROMOSOME SEGREGATION,0.12259,-0.034518,-0.043649,0,0
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.81668,-0.034534,0.0091153,0,0
6,GO SUBSTANTIA NIGRA DEVELOPMENT,0.62113,-0.03477,-0.047274,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.38408,-0.034804,-0.028389,0,0
6,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.99651,-0.034977,-0.0036248,0,0
6,GO CYTOSOLIC TRANSPORT,0.36526,-0.03502,-0.030797,0,0
6,GO ENERGY RESERVE METABOLIC PROCESS,0.51459,-0.035137,-0.030078,0,0
6,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.2,-0.035363,-0.031391,0,0
6,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.79636,-0.03559,-0.02196,0,0
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.39371,-0.035609,-0.026577,0,0
6,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.67776,-0.035659,-0.014561,0,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.43367,-0.035699,-0.042587,0,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.21256,-0.035736,-0.040174,0,0
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.093897,-0.035767,-0.054094,0,0
6,GO RESPONSE TO PEPTIDE,0.25729,-0.035808,-0.036664,0,0
6,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.22235,-0.035875,-0.065438,0,0
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.89215,-0.035892,0.015056,0,0
6,GO CIRCADIAN RHYTHM,0.24643,-0.035946,-0.029111,0,0
6,GO RESPONSE TO HYDROXYUREA,0.27999,-0.035971,-0.074191,0,0
6,GO REGULATION OF HEAT GENERATION,0.54903,-0.036122,-0.056632,0,0
6,GO NEGATIVE REGULATION OF CELL GROWTH,0.58456,-0.036219,-0.018153,0,0
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.31653,-0.036249,-0.052113,0,0
6,GO CERAMIDE CATABOLIC PROCESS,0.55487,-0.03626,-0.098518,0,0
6,GO CELL REDOX HOMEOSTASIS,0.92682,-0.036266,-0.024957,0,0
6,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.54321,-0.03635,-0.019318,0,0
6,GO PIGMENT CELL DIFFERENTIATION,0.38408,-0.036384,-0.055867,0,0
6,GO RESPONSE TO HYDROPEROXIDE,0.95466,-0.03645,-0.0058813,0,0
6,GO NEURON APOPTOTIC PROCESS,0.63978,-0.036481,-0.0072482,0,0
6,GO RESPONSE TO THYROID HORMONE,0.82348,-0.036511,-0.029967,0,0
6,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.38408,-0.036559,-0.050379,0,0
6,GO SEQUESTERING OF TRIGLYCERIDE,0.72313,-0.036686,0.025592,0,0
6,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.13583,-0.036791,-0.10331,0,0
6,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.38408,-0.036805,-0.071526,0,0
6,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26471,-0.036864,-0.060497,0,0
6,GO PEPTIDE CATABOLIC PROCESS,0.36991,-0.036872,-0.066441,0,0
6,GO RESPONSE TO ACID CHEMICAL,0.80989,-0.036963,-0.013388,0,0
6,GO CELLULAR RESPONSE TO PEPTIDE,0.14769,-0.037064,-0.045112,0,0
6,GO DENDRITIC CELL CHEMOTAXIS,0.27999,-0.037255,-0.097812,0,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.93377,-0.03729,-0.0008696,0,0
6,GO VESICLE ORGANIZATION,0.053746,-0.037366,-0.070643,0,0
6,GO NEPHRON MORPHOGENESIS,0.20309,-0.037413,-0.073062,0,0
6,GO LIPID MODIFICATION,0.061812,-0.037429,-0.071872,0,0
6,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.28785,-0.037451,-0.044029,0,0
6,GO GLIAL CELL DEVELOPMENT,0.40349,-0.037506,-0.044883,0,0
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.73628,-0.037519,-0.033958,0,0
6,GO LOCOMOTOR RHYTHM,0.94073,-0.037552,0.010264,0,0
6,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.51459,-0.037629,-0.069764,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE,0.12049,-0.037645,-0.032588,0,0
6,GO MACROMOLECULE DEPALMITOYLATION,0.29992,-0.03767,-0.062206,0,0
6,GO RENAL SYSTEM PROCESS,0.084046,-0.037818,-0.092098,0,0
6,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.84397,-0.038001,-0.039616,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.2,-0.038061,-0.10665,0,0
6,GO DE NOVO PROTEIN FOLDING,0.31653,-0.038069,-0.038373,0,0
6,GO REGULATION OF AMINO ACID TRANSPORT,0.59664,-0.038191,-0.018397,0,0
6,GO REGULATION OF MULTI ORGANISM PROCESS,0.53167,-0.038201,-0.051807,0,0
6,GO RESPONSE TO ACTIVITY,0.23937,-0.03821,-0.067827,0,0
6,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.049546,-0.03837,-0.055105,0,0
6,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.54903,-0.038384,-0.041155,0,0
6,GO RESPONSE TO GROWTH FACTOR,0.20309,-0.03839,-0.059884,0,0
6,GO PROTEIN DEPHOSPHORYLATION,0.51459,-0.038394,-0.014103,0,0
6,GO N GLYCAN PROCESSING,0.39858,-0.038396,-0.10408,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.11841,-0.038424,-0.059097,0,0
6,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.49227,-0.038452,-0.11563,0,0
6,GO APPENDAGE DEVELOPMENT,0.12689,-0.038465,-0.09591,0,0
6,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.3746,-0.038467,-0.10747,0,0
6,GO CARNITINE SHUTTLE,0.91293,-0.038579,0.013771,0,0
6,GO ORGANELLE LOCALIZATION,0.05824,-0.038687,-0.039002,0,0
6,GO TRANSFERRIN TRANSPORT,0.2839,-0.038787,-0.062721,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.084046,-0.038791,-0.06953,0,0
6,GO REGULATION OF MITOTIC CELL CYCLE,0.073629,-0.038847,-0.04078,0,0
6,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.48678,-0.038902,-0.067253,0,0
6,GO DIET INDUCED THERMOGENESIS,0.73628,-0.038937,0.06081,0,0
6,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.29586,-0.039185,-0.04237,0,0
6,GO DNA MODIFICATION,0.17653,-0.039344,-0.043046,0,0
6,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.057089,-0.039424,-0.10535,0,0
6,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.12473,-0.039426,-0.062679,0,0
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.099158,-0.03947,-0.056999,0,0
6,GO CENTRIOLE CENTRIOLE COHESION,0.84397,-0.039504,0.013789,0,0
6,GO REGENERATION,0.44924,-0.039542,-0.050252,0,0
6,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.061812,-0.039547,-0.085658,0,0
6,GO PEROXISOMAL TRANSPORT,0.33812,-0.039597,-0.047467,0,0
6,GO REGULATION OF INSULIN SECRETION,0.91987,-0.039604,-0.00057665,0,0
6,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.22905,-0.039639,-0.047706,0,0
6,GO NEGATIVE REGULATION OF DNA REPLICATION,0.59664,-0.039711,-0.031453,0,0
6,GO ADIPOSE TISSUE DEVELOPMENT,0.86455,-0.03972,-0.00070276,0,0
6,GO NEURON PROJECTION REGENERATION,0.89215,-0.039762,0.010796,0,0
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.84397,-0.039803,-0.0012998,0,0
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.71658,-0.039815,-0.06205,0,0
6,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.11039,-0.0399,-0.060889,0,0
6,GO AXIS ELONGATION,0.43883,-0.039958,-0.092542,0,0
6,GO REGULATION OF BLOOD PRESSURE,0.27611,-0.039994,-0.057518,0,0
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.80312,-0.039999,-0.020449,0,0
6,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.26847,-0.04001,-0.029269,0,0
6,GO LIPID OXIDATION,0.39371,-0.040258,-0.057369,0,0
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.51459,-0.040537,-0.031294,0,0
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.20309,-0.040573,-0.078009,0,0
6,GO METANEPHROS DEVELOPMENT,0.18219,-0.040599,-0.08717,0,0
6,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.59664,-0.040689,-0.083843,0,0
6,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.9686,-0.040872,-0.0072722,0,0
6,GO VAGINA DEVELOPMENT,0.66501,-0.040942,-0.065526,0,0
6,GO NEGATIVE REGULATION OF TRANSPORT,0.30402,-0.040996,-0.030411,0,0
6,GO REGULATION OF GASTRIC ACID SECRETION,0.74288,-0.041092,-0.053444,0,0
6,GO ANIMAL ORGAN FORMATION,0.64605,-0.041307,-0.04753,0,0
6,GO REGULATION OF PROTEIN POLYMERIZATION,0.62113,-0.041312,-0.014243,0,0
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.070855,-0.041433,-0.062038,0,0
6,GO CHOLESTEROL STORAGE,0.55487,-0.041642,-0.043475,0,0
6,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.43367,-0.041695,-0.070172,0,0
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.31232,-0.041744,-0.037809,0,0
6,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.11841,-0.041768,-0.1354,0,0
6,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.41341,-0.041783,-0.041813,0,0
6,GO STEROID BIOSYNTHETIC PROCESS,0.5726,-0.041792,-0.0294,0,0
6,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.13355,-0.041859,-0.046722,0,0
6,GO PROTEIN AUTOPHOSPHORYLATION,0.47588,-0.04197,-0.025186,0,0
6,GO CHRONIC INFLAMMATORY RESPONSE,0.65234,-0.041986,-0.10079,0,0
6,GO PEPTIDYL AMINO ACID MODIFICATION,0.049546,-0.04202,-0.041943,0,0
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.98953,-0.042116,0.020262,0,0
6,GO CERAMIDE METABOLIC PROCESS,0.12049,-0.042272,-0.079071,0,0
6,GO PEROXISOME ORGANIZATION,0.22905,-0.04234,-0.053457,0,0
6,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.75615,-0.042351,-0.032161,0,0
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.26847,-0.042466,-0.059192,0,0
6,GO NEGATIVE REGULATION OF GENE SILENCING,0.71658,-0.042635,0.017626,0,0
6,GO ENDOSOME TO LYSOSOME TRANSPORT,0.19695,-0.042642,-0.054506,0,0
6,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.96163,-0.042652,-0.013778,0,0
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.21256,-0.042748,-0.068053,0,0
6,GO OOGENESIS,0.093897,-0.042759,-0.089788,0,0
6,GO VITAMIN D METABOLIC PROCESS,0.53167,-0.042766,-0.062195,0,0
6,GO REGULATION OF SISTER CHROMATID COHESION,0.53742,-0.042845,-0.027221,0,0
6,GO CD40 SIGNALING PATHWAY,0.34702,-0.042873,-0.12019,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.1313,-0.04288,-0.061497,0,0
6,GO REGULATION OF CILIUM MOVEMENT,0.061812,-0.042892,-0.10529,0,0
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.61497,-0.04295,-0.0063505,0,0
6,GO REGULATION OF APPETITE,0.31232,-0.042951,-0.063649,0,0
6,GO ZINC ION HOMEOSTASIS,0.52594,-0.042958,-0.094631,0,0
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.004408,-0.042958,-0.071349,0,0
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.72969,-0.043058,-0.013679,0,0
6,GO ASTROCYTE ACTIVATION,0.30402,-0.043064,-0.078155,0,0
6,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.38408,-0.043199,-0.024521,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29184,-0.043241,-0.051012,0,0
6,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.19095,-0.043286,-0.058209,0,0
6,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.064293,-0.04336,-0.054893,0,0
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.53167,-0.043416,-0.034598,0,0
6,GO MAINTENANCE OF CELL NUMBER,0.1028,-0.043477,-0.074725,0,0
6,GO MEMBRANE ORGANIZATION,0.33812,-0.043611,-0.030583,0,0
6,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.082489,-0.043676,-0.056599,0,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.79636,-0.043696,-0.0084209,0,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.78289,-0.043801,-0.027243,0,0
6,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.36991,-0.043886,-0.054294,0,0
6,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.16294,-0.044033,-0.045415,0,0
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.46512,-0.044044,-0.047773,0,0
6,GO REGULATION OF MITOPHAGY,0.25729,-0.044058,-0.068177,0,0
6,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.55487,-0.044097,-0.048412,0,0
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.56666,-0.04418,-0.033172,0,0
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.21256,-0.044222,-0.038824,0,0
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.14526,-0.044224,-0.094239,0,0
6,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.44924,-0.044239,-0.077296,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.05824,-0.044253,-0.04826,0,0
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.14769,-0.044285,-0.058075,0,0
6,GO PROTEIN POLYMERIZATION,0.42855,-0.044392,-0.022277,0,0
6,GO TOR SIGNALING,0.15517,-0.044434,-0.034649,0,0
6,GO RESPONSE TO HORMONE,0.29184,-0.044482,-0.03894,0,0
6,GO REGULATION OF SECRETION,0.17099,-0.044584,-0.046648,0,0
6,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.31232,-0.044735,-0.068603,0,0
6,GO HETEROCHROMATIN ORGANIZATION,0.04854,-0.044763,-0.052471,0,0
6,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.52025,-0.044783,-0.023919,0,0
6,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.29586,-0.044801,-0.12579,0,0
6,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.78962,-0.044913,0.036864,0,0
6,GO SPINDLE ASSEMBLY,0.05824,-0.044964,-0.053659,0,0
6,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.41842,-0.04497,-0.073289,0,0
6,GO RESPONSE TO INTERLEUKIN 1,0.088862,-0.044973,-0.10864,0,0
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.85082,-0.045019,-0.013569,0,0
6,GO POSITIVE REGULATION OF CELL DEATH,0.21905,-0.045074,-0.044078,0,0
6,GO PHOSPHOLIPID CATABOLIC PROCESS,0.054842,-0.045134,-0.14388,0,0
6,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.8303,-0.045257,-0.051683,0,0
6,GO ORGANELLE ASSEMBLY,0.0066042,-0.045259,-0.058024,0,0
6,GO CALCINEURIN MEDIATED SIGNALING,0.42347,-0.045265,-0.037511,0,0
6,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.72969,-0.04527,-0.037436,0,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17099,-0.045311,-0.073217,0,0
6,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.1313,-0.045372,-0.06962,0,0
6,GO POSITIVE REGULATION OF TRANSPORT,0.14769,-0.045383,-0.037579,0,0
6,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.83713,-0.045384,-0.031136,0,0
6,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.94769,-0.045392,-0.018674,0,0
6,GO RECEPTOR CATABOLIC PROCESS,0.44402,-0.045482,-0.055209,0,0
6,GO RESPONSE TO KETONE,0.17099,-0.045567,-0.077068,0,0
6,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.69061,-0.045643,-0.045265,0,0
6,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.079444,-0.045653,-0.065112,0,0
6,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0695,-0.045681,-0.090317,0,0
6,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.20309,-0.045849,-0.066294,0,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.22568,-0.045864,-0.093317,0,0
6,GO NEGATIVE REGULATION OF CELL DEATH,0.055956,-0.046016,-0.073182,0,0
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.62113,-0.046024,0.076036,0,0
6,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.48678,-0.046026,-0.060973,0,0
6,GO ASTROCYTE DEVELOPMENT,0.43883,-0.046047,-0.057739,0,0
6,GO CHLORIDE ION HOMEOSTASIS,0.73628,-0.046056,-0.023494,0,0
6,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.17653,-0.04608,-0.052696,0,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.23937,-0.046175,-0.13623,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.18219,-0.046193,-0.029822,0,0
6,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.24643,-0.046277,-0.050009,0,0
6,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12259,-0.0464,-0.055246,0,0
6,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.60272,-0.046604,-0.025664,0,0
6,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.27999,-0.046728,-0.2537,0,0
6,GO BONE MINERALIZATION,0.59664,-0.046734,-0.031952,0,0
6,GO RESPONSE TO NUTRIENT,0.32938,-0.046753,-0.060608,0,0
6,GO REGULATION OF GLUCOSE IMPORT,0.29586,-0.046767,-0.05418,0,0
6,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.44402,-0.046786,-0.032654,0,0
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.24643,-0.046825,-0.039587,0,0
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.22235,-0.046875,-0.044578,0,0
6,GO RESPONSE TO PAIN,0.65866,-0.047002,-0.062546,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.077957,-0.047005,-0.087691,0,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.13814,-0.047021,-0.037595,0,0
6,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.13583,-0.047041,-0.062751,0,0
6,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.25363,-0.047043,-0.053979,0,0
6,GO RESPONSE TO INORGANIC SUBSTANCE,0.085627,-0.047119,-0.056345,0,0
6,GO STEROL BIOSYNTHETIC PROCESS,0.7495,-0.047182,0.022279,0,0
6,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.11039,-0.047234,-0.072339,0,0
6,GO LIPID HOMEOSTASIS,0.18508,-0.047324,-0.072075,0,0
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.54903,-0.047375,-0.017306,0,0
6,GO JNK CASCADE,0.17653,-0.047471,-0.046982,0,0
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.9686,-0.047642,0.0054404,0,0
6,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.092194,-0.047734,-0.074036,0,0
6,GO NUCLEUS ORGANIZATION,0.066855,-0.047765,-0.048761,0,0
6,GO REGULATION OF DNA RECOMBINATION,0.43367,-0.047786,-0.033608,0,0
6,GO OSTEOCLAST DIFFERENTIATION,0.59664,-0.047815,-0.013753,0,0
6,GO MEMBRANE LIPID METABOLIC PROCESS,0.077957,-0.048062,-0.084675,0,0
6,GO REGULATION OF LIPID LOCALIZATION,0.25729,-0.048159,-0.055455,0,0
6,GO CELLULAR RESPONSE TO STEROL,0.98255,-0.048185,0.0053542,0,0
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.29992,-0.048244,-0.041564,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.8303,-0.048266,-0.017858,0,0
6,GO MECHANORECEPTOR DIFFERENTIATION,0.15015,-0.048332,-0.12801,0,0
6,GO GLUCOSE IMPORT,0.25363,-0.048497,-0.047554,0,0
6,GO PENILE ERECTION,0.74288,-0.048522,-0.028242,0,0
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.12049,-0.048531,-0.082053,0,0
6,GO VACUOLAR ACIDIFICATION,0.16294,-0.048637,-0.11439,0,0
6,GO REGULATION OF PHOSPHATASE ACTIVITY,0.18219,-0.048821,-0.045107,0,0
6,GO MANGANESE ION TRANSPORT,0.72313,-0.048862,-0.010146,0,0
6,GO REGULATION OF MUSCLE HYPERTROPHY,0.21905,-0.048885,-0.066053,0,0
6,GO HISTONE H3 ACETYLATION,0.13583,-0.048885,-0.042872,0,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.092194,-0.049001,-0.069983,0,0
6,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.3746,-0.049032,-0.15971,0,0
6,GO RESPONSE TO TUMOR CELL,0.26098,-0.049036,-0.1034,0,0
6,GO KETONE BIOSYNTHETIC PROCESS,0.64605,-0.049193,-0.053361,0,0
6,GO RESPONSE TO ENDOGENOUS STIMULUS,0.11039,-0.049196,-0.049893,0,0
6,GO PEPTIDYL PROLINE HYDROXYLATION,0.82348,-0.049413,-0.061782,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.26847,-0.049473,-0.043069,0,0
6,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.060602,-0.049595,-0.054655,0,0
6,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.22905,-0.049611,-0.14107,0,0
6,GO INTEGRIN ACTIVATION,0.35153,-0.049632,-0.079514,0,0
6,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.83713,-0.049665,0.00089528,0,0
6,GO MEMBRANE INVAGINATION,0.20937,-0.049668,-0.072821,0,0
6,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.15517,-0.049676,-0.13311,0,0
6,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.10096,-0.049693,-0.16087,0,0
6,GO SCHWANN CELL DIFFERENTIATION,0.43883,-0.04979,-0.039119,0,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.22568,-0.049796,-0.044982,0,0
6,GO SINGLE FERTILIZATION,0.090515,-0.049836,-0.05013,0,0
6,GO MITOTIC SPINDLE ORGANIZATION,0.1313,-0.04992,-0.059113,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.77618,-0.049942,-0.013333,0,0
6,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.075049,-0.049967,-0.085534,0,0
6,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.44402,-0.049996,-0.022489,0,0
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.7495,-0.050075,-0.022681,0,0
6,GO BIOLOGICAL ADHESION,0.13355,-0.050117,-0.073472,0,0
6,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23589,-0.050222,-0.094412,0,0
6,GO LYMPHOCYTE MIGRATION,0.24288,-0.050246,-0.078135,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.21905,-0.050306,-0.091423,0,0
6,GO ARACHIDONIC ACID SECRETION,0.26847,-0.050416,-0.084436,0,0
6,GO REGIONALIZATION,0.29992,-0.050447,-0.039031,0,0
6,GO KINETOCHORE ORGANIZATION,0.41341,-0.050601,-0.055677,0,0
6,GO EPITHELIAL CELL PROLIFERATION,0.053746,-0.050618,-0.10607,0,0
6,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.20937,-0.050746,-0.1183,0,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.70355,-0.050754,-0.029724,0,0
6,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.93377,-0.050779,0.004387,0,0
6,GO RESPONSE TO ALKALOID,0.33373,-0.050782,-0.045193,0,0
6,GO CERAMIDE BIOSYNTHETIC PROCESS,0.17653,-0.050807,-0.069296,0,0
6,GO CAMERA TYPE EYE DEVELOPMENT,0.26471,-0.05083,-0.039678,0,0
6,GO MITOTIC NUCLEAR DIVISION,0.12689,-0.050997,-0.040191,0,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.99651,-0.051017,-0.015055,0,0
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.11434,-0.051027,-0.046379,0,0
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.91987,-0.051057,-0.0029276,0,0
6,GO STRESS FIBER ASSEMBLY,0.40349,-0.051068,-0.051594,0,0
6,GO REGULATION OF LIPID TRANSPORT,0.32077,-0.051105,-0.056605,0,0
6,GO REGULATION OF TUBE SIZE,0.19393,-0.051248,-0.067098,0,0
6,GO CELL CYCLE CHECKPOINT,0.082489,-0.05134,-0.045361,0,0
6,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.19393,-0.051372,-0.079947,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.28785,-0.051375,-0.076763,0,0
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.50337,-0.051386,-0.034784,0,0
6,GO SPHINGOLIPID METABOLIC PROCESS,0.14526,-0.051479,-0.072734,0,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48678,-0.05157,-0.073262,0,0
6,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.25729,-0.051725,-0.090823,0,0
6,GO PIGMENTATION,0.12908,-0.051755,-0.068555,0,0
6,GO OVULATION,0.44402,-0.051842,-0.081234,0,0
6,GO LIPOPROTEIN CATABOLIC PROCESS,0.20309,-0.05186,-0.10054,0,0
6,GO RESPONSE TO CHEMOKINE,0.54903,-0.051865,-0.045098,0,0
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.093897,-0.051995,-0.11452,0,0
6,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.24643,-0.052098,-0.041733,0,0
6,GO REGULATION OF CELL DEATH,0.079444,-0.052102,-0.059277,0,0
6,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.15517,-0.052159,-0.046643,0,0
6,GO REGULATION OF ORGANIC ACID TRANSPORT,0.33373,-0.052205,-0.060209,0,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.35153,-0.052596,-0.088513,0,0
6,GO RESPONSE TO VITAMIN,0.55487,-0.052661,-0.045344,0,0
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.54321,-0.052702,-0.047104,0,0
6,GO REGULATION OF LIPID METABOLIC PROCESS,0.3746,-0.052811,-0.037548,0,0
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.71006,-0.052823,-0.083316,0,0
6,GO RESPONSE TO PEPTIDE HORMONE,0.17374,-0.052919,-0.042604,0,0
6,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.75615,-0.053214,-0.024949,0,0
6,GO RESPONSE TO TOXIC SUBSTANCE,0.13583,-0.053266,-0.066299,0,0
6,GO REGULATION OF GTPASE ACTIVITY,0.38888,-0.0533,-0.023923,0,0
6,GO PHAGOCYTOSIS,0.2839,-0.053521,-0.068683,0,0
6,GO NEGATIVE REGULATION OF SECRETION,0.12473,-0.053615,-0.055788,0,0
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.46512,-0.053724,-0.024273,0,0
6,GO ATP TRANSPORT,0.89907,-0.053776,0.0065594,0,0
6,GO PROTEIN LOCALIZATION TO LYSOSOME,0.52594,-0.053879,-0.040107,0,0
6,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.10096,-0.053887,-0.04293,0,0
6,GO EMBRYO DEVELOPMENT,0.1028,-0.053924,-0.053059,0,0
6,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.22235,-0.053968,-0.061382,0,0
6,GO ESTROGEN METABOLIC PROCESS,0.27227,-0.054029,-0.073494,0,0
6,GO THYMIC T CELL SELECTION,0.20309,-0.054055,-0.050215,0,0
6,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.27999,-0.054061,-0.15296,0,0
6,GO AMINO ACID BETAINE METABOLIC PROCESS,0.5726,-0.05411,-0.066397,0,0
6,GO SYMBIOTIC PROCESS,0.087232,-0.054117,-0.079782,0,0
6,GO RESPONSE TO NITROGEN COMPOUND,0.20309,-0.054237,-0.035746,0,0
6,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.093897,-0.054293,-0.060521,0,0
6,GO STRIATED MUSCLE ADAPTATION,0.63354,-0.054364,-0.021443,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.43367,-0.054601,-0.011595,0,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11039,-0.054657,-0.054942,0,0
6,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.25729,-0.054699,-0.077944,0,0
6,GO MESENCHYME MORPHOGENESIS,0.092194,-0.054741,-0.13341,0,0
6,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.48131,-0.054777,-0.025516,0,0
6,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.43367,-0.054815,-0.060493,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.32938,-0.054824,-0.034578,0,0
6,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.2,-0.05483,-0.098465,0,0
6,GO REGULATION OF PROTEIN DEACETYLATION,0.69061,-0.055013,-0.013454,0,0
6,GO ACTIVATION OF MAPK ACTIVITY,0.2,-0.055256,-0.055429,0,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.076492,-0.055397,-0.065251,0,0
6,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.39858,-0.055449,-0.042461,0,0
6,GO PRE MIRNA PROCESSING,0.51459,-0.055494,-0.034901,0,0
6,GO SELECTIVE AUTOPHAGY,0.19695,-0.055543,-0.07192,0,0
6,GO CYTOSKELETON ORGANIZATION,0.04854,-0.055548,-0.051262,0,0
6,GO APOPTOTIC PROCESS,0.1028,-0.055601,-0.054798,0,0
6,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.41842,-0.055681,-0.052568,0,0
6,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.25001,-0.055796,-0.043774,0,0
6,GO DEVELOPMENTAL PIGMENTATION,0.14769,-0.055822,-0.076351,0,0
6,GO DEMETHYLATION,0.088862,-0.055835,-0.051845,0,0
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.47588,-0.05587,-0.023843,0,0
6,GO PROTEIN LOCALIZATION TO VACUOLE,0.2839,-0.056102,-0.05852,0,0
6,GO REGULATION OF CILIUM ASSEMBLY,0.10654,-0.056109,-0.057024,0,0
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13355,-0.056217,-0.044563,0,0
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.53742,-0.056224,0.12115,0,0
6,GO CELL CELL RECOGNITION,0.11841,-0.056289,-0.073026,0,0
6,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.93377,-0.056476,-0.015392,0,0
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.34702,-0.05653,-0.031693,0,0
6,GO MAINTENANCE OF ORGANELLE LOCATION,0.43367,-0.056572,-0.024253,0,0
6,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14048,-0.056629,-0.12413,0,0
6,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.74288,-0.056701,-0.022079,0,0
6,GO SINGLE STRAND BREAK REPAIR,0.38408,-0.056713,-0.047228,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.22235,-0.056787,-0.051562,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.60272,-0.057025,-0.0053905,0,0
6,GO REGULATION OF FAT CELL DIFFERENTIATION,0.16032,-0.05722,-0.075605,0,0
6,GO POSITIVE REGULATION OF JNK CASCADE,0.12259,-0.057266,-0.061562,0,0
6,GO REGULATION OF BONE MINERALIZATION,0.32506,-0.057299,-0.06991,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.065563,-0.05744,-0.13976,0,0
6,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.43367,-0.057444,-0.057828,0,0
6,GO RESPONSE TO TESTOSTERONE,0.4598,-0.057452,-0.053363,0,0
6,GO REGULATION OF KIDNEY DEVELOPMENT,0.33812,-0.057477,-0.081057,0,0
6,GO MEMBRANE PROTEIN PROTEOLYSIS,0.11039,-0.057543,-0.13967,0,0
6,GO PROTEIN MANNOSYLATION,0.69707,-0.057564,-0.020375,0,0
6,GO MICROTUBULE BASED TRANSPORT,0.16828,-0.05759,-0.040918,0,0
6,GO HISTONE H4 ACETYLATION,0.087232,-0.057684,-0.047474,0,0
6,GO SENSORY PERCEPTION,0.11841,-0.057936,-0.04304,0,0
6,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.32077,-0.058163,-0.063558,0,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS,0.12908,-0.058167,-0.06074,0,0
6,GO AMYLOID BETA METABOLIC PROCESS,0.30402,-0.058198,-0.055448,0,0
6,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.38408,-0.058241,-0.092118,0,0
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.042857,-0.058243,-0.13615,0,0
6,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.077957,-0.058284,-0.05069,0,0
6,GO RESPONSE TO DEXAMETHASONE,0.49227,-0.058314,-0.050802,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.18219,-0.058361,-0.082675,0,0
6,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.91987,-0.058464,0.0099453,0,0
6,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.15517,-0.058631,-0.077146,0,0
6,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.31653,-0.05865,-0.095502,0,0
6,GO EMBRYONIC ORGAN MORPHOGENESIS,0.059411,-0.058702,-0.086829,0,0
6,GO REGULATION OF NUCLEASE ACTIVITY,0.11434,-0.058703,-0.11516,0,0
6,GO GLYCOSYLATION,0.15517,-0.058708,-0.07068,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.32077,-0.058723,-0.035755,0,0
6,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.16828,-0.058764,-0.069985,0,0
6,GO FATTY ACID BETA OXIDATION,0.32077,-0.058862,-0.064597,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.085627,-0.059026,-0.091971,0,0
6,GO CAMP BIOSYNTHETIC PROCESS,0.36064,-0.059118,-0.096058,0,0
6,GO NEURONAL ACTION POTENTIAL,0.25001,-0.059138,-0.076407,0,0
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.76948,-0.059148,-0.0038809,0,0
6,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.19095,-0.05917,-0.1236,0,0
6,GO POSITIVE REGULATION OF MAPK CASCADE,0.35607,-0.059229,-0.048949,0,0
6,GO TONGUE DEVELOPMENT,0.41341,-0.059263,-0.085089,0,0
6,GO GOLGI RIBBON FORMATION,0.38888,-0.059418,-0.062741,0,0
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.48678,-0.059444,-0.068701,0,0
6,GO GLYCOLIPID CATABOLIC PROCESS,0.24643,-0.059615,-0.15713,0,0
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.12049,-0.059713,-0.082747,0,0
6,GO RESPONSE TO FUNGUS,0.30815,-0.059877,-0.047315,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.18219,-0.05992,-0.097341,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.095625,-0.059945,-0.069165,0,0
6,GO T CELL CHEMOTAXIS,0.12049,-0.059949,-0.082357,0,0
6,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.98953,-0.059995,0.029895,0,0
6,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.23937,-0.060031,-0.081232,0,0
6,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.059411,-0.060173,-0.10032,0,0
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.26098,-0.06027,-0.040523,0,0
6,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.12473,-0.060364,-0.082909,0,0
6,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.13583,-0.06039,-0.067139,0,0
6,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.20309,-0.0604,-0.10067,0,0
6,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.12259,-0.060446,-0.085593,0,0
6,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.36991,-0.060454,-0.041694,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.92682,-0.060632,0.0018042,0,0
6,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.12908,-0.060711,-0.11151,0,0
6,GO NEGATIVE REGULATION OF GROWTH,0.14048,-0.060887,-0.052195,0,0
6,GO RESPONSE TO INTERLEUKIN 15,0.17653,-0.060934,-0.11468,0,0
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.44402,-0.061,-0.041059,0,0
6,GO APPENDAGE MORPHOGENESIS,0.15773,-0.061007,-0.10467,0,0
6,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.53742,-0.061014,-0.037754,0,0
6,GO SEX DIFFERENTIATION,0.11636,-0.061016,-0.050249,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.19095,-0.061072,-0.057507,0,0
6,GO CELLULAR HORMONE METABOLIC PROCESS,0.36991,-0.061221,-0.056979,0,0
6,GO FC RECEPTOR SIGNALING PATHWAY,0.082489,-0.061364,-0.077825,0,0
6,GO REGULATION OF HORMONE METABOLIC PROCESS,0.2,-0.061378,-0.1525,0,0
6,GO CELL DIFFERENTIATION IN SPINAL CORD,0.25729,-0.061488,-0.067297,0,0
6,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.63978,-0.061547,-0.025898,0,0
6,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.15517,-0.061581,-0.11519,0,0
6,GO REGULATION OF TOR SIGNALING,0.15015,-0.061624,-0.047396,0,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11841,-0.0617,-0.068346,0,0
6,GO ESTABLISHMENT OF CELL POLARITY,0.05161,-0.061757,-0.075136,0,0
6,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.25001,-0.061778,-0.080982,0,0
6,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.24288,-0.061829,-0.1638,0,0
6,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.059411,-0.061852,-0.081493,0,0
6,GO RENAL FILTRATION,0.55487,-0.061867,-0.041388,0,0
6,GO HISTONE H3 K14 ACETYLATION,0.33812,-0.06193,-0.0471,0,0
6,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.51459,-0.062005,-0.030543,0,0
6,GO MODIFIED AMINO ACID TRANSPORT,0.16294,-0.062178,-0.10012,0,0
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.22235,-0.062194,-0.090051,0,0
6,GO ANATOMICAL STRUCTURE MATURATION,0.16559,-0.062198,-0.044743,0,0
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.80312,-0.062241,-0.021675,0,0
6,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.045624,-0.0624,-0.12938,0,0
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.44402,-0.062587,-0.02347,0,0
6,GO CELLULAR LIPID METABOLIC PROCESS,0.053746,-0.062759,-0.071512,0,0
6,GO PULMONARY VALVE DEVELOPMENT,0.33373,-0.062824,-0.10819,0,0
6,GO REGULATION OF VASOCONSTRICTION,0.19695,-0.062861,-0.070382,0,0
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.019739,-0.062998,-0.085776,0,0
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.32077,-0.063034,-0.033723,0,0
6,GO HYALURONAN METABOLIC PROCESS,0.35153,-0.063039,-0.069863,0,0
6,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.15015,-0.063307,-0.057595,0,0
6,GO POSITIVE REGULATION OF CELL AGING,0.1028,-0.063568,-0.11919,0,0
6,GO OOCYTE MATURATION,0.66501,-0.063675,-0.020409,0,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.065563,-0.063757,-0.063544,0,0
6,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.13583,-0.0638,-0.086583,0,0
6,GO POSITIVE THYMIC T CELL SELECTION,0.25001,-0.063803,-0.094649,0,0
6,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.85768,-0.063809,0.0040887,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.36064,-0.063845,-0.049305,0,0
6,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.23589,-0.063872,-0.10514,0,0
6,GO VACUOLE ORGANIZATION,0.049546,-0.063873,-0.080909,0,0
6,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.70355,-0.064012,-0.031214,0,0
6,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.14048,-0.06404,-0.070882,0,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.13583,-0.064134,-0.12509,0,0
6,GO REGULATION OF STEROID METABOLIC PROCESS,0.27611,-0.064153,-0.061548,0,0
6,GO REGULATION OF CELL MATURATION,0.087232,-0.064441,-0.072833,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.55487,-0.064485,0.094908,0,0
6,GO PROTEIN LOCALIZATION TO CILIUM,0.066855,-0.06483,-0.10504,0,0
6,GO GPI ANCHOR METABOLIC PROCESS,0.18219,-0.064888,-0.10029,0,0
6,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.053746,-0.064966,-0.079914,0,0
6,GO MONOCARBOXYLIC ACID TRANSPORT,0.43367,-0.065007,-0.031353,0,0
6,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.18219,-0.065068,-0.11325,0,0
6,GO LIPID BIOSYNTHETIC PROCESS,0.060602,-0.065325,-0.070494,0,0
6,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.16294,-0.065333,-0.050958,0,0
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.065418,-0.049418,0,0
6,GO PRIMARY MIRNA PROCESSING,0.48131,-0.065474,-0.048068,0,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.52594,-0.065615,-0.050706,0,0
6,GO POSITIVE REGULATION OF PROTEIN BINDING,0.49227,-0.065623,-0.042442,0,0
6,GO REGULATION OF EXIT FROM MITOSIS,0.14048,-0.065695,-0.089292,0,0
6,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.76948,-0.065715,0.0055686,0,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.18219,-0.065767,-0.079642,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.11434,-0.065784,-0.15275,0,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.068167,-0.065843,-0.055671,0,0
6,GO FATTY ACID CATABOLIC PROCESS,0.088862,-0.066178,-0.098585,0,0
6,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.059411,-0.066245,-0.086528,0,0
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.12259,-0.066303,-0.10011,0,0
6,GO REGULATION OF ANION TRANSPORT,0.092194,-0.066316,-0.072435,0,0
6,GO RESPONSE TO MINERALOCORTICOID,0.24643,-0.066361,-0.08214,0,0
6,GO HYALURONAN BIOSYNTHETIC PROCESS,0.22568,-0.06646,-0.10443,0,0
6,GO EPIBOLY,0.29184,-0.066593,-0.129,0,0
6,GO EATING BEHAVIOR,0.21905,-0.066676,-0.069817,0,0
6,GO CELLULAR RESPONSE TO CAMP,0.69061,-0.06671,0.0053828,0,0
6,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.061812,-0.066742,-0.086157,0,0
6,GO DETECTION OF ABIOTIC STIMULUS,0.05824,-0.066789,-0.083841,0,0
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.65866,-0.066992,-0.020116,0,0
6,GO TUMOR NECROSIS FACTOR SECRETION,0.05161,-0.067007,-0.10693,0,0
6,GO INTERFERON GAMMA PRODUCTION,0.12049,-0.06706,-0.076101,0,0
6,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.59664,-0.067076,-0.059338,0,0
6,GO VITAMIN METABOLIC PROCESS,0.98255,-0.067183,0.0024998,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.74288,-0.067271,-0.035863,0,0
6,GO NEURAL RETINA DEVELOPMENT,0.78289,-0.067299,-0.0081928,0,0
6,GO AMEBOIDAL TYPE CELL MIGRATION,0.082489,-0.067305,-0.089652,0,0
6,GO CELLULAR RESPONSE TO SALT STRESS,0.4598,-0.067345,-0.088499,0,0
6,GO RESPONSE TO OXIDATIVE STRESS,0.095625,-0.067411,-0.069622,0,0
6,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.095625,-0.067649,-0.063693,0,0
6,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.10845,-0.067715,-0.05579,0,0
6,GO REGULATION OF PROSTAGLANDIN SECRETION,0.4545,-0.06773,-0.059121,0,0
6,GO REGULATION OF JUN KINASE ACTIVITY,0.064293,-0.067756,-0.080653,0,0
6,GO HISTONE H2A ACETYLATION,0.22235,-0.067757,-0.061376,0,0
6,GO REGULATION OF BONE DEVELOPMENT,0.16559,-0.067791,-0.08264,0,0
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.81668,-0.067959,0.006514,0,0
6,GO REGULATION OF MAPK CASCADE,0.21256,-0.068029,-0.055321,0,0
6,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.097379,-0.068033,-0.14833,0,0
6,GO MEMBRANE RAFT ASSEMBLY,0.4598,-0.068115,-0.19913,0,0
6,GO STEROID HORMONE SECRETION,0.25001,-0.068121,-0.099478,0,0
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.39858,-0.068122,-0.048999,0,0
6,GO FOREBRAIN NEURON DIFFERENTIATION,0.25363,-0.068167,-0.091611,0,0
6,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.27611,-0.068202,-0.070329,0,0
6,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94769,-0.06822,0.063735,0,0
6,GO STEROID CATABOLIC PROCESS,0.4545,-0.068223,-0.067968,0,0
6,GO LIPID METABOLIC PROCESS,0.082489,-0.06838,-0.061218,0,0
6,GO BONE MATURATION,0.39371,-0.068413,-0.070685,0,0
6,GO FATTY ACID BIOSYNTHETIC PROCESS,0.10465,-0.068465,-0.090477,0,0
6,GO CELLULAR RESPONSE TO LIPID,0.17653,-0.068646,-0.067613,0,0
6,GO GLYCOPROTEIN CATABOLIC PROCESS,0.38888,-0.068737,-0.15186,0,0
6,GO TROPHOBLAST CELL MIGRATION,0.24643,-0.068763,-0.17683,0,0
6,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.11636,-0.068841,-0.13751,0,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.11039,-0.068864,-0.084924,0,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.15773,-0.068878,-0.087709,0,0
6,GO DETECTION OF BIOTIC STIMULUS,0.49227,-0.069196,-0.09461,0,0
6,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.25729,-0.069239,-0.044835,0,0
6,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.44924,-0.069307,-0.059768,0,0
6,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.32938,-0.069376,-0.083875,0,0
6,GO REGULATION OF PROTEIN IMPORT,0.14048,-0.069387,-0.10439,0,0
6,GO RESPONSE TO CORTICOSTEROID,0.10845,-0.069552,-0.097558,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.063042,-0.069572,-0.07148,0,0
6,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.055956,-0.069583,-0.079324,0,0
6,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.14285,-0.06961,-0.12077,0,0
6,GO MAGNESIUM ION HOMEOSTASIS,0.52025,-0.069614,-0.072431,0,0
6,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.65866,-0.069665,-0.029161,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.42347,-0.069711,-0.12189,0,0
6,GO STEM CELL PROLIFERATION,0.085627,-0.069873,-0.088511,0,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.49227,-0.069902,-0.047194,0,0
6,GO MUSCLE CELL DEVELOPMENT,0.14048,-0.069984,-0.069522,0,0
6,GO MUSCLE ADAPTATION,0.05161,-0.070042,-0.090495,0,0
6,GO RESPONSE TO EPINEPHRINE,1,-0.070059,0.0084342,0,0
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.36526,-0.070127,-0.11902,0,0
6,GO L PHENYLALANINE METABOLIC PROCESS,0.34256,-0.070147,-0.16427,0,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.04854,-0.07016,-0.070453,0,0
6,GO RESPONSE TO SALT STRESS,0.17099,-0.070179,-0.097227,0,0
6,GO CELLULAR RESPONSE TO FATTY ACID,0.55487,-0.07019,-0.051358,0,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.32077,-0.070281,-0.075533,0,0
6,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.21579,-0.070396,-0.15765,0,0
6,GO OOCYTE DIFFERENTIATION,0.088862,-0.070457,-0.11075,0,0
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.23589,-0.070469,-0.048612,0,0
6,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.077957,-0.070546,-0.10172,0,0
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.076492,-0.070944,-0.075557,0,0
6,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.52025,-0.071008,-0.14249,0,0
6,GO POSITIVE REGULATION OF ERAD PATHWAY,0.18508,-0.071112,-0.073072,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12473,-0.071121,-0.13684,0,0
6,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.088862,-0.07116,-0.081142,0,0
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.26471,-0.071183,-0.050459,0,0
6,GO UV DAMAGE EXCISION REPAIR,0.41842,-0.07124,-0.038872,0,0
6,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.34702,-0.071327,-0.081445,0,0
6,GO HISTONE H4 K5 ACETYLATION,0.66501,-0.071361,-0.014335,0,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19393,-0.071443,-0.10888,0,0
6,GO POSITIVE REGULATION OF DNA REPLICATION,0.12908,-0.071506,-0.057411,0,0
6,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.16032,-0.071682,-0.19393,0,0
6,GO BRANCH ELONGATION OF AN EPITHELIUM,0.20309,-0.071726,-0.19148,0,0
6,GO RESPONSE TO STEROID HORMONE,0.090515,-0.071862,-0.082773,0,0
6,GO REGULATION OF ERAD PATHWAY,0.11039,-0.072218,-0.056497,0,0
6,GO NEUTROPHIL CHEMOTAXIS,0.088862,-0.072555,-0.076916,0,0
6,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.079444,-0.072652,-0.096508,0,0
6,GO CELL MATURATION,0.095625,-0.072739,-0.059033,0,0
6,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.26098,-0.072774,-0.040754,0,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.22905,-0.072841,-0.10171,0,0
6,GO FEMALE GAMETE GENERATION,0.05824,-0.072977,-0.071017,0,0
6,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.14526,-0.073112,-0.063294,0,0
6,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.11636,-0.073163,-0.12615,0,0
6,GO RESPONSE TO GROWTH HORMONE,0.38888,-0.073195,-0.069182,0,0
6,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.42855,-0.073636,-0.063622,0,0
6,GO LENS FIBER CELL DIFFERENTIATION,0.31232,-0.073693,-0.086789,0,0
6,GO REGULATION OF AMYLOID BETA CLEARANCE,0.19695,-0.073724,-0.14012,0,0
6,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.084046,-0.073751,-0.072273,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.059411,-0.073851,-0.076544,0,0
6,GO REGULATION OF HORMONE SECRETION,0.17653,-0.074032,-0.05161,0,0
6,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.13583,-0.074207,-0.10346,0,0
6,GO POTASSIUM ION HOMEOSTASIS,0.19695,-0.074241,-0.085051,0,0
6,GO SPERM EGG RECOGNITION,0.14526,-0.07425,-0.060326,0,0
6,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.25729,-0.074747,-0.10372,0,0
6,GO FUCOSE METABOLIC PROCESS,0.33812,-0.074971,-0.086857,0,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.082489,-0.075002,-0.073294,0,0
6,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.27999,-0.075064,-0.074805,0,0
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.29586,-0.075212,-0.11366,0,0
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.10654,-0.075306,-0.11015,0,0
6,GO SPERM MOTILITY,0.012203,-0.075329,-0.091459,0,0
6,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.16559,-0.075576,-0.098151,0,0
6,GO REGULATION OF MAP KINASE ACTIVITY,0.077957,-0.075608,-0.077803,0,0
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.42347,-0.075615,-0.030029,0,0
6,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.095625,-0.075639,-0.089565,0,0
6,GO CELLULAR RESPONSE TO IRON ION,0.076492,-0.075751,-0.2086,0,0
6,GO MODULATION BY VIRUS OF HOST PROCESS,0.10096,-0.075787,-0.081429,0,0
6,GO DIGESTIVE TRACT MORPHOGENESIS,0.34256,-0.075824,-0.063825,0,0
6,GO NEGATIVE REGULATION OF TOR SIGNALING,0.66501,-0.075893,-0.013919,0,0
6,GO HISTONE H3 DEACETYLATION,0.16294,-0.076023,-0.060796,0,0
6,GO REGULATION OF VIRAL TRANSCRIPTION,0.068167,-0.07605,-0.079694,0,0
6,GO POSITIVE REGULATION OF HAIR CYCLE,0.27227,-0.076241,-0.12255,0,0
6,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.188,-0.076252,-0.099063,0,0
6,GO OXALATE TRANSPORT,0.18508,-0.076339,-0.070137,0,0
6,GO STEROL METABOLIC PROCESS,0.36991,-0.076559,-0.044179,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.28785,-0.076608,-0.048475,0,0
6,GO GOLGI VESICLE TRANSPORT,0.064293,-0.076635,-0.067156,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.12259,-0.076699,-0.13211,0,0
6,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.14285,-0.076791,-0.075534,0,0
6,GO PEPTIDE HORMONE SECRETION,0.53167,-0.077103,-0.0186,0,0
6,GO OLIGODENDROCYTE DIFFERENTIATION,0.25363,-0.077124,-0.059487,0,0
6,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.16032,-0.077268,-0.064251,0,0
6,GO SENSORY SYSTEM DEVELOPMENT,0.12049,-0.077274,-0.06012,0,0
6,GO KIDNEY MORPHOGENESIS,0.054842,-0.077294,-0.10155,0,0
6,GO RESPONSE TO LIPID,0.13355,-0.077308,-0.066226,0,0
6,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.070855,-0.077435,-0.099518,0,0
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.031059,-0.07751,-0.091504,0,0
6,GO RESPONSE TO VITAMIN D,0.80989,-0.077594,0.039877,0,0
6,GO CARDIAC ATRIUM MORPHOGENESIS,0.53167,-0.077645,-0.031668,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40349,-0.077647,-0.11588,0,0
6,GO NEUROTRANSMITTER METABOLIC PROCESS,0.19095,-0.077662,-0.098862,0,0
6,GO SENSORY ORGAN DEVELOPMENT,0.084046,-0.077666,-0.067344,0,0
6,GO REGULATION OF MACROPHAGE ACTIVATION,0.16294,-0.077716,-0.099133,0,0
6,GO REGULATION OF LYSOSOMAL LUMEN PH,0.21905,-0.077791,-0.1154,0,0
6,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.63354,-0.07786,0.021852,0,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.16559,-0.077919,-0.073781,0,0
6,GO NEUTROPHIL MIGRATION,0.082489,-0.078095,-0.096768,0,0
6,GO CELL AGING,0.061812,-0.078269,-0.080006,0,0
6,GO ARTERY MORPHOGENESIS,0.11039,-0.078324,-0.10161,0,0
6,GO MONOSACCHARIDE METABOLIC PROCESS,0.1313,-0.078506,-0.057484,0,0
6,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.093897,-0.078605,-0.17566,0,0
6,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.21579,-0.078614,-0.08538,0,0
6,GO REGULATION OF HORMONE LEVELS,0.095625,-0.078628,-0.068587,0,0
6,GO DEVELOPMENTAL INDUCTION,0.17099,-0.078658,-0.1118,0,0
6,GO REGULATION OF OSSIFICATION,0.12049,-0.078785,-0.0924,0,0
6,GO RESPONSE TO FLUID SHEAR STRESS,0.10845,-0.07879,-0.13168,0,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.15517,-0.078833,-0.093369,0,0
6,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.077957,-0.078852,-0.08791,0,0
6,GO FOREBRAIN MORPHOGENESIS,0.82348,-0.078887,-0.0056324,0,0
6,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.17653,-0.078912,-0.081512,0,0
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.087232,-0.079113,-0.065285,0,0
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.13814,-0.079144,-0.091213,0,0
6,GO SULFUR COMPOUND TRANSPORT,0.072231,-0.079169,-0.082162,0,0
6,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.39858,-0.079174,-0.063072,0,0
6,GO INCLUSION BODY ASSEMBLY,0.89907,-0.079179,0.033338,0,0
6,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.082489,-0.079539,-0.095341,0,0
6,GO PROTEIN MONOUBIQUITINATION,0.0049174,-0.079687,-0.077954,0,0
6,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.62732,-0.079689,-0.12377,0,0
6,GO POSITIVE REGULATION OF CYTOKINESIS,0.17653,-0.079723,-0.071325,0,0
6,GO STEROID ESTERIFICATION,0.11434,-0.079851,-0.19435,0,0
6,GO EMBRYO IMPLANTATION,0.24643,-0.079902,-0.10811,0,0
6,GO CENTRIOLE ASSEMBLY,0.13814,-0.079905,-0.068935,0,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.10096,-0.079933,-0.089764,0,0
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.15517,-0.079957,-0.097999,0,0
6,GO HEMIDESMOSOME ASSEMBLY,0.66501,-0.079977,-0.12878,0,0
6,GO PHOSPHOLIPID EFFLUX,0.21905,-0.080125,-0.1366,0,0
6,GO REGULATION OF ENDOCRINE PROCESS,0.049546,-0.08022,-0.12088,0,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.088862,-0.080256,-0.13641,0,0
6,GO HORMONE TRANSPORT,0.19695,-0.080339,-0.05185,0,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32938,-0.080418,-0.079,0,0
6,GO COBALAMIN METABOLIC PROCESS,0.21256,-0.08045,-0.092696,0,0
6,GO KERATINOCYTE MIGRATION,0.61497,-0.08049,-0.039674,0,0
6,GO AMINE METABOLIC PROCESS,0.12049,-0.080577,-0.079885,0,0
6,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.60883,-0.080587,-0.0053089,0,0
6,GO NEGATIVE REGULATION OF MAPK CASCADE,0.11434,-0.08078,-0.068347,0,0
6,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.14285,-0.08084,-0.24794,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.17934,-0.080883,-0.082861,0,0
6,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.38888,-0.081216,-0.039415,0,0
6,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.89907,-0.08135,0.012913,0,0
6,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.79636,-0.081497,-0.014733,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.36064,-0.081499,-0.088131,0,0
6,GO REGULATION OF GLIAL CELL MIGRATION,0.46512,-0.081511,-0.043248,0,0
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.21905,-0.081737,-0.10744,0,0
6,GO MALE MEIOSIS I,0.14526,-0.081746,-0.16335,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.27999,-0.081823,-0.079765,0,0
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.36991,-0.081949,-0.11858,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.11039,-0.081967,-0.073009,0,0
6,GO DETECTION OF LIGHT STIMULUS,0.17934,-0.082008,-0.068604,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.98953,-0.082031,0.0090464,0,0
6,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.057089,-0.082351,-0.1822,0,0
6,GO FOREBRAIN GENERATION OF NEURONS,0.12908,-0.082473,-0.10733,0,0
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.049546,-0.082713,-0.09224,0,0
6,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.11636,-0.082782,-0.07921,0,0
6,GO REGULATION OF LIPID STORAGE,0.087232,-0.082949,-0.091851,0,0
6,GO REGULATION OF KERATINOCYTE MIGRATION,0.14526,-0.082951,-0.092192,0,0
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.21579,-0.082956,-0.10327,0,0
6,GO ERYTHROCYTE MATURATION,0.12049,-0.08344,-0.088107,0,0
6,GO PROTEIN DEGLYCOSYLATION,0.11039,-0.08417,-0.14361,0,0
6,GO REGULATION OF HAIR CYCLE,0.20937,-0.084269,-0.10289,0,0
6,GO POSITIVE REGULATION OF CELL DIVISION,0.20937,-0.084536,-0.056248,0,0
6,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.39858,-0.084864,-0.049769,0,0
6,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.12473,-0.0849,-0.10945,0,0
6,GO GASTRIC ACID SECRETION,0.60883,-0.08499,-0.037888,0,0
6,GO CARDIAC CELL DEVELOPMENT,0.20309,-0.085085,-0.06729,0,0
6,GO CELLULAR RESPONSE TO NUTRIENT,0.55487,-0.085163,-0.041185,0,0
6,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.10654,-0.085236,-0.081822,0,0
6,GO B CELL HOMEOSTASIS,0.32506,-0.085482,-0.0654,0,0
6,GO P38MAPK CASCADE,0.095625,-0.085628,-0.11232,0,0
6,GO INNER EAR MORPHOGENESIS,0.055956,-0.085652,-0.10908,0,0
6,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.18508,-0.085753,-0.10198,0,0
6,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.04854,-0.085844,-0.10889,0,0
6,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.050569,-0.086101,-0.12924,0,0
6,GO LIPOPROTEIN METABOLIC PROCESS,0.076492,-0.086105,-0.076304,0,0
6,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.36064,-0.086299,-0.092187,0,0
6,GO SPHINGOID METABOLIC PROCESS,0.29586,-0.086473,-0.083811,0,0
6,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.082489,-0.086596,-0.067863,0,0
6,GO TEMPERATURE HOMEOSTASIS,0.087232,-0.086657,-0.064314,0,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.25363,-0.086693,-0.11179,0,0
6,GO INOSITOL METABOLIC PROCESS,0.060602,-0.086994,-0.11438,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.13814,-0.087059,-0.083389,0,0
6,GO CARDIAC MYOFIBRIL ASSEMBLY,0.059411,-0.0872,-0.13205,0,0
6,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.67776,-0.087223,-0.074606,0,0
6,GO MULTI ORGANISM CELLULAR PROCESS,0.092194,-0.087339,-0.18318,0,0
6,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.13814,-0.087407,-0.19943,0,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.057089,-0.087547,-0.16547,0,0
6,GO OTIC VESICLE DEVELOPMENT,0.68418,-0.087736,-0.044953,0,0
6,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.080955,-0.087739,-0.094854,0,0
6,GO ACTIN CROSSLINK FORMATION,0.87144,-0.087869,0.077755,0,0
6,GO STEROL HOMEOSTASIS,0.20621,-0.088167,-0.089323,0,0
6,GO TISSUE REGENERATION,0.1028,-0.088299,-0.11001,0,0
6,GO CELLULAR GLUCAN METABOLIC PROCESS,0.13814,-0.088552,-0.066869,0,0
6,GO POSITIVE REGULATION OF MITOPHAGY,0.13583,-0.088655,-0.096032,0,0
6,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10096,-0.088765,-0.076278,0,0
6,GO WHITE FAT CELL DIFFERENTIATION,0.095625,-0.088786,-0.10801,0,0
6,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.13355,-0.088807,-0.1344,0,0
6,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.072231,-0.089101,-0.11879,0,0
6,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.16559,-0.089316,-0.093759,0,0
6,GO RESPONSE TO HYDROGEN PEROXIDE,0.053746,-0.089326,-0.087658,0,0
6,GO POSITIVE CHEMOTAXIS,0.068167,-0.089478,-0.12492,0,0
6,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.15015,-0.089579,-0.11969,0,0
6,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.04854,-0.089702,-0.075698,0,0
6,GO DISTAL TUBULE DEVELOPMENT,0.28785,-0.089763,-0.11846,0,0
6,GO RNA DESTABILIZATION,0.087232,-0.090047,-0.076442,0,0
6,GO REGULATION OF COLLATERAL SPROUTING,0.91987,-0.090175,-0.0011283,0,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.87144,-0.090279,-0.050626,0,0
6,GO FUCOSYLATION,0.42347,-0.090311,-0.05878,0,0
6,GO MUSCLE FIBER DEVELOPMENT,0.12473,-0.090507,-0.078158,0,0
6,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.31653,-0.090544,-0.089967,0,0
6,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.26098,-0.09056,-0.093363,0,0
6,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.084046,-0.09068,-0.10219,0,0
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.21256,-0.090789,-0.040896,0,0
6,GO CYCLOOXYGENASE PATHWAY,0.89907,-0.090943,-0.0083277,0,0
6,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.087232,-0.091064,-0.091989,0,0
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.054842,-0.091353,-0.054921,0,0
6,GO INSULIN SECRETION,0.41842,-0.091501,-0.034162,0,0
6,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.072231,-0.091962,-0.18076,0,0
6,GO MACROPHAGE PROLIFERATION,0.43883,-0.091977,-0.11518,0,0
6,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.073629,-0.092056,-0.086216,0,0
6,GO LUNG MORPHOGENESIS,0.072231,-0.092227,-0.14341,0,0
6,GO CELLULAR COMPONENT MAINTENANCE,0.015203,-0.092248,-0.10601,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.21256,-0.092277,-0.063994,0,0
6,GO PROTEIN INSERTION INTO MEMBRANE,0.095625,-0.092371,-0.060268,0,0
6,GO VENTRAL SPINAL CORD DEVELOPMENT,0.12908,-0.092676,-0.074987,0,0
6,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.063042,-0.0929,-0.13949,0,0
6,GO RNA DECAPPING,0.063042,-0.093165,-0.084048,0,0
6,GO RESPONSE TO FOOD,0.064293,-0.093167,-0.092211,0,0
6,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.12689,-0.093304,-0.11504,0,0
6,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.38408,-0.093305,-0.080008,0,0
6,GO PHAGOSOME MATURATION,0.14526,-0.093437,-0.085654,0,0
6,GO GLUTAMATE METABOLIC PROCESS,0.14285,-0.093568,-0.094321,0,0
6,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.10096,-0.093605,-0.091261,0,0
6,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.48678,-0.093985,-0.065317,0,0
6,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.12049,-0.094103,-0.18566,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.75615,-0.09437,-0.026685,0,0
6,GO MEIOTIC CHROMOSOME SEPARATION,0.080955,-0.094409,-0.083872,0,0
6,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.04854,-0.094558,-0.099281,0,0
6,GO SUBPALLIUM DEVELOPMENT,0.21905,-0.094589,-0.086714,0,0
6,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.063042,-0.094642,-0.11428,0,0
6,GO KINETOCHORE ASSEMBLY,0.57857,-0.094721,-0.053244,0,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.15264,-0.095036,-0.13654,0,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.090515,-0.095162,-0.13351,0,0
6,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.44402,-0.095188,-0.03795,0,0
6,GO STEROID METABOLIC PROCESS,0.079444,-0.095191,-0.083801,0,0
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.099158,-0.095222,-0.11135,0,0
6,GO PROTEIN REFOLDING,0.29586,-0.09544,-0.053965,0,0
6,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.99651,-0.095512,-0.06923,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.18508,-0.095779,-0.12623,0,0
6,GO MITOCHONDRIAL FUSION,0.031748,-0.0959,-0.098395,0,0
6,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30402,-0.096014,-0.34622,0,0
6,GO REGULATION OF SPROUTING ANGIOGENESIS,0.052669,-0.096441,-0.12145,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16294,-0.096559,-0.099548,0,0
6,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.44402,-0.09674,-0.097956,0,0
6,GO REGULATION OF HISTONE H4 ACETYLATION,0.23937,-0.097144,-0.072208,0,0
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.20309,-0.097336,-0.073089,0,0
6,GO HISTONE H2A MONOUBIQUITINATION,0.070855,-0.097522,-0.078017,0,0
6,GO CYTOPLASM ORGANIZATION,0.084046,-0.097634,-0.12684,0,0
6,GO MITOTIC SPINDLE ASSEMBLY,0.0032441,-0.097681,-0.12134,0,0
6,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.64605,-0.097792,-0.053434,0,0
6,GO RENAL WATER HOMEOSTASIS,0.13355,-0.097948,-0.091902,0,0
6,GO ECTODERM DEVELOPMENT,0.015574,-0.09795,-0.11081,0,0
6,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.15264,-0.09813,-0.10051,0,0
6,GO CATECHOLAMINE METABOLIC PROCESS,0.81668,-0.098187,0.018086,0,0
6,GO SPROUTING ANGIOGENESIS,0.073629,-0.098418,-0.10615,0,0
6,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050569,-0.098544,-0.10396,0,0
6,GO AUTOPHAGY OF NUCLEUS,0.054842,-0.098654,-0.13863,0,0
6,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.19695,-0.098759,-0.10064,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.001986,-0.098769,-0.11462,0,0
6,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.5726,-0.098813,-0.040628,0,0
6,GO PROTEIN LOCALIZATION TO ENDOSOME,0.12473,-0.098825,-0.1131,0,0
6,GO MESODERM MORPHOGENESIS,0.077957,-0.098903,-0.11643,0,0
6,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.060602,-0.099032,-0.18398,0,0
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.080955,-0.099088,-0.11472,0,0
6,GO ANDROGEN METABOLIC PROCESS,0.47588,-0.09924,-0.057015,0,0
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.23937,-0.099259,-0.062738,0,0
6,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.26098,-0.099356,-0.063304,0,0
6,GO RESPONSE TO STEROL DEPLETION,0.25363,-0.099511,-0.10718,0,0
6,GO T CELL APOPTOTIC PROCESS,0.084046,-0.099884,-0.11709,0,0
6,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.12259,-0.099893,-0.08762,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.62732,-0.10003,-0.082911,0,0
6,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.085627,-0.10012,-0.096106,0,0
6,GO HEART INDUCTION,0.36064,-0.10018,-0.082211,0,0
6,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.4978,-0.10032,-0.068885,0,0
6,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.33812,-0.10033,-0.061251,0,0
6,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.072231,-0.10036,-0.1479,0,0
6,GO NEGATIVE REGULATION OF COAGULATION,0.32938,-0.10056,-0.14047,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.097379,-0.10059,-0.072517,0,0
6,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.64605,-0.10088,-0.066347,0,0
6,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.20309,-0.10109,-0.14733,0,0
6,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.092194,-0.10111,-0.078679,0,0
6,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.60883,-0.10114,-0.049575,0,0
6,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.34256,-0.10131,-0.11721,0,0
6,GO RELAXATION OF CARDIAC MUSCLE,0.46512,-0.10141,-0.083864,0,0
6,GO NOTOCHORD DEVELOPMENT,0.39371,-0.10143,-0.12899,0,0
6,GO MACROPHAGE APOPTOTIC PROCESS,0.11434,-0.10143,-0.12999,0,0
6,GO MALE MEIOTIC NUCLEAR DIVISION,0.11636,-0.1018,-0.11731,0,0
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0054795,-0.10192,-0.097993,0,0
6,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.15773,-0.10298,-0.10393,0,0
6,GO GOLGI LOCALIZATION,0.095625,-0.10299,-0.088866,0,0
6,GO EPITHELIAL CELL FATE COMMITMENT,0.35607,-0.10336,-0.057254,0,0
6,GO RESPONSE TO COLD,0.090515,-0.10342,-0.13864,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.20621,-0.10359,-0.083018,0,0
6,GO DEFINITIVE HEMOPOIESIS,0.34256,-0.10408,-0.054531,0,0
6,GO SULFATION,0.11235,-0.10413,-0.13199,0,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.16828,-0.10432,-0.20675,0,0
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.23937,-0.10438,-0.14381,0,0
6,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.023741,-0.10443,-0.11891,0,0
6,GO MUSCLE CELL APOPTOTIC PROCESS,0.10845,-0.10455,-0.077879,0,0
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.041093,-0.10467,-0.12192,0,0
6,GO CARDIAC ATRIUM DEVELOPMENT,0.85768,-0.10474,-0.010847,0,0
6,GO XENOBIOTIC CATABOLIC PROCESS,0.7495,-0.10487,-0.049168,0,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.05824,-0.10505,-0.15867,0,0
6,GO KETONE BODY METABOLIC PROCESS,0.47049,-0.10567,-0.069096,0,0
6,GO PANCREATIC JUICE SECRETION,0.24288,-0.10591,-0.073648,0,0
6,GO RESPONSE TO ESTRADIOL,0.093897,-0.10593,-0.083027,0,0
6,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.55487,-0.10596,-0.081441,0,0
6,GO OLFACTORY LOBE DEVELOPMENT,0.40843,-0.10605,-0.070457,0,0
6,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.22235,-0.10614,-0.084726,0,0
6,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.12049,-0.1064,-0.078279,0,0
6,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.1313,-0.1066,-0.088014,0,0
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.7495,-0.10672,-0.023395,0,0
6,GO DIENCEPHALON DEVELOPMENT,0.092194,-0.10818,-0.10951,0,0
6,GO FATTY ACID DERIVATIVE TRANSPORT,0.25363,-0.10856,-0.05197,0,0
6,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.38408,-0.10867,-0.090366,0,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.27227,-0.10892,-0.076187,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.097379,-0.10894,-0.1109,0,0
6,GO REGULATION OF FATTY ACID TRANSPORT,0.24643,-0.1092,-0.076207,0,0
6,GO MRNA TRANSCRIPTION,0.25363,-0.10935,-0.072209,0,0
6,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.41341,-0.10941,-0.042975,0,0
6,GO NUCLEOSIDE CATABOLIC PROCESS,0.053746,-0.10949,-0.15808,0,0
6,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.63978,-0.10983,-0.14513,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.082489,-0.11013,-0.081344,0,0
6,GO FAT CELL PROLIFERATION,0.26098,-0.11081,-0.081584,0,0
6,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.16828,-0.11097,-0.14394,0,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.072231,-0.11222,-0.16981,0,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.75615,-0.11251,-0.048589,0,0
6,GO KETONE CATABOLIC PROCESS,0.070855,-0.11282,-0.1894,0,0
6,GO RESPONSE TO INSECTICIDE,0.80989,-0.11311,-0.013078,0,0
6,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.079444,-0.11333,-0.084827,0,0
6,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.12049,-0.1136,-0.28901,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.068167,-0.11386,-0.18963,0,0
6,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.47588,-0.11402,-0.045653,0,0
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.21579,-0.1141,-0.11565,0,0
6,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.099158,-0.11447,-0.17675,0,0
6,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.91293,-0.11454,0.022408,0,0
6,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.12259,-0.11456,-0.16197,0,0
6,GO MEMBRANE LIPID CATABOLIC PROCESS,0.060602,-0.11507,-0.16772,0,0
6,GO LIPOPROTEIN LOCALIZATION,0.14285,-0.11514,-0.10287,0,0
6,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.072231,-0.11557,-0.12803,0,0
6,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.049546,-0.11558,-0.19466,0,0
6,GO MYOTUBE DIFFERENTIATION,0.10096,-0.11618,-0.088465,0,0
6,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.12049,-0.11621,-0.17828,0,0
6,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.23937,-0.11666,-0.12927,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.088862,-0.11691,-0.12826,0,0
6,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.25001,-0.11722,-0.16384,0,0
6,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.2,-0.11725,-0.11246,0,0
6,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.092194,-0.11832,-0.1604,0,0
6,GO NEURON FATE COMMITMENT,0.41341,-0.11835,-0.040205,0,0
6,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.15015,-0.11851,-0.15717,0,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.095625,-0.11896,-0.12616,0,0
6,GO CARDIOCYTE DIFFERENTIATION,0.17934,-0.11901,-0.068565,0,0
6,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.090515,-0.11902,-0.13531,0,0
6,GO HORMONE METABOLIC PROCESS,0.11434,-0.1193,-0.098397,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.72313,-0.11935,-0.041044,0,0
6,GO STEROL IMPORT,0.34702,-0.11938,-0.055777,0,0
6,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.085627,-0.11962,-0.18799,0,0
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.25729,-0.11971,-0.079686,0,0
6,GO REGULATION OF HISTONE DEACETYLATION,0.054842,-0.11977,-0.10854,0,0
6,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.27611,-0.12024,-0.076403,0,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.049546,-0.12065,-0.13147,0,0
6,GO RESPONSE TO MURAMYL DIPEPTIDE,0.087232,-0.12111,-0.15455,0,0
6,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.038561,-0.12132,-0.16502,0,0
6,GO HISTONE H3 K9 TRIMETHYLATION,0.11434,-0.12172,-0.08329,0,0
6,GO HEART FORMATION,0.25001,-0.12187,-0.08206,0,0
6,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.41842,-0.12194,-0.056898,0,0
6,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.052669,-0.12216,-0.15298,0,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.085627,-0.12254,-0.10509,0,0
6,GO T HELPER 2 CELL DIFFERENTIATION,0.33373,-0.12264,-0.19267,0,0
6,GO TISSUE MIGRATION,0.052669,-0.12264,-0.10693,0,0
6,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.36064,-0.12265,-0.09638,0,0
6,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.16828,-0.12326,-0.14239,0,0
6,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.25001,-0.12327,-0.12467,0,0
6,GO NEGATIVE REGULATION OF CELL SIZE,0.082489,-0.12343,-0.094469,0,0
6,GO SYNAPTIC VESICLE BUDDING,0.15015,-0.12357,-0.10189,0,0
6,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.63354,-0.12361,-0.079345,0,0
6,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.22568,-0.12369,-0.10727,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.35153,-0.12382,-0.085274,0,0
6,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.084046,-0.12411,-0.18517,0,0
6,GO REGULATION OF MESODERM DEVELOPMENT,0.14285,-0.12419,-0.11158,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.13583,-0.12451,-0.12157,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.21579,-0.12457,-0.073951,0,0
6,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.04854,-0.12484,-0.15094,0,0
6,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.12908,-0.125,-0.10917,0,0
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.04854,-0.12536,-0.11375,0,0
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10096,-0.12573,-0.1186,0,0
6,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.18219,-0.126,-0.11398,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.05161,-0.12619,-0.18499,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.054842,-0.12653,-0.11945,0,0
6,GO CYSTEINE METABOLIC PROCESS,0.56666,-0.12668,-0.065246,0,0
6,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.054842,-0.12674,-0.11463,0,0
6,GO RESPONSE TO DIETARY EXCESS,0.46512,-0.12681,-0.073083,0,0
6,GO POLYAMINE METABOLIC PROCESS,0.05161,-0.12688,-0.10507,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.15264,-0.12731,-0.085475,0,0
6,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.076492,-0.1274,-0.17121,0,0
6,GO RESPONSE TO CADMIUM ION,0.11039,-0.12778,-0.12653,0,0
6,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.075049,-0.12815,-0.11737,0,0
6,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.060602,-0.12853,-0.15283,0,0
6,GO NEUTROPHIL HOMEOSTASIS,0.29992,-0.12898,-0.14992,0,0
6,GO CILIUM ORGANIZATION,0.00052342,-0.12901,-0.13345,0,0
6,GO REGULATION OF GTP BINDING,0.40843,-0.12916,-0.069615,0,0
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.090515,-0.12965,-0.19235,0,0
6,GO ETHER BIOSYNTHETIC PROCESS,0.12689,-0.12983,-0.19409,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.076492,-0.1303,-0.10402,0,0
6,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.095625,-0.13039,-0.10267,0,0
6,GO AMMONIUM TRANSPORT,0.10845,-0.13054,-0.19741,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.072231,-0.1308,-0.1429,0,0
6,GO LIPID EXPORT FROM CELL,0.076492,-0.1312,-0.11281,0,0
6,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.05161,-0.13174,-0.18714,0,0
6,GO BILE ACID BIOSYNTHETIC PROCESS,0.057089,-0.13195,-0.10423,0,0
6,GO REGULATION OF RESPONSE TO TUMOR CELL,0.077957,-0.13235,-0.13666,0,0
6,GO HISTONE H2A UBIQUITINATION,0.0036303,-0.13238,-0.12349,0,0
6,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.052669,-0.13279,-0.10656,0,0
6,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.12908,-0.13297,-0.23336,0,0
6,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.12689,-0.13369,-0.12255,0,0
6,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13355,-0.13395,-0.18851,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.099158,-0.13406,-0.087686,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.32938,-0.13435,-0.081308,0,0
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010245,-0.13504,-0.138,0,0
6,GO NEGATIVE REGULATION OF WOUND HEALING,0.066855,-0.1352,-0.15909,0,0
6,GO ADHERENS JUNCTION ORGANIZATION,0.072231,-0.13536,-0.10553,0,0
6,GO METANEPHRIC NEPHRON DEVELOPMENT,0.1313,-0.13603,-0.097823,0,0
6,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.29992,-0.13626,-0.13545,0,0
6,GO REGULATION OF NEURON MATURATION,0.4598,-0.13662,-0.043819,0,0
6,GO RETINOL METABOLIC PROCESS,0.057089,-0.13684,-0.17424,0,0
6,GO PLASMA MEMBRANE FUSION,0.13814,-0.13697,-0.13578,0,0
6,GO FORELIMB MORPHOGENESIS,0.15264,-0.137,-0.11631,0,0
6,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.19695,-0.13708,-0.070767,0,0
6,GO ENDOCRINE PANCREAS DEVELOPMENT,0.2839,-0.13874,-0.069496,0,0
6,GO REGULATION OF SPINDLE ORGANIZATION,0.00026003,-0.13967,-0.1549,0,0
6,GO UTERUS DEVELOPMENT,0.27999,-0.14048,-0.068691,0,0
6,GO REGULATION OF RENAL SYSTEM PROCESS,0.12473,-0.14058,-0.11492,0,0
6,GO MEMBRANE FISSION,0.055956,-0.14069,-0.11701,0,0
6,GO PROTEIN K11 LINKED UBIQUITINATION,0.0028957,-0.14073,-0.1457,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24288,-0.14184,-0.10259,0,0
6,GO L ASCORBIC ACID METABOLIC PROCESS,0.37932,-0.1419,-0.095205,0,0
6,GO REGULATION OF MITOCHONDRIAL FUSION,0.05824,-0.14226,-0.10691,0,0
6,GO PHOTORECEPTOR CELL MAINTENANCE,0.052669,-0.14262,-0.11501,0,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.097379,-0.14286,-0.1077,0,0
6,GO PHOTOTRANSDUCTION,0.0073363,-0.14296,-0.14348,0,0
6,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.21905,-0.14358,-0.11073,0,0
6,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.16294,-0.14358,-0.17508,0,0
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.082489,-0.14419,-0.11358,0,0
6,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.24288,-0.14552,-0.19843,0,0
6,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.15264,-0.14566,-0.16436,0,0
6,GO ANIMAL ORGAN MATURATION,0.13355,-0.14576,-0.10707,0,0
6,GO CARNITINE METABOLIC PROCESS,0.38888,-0.14588,-0.064017,0,0
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.26847,-0.14619,-0.090231,0,0
6,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.53742,-0.14649,-0.16679,0,0
6,GO NEGATIVE REGULATION OF BONE REMODELING,0.10845,-0.14707,-0.17964,0,0
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.35607,-0.1471,-0.082958,0,0
6,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.066855,-0.14727,-0.1549,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.19393,-0.14817,-0.10305,0,0
6,GO PLATELET DEGRANULATION,0.20621,-0.1483,-0.1132,0,0
6,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.21256,-0.14852,-0.17387,0,0
6,GO DISACCHARIDE METABOLIC PROCESS,0.05161,-0.1488,-0.1726,0,0
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.48131,-0.14951,-0.075744,0,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.32506,-0.14965,-0.11279,0,0
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.093897,-0.14977,-0.11086,0,0
6,GO COPULATION,0.068167,-0.1504,-0.11843,0,0
6,GO REGULATION OF MYOBLAST FUSION,0.12049,-0.15075,-0.17769,0,0
6,GO MACROPHAGE CYTOKINE PRODUCTION,0.20309,-0.15141,-0.14563,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.26098,-0.15142,-0.14635,0,0
6,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.21579,-0.15203,-0.12687,0,0
6,GO DETECTION OF CALCIUM ION,0.2,-0.15249,-0.13043,0,0
6,GO REGULATION OF HEART MORPHOGENESIS,0.22568,-0.15254,-0.10321,0,0
6,GO MICROTUBULE SEVERING,0.024846,-0.15297,-0.14641,0,0
6,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.20309,-0.15304,-0.15205,0,0
6,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.12689,-0.15324,-0.15939,0,0
6,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0028957,-0.15332,-0.18154,0,0
6,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.070855,-0.15402,-0.13608,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.15015,-0.15425,-0.13189,0,0
6,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0049174,-0.1545,-0.18074,0,0
6,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.17099,-0.1547,-0.067165,0,0
6,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.29586,-0.15483,-0.054061,0,0
6,GO AMYLOID FIBRIL FORMATION,0.33373,-0.15512,-0.11336,0,0
6,GO SEROTONIN SECRETION,0.14526,-0.15553,-0.095884,0,0
6,GO GANGLION DEVELOPMENT,0.1313,-0.15648,-0.18093,0,0
6,GO HYALURONAN CATABOLIC PROCESS,0.20309,-0.15652,-0.16605,0,0
6,GO EPITHELIAL CELL MATURATION,0.070855,-0.1566,-0.13123,0,0
6,GO T CELL EXTRAVASATION,0.13583,-0.15669,-0.23466,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.073629,-0.15673,-0.15122,0,0
6,GO TELOMERE CAPPING,0.0041716,-0.15682,-0.11467,0,0
6,GO ADHERENS JUNCTION ASSEMBLY,0.23589,-0.15705,-0.067929,0,0
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.007729,-0.1573,-0.18045,0,0
6,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.18508,-0.15763,-0.13072,0,0
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0017641,-0.15846,-0.16745,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.12259,-0.15903,-0.20717,0,0
6,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.25363,-0.15953,-0.13287,0,0
6,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.054842,-0.1597,-0.22913,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.070855,-0.16018,-0.14161,0,0
6,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.25001,-0.16144,-0.11423,0,0
6,GO TYPE 2 IMMUNE RESPONSE,0.065563,-0.16191,-0.19482,0,0
6,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.42347,-0.1623,-0.10631,0,0
6,GO CELL FATE DETERMINATION,0.0094949,-0.16255,-0.18638,0,0
6,GO REGULATION OF HELICASE ACTIVITY,0.21256,-0.16348,-0.1121,0,0
6,GO LACTATE METABOLIC PROCESS,0.077957,-0.16484,-0.14518,0,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.74288,-0.16555,-0.03071,0,0
6,GO NEGATIVE REGULATION OF JNK CASCADE,0.011904,-0.16609,-0.13149,0,0
6,GO LYSINE METABOLIC PROCESS,0.082489,-0.16717,-0.21034,0,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.20621,-0.16786,-0.12081,0,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.080955,-0.16839,-0.11155,0,0
6,GO TRNA CATABOLIC PROCESS,0.24643,-0.16872,-0.13514,0,0
6,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.10465,-0.16995,-0.22625,0,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.049546,-0.17037,-0.23522,0,0
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.18219,-0.17115,-0.077585,0,0
6,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.004408,-0.17196,-0.17018,0,0
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.53167,-0.17269,-0.038424,0,0
6,GO INTERMEDIATE FILAMENT ORGANIZATION,0.23245,-0.17407,-0.10281,0,0
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0022992,-0.17542,-0.16577,0,0
6,GO METANEPHROS MORPHOGENESIS,0.25001,-0.17581,-0.075415,0,0
6,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0025083,-0.17613,-0.17621,0,0
6,GO SPERM AXONEME ASSEMBLY,0.018398,-0.17897,-0.14658,0,0
6,GO MITOCHONDRIAL DEPOLARIZATION,0.11039,-0.17905,-0.12555,0,0
6,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.14769,-0.17951,-0.12749,0,0
6,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.21256,-0.17955,-0.1377,0,0
6,GO BRONCHUS DEVELOPMENT,0.20309,-0.18006,-0.13595,0,0
6,GO ETHANOL CATABOLIC PROCESS,0.27999,-0.18063,-0.10727,0,0
6,GO CELL FATE SPECIFICATION,0.013798,-0.18077,-0.14292,0,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.12689,-0.18205,-0.097632,0,0
6,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.10654,-0.18215,-0.1864,0,0
6,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.080955,-0.18238,-0.2116,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00036427,-0.18249,-0.21438,0,0
6,GO REGULATION OF TELOMERE CAPPING,0.0025083,-0.18534,-0.14784,0,0
6,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.12689,-0.18625,-0.15532,0,0
6,GO INTRACILIARY TRANSPORT,0.0025083,-0.18655,-0.20942,0,0
6,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.16032,-0.1866,-0.18686,0,0
6,GO GENITALIA MORPHOGENESIS,0.1028,-0.18737,-0.14642,0,0
6,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.072231,-0.18966,-0.20207,0,0
6,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.22235,-0.18976,-0.20246,0,0
6,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.080955,-0.18988,-0.14246,0,0
6,GO POSITIVE REGULATION OF VASCULOGENESIS,0.32938,-0.18998,-0.11467,0,0
6,GO RESPONSE TO AUDITORY STIMULUS,0.11235,-0.19042,-0.13911,0,0
6,GO RENAL ABSORPTION,0.082489,-0.19141,-0.23081,0,0
6,GO ETHANOL OXIDATION,0.15773,-0.19142,-0.23688,0,0
6,GO REGULATION OF CHLORIDE TRANSPORT,0.05824,-0.19226,-0.1733,0,0
6,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0040578,-0.19241,-0.17525,0,0
6,GO GALACTOSE METABOLIC PROCESS,0.10465,-0.19284,-0.15601,0,0
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.17934,-0.19379,-0.14419,0,0
6,GO NON MOTILE CILIUM ASSEMBLY,0.0062634,-0.19384,-0.15592,0,0
6,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00072223,-0.19512,-0.22377,0,0
6,GO PROXIMAL DISTAL PATTERN FORMATION,0.18508,-0.19669,-0.13112,0,0
6,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0090226,-0.19698,-0.16844,0,0
6,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.17934,-0.19725,-0.1207,0,0
6,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.12473,-0.1974,-0.18682,0,0
6,GO MICROVILLUS ASSEMBLY,0.053746,-0.19753,-0.20991,0,0
6,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.073629,-0.19844,-0.1825,0,0
6,GO SARCOMERE ORGANIZATION,0.0040578,-0.19847,-0.18119,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.050569,-0.19937,-0.14583,0,0
6,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.075049,-0.20108,-0.12896,0,0
6,GO CARDIOBLAST DIFFERENTIATION,0.10654,-0.20179,-0.12994,0,0
6,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.11636,-0.20224,-0.095155,0,0
6,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.1313,-0.20253,-0.1455,0,0
6,GO PARTURITION,0.082489,-0.2036,-0.1589,0,0
6,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.070855,-0.20441,-0.18912,0,0
6,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.17374,-0.20468,-0.1526,0,0
6,GO SECONDARY HEART FIELD SPECIFICATION,0.017549,-0.20492,-0.26988,0,0
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.049546,-0.20493,-0.15013,0,0
6,GO PHOSPHOLIPID DEPHOSPHORYLATION,9.389e-05,-0.2064,-0.21255,0,0
6,GO CLATHRIN COAT ASSEMBLY,0.11039,-0.20747,-0.10216,0,0
6,GO SEQUESTERING OF ACTIN MONOMERS,0.25729,-0.20766,-0.15062,0,0
6,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033166,-0.20879,-0.1891,0,0
6,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.00014935,-0.2089,-0.20287,0,0
6,GO CENTROSOME SEPARATION,0.0067808,-0.20902,-0.19563,0,0
6,GO REGULATION OF STEM CELL DIVISION,0.12259,-0.20926,-0.10614,0,0
6,GO FOREBRAIN NEURON FATE COMMITMENT,0.13583,-0.20935,-0.15585,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00030804,-0.21007,-0.19438,0,0
6,GO HORMONE CATABOLIC PROCESS,0.0040578,-0.21298,-0.268,0,0
6,GO DORSAL SPINAL CORD DEVELOPMENT,0.40349,-0.21308,-0.034826,0,0
6,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.12473,-0.2133,-0.15283,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0039469,-0.2135,-0.28308,0,0
6,GO REGULATION OF ANIMAL ORGAN FORMATION,0.16828,-0.21457,-0.11528,0,0
6,GO ATRIAL SEPTUM DEVELOPMENT,0.05161,-0.21646,-0.16836,0,0
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.076492,-0.21747,-0.23213,0,0
6,GO TERPENOID BIOSYNTHETIC PROCESS,0.059411,-0.21796,-0.28744,0,0
6,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.21579,-0.22055,-0.073047,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.0083534,-0.22244,-0.24134,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.10845,-0.22751,-0.16087,0,0
6,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.011047,-0.22869,-0.19893,0,0
6,GO TRIGEMINAL NERVE DEVELOPMENT,0.060602,-0.22914,-0.31862,0,0
6,GO INTRACILIARY RETROGRADE TRANSPORT,0.063042,-0.22994,-0.19183,0,0
6,GO CELL JUNCTION MAINTENANCE,0.0011549,-0.23176,-0.2268,0,0
6,GO THYMOCYTE APOPTOTIC PROCESS,0.079444,-0.23252,-0.16641,0,0
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.12689,-0.23289,-0.19345,0,0
6,GO RADIAL GLIAL CELL DIFFERENTIATION,0.05161,-0.23341,-0.20904,0,0
6,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.21905,-0.23403,-0.11081,0,0
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0013457,-0.23426,-0.22204,0,0
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.084046,-0.23463,-0.20178,0,0
6,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0020453,-0.23597,-0.2163,0,0
6,GO REGULATION OF GLOMERULAR FILTRATION,0.076492,-0.23651,-0.24512,0,0
6,GO SKELETAL MUSCLE ADAPTATION,0.04854,-0.23652,-0.1312,0,0
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.17934,-0.23766,-0.081558,0,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.23937,-0.23921,-0.13675,0,0
6,GO RETINAL ROD CELL DIFFERENTIATION,0.15264,-0.23973,-0.14753,0,0
6,GO ATRIAL SEPTUM MORPHOGENESIS,0.03245,-0.23999,-0.22587,0,0
6,GO OUTER DYNEIN ARM ASSEMBLY,0.001191,-0.24059,-0.28135,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,1.8521e-05,-0.24306,-0.24897,0,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,-0.2446,-0.21774,0,0
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00081984,-0.24588,-0.26629,0,0
6,GO RETINAL METABOLIC PROCESS,0.077957,-0.25064,-0.21635,0,0
6,GO REGULATION OF SPINDLE ASSEMBLY,7.3528e-06,-0.25391,-0.26491,0,0
6,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0001165,-0.25592,-0.26039,0,0
6,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.054842,-0.25594,-0.24168,0,0
6,GO PITUITARY GLAND DEVELOPMENT,0.001986,-0.25694,-0.27516,0,0
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.19393,-0.25813,-0.1016,0,0
6,GO MYOBLAST MIGRATION,0.082489,-0.2586,-0.2141,0,0
6,GO HEART FIELD SPECIFICATION,0.060602,-0.26833,-0.17541,0,0
6,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.061812,-0.26905,-0.21526,0,0
6,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0017123,-0.26948,-0.25984,0,0
6,GO INTERLEUKIN 13 PRODUCTION,0.0059384,-0.26991,-0.26897,0,0
6,GO FRUCTOSE METABOLIC PROCESS,0.079444,-0.2717,-0.24901,0,0
6,GO REGULATION OF CELL FATE COMMITMENT,0.00050664,-0.2724,-0.26348,0,0
6,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.00055855,-0.27266,-0.22664,0,0
6,GO GDP METABOLIC PROCESS,0.0099891,-0.27545,-0.23466,0,0
6,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.068167,-0.27576,-0.22095,0,0
6,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.070855,-0.29173,-0.17678,0,0
6,GO CARDIOBLAST PROLIFERATION,0.43883,-0.2964,-0.11467,0,0
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.057089,-0.31534,-0.16377,0,0
6,GO IMMATURE B CELL DIFFERENTIATION,0.0019282,-0.31535,-0.23545,0,0
6,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00081984,-0.31857,-0.24577,0,0
6,GO GABAERGIC NEURON DIFFERENTIATION,0.095625,-0.32207,-0.1348,0,0
6,GO DOPAMINE BIOSYNTHETIC PROCESS,0.097379,-0.32331,-0.24581,0,0
6,GO BILE ACID AND BILE SALT TRANSPORT,3.5759e-05,-0.33346,-0.36409,0,0
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00010462,-0.35389,-0.41795,0,0
6,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,7.0571e-06,-0.35948,-0.3418,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,5.4977e-07,-0.36655,-0.37184,0,0
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.0025083,-0.36907,-0.34298,0,0
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.035393,-0.37892,-0.28382,0,0
6,GO RESPONSE TO MUSCLE INACTIVITY,2.9532e-05,-0.38095,-0.37791,0,0
6,GO MEGAKARYOCYTE DEVELOPMENT,0.00028792,-0.38116,-0.38153,0,0
6,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.12689,-0.38618,-0.17745,0,0
6,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00013917,-0.43491,-0.44366,0,0
6,GO NEURON FATE SPECIFICATION,0.0081404,-0.43561,-0.28917,0,0
6,GO ADENOHYPOPHYSIS DEVELOPMENT,0.04854,-0.43791,-0.27687,0,0
6,GO REGULATION OF CELL FATE SPECIFICATION,9.0551e-05,-0.45104,-0.41235,0,0
6,GO RETINA LAYER FORMATION,0.00010845,-0.48066,-0.42623,0,0
6,GO CARDIAC CELL FATE COMMITMENT,0.0027346,-0.52433,-0.42865,0,0
6,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00020448,-0.53073,-0.48748,0,0
6,GO PROTEIN AUTO ADP RIBOSYLATION,5.6174e-05,-0.53712,-0.45348,0,0
6,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,2.2524e-05,-0.55124,-0.4387,0,0
6,GO NEGATIVE REGULATION OF ANOIKIS,2.8077e-06,-0.57759,-0.60574,0,0
6,GO NOSE DEVELOPMENT,0.0001547,-0.96706,-0.65925,0,0
7,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,1.5201e-05,1.0472,0.90548,1,1
7,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,5.9841e-06,0.90597,1.0108,1,1
7,GO GABAERGIC NEURON DIFFERENTIATION,2.1702e-06,0.68717,0.7666,1,1
7,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0017123,0.64763,0.49011,1,1
7,GO ADENOHYPOPHYSIS DEVELOPMENT,7.2754e-05,0.61888,0.606,1,1
7,GO MECHANOSENSORY BEHAVIOR,0.001228,0.59272,0.53396,1,1
7,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0015653,0.55704,0.47044,1,1
7,GO INNER DYNEIN ARM ASSEMBLY,0.00010092,0.53434,0.50788,1,1
7,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00045924,0.52776,0.60567,1,1
7,GO RETINAL GANGLION CELL AXON GUIDANCE,2.2524e-05,0.52225,0.57146,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00010092,0.50898,0.38187,1,1
7,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.4421e-05,0.50846,0.57311,1,1
7,GO SUBPALLIUM DEVELOPMENT,3.0576e-06,0.49145,0.48554,1,1
7,GO SYNAPTIC VESICLE CLUSTERING,0.00019079,0.48694,0.60249,1,1
7,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0034322,0.48653,0.5448,1,1
7,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00036427,0.48278,0.44306,1,1
7,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.001872,0.48135,0.51505,1,1
7,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0016129,0.45866,0.53175,1,1
7,GO DETECTION OF CALCIUM ION,0.00063551,0.44595,0.36355,1,1
7,GO OLFACTORY LOBE DEVELOPMENT,6.4994e-06,0.44227,0.44332,1,1
7,GO POSITIVE REGULATION OF BEHAVIOR,0.00016595,0.43389,0.35066,1,1
7,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0036303,0.43385,0.48183,1,1
7,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,2.9301e-06,0.43118,0.40785,1,1
7,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0037331,0.42824,0.43524,1,1
7,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00087311,0.42609,0.3715,1,1
7,GO HEART FIELD SPECIFICATION,0.00050664,0.42319,0.4163,1,1
7,GO BEHAVIORAL RESPONSE TO COCAINE,0.001872,0.42002,0.39376,1,1
7,GO TELENCEPHALON REGIONALIZATION,0.02166,0.41896,0.31714,1,1
7,GO RESPONSE TO FORSKOLIN,0.010506,0.41714,0.26898,1,1
7,GO NEUROTRANSMITTER REUPTAKE,0.00034072,0.41564,0.33381,1,1
7,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0039469,0.41061,0.37468,1,1
7,GO SEROTONIN TRANSPORT,0.00095906,0.40872,0.33248,1,1
7,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00024286,0.40273,0.41787,1,1
7,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00031859,0.40215,0.33977,1,1
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.00057693,0.39947,0.36481,1,1
7,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.9263e-05,0.39931,0.54263,1,1
7,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,2.6307e-05,0.39911,0.371,1,1
7,GO UTERUS DEVELOPMENT,0.0011549,0.39532,0.30409,1,1
7,GO GLIAL CELL FATE COMMITMENT,0.011047,0.39161,0.37077,1,1
7,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00012964,0.38782,0.34953,1,1
7,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0062634,0.38445,0.34534,1,1
7,GO NEUROTRANSMITTER UPTAKE,0.00036427,0.38178,0.28941,1,1
7,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00018427,0.37925,0.39102,1,1
7,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.00026003,0.37915,0.42595,1,1
7,GO REGULATION OF MESODERM DEVELOPMENT,0.00019753,0.37897,0.28855,1,1
7,GO STARTLE RESPONSE,0.00019753,0.37447,0.46168,1,1
7,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0001165,0.37244,0.39749,1,1
7,GO EXPLORATION BEHAVIOR,0.0011549,0.37138,0.34996,1,1
7,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0085714,0.36419,0.34725,1,1
7,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0011549,0.36303,0.45766,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00040247,0.36111,0.33342,1,1
7,GO REFLEX,0.0069616,0.35881,0.27648,1,1
7,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,9.0551e-05,0.35306,0.364,1,1
7,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.017137,0.35288,0.24833,1,1
7,GO AXONAL FASCICULATION,0.0029794,0.35188,0.35444,1,1
7,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.00031859,0.34417,0.31337,1,1
7,GO MOTILE CILIUM ASSEMBLY,0.00022676,0.34322,0.31428,1,1
7,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.00023468,0.34294,0.28668,1,1
7,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00014418,0.34294,0.36883,1,1
7,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00041602,0.34167,0.33587,1,1
7,GO REGULATION OF RECEPTOR CLUSTERING,0.0017641,0.34133,0.35637,1,1
7,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00069957,0.33678,0.41003,1,1
7,GO CIRCADIAN SLEEP WAKE CYCLE,0.00016595,0.3362,0.29993,1,1
7,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0014299,0.33479,0.2921,1,1
7,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0056288,0.33308,0.26323,1,1
7,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0010528,0.33293,0.30591,1,1
7,GO MICROTUBULE DEPOLYMERIZATION,6.5149e-05,0.33239,0.30961,1,1
7,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.0040578,0.32775,0.24172,1,1
7,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00021167,0.3255,0.31628,1,1
7,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0027346,0.32442,0.2719,1,1
7,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0075304,0.32431,0.40412,1,1
7,GO RESPONSE TO ISOQUINOLINE ALKALOID,2.3418e-05,0.32341,0.32914,1,1
7,GO HEART INDUCTION,0.014138,0.32237,0.37259,1,1
7,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0039469,0.32202,0.29285,1,1
7,GO PREPULSE INHIBITION,0.023741,0.319,0.40783,1,1
7,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.00027832,0.31834,0.33988,1,1
7,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00074557,0.3179,0.39642,1,1
7,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0026572,0.31781,0.30593,1,1
7,GO COMMISSURAL NEURON AXON GUIDANCE,0.038561,0.31743,0.22101,1,1
7,GO GLYCINE TRANSPORT,0.0085714,0.31556,0.2556,1,1
7,GO LONG TERM SYNAPTIC DEPRESSION,0.00014418,0.31419,0.31159,1,1
7,GO FOREBRAIN GENERATION OF NEURONS,3.4421e-05,0.31294,0.34518,1,1
7,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00084609,0.30667,0.35005,1,1
7,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0090226,0.30581,0.37492,1,1
7,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.011904,0.30484,0.33474,1,1
7,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.035393,0.30296,0.20175,1,1
7,GO TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION,0.004408,0.30199,0.29611,1,1
7,GO MESODERMAL CELL FATE SPECIFICATION,0.0054795,0.3016,0.25339,1,1
7,GO RESPONSE TO EPINEPHRINE,0.029719,0.30133,0.27175,1,1
7,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00011241,0.30091,0.3514,1,1
7,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0018173,0.29923,0.29236,1,1
7,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0051916,0.29781,0.39693,1,1
7,GO REGULATION OF CILIUM BEAT FREQUENCY,4.4878e-05,0.29696,0.33265,1,1
7,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0011199,0.29669,0.34729,1,1
7,GO GAMMA DELTA T CELL DIFFERENTIATION,0.02843,0.29516,0.29207,1,1
7,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.044685,0.29463,0.19279,1,1
7,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0073363,0.29301,0.20409,1,1
7,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00034072,0.29297,0.32711,1,1
7,GO RECEPTOR LOCALIZATION TO SYNAPSE,7.547e-05,0.28884,0.3578,1,1
7,GO RESPONSE TO COCAINE,0.00011241,0.28865,0.27084,1,1
7,GO GLUTAMATE SECRETION,0.0015189,0.28665,0.25336,1,1
7,GO RESPONSE TO AUDITORY STIMULUS,0.0017123,0.28608,0.36231,1,1
7,GO BONE MATURATION,0.012508,0.28556,0.24226,1,1
7,GO SYNAPTIC VESICLE DOCKING,0.0020453,0.2854,0.31535,1,1
7,GO EXTRACELLULAR TRANSPORT,0.001191,0.28456,0.27301,1,1
7,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00010462,0.284,0.30471,1,1
7,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.4205e-05,0.28342,0.37102,1,1
7,GO RESPONSE TO POTASSIUM ION,0.02843,0.28196,0.20068,1,1
7,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.001662,0.28175,0.25109,1,1
7,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0024367,0.27884,0.29941,1,1
7,GO NEURON RECOGNITION,0.00032948,0.27769,0.33641,1,1
7,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0036303,0.2766,0.22958,1,1
7,GO REGULATION OF VESICLE FUSION,0.030383,0.27604,0.22127,1,1
7,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.038561,0.27557,0.27342,1,1
7,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.033894,0.2754,0.31575,1,1
7,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00024286,0.27523,0.20539,1,1
7,GO LONG TERM SYNAPTIC POTENTIATION,0.00019753,0.27466,0.25277,1,1
7,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00036427,0.27382,0.30352,1,1
7,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0060989,0.27285,0.28277,1,1
7,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.0046564,0.27103,0.20515,1,1
7,GO REGULATION OF FILOPODIUM ASSEMBLY,0.00022676,0.271,0.2781,1,1
7,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0013054,0.26989,0.3281,1,1
7,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0015189,0.26968,0.24344,1,1
7,GO FILOPODIUM ASSEMBLY,0.00022676,0.2682,0.24745,1,1
7,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00047456,0.26806,0.3052,1,1
7,GO RESPONSE TO INSECTICIDE,0.0018173,0.26766,0.30361,1,1
7,GO NEURONAL ACTION POTENTIAL,0.015203,0.26585,0.23796,1,1
7,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.016339,0.26481,0.23247,1,1
7,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.0033369,0.26343,0.20568,1,1
7,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.011904,0.26285,0.25616,1,1
7,GO ANTEROGRADE AXONAL TRANSPORT,3.1888e-05,0.26258,0.24836,1,1
7,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0073363,0.26234,0.21468,1,1
7,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0028957,0.26156,0.18038,1,1
7,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0053338,0.26067,0.23707,1,1
7,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.011904,0.25989,0.2021,1,1
7,GO CATECHOLAMINE UPTAKE,0.040234,0.2598,0.18973,1,1
7,GO ADULT LOCOMOTORY BEHAVIOR,0.00059588,0.25895,0.23034,1,1
7,GO FOREBRAIN NEURON DEVELOPMENT,0.0017641,0.25892,0.33187,1,1
7,GO MESODERMAL CELL FATE COMMITMENT,0.02268,0.25878,0.19883,1,1
7,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0010528,0.25855,0.20705,1,1
7,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0014299,0.25763,0.2717,1,1
7,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0073363,0.25614,0.28617,1,1
7,GO LONG TERM MEMORY,0.00030804,0.25606,0.26381,1,1
7,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.021165,0.25596,0.2564,1,1
7,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.001662,0.25571,0.21411,1,1
7,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,7.8282e-05,0.25381,0.28567,1,1
7,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,4.4878e-05,0.25316,0.23249,1,1
7,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0097392,0.25243,0.25372,1,1
7,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.027803,0.25188,0.28128,1,1
7,GO SYNAPTIC VESICLE LOCALIZATION,3.1888e-05,0.25183,0.32623,1,1
7,GO POSITIVE REGULATION OF FERTILIZATION,0.042857,0.25035,0.1849,1,1
7,GO PROTEIN LOCALIZATION TO SYNAPSE,5.8301e-05,0.24948,0.35311,1,1
7,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.011904,0.24796,0.2125,1,1
7,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00035231,0.24719,0.2232,1,1
7,GO SYNAPTIC VESICLE TRANSPORT,1.4039e-05,0.24705,0.26883,1,1
7,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0021062,0.24688,0.19235,1,1
7,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0038387,0.24654,0.20846,1,1
7,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0011199,0.24633,0.31691,1,1
7,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0017641,0.24569,0.22949,1,1
7,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00027832,0.24536,0.29423,1,1
7,GO WALKING BEHAVIOR,0.00029782,0.24391,0.28964,1,1
7,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0010528,0.24367,0.24339,1,1
7,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0013872,0.24332,0.25259,1,1
7,GO PRESYNAPSE ORGANIZATION,0.0071468,0.24212,0.204,1,1
7,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00092958,0.24161,0.22539,1,1
7,GO RESPONSE TO PARATHYROID HORMONE,0.0067808,0.24123,0.20829,1,1
7,GO RECEPTOR CLUSTERING,0.0011549,0.24092,0.29132,1,1
7,GO REGULATION OF SYNAPTIC PLASTICITY,0.00021909,0.24081,0.24542,1,1
7,GO EXCITATORY SYNAPSE ASSEMBLY,0.0014299,0.23746,0.41407,1,1
7,GO NEUROTRANSMITTER TRANSPORT,2.6307e-05,0.23722,0.29226,1,1
7,GO RESPONSE TO DOPAMINE,0.00011241,0.23626,0.20425,1,1
7,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,3.8583e-05,0.2357,0.27214,1,1
7,GO MESENCHYME MORPHOGENESIS,0.016734,0.23481,0.17064,1,1
7,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0073363,0.23376,0.23193,1,1
7,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.041093,0.23291,0.17274,1,1
7,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0010206,0.23183,0.24202,1,1
7,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.023741,0.22994,0.18493,1,1
7,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012074,0.22906,0.33648,1,1
7,GO LIPOPROTEIN LOCALIZATION,0.0064317,0.229,0.15581,1,1
7,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0016129,0.22732,0.22891,1,1
7,GO NEUROTRANSMITTER SECRETION,2.1663e-05,0.22547,0.3093,1,1
7,GO SECONDARY PALATE DEVELOPMENT,0.0032441,0.22544,0.23041,1,1
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0018173,0.22381,0.23131,1,1
7,GO RESPONSE TO INACTIVITY,0.0067808,0.22351,0.21941,1,1
7,GO RHYTHMIC BEHAVIOR,0.00090094,0.22344,0.18221,1,1
7,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00074557,0.22211,0.25039,1,1
7,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00041602,0.22132,0.27715,1,1
7,GO ADHERENS JUNCTION ASSEMBLY,0.019283,0.22118,0.15772,1,1
7,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0021062,0.22066,0.22512,1,1
7,GO REGULATION OF NEUROTRANSMITTER LEVELS,4.6597e-05,0.21869,0.26752,1,1
7,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0062634,0.21733,0.21637,1,1
7,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0085714,0.21634,0.15347,1,1
7,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.0034322,0.21578,0.23198,1,1
7,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.018836,0.21476,0.11938,1,1
7,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.0081404,0.21444,0.22113,1,1
7,GO AXONEME ASSEMBLY,0.0022332,0.21293,0.24907,1,1
7,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.001986,0.21142,0.21508,1,1
7,GO CALCIUM ION IMPORT INTO CYTOSOL,0.031059,0.20782,0.20738,1,1
7,GO PROTEIN POLYGLUTAMYLATION,0.0015653,0.2072,0.2106,1,1
7,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.001191,0.20655,0.18244,1,1
7,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0081404,0.20635,0.19262,1,1
7,GO MALE MEIOTIC NUCLEAR DIVISION,0.016339,0.20631,0.10976,1,1
7,GO RESPONSE TO ALKALOID,3.5759e-05,0.20611,0.20609,1,1
7,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0025083,0.20596,0.15457,1,1
7,GO GENETIC IMPRINTING,0.0013872,0.20554,0.212,1,1
7,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.017969,0.20454,0.15041,1,1
7,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00012512,0.20411,0.27404,1,1
7,GO ADULT BEHAVIOR,0.00018427,0.20375,0.22098,1,1
7,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00011241,0.20353,0.26472,1,1
7,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00074557,0.20344,0.22736,1,1
7,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.014486,0.20327,0.16429,1,1
7,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00034072,0.2024,0.25756,1,1
7,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.001872,0.20214,0.20358,1,1
7,GO MOTOR NEURON AXON GUIDANCE,0.018398,0.20194,0.14969,1,1
7,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,1.5816e-05,0.20174,0.19198,1,1
7,GO MICROTUBULE BUNDLE FORMATION,0.00016595,0.20104,0.21681,1,1
7,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0017641,0.20088,0.16085,1,1
7,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.00069957,0.20038,0.31225,1,1
7,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.033894,0.20007,0.16775,1,1
7,GO GENITALIA DEVELOPMENT,0.036164,0.19975,0.12192,1,1
7,GO RESPONSE TO CATECHOLAMINE,9.7346e-05,0.19891,0.21686,1,1
7,GO PRESYNAPTIC ENDOCYTOSIS,0.0010206,0.19874,0.21474,1,1
7,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0075304,0.19846,0.23114,1,1
7,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0025817,0.19833,0.20251,1,1
7,GO LOCALIZATION WITHIN MEMBRANE,0.00022676,0.19733,0.24293,1,1
7,GO DENDRITE DEVELOPMENT,0.00010845,0.19589,0.20353,1,1
7,GO DENDRITE EXTENSION,0.00028792,0.1942,0.32875,1,1
7,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00090094,0.19418,0.20426,1,1
7,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.012508,0.19282,0.16394,1,1
7,GO MEMBRANE DEPOLARIZATION,0.0064317,0.19252,0.18324,1,1
7,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0028141,0.1923,0.17841,1,1
7,GO LOCOMOTORY BEHAVIOR,0.0028957,0.19195,0.16738,1,1
7,GO REGULATION OF BEHAVIOR,0.00090094,0.19153,0.20994,1,1
7,GO DENDRITE MORPHOGENESIS,0.00035231,0.1915,0.22514,1,1
7,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.031059,0.19106,0.2687,1,1
7,GO MEMORY,0.00059588,0.18952,0.17276,1,1
7,GO ACROSOME REACTION,0.00037661,0.18915,0.21087,1,1
7,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.010245,0.18826,0.26211,1,1
7,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.00037661,0.18752,0.18713,1,1
7,GO BRAIN MORPHOGENESIS,0.013798,0.18741,0.13956,1,1
7,GO MICROTUBULE POLYMERIZATION,0.00017796,0.18707,0.19073,1,1
7,GO DENDRITIC SPINE MORPHOGENESIS,0.0041716,0.18705,0.23775,1,1
7,GO SYNAPTIC VESICLE RECYCLING,0.00067758,0.18682,0.21853,1,1
7,GO REGULATION OF AXONOGENESIS,0.0010206,0.18542,0.2,1,1
7,GO TRANSMISSION OF NERVE IMPULSE,0.0032441,0.18427,0.2262,1,1
7,GO RESPONSE TO ACETYLCHOLINE,0.0020453,0.18273,0.30865,1,1
7,GO REGULATION OF GOLGI ORGANIZATION,0.00032948,0.18183,0.1805,1,1
7,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00054072,0.18049,0.15785,1,1
7,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0021689,0.18048,0.24302,1,1
7,GO ETHANOL CATABOLIC PROCESS,0.018836,0.17991,0.17578,1,1
7,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0018173,0.17823,0.26191,1,1
7,GO ENDOCARDIAL CUSHION FORMATION,0.017137,0.17797,0.2034,1,1
7,GO NEURON MIGRATION,0.00059588,0.17753,0.23537,1,1
7,GO CEREBELLAR CORTEX DEVELOPMENT,0.023205,0.17654,0.14068,1,1
7,GO ENDODERMAL CELL FATE COMMITMENT,0.0020453,0.17648,0.19481,1,1
7,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.0012662,0.17617,0.14773,1,1
7,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.033166,0.17546,0.23106,1,1
7,GO METANEPHRIC COLLECTING DUCT DEVELOPMENT,0.019283,0.1748,0.29289,1,1
7,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00023468,0.17459,0.21258,1,1
7,GO SYNAPTIC SIGNALING,0.00012512,0.17429,0.20476,1,1
7,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00063551,0.17423,0.28186,1,1
7,GO SLEEP,0.0049174,0.17335,0.15974,1,1
7,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00019753,0.17316,0.19649,1,1
7,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.044685,0.17268,0.25308,1,1
7,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00054072,0.1726,0.16213,1,1
7,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00010092,0.17194,0.2102,1,1
7,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.023741,0.17172,0.13317,1,1
7,GO REGULATION OF MEMBRANE POTENTIAL,0.0020453,0.17163,0.16755,1,1
7,GO REGULATION OF CILIUM MOVEMENT,0.023205,0.1711,0.13807,1,1
7,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.036164,0.17071,0.16356,1,1
7,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00092958,0.17039,0.16575,1,1
7,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0060989,0.16979,0.27553,1,1
7,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00040247,0.16921,0.23842,1,1
7,GO MONOAMINE TRANSPORT,0.013798,0.16789,0.21453,1,1
7,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.014841,0.16719,0.16333,1,1
7,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0047853,0.16685,0.18176,1,1
7,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0016129,0.16606,0.21126,1,1
7,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0041716,0.16605,0.17375,1,1
7,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0029794,0.16594,0.18235,1,1
7,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.00098941,0.1655,0.14391,1,1
7,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.014486,0.16482,0.14936,1,1
7,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0038387,0.16387,0.15564,1,1
7,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0032441,0.16352,0.15496,1,1
7,GO MEIOTIC CHROMOSOME SEPARATION,0.0045306,0.16276,0.1415,1,1
7,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00084609,0.1626,0.18534,1,1
7,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00098941,0.1626,0.15094,1,1
7,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,5.2139e-05,0.1617,0.17274,1,1
7,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.00057693,0.16166,0.26908,1,1
7,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.02268,0.16155,0.13684,1,1
7,GO COGNITION,0.00072223,0.15786,0.14953,1,1
7,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0046564,0.15696,0.20041,1,1
7,GO HYPOTHALAMUS DEVELOPMENT,0.040234,0.15672,0.17399,1,1
7,GO NEURON PROJECTION GUIDANCE,0.007729,0.15607,0.14612,1,1
7,GO REGULATION OF CARDIAC CONDUCTION,0.016734,0.15598,0.1228,1,1
7,GO REGULATION OF NEURON MIGRATION,0.021165,0.15579,0.14417,1,1
7,GO REGULATION OF DENDRITE DEVELOPMENT,0.0019282,0.15379,0.16087,1,1
7,GO ESTROGEN BIOSYNTHETIC PROCESS,0.02166,0.15302,0.14238,1,1
7,GO FOREBRAIN CELL MIGRATION,0.015953,0.15223,0.14742,1,1
7,GO AXON DEVELOPMENT,0.0022992,0.15208,0.15996,1,1
7,GO CELL PART MORPHOGENESIS,0.00087311,0.15066,0.15303,1,1
7,GO MEIOTIC CHROMOSOME SEGREGATION,0.0019282,0.15036,0.13315,1,1
7,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0023671,0.15035,0.20757,1,1
7,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.038561,0.14978,0.13435,1,1
7,GO LIMBIC SYSTEM DEVELOPMENT,0.0071468,0.14929,0.12454,1,1
7,GO NEUROTRANSMITTER METABOLIC PROCESS,0.047551,0.14857,0.16747,1,1
7,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0017123,0.14837,0.15003,1,1
7,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0029794,0.14673,0.15041,1,1
7,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0049174,0.14651,0.14028,1,1
7,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.011612,0.14464,0.15658,1,1
7,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0029794,0.1437,0.14315,1,1
7,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.001662,0.14311,0.12904,1,1
7,GO ACTION POTENTIAL,0.0054795,0.14272,0.16232,1,1
7,GO FEMALE GENITALIA DEVELOPMENT,0.044685,0.1413,0.12511,1,1
7,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.00034072,0.14045,0.15271,1,1
7,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.02068,0.14009,0.10703,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0036303,0.13941,0.27111,1,1
7,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.018398,0.13846,0.16909,1,1
7,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.007729,0.13841,0.1787,1,1
7,GO VESICLE DOCKING,0.015953,0.13836,0.11237,1,1
7,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.01282,0.13788,0.13391,1,1
7,GO NEURON PROJECTION EXTENSION,0.0033369,0.13732,0.15664,1,1
7,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0085714,0.137,0.11331,1,1
7,GO CELLULAR RESPONSE TO ALKALOID,0.03939,0.13471,0.13529,1,1
7,GO MEIOSIS I CELL CYCLE PROCESS,0.0013457,0.13322,0.13195,1,1
7,GO REGULATION OF MICROTUBULE BASED PROCESS,1.1493e-05,0.13277,0.1421,1,1
7,GO POSITIVE REGULATION OF AXONOGENESIS,0.011326,0.13259,0.15848,1,1
7,GO RESPONSE TO AMINE,0.027803,0.1315,0.15913,1,1
7,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00021167,0.13092,0.13141,1,1
7,GO HIPPOCAMPUS DEVELOPMENT,0.018398,0.12877,0.11779,1,1
7,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0024367,0.12829,0.12934,1,1
7,GO DICARBOXYLIC ACID TRANSPORT,0.0024367,0.12821,0.13842,1,1
7,GO EXOCYTIC PROCESS,0.0025817,0.12731,0.17601,1,1
7,GO VISUAL BEHAVIOR,0.0040578,0.12713,0.12881,1,1
7,GO REGULATION OF NEURON DIFFERENTIATION,0.001872,0.12684,0.13145,1,1
7,GO RESPIRATORY SYSTEM PROCESS,0.0054795,0.12671,0.19332,1,1
7,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.017549,0.12645,0.11231,1,1
7,GO POSITIVE REGULATION OF OSSIFICATION,0.022165,0.12572,0.14044,1,1
7,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.02268,0.12537,0.11325,1,1
7,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.023741,0.12453,0.10259,1,1
7,GO CILIUM MOVEMENT,0.033894,0.1242,0.11324,1,1
7,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.00072223,0.12404,0.13289,1,1
7,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.010245,0.12391,0.13906,1,1
7,GO NEURON DEVELOPMENT,0.00081984,0.12333,0.13413,1,1
7,GO REGULATION OF RECEPTOR INTERNALIZATION,0.013139,0.12285,0.12911,1,1
7,GO MICROTUBULE BASED TRANSPORT,0.00057693,0.1226,0.14679,1,1
7,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.027803,0.12253,0.14357,1,1
7,GO REGULATION OF PROTEIN POLYMERIZATION,0.0032441,0.12241,0.10419,1,1
7,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.00353,0.12099,0.16244,1,1
7,GO SENSORY PERCEPTION OF PAIN,0.014486,0.11942,0.11375,1,1
7,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0042883,0.11915,0.10491,1,1
7,GO CELLULAR COMPONENT MORPHOGENESIS,0.0014738,0.11911,0.13379,1,1
7,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.009256,0.11811,0.091169,1,1
7,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.001662,0.11772,0.12214,1,1
7,GO DENDRITIC SPINE DEVELOPMENT,0.0046564,0.11696,0.18233,1,1
7,GO CARDIAC MUSCLE CELL PROLIFERATION,0.03939,0.11507,0.10923,1,1
7,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,3.0689e-05,0.11392,0.13968,1,1
7,GO CELL RECOGNITION,0.014486,0.11368,0.099334,1,1
7,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0094949,0.11246,0.10096,1,1
7,GO HOMOLOGOUS RECOMBINATION,0.031059,0.10962,0.10074,1,1
7,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0021689,0.10603,0.10849,1,1
7,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00065623,0.10585,0.13522,1,1
7,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.016734,0.10563,0.085724,1,1
7,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0083534,0.10508,0.11004,1,1
7,GO POSITIVE REGULATION OF EXOCYTOSIS,0.017137,0.10295,0.12031,1,1
7,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.031059,0.10262,0.097725,1,1
7,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.045624,0.10241,0.095348,1,1
7,GO RESPONSE TO NERVE GROWTH FACTOR,0.0049174,0.10228,0.1301,1,1
7,GO NEURON DIFFERENTIATION,0.0010859,0.099475,0.12172,1,1
7,GO MICROTUBULE BASED MOVEMENT,0.014138,0.099067,0.09451,1,1
7,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0014738,0.09895,0.087035,1,1
7,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.029719,0.098181,0.13037,1,1
7,GO CELL PROJECTION ORGANIZATION,0.00044439,0.097926,0.10901,1,1
7,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.027803,0.0978,0.12113,1,1
7,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.042857,0.097751,0.062565,1,1
7,GO REGULATION OF CYTOKINESIS,0.015574,0.096861,0.10759,1,1
7,GO TELENCEPHALON DEVELOPMENT,0.0018173,0.096782,0.12124,1,1
7,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.023205,0.096206,0.11792,1,1
7,GO CELL PROJECTION ASSEMBLY,0.017969,0.095885,0.072966,1,1
7,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.021165,0.095594,0.14466,1,1
7,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0030654,0.095587,0.090015,1,1
7,GO PROTEIN POLYMERIZATION,0.004408,0.095581,0.088215,1,1
7,GO PROTEIN DEPHOSPHORYLATION,0.00090094,0.095468,0.086083,1,1
7,GO GERM CELL DEVELOPMENT,0.0094949,0.09487,0.0883,1,1
7,GO PATTERN SPECIFICATION PROCESS,0.017549,0.094383,0.086591,1,1
7,GO ANATOMICAL STRUCTURE MATURATION,0.0060989,0.094168,0.098116,1,1
7,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.010506,0.093999,0.07304,1,1
7,GO PEPTIDYL THREONINE MODIFICATION,0.0049174,0.093987,0.085076,1,1
7,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0047853,0.092207,0.11917,1,1
7,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0075304,0.091907,0.086515,1,1
7,GO FOREBRAIN DEVELOPMENT,0.007729,0.091793,0.10147,1,1
7,GO REGULATION OF EXOCYTOSIS,0.010245,0.090643,0.11005,1,1
7,GO NEGATIVE REGULATION OF NEURON DEATH,0.0049174,0.088231,0.071103,1,1
7,GO SPECIFICATION OF SYMMETRY,0.019739,0.087158,0.073371,1,1
7,GO NEUROGENESIS,0.0015653,0.084082,0.10564,1,1
7,GO HEAD DEVELOPMENT,0.0053338,0.081805,0.088921,1,1
7,GO MICROTUBULE BASED PROCESS,0.001191,0.08169,0.081316,1,1
7,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.029068,0.080696,0.082698,1,1
7,GO REGULATION OF CELL DEVELOPMENT,0.0046564,0.080333,0.091845,1,1
7,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0059384,0.079168,0.083056,1,1
7,GO SPERMATID DIFFERENTIATION,0.0073363,0.07902,0.106,1,1
7,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.034637,0.078185,0.060649,1,1
7,GO CELL MORPHOGENESIS,0.015203,0.078161,0.087112,1,1
7,GO MEIOTIC CELL CYCLE,0.040234,0.075999,0.06808,1,1
7,GO VESICLE LOCALIZATION,0.0028141,0.075661,0.076558,1,1
7,GO NEURON APOPTOTIC PROCESS,0.010506,0.072912,0.060876,1,1
7,GO POSITIVE REGULATION OF RNA SPLICING,0.034637,0.071972,0.065009,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.041967,0.069069,0.082146,1,1
7,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.026586,0.068731,0.050505,1,1
7,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011326,0.067116,0.091414,1,1
7,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.02068,0.061505,0.059419,1,1
7,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.02268,0.058908,0.051264,1,1
7,GO MEIOTIC CELL CYCLE PROCESS,0.019739,0.057476,0.07292,1,1
7,GO NEURON CELL CELL ADHESION,0.00047456,0.39868,0.52455,1,0
7,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0024367,0.39207,0.51358,1,0
7,GO DOPAMINE BIOSYNTHETIC PROCESS,0.017137,0.38893,0.3946,1,0
7,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0073363,0.35828,0.35025,1,0
7,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.012508,0.35461,0.43546,1,0
7,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.007729,0.33072,0.34966,1,0
7,GO FOREBRAIN NEURON FATE COMMITMENT,0.013798,0.32255,0.5274,1,0
7,GO DENSE CORE GRANULE TRANSPORT,0.020205,0.31328,0.39265,1,0
7,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00353,0.30089,0.27529,1,0
7,GO POSTSYNAPSE ASSEMBLY,0.0059384,0.29248,0.39455,1,0
7,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.02268,0.28684,0.16384,1,0
7,GO BIOLOGICAL PHASE,0.040234,0.2779,0.25115,1,0
7,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.0013457,0.26482,0.29414,1,0
7,GO MINERALOCORTICOID METABOLIC PROCESS,0.013798,0.26168,0.27485,1,0
7,GO REGULATION OF MEMBRANE INVAGINATION,0.00065623,0.25707,0.29885,1,0
7,GO SNARE COMPLEX ASSEMBLY,0.044685,0.25227,0.14266,1,0
7,GO VOCALIZATION BEHAVIOR,0.007729,0.25216,0.40927,1,0
7,GO REGULATION OF DOPAMINE SECRETION,0.014138,0.23801,0.33217,1,0
7,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.043763,0.22216,0.2204,1,0
7,GO HEMIDESMOSOME ASSEMBLY,0.037747,0.21944,0.1881,1,0
7,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.031059,0.21647,0.13256,1,0
7,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.033894,0.21614,0.17195,1,0
7,GO RESPONSE TO IMMOBILIZATION STRESS,0.029719,0.21585,0.15932,1,0
7,GO NEURONAL ION CHANNEL CLUSTERING,0.036948,0.21465,0.30171,1,0
7,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.024846,0.21442,0.20467,1,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.031059,0.21109,0.19665,1,0
7,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.045624,0.21079,0.1947,1,0
7,GO SYNAPTIC VESICLE PRIMING,0.019283,0.20774,0.2664,1,0
7,GO ETHANOL METABOLIC PROCESS,0.034637,0.20687,0.14584,1,0
7,GO DOPAMINE TRANSPORT,0.018398,0.2039,0.2768,1,0
7,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.043763,0.20359,0.20869,1,0
7,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0016129,0.19663,0.25174,1,0
7,GO GASTRIC ACID SECRETION,0.026586,0.19623,0.15648,1,0
7,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0099891,0.19492,0.33039,1,0
7,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.001662,0.19211,0.23489,1,0
7,GO CELL DIFFERENTIATION IN HINDBRAIN,0.046579,0.19201,0.15647,1,0
7,GO NEURAL NUCLEUS DEVELOPMENT,0.0085714,0.18743,0.20848,1,0
7,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.036948,0.18664,0.16012,1,0
7,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0054795,0.18587,0.22412,1,0
7,GO REGULATION OF BONE DEVELOPMENT,0.004408,0.18527,0.14984,1,0
7,GO REGULATION OF LIGASE ACTIVITY,0.03245,0.18027,0.1417,1,0
7,GO CELLULAR RESPONSE TO CALCIUM ION,0.0036303,0.17961,0.16746,1,0
7,GO INTERLEUKIN 5 PRODUCTION,0.022165,0.17715,0.19449,1,0
7,GO PROXIMAL DISTAL PATTERN FORMATION,0.045624,0.17458,0.23633,1,0
7,GO REGULATION OF DENDRITE EXTENSION,0.0028957,0.17125,0.37936,1,0
7,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.041967,0.16436,0.1922,1,0
7,GO AMINE TRANSPORT,0.010506,0.15542,0.21931,1,0
7,GO REGULATION OF BONE MINERALIZATION,0.02268,0.15211,0.13141,1,0
7,GO REGULATION OF FIBROBLAST MIGRATION,0.015574,0.15028,0.097432,1,0
7,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.042857,0.14897,0.30693,1,0
7,GO REGULATION OF BIOMINERALIZATION,0.029719,0.14859,0.10847,1,0
7,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.023741,0.14802,0.23487,1,0
7,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0090226,0.14516,0.20788,1,0
7,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.045624,0.14514,0.16407,1,0
7,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.013798,0.14474,0.18392,1,0
7,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.011904,0.14225,0.15217,1,0
7,GO CELL PROLIFERATION IN FOREBRAIN,0.024846,0.1411,0.16613,1,0
7,GO REGULATION OF POTASSIUM ION TRANSPORT,0.02068,0.13945,0.11276,1,0
7,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.021165,0.13937,0.17172,1,0
7,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0066042,0.13929,0.25588,1,0
7,GO LEARNING,0.018398,0.13688,0.13736,1,0
7,GO POSTSYNAPSE ORGANIZATION,0.0083534,0.13674,0.16944,1,0
7,GO REGULATION OF HEART GROWTH,0.041093,0.13553,0.10229,1,0
7,GO MULTICELLULAR ORGANISMAL SIGNALING,0.011904,0.13399,0.159,1,0
7,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.045624,0.13356,0.1016,1,0
7,GO CARDIAC CONDUCTION,0.023205,0.13342,0.14741,1,0
7,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.016339,0.13299,0.17387,1,0
7,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.02166,0.13284,0.21905,1,0
7,GO MITOCHONDRION DISTRIBUTION,0.031059,0.13123,0.13523,1,0
7,GO REGULATION OF ACROSOME REACTION,0.044685,0.12989,0.18614,1,0
7,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0059384,0.12956,0.13098,1,0
7,GO NEUROMUSCULAR PROCESS,0.0097392,0.12919,0.13297,1,0
7,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.014138,0.12851,0.14427,1,0
7,GO DOPAMINE METABOLIC PROCESS,0.015203,0.12776,0.20781,1,0
7,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.041967,0.127,0.13197,1,0
7,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0094949,0.12614,0.1286,1,0
7,GO POTASSIUM ION TRANSPORT,0.016339,0.12472,0.12851,1,0
7,GO NEURON PROJECTION ORGANIZATION,0.036948,0.12425,0.14711,1,0
7,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.047551,0.12054,0.09719,1,0
7,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.015203,0.12026,0.15295,1,0
7,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.035393,0.11785,0.17098,1,0
7,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0062634,0.11723,0.1883,1,0
7,GO SYNAPSE ORGANIZATION,0.0071468,0.11682,0.15821,1,0
7,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.011612,0.11588,0.19399,1,0
7,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0059384,0.11531,0.17797,1,0
7,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0085714,0.11449,0.16505,1,0
7,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.013465,0.11203,0.11204,1,0
7,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.016734,0.1112,0.15679,1,0
7,GO REGULATION OF TRANSPORTER ACTIVITY,0.0079323,0.10753,0.13021,1,0
7,GO BEHAVIOR,0.00353,0.10557,0.11694,1,0
7,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.02068,0.10357,0.10596,1,0
7,GO DEVELOPMENTAL CELL GROWTH,0.0090226,0.10316,0.11977,1,0
7,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.010773,0.103,0.18296,1,0
7,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0071468,0.10183,0.16691,1,0
7,GO GLIAL CELL DIFFERENTIATION,0.029068,0.10034,0.086629,1,0
7,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.036948,0.099927,0.12062,1,0
7,GO TELOMERIC LOOP DISASSEMBLY,0.033166,0.098318,0.15097,1,0
7,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.033166,0.097046,0.095574,1,0
7,GO SENSORY PERCEPTION OF SMELL,0.011904,0.096498,0.083906,1,0
7,GO NERVOUS SYSTEM PROCESS,0.0050528,0.096434,0.090987,1,0
7,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.047551,0.095581,0.12298,1,0
7,GO REGULATION OF ION TRANSPORT,0.037747,0.093151,0.081141,1,0
7,GO RESPONSE TO FOOD,0.034637,0.089791,0.12194,1,0
7,GO ACID SECRETION,0.019283,0.088166,0.1092,1,0
7,GO DEVELOPMENTAL MATURATION,0.0056288,0.087271,0.11417,1,0
7,GO PROTEIN HETEROOLIGOMERIZATION,0.0081404,0.08695,0.14545,1,0
7,GO HINDBRAIN MORPHOGENESIS,0.042857,0.084408,0.10506,1,0
7,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0050528,0.083671,0.091446,1,0
7,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.036164,0.080292,0.065734,1,0
7,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.03245,0.08014,0.092324,1,0
7,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.041967,0.079987,0.10154,1,0
7,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.023205,0.078552,0.095017,1,0
7,GO ADHERENS JUNCTION ORGANIZATION,0.02843,0.077736,0.14265,1,0
7,GO REGULATION OF SYNAPSE ASSEMBLY,0.038561,0.076759,0.15017,1,0
7,GO CELL CELL SIGNALING,0.0059384,0.073937,0.080744,1,0
7,GO NEURON DEATH,0.013465,0.073874,0.059387,1,0
7,GO SIGNAL RELEASE,0.027803,0.068199,0.08811,1,0
7,GO REGULATION OF DEVELOPMENTAL GROWTH,0.045624,0.066866,0.068144,1,0
7,GO CELL VOLUME HOMEOSTASIS,0.043763,0.06491,0.076127,1,0
7,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.031059,0.061059,0.076981,1,0
7,GO MITOCHONDRION LOCALIZATION,0.023741,0.05954,0.11311,1,0
7,GO DEPHOSPHORYLATION,0.0071468,0.057247,0.06337,1,0
7,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.025414,0.056321,0.10884,1,0
7,GO CELL MATURATION,0.034637,0.054217,0.075833,1,0
7,GO REGULATION OF TRANSPORT,0.042857,0.049516,0.04531,1,0
7,GO REGULATION OF CIRCADIAN RHYTHM,0.044685,0.035384,0.064379,1,0
7,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.044685,-0.035195,-0.068769,1,0
7,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.033166,-0.047518,-0.057371,1,0
7,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.030383,-0.048774,-0.093544,1,0
7,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.016339,-0.048835,-0.084927,1,0
7,GO PROTEIN LOCALIZATION TO ORGANELLE,0.041093,-0.051397,-0.050054,1,0
7,GO AGING,0.047551,-0.051681,-0.07677,1,0
7,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.022165,-0.051691,-0.089222,1,0
7,GO REGULATION OF VASOCONSTRICTION,0.031748,-0.052351,-0.12018,1,0
7,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.024846,-0.052765,-0.074333,1,0
7,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.038561,-0.053177,-0.072538,1,0
7,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.044685,-0.053475,-0.072091,1,0
7,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.009256,-0.053608,-0.069532,1,0
7,GO P BODY ASSEMBLY,0.040234,-0.057215,-0.086248,1,0
7,GO REGULATION OF CATABOLIC PROCESS,0.027803,-0.057686,-0.055955,1,0
7,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.046579,-0.058691,-0.097605,1,0
7,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.044685,-0.060192,-0.15126,1,0
7,GO REGULATION OF CELL CYCLE ARREST,0.024288,-0.061036,-0.10188,1,0
7,GO RNA DECAPPING,0.018836,-0.062435,-0.10774,1,0
7,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.044685,-0.066576,-0.080598,1,0
7,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0085714,-0.068645,-0.083471,1,0
7,GO TRANSITION METAL ION TRANSPORT,0.042857,-0.068645,-0.072934,1,0
7,GO IRON ION HOMEOSTASIS,0.037747,-0.071547,-0.12533,1,0
7,GO LONG CHAIN FATTY ACID TRANSPORT,0.038561,-0.071968,-0.086766,1,0
7,GO REGULATION OF DNA METHYLATION,0.02843,-0.073248,-0.13919,1,0
7,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.033894,-0.073307,-0.049527,1,0
7,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.031059,-0.073327,-0.064375,1,0
7,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.047551,-0.073358,-0.084922,1,0
7,GO MAINTENANCE OF PROTEIN LOCATION,0.020205,-0.073554,-0.096256,1,0
7,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.036164,-0.073899,-0.089529,1,0
7,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.046579,-0.073969,-0.06451,1,0
7,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.007729,-0.074693,-0.12355,1,0
7,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0041716,-0.074724,-0.13204,1,0
7,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.027803,-0.075283,-0.11284,1,0
7,GO TRANSITION METAL ION HOMEOSTASIS,0.037747,-0.075499,-0.1035,1,0
7,GO MULTI ORGANISM LOCALIZATION,0.03245,-0.076211,-0.10974,1,0
7,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.015574,-0.076787,-0.18109,1,0
7,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.024846,-0.077478,-0.1209,1,0
7,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.025994,-0.077614,-0.072466,1,0
7,GO FATTY ACID TRANSPORT,0.029068,-0.078282,-0.098051,1,0
7,GO MALE SEX DIFFERENTIATION,0.025994,-0.078536,-0.091776,1,0
7,GO CELLULAR RESPONSE TO STARVATION,0.041967,-0.078706,-0.10402,1,0
7,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.010506,-0.07872,-0.17859,1,0
7,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.020205,-0.078745,-0.093147,1,0
7,GO MRNA METABOLIC PROCESS,0.023741,-0.078936,-0.083657,1,0
7,GO DEMETHYLATION,0.041967,-0.079161,-0.07098,1,0
7,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.046579,-0.079321,-0.16575,1,0
7,GO REGULATION OF MRNA CATABOLIC PROCESS,0.044685,-0.079501,-0.085199,1,0
7,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0069616,-0.080434,-0.16681,1,0
7,GO RESPONSE TO IONIZING RADIATION,0.025414,-0.080572,-0.099196,1,0
7,GO LIPID HOMEOSTASIS,0.0053338,-0.081686,-0.12072,1,0
7,GO RESPONSE TO GAMMA RADIATION,0.030383,-0.081805,-0.10135,1,0
7,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.017969,-0.082253,-0.14136,1,0
7,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.043763,-0.082406,-0.15173,1,0
7,GO ORGANELLE DISASSEMBLY,0.025414,-0.082946,-0.080451,1,0
7,GO ALCOHOL BIOSYNTHETIC PROCESS,0.042857,-0.083275,-0.083939,1,0
7,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.030383,-0.083792,-0.11429,1,0
7,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.046579,-0.08384,-0.12238,1,0
7,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.037747,-0.084194,-0.16806,1,0
7,GO REGULATION OF INFLAMMATORY RESPONSE,0.036948,-0.08476,-0.099461,1,0
7,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.035393,-0.084907,-0.082608,1,0
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0085714,-0.084972,-0.083675,1,0
7,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.019283,-0.085948,-0.18112,1,0
7,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.022165,-0.086231,-0.1139,1,0
7,GO POSITIVE REGULATION OF AUTOPHAGY,0.046579,-0.086587,-0.084841,1,0
7,GO FATTY ACID CATABOLIC PROCESS,0.038561,-0.086886,-0.12708,1,0
7,GO IRON ION TRANSPORT,0.0097392,-0.087214,-0.10673,1,0
7,GO LIVER REGENERATION,0.03245,-0.087653,-0.16507,1,0
7,GO CYTOKINE METABOLIC PROCESS,0.023741,-0.087983,-0.14193,1,0
7,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.018398,-0.0883,-0.1352,1,0
7,GO RESPONSE TO ETHER,0.009256,-0.088352,-0.1333,1,0
7,GO REGULATION OF MACROAUTOPHAGY,0.025994,-0.088546,-0.06113,1,0
7,GO HISTONE DEACETYLATION,0.013465,-0.088788,-0.081658,1,0
7,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.027188,-0.08885,-0.13769,1,0
7,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.041967,-0.088874,-0.14201,1,0
7,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.038561,-0.08992,-0.21579,1,0
7,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.007729,-0.089921,-0.19409,1,0
7,GO THIOESTER METABOLIC PROCESS,0.015574,-0.090254,-0.12146,1,0
7,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.031748,-0.090707,-0.095329,1,0
7,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.019283,-0.091054,-0.083854,1,0
7,GO T CELL DIFFERENTIATION,0.012203,-0.091388,-0.10962,1,0
7,GO REGULATION OF PINOCYTOSIS,0.02166,-0.091645,-0.208,1,0
7,GO RESPONSE TO ESTROGEN,0.026586,-0.092879,-0.14199,1,0
7,GO DRUG CATABOLIC PROCESS,0.014486,-0.093007,-0.12617,1,0
7,GO MEGAKARYOCYTE DIFFERENTIATION,0.022165,-0.093093,-0.074473,1,0
7,GO MANNOSYLATION,0.018836,-0.093472,-0.11422,1,0
7,GO LYMPHOCYTE DIFFERENTIATION,0.0090226,-0.093619,-0.098442,1,0
7,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0029794,-0.09369,-0.10104,1,0
7,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.017969,-0.093691,-0.083831,1,0
7,GO SELECTIVE AUTOPHAGY,0.011904,-0.093774,-0.1194,1,0
7,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0064317,-0.093904,-0.14886,1,0
7,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.02843,-0.094168,-0.13745,1,0
7,GO INTERACTION WITH SYMBIONT,0.029719,-0.09423,-0.10788,1,0
7,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.03245,-0.094509,-0.11254,1,0
7,GO MYELOID CELL HOMEOSTASIS,0.043763,-0.09546,-0.089735,1,0
7,GO PROTEIN HOMOTETRAMERIZATION,0.033166,-0.09611,-0.088302,1,0
7,GO REGULATION OF LIPID LOCALIZATION,0.010245,-0.09619,-0.11995,1,0
7,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.038561,-0.097985,-0.15561,1,0
7,GO NEGATIVE REGULATION OF AUTOPHAGY,0.047551,-0.09817,-0.086505,1,0
7,GO B CELL DIFFERENTIATION,0.012203,-0.098425,-0.11117,1,0
7,GO MODULATION BY VIRUS OF HOST PROCESS,0.016734,-0.098472,-0.11526,1,0
7,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.02068,-0.09866,-0.1192,1,0
7,GO KERATINOCYTE DIFFERENTIATION,0.041967,-0.098983,-0.14817,1,0
7,GO POSITIVE REGULATION OF HEMOPOIESIS,0.013465,-0.0995,-0.13228,1,0
7,GO PROTEIN MANNOSYLATION,0.03939,-0.099542,-0.12291,1,0
7,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0010206,-0.099564,-0.12433,1,0
7,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.036948,-0.10018,-0.13443,1,0
7,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.040234,-0.10061,-0.1671,1,0
7,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.033166,-0.10092,-0.10641,1,0
7,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.013798,-0.10137,-0.090259,1,0
7,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.010245,-0.10185,-0.16674,1,0
7,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.031748,-0.1019,-0.15875,1,0
7,GO VIRAL LIFE CYCLE,0.02268,-0.10205,-0.14034,1,0
7,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.016734,-0.1025,-0.16933,1,0
7,GO NEGATIVE REGULATION OF DNA REPLICATION,0.036948,-0.10267,-0.14388,1,0
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.034637,-0.10341,-0.11463,1,0
7,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.018398,-0.10356,-0.16567,1,0
7,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.029068,-0.1037,-0.14289,1,0
7,GO RESPONSE TO HEAT,0.036164,-0.1039,-0.085792,1,0
7,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.02843,-0.10441,-0.15166,1,0
7,GO POSITIVE REGULATION OF LIPID STORAGE,0.02843,-0.10559,-0.14521,1,0
7,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.037747,-0.10588,-0.14627,1,0
7,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.023205,-0.1071,-0.1458,1,0
7,GO CELLULAR KETONE METABOLIC PROCESS,0.02166,-0.10716,-0.11501,1,0
7,GO TOXIN TRANSPORT,0.047551,-0.10755,-0.099831,1,0
7,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.020205,-0.10819,-0.11739,1,0
7,GO ACETYL COA BIOSYNTHETIC PROCESS,0.027188,-0.10891,-0.1708,1,0
7,GO FIBROBLAST PROLIFERATION,0.019283,-0.10915,-0.1647,1,0
7,GO DEFENSE RESPONSE TO FUNGUS,0.042857,-0.10923,-0.098659,1,0
7,GO REGULATION OF VIRAL LIFE CYCLE,0.02268,-0.10928,-0.20295,1,0
7,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.023741,-0.10934,-0.11299,1,0
7,GO RNA CATABOLIC PROCESS,0.022165,-0.10994,-0.12074,1,0
7,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.042857,-0.11026,-0.14132,1,0
7,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.042857,-0.11037,-0.10826,1,0
7,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,-0.11075,-0.080849,1,0
7,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0059384,-0.11082,-0.12324,1,0
7,GO THIOESTER BIOSYNTHETIC PROCESS,0.018398,-0.11086,-0.14106,1,0
7,GO NIK NF KAPPAB SIGNALING,0.01282,-0.11103,-0.1409,1,0
7,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.031748,-0.11132,-0.093457,1,0
7,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.041967,-0.11136,-0.12314,1,0
7,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.0097392,-0.11136,-0.11072,1,0
7,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.02068,-0.11161,-0.11728,1,0
7,GO NEGATIVE REGULATION OF GENE SILENCING,0.013465,-0.1121,-0.15134,1,0
7,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.011612,-0.11217,-0.14178,1,0
7,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0097392,-0.11242,-0.15056,1,0
7,GO LUNG MORPHOGENESIS,0.036948,-0.1127,-0.1539,1,0
7,GO MYOBLAST DIFFERENTIATION,0.024288,-0.11293,-0.15795,1,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0039469,-0.11341,-0.16406,1,0
7,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.043763,-0.11342,-0.15375,1,0
7,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.034637,-0.11367,-0.18296,1,0
7,GO RESPONSE TO INTERLEUKIN 15,0.027803,-0.11376,-0.20534,1,0
7,GO SYMBIOTIC PROCESS,0.0045306,-0.11478,-0.11709,1,0
7,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.038561,-0.11491,-0.14266,1,0
7,GO DNA DEALKYLATION,0.046579,-0.11537,-0.11144,1,0
7,GO STEROL BIOSYNTHETIC PROCESS,0.001986,-0.11543,-0.1613,1,0
7,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.017137,-0.11597,-0.16848,1,0
7,GO METHIONINE METABOLIC PROCESS,0.0069616,-0.11659,-0.15307,1,0
7,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.029719,-0.11683,-0.14932,1,0
7,GO RNA DESTABILIZATION,0.0051916,-0.11691,-0.1313,1,0
7,GO LEUKOTRIENE METABOLIC PROCESS,0.019739,-0.11814,-0.16272,1,0
7,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.02843,-0.11885,-0.14451,1,0
7,GO CARBOHYDRATE CATABOLIC PROCESS,0.018836,-0.1191,-0.09474,1,0
7,GO ER NUCLEUS SIGNALING PATHWAY,0.019739,-0.11947,-0.15305,1,0
7,GO ACUTE INFLAMMATORY RESPONSE,0.02166,-0.11953,-0.16768,1,0
7,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.027188,-0.12038,-0.1227,1,0
7,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.015203,-0.12068,-0.18197,1,0
7,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.001662,-0.12095,-0.16564,1,0
7,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.044685,-0.12166,-0.13599,1,0
7,GO PROTEIN LOCALIZATION TO ENDOSOME,0.044685,-0.12168,-0.12787,1,0
7,GO HISTONE H4 DEACETYLATION,0.041967,-0.12182,-0.11849,1,0
7,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.02166,-0.12259,-0.18573,1,0
7,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.011612,-0.1226,-0.11763,1,0
7,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0047853,-0.12265,-0.12738,1,0
7,GO REGULATION OF RESPIRATORY BURST,0.031748,-0.12271,-0.17276,1,0
7,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0083534,-0.12346,-0.14153,1,0
7,GO CELL KILLING,0.025994,-0.12351,-0.1199,1,0
7,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.013798,-0.12375,-0.14668,1,0
7,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.012508,-0.12389,-0.16771,1,0
7,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.045624,-0.12407,-0.1299,1,0
7,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0083534,-0.12439,-0.17517,1,0
7,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.029068,-0.12466,-0.12031,1,0
7,GO KERATAN SULFATE METABOLIC PROCESS,0.046579,-0.12472,-0.14791,1,0
7,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.0034322,-0.12485,-0.18633,1,0
7,GO T CELL DIFFERENTIATION IN THYMUS,0.0047853,-0.1252,-0.12727,1,0
7,GO REGULATION OF CHOLESTEROL EFFLUX,0.03245,-0.12524,-0.11881,1,0
7,GO RESPONSE TO UV C,0.031748,-0.12566,-0.13257,1,0
7,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.036164,-0.12819,-0.27378,1,0
7,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.034637,-0.12858,-0.15379,1,0
7,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.024846,-0.12865,-0.19102,1,0
7,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.020205,-0.12871,-0.1457,1,0
7,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0007696,-0.12923,-0.18048,1,0
7,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.041967,-0.12958,-0.18388,1,0
7,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.034637,-0.12991,-0.13203,1,0
7,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0031536,-0.12995,-0.17156,1,0
7,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.041093,-0.13001,-0.16128,1,0
7,GO MYELOID LEUKOCYTE ACTIVATION,0.036948,-0.1303,-0.1201,1,0
7,GO DIOL METABOLIC PROCESS,0.038561,-0.13085,-0.13699,1,0
7,GO STEROL METABOLIC PROCESS,0.0047853,-0.13139,-0.13681,1,0
7,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00098941,-0.13154,-0.15661,1,0
7,GO RESPONSE TO ANTIBIOTIC,0.010245,-0.13155,-0.14166,1,0
7,GO REGULATION OF FATTY ACID TRANSPORT,0.033166,-0.13177,-0.12299,1,0
7,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00095906,-0.13226,-0.21863,1,0
7,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.033894,-0.13236,-0.16184,1,0
7,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.033894,-0.13249,-0.12033,1,0
7,GO MEMBRANE LIPID CATABOLIC PROCESS,0.011904,-0.1327,-0.17833,1,0
7,GO MYOTUBE DIFFERENTIATION,0.042857,-0.13296,-0.11324,1,0
7,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.018398,-0.1332,-0.13495,1,0
7,GO REGULATION OF LIPID TRANSPORT,0.0037331,-0.13352,-0.12855,1,0
7,GO IRON ION TRANSMEMBRANE TRANSPORT,0.016734,-0.13352,-0.16447,1,0
7,GO CELLULAR RESPONSE TO X RAY,0.0037331,-0.13358,-0.20913,1,0
7,GO LACTATE METABOLIC PROCESS,0.013465,-0.1343,-0.1719,1,0
7,GO THYMUS DEVELOPMENT,0.0067808,-0.13512,-0.15241,1,0
7,GO REGULATION OF ATP METABOLIC PROCESS,0.00028792,-0.13539,-0.14608,1,0
7,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.038561,-0.13623,-0.27432,1,0
7,GO VIRAL GENOME REPLICATION,0.007729,-0.13653,-0.21065,1,0
7,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.037747,-0.1369,-0.18414,1,0
7,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.037747,-0.13722,-0.1088,1,0
7,GO BASIC AMINO ACID TRANSPORT,0.044685,-0.13727,-0.19295,1,0
7,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0047853,-0.13817,-0.1625,1,0
7,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.017969,-0.13827,-0.22853,1,0
7,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.024288,-0.13832,-0.13799,1,0
7,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.00353,-0.13832,-0.17297,1,0
7,GO RECEPTOR BIOSYNTHETIC PROCESS,0.036948,-0.13857,-0.12784,1,0
7,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.013465,-0.13891,-0.14624,1,0
7,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0014299,-0.13902,-0.11668,1,0
7,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.014138,-0.13905,-0.10731,1,0
7,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.042857,-0.13933,-0.14258,1,0
7,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.019283,-0.14007,-0.17954,1,0
7,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.02843,-0.14078,-0.16534,1,0
7,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.014841,-0.14134,-0.18026,1,0
7,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0025817,-0.14204,-0.21949,1,0
7,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.017969,-0.14272,-0.16031,1,0
7,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.021165,-0.14276,-0.17866,1,0
7,GO STEROL TRANSPORT,0.0031536,-0.14291,-0.17896,1,0
7,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.0094949,-0.14344,-0.19818,1,0
7,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,3.7145e-05,-0.14352,-0.16367,1,0
7,GO RESPONSE TO X RAY,0.018398,-0.14396,-0.1779,1,0
7,GO REGULATION OF STEROID METABOLIC PROCESS,0.029068,-0.14463,-0.12999,1,0
7,GO RESPONSE TO FUNGUS,0.043763,-0.14487,-0.0961,1,0
7,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.027188,-0.14494,-0.13092,1,0
7,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0073363,-0.14508,-0.18353,1,0
7,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0038387,-0.14559,-0.20843,1,0
7,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.043763,-0.14611,-0.1552,1,0
7,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00050664,-0.14625,-0.17527,1,0
7,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.043763,-0.14664,-0.17217,1,0
7,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.038561,-0.14694,-0.12277,1,0
7,GO REGULATION OF FATTY ACID OXIDATION,0.0045306,-0.14759,-0.19449,1,0
7,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.013465,-0.14759,-0.19291,1,0
7,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0099891,-0.14805,-0.16888,1,0
7,GO LIPID OXIDATION,0.0036303,-0.14812,-0.15629,1,0
7,GO GOLGI RIBBON FORMATION,0.035393,-0.14853,-0.12331,1,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0022332,-0.14855,-0.21229,1,0
7,GO RESPONSE TO COLD,0.037747,-0.14858,-0.15138,1,0
7,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.011612,-0.14925,-0.23298,1,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0083534,-0.14935,-0.19297,1,0
7,GO REGULATION OF TRANSPOSITION,0.041967,-0.14952,-0.21437,1,0
7,GO ENERGY HOMEOSTASIS,0.015203,-0.14978,-0.16116,1,0
7,GO SYNCYTIUM FORMATION,0.018398,-0.15036,-0.15797,1,0
7,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.016734,-0.15046,-0.12756,1,0
7,GO OXALATE TRANSPORT,0.019739,-0.15065,-0.1164,1,0
7,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.037747,-0.15119,-0.3138,1,0
7,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.018398,-0.15161,-0.27098,1,0
7,GO HISTONE SERINE PHOSPHORYLATION,0.010506,-0.15162,-0.19433,1,0
7,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.023205,-0.15375,-0.24276,1,0
7,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.040234,-0.1546,-0.19217,1,0
7,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.018836,-0.15507,-0.16539,1,0
7,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0023671,-0.1551,-0.14825,1,0
7,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0057817,-0.15524,-0.16532,1,0
7,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.040234,-0.15557,-0.15602,1,0
7,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.045624,-0.15558,-0.16223,1,0
7,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0085714,-0.15604,-0.19372,1,0
7,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0015189,-0.15647,-0.2284,1,0
7,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0030654,-0.15658,-0.1543,1,0
7,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0017123,-0.15659,-0.20282,1,0
7,GO RESPONSE TO STEROL,0.0062634,-0.15681,-0.15764,1,0
7,GO ONE CARBON COMPOUND TRANSPORT,0.016734,-0.15713,-0.1833,1,0
7,GO REGULATION OF STEROL TRANSPORT,0.0028141,-0.15823,-0.18277,1,0
7,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.027188,-0.1584,-0.22276,1,0
7,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.030383,-0.15869,-0.15479,1,0
7,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0090226,-0.15877,-0.16483,1,0
7,GO REGULATION OF STEM CELL DIFFERENTIATION,0.004408,-0.15912,-0.17381,1,0
7,GO RESPONSE TO MANGANESE ION,0.0083534,-0.15915,-0.19802,1,0
7,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.044685,-0.15935,-0.21987,1,0
7,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0031536,-0.16023,-0.25065,1,0
7,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.023205,-0.16288,-0.18817,1,0
7,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.044685,-0.16324,-0.32772,1,0
7,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.0030654,-0.16402,-0.17795,1,0
7,GO RECEPTOR CATABOLIC PROCESS,0.033166,-0.16406,-0.143,1,0
7,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0018173,-0.1653,-0.21461,1,0
7,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0018173,-0.16573,-0.19759,1,0
7,GO REGULATION OF MACROPHAGE ACTIVATION,0.0040578,-0.16616,-0.16238,1,0
7,GO GLYCOLIPID CATABOLIC PROCESS,0.03245,-0.16657,-0.20041,1,0
7,GO REPLICATIVE SENESCENCE,0.03245,-0.16715,-0.20184,1,0
7,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.014138,-0.16751,-0.22544,1,0
7,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.027803,-0.16752,-0.24284,1,0
7,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0013457,-0.16815,-0.18007,1,0
7,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.02166,-0.16819,-0.16806,1,0
7,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.027803,-0.16856,-0.23466,1,0
7,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0036303,-0.16867,-0.16534,1,0
7,GO MUSCLE CELL MIGRATION,0.02166,-0.16882,-0.16204,1,0
7,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.030383,-0.16927,-0.1907,1,0
7,GO FATTY ACID BETA OXIDATION,0.0053338,-0.16931,-0.15987,1,0
7,GO VACUOLAR ACIDIFICATION,0.0051916,-0.16951,-0.17041,1,0
7,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0017641,-0.17055,-0.16684,1,0
7,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00353,-0.17065,-0.20017,1,0
7,GO POSITIVE REGULATION OF CELL AGING,0.0018173,-0.17104,-0.26436,1,0
7,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00032948,-0.1711,-0.3127,1,0
7,GO REGULATION OF VIRAL GENOME REPLICATION,0.01282,-0.17127,-0.24112,1,0
7,GO COPPER ION HOMEOSTASIS,0.047551,-0.1717,-0.15122,1,0
7,GO CERAMIDE CATABOLIC PROCESS,0.010245,-0.17248,-0.19752,1,0
7,GO REGULATION OF B CELL DIFFERENTIATION,0.013798,-0.17259,-0.18815,1,0
7,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.0022992,-0.17264,-0.21509,1,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010206,-0.17301,-0.20959,1,0
7,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.031748,-0.1732,-0.13821,1,0
7,GO NUCLEUS LOCALIZATION,0.014486,-0.1733,-0.17503,1,0
7,GO CHOLESTEROL EFFLUX,0.0087944,-0.1746,-0.14557,1,0
7,GO SPHINGOID METABOLIC PROCESS,0.0033369,-0.17525,-0.19692,1,0
7,GO PROTEIN DEGLYCOSYLATION,0.0085714,-0.17614,-0.21529,1,0
7,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.007729,-0.17723,-0.23012,1,0
7,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.0040578,-0.17757,-0.15006,1,0
7,GO STEROL HOMEOSTASIS,0.0017123,-0.17791,-0.18916,1,0
7,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.030383,-0.17814,-0.18625,1,0
7,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.033166,-0.17822,-0.22551,1,0
7,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0042883,-0.17835,-0.16824,1,0
7,GO INTESTINAL ABSORPTION,0.017549,-0.17839,-0.21964,1,0
7,GO INTEGRIN ACTIVATION,0.0090226,-0.17901,-0.20748,1,0
7,GO VIRAL RNA GENOME REPLICATION,0.02166,-0.17912,-0.16558,1,0
7,GO RESPONSE TO HYPEROXIA,0.033894,-0.17919,-0.19701,1,0
7,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.020205,-0.1793,-0.15535,1,0
7,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0033369,-0.17956,-0.20213,1,0
7,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0017123,-0.18073,-0.17088,1,0
7,GO FOAM CELL DIFFERENTIATION,0.0066042,-0.18088,-0.19768,1,0
7,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00045924,-0.1817,-0.30574,1,0
7,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.030383,-0.18183,-0.16065,1,0
7,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.012203,-0.18259,-0.19368,1,0
7,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0033369,-0.18329,-0.20887,1,0
7,GO THYROID HORMONE METABOLIC PROCESS,0.0056288,-0.18553,-0.16353,1,0
7,GO CARNITINE SHUTTLE,0.045624,-0.18557,-0.15665,1,0
7,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00041602,-0.18629,-0.18548,1,0
7,GO BROWN FAT CELL DIFFERENTIATION,0.038561,-0.1865,-0.13556,1,0
7,GO LAMELLIPODIUM MORPHOGENESIS,0.018398,-0.18719,-0.21231,1,0
7,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0087944,-0.18726,-0.2554,1,0
7,GO REGULATION OF MAST CELL ACTIVATION,0.018398,-0.18731,-0.17614,1,0
7,GO TYPE 2 IMMUNE RESPONSE,0.038561,-0.18803,-0.20963,1,0
7,GO REGULATION OF HISTONE DEACETYLATION,0.013798,-0.18809,-0.15286,1,0
7,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.009256,-0.18814,-0.19514,1,0
7,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0037331,-0.18913,-0.22017,1,0
7,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.024288,-0.19136,-0.15779,1,0
7,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.026586,-0.1916,-0.20528,1,0
7,GO TRANSCRIPTION BY RNA POLYMERASE I,0.011904,-0.19172,-0.13813,1,0
7,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.013465,-0.19232,-0.21579,1,0
7,GO INTRACELLULAR MRNA LOCALIZATION,0.026586,-0.19311,-0.1836,1,0
7,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.017969,-0.1937,-0.25196,1,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0013872,-0.19534,-0.22115,1,0
7,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0054795,-0.19593,-0.13601,1,0
7,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00032948,-0.19657,-0.19684,1,0
7,GO RESPONSE TO INTERLEUKIN 12,0.02843,-0.19706,-0.15361,1,0
7,GO INTRACELLULAR STEROL TRANSPORT,0.0012662,-0.19884,-0.24035,1,0
7,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.041093,-0.19966,-0.14066,1,0
7,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0060989,-0.20047,-0.23845,1,0
7,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.02068,-0.2008,-0.24071,1,0
7,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.013465,-0.20132,-0.20185,1,0
7,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00010845,-0.20284,-0.21851,1,0
7,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.010245,-0.2029,-0.23778,1,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.012203,-0.20322,-0.15225,1,0
7,GO CHOLESTEROL STORAGE,0.020205,-0.20407,-0.16768,1,0
7,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.011047,-0.20502,-0.26882,1,0
7,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0045306,-0.20591,-0.23088,1,0
7,GO TRANSCYTOSIS,0.018836,-0.20593,-0.15919,1,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.02843,-0.20594,-0.27587,1,0
7,GO REGULATION OF LYSOSOMAL LUMEN PH,0.010506,-0.20625,-0.18538,1,0
7,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0019282,-0.20671,-0.24714,1,0
7,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.010506,-0.20741,-0.25492,1,0
7,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00049035,-0.20769,-0.18894,1,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0073363,-0.20968,-0.17246,1,0
7,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.027188,-0.20968,-0.24073,1,0
7,GO PROTEIN DEMANNOSYLATION,0.0094949,-0.20971,-0.20049,1,0
7,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00016595,-0.21002,-0.22244,1,0
7,GO ZYMOGEN INHIBITION,0.024288,-0.21007,-0.23785,1,0
7,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.00063551,-0.21256,-0.19722,1,0
7,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00081984,-0.21326,-0.2065,1,0
7,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.016339,-0.21381,-0.20397,1,0
7,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.00098941,-0.2142,-0.25508,1,0
7,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.016339,-0.21426,-0.34283,1,0
7,GO DETERMINATION OF ADULT LIFESPAN,0.0001547,-0.21554,-0.25959,1,0
7,GO DENDRITIC CELL APOPTOTIC PROCESS,0.042857,-0.21641,-0.23043,1,0
7,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0027346,-0.21671,-0.22276,1,0
7,GO LEUKOCYTE AGGREGATION,0.031059,-0.21745,-0.27355,1,0
7,GO MALE SEX DETERMINATION,0.0036303,-0.21781,-0.27931,1,0
7,GO CELLULAR RESPONSE TO STEROL,0.00035231,-0.22028,-0.24572,1,0
7,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.010245,-0.22142,-0.23332,1,0
7,GO MRNA TRANSCRIPTION,0.00023468,-0.2217,-0.2348,1,0
7,GO DISACCHARIDE METABOLIC PROCESS,0.0079323,-0.22269,-0.21577,1,0
7,GO POSITIVE REGULATION OF CELL SIZE,0.023741,-0.22273,-0.21024,1,0
7,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.00018427,-0.22306,-0.22528,1,0
7,GO REGULATION OF PODOSOME ASSEMBLY,0.043763,-0.22324,-0.17621,1,0
7,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.018398,-0.22448,-0.24093,1,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.026586,-0.22635,-0.2621,1,0
7,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00032948,-0.22661,-0.22259,1,0
7,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00087311,-0.22746,-0.2231,1,0
7,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0046564,-0.22763,-0.19789,1,0
7,GO REGULATION OF HELICASE ACTIVITY,0.034637,-0.22826,-0.15708,1,0
7,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.033166,-0.22891,-0.26837,1,0
7,GO MESENCHYMAL CELL PROLIFERATION,0.023741,-0.22969,-0.17849,1,0
7,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.013798,-0.23022,-0.19267,1,0
7,GO THYMOCYTE APOPTOTIC PROCESS,0.036164,-0.23207,-0.19706,1,0
7,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00052342,-0.23275,-0.39105,1,0
7,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.0010528,-0.23298,-0.26195,1,0
7,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.046579,-0.23337,-0.1811,1,0
7,GO VIRAL GENE EXPRESSION,0.016734,-0.2337,-0.19808,1,0
7,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.001986,-0.23401,-0.23655,1,0
7,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007729,-0.23414,-0.22116,1,0
7,GO URETER DEVELOPMENT,0.007729,-0.23493,-0.25904,1,0
7,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00012512,-0.23503,-0.36781,1,0
7,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.044685,-0.23521,-0.20797,1,0
7,GO RESPONSE TO THYROID HORMONE,0.0047853,-0.23572,-0.24189,1,0
7,GO MITOCHONDRIAL RNA PROCESSING,0.0029794,-0.23588,-0.26093,1,0
7,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.033166,-0.23645,-0.21638,1,0
7,GO INTRACELLULAR LIPID TRANSPORT,0.00092958,-0.23794,-0.20717,1,0
7,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.004408,-0.23821,-0.26463,1,0
7,GO ANIMAL ORGAN REGENERATION,0.0033369,-0.23824,-0.19662,1,0
7,GO T CELL MEDIATED CYTOTOXICITY,0.009256,-0.2398,-0.29888,1,0
7,GO AXIS ELONGATION,0.007729,-0.24049,-0.25441,1,0
7,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.014138,-0.24099,-0.22829,1,0
7,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.00020448,-0.2428,-0.30746,1,0
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.024846,-0.24597,-0.17679,1,0
7,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00034072,-0.24669,-0.34909,1,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0075304,-0.24706,-0.333,1,0
7,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0038387,-0.24825,-0.25033,1,0
7,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0006154,-0.24854,-0.28365,1,0
7,GO RESPONSE TO NITROSATIVE STRESS,0.029719,-0.25005,-0.229,1,0
7,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00057693,-0.25024,-0.24413,1,0
7,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0026572,-0.25313,-0.24902,1,0
7,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0032441,-0.25332,-0.22931,1,0
7,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0027346,-0.25349,-0.28443,1,0
7,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0049174,-0.254,-0.30385,1,0
7,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0014299,-0.2564,-0.32113,1,0
7,GO RESPONSE TO INTERFERON BETA,0.046579,-0.25667,-0.35744,1,0
7,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.00095906,-0.25692,-0.24679,1,0
7,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.0057817,-0.25749,-0.32743,1,0
7,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.02843,-0.2577,-0.21564,1,0
7,GO VIRAL TRANSLATION,0.031059,-0.25979,-0.19982,1,0
7,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0067808,-0.26176,-0.24435,1,0
7,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.001986,-0.26284,-0.23684,1,0
7,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.015203,-0.26287,-0.2128,1,0
7,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0056288,-0.2644,-0.2341,1,0
7,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.8282e-05,-0.26688,-0.34406,1,0
7,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.025994,-0.26752,-0.25068,1,0
7,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.036164,-0.26755,-0.18577,1,0
7,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.011612,-0.26811,-0.31279,1,0
7,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0027346,-0.26956,-0.38607,1,0
7,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00010092,-0.26962,-0.25998,1,0
7,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,9.7346e-05,-0.27308,-0.27764,1,0
7,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.018398,-0.27386,-0.22733,1,0
7,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00063551,-0.27388,-0.37376,1,0
7,GO ER OVERLOAD RESPONSE,0.0066042,-0.27626,-0.20666,1,0
7,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.02843,-0.27701,-0.24417,1,0
7,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.011047,-0.27764,-0.27606,1,0
7,GO SKELETAL MUSCLE CELL PROLIFERATION,0.00036427,-0.28123,-0.28769,1,0
7,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0019282,-0.28226,-0.33166,1,0
7,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.011326,-0.2833,-0.28276,1,0
7,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0022992,-0.28334,-0.31177,1,0
7,GO RESPONSE TO INTERFERON ALPHA,0.014841,-0.28773,-0.39705,1,0
7,GO LINOLEIC ACID METABOLIC PROCESS,0.0099891,-0.28864,-0.2356,1,0
7,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.037747,-0.29099,-0.27954,1,0
7,GO NOTOCHORD DEVELOPMENT,0.0099891,-0.29154,-0.26432,1,0
7,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.01282,-0.29284,-0.22397,1,0
7,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.004408,-0.2964,-0.25612,1,0
7,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00020448,-0.29644,-0.30114,1,0
7,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.018836,-0.29665,-0.23921,1,0
7,GO RESPONSE TO TESTOSTERONE,0.00026003,-0.29717,-0.2418,1,0
7,GO RESPONSE TO STEROL DEPLETION,0.001872,-0.29951,-0.29398,1,0
7,GO LEYDIG CELL DIFFERENTIATION,0.010506,-0.30113,-0.30474,1,0
7,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,0.024288,-0.30227,-0.25602,1,0
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.046579,-0.30681,-0.22548,1,0
7,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.00028792,-0.30845,-0.33138,1,0
7,GO MUSCLE ATROPHY,0.0051916,-0.31063,-0.263,1,0
7,GO MITOCHONDRIAL TRNA PROCESSING,0.00026003,-0.31711,-0.31934,1,0
7,GO BRANCH ELONGATION OF AN EPITHELIUM,0.011326,-0.31735,-0.38902,1,0
7,GO REGULATORY T CELL DIFFERENTIATION,3.0689e-05,-0.31857,-0.36986,1,0
7,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,6.7596e-05,-0.31878,-0.36147,1,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.033166,-0.31997,-0.25036,1,0
7,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0018173,-0.32428,-0.27397,1,0
7,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00012074,-0.32675,-0.31682,1,0
7,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00047456,-0.33714,-0.3678,1,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.0023671,-0.34654,-0.29541,1,0
7,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0018173,-0.35096,-0.35284,1,0
7,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0057817,-0.35842,-0.24468,1,0
7,GO MEMBRANE RAFT ASSEMBLY,0.021165,-0.36004,-0.50943,1,0
7,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,6.5149e-05,-0.3628,-0.33058,1,0
7,GO HEPATOCYTE APOPTOTIC PROCESS,0.013798,-0.36283,-0.31273,1,0
7,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0024367,-0.3707,-0.36515,1,0
7,GO DNA DEAMINATION,0.036164,-0.3715,-0.26206,1,0
7,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0015189,-0.37161,-0.3075,1,0
7,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0066042,-0.37216,-0.28459,1,0
7,GO T HELPER 2 CELL DIFFERENTIATION,6.5149e-05,-0.37695,-0.48907,1,0
7,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.024288,-0.37838,-0.29409,1,0
7,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00026003,-0.40096,-0.43918,1,0
7,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.017137,-0.41005,-0.37377,1,0
7,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0097392,-0.41326,-0.26826,1,0
7,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0083534,-0.41366,-0.46848,1,0
7,GO KERATINOCYTE DEVELOPMENT,0.024846,-0.4534,-0.32042,1,0
7,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,7.013e-05,-0.45473,-0.49518,1,0
7,GO BASE CONVERSION OR SUBSTITUTION EDITING,9.7346e-05,-0.46075,-0.40717,1,0
7,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.012203,-0.46252,-0.32913,1,0
7,GO BLEB ASSEMBLY,0.0067808,-0.46362,-0.46966,1,0
7,GO MYOBLAST MIGRATION,2.4346e-05,-0.47756,-0.5513,1,0
7,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,3.3132e-05,-0.49052,-0.5598,1,0
7,GO HISTAMINE TRANSPORT,0.0041716,-0.49574,-0.396,1,0
7,GO HISTAMINE SECRETION,0.0075304,-0.56432,-0.38794,1,0
7,GO ECTODERMAL PLACODE DEVELOPMENT,0.0019282,-0.56969,-0.46317,1,0
7,GO CYTIDINE TO URIDINE EDITING,0.0054795,-0.577,-0.47162,1,0
7,GO TONGUE MORPHOGENESIS,0.00049035,-0.58704,-0.51767,1,0
7,GO BONE TRABECULA FORMATION,0.077957,0.39218,0.28869,0,1
7,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.075049,0.37737,0.33943,0,1
7,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.13355,0.3575,0.18733,0,1
7,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.049546,0.314,0.26003,0,1
7,GO RETROGRADE TRANS SYNAPTIC SIGNALING,0.079444,0.31018,0.33942,0,1
7,GO SHORT TERM MEMORY,0.073629,0.29551,0.22772,0,1
7,GO CARTILAGE MORPHOGENESIS,0.16559,0.29304,0.16391,0,1
7,GO POSITIVE REGULATION OF VESICLE FUSION,0.099158,0.27767,0.18601,0,1
7,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.082489,0.26021,0.18189,0,1
7,GO CARDIAC VENTRICLE FORMATION,0.068167,0.25737,0.27438,0,1
7,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.053746,0.251,0.23277,0,1
7,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.21905,0.24832,0.11946,0,1
7,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.17653,0.24287,0.13281,0,1
7,GO BONE TRABECULA MORPHOGENESIS,0.14526,0.23573,0.19942,0,1
7,GO HETEROTYPIC CELL CELL ADHESION,0.11636,0.22456,0.11905,0,1
7,GO SYNAPTIC VESICLE BUDDING,0.057089,0.22267,0.13671,0,1
7,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.12908,0.20807,0.12759,0,1
7,GO FAT CELL PROLIFERATION,0.29992,0.20573,0.019822,0,1
7,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.11235,0.20453,0.12532,0,1
7,GO POSITIVE REGULATION OF URINE VOLUME,0.05161,0.2033,0.10492,0,1
7,GO CELLULAR RESPONSE TO COPPER ION,0.36526,0.20049,0.036549,0,1
7,GO MEGAKARYOCYTE DEVELOPMENT,0.13583,0.19456,0.14704,0,1
7,GO POSITIVE REGULATION OF NEURON MIGRATION,0.21579,0.19223,0.11582,0,1
7,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.22235,0.192,0.054199,0,1
7,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.063042,0.19118,0.16693,0,1
7,GO C4 DICARBOXYLATE TRANSPORT,0.14769,0.1899,0.09587,0,1
7,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.1028,0.18754,0.12954,0,1
7,GO FUCOSYLATION,0.097379,0.18219,0.10744,0,1
7,GO PROTEIN TRIMERIZATION,0.62732,0.1814,0.011329,0,1
7,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.076492,0.18015,0.14794,0,1
7,GO OUTER DYNEIN ARM ASSEMBLY,0.084046,0.17866,0.1331,0,1
7,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.084046,0.17486,0.13957,0,1
7,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.072231,0.17414,0.12423,0,1
7,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.23245,0.17304,0.10504,0,1
7,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.097379,0.17258,0.13805,0,1
7,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.15264,0.17251,0.13413,0,1
7,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.077957,0.17205,0.14696,0,1
7,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.072231,0.17187,0.14868,0,1
7,GO REGULATION OF FERTILIZATION,0.061812,0.17117,0.11018,0,1
7,GO AMINE BIOSYNTHETIC PROCESS,0.42855,0.16824,0.063551,0,1
7,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.087232,0.16691,0.099075,0,1
7,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.22568,0.16663,0.086611,0,1
7,GO PROTEIN LOCALIZATION TO CILIUM,0.099158,0.16594,0.11192,0,1
7,GO FEVER GENERATION,0.34702,0.16404,0.061322,0,1
7,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.11434,0.16381,0.18492,0,1
7,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.10845,0.16309,0.13367,0,1
7,GO RESPONSE TO MUSCLE INACTIVITY,0.059411,0.16125,0.16219,0,1
7,GO REGULATION OF LIPID KINASE ACTIVITY,0.076492,0.16036,0.089102,0,1
7,GO REGULATION OF AXON GUIDANCE,0.12473,0.15941,0.072713,0,1
7,GO REGULATION OF ODONTOGENESIS,0.079444,0.15818,0.13411,0,1
7,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.18508,0.15795,0.088187,0,1
7,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.18508,0.15786,0.035624,0,1
7,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.063042,0.15691,0.13055,0,1
7,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.072231,0.15586,0.10878,0,1
7,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.070855,0.15538,0.20608,0,1
7,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.20621,0.15191,0.088336,0,1
7,GO VASCULAR WOUND HEALING,0.84397,0.15168,-0.099313,0,1
7,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.15517,0.14788,0.16077,0,1
7,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.38408,0.14773,0.13936,0,1
7,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.52025,0.14514,0.046048,0,1
7,GO DNA STRAND ELONGATION,0.32938,0.14471,0.027471,0,1
7,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.076492,0.1419,0.097864,0,1
7,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.29992,0.14005,0.050686,0,1
7,GO MICROTUBULE ANCHORING AT CENTROSOME,0.11434,0.13914,0.11739,0,1
7,GO MEMBRANE FISSION,0.082489,0.13909,0.11154,0,1
7,GO REGULATION OF TELOMERE CAPPING,0.099158,0.13853,0.10827,0,1
7,GO CHROMATIN DISASSEMBLY,0.10654,0.13711,0.10564,0,1
7,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.15015,0.13597,0.087397,0,1
7,GO POSITIVE REGULATION OF AXON EXTENSION,0.13814,0.13454,0.084283,0,1
7,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.060602,0.1345,0.1323,0,1
7,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.26471,0.13306,0.061544,0,1
7,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.13814,0.13282,0.072953,0,1
7,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.10465,0.13179,0.11734,0,1
7,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.055956,0.13081,0.11985,0,1
7,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.23245,0.13063,0.042415,0,1
7,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.068167,0.12826,0.10255,0,1
7,GO RETINAL CONE CELL DIFFERENTIATION,0.51459,0.12583,0.015329,0,1
7,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.12259,0.1242,0.074773,0,1
7,GO OLIGODENDROCYTE DIFFERENTIATION,0.060602,0.1234,0.093281,0,1
7,GO REGULATION OF GLIOGENESIS,0.12689,0.12299,0.060481,0,1
7,GO AMMONIUM ION METABOLIC PROCESS,0.38888,0.12263,0.060249,0,1
7,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.19095,0.12116,0.10944,0,1
7,GO NON MOTILE CILIUM ASSEMBLY,0.1028,0.12044,0.09983,0,1
7,GO NOTCH SIGNALING PATHWAY,0.16294,0.11839,0.061322,0,1
7,GO AXON EXTENSION,0.065563,0.11815,0.10438,0,1
7,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.076492,0.11796,0.12604,0,1
7,GO CELL CYCLE DNA REPLICATION,0.39858,0.11761,0.015054,0,1
7,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.073629,0.11743,0.12156,0,1
7,GO RENAL WATER HOMEOSTASIS,0.12908,0.11635,0.09659,0,1
7,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.064293,0.11449,0.076394,0,1
7,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.16559,0.11443,0.098768,0,1
7,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.059411,0.11122,0.091323,0,1
7,GO ANIMAL ORGAN MATURATION,0.05824,0.11064,0.1438,0,1
7,GO DNA REPLICATION INITIATION,0.25001,0.11057,0.044335,0,1
7,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.05161,0.1105,0.13156,0,1
7,GO RESPONSE TO ELECTRICAL STIMULUS,0.12049,0.11038,0.073554,0,1
7,GO REGULATION OF EXTENT OF CELL GROWTH,0.060602,0.11026,0.10526,0,1
7,GO NEGATIVE REGULATION OF GLIOGENESIS,0.12259,0.10936,0.083601,0,1
7,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.050569,0.10877,0.1348,0,1
7,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.16828,0.10687,0.053326,0,1
7,GO NEGATIVE REGULATION OF AXON EXTENSION,0.16828,0.1063,0.092902,0,1
7,GO NEUTRAL LIPID CATABOLIC PROCESS,0.1028,0.10488,0.084825,0,1
7,GO MICROTUBULE ANCHORING,0.16032,0.10401,0.065038,0,1
7,GO RDNA HETEROCHROMATIN ASSEMBLY,0.11039,0.1026,0.10138,0,1
7,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.23589,0.10144,0.090035,0,1
7,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.093897,0.10058,0.098959,0,1
7,GO CELLULAR COMPONENT MAINTENANCE,0.073629,0.10035,0.084101,0,1
7,GO REGULATION OF CELL MORPHOGENESIS,0.04854,0.10019,0.078957,0,1
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.076492,0.099523,0.066343,0,1
7,GO REGULATION OF CELL FATE COMMITMENT,0.14526,0.097935,0.072069,0,1
7,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.12689,0.096732,0.070506,0,1
7,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.099158,0.095468,0.051912,0,1
7,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.059411,0.094738,0.13784,0,1
7,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.21579,0.093366,0.045263,0,1
7,GO CENTROSOME DUPLICATION,0.31653,0.093283,0.043679,0,1
7,GO CENTRIOLE CENTRIOLE COHESION,0.064293,0.092722,0.11095,0,1
7,GO MITOTIC SPINDLE ASSEMBLY,0.17099,0.091525,0.07144,0,1
7,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.060602,0.09141,0.069022,0,1
7,GO SPERMATID NUCLEUS DIFFERENTIATION,0.12689,0.090095,0.095932,0,1
7,GO SENSORY PERCEPTION OF TASTE,0.068167,0.088543,0.063045,0,1
7,GO RECEPTOR INTERNALIZATION,0.072231,0.087719,0.088495,0,1
7,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.093897,0.085767,0.053305,0,1
7,GO REGULATION OF CENTROSOME CYCLE,0.15015,0.085154,0.047644,0,1
7,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.076492,0.084397,0.07647,0,1
7,GO GLIOGENESIS,0.054842,0.083221,0.06673,0,1
7,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.34702,0.080276,0.057198,0,1
7,GO NUCLEAR BODY ORGANIZATION,0.1028,0.080205,0.099539,0,1
7,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.084046,0.079139,0.14973,0,1
7,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.16828,0.076936,0.076374,0,1
7,GO MITOCHONDRION MORPHOGENESIS,0.11434,0.076572,0.077583,0,1
7,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.1028,0.075321,0.047944,0,1
7,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.077957,0.074606,0.062143,0,1
7,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.41842,0.074324,0.034998,0,1
7,GO SPERM MOTILITY,0.17653,0.07404,0.067729,0,1
7,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.13814,0.072671,0.042118,0,1
7,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.41842,0.072396,0.055245,0,1
7,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.16032,0.070689,0.062661,0,1
7,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.22568,0.07052,0.044122,0,1
7,GO NEUTRAL AMINO ACID TRANSPORT,0.21256,0.069462,0.035216,0,1
7,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.11039,0.068534,0.098317,0,1
7,GO CILIUM ORGANIZATION,0.065563,0.068448,0.082528,0,1
7,GO RECOMBINATIONAL REPAIR,0.24643,0.0684,0.03302,0,1
7,GO HISTONE H4 ACETYLATION,0.085627,0.06757,0.056566,0,1
7,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.082489,0.067552,0.10607,0,1
7,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.29184,0.067477,0.033909,0,1
7,GO DNA REPLICATION CHECKPOINT,0.41842,0.067269,0.038721,0,1
7,GO REGULATION OF SPINDLE ORGANIZATION,0.13355,0.066162,0.074045,0,1
7,GO REGULATION OF ACTIN FILAMENT LENGTH,0.1028,0.063395,0.042072,0,1
7,GO TRANSCRIPTION BY RNA POLYMERASE III,0.082489,0.061835,0.073203,0,1
7,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.072231,0.059451,0.062919,0,1
7,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.5726,0.058581,0.0034702,0,1
7,GO REGULATION OF PHOSPHATASE ACTIVITY,0.11636,0.058146,0.041092,0,1
7,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.87144,0.055488,-0.020895,0,1
7,GO DNA DEPENDENT DNA REPLICATION,0.94769,0.053865,-0.011145,0,1
7,GO SEXUAL REPRODUCTION,0.12049,0.049264,0.041728,0,1
7,GO ORGANELLE FISSION,0.38888,0.046623,0.016765,0,1
7,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.059411,0.046537,0.041099,0,1
7,GO MALE GAMETE GENERATION,0.097379,0.045055,0.050472,0,1
7,GO ORGANELLE ASSEMBLY,0.16294,0.043874,0.029632,0,1
7,GO NUCLEAR CHROMOSOME SEGREGATION,0.22905,0.039634,0.042406,0,1
7,GO CAMERA TYPE EYE MORPHOGENESIS,0.085627,0.039467,0.10137,0,1
7,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.58456,0.037536,0.025342,0,1
7,GO DNA RECOMBINATION,0.31653,0.037213,0.018011,0,1
7,GO GAMETE GENERATION,0.12259,0.036907,0.044413,0,1
7,GO CYTOKINESIS,0.05161,0.034925,0.071811,0,1
7,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.36526,0.026588,0.021486,0,1
7,GO DNA REPLICATION,0.76948,0.020871,-0.024504,0,1
7,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0028141,0.4556,0.437,0,0
7,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.018398,0.41932,0.31294,0,0
7,GO RETINA LAYER FORMATION,0.00065623,0.39293,0.44452,0,0
7,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0056288,0.34736,0.33126,0,0
7,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.61497,0.33936,0.083684,0,0
7,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0028957,0.335,0.35118,0,0
7,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0071468,0.3224,0.34756,0,0
7,GO SECONDARY HEART FIELD SPECIFICATION,0.0059384,0.30843,0.35542,0,0
7,GO ETHANOL OXIDATION,0.0695,0.28906,0.15459,0,0
7,GO FOREBRAIN NEURON DIFFERENTIATION,0.00020448,0.28504,0.36611,0,0
7,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.080955,0.28431,0.28368,0,0
7,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.69707,0.27235,0.041562,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0050528,0.26832,0.31377,0,0
7,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.16828,0.2617,0.15951,0,0
7,GO NEURAL RETINA DEVELOPMENT,0.0013054,0.25751,0.24902,0,0
7,GO REGULATION OF MICROTUBULE BINDING,0.00023468,0.25187,0.25656,0,0
7,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.092194,0.24585,0.13472,0,0
7,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,0.14048,0.2435,0.18221,0,0
7,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0024367,0.2422,0.27983,0,0
7,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0039469,0.2343,0.3057,0,0
7,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0066042,0.23404,0.2675,0,0
7,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.088862,0.23304,0.26155,0,0
7,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0051916,0.23037,0.24797,0,0
7,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0019282,0.23018,0.34423,0,0
7,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.29184,0.22951,0.049482,0,0
7,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.030383,0.22927,0.25683,0,0
7,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0099891,0.22908,0.36371,0,0
7,GO CLATHRIN COAT ASSEMBLY,0.057089,0.22905,0.17104,0,0
7,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.070855,0.22876,0.17604,0,0
7,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.14769,0.22836,0.14607,0,0
7,GO CHAPERONE MEDIATED AUTOPHAGY,0.27611,0.22824,0.11572,0,0
7,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.10654,0.22734,0.17127,0,0
7,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.064293,0.22274,0.15824,0,0
7,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.16828,0.22259,0.18779,0,0
7,GO SECRETORY GRANULE LOCALIZATION,0.05161,0.22151,0.26122,0,0
7,GO SYNAPTIC VESICLE MATURATION,0.095625,0.22138,0.23878,0,0
7,GO RESPONSE TO DIETARY EXCESS,0.13583,0.22068,0.13352,0,0
7,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.070855,0.22061,0.18839,0,0
7,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.010506,0.21817,0.2374,0,0
7,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.17099,0.21673,0.28252,0,0
7,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.025414,0.21122,0.21068,0,0
7,GO CELL JUNCTION MAINTENANCE,0.0021689,0.20489,0.22768,0,0
7,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.5726,0.20407,0.019786,0,0
7,GO CELL FATE DETERMINATION,0.088862,0.20215,0.15048,0,0
7,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.064293,0.20149,0.25667,0,0
7,GO CARDIAC CHAMBER FORMATION,0.059411,0.20121,0.2561,0,0
7,GO CATECHOLAMINE METABOLIC PROCESS,0.0028141,0.2011,0.22612,0,0
7,GO AXONAL TRANSPORT,6.7596e-05,0.20068,0.21937,0,0
7,GO HAIR FOLLICLE MATURATION,0.068167,0.19858,0.12526,0,0
7,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00010845,0.1972,0.28174,0,0
7,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.41842,0.19325,0.028081,0,0
7,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.024288,0.19084,0.33968,0,0
7,GO HEART FORMATION,0.025994,0.18995,0.19339,0,0
7,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.011047,0.18985,0.16129,0,0
7,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.14285,0.18841,0.13551,0,0
7,GO CARDIOBLAST DIFFERENTIATION,0.33812,0.18776,0.049267,0,0
7,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.19695,0.18641,0.12204,0,0
7,GO CELL MIGRATION IN HINDBRAIN,0.050569,0.18572,0.22823,0,0
7,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.10654,0.1857,0.16612,0,0
7,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.26098,0.18233,0.11064,0,0
7,GO MALE MEIOSIS I,0.015953,0.18147,0.17355,0,0
7,GO SKIN MORPHOGENESIS,0.30402,0.18117,0.095609,0,0
7,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.1313,0.17973,0.12673,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.80312,0.17947,0.013424,0,0
7,GO PYRAMIDAL NEURON DIFFERENTIATION,0.27611,0.17775,0.12624,0,0
7,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.046579,0.17762,0.2274,0,0
7,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.36064,0.17631,0.068253,0,0
7,GO REGULATION OF BMP SIGNALING PATHWAY,0.076492,0.17553,0.095667,0,0
7,GO CAMP BIOSYNTHETIC PROCESS,0.31232,0.17521,0.1072,0,0
7,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.092194,0.17505,0.090443,0,0
7,GO RADIAL GLIAL CELL DIFFERENTIATION,0.082489,0.17389,0.15386,0,0
7,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.13583,0.17316,0.13855,0,0
7,GO FUCOSE METABOLIC PROCESS,0.15773,0.17248,0.10013,0,0
7,GO INCLUSION BODY ASSEMBLY,0.36991,0.17138,0.061448,0,0
7,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.10845,0.17102,0.1918,0,0
7,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.010506,0.16887,0.17728,0,0
7,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.021165,0.16881,0.25538,0,0
7,GO GROOMING BEHAVIOR,0.029068,0.16877,0.2073,0,0
7,GO RESPONSE TO HISTAMINE,0.16559,0.16834,0.11157,0,0
7,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.085627,0.1683,0.10987,0,0
7,GO SEROTONIN METABOLIC PROCESS,0.10465,0.16686,0.19856,0,0
7,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.065563,0.16609,0.13495,0,0
7,GO REGULATION OF GROWTH HORMONE SECRETION,0.05161,0.16589,0.27487,0,0
7,GO MESODERMAL CELL DIFFERENTIATION,0.10096,0.16492,0.082674,0,0
7,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.072231,0.16359,0.17517,0,0
7,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.35607,0.16344,0.086517,0,0
7,GO SYNAPSE ASSEMBLY,0.0079323,0.16333,0.19043,0,0
7,GO CEREBELLAR CORTEX FORMATION,0.015574,0.16266,0.20595,0,0
7,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.11636,0.16201,0.27733,0,0
7,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.14285,0.16193,0.15437,0,0
7,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.18219,0.16158,0.13545,0,0
7,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.31653,0.16146,0.085675,0,0
7,GO DORSAL VENTRAL AXIS SPECIFICATION,0.14048,0.16102,0.17317,0,0
7,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.11636,0.16046,0.098279,0,0
7,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.55487,0.16012,0.035464,0,0
7,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.036948,0.15963,0.19195,0,0
7,GO STABILIZATION OF MEMBRANE POTENTIAL,0.12908,0.15883,0.18488,0,0
7,GO RRNA PSEUDOURIDINE SYNTHESIS,0.20309,0.15849,0.096601,0,0
7,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0037331,0.15703,0.17615,0,0
7,GO REGULATION OF GASTRULATION,0.057089,0.15642,0.09172,0,0
7,GO PARAXIAL MESODERM MORPHOGENESIS,0.27227,0.15594,0.1215,0,0
7,GO GENITALIA MORPHOGENESIS,0.3746,0.15573,0.048811,0,0
7,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.14769,0.15472,0.12048,0,0
7,GO REGULATION OF TUBULIN DEACETYLATION,0.25729,0.15467,0.14894,0,0
7,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.29586,0.15467,0.027831,0,0
7,GO OSTEOBLAST PROLIFERATION,0.23937,0.15395,0.074557,0,0
7,GO INNERVATION,0.42347,0.15274,0.12999,0,0
7,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.11841,0.15269,0.18659,0,0
7,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.25363,0.15252,0.15113,0,0
7,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.61497,0.15139,0.030306,0,0
7,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.87144,0.15073,-0.011027,0,0
7,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.39371,0.15058,0.053816,0,0
7,GO PROSTATE GLAND GROWTH,0.44924,0.15008,0.0057953,0,0
7,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.13355,0.14876,0.11446,0,0
7,GO HORMONE CATABOLIC PROCESS,0.38888,0.14867,0.049339,0,0
7,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.084046,0.14793,0.15911,0,0
7,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.21905,0.14739,0.10246,0,0
7,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.2,0.14692,0.09619,0,0
7,GO OXYGEN TRANSPORT,0.36064,0.14605,0.15169,0,0
7,GO CEREBRAL CORTEX CELL MIGRATION,0.035393,0.14583,0.15125,0,0
7,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.60272,0.14492,0.014134,0,0
7,GO CARDIAC MYOFIBRIL ASSEMBLY,0.16828,0.14454,0.13807,0,0
7,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.54321,0.14408,0.036022,0,0
7,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.19095,0.14364,0.12652,0,0
7,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0071468,0.14319,0.15641,0,0
7,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.19095,0.14314,0.11297,0,0
7,GO CEREBELLAR CORTEX MORPHOGENESIS,0.060602,0.14257,0.1238,0,0
7,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.63354,0.14211,0.057855,0,0
7,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.073629,0.14185,0.13883,0,0
7,GO RESPONSE TO INTERLEUKIN 18,0.88523,0.1418,-0.065112,0,0
7,GO DIVALENT METAL ION EXPORT,0.10465,0.14111,0.14074,0,0
7,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.11841,0.14099,0.17025,0,0
7,GO PSEUDOPODIUM ORGANIZATION,0.62732,0.14059,0.043816,0,0
7,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.19095,0.14041,0.078448,0,0
7,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.070855,0.14024,0.095444,0,0
7,GO PHOSPHOLIPID EFFLUX,0.62113,0.13982,0.014675,0,0
7,GO EPIBOLY,0.91293,0.13969,-0.062083,0,0
7,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.1313,0.13928,0.077541,0,0
7,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.050569,0.13852,0.18971,0,0
7,GO REGULATION OF COLLATERAL SPROUTING,0.12908,0.13813,0.16116,0,0
7,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.33373,0.13784,0.082687,0,0
7,GO INTRACILIARY TRANSPORT,0.065563,0.13749,0.15604,0,0
7,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.088862,0.13728,0.13236,0,0
7,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.097379,0.1371,0.13589,0,0
7,GO REGULATION OF AMYLOID BETA CLEARANCE,0.32077,0.13692,0.025473,0,0
7,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.063042,0.13634,0.15879,0,0
7,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.15773,0.13602,0.10657,0,0
7,GO ACIDIC AMINO ACID TRANSPORT,0.0038387,0.13593,0.16012,0,0
7,GO RESPONSE TO LIGHT INTENSITY,0.12259,0.13559,0.10602,0,0
7,GO GAMMA DELTA T CELL ACTIVATION,0.055956,0.13507,0.19285,0,0
7,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.39858,0.135,0.040306,0,0
7,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.3746,0.13487,0.052283,0,0
7,GO VAGINA DEVELOPMENT,0.44924,0.13479,0.058208,0,0
7,GO DISTAL TUBULE DEVELOPMENT,0.16032,0.13456,0.1463,0,0
7,GO AXO DENDRITIC TRANSPORT,0.00045924,0.13452,0.16372,0,0
7,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.42855,0.13436,0.070796,0,0
7,GO LIMB BUD FORMATION,0.27611,0.13419,0.17355,0,0
7,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.49227,0.13408,0.033997,0,0
7,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.36526,0.13404,0.037234,0,0
7,GO VITAMIN CATABOLIC PROCESS,0.34702,0.13383,0.03805,0,0
7,GO RESPONSE TO AMPHETAMINE,0.063042,0.13373,0.15657,0,0
7,GO DERMATAN SULFATE METABOLIC PROCESS,0.15264,0.13307,0.11176,0,0
7,GO PROTEIN LOCALIZATION TO CHROMATIN,0.15517,0.13251,0.059234,0,0
7,GO REPLACEMENT OSSIFICATION,0.095625,0.13249,0.13631,0,0
7,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.001872,0.13199,0.17805,0,0
7,GO NEURAL CREST CELL MIGRATION,0.14048,0.13054,0.068617,0,0
7,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.3746,0.12961,0.051661,0,0
7,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.11841,0.12946,0.1097,0,0
7,GO REGULATION OF GLUTAMATE SECRETION,0.15264,0.12935,0.13953,0,0
7,GO PITUITARY GLAND DEVELOPMENT,0.097379,0.12907,0.1482,0,0
7,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.12049,0.12888,0.14039,0,0
7,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.54321,0.12877,0.10358,0,0
7,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.072231,0.1284,0.15952,0,0
7,GO EPOXYGENASE P450 PATHWAY,0.39371,0.12799,0.038328,0,0
7,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.27227,0.12788,0.14484,0,0
7,GO FOREBRAIN REGIONALIZATION,0.075049,0.12766,0.18622,0,0
7,GO PHOTORECEPTOR CELL DEVELOPMENT,0.088862,0.1273,0.098445,0,0
7,GO POSITIVE REGULATION OF HEAT GENERATION,0.14285,0.12699,0.13666,0,0
7,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.93377,0.12681,-0.060717,0,0
7,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.26847,0.12673,0.066585,0,0
7,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.27227,0.12672,0.026924,0,0
7,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.16032,0.12617,0.066768,0,0
7,GO BONE CELL DEVELOPMENT,0.049546,0.12609,0.11327,0,0
7,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.2839,0.12597,0.091188,0,0
7,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.027188,0.12587,0.15506,0,0
7,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.51459,0.12542,0.024519,0,0
7,GO HYPEROSMOTIC SALINITY RESPONSE,0.49227,0.12519,0.048089,0,0
7,GO MATING BEHAVIOR,0.061812,0.12485,0.14127,0,0
7,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.20309,0.12483,0.098477,0,0
7,GO GALACTOSE METABOLIC PROCESS,0.85768,0.12431,-0.018917,0,0
7,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.48131,0.12408,0.019627,0,0
7,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.070855,0.1239,0.17003,0,0
7,GO STRIATUM DEVELOPMENT,0.080955,0.12349,0.18411,0,0
7,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.30402,0.12312,0.22282,0,0
7,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.51459,0.12308,0.020008,0,0
7,GO RESPONSE TO VITAMIN D,0.47049,0.12279,0.068184,0,0
7,GO REGULATION OF HEART RATE,0.15773,0.12262,0.083471,0,0
7,GO PLASMA MEMBRANE REPAIR,0.53742,0.12209,0.055614,0,0
7,GO OPTIC NERVE DEVELOPMENT,0.36991,0.12181,0.08139,0,0
7,GO SUCKLING BEHAVIOR,0.61497,0.12119,0.031619,0,0
7,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.1028,0.12105,0.12673,0,0
7,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.15773,0.12097,0.095212,0,0
7,GO TELENCEPHALON GLIAL CELL MIGRATION,0.16559,0.12059,0.12174,0,0
7,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.012508,0.12024,0.19297,0,0
7,GO GLUCOCORTICOID METABOLIC PROCESS,0.18219,0.11876,0.11021,0,0
7,GO MICROTUBULE SEVERING,0.017137,0.11839,0.16889,0,0
7,GO HEPATOCYTE DIFFERENTIATION,0.23937,0.11834,0.089808,0,0
7,GO VASCULAR TRANSPORT,0.49227,0.1181,0.035706,0,0
7,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.71006,0.11784,0.0039734,0,0
7,GO SYNAPTIC MEMBRANE ADHESION,0.14769,0.11747,0.17204,0,0
7,GO NEURON CELLULAR HOMEOSTASIS,0.36064,0.11744,0.1024,0,0
7,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.89907,0.11722,-0.029312,0,0
7,GO BONE MINERALIZATION,0.095625,0.11691,0.082688,0,0
7,GO NOREPINEPHRINE METABOLIC PROCESS,0.31232,0.11682,0.14981,0,0
7,GO VENTRAL SPINAL CORD DEVELOPMENT,0.090515,0.11678,0.11423,0,0
7,GO TRNA WOBBLE URIDINE MODIFICATION,0.14769,0.11671,0.079181,0,0
7,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.38888,0.11542,0.093752,0,0
7,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.23937,0.11499,0.14249,0,0
7,GO ATRIAL SEPTUM MORPHOGENESIS,0.59059,0.11491,0.0388,0,0
7,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.25363,0.11442,0.098549,0,0
7,GO NEURON PROJECTION ARBORIZATION,0.052669,0.11432,0.13684,0,0
7,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.96163,0.11393,-0.0034968,0,0
7,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.061812,0.11366,0.1184,0,0
7,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0037331,0.11331,0.12208,0,0
7,GO VIRAL LATENCY,0.67137,0.11312,0.014874,0,0
7,GO STORE OPERATED CALCIUM ENTRY,0.076492,0.11305,0.12053,0,0
7,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.14285,0.11287,0.10499,0,0
7,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.04854,0.11283,0.22261,0,0
7,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.35153,0.11251,0.092464,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.47049,0.1124,0.030774,0,0
7,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.13814,0.11214,0.12956,0,0
7,GO REGULATION OF GASTRIC ACID SECRETION,0.23937,0.11191,0.036609,0,0
7,GO CORTICOSTEROID HORMONE SECRETION,0.8303,0.11189,-0.0098144,0,0
7,GO CAMP METABOLIC PROCESS,0.22568,0.1117,0.081244,0,0
7,GO MATING,0.090515,0.11167,0.083437,0,0
7,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.18508,0.11163,0.1503,0,0
7,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0031536,0.11138,0.11387,0,0
7,GO DETECTION OF VISIBLE LIGHT,0.057089,0.11099,0.04475,0,0
7,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.14285,0.1108,0.13896,0,0
7,GO NEURON FATE SPECIFICATION,0.77618,0.11079,0.081197,0,0
7,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.72313,0.11062,-0.0040417,0,0
7,GO MACROPHAGE PROLIFERATION,0.26471,0.11053,0.10088,0,0
7,GO REGULATION OF RECEPTOR BINDING,0.40349,0.11018,0.077372,0,0
7,GO TRIGEMINAL NERVE DEVELOPMENT,0.40349,0.11005,0.099589,0,0
7,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.23937,0.10998,0.051314,0,0
7,GO REGULATION OF RESPONSE TO FOOD,0.19393,0.10993,0.071365,0,0
7,GO INDOLALKYLAMINE METABOLIC PROCESS,0.27999,0.10967,0.07177,0,0
7,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.68418,0.10948,0.051408,0,0
7,GO POSITIVE REGULATION OF HEART CONTRACTION,0.29184,0.10918,0.066955,0,0
7,GO LOCOMOTOR RHYTHM,0.077957,0.10909,0.12333,0,0
7,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.37932,0.10892,0.026061,0,0
7,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.17374,0.10879,0.13866,0,0
7,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.15517,0.1086,0.13415,0,0
7,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.44924,0.10853,0.099777,0,0
7,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.27227,0.10851,0.088332,0,0
7,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.34256,0.10845,0.043427,0,0
7,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0051916,0.10843,0.33733,0,0
7,GO POTASSIUM ION HOMEOSTASIS,0.061812,0.10832,0.11624,0,0
7,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.22235,0.10797,0.12278,0,0
7,GO DETOXIFICATION OF INORGANIC COMPOUND,0.85768,0.10793,-0.10388,0,0
7,GO NOSE DEVELOPMENT,0.25363,0.1078,0.18183,0,0
7,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.11636,0.10741,0.11081,0,0
7,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.23589,0.10623,0.098832,0,0
7,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.080955,0.10594,0.092687,0,0
7,GO NEGATIVE REGULATION OF BEHAVIOR,0.14526,0.10594,0.093979,0,0
7,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.4978,0.10511,0.057174,0,0
7,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.034637,0.10509,0.097655,0,0
7,GO RESPONSE TO FLUID SHEAR STRESS,0.31653,0.10475,0.044063,0,0
7,GO AMYLOID BETA METABOLIC PROCESS,0.25001,0.1046,0.073996,0,0
7,GO PULMONARY VALVE MORPHOGENESIS,0.19393,0.10456,0.18507,0,0
7,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.070855,0.10443,0.12599,0,0
7,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.7495,0.10426,0.015646,0,0
7,GO REGULATION OF ANIMAL ORGAN FORMATION,0.14526,0.10424,0.10463,0,0
7,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.32077,0.10395,0.047301,0,0
7,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.05161,0.10356,0.098028,0,0
7,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.25729,0.10342,0.054629,0,0
7,GO RESPONSE TO ETHANOL,0.43367,0.10313,0.03206,0,0
7,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.66501,0.10306,-0.049864,0,0
7,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.084046,0.103,0.060134,0,0
7,GO RESPONSE TO L GLUTAMATE,0.37932,0.10291,0.084668,0,0
7,GO PROTEIN TARGETING TO LYSOSOME,0.83713,0.10269,-0.040622,0,0
7,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.50337,0.10255,0.039486,0,0
7,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.15015,0.10203,0.066738,0,0
7,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.60272,0.10171,0.045345,0,0
7,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.19095,0.10168,0.05388,0,0
7,GO LIPOXYGENASE PATHWAY,0.23589,0.10147,0.12846,0,0
7,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.29586,0.10128,0.10459,0,0
7,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.24643,0.10124,0.075156,0,0
7,GO TRIGLYCERIDE CATABOLIC PROCESS,0.12049,0.10122,0.095917,0,0
7,GO I KAPPAB PHOSPHORYLATION,0.20937,0.10121,0.058552,0,0
7,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.24288,0.10116,0.10243,0,0
7,GO CELLULAR RESPONSE TO CAMP,0.080955,0.10091,0.069711,0,0
7,GO EMBRYONIC PATTERN SPECIFICATION,0.029068,0.10084,0.14891,0,0
7,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.29184,0.10074,0.075209,0,0
7,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.25729,0.10066,0.16716,0,0
7,GO GROWTH HORMONE SECRETION,0.05161,0.10048,0.20434,0,0
7,GO REGULATION OF CILIUM ASSEMBLY,0.061812,0.10039,0.085622,0,0
7,GO FOLIC ACID METABOLIC PROCESS,0.91987,0.10026,-0.0081195,0,0
7,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.084046,0.10023,0.076839,0,0
7,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.32938,0.099817,0.058322,0,0
7,GO REGULATION OF SODIUM ION TRANSPORT,0.097379,0.099523,0.081784,0,0
7,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.23937,0.098973,0.043746,0,0
7,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.14048,0.098762,0.097707,0,0
7,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.15015,0.098739,0.1042,0,0
7,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.090515,0.098401,0.08259,0,0
7,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.10465,0.098214,0.070399,0,0
7,GO MALE GENITALIA DEVELOPMENT,0.47588,0.098153,0.054215,0,0
7,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.19393,0.098058,0.081544,0,0
7,GO POSITIVE REGULATION OF HAIR CYCLE,0.22568,0.097446,0.10149,0,0
7,GO MEMBRANE BIOGENESIS,0.079444,0.097394,0.13756,0,0
7,GO TUBULIN DEACETYLATION,0.24643,0.097372,0.1273,0,0
7,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.26471,0.096801,0.078837,0,0
7,GO RETROGRADE AXONAL TRANSPORT,0.052669,0.096512,0.12324,0,0
7,GO CORONARY VASCULATURE DEVELOPMENT,0.40349,0.096462,0.047415,0,0
7,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.61497,0.096316,0.030767,0,0
7,GO RESPONSE TO GLUCAGON,0.036948,0.096303,0.1171,0,0
7,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.18508,0.096089,0.11598,0,0
7,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.4545,0.095289,0.12237,0,0
7,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.53742,0.095266,0.020866,0,0
7,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.28785,0.095018,0.081025,0,0
7,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.11039,0.094726,0.14991,0,0
7,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0050528,0.094636,0.079514,0,0
7,GO SYNAPTIC TRANSMISSION GABAERGIC,0.188,0.094513,0.057226,0,0
7,GO ERBB2 SIGNALING PATHWAY,0.075049,0.094064,0.070396,0,0
7,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.40349,0.094,0.030386,0,0
7,GO COLLECTING DUCT DEVELOPMENT,0.28785,0.093778,0.15331,0,0
7,GO HINDLIMB MORPHOGENESIS,0.94073,0.093691,-0.0045394,0,0
7,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.29184,0.093598,0.06536,0,0
7,GO CELLULAR RESPONSE TO ZINC ION,0.56666,0.093476,-0.037889,0,0
7,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.84397,0.093418,0.0041816,0,0
7,GO DIENCEPHALON DEVELOPMENT,0.10654,0.093357,0.10293,0,0
7,GO PALLIUM DEVELOPMENT,0.0079323,0.092967,0.098995,0,0
7,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.23937,0.092951,0.04094,0,0
7,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.76281,0.092925,0.038843,0,0
7,GO LYMPHOCYTE CHEMOTAXIS,0.92682,0.092882,-0.0079389,0,0
7,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.39371,0.092652,0.029499,0,0
7,GO DENDRITE SELF AVOIDANCE,0.33373,0.092529,0.083649,0,0
7,GO TRANSPORT ALONG MICROTUBULE,0.0021062,0.092192,0.11956,0,0
7,GO CALCIUM ION IMPORT,0.077957,0.092189,0.079696,0,0
7,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.57857,0.092074,0.030113,0,0
7,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.095625,0.092025,0.1898,0,0
7,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.12473,0.091623,0.11672,0,0
7,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.50896,0.091518,0.022278,0,0
7,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.75615,0.091299,0.036944,0,0
7,GO PROTEIN LOCALIZATION TO AXON,0.39858,0.091156,0.23242,0,0
7,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.47588,0.091067,0.046169,0,0
7,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.29992,0.090992,0.080991,0,0
7,GO REGULATION OF NEURON PROJECTION REGENERATION,0.17099,0.090761,0.084851,0,0
7,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.12908,0.090731,0.11018,0,0
7,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.097379,0.090717,0.089194,0,0
7,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.15773,0.090576,0.077874,0,0
7,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.50896,0.09047,0.0468,0,0
7,GO HEART PROCESS,0.063042,0.090192,0.086308,0,0
7,GO VITAMIN TRANSPORT,0.23589,0.090174,0.060524,0,0
7,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51459,0.089879,0.038567,0,0
7,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.084046,0.089652,0.11616,0,0
7,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.21579,0.089521,0.085417,0,0
7,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.2839,0.089267,0.050268,0,0
7,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.16828,0.08922,0.05999,0,0
7,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.17653,0.089155,0.053244,0,0
7,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.21579,0.088811,0.07656,0,0
7,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.22235,0.088707,0.19179,0,0
7,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.41842,0.088497,0.078319,0,0
7,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.30402,0.088315,0.029626,0,0
7,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.87144,0.088234,-0.014138,0,0
7,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.060602,0.088221,0.092288,0,0
7,GO RESPONSE TO CAMP,0.16032,0.08799,0.051993,0,0
7,GO REGULATION OF CYCLASE ACTIVITY,0.11841,0.087876,0.089314,0,0
7,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.079444,0.087842,0.084126,0,0
7,GO ADULT FEEDING BEHAVIOR,0.36991,0.08777,0.04169,0,0
7,GO ESTROGEN METABOLIC PROCESS,0.13355,0.087209,0.052907,0,0
7,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.16828,0.086869,0.10474,0,0
7,GO REGULATION OF TELOMERASE ACTIVITY,0.29992,0.086755,0.047032,0,0
7,GO REGULATION OF KERATINOCYTE MIGRATION,0.25729,0.08662,0.062601,0,0
7,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.47588,0.086479,0.023144,0,0
7,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.52594,0.08645,0.010661,0,0
7,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.10845,0.086316,0.13175,0,0
7,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.22568,0.086299,0.037654,0,0
7,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.30402,0.086243,0.044074,0,0
7,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.73628,0.086149,0.02846,0,0
7,GO SEROTONIN SECRETION,0.36064,0.085858,0.089304,0,0
7,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.28785,0.085822,0.039209,0,0
7,GO CORONARY VASCULATURE MORPHOGENESIS,0.49227,0.085772,0.030414,0,0
7,GO INSULIN SECRETION,0.27999,0.085523,0.062936,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.13814,0.085261,0.0738,0,0
7,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.43367,0.084435,0.0615,0,0
7,GO MACROPHAGE CYTOKINE PRODUCTION,0.62113,0.084429,0.0062857,0,0
7,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.30815,0.084425,0.063111,0,0
7,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.48131,0.084402,0.071254,0,0
7,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.64605,0.084317,-0.017301,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.084046,0.084178,0.10735,0,0
7,GO CELLULAR GLUCOSE HOMEOSTASIS,0.073629,0.083682,0.058109,0,0
7,GO GANGLIOSIDE METABOLIC PROCESS,0.44924,0.083561,0.031336,0,0
7,GO OSTEOCLAST DEVELOPMENT,0.23245,0.083536,0.083256,0,0
7,GO CELLULAR RESPONSE TO VITAMIN D,0.35153,0.083499,0.068321,0,0
7,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.24288,0.083344,0.060287,0,0
7,GO NEURAL CREST CELL DIFFERENTIATION,0.13814,0.083265,0.052101,0,0
7,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.81668,0.083146,0.022627,0,0
7,GO REGULATION OF ENDOCYTOSIS,0.13355,0.082937,0.057019,0,0
7,GO REGULATION OF AMYLOID BETA FORMATION,0.26847,0.082813,0.076093,0,0
7,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.71658,0.082794,0.020828,0,0
7,GO REGULATION OF PROTEIN FOLDING,0.62113,0.082675,-0.009742,0,0
7,GO ERYTHROCYTE MATURATION,0.41842,0.082674,0.035995,0,0
7,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.62732,0.08264,0.016672,0,0
7,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.23245,0.082574,0.091319,0,0
7,GO DEVELOPMENTAL PIGMENTATION,0.69061,0.082173,0.015646,0,0
7,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.33373,0.082146,0.039629,0,0
7,GO RESPONSE TO BMP,0.053746,0.082065,0.094186,0,0
7,GO PROTEIN DEPOLYMERIZATION,0.0097392,0.08206,0.10957,0,0
7,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.076492,0.081971,0.14634,0,0
7,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.26847,0.081691,0.06574,0,0
7,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.65866,0.081584,0.027043,0,0
7,GO ACROSOME ASSEMBLY,0.27611,0.081302,0.088721,0,0
7,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.67776,0.081268,-0.018752,0,0
7,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.066855,0.080961,0.074739,0,0
7,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.29992,0.080708,0.051547,0,0
7,GO FRUCTOSE METABOLIC PROCESS,0.41341,0.080581,0.081001,0,0
7,GO TOXIN METABOLIC PROCESS,0.4545,0.08036,0.088272,0,0
7,GO INTERFERON BETA PRODUCTION,0.21579,0.080335,0.033086,0,0
7,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.052669,0.079862,0.10981,0,0
7,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.74288,0.079763,0.023072,0,0
7,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.31232,0.079747,0.037858,0,0
7,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.10845,0.079639,0.18979,0,0
7,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.092194,0.079613,0.063092,0,0
7,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.65234,0.079565,-0.018327,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.23937,0.079528,0.03978,0,0
7,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.16032,0.079454,0.049168,0,0
7,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.075049,0.07944,0.12701,0,0
7,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.24288,0.079352,0.060846,0,0
7,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.46512,0.079173,0.013088,0,0
7,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.088862,0.079143,0.076893,0,0
7,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.39371,0.079059,0.057458,0,0
7,GO REGULATION OF HIPPO SIGNALING,0.41341,0.078788,0.062526,0,0
7,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0695,0.078751,0.12896,0,0
7,GO NEGATIVE REGULATION OF PROTEIN SUMOYLATION,0.43883,0.078684,0.12135,0,0
7,GO DIACYLGLYCEROL METABOLIC PROCESS,0.22905,0.078586,0.046971,0,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.11434,0.078573,0.097972,0,0
7,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.59059,0.078328,-0.0096503,0,0
7,GO ODONTOGENESIS,0.061812,0.078087,0.091737,0,0
7,GO REGULATION OF CENTROSOME DUPLICATION,0.43367,0.077995,0.040354,0,0
7,GO CELLULAR ANION HOMEOSTASIS,0.25363,0.077992,0.07373,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.4545,0.077759,0.035167,0,0
7,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.099158,0.077734,0.18987,0,0
7,GO REGULATION OF BLOOD CIRCULATION,0.10654,0.077695,0.068029,0,0
7,GO REGULATION OF CELL PROJECTION SIZE,0.78289,0.077612,0.025859,0,0
7,GO STEROID HORMONE SECRETION,0.80312,0.077605,-0.02719,0,0
7,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.27227,0.077604,0.040471,0,0
7,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.43883,0.0775,0.048025,0,0
7,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.49227,0.07744,0.068471,0,0
7,GO VITAMIN D METABOLIC PROCESS,0.89215,0.0772,-0.080547,0,0
7,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.36991,0.077153,0.031298,0,0
7,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.39858,0.07711,0.17307,0,0
7,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.055956,0.076939,0.10261,0,0
7,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.15015,0.07686,0.061392,0,0
7,GO RESPONSE TO ATP,0.05824,0.076856,0.070842,0,0
7,GO NEUROBLAST DIVISION,0.37932,0.076658,0.069332,0,0
7,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.94073,0.07661,-0.032424,0,0
7,GO RESPONSE TO MAGNESIUM ION,0.37932,0.076489,0.10667,0,0
7,GO POSITIVE REGULATION OF VASCULOGENESIS,0.27999,0.076351,0.069737,0,0
7,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.32506,0.07632,0.13458,0,0
7,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.5726,0.075986,-0.014275,0,0
7,GO ROOF OF MOUTH DEVELOPMENT,0.053746,0.075969,0.11213,0,0
7,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.084046,0.075858,0.076967,0,0
7,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.099158,0.075748,0.092817,0,0
7,GO NEGATIVE REGULATION OF DNA BINDING,0.13355,0.075733,0.075622,0,0
7,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.98255,0.075618,-0.02581,0,0
7,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.5726,0.075404,0.002368,0,0
7,GO REGULATION OF LYASE ACTIVITY,0.30815,0.075338,0.058814,0,0
7,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.33373,0.074955,0.081085,0,0
7,GO PIRNA METABOLIC PROCESS,0.1313,0.0748,0.11989,0,0
7,GO DENTATE GYRUS DEVELOPMENT,0.76948,0.074795,-0.006193,0,0
7,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.084046,0.074751,0.068079,0,0
7,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.21256,0.074718,0.041303,0,0
7,GO TELOMERE CAPPING,0.099158,0.074631,0.07382,0,0
7,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.14769,0.074625,0.071831,0,0
7,GO RESPONSE TO ZINC ION,0.38408,0.074607,0.026984,0,0
7,GO PROTEIN DESTABILIZATION,0.3746,0.074446,0.026879,0,0
7,GO METENCEPHALON DEVELOPMENT,0.097379,0.074141,0.094595,0,0
7,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.12049,0.074093,0.069923,0,0
7,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.15264,0.074023,0.17219,0,0
7,GO MRNA SPLICE SITE SELECTION,0.087232,0.073932,0.12193,0,0
7,GO DIGESTIVE SYSTEM DEVELOPMENT,0.2,0.073887,0.060146,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.31232,0.073746,0.04559,0,0
7,GO GAS TRANSPORT,0.4545,0.073742,0.079088,0,0
7,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.30815,0.073634,0.040521,0,0
7,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.30402,0.073612,0.069004,0,0
7,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.66501,0.073444,0.02045,0,0
7,GO RESPONSE TO VITAMIN A,0.89215,0.073303,-0.014622,0,0
7,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.31653,0.073268,0.073802,0,0
7,GO INHIBITORY SYNAPSE ASSEMBLY,0.19695,0.073259,0.15015,0,0
7,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.25001,0.073151,0.11571,0,0
7,GO REGULATION OF CENTRIOLE REPLICATION,0.19095,0.07291,0.049429,0,0
7,GO CATECHOLAMINE SECRETION,0.049546,0.07291,0.22022,0,0
7,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.080955,0.072891,0.11341,0,0
7,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.26098,0.07288,0.056581,0,0
7,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.11841,0.072786,0.085952,0,0
7,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.15517,0.072755,0.10303,0,0
7,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.25001,0.072754,0.063777,0,0
7,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.60883,0.07271,0.071263,0,0
7,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.90599,0.072505,-0.01687,0,0
7,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.38888,0.072453,0.041424,0,0
7,GO MUSCLE FILAMENT SLIDING,0.72969,0.072426,0.011618,0,0
7,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.4978,0.072328,0.035973,0,0
7,GO BIOMINERALIZATION,0.093897,0.072227,0.073182,0,0
7,GO LIPID DROPLET ORGANIZATION,0.27999,0.072132,0.031487,0,0
7,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.11636,0.072029,0.14581,0,0
7,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.36526,0.071941,0.014856,0,0
7,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.072231,0.071727,0.09719,0,0
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.097379,0.071665,0.10604,0,0
7,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.23245,0.071496,0.064652,0,0
7,GO CELLULAR HORMONE METABOLIC PROCESS,0.33373,0.071357,0.026912,0,0
7,GO DORSAL SPINAL CORD DEVELOPMENT,0.072231,0.071127,0.21352,0,0
7,GO RESPONSE TO COPPER ION,0.91293,0.071126,-0.045153,0,0
7,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.15264,0.071068,0.05386,0,0
7,GO MITRAL VALVE DEVELOPMENT,0.33812,0.070963,0.033131,0,0
7,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.57857,0.070857,0.03979,0,0
7,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.76281,0.070798,0.033293,0,0
7,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.71658,0.07063,0.0010285,0,0
7,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.35607,0.070572,0.042707,0,0
7,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.19695,0.070344,0.057179,0,0
7,GO PANCREAS DEVELOPMENT,0.40843,0.070335,0.048151,0,0
7,GO REGULATION OF CELLULAR COMPONENT SIZE,0.14048,0.070139,0.041753,0,0
7,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.11039,0.070089,0.09437,0,0
7,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.29184,0.07007,0.14726,0,0
7,GO DORSAL VENTRAL PATTERN FORMATION,0.052669,0.070041,0.10869,0,0
7,GO PHAGOSOME MATURATION,0.4545,0.069926,0.012576,0,0
7,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.39858,0.069784,0.02428,0,0
7,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.40349,0.069765,0.066671,0,0
7,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.59059,0.069739,0.024345,0,0
7,GO GMP METABOLIC PROCESS,0.11841,0.06962,0.094933,0,0
7,GO SKELETAL MUSCLE ADAPTATION,0.3746,0.06961,0.075946,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.32506,0.06951,0.051534,0,0
7,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.38408,0.069424,0.024087,0,0
7,GO ENDOTHELIAL CELL MORPHOGENESIS,0.85768,0.069394,-0.002106,0,0
7,GO RESPONSE TO AXON INJURY,0.082489,0.0693,0.078609,0,0
7,GO MRNA METHYLATION,0.78962,0.069067,-0.012778,0,0
7,GO CARDIAC CELL FATE COMMITMENT,0.99651,0.069028,-0.0057008,0,0
7,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.25363,0.068765,0.065314,0,0
7,GO CATION TRANSMEMBRANE TRANSPORT,0.11434,0.068537,0.057767,0,0
7,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.4545,0.068523,0.061895,0,0
7,GO REGULATION OF URINE VOLUME,0.39858,0.068316,0.024371,0,0
7,GO IMPORT INTO CELL,0.088862,0.068277,0.080311,0,0
7,GO ENGULFMENT OF APOPTOTIC CELL,0.37932,0.068232,0.026312,0,0
7,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.30402,0.068175,0.090367,0,0
7,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.17099,0.068111,0.038443,0,0
7,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.17374,0.068073,0.11311,0,0
7,GO REGULATION OF INSULIN SECRETION,0.19393,0.068,0.055454,0,0
7,GO ANIMAL ORGAN FORMATION,0.19695,0.067977,0.069193,0,0
7,GO REGULATION OF HEART MORPHOGENESIS,0.34702,0.067844,0.087041,0,0
7,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.1313,0.067611,0.057781,0,0
7,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.56666,0.067584,0.016906,0,0
7,GO CATION TRANSPORT,0.13583,0.06753,0.047832,0,0
7,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.17934,0.067451,0.066073,0,0
7,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.24643,0.067305,0.05036,0,0
7,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.43367,0.067304,0.043167,0,0
7,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.44402,0.067147,0.063326,0,0
7,GO MEMBRANE REPOLARIZATION,0.37932,0.067132,0.067271,0,0
7,GO NEUROBLAST PROLIFERATION,0.14769,0.066794,0.12809,0,0
7,GO PEPTIDYL SERINE MODIFICATION,0.13583,0.06654,0.040541,0,0
7,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.22568,0.066525,0.050498,0,0
7,GO CELL JUNCTION ORGANIZATION,0.050569,0.066419,0.072853,0,0
7,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.69707,0.066376,0.028781,0,0
7,GO VESICLE CYTOSKELETAL TRAFFICKING,0.017549,0.066323,0.082591,0,0
7,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.38888,0.066299,0.027791,0,0
7,GO POSITIVE REGULATION OF MRNA PROCESSING,0.21579,0.066126,0.053788,0,0
7,GO RENAL VESICLE DEVELOPMENT,0.36064,0.066054,0.068757,0,0
7,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0695,0.066044,0.087156,0,0
7,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.75615,0.066044,0.0041066,0,0
7,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.95466,0.065982,-0.016822,0,0
7,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.17374,0.065835,0.028235,0,0
7,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.42855,0.065819,0.038208,0,0
7,GO VITAMIN METABOLIC PROCESS,0.35607,0.065706,0.026444,0,0
7,GO PLATELET MORPHOGENESIS,0.69707,0.065652,0.020627,0,0
7,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.63978,0.065476,0.071443,0,0
7,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.12908,0.065435,0.067894,0,0
7,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.49227,0.065105,0.054218,0,0
7,GO TAXIS,0.13583,0.064987,0.049228,0,0
7,GO RESPONSE TO CALCIUM ION,0.070855,0.064395,0.079764,0,0
7,GO RESPONSE TO NITRIC OXIDE,0.4978,0.064349,0.0083438,0,0
7,GO PROTEIN AUTOPHOSPHORYLATION,0.31232,0.064346,0.036481,0,0
7,GO MITOTIC SPINDLE ORGANIZATION,0.17099,0.064222,0.044716,0,0
7,GO COBALAMIN METABOLIC PROCESS,0.082489,0.064017,0.097387,0,0
7,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.29184,0.063999,0.040084,0,0
7,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.70355,0.063917,-0.0054463,0,0
7,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.64605,0.063897,0.029851,0,0
7,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.21579,0.063829,0.052875,0,0
7,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.95466,0.063778,-0.046147,0,0
7,GO HEART GROWTH,0.18508,0.06377,0.04884,0,0
7,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.36064,0.063652,0.093901,0,0
7,GO AMYLOID BETA FORMATION,0.35153,0.063537,0.060877,0,0
7,GO RESPONSE TO ORGANOPHOSPHORUS,0.16032,0.063525,0.0391,0,0
7,GO REGIONALIZATION,0.090515,0.063506,0.071779,0,0
7,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.37932,0.063338,0.055074,0,0
7,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.2,0.063302,0.063549,0,0
7,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.24643,0.063242,0.059357,0,0
7,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.18219,0.063156,0.11176,0,0
7,GO ESTABLISHMENT OF CELL POLARITY,0.74288,0.063074,0.0069713,0,0
7,GO NEURON MATURATION,0.16559,0.063026,0.10922,0,0
7,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.72313,0.062861,-0.021402,0,0
7,GO REGULATION OF MRNA BINDING,0.79636,0.062704,-0.002378,0,0
7,GO MUSCLE FIBER DEVELOPMENT,0.73628,0.062286,-0.0070292,0,0
7,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.67137,0.06209,0.042695,0,0
7,GO DENDRITIC CELL DIFFERENTIATION,0.50337,0.06199,0.034876,0,0
7,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.50896,0.061979,0.018202,0,0
7,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.38888,0.06182,0.025915,0,0
7,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.073629,0.061812,0.069862,0,0
7,GO ORGANELLE MEMBRANE FUSION,0.71658,0.061812,0.0037854,0,0
7,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.099158,0.06176,0.030005,0,0
7,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.65234,0.061748,0.015482,0,0
7,GO OOCYTE MATURATION,0.15264,0.061618,0.082493,0,0
7,GO MESODERM MORPHOGENESIS,0.56666,0.06153,0.024666,0,0
7,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.20937,0.061527,0.080348,0,0
7,GO REGULATION OF MICROVILLUS ORGANIZATION,0.78962,0.061481,0.048726,0,0
7,GO BASEMENT MEMBRANE ASSEMBLY,0.44924,0.061445,0.050225,0,0
7,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.81668,0.061372,-0.021344,0,0
7,GO FORMATION OF PRIMARY GERM LAYER,0.71006,0.061367,-0.013505,0,0
7,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.28785,0.061315,0.048061,0,0
7,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.60883,0.061296,0.021955,0,0
7,GO CARDIOBLAST PROLIFERATION,0.76281,0.061284,-0.011509,0,0
7,GO T CELL HOMEOSTASIS,0.83713,0.061276,-0.00087427,0,0
7,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.33812,0.061272,0.053447,0,0
7,GO CELLULAR RESPONSE TO DRUG,0.76281,0.061173,0.0058412,0,0
7,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.34702,0.061138,0.013408,0,0
7,GO SNORNA 3 END PROCESSING,0.40843,0.061053,0.055974,0,0
7,GO ANATOMICAL STRUCTURE REGRESSION,0.44402,0.060982,0.1035,0,0
7,GO STEROID CATABOLIC PROCESS,0.16828,0.060933,0.079522,0,0
7,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.17374,0.060931,0.095292,0,0
7,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.40349,0.060866,0.0057909,0,0
7,GO REGULATION OF AMINO ACID TRANSPORT,0.26847,0.060719,0.079029,0,0
7,GO FEMALE GAMETE GENERATION,0.14526,0.060653,0.052466,0,0
7,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.51459,0.060557,0.061384,0,0
7,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.10654,0.060543,0.055594,0,0
7,GO REGULATION OF CAMP MEDIATED SIGNALING,0.33812,0.060378,0.046118,0,0
7,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.8303,0.060256,-0.051939,0,0
7,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.38888,0.060194,2.87e-05,0,0
7,GO RESPONSE TO REDOX STATE,0.54321,0.060136,0.023684,0,0
7,GO REGULATION OF SYSTEM PROCESS,0.12908,0.060132,0.053481,0,0
7,GO CELLULAR RESPONSE TO CADMIUM ION,0.94073,0.059936,-0.058521,0,0
7,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.11636,0.059935,0.14268,0,0
7,GO METAL ION TRANSPORT,0.15773,0.059911,0.040894,0,0
7,GO NEURON REMODELING,0.41341,0.059714,0.082531,0,0
7,GO SPINAL CORD DEVELOPMENT,0.053746,0.059701,0.093207,0,0
7,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.26471,0.05967,0.046584,0,0
7,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.65234,0.059652,-0.077849,0,0
7,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.11434,0.059479,0.11576,0,0
7,GO LABYRINTHINE LAYER DEVELOPMENT,0.43367,0.059474,0.060131,0,0
7,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.13814,0.059473,0.060391,0,0
7,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.2839,0.059301,0.056887,0,0
7,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.093897,0.059121,0.069951,0,0
7,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.26847,0.059079,0.049728,0,0
7,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.95466,0.05889,-0.023381,0,0
7,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.78289,0.058845,-0.04201,0,0
7,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.10654,0.05881,0.053919,0,0
7,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.17934,0.058624,0.094895,0,0
7,GO PIGMENT ACCUMULATION,0.86455,0.058353,-0.0048586,0,0
7,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.54903,0.058293,-0.0055947,0,0
7,GO MEMBRANE HYPERPOLARIZATION,0.24643,0.058289,0.12823,0,0
7,GO SPERM AXONEME ASSEMBLY,0.55487,0.058284,0.040576,0,0
7,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.22235,0.057848,0.046033,0,0
7,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.099158,0.057585,0.067454,0,0
7,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.46512,0.057532,0.097122,0,0
7,GO REPRODUCTIVE BEHAVIOR,0.32938,0.057366,0.058941,0,0
7,GO REGULATION OF CELL MATURATION,0.52594,0.057308,0.044462,0,0
7,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.30815,0.057079,0.053169,0,0
7,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.39371,0.057024,0.043131,0,0
7,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.28785,0.056844,0.08193,0,0
7,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.38888,0.056518,0.063972,0,0
7,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.38888,0.056507,0.049309,0,0
7,GO REGULATION OF NEUROBLAST PROLIFERATION,0.65866,0.05643,0.04154,0,0
7,GO REGULATION OF SECRETION,0.075049,0.056379,0.047032,0,0
7,GO COLLATERAL SPROUTING,0.30815,0.056296,0.10036,0,0
7,GO GDP METABOLIC PROCESS,0.090515,0.056169,0.17714,0,0
7,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.049546,0.056034,0.056361,0,0
7,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.71658,0.055951,0.014943,0,0
7,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.38888,0.055893,0.049656,0,0
7,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.25001,0.055714,0.10069,0,0
7,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.50896,0.055637,0.040153,0,0
7,GO CARDIAC SEPTUM MORPHOGENESIS,0.32077,0.055343,0.069223,0,0
7,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.94073,0.055214,-0.037067,0,0
7,GO MODIFIED AMINO ACID TRANSPORT,0.024288,0.055174,0.11772,0,0
7,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.21579,0.055142,0.029381,0,0
7,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.064293,0.055122,0.0706,0,0
7,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.12259,0.054921,0.082941,0,0
7,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.36991,0.05489,0.031594,0,0
7,GO SUBSTANTIA NIGRA DEVELOPMENT,0.11841,0.054887,0.086952,0,0
7,GO CELL GROWTH,0.22235,0.054869,0.029341,0,0
7,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.14285,0.054852,0.03214,0,0
7,GO CORPUS CALLOSUM DEVELOPMENT,0.7495,0.054842,-0.029302,0,0
7,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.69061,0.054818,0.014679,0,0
7,GO RESPONSE TO PROSTAGLANDIN E,0.63354,0.054692,0.011502,0,0
7,GO EXPORT ACROSS PLASMA MEMBRANE,0.088862,0.054574,0.12459,0,0
7,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.75615,0.054506,0.027516,0,0
7,GO NEGATIVE CHEMOTAXIS,0.61497,0.054485,0.0073893,0,0
7,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.16294,0.054444,0.052914,0,0
7,GO PHOSPHATE ION TRANSPORT,0.21579,0.054281,0.057909,0,0
7,GO ADRENAL GLAND DEVELOPMENT,0.22235,0.054274,0.1125,0,0
7,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.10654,0.054228,0.073474,0,0
7,GO POSITIVE REGULATION OF NEURON DEATH,0.1028,0.054215,0.060476,0,0
7,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.96163,0.054143,-0.036661,0,0
7,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.81668,0.054102,-0.016236,0,0
7,GO REGULATION OF CELL FATE SPECIFICATION,0.10654,0.054083,0.15167,0,0
7,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.2839,0.053798,0.083203,0,0
7,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.56666,0.053785,0.0096027,0,0
7,GO GASTRULATION WITH MOUTH FORMING SECOND,0.34702,0.053595,0.069946,0,0
7,GO ORGANIC CATION TRANSPORT,0.18508,0.053481,0.065185,0,0
7,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.14048,0.053417,0.042985,0,0
7,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.49227,0.053329,0.011406,0,0
7,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.12908,0.053302,0.080202,0,0
7,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.46512,0.053298,0.033391,0,0
7,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.04854,0.053294,0.050699,0,0
7,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.14769,0.053124,0.059656,0,0
7,GO REGULATION OF MEMBRANE REPOLARIZATION,0.57857,0.053093,0.018718,0,0
7,GO CARDIAC SEPTUM DEVELOPMENT,0.32938,0.052941,0.040895,0,0
7,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.17653,0.052268,0.052706,0,0
7,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.11039,0.052146,0.053385,0,0
7,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.29586,0.051989,0.027618,0,0
7,GO SINGLE STRAND BREAK REPAIR,0.77618,0.051976,0.0090934,0,0
7,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.23937,0.051964,0.068655,0,0
7,GO CEREBRAL CORTEX DEVELOPMENT,0.082489,0.051844,0.077135,0,0
7,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.91987,0.051815,-0.042225,0,0
7,GO HISTONE H3 K4 METHYLATION,0.24643,0.05169,0.051119,0,0
7,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.27999,0.051526,0.030679,0,0
7,GO DIGESTIVE TRACT MORPHOGENESIS,0.43367,0.051511,0.038964,0,0
7,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.23245,0.051463,0.035725,0,0
7,GO REGULATION OF CELL CYCLE CHECKPOINT,0.5726,0.051443,0.01481,0,0
7,GO RRNA METHYLATION,0.29184,0.051303,0.05737,0,0
7,GO APPENDAGE DEVELOPMENT,0.17653,0.051276,0.0746,0,0
7,GO SIGNAL PEPTIDE PROCESSING,0.56075,0.051237,0.048092,0,0
7,GO SINGLE FERTILIZATION,0.29992,0.051125,0.034369,0,0
7,GO CELLULAR RESPONSE TO DSRNA,0.79636,0.051122,-0.068869,0,0
7,GO T CELL CHEMOTAXIS,0.78962,0.051114,-0.035584,0,0
7,GO RECEPTOR METABOLIC PROCESS,0.50896,0.051062,0.025973,0,0
7,GO HEXOSE CATABOLIC PROCESS,0.59059,0.051016,0.030171,0,0
7,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.36064,0.050896,0.08025,0,0
7,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.13583,0.050858,0.10736,0,0
7,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.36526,0.050848,0.056687,0,0
7,GO POSITIVE REGULATION OF HORMONE SECRETION,0.31232,0.050843,0.046422,0,0
7,GO RRNA CATABOLIC PROCESS,0.96163,0.050676,-0.011845,0,0
7,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.42347,0.050672,0.051569,0,0
7,GO DETECTION OF LIGHT STIMULUS,0.20937,0.05063,0.023425,0,0
7,GO ECTODERM DEVELOPMENT,0.40843,0.050515,0.023802,0,0
7,GO REGULATION OF MYELINATION,0.16559,0.050365,0.07203,0,0
7,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.15264,0.050339,0.10734,0,0
7,GO REGULATION OF PROTEIN ACETYLATION,0.30815,0.050306,0.028713,0,0
7,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.31653,0.0502,0.16399,0,0
7,GO ACTIN CROSSLINK FORMATION,0.33812,0.050151,0.09664,0,0
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.56666,0.05011,0.013325,0,0
7,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.43883,0.050107,0.045627,0,0
7,GO CELL DIFFERENTIATION IN SPINAL CORD,0.13814,0.050031,0.099735,0,0
7,GO NUCLEOSOME ORGANIZATION,0.54321,0.049849,0.018976,0,0
7,GO PROTEIN LOCALIZATION TO LYSOSOME,0.26471,0.04976,0.054347,0,0
7,GO INTRA S DNA DAMAGE CHECKPOINT,0.32938,0.049686,0.036694,0,0
7,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.83713,0.049652,-0.064687,0,0
7,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.88523,0.049493,-0.027262,0,0
7,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.23937,0.04941,0.10702,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.1313,0.049368,0.058427,0,0
7,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.24643,0.049205,0.050174,0,0
7,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.49227,0.049136,0.036423,0,0
7,GO SULFATION,0.25363,0.049096,0.089767,0,0
7,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.5726,0.049058,0.057871,0,0
7,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.15015,0.048933,0.062151,0,0
7,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.32506,0.048783,0.030231,0,0
7,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.32938,0.048732,0.04845,0,0
7,GO ORGAN INDUCTION,0.65234,0.048522,0.046925,0,0
7,GO B CELL HOMEOSTASIS,0.23245,0.048512,0.064752,0,0
7,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.76281,0.048479,0.0029575,0,0
7,GO MONOVALENT INORGANIC CATION TRANSPORT,0.12689,0.04819,0.065783,0,0
7,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.58456,0.048098,0.030448,0,0
7,GO SENSORY SYSTEM DEVELOPMENT,0.075049,0.048085,0.064916,0,0
7,GO OOGENESIS,0.13355,0.048033,0.090156,0,0
7,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.27227,0.048016,0.049145,0,0
7,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.56075,0.04778,0.008899,0,0
7,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.22568,0.047692,0.042879,0,0
7,GO POSITIVE REGULATION OF INSULIN SECRETION,0.52594,0.047686,0.019175,0,0
7,GO PROTEIN COMPLEX OLIGOMERIZATION,0.53167,0.047631,0.017769,0,0
7,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.47049,0.047567,0.06163,0,0
7,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.67137,0.047549,0.020323,0,0
7,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.22568,0.047414,0.040245,0,0
7,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.29586,0.047408,0.13145,0,0
7,GO EPITHELIAL CELL MATURATION,0.43883,0.047401,0.090411,0,0
7,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.061812,0.047401,0.044847,0,0
7,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.50896,0.04735,0.034805,0,0
7,GO RESPONSE TO WATER,0.62732,0.04725,0.047987,0,0
7,GO CRANIAL NERVE MORPHOGENESIS,0.41842,0.047157,0.095739,0,0
7,GO REGULATION OF DEPHOSPHORYLATION,0.087232,0.047006,0.04348,0,0
7,GO RESPONSE TO ALCOHOL,0.62113,0.046817,0.016449,0,0
7,GO PEPTIDE HORMONE SECRETION,0.27227,0.046679,0.056318,0,0
7,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.28785,0.046637,0.049409,0,0
7,GO FOREBRAIN MORPHOGENESIS,0.90599,0.046631,0.0010344,0,0
7,GO INTERLEUKIN 12 PRODUCTION,0.52594,0.046495,0.022048,0,0
7,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.81668,0.046363,-0.038698,0,0
7,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.57857,0.046304,0.019983,0,0
7,GO FIBROBLAST MIGRATION,0.41842,0.046273,0.0067277,0,0
7,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.188,0.04627,0.166,0,0
7,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.31653,0.046266,0.019632,0,0
7,GO NUCLEOSOME ASSEMBLY,0.56075,0.046054,0.027141,0,0
7,GO REGULATION OF RIBOSOME BIOGENESIS,0.65234,0.045983,-0.081794,0,0
7,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.64605,0.045934,0.048996,0,0
7,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.32938,0.045926,0.013468,0,0
7,GO SPINAL CORD PATTERNING,0.2839,0.045824,0.12662,0,0
7,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.69707,0.045749,0.010541,0,0
7,GO SENSORY PERCEPTION,0.14526,0.045736,0.039458,0,0
7,GO LEFT RIGHT PATTERN FORMATION,0.58456,0.045735,0.033074,0,0
7,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.16828,0.04572,0.057886,0,0
7,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.27999,0.045719,0.063264,0,0
7,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.83713,0.045718,-0.061595,0,0
7,GO CELL FATE SPECIFICATION,0.50896,0.045701,0.049252,0,0
7,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.65866,0.045682,0.0091319,0,0
7,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.50337,0.045663,0.007814,0,0
7,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.39371,0.045653,0.039561,0,0
7,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.33373,0.045542,0.043576,0,0
7,GO DETECTION OF TEMPERATURE STIMULUS,0.56075,0.045499,0.054758,0,0
7,GO RESPONSE TO CARBOHYDRATE,0.29184,0.045493,0.020061,0,0
7,GO DEFINITIVE HEMOPOIESIS,0.60883,0.04549,0.047045,0,0
7,GO POSITIVE REGULATION OF CHEMOTAXIS,0.52594,0.045214,0.014305,0,0
7,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.47588,0.045093,0.017936,0,0
7,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.85768,0.045084,0.0028685,0,0
7,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.38888,0.045021,0.035138,0,0
7,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.2,0.044974,0.050621,0,0
7,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.95466,0.044915,0.027161,0,0
7,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.11434,0.044897,0.11857,0,0
7,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.70355,0.044888,0.0024609,0,0
7,GO T CELL APOPTOTIC PROCESS,0.38408,0.044878,-0.067921,0,0
7,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.69707,0.044808,0.019276,0,0
7,GO REGULATION OF CHEMOTAXIS,0.27999,0.044799,0.032799,0,0
7,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.16828,0.044768,0.10391,0,0
7,GO PSEUDOURIDINE SYNTHESIS,0.73628,0.044725,0.0028117,0,0
7,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.62732,0.044721,0.016433,0,0
7,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.94073,0.044614,-0.015973,0,0
7,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.94073,0.044605,-0.0096668,0,0
7,GO RNA POLYADENYLATION,0.94769,0.044528,-0.011079,0,0
7,GO MITOTIC RECOMBINATION,0.97557,0.04434,-0.0095589,0,0
7,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.13355,0.044265,0.075676,0,0
7,GO NEURAL PRECURSOR CELL PROLIFERATION,0.10096,0.044232,0.087945,0,0
7,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.36526,0.044183,0.065551,0,0
7,GO REGULATION OF EXOSOMAL SECRETION,0.90599,0.044182,-0.014598,0,0
7,GO AMINO ACID TRANSPORT,0.188,0.044085,0.047076,0,0
7,GO PULMONARY VALVE DEVELOPMENT,0.37932,0.044076,0.11025,0,0
7,GO RESPONSE TO MONOSACCHARIDE,0.30815,0.044073,0.0203,0,0
7,GO PLATELET ACTIVATION,0.93377,0.044019,-0.0066278,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.88523,0.04391,-0.046764,0,0
7,GO RESPONSE TO MISFOLDED PROTEIN,0.22235,0.043884,0.076222,0,0
7,GO REGULATION OF CELL DIVISION,0.12473,0.043844,0.042954,0,0
7,GO MESONEPHROS DEVELOPMENT,0.44402,0.043806,0.041411,0,0
7,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.21579,0.043783,0.020984,0,0
7,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.85082,0.043759,-0.018194,0,0
7,GO MEMBRANE DOCKING,0.097379,0.043629,0.051732,0,0
7,GO PROTEIN HOMOOLIGOMERIZATION,0.44924,0.043521,0.019249,0,0
7,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.86455,0.043518,-0.024882,0,0
7,GO NCRNA CATABOLIC PROCESS,0.8303,0.043355,-0.019905,0,0
7,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.89907,0.043354,-0.012114,0,0
7,GO PEPTIDYL HISTIDINE MODIFICATION,0.91987,0.043312,-0.013186,0,0
7,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.47588,0.04331,0.045398,0,0
7,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.91987,0.043272,-0.039481,0,0
7,GO PROTEIN LOCALIZATION TO VACUOLE,0.52594,0.043226,0.01471,0,0
7,GO MEMBRANE INVAGINATION,0.39858,0.043144,0.030559,0,0
7,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.30815,0.042983,0.065396,0,0
7,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.47588,0.042882,0.020632,0,0
7,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.29586,0.04278,0.037481,0,0
7,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.31232,0.04253,0.047517,0,0
7,GO REGULATION OF HORMONE SECRETION,0.33812,0.042528,0.033865,0,0
7,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.63354,0.042436,0.0005261,0,0
7,GO DENDRITIC TRANSPORT,0.31653,0.042351,0.10197,0,0
7,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.54321,0.042327,0.027727,0,0
7,GO ION TRANSPORT,0.22568,0.042242,0.031585,0,0
7,GO REGULATION OF GTPASE ACTIVITY,0.35153,0.042196,0.028705,0,0
7,GO PROTEIN AUTO ADP RIBOSYLATION,0.47049,0.042185,0.0085856,0,0
7,GO REGULATION OF ENDOCRINE PROCESS,0.94073,0.042102,0.0011439,0,0
7,GO REGULATION OF T CELL CHEMOTAXIS,0.96163,0.042039,-0.017203,0,0
7,GO OSTEOBLAST DIFFERENTIATION,0.35607,0.042027,0.020725,0,0
7,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.27611,0.042012,0.038492,0,0
7,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.40843,0.042,0.051417,0,0
7,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.89907,0.041972,-0.037842,0,0
7,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.59664,0.041921,0.022754,0,0
7,GO MITOTIC DNA REPLICATION,0.80989,0.041874,-0.028075,0,0
7,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.56075,0.041862,0.012622,0,0
7,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.76948,0.041602,0.020013,0,0
7,GO REGULATION OF ACTIN NUCLEATION,0.42855,0.0415,0.017388,0,0
7,GO REGULATION OF ORGANELLE ORGANIZATION,0.15264,0.041441,0.023467,0,0
7,GO SODIUM ION HOMEOSTASIS,0.71006,0.041312,0.011002,0,0
7,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.22568,0.041253,0.067131,0,0
7,GO PROTEIN KINASE A SIGNALING,0.4598,0.04122,0.034997,0,0
7,GO NEUROTROPHIN SIGNALING PATHWAY,0.71658,0.041186,0.028924,0,0
7,GO REGULATION OF OSSIFICATION,0.29992,0.041158,0.046052,0,0
7,GO INTERFERON GAMMA PRODUCTION,0.65234,0.041125,-0.0017401,0,0
7,GO TRNA 5 LEADER REMOVAL,0.53167,0.041044,0.027692,0,0
7,GO REGULATION OF NEUTROPHIL MIGRATION,0.93377,0.040983,-0.034584,0,0
7,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.25001,0.040961,0.079692,0,0
7,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.97557,0.040895,-0.037795,0,0
7,GO PHOTOTRANSDUCTION,0.23245,0.040873,0.027507,0,0
7,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.13355,0.040812,0.13496,0,0
7,GO REGULATION OF MEIOTIC CELL CYCLE,0.12689,0.040765,0.062904,0,0
7,GO NEGATIVE REGULATION OF COAGULATION,0.67776,0.040724,-0.098634,0,0
7,GO MYELOID CELL DEVELOPMENT,0.4598,0.0407,0.032291,0,0
7,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.52594,0.040654,0.021559,0,0
7,GO BLASTOCYST GROWTH,0.81668,0.040615,0.043826,0,0
7,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.15264,0.040546,0.036908,0,0
7,GO REGULATION OF SPROUTING ANGIOGENESIS,0.62732,0.040491,-0.035394,0,0
7,GO REGULATION OF ENDOCYTIC RECYCLING,0.39858,0.040472,0.11784,0,0
7,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.81668,0.040464,-0.021294,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.56075,0.040457,0.00092648,0,0
7,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.1313,0.040418,0.053103,0,0
7,GO HISTONE H3 DEACETYLATION,0.42347,0.040417,-0.034808,0,0
7,GO TELOMERE ORGANIZATION,0.76281,0.040402,-0.00059783,0,0
7,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.62113,0.040281,0.0057847,0,0
7,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.82348,0.040249,0.013763,0,0
7,GO ATP TRANSPORT,0.56075,0.040238,0.026067,0,0
7,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.44924,0.040204,0.058525,0,0
7,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.95466,0.040178,-0.015782,0,0
7,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.13583,0.040142,0.031562,0,0
7,GO HISTONE PHOSPHORYLATION,0.8303,0.040125,0.0041636,0,0
7,GO KIDNEY MORPHOGENESIS,0.76948,0.040105,0.0082862,0,0
7,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.14048,0.040099,0.1046,0,0
7,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.85768,0.040093,-0.01182,0,0
7,GO PROTEIN TARGETING TO VACUOLE,0.83713,0.040066,-0.045924,0,0
7,GO ACTIVATED T CELL PROLIFERATION,0.53167,0.040051,0.031254,0,0
7,GO EMBRYONIC AXIS SPECIFICATION,0.27227,0.040037,0.078751,0,0
7,GO SPHINGOMYELIN METABOLIC PROCESS,0.84397,0.039968,-0.013776,0,0
7,GO RUFFLE ASSEMBLY,0.30402,0.039943,0.043808,0,0
7,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.66501,0.039864,-0.062345,0,0
7,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.68418,0.039822,0.025346,0,0
7,GO CHRONIC INFLAMMATORY RESPONSE,0.33812,0.039797,0.028316,0,0
7,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.35153,0.039739,0.034642,0,0
7,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.41341,0.03967,0.059274,0,0
7,GO NUCLEOTIDE TRANSPORT,0.85082,0.039669,0.0028248,0,0
7,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.53167,0.039585,0.014654,0,0
7,GO HEAT GENERATION,0.27227,0.03956,0.080333,0,0
7,GO ION TRANSMEMBRANE TRANSPORT,0.19393,0.03953,0.04119,0,0
7,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.89907,0.039528,0.0060118,0,0
7,GO EXIT FROM MITOSIS,0.17374,0.039386,0.074745,0,0
7,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.62113,0.039313,0.012365,0,0
7,GO RRNA MODIFICATION,0.23589,0.039209,0.06673,0,0
7,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.87833,0.039176,-0.08518,0,0
7,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.89215,0.039162,-0.05356,0,0
7,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.51459,0.03909,0.022085,0,0
7,GO CARDIAC VENTRICLE DEVELOPMENT,0.31232,0.039073,0.042416,0,0
7,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.42347,0.038878,0.023256,0,0
7,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.55487,0.038813,0.014195,0,0
7,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.9686,0.038717,-0.019143,0,0
7,GO ENSHEATHMENT OF NEURONS,0.43883,0.038682,0.033778,0,0
7,GO HORMONE TRANSPORT,0.44402,0.038595,0.029525,0,0
7,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.76281,0.038592,-0.014736,0,0
7,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.62113,0.038571,0.025504,0,0
7,GO MICROTUBULE NUCLEATION,0.60272,0.038521,0.018152,0,0
7,GO REGULATION OF MUSCLE ADAPTATION,0.98255,0.038377,-0.013807,0,0
7,GO CYTOSKELETON ORGANIZATION,0.188,0.038332,0.030673,0,0
7,GO REGULATION OF HEAT GENERATION,0.27999,0.038292,0.11891,0,0
7,GO REGULATION OF METAL ION TRANSPORT,0.35153,0.038233,0.030655,0,0
7,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.87833,0.038194,0.0026484,0,0
7,GO REGULATION OF MRNA POLYADENYLATION,0.14048,0.038106,0.07471,0,0
7,GO DETECTION OF ABIOTIC STIMULUS,0.40843,0.038032,0.031198,0,0
7,GO REGULATION OF SPINDLE CHECKPOINT,0.74288,0.037957,-0.047991,0,0
7,GO REGULATION OF PLASMINOGEN ACTIVATION,0.81668,0.037951,-0.15112,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.54903,0.037934,0.0089038,0,0
7,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.40843,0.037855,0.019417,0,0
7,GO POSITIVE REGULATION OF GROWTH,0.19695,0.037832,0.036017,0,0
7,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.44402,0.037756,0.018029,0,0
7,GO NEURON FATE COMMITMENT,0.64605,0.037733,0.065577,0,0
7,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.60883,0.037691,0.011358,0,0
7,GO REGULATION OF CELL SIZE,0.23245,0.037635,0.040555,0,0
7,GO GLUTAMATE METABOLIC PROCESS,0.2839,0.0376,0.053292,0,0
7,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.42347,0.037532,0.022365,0,0
7,GO VITAMIN D BIOSYNTHETIC PROCESS,0.92682,0.037527,-0.091974,0,0
7,GO LYMPHOCYTE COSTIMULATION,0.5726,0.037422,0.019396,0,0
7,GO EXECUTION PHASE OF APOPTOSIS,0.5726,0.037355,0.0022845,0,0
7,GO CELLULAR RESPONSE TO AMYLOID BETA,0.4598,0.037312,0.050147,0,0
7,GO PEPTIDYL CYSTEINE MODIFICATION,0.43883,0.037135,0.030469,0,0
7,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.72313,0.037032,-0.0014617,0,0
7,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.65234,0.036986,0.038445,0,0
7,GO POSITIVE REGULATION OF CELL GROWTH,0.13583,0.036925,0.041409,0,0
7,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.55487,0.03673,-0.043356,0,0
7,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.62732,0.036711,-0.13997,0,0
7,GO DEVELOPMENTAL GROWTH,0.188,0.036695,0.037355,0,0
7,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.82348,0.036526,-0.012348,0,0
7,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.88523,0.036406,0.010041,0,0
7,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.46512,0.036338,0.036546,0,0
7,GO CGMP METABOLIC PROCESS,0.70355,0.036336,0.024091,0,0
7,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.74288,0.036263,-0.036286,0,0
7,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.11235,0.03622,0.088627,0,0
7,GO FEAR RESPONSE,0.32938,0.036022,0.048364,0,0
7,GO BILE ACID METABOLIC PROCESS,0.58456,0.0359,0.020732,0,0
7,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.41842,0.035868,0.03378,0,0
7,GO REGULATION OF TOLERANCE INDUCTION,0.26471,0.035789,0.086911,0,0
7,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.50337,0.035781,0.0016788,0,0
7,GO SPINDLE ORGANIZATION,0.19393,0.035658,0.033069,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.65866,0.035612,0.046339,0,0
7,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.34256,0.035482,0.071222,0,0
7,GO COCHLEA DEVELOPMENT,0.35153,0.035452,0.078298,0,0
7,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.70355,0.035449,-0.017414,0,0
7,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.55487,0.035314,-0.1112,0,0
7,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.17653,0.035149,0.071391,0,0
7,GO REGULATION OF HISTONE UBIQUITINATION,0.65234,0.035024,-0.0031594,0,0
7,GO PROTEIN NITROSYLATION,0.70355,0.034971,0.012082,0,0
7,GO MEMBRANE FUSION,0.71006,0.034922,0.0062109,0,0
7,GO BODY MORPHOGENESIS,0.57857,0.03486,0.019062,0,0
7,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.41341,0.03486,0.054468,0,0
7,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.48678,0.034848,0.09565,0,0
7,GO PROSTAGLANDIN SECRETION,0.90599,0.034839,-0.02285,0,0
7,GO ERYTHROCYTE DEVELOPMENT,0.94073,0.034719,-0.0023763,0,0
7,GO INTRACILIARY RETROGRADE TRANSPORT,0.30402,0.034672,0.099215,0,0
7,GO ENDOSOMAL TRANSPORT,0.17099,0.034651,0.02783,0,0
7,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.32938,0.034616,0.054421,0,0
7,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.38888,0.034613,0.023129,0,0
7,GO IMMUNOGLOBULIN SECRETION,0.76948,0.034611,-0.010402,0,0
7,GO AMYLOID BETA CLEARANCE,0.8303,0.034549,-0.061971,0,0
7,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.2839,0.034465,0.085502,0,0
7,GO REGULATION OF CELLULAR LOCALIZATION,0.16294,0.034307,0.029832,0,0
7,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.97557,0.034247,-0.032815,0,0
7,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.79636,0.034236,0.016465,0,0
7,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.53167,0.0342,0.030585,0,0
7,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.72969,0.034074,0.0030467,0,0
7,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.85082,0.033935,0.011082,0,0
7,GO ENDODERMAL CELL DIFFERENTIATION,0.51459,0.033931,-0.043866,0,0
7,GO METANEPHROS MORPHOGENESIS,0.14048,0.033922,0.14936,0,0
7,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.78289,0.033772,0.010617,0,0
7,GO ARACHIDONIC ACID METABOLIC PROCESS,0.8303,0.033723,-0.0086825,0,0
7,GO RESPONSE TO HYDROPEROXIDE,0.89907,0.033602,-0.024997,0,0
7,GO CELLULAR RESPONSE TO VITAMIN,0.20621,0.033571,0.10646,0,0
7,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.86455,0.033541,-0.048276,0,0
7,GO HISTONE H3 K9 ACETYLATION,0.78962,0.033213,-0.0027989,0,0
7,GO HEAD MORPHOGENESIS,0.42855,0.033123,0.049958,0,0
7,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.42855,0.033092,0.02867,0,0
7,GO HINDBRAIN DEVELOPMENT,0.15264,0.033077,0.078939,0,0
7,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.61497,0.033051,0.015366,0,0
7,GO CELL JUNCTION ASSEMBLY,0.19095,0.032999,0.052537,0,0
7,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.38888,0.032853,0.022661,0,0
7,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.89907,0.032849,-0.011375,0,0
7,GO CELLULAR OXIDANT DETOXIFICATION,0.94769,0.032846,-0.01595,0,0
7,GO ASSOCIATIVE LEARNING,0.55487,0.03277,0.037907,0,0
7,GO TRACHEA MORPHOGENESIS,0.96163,0.032751,0.023653,0,0
7,GO TOOTH MINERALIZATION,0.43367,0.032746,0.052274,0,0
7,GO OVULATION,0.79636,0.032694,-0.0044193,0,0
7,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.77618,0.03266,-0.070788,0,0
7,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.48131,0.032623,0.043585,0,0
7,GO GLUCOSE IMPORT,0.61497,0.032559,0.016942,0,0
7,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.63354,0.032544,0.0069311,0,0
7,GO RESPONSE TO AMYLOID BETA,0.19695,0.032452,0.069182,0,0
7,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.67137,0.032357,0.0066134,0,0
7,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.47588,0.032347,0.024989,0,0
7,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.59059,0.032314,0.025501,0,0
7,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.80989,0.03227,0.0074321,0,0
7,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.65234,0.032187,-0.013646,0,0
7,GO BONE DEVELOPMENT,0.61497,0.032122,0.0017214,0,0
7,GO INTERLEUKIN 4 PRODUCTION,0.68418,0.032051,-0.049545,0,0
7,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.64605,0.031992,0.032655,0,0
7,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.37932,0.031981,0.039757,0,0
7,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.4598,0.031924,0.015724,0,0
7,GO POSITIVE REGULATION OF CELL DIVISION,0.58456,0.031891,0.010625,0,0
7,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.8303,0.031841,0.0014829,0,0
7,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.3746,0.031761,0.049498,0,0
7,GO CELL CELL JUNCTION ORGANIZATION,0.91293,0.031737,0.00095955,0,0
7,GO CELL CELL ADHESION,0.49227,0.031668,0.013626,0,0
7,GO SPROUTING ANGIOGENESIS,0.64605,0.031655,0.020371,0,0
7,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.32506,0.031645,0.020461,0,0
7,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.44924,0.031606,0.017024,0,0
7,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.87833,0.031554,-0.045708,0,0
7,GO CHROMOSOME SEGREGATION,0.36991,0.031534,0.025044,0,0
7,GO DNA DOUBLE STRAND BREAK PROCESSING,0.56075,0.031526,0.036375,0,0
7,GO CIRCADIAN RHYTHM,0.23589,0.031418,0.026845,0,0
7,GO B CELL RECEPTOR SIGNALING PATHWAY,0.99651,0.031348,-0.019832,0,0
7,GO CELL DIVISION,0.40843,0.031316,0.01522,0,0
7,GO POSITIVE REGULATION OF SECRETION,0.15264,0.031285,0.038403,0,0
7,GO MESENCHYMAL CELL DIFFERENTIATION,0.38888,0.031238,0.019027,0,0
7,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.30815,0.031188,0.02499,0,0
7,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.77618,0.031132,0.032695,0,0
7,GO EYE MORPHOGENESIS,0.12689,0.031118,0.078068,0,0
7,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.53742,0.0311,0.037041,0,0
7,GO REGULATION OF PEPTIDE SECRETION,0.56075,0.031097,0.0069055,0,0
7,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.92682,0.03109,-0.02129,0,0
7,GO UV DAMAGE EXCISION REPAIR,0.87833,0.031062,0.0053255,0,0
7,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.94073,0.03087,-0.028929,0,0
7,GO ESCRT COMPLEX DISASSEMBLY,0.66501,0.030649,0.056729,0,0
7,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.65234,0.030638,0.085479,0,0
7,GO CAMERA TYPE EYE DEVELOPMENT,0.21579,0.03061,0.040215,0,0
7,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.47049,0.030576,-0.096927,0,0
7,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.92682,0.030543,0.016015,0,0
7,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.94073,0.030535,-0.034574,0,0
7,GO VIRAL RELEASE FROM HOST CELL,0.74288,0.030533,-0.0015132,0,0
7,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.19095,0.03047,0.049931,0,0
7,GO INTERLEUKIN 2 PRODUCTION,0.76281,0.030445,-0.045092,0,0
7,GO PROTEIN TARGETING TO MITOCHONDRION,0.85768,0.030286,-0.0028708,0,0
7,GO REGULATION OF TELOMERE MAINTENANCE,0.83713,0.030265,0.0024316,0,0
7,GO DIVALENT INORGANIC CATION TRANSPORT,0.38408,0.030247,0.026608,0,0
7,GO HISTONE H3 ACETYLATION,0.40843,0.030199,0.019165,0,0
7,GO RESPONSE TO NITROGEN COMPOUND,0.40349,0.030127,0.017272,0,0
7,GO ADAPTATION OF SIGNALING PATHWAY,0.31232,0.030116,0.050801,0,0
7,GO NEGATIVE REGULATION OF ION TRANSPORT,0.34256,0.030111,0.030686,0,0
7,GO INNER CELL MASS CELL PROLIFERATION,0.70355,0.030076,0.035979,0,0
7,GO LAMELLIPODIUM ASSEMBLY,0.91987,0.030053,0.0022948,0,0
7,GO V D J RECOMBINATION,0.32938,0.030045,0.078632,0,0
7,GO CELLULAR RESPONSE TO PH,0.22568,0.030004,0.051422,0,0
7,GO POSITIVE REGULATION OF HEART RATE,0.60883,0.029914,0.043413,0,0
7,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.29184,0.029873,0.0086391,0,0
7,GO CARBOHYDRATE PHOSPHORYLATION,0.92682,0.029825,0.0085134,0,0
7,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.36526,0.029738,0.0061741,0,0
7,GO CELLULAR EXTRAVASATION,0.21905,0.029665,0.05213,0,0
7,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.34256,0.029615,0.040933,0,0
7,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.80989,0.029587,-0.078021,0,0
7,GO EOSINOPHIL CHEMOTAXIS,0.58456,0.029549,0.036422,0,0
7,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.23245,0.029492,0.02952,0,0
7,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.60883,0.029408,0.030708,0,0
7,GO CELLULAR RESPONSE TO NUTRIENT,0.3746,0.029356,0.074905,0,0
7,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.47588,0.029178,0.026173,0,0
7,GO MAST CELL MIGRATION,0.55487,0.029144,0.045465,0,0
7,GO RHYTHMIC PROCESS,0.32938,0.029141,0.026945,0,0
7,GO CELL CYCLE G2 M PHASE TRANSITION,0.74288,0.029057,-0.0087276,0,0
7,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.84397,0.028974,-0.007775,0,0
7,GO NADP METABOLIC PROCESS,0.78962,0.028902,-0.005133,0,0
7,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.54321,0.028788,0.0086188,0,0
7,GO PEPTIDE SECRETION,0.26471,0.02876,0.022138,0,0
7,GO RELAXATION OF CARDIAC MUSCLE,0.4978,0.02869,0.079683,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.49227,0.02867,0.050559,0,0
7,GO CYCLOOXYGENASE PATHWAY,0.48131,0.02866,0.030954,0,0
7,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.69061,0.028645,-0.035681,0,0
7,GO HISTONE DEUBIQUITINATION,0.62113,0.028569,0.017029,0,0
7,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.44924,0.028355,0.024623,0,0
7,GO RESPONSE TO OXYGEN RADICAL,0.72313,0.028255,0.0075438,0,0
7,GO REGULATION OF DNA REPAIR,0.48131,0.028254,0.013885,0,0
7,GO FERTILIZATION,0.30402,0.028208,0.029778,0,0
7,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.37932,0.028093,0.050457,0,0
7,GO ACTIVATION OF GTPASE ACTIVITY,0.42855,0.028085,-0.031836,0,0
7,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.63354,0.027979,0.026046,0,0
7,GO POSITIVE REGULATION OF CELL MATURATION,0.62113,0.027959,-0.073929,0,0
7,GO TRNA WOBBLE BASE MODIFICATION,0.62113,0.027832,0.027899,0,0
7,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.46512,0.027827,-0.065256,0,0
7,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.62113,0.027812,0.038872,0,0
7,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.98255,0.027752,-0.025412,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.47049,0.027674,-0.093505,0,0
7,GO REGULATION OF ORGANELLE ASSEMBLY,0.25001,0.027671,0.017556,0,0
7,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.31653,0.027645,0.051798,0,0
7,GO REGULATION OF ORGAN GROWTH,0.54903,0.027639,0.025001,0,0
7,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.90599,0.027571,0.0010064,0,0
7,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.89907,0.027394,-0.015164,0,0
7,GO POSITIVE REGULATION OF DNA REPAIR,0.73628,0.027383,0.004059,0,0
7,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.43367,0.027235,0.016853,0,0
7,GO RNA STABILIZATION,0.72969,0.027094,0.042357,0,0
7,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.29586,0.027023,0.052994,0,0
7,GO REPRODUCTION,0.40843,0.026982,0.019432,0,0
7,GO RNA INTERFERENCE,0.76948,0.026969,0.012556,0,0
7,GO SCHWANN CELL DEVELOPMENT,0.69707,0.026894,0.017228,0,0
7,GO ERROR PRONE TRANSLESION SYNTHESIS,0.91293,0.026842,0.0085926,0,0
7,GO REGULATION OF MIRNA METABOLIC PROCESS,0.65234,0.026798,0.01754,0,0
7,GO ALANINE TRANSPORT,0.92682,0.026682,-0.041858,0,0
7,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.32506,0.026611,0.025617,0,0
7,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.94769,0.026587,0.00025254,0,0
7,GO RESPONSE TO GROWTH FACTOR,0.49227,0.026483,0.017698,0,0
7,GO MITOTIC CYTOKINESIS,0.17934,0.026417,0.054004,0,0
7,GO G2 DNA DAMAGE CHECKPOINT,0.74288,0.026414,0.0059301,0,0
7,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.55487,0.026338,0.026016,0,0
7,GO SEMI LUNAR VALVE DEVELOPMENT,0.76281,0.026324,0.04293,0,0
7,GO SEQUESTERING OF CALCIUM ION,0.70355,0.026292,0.022075,0,0
7,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.80989,0.026153,0.007276,0,0
7,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.54321,0.026121,0.025235,0,0
7,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.18219,0.025953,0.096731,0,0
7,GO POSITIVE REGULATION OF HEART GROWTH,0.7495,0.025937,-0.023161,0,0
7,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.62113,0.025933,0.0093592,0,0
7,GO MELANOCYTE DIFFERENTIATION,0.47588,0.025923,0.026597,0,0
7,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.95466,0.025799,-0.057614,0,0
7,GO NEGATIVE REGULATION OF CELL GROWTH,0.37932,0.02578,0.025384,0,0
7,GO SODIUM ION TRANSPORT,0.21905,0.025745,0.043959,0,0
7,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.69061,0.02574,0.017153,0,0
7,GO RESPONSE TO METAL ION,0.29992,0.025682,0.031966,0,0
7,GO HEART VALVE DEVELOPMENT,0.76281,0.02553,0.021382,0,0
7,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.84397,0.025445,0.018684,0,0
7,GO RESPONSE TO LIGHT STIMULUS,0.35607,0.025317,0.017839,0,0
7,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.52594,0.025316,0.021951,0,0
7,GO VITAMIN BIOSYNTHETIC PROCESS,0.94073,0.02527,-0.026988,0,0
7,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.76281,0.025238,-0.024888,0,0
7,GO ENDOCYTOSIS,0.7495,0.025161,0.0087958,0,0
7,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.37932,0.025108,0.038111,0,0
7,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.68418,0.025101,0.060743,0,0
7,GO NON RECOMBINATIONAL REPAIR,0.91293,0.02507,-0.008662,0,0
7,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.72313,0.025054,0.0073271,0,0
7,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.65866,0.025029,-0.0013729,0,0
7,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.81668,0.024915,-0.045046,0,0
7,GO MAINTENANCE OF CELL POLARITY,0.85082,0.024891,-0.005263,0,0
7,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.53167,0.024861,0.016181,0,0
7,GO EOSINOPHIL MIGRATION,0.65866,0.024795,0.027339,0,0
7,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.79636,0.024779,6.1125e-05,0,0
7,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.78962,0.024764,-0.0030898,0,0
7,GO MITOTIC DNA REPLICATION CHECKPOINT,0.63354,0.024683,-0.017382,0,0
7,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.7495,0.024669,-0.00097093,0,0
7,GO TRNA 5 END PROCESSING,0.65234,0.024644,0.016291,0,0
7,GO MYELOID DENDRITIC CELL ACTIVATION,0.61497,0.024611,-0.0030522,0,0
7,GO KETONE BIOSYNTHETIC PROCESS,0.51459,0.024489,0.030617,0,0
7,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.96163,0.024391,-0.009074,0,0
7,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.91293,0.024271,0.02261,0,0
7,GO REGULATION OF LEUKOCYTE MIGRATION,0.97557,0.024239,-0.03652,0,0
7,GO ORGANELLE LOCALIZATION,0.053746,0.024199,0.04057,0,0
7,GO ORGANELLE FUSION,0.77618,0.02418,0.0033476,0,0
7,GO PROTEIN SUMOYLATION,0.68418,0.024081,0.0070962,0,0
7,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4978,0.024076,0.057391,0,0
7,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.97557,0.024054,-0.023698,0,0
7,GO CIRCULATORY SYSTEM PROCESS,0.48678,0.023966,0.019317,0,0
7,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.48131,0.023851,0.085494,0,0
7,GO METANEPHRIC NEPHRON DEVELOPMENT,0.71006,0.023672,0.021016,0,0
7,GO GLYCEROLIPID CATABOLIC PROCESS,0.70355,0.023583,0.012009,0,0
7,GO PIGMENT GRANULE LOCALIZATION,0.60883,0.023531,0.056116,0,0
7,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.63354,0.023394,0.028763,0,0
7,GO RETINOL METABOLIC PROCESS,0.77618,0.023363,-0.0081547,0,0
7,GO ERBB SIGNALING PATHWAY,0.70355,0.023327,-0.039756,0,0
7,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.32506,0.023296,0.042904,0,0
7,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.25001,0.023273,0.085858,0,0
7,GO REGULATION OF HORMONE LEVELS,0.40843,0.023256,0.020595,0,0
7,GO ENDODERM FORMATION,0.61497,0.023146,-0.03792,0,0
7,GO TYPE I INTERFERON PRODUCTION,0.85768,0.023077,-0.028055,0,0
7,GO MULTICELLULAR ORGANISM REPRODUCTION,0.26847,0.022979,0.029471,0,0
7,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.52025,0.022964,0.031086,0,0
7,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.76281,0.022831,0.0027764,0,0
7,GO CHROMOSOME LOCALIZATION,0.94769,0.022694,-0.014511,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.84397,0.022665,-0.027957,0,0
7,GO LYMPHOCYTE HOMEOSTASIS,0.41341,0.022652,0.019726,0,0
7,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.63978,0.022593,-0.0029892,0,0
7,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.65866,0.02257,-0.022381,0,0
7,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.76281,0.022534,-0.024075,0,0
7,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.22568,0.022512,-0.1456,0,0
7,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.91987,0.02232,-0.00081781,0,0
7,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.43367,0.022118,0.020451,0,0
7,GO PROTEIN REFOLDING,0.88523,0.021985,-0.043043,0,0
7,GO ANDROGEN METABOLIC PROCESS,0.62732,0.021928,-0.049516,0,0
7,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.50337,0.021905,0.021853,0,0
7,GO NEGATIVE REGULATION OF DNA REPAIR,0.62732,0.021665,-0.013737,0,0
7,GO HEART TRABECULA FORMATION,0.76281,0.021598,-0.092372,0,0
7,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.13355,0.021552,0.093604,0,0
7,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.72313,0.021539,0.012664,0,0
7,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.71006,0.021522,0.028137,0,0
7,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.63354,0.021492,0.0058852,0,0
7,GO ALPHA BETA T CELL PROLIFERATION,0.85768,0.021472,-0.04471,0,0
7,GO PLATELET DEGRANULATION,0.43367,0.021471,-0.0846,0,0
7,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.68418,0.021405,0.0092507,0,0
7,GO GANGLION DEVELOPMENT,0.40843,0.021375,0.16765,0,0
7,GO RESPONSE TO TOXIC SUBSTANCE,0.22235,0.021362,0.043838,0,0
7,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.96163,0.021342,-0.048759,0,0
7,GO STRIATED MUSCLE CELL PROLIFERATION,0.65866,0.021279,0.010355,0,0
7,GO APPENDAGE MORPHOGENESIS,0.24288,0.021247,0.075201,0,0
7,GO CARBOHYDRATE HOMEOSTASIS,0.48678,0.021224,0.014404,0,0
7,GO AUTOPHAGY OF NUCLEUS,0.4978,0.021205,-0.067276,0,0
7,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.69707,0.02118,0.006769,0,0
7,GO STRIATED MUSCLE CONTRACTION,0.22905,0.021174,0.055371,0,0
7,GO REGULATION OF BONE REMODELING,0.74288,0.020971,-0.057414,0,0
7,GO CALCIUM MEDIATED SIGNALING,0.46512,0.020939,0.016912,0,0
7,GO SENSORY PERCEPTION OF BITTER TASTE,0.42855,0.020876,-0.0023406,0,0
7,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.5726,0.020861,-0.0067879,0,0
7,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.94073,0.020854,-0.0019009,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.9686,0.020836,-0.012058,0,0
7,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.87833,0.020803,-0.0024186,0,0
7,GO RESPONSE TO IRON ION,0.98255,0.02078,-0.019261,0,0
7,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.28785,0.020776,0.01539,0,0
7,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.56666,0.020643,0.036914,0,0
7,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.58456,0.020502,0.06586,0,0
7,GO GLIAL CELL MIGRATION,0.78962,0.020493,0.010584,0,0
7,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.94769,0.020463,-0.020527,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.98255,0.020462,-0.034533,0,0
7,GO SPINDLE ASSEMBLY,0.36991,0.020279,0.038261,0,0
7,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.25001,0.020215,0.024945,0,0
7,GO TRACHEA DEVELOPMENT,0.52594,0.020178,0.040334,0,0
7,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.94073,0.020128,0.0010285,0,0
7,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.75615,0.020111,-0.044375,0,0
7,GO SULFUR COMPOUND CATABOLIC PROCESS,0.71658,0.020096,-0.0020047,0,0
7,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.97557,0.020073,-0.00011817,0,0
7,GO NEGATIVE REGULATION OF TRANSPORT,0.36991,0.019998,0.025939,0,0
7,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.67776,0.019989,0.016906,0,0
7,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.48678,0.019985,0.02131,0,0
7,GO MUSCLE CONTRACTION,0.59059,0.019845,0.013401,0,0
7,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.84397,0.019825,0.003863,0,0
7,GO PROTEIN ACETYLATION,0.31653,0.019823,0.020257,0,0
7,GO EATING BEHAVIOR,0.9686,0.019816,0.013512,0,0
7,GO RNA METHYLATION,0.95466,0.019712,-0.021295,0,0
7,GO BIOLOGICAL ADHESION,0.70355,0.019688,0.00086078,0,0
7,GO CHLORIDE ION HOMEOSTASIS,0.84397,0.01962,0.0085928,0,0
7,GO MULTIVESICULAR BODY SORTING PATHWAY,0.5726,0.019591,0.029994,0,0
7,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.73628,0.01957,-0.039313,0,0
7,GO ASYMMETRIC CELL DIVISION,0.94769,0.019517,-0.012926,0,0
7,GO CARDIAC MUSCLE CONTRACTION,0.29184,0.01944,0.055462,0,0
7,GO SCHWANN CELL DIFFERENTIATION,0.87144,0.019356,0.0050139,0,0
7,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.36526,0.019356,-0.070109,0,0
7,GO SMOOTH MUSCLE CONTRACTION,0.71658,0.019322,0.00026813,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.85768,0.019187,-0.0025041,0,0
7,GO CERAMIDE BIOSYNTHETIC PROCESS,0.79636,0.019098,-0.0078884,0,0
7,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.65866,0.019079,-0.045423,0,0
7,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.91987,0.019044,-0.011627,0,0
7,GO RNA 3 END PROCESSING,0.98255,0.018992,-0.0027436,0,0
7,GO FIBROBLAST ACTIVATION,0.4598,0.018981,-0.084704,0,0
7,GO SYNAPSE MATURATION,0.52594,0.01898,0.11322,0,0
7,GO CHLORIDE TRANSPORT,0.78962,0.018925,0.0098728,0,0
7,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.56075,0.018909,0.039862,0,0
7,GO METAL ION HOMEOSTASIS,0.89215,0.018886,-0.009455,0,0
7,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.66501,0.018821,-0.048351,0,0
7,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.94769,0.018753,-0.016055,0,0
7,GO REGULATION OF SPINDLE ASSEMBLY,0.76281,0.018636,0.024882,0,0
7,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.62113,0.01853,0.0021701,0,0
7,GO REGULATION OF ISOTYPE SWITCHING,0.78289,0.018512,-0.078704,0,0
7,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.68418,0.01838,0.02664,0,0
7,GO CELL CELL SIGNALING BY WNT,0.75615,0.01836,-0.00079314,0,0
7,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.25729,0.018209,-0.054899,0,0
7,GO CALCIUM ION REGULATED EXOCYTOSIS,0.34256,0.018001,0.12556,0,0
7,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.87144,0.017948,-0.033922,0,0
7,GO NEGATIVE REGULATION OF BINDING,0.19695,0.017807,0.041902,0,0
7,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.98953,0.017806,-0.0076422,0,0
7,GO PEPTIDYL LYSINE ACETYLATION,0.20309,0.017781,0.027931,0,0
7,GO SENSORY ORGAN DEVELOPMENT,0.19095,0.017779,0.042857,0,0
7,GO ACTIN FILAMENT ORGANIZATION,0.68418,0.017752,0.0069225,0,0
7,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.57857,0.01768,0.021263,0,0
7,GO RESPONSE TO MECHANICAL STIMULUS,0.73628,0.017636,0.0064199,0,0
7,GO REGULATION OF DNA METABOLIC PROCESS,0.59664,0.01759,0.0032051,0,0
7,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.66501,0.017579,0.045009,0,0
7,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.90599,0.017572,-0.021767,0,0
7,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.66501,0.017489,0.026665,0,0
7,GO POSITIVE REGULATION OF ION TRANSPORT,0.55487,0.017477,0.026838,0,0
7,GO POSITIVE REGULATION OF PROTEIN BINDING,0.99651,0.01747,-0.003491,0,0
7,GO NEPHRIC DUCT MORPHOGENESIS,0.92682,0.017386,-0.026896,0,0
7,GO REGULATION OF CELL SUBSTRATE ADHESION,0.57857,0.017297,-0.061298,0,0
7,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.78289,0.017242,-0.061928,0,0
7,GO SISTER CHROMATID SEGREGATION,0.74288,0.017226,0.0071594,0,0
7,GO PROTEIN ADP RIBOSYLATION,0.65866,0.01714,-0.067615,0,0
7,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.98255,0.01711,-0.017245,0,0
7,GO FEEDING BEHAVIOR,0.27227,0.017061,0.047699,0,0
7,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.84397,0.01703,-0.034843,0,0
7,GO MITOTIC CELL CYCLE,0.8303,0.017023,-0.0068277,0,0
7,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.98953,0.016997,-0.00068551,0,0
7,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.99651,0.016997,-0.0064964,0,0
7,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.76948,0.016982,0.0073622,0,0
7,GO PROTEIN ACYLATION,0.33373,0.016783,0.021061,0,0
7,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.55487,0.016715,0.041598,0,0
7,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.85768,0.016709,-0.026752,0,0
7,GO MICROVILLUS ASSEMBLY,0.78962,0.016701,-0.054586,0,0
7,GO CELL CELL JUNCTION ASSEMBLY,0.94073,0.016678,-0.002315,0,0
7,GO RESPONSE TO PROSTAGLANDIN,0.78962,0.016625,-0.029277,0,0
7,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.33812,0.016603,0.035907,0,0
7,GO PROTEIN DENEDDYLATION,0.80312,0.016543,-0.024229,0,0
7,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.85082,0.016518,-0.001204,0,0
7,GO MULTI ORGANISM PROCESS,0.69061,0.016374,0.010641,0,0
7,GO POLYOL TRANSPORT,0.95466,0.016362,-0.011066,0,0
7,GO HOMOCYSTEINE METABOLIC PROCESS,0.81668,0.016329,-0.047688,0,0
7,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.66501,0.016313,0.018757,0,0
7,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.72313,0.016301,0.0068526,0,0
7,GO ZINC ION TRANSPORT,0.93377,0.016297,-0.0043357,0,0
7,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.46512,0.016274,-0.093584,0,0
7,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.97557,0.016199,-0.007011,0,0
7,GO CARDIAC VENTRICLE MORPHOGENESIS,0.63354,0.016114,0.027692,0,0
7,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.86455,0.016104,-0.03679,0,0
7,GO VACUOLAR TRANSPORT,0.64605,0.016078,-0.027835,0,0
7,GO REGULATION OF RESPONSE TO WOUNDING,0.29586,0.016063,-0.061134,0,0
7,GO SECOND MESSENGER MEDIATED SIGNALING,0.53167,0.016062,0.016657,0,0
7,GO EPITHELIAL TUBE MORPHOGENESIS,0.77618,0.016038,-0.006393,0,0
7,GO PROTEIN LOCALIZATION TO MEMBRANE,0.92682,0.015939,-0.0011957,0,0
7,GO REGULATION OF PROTEIN DEACETYLATION,0.76948,0.01593,-0.023127,0,0
7,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.40349,0.01586,-0.071726,0,0
7,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.88523,0.015851,-0.045996,0,0
7,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.32506,0.015842,0.030215,0,0
7,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.83713,0.015656,-0.016366,0,0
7,GO REGULATION OF GLUCOSE IMPORT,0.67776,0.015632,0.020641,0,0
7,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.61497,0.015613,0.0077766,0,0
7,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.62113,0.015589,-0.024376,0,0
7,GO PROTEIN K63 LINKED UBIQUITINATION,0.52025,0.015533,0.011747,0,0
7,GO OLIGODENDROCYTE DEVELOPMENT,0.59059,0.015526,0.021783,0,0
7,GO HISTONE UBIQUITINATION,0.73628,0.015449,-0.011234,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.67137,0.015432,0.0057316,0,0
7,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.67137,0.01539,0.01547,0,0
7,GO MICROVILLUS ORGANIZATION,0.80312,0.015361,-0.0070807,0,0
7,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.47049,0.015337,0.01558,0,0
7,GO REGULATION OF HAIR CYCLE,0.7495,0.015315,0.0084487,0,0
7,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.86455,0.015306,-0.011724,0,0
7,GO ENDOCYTIC RECYCLING,0.79636,0.015304,0.0076858,0,0
7,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.71006,0.015269,-0.025667,0,0
7,GO BILE ACID BIOSYNTHETIC PROCESS,0.63978,0.015259,0.013668,0,0
7,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.90599,0.015185,-0.012203,0,0
7,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.91987,0.015162,-0.010044,0,0
7,GO INTERMEDIATE FILAMENT BASED PROCESS,0.66501,0.015103,-0.044051,0,0
7,GO CYTOLYSIS,0.73628,0.015073,-0.06166,0,0
7,GO CELLULAR SODIUM ION HOMEOSTASIS,0.53742,0.015021,0.060552,0,0
7,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.89907,0.014994,0.0044121,0,0
7,GO DOUBLE STRAND BREAK REPAIR,0.80989,0.014931,0.0033677,0,0
7,GO PEPTIDYL AMINO ACID MODIFICATION,0.48678,0.01487,0.0094785,0,0
7,GO VESICLE BUDDING FROM MEMBRANE,0.75615,0.014817,-0.020448,0,0
7,GO SULFUR AMINO ACID METABOLIC PROCESS,0.95466,0.014713,-0.025631,0,0
7,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.24643,0.014659,0.031278,0,0
7,GO NEPHRIC DUCT DEVELOPMENT,0.57857,0.014624,0.069044,0,0
7,GO POSITIVE REGULATION OF DNA BINDING,0.80312,0.014612,-0.00066185,0,0
7,GO RESPONSE TO GROWTH HORMONE,0.72313,0.014548,0.014599,0,0
7,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.47049,0.01449,-0.049457,0,0
7,GO MIRNA METABOLIC PROCESS,0.87144,0.014456,-0.020413,0,0
7,GO MITOTIC METAPHASE PLATE CONGRESSION,0.85082,0.014306,0.0043385,0,0
7,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.63354,0.014274,0.032878,0,0
7,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.53742,0.01425,0.040424,0,0
7,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.46512,0.014176,0.015297,0,0
7,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.84397,0.014052,-0.02226,0,0
7,GO NUCLEAR ENVELOPE REASSEMBLY,0.48131,0.014017,0.029185,0,0
7,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.67776,0.014014,0.051354,0,0
7,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.80989,0.014008,-0.032856,0,0
7,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.75615,0.013979,-0.0027084,0,0
7,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.76948,0.013969,-0.037774,0,0
7,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.7495,0.013956,-0.12707,0,0
7,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.82348,0.013941,0.00016333,0,0
7,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.76948,0.013916,0.037473,0,0
7,GO REGULATION OF CELL CELL ADHESION,0.86455,0.013812,-0.013459,0,0
7,GO NEGATIVE REGULATION OF GROWTH,0.55487,0.013778,0.013547,0,0
7,GO POSITIVE REGULATION OF TRANSPORT,0.40349,0.013773,0.017994,0,0
7,GO RESPONSE TO RADIATION,0.72969,0.013654,-0.0050438,0,0
7,GO REGULATION OF DNA RECOMBINATION,0.32077,0.013634,0.015307,0,0
7,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.48131,0.013583,0.065907,0,0
7,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.75615,0.013579,0.0064302,0,0
7,GO CELL CYCLE,0.78289,0.013576,-0.0006163,0,0
7,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.66501,0.013545,-0.019847,0,0
7,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.77618,0.013535,0.0037404,0,0
7,GO LABYRINTHINE LAYER MORPHOGENESIS,0.8303,0.013464,0.070405,0,0
7,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.94073,0.013428,-0.0046283,0,0
7,GO REGULATION OF DNA CATABOLIC PROCESS,0.63354,0.013424,-0.02318,0,0
7,GO PARAXIAL MESODERM DEVELOPMENT,0.91293,0.013421,0.0030765,0,0
7,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.99651,0.013372,0.0040563,0,0
7,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.85082,0.013359,-0.071224,0,0
7,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.53742,0.013328,0.03507,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.63354,0.013281,-0.01207,0,0
7,GO REGULATION OF RNA BINDING,0.78962,0.013252,-0.033772,0,0
7,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.78289,0.013232,-0.032638,0,0
7,GO ACTIN FILAMENT BASED PROCESS,0.69061,0.013227,0.0057564,0,0
7,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.89215,0.013222,-0.0049207,0,0
7,GO MUSCLE SYSTEM PROCESS,0.98953,0.013165,-0.0029796,0,0
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.81668,0.013147,0.006561,0,0
7,GO MITOTIC CHROMOSOME CONDENSATION,0.77618,0.013042,0.012098,0,0
7,GO HISTONE H4 K5 ACETYLATION,0.78289,0.012946,-0.014057,0,0
7,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.87144,0.012941,-0.010474,0,0
7,GO REGULATION OF NUCLEAR DIVISION,0.70355,0.01293,-0.015089,0,0
7,GO NEGATIVE REGULATION OF CELL AGING,0.85082,0.012875,-0.024301,0,0
7,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.40349,0.012873,0.065418,0,0
7,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.80312,0.012813,0.0015172,0,0
7,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.76281,0.012751,0.0053714,0,0
7,GO VIRAL BUDDING,0.36526,0.012666,0.065841,0,0
7,GO ENDOCRINE HORMONE SECRETION,0.88523,0.01265,-0.011742,0,0
7,GO PROSTATE GLAND MORPHOGENESIS,0.67137,0.012634,-0.1069,0,0
7,GO T HELPER 1 CELL DIFFERENTIATION,0.80312,0.012617,-0.12676,0,0
7,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.71006,0.012574,-0.0088485,0,0
7,GO REGULATION OF GROWTH,0.61497,0.012496,0.0078708,0,0
7,GO CELLULAR ION HOMEOSTASIS,0.94769,0.012471,-0.0026303,0,0
7,GO LEUKOCYTE CHEMOTAXIS,0.91987,0.012432,-0.023499,0,0
7,GO EMBRYO DEVELOPMENT,0.43883,0.012422,0.01307,0,0
7,GO POSITIVE REGULATION OF BINDING,0.64605,0.012366,-0.016065,0,0
7,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.76281,0.01235,0.0053511,0,0
7,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.80312,0.012333,0.0315,0,0
7,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.27999,0.012273,0.037312,0,0
7,GO CD40 SIGNALING PATHWAY,0.29184,0.012143,-0.15903,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.77618,0.012131,-0.03106,0,0
7,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.98255,0.012071,-0.0071822,0,0
7,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.89907,0.012041,-0.010679,0,0
7,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.41341,0.012011,-0.11419,0,0
7,GO GOLGI LOCALIZATION,0.70355,0.011981,0.025267,0,0
7,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.9686,0.011951,-0.042655,0,0
7,GO PEPTIDYL ARGININE MODIFICATION,0.95466,0.011947,-0.0048649,0,0
7,GO NEURON PROJECTION REGENERATION,0.44924,0.011926,0.049741,0,0
7,GO DRINKING BEHAVIOR,0.53167,0.011891,0.033205,0,0
7,GO CHROMOSOME SEPARATION,0.78962,0.011873,0.0015872,0,0
7,GO OUTFLOW TRACT MORPHOGENESIS,0.32506,0.011872,0.089506,0,0
7,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.71006,0.011858,0.0067144,0,0
7,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.17099,0.011852,0.068295,0,0
7,GO HEART TRABECULA MORPHOGENESIS,0.70355,0.011844,-0.043644,0,0
7,GO AXIS SPECIFICATION,0.76281,0.011823,0.020285,0,0
7,GO CELL CHEMOTAXIS,0.93377,0.011822,-0.011163,0,0
7,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.65866,0.01181,0.0013279,0,0
7,GO RESPONSE TO INORGANIC SUBSTANCE,0.40843,0.011747,0.024513,0,0
7,GO ENDOCRINE PANCREAS DEVELOPMENT,0.95466,0.011671,-0.0030273,0,0
7,GO CELL CYCLE PHASE TRANSITION,0.91987,0.01166,-0.015371,0,0
7,GO RECEPTOR RECYCLING,0.38888,0.011585,0.045629,0,0
7,GO TRANSEPITHELIAL TRANSPORT,0.91987,0.01153,-0.032828,0,0
7,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.75615,0.011494,0.00015944,0,0
7,GO VENTRICULAR SEPTUM DEVELOPMENT,0.77618,0.011476,0.011225,0,0
7,GO PROTEIN PALMITOYLATION,0.48678,0.011475,0.046287,0,0
7,GO REGULATION OF DNA BINDING,0.98255,0.011462,-0.0031269,0,0
7,GO METANEPHROS DEVELOPMENT,0.47049,0.011426,-0.060796,0,0
7,GO NEUROINFLAMMATORY RESPONSE,0.94769,0.011392,-0.02737,0,0
7,GO RESPONSE TO DSRNA,0.53742,0.011317,0.0080756,0,0
7,GO PEPTIDYL LYSINE MODIFICATION,0.49227,0.01125,0.011426,0,0
7,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.80989,0.011166,-0.044456,0,0
7,GO REGULATION OF BLOOD PRESSURE,0.78962,0.011079,-0.024638,0,0
7,GO KETONE BODY METABOLIC PROCESS,0.56666,0.010985,-0.077521,0,0
7,GO TRANSMEMBRANE TRANSPORT,0.42347,0.010985,0.018416,0,0
7,GO T HELPER CELL LINEAGE COMMITMENT,0.74288,0.010981,0.027981,0,0
7,GO OVULATION CYCLE PROCESS,0.70355,0.010963,0.010564,0,0
7,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.94769,0.010943,-0.010538,0,0
7,GO CELLULAR HOMEOSTASIS,0.98255,0.010877,-0.0014313,0,0
7,GO EMBRYONIC EYE MORPHOGENESIS,0.34702,0.01081,0.056864,0,0
7,GO SNORNA METABOLIC PROCESS,0.65234,0.010781,0.027765,0,0
7,GO REGULATION OF CELL DIFFERENTIATION,0.30402,0.010512,0.022496,0,0
7,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.80989,0.010372,-0.046863,0,0
7,GO PURINE NUCLEOTIDE TRANSPORT,0.94769,0.01035,-0.0060068,0,0
7,GO CELL MOTILITY,0.82348,0.010306,-0.0037249,0,0
7,GO ATP DEPENDENT CHROMATIN REMODELING,0.68418,0.010285,-0.015571,0,0
7,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.42855,0.010285,0.04455,0,0
7,GO POSITIVE REGULATION OF SIGNALING,0.89215,0.010273,-0.0049136,0,0
7,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.69061,0.010165,0.0014946,0,0
7,GO REGULATION OF CHROMOSOME SEPARATION,0.64605,0.010118,-0.039612,0,0
7,GO OVARIAN FOLLICLE DEVELOPMENT,0.72313,0.010044,-0.051242,0,0
7,GO CANONICAL WNT SIGNALING PATHWAY,0.59664,0.010033,0.011777,0,0
7,GO REGULATION OF OOGENESIS,0.29184,0.010027,0.08019,0,0
7,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.59664,0.0099661,-0.044892,0,0
7,GO REGULATION OF TRANSFERASE ACTIVITY,0.63354,0.0099458,0.012962,0,0
7,GO ERAD PATHWAY,0.88523,0.0099275,-0.023298,0,0
7,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.83713,0.0099241,-0.023129,0,0
7,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.66501,0.0098988,-0.034025,0,0
7,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.84397,0.0098071,0.056644,0,0
7,GO CARDIAC ATRIUM MORPHOGENESIS,0.96163,0.0097668,-0.024009,0,0
7,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.96163,0.0097413,0.0022379,0,0
7,GO RETINOIC ACID METABOLIC PROCESS,0.80989,0.0097149,0.0093489,0,0
7,GO STRIATED MUSCLE ADAPTATION,0.65866,0.0097046,-0.036035,0,0
7,GO NEGATIVE REGULATION OF SIGNALING,0.99651,0.0096644,-0.004695,0,0
7,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.89215,0.0096352,-0.00071226,0,0
7,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.94769,0.0095625,-0.0066488,0,0
7,GO ARTERY DEVELOPMENT,1,0.0094756,-0.0086516,0,0
7,GO REGULATION OF CHROMOSOME SEGREGATION,0.91293,0.0093558,-0.017604,0,0
7,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.7495,0.0093138,0.0013321,0,0
7,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.94073,0.0091674,-0.016119,0,0
7,GO RUFFLE ORGANIZATION,0.69061,0.0091668,-0.027889,0,0
7,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.57857,0.0091151,0.036025,0,0
7,GO RESPONSE TO NICOTINE,0.32077,0.0090733,0.080103,0,0
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.46512,0.008998,-0.054725,0,0
7,GO FACE DEVELOPMENT,0.44924,0.0089761,0.036546,0,0
7,GO SUPEROXIDE METABOLIC PROCESS,0.65866,0.0088697,-0.033198,0,0
7,GO BLASTOCYST DEVELOPMENT,0.98953,0.0087549,-0.00063063,0,0
7,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.89215,0.0087115,0.002169,0,0
7,GO IRON SULFUR CLUSTER ASSEMBLY,0.96163,0.0086696,-0.0061781,0,0
7,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.78962,0.008655,0.0044441,0,0
7,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.76948,0.0086316,0.0073009,0,0
7,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.71658,0.00862,-0.078138,0,0
7,GO STEM CELL DIVISION,0.60883,0.0085672,-0.060528,0,0
7,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.46512,0.0084646,0.022906,0,0
7,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.87833,0.0083009,0.0039408,0,0
7,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.61497,0.0082933,0.011489,0,0
7,GO EMBRYONIC MORPHOGENESIS,0.4978,0.0081305,0.017694,0,0
7,GO NADH METABOLIC PROCESS,0.98953,0.0081013,-0.013925,0,0
7,GO GASTRULATION,0.85082,0.0080923,-0.033682,0,0
7,GO POSITIVE REGULATION OF COAGULATION,0.88523,0.0080315,-0.024181,0,0
7,GO ETHER METABOLIC PROCESS,0.81668,0.0079593,-0.046227,0,0
7,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.39858,0.0079553,0.029263,0,0
7,GO PIGMENT GRANULE MATURATION,0.96163,0.007845,-0.019991,0,0
7,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.74288,0.0078073,0.025333,0,0
7,GO PLASMA MEMBRANE TUBULATION,0.76281,0.0077041,0.0052184,0,0
7,GO SOMATIC STEM CELL DIVISION,0.42855,0.0076638,-0.10304,0,0
7,GO GROWTH,0.62732,0.007582,0.0082736,0,0
7,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.44924,0.0075585,-0.057969,0,0
7,GO NEURAL TUBE PATTERNING,0.9686,0.0075163,-0.025799,0,0
7,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.87833,0.0074045,-0.013283,0,0
7,GO MITOCHONDRIAL TRANSLATION,0.53167,0.0073514,-0.048312,0,0
7,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.86455,0.0073448,-0.053404,0,0
7,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.85082,0.0073284,0.0084912,0,0
7,GO CARDIAC CHAMBER DEVELOPMENT,0.38888,0.0072818,0.031834,0,0
7,GO NEPHRON DEVELOPMENT,0.71658,0.00716,0.0094186,0,0
7,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.31653,0.0069731,-0.096687,0,0
7,GO REGULATION OF PROTEIN BINDING,0.86455,0.0069694,0.0025033,0,0
7,GO WHITE FAT CELL DIFFERENTIATION,0.98953,0.0069207,0.0062834,0,0
7,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.78962,0.0068893,-0.044901,0,0
7,GO NEGATIVE REGULATION OF RNA SPLICING,0.53742,0.0068772,0.041835,0,0
7,GO EMBRYONIC ORGAN MORPHOGENESIS,0.72313,0.0068539,0.014177,0,0
7,GO LIPID DIGESTION,0.95466,0.006836,-0.05656,0,0
7,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.72969,0.0068346,0.056149,0,0
7,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.42347,0.0068102,-0.12297,0,0
7,GO NUCLEOSIDE SALVAGE,0.74288,0.006704,-0.071158,0,0
7,GO POLYSACCHARIDE METABOLIC PROCESS,0.96163,0.0067019,-0.023831,0,0
7,GO LEFT RIGHT AXIS SPECIFICATION,0.62732,0.0066884,-0.079891,0,0
7,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.67776,0.0066706,-0.046425,0,0
7,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.80312,0.0066364,-0.037397,0,0
7,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.72969,0.0066208,-0.013424,0,0
7,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.79636,0.0066107,0.0027376,0,0
7,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.78962,0.0064969,0.0068749,0,0
7,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.37932,0.0064353,-0.065858,0,0
7,GO MESODERM DEVELOPMENT,0.93377,0.0064315,-0.019858,0,0
7,GO GLIAL CELL APOPTOTIC PROCESS,0.97557,0.0064241,-0.020341,0,0
7,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.96163,0.0063047,-0.0029292,0,0
7,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.34702,0.006303,0.072106,0,0
7,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.8303,0.006205,-0.030623,0,0
7,GO SPERM CAPACITATION,0.89215,0.006182,-0.00994,0,0
7,GO ANION HOMEOSTASIS,0.80312,0.0059649,-0.01678,0,0
7,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.76948,0.0059275,-0.022711,0,0
7,GO REGULATION OF CHROMATIN ORGANIZATION,0.38888,0.0058302,-0.024679,0,0
7,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.74288,0.0057658,0.026267,0,0
7,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.7495,0.0057246,0.0044986,0,0
7,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.95466,0.0056145,-0.012642,0,0
7,GO POSITIVE REGULATION OF MYELINATION,0.84397,0.0055816,-0.021609,0,0
7,GO REGULATION OF CELL CYCLE PROCESS,0.4978,0.0054456,-0.023484,0,0
7,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.88523,0.0054446,-0.031344,0,0
7,GO SENSORY ORGAN MORPHOGENESIS,0.50337,0.0053885,0.027377,0,0
7,GO SISTER CHROMATID COHESION,0.44924,0.0053314,0.036496,0,0
7,GO NEPHRON EPITHELIUM DEVELOPMENT,1,0.005239,-0.0015944,0,0
7,GO ORGANIC ACID TRANSPORT,0.99651,0.0052201,-0.015006,0,0
7,GO REGULATION OF FEEDING BEHAVIOR,0.65234,0.0051522,-0.060619,0,0
7,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.69061,0.0051042,0.026546,0,0
7,GO TRABECULA MORPHOGENESIS,0.70355,0.00503,0.025873,0,0
7,GO MISMATCH REPAIR,0.80989,0.0049641,0.0063146,0,0
7,GO CELL CYCLE PROCESS,0.98953,0.0048952,-0.0050607,0,0
7,GO REGULATION OF HISTONE METHYLATION,0.73628,0.0048275,-0.0016821,0,0
7,GO SNRNA TRANSCRIPTION,0.61497,0.0048125,0.010418,0,0
7,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.93377,0.0047585,0.0029986,0,0
7,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.84397,0.0047508,-0.016175,0,0
7,GO STRESS GRANULE ASSEMBLY,0.74288,0.0047025,-0.019061,0,0
7,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.96163,0.004674,0.0039346,0,0
7,GO SKELETAL SYSTEM DEVELOPMENT,0.73628,0.0046021,0.0032662,0,0
7,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.22905,0.0045879,0.073647,0,0
7,GO PHAGOLYSOSOME ASSEMBLY,0.60883,0.0045434,0.015762,0,0
7,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.75615,0.0045336,0.027722,0,0
7,GO GLYCEROL ETHER METABOLIC PROCESS,0.67776,0.004445,-0.047408,0,0
7,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.91293,0.0043131,-0.074159,0,0
7,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.91987,0.0042994,-0.032877,0,0
7,GO CARBOHYDRATE TRANSPORT,0.90599,0.0042917,-0.013783,0,0
7,GO ORGANIC ANION TRANSPORT,0.95466,0.0042501,-0.014915,0,0
7,GO OSSIFICATION,0.88523,0.004225,-0.01418,0,0
7,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.81668,0.0041821,0.014903,0,0
7,GO INTERLEUKIN 17 PRODUCTION,0.78289,0.0041278,-0.0078465,0,0
7,GO KERATINOCYTE MIGRATION,0.90599,0.0040949,-0.0066118,0,0
7,GO METAPHASE PLATE CONGRESSION,0.78289,0.0040848,-0.018938,0,0
7,GO REGULATION OF CELL CYCLE,0.69707,0.004061,-0.015171,0,0
7,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.92682,0.003997,-0.011985,0,0
7,GO VESICLE ORGANIZATION,0.69061,0.0039472,-0.0016458,0,0
7,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.77618,0.0038541,-0.050274,0,0
7,GO DOSAGE COMPENSATION,0.33812,0.0038186,-0.061127,0,0
7,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.5726,0.0037862,-0.082781,0,0
7,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.88523,0.0037113,0.001695,0,0
7,GO MIDBRAIN DEVELOPMENT,0.89215,0.0036696,-0.0053444,0,0
7,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.69061,0.0035807,-0.040411,0,0
7,GO IMPORT ACROSS PLASMA MEMBRANE,0.98255,0.0034833,-0.0057047,0,0
7,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.97557,0.0034703,-0.0064578,0,0
7,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.69061,0.0034518,-0.037294,0,0
7,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.67137,0.0034372,-0.028997,0,0
7,GO CELLULAR RESPONSE TO ALCOHOL,0.71658,0.0034274,-0.032036,0,0
7,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.31653,0.0033075,-0.067968,0,0
7,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.85768,0.0032357,0.0050943,0,0
7,GO SECRETORY GRANULE ORGANIZATION,0.58456,0.0032256,0.04353,0,0
7,GO ERK1 AND ERK2 CASCADE,0.82348,0.0031864,-0.025752,0,0
7,GO EMBRYONIC HEMOPOIESIS,0.85768,0.0031247,-0.0081811,0,0
7,GO CGMP MEDIATED SIGNALING,0.30815,0.0031094,0.07892,0,0
7,GO DNA LIGATION,0.79636,0.003076,-0.020442,0,0
7,GO CENTRIOLE ASSEMBLY,0.63354,0.0030195,0.029371,0,0
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.69061,0.003014,-0.079542,0,0
7,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.70355,0.0029983,0.037766,0,0
7,GO CHYLOMICRON ASSEMBLY,0.84397,0.0029764,-0.057933,0,0
7,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.59664,0.0029688,-0.043488,0,0
7,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.32506,0.0029427,0.081731,0,0
7,GO REGULATION OF GLIAL CELL MIGRATION,0.90599,0.0029391,-0.010954,0,0
7,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.80312,0.0029074,-0.040395,0,0
7,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.73628,0.0028757,-0.033625,0,0
7,GO EMBRYONIC DIGIT MORPHOGENESIS,0.91987,0.0028622,-0.0060186,0,0
7,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.38408,0.0028183,-0.046599,0,0
7,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.29586,0.0027497,0.048264,0,0
7,GO BASE EXCISION REPAIR,0.60272,0.0027414,-0.018885,0,0
7,GO RENAL TUBULE DEVELOPMENT,0.99651,0.0027316,-0.0077134,0,0
7,GO RESPONSE TO ANGIOTENSIN,0.63978,0.0026252,-0.079102,0,0
7,GO RESPONSE TO INTERLEUKIN 4,0.96163,0.002618,-0.010871,0,0
7,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.8303,0.0026058,-0.04028,0,0
7,GO REGULATION OF PROTEIN SUMOYLATION,0.7495,0.0025743,0.019416,0,0
7,GO CELL CYCLE CHECKPOINT,0.87144,0.0025563,-0.019817,0,0
7,GO AORTA DEVELOPMENT,0.9686,0.0024724,0.00084202,0,0
7,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.99651,0.0024213,-0.045373,0,0
7,GO NEGATIVE REGULATION OF MAPK CASCADE,0.78962,0.0024024,-0.019424,0,0
7,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.63354,0.0023994,-0.028426,0,0
7,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.89907,0.002333,-0.0056351,0,0
7,GO CELLULAR DEFENSE RESPONSE,0.32938,0.0023167,-0.11984,0,0
7,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.92682,0.0022601,-0.002147,0,0
7,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.94769,0.0021216,-0.0087064,0,0
7,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.66501,0.002068,0.038682,0,0
7,GO PEPTIDYL ARGININE N METHYLATION,0.94073,0.0020567,-0.020281,0,0
7,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.69061,0.0020549,0.0091943,0,0
7,GO EMBRYONIC ORGAN DEVELOPMENT,0.64605,0.0020262,0.0070027,0,0
7,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.48131,0.0019164,-0.034672,0,0
7,GO CARDIAC MUSCLE CELL CONTRACTION,0.39371,0.0019148,0.071075,0,0
7,GO PROTEIN HETEROTETRAMERIZATION,0.69061,0.0018615,0.0091867,0,0
7,GO GLUTAMINE METABOLIC PROCESS,0.87144,0.0017886,0.0033463,0,0
7,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1,0.0017864,-0.0078232,0,0
7,GO VESICLE TARGETING,0.81668,0.0017439,-0.020781,0,0
7,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.63354,0.0017041,-0.095072,0,0
7,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.50896,0.001699,-0.038775,0,0
7,GO SULFUR COMPOUND TRANSPORT,0.74288,0.001677,-0.031415,0,0
7,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.89215,0.0016043,0.0019383,0,0
7,GO SPHINGOLIPID METABOLIC PROCESS,0.61497,0.0015954,-0.041485,0,0
7,GO DIVALENT INORGANIC ANION HOMEOSTASIS,0.75615,0.0015761,0.0060394,0,0
7,GO POST EMBRYONIC DEVELOPMENT,0.88523,0.0015149,0.0012201,0,0
7,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.89215,0.001511,-0.025849,0,0
7,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.65866,0.0013053,0.004169,0,0
7,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.77618,0.0011859,0.015475,0,0
7,GO MONONUCLEAR CELL MIGRATION,0.96163,0.0011792,-0.016285,0,0
7,GO REGULATION OF COAGULATION,0.89907,0.0011492,-0.045826,0,0
7,GO HISTONE ARGININE METHYLATION,0.64605,0.0011296,-0.021428,0,0
7,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.75615,0.0011074,0.0212,0,0
7,GO REGULATION OF PHAGOCYTOSIS,0.87144,0.0010989,-0.017359,0,0
7,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.43367,0.001048,-0.047644,0,0
7,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.74288,0.00091721,-0.017898,0,0
7,GO DNA METABOLIC PROCESS,0.70355,0.00089014,-0.017207,0,0
7,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.86455,0.00086076,0.00054102,0,0
7,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,1,0.00079638,-8.1441e-05,0,0
7,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.76948,0.00072948,-0.018529,0,0
7,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.64605,0.00071222,-0.042407,0,0
7,GO REGULATION OF WNT SIGNALING PATHWAY,0.67776,0.00070331,0.0067426,0,0
7,GO LUNG EPITHELIUM DEVELOPMENT,0.99651,0.00069181,0.0045257,0,0
7,GO GLAND DEVELOPMENT,0.76948,0.0006855,-0.023997,0,0
7,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.91293,0.00066429,-0.033492,0,0
7,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.98953,0.00065646,-0.0026472,0,0
7,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.60883,0.00064822,-0.033015,0,0
7,GO REGULATION OF HISTONE MODIFICATION,0.36991,0.00063665,-0.031703,0,0
7,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.65234,0.00062605,0.015784,0,0
7,GO RESPONSE TO INTERLEUKIN 7,0.16559,0.0005828,-0.084435,0,0
7,GO NEURAL TUBE DEVELOPMENT,0.80989,0.00052934,-0.034688,0,0
7,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.81668,0.00049805,-0.035047,0,0
7,GO RESPONSE TO XENOBIOTIC STIMULUS,0.76948,0.00048778,-0.049843,0,0
7,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.75615,0.0004194,-0.022039,0,0
7,GO REGULATION OF HISTONE PHOSPHORYLATION,0.9686,0.00040532,0.0068897,0,0
7,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.37932,0.00031544,-0.068213,0,0
7,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.99651,0.0002286,0.0050094,0,0
7,GO REGULATION OF RUFFLE ASSEMBLY,0.95466,0.00021661,-0.018533,0,0
7,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.52594,0.00021521,-0.031512,0,0
7,GO COVALENT CHROMATIN MODIFICATION,0.79636,0.00016792,-0.0061294,0,0
7,GO PROTEIN K11 LINKED UBIQUITINATION,0.82348,0.0001541,-0.022014,0,0
7,GO SECONDARY METABOLIC PROCESS,0.99651,5.2539e-05,-0.01913,0,0
7,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.94073,3.537e-05,-0.0028937,0,0
7,GO EPITHELIUM DEVELOPMENT,0.5726,-2.0531e-05,-0.038086,0,0
7,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.92682,-0.00018449,-0.021351,0,0
7,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.78962,-0.00020445,-0.01749,0,0
7,GO REGULATION OF MUSCLE CONTRACTION,1,-0.00026456,0.0045409,0,0
7,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.37932,-0.00028908,0.078092,0,0
7,GO SEX DIFFERENTIATION,0.98255,-0.00029833,-0.0097717,0,0
7,GO SPLEEN DEVELOPMENT,0.92682,-0.00032371,-0.0068642,0,0
7,GO PEPTIDYL ARGININE METHYLATION,0.98255,-0.0003955,-0.0049856,0,0
7,GO REGULATION OF CALCIUM ION TRANSPORT,0.70355,-0.00044877,0.015973,0,0
7,GO REGULATION OF FAT CELL DIFFERENTIATION,0.72969,-0.00052243,-0.029538,0,0
7,GO PIGMENTATION,0.81668,-0.00056926,-0.019149,0,0
7,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.96163,-0.00057008,-0.012738,0,0
7,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.41341,-0.00059049,-0.056044,0,0
7,GO PEROXISOME ORGANIZATION,0.39371,-0.00060721,-0.06436,0,0
7,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.48131,-0.00061043,-0.053275,0,0
7,GO MYELIN MAINTENANCE,0.97557,-0.00068607,-0.017265,0,0
7,GO LIPOSACCHARIDE METABOLIC PROCESS,0.88523,-0.00068825,-0.025552,0,0
7,GO PEPTIDYL LYSINE TRIMETHYLATION,0.90599,-0.00070188,-0.0035475,0,0
7,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.61497,-0.000734,-0.050109,0,0
7,GO WATER HOMEOSTASIS,0.79636,-0.00073793,-0.0046908,0,0
7,GO NON CANONICAL WNT SIGNALING PATHWAY,0.71006,-0.00074185,-0.018479,0,0
7,GO POSITIVE REGULATION OF CELL ADHESION,0.56666,-0.00075517,-0.052476,0,0
7,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.98255,-0.00076005,-0.02809,0,0
7,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.89215,-0.00085026,-0.0034996,0,0
7,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.77618,-0.00085186,0.005269,0,0
7,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.62113,-0.00088307,-0.027129,0,0
7,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.86455,-0.00094382,0.0024652,0,0
7,GO ION HOMEOSTASIS,0.81668,-0.00099619,-0.010795,0,0
7,GO SIALYLATION,0.78962,-0.0010548,0.01696,0,0
7,GO G0 TO G1 TRANSITION,0.80989,-0.0010569,0.01078,0,0
7,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.9686,-0.001089,-0.027504,0,0
7,GO DETECTION OF MECHANICAL STIMULUS,0.76281,-0.0011782,0.038515,0,0
7,GO AORTA MORPHOGENESIS,0.83713,-0.0012567,-0.06981,0,0
7,GO NUCLEUS ORGANIZATION,0.98953,-0.0012723,-0.010673,0,0
7,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.32506,-0.0012736,-0.083903,0,0
7,GO LIPID PHOSPHORYLATION,0.69061,-0.0012825,0.014771,0,0
7,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.94073,-0.001291,-0.01309,0,0
7,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.91293,-0.0013478,-0.0099524,0,0
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.5726,-0.0013547,0.029184,0,0
7,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.36526,-0.0014041,0.044847,0,0
7,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.65234,-0.0014534,0.018235,0,0
7,GO LEUKOCYTE HOMEOSTASIS,0.89907,-0.0014662,-0.024976,0,0
7,GO REGULATION OF T CELL MIGRATION,0.99651,-0.0015636,-0.011228,0,0
7,GO ENDOTHELIAL CELL MIGRATION,0.8303,-0.0015834,-0.023908,0,0
7,GO ENDOTHELIAL CELL PROLIFERATION,0.69707,-0.0016181,-0.03462,0,0
7,GO OOCYTE DIFFERENTIATION,0.30815,-0.0016705,0.074767,0,0
7,GO ENERGY RESERVE METABOLIC PROCESS,0.81668,-0.0017052,-0.015734,0,0
7,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.76281,-0.001742,0.0031986,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION,0.90599,-0.0017501,-0.0058425,0,0
7,GO SECRETION,0.91987,-0.001807,-0.012747,0,0
7,GO SKELETAL SYSTEM MORPHOGENESIS,0.90599,-0.0018312,0.00098598,0,0
7,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.91293,-0.0018893,-0.016859,0,0
7,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.84397,-0.0019158,-0.0043746,0,0
7,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.98255,-0.0019822,0.015574,0,0
7,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.78289,-0.0020293,-0.017922,0,0
7,GO UROGENITAL SYSTEM DEVELOPMENT,0.76281,-0.002034,-0.0010998,0,0
7,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.94073,-0.0020873,-0.0074675,0,0
7,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.87144,-0.0020956,-0.0094489,0,0
7,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.94073,-0.0021513,-0.04448,0,0
7,GO ESTROUS CYCLE,0.75615,-0.0021767,0.02946,0,0
7,GO OXIDATIVE DEMETHYLATION,0.84397,-0.0022236,0.0035134,0,0
7,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.71006,-0.0022516,0.037912,0,0
7,GO STEM CELL PROLIFERATION,0.55487,-0.0023059,0.042794,0,0
7,GO CHEMICAL HOMEOSTASIS,0.72969,-0.0023224,-0.018415,0,0
7,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.67137,-0.0023969,-0.050172,0,0
7,GO MITOCHONDRIAL DEPOLARIZATION,0.78289,-0.0024073,-0.048601,0,0
7,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.46512,-0.002437,-0.13497,0,0
7,GO PHOTORECEPTOR CELL MAINTENANCE,0.87833,-0.0024528,-0.02336,0,0
7,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.71006,-0.0024689,-0.036303,0,0
7,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.64605,-0.0024798,-0.036962,0,0
7,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.65866,-0.0024868,-0.047526,0,0
7,GO REGULATION OF PEPTIDE TRANSPORT,0.99651,-0.0025159,-0.0061665,0,0
7,GO NEGATIVE T CELL SELECTION,0.79636,-0.0026451,-0.062082,0,0
7,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.87144,-0.002683,-0.010236,0,0
7,GO NEUTROPHIL MIGRATION,0.27227,-0.0027082,-0.075054,0,0
7,GO NEGATIVE REGULATION OF WOUND HEALING,0.40843,-0.0027832,-0.08654,0,0
7,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.78289,-0.002805,-0.018166,0,0
7,GO MYOTUBE CELL DEVELOPMENT,0.78962,-0.0028408,-0.02236,0,0
7,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.62732,-0.0028836,-0.086482,0,0
7,GO ASTROCYTE DIFFERENTIATION,0.69707,-0.0029109,-0.028221,0,0
7,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.88523,-0.0029305,-0.019665,0,0
7,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.91987,-0.0029966,-0.027081,0,0
7,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.7495,-0.0030711,0.0092395,0,0
7,GO COAGULATION,0.78289,-0.0031116,-0.03773,0,0
7,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.40843,-0.0032598,-0.091991,0,0
7,GO REGULATION OF MITOTIC CELL CYCLE,0.67776,-0.0032789,-0.024148,0,0
7,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.98255,-0.003309,-0.012469,0,0
7,GO GOLGI VESICLE TRANSPORT,0.34702,-0.0033112,-0.038758,0,0
7,GO MACROPHAGE DIFFERENTIATION,0.63354,-0.0033285,-0.06306,0,0
7,GO CRANIAL NERVE DEVELOPMENT,0.9686,-0.0033852,0.012992,0,0
7,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.93377,-0.0034226,-0.008498,0,0
7,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.89907,-0.0035324,0.013644,0,0
7,GO PANCREATIC JUICE SECRETION,0.64605,-0.003535,-0.052451,0,0
7,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.98255,-0.0036581,-0.022901,0,0
7,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.76948,-0.0037045,-0.0045199,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.69707,-0.0037334,-0.045985,0,0
7,GO WATER TRANSPORT,0.70355,-0.0037564,-0.044037,0,0
7,GO HISTONE H3 K14 ACETYLATION,0.82348,-0.0037627,0.0011438,0,0
7,GO MULTICELLULAR ORGANISM GROWTH,0.70355,-0.0037943,-0.020045,0,0
7,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.94769,-0.0038065,-0.013929,0,0
7,GO SPINDLE LOCALIZATION,0.92682,-0.0039052,-0.026084,0,0
7,GO MITOPHAGY,0.35607,-0.0039115,-0.076246,0,0
7,GO TISSUE MORPHOGENESIS,0.75615,-0.0039348,-0.02311,0,0
7,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.95466,-0.0039397,0.0070662,0,0
7,GO BONE REMODELING,0.61497,-0.0040209,-0.051989,0,0
7,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.8303,-0.0040895,-0.015984,0,0
7,GO LIPOPROTEIN CATABOLIC PROCESS,0.48131,-0.0041131,-0.066441,0,0
7,GO ADIPOSE TISSUE DEVELOPMENT,0.86455,-0.0041499,-0.010662,0,0
7,GO CELLULAR RESPONSE TO IRON ION,0.41842,-0.0042077,-0.12676,0,0
7,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.72313,-0.0042293,0.029906,0,0
7,GO NEPHRON MORPHOGENESIS,0.85082,-0.004464,0.0099206,0,0
7,GO ZINC ION HOMEOSTASIS,0.86455,-0.0046158,-0.06338,0,0
7,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.80312,-0.0046174,0.042387,0,0
7,GO REGULATION OF RECEPTOR RECYCLING,0.54903,-0.0047164,0.029871,0,0
7,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.57857,-0.0047904,-0.076284,0,0
7,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.8303,-0.0048062,-0.012935,0,0
7,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.61497,-0.0048146,-0.072223,0,0
7,GO ENDOSOME ORGANIZATION,0.78289,-0.0048252,0.0019255,0,0
7,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.89215,-0.0050131,0.00054369,0,0
7,GO MITOCHONDRIAL PROTEIN PROCESSING,0.97557,-0.0050861,-0.0067774,0,0
7,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.81668,-0.0051174,-0.024836,0,0
7,GO CORTICAL CYTOSKELETON ORGANIZATION,0.53167,-0.0051425,0.02682,0,0
7,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.38888,-0.005215,0.070493,0,0
7,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.87833,-0.0052457,-0.011041,0,0
7,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.72969,-0.0052601,-0.018169,0,0
7,GO REGULATION OF CHROMOSOME ORGANIZATION,0.9686,-0.0052725,-0.015843,0,0
7,GO HISTONE H2A MONOUBIQUITINATION,0.97557,-0.005347,0.0094536,0,0
7,GO INOSITOL LIPID MEDIATED SIGNALING,0.74288,-0.0053892,0.0036938,0,0
7,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.92682,-0.0053968,-0.019978,0,0
7,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.76948,-0.005445,-0.030658,0,0
7,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.63978,-0.0056897,-0.025025,0,0
7,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.78289,-0.0057578,-0.012816,0,0
7,GO KIDNEY EPITHELIUM DEVELOPMENT,0.69061,-0.0058287,0.016122,0,0
7,GO INNER EAR MORPHOGENESIS,0.68418,-0.0058893,-0.021606,0,0
7,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.55487,-0.0058952,-0.045693,0,0
7,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.80989,-0.0060068,-0.006945,0,0
7,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.25363,-0.0060116,-0.10816,0,0
7,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.66501,-0.006041,0.015987,0,0
7,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.76281,-0.0060688,-0.036207,0,0
7,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.49227,-0.00608,-0.056625,0,0
7,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.54903,-0.0061731,-0.051046,0,0
7,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.8303,-0.0062188,-0.0092113,0,0
7,GO RESPONSE TO MUSCLE STRETCH,0.76948,-0.0062849,-0.052358,0,0
7,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.85768,-0.0063275,-0.011924,0,0
7,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.69707,-0.006343,-0.011361,0,0
7,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.76281,-0.0063811,-0.0133,0,0
7,GO MITOCHONDRIAL TRANSPORT,0.92682,-0.0064441,0.0033756,0,0
7,GO MEMBRANE ORGANIZATION,0.83713,-0.0064917,-0.0011915,0,0
7,GO INTERFERON ALPHA PRODUCTION,0.80312,-0.0065732,-0.023235,0,0
7,GO REGULATION OF ACTION POTENTIAL,0.80989,-0.0065806,0.017162,0,0
7,GO L AMINO ACID TRANSPORT,0.60883,-0.0065867,-0.011489,0,0
7,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.27611,-0.0065956,-0.11447,0,0
7,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.59059,-0.0066432,-0.041283,0,0
7,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.91987,-0.0066572,-0.013146,0,0
7,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.23937,-0.0066783,-0.11764,0,0
7,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.81668,-0.0067013,0.052387,0,0
7,GO ARTERY MORPHOGENESIS,0.53742,-0.0067246,-0.04957,0,0
7,GO SMALL MOLECULE CATABOLIC PROCESS,0.40349,-0.0067356,-0.043383,0,0
7,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.9686,-0.0067464,-0.0049938,0,0
7,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.24643,-0.0067798,-0.058192,0,0
7,GO PIGMENT CELL DIFFERENTIATION,0.65234,-0.0067827,0.012895,0,0
7,GO GRANULOCYTE MIGRATION,0.32938,-0.0068213,-0.081178,0,0
7,GO RESPONSE TO LITHIUM ION,0.78289,-0.006848,0.057369,0,0
7,GO REGULATION OF WOUND HEALING,0.34702,-0.0069475,-0.073418,0,0
7,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.91987,-0.006964,-0.0013395,0,0
7,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.65234,-0.0069645,-0.031486,0,0
7,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.65866,-0.0070274,0.028579,0,0
7,GO SERTOLI CELL DIFFERENTIATION,0.50337,-0.0070364,-0.06669,0,0
7,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.50896,-0.0070366,-0.07036,0,0
7,GO CHROMOSOME ORGANIZATION,0.89907,-0.0070918,-0.0074593,0,0
7,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.9686,-0.0071004,-0.015186,0,0
7,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.72313,-0.0071052,-0.052941,0,0
7,GO RESPONSE TO LEPTIN,0.96163,-0.007117,0.003301,0,0
7,GO PROTEIN MATURATION,0.89907,-0.0071253,-0.022316,0,0
7,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.71658,-0.0071598,0.012255,0,0
7,GO TISSUE REGENERATION,0.75615,-0.0071668,-0.019414,0,0
7,GO PEROXISOMAL TRANSPORT,0.42347,-0.0072482,-0.066491,0,0
7,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.94769,-0.007268,-0.0024274,0,0
7,GO B CELL PROLIFERATION,0.5726,-0.007355,-0.048581,0,0
7,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.94073,-0.0074265,-0.0090475,0,0
7,GO RESPONSE TO ENDOGENOUS STIMULUS,0.90599,-0.0075478,-0.009367,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.98255,-0.0076152,0.012259,0,0
7,GO HISTONE H2B UBIQUITINATION,0.30402,-0.0076234,-0.077892,0,0
7,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.69061,-0.0076264,-0.01825,0,0
7,GO NEUTROPHIL CHEMOTAXIS,0.44402,-0.007654,-0.054882,0,0
7,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.96163,-0.0076566,-0.020102,0,0
7,GO HOMEOSTASIS OF NUMBER OF CELLS,0.21579,-0.0076583,-0.054463,0,0
7,GO REGULATION OF PHOSPHORYLATION,0.75615,-0.0076981,-0.016016,0,0
7,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.98255,-0.0077828,-0.0036802,0,0
7,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.68418,-0.0077935,-0.050444,0,0
7,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.36526,-0.0078977,0.052732,0,0
7,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.94073,-0.0079757,-0.033145,0,0
7,GO NCRNA TRANSCRIPTION,0.98953,-0.0079851,-0.0056764,0,0
7,GO ANION TRANSPORT,0.89215,-0.0080088,-0.016046,0,0
7,GO POSITIVE REGULATION OF GLIOGENESIS,0.60272,-0.0080188,-0.041743,0,0
7,GO REGULATION OF HYDROLASE ACTIVITY,0.94073,-0.0080407,-0.0053556,0,0
7,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.87144,-0.0080799,-0.01857,0,0
7,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.30815,-0.0081146,-0.092846,0,0
7,GO GRANULOCYTE CHEMOTAXIS,0.42855,-0.0081381,-0.066698,0,0
7,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.99651,-0.0081931,0.0072526,0,0
7,GO REGULATION OF BODY FLUID LEVELS,0.65866,-0.0082277,-0.031986,0,0
7,GO GPI ANCHOR METABOLIC PROCESS,0.97557,-0.008267,-0.0099864,0,0
7,GO ORGANELLE INHERITANCE,0.51459,-0.0082719,-0.036008,0,0
7,GO POLYSACCHARIDE CATABOLIC PROCESS,0.50896,-0.0083304,-0.055352,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.36991,-0.0083332,-0.029084,0,0
7,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.88523,-0.0084083,-0.011066,0,0
7,GO GLYCOSYLATION,0.91293,-0.0085978,-0.022519,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.77618,-0.0086036,-0.02917,0,0
7,GO MATERNAL PLACENTA DEVELOPMENT,0.7495,-0.0086394,-0.040653,0,0
7,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.94073,-0.0086448,0.0065372,0,0
7,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.54321,-0.0086569,-0.071494,0,0
7,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.85768,-0.008681,-0.013428,0,0
7,GO PROTEIN FOLDING,0.50337,-0.008683,-0.047527,0,0
7,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.4545,-0.0087336,-0.04462,0,0
7,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.26471,-0.008742,-0.11547,0,0
7,GO PEPTIDE CATABOLIC PROCESS,0.56075,-0.0087455,-0.05204,0,0
7,GO REGULATION OF T CELL ACTIVATION,0.58456,-0.008747,-0.04945,0,0
7,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.87833,-0.0088369,0.0069391,0,0
7,GO CELL FATE COMMITMENT,0.85768,-0.008837,0.014574,0,0
7,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.29992,-0.0088582,-0.049424,0,0
7,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.79636,-0.0088643,-0.013178,0,0
7,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.38888,-0.0088947,-0.036849,0,0
7,GO RESPONSE TO MINERALOCORTICOID,0.73628,-0.0089326,-0.040521,0,0
7,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.67776,-0.008941,-0.022032,0,0
7,GO OSTEOCLAST DIFFERENTIATION,0.96163,-0.0089436,-0.0059533,0,0
7,GO REGULATION OF VASCULAR PERMEABILITY,0.47588,-0.0089663,-0.045052,0,0
7,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.60883,-0.0090251,-0.02532,0,0
7,GO HORMONE METABOLIC PROCESS,0.91987,-0.0091729,-0.018095,0,0
7,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.84397,-0.0092075,-0.013671,0,0
7,GO ICOSANOID METABOLIC PROCESS,0.89907,-0.009211,-0.045383,0,0
7,GO POSITIVE REGULATION OF TOR SIGNALING,0.83713,-0.0092552,-0.0045433,0,0
7,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.82348,-0.0092577,0.056987,0,0
7,GO REGULATION OF BINDING,0.9686,-0.0092585,-0.0052899,0,0
7,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.42347,-0.0093252,-0.072444,0,0
7,GO REGULATION OF CELL DEATH,0.48131,-0.0093814,-0.028147,0,0
7,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.98255,-0.0093832,-0.035157,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.94073,-0.0093865,-0.0090892,0,0
7,GO GLIAL CELL PROLIFERATION,0.96163,-0.0094299,-0.0042226,0,0
7,GO DETECTION OF STIMULUS,0.67776,-0.0094357,0.0066825,0,0
7,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.91293,-0.0094455,-0.013071,0,0
7,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.44924,-0.0094917,-0.04828,0,0
7,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.38888,-0.0094943,-0.050326,0,0
7,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.67776,-0.0095263,-0.035839,0,0
7,GO MUSCLE ORGAN DEVELOPMENT,0.87144,-0.0095769,0.003221,0,0
7,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.85768,-0.0096236,0.0044218,0,0
7,GO CHROMATIN ORGANIZATION,0.62113,-0.0096295,-0.0094937,0,0
7,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.62113,-0.0096555,0.045432,0,0
7,GO MITOCHONDRIAL TRANSCRIPTION,0.82348,-0.0097482,-0.026549,0,0
7,GO PROTEIN NEDDYLATION,0.98255,-0.0097501,0.0050763,0,0
7,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.90599,-0.0098973,0.0023203,0,0
7,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.78289,-0.0099109,-0.01217,0,0
7,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.85768,-0.0099348,0.0037267,0,0
7,GO MYELOID LEUKOCYTE MIGRATION,0.9686,-0.01,-0.0242,0,0
7,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.78289,-0.010052,-0.026362,0,0
7,GO HOMOTYPIC CELL CELL ADHESION,0.59664,-0.010098,-0.04001,0,0
7,GO OVULATION CYCLE,0.80989,-0.010118,0.0074364,0,0
7,GO PLACENTA DEVELOPMENT,0.69061,-0.01017,-0.026957,0,0
7,GO CALCINEURIN MEDIATED SIGNALING,0.71658,-0.010396,-0.023763,0,0
7,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.94073,-0.010538,-0.010766,0,0
7,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.73628,-0.010558,-0.054603,0,0
7,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.38408,-0.010617,-0.039562,0,0
7,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.59059,-0.010625,-0.051219,0,0
7,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.76948,-0.010626,-0.0090033,0,0
7,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.59664,-0.010668,0.016951,0,0
7,GO RIG I SIGNALING PATHWAY,0.46512,-0.010794,-0.070725,0,0
7,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.51459,-0.010902,-0.042538,0,0
7,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.61497,-0.010905,-0.01921,0,0
7,GO ACTIVATION OF MAPK ACTIVITY,0.62113,-0.010963,-0.028636,0,0
7,GO REGULATION OF CGMP MEDIATED SIGNALING,0.97557,-0.011079,-0.020866,0,0
7,GO ACTIN CYTOSKELETON REORGANIZATION,0.53742,-0.011089,-0.038265,0,0
7,GO RESPONSE TO VITAMIN,0.75615,-0.011131,-0.039672,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.63354,-0.011156,0.035286,0,0
7,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.59059,-0.011206,-0.049288,0,0
7,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.65234,-0.011212,-0.016855,0,0
7,GO REGULATION OF INTEGRIN ACTIVATION,0.68418,-0.011223,-0.025329,0,0
7,GO IMMATURE T CELL PROLIFERATION,0.4978,-0.011243,-0.08125,0,0
7,GO ANIMAL ORGAN MORPHOGENESIS,0.64605,-0.011354,0.016317,0,0
7,GO ACUTE PHASE RESPONSE,0.41341,-0.011502,-0.080456,0,0
7,GO NODAL SIGNALING PATHWAY,0.80312,-0.011554,0.01255,0,0
7,GO MONOSACCHARIDE CATABOLIC PROCESS,0.85768,-0.01171,-0.0093859,0,0
7,GO AUTOPHAGY OF MITOCHONDRION,0.23589,-0.011892,-0.060917,0,0
7,GO FAT CELL DIFFERENTIATION,0.3746,-0.011944,-0.050907,0,0
7,GO RNA CAPPING,0.76948,-0.011993,-0.01524,0,0
7,GO PEPTIDYL LYSINE METHYLATION,0.87144,-0.012152,0.0029658,0,0
7,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.94073,-0.012169,-0.0011919,0,0
7,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.36991,-0.012193,-0.052563,0,0
7,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.47049,-0.012225,-0.074092,0,0
7,GO INACTIVATION OF MAPK ACTIVITY,0.9686,-0.012247,-0.0013406,0,0
7,GO HISTONE H4 K16 ACETYLATION,0.80989,-0.012258,0.0010187,0,0
7,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.47049,-0.012262,-0.080094,0,0
7,GO MUSCLE ADAPTATION,0.76948,-0.012271,-0.030417,0,0
7,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.4598,-0.012311,-0.047249,0,0
7,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.36064,-0.012321,-0.055656,0,0
7,GO RESPONSE TO ACID CHEMICAL,0.91987,-0.01238,-0.0098379,0,0
7,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.84397,-0.01248,-0.00307,0,0
7,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.77618,-0.012498,0.019425,0,0
7,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.83713,-0.012499,0.010626,0,0
7,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.98953,-0.012527,-0.0091601,0,0
7,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.72313,-0.012591,-0.02743,0,0
7,GO FEMALE SEX DIFFERENTIATION,0.7495,-0.012654,0.011532,0,0
7,GO REGULATION OF CELL MATRIX ADHESION,0.51459,-0.012723,-0.056347,0,0
7,GO INORGANIC ANION TRANSPORT,0.91987,-0.012771,-0.0095357,0,0
7,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.56666,-0.012802,0.076815,0,0
7,GO LYSOSOME LOCALIZATION,0.26098,-0.012901,-0.062808,0,0
7,GO PEPTIDYL LYSINE DIMETHYLATION,0.99651,-0.012934,0.0097527,0,0
7,GO PRE MIRNA PROCESSING,0.60883,-0.012937,-0.04717,0,0
7,GO EMBRYONIC BODY MORPHOGENESIS,0.74288,-0.012941,0.018965,0,0
7,GO PROTEIN PROCESSING,0.68418,-0.012957,-0.039231,0,0
7,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.72313,-0.013032,-0.020519,0,0
7,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.36526,-0.013035,-0.10749,0,0
7,GO MRNA CLEAVAGE,0.81668,-0.013084,-0.0060064,0,0
7,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.59059,-0.013124,-0.040546,0,0
7,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.92682,-0.013264,-0.015936,0,0
7,GO SMOOTHENED SIGNALING PATHWAY,0.86455,-0.013278,-0.011482,0,0
7,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.42855,-0.013284,-0.05152,0,0
7,GO PRIMARY MIRNA PROCESSING,0.46512,-0.013305,-0.060852,0,0
7,GO NEUTRAL LIPID METABOLIC PROCESS,0.27611,-0.013359,-0.05653,0,0
7,GO MITOTIC NUCLEAR DIVISION,0.89907,-0.013363,-0.01377,0,0
7,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.78962,-0.013375,-0.010766,0,0
7,GO RENAL SYSTEM PROCESS,0.62113,-0.013469,-0.028778,0,0
7,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.83713,-0.013672,-0.032677,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.41842,-0.013681,-0.059943,0,0
7,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.72313,-0.013787,-0.030149,0,0
7,GO MAINTENANCE OF CELL NUMBER,0.47588,-0.013857,-0.047919,0,0
7,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.89215,-0.01388,-0.030239,0,0
7,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.62732,-0.01401,-0.013698,0,0
7,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.41842,-0.014019,-0.022382,0,0
7,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.91293,-0.014054,-0.016864,0,0
7,GO TELOMERASE RNA LOCALIZATION,0.68418,-0.014094,-0.055339,0,0
7,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.43883,-0.014104,0.025743,0,0
7,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.73628,-0.014108,-0.0094503,0,0
7,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.27227,-0.014118,-0.047247,0,0
7,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.2839,-0.01415,-0.062937,0,0
7,GO HORMONE MEDIATED SIGNALING PATHWAY,0.41341,-0.014262,-0.031841,0,0
7,GO O GLYCAN PROCESSING,0.89215,-0.014399,-0.04579,0,0
7,GO CELLULAR MACROMOLECULE LOCALIZATION,0.66501,-0.014472,-0.0090759,0,0
7,GO NEGATIVE REGULATION OF CELL CYCLE,0.14769,-0.014492,-0.041574,0,0
7,GO ALDITOL METABOLIC PROCESS,0.53167,-0.014521,-0.054362,0,0
7,GO RETINAL ROD CELL DIFFERENTIATION,0.92682,-0.014585,-0.010662,0,0
7,GO AUTOPHAGIC CELL DEATH,0.68418,-0.014702,-0.046539,0,0
7,GO APOPTOTIC PROCESS,0.38888,-0.014707,-0.030237,0,0
7,GO NEURAL TUBE FORMATION,0.69707,-0.014772,-0.033138,0,0
7,GO CELLULAR RESPONSE TO VIRUS,0.81668,-0.014789,-0.032129,0,0
7,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.76281,-0.014861,-0.0029762,0,0
7,GO DNA BIOSYNTHETIC PROCESS,0.97557,-0.014862,-0.0067602,0,0
7,GO DNA REPAIR,0.4545,-0.014895,-0.024412,0,0
7,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.76281,-0.014921,-0.085086,0,0
7,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.46512,-0.014962,-0.075047,0,0
7,GO CELL MATRIX ADHESION,0.42855,-0.015168,-0.059476,0,0
7,GO NEGATIVE REGULATION OF SECRETION,0.9686,-0.015223,-0.0046405,0,0
7,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.34702,-0.015261,-0.05068,0,0
7,GO MACROPHAGE CHEMOTAXIS,0.69061,-0.015338,-0.05065,0,0
7,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.63354,-0.015375,-0.031673,0,0
7,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.63354,-0.015376,-0.0050682,0,0
7,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.70355,-0.01539,-0.051272,0,0
7,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.85768,-0.015414,-0.025395,0,0
7,GO ESTABLISHMENT OF TISSUE POLARITY,0.30815,-0.015449,-0.054522,0,0
7,GO ENDOTHELIUM DEVELOPMENT,0.54903,-0.015518,-0.040617,0,0
7,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.44402,-0.015608,-0.024756,0,0
7,GO NEGATIVE REGULATION OF CELL ADHESION,0.87833,-0.01564,-0.021333,0,0
7,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.83713,-0.015746,0.0089648,0,0
7,GO EXTRACELLULAR VESICLE BIOGENESIS,0.84397,-0.015848,0.0081729,0,0
7,GO TUBE MORPHOGENESIS,0.84397,-0.015859,-0.022947,0,0
7,GO AORTIC VALVE DEVELOPMENT,0.92682,-0.015893,0.015928,0,0
7,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.25001,-0.015938,-0.032844,0,0
7,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.27999,-0.016006,-0.03248,0,0
7,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.58456,-0.016061,-0.064244,0,0
7,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.89907,-0.016069,-0.035192,0,0
7,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.49227,-0.016158,-0.028079,0,0
7,GO REGULATION OF VASCULATURE DEVELOPMENT,0.46512,-0.016201,-0.060353,0,0
7,GO NEGATIVE REGULATION OF CELL DIVISION,0.93377,-0.016213,-0.019787,0,0
7,GO REGULATION OF VIRAL TRANSCRIPTION,0.11434,-0.016237,-0.084578,0,0
7,GO GLIAL CELL DEVELOPMENT,0.99651,-0.016251,0.0031853,0,0
7,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.39371,-0.016271,-0.042329,0,0
7,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.71658,-0.016306,-0.042056,0,0
7,GO ORGAN GROWTH,0.89907,-0.016332,-0.013768,0,0
7,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.80989,-0.016338,-0.0011937,0,0
7,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.39371,-0.016342,-0.089196,0,0
7,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.49227,-0.016378,-0.06337,0,0
7,GO HISTONE H2A ACETYLATION,0.78962,-0.01638,-0.012755,0,0
7,GO IN UTERO EMBRYONIC DEVELOPMENT,0.46512,-0.016391,-0.033161,0,0
7,GO PENTOSE METABOLIC PROCESS,0.3746,-0.016395,-0.10763,0,0
7,GO DETECTION OF OTHER ORGANISM,0.64605,-0.016447,-0.098689,0,0
7,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.59664,-0.016477,-0.051278,0,0
7,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.69707,-0.016503,-0.01904,0,0
7,GO PROTEIN METHYLATION,0.80312,-0.016506,0.0029848,0,0
7,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.26847,-0.016549,-0.047354,0,0
7,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.72313,-0.016559,-0.019629,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.59664,-0.016575,-0.025039,0,0
7,GO REGULATION OF ERAD PATHWAY,0.65234,-0.016593,-0.016241,0,0
7,GO RESPONSE TO TUMOR CELL,0.59059,-0.016615,-0.068056,0,0
7,GO PEPTIDE CROSS LINKING,0.19393,-0.016668,-0.15626,0,0
7,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.93377,-0.016669,-0.021909,0,0
7,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.73628,-0.016702,-0.022393,0,0
7,GO MITOTIC SISTER CHROMATID SEGREGATION,0.8303,-0.016739,-0.016195,0,0
7,GO CELL SUBSTRATE ADHESION,0.59059,-0.016755,-0.057177,0,0
7,GO ENDOSOME TO LYSOSOME TRANSPORT,0.59664,-0.016756,-0.033065,0,0
7,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.35153,-0.016797,0.052875,0,0
7,GO LAMELLIPODIUM ORGANIZATION,0.42855,-0.016812,-0.044301,0,0
7,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.96163,-0.01686,-0.049386,0,0
7,GO REGULATION OF CELL POPULATION PROLIFERATION,0.43883,-0.016879,-0.035645,0,0
7,GO NEGATIVE REGULATION OF CELL DEATH,0.18508,-0.016907,-0.052354,0,0
7,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.65234,-0.016977,-0.045726,0,0
7,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.42855,-0.016978,-0.045513,0,0
7,GO PROTEIN INSERTION INTO MEMBRANE,0.96163,-0.017062,0.015332,0,0
7,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.48131,-0.017085,-0.07271,0,0
7,GO ACTIN FILAMENT BASED MOVEMENT,0.71658,-0.017105,-0.011427,0,0
7,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.26471,-0.017173,-0.038936,0,0
7,GO LEUKOCYTE CELL CELL ADHESION,0.26847,-0.017182,-0.076222,0,0
7,GO MYOBLAST PROLIFERATION,0.7495,-0.017245,-0.055372,0,0
7,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.30815,-0.017303,-0.055448,0,0
7,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.31653,-0.017401,-0.029173,0,0
7,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.42347,-0.017457,-0.069287,0,0
7,GO HISTONE H3 K36 METHYLATION,0.48131,-0.017458,0.058684,0,0
7,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.41341,-0.017553,-0.075845,0,0
7,GO T CELL RECEPTOR SIGNALING PATHWAY,0.32938,-0.017571,-0.053288,0,0
7,GO EMBRYONIC PLACENTA DEVELOPMENT,0.98953,-0.017584,0.0051442,0,0
7,GO RNA 5 END PROCESSING,0.98953,-0.017634,-0.015268,0,0
7,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.43883,-0.017701,-0.038673,0,0
7,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.49227,-0.017702,-0.022113,0,0
7,GO TRANSLATIONAL TERMINATION,0.51459,-0.017707,-0.035787,0,0
7,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.77618,-0.017745,-0.019599,0,0
7,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.62732,-0.01776,-0.011563,0,0
7,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.7495,-0.017895,-0.020445,0,0
7,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.44924,-0.017899,-0.062967,0,0
7,GO HEART MORPHOGENESIS,0.69707,-0.017951,0.011829,0,0
7,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.88523,-0.017974,0.0015192,0,0
7,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.81668,-0.018029,-0.049289,0,0
7,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.41842,-0.018031,-0.0388,0,0
7,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.13814,-0.018043,-0.098515,0,0
7,GO CERAMIDE METABOLIC PROCESS,0.36526,-0.018069,-0.04371,0,0
7,GO EPITHELIAL CELL DIFFERENTIATION,0.40843,-0.018107,-0.059622,0,0
7,GO T CELL CYTOKINE PRODUCTION,0.72969,-0.018128,-0.009601,0,0
7,GO RESPONSE TO DRUG,0.48678,-0.018209,-0.030536,0,0
7,GO MAMMARY GLAND DEVELOPMENT,0.60272,-0.018232,-0.026744,0,0
7,GO MITOTIC CELL CYCLE CHECKPOINT,0.41341,-0.018279,-0.040959,0,0
7,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.57857,-0.01831,-0.077461,0,0
7,GO HYPOTONIC RESPONSE,0.35153,-0.018316,-0.10157,0,0
7,GO TUMOR NECROSIS FACTOR SECRETION,0.65234,-0.018357,-0.039861,0,0
7,GO DNA PACKAGING,0.96163,-0.018367,-0.001157,0,0
7,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.188,-0.018384,-0.047597,0,0
7,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.26098,-0.018417,-0.16316,0,0
7,GO POSITIVE REGULATION OF CELL DEATH,0.71658,-0.018471,-0.020935,0,0
7,GO GOLGI VESICLE BUDDING,0.53742,-0.018549,-0.04858,0,0
7,GO PROTEIN MONOUBIQUITINATION,0.92682,-0.018614,-0.0067455,0,0
7,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.36526,-0.018621,-0.073794,0,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.86455,-0.018624,-0.064519,0,0
7,GO REGULATION OF CELL ADHESION,0.7495,-0.018655,-0.030651,0,0
7,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.60883,-0.018711,-0.075292,0,0
7,GO REGULATION OF MEMBRANE PERMEABILITY,0.59059,-0.018857,0.054022,0,0
7,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.91293,-0.018868,0.013895,0,0
7,GO COPII COATED VESICLE BUDDING,0.76948,-0.018892,-0.039974,0,0
7,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.62732,-0.018896,-0.019357,0,0
7,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.91987,-0.018932,-0.034795,0,0
7,GO MRNA 3 END PROCESSING,0.38408,-0.01894,-0.029115,0,0
7,GO LEUKOCYTE MIGRATION,0.66501,-0.018958,-0.038138,0,0
7,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.9686,-0.019167,0.01006,0,0
7,GO THYMIC T CELL SELECTION,0.24288,-0.019191,-0.090249,0,0
7,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.83713,-0.019224,-0.012302,0,0
7,GO REGULATION OF B CELL PROLIFERATION,0.59059,-0.019257,-0.060377,0,0
7,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.97557,-0.019292,-0.025501,0,0
7,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.42855,-0.019323,-0.06869,0,0
7,GO RESPONSE TO ISCHEMIA,0.56666,-0.019436,-0.036862,0,0
7,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.80312,-0.019454,-0.01858,0,0
7,GO MESENCHYME DEVELOPMENT,0.71658,-0.019483,-0.012573,0,0
7,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.63978,-0.019511,-0.01879,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.40349,-0.019602,-0.07209,0,0
7,GO MEMBRANE LIPID METABOLIC PROCESS,0.51459,-0.019607,-0.048151,0,0
7,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.82348,-0.019656,-0.010604,0,0
7,GO HOMEOSTATIC PROCESS,0.43883,-0.019664,-0.02273,0,0
7,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.50337,-0.019684,-0.07081,0,0
7,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.69061,-0.019704,-0.077124,0,0
7,GO MYELOID CELL DIFFERENTIATION,0.26471,-0.019712,-0.045917,0,0
7,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.55487,-0.019753,-0.033938,0,0
7,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.79636,-0.019791,-0.059324,0,0
7,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.87833,-0.019803,0.0089001,0,0
7,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.43367,-0.01981,-0.028751,0,0
7,GO NOTCH RECEPTOR PROCESSING,0.7495,-0.019938,0.068833,0,0
7,GO STEROL IMPORT,0.39858,-0.019974,-0.10797,0,0
7,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.89907,-0.02004,0.0019495,0,0
7,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.79636,-0.020068,-0.011876,0,0
7,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.30402,-0.020129,-0.030942,0,0
7,GO LIPOPROTEIN METABOLIC PROCESS,0.76948,-0.020227,-0.030753,0,0
7,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.28785,-0.020237,-0.11153,0,0
7,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.39858,-0.020282,-0.08026,0,0
7,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.65234,-0.020293,-0.033761,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.72969,-0.0203,-0.027295,0,0
7,GO ALPHA AMINO ACID METABOLIC PROCESS,0.33812,-0.020303,-0.059273,0,0
7,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.76948,-0.020334,0.048656,0,0
7,GO TUBE DEVELOPMENT,0.87144,-0.020415,-0.016816,0,0
7,GO REGULATION OF MRNA PROCESSING,0.4978,-0.020439,-0.017895,0,0
7,GO INTRACELLULAR TRANSPORT,0.29992,-0.020476,-0.0215,0,0
7,GO VENTRICULAR SYSTEM DEVELOPMENT,0.90599,-0.02054,-0.0080304,0,0
7,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.51459,-0.020742,-0.023247,0,0
7,GO POSITIVE REGULATION OF CELL CYCLE,0.21256,-0.020748,-0.046412,0,0
7,GO EPITHELIAL CELL CELL ADHESION,0.66501,-0.020754,-0.04201,0,0
7,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.40349,-0.02086,-0.02659,0,0
7,GO B CELL MEDIATED IMMUNITY,0.34702,-0.020868,-0.096783,0,0
7,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.58456,-0.020872,-0.048373,0,0
7,GO POSITIVE REGULATION OF CYTOKINESIS,0.53167,-0.020874,0.044033,0,0
7,GO ACTIVATION OF JUN KINASE ACTIVITY,0.94073,-0.020898,0.0057852,0,0
7,GO GOLGI ORGANIZATION,0.38408,-0.020902,-0.038219,0,0
7,GO POSITIVE THYMIC T CELL SELECTION,0.32077,-0.020991,-0.076729,0,0
7,GO MORPHOGENESIS OF AN EPITHELIUM,0.72313,-0.021048,-0.0312,0,0
7,GO RESPONSE TO WOUNDING,0.48678,-0.02125,-0.050862,0,0
7,GO DNA MODIFICATION,0.076492,-0.021255,-0.047429,0,0
7,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.56666,-0.021267,-0.025948,0,0
7,GO LUNG CELL DIFFERENTIATION,0.98953,-0.021318,0.007116,0,0
7,GO DNA INTEGRITY CHECKPOINT,0.39371,-0.021356,-0.036554,0,0
7,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.50337,-0.021405,-0.027765,0,0
7,GO NEGATIVE REGULATION OF CELL SIZE,0.87833,-0.02151,0.011709,0,0
7,GO HISTONE MONOUBIQUITINATION,0.39858,-0.021538,-0.026173,0,0
7,GO CYSTEINE METABOLIC PROCESS,0.55487,-0.021587,0.016444,0,0
7,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.62113,-0.021681,-0.0332,0,0
7,GO PHOSPHOLIPID METABOLIC PROCESS,0.42347,-0.02169,-0.032179,0,0
7,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.18219,-0.021812,-0.094531,0,0
7,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.4545,-0.021814,-0.074411,0,0
7,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.44402,-0.021877,-0.099451,0,0
7,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.38408,-0.021974,-0.037312,0,0
7,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.40843,-0.02198,-0.015673,0,0
7,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.22235,-0.022066,-0.077128,0,0
7,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.65866,-0.022068,-0.034981,0,0
7,GO AMINE METABOLIC PROCESS,0.25001,-0.022157,-0.070832,0,0
7,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.48678,-0.02221,-0.033228,0,0
7,GO CHROMOSOME CONDENSATION,0.63978,-0.022215,-0.012747,0,0
7,GO HEART DEVELOPMENT,0.87833,-0.022354,-0.002558,0,0
7,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.95466,-0.022363,0.030585,0,0
7,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.41341,-0.022378,-0.074135,0,0
7,GO POSITIVE REGULATION OF ANION TRANSPORT,0.20621,-0.022447,-0.086357,0,0
7,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.97557,-0.022452,0.0017332,0,0
7,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.19393,-0.022465,-0.034395,0,0
7,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.25363,-0.022574,-0.036606,0,0
7,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.36064,-0.022632,-0.098332,0,0
7,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.15517,-0.022635,-0.077775,0,0
7,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.80989,-0.022663,-0.024936,0,0
7,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.74288,-0.022735,-0.038126,0,0
7,GO VASODILATION,0.71658,-0.022759,-0.063195,0,0
7,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.22568,-0.022772,-0.090464,0,0
7,GO HISTONE EXCHANGE,0.38408,-0.022792,-0.041757,0,0
7,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.97557,-0.022816,-0.010904,0,0
7,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.44402,-0.022824,-0.040898,0,0
7,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.67137,-0.022852,0.015911,0,0
7,GO PROSTAGLANDIN TRANSPORT,0.64605,-0.022854,-0.044896,0,0
7,GO ATP BIOSYNTHETIC PROCESS,0.79636,-0.022865,-0.0081078,0,0
7,GO CELLULAR RESPONSE TO PEPTIDE,0.3746,-0.022877,-0.031171,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.29184,-0.022903,-0.12544,0,0
7,GO NUCLEAR PORE ORGANIZATION,0.30402,-0.022928,-0.078634,0,0
7,GO PLATELET AGGREGATION,0.66501,-0.022956,-0.033509,0,0
7,GO RNA LOCALIZATION,0.60883,-0.02299,-0.029272,0,0
7,GO REGULATION OF EXCRETION,0.48678,-0.02301,-0.074391,0,0
7,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.62113,-0.023061,-0.074767,0,0
7,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.48131,-0.023102,-0.054169,0,0
7,GO MONOSACCHARIDE METABOLIC PROCESS,0.87833,-0.023102,-0.0090396,0,0
7,GO CYTOSOLIC TRANSPORT,0.34256,-0.02322,-0.040147,0,0
7,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.71006,-0.023242,-0.017253,0,0
7,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.50337,-0.023313,-0.028704,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.41842,-0.023338,-0.082877,0,0
7,GO NUCLEOBASE METABOLIC PROCESS,0.25729,-0.023462,-0.075568,0,0
7,GO RESPONSE TO PEPTIDE,0.23245,-0.023483,-0.038046,0,0
7,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.5726,-0.023576,0.082376,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.42347,-0.023582,-0.050833,0,0
7,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.91987,-0.023596,-0.039192,0,0
7,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.34256,-0.023686,-0.037837,0,0
7,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.52025,-0.023734,-0.075221,0,0
7,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.62732,-0.023736,-0.019151,0,0
7,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.65234,-0.023877,-0.035261,0,0
7,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.62113,-0.023898,-0.035824,0,0
7,GO MITOCHONDRIAL FISSION,0.41842,-0.023913,-0.049709,0,0
7,GO LIPID DROPLET FORMATION,0.58456,-0.023956,-0.085485,0,0
7,GO GLYCEROLIPID METABOLIC PROCESS,0.46512,-0.023965,-0.027405,0,0
7,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.23245,-0.023987,-0.054863,0,0
7,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.56075,-0.024056,-0.015469,0,0
7,GO ANION TRANSMEMBRANE TRANSPORT,0.48678,-0.024096,-0.029474,0,0
7,GO RESPONSE TO VIRUS,0.39371,-0.024138,-0.08644,0,0
7,GO HAIR CELL DIFFERENTIATION,0.26471,-0.024247,-0.10579,0,0
7,GO RESPONSE TO ESTRADIOL,0.82348,-0.024268,0.014959,0,0
7,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.5726,-0.024312,-0.045364,0,0
7,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.47049,-0.024326,-0.028769,0,0
7,GO PROSTATIC BUD FORMATION,0.84397,-0.024367,-0.069496,0,0
7,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.3746,-0.024409,-0.035022,0,0
7,GO GLIAL CELL ACTIVATION,0.58456,-0.024427,-0.05878,0,0
7,GO MRNA MODIFICATION,0.46512,-0.024441,-0.072581,0,0
7,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.39858,-0.024445,-0.090074,0,0
7,GO SULFATE TRANSPORT,0.29586,-0.024586,-0.03333,0,0
7,GO INTERLEUKIN 13 PRODUCTION,0.70355,-0.024643,-0.057162,0,0
7,GO RNA EXPORT FROM NUCLEUS,0.40349,-0.024646,-0.040274,0,0
7,GO REGULATION OF MACROPHAGE MIGRATION,0.48131,-0.024656,-0.043857,0,0
7,GO LYTIC VACUOLE ORGANIZATION,0.62113,-0.024804,-0.034474,0,0
7,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.60883,-0.024811,-0.12826,0,0
7,GO LYSINE METABOLIC PROCESS,0.82348,-0.024812,-0.034805,0,0
7,GO REGULATION OF TRANSLATIONAL ELONGATION,0.49227,-0.02483,-0.045031,0,0
7,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.75615,-0.024831,-0.039913,0,0
7,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.90599,-0.024863,-0.0056454,0,0
7,GO MUSCLE ORGAN MORPHOGENESIS,0.69061,-0.02488,-0.026506,0,0
7,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.39858,-0.024886,-0.06011,0,0
7,GO TRICARBOXYLIC ACID CYCLE,0.65234,-0.024906,-0.045663,0,0
7,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.53167,-0.024996,0.051847,0,0
7,GO REGULATION OF B CELL ACTIVATION,0.38888,-0.025009,-0.067548,0,0
7,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.95466,-0.025029,0.006486,0,0
7,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.68418,-0.025037,-0.048842,0,0
7,GO EAR MORPHOGENESIS,0.54903,-0.025087,-0.030266,0,0
7,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.63354,-0.025106,0.14192,0,0
7,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.4545,-0.025147,-0.041267,0,0
7,GO FC RECEPTOR SIGNALING PATHWAY,0.86455,-0.025175,-0.015207,0,0
7,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.41842,-0.025213,-0.036792,0,0
7,GO JNK CASCADE,0.59664,-0.025259,-0.020788,0,0
7,GO HISTONE METHYLATION,0.84397,-0.02527,0.0064398,0,0
7,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.52594,-0.025303,-0.020763,0,0
7,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.69707,-0.025304,-0.04812,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.3746,-0.025322,-0.080919,0,0
7,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.63978,-0.025338,-0.068064,0,0
7,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.69061,-0.025338,-0.012899,0,0
7,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.23245,-0.025398,-0.061926,0,0
7,GO GLYCOSIDE METABOLIC PROCESS,0.72969,-0.025483,-0.078667,0,0
7,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.48131,-0.025497,-0.034732,0,0
7,GO TRANSLATIONAL ELONGATION,0.4598,-0.025559,-0.050263,0,0
7,GO PEPTIDYL TYROSINE MODIFICATION,0.67776,-0.025579,-0.026907,0,0
7,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.2839,-0.025595,-0.057148,0,0
7,GO MITOCHONDRIAL FUSION,0.66501,-0.025672,-0.018691,0,0
7,GO CENTROSOME SEPARATION,0.89907,-0.025691,0.0096987,0,0
7,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.32506,-0.025711,-0.02139,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.57857,-0.025711,-0.030724,0,0
7,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.42855,-0.025775,-0.059309,0,0
7,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.66501,-0.025788,0.01818,0,0
7,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.31653,-0.025792,-0.03702,0,0
7,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.36064,-0.025816,-0.11053,0,0
7,GO ACTIN FILAMENT NETWORK FORMATION,0.74288,-0.025818,0.041188,0,0
7,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.18219,-0.025827,-0.027985,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.35607,-0.025906,-0.0796,0,0
7,GO CONNECTIVE TISSUE DEVELOPMENT,0.62113,-0.025931,-0.027963,0,0
7,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.87833,-0.026008,-0.0074622,0,0
7,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.36064,-0.026062,-0.047066,0,0
7,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.56666,-0.026082,-0.038884,0,0
7,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.22235,-0.026089,-0.065013,0,0
7,GO REGULATION OF PLATELET ACTIVATION,0.67776,-0.026188,-0.048258,0,0
7,GO ASTROCYTE DEVELOPMENT,0.42347,-0.026214,-0.06437,0,0
7,GO RESPONSE TO PH,0.70355,-0.026218,-0.025946,0,0
7,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.80989,-0.02623,-0.025397,0,0
7,GO CELLULAR GLUCAN METABOLIC PROCESS,0.54321,-0.026292,-0.036006,0,0
7,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.3746,-0.026333,-0.050926,0,0
7,GO PROTEIN KINASE B SIGNALING,0.67137,-0.026349,-0.031651,0,0
7,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.22568,-0.026362,-0.063299,0,0
7,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.48131,-0.026371,-0.021887,0,0
7,GO POSITIVE REGULATION OF MAPK CASCADE,0.59059,-0.026406,-0.030688,0,0
7,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.96163,-0.026603,0.012973,0,0
7,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.51459,-0.026618,-0.040432,0,0
7,GO CELL JUNCTION DISASSEMBLY,0.47588,-0.026634,0.055991,0,0
7,GO BLOOD VESSEL MORPHOGENESIS,0.48678,-0.026677,-0.045609,0,0
7,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.62113,-0.026829,-0.03592,0,0
7,GO ENDOCRINE SYSTEM DEVELOPMENT,0.43883,-0.026919,0.048769,0,0
7,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.4978,-0.026965,-0.051289,0,0
7,GO SERTOLI CELL DEVELOPMENT,0.89907,-0.027001,-0.027813,0,0
7,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.82348,-0.027085,0.0051422,0,0
7,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.27227,-0.027139,-0.098096,0,0
7,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.77618,-0.027174,-0.010614,0,0
7,GO VASCULATURE DEVELOPMENT,0.62113,-0.027223,-0.04274,0,0
7,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.77618,-0.027254,-0.019325,0,0
7,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.70355,-0.027293,-0.068856,0,0
7,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.91987,-0.027344,0.0014629,0,0
7,GO PEPTIDYL METHIONINE MODIFICATION,0.62113,-0.027374,-0.040413,0,0
7,GO BODY FLUID SECRETION,0.50896,-0.027399,-0.042289,0,0
7,GO INTRACELLULAR PROTEIN TRANSPORT,0.31232,-0.027466,-0.024561,0,0
7,GO REVERSE CHOLESTEROL TRANSPORT,0.44402,-0.027496,-0.10894,0,0
7,GO ORGANIC ACID CATABOLIC PROCESS,0.23245,-0.027539,-0.067565,0,0
7,GO REGULATION OF MAP KINASE ACTIVITY,0.52025,-0.027578,-0.029745,0,0
7,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.41341,-0.02775,-0.025622,0,0
7,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.68418,-0.027767,-0.030733,0,0
7,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.76281,-0.027804,0.012521,0,0
7,GO RESPONSE TO ABIOTIC STIMULUS,0.40349,-0.028087,-0.028121,0,0
7,GO KILLING OF CELLS OF OTHER ORGANISM,0.54321,-0.028089,-0.02864,0,0
7,GO PROTEIN CATABOLIC PROCESS,0.39858,-0.028122,-0.032757,0,0
7,GO PROTEOLYSIS,0.74288,-0.028161,-0.026804,0,0
7,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.39858,-0.028216,-0.070455,0,0
7,GO NUCLEOSIDE CATABOLIC PROCESS,0.56075,-0.028232,-0.069861,0,0
7,GO COPULATION,0.80989,-0.028233,-0.013759,0,0
7,GO SKIN EPIDERMIS DEVELOPMENT,0.40843,-0.028428,-0.059949,0,0
7,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.94073,-0.028432,-0.029358,0,0
7,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.88523,-0.028456,-0.033328,0,0
7,GO EPITHELIAL CELL FATE COMMITMENT,0.4978,-0.028466,-0.058103,0,0
7,GO REGULATION OF PROTEOLYSIS,0.7495,-0.028473,-0.035267,0,0
7,GO REGULATION OF ORGANIC ACID TRANSPORT,0.93377,-0.028474,-0.017593,0,0
7,GO REGULATION OF TUBE SIZE,0.32077,-0.028517,-0.051514,0,0
7,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.60272,-0.028594,-0.023504,0,0
7,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.69707,-0.028631,-0.019356,0,0
7,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.54903,-0.028683,-0.025057,0,0
7,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.061812,-0.0287,-0.11879,0,0
7,GO SPERM EGG RECOGNITION,0.38888,-0.028809,-0.052167,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.95466,-0.028977,0.01386,0,0
7,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.98953,-0.028996,0.00077157,0,0
7,GO MULTIVESICULAR BODY ORGANIZATION,0.81668,-0.029001,0.0060163,0,0
7,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.3746,-0.029041,-0.040162,0,0
7,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.29586,-0.029051,-0.12303,0,0
7,GO REGULATION OF RESPONSE TO STRESS,0.25001,-0.029058,-0.044867,0,0
7,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.37932,-0.029105,-0.060078,0,0
7,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.11636,-0.029124,-0.061552,0,0
7,GO XENOBIOTIC TRANSPORT,0.65866,-0.029199,-0.056141,0,0
7,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.65866,-0.029237,-0.04463,0,0
7,GO MAINTENANCE OF ORGANELLE LOCATION,0.54321,-0.029259,-0.04004,0,0
7,GO MITOCHONDRIAL GENE EXPRESSION,0.32077,-0.029259,-0.069201,0,0
7,GO TOR SIGNALING,0.27999,-0.029311,-0.031962,0,0
7,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.57857,-0.029439,-0.029073,0,0
7,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.63354,-0.029476,-0.028776,0,0
7,GO DE NOVO PROTEIN FOLDING,0.3746,-0.029497,-0.061722,0,0
7,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.78289,-0.02952,0.01894,0,0
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.4598,-0.029558,-0.024366,0,0
7,GO PROTEIN HYDROXYLATION,0.22905,-0.02958,-0.12837,0,0
7,GO PEPTIDYL PROLINE HYDROXYLATION,0.2839,-0.029602,-0.13485,0,0
7,GO MITOCHONDRION ORGANIZATION,0.71658,-0.02963,-0.0060424,0,0
7,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.52025,-0.029659,-0.039334,0,0
7,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.3746,-0.029767,-0.023868,0,0
7,GO EPITHELIAL CELL PROLIFERATION,0.36526,-0.029768,-0.059975,0,0
7,GO PROTEIN O LINKED GLYCOSYLATION,0.66501,-0.029868,-0.043338,0,0
7,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.060602,-0.029986,-0.052824,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.87833,-0.030042,-0.046588,0,0
7,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.31232,-0.030075,-0.072632,0,0
7,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.33812,-0.030076,-0.023746,0,0
7,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.83713,-0.030079,-0.038878,0,0
7,GO HEMOGLOBIN METABOLIC PROCESS,0.5726,-0.030144,-0.054398,0,0
7,GO GENE SILENCING,0.17374,-0.030149,-0.038515,0,0
7,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.47588,-0.030255,-0.057961,0,0
7,GO TETRAPYRROLE METABOLIC PROCESS,0.4545,-0.03026,-0.069459,0,0
7,GO POSITIVE REGULATION OF DNA REPLICATION,0.42855,-0.030265,-0.039694,0,0
7,GO ACTIN NUCLEATION,0.94073,-0.030303,-0.0072056,0,0
7,GO CIRCULATORY SYSTEM DEVELOPMENT,0.71006,-0.030305,-0.025192,0,0
7,GO LIPID TRANSLOCATION,0.67137,-0.030306,-0.035259,0,0
7,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.10465,-0.030322,-0.18359,0,0
7,GO T CELL SELECTION,0.079444,-0.030363,-0.090622,0,0
7,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.37932,-0.030378,-0.036376,0,0
7,GO CELLULAR COMPONENT DISASSEMBLY,0.55487,-0.030387,-0.014102,0,0
7,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.44402,-0.030472,-0.042179,0,0
7,GO COENZYME A BIOSYNTHETIC PROCESS,0.46512,-0.030502,-0.024659,0,0
7,GO DEVELOPMENTAL INDUCTION,0.82348,-0.030584,0.032251,0,0
7,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.8303,-0.030593,0.041718,0,0
7,GO VIRION ASSEMBLY,0.91987,-0.030637,0.0050072,0,0
7,GO PROTEIN STABILIZATION,0.17099,-0.030671,-0.047486,0,0
7,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.61497,-0.030681,-0.022039,0,0
7,GO RESPONSE TO CHEMOKINE,0.77618,-0.030735,-0.033855,0,0
7,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.76281,-0.030885,-0.022857,0,0
7,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.59664,-0.03089,-0.01978,0,0
7,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.71006,-0.03091,0.058658,0,0
7,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.42855,-0.030919,-0.030143,0,0
7,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.20309,-0.030992,-0.058805,0,0
7,GO RESPONSE TO OXIDATIVE STRESS,0.34702,-0.03104,-0.044798,0,0
7,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.04854,-0.031166,-0.066305,0,0
7,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29184,-0.031172,-0.10923,0,0
7,GO MACROMOLECULE CATABOLIC PROCESS,0.063042,-0.031222,-0.052876,0,0
7,GO MRNA PROCESSING,0.25001,-0.031239,-0.038113,0,0
7,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.41341,-0.031297,-0.04457,0,0
7,GO TERPENOID METABOLIC PROCESS,0.48131,-0.031302,-0.046255,0,0
7,GO MAINTENANCE OF LOCATION IN CELL,0.2839,-0.031336,-0.037547,0,0
7,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.56075,-0.03137,-0.017452,0,0
7,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.31653,-0.031376,-0.041848,0,0
7,GO PHOSPHOLIPID HOMEOSTASIS,0.72313,-0.031392,-0.037573,0,0
7,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.20937,-0.031462,-0.06701,0,0
7,GO LEUKOCYTE TETHERING OR ROLLING,0.63978,-0.031503,-0.021183,0,0
7,GO CHEMOSENSORY BEHAVIOR,0.98953,-0.031624,-0.0079301,0,0
7,GO GLYCINE METABOLIC PROCESS,0.40843,-0.031739,-0.1057,0,0
7,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.60272,-0.031778,-0.026655,0,0
7,GO CELL CYCLE ARREST,0.12473,-0.031823,-0.04998,0,0
7,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.99651,-0.031909,-0.014626,0,0
7,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.7495,-0.031948,0.045058,0,0
7,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.53742,-0.032047,-0.024139,0,0
7,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.41341,-0.032053,-0.033944,0,0
7,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.22235,-0.032103,-0.028569,0,0
7,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.35607,-0.032132,-0.063996,0,0
7,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.61497,-0.032224,-0.016137,0,0
7,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.85082,-0.032287,-0.01695,0,0
7,GO PLASMA MEMBRANE ORGANIZATION,0.70355,-0.032322,-0.01561,0,0
7,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.41842,-0.032378,-0.019647,0,0
7,GO REGULATION OF PLATELET AGGREGATION,0.75615,-0.032406,-0.028446,0,0
7,GO REGULATION OF MAPK CASCADE,0.57857,-0.03242,-0.027614,0,0
7,GO TRABECULA FORMATION,0.3746,-0.032488,0.072751,0,0
7,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.31653,-0.032499,-0.045623,0,0
7,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.26098,-0.032506,-0.037934,0,0
7,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.46512,-0.032569,0.12066,0,0
7,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.93377,-0.032596,-0.0045399,0,0
7,GO RENAL SODIUM EXCRETION,0.23589,-0.032604,-0.096397,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.4545,-0.032638,-0.073182,0,0
7,GO REGULATION OF PROTEIN TARGETING,0.75615,-0.032641,-0.0010179,0,0
7,GO EXOCYTOSIS,0.39371,-0.032665,-0.045278,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.22235,-0.032721,-0.039218,0,0
7,GO POSITIVE REGULATION OF T CELL MIGRATION,0.99651,-0.032723,-0.0061113,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.21256,-0.032728,-0.057744,0,0
7,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.36064,-0.032729,-0.035237,0,0
7,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.30402,-0.032869,-0.12918,0,0
7,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.32077,-0.032971,-0.049536,0,0
7,GO COLLAGEN FIBRIL ORGANIZATION,0.96163,-0.032973,-0.050164,0,0
7,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.48131,-0.033143,-0.047624,0,0
7,GO FIBRINOLYSIS,0.71658,-0.033147,-0.13671,0,0
7,GO MRNA TRANSPORT,0.42855,-0.033162,-0.034274,0,0
7,GO REGULATION OF STEM CELL PROLIFERATION,0.60272,-0.033209,0.019343,0,0
7,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.59059,-0.033238,-0.048025,0,0
7,GO GOLGI TO VACUOLE TRANSPORT,0.32077,-0.033254,-0.097972,0,0
7,GO RNA MODIFICATION,0.15015,-0.033287,-0.072031,0,0
7,GO NAD METABOLIC PROCESS,0.87833,-0.033321,-0.018443,0,0
7,GO EMBRYONIC BRAIN DEVELOPMENT,0.48131,-0.033329,-0.064211,0,0
7,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.50896,-0.03333,-0.073993,0,0
7,GO AMINOGLYCAN CATABOLIC PROCESS,0.41341,-0.033357,-0.097917,0,0
7,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.18508,-0.033366,-0.073498,0,0
7,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.27611,-0.033412,-0.063829,0,0
7,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.91987,-0.033446,-0.0045352,0,0
7,GO MUSCLE TISSUE DEVELOPMENT,0.72313,-0.033476,-0.022134,0,0
7,GO STEM CELL DIFFERENTIATION,0.44402,-0.033487,-0.032779,0,0
7,GO PROTEIN KINASE C SIGNALING,0.82348,-0.03349,-0.021043,0,0
7,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.40349,-0.033656,-0.043262,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.38888,-0.033675,-0.062648,0,0
7,GO REGULATION OF CELLULAR EXTRAVASATION,0.74288,-0.033815,0.039339,0,0
7,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.30402,-0.033848,-0.046463,0,0
7,GO RESPONSE TO OXYGEN LEVELS,0.35153,-0.033855,-0.047284,0,0
7,GO REGULATION OF MITOPHAGY,0.25001,-0.033917,-0.0929,0,0
7,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.25729,-0.033942,-0.083085,0,0
7,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.3746,-0.033946,-0.02821,0,0
7,GO HISTONE H3 K9 TRIMETHYLATION,0.78289,-0.033949,-0.025328,0,0
7,GO RESPONSE TO CAFFEINE,0.7495,-0.033966,-0.028151,0,0
7,GO DNA METHYLATION OR DEMETHYLATION,0.26471,-0.033972,-0.033543,0,0
7,GO NEGATIVE REGULATION OF OSSIFICATION,0.80312,-0.033997,-0.012365,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.31232,-0.033999,-0.096843,0,0
7,GO RESPONSE TO INTERLEUKIN 2,0.37932,-0.03409,-0.086386,0,0
7,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.50896,-0.034093,-0.080475,0,0
7,GO ALCOHOL CATABOLIC PROCESS,0.84397,-0.034105,-0.0062162,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.29586,-0.034121,-0.070529,0,0
7,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.12473,-0.034128,-0.087356,0,0
7,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.10096,-0.034187,-0.056386,0,0
7,GO HISTONE H3 K27 METHYLATION,0.74288,-0.034221,-0.021721,0,0
7,GO POLYOL BIOSYNTHETIC PROCESS,0.38888,-0.034224,-0.037873,0,0
7,GO RESPONSE TO ACTIVITY,0.33373,-0.03424,-0.039319,0,0
7,GO RNA PROCESSING,0.13814,-0.034308,-0.060677,0,0
7,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.13355,-0.034359,-0.079706,0,0
7,GO APOPTOTIC SIGNALING PATHWAY,0.31232,-0.034409,-0.048428,0,0
7,GO REGULATION OF MRNA 3 END PROCESSING,0.22235,-0.034419,-0.060831,0,0
7,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.5726,-0.034613,-0.10031,0,0
7,GO POSITIVE REGULATION OF JNK CASCADE,0.86455,-0.034667,-0.0077523,0,0
7,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.5726,-0.0347,-0.055247,0,0
7,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.78289,-0.034715,-0.026518,0,0
7,GO RESPONSE TO INSULIN,0.090515,-0.034741,-0.054722,0,0
7,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.26847,-0.034767,-0.099285,0,0
7,GO REGULATION OF INTRACELLULAR TRANSPORT,0.66501,-0.034809,-0.017708,0,0
7,GO MOLTING CYCLE,0.37932,-0.034865,-0.065417,0,0
7,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.2,-0.034867,-0.050787,0,0
7,GO CELLULAR IRON ION HOMEOSTASIS,0.11434,-0.034964,-0.09086,0,0
7,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.27611,-0.035039,-0.074207,0,0
7,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.76948,-0.035072,-0.059892,0,0
7,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.4978,-0.035097,-0.044236,0,0
7,GO AMELOGENESIS,0.71658,-0.03513,-0.023797,0,0
7,GO PROTEIN POLYUBIQUITINATION,0.27999,-0.035152,-0.036516,0,0
7,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.44402,-0.035194,-0.017719,0,0
7,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.88523,-0.035334,0.007235,0,0
7,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.55487,-0.035364,-0.073523,0,0
7,GO REGULATION OF PEPTIDASE ACTIVITY,0.69061,-0.035372,-0.042092,0,0
7,GO CHROMATIN SILENCING AT TELOMERE,0.63354,-0.035433,-0.015216,0,0
7,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.27611,-0.035477,-0.064771,0,0
7,GO RESPONSE TO INTERLEUKIN 1,0.23937,-0.035483,-0.088297,0,0
7,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.092194,-0.035516,-0.18075,0,0
7,GO MRNA EXPORT FROM NUCLEUS,0.41341,-0.035651,-0.03438,0,0
7,GO ALDEHYDE CATABOLIC PROCESS,0.65866,-0.035665,-0.0038803,0,0
7,GO BONE RESORPTION,0.41842,-0.035669,-0.069761,0,0
7,GO PROTEIN TARGETING,0.23937,-0.035673,-0.059461,0,0
7,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.20309,-0.035682,-0.075318,0,0
7,GO CARDIOLIPIN METABOLIC PROCESS,0.32077,-0.035705,-0.076565,0,0
7,GO GLYCOPROTEIN METABOLIC PROCESS,0.52025,-0.035724,-0.031456,0,0
7,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.23937,-0.035741,-0.042913,0,0
7,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.43367,-0.035764,-0.038447,0,0
7,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.15517,-0.035823,-0.11992,0,0
7,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.85768,-0.035841,-0.0057279,0,0
7,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.8303,-0.035877,-0.016239,0,0
7,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.43367,-0.03589,-0.0194,0,0
7,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.71006,-0.035909,-0.057841,0,0
7,GO SEQUESTERING OF METAL ION,0.80312,-0.035924,-0.056838,0,0
7,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.7495,-0.035934,-0.014138,0,0
7,GO METHYLATION,0.35153,-0.035943,-0.025654,0,0
7,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.96163,-0.035951,0.00059785,0,0
7,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.47049,-0.036014,-0.031327,0,0
7,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.22905,-0.036046,-0.030346,0,0
7,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.55487,-0.036053,-0.023939,0,0
7,GO POLYOL METABOLIC PROCESS,0.50337,-0.03612,-0.017637,0,0
7,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.72313,-0.03618,-0.013248,0,0
7,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.37932,-0.036195,-0.059388,0,0
7,GO REGULATION OF PROTEIN GLYCOSYLATION,0.44402,-0.036276,-0.074689,0,0
7,GO KETONE CATABOLIC PROCESS,0.96163,-0.036328,-0.093514,0,0
7,GO SPINDLE MIDZONE ASSEMBLY,0.40843,-0.036338,-0.036647,0,0
7,GO MACROAUTOPHAGY,0.13355,-0.036359,-0.048514,0,0
7,GO AMEBOIDAL TYPE CELL MIGRATION,0.69061,-0.036394,-0.027339,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.27227,-0.036404,-0.057369,0,0
7,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.78289,-0.036446,0.0043409,0,0
7,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.31653,-0.036461,-0.077673,0,0
7,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.38888,-0.036535,-0.053525,0,0
7,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.94769,-0.036594,0.0089573,0,0
7,GO CARDIAC CELL DEVELOPMENT,0.34256,-0.036689,-0.060931,0,0
7,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.51459,-0.036723,-0.028074,0,0
7,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.22235,-0.036812,-0.059522,0,0
7,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.71006,-0.036836,-0.075381,0,0
7,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.29992,-0.036848,-0.036262,0,0
7,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.83713,-0.036897,-0.064109,0,0
7,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.38888,-0.037088,-0.067813,0,0
7,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.24288,-0.037118,-0.062887,0,0
7,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.52594,-0.037167,-0.029714,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.16294,-0.03735,-0.042353,0,0
7,GO REGULATION OF NEURON MATURATION,0.65866,-0.037358,-0.026743,0,0
7,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.41842,-0.037503,-0.082532,0,0
7,GO COPII COATED VESICLE CARGO LOADING,0.19393,-0.037532,-0.07711,0,0
7,GO REGULATION OF RNA SPLICING,0.4598,-0.037535,-0.013667,0,0
7,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.17934,-0.037669,-0.047431,0,0
7,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.72969,-0.037671,-0.010074,0,0
7,GO NCRNA 3 END PROCESSING,0.79636,-0.037731,0.033401,0,0
7,GO COENZYME A METABOLIC PROCESS,0.58456,-0.037801,-0.028113,0,0
7,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.72313,-0.037801,-0.0076796,0,0
7,GO ESTABLISHMENT OF RNA LOCALIZATION,0.60272,-0.037946,-0.027608,0,0
7,GO GLUCOSE METABOLIC PROCESS,0.91987,-0.037948,-0.017615,0,0
7,GO RESPONSE TO NUTRIENT,0.30402,-0.037977,-0.058933,0,0
7,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.47049,-0.038016,-0.034322,0,0
7,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.95466,-0.038022,-0.027268,0,0
7,GO LYMPH VESSEL MORPHOGENESIS,0.77618,-0.038029,-0.032746,0,0
7,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.66501,-0.038055,-0.03404,0,0
7,GO LIPID BIOSYNTHETIC PROCESS,0.26847,-0.038085,-0.049652,0,0
7,GO DNA CONFORMATION CHANGE,0.26847,-0.038222,-0.033452,0,0
7,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.15264,-0.038494,-0.10937,0,0
7,GO TRANSLESION SYNTHESIS,0.27999,-0.038722,-0.054693,0,0
7,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.51459,-0.038756,-0.073787,0,0
7,GO INTERSTRAND CROSS LINK REPAIR,0.7495,-0.038863,-0.0090691,0,0
7,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.52025,-0.038871,-0.014833,0,0
7,GO CELLULAR RESPONSE TO ATP,0.62732,-0.0389,-0.040943,0,0
7,GO RESPONSE TO HYDROGEN PEROXIDE,0.4978,-0.038942,-0.029653,0,0
7,GO PROTEIN TETRAMERIZATION,0.23245,-0.038963,-0.043198,0,0
7,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.68418,-0.039047,-0.077504,0,0
7,GO CYTOKINETIC PROCESS,0.4545,-0.039079,-0.036234,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.30402,-0.039082,-0.089692,0,0
7,GO LIPID EXPORT FROM CELL,0.97557,-0.039163,0.0054842,0,0
7,GO DNA METHYLATION,0.68418,-0.039202,-0.016136,0,0
7,GO PROTEIN DEMETHYLATION,0.23245,-0.039205,-0.057566,0,0
7,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.39371,-0.039223,-0.049893,0,0
7,GO RESPONSE TO AMINO ACID STARVATION,0.60272,-0.039234,-0.035847,0,0
7,GO ENDOTHELIAL CELL DEVELOPMENT,0.41842,-0.039234,-0.061813,0,0
7,GO CARTILAGE DEVELOPMENT,0.47588,-0.039277,-0.037759,0,0
7,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.14526,-0.03929,-0.083438,0,0
7,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.69707,-0.039362,-0.055094,0,0
7,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.27227,-0.039375,-0.063684,0,0
7,GO STEROID BIOSYNTHETIC PROCESS,0.14285,-0.039428,-0.077897,0,0
7,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.3746,-0.039453,-0.060404,0,0
7,GO MAGNESIUM ION HOMEOSTASIS,0.72313,-0.039456,0.023602,0,0
7,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.58456,-0.03954,-0.030349,0,0
7,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.3746,-0.039566,-0.03959,0,0
7,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.10845,-0.039676,-0.083512,0,0
7,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.23589,-0.039691,-0.096155,0,0
7,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.34702,-0.039703,-0.087646,0,0
7,GO REGULATION OF CALCIUM ION IMPORT,0.48131,-0.039767,-0.042725,0,0
7,GO B CELL ACTIVATION,0.35153,-0.039782,-0.050822,0,0
7,GO RESPIRATORY SYSTEM DEVELOPMENT,0.19393,-0.039786,-0.071611,0,0
7,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.88523,-0.039907,0.0079229,0,0
7,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.56666,-0.039911,-0.043378,0,0
7,GO ACTIN MEDIATED CELL CONTRACTION,0.8303,-0.039916,-0.0035788,0,0
7,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.48131,-0.039985,-0.042919,0,0
7,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.32077,-0.040014,-0.082079,0,0
7,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.27611,-0.040043,-0.078545,0,0
7,GO REGULATION OF FIBRINOLYSIS,0.75615,-0.040117,-0.1159,0,0
7,GO RESPONSE TO KETONE,0.2,-0.040163,-0.063968,0,0
7,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.19095,-0.040204,-0.048053,0,0
7,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.42347,-0.040265,-0.059401,0,0
7,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.16559,-0.040357,-0.058544,0,0
7,GO IMP METABOLIC PROCESS,0.92682,-0.040376,-0.062322,0,0
7,GO PROTEIN K48 LINKED UBIQUITINATION,0.62732,-0.040479,-0.024788,0,0
7,GO RESPONSE TO PAIN,0.78962,-0.040512,-0.0090497,0,0
7,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.44402,-0.040537,-0.060999,0,0
7,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.26847,-0.040547,-0.048016,0,0
7,GO REGULATION OF MULTI ORGANISM PROCESS,0.63354,-0.040561,-0.040149,0,0
7,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.52594,-0.040563,-0.027061,0,0
7,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.22905,-0.040654,-0.089665,0,0
7,GO REGULATION OF APPETITE,0.50337,-0.04076,-0.053599,0,0
7,GO RESPONSE TO GONADOTROPIN,0.17099,-0.040765,-0.1184,0,0
7,GO MACROMOLECULE DEACYLATION,0.30402,-0.040785,-0.033117,0,0
7,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.51459,-0.04081,-0.02937,0,0
7,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.20937,-0.040846,-0.051679,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.9686,-0.040975,0.011834,0,0
7,GO FATTY ACID BIOSYNTHETIC PROCESS,0.10654,-0.040985,-0.089208,0,0
7,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.28785,-0.041019,-0.055301,0,0
7,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.66501,-0.041024,-0.019884,0,0
7,GO REGULATION OF CELL ACTIVATION,0.30815,-0.041042,-0.063543,0,0
7,GO CELL CYCLE G1 S PHASE TRANSITION,0.50896,-0.041126,-0.029754,0,0
7,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.78289,-0.041127,-0.032883,0,0
7,GO ADULT HEART DEVELOPMENT,0.65866,-0.041161,-0.057262,0,0
7,GO MAGNESIUM ION TRANSPORT,0.5726,-0.041169,-0.05153,0,0
7,GO LYSOSOMAL TRANSPORT,0.4978,-0.041187,-0.030757,0,0
7,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.4545,-0.041212,-0.061487,0,0
7,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.34256,-0.041213,-0.10745,0,0
7,GO NUCLEOTIDE EXCISION REPAIR,0.23245,-0.041324,-0.044917,0,0
7,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.40843,-0.041389,-0.025558,0,0
7,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.4545,-0.041439,-0.026517,0,0
7,GO GLUCOSE CATABOLIC PROCESS,0.42855,-0.041445,-0.072333,0,0
7,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.18219,-0.041486,-0.095999,0,0
7,GO MITOCHONDRIAL DNA REPLICATION,0.44924,-0.041573,-0.043789,0,0
7,GO PROSTATE GLAND DEVELOPMENT,0.33373,-0.041674,-0.11072,0,0
7,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.47049,-0.041846,-0.03636,0,0
7,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.28785,-0.04187,-0.071918,0,0
7,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.68418,-0.0419,-0.075899,0,0
7,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.59664,-0.041959,-0.04674,0,0
7,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.46512,-0.041959,-0.02352,0,0
7,GO DIGESTION,0.76281,-0.042007,-0.014299,0,0
7,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.22235,-0.042134,-0.050548,0,0
7,GO FACIAL NERVE MORPHOGENESIS,0.77618,-0.042136,-0.053635,0,0
7,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.2839,-0.042247,-0.040849,0,0
7,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.36526,-0.042261,-0.064873,0,0
7,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.69707,-0.042276,-0.026961,0,0
7,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.21256,-0.042289,-0.050392,0,0
7,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.32506,-0.04229,-0.084809,0,0
7,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.46512,-0.042329,-0.048097,0,0
7,GO NERVE DEVELOPMENT,0.67776,-0.042387,0.033713,0,0
7,GO POSITIVE T CELL SELECTION,0.12689,-0.042398,-0.081071,0,0
7,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.2,-0.042434,-0.12,0,0
7,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.10845,-0.042472,-0.12579,0,0
7,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.22235,-0.042651,-0.056205,0,0
7,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.36064,-0.042696,-0.080642,0,0
7,GO ASTROCYTE ACTIVATION,0.36064,-0.04273,-0.080844,0,0
7,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.44402,-0.042814,-0.074802,0,0
7,GO RNA SPLICING,0.26471,-0.042817,-0.034396,0,0
7,GO ORGANIC ACID METABOLIC PROCESS,0.11434,-0.042846,-0.060948,0,0
7,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.14285,-0.042863,-0.09499,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.20309,-0.042886,-0.076332,0,0
7,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.19095,-0.042913,-0.17249,0,0
7,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.42347,-0.042916,-0.067315,0,0
7,GO DNA CATABOLIC PROCESS,0.26847,-0.042977,-0.022649,0,0
7,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.33373,-0.042992,-0.076578,0,0
7,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.049546,-0.043013,-0.12602,0,0
7,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.80989,-0.043053,-0.01087,0,0
7,GO LEUKOCYTE DIFFERENTIATION,0.064293,-0.043095,-0.076625,0,0
7,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.33373,-0.043134,-0.061698,0,0
7,GO ERROR FREE TRANSLESION SYNTHESIS,0.42855,-0.043288,-0.04703,0,0
7,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.17934,-0.043306,-0.052777,0,0
7,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.65234,-0.043461,-0.09167,0,0
7,GO RESPONSE TO HORMONE,0.14285,-0.043479,-0.053009,0,0
7,GO ZYMOGEN ACTIVATION,0.29992,-0.04351,-0.13709,0,0
7,GO WOUND HEALING,0.33812,-0.043571,-0.069758,0,0
7,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.15773,-0.043605,-0.058598,0,0
7,GO CELLULAR RESPONSE TO RADIATION,0.34702,-0.043687,-0.035044,0,0
7,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.36526,-0.043714,-0.11193,0,0
7,GO PHAGOCYTOSIS RECOGNITION,0.87833,-0.043764,-0.032491,0,0
7,GO CELLULAR LIPID METABOLIC PROCESS,0.29586,-0.043866,-0.046614,0,0
7,GO INTERLEUKIN 6 PRODUCTION,0.60883,-0.043913,-0.025609,0,0
7,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.59059,-0.043943,-0.030636,0,0
7,GO MULTICELLULAR ORGANISM AGING,0.23589,-0.043943,-0.056944,0,0
7,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.54321,-0.043967,-0.048863,0,0
7,GO HISTONE H3 K4 TRIMETHYLATION,0.71006,-0.044022,-0.013019,0,0
7,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.99651,-0.044083,-0.019453,0,0
7,GO REGULATION OF MRNA METABOLIC PROCESS,0.072231,-0.044148,-0.054941,0,0
7,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.52025,-0.044202,-0.049483,0,0
7,GO ALPHA BETA T CELL ACTIVATION,0.05824,-0.044228,-0.11441,0,0
7,GO AUTOPHAGOSOME ORGANIZATION,0.087232,-0.044258,-0.085703,0,0
7,GO STRESS FIBER ASSEMBLY,0.4598,-0.04429,-0.043031,0,0
7,GO POLYAMINE METABOLIC PROCESS,0.2839,-0.044377,-0.063225,0,0
7,GO KERATINIZATION,0.22905,-0.044407,-0.097231,0,0
7,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.20937,-0.04446,-0.038331,0,0
7,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.32506,-0.044507,-0.053441,0,0
7,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.15773,-0.044607,-0.18033,0,0
7,GO DNA DEMETHYLATION,0.44402,-0.044634,-0.057609,0,0
7,GO ICOSANOID BIOSYNTHETIC PROCESS,0.25729,-0.044722,-0.10117,0,0
7,GO REGULATION OF NECROTIC CELL DEATH,0.37932,-0.044785,-0.099287,0,0
7,GO OLIGOPEPTIDE TRANSPORT,0.99651,-0.044807,-0.007043,0,0
7,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.25729,-0.04486,-0.05141,0,0
7,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.44924,-0.044974,-0.031091,0,0
7,GO ENDOCARDIUM DEVELOPMENT,0.16032,-0.045075,-0.15978,0,0
7,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.50337,-0.04523,-0.045822,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.39371,-0.045246,-0.05884,0,0
7,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.17374,-0.045377,-0.086432,0,0
7,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.31232,-0.045448,-0.06218,0,0
7,GO POSITIVE REGULATION OF MITOPHAGY,0.29992,-0.04547,-0.086951,0,0
7,GO RESPONSE TO UV,0.18508,-0.045508,-0.04763,0,0
7,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.28785,-0.045585,-0.061571,0,0
7,GO DETOXIFICATION,0.61497,-0.045658,-0.032644,0,0
7,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.60883,-0.045764,-0.055536,0,0
7,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.39858,-0.045965,-0.044108,0,0
7,GO TROPHOBLAST CELL MIGRATION,0.5726,-0.045978,-0.094112,0,0
7,GO INTERLEUKIN 10 PRODUCTION,0.49227,-0.046129,-0.053889,0,0
7,GO POSITIVE REGULATION OF CELL ACTIVATION,0.16032,-0.046139,-0.080658,0,0
7,GO REGULATION OF CELLULAR PH,0.095625,-0.046215,-0.063043,0,0
7,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.37932,-0.046227,-0.089398,0,0
7,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.32506,-0.046253,-0.036265,0,0
7,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.14526,-0.046291,-0.076886,0,0
7,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.56666,-0.04636,-0.030646,0,0
7,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.3746,-0.046423,-0.094948,0,0
7,GO AMYLOID FIBRIL FORMATION,1,-0.046436,0.0081512,0,0
7,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.21905,-0.046437,-0.089483,0,0
7,GO REGULATION OF PROTEIN STABILITY,0.25363,-0.046443,-0.040306,0,0
7,GO CELLULAR RESPONSE TO UV,0.29992,-0.046451,-0.039601,0,0
7,GO NCRNA METABOLIC PROCESS,0.4598,-0.046477,-0.051672,0,0
7,GO EPITHELIAL TUBE FORMATION,0.33812,-0.046486,-0.053406,0,0
7,GO FOREGUT MORPHOGENESIS,0.27999,-0.046633,-0.12183,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.4978,-0.046822,-0.028342,0,0
7,GO LYMPHOCYTE ACTIVATION,0.22905,-0.046853,-0.065067,0,0
7,GO CELLULAR RESPONSE TO LIPID,0.1028,-0.04687,-0.073797,0,0
7,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.3746,-0.04687,-0.073721,0,0
7,GO RRNA TRANSCRIPTION,0.22235,-0.046893,-0.07909,0,0
7,GO GLOMERULUS DEVELOPMENT,0.78962,-0.046942,-0.00232,0,0
7,GO MITOTIC CYTOKINETIC PROCESS,0.79636,-0.047032,0.0085302,0,0
7,GO POSITIVE REGULATION OF PROTEOLYSIS,0.47588,-0.0471,-0.028131,0,0
7,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.2839,-0.047144,-0.13267,0,0
7,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.48131,-0.047201,-0.035575,0,0
7,GO HUMORAL IMMUNE RESPONSE,0.075049,-0.047223,-0.090757,0,0
7,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.25729,-0.047405,-0.053482,0,0
7,GO CALCIUM IMPORT INTO THE MITOCHONDRION,0.99651,-0.04743,0.013666,0,0
7,GO CHROMATIN REMODELING AT CENTROMERE,0.41341,-0.047496,-0.0427,0,0
7,GO L GLUTAMATE IMPORT,0.71006,-0.047626,-0.029159,0,0
7,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.36991,-0.047816,-0.094593,0,0
7,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.63354,-0.047818,-0.028747,0,0
7,GO GLYCOPROTEIN CATABOLIC PROCESS,0.9686,-0.047995,0.0026549,0,0
7,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.29184,-0.048006,-0.094686,0,0
7,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.7495,-0.048139,0.051028,0,0
7,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.30402,-0.048162,-0.10294,0,0
7,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.27227,-0.048184,-0.073887,0,0
7,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.076492,-0.048256,-0.14569,0,0
7,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.87144,-0.048283,-0.015331,0,0
7,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.28785,-0.048362,-0.043671,0,0
7,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.23245,-0.048455,-0.085573,0,0
7,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.085627,-0.048519,-0.089113,0,0
7,GO NUCLEAR TRANSPORT,0.054842,-0.048608,-0.064592,0,0
7,GO TRNA METHYLATION,0.27999,-0.048628,-0.083075,0,0
7,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16828,-0.0487,-0.056546,0,0
7,GO ENDODERM DEVELOPMENT,0.39371,-0.048716,-0.12041,0,0
7,GO BILE ACID AND BILE SALT TRANSPORT,0.40843,-0.048791,-0.10046,0,0
7,GO FORELIMB MORPHOGENESIS,0.65234,-0.048821,-0.042006,0,0
7,GO SKELETAL MUSCLE CONTRACTION,0.82348,-0.04892,0.020274,0,0
7,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.12473,-0.049058,-0.064862,0,0
7,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.079444,-0.049123,-0.08937,0,0
7,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.11235,-0.049175,-0.097121,0,0
7,GO RESPONSE TO PEPTIDOGLYCAN,0.47588,-0.049197,-0.073415,0,0
7,GO MUSCLE HYPERTROPHY,0.12259,-0.049209,-0.087541,0,0
7,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.20937,-0.049217,-0.045274,0,0
7,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.8303,-0.049229,-0.0569,0,0
7,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.20309,-0.049244,-0.028074,0,0
7,GO HYALURONAN CATABOLIC PROCESS,0.64605,-0.049282,-0.1321,0,0
7,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.32077,-0.049309,-0.077523,0,0
7,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.53742,-0.049372,-0.065355,0,0
7,GO EXOCRINE SYSTEM DEVELOPMENT,0.44402,-0.049392,-0.079067,0,0
7,GO PROTEIN AUTOPROCESSING,0.35153,-0.049399,-0.064149,0,0
7,GO NATURAL KILLER CELL PROLIFERATION,0.077957,-0.049449,-0.19261,0,0
7,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.36991,-0.049563,-0.073798,0,0
7,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.26471,-0.049656,-0.092574,0,0
7,GO ALCOHOL METABOLIC PROCESS,0.13814,-0.049783,-0.063575,0,0
7,GO MEIOTIC SPINDLE ORGANIZATION,0.14526,-0.049811,-0.079972,0,0
7,GO POSITIVE REGULATION OF TRANSLATION,0.24643,-0.049838,-0.076485,0,0
7,GO RESPONSE TO BIOTIC STIMULUS,0.22568,-0.049937,-0.074871,0,0
7,GO LIPID STORAGE,0.26098,-0.049964,-0.075629,0,0
7,GO REGULATION OF LIPASE ACTIVITY,0.32506,-0.050012,-0.059037,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.27611,-0.050056,-0.065555,0,0
7,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.76281,-0.050079,0.05115,0,0
7,GO MAINTENANCE OF LOCATION,0.27999,-0.05027,-0.041112,0,0
7,GO SULFUR COMPOUND METABOLIC PROCESS,0.17374,-0.050349,-0.065026,0,0
7,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.23589,-0.050349,-0.073207,0,0
7,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.67137,-0.050363,-0.05013,0,0
7,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.39371,-0.050431,-0.066175,0,0
7,GO ACTIVATION OF IMMUNE RESPONSE,0.48131,-0.050463,-0.042721,0,0
7,GO REGULATION OF ATPASE ACTIVITY,0.20937,-0.050471,-0.049566,0,0
7,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.26847,-0.050491,-0.056572,0,0
7,GO ACTIVATION OF MAPKKK ACTIVITY,0.95466,-0.05053,0.01121,0,0
7,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.15773,-0.050608,-0.085452,0,0
7,GO REGULATION OF LYMPHOCYTE MIGRATION,0.56075,-0.05066,-0.04369,0,0
7,GO REGULATION OF TRANSLATIONAL INITIATION,0.29992,-0.050692,-0.031142,0,0
7,GO INFLAMMATORY RESPONSE,0.24643,-0.05071,-0.076074,0,0
7,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.34256,-0.050921,-0.077519,0,0
7,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.38408,-0.050946,-0.044783,0,0
7,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.9686,-0.050958,0.0067358,0,0
7,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.43883,-0.050993,-0.057656,0,0
7,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.47049,-0.051085,-0.033727,0,0
7,GO PYRUVATE METABOLIC PROCESS,0.054842,-0.051102,-0.087137,0,0
7,GO 3 UTR MEDIATED MRNA STABILIZATION,0.80312,-0.05114,0.13614,0,0
7,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.19095,-0.05123,-0.079568,0,0
7,GO NUCLEAR ENVELOPE ORGANIZATION,0.053746,-0.051282,-0.078401,0,0
7,GO RESPONSE TO PEPTIDE HORMONE,0.1313,-0.051286,-0.04795,0,0
7,GO EPIDERMIS DEVELOPMENT,0.095625,-0.051298,-0.12082,0,0
7,GO REGULATION OF SISTER CHROMATID COHESION,0.76281,-0.051312,-0.015033,0,0
7,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.20621,-0.051332,-0.10088,0,0
7,GO PROTEIN IMPORT,0.060602,-0.051419,-0.068415,0,0
7,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.81668,-0.051456,-0.045196,0,0
7,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.96163,-0.051477,-0.002546,0,0
7,GO POSITIVE REGULATION OF VIRAL PROCESS,0.14048,-0.051488,-0.064245,0,0
7,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.44924,-0.051517,-0.068423,0,0
7,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.77618,-0.051568,-0.029371,0,0
7,GO CARDIAC CHAMBER MORPHOGENESIS,0.66501,-0.051666,0.014588,0,0
7,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.98953,-0.051727,-0.081062,0,0
7,GO HISTONE H3 K9 MODIFICATION,0.10465,-0.051734,-0.071361,0,0
7,GO REGULATION OF ANION TRANSPORT,0.40843,-0.051759,-0.046648,0,0
7,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.4545,-0.051849,-0.026145,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.29586,-0.051894,-0.062033,0,0
7,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.14048,-0.051907,-0.075782,0,0
7,GO IMPORT INTO NUCLEUS,0.052669,-0.051981,-0.074544,0,0
7,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.41842,-0.052039,-0.040491,0,0
7,GO AUTOPHAGOSOME MATURATION,0.10465,-0.052052,-0.11852,0,0
7,GO TISSUE MIGRATION,0.41341,-0.052088,-0.054922,0,0
7,GO MONOCARBOXYLIC ACID TRANSPORT,0.11841,-0.052122,-0.069507,0,0
7,GO SMOOTH MUSCLE CELL MIGRATION,0.38888,-0.052127,-0.084186,0,0
7,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.31232,-0.05214,-0.059782,0,0
7,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.2839,-0.052216,-0.097162,0,0
7,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.63978,-0.052267,-0.021802,0,0
7,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.19695,-0.052283,-0.061933,0,0
7,GO EMBRYO IMPLANTATION,0.15264,-0.0523,-0.11969,0,0
7,GO REGULATION OF PROTEIN MATURATION,0.26098,-0.052367,-0.075729,0,0
7,GO LEUKOCYTE PROLIFERATION,0.39858,-0.052368,-0.062344,0,0
7,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.2839,-0.052399,-0.065984,0,0
7,GO LIPID METABOLIC PROCESS,0.31653,-0.052415,-0.045365,0,0
7,GO RELAXATION OF MUSCLE,0.59664,-0.052431,0.047387,0,0
7,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.2839,-0.052595,-0.092387,0,0
7,GO BONE MORPHOGENESIS,0.54903,-0.052602,-0.047797,0,0
7,GO RESPONSE TO DEXAMETHASONE,0.48131,-0.052748,-0.067788,0,0
7,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.29992,-0.052777,-0.10705,0,0
7,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.61497,-0.052813,-0.0099801,0,0
7,GO MECHANORECEPTOR DIFFERENTIATION,0.24643,-0.052849,-0.082728,0,0
7,GO NUCLEAR EXPORT,0.077957,-0.052855,-0.070221,0,0
7,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.13583,-0.052865,-0.15236,0,0
7,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.090515,-0.053018,-0.063098,0,0
7,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.13355,-0.053078,-0.084985,0,0
7,GO LIPID MODIFICATION,0.13814,-0.053114,-0.059544,0,0
7,GO HISTONE H3 K9 DEMETHYLATION,0.49227,-0.053137,-0.055647,0,0
7,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.44924,-0.053159,-0.041094,0,0
7,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.15773,-0.053213,-0.17423,0,0
7,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.39371,-0.053242,-0.037254,0,0
7,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.30815,-0.053283,-0.080017,0,0
7,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.59664,-0.053309,-0.021108,0,0
7,GO EXTRACELLULAR MATRIX ASSEMBLY,0.83713,-0.053332,-0.050282,0,0
7,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11039,-0.053344,-0.14363,0,0
7,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.088862,-0.053371,-0.08984,0,0
7,GO ACTIVATION OF MAPKK ACTIVITY,0.188,-0.053421,-0.077074,0,0
7,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.62732,-0.053448,-0.037873,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.10845,-0.053468,-0.12986,0,0
7,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.95466,-0.053501,0.0030193,0,0
7,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.31232,-0.053523,-0.050577,0,0
7,GO DIET INDUCED THERMOGENESIS,0.7495,-0.053528,-0.027904,0,0
7,GO TRIGLYCERIDE METABOLIC PROCESS,0.14285,-0.053598,-0.070285,0,0
7,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.36991,-0.053632,-0.070413,0,0
7,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.5726,-0.053671,-0.084953,0,0
7,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.17099,-0.053689,-0.1902,0,0
7,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.59059,-0.053704,-0.044447,0,0
7,GO POSITIVE REGULATION OF TISSUE REMODELING,0.21905,-0.053759,-0.10237,0,0
7,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.32506,-0.053794,-0.046121,0,0
7,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.33812,-0.054032,-0.059942,0,0
7,GO T CELL PROLIFERATION,0.32077,-0.05406,-0.07035,0,0
7,GO LENS FIBER CELL DIFFERENTIATION,0.27611,-0.05408,-0.069757,0,0
7,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.18219,-0.05411,-0.07459,0,0
7,GO RESPONSE TO LIPID,0.29992,-0.054132,-0.048326,0,0
7,GO DRUG METABOLIC PROCESS,0.43367,-0.054198,-0.049736,0,0
7,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.35153,-0.054267,-0.069552,0,0
7,GO PROTEIN OXIDATION,0.62732,-0.054296,-0.06862,0,0
7,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.070855,-0.054352,-0.086955,0,0
7,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.34702,-0.05444,-0.049147,0,0
7,GO TOLERANCE INDUCTION,0.78289,-0.05449,-0.086891,0,0
7,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.25363,-0.054502,-0.14864,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.39371,-0.054504,-0.038439,0,0
7,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.80989,-0.054541,-0.021962,0,0
7,GO RESPONSE TO PROTOZOAN,0.092194,-0.054606,-0.14025,0,0
7,GO RESPONSE TO BACTERIUM,0.16032,-0.054626,-0.077504,0,0
7,GO REGULATION OF PH,0.15773,-0.054668,-0.056928,0,0
7,GO POSITIVE REGULATION OF ORGAN GROWTH,0.66501,-0.05469,-0.03491,0,0
7,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.41341,-0.054814,-0.088091,0,0
7,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.70355,-0.054947,-0.0097135,0,0
7,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.54903,-0.054959,-0.021392,0,0
7,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.69707,-0.05505,-0.037522,0,0
7,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.60883,-0.05519,-0.042168,0,0
7,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.095625,-0.055193,-0.1021,0,0
7,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.54903,-0.055248,-0.032891,0,0
7,GO LYMPHOCYTE MIGRATION,0.26098,-0.055264,-0.066494,0,0
7,GO ATRIAL SEPTUM DEVELOPMENT,0.7495,-0.055338,-0.031143,0,0
7,GO EPITHELIAL CELL DEVELOPMENT,0.33812,-0.055396,-0.057464,0,0
7,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.56075,-0.055521,-0.049291,0,0
7,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20621,-0.055586,-0.084437,0,0
7,GO DEFENSE RESPONSE TO VIRUS,0.27227,-0.055603,-0.11669,0,0
7,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.059411,-0.055622,-0.11808,0,0
7,GO IMMUNE SYSTEM DEVELOPMENT,0.063042,-0.055736,-0.067519,0,0
7,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.15015,-0.055738,-0.11763,0,0
7,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.23589,-0.055834,-0.064096,0,0
7,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.20621,-0.055856,-0.082921,0,0
7,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.3746,-0.055875,-0.093898,0,0
7,GO EPITHELIAL STRUCTURE MAINTENANCE,0.65234,-0.055881,-0.01168,0,0
7,GO REGULATION OF REPRODUCTIVE PROCESS,0.16828,-0.055898,-0.046282,0,0
7,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.31232,-0.055917,-0.11158,0,0
7,GO POSTREPLICATION REPAIR,0.36991,-0.055975,-0.032171,0,0
7,GO CHONDROCYTE DIFFERENTIATION,0.5726,-0.056087,-0.027643,0,0
7,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.13583,-0.056143,-0.067544,0,0
7,GO LACTATION,0.7495,-0.056151,-0.017239,0,0
7,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.31653,-0.05621,-0.072867,0,0
7,GO RETINA HOMEOSTASIS,0.11841,-0.056234,-0.051241,0,0
7,GO ANTIMICROBIAL HUMORAL RESPONSE,0.090515,-0.056254,-0.097079,0,0
7,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.080955,-0.056304,-0.054272,0,0
7,GO POSITIVE REGULATION OF ERAD PATHWAY,0.11434,-0.056362,-0.091295,0,0
7,GO REGULATION OF CELL SHAPE,0.16294,-0.056434,-0.071951,0,0
7,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.44924,-0.056436,-0.054188,0,0
7,GO KINETOCHORE ORGANIZATION,0.34702,-0.056446,-0.079816,0,0
7,GO T CELL ACTIVATION,0.18219,-0.056602,-0.078731,0,0
7,GO AMINO ACID BETAINE METABOLIC PROCESS,0.26098,-0.056642,-0.099378,0,0
7,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.3746,-0.056708,-0.12354,0,0
7,GO REGULATION OF SYNAPSE MATURATION,0.91987,-0.056872,-0.01029,0,0
7,GO REGULATION OF AUTOPHAGY,0.077957,-0.056971,-0.041855,0,0
7,GO REGULATION OF HEMOPOIESIS,0.076492,-0.056979,-0.076246,0,0
7,GO CRISTAE FORMATION,0.43367,-0.057088,-0.055174,0,0
7,GO SKELETAL MUSCLE TISSUE REGENERATION,0.59059,-0.057182,-0.067829,0,0
7,GO CARBOHYDRATE METABOLIC PROCESS,0.17934,-0.057235,-0.039123,0,0
7,GO REGULATION OF STEM CELL DIVISION,0.34702,-0.057275,-0.085359,0,0
7,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.67137,-0.057326,-0.042637,0,0
7,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.91987,-0.057397,-0.018103,0,0
7,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.20309,-0.057436,-0.071264,0,0
7,GO MAST CELL MEDIATED IMMUNITY,0.076492,-0.057452,-0.14345,0,0
7,GO ENTRY OF BACTERIUM INTO HOST CELL,0.55487,-0.05747,-0.13101,0,0
7,GO PHOSPHOLIPID TRANSPORT,0.33373,-0.057505,-0.048266,0,0
7,GO SUPEROXIDE ANION GENERATION,0.12689,-0.057625,-0.14669,0,0
7,GO EAR DEVELOPMENT,0.4978,-0.057676,-0.030532,0,0
7,GO REGULATION OF GENE SILENCING,0.1028,-0.057696,-0.063089,0,0
7,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.73628,-0.057712,-0.069088,0,0
7,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.077957,-0.057726,-0.095333,0,0
7,GO RESPONSE TO INTERLEUKIN 6,0.2,-0.057946,-0.08412,0,0
7,GO EPIDERMAL CELL DIFFERENTIATION,0.04854,-0.057956,-0.13244,0,0
7,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.57857,-0.057987,-0.042887,0,0
7,GO RESPONSE TO TEMPERATURE STIMULUS,0.076492,-0.057992,-0.064071,0,0
7,GO PROTON TRANSMEMBRANE TRANSPORT,0.31653,-0.0582,-0.031671,0,0
7,GO INTERMEMBRANE LIPID TRANSFER,0.62732,-0.058285,-0.011292,0,0
7,GO SOMITOGENESIS,0.46512,-0.058431,-0.04122,0,0
7,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.80312,-0.058448,-0.012122,0,0
7,GO REGULATION OF GLIAL CELL PROLIFERATION,0.19095,-0.058527,-0.12813,0,0
7,GO LIPID LOCALIZATION,0.049546,-0.058532,-0.091189,0,0
7,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.66501,-0.058608,-0.016243,0,0
7,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.99651,-0.058631,-0.0021053,0,0
7,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.11636,-0.058637,-0.1181,0,0
7,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.42347,-0.058821,-0.022092,0,0
7,GO REGULATION OF PROSTAGLANDIN SECRETION,0.54903,-0.058852,-0.036981,0,0
7,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.80312,-0.058857,-0.054858,0,0
7,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.26847,-0.058879,-0.050998,0,0
7,GO REGULATION OF WATER LOSS VIA SKIN,0.27611,-0.058928,-0.13742,0,0
7,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.36526,-0.058948,-0.084259,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.67137,-0.059019,-0.049078,0,0
7,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.10096,-0.059051,-0.098021,0,0
7,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.2839,-0.059086,-0.092005,0,0
7,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.48131,-0.059133,-0.03436,0,0
7,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.16032,-0.059174,-0.097372,0,0
7,GO PHOSPHOLIPID CATABOLIC PROCESS,0.055956,-0.059263,-0.1315,0,0
7,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.12689,-0.059379,-0.067571,0,0
7,GO RRNA METABOLIC PROCESS,0.35607,-0.059421,-0.078519,0,0
7,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.12049,-0.059506,-0.11445,0,0
7,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.8303,-0.059567,-0.015141,0,0
7,GO CELLULAR RESPONSE TO KETONE,0.28785,-0.059578,-0.054249,0,0
7,GO CELLULAR PIGMENTATION,0.44924,-0.05961,-0.026673,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.13814,-0.05961,-0.099178,0,0
7,GO PROTEIN AUTOUBIQUITINATION,0.053746,-0.059649,-0.053413,0,0
7,GO CONVERGENT EXTENSION,0.66501,-0.059836,-0.02992,0,0
7,GO PHAGOCYTOSIS,0.63978,-0.059888,-0.036733,0,0
7,GO PIGMENT BIOSYNTHETIC PROCESS,0.41842,-0.05989,-0.041481,0,0
7,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.33373,-0.059943,-0.0914,0,0
7,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.25001,-0.059968,-0.081146,0,0
7,GO AMINE CATABOLIC PROCESS,0.21905,-0.060061,-0.12851,0,0
7,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.20621,-0.06011,-0.09215,0,0
7,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.4598,-0.060111,-0.041047,0,0
7,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.4978,-0.060148,-0.10326,0,0
7,GO REGULATION OF DNA REPLICATION,0.21905,-0.060155,-0.048123,0,0
7,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.26098,-0.06021,-0.11841,0,0
7,GO REGULATION OF TISSUE REMODELING,0.50337,-0.06021,-0.063771,0,0
7,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.61497,-0.06022,-0.025486,0,0
7,GO REGULATION OF CHROMATIN ASSEMBLY,0.088862,-0.060473,-0.071998,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.25363,-0.060489,-0.043875,0,0
7,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.25729,-0.060607,-0.1022,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.50337,-0.060613,-0.046257,0,0
7,GO PHOTOPERIODISM,0.35607,-0.060636,-0.046043,0,0
7,GO REGULATION OF VACUOLE ORGANIZATION,0.22905,-0.060651,-0.064645,0,0
7,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.54321,-0.060662,-0.083717,0,0
7,GO PENILE ERECTION,0.27611,-0.060734,-0.091105,0,0
7,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.32077,-0.060756,-0.081087,0,0
7,GO PINOCYTOSIS,0.084046,-0.060757,-0.15091,0,0
7,GO NEGATIVE REGULATION OF JNK CASCADE,0.057089,-0.06078,-0.11935,0,0
7,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.16032,-0.06093,-0.099401,0,0
7,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.063042,-0.060933,-0.089555,0,0
7,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.50896,-0.060977,-0.098155,0,0
7,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.68418,-0.060977,-0.02134,0,0
7,GO ACETYL COA METABOLIC PROCESS,0.24288,-0.061073,-0.078722,0,0
7,GO RRNA 3 END PROCESSING,0.13814,-0.06112,-0.10447,0,0
7,GO NUCLEOTIDE PHOSPHORYLATION,0.13355,-0.061142,-0.071624,0,0
7,GO REGULATION OF CELL AGING,0.11636,-0.061305,-0.10434,0,0
7,GO QUINONE METABOLIC PROCESS,0.20937,-0.061308,-0.14997,0,0
7,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.65866,-0.061474,-0.048707,0,0
7,GO PIGMENT GRANULE ORGANIZATION,0.12473,-0.061524,-0.054921,0,0
7,GO HORMONE BIOSYNTHETIC PROCESS,0.71006,-0.061623,-0.027489,0,0
7,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.36991,-0.061669,-0.056333,0,0
7,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.20937,-0.061713,-0.051791,0,0
7,GO REGULATION OF TOR SIGNALING,0.10654,-0.061744,-0.051083,0,0
7,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.12908,-0.061833,-0.13546,0,0
7,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.38888,-0.061962,-0.095043,0,0
7,GO LIPID CATABOLIC PROCESS,0.10465,-0.062021,-0.072463,0,0
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.57857,-0.062047,-0.059513,0,0
7,GO DORSAL AORTA DEVELOPMENT,0.96163,-0.062068,-0.032041,0,0
7,GO REGULATION OF MYOBLAST FUSION,0.18219,-0.062116,-0.13896,0,0
7,GO CELLULAR RESPONSE TO RETINOIC ACID,0.092194,-0.062158,-0.13166,0,0
7,GO SKIN DEVELOPMENT,0.10096,-0.062165,-0.114,0,0
7,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.093897,-0.062212,-0.093252,0,0
7,GO AROMATIC AMINO ACID TRANSPORT,0.30815,-0.062256,-0.13102,0,0
7,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.16559,-0.062366,-0.11494,0,0
7,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.58456,-0.062386,-0.052634,0,0
7,GO FOCAL ADHESION ASSEMBLY,0.27999,-0.062468,-0.085168,0,0
7,GO LATERAL MESODERM DEVELOPMENT,0.80312,-0.062507,-0.06328,0,0
7,GO CYTOKINE SECRETION,0.47049,-0.062572,-0.046918,0,0
7,GO VACUOLE ORGANIZATION,0.15264,-0.062572,-0.065195,0,0
7,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.56666,-0.06258,-0.078058,0,0
7,GO PROTEIN N LINKED GLYCOSYLATION,0.11235,-0.062621,-0.090679,0,0
7,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.78962,-0.062634,-0.014552,0,0
7,GO HISTONE H2A UBIQUITINATION,0.44402,-0.062696,-0.026984,0,0
7,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.93377,-0.062779,-0.029091,0,0
7,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.36526,-0.062811,-0.087734,0,0
7,GO TISSUE HOMEOSTASIS,0.0695,-0.062834,-0.070863,0,0
7,GO REPLICATION FORK PROCESSING,0.69061,-0.062901,-0.01999,0,0
7,GO PERICARDIUM DEVELOPMENT,0.66501,-0.062903,-0.043732,0,0
7,GO OTIC VESICLE MORPHOGENESIS,0.84397,-0.062921,0.0072821,0,0
7,GO MAST CELL ACTIVATION,0.049546,-0.062922,-0.14617,0,0
7,GO NECROTIC CELL DEATH,0.16828,-0.062988,-0.11217,0,0
7,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.095625,-0.063273,-0.060264,0,0
7,GO B CELL APOPTOTIC PROCESS,0.22235,-0.063385,-0.14014,0,0
7,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.23589,-0.063515,-0.10923,0,0
7,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.14285,-0.063621,-0.089065,0,0
7,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.14526,-0.063625,-0.054933,0,0
7,GO MEMBRANE DISASSEMBLY,0.2839,-0.063689,-0.090048,0,0
7,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.83713,-0.063728,0.049281,0,0
7,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.26847,-0.064006,-0.07422,0,0
7,GO MITOTIC CELL CYCLE ARREST,0.55487,-0.064201,-0.042148,0,0
7,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.20309,-0.064285,-0.065051,0,0
7,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.35153,-0.064312,-0.029852,0,0
7,GO CERAMIDE TRANSPORT,0.34702,-0.064384,-0.080492,0,0
7,GO AEROBIC RESPIRATION,0.25729,-0.064397,-0.07062,0,0
7,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.52594,-0.064399,-0.11431,0,0
7,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.073629,-0.064416,-0.091804,0,0
7,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.22905,-0.064447,-0.10364,0,0
7,GO REGULATION OF IMMUNE RESPONSE,0.28785,-0.064489,-0.057782,0,0
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.34702,-0.064532,-0.072344,0,0
7,GO APOPTOTIC DNA FRAGMENTATION,0.39371,-0.0646,-0.024893,0,0
7,GO REGULATION OF CARTILAGE DEVELOPMENT,0.36526,-0.064607,-0.027375,0,0
7,GO FATTY ACID METABOLIC PROCESS,0.065563,-0.064712,-0.086605,0,0
7,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.27999,-0.06487,-0.045479,0,0
7,GO REGULATION OF MUSCLE HYPERTROPHY,0.14048,-0.065014,-0.094545,0,0
7,GO IMMUNOLOGICAL MEMORY PROCESS,0.17934,-0.065028,-0.12575,0,0
7,GO HISTONE H3 K9 METHYLATION,0.063042,-0.06504,-0.081467,0,0
7,GO REGULATION OF VASCULOGENESIS,0.36064,-0.065176,-0.098003,0,0
7,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.26098,-0.065207,-0.063407,0,0
7,GO CHROMATIN REMODELING,0.14769,-0.065319,-0.044063,0,0
7,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.17653,-0.065346,-0.14323,0,0
7,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.073629,-0.065377,-0.079829,0,0
7,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.28785,-0.065389,-0.081054,0,0
7,GO EPIDERMIS MORPHOGENESIS,0.44402,-0.065448,-0.081349,0,0
7,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.84397,-0.065535,-0.021689,0,0
7,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.82348,-0.065619,-0.00040515,0,0
7,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.057089,-0.065697,-0.06918,0,0
7,GO CELL ACTIVATION,0.11235,-0.065722,-0.082546,0,0
7,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.20937,-0.065746,-0.065976,0,0
7,GO HYALURONAN METABOLIC PROCESS,0.21256,-0.065812,-0.10414,0,0
7,GO REGULATION OF ERBB SIGNALING PATHWAY,0.14285,-0.065834,-0.098926,0,0
7,GO REGULATION OF TRANSLATIONAL FIDELITY,0.44924,-0.06585,-0.07312,0,0
7,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.53167,-0.065855,-0.030947,0,0
7,GO PARTURITION,0.87144,-0.065947,-0.028748,0,0
7,GO LYMPH NODE DEVELOPMENT,0.25001,-0.066012,-0.063341,0,0
7,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.27227,-0.066056,-0.094989,0,0
7,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.40349,-0.066146,-0.041586,0,0
7,GO P38MAPK CASCADE,0.055956,-0.066207,-0.16501,0,0
7,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.16559,-0.0663,-0.12535,0,0
7,GO UV PROTECTION,0.44402,-0.066436,-0.071361,0,0
7,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.29586,-0.066543,-0.13237,0,0
7,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.37932,-0.066545,-0.10878,0,0
7,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.17934,-0.066573,-0.060295,0,0
7,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.20309,-0.06663,-0.063069,0,0
7,GO ISOPRENOID METABOLIC PROCESS,0.33812,-0.066672,-0.063246,0,0
7,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.15264,-0.066752,-0.099383,0,0
7,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.63354,-0.066755,-0.050644,0,0
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.12049,-0.06678,-0.13989,0,0
7,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.20309,-0.066823,-0.094768,0,0
7,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.35153,-0.066867,-0.10819,0,0
7,GO RESPONSE TO CORTICOSTEROID,0.26847,-0.066873,-0.067737,0,0
7,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.21256,-0.066929,-0.11109,0,0
7,GO REGULATION OF JUN KINASE ACTIVITY,0.11434,-0.066929,-0.07656,0,0
7,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.092194,-0.067004,-0.093265,0,0
7,GO TERPENOID BIOSYNTHETIC PROCESS,0.54903,-0.06701,-0.083381,0,0
7,GO CARDIAC ATRIUM DEVELOPMENT,0.49227,-0.06709,-0.0521,0,0
7,GO POLYOL CATABOLIC PROCESS,0.30402,-0.067116,-0.046508,0,0
7,GO REGULATION OF LIPID METABOLIC PROCESS,0.053746,-0.067178,-0.081418,0,0
7,GO MACROPHAGE ACTIVATION,0.13355,-0.067207,-0.078268,0,0
7,GO CHONDROCYTE DEVELOPMENT,0.59664,-0.067209,-0.059169,0,0
7,GO COCHLEA MORPHOGENESIS,0.36526,-0.067312,-0.055792,0,0
7,GO SECRETION BY TISSUE,0.26847,-0.067525,-0.09254,0,0
7,GO FLUID TRANSPORT,0.14769,-0.067559,-0.085343,0,0
7,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.17374,-0.067643,-0.066456,0,0
7,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.066855,-0.067653,-0.13199,0,0
7,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.29184,-0.067817,-0.069134,0,0
7,GO ADAPTIVE IMMUNE RESPONSE,0.31232,-0.067884,-0.086203,0,0
7,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.39858,-0.067968,-0.064033,0,0
7,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.73628,-0.068004,-0.075027,0,0
7,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.65866,-0.068015,-0.015849,0,0
7,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.16559,-0.068071,-0.1118,0,0
7,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.26847,-0.068115,-0.073133,0,0
7,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.91293,-0.068119,0.021249,0,0
7,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.35607,-0.06812,-0.10683,0,0
7,GO OXIDATION REDUCTION PROCESS,0.11235,-0.068168,-0.066016,0,0
7,GO HETEROCHROMATIN ORGANIZATION,0.011326,-0.068435,-0.064813,0,0
7,GO PEPTIDYL PROLINE MODIFICATION,0.17099,-0.068456,-0.1064,0,0
7,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.16032,-0.068539,-0.071077,0,0
7,GO IMMUNOGLOBULIN PRODUCTION,0.11636,-0.068615,-0.076797,0,0
7,GO REGULATION OF PROTEIN IMPORT,0.18219,-0.06863,-0.093463,0,0
7,GO RESPONSE TO CYTOKINE,0.17374,-0.06871,-0.08458,0,0
7,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.076492,-0.06887,-0.10614,0,0
7,GO POSITIVE REGULATION OF WOUND HEALING,0.15264,-0.068935,-0.1309,0,0
7,GO CELL AGGREGATION,0.8303,-0.068962,0.0097362,0,0
7,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.73628,-0.068998,-0.027366,0,0
7,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12689,-0.068999,-0.087531,0,0
7,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.26847,-0.069055,-0.081804,0,0
7,GO AMINO SUGAR METABOLIC PROCESS,0.11636,-0.069066,-0.079641,0,0
7,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.099158,-0.069099,-0.11436,0,0
7,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.14048,-0.069151,-0.061375,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.32077,-0.069214,-0.080472,0,0
7,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.9686,-0.069285,0.025409,0,0
7,GO INNATE IMMUNE RESPONSE,0.16559,-0.069301,-0.087875,0,0
7,GO TUBE FORMATION,0.20621,-0.069425,-0.072589,0,0
7,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.092194,-0.069466,-0.086327,0,0
7,GO NEGATIVE REGULATION OF BONE REMODELING,0.87144,-0.06948,-0.015086,0,0
7,GO PEPTIDYL ASPARAGINE MODIFICATION,0.064293,-0.069666,-0.11187,0,0
7,GO CELLULAR HYPEROSMOTIC RESPONSE,0.31232,-0.069691,-0.081894,0,0
7,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.19095,-0.069784,-0.1023,0,0
7,GO HEART VALVE FORMATION,0.72313,-0.06982,0.073752,0,0
7,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.26098,-0.069864,-0.078649,0,0
7,GO ALPHA BETA T CELL DIFFERENTIATION,0.085627,-0.069939,-0.11909,0,0
7,GO PORE COMPLEX ASSEMBLY,0.1313,-0.06999,-0.096437,0,0
7,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.30815,-0.070001,-0.086733,0,0
7,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.066855,-0.070012,-0.091252,0,0
7,GO PROTEASOME ASSEMBLY,0.070855,-0.070045,-0.12796,0,0
7,GO REGULATION OF CELL KILLING,0.075049,-0.070074,-0.11654,0,0
7,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.41341,-0.070141,-0.05708,0,0
7,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.36526,-0.070224,-0.082036,0,0
7,GO NCRNA PROCESSING,0.36064,-0.070259,-0.067741,0,0
7,GO MEMBRANE PROTEIN PROTEOLYSIS,0.36526,-0.070278,-0.10369,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.16559,-0.070454,-0.11084,0,0
7,GO PH REDUCTION,0.15773,-0.070564,-0.058988,0,0
7,GO HISTONE MRNA METABOLIC PROCESS,0.088862,-0.070625,-0.073872,0,0
7,GO INTERLEUKIN 8 PRODUCTION,0.27227,-0.070657,-0.10502,0,0
7,GO REGULATION OF CELLULAR RESPIRATION,0.35607,-0.070706,-0.066743,0,0
7,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.13355,-0.070794,-0.090154,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.54903,-0.070813,-0.10577,0,0
7,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.29992,-0.070844,-0.13779,0,0
7,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.17374,-0.070906,-0.11539,0,0
7,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.25363,-0.071105,-0.19877,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.10096,-0.071205,-0.082635,0,0
7,GO N GLYCAN PROCESSING,0.57857,-0.071217,-0.04534,0,0
7,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.099158,-0.071268,-0.15084,0,0
7,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.082489,-0.071307,-0.09757,0,0
7,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.41341,-0.071319,-0.073557,0,0
7,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.19393,-0.071584,-0.086303,0,0
7,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.10845,-0.071633,-0.11582,0,0
7,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.71658,-0.071701,-0.052579,0,0
7,GO T CELL MIGRATION,0.10654,-0.071846,-0.1013,0,0
7,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.31653,-0.071906,-0.10983,0,0
7,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.093897,-0.072183,-0.12823,0,0
7,GO CARDIOCYTE DIFFERENTIATION,0.70355,-0.072184,-0.024976,0,0
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.67137,-0.07228,-0.05193,0,0
7,GO CHROMATIN SILENCING,0.23245,-0.07236,-0.032769,0,0
7,GO CELL CELL JUNCTION MAINTENANCE,0.4545,-0.072434,-0.040588,0,0
7,GO POST ANAL TAIL MORPHOGENESIS,0.36526,-0.072501,-0.069489,0,0
7,GO PARENTAL BEHAVIOR,0.29992,-0.072523,-0.10781,0,0
7,GO GRANULOCYTE DIFFERENTIATION,0.11235,-0.072592,-0.095314,0,0
7,GO ENDOCRINE PROCESS,0.2839,-0.07262,-0.058631,0,0
7,GO CELL PROLIFERATION IN HINDBRAIN,0.57857,-0.072657,-0.044986,0,0
7,GO MACROPHAGE MIGRATION,0.32938,-0.072702,-0.077421,0,0
7,GO BASEMENT MEMBRANE ORGANIZATION,0.66501,-0.072703,-0.090759,0,0
7,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.24288,-0.072709,-0.083495,0,0
7,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.68418,-0.072759,-0.032099,0,0
7,GO ADAPTIVE THERMOGENESIS,0.46512,-0.072769,-0.033639,0,0
7,GO RESPONSE TO STARVATION,0.057089,-0.072834,-0.089048,0,0
7,GO REGULATION OF EXIT FROM MITOSIS,0.63354,-0.07292,-0.032867,0,0
7,GO PEROXISOMAL MEMBRANE TRANSPORT,0.10845,-0.072985,-0.097152,0,0
7,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.28785,-0.073237,-0.083876,0,0
7,GO T CELL MEDIATED IMMUNITY,0.32506,-0.073254,-0.11754,0,0
7,GO REGULATION OF TORC1 SIGNALING,0.077957,-0.073286,-0.064197,0,0
7,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.26847,-0.073316,-0.12021,0,0
7,GO UBIQUINONE METABOLIC PROCESS,0.076492,-0.073351,-0.10154,0,0
7,GO DEFENSE RESPONSE TO BACTERIUM,0.061812,-0.073372,-0.10009,0,0
7,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.31232,-0.073391,-0.050205,0,0
7,GO CELL CELL RECOGNITION,0.059411,-0.073543,-0.091297,0,0
7,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.44924,-0.073608,-0.047449,0,0
7,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.16294,-0.073612,-0.13681,0,0
7,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.15773,-0.074005,-0.11466,0,0
7,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.36526,-0.07401,-0.061368,0,0
7,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.050569,-0.074034,-0.072613,0,0
7,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.15773,-0.074085,-0.060422,0,0
7,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.58456,-0.07424,-0.12475,0,0
7,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.36526,-0.074344,-0.056323,0,0
7,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.14769,-0.074421,-0.12963,0,0
7,GO PROTEOGLYCAN METABOLIC PROCESS,0.80312,-0.07445,-0.023044,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.24288,-0.074467,-0.19338,0,0
7,GO CELLULAR SENESCENCE,0.28785,-0.074665,-0.054936,0,0
7,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.24643,-0.074784,-0.069688,0,0
7,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.188,-0.074893,-0.13871,0,0
7,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.54903,-0.074957,-0.037542,0,0
7,GO T CELL EXTRAVASATION,0.33373,-0.075023,-0.16562,0,0
7,GO THALAMUS DEVELOPMENT,0.72313,-0.075282,-0.009128,0,0
7,GO DNA GEOMETRIC CHANGE,0.12689,-0.075294,-0.05991,0,0
7,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.38408,-0.075332,-0.069382,0,0
7,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.16294,-0.075343,-0.10883,0,0
7,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.188,-0.075515,-0.10768,0,0
7,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.18508,-0.075582,-0.1136,0,0
7,GO CORNIFICATION,0.17653,-0.07561,-0.12914,0,0
7,GO COMPLEMENT ACTIVATION,0.11434,-0.075611,-0.10774,0,0
7,GO CELLULAR AMIDE METABOLIC PROCESS,0.077957,-0.075645,-0.070625,0,0
7,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.12049,-0.075813,-0.15401,0,0
7,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.24288,-0.076065,0.053748,0,0
7,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.48678,-0.076152,-0.07856,0,0
7,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.73628,-0.07617,0.003053,0,0
7,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.16559,-0.076263,-0.097352,0,0
7,GO MUSCLE STRUCTURE DEVELOPMENT,0.26471,-0.076265,-0.044166,0,0
7,GO MACROPHAGE APOPTOTIC PROCESS,0.23937,-0.076354,-0.11156,0,0
7,GO C21 STEROID HORMONE METABOLIC PROCESS,0.73628,-0.076401,-0.039505,0,0
7,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.054842,-0.07643,-0.15544,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.095625,-0.07647,-0.10289,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.12689,-0.076498,-0.13407,0,0
7,GO PROTEIN ACTIVATION CASCADE,0.2,-0.076631,-0.14989,0,0
7,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.89215,-0.076963,0.025407,0,0
7,GO ACTIVATION OF JNKK ACTIVITY,0.40349,-0.076983,-0.051261,0,0
7,GO LYMPHANGIOGENESIS,0.39371,-0.077073,-0.063804,0,0
7,GO PEPTIDE BIOSYNTHETIC PROCESS,0.073629,-0.077093,-0.093736,0,0
7,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.092194,-0.077103,-0.089874,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION,0.16294,-0.077113,-0.11192,0,0
7,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.16294,-0.077347,-0.12393,0,0
7,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.085627,-0.077363,-0.16072,0,0
7,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.70355,-0.077416,-0.051404,0,0
7,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.099158,-0.07753,-0.073875,0,0
7,GO SEGMENTATION,0.23937,-0.077572,-0.057597,0,0
7,GO CHEMOKINE PRODUCTION,0.10465,-0.077619,-0.11952,0,0
7,GO REGENERATION,0.20621,-0.077692,-0.06293,0,0
7,GO REGULATION OF INNATE IMMUNE RESPONSE,0.18508,-0.077728,-0.078076,0,0
7,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.24288,-0.077747,-0.064721,0,0
7,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.4545,-0.077835,-0.03666,0,0
7,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.21256,-0.077903,-0.14346,0,0
7,GO SNRNA METABOLIC PROCESS,0.64605,-0.077936,-0.0090797,0,0
7,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.76281,-0.078032,-0.028419,0,0
7,GO REGULATION OF GLUCONEOGENESIS,0.11841,-0.078129,-0.067569,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.16828,-0.078202,-0.10977,0,0
7,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.66501,-0.07834,-0.0069746,0,0
7,GO APOPTOTIC CELL CLEARANCE,0.36526,-0.078349,-0.11729,0,0
7,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.93377,-0.078447,-0.031336,0,0
7,GO ACTIN FILAMENT BASED TRANSPORT,0.29184,-0.078582,-0.085177,0,0
7,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.60272,-0.078593,-0.027247,0,0
7,GO ARACHIDONIC ACID SECRETION,0.076492,-0.078596,-0.089368,0,0
7,GO NATURAL KILLER CELL ACTIVATION,0.061812,-0.078629,-0.11049,0,0
7,GO PRENYLATION,0.72969,-0.07871,-0.0040584,0,0
7,GO VASCULOGENESIS,0.188,-0.078752,-0.12677,0,0
7,GO REGULATION OF DEFENSE RESPONSE,0.14048,-0.078761,-0.079614,0,0
7,GO MUSCLE CELL DIFFERENTIATION,0.20937,-0.078883,-0.056246,0,0
7,GO MYOFIBRIL ASSEMBLY,0.66501,-0.078957,-0.0090273,0,0
7,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.05161,-0.078966,-0.09195,0,0
7,GO CELLULAR RESPONSE TO MANGANESE ION,0.48131,-0.079062,-0.046735,0,0
7,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.19393,-0.079093,-0.11143,0,0
7,GO APICAL PROTEIN LOCALIZATION,0.46512,-0.079157,-0.036111,0,0
7,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.41842,-0.07927,-0.11949,0,0
7,GO GTP METABOLIC PROCESS,0.32938,-0.07929,-0.082338,0,0
7,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.13355,-0.079326,-0.059988,0,0
7,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.097379,-0.079347,-0.10128,0,0
7,GO POSITIVE REGULATION OF CELL KILLING,0.27999,-0.079458,-0.079918,0,0
7,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.17099,-0.079464,-0.070242,0,0
7,GO REGULATION OF DEACETYLASE ACTIVITY,0.19695,-0.079493,-0.099667,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.077957,-0.079504,-0.06542,0,0
7,GO VESICLE CARGO LOADING,0.085627,-0.079526,-0.1096,0,0
7,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.29586,-0.079532,-0.069143,0,0
7,GO REGULATION OF MITOCHONDRIAL FUSION,0.63354,-0.079633,-0.04574,0,0
7,GO AMINO SUGAR CATABOLIC PROCESS,0.090515,-0.079792,-0.13571,0,0
7,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.14285,-0.079989,-0.10172,0,0
7,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.29184,-0.080099,-0.076022,0,0
7,GO OTIC VESICLE DEVELOPMENT,0.77618,-0.080122,-0.043306,0,0
7,GO MYELOID CELL APOPTOTIC PROCESS,0.099158,-0.080219,-0.12788,0,0
7,GO ACTIN FILAMENT DEPOLYMERIZATION,0.33812,-0.080372,-0.056255,0,0
7,GO TEMPERATURE HOMEOSTASIS,0.53742,-0.080491,-0.021969,0,0
7,GO T CELL LINEAGE COMMITMENT,0.10654,-0.080575,-0.068687,0,0
7,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.21256,-0.080605,-0.10392,0,0
7,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.41842,-0.080638,-0.07099,0,0
7,GO REGULATION OF T CELL DIFFERENTIATION,0.061812,-0.080686,-0.091565,0,0
7,GO ENDOTHELIAL CELL CHEMOTAXIS,0.60272,-0.080693,-0.06778,0,0
7,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.25363,-0.080866,-0.13642,0,0
7,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.86455,-0.08091,0.052543,0,0
7,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.15773,-0.081002,-0.22667,0,0
7,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.20621,-0.081002,-0.10332,0,0
7,GO BLASTOCYST FORMATION,0.099158,-0.081037,-0.10182,0,0
7,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.075049,-0.081081,-0.12364,0,0
7,GO FATTY ACID HOMEOSTASIS,0.1313,-0.081157,-0.15222,0,0
7,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.2839,-0.081214,-0.061125,0,0
7,GO KINETOCHORE ASSEMBLY,0.24288,-0.081365,-0.08736,0,0
7,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.13355,-0.081451,-0.10813,0,0
7,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.18219,-0.081458,-0.072704,0,0
7,GO POSITIVE CHEMOTAXIS,0.1313,-0.081667,-0.093732,0,0
7,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.188,-0.081915,-0.11948,0,0
7,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.76948,-0.082002,-0.022153,0,0
7,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.23589,-0.082047,-0.083326,0,0
7,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.16294,-0.082099,-0.065532,0,0
7,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.090515,-0.082219,-0.076029,0,0
7,GO MACROMOLECULE DEPALMITOYLATION,0.070855,-0.082251,-0.099527,0,0
7,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.5726,-0.082313,-0.060782,0,0
7,GO AMINO ACID IMPORT,0.057089,-0.082328,-0.14245,0,0
7,GO REGULATION OF GONAD DEVELOPMENT,0.11235,-0.082421,-0.12453,0,0
7,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.24643,-0.082441,-0.106,0,0
7,GO EXCRETION,0.13355,-0.082529,-0.077521,0,0
7,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.23937,-0.082563,-0.042513,0,0
7,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.12473,-0.082608,-0.14742,0,0
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.14526,-0.082617,-0.15392,0,0
7,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.22235,-0.08265,-0.053318,0,0
7,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.21579,-0.08268,-0.053414,0,0
7,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.11235,-0.082722,-0.12901,0,0
7,GO RESPONSE TO RETINOIC ACID,0.095625,-0.082725,-0.083649,0,0
7,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.188,-0.082808,-0.057296,0,0
7,GO SNRNA PROCESSING,0.58456,-0.082849,0.0045731,0,0
7,GO TISSUE REMODELING,0.26471,-0.083037,-0.089569,0,0
7,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.23245,-0.08324,-0.13906,0,0
7,GO MUSCLE CELL DEVELOPMENT,0.20309,-0.083281,-0.061213,0,0
7,GO RESPONSE TO CADMIUM ION,0.18508,-0.083437,-0.12776,0,0
7,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.11841,-0.083471,-0.10622,0,0
7,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.80312,-0.083492,-0.038958,0,0
7,GO TRNA TRANSPORT,0.14769,-0.083577,-0.077792,0,0
7,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.18219,-0.083605,-0.17164,0,0
7,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.14526,-0.083701,-0.11211,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.087232,-0.083903,-0.18812,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.17653,-0.084193,-0.076113,0,0
7,GO CYTOKINE PRODUCTION,0.35607,-0.084734,-0.071383,0,0
7,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.43883,-0.084775,-0.075411,0,0
7,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.12473,-0.084816,-0.063099,0,0
7,GO REGULATION OF POSITIVE CHEMOTAXIS,0.31232,-0.084849,-0.071672,0,0
7,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.05824,-0.084862,-0.12927,0,0
7,GO NOREPINEPHRINE TRANSPORT,0.35607,-0.085075,-0.051774,0,0
7,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.91987,-0.085208,0.0099995,0,0
7,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.25729,-0.085248,-0.10727,0,0
7,GO RESPONSE TO LEAD ION,0.56666,-0.085792,-0.031791,0,0
7,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.16559,-0.085932,-0.057326,0,0
7,GO DIGESTIVE SYSTEM PROCESS,0.17653,-0.085963,-0.062656,0,0
7,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.073629,-0.086166,-0.084757,0,0
7,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.059411,-0.086487,-0.17677,0,0
7,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.049546,-0.086503,-0.099144,0,0
7,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.32938,-0.086584,-0.071112,0,0
7,GO INTERLEUKIN 1 BETA PRODUCTION,0.37932,-0.086729,-0.085501,0,0
7,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.093897,-0.086878,-0.10077,0,0
7,GO IMMATURE B CELL DIFFERENTIATION,0.55487,-0.087059,-0.034404,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.48678,-0.087098,-0.052278,0,0
7,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.48678,-0.08713,-0.039429,0,0
7,GO RESPONSE TO STEROID HORMONE,0.10845,-0.08717,-0.077345,0,0
7,GO REGULATION OF KIDNEY DEVELOPMENT,0.27611,-0.087354,-0.083269,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.48678,-0.087364,-0.068773,0,0
7,GO KERATINOCYTE PROLIFERATION,0.22568,-0.087398,-0.12501,0,0
7,GO RESPONSE TO INTERFERON GAMMA,0.19393,-0.087417,-0.14209,0,0
7,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.12259,-0.087468,-0.065354,0,0
7,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.31653,-0.087503,-0.094672,0,0
7,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.46512,-0.087682,-0.031281,0,0
7,GO ASTRAL MICROTUBULE ORGANIZATION,0.33373,-0.08775,-0.057962,0,0
7,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.38408,-0.087797,-0.086862,0,0
7,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.27611,-0.08781,-0.064743,0,0
7,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.060602,-0.087886,-0.11665,0,0
7,GO LYMPHOCYTE APOPTOTIC PROCESS,0.31653,-0.087907,-0.073884,0,0
7,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.05824,-0.087955,-0.11495,0,0
7,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.13583,-0.087978,-0.10846,0,0
7,GO GAP JUNCTION ASSEMBLY,0.13583,-0.088286,-0.18913,0,0
7,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.16559,-0.088331,-0.063158,0,0
7,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.16828,-0.088747,-0.17982,0,0
7,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.2839,-0.088758,-0.087708,0,0
7,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.092194,-0.08883,-0.15535,0,0
7,GO DEFENSE RESPONSE,0.15517,-0.088891,-0.081966,0,0
7,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.56666,-0.088939,-0.02602,0,0
7,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.27227,-0.089175,-0.098428,0,0
7,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.62732,-0.089196,-0.027801,0,0
7,GO REGULATION OF RENAL SYSTEM PROCESS,0.32938,-0.089372,-0.081521,0,0
7,GO PRO B CELL DIFFERENTIATION,0.27611,-0.089525,-0.10518,0,0
7,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.32506,-0.08958,-0.13732,0,0
7,GO REGULATION OF HISTONE H4 ACETYLATION,0.18219,-0.089606,-0.07825,0,0
7,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.17653,-0.089612,-0.13006,0,0
7,GO CENTROMERE COMPLEX ASSEMBLY,0.12049,-0.089626,-0.084286,0,0
7,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.15015,-0.089727,-0.13151,0,0
7,GO REGULATION OF CHLORIDE TRANSPORT,0.38888,-0.089851,-0.096142,0,0
7,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.05161,-0.089891,-0.090796,0,0
7,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.33812,-0.090112,-0.095183,0,0
7,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.059411,-0.090141,-0.11388,0,0
7,GO ONE CARBON METABOLIC PROCESS,0.095625,-0.090202,-0.10278,0,0
7,GO REGULATION OF SYMBIOTIC PROCESS,0.053746,-0.090255,-0.14404,0,0
7,GO MONOCYTE CHEMOTAXIS,0.64605,-0.0903,-0.050719,0,0
7,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.39371,-0.09038,-0.060133,0,0
7,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.15264,-0.090447,-0.09541,0,0
7,GO INSEMINATION,0.23937,-0.09054,-0.086978,0,0
7,GO GLUTATHIONE METABOLIC PROCESS,0.4545,-0.090544,-0.056845,0,0
7,GO BLOOD VESSEL REMODELING,0.2,-0.09065,-0.11583,0,0
7,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.076492,-0.090734,-0.12964,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.10096,-0.091031,-0.13178,0,0
7,GO RESPONSE TO PROGESTERONE,0.10654,-0.091062,-0.13332,0,0
7,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.5726,-0.0912,-0.12186,0,0
7,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.61497,-0.091318,-0.076673,0,0
7,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.25729,-0.091398,-0.053557,0,0
7,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.69061,-0.091432,-0.030231,0,0
7,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.066855,-0.091451,-0.12552,0,0
7,GO CELLULAR RESPONSE TO HEAT,0.21579,-0.091541,-0.057004,0,0
7,GO LEUKOCYTE MEDIATED IMMUNITY,0.066855,-0.091578,-0.10907,0,0
7,GO ELECTRON TRANSPORT CHAIN,0.26847,-0.091704,-0.060735,0,0
7,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.62113,-0.091704,-0.045765,0,0
7,GO LENS FIBER CELL DEVELOPMENT,0.22905,-0.091758,-0.11535,0,0
7,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.16828,-0.091945,-0.089967,0,0
7,GO AMIDE BIOSYNTHETIC PROCESS,0.055956,-0.092021,-0.083856,0,0
7,GO FATTY ACID DERIVATIVE TRANSPORT,0.1028,-0.09216,-0.082223,0,0
7,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.1313,-0.092335,-0.076336,0,0
7,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.12049,-0.09248,-0.097105,0,0
7,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.084046,-0.092524,-0.14649,0,0
7,GO OSTEOBLAST DEVELOPMENT,0.22905,-0.092597,-0.10025,0,0
7,GO TRNA METABOLIC PROCESS,0.4545,-0.092664,-0.038071,0,0
7,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.92682,-0.092699,-0.0044601,0,0
7,GO REGULATION OF CHROMATIN BINDING,0.22905,-0.092947,-0.055247,0,0
7,GO DENDRITIC CELL MIGRATION,0.16294,-0.09298,-0.10709,0,0
7,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.13583,-0.093186,-0.10468,0,0
7,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.12689,-0.093254,-0.10453,0,0
7,GO TRNA PROCESSING,0.50337,-0.093283,-0.035446,0,0
7,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.23245,-0.093574,-0.15818,0,0
7,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.50337,-0.093587,-0.050243,0,0
7,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.12473,-0.094081,-0.11862,0,0
7,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.15264,-0.094269,-0.21488,0,0
7,GO DECIDUALIZATION,0.79636,-0.094289,-0.012418,0,0
7,GO MOVEMENT IN HOST ENVIRONMENT,0.16032,-0.094531,-0.13197,0,0
7,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.10465,-0.094683,-0.11194,0,0
7,GO LYMPHOCYTE MEDIATED IMMUNITY,0.24643,-0.094816,-0.091605,0,0
7,GO PEPTIDE METABOLIC PROCESS,0.12049,-0.094884,-0.073382,0,0
7,GO RESPONSE TO SALT,0.13583,-0.094906,-0.080423,0,0
7,GO IMMUNE RESPONSE TO TUMOR CELL,0.15015,-0.094995,-0.16283,0,0
7,GO INOSITOL METABOLIC PROCESS,0.13355,-0.095132,-0.094002,0,0
7,GO CARNITINE METABOLIC PROCESS,0.33812,-0.095528,-0.098673,0,0
7,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.24643,-0.095734,-0.089596,0,0
7,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.24288,-0.095937,-0.077485,0,0
7,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.087232,-0.096159,-0.13583,0,0
7,GO CYTOCHROME COMPLEX ASSEMBLY,0.4598,-0.09624,-0.050906,0,0
7,GO TRNA MODIFICATION,0.15015,-0.096256,-0.078472,0,0
7,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.59664,-0.096283,-0.031197,0,0
7,GO IRON COORDINATION ENTITY TRANSPORT,0.79636,-0.096538,-0.023129,0,0
7,GO BICARBONATE TRANSPORT,0.2,-0.096578,-0.07381,0,0
7,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.29992,-0.096615,-0.093246,0,0
7,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.21256,-0.096788,-0.092776,0,0
7,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.24288,-0.096893,-0.11805,0,0
7,GO L ASCORBIC ACID METABOLIC PROCESS,0.39858,-0.096973,-0.098196,0,0
7,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.1028,-0.097147,-0.059294,0,0
7,GO PROGRAMMED NECROTIC CELL DEATH,0.17099,-0.097256,-0.11173,0,0
7,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.36991,-0.097378,-0.075972,0,0
7,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.066855,-0.097383,-0.11872,0,0
7,GO MANGANESE ION TRANSPORT,0.070855,-0.097386,-0.10471,0,0
7,GO MUSCLE CELL PROLIFERATION,0.15773,-0.097739,-0.078048,0,0
7,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.068167,-0.097781,-0.17704,0,0
7,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.11841,-0.097825,-0.090389,0,0
7,GO MYOBLAST FUSION,0.20309,-0.097864,-0.11137,0,0
7,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.29992,-0.0979,-0.048869,0,0
7,GO CELLULAR RESPONSE TO FATTY ACID,0.38408,-0.098158,-0.070908,0,0
7,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.14285,-0.098234,-0.089556,0,0
7,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.12908,-0.098278,-0.11275,0,0
7,GO ACTIN FILAMENT SEVERING,0.25001,-0.098484,-0.1386,0,0
7,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.095625,-0.098494,-0.16374,0,0
7,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.057089,-0.098859,-0.13054,0,0
7,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.83713,-0.098887,0.093438,0,0
7,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.40843,-0.098912,-0.091181,0,0
7,GO NUCLEOSIDE METABOLIC PROCESS,0.26471,-0.098986,-0.055442,0,0
7,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.19695,-0.099018,-0.16675,0,0
7,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.37932,-0.099124,-0.15383,0,0
7,GO LYMPH VESSEL DEVELOPMENT,0.25363,-0.099143,-0.092931,0,0
7,GO CELLULAR RESPIRATION,0.24288,-0.099223,-0.063382,0,0
7,GO RIBOSOME BIOGENESIS,0.2839,-0.099398,-0.099705,0,0
7,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.057089,-0.099439,-0.1475,0,0
7,GO RESPONSE TO SALT STRESS,0.14285,-0.099455,-0.10374,0,0
7,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.10465,-0.099703,-0.21831,0,0
7,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.085627,-0.09988,-0.098397,0,0
7,GO IMMUNE EFFECTOR PROCESS,0.14285,-0.099895,-0.10246,0,0
7,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.15264,-0.099903,-0.13653,0,0
7,GO RETINAL METABOLIC PROCESS,0.31653,-0.10024,-0.17354,0,0
7,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.082489,-0.10039,-0.090878,0,0
7,GO HEPARIN METABOLIC PROCESS,0.3746,-0.10053,-0.11805,0,0
7,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.22235,-0.10085,-0.13068,0,0
7,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.072231,-0.10085,-0.14849,0,0
7,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.35607,-0.10113,-0.082128,0,0
7,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.54321,-0.10115,-0.044527,0,0
7,GO REGULATION OF GTP BINDING,0.15773,-0.1012,-0.11092,0,0
7,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.17099,-0.10141,-0.062422,0,0
7,GO TORC1 SIGNALING,0.059411,-0.10147,-0.063132,0,0
7,GO RESPONSE TO CORTICOSTERONE,0.95466,-0.10158,-0.015339,0,0
7,GO AMINO ACID ACTIVATION,0.7495,-0.10159,-0.032094,0,0
7,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.18219,-0.10163,-0.074991,0,0
7,GO MUSCLE CELL APOPTOTIC PROCESS,0.2,-0.10172,-0.062923,0,0
7,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.3746,-0.10173,-0.023479,0,0
7,GO SOMITE DEVELOPMENT,0.11039,-0.10191,-0.076598,0,0
7,GO CELL AGING,0.085627,-0.10194,-0.083841,0,0
7,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.17653,-0.10255,-0.07252,0,0
7,GO RESPONSE TO OSMOTIC STRESS,0.05161,-0.1029,-0.11172,0,0
7,GO MODULATION BY HOST OF VIRAL PROCESS,0.095625,-0.10298,-0.14576,0,0
7,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.17934,-0.10308,-0.10572,0,0
7,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.097379,-0.10324,-0.22935,0,0
7,GO MATURE B CELL DIFFERENTIATION,0.14285,-0.10333,-0.15251,0,0
7,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.15015,-0.10336,-0.097146,0,0
7,GO MIDBODY ABSCISSION,0.54903,-0.10341,0.0066285,0,0
7,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.90599,-0.10342,-0.017534,0,0
7,GO STEROID METABOLIC PROCESS,0.073629,-0.10374,-0.093288,0,0
7,GO MYELIN ASSEMBLY,0.17374,-0.10378,-0.11395,0,0
7,GO SMOOTH MUSCLE CELL PROLIFERATION,0.092194,-0.10389,-0.1084,0,0
7,GO ACYLGLYCEROL HOMEOSTASIS,0.072231,-0.10421,-0.1204,0,0
7,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.077957,-0.10436,-0.11131,0,0
7,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.063042,-0.10437,-0.10718,0,0
7,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.15015,-0.10443,-0.16227,0,0
7,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.16559,-0.10477,-0.10918,0,0
7,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.26847,-0.105,-0.079811,0,0
7,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.2839,-0.10502,-0.073776,0,0
7,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.15773,-0.10504,-0.14574,0,0
7,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.61497,-0.10514,-0.068859,0,0
7,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.053746,-0.10539,-0.17081,0,0
7,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.10845,-0.10552,-0.13672,0,0
7,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.21579,-0.10589,-0.082264,0,0
7,GO APICAL JUNCTION ASSEMBLY,0.20309,-0.10609,-0.084885,0,0
7,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.22568,-0.10613,-0.087063,0,0
7,GO ERYTHROCYTE HOMEOSTASIS,0.061812,-0.10636,-0.082541,0,0
7,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.080955,-0.10639,-0.19176,0,0
7,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.05824,-0.10639,-0.098482,0,0
7,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.064293,-0.10654,-0.17385,0,0
7,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.10654,-0.10657,-0.08658,0,0
7,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.32077,-0.1066,-0.10871,0,0
7,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.33812,-0.10675,-0.06737,0,0
7,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.12049,-0.10683,-0.077912,0,0
7,GO POSITIVE REGULATION OF BONE RESORPTION,0.052669,-0.10685,-0.18093,0,0
7,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.29586,-0.10699,-0.086107,0,0
7,GO CELL REDOX HOMEOSTASIS,0.20937,-0.10703,-0.090735,0,0
7,GO PLASMA MEMBRANE FUSION,0.21905,-0.10704,-0.095092,0,0
7,GO REGULATION OF NUCLEASE ACTIVITY,0.33812,-0.10706,-0.061144,0,0
7,GO RNA SURVEILLANCE,0.15517,-0.10708,-0.091371,0,0
7,GO SARCOMERE ORGANIZATION,0.32506,-0.10721,-0.050024,0,0
7,GO LEUKOCYTE APOPTOTIC PROCESS,0.11636,-0.1075,-0.10385,0,0
7,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.11636,-0.10752,-0.20685,0,0
7,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.017137,-0.10756,-0.17293,0,0
7,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.21256,-0.10775,-0.115,0,0
7,GO METHIONINE BIOSYNTHETIC PROCESS,0.072231,-0.10778,-0.14407,0,0
7,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.52594,-0.10781,-0.11545,0,0
7,GO ETHER BIOSYNTHETIC PROCESS,0.24643,-0.10782,-0.1305,0,0
7,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.060602,-0.1079,-0.13633,0,0
7,GO CELLULAR LIPID CATABOLIC PROCESS,0.053746,-0.10807,-0.09503,0,0
7,GO RESPONSE TO LEUCINE,0.10845,-0.10813,-0.13353,0,0
7,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.055956,-0.10824,-0.13722,0,0
7,GO CYTOPLASM ORGANIZATION,0.39858,-0.10827,-0.097713,0,0
7,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.1313,-0.10842,-0.063657,0,0
7,GO REGULATION OF FLAGELLATED SPERM MOTILITY,0.26098,-0.1087,-0.071719,0,0
7,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.27227,-0.10875,-0.15804,0,0
7,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.16559,-0.1089,-0.076946,0,0
7,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.095625,-0.10907,-0.10294,0,0
7,GO STEROID ESTERIFICATION,0.24288,-0.10938,-0.1585,0,0
7,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.85768,-0.10948,-0.0026339,0,0
7,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.053746,-0.10967,-0.11898,0,0
7,GO POLYAMINE BIOSYNTHETIC PROCESS,0.17934,-0.10968,-0.095841,0,0
7,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.10654,-0.10969,-0.11002,0,0
7,GO HYPEROSMOTIC RESPONSE,0.4598,-0.11006,-0.051209,0,0
7,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.44924,-0.11018,-0.063161,0,0
7,GO CELLULAR RESPONSE TO SALT STRESS,0.079444,-0.11046,-0.16632,0,0
7,GO MATURATION OF 5 8S RRNA,0.23589,-0.11054,-0.097217,0,0
7,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.15773,-0.11065,-0.10449,0,0
7,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.079444,-0.11069,-0.14078,0,0
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.27227,-0.1107,-0.16199,0,0
7,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.095625,-0.11074,-0.10332,0,0
7,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.095625,-0.11082,-0.099784,0,0
7,GO REGULATION OF MITOCHONDRIAL FISSION,0.04854,-0.11087,-0.10154,0,0
7,GO TONIC SMOOTH MUSCLE CONTRACTION,0.063042,-0.11102,-0.17917,0,0
7,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.19695,-0.11115,-0.14188,0,0
7,GO PHAGOSOME ACIDIFICATION,0.19393,-0.11115,-0.074515,0,0
7,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.092194,-0.1113,-0.13274,0,0
7,GO NCRNA EXPORT FROM NUCLEUS,0.11434,-0.11136,-0.086307,0,0
7,GO RESPONSE TO FATTY ACID,0.088862,-0.11142,-0.096124,0,0
7,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.59664,-0.11145,-0.033653,0,0
7,GO NEURAL CREST FORMATION,0.36991,-0.11164,-0.080009,0,0
7,GO ENTRY INTO HOST,0.084046,-0.1117,-0.17079,0,0
7,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.049546,-0.11177,-0.12308,0,0
7,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.2839,-0.11179,-0.08112,0,0
7,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.1313,-0.11182,-0.12096,0,0
7,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.13583,-0.11242,-0.093873,0,0
7,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.19695,-0.1126,-0.066677,0,0
7,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.56666,-0.11297,-0.053942,0,0
7,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.25729,-0.11331,-0.10989,0,0
7,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.33373,-0.11336,-0.099636,0,0
7,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.85768,-0.11341,0.00085742,0,0
7,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.04854,-0.11348,-0.16856,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.090515,-0.11367,-0.18923,0,0
7,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.16294,-0.1138,-0.10084,0,0
7,GO HEME METABOLIC PROCESS,0.076492,-0.1139,-0.17315,0,0
7,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.12908,-0.11391,-0.15091,0,0
7,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.54903,-0.11397,-0.092791,0,0
7,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.29184,-0.1141,-0.080247,0,0
7,GO BLASTODERM SEGMENTATION,0.44402,-0.11413,-0.068124,0,0
7,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.11841,-0.11478,-0.18811,0,0
7,GO REGULATION OF SENSORY PERCEPTION,0.29184,-0.11482,-0.05003,0,0
7,GO BONE GROWTH,0.48678,-0.11507,-0.067075,0,0
7,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.29992,-0.11549,-0.099693,0,0
7,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.16032,-0.11574,-0.095065,0,0
7,GO INTERLEUKIN 1 PRODUCTION,0.20621,-0.11586,-0.11909,0,0
7,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.26098,-0.11591,-0.12708,0,0
7,GO INTERACTION WITH HOST,0.068167,-0.11595,-0.12302,0,0
7,GO HIPPO SIGNALING,0.15015,-0.11626,-0.15383,0,0
7,GO MITOCHONDRIAL GENOME MAINTENANCE,0.10845,-0.11673,-0.077575,0,0
7,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.099158,-0.11678,-0.11537,0,0
7,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.16828,-0.11701,-0.11105,0,0
7,GO ALDITOL PHOSPHATE METABOLIC PROCESS,0.24643,-0.11704,-0.14301,0,0
7,GO NEGATIVE REGULATION OF LIPID STORAGE,0.059411,-0.11709,-0.14239,0,0
7,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.060602,-0.1173,-0.1172,0,0
7,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.33373,-0.11735,-0.081317,0,0
7,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.080955,-0.11737,-0.10212,0,0
7,GO BEHAVIORAL RESPONSE TO PAIN,0.41341,-0.11737,-0.070894,0,0
7,GO RESPONSE TO MURAMYL DIPEPTIDE,0.37932,-0.11739,-0.070243,0,0
7,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.097379,-0.11751,-0.18228,0,0
7,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.18508,-0.1176,-0.12091,0,0
7,GO TRANSFERRIN TRANSPORT,0.14769,-0.11789,-0.072389,0,0
7,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.39371,-0.11806,-0.056636,0,0
7,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.24288,-0.11824,-0.093447,0,0
7,GO OXIDATIVE PHOSPHORYLATION,0.23589,-0.11855,-0.066275,0,0
7,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.14769,-0.11866,-0.14163,0,0
7,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.16032,-0.11868,-0.088163,0,0
7,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.082489,-0.11868,-0.1557,0,0
7,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.076492,-0.1188,-0.15093,0,0
7,GO REGULATION OF LIPID STORAGE,0.085627,-0.11884,-0.096916,0,0
7,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.095625,-0.11884,-0.11851,0,0
7,GO DIOL BIOSYNTHETIC PROCESS,0.085627,-0.11915,-0.12374,0,0
7,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.67776,-0.11936,-0.0014456,0,0
7,GO KERATAN SULFATE CATABOLIC PROCESS,0.14048,-0.1194,-0.1582,0,0
7,GO RESPIRATORY BURST,0.052669,-0.11952,-0.13702,0,0
7,GO PROGESTERONE METABOLIC PROCESS,0.39858,-0.11965,-0.10417,0,0
7,GO RESPONSE TO HYDROXYUREA,0.46512,-0.11972,-0.025352,0,0
7,GO SEGMENT SPECIFICATION,0.054842,-0.11996,-0.18828,0,0
7,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.097379,-0.1203,-0.10443,0,0
7,GO SEX DETERMINATION,0.068167,-0.12077,-0.12209,0,0
7,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.29184,-0.12077,-0.1061,0,0
7,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.04854,-0.1209,-0.14075,0,0
7,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.079444,-0.12112,-0.22414,0,0
7,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.072231,-0.12197,-0.10413,0,0
7,GO REGULATION OF METANEPHROS DEVELOPMENT,0.077957,-0.12202,-0.22879,0,0
7,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.4545,-0.12213,-0.091955,0,0
7,GO NEGATIVE REGULATION OF TOR SIGNALING,0.070855,-0.12214,-0.073496,0,0
7,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.23245,-0.12253,-0.17103,0,0
7,GO NADPH REGENERATION,0.21256,-0.12271,-0.12416,0,0
7,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.099158,-0.12288,-0.16468,0,0
7,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.065563,-0.12295,-0.1597,0,0
7,GO MUSCLE CELL FATE COMMITMENT,0.11434,-0.12302,-0.16527,0,0
7,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.18508,-0.12316,-0.084113,0,0
7,GO CELLULAR RESPONSE TO LITHIUM ION,0.11636,-0.12374,-0.1255,0,0
7,GO PROSTANOID METABOLIC PROCESS,0.29184,-0.12376,-0.12946,0,0
7,GO BASE EXCISION REPAIR AP SITE FORMATION,0.19393,-0.12391,-0.076258,0,0
7,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.072231,-0.12402,-0.11989,0,0
7,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.076492,-0.12423,-0.12582,0,0
7,GO DENDRITIC CELL CHEMOTAXIS,0.32077,-0.12443,-0.085059,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.14526,-0.12471,-0.11212,0,0
7,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.19095,-0.12514,-0.13126,0,0
7,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.052669,-0.12538,-0.15716,0,0
7,GO PROTEIN TARGETING TO MEMBRANE,0.092194,-0.12609,-0.11754,0,0
7,GO CELLULAR RESPONSE TO ETHANOL,0.23937,-0.12629,-0.11821,0,0
7,GO AMMONIUM TRANSPORT,0.063042,-0.12649,-0.14061,0,0
7,GO MATURATION OF SSU RRNA,0.27999,-0.12655,-0.10676,0,0
7,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.32077,-0.12661,-0.041358,0,0
7,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.14769,-0.12758,-0.14976,0,0
7,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.27611,-0.12763,-0.11491,0,0
7,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.10654,-0.12778,-0.11005,0,0
7,GO HYALURONAN BIOSYNTHETIC PROCESS,0.15773,-0.12781,-0.092038,0,0
7,GO REGULATION OF GLOMERULAR FILTRATION,0.40843,-0.12809,-0.12332,0,0
7,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.057089,-0.1281,-0.1001,0,0
7,GO SALIVARY GLAND DEVELOPMENT,0.78962,-0.12814,-0.067615,0,0
7,GO GONADOTROPIN SECRETION,0.25729,-0.12819,-0.12145,0,0
7,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.12689,-0.12823,-0.11906,0,0
7,GO NAD BIOSYNTHETIC PROCESS,0.27227,-0.12848,-0.049205,0,0
7,GO NATURAL KILLER CELL DIFFERENTIATION,0.20621,-0.12866,-0.068202,0,0
7,GO DETECTION OF BIOTIC STIMULUS,0.080955,-0.1287,-0.16556,0,0
7,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.17374,-0.12893,-0.095857,0,0
7,GO REGULATION OF TRANSLATIONAL TERMINATION,0.12259,-0.12895,-0.11927,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0695,-0.12896,-0.2066,0,0
7,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.14285,-0.12905,-0.13173,0,0
7,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.79636,-0.12955,-0.034878,0,0
7,GO LIPID IMPORT INTO CELL,0.33373,-0.1296,-0.076786,0,0
7,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.05824,-0.13003,-0.11133,0,0
7,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.4545,-0.13004,-0.049137,0,0
7,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.18508,-0.13011,-0.13547,0,0
7,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.064293,-0.13016,-0.1201,0,0
7,GO PROSTANOID BIOSYNTHETIC PROCESS,0.29184,-0.13099,-0.13052,0,0
7,GO ENAMEL MINERALIZATION,0.39858,-0.13102,-0.076883,0,0
7,GO ELASTIC FIBER ASSEMBLY,0.62113,-0.13127,-0.090467,0,0
7,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.11235,-0.13139,-0.11034,0,0
7,GO NOREPINEPHRINE SECRETION,0.22905,-0.13141,-0.10168,0,0
7,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.30402,-0.13145,-0.084187,0,0
7,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.36526,-0.1315,-0.051617,0,0
7,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.084046,-0.13155,-0.11581,0,0
7,GO AMINOGLYCAN METABOLIC PROCESS,0.19095,-0.13156,-0.088863,0,0
7,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.33373,-0.13163,-0.11542,0,0
7,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.29184,-0.13193,-0.06405,0,0
7,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.24643,-0.13207,-0.13295,0,0
7,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.070855,-0.13228,-0.22572,0,0
7,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.188,-0.13247,-0.082556,0,0
7,GO MUCUS SECRETION,0.38408,-0.13261,-0.16851,0,0
7,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29184,-0.13315,-0.14793,0,0
7,GO ANOIKIS,0.10845,-0.13316,-0.14376,0,0
7,GO PIGMENT METABOLIC PROCESS,0.087232,-0.13363,-0.099955,0,0
7,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.19393,-0.13372,-0.08747,0,0
7,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.16559,-0.13374,-0.12257,0,0
7,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.077957,-0.13376,-0.15527,0,0
7,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.060602,-0.13377,-0.21618,0,0
7,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.62732,-0.13378,-0.064596,0,0
7,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.04854,-0.13434,-0.13591,0,0
7,GO ATP METABOLIC PROCESS,0.084046,-0.13444,-0.06843,0,0
7,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.31653,-0.13458,-0.11537,0,0
7,GO GOLGI TO ENDOSOME TRANSPORT,0.075049,-0.13471,-0.11347,0,0
7,GO MONONUCLEAR CELL DIFFERENTIATION,0.061812,-0.13475,-0.13747,0,0
7,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.13814,-0.13495,-0.1087,0,0
7,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.088862,-0.13521,-0.12887,0,0
7,GO GLAND MORPHOGENESIS,0.065563,-0.13545,-0.15847,0,0
7,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.00014418,-0.13576,-0.14419,0,0
7,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.10845,-0.13607,-0.11844,0,0
7,GO DENDRITIC SPINE MAINTENANCE,0.17653,-0.13608,-0.092311,0,0
7,GO RESPONSE TO ACIDIC PH,0.35153,-0.1362,-0.075574,0,0
7,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.10845,-0.13631,-0.21568,0,0
7,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.068167,-0.13673,-0.2027,0,0
7,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.13814,-0.13692,-0.13285,0,0
7,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.84397,-0.13718,-0.064003,0,0
7,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.052669,-0.13808,-0.13846,0,0
7,GO THYROID GLAND DEVELOPMENT,0.079444,-0.1381,-0.13147,0,0
7,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.068167,-0.1385,-0.13894,0,0
7,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.32506,-0.13876,-0.15266,0,0
7,GO GERMINAL CENTER FORMATION,0.15773,-0.13902,-0.18837,0,0
7,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.061812,-0.13919,-0.11038,0,0
7,GO PLASMINOGEN ACTIVATION,0.2839,-0.13943,-0.17929,0,0
7,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.76948,-0.13956,-0.050671,0,0
7,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.20621,-0.13973,-0.14498,0,0
7,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.10654,-0.1398,-0.1677,0,0
7,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.12259,-0.13988,-0.20333,0,0
7,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.30402,-0.1405,-0.087514,0,0
7,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.057089,-0.14051,-0.16679,0,0
7,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,0.093897,-0.1406,-0.20976,0,0
7,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.25001,-0.14092,-0.17682,0,0
7,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.12689,-0.14093,-0.094543,0,0
7,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.41842,-0.1411,-0.13221,0,0
7,GO RESPONSE TO MUSCLE ACTIVITY,0.060602,-0.14118,-0.15784,0,0
7,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.29184,-0.14171,-0.1389,0,0
7,GO PROTEIN O LINKED MANNOSYLATION,0.013139,-0.14182,-0.14125,0,0
7,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.23589,-0.14184,-0.089212,0,0
7,GO COLLAGEN CATABOLIC PROCESS,0.13583,-0.14204,-0.13291,0,0
7,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.22905,-0.14224,-0.067888,0,0
7,GO MITOTIC SISTER CHROMATID COHESION,0.20937,-0.14235,-0.065312,0,0
7,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.059411,-0.14239,-0.12706,0,0
7,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.23937,-0.14278,-0.053363,0,0
7,GO AMP METABOLIC PROCESS,0.088862,-0.14292,-0.17395,0,0
7,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.59059,-0.14363,-0.077676,0,0
7,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.097379,-0.14364,-0.090289,0,0
7,GO REGULATION OF HORMONE METABOLIC PROCESS,0.14526,-0.14365,-0.1651,0,0
7,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.090515,-0.14375,-0.19398,0,0
7,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.053746,-0.14386,-0.18385,0,0
7,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.12259,-0.14395,-0.15397,0,0
7,GO SEQUESTERING OF ACTIN MONOMERS,0.4598,-0.1444,0.0073412,0,0
7,GO MATURATION OF LSU RRNA,0.26098,-0.14466,-0.13288,0,0
7,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.1313,-0.14469,-0.11231,0,0
7,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.27611,-0.1451,-0.081037,0,0
7,GO COLLAGEN METABOLIC PROCESS,0.17099,-0.14532,-0.13719,0,0
7,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.14769,-0.14543,-0.15937,0,0
7,GO RIBOSOME ASSEMBLY,0.099158,-0.14561,-0.17788,0,0
7,GO LUNG ALVEOLUS DEVELOPMENT,0.076492,-0.14656,-0.11652,0,0
7,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.17653,-0.14764,-0.12522,0,0
7,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.31232,-0.14781,-0.071667,0,0
7,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.11039,-0.14807,-0.14624,0,0
7,GO NEUTROPHIL HOMEOSTASIS,0.075049,-0.14914,-0.23295,0,0
7,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.010773,-0.14941,-0.16143,0,0
7,GO REGULATION OF SKELETAL MUSCLE CONTRACTION,0.43883,-0.14981,-0.060884,0,0
7,GO MULTI ORGANISM CELLULAR PROCESS,0.065563,-0.15117,-0.18986,0,0
7,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.39858,-0.15118,-0.10405,0,0
7,GO CARDIAC MUSCLE FIBER DEVELOPMENT,0.066855,-0.15172,-0.12239,0,0
7,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.10096,-0.1519,-0.21659,0,0
7,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.16294,-0.15195,-0.089793,0,0
7,GO NEGATIVE REGULATION OF ANOIKIS,0.13814,-0.15196,-0.19886,0,0
7,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.11039,-0.15246,-0.13986,0,0
7,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.059411,-0.15252,-0.20632,0,0
7,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.1028,-0.15284,-0.098512,0,0
7,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.12473,-0.1535,-0.16738,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.093897,-0.15395,-0.1915,0,0
7,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.29184,-0.15409,-0.10159,0,0
7,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.22235,-0.15514,-0.13164,0,0
7,GO LIVER MORPHOGENESIS,0.10654,-0.15542,-0.15526,0,0
7,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.050569,-0.15559,-0.19579,0,0
7,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.90599,-0.15562,0.011123,0,0
7,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.097379,-0.15596,-0.10333,0,0
7,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.065563,-0.156,-0.18989,0,0
7,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0045306,-0.156,-0.17988,0,0
7,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.057089,-0.15616,-0.17191,0,0
7,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0695,-0.15626,-0.13116,0,0
7,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.088862,-0.15648,-0.13266,0,0
7,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.05824,-0.15671,-0.28344,0,0
7,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.61497,-0.15676,-0.078687,0,0
7,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.56075,-0.15684,-0.059934,0,0
7,GO REGULATION OF RESPONSE TO TUMOR CELL,0.053746,-0.15689,-0.14692,0,0
7,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.065563,-0.158,-0.29733,0,0
7,GO REGULATION OF ANOIKIS,0.064293,-0.15845,-0.2123,0,0
7,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.079444,-0.15926,-0.14953,0,0
7,GO XENOBIOTIC CATABOLIC PROCESS,0.65234,-0.15951,-0.061211,0,0
7,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.065563,-0.16004,-0.27875,0,0
7,GO COPPER ION TRANSPORT,0.095625,-0.16023,-0.12345,0,0
7,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.30815,-0.16026,-0.11071,0,0
7,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.085627,-0.16064,-0.15228,0,0
7,GO INTERMEDIATE FILAMENT ORGANIZATION,0.055956,-0.16068,-0.13556,0,0
7,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.052669,-0.16111,-0.22302,0,0
7,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.057089,-0.16141,-0.14476,0,0
7,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.052669,-0.16375,-0.18581,0,0
7,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.077957,-0.16384,-0.16494,0,0
7,GO REGULATION OF ICOSANOID SECRETION,0.088862,-0.16405,-0.1056,0,0
7,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.03245,-0.1641,-0.15877,0,0
7,GO MIDGUT DEVELOPMENT,0.41842,-0.16412,-0.067318,0,0
7,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.073629,-0.16445,-0.16457,0,0
7,GO MAMMARY GLAND MORPHOGENESIS,0.068167,-0.16447,-0.16675,0,0
7,GO URONIC ACID METABOLIC PROCESS,0.16032,-0.16458,-0.042836,0,0
7,GO CELLULAR RESPONSE TO INTERFERON BETA,0.12259,-0.16662,-0.17604,0,0
7,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.05161,-0.16671,-0.13356,0,0
7,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.084046,-0.16688,-0.1564,0,0
7,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0026572,-0.16702,-0.17807,0,0
7,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.11434,-0.16743,-0.2317,0,0
7,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.11636,-0.16744,-0.16616,0,0
7,GO RESPONSE TO UV B,0.064293,-0.16753,-0.13508,0,0
7,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.05824,-0.16766,-0.16916,0,0
7,GO BARBED END ACTIN FILAMENT CAPPING,0.12049,-0.16769,-0.14945,0,0
7,GO KIDNEY MESENCHYME DEVELOPMENT,0.011904,-0.16811,-0.31593,0,0
7,GO CHONDROCYTE PROLIFERATION,0.21905,-0.16846,-0.12649,0,0
7,GO CELLULAR COPPER ION HOMEOSTASIS,0.070855,-0.1695,-0.15551,0,0
7,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.12473,-0.17034,-0.12472,0,0
7,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.16294,-0.17063,-0.11682,0,0
7,GO BRONCHUS DEVELOPMENT,0.48678,-0.17116,0.0097589,0,0
7,GO L SERINE METABOLIC PROCESS,0.27611,-0.17179,-0.14337,0,0
7,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.017549,-0.17253,-0.17054,0,0
7,GO PODOSOME ASSEMBLY,0.057089,-0.17303,-0.13673,0,0
7,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.33373,-0.17328,-0.23858,0,0
7,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.20309,-0.17426,-0.12828,0,0
7,GO L PHENYLALANINE METABOLIC PROCESS,0.23245,-0.17445,-0.11524,0,0
7,GO TETRAHYDROFOLATE INTERCONVERSION,0.33373,-0.1753,-0.10764,0,0
7,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.04854,-0.17614,-0.13319,0,0
7,GO TRANSPOSITION,0.04854,-0.17654,-0.17356,0,0
7,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.084046,-0.17657,-0.26384,0,0
7,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.69707,-0.17761,-0.040773,0,0
7,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.063042,-0.17906,-0.21486,0,0
7,GO LATERAL VENTRICLE DEVELOPMENT,0.17099,-0.17926,-0.10737,0,0
7,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0056288,-0.17936,-0.18729,0,0
7,GO FATTY ACYL COA METABOLIC PROCESS,0.017969,-0.17978,-0.14407,0,0
7,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.054842,-0.17998,-0.19639,0,0
7,GO NEGATIVE REGULATION OF CELL KILLING,0.21256,-0.18031,-0.23432,0,0
7,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.1313,-0.18183,-0.094385,0,0
7,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0695,-0.18218,-0.15488,0,0
7,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.077957,-0.18269,-0.25516,0,0
7,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.11039,-0.1832,-0.14407,0,0
7,GO TRNA CATABOLIC PROCESS,0.50337,-0.1832,-0.1149,0,0
7,GO REGULATION OF PROTON TRANSPORT,0.070855,-0.18398,-0.1359,0,0
7,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.10654,-0.18427,-0.14579,0,0
7,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.29586,-0.18531,-0.097133,0,0
7,GO RESPONSE TO TYPE I INTERFERON,0.0695,-0.18547,-0.26213,0,0
7,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.10465,-0.18653,-0.15114,0,0
7,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.012508,-0.18723,-0.18575,0,0
7,GO ADHESION OF SYMBIONT TO HOST,0.30402,-0.18795,-0.097407,0,0
7,GO TYPE B PANCREATIC CELL PROLIFERATION,0.11434,-0.18836,-0.18243,0,0
7,GO MEMBRANE RAFT ORGANIZATION,0.13814,-0.18901,-0.24276,0,0
7,GO NUCLEAR MIGRATION,0.05824,-0.18926,-0.1278,0,0
7,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.063042,-0.18926,-0.16742,0,0
7,GO COLLAGEN BIOSYNTHETIC PROCESS,0.11841,-0.18958,-0.20261,0,0
7,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.10465,-0.19114,-0.13235,0,0
7,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.36526,-0.19115,-0.13286,0,0
7,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.11039,-0.1913,-0.14677,0,0
7,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.10465,-0.19131,-0.17668,0,0
7,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.15264,-0.19141,-0.14326,0,0
7,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.063042,-0.19181,-0.21935,0,0
7,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.034637,-0.19312,-0.1327,0,0
7,GO RENAL FILTRATION,0.33373,-0.19352,-0.10874,0,0
7,GO CELL ADHESION MEDIATED BY INTEGRIN,0.055956,-0.19501,-0.17775,0,0
7,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.061812,-0.19661,-0.15948,0,0
7,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.15773,-0.19819,-0.09683,0,0
7,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.14769,-0.19834,-0.17566,0,0
7,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.11235,-0.19849,-0.17694,0,0
7,GO ARGININE METABOLIC PROCESS,0.097379,-0.19858,-0.18634,0,0
7,GO FIBROBLAST APOPTOTIC PROCESS,0.10465,-0.20005,-0.12817,0,0
7,GO MIDDLE EAR MORPHOGENESIS,0.010773,-0.20116,-0.23752,0,0
7,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.20937,-0.2055,-0.14803,0,0
7,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.26471,-0.20885,-0.1277,0,0
7,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.088862,-0.20902,-0.19227,0,0
7,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.0064317,-0.20967,-0.24566,0,0
7,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.22235,-0.21105,-0.11271,0,0
7,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.7495,-0.21163,-0.013997,0,0
7,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.16559,-0.21295,-0.22172,0,0
7,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.22235,-0.21451,-0.14878,0,0
7,GO EPITHELIAL CELL MORPHOGENESIS,0.15264,-0.21742,-0.1452,0,0
7,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.087232,-0.21846,-0.23168,0,0
7,GO CYTOPLASMIC TRANSLATION,0.057089,-0.21884,-0.20157,0,0
7,GO NUCLEOTIDE SALVAGE,0.11039,-0.21962,-0.1881,0,0
7,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.054842,-0.22033,-0.20048,0,0
7,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.11434,-0.22229,-0.14754,0,0
7,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.21256,-0.22238,-0.14917,0,0
7,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.13583,-0.22247,-0.22489,0,0
7,GO INTESTINAL LIPID ABSORPTION,0.04854,-0.22287,-0.22777,0,0
7,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.16294,-0.22399,-0.082717,0,0
7,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.00079435,-0.22475,-0.18915,0,0
7,GO TRANSLATIONAL INITIATION,0.053746,-0.22626,-0.17597,0,0
7,GO SEQUESTERING OF TRIGLYCERIDE,0.014486,-0.22789,-0.16474,0,0
7,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.188,-0.22843,-0.18111,0,0
7,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.24288,-0.23558,-0.27618,0,0
7,GO PURINE CONTAINING COMPOUND SALVAGE,0.38888,-0.23731,-0.083361,0,0
7,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0010528,-0.24114,-0.2411,0,0
7,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.063042,-0.24143,-0.18547,0,0
7,GO TONGUE DEVELOPMENT,0.059411,-0.24223,-0.15588,0,0
7,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.15517,-0.24327,-0.17141,0,0
7,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.18508,-0.24378,-0.16399,0,0
7,GO RENAL ABSORPTION,0.073629,-0.25866,-0.2267,0,0
7,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.060602,-0.25944,-0.21488,0,0
7,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.14526,-0.2615,-0.20717,0,0
7,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.11039,-0.26456,-0.36955,0,0
7,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.082489,-0.26623,-0.2056,0,0
7,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.073629,-0.26637,-0.22299,0,0
7,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.021165,-0.27609,-0.26978,0,0
7,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0013872,-0.28369,-0.19832,0,0
7,GO TRIPARTITE REGIONAL SUBDIVISION,0.093897,-0.28544,-0.18226,0,0
7,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.092194,-0.28688,-0.23212,0,0
7,GO NEPHRON TUBULE FORMATION,0.066855,-0.29755,-0.20269,0,0
7,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.013465,-0.298,-0.22247,0,0
7,GO INFLAMMATORY RESPONSE TO WOUNDING,0.12473,-0.31931,-0.25924,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.068167,-0.43262,-0.47335,0,0
7,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.077957,-0.51106,-0.56646,0,0
7,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.00011241,-0.62055,-0.57097,0,0
